Psyllid ID: psy3714

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------
Protein Sequence
MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIVNSVPVVGE
Secondary Structure (PSIPRED)
cHHHHHHHHHHHHHHHcccccccccccccccccccccEEEEcccccccccccccEEEEEEccccccHHHHcccccccccHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccHHHHHHHccccccccHHccccccccccccccccccccccccccccccccccHHHHHHHHcccccccEEEEEEcccccEEEEEccccccHHHHHHHHHHHHcccccccEEEEcEEEccccccccEEEEEEEcccHHHHHHHccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEEEcccccccccccccEEEEEcccccccccccccccccccHHHHHHHHcccccccccccccccccEEccccccccccHHHHcccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHccEEcccccHHHEEEEccccEEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHccHHHHHHHHHccccccHHHHHccccccccccHHHHccHHHHcHHHcccccccHHHEEEEEEEEEcccEEEEEEEEcccccEEEEEEEccccHHHHHHHHHHHHHccccccEccEEEEEEccccccEEEEEEccccccHHHHcccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEccccEEEEccccccEEcccccccccccccHHHccHHHHccccccccccHHHHHHHcccccccHHHHcccccHHHccHHHHHHHHHHccccHHHccHHHHcccccHHHccHHHHHHHHHHccccHHHcccHHHHHccHHHccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MRIATGASMALDYChsmgimhrdvkphnvmidhenrkLRLIDwglaefyhpgqeyNVRVAsryfkgpellaDYQMYDYSLDMWSLGCMLASmifrkepffhghdNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADILGRARVYADvnshkpreywdyesyvvdwgqqddYQLVRKLGRGKYSEVFEAInvqssdkcVVKILKPVKKKKIKREIKILENlrggtniitlqavvkdpvsrtpaliFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYChsmgimhrdvkphnvmidhenrkLRLIDwglaefyhpgqeyNVRVAsryfkgpellADYQYHIELDPRFADILGRHSRKRWERFVHtenqhlvspealdfldknilgrhsrKRWERFVHtenqhlvspeaLDFLDKLLRYDHYERLtareamdhpyfypivkdqsrhtlpsssptpivnsvpvvge
Flexible Loop (DISEMBL)
MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFeainvqssdkcvvkilkpvkkkkikreikilenlrggtniitlQAVVKDPVSRTPALIfehvnntdfkqLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHtenqhlvspealdfldkNILGRHSRKRWERFVhtenqhlvspealDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSrhtlpsssptpivnsvpvvge
Low Complexity Region (SEG)
MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDkcvvkilkpvkkkkikreikiLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIVNSVPVVGE
Disordered region (IsUnstruct)
********MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK************************
Disordered Region (DISOPRED)
MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR*************SV*****
Disordered Region (DISEMBL)
MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIVNSVPVVGE
Disordered Region (DISPRO)
MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSS*************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIVNSVPVVGE
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	467	2.2.26 [Sep-21-2011]
O76484	353	Casein kinase II subunit	N/A	N/A	0.625	0.827	0.683	1e-128
P28020	392	Casein kinase II subunit	N/A	N/A	0.631	0.752	0.653	1e-124
P21868	391	Casein kinase II subunit	yes	N/A	0.629	0.751	0.648	1e-121
P68400	391	Casein kinase II subunit	yes	N/A	0.629	0.751	0.643	1e-120
P68399	391	Casein kinase II subunit	yes	N/A	0.629	0.751	0.643	1e-120
Q60737	391	Casein kinase II subunit	yes	N/A	0.631	0.754	0.642	1e-120
P19139	391	Casein kinase II subunit	yes	N/A	0.631	0.754	0.639	1e-120
P08181	336	Casein kinase II subunit	yes	N/A	0.578	0.803	0.685	1e-119
P33674	391	Casein kinase II subunit	yes	N/A	0.629	0.751	0.638	1e-119
P21869	350	Casein kinase II subunit	no	N/A	0.593	0.791	0.617	1e-110

>sp|O76484|CSK2A_SPOFR Casein kinase II subunit alpha OS=Spodoptera frugiperda PE=2 SV=1

 Score =  458 bits (1178), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 259/379 (68%), Positives = 276/379 (72%), Gaps = 87/379 (22%)

Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDK 198
           +  RARVYADVNS +PREYWDYESYVVDWG Q+DYQLVRKLGRGKYSEVFEAIN+ +++K
Sbjct: 5   VPSRARVYADVNSQRPREYWDYESYVVDWGNQEDYQLVRKLGRGKYSEVFEAINITNNEK 64

Query: 199 CVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
           CVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL
Sbjct: 65  CVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 124

Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTL+DYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH++RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLSDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHDHRKLRLIDWGLAEFYHP 184

Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQ+YNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQDYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244

Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           YHIELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 245 IAKVLGTEELFEYLDKYHIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 299

Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                       FLD+LLRYDHYER TAREAMDHPYFYPIVK+Q
Sbjct: 300 ----------------------------FLDRLLRYDHYERYTAREAMDHPYFYPIVKEQ 331

Query: 446 SRHTLPSSSPTPIVNSVPV 464
            R  + S+SPTP     P+
Sbjct: 332 GR-MVSSNSPTPNALQGPI 349

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May participate in Wnt signaling.
Spodoptera frugiperda (taxid: 7108)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P28020|CSK21_XENLA Casein kinase II subunit alpha OS=Xenopus laevis GN=csnk2a1 PE=2 SV=2

 Score =  444 bits (1141), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 251/384 (65%), Positives = 274/384 (71%), Gaps = 89/384 (23%)

Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDK 198
           +  RARVY DVN+H+PR+YWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++K
Sbjct: 5   VPSRARVYTDVNTHRPRDYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64

Query: 199 CVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
            VVKILKPVKKKKIKREIKILENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124

Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184

Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244

Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALDF    
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF---- 300

Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                        LDKLLRYDH  RLTAREAMDHPYFYPIVKDQ
Sbjct: 301 -----------------------------LDKLLRYDHQTRLTAREAMDHPYFYPIVKDQ 331

Query: 446 SR---HTLPSSSPTPIVNSVPVVG 466
           SR     +PS S TP+ ++  + G
Sbjct: 332 SRMGGSNMPSGSSTPVSSASMMSG 355

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P21868|CSK21_CHICK Casein kinase II subunit alpha OS=Gallus gallus GN=CSNK2A1 PE=2 SV=1

 Score =  436 bits (1120), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 249/384 (64%), Positives = 273/384 (71%), Gaps = 90/384 (23%)

Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDK 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++K
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64

Query: 199 CVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
            VVKILKPVKKKKIKREIKILENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124

Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184

Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244

Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALDF    
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF---- 300

Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                        LDKLLRYDH  RLTAREAM+HPYFYPIVKDQ
Sbjct: 301 -----------------------------LDKLLRYDHQSRLTAREAMEHPYFYPIVKDQ 331

Query: 446 SR---HTLPSSSPTPIVNSVPVVG 466
           +R     +P  S TP+ ++  + G
Sbjct: 332 ARMGSSNMPGGS-TPVSSASMMSG 354

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P68400|CSK21_HUMAN Casein kinase II subunit alpha OS=Homo sapiens GN=CSNK2A1 PE=1 SV=1

 Score =  432 bits (1110), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 247/384 (64%), Positives = 273/384 (71%), Gaps = 90/384 (23%)

Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDK 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++K
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64

Query: 199 CVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
            VVKILKPVKKKKIKREIKILENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124

Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184

Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244

Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALDF    
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF---- 300

Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                        LDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 301 -----------------------------LDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

Query: 446 SR---HTLPSSSPTPIVNSVPVVG 466
           +R    ++P  S TP+ ++  + G
Sbjct: 332 ARMGSSSMPGGS-TPVSSANMMSG 354

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P68399|CSK21_BOVIN Casein kinase II subunit alpha OS=Bos taurus GN=CSNK2A1 PE=1 SV=1

 Score =  432 bits (1110), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 247/384 (64%), Positives = 273/384 (71%), Gaps = 90/384 (23%)

Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDK 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++K
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64

Query: 199 CVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
            VVKILKPVKKKKIKREIKILENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124

Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184

Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244

Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALDF    
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF---- 300

Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                        LDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 301 -----------------------------LDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

Query: 446 SR---HTLPSSSPTPIVNSVPVVG 466
           +R    ++P  S TP+ ++  + G
Sbjct: 332 ARMGSSSMPGGS-TPVSSANMMSG 354

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q60737|CSK21_MOUSE Casein kinase II subunit alpha OS=Mus musculus GN=Csnk2a1 PE=1 SV=2

 Score =  431 bits (1109), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 246/383 (64%), Positives = 271/383 (70%), Gaps = 88/383 (22%)

Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDK 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++K
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64

Query: 199 CVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
            VVKILKPVKKKKIKREIKILENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124

Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184

Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244

Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALDF    
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF---- 300

Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                        LDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 301 -----------------------------LDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

Query: 446 SRHTLPS--SSPTPIVNSVPVVG 466
           +R +  S     TP+ ++  + G
Sbjct: 332 ARMSSTSMAGGSTPVSSANMMSG 354

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P19139|CSK21_RAT Casein kinase II subunit alpha OS=Rattus norvegicus GN=Csnk2a1 PE=1 SV=2

 Score =  431 bits (1107), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 245/383 (63%), Positives = 271/383 (70%), Gaps = 88/383 (22%)

Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDK 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++K
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64

Query: 199 CVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
            VVKILKPVKKKKIKREIKILENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124

Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184

Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244

Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALDF    
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF---- 300

Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                        LDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 301 -----------------------------LDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

Query: 446 SRHTLP--SSSPTPIVNSVPVVG 466
           +R +    +   TP+ ++  + G
Sbjct: 332 ARMSSAGMAGGSTPVSSANMMSG 354

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P08181|CSK2A_DROME Casein kinase II subunit alpha OS=Drosophila melanogaster GN=CkIIalpha PE=1 SV=2

 Score =  428 bits (1101), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 244/356 (68%), Positives = 257/356 (72%), Gaps = 86/356 (24%)

Query: 143 ARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVK 202
           ARVY DVN+HKP EYWDYE+YVVDWG QDDYQLVRKLGRGKYSEVFEAIN+ +++KCVVK
Sbjct: 7   ARVYTDVNAHKPDEYWDYENYVVDWGNQDDYQLVRKLGRGKYSEVFEAINITTTEKCVVK 66

Query: 203 ILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTL 262
           ILKPVKKKKIKREIKILENLRGGTNIITL AVVKDPVSRTPALIFEHVNNTDFKQLYQTL
Sbjct: 67  ILKPVKKKKIKREIKILENLRGGTNIITLLAVVKDPVSRTPALIFEHVNNTDFKQLYQTL 126

Query: 263 TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 322
           TDY+IRYYL+ELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY
Sbjct: 127 TDYEIRYYLFELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 186

Query: 323 NVRVASRYFKGPELLADYQ----------------------------------------- 341
           NVRVASRYFKGPELL DYQ                                         
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246

Query: 342 ------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGR 389
                       Y+I+LDPRF DIL RHSRKRWERFVH++NQHLVSPEALD         
Sbjct: 247 LGTEELYAYLDKYNIDLDPRFHDILQRHSRKRWERFVHSDNQHLVSPEALD--------- 297

Query: 390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                   FLDKLLRYDH +RLTAREAM HPYF PIV  Q
Sbjct: 298 ------------------------FLDKLLRYDHVDRLTAREAMAHPYFLPIVNGQ 329

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May participate in Wnt signaling.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P33674|CSK21_RABIT Casein kinase II subunit alpha OS=Oryctolagus cuniculus GN=CSNK2A1 PE=2 SV=1

 Score =  427 bits (1099), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 245/384 (63%), Positives = 270/384 (70%), Gaps = 90/384 (23%)

Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDK 198
           +  R RVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++K
Sbjct: 5   VPSRVRVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64

Query: 199 CVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
            VVKILKPVKKKKIKREIKILENLRGG NIITL  +VKDP SRTPAL FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPASRTPALAFEHVNNTDFKQL 124

Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184

Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244

Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALDF    
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF---- 300

Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                        LDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 301 -----------------------------LDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

Query: 446 SR---HTLPSSSPTPIVNSVPVVG 466
           +R    ++P  S TP+ ++  + G
Sbjct: 332 ARMGSSSMPGGS-TPVSSANMMSG 354

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P21869|CSK22_CHICK Casein kinase II subunit alpha' OS=Gallus gallus PE=2 SV=1

 Score =  399 bits (1025), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 226/366 (61%), Positives = 255/366 (69%), Gaps = 89/366 (24%)

Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV 200
            RARVYA+VNS + REYWDYE++V  WG QDDYQLVRKLGRGKYSEVFEAIN+ ++++ V
Sbjct: 8   SRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVV 67

Query: 201 VKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
           VKILKPVKKKKIKRE+KILENLRGGTNII L   VKDPVS+TPAL+FE++NNTDFKQLYQ
Sbjct: 68  VKILKPVKKKKIKREVKILENLRGGTNIINLIDTVKDPVSKTPALVFEYINNTDFKQLYQ 127

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
            LTD+DIR+Y+YELLKALDYCHSMGIMHRDVKPHNVMIDH+ +KLRLIDWGLAEFYHP Q
Sbjct: 128 ILTDFDIRFYMYELLKALDYCHSMGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQ 187

Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL DYQ                                       
Sbjct: 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGQDNYDQLVRIA 247

Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         YHIELDP F DILG+HSRKRWE F+H+EN+HLVSPE L        
Sbjct: 248 KVLGTDELYGYLKKYHIELDPHFNDILGQHSRKRWENFIHSENRHLVSPEVL-------- 299

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                                    D LDKLLRYDH +RLTA+EAM+HPYFYP+VK+QS+
Sbjct: 300 -------------------------DLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQ 334

Query: 448 HTLPSS 453
              PSS
Sbjct: 335 ---PSS 337

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	467
307169930	388	Casein kinase II subunit alpha [Camponot	0.623	0.75	0.721	1e-135
307207058	418	Casein kinase II subunit alpha [Harpegna	0.625	0.698	0.716	1e-134
332021916	350	Casein kinase II subunit alpha [Acromyrm	0.623	0.831	0.716	1e-133
380018568	405	PREDICTED: LOW QUALITY PROTEIN: casein k	0.623	0.718	0.705	1e-131
328791276	468	PREDICTED: casein kinase II subunit alph	0.623	0.621	0.705	1e-131
340720756	465	PREDICTED: casein kinase II subunit alph	0.623	0.625	0.705	1e-131
350412594	465	PREDICTED: casein kinase II subunit alph	0.623	0.625	0.705	1e-131
328707390	419	PREDICTED: casein kinase II subunit alph	0.612	0.682	0.703	1e-129
383847176	465	PREDICTED: casein kinase II subunit alph	0.623	0.625	0.692	1e-129
229577115	350	casein kinase II alpha subunit [Nasonia	0.623	0.831	0.697	1e-129

>gi|307169930|gb|EFN62439.1| Casein kinase II subunit alpha [Camponotus floridanus]

 Score =  486 bits (1252), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 272/377 (72%), Positives = 282/377 (74%), Gaps = 86/377 (22%)

Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV 200
            RARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINV +++KCV
Sbjct: 5   SRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVTNNEKCV 64

Query: 201 VKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
           VKILKPVKKKKIKREIKILENL+GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ
Sbjct: 65  VKILKPVKKKKIKREIKILENLKGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 124

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ
Sbjct: 125 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 184

Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL DYQ                                       
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244

Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         YHIELDPRF DILGRHSRKRWERFVH+ENQHLVSPE+LD       
Sbjct: 245 KVLGTEELFEYLDKYHIELDPRFNDILGRHSRKRWERFVHSENQHLVSPESLD------- 297

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                                     FLDKLLRYDHYERLTAREAM+HPYFYPIVK+Q R
Sbjct: 298 --------------------------FLDKLLRYDHYERLTAREAMEHPYFYPIVKEQGR 331

Query: 448 HTLPSSSPTPIVNSVPV 464
            T+ SSSPTP+  SVPV
Sbjct: 332 LTMVSSSPTPMTGSVPV 348

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307207058|gb|EFN84867.1| Casein kinase II subunit alpha [Harpegnathos saltator]

 Score =  486 bits (1251), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 271/378 (71%), Positives = 281/378 (74%), Gaps = 86/378 (22%)

Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV 200
            RARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINV +++KCV
Sbjct: 5   SRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVTNNEKCV 64

Query: 201 VKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
           VKILKPVKKKKIKREIKILENL+GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ
Sbjct: 65  VKILKPVKKKKIKREIKILENLKGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 124

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TL DYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ
Sbjct: 125 TLNDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 184

Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL DYQ                                       
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244

Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         YHIELDPRF DILGRHSRKRWERFVH+ENQHLVSPE+LD       
Sbjct: 245 KVLGTEELFEYLDKYHIELDPRFNDILGRHSRKRWERFVHSENQHLVSPESLD------- 297

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                                     FLDKLLRYDHYERLTAREAM+HPYFYPIVK+Q R
Sbjct: 298 --------------------------FLDKLLRYDHYERLTAREAMEHPYFYPIVKEQGR 331

Query: 448 HTLPSSSPTPIVNSVPVV 465
            T+ SSSPTP+  SVPV 
Sbjct: 332 LTMVSSSPTPMTGSVPVA 349

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332021916|gb|EGI62250.1| Casein kinase II subunit alpha [Acromyrmex echinatior]

 Score =  483 bits (1242), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 270/377 (71%), Positives = 281/377 (74%), Gaps = 86/377 (22%)

Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV 200
            RARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINV +++ CV
Sbjct: 5   SRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVTNNENCV 64

Query: 201 VKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
           VKILKPVKKKKIKREIKILENL+GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ
Sbjct: 65  VKILKPVKKKKIKREIKILENLKGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 124

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ
Sbjct: 125 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 184

Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL DYQ                                       
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244

Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         YHIELDPRF DILGRHSRKRWERFVH+ENQHLVSP++LD       
Sbjct: 245 KVLGTEELFEYLDKYHIELDPRFNDILGRHSRKRWERFVHSENQHLVSPDSLD------- 297

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                                     FLDKLLRYDHYERLTAREAM+HPYFYPIVK+Q R
Sbjct: 298 --------------------------FLDKLLRYDHYERLTAREAMEHPYFYPIVKEQGR 331

Query: 448 HTLPSSSPTPIVNSVPV 464
            T+ SSSPTP+  SVPV
Sbjct: 332 LTMVSSSPTPMAGSVPV 348

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380018568|ref|XP_003693199.1| PREDICTED: LOW QUALITY PROTEIN: casein kinase II subunit alpha-like [Apis florea]

 Score =  476 bits (1225), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 266/377 (70%), Positives = 278/377 (73%), Gaps = 86/377 (22%)

Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV 200
            RARVY DVNSHK R+YWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAIN+ +++KCV
Sbjct: 5   SRARVYTDVNSHKSRDYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINITNNEKCV 64

Query: 201 VKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
           VKILKPVKKKKIKREIKILENL+GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ
Sbjct: 65  VKILKPVKKKKIKREIKILENLKGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 124

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ
Sbjct: 125 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 184

Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL DYQ                                       
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244

Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         YHIELDPRF DILGRHSRKRWERF+H+ENQHLVS E+LD       
Sbjct: 245 KVLGTEELFEYLEKYHIELDPRFNDILGRHSRKRWERFMHSENQHLVSHESLD------- 297

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                                     FLDKLLRYDHYERLTAREAM+HPYFYPIVKDQ R
Sbjct: 298 --------------------------FLDKLLRYDHYERLTAREAMEHPYFYPIVKDQGR 331

Query: 448 HTLPSSSPTPIVNSVPV 464
             + SSSPTPI  S+PV
Sbjct: 332 LNMVSSSPTPITGSLPV 348

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328791276|ref|XP_623397.2| PREDICTED: casein kinase II subunit alpha isoform 2 [Apis mellifera]

 Score =  474 bits (1220), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 266/377 (70%), Positives = 278/377 (73%), Gaps = 86/377 (22%)

Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV 200
            RARVY DVNSHK R+YWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAIN+ +++KCV
Sbjct: 5   SRARVYTDVNSHKSRDYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINITNNEKCV 64

Query: 201 VKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
           VKILKPVKKKKIKREIKILENL+GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ
Sbjct: 65  VKILKPVKKKKIKREIKILENLKGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 124

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ
Sbjct: 125 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 184

Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL DYQ                                       
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244

Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         YHIELDPRF DILGRHSRKRWERF+H+ENQHLVS E+LD       
Sbjct: 245 KVLGTEELFEYLEKYHIELDPRFNDILGRHSRKRWERFMHSENQHLVSHESLD------- 297

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                                     FLDKLLRYDHYERLTAREAM+HPYFYPIVKDQ R
Sbjct: 298 --------------------------FLDKLLRYDHYERLTAREAMEHPYFYPIVKDQGR 331

Query: 448 HTLPSSSPTPIVNSVPV 464
             + SSSPTPI  S+PV
Sbjct: 332 LNMVSSSPTPITGSLPV 348

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340720756|ref|XP_003398797.1| PREDICTED: casein kinase II subunit alpha-like [Bombus terrestris]

 Score =  474 bits (1220), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 266/377 (70%), Positives = 278/377 (73%), Gaps = 86/377 (22%)

Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV 200
            RARVY DVNSHK R+YWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAIN+ +++KCV
Sbjct: 5   SRARVYTDVNSHKSRDYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINITNNEKCV 64

Query: 201 VKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
           VKILKPVKKKKIKREIKILENL+GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ
Sbjct: 65  VKILKPVKKKKIKREIKILENLKGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 124

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ
Sbjct: 125 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 184

Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL DYQ                                       
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244

Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         YHIELDPRF DILGRHSRKRWERF+H+ENQHLVS E+LD       
Sbjct: 245 KVLGTEELFEYLEKYHIELDPRFNDILGRHSRKRWERFMHSENQHLVSHESLD------- 297

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                                     FLDKLLRYDHYERLTAREAM+HPYFYPIVKDQ R
Sbjct: 298 --------------------------FLDKLLRYDHYERLTAREAMEHPYFYPIVKDQGR 331

Query: 448 HTLPSSSPTPIVNSVPV 464
             + SSSPTPI  S+PV
Sbjct: 332 LNMVSSSPTPITGSLPV 348

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350412594|ref|XP_003489699.1| PREDICTED: casein kinase II subunit alpha-like [Bombus impatiens]

 Score =  474 bits (1220), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 266/377 (70%), Positives = 278/377 (73%), Gaps = 86/377 (22%)

Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV 200
            RARVY DVNSHK R+YWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAIN+ +++KCV
Sbjct: 5   SRARVYTDVNSHKSRDYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINITNNEKCV 64

Query: 201 VKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
           VKILKPVKKKKIKREIKILENL+GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ
Sbjct: 65  VKILKPVKKKKIKREIKILENLKGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 124

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ
Sbjct: 125 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 184

Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL DYQ                                       
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244

Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         YHIELDPRF DILGRHSRKRWERF+H+ENQHLVS E+LD       
Sbjct: 245 KVLGTEELFEYLEKYHIELDPRFNDILGRHSRKRWERFMHSENQHLVSHESLD------- 297

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                                     FLDKLLRYDHYERLTAREAM+HPYFYPIVKDQ R
Sbjct: 298 --------------------------FLDKLLRYDHYERLTAREAMEHPYFYPIVKDQGR 331

Query: 448 HTLPSSSPTPIVNSVPV 464
             + SSSPTPI  S+PV
Sbjct: 332 LNMVSSSPTPITGSLPV 348

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328707390|ref|XP_001942962.2| PREDICTED: casein kinase II subunit alpha-like isoform 1 [Acyrthosiphon pisum]

 Score =  469 bits (1208), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 263/374 (70%), Positives = 277/374 (74%), Gaps = 88/374 (23%)

Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV 200
            RARVYADVNSHKPREYWDYESY V+WGQQDDYQLVRKLGRGKYSEVFEAI+V +S+KCV
Sbjct: 63  SRARVYADVNSHKPREYWDYESYTVEWGQQDDYQLVRKLGRGKYSEVFEAIDVTNSEKCV 122

Query: 201 VKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
           VKILKPVKKKKIKREIKILENLRGGTNII+LQAVVKDPVSRTPALIFEHVNN DFKQLYQ
Sbjct: 123 VKILKPVKKKKIKREIKILENLRGGTNIISLQAVVKDPVSRTPALIFEHVNNMDFKQLYQ 182

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TL DYDIR+YLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ
Sbjct: 183 TLNDYDIRFYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 242

Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELLADYQ                                       
Sbjct: 243 EYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 302

Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         YH+ELDPRF+DILGRHSRKRWERFVH+ENQHLV+PEALD       
Sbjct: 303 KVLGTEELFEYLDKYHVELDPRFSDILGRHSRKRWERFVHSENQHLVTPEALD------- 355

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                                     FLDKLLRYDH+ERLTAREAMDHPYFYP+VK+QSR
Sbjct: 356 --------------------------FLDKLLRYDHFERLTAREAMDHPYFYPVVKEQSR 389

Query: 448 HTLPSS--SPTPIV 459
             L +S  SPTPI 
Sbjct: 390 INLGTSSVSPTPIT 403

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383847176|ref|XP_003699231.1| PREDICTED: casein kinase II subunit alpha-like [Megachile rotundata]

 Score =  469 bits (1207), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 261/377 (69%), Positives = 277/377 (73%), Gaps = 86/377 (22%)

Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV 200
            RARVY DVN+ KPR+YWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAIN+ +++KCV
Sbjct: 5   SRARVYTDVNARKPRDYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINITNNEKCV 64

Query: 201 VKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
           VKILKPVKKKKIKREIKILENL+GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ
Sbjct: 65  VKILKPVKKKKIKREIKILENLKGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 124

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ
Sbjct: 125 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 184

Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL D+Q                                       
Sbjct: 185 EYNVRVASRYFKGPELLVDFQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244

Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         YHIELDPRF DILGRHSRKRWERF+H+ENQHLVS E+LD       
Sbjct: 245 KVLGTEELFEYLEKYHIELDPRFNDILGRHSRKRWERFMHSENQHLVSHESLD------- 297

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                                     FLDKLLRYDHYERLTAREAM+HPYFYPI K+Q R
Sbjct: 298 --------------------------FLDKLLRYDHYERLTAREAMEHPYFYPIAKEQGR 331

Query: 448 HTLPSSSPTPIVNSVPV 464
             + SSSPTP+  S+PV
Sbjct: 332 LNMVSSSPTPVTGSLPV 348

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|229577115|ref|NP_001153430.1| casein kinase II alpha subunit [Nasonia vitripennis] gi|229577119|ref|NP_001153431.1| casein kinase II alpha subunit [Nasonia vitripennis]

 Score =  469 bits (1206), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 263/377 (69%), Positives = 277/377 (73%), Gaps = 86/377 (22%)

Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV 200
            RARVY DVNSHKPREYWDYESYVV+WGQQDDYQLV+KLGRGKYSEVFEA N+ +++KCV
Sbjct: 5   SRARVYTDVNSHKPREYWDYESYVVNWGQQDDYQLVKKLGRGKYSEVFEAYNITNNEKCV 64

Query: 201 VKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
           VKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFK LYQ
Sbjct: 65  VKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKLLYQ 124

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TLTDYDIRYYLYELLKAL+YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ
Sbjct: 125 TLTDYDIRYYLYELLKALEYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 184

Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL DYQ                                       
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMFASMIFRKEPFFHGHDNYDQLVRIA 244

Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         YHIELD RF DILGRHSRKRWERFVH++NQHLVSPE+LD       
Sbjct: 245 KVLGTEELFEYLDKYHIELDVRFNDILGRHSRKRWERFVHSDNQHLVSPESLD------- 297

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                                     FLDKLLRYDHYERLTAREAMDHPYFYPIVK+Q R
Sbjct: 298 --------------------------FLDKLLRYDHYERLTAREAMDHPYFYPIVKEQGR 331

Query: 448 HTLPSSSPTPIVNSVPV 464
             + SSSPTP+  S+PV
Sbjct: 332 MAMVSSSPTPMTGSLPV 348

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	467
UNIPROTKB|P21868	391	CSNK2A1 "Casein kinase II subu	0.441	0.526	0.777	8.5e-119
UNIPROTKB|E7EU96	385	CSNK2A1 "Casein kinase II subu	0.441	0.535	0.777	4.7e-118
UNIPROTKB|P68399	391	CSNK2A1 "Casein kinase II subu	0.441	0.526	0.777	7.6e-118
UNIPROTKB|E2RHZ1	391	CSNK2A1 "Uncharacterized prote	0.441	0.526	0.777	7.6e-118
UNIPROTKB|P68400	391	CSNK2A1 "Casein kinase II subu	0.441	0.526	0.777	7.6e-118
UNIPROTKB|F2Z5I5	391	CSNK2A1 "Uncharacterized prote	0.441	0.526	0.777	7.6e-118
MGI|MGI:88543	391	Csnk2a1 "casein kinase 2, alph	0.441	0.526	0.777	1.2e-117
RGD|621663	391	Csnk2a1 "casein kinase 2, alph	0.441	0.526	0.777	3.3e-117
UNIPROTKB|P19139	391	Csnk2a1 "Casein kinase II subu	0.441	0.526	0.777	3.3e-117
UNIPROTKB|P33674	391	CSNK2A1 "Casein kinase II subu	0.441	0.526	0.768	1.4e-116

UNIPROTKB|P21868 CSNK2A1 "Casein kinase II subunit alpha" [Gallus gallus (taxid:9031)]

 Score = 869 (311.0 bits), Expect = 8.5e-119, Sum P(2) = 8.5e-119
 Identities = 161/207 (77%), Positives = 175/207 (84%)

Query:   142 RARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXX 201
             RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++    
Sbjct:     8 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 67

Query:   202 XXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT 261
                              LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQLYQT
Sbjct:    68 KILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT 127

Query:   262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
             LTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHPGQE
Sbjct:   128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187

Query:   322 YNVRVASRYFKGPELLADYQ-YHIELD 347
             YNVRVASRYFKGPELL DYQ Y   LD
Sbjct:   188 YNVRVASRYFKGPELLVDYQMYDYSLD 214

GO:0005524 "ATP binding" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0016580 "Sin3 complex" evidence=IEA

GO:0016581 "NuRD complex" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0047485 "protein N-terminus binding" evidence=IEA

GO:0071174 "mitotic spindle checkpoint" evidence=IEA

GO:0031519 "PcG protein complex" evidence=ISS

UNIPROTKB|E7EU96 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)]

 Score = 869 (311.0 bits), Expect = 4.7e-118, Sum P(2) = 4.7e-118
 Identities = 161/207 (77%), Positives = 175/207 (84%)

Query:   142 RARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXX 201
             RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++    
Sbjct:     8 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 67

Query:   202 XXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT 261
                              LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQLYQT
Sbjct:    68 KILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT 127

Query:   262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
             LTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHPGQE
Sbjct:   128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187

Query:   322 YNVRVASRYFKGPELLADYQ-YHIELD 347
             YNVRVASRYFKGPELL DYQ Y   LD
Sbjct:   188 YNVRVASRYFKGPELLVDYQMYDYSLD 214

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P68399 CSNK2A1 "Casein kinase II subunit alpha" [Bos taurus (taxid:9913)]

 Score = 869 (311.0 bits), Expect = 7.6e-118, Sum P(2) = 7.6e-118
 Identities = 161/207 (77%), Positives = 175/207 (84%)

Query:   142 RARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXX 201
             RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++    
Sbjct:     8 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 67

Query:   202 XXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT 261
                              LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQLYQT
Sbjct:    68 KILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT 127

Query:   262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
             LTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHPGQE
Sbjct:   128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187

Query:   322 YNVRVASRYFKGPELLADYQ-YHIELD 347
             YNVRVASRYFKGPELL DYQ Y   LD
Sbjct:   188 YNVRVASRYFKGPELLVDYQMYDYSLD 214

GO:0047485 "protein N-terminus binding" evidence=ISS

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0071174 "mitotic spindle checkpoint" evidence=ISS

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=ISS

GO:0031519 "PcG protein complex" evidence=ISS

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E2RHZ1 CSNK2A1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 869 (311.0 bits), Expect = 7.6e-118, Sum P(2) = 7.6e-118
 Identities = 161/207 (77%), Positives = 175/207 (84%)

Query:   142 RARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXX 201
             RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++    
Sbjct:     8 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 67

Query:   202 XXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT 261
                              LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQLYQT
Sbjct:    68 KILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT 127

Query:   262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
             LTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHPGQE
Sbjct:   128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187

Query:   322 YNVRVASRYFKGPELLADYQ-YHIELD 347
             YNVRVASRYFKGPELL DYQ Y   LD
Sbjct:   188 YNVRVASRYFKGPELLVDYQMYDYSLD 214

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0071174 "mitotic spindle checkpoint" evidence=IEA

GO:0047485 "protein N-terminus binding" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IEA

GO:0031519 "PcG protein complex" evidence=IEA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0016581 "NuRD complex" evidence=IEA

GO:0016580 "Sin3 complex" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

UNIPROTKB|P68400 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)]

 Score = 869 (311.0 bits), Expect = 7.6e-118, Sum P(2) = 7.6e-118
 Identities = 161/207 (77%), Positives = 175/207 (84%)

Query:   142 RARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXX 201
             RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++    
Sbjct:     8 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 67

Query:   202 XXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT 261
                              LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQLYQT
Sbjct:    68 KILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT 127

Query:   262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
             LTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHPGQE
Sbjct:   128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187

Query:   322 YNVRVASRYFKGPELLADYQ-YHIELD 347
             YNVRVASRYFKGPELL DYQ Y   LD
Sbjct:   188 YNVRVASRYFKGPELLVDYQMYDYSLD 214

GO:0005524 "ATP binding" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA;TAS

GO:0047485 "protein N-terminus binding" evidence=IPI

GO:0005515 "protein binding" evidence=IPI

GO:0045732 "positive regulation of protein catabolic process" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0030307 "positive regulation of cell growth" evidence=IDA

GO:0008284 "positive regulation of cell proliferation" evidence=IDA

GO:0031519 "PcG protein complex" evidence=IDA

GO:0071174 "mitotic spindle checkpoint" evidence=IMP

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IMP

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IMP

GO:0051879 "Hsp90 protein binding" evidence=TAS

GO:0061077 "chaperone-mediated protein folding" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005886 "plasma membrane" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0007411 "axon guidance" evidence=TAS

GO:0016581 "NuRD complex" evidence=IDA

GO:0016580 "Sin3 complex" evidence=IDA

UNIPROTKB|F2Z5I5 CSNK2A1 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 869 (311.0 bits), Expect = 7.6e-118, Sum P(2) = 7.6e-118
 Identities = 161/207 (77%), Positives = 175/207 (84%)

Query:   142 RARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXX 201
             RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++    
Sbjct:     8 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 67

Query:   202 XXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT 261
                              LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQLYQT
Sbjct:    68 KILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT 127

Query:   262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
             LTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHPGQE
Sbjct:   128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187

Query:   322 YNVRVASRYFKGPELLADYQ-YHIELD 347
             YNVRVASRYFKGPELL DYQ Y   LD
Sbjct:   188 YNVRVASRYFKGPELLVDYQMYDYSLD 214

GO:0071174 "mitotic spindle checkpoint" evidence=IEA

GO:0047485 "protein N-terminus binding" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IEA

GO:0031519 "PcG protein complex" evidence=IEA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0016581 "NuRD complex" evidence=IEA

GO:0016580 "Sin3 complex" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:88543 Csnk2a1 "casein kinase 2, alpha 1 polypeptide" [Mus musculus (taxid:10090)]

 Score = 869 (311.0 bits), Expect = 1.2e-117, Sum P(2) = 1.2e-117
 Identities = 161/207 (77%), Positives = 175/207 (84%)

Query:   142 RARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXX 201
             RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++    
Sbjct:     8 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 67

Query:   202 XXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT 261
                              LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQLYQT
Sbjct:    68 KILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT 127

Query:   262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
             LTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHPGQE
Sbjct:   128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187

Query:   322 YNVRVASRYFKGPELLADYQ-YHIELD 347
             YNVRVASRYFKGPELL DYQ Y   LD
Sbjct:   188 YNVRVASRYFKGPELLVDYQMYDYSLD 214

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005956 "protein kinase CK2 complex" evidence=TAS

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;IDA

GO:0006915 "apoptotic process" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IDA

GO:0008284 "positive regulation of cell proliferation" evidence=ISO

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0016301 "kinase activity" evidence=IDA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016580 "Sin3 complex" evidence=ISO

GO:0016581 "NuRD complex" evidence=ISO

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IDA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=ISO

GO:0030307 "positive regulation of cell growth" evidence=ISO

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=ISO

GO:0045732 "positive regulation of protein catabolic process" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0047485 "protein N-terminus binding" evidence=ISO

GO:0050790 "regulation of catalytic activity" evidence=IDA

GO:0071174 "mitotic spindle checkpoint" evidence=ISO

RGD|621663 Csnk2a1 "casein kinase 2, alpha 1 polypeptide" [Rattus norvegicus (taxid:10116)]

 Score = 869 (311.0 bits), Expect = 3.3e-117, Sum P(2) = 3.3e-117
 Identities = 161/207 (77%), Positives = 175/207 (84%)

Query:   142 RARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXX 201
             RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++    
Sbjct:     8 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 67

Query:   202 XXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT 261
                              LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQLYQT
Sbjct:    68 KILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT 127

Query:   262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
             LTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHPGQE
Sbjct:   128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187

Query:   322 YNVRVASRYFKGPELLADYQ-YHIELD 347
             YNVRVASRYFKGPELL DYQ Y   LD
Sbjct:   188 YNVRVASRYFKGPELLVDYQMYDYSLD 214

GO:0001558 "regulation of cell growth" evidence=NAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005956 "protein kinase CK2 complex" evidence=TAS

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0008013 "beta-catenin binding" evidence=IEA;ISO

GO:0008284 "positive regulation of cell proliferation" evidence=ISO

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0016301 "kinase activity" evidence=ISO

GO:0016580 "Sin3 complex" evidence=IEA;ISO

GO:0016581 "NuRD complex" evidence=IEA;ISO

GO:0019888 "protein phosphatase regulator activity" evidence=IEA;ISO

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=ISO;ISS

GO:0030307 "positive regulation of cell growth" evidence=ISO

GO:0031519 "PcG protein complex" evidence=ISO;ISS

GO:0042127 "regulation of cell proliferation" evidence=NAS

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=ISO;ISS

GO:0045732 "positive regulation of protein catabolic process" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=IEA;ISO

GO:0047485 "protein N-terminus binding" evidence=IEA;ISO

GO:0050790 "regulation of catalytic activity" evidence=ISO

GO:0071174 "mitotic spindle checkpoint" evidence=ISO;ISS

UNIPROTKB|P19139 Csnk2a1 "Casein kinase II subunit alpha" [Rattus norvegicus (taxid:10116)]

 Score = 869 (311.0 bits), Expect = 3.3e-117, Sum P(2) = 3.3e-117
 Identities = 161/207 (77%), Positives = 175/207 (84%)

Query:   142 RARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXX 201
             RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++    
Sbjct:     8 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 67

Query:   202 XXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT 261
                              LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQLYQT
Sbjct:    68 KILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT 127

Query:   262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
             LTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHPGQE
Sbjct:   128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187

Query:   322 YNVRVASRYFKGPELLADYQ-YHIELD 347
             YNVRVASRYFKGPELL DYQ Y   LD
Sbjct:   188 YNVRVASRYFKGPELLVDYQMYDYSLD 214

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P33674 CSNK2A1 "Casein kinase II subunit alpha" [Oryctolagus cuniculus (taxid:9986)]

 Score = 857 (306.7 bits), Expect = 1.4e-116, Sum P(2) = 1.4e-116
 Identities = 159/207 (76%), Positives = 172/207 (83%)

Query:   142 RARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXX 201
             R RVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++    
Sbjct:     8 RVRVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 67

Query:   202 XXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT 261
                              LENLRGG NIITL  +VKDP SRTPAL FEHVNNTDFKQLYQT
Sbjct:    68 KILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPASRTPALAFEHVNNTDFKQLYQT 127

Query:   262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
             LTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHPGQE
Sbjct:   128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187

Query:   322 YNVRVASRYFKGPELLADYQ-YHIELD 347
             YNVRVASRYFKGPELL DYQ Y   LD
Sbjct:   188 YNVRVASRYFKGPELLVDYQMYDYSLD 214

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=ISS

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=ISS

GO:0071174 "mitotic spindle checkpoint" evidence=ISS

GO:0031519 "PcG protein complex" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P19454	CSK22_YEAST	2, ., 7, ., 1, 1, ., 1	0.5205	0.6316	0.8702	yes	N/A
Q54LR6	Y6481_DICDI	2, ., 7, ., 1, 1, ., 1	0.5031	0.6252	0.4826	yes	N/A
P33674	CSK21_RABIT	2, ., 7, ., 1, 1, ., 1	0.6380	0.6295	0.7519	yes	N/A
P21868	CSK21_CHICK	2, ., 7, ., 1, 1, ., 1	0.6484	0.6295	0.7519	yes	N/A
P68399	CSK21_BOVIN	2, ., 7, ., 1, 1, ., 1	0.6432	0.6295	0.7519	yes	N/A
O64816	CSK2P_ARATH	2, ., 7, ., 1, 1, ., 1	0.5516	0.6038	0.6527	yes	N/A
P18334	CSK2A_CAEEL	2, ., 7, ., 1, 1, ., 1	0.6270	0.5910	0.7666	yes	N/A
P08181	CSK2A_DROME	2, ., 7, ., 1, 1, ., 1	0.6853	0.5781	0.8035	yes	N/A
P19139	CSK21_RAT	2, ., 7, ., 1, 1, ., 1	0.6396	0.6316	0.7544	yes	N/A
P28547	CSK2A_THEPA	2, ., 7, ., 1, 1, ., 1	0.5880	0.6381	0.8563	yes	N/A
P68400	CSK21_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6432	0.6295	0.7519	yes	N/A
Q8SRU0	CSK2A_ENCCU	2, ., 7, ., 1, 1, ., 1	0.4326	0.6316	0.9247	yes	N/A
P40231	CSK2A_SCHPO	2, ., 7, ., 1, 1, ., 1	0.5727	0.6445	0.9066	yes	N/A
Q60737	CSK21_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6422	0.6316	0.7544	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	467
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-51
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-38
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-36
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-35
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-35
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-34
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-34
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-31
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-31
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-31
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-30
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-30
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-30
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-30
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-27
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-27
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-27
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-27
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-26
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-26
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-26
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-26
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-26
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-26
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-26
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-26
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-25
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-25
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-25
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-25
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-25
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-24
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-23
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-23
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-23
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-23
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-23
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-23
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-22
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-22
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-22
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-22
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-21
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-21
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-21
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-21
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-21
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-21
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-21
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-21
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-21
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-21
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-21
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-20
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-20
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-20
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-20
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-20
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-20
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-19
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-19
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-19
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-19
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-19
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-19
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-19
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-19
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-19
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-19
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-19
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-18
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-18
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-18
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-18
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-18
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-18
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-18
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-17
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-17
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-17
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-17
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-17
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-16
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-16
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-16
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-15
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-15
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-15
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-15
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-14
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-14
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-13
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-13
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-13
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-13
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-13
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-13
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-12
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-12
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-12
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-12
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-12
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-11
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-11
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-10
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-10
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-10
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-10
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-09
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-09
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-09
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-09
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-09
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-09
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-09
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-09
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-09
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	9e-09
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-08
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-08
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-08
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-08
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-08
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-08
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-08
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-08
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-07
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-07
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-07
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-07
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-07
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-07
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-07
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-07
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-07
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	9e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-06
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-06
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-06
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-06
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-06
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-06
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-06
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-06
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-06
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-06
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-06
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-06
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-06
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-06
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	5e-06
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-06
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-06
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-06
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-06
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	9e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	9e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-05
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-05
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-05
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-05
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-05
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-05
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-05
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-05
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-05
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-05
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-05
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-05
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-05
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-05
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-05
pfam01636	238	pfam01636, APH, Phosphotransferase enzyme family	5e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	7e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-05
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-05
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-04
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-04
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-04
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-04
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-04
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-04
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-04
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-04
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-04
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-04
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-04
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-04
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-04
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-04
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-04
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-04
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-04
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-04
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-04
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-04
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-04
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-04
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	7e-04
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-04
cd08340	81	cd08340, DED_c-FLIP_repeat2, Death Effector Domain	9e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	0.001
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.001
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	0.001
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.001
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	0.001
pfam01636	238	pfam01636, APH, Phosphotransferase enzyme family	0.001
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	0.001
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	0.001
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.001
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.001
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.001
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	0.001
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	0.001
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	0.001
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	0.002
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	0.002
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	0.002
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	0.002
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	0.002
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	0.002
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.002
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	0.003
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	0.003
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.003
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.003
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	0.003
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	0.003
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	0.003
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	0.003
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	0.004
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	0.004
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	0.004
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	0.004
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.004
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	0.004
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	0.004
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.004
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	0.004
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	0.004
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	0.004
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	0.004
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  175 bits (446), Expect = 9e-52
 Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 46/286 (16%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK-----REIKILENLRGGTN 227
           Y+L+RKLG G +  V++A +  +     VKILK   +K  K     REI+IL  L    N
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHP-N 59

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYCHSM 284
           I+ L    +D       L+ E+    D          L++ + +    ++L+ L+Y HS 
Sbjct: 60  IVRLIDAFEDK--DHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLADYQYH 343
           GI+HRD+KP N+++D     +++ D+GLA+            V + ++  PE+L     +
Sbjct: 118 GIIHRDLKPENILLDENGV-VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176

Query: 344 IELDPRFADI-----------LGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR 392
               P+  D+            G+        F           + L  + + +      
Sbjct: 177 ---GPK-VDVWSLGVILYELLTGKP------PF-----SGENILDQLQLIRRILGPPLEF 221

Query: 393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
              +           S EA D + K L  D  +R TA E + HP+F
Sbjct: 222 DEPKW-------SSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  175 bits (445), Expect = 1e-51
 Identities = 84/284 (29%), Positives = 132/284 (46%), Gaps = 48/284 (16%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK----IKREIKILENLRGGTNI 228
           Y+++ KLG G + +V+ A + ++     +K++K  K KK    I REIKIL+ L+   NI
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKH-PNI 59

Query: 229 ITLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYCHSMG 285
           + L  V +D       L+ E+    D   L      L++ + R+YL ++L AL+Y HS G
Sbjct: 60  VRLYDVFEDEDKLY--LVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 286 IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE 345
           I+HRD+KP N+++D +   ++L D+GLA    PG++    V +  +  PE+L    Y   
Sbjct: 118 IVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176

Query: 346 LDPRFADI-----------LGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR 394
                 DI            G+        F   +    +         K I        
Sbjct: 177 -----VDIWSLGVILYELLTGKPP------FPGDDQLLELF--------KKIGKPKPPFP 217

Query: 395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
              +        +SPEA D + KLL  D  +RLTA EA+ HP+F
Sbjct: 218 PPEW-------DISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  139 bits (352), Expect = 7e-38
 Identities = 84/304 (27%), Positives = 141/304 (46%), Gaps = 60/304 (19%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK-IK----REIKILENLRGGTN 227
           Y+ + KLG G Y  V++A + ++ +   +K ++   +++ I     REI +L+ L+   N
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH-PN 59

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQL----YQTLTDYDIRYYLYELLKALDYCHS 283
           I+ L  V+     R   L+FE+ +  D K+        L+   I+  +Y+LL+ L YCHS
Sbjct: 60  IVKLLDVIHTE--RKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE-LLADYQ 341
             I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++ PE LL    
Sbjct: 117 HRILHRDLKPQNILINRDGV-LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175

Query: 342 YHIELD---------------PRFA------------DILGRHSRKRWERFVHTENQHLV 374
           Y   +D               P F              ILG  + + W            
Sbjct: 176 YSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV--------- 226

Query: 375 SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD 434
               L    K    +   K  E+ +   +     PE +D L K+L+Y+  +R++A+EA+ 
Sbjct: 227 --TKLPD-YKPTFPKFPPKDLEKVLPRLD-----PEGIDLLSKMLQYNPAKRISAKEALK 278

Query: 435 HPYF 438
           HPYF
Sbjct: 279 HPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  135 bits (342), Expect = 5e-36
 Identities = 92/310 (29%), Positives = 150/310 (48%), Gaps = 57/310 (18%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVK-ILKPVKK----KKIKREIKILENLRGGTN 227
           Y+L++ +G G Y  V  A++ ++  K  +K I          K+I REIK+L +LR   N
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRH-EN 60

Query: 228 IITLQAVVKDPVSRTPALIFEHVN------NTDFKQLY---QTLTDYDIRYYLYELLKAL 278
           II L  +++ P        F  V        TD  ++    Q LTD  I+Y+LY++L+ L
Sbjct: 61  IIGLLDILRPPSPED----FNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGL 116

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-----EFYHPGQ--EYNVRVASRYF 331
            Y HS  ++HRD+KP N++++  N  L++ D+GLA     +    G   EY   V +R++
Sbjct: 117 KYLHSANVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEY---VVTRWY 172

Query: 332 KGPELLADYQ-YHIELDPR-----FADIL-------GRHSRKRWERFVHT-------ENQ 371
           + PELL     Y   +D       FA++L       GR    +    V         + +
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232

Query: 372 HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTARE 431
            + S +A ++L    L +  +K   +          SPEA+D L+K+L +D  +R+TA E
Sbjct: 233 FITSEKARNYLKS--LPKKPKKPLSKLFPGA-----SPEAIDLLEKMLVFDPKKRITADE 285

Query: 432 AMDHPYFYPI 441
           A+ HPY   +
Sbjct: 286 ALAHPYLAQL 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  133 bits (337), Expect = 3e-35
 Identities = 85/299 (28%), Positives = 149/299 (49%), Gaps = 40/299 (13%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSD--KCVVKILKPVKKKKIK-----REIKILENLRGG 225
           Y+L+++LG+G Y  V  A N ++S+     +K +  V  KKI      RE+K+L + RG 
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 226 TNIITL---QAVVKDPVSRTPALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALD 279
            NI  L     V     +     ++E +   D  Q+    Q LTD   + ++Y++L  L 
Sbjct: 62  KNITCLYDMDIVFPGNFNEL--YLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK 119

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR-----VASRYFKGP 334
           Y HS  ++HRD+KP N++++  + +L++ D+GLA  +      N       VA+R+++ P
Sbjct: 120 YIHSANVLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178

Query: 335 ELLADYQ-YHIELDPR-----FADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILG 388
           E++  +Q Y   +D        A++LGR    + + +V   NQ L   + L   D+  L 
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQIL---QVLGTPDEETLS 235

Query: 389 RHSRKRWERFVHTENQHL----------VSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
           R    + + ++ +                +P ALD L+KLL +D  +R++  EA++HPY
Sbjct: 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  130 bits (329), Expect = 8e-35
 Identities = 40/134 (29%), Positives = 67/134 (50%), Gaps = 5/134 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE 68
            L+Y HS GI+HRD+KP N+++D     +++ D+GLA+            V + ++  PE
Sbjct: 110 GLEYLHSNGIIHRDLKPENILLDENGV-VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPE 168

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY 128
           +L     Y   +D+WSLG +L  ++  K PF  G +  DQL  I ++LG    F+     
Sbjct: 169 VLLGGNGYGPKVDVWSLGVILYELLTGKPPFS-GENILDQLQLIRRILGPPLEFDE--PK 225

Query: 129 HIELDPRFADILGR 142
                    D++ +
Sbjct: 226 WSSGSEEAKDLIKK 239

Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  130 bits (330), Expect = 1e-34
 Identities = 83/305 (27%), Positives = 143/305 (46%), Gaps = 57/305 (18%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK-----IKREIKILENLRGGTN 227
           Y+ + ++G G Y +V++A N ++ +   +K ++   +K+       REIK+L+ LR   N
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PN 59

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQL----YQTLTDYDIRYYLYELLKALDYCHS 283
           I+ L+ +V      +  ++FE++++ D   L        T+  I+ Y+ +LL+ L Y HS
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPELL---A 338
            GI+HRD+K  N++I+++   L+L D+GLA  Y      +Y  RV + +++ PELL    
Sbjct: 119 NGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 339 DYQYHI----------EL---DPRFA------------DILGRHSRKRWERFVHTENQHL 373
            Y   +          EL    P F             ++ G  + + W           
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW----------- 226

Query: 374 VSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
             P          L +  +    R      +HL+ P ALD LDKLL  D  +R++A +A+
Sbjct: 227 --PGVSKLPWFENL-KPKKPYKRRLREFF-KHLIDPSALDLLDKLLTLDPKKRISADQAL 282

Query: 434 DHPYF 438
            H YF
Sbjct: 283 QHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  126 bits (318), Expect = 7e-34
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 12/174 (6%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK----IKREIKILENLRGGTNIITLQAV 234
           LG G +  V+ A + ++  K  +KI+K          + REI+IL+ L    NI+ L  V
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGV 59

Query: 235 VKDPVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRD 290
            +D       L+ E+      K L +     L++ +I   L ++L+ L+Y HS GI+HRD
Sbjct: 60  FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117

Query: 291 VKPHNVMIDHENRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLADYQYH 343
           +KP N+++D +N K++L D+GL++            V +  +  PE+L    Y+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  128 bits (323), Expect = 7e-34
 Identities = 93/292 (31%), Positives = 148/292 (50%), Gaps = 35/292 (11%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-----PVKKKKIKREIKILENLRGGTN 227
           YQ + K+G G Y  V++A +  + +   +K +K         K   REIK+L+ L    N
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH-PN 59

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKALDYCHS 283
           II L  V +        L+FE ++ TD  +L +     L +  I+ YLY+LL+ L +CHS
Sbjct: 60  IIKLLDVFRHK--GDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE-LLADYQ 341
            GI+HRD+KP N++I+     L+L D+GLA  F  P + Y   V +R+++ PE LL D  
Sbjct: 117 HGILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 342 YHIELD-----PRFADIL-------GRHSRKRWERFVHTENQHLVSPEALDFLDKNILGR 389
           Y   +D       FA++L       G+    +  +   T    L +P+   +     L R
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT----LGTPDPEVWPKFTSLAR 231

Query: 390 HSRKRWERFVHTENQHL---VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           + +  + +        L    SP+ALD L ++L YD ++R+TA +A+ HPYF
Sbjct: 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  124 bits (310), Expect = 2e-31
 Identities = 74/291 (25%), Positives = 125/291 (42%), Gaps = 31/291 (10%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK------IKREIKILENLRGG 225
            Y+++RKLG G + EV+ A + +      +K+L    + K        REI+IL +L   
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ------TLTDYDIRYYLYELLKALD 279
            NI+ L    +D  S    L+ E+V+    + L +       L++ +  + L ++L AL+
Sbjct: 58  PNIVKLYDFFQDEGS--LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-------HPGQEYNVRVASRYFK 332
           Y HS GI+HRD+KP N+++D + R ++LID+GLA+               +  V +  + 
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 333 GPELLADYQYHIELDPRFADI--LGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRH 390
            PE+L      +      +DI  LG      +E              +       I+   
Sbjct: 176 APEVL--LGLSLAYASSSSDIWSLGITL---YELLTGLPPFEGEKNSSATSQTLKIILEL 230

Query: 391 SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
                   +   N  L+S  A D L KLL  D   RL++   + H     +
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281

Length = 384

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  121 bits (306), Expect = 2e-31
 Identities = 82/312 (26%), Positives = 133/312 (42%), Gaps = 70/312 (22%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVK-ILKPVKKKKIK----REIKILENLRGGT 226
            Y+++ ++G G +  VF+A + ++ +   +K +     +  I     REIK L+  +   
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHP- 59

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-------IRYYLYELLKALD 279
            ++ L  V          L+ E++ +     L + L D +       ++ Y+  LLK + 
Sbjct: 60  YVVKLLDVFPHGSGF--VLVMEYMPSD----LSEVLRDEERPLPEAQVKSYMRMLLKGVA 113

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELL 337
           Y H+ GIMHRD+KP N++I   +  L++ D+GLA  +   +   Y+ +VA+R+++ PELL
Sbjct: 114 YMHANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172

Query: 338 ADYQ-YHIELD---------------PRFA------------DILGRHSRKRWERFVHTE 369
              + Y   +D               P F               LG  + + W       
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETW------- 225

Query: 370 NQHLVSPEALDFLDKN-ILGRHS-RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL 427
                 P      D N I    S     E           SPEALD L  LL YD  +RL
Sbjct: 226 ------PGLTSLPDYNKITFPESKPIPLEEIFPD-----ASPEALDLLKGLLVYDPSKRL 274

Query: 428 TAREAMDHPYFY 439
           +A EA+ HPYF 
Sbjct: 275 SAAEALRHPYFT 286

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  120 bits (304), Expect = 5e-31
 Identities = 87/304 (28%), Positives = 124/304 (40%), Gaps = 56/304 (18%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-----PVKKKKIKREIKILENLRGGTN 227
           Y+++  +G G Y  V +  N  + +   +K  K        KK   RE+K+L  LR   N
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH-EN 61

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQL--YQTLTDYD-IRYYLYELLKALDYCHSM 284
           I+ L+   +        L+FE+V  T  + L         D +R Y+++LL+A+ YCHS 
Sbjct: 62  IVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH--PGQEYNVRVASRYFKGPELL-ADYQ 341
            I+HRD+KP N+++  E+  L+L D+G A      P       VA+R+++ PELL  D  
Sbjct: 120 NIIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 342 YHIELD---------------PRFA------------DILGRHSRKRWERFVHTENQHLV 374
           Y   +D               P F               LG       E F    N    
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS--NPRFA 236

Query: 375 SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD 434
                +      L R                 VS  ALDFL   LR D  ERLT  E + 
Sbjct: 237 GVAFPEPSQPESLERRYPG------------KVSSPALDFLKACLRMDPKERLTCDELLQ 284

Query: 435 HPYF 438
           HPYF
Sbjct: 285 HPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  118 bits (299), Expect = 1e-30
 Identities = 42/133 (31%), Positives = 73/133 (54%), Gaps = 8/133 (6%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           AL+Y HS GI+HRD+KP N+++D +   ++L D+GLA    PG++    V +  +  PE+
Sbjct: 109 ALEYLHSKGIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEV 167

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYH 129
           L   + Y  ++D+WSLG +L  ++  K PF       DQL+ + K +G  +         
Sbjct: 168 L-LGKGYGKAVDIWSLGVILYELLTGKPPF----PGDDQLLELFKKIGKPK--PPFPPPE 220

Query: 130 IELDPRFADILGR 142
            ++ P   D++ +
Sbjct: 221 WDISPEAKDLIRK 233

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  118 bits (299), Expect = 2e-30
 Identities = 91/297 (30%), Positives = 144/297 (48%), Gaps = 46/297 (15%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSD----KCVVKILKPVKKKKIKREIKILENLRGGTNI 228
           Y+++ K+G G +SEV +A + ++      KC+ K  K +++    REI+ L  L    NI
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 229 ITLQAVVKDPVSRTPALIFE--HVNNTDF-KQLYQTLTDYDIRYYLYELLKALDYCHSMG 285
           + L  V+ D  +   AL+FE   +N  +  K   + L +  ++ Y+Y+LLK+LD+ H  G
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 286 IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE-LLADYQYHI 344
           I HRD+KP N++I  +   L+L D+G     +    Y   +++R+++ PE LL D  Y  
Sbjct: 121 IFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGP 178

Query: 345 ELDPR-----FADILGRHSRKRWERFVHTENQHLVSPEALDFLDK--NILG--------- 388
           ++D       F +IL               N+       LD + K  ++LG         
Sbjct: 179 KMDIWAVGCVFFEILSLFP------LFPGTNE-------LDQIAKIHDVLGTPDAEVLKK 225

Query: 389 -RHSRKRWERFVHTENQ------HLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            R SR     F   +           S E LD L KLL YD  ER+TA++A+ HPYF
Sbjct: 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  118 bits (299), Expect = 3e-30
 Identities = 94/321 (29%), Positives = 157/321 (48%), Gaps = 62/321 (19%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK--------REIKILENLRG 224
           Y+  +KLG G Y+ V++A + ++     +K +K  ++K+ K        REIK+L+ L+ 
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 225 GTNIITLQAV--VKDPVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKAL 278
             NII L  V   K  ++    L+FE +  TD +++ +     LT  DI+ Y+   L+ L
Sbjct: 62  -PNIIGLLDVFGHKSNIN----LVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPE-L 336
           +Y HS  I+HRD+KP+N++I   +  L+L D+GLA  +  P ++   +V +R+++ PE L
Sbjct: 116 EYLHSNWILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELL 174

Query: 337 LADYQYHIELDPR-----FADILGRHSRKRWERFVHTENQHLVSPEALDFLDK--NILGR 389
                Y + +D       FA++L R        F+  ++        +D L K    LG 
Sbjct: 175 FGARHYGVGVDMWSVGCIFAELLLR----VP--FLPGDSD-------IDQLGKIFEALGT 221

Query: 390 HSRKRWE---------RFVHTENQHL------VSPEALDFLDKLLRYDHYERLTAREAMD 434
            + + W           F       L       S +ALD L +LL  +  +R+TAR+A++
Sbjct: 222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281

Query: 435 HPYFYPIVKDQSRHTLPSSSP 455
           HPYF     +    T PS  P
Sbjct: 282 HPYF----SNDPAPTPPSQLP 298

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  117 bits (297), Expect = 5e-30
 Identities = 48/122 (39%), Positives = 74/122 (60%), Gaps = 5/122 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L YCHS  I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++ PE
Sbjct: 110 GLAYCHSHRILHRDLKPQNILINRDGV-LKLADFGLARAFGIPLRTYTHEVVTLWYRAPE 168

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD 126
           +L   + Y  ++D+WS+GC+ A MI   +P F G    DQL +I ++LGT  EE +  + 
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMI-TGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT 227

Query: 127 KY 128
           K 
Sbjct: 228 KL 229

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  112 bits (281), Expect = 1e-27
 Identities = 92/307 (29%), Positives = 154/307 (50%), Gaps = 54/307 (17%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL-----KPVKKKKIKREIKILENLRGGTN 227
           Y  ++ +GRG Y  V  A N ++++K  +K +       +  K+  REIK+L +L    N
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDH-EN 65

Query: 228 IITLQAVVKDPVSRTPALIFEHVN------NTDFKQLY---QTLTDYDIRYYLYELLKAL 278
           +I ++ ++  P  R     F  V       +TD  Q+    QTL+D   +Y+LY+LL+ L
Sbjct: 66  VIAIKDIMP-PPHRE---AFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-------EFYHPGQEYNVRVASRYF 331
            Y HS  ++HRD+KP N++++  N  L++ D+GLA       +F     EY   V +R++
Sbjct: 122 KYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEKGDFM---TEY---VVTRWY 174

Query: 332 KGPELL---ADYQYHIEL---DPRFADILGRHSRKRWERFVHTEN---QHLVSP--EALD 380
           + PELL   ++Y   I++      FA++LGR      + +VH      + L SP  E L 
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234

Query: 381 FLDKNILGRHSRKRWERFVHTENQHL------VSPEALDFLDKLLRYDHYERLTAREAMD 434
           F+        +R+      +T  Q         +P A+D L+K+L +D  +R+T  EA+ 
Sbjct: 235 FIRNE----KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290

Query: 435 HPYFYPI 441
           HPY   +
Sbjct: 291 HPYLASL 297

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 2e-27
 Identities = 51/133 (38%), Positives = 74/133 (55%), Gaps = 13/133 (9%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH--PGQEYNVRVASRYFKGP 67
           A+ YCHS  I+HRD+KP N+++  E+  L+L D+G A      P       VA+R+++ P
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDK 127
           ELL     Y   +D+W++GC++A ++   EP F G  + DQL  I K LG       L  
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELL-DGEPLFPGDSDIDQLYLIQKCLGP------LPP 223

Query: 128 YHIEL---DPRFA 137
            H EL   +PRFA
Sbjct: 224 SHQELFSSNPRFA 236

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  109 bits (276), Expect = 3e-27
 Identities = 46/123 (37%), Positives = 72/123 (58%), Gaps = 6/123 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGP 67
            L Y HS GI+HRD+K  N++I+++   L+L D+GLA  Y      +Y  RV + +++ P
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPP 170

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEELFEYL 125
           ELL     Y   +DMWS+GC+LA + F  +P F G    +QL +I ++ G  T+E +  +
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAEL-FLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229

Query: 126 DKY 128
            K 
Sbjct: 230 SKL 232

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  110 bits (278), Expect = 5e-27
 Identities = 90/322 (27%), Positives = 153/322 (47%), Gaps = 67/322 (20%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL-----KPVKKKKIKREIKILENLRGG 225
             Y+ +  +G G Y  V  AI+ +S  K  +K +      P   K+  RE+KIL + +  
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH- 63

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY-----------------QTLTDYDIR 268
            NII ++ +++ P +             DFK +Y                 Q LT+  IR
Sbjct: 64  DNIIAIRDILRPPGA-------------DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIR 110

Query: 269 YYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR--- 325
           Y+LY+LL+ L Y HS  ++HRD+KP N++++ E+ +LR+ D+G+A         +     
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSSPTEHKYFMT 169

Query: 326 --VASRYFKGPELL---ADYQYHIEL---DPRFADILGRHSRKRWERFVH---------- 367
             VA+R+++ PELL    +Y   I++      FA++LGR      + +VH          
Sbjct: 170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229

Query: 368 TENQHLVSPEALDFLDKNI--LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYE 425
           + ++ +++    D + K I  L R     W +          SPEALD L ++L++D  E
Sbjct: 230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPK-----ASPEALDLLSQMLQFDPEE 284

Query: 426 RLTAREAMDHPYF--YPIVKDQ 445
           R+T  +A+ HP+   Y    D+
Sbjct: 285 RITVEQALQHPFLAQYHDPDDE 306

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  109 bits (276), Expect = 9e-27
 Identities = 91/310 (29%), Positives = 147/310 (47%), Gaps = 64/310 (20%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKI-------------KREIKIL 219
           Y++++KLG+G Y  V++AI+ ++ +         V  KKI              REI  L
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEV--------VALKKIFDAFRNATDAQRTFREIMFL 60

Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKA 277
           + L    NI+ L  V+K    +   L+FE++  TD   + +   L D   RY +Y+LLKA
Sbjct: 61  QELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKA 119

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR------VASRYF 331
           L Y HS  ++HRD+KP N++++ + R ++L D+GLA      +E          VA+R++
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWY 178

Query: 332 KGPE-LLADYQYHIELD---------------PRFADILGRHSRKRWERFVHT------- 368
           + PE LL   +Y   +D               P F    G  +  + E+ +         
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP---GTSTLNQLEKIIEVIGPPSAE 235

Query: 369 ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT 428
           + + + SP A   LD ++  R  +   E           S +ALD L KLL ++  +RLT
Sbjct: 236 DIESIKSPFAATMLD-SLPSRPRKPLDELLPKA------SDDALDLLKKLLVFNPNKRLT 288

Query: 429 AREAMDHPYF 438
           A EA++HPY 
Sbjct: 289 AEEALEHPYV 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  108 bits (272), Expect = 1e-26
 Identities = 40/112 (35%), Positives = 70/112 (62%), Gaps = 4/112 (3%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKG 66
             + Y H+ GIMHRD+KP N++I   +  L++ D+GLA  +   +   Y+ +VA+R+++ 
Sbjct: 110 KGVAYMHANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRA 168

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           PELL   + YD  +D+W++GC+ A ++    P F G ++ +QL  + + LGT
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAELL-NGSPLFPGENDIEQLAIVFRTLGT 219

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  109 bits (274), Expect = 1e-26
 Identities = 86/325 (26%), Positives = 137/325 (42%), Gaps = 64/325 (19%)

Query: 164 VVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVK-ILKPVKKKKIK----REIKI 218
                +  DY+++ KLG G + EV++A  +++     +K IL   +K        REIKI
Sbjct: 1   FYGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKI 60

Query: 219 LENLRGGTNIITL--QAVVKDPVSRTPALIFEHV------------NNTDFKQLYQTLTD 264
           L+ L+   N++ L   AV +   S+        V             N   K     LT+
Sbjct: 61  LKKLKH-PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-----LTE 114

Query: 265 YDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-------- 316
             I+ Y+ +LL+ ++Y H   I+HRD+K  N++ID+    L++ D+GLA  Y        
Sbjct: 115 SQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPK 173

Query: 317 HPG----QEYNVRVASRYFKGPELLA-DYQYHIELD---------------PRFADILGR 356
             G    ++Y   V +R+++ PELL  + +Y   +D               P        
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233

Query: 357 HSRKRWERFVHTENQHLVSPEALD---FLDKNILGRHSRKRWERFVHTENQHLVSPEALD 413
                  +   T  +    P           +    + R   ERF        + PE LD
Sbjct: 234 DQLHLIFKLCGTPTEETW-PGWRSLPGCEGVHSFTNYPRTLEERFGK------LGPEGLD 286

Query: 414 FLDKLLRYDHYERLTAREAMDHPYF 438
            L KLL  D Y+RLTA +A++HPYF
Sbjct: 287 LLSKLLSLDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  107 bits (270), Expect = 1e-26
 Identities = 54/180 (30%), Positives = 98/180 (54%), Gaps = 15/180 (8%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK---IKREIKILENLRGGTNI 228
            ++++ K+G+G + EV++A + ++  +  +K++K   K+K   I  EI+IL+  +   NI
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHP-NI 59

Query: 229 ITLQA--VVKDPVSRTPALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCH 282
           +      + KD +     ++ E  +    K L     QTLT+  I Y   ELLK L+Y H
Sbjct: 60  VKYYGSYLKKDELW----IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
           S GI+HRD+K  N+++  +  +++LID+GL+      +  N  V + Y+  PE++    Y
Sbjct: 116 SNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY 174

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 2e-26
 Identities = 46/110 (41%), Positives = 69/110 (62%), Gaps = 3/110 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS GI+HRD+KP N++I+     L+L D+GLA  F  P + Y   V +R+++ PE
Sbjct: 110 GLAFCHSHGILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPE 168

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           LL   + Y   +D+WS+GC+ A ++ R+ P F G    DQL +I + LGT
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRR-PLFPGKSEIDQLFKIFRTLGT 217

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  108 bits (271), Expect = 2e-26
 Identities = 88/310 (28%), Positives = 149/310 (48%), Gaps = 66/310 (21%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-------PVKKKKIKREIKILENLR 223
           + Y+ + K+G G Y  VF+  N ++    +V I K       PV KK   REI++L+ L+
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQ--IVAIKKFVESEDDPVIKKIALREIRMLKQLK 58

Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
              N++ L  V +    R   L+FE+ ++T   +L +    + ++ I+  +++ L+A+++
Sbjct: 59  HP-NLVNLIEVFRR--KRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELL-A 338
           CH    +HRDVKP N++I  + + ++L D+G A     PG +Y   VA+R+++ PELL  
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQ-IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174

Query: 339 DYQYHIELDP-----RFADIL-------GR-------HSRKRWERFV--HTE----NQ-- 371
           D QY   +D       FA++L       G+         RK     +  H +    NQ  
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234

Query: 372 ---HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT 428
               +  PE  + L+             +F +      +S  AL FL   L+ D  ERL+
Sbjct: 235 KGLSIPEPETREPLE------------SKFPN------ISSPALSFLKGCLQMDPTERLS 276

Query: 429 AREAMDHPYF 438
             E ++HPYF
Sbjct: 277 CEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  108 bits (272), Expect = 2e-26
 Identities = 87/303 (28%), Positives = 146/303 (48%), Gaps = 56/303 (18%)

Query: 173 YQLVRKLGRGKYSEVFEAIN-VQSSDKCVVKILKP----VKKKKIKREIKILENLRGGTN 227
           Y  ++ +G G +  V  A + +   +  + KI+KP    V  K+  RE+K+L++LR   N
Sbjct: 12  YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH-EN 70

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCHSMG 285
           II+L  +   P           +  TD  +L  +  L    I+Y+LY++L+ L Y HS G
Sbjct: 71  IISLSDIFISP--LEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG 128

Query: 286 IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ-YHI 344
           ++HRD+KP N++I+ EN  L++ D+GLA    P  +    V++RY++ PE++  +Q Y +
Sbjct: 129 VVHRDLKPSNILIN-ENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDV 185

Query: 345 ELD---------------PRF------------ADILGRHSRKRWERFVHTENQHLVSPE 377
           E+D               P F             D+LG       +  ++T    + S  
Sbjct: 186 EVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP----DDVINT----ICSEN 237

Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
            L F+        S  + E    +E      P A+D L+K+L +D  +R++A EA+ HPY
Sbjct: 238 TLRFV-------QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290

Query: 438 FYP 440
             P
Sbjct: 291 LAP 293

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 5e-26
 Identities = 80/313 (25%), Positives = 136/313 (43%), Gaps = 77/313 (24%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK--------REIKILENLRG 224
           Y+++++LG G +  V+ A N ++ +   +K +K    KK          RE+K L  L  
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNE 56

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD--------IRYYLYELLK 276
             NI+ L+ V ++  +     +FE++       LYQ + D          IR  +Y++L+
Sbjct: 57  HPNIVKLKEVFRE--NDELYFVFEYMEGN----LYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 336
            L + H  G  HRD+KP N+++      +++ D+GLA        Y   V++R+++ PE+
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169

Query: 337 LADYQYH----------------IELDPRFA------------DILGRHSRKRWERFVHT 368
           L     +                  L P F              +LG  +++ W      
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW------ 223

Query: 369 ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLV---SPEALDFLDKLLRYDHYE 425
                  PE      K  LG     R+ +F  T    L+   SPEA+D +  +LR+D  +
Sbjct: 224 -------PEGYKLASK--LGF----RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKK 270

Query: 426 RLTAREAMDHPYF 438
           R TA +A+ HPYF
Sbjct: 271 RPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 6e-26
 Identities = 91/302 (30%), Positives = 140/302 (46%), Gaps = 55/302 (18%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK-------------REIKIL 219
           YQ V K+G G Y  V++A +  + +         V  KKI+             REI +L
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEI--------VALKKIRLETEDEGVPSTAIREISLL 52

Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL-----YQTLTDYDIRYYLYEL 274
           + L    NI+ L  VV         L+FE ++  D K+         L    I+ YLY+L
Sbjct: 53  KELNHP-NIVRLLDVVHS--ENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQL 108

Query: 275 LKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKG 333
           L+ + YCHS  ++HRD+KP N++ID E   L+L D+GLA  F  P + Y   V + +++ 
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167

Query: 334 PE-LLADYQYHIELDPR-----FADILGRHSR----------KRWERFVHTENQHLVSPE 377
           PE LL   QY   +D       FA+++ R              R  R + T ++  V P 
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDED-VWPG 226

Query: 378 ALDFLD-KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                D K    + +R+   + V       +  + LD L K+L YD  +R++A+ A+ HP
Sbjct: 227 VTSLPDYKPTFPKWARQDLSKVVPN-----LDEDGLDLLSKMLVYDPAKRISAKAALQHP 281

Query: 437 YF 438
           YF
Sbjct: 282 YF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  105 bits (263), Expect = 2e-25
 Identities = 90/304 (29%), Positives = 145/304 (47%), Gaps = 54/304 (17%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK------PVKKKKIKREIKILENLRG 224
           D Y+ V K+G G Y  V++A +  +++   +K ++       V    I REI +L+ ++ 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQH 60

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-----IRYYLYELLKALD 279
           G NI+ LQ VV     +   L+FE+++  D K+   +  D+      I+ YLY++L+ + 
Sbjct: 61  G-NIVRLQDVVHS--EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE-LL 337
           YCHS  ++HRD+KP N++ID     L+L D+GLA  F  P + +   V + +++ PE LL
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176

Query: 338 ADYQYHIELDPRFADILGRHSRKRWER---FVHTENQHLVSP--EALDFLDK--NILGRH 390
               Y   +D              W     F    NQ  + P    +D L K   ILG  
Sbjct: 177 GSRHYSTPVD-------------IWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTP 223

Query: 391 SRKRW----------ERFVHTENQHL------VSPEALDFLDKLLRYDHYERLTAREAMD 434
           + + W            F     + L      + P  +D L K+LR D  +R+TAR A++
Sbjct: 224 NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283

Query: 435 HPYF 438
           H YF
Sbjct: 284 HEYF 287

Length = 294

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  105 bits (263), Expect = 2e-25
 Identities = 85/312 (27%), Positives = 139/312 (44%), Gaps = 62/312 (19%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK-----------REIKIL 219
           D Y+ + K+G G Y +V++A +  +        L  +KK +++           REI +L
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLL 54

Query: 220 ENLRGGTNIITLQAVVKDPVSRTPA---LIFEHVNNTDFKQLYQT--------LTDYDIR 268
           + L     I+ L  V             L+FE+++ +D K+   +        L    I+
Sbjct: 55  QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIK 113

Query: 269 YYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVA 327
            ++Y+LLK + +CH  G+MHRD+KP N+++D +   L++ D GL   F  P + Y   + 
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173

Query: 328 SRYFKGPE-LLADYQYHIELDP-RFADILGRHSRKRWERFVHTENQHLVS---------- 375
           + +++ PE LL    Y   +D      I    SRK+      +E Q L+           
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233

Query: 376 ---PEALDFLDKNILGRHSRKRWERFVHTENQHL------VSPEALDFLDKLLRYDHYER 426
              P      D           W  F   + Q L      +SPE LD L K+LRYD  +R
Sbjct: 234 QVWPGVSKLRD-----------WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKR 282

Query: 427 LTAREAMDHPYF 438
           ++A+ A+ HPYF
Sbjct: 283 ISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  104 bits (262), Expect = 2e-25
 Identities = 81/313 (25%), Positives = 132/313 (42%), Gaps = 78/313 (24%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP---VKKKK---IKREIKILENLRG 224
           DD++  + +G G +S V  A   +++ +  +KIL     +K+KK   +K E ++L  L G
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 225 GTNIITLQAVVKDPVSRTPALIF--EHVNNTDFKQL---YQTLTDYDIRYYLYELLKALD 279
              II L    +D  +    L F  E+  N +  Q    Y +L +   R+Y  E+L AL+
Sbjct: 61  HPGIIKLYYTFQDEEN----LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           Y HS GI+HRD+KP N+++D +   +++ D+G A+   P                     
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPE---------------- 159

Query: 340 YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD---------------FLDK 384
                + D    D     +R+R+  FV T     VSPE L+                + +
Sbjct: 160 ---SNKGDATNIDSQIEKNRRRFASFVGT--AEYVSPELLNEKPAGKSSDLWALGCIIYQ 214

Query: 385 NILGRHSRKRWERFVHTENQHLV---------------SPEALDFLDKLLRYDHYERLTA 429
            + G+        F    N++L                 P+A D ++KLL  D  +RL  
Sbjct: 215 MLTGKPP------F-RGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV 267

Query: 430 REAMD----HPYF 438
            E  D    HP+F
Sbjct: 268 NEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 4e-25
 Identities = 86/307 (28%), Positives = 141/307 (45%), Gaps = 57/307 (18%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKK----KIKREIKILENLRGGT 226
             YQ +  +G G Y  V  A +  +  K  +K + P + +    +  REIKIL   +   
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKH-E 63

Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P   S     I + +  TD  +L   Q L++  I+Y+LY++L+ L Y H
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-----EFYHPGQ--EYNVRVASRYFKGPE 335
           S  ++HRD+KP N++++  N  L++ D+GLA     E  H G   EY   VA+R+++ PE
Sbjct: 124 SANVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEY---VATRWYRAPE 179

Query: 336 -LLADYQYHIELD---------------PRFADILGRHSRKRWERFVHTEN---QHLVSP 376
            +L    Y   +D               P F    G+        ++H  N     L +P
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP---GKD-------YLHQLNLILGVLGTP 229

Query: 377 EALDFLDKNILGRHSRKRWERFVHTENQHL------VSPEALDFLDKLLRYDHYERLTAR 430
              D     I+   +R   +                  P+ALD LDK+L ++ ++R+T  
Sbjct: 230 SQEDL--NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVE 287

Query: 431 EAMDHPY 437
           EA+ HPY
Sbjct: 288 EALAHPY 294

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  104 bits (261), Expect = 5e-25
 Identities = 44/110 (40%), Positives = 70/110 (63%), Gaps = 3/110 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPE 68
            L+Y HS  I+HRD+KP+N++I   +  L+L D+GLA  +  P ++   +V +R+++ PE
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPE 172

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           LL   + Y   +DMWS+GC+ A ++ R  PF  G  + DQL +I + LGT
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGT 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  105 bits (262), Expect = 6e-25
 Identities = 91/307 (29%), Positives = 149/307 (48%), Gaps = 51/307 (16%)

Query: 167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL-KP----VKKKKIKREIKILEN 221
           W   + YQ +  +G G Y  V  A + +   K  VK L +P    +  ++  RE+++L++
Sbjct: 11  WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH 70

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNN---------TDFKQL--YQTLTDYDIRYY 270
           ++   N+I L  V       TPA   E+ N           D   +   Q L+D  +++ 
Sbjct: 71  MKH-ENVIGLLDVF------TPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123

Query: 271 LYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 330
           +Y+LL+ L Y HS GI+HRD+KP NV ++ E+ +LR++D+GLA       E    VA+R+
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNVAVN-EDCELRILDFGLAR--QADDEMTGYVATRW 180

Query: 331 FKGPELLADYQYH-------------IELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
           ++ PE++ ++ ++              EL    A   G     + +R +  E     SPE
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM--EVVGTPSPE 238

Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQHL------VSPEALDFLDKLLRYDHYERLTARE 431
            L    K I   H+RK  +   H   Q L       +P A+D L+K+L  D  +R++A E
Sbjct: 239 VL----KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASE 294

Query: 432 AMDHPYF 438
           A+ HPYF
Sbjct: 295 ALAHPYF 301

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  103 bits (259), Expect = 2e-24
 Identities = 46/116 (39%), Positives = 69/116 (59%), Gaps = 12/116 (10%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-----EFYHPGQ--EYNVRVASR 62
            L Y HS  ++HRD+KP N++++  N  L++ D+GLA     +    G   EY   V +R
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEY---VVTR 170

Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +++ PELL     Y  ++D+WS+GC+ A ++ RK P F G D  DQL  I +VLGT
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK-PLFPGRDYIDQLNLIVEVLGT 225

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  100 bits (251), Expect = 2e-23
 Identities = 44/114 (38%), Positives = 73/114 (64%), Gaps = 7/114 (6%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR-----VASRYF 64
            L Y HS  ++HRD+KP N++++  + +L++ D+GLA  +      N       VA+R++
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175

Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + PE++  +Q Y  ++D+WS+GC+LA ++ RK P F G D  DQL +I +VLGT
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQILQVLGT 228

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 98.3 bits (245), Expect = 6e-23
 Identities = 41/107 (38%), Positives = 64/107 (59%), Gaps = 2/107 (1%)

Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLA 71
           +CH  G+MHRD+KP N+++D +   L++ D GL   F  P + Y   + + +++ PE+L 
Sbjct: 125 HCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLL 184

Query: 72  DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
               Y   +D+WS+GC+ A M  RK+P F G     QL+ I K+LGT
Sbjct: 185 GSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSELQQLLHIFKLLGT 230

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 97.8 bits (244), Expect = 7e-23
 Identities = 46/110 (41%), Positives = 68/110 (61%), Gaps = 3/110 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE 68
            + YCHS  ++HRD+KP N++ID E   L+L D+GLA  F  P + Y   V + +++ PE
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 169

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +L   + Y   +D+WS+GC+ A M+ R+ P F G    DQL RI + LGT
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRR-PLFPGDSEIDQLFRIFRTLGT 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 97.9 bits (244), Expect = 7e-23
 Identities = 44/109 (40%), Positives = 72/109 (66%), Gaps = 2/109 (1%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPEL 69
           L +CHS  ++HRD+KP N++I+ +N +L+L D+GLA  +  P + Y+  V + +++ P++
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 170

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           L   ++Y  S+DMWS GC+ A +     P F G+D  DQL RI ++LGT
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 98.9 bits (247), Expect = 7e-23
 Identities = 84/323 (26%), Positives = 148/323 (45%), Gaps = 79/323 (24%)

Query: 167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL-----KPVKKKKIKREIKILEN 221
           W   D YQ +  +G G Y +V  A + ++  K  +K L       +  K+  RE+++L++
Sbjct: 11  WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKH 70

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY----------------QTLTDY 265
           +    N+I L  V       TPA     +   DF+ +Y                Q L+D 
Sbjct: 71  MDH-ENVIGLLDVF------TPA---SSLE--DFQDVYLVTHLMGADLNNIVKCQKLSDD 118

Query: 266 DIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR 325
            I++ +Y++L+ L Y HS GI+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLAR--HTDDEMTGY 175

Query: 326 VASRYFKGPELLADY-QY---------------------------HIELDPRFADILGRH 357
           VA+R+++ PE++ ++  Y                           HI+   R  +++G  
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235

Query: 358 SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDK 417
                E  +    Q + S  A +++    L +  +K    F    +    +P A+D L+K
Sbjct: 236 D----EELL----QKISSESARNYIQS--LPQMPKK---DFKEVFSGA--NPLAIDLLEK 280

Query: 418 LLRYDHYERLTAREAMDHPYFYP 440
           +L  D  +R+TA EA+ HPY   
Sbjct: 281 MLVLDPDKRITAAEALAHPYLAE 303

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 98.6 bits (245), Expect = 9e-23
 Identities = 85/308 (27%), Positives = 149/308 (48%), Gaps = 53/308 (17%)

Query: 167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL-KP----VKKKKIKREIKILEN 221
           W   + YQ +  +G G Y  V  A + ++  +  VK L +P    +  K+  RE+++L++
Sbjct: 13  WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 72

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNN---------TDFKQLY--QTLTDYDIRYY 270
           ++   N+I L  V       TPA   E  N+          D   +   Q LTD  +++ 
Sbjct: 73  MKH-ENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125

Query: 271 LYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 330
           +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRW 182

Query: 331 FKGPELLADY-QYHIELDPR-----FADIL-GR---------HSRKRWERFVHTENQHLV 374
           ++ PE++ ++  Y+  +D        A++L GR            K   R V T    L+
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 242

Query: 375 ----SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAR 430
               S  A +++    L +  +  +       N     P A+D L+K+L  D  +R+TA 
Sbjct: 243 KKISSESARNYIQS--LTQMPKMNFANVFIGAN-----PLAVDLLEKMLVLDSDKRITAA 295

Query: 431 EAMDHPYF 438
           +A+ H YF
Sbjct: 296 QALAHAYF 303

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 79/310 (25%), Positives = 140/310 (45%), Gaps = 57/310 (18%)

Query: 167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK----REIKILENL 222
           +G+ + Y+ + KLG G Y+ V++  +  +     +K ++   ++       RE  +L++L
Sbjct: 1   FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL 60

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKAL 278
           +   NI+TL  ++     +T  L+FE+++ TD KQ        L+ +++R +L++LL+ L
Sbjct: 61  KH-ANIVTLHDIIH--TKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE-L 336
            YCH   ++HRD+KP N++I     +L+L D+GLA     P + Y+  V + +++ P+ L
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVL 175

Query: 337 LADYQYHIELD---------------PRFA-------------DILGRHSRKRWERFVHT 368
           L   +Y   LD               P F               +LG  + + W      
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235

Query: 369 ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT 428
                  P +  F     L  H      R           P   +   K L+Y+  +R++
Sbjct: 236 PE---FKPYSFPFYPPRPLINH----APRL-------DRIPHGEELALKFLQYEPKKRIS 281

Query: 429 AREAMDHPYF 438
           A EAM HPYF
Sbjct: 282 AAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 99.7 bits (248), Expect = 1e-22
 Identities = 55/132 (41%), Positives = 77/132 (58%), Gaps = 10/132 (7%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           AL Y HS  I HRD+KP N++ID     L+L D+G A+    GQ     + SR+++ PEL
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPEL 241

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEELFEYLDK 127
           +     Y   +D+WSLGC++A MI    P F G  + DQLVRI +VLG  TE+  +    
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQVLGTPTEDQLK---- 296

Query: 128 YHIELDPRFADI 139
              E++P +ADI
Sbjct: 297 ---EMNPNYADI 305

Length = 440

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 95.0 bits (237), Expect = 2e-22
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 1/93 (1%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQEYNVRV 59
           +RI       L+Y HS GI+HRD+KP N+++D +N K++L D+GL++            V
Sbjct: 95  LRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154

Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASM 92
            +  +  PE+L     Y    D+WSLG +L  +
Sbjct: 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 96.8 bits (241), Expect = 4e-22
 Identities = 86/317 (27%), Positives = 141/317 (44%), Gaps = 43/317 (13%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK---REIKILENLRGGTNII 229
           Y  +R LG G    VF A++     +  VK +     + +K   REIKI+  L    NI+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDH-DNIV 65

Query: 230 T-----------LQAVVKDPVSRTPALIFEHVNNTDFKQL--YQTLTDYDIRYYLYELLK 276
                       L   V          I +    TD   +     L++   R ++Y+LL+
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125

Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFK 332
            L Y HS  ++HRD+KP NV I+ E+  L++ D+GLA    P   +    +  + +++++
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185

Query: 333 GPELL---ADYQYHIELDPR---FADIL-------GRHSRKRWERFVHTENQHLVSPEAL 379
            P LL    +Y   I++      FA++L       G H  ++ +  +  E+  +V  E  
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL--ESVPVVREEDR 243

Query: 380 DFLDKNILGRHSRKRWERFVHTENQHL---VSPEALDFLDKLLRYDHYERLTAREAMDHP 436
           + L   I         E       + L   V+PEALDFL+++L ++  +RLTA EA+ HP
Sbjct: 244 NELLNVIPSFVRNDGGE--PRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP 301

Query: 437 YF--YPIVKDQSRHTLP 451
           Y   Y    D+     P
Sbjct: 302 YMSCYSCPFDEPVSLHP 318

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 42/107 (39%), Positives = 67/107 (62%), Gaps = 2/107 (1%)

Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLA 71
           YCHS  ++HRD+KP N++ID     L+L D+GLA  F  P + +   V + +++ PE+L 
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176

Query: 72  DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
             + Y   +D+WS+GC+ A M+ +K P F G    D+L +I ++LGT
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK-PLFPGDSEIDELFKIFRILGT 222

Length = 294

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 78/309 (25%), Positives = 147/309 (47%), Gaps = 46/309 (14%)

Query: 167 WGQQ--DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK-----IKREIKIL 219
           WG++  D + ++ ++G G Y +V++A +  + +   +K ++   +K+       REIKIL
Sbjct: 1   WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKIL 60

Query: 220 ENLRGGTNIITLQAVVKDPVSRTP--------ALIFEHVNNTDFKQLYQTLTDYD---IR 268
             L    NI+ L+ +V D               L+FE++++     L   L  +    I+
Sbjct: 61  RQLNH-RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119

Query: 269 YYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRV 326
            ++ +LL+ L+YCH    +HRD+K  N++++++  +++L D+GLA  Y+  +   Y  +V
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPYTNKV 178

Query: 327 ASRYFKGPE-LLADYQYHIELDP-RFADILGRHSRKRWERFVHTENQHL----------- 373
            + +++ PE LL + +Y   +D      ILG    K+     + E   L           
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238

Query: 374 --VSPEALDFLDKNILG---RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT 428
             V P+ +     N +    ++ R+  E F        +   ALD LD +L  D  +R T
Sbjct: 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEF------SFIPTPALDLLDHMLTLDPSKRCT 292

Query: 429 AREAMDHPY 437
           A EA++ P+
Sbjct: 293 AEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 46/141 (32%), Positives = 77/141 (54%), Gaps = 16/141 (11%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE 68
            +++CHS  I+HRD+KP N+++  ++  ++L D+G A     PG+ Y   VA+R+++ PE
Sbjct: 112 GIEFCHSHNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE 170

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY 128
           LL     Y  ++D+W++GC++  M    EP F G  + DQL  I K LG           
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEM-LTGEPLFPGDSDIDQLYHIIKCLGN---------- 219

Query: 129 HIELDPRFADILGRARVYADV 149
              L PR  +I  +  ++A +
Sbjct: 220 ---LIPRHQEIFQKNPLFAGM 237

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 93.1 bits (231), Expect = 4e-21
 Identities = 82/320 (25%), Positives = 156/320 (48%), Gaps = 56/320 (17%)

Query: 167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK----REIKILENL 222
           +G+ + Y  + KLG G Y+ V++  +  + +   +K ++   ++       RE+ +L++L
Sbjct: 2   FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL 61

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTD-------YDIRYYLYELL 275
           +   NI+TL  ++     ++  L+FE+++    K L Q L D       ++++ +L++LL
Sbjct: 62  KHA-NIVTLHDIIH--TEKSLTLVFEYLD----KDLKQYLDDCGNSINMHNVKLFLFQLL 114

Query: 276 KALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGP 334
           + L+YCH   ++HRD+KP N++I+ E  +L+L D+GLA     P + Y+  V + +++ P
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173

Query: 335 E-LLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP-----EALDFLDKNILG 388
           + LL    Y  ++D      +          F        + P     E L F+ + ILG
Sbjct: 174 DILLGSTDYSTQIDMWGVGCI----------FYEMSTGRPLFPGSTVEEQLHFIFR-ILG 222

Query: 389 RHSRKRWERFVHTE-----NQHLVSPEAL------------DFLDKLLRYDHYERLTARE 431
             + + W   +  E     N      + L            + L KLL+++  +R++A E
Sbjct: 223 TPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEE 282

Query: 432 AMDHPYFYPIVKDQSRHTLP 451
           AM HPYF+ +   +  H LP
Sbjct: 283 AMKHPYFHCL--GERIHKLP 300

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 92.6 bits (230), Expect = 4e-21
 Identities = 80/302 (26%), Positives = 141/302 (46%), Gaps = 55/302 (18%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK-------------REIKIL 219
           +Q V K+G G Y  V++A N  +         + V  KKI+             REI +L
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTG--------EVVALKKIRLDTETEGVPSTAIREISLL 53

Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT-----LTDYDIRYYLYEL 274
           + L    NI+ L  V+         L+FE ++  D K+         +    I+ YL++L
Sbjct: 54  KELNH-PNIVKLLDVIHT--ENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQL 109

Query: 275 LKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKG 333
           L+ L +CHS  ++HRD+KP N++I+     ++L D+GLA  F  P + Y   V + +++ 
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 168

Query: 334 PELLADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPE 377
           PE+L   +Y+        L   FA+++ R +            R  R + T ++ +V P 
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPG 227

Query: 378 ALDFLD-KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                D K    + +R+ + + V       +  +  D L ++L YD  +R++A+ A+ HP
Sbjct: 228 VTSLPDYKPSFPKWARQDFSKVVPP-----LDEDGRDLLSQMLHYDPNKRISAKAALAHP 282

Query: 437 YF 438
           +F
Sbjct: 283 FF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 92.5 bits (230), Expect = 4e-21
 Identities = 43/107 (40%), Positives = 65/107 (60%), Gaps = 3/107 (2%)

Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLA 71
           +CHS  ++HRD+KP N++ID     ++L D+GLA  F  P + Y   V + +++ PE+L 
Sbjct: 116 FCHSRRVLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLL 174

Query: 72  DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
               Y   +D+WS+G + A M  +K P FHG    DQL RI ++LGT
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK-PLFHGDSEIDQLFRIFRILGT 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 93.5 bits (233), Expect = 6e-21
 Identities = 46/114 (40%), Positives = 77/114 (67%), Gaps = 6/114 (5%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS GI+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 130 GLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 186

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EEL 121
           + ++  Y+ ++D+WS+GC++A ++  K   F G D+ DQL RI  ++GT  EEL
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGK-TLFPGSDHIDQLKRIMNLVGTPDEEL 239

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 92.2 bits (229), Expect = 6e-21
 Identities = 43/109 (39%), Positives = 67/109 (61%), Gaps = 3/109 (2%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPEL 69
           L +CHS  ++HRD+KP N++I+     ++L D+GLA  F  P + Y   V + +++ PE+
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 171

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFPGDSEIDQLFRIFRTLGT 219

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 92.2 bits (229), Expect = 7e-21
 Identities = 69/301 (22%), Positives = 130/301 (43%), Gaps = 53/301 (17%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK----REIKILENLRGGTNI 228
           ++ + KLG G Y+ V++  N  + +   +K +    ++       REI +++ L+   NI
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH-ENI 60

Query: 229 ITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDY------DIRYYLYELLKALDYCH 282
           + L  V+         L+FE+++  D K+   T           ++ + Y+LLK + +CH
Sbjct: 61  VRLHDVIH--TENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE-LLADY 340
              ++HRD+KP N++I+     L+L D+GLA  F  P   ++  V + +++ P+ LL   
Sbjct: 118 ENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176

Query: 341 QYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLV-----SPEALD 380
            Y   +D               P F          +  R + T  +         PE   
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY-- 234

Query: 381 FLDKNILGRHSRKRWERFVHTENQHLV---SPEALDFLDKLLRYDHYERLTAREAMDHPY 437
                      +  + R+   + Q L     P  +D L +LL+ +   R++A +A+ HP+
Sbjct: 235 -----------KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Query: 438 F 438
           F
Sbjct: 284 F 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 91.5 bits (228), Expect = 7e-21
 Identities = 66/263 (25%), Positives = 112/263 (42%), Gaps = 53/263 (20%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVK--ILKPVKKKK---IKREIKILENLRGGT 226
           ++     LGRG +  V+ A++  + +   VK   L    +++   ++REI+IL +L+   
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-P 59

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNN---TDFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           NI+      +D    T  +  E+V+    +   + +  L +  IR Y  ++L+ L Y HS
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG------PELL 337
            GI+HRD+K  N+++D  +  ++L D+G A+      +      +   +G      PE++
Sbjct: 120 NGIVHRDIKGANILVD-SDGVVKLADFGCAKR---LGDIETGEGTGSVRGTPYWMAPEVI 175

Query: 338 ADYQYHIELDPRFADI--LG-----RHSRKR-WERFVHTENQH----------------- 372
                  E   R ADI  LG       + K  W       N                   
Sbjct: 176 RG-----EEYGRAADIWSLGCTVIEMATGKPPWSEL---GNPMAALYKIGSSGEPPEIPE 227

Query: 373 LVSPEALDFLDKNILGRHSRKRW 395
            +S EA DFL K  L R  +KR 
Sbjct: 228 HLSEEAKDFLRK-CLRRDPKKRP 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 93.1 bits (231), Expect = 8e-21
 Identities = 44/108 (40%), Positives = 73/108 (67%), Gaps = 4/108 (3%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 70
           L Y H+ GI+HRD+KP N+ ++ E+ +L+++D+GLA       E    V +R+++ PE++
Sbjct: 131 LKYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--QTDSEMTGYVVTRWYRAPEVI 187

Query: 71  ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            ++  Y  ++D+WS+GC++A M+  K P F GHD+ DQL+ I KV GT
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK-PLFKGHDHLDQLMEIMKVTGT 234

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 44/108 (40%), Positives = 68/108 (62%), Gaps = 4/108 (3%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 70
           L Y HS G++HRD+KP N++I+ EN  L++ D+GLA    P  +    V++RY++ PE++
Sbjct: 121 LKYVHSAGVVHRDLKPSNILIN-ENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIM 177

Query: 71  ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
             +Q YD  +D+WS GC+ A M    +P F G D+ +Q   I  +LGT
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEM-LEGKPLFPGKDHVNQFSIITDLLGT 224

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 92.7 bits (230), Expect = 1e-20
 Identities = 85/328 (25%), Positives = 163/328 (49%), Gaps = 53/328 (16%)

Query: 167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL-KPVKK----KKIKREIKILEN 221
           W   + Y  ++++G G Y  V  AI+ ++ +K  +K L +P +     K+  RE+ +L++
Sbjct: 11  WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH 70

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNN---------TDFKQLY-QTLTDYDIRYYL 271
           ++   N+I L  V       T A+  +   +         TD +++    L++  ++Y +
Sbjct: 71  MQH-ENVIGLLDV------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123

Query: 272 YELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 331
           Y++L  L Y HS GI+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    V +R++
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--HADAEMTGYVVTRWY 180

Query: 332 KGPELLADYQYHIE------LDPRFADILGRHSRKRWERFVHTENQHLV-----SPEALD 380
           + PE++ ++ ++ +      +    A++L   +  + + ++    Q L       PE + 
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240

Query: 381 FLD----KNI---LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
            L+    K+    L ++ RK +            SP+A+D L+K+L  D  +RLTA EA+
Sbjct: 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPK-----ASPQAVDLLEKMLELDVDKRLTATEAL 295

Query: 434 DHPYFYPIVKDQSRHTLPSSSPTPIVNS 461
           +HPYF     D  R     +   P  +S
Sbjct: 296 EHPYF-----DSFRDADEETEQQPYDDS 318

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 40/109 (36%), Positives = 71/109 (65%), Gaps = 3/109 (2%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPEL 69
           + +CH   ++HRD+KP N++I+     L+L D+GLA  F  P   ++  V + +++ P++
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDV 171

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           L   + Y  S+D+WS+GC++A MI  + P F G +N DQL++I +++GT
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTNNEDQLLKIFRIMGT 219

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 90.8 bits (225), Expect = 3e-20
 Identities = 83/319 (26%), Positives = 157/319 (49%), Gaps = 50/319 (15%)

Query: 167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK----REIKILENL 222
           +G+ + Y  + KLG G Y+ VF+  +  + +   +K ++   ++       RE+ +L++L
Sbjct: 2   FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL 61

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKAL 278
           +   NI+TL  +V    S T  L+FE+++  D KQ        ++ ++++ +LY++L+ L
Sbjct: 62  KHA-NIVTLHDIVHTDKSLT--LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGL 117

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE-L 336
            YCH   ++HRD+KP N++I+ E  +L+L D+GLA     P + Y+  V + +++ P+ L
Sbjct: 118 AYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176

Query: 337 LADYQYHIELDPR-----FADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS 391
           L   +Y  ++D       F ++     R  +      +  HL+           +LG  +
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMAS--GRPLFPGSTVEDELHLIF---------RLLGTPT 225

Query: 392 RKRWE-----------RFVHTENQHLVS------PEALDFLDKLLRYDHYERLTAREAMD 434
            + W             F   + Q L++       E ++ L K L+Y+  +R++A EAM 
Sbjct: 226 EETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285

Query: 435 HPYFYPIVKDQSRHTLPSS 453
           H YF  +      H+LP S
Sbjct: 286 HAYFRSL--GTRIHSLPES 302

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 40/110 (36%), Positives = 68/110 (61%), Gaps = 3/110 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            + + H   I+HRD+K  N+++++    L++ D+GLA E+  P + Y   V + +++ PE
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLKPYTQLVVTLWYRAPE 176

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           LL   + Y  ++DMWS+GC+ A ++  K+P F G    DQL +I K+LGT
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELL-TKKPLFPGKSEIDQLNKIFKLLGT 225

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 89.0 bits (221), Expect = 9e-20
 Identities = 85/303 (28%), Positives = 146/303 (48%), Gaps = 54/303 (17%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK-------------REIKI 218
           DY  + K+G G Y  V++  N ++         + V  KKI+             REI +
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTG--------QIVAMKKIRLESEEEGVPSTAIREISL 52

Query: 219 LENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD------IRYYLY 272
           L+ L+   NI+ LQ V+    SR   LIFE ++  D K+   +L          ++ YLY
Sbjct: 53  LKELQH-PNIVCLQDVLMQE-SRL-YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLY 108

Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYF 331
           ++L+ + +CHS  ++HRD+KP N++ID     ++L D+GLA  F  P + Y   V + ++
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVVTLWY 167

Query: 332 KGPE-LLADYQYHIELD-----PRFADILGR----HSRK------RWERFVHTENQHLVS 375
           + PE LL   +Y   +D       FA++  +    H         R  R + T  +  V 
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE-DVW 226

Query: 376 PEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH 435
           P      D     +++  +W++         +  + LD L+K+L YD  +R++A++A++H
Sbjct: 227 PGVTSLPDY----KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282

Query: 436 PYF 438
           PYF
Sbjct: 283 PYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 80/305 (26%), Positives = 140/305 (45%), Gaps = 60/305 (19%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL------KPVKKKKIKREIKILENLRGGT 226
           Y+ +  +G G Y  V +  + ++     +K        K VKK  + REI++L+ LR   
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQLRH-E 60

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N++ L  V +    +   L+FE V++T   D ++    L +  +R YL+++L+ +++CHS
Sbjct: 61  NLVNLIEVFRR--KKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELL-ADYQ 341
             I+HRD+KP N+++  ++  ++L D+G A     PG+ Y   VA+R+++ PELL  D +
Sbjct: 119 HNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177

Query: 342 Y------------HIEL---DPRF---ADI---------LGRHSRKRWERFVHTE-NQHL 373
           Y              E+   +P F   +DI         LG    +  E F        +
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237

Query: 374 VSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
             PE      K I      KR+ +          S   LD   + LR D  +R ++ + +
Sbjct: 238 RLPEV-----KEIEP--LEKRFPKL---------SGLVLDLAKQCLRIDPDDRPSSSQLL 281

Query: 434 DHPYF 438
            H +F
Sbjct: 282 HHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 83/306 (27%), Positives = 140/306 (45%), Gaps = 45/306 (14%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVK-ILKPVKKKKIK----REIKILENLRGG 225
             Y+ + K+G+G + EVF+A + ++     +K +L   +K+       REIKIL+ L+  
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKH- 70

Query: 226 TNIITLQAVVKDPVSR------TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELL 275
            N++ L  + +   +       +  L+FE   + D   L        T  +I+  +  LL
Sbjct: 71  ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 276 KALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-----PGQEYNVRVASRY 330
             L Y H   I+HRD+K  N++I  ++  L+L D+GLA  +          Y  RV + +
Sbjct: 130 NGLYYIHRNKILHRDMKAANILIT-KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188

Query: 331 FKGPE-LLADYQYHIELDPRFAD-ILGRHSRKRWERFV----HTENQHL---------VS 375
           ++ PE LL +  Y   +D   A  I+     + W R      +TE   L         ++
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMA----EMWTRSPIMQGNTEQHQLTLISQLCGSIT 244

Query: 376 PEALDFLDKNILGRHSR--KRWERFVHTENQHLVS-PEALDFLDKLLRYDHYERLTAREA 432
           PE    +DK  L +     +  +R V    +  V  P ALD +DKLL  D  +R+ A  A
Sbjct: 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304

Query: 433 MDHPYF 438
           ++H +F
Sbjct: 305 LNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 89.0 bits (220), Expect = 2e-19
 Identities = 44/108 (40%), Positives = 75/108 (69%), Gaps = 4/108 (3%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 70
           L Y HS GI+HRD+KP NV ++ E+ +LR++D+GLA       E    VA+R+++ PE++
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVN-EDCELRILDFGLAR--QADDEMTGYVATRWYRAPEIM 187

Query: 71  ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            ++  Y+ ++D+WS+GC++A ++ + +  F G+D  DQL RI +V+GT
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELL-KGKALFPGNDYIDQLKRIMEVVGT 234

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 76/302 (25%), Positives = 143/302 (47%), Gaps = 44/302 (14%)

Query: 167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK----REIKILENL 222
           +G+ + Y  + KLG G Y+ VF+  +  + +   +K ++   ++       RE+ +L+NL
Sbjct: 1   FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL 60

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKAL 278
           +   NI+TL  ++     R   L+FE++++ D KQ        ++ ++++ ++++LL+ L
Sbjct: 61  KH-ANIVTLHDIIH--TERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGL 116

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE-L 336
            YCH   I+HRD+KP N++I+ E  +L+L D+GLA     P + Y+  V + +++ P+ L
Sbjct: 117 SYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 175

Query: 337 LADYQYHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK 393
           L   +Y   +D      +       R  +      E  HL+           +LG  + +
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF---------RLLGTPTEE 226

Query: 394 RWERFVHTEN-------QHLVSP----------EALDFLDKLLRYDHYERLTAREAMDHP 436
            W      E        Q+   P          + +D L  LL Y+   R++A  A+ H 
Sbjct: 227 TWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286

Query: 437 YF 438
           YF
Sbjct: 287 YF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 46/116 (39%), Positives = 71/116 (61%), Gaps = 12/116 (10%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-----EFYHPGQ--EYNVRVASR 62
            L Y HS  ++HRD+KP N++++  N  L++ D+GLA     E  H G   EY   VA+R
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEY---VATR 173

Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +++ PE++ + + Y  ++D+WS+GC+LA M+  + P F G D   QL  I  VLGT
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFPGKDYLHQLNLILGVLGT 228

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 89.7 bits (222), Expect = 3e-19
 Identities = 81/301 (26%), Positives = 143/301 (47%), Gaps = 49/301 (16%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVK-ILKPVKKKKIKREIKILENLRGGTNIITL 231
           Y+L   +G G +  V+EAI + +S+K  +K +L+  + K   RE+ I++NL    NII L
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIMKNL-NHINIIFL 124

Query: 232 ------QAVVKDPVSRTPALIFEHVNNTDFKQLY------QTLTDYDIRYYLYELLKALD 279
                 +   K+  +    ++ E +  T  K +         L  + ++ Y Y+L +AL 
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-- 337
           Y HS  I HRD+KP N++ID     L+L D+G A+    GQ     + SR+++ PEL+  
Sbjct: 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244

Query: 338 -ADYQYHIEL-------------DPRFADILGRHSRKRWERFVH-----TENQ-HLVSPE 377
             +Y  HI+L              P F+   G+ S  +  R +      TE+Q   ++P 
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMILGYPIFS---GQSSVDQLVRIIQVLGTPTEDQLKEMNPN 301

Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
             D    ++  +  +K + +            +A++F+ + L+Y+  +RL   EA+  P+
Sbjct: 302 YADIKFPDVKPKDLKKVFPKG--------TPDDAINFISQFLKYEPLKRLNPIEALADPF 353

Query: 438 F 438
           F
Sbjct: 354 F 354

Length = 440

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 36/110 (32%), Positives = 68/110 (61%), Gaps = 4/110 (3%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPE 68
           L+YCH    +HRD+K  N++++++  +++L D+GLA  Y+  +   Y  +V + +++ PE
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPYTNKVITLWYRPPE 187

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           LL   + Y  ++D+WS GC+L  + F K+P F  +    QL  I+++ G+
Sbjct: 188 LLLGEERYGPAIDVWSCGCILGEL-FTKKPIFQANQELAQLELISRLCGS 236

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 76/299 (25%), Positives = 137/299 (45%), Gaps = 49/299 (16%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--------KKKIKREIKILENLRG 224
           Y+ + K+G G Y  VF+A N ++ +   +  LK V+             REI +L+ L+ 
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKELKH 58

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDY----DIRYYLYELLKALDY 280
             NI+ L  V+      T  L+FE+ +  D K+ + +         ++ ++++LLK L +
Sbjct: 59  -KNIVRLYDVLHSDKKLT--LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE-LLA 338
           CHS  ++HRD+KP N++I+ +N +L+L D+GLA  +  P + Y+  V + +++ P+ L  
Sbjct: 115 CHSHNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173

Query: 339 DYQYHIELDPRFAD-ILGRHSRKRWERFVHTENQHLVSPEALDFLDK--NILGRHSRKRW 395
              Y   +D   A  I    +      F   +          D L +   +LG  + + W
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--------DQLKRIFRLLGTPTEESW 225

Query: 396 ERFVHTEN-------------QHLV---SPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                  +              ++V   +    D L  LL  +  +R++A EA+ HPYF
Sbjct: 226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 86.4 bits (215), Expect = 4e-19
 Identities = 40/184 (21%), Positives = 82/184 (44%), Gaps = 17/184 (9%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI-----LKPVKKKKIKREIKILENLRGGT 226
            Y++++++G+G + +V+           V+K      +   +++    E+KIL+ L    
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-P 59

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTD-------FKQLYQTLTDYDIRYYLYELLKALD 279
           NII      ++       ++ E+ +  D        K+  +   +  I  +  +L  AL 
Sbjct: 60  NIIKYYESFEEKGKL--CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGPELLA 338
           Y HS  I+HRD+KP N+ +      ++L D+G+++      +     V + Y+  PEL  
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQ 176

Query: 339 DYQY 342
           +  Y
Sbjct: 177 NKPY 180

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 87.3 bits (216), Expect = 6e-19
 Identities = 80/308 (25%), Positives = 156/308 (50%), Gaps = 53/308 (17%)

Query: 167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL-KPVKK----KKIKREIKILEN 221
           W   D Y+ ++++G G Y  V  A++ ++  K  +K L +P +     K+  RE+++L++
Sbjct: 11  WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH 70

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNN---------TDFKQL--YQTLTDYDIRYY 270
           ++   N+I L  V       TP L  +  ++         TD  +L  ++ L++  I++ 
Sbjct: 71  MKH-ENVIGLLDVF------TPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFL 123

Query: 271 LYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 330
           +Y++LK L Y H+ GI+HRD+KP N+ ++ E+ +L+++D+GLA       E    V +R+
Sbjct: 124 VYQMLKGLKYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--QTDSEMTGYVVTRW 180

Query: 331 FKGPELLADYQYHIELDPRFA-------DILGR-------HSRKRWERFVHTEN------ 370
           ++ PE++ ++ ++ +    ++        + G+       H  +  E    T        
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240

Query: 371 QHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAR 430
           Q L S +A +++ K  L R  +K +   +        +P A++ L+K+L  D   R+TA 
Sbjct: 241 QKLQSEDAKNYVKK--LPRFRKKDFRSLLPN-----ANPLAVNVLEKMLVLDAESRITAA 293

Query: 431 EAMDHPYF 438
           EA+ HPYF
Sbjct: 294 EALAHPYF 301

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 6e-19
 Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 17/198 (8%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGGTNI 228
             ++LV  +G G Y +V++A + ++     +KI+  ++  +++IK E  IL       NI
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65

Query: 229 ITLQAVVKDPVSRTPA----LIFEHVNN---TD----FKQLYQTLTDYDIRYYLYELLKA 277
            T                  L+ E       TD     ++  + L +  I Y L E L+ 
Sbjct: 66  ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPEL 336
           L Y H   ++HRD+K  N+++      ++L+D+G+ A+        N  + + Y+  PE+
Sbjct: 126 LAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184

Query: 337 LA-DYQYHIELDPRFADI 353
           +A D Q     D R +D+
Sbjct: 185 IACDEQPDASYDAR-SDV 201

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 85.3 bits (212), Expect = 9e-19
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 2/98 (2%)

Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +       L+Y HS GI+HRD+K  N+++  +  +++LID+GL+      +  N  V + 
Sbjct: 103 VCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKARNTMVGTP 161

Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           Y+  PE++   + YDY  D+WSLG     +   K P+ 
Sbjct: 162 YWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYS 198

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 86.8 bits (215), Expect = 1e-18
 Identities = 85/321 (26%), Positives = 154/321 (47%), Gaps = 49/321 (15%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTN 227
           Y++   +G+G Y  V  AI+  + +K  +K +  V        +I REIK+L  LR   +
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRH-PD 60

Query: 228 IITLQAVVKDPVSRT---PALIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYC 281
           I+ ++ ++  P  R      ++FE +  +D  Q+ +    LT    +++LY+LL+AL Y 
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH---PGQEY-NVRVASRYFKGPELL 337
           H+  + HRD+KP N++ +  + KL++ D+GLA       P   +    VA+R+++ PEL 
Sbjct: 120 HTANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178

Query: 338 ADY--QYHIELDPR-----FADIL-GR---------HSRKRWERFVHTENQHLVS----P 376
             +  +Y   +D       FA++L G+         H        + T +   +S     
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238

Query: 377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
           +A  +L  ++  +      ++F + +      P AL  L++LL +D  +R TA EA+  P
Sbjct: 239 KARRYLS-SMRKKQPVPFSQKFPNAD------PLALRLLERLLAFDPKDRPTAEEALADP 291

Query: 437 YFYPIVKDQSRHTLPSSSPTP 457
           YF  + K +     PS+ P  
Sbjct: 292 YFKGLAKVERE---PSAQPIT 309

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 40/109 (36%), Positives = 66/109 (60%), Gaps = 3/109 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE 68
           A+++CH    +HRDVKP N++I  + + ++L D+G A     PG +Y   VA+R+++ PE
Sbjct: 112 AVNFCHKHNCIHRDVKPENILITKQGQ-IKLCDFGFARILTGPGDDYTDYVATRWYRAPE 170

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           LL     Y   +D+W++GC+ A ++   +P + G  + DQL  I K LG
Sbjct: 171 LLVGDTQYGPPVDVWAIGCVFAELL-TGQPLWPGKSDVDQLYLIRKTLG 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 43/107 (40%), Positives = 71/107 (66%), Gaps = 4/107 (3%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 70
           L Y HS GI+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    V +R+++ PE++
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVI 186

Query: 71  ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
            ++  Y+ ++D+WS+GC++A M+  K   F G D  DQL +I KV G
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQILKVTG 232

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 80/316 (25%), Positives = 141/316 (44%), Gaps = 75/316 (23%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK---IK--REIKILENLRGG 225
           D+Y+ + ++  G Y  V+ A + ++ +   +K LK  K+K+   I   REI IL  L+  
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQH- 63

Query: 226 TNIITLQAVVKDPVSRTPALIF------EHVNNTDFKQLYQTLTDY----DIRYYLYELL 275
            NI+T++ VV   V      I+      EH    D K L +T+       +++  + +LL
Sbjct: 64  PNIVTVKEVV---VGSNLDKIYMVMEYVEH----DLKSLMETMKQPFLQSEVKCLMLQLL 116

Query: 276 KALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 334
             + + H   I+HRD+K  N+++++    L++ D+GLA E+  P + Y   V + +++ P
Sbjct: 117 SGVAHLHDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLKPYTQLVVTLWYRAP 175

Query: 335 ELL---ADYQYHIEL-------------DPRFA------------DILGRHSRKRWERFV 366
           ELL    +Y   I++              P F              +LG  + K W  F 
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF- 234

Query: 367 HTENQHLVSPEALDFLDKNILGRH----SRKRWERFVHTENQHLVSPEALDFLDKLLRYD 422
                       L    K    ++     RK++     ++N         D L++LL YD
Sbjct: 235 ----------SELPGAKKKTFTKYPYNQLRKKFPALSLSDN-------GFDLLNRLLTYD 277

Query: 423 HYERLTAREAMDHPYF 438
             +R++A +A+ HPYF
Sbjct: 278 PAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 41/113 (36%), Positives = 67/113 (59%), Gaps = 7/113 (6%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR-----VASRYFK 65
           L Y HS  ++HRD+KP N++++ E+ +LR+ D+G+A         +       VA+R+++
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178

Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PELL     Y  ++DMWS+GC+ A M+ R++  F G +   QL  I  VLG+
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ-LFPGKNYVHQLKLILSVLGS 230

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 85.1 bits (210), Expect = 5e-18
 Identities = 40/111 (36%), Positives = 73/111 (65%), Gaps = 4/111 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 188

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT  
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPG 238

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 83.8 bits (208), Expect = 5e-18
 Identities = 39/114 (34%), Positives = 65/114 (57%), Gaps = 13/114 (11%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----VASRYFK 65
            +D+ HS  I+HRD+KP N+++  + + +++ D+GLA  Y     + +     V + +++
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIY----SFEMALTSVVVTLWYR 173

Query: 66  GPE-LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE LL     Y   +DMWS+GC+ A + FR+ P F G    DQL +I  V+G 
Sbjct: 174 APEVLLQSS--YATPVDMWSVGCIFAEL-FRRRPLFRGTSEADQLDKIFDVIGL 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 84.5 bits (210), Expect = 6e-18
 Identities = 42/114 (36%), Positives = 67/114 (58%), Gaps = 8/114 (7%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR------VASRY 63
           AL Y HS  ++HRD+KP N++++ + R ++L D+GLA      +E          VA+R+
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRW 177

Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           ++ PE+L     Y   +DMWS+GC+L  M+  K P F G    +QL +I +V+G
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK-PLFPGTSTLNQLEKIIEVIG 230

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 76/327 (23%), Positives = 137/327 (41%), Gaps = 101/327 (30%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK-------------REIKIL 219
           Y+ + ++G G Y  V++A ++ +         + V  KK++             REI +L
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTG--------RFVALKKVRVPLSEEGIPLSTLREIALL 52

Query: 220 ENLR--GGTNIITLQAVVKDP-VSR--TPALIFEHVNNTDFKQLYQTLTDY--------- 265
           + L      NI+ L  V   P   R     L+FEHV+        Q L  Y         
Sbjct: 53  KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD--------QDLATYLSKCPKPGL 104

Query: 266 ---DIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 322
               I+  + +LL+ +D+ HS  I+HRD+KP N+++  + + +++ D+GLA  Y     +
Sbjct: 105 PPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIY----SF 159

Query: 323 NVR----VASRYFKGPELLADYQYHIELD---------------PRFA------------ 351
            +     V + +++ PE+L    Y   +D               P F             
Sbjct: 160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIF 219

Query: 352 DILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEA 411
           D++G  S + W R V       +   +           ++ + ++ FV       +  E 
Sbjct: 220 DVIGLPSEEEWPRNV------SLPRSSFP--------SYTPRSFKSFVPE-----ICEEG 260

Query: 412 LDFLDKLLRYDHYERLTAREAMDHPYF 438
           LD L K+L ++ ++R++A EA+ HPYF
Sbjct: 261 LDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 46/110 (41%), Positives = 64/110 (58%), Gaps = 5/110 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGP 67
           A+ +CH   I+HRD+KP N++I H N  L+L D+G A     G    Y   VA+R+++ P
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISH-NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           ELL     Y  ++DMWS+GC+L  +    +P F G    DQL  I KVLG
Sbjct: 171 ELLLGAP-YGKAVDMWSVGCILGELS-DGQPLFPGESEIDQLFTIQKVLG 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 74/288 (25%), Positives = 121/288 (42%), Gaps = 53/288 (18%)

Query: 176 VRKLGRGKYSEVFEAINVQSSDKCVVKILKP---VKKKKI---KREIKILENLRGGTNII 229
           ++ + +G +  V+ A    + D   +K+LK    + K ++   K E  I+        + 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 230 TLQAVV--KDPVSRTPALIFEHVNNTDFKQLYQTLTDYD---IRYYLYELLKALDYCHSM 284
            L      KD +     L+ E++N  D   L +TL        + Y+ E++  ++  H  
Sbjct: 61  KLYYSFQSKDYL----YLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHI 344
           GI+HRD+KP N++ID +   L+L D+GL+         N     ++   P+ LA      
Sbjct: 117 GIIHRDIKPENLLID-QTGHLKLTDFGLSR--------NGLENKKFVGTPDYLA------ 161

Query: 345 ELDPRFADILGRHSRKRW--------ERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE 396
              P     +G      W        E        H  +P+A+ F   NIL R  R  W 
Sbjct: 162 ---PETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-F--DNILSR--RINWP 213

Query: 397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTA---REAMDHPYFYPI 441
             V        SPEA+D +++LL  D  +RL A   +E   HP+F  I
Sbjct: 214 EEVKE----FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 83.6 bits (205), Expect = 2e-17
 Identities = 41/149 (27%), Positives = 65/149 (43%), Gaps = 12/149 (8%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-------HPGQEYNVRVASR 62
           AL+Y HS GI+HRD+KP N+++D + R ++LID+GLA+               +  V + 
Sbjct: 113 ALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 63  YFKGPELLADY--QMYDYSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQLVRIAKVLGT 118
            +  PE+L          S D+WSLG  L  ++    PF          Q ++I   L T
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232

Query: 119 EEL-FEYLDKYHIELDPRFADILGRARVY 146
             L           +    +D+L +    
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAK 261

Length = 384

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 36/109 (33%), Positives = 61/109 (55%), Gaps = 3/109 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +LD+ H  GI HRD+KP N++I  +   L+L D+G     +    Y   +++R+++ PE 
Sbjct: 112 SLDHMHRNGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPEC 169

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           L     Y   +D+W++GC+   ++    P F G +  DQ+ +I  VLGT
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLF-PLFPGTNELDQIAKIHDVLGT 217

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 41/120 (34%), Positives = 66/120 (55%), Gaps = 14/120 (11%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY--------HPG----QEYNVR 58
           ++Y H   I+HRD+K  N++ID+    L++ D+GLA  Y          G    ++Y   
Sbjct: 128 INYLHENHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           V +R+++ PELL   + Y  ++D+W +GC+ A M  R+ P   G  + DQL  I K+ GT
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PILQGKSDIDQLHLIFKLCGT 245

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 43/110 (39%), Positives = 63/110 (57%), Gaps = 4/110 (3%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPEL 69
           L YCH   ++HRD+KP N++I     +L+L D+GLA     P + Y+  V + +++ P++
Sbjct: 116 LAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDV 174

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVRIAKVLGT 118
           L     Y  SLDMW +GC+   M     P F G  D  DQL +I +VLGT
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMA-TGRPLFPGSTDVEDQLHKIFRVLGT 223

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 81.4 bits (202), Expect = 3e-17
 Identities = 37/109 (33%), Positives = 60/109 (55%), Gaps = 2/109 (1%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L + H  G  HRD+KP N+++      +++ D+GLA        Y   V++R+++ PE+
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           L     Y   +D+W+LGC++A + +   P F G    DQL +I  VLGT
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAEL-YTLRPLFPGSSEIDQLYKICSVLGT 217

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 39/111 (35%), Positives = 64/111 (57%), Gaps = 3/111 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           L     Y   +D+WS+GC+ A M FR++P F G  + DQL +I  V+G   
Sbjct: 181 LLQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPG 229

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 81.2 bits (200), Expect = 5e-17
 Identities = 78/310 (25%), Positives = 135/310 (43%), Gaps = 57/310 (18%)

Query: 167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK----REIKILENL 222
           +G    Y  + KLG G Y+ V++ I+  +     +K++    ++ +     RE  +L+ L
Sbjct: 1   FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKAL 278
           +   NI+ L  ++    + T   +FE+++ TD  Q        L  Y++R ++++LL+ L
Sbjct: 61  KHA-NIVLLHDIIHTKETLT--FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGL 116

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE-L 336
            Y H   I+HRD+KP N++I +   +L+L D+GLA     P Q Y+  V + +++ P+ L
Sbjct: 117 AYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL 175

Query: 337 LADYQYHIELD---------------PRFA-------------DILGRHSRKRWERFVHT 368
           L    Y   LD               P F               +LG  +   W      
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235

Query: 369 ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT 428
            N     PE         L    R  W+R           P+A D   ++L     +R++
Sbjct: 236 PN---YKPEWFLPCKPQQL----RVVWKRLSR-------PPKAEDLASQMLMMFPKDRIS 281

Query: 429 AREAMDHPYF 438
           A++A+ HPYF
Sbjct: 282 AQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 45/125 (36%), Positives = 73/125 (58%), Gaps = 17/125 (13%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-------EFYHPGQEYNVRVASRY 63
           L Y HS  ++HRD+KP N++++  N  L++ D+GLA       +F     EY   V +R+
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEKGDFM---TEY---VVTRW 173

Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EEL 121
           ++ PELL +   Y  ++D+WS+GC+ A ++ RK P F G D   QL  I ++LG+  EE 
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK-PLFPGKDYVHQLKLITELLGSPSEED 232

Query: 122 FEYLD 126
             ++ 
Sbjct: 233 LGFIR 237

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 79.4 bits (195), Expect = 2e-16
 Identities = 80/310 (25%), Positives = 139/310 (44%), Gaps = 57/310 (18%)

Query: 167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK----REIKILENL 222
           +G+ D Y+ + KLG G Y+ V++  +  +     +K+++  +++       RE  +L+ L
Sbjct: 1   FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKAL 278
           +   NI+ L  ++      T  L+FE+V+ TD  Q        L   +++ +L++LL+ L
Sbjct: 61  KHA-NIVLLHDIIH--TKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGL 116

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE-L 336
            Y H   I+HRD+KP N++I  +  +L+L D+GLA     P   Y+  V + +++ P+ L
Sbjct: 117 SYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175

Query: 337 LADYQYHIELD------------------PRFADI----------LGRHSRKRWERFVHT 368
           L   +Y   LD                  P   DI          LG  +   W   VH+
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG-VHS 234

Query: 369 ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT 428
              H        +  KN+     R+ W +  +  +       A D   KLL+     RL+
Sbjct: 235 L-PHFKPERFTLYSPKNL-----RQAWNKLSYVNH-------AEDLASKLLQCFPKNRLS 281

Query: 429 AREAMDHPYF 438
           A+ A+ H YF
Sbjct: 282 AQAALSHEYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 77.3 bits (190), Expect = 7e-16
 Identities = 76/295 (25%), Positives = 132/295 (44%), Gaps = 35/295 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGG 225
           + ++++  +G G Y  V +  + ++ +   +K  K  +     K+   RE+K+L  L+  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQ- 59

Query: 226 TNIITLQAVVKDPVSRTPAL--IFEHVNNTDFKQLYQTLTDY---DIRYYLYELLKALDY 280
            NI+ L    K+   R   L  +FE+V     + L +         +R Y+Y+L+KA+ +
Sbjct: 60  ENIVEL----KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLA 338
           CH   I+HRD+KP N++I H N  L+L D+G A     G    Y   VA+R+++ PELL 
Sbjct: 116 CHKNDIVHRDIKPENLLISH-NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174

Query: 339 DYQYHIELDP-RFADILGRHSRKRWERFVHTENQHLVS---------PEALDFLDKNILG 388
              Y   +D      ILG  S  +      +E   L +          E +     N   
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN--P 232

Query: 389 RHSRKRWERFVHTEN-----QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           R    R+    H ++       ++S   LD +  LL+ +  +R    + ++HP F
Sbjct: 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 76.4 bits (189), Expect = 1e-15
 Identities = 35/94 (37%), Positives = 57/94 (60%), Gaps = 3/94 (3%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
           +AL+Y HS+GI++RD+KP N+++D +   ++L D+GLA E    G   N    +  +  P
Sbjct: 104 LALEYLHSLGIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAP 162

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           E+L   + Y  ++D WSLG +L  M+  K PF+ 
Sbjct: 163 EVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYA 195

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 40/113 (35%), Positives = 67/113 (59%), Gaps = 4/113 (3%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV--RVASRYFKGPE 68
           L Y HS GI+HRD+KP N++++  N  L++ D+GLA    P +  ++   V ++Y++ PE
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
           +L   + Y  ++D+WS+GC+ A ++ R+   F       QL  I  +LGT  L
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRR-ILFQAQSPIQQLDLITDLLGTPSL 226

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 39/107 (36%), Positives = 64/107 (59%), Gaps = 3/107 (2%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 70
           LD+ H+  I+HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+L
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179

Query: 71  ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
                Y   +DMWS+GC+ A M FR++P F G+   DQL +I  ++G
Sbjct: 180 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 41/150 (27%), Positives = 82/150 (54%), Gaps = 12/150 (8%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK-----IKREIKILENLRGGT 226
           +YQL   +GRG +  V++ +N+++ D   +K +   K K+     I +EI +L+NL+   
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-P 59

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD---IRYYLYELLKALDYCHS 283
           NI+     ++   S +  +I E+  N   +Q+ +    +    +  Y+Y++L+ L Y H 
Sbjct: 60  NIVKYIGSIET--SDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE 117

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            G++HRD+K  N++   +   ++L D+G+A
Sbjct: 118 QGVIHRDIKAANILTTKDG-VVKLADFGVA 146

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 82/336 (24%), Positives = 132/336 (39%), Gaps = 91/336 (27%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK--------------REIKI 218
           Y++   +GRG Y  V++A      D     I      KK K              REI +
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAI------KKFKGDKEQYTGISQSACREIAL 55

Query: 219 LENLRGGTNIITLQAVVKDPVSRTPALIF---EHVNNTDFKQLYQ--------TLTDYDI 267
           L  L+   N+++L  V  +   ++  L+F   EH    D  Q+ +        ++    +
Sbjct: 56  LRELKH-ENVVSLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMV 110

Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHN--VMIDHENR-KLRLIDWGLAEFYH----PGQ 320
           +  L+++L  + Y HS  ++HRD+KP N  VM +   R  +++ D GLA  ++    P  
Sbjct: 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Query: 321 EYNVRVASRYFKGPELL---ADYQYHIE-------------LDPRF----ADI------- 353
           + +  V + +++ PELL     Y   I+             L+P F    A I       
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230

Query: 354 ----------LGRHSRKRWERFVHT-ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE 402
                     LG  + K W       E   L+          N L +   K  +      
Sbjct: 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKP----- 285

Query: 403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                  +  D L KLL YD  +R+TA EA++HPYF
Sbjct: 286 -----DSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 78/302 (25%), Positives = 122/302 (40%), Gaps = 84/302 (27%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR--------EIKILENLRGGTNIIT 230
           + +G Y  VF A    + D   +K++K  K   I++        E  IL   +       
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQAQS------ 52

Query: 231 LQAVVKDPVSRTPA----LIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYCHS 283
              VVK   S        L+ E++   D   L     +L +   R Y+ E++ AL+Y HS
Sbjct: 53  -PYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHS 111

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR---------YFKGP 334
            GI+HRD+KP N++ID  N  L+L D+GL++     ++ N+    +          +  P
Sbjct: 112 NGIIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Query: 335 ELLADYQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEAL 379
           E++    +   +D               P F                H E      PE +
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPF----------------HGET-----PEEI 209

Query: 380 DFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAR---EAMDHP 436
            F  +NIL    +  W   V       VS EA+D + KLL  D  +RL A+   E  +HP
Sbjct: 210 -F--QNILNG--KIEWPEDVE------VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP 258

Query: 437 YF 438
           +F
Sbjct: 259 FF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 74.9 bits (185), Expect = 5e-15
 Identities = 36/112 (32%), Positives = 55/112 (49%), Gaps = 23/112 (20%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP---------------GQ 53
           +AL+Y HS GI+HRD+KP N+++D +   +++ D+G A+   P                Q
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 54  EYNVRVASRYFKG------PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               R     F G      PELL +      S D+W+LGC++  M+  K PF
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPF 222

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 75.6 bits (186), Expect = 7e-15
 Identities = 73/302 (24%), Positives = 141/302 (46%), Gaps = 48/302 (15%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKIL-----EN 221
           D +  R +G G +  V+   + +   +  +K +  V       K++ RE+K+L     +N
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN 60

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVN------NTDFKQLY---QTLTDYDIRYYLY 272
           +    +I  LQ    DP        FE +        +D  ++    Q L+   ++ +LY
Sbjct: 61  VLSALDI--LQPPHIDP--------FEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLY 110

Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV--RVASRY 330
           ++L+ L Y HS GI+HRD+KP N++++  N  L++ D+GLA    P +  ++   V ++Y
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169

Query: 331 FKGPELLADYQ-YHIELDPR-----FADILGRHSRKRWERFVHTENQ---HLVSPEALDF 381
           ++ PE+L   + Y   +D       FA++LGR    + +  +   +     L +P     
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229

Query: 382 LD------KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH 435
                    +IL    +      ++T +    + EA+  L ++L +D  +R++A +A+ H
Sbjct: 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQA-THEAVHLLCRMLVFDPDKRISAADALAH 288

Query: 436 PY 437
           PY
Sbjct: 289 PY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 74.6 bits (183), Expect = 8e-15
 Identities = 42/121 (34%), Positives = 69/121 (57%), Gaps = 6/121 (4%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPEL 69
           L Y H   I+HRD+KP N++I +   +L+L D+GLA     P Q Y+  V + +++ P++
Sbjct: 116 LAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV 174

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLG--TEELFEYLD 126
           L     Y  +LD+W  GC+   M  + +P F G  + ++QL +I  VLG  TE+ +  + 
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEM-LQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233

Query: 127 K 127
           K
Sbjct: 234 K 234

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 73.7 bits (182), Expect = 9e-15
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 5/104 (4%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGP 67
           +AL Y HS  I+HRD+KP N+ +      ++L D+G+++      +     V + Y+  P
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 111
           EL  +   Y+Y  D+WSLGC+L  +   K PF    +N  +L  
Sbjct: 173 ELCQNKP-YNYKSDIWSLGCVLYELCTLKHPF--EGENLLELAL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 11/111 (9%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 66
            L Y HS GI+HRD+K  N+++D  +  ++L D+G A+      +      +   +G   
Sbjct: 113 GLAYLHSNGIVHRDIKGANILVD-SDGVVKLADFGCAKR---LGDIETGEGTGSVRGTPY 168

Query: 67  ---PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
              PE++   + Y  + D+WSLGC +  M   K P+    +    L +I  
Sbjct: 169 WMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 72/306 (23%), Positives = 131/306 (42%), Gaps = 60/306 (19%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGG 225
           D+Q++ ++G+G Y +VF A    + +   +K +K        + + +  E  IL   +  
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCH 282
             ++ L    +D      A+  E+V   DF+ L      L++   R+Y+ E+ +A+D  H
Sbjct: 62  W-LVKLLYAFQDDEYLYLAM--EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGPELLADYQ 341
            +G +HRD+KP N +ID     ++L D+GL++       Y N  V S  +  PE+L    
Sbjct: 119 ELGYIHRDLKPENFLIDASGH-IKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGKG 174

Query: 342 YHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI 386
           Y   +D               P F+   G    + WE                     N+
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFS---GSTPNETWE---------------------NL 210

Query: 387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTARE-AMDHPYFYPIVKDQ 445
              + ++  +R V+ + +  +S EA D + KL+  D   R  + E   +HP+F  +  ++
Sbjct: 211 K--YWKETLQRPVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFKEVDWNE 267

Query: 446 SRHTLP 451
            R   P
Sbjct: 268 LRELKP 273

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 39/121 (32%), Positives = 63/121 (52%), Gaps = 17/121 (14%)

Query: 15  HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA---------------EFYHPGQEYNVRV 59
           H    MHRD+ P N+ I+ +    ++ D+GLA               E     +E   +V
Sbjct: 136 HKWYFMHRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKV 194

Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
            + +++ PELL   + Y +++DMWS+GC+ A ++  K P F G +  DQL RI ++LGT 
Sbjct: 195 VTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFPGENEIDQLGRIFELLGTP 253

Query: 120 E 120
            
Sbjct: 254 N 254

Length = 335

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 72/325 (22%), Positives = 128/325 (39%), Gaps = 60/325 (18%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP---VKKKKI-----KREIKILENL 222
           DD+++++ +GRG + EV+   +  +     +K+L+    +K+ +I     +R+I    + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALD 279
                I+ L    +D       L+ E++   D   L        +   R+Y+ EL+ ALD
Sbjct: 61  PW---IVKLYYSFQD--EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
             H +G +HRD+KP N++ID +   ++L D+GL +  +                      
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKA-------------KDREYYL 161

Query: 340 YQYHIELDPRFADILGR-HSRKRWERFVHTENQHLVSPEAL---------D--------- 380
              H  L      +  R H ++R            ++PE L         D         
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221

Query: 381 --------FLDKNILGRHSR-KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-AR 430
                   F    +   +++   W+  +       VSPEA+D + +LL  D  +RL    
Sbjct: 222 EMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFE 280

Query: 431 EAMDHPYFYPIVKDQSRHTLPSSSP 455
           E   HP+F  I  +  R T P   P
Sbjct: 281 EIKSHPFFKGIDWENLRETKPPFVP 305

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 3/114 (2%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           +AL+Y HS GI+HRD+KP N+++D E   + + D+ +A    P         +  +  PE
Sbjct: 111 LALEYLHSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE 169

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELF 122
           +L   Q Y  ++D WSLG      +  K P + GH    +    AK    + L+
Sbjct: 170 VLCR-QGYSVAVDWWSLGVTAYECLRGKRP-YRGHSRTIRDQIRAKQETADVLY 221

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 14/150 (9%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-----PVKKKKIKREIKILENLRGGTN 227
           +Q   K+G G + +V+ A+N+ + +   VK ++     P   K+I  E+K+LE L+   N
Sbjct: 2   WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-PN 60

Query: 228 IITLQAVVKDPVSRTPALIFEHVNN----TDFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           ++    V    V R    IF    +     +  +  + L ++ IR Y  +LL+ L Y HS
Sbjct: 61  LVKYYGV---EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            GI+HRD+KP N+ +DH N  ++L D+G A
Sbjct: 118 HGIVHRDIKPANIFLDH-NGVIKLGDFGCA 146

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 40/109 (36%), Positives = 64/109 (58%), Gaps = 3/109 (2%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPEL 69
           L YCH   I+HRD+KP N++I+ E  +L+L D+GLA     P + Y+  V + +++ P++
Sbjct: 116 LSYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 174

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           L     Y   +DMW +GC+L  M   + P F G    ++L  I ++LGT
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEELHLIFRLLGT 222

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 37/110 (33%), Positives = 62/110 (56%), Gaps = 3/110 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPE 68
            L Y H   I+HRD+K  N+++  +   L++ D+GLA  Y  P +    +V + +++ PE
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLARTYGLPAKPMTPKVVTLWYRAPE 178

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           LL     Y  ++DMW++GC+LA +    +P   G    +QL  I ++LGT
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAEL-LAHKPLLPGKSEIEQLDLIIQLLGT 227

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 39/110 (35%), Positives = 64/110 (58%), Gaps = 3/110 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE 68
            L+YCH   ++HRD+KP N++I+ E  +L+L D+GLA     P + Y+  V + +++ P+
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPD 174

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +L     Y   +DMW +GC+   M   + P F G    +QL  I ++LGT
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFIFRILGT 223

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 71.9 bits (176), Expect = 7e-14
 Identities = 39/110 (35%), Positives = 63/110 (57%), Gaps = 3/110 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE 68
            L YCH   ++HRD+KP N++I+ E  +L+L D+GLA     P + Y+  V + +++ P+
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 174

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +L     Y   +DMW +GC+   M   + P F G    D+L  I ++LGT
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDELHLIFRLLGT 223

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 40/202 (19%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK--------REIKILENLRG 224
           Y+ V ++G G Y +VF+A ++++  + V   LK V+ +  +        RE+ +L +L  
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 225 --GTNIITLQAVVKDPVSRTP-----ALIFEHVNNTDFKQLYQTLTDY------------ 265
               N++ L  V    VSRT       L+FEHV+        Q LT Y            
Sbjct: 61  FEHPNVVRLFDVCT--VSRTDRETKLTLVFEHVD--------QDLTTYLDKVPEPGVPTE 110

Query: 266 DIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR 325
            I+  +++LL+ LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         
Sbjct: 111 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQMALTSV 169

Query: 326 VASRYFKGPELLADYQYHIELD 347
           V + +++ PE+L    Y   +D
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVD 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 71.3 bits (174), Expect = 1e-13
 Identities = 42/110 (38%), Positives = 59/110 (53%), Gaps = 2/110 (1%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE 68
            L Y H   I+HRD+KP N++I  +  +L+L D+GLA     P   Y+  V + +++ P+
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPD 173

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +L     Y   LDMW +GC+   MI     F    D  DQL RI  VLGT
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT 223

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 35/91 (38%), Positives = 52/91 (57%), Gaps = 6/91 (6%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGPE 68
           A+D  H +G +HRD+KP N +ID     ++L D+GL++       Y N  V S  +  PE
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGH-IKLTDFGLSK---GIVTYANSVVGSPDYMAPE 168

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +L   + YD+++D WSLGCML   +    PF
Sbjct: 169 VLRG-KGYDFTVDYWSLGCMLYEFLCGFPPF 198

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 20/155 (12%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR---------EIKILENLRGGTNII 229
           LG+G + +V       +     +K+LK   KKKI +         E  IL  +     I+
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK---KKKIIKRKEVEHTLTERNILSRINH-PFIV 56

Query: 230 TLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGI 286
            L    +        L+ E+    + F  L +    ++   R+Y  E++ AL+Y HS+GI
Sbjct: 57  KLHYAFQTEEKLY--LVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114

Query: 287 MHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQ 320
           ++RD+KP N+++D +   ++L D+GLA E    G 
Sbjct: 115 IYRDLKPENILLDADGH-IKLTDFGLAKELSSEGS 148

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 40/147 (27%), Positives = 68/147 (46%), Gaps = 17/147 (11%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILKPVKK--------KKIKREIKILENLRGGTNIIT 230
           LG G +  V+E +N+   D   VK +             K++++EI +L  L+   NI+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQ 66

Query: 231 LQAVVKDPVSRTPALIF-EHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYCHSMGI 286
                +         IF E V      +L   Y +  +  IR Y  ++L  L+Y H    
Sbjct: 67  YLGTER---EEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123

Query: 287 MHRDVKPHNVMIDHENRKLRLIDWGLA 313
           +HRD+K  N+++D  N  ++L D+G+A
Sbjct: 124 VHRDIKGANILVD-TNGVVKLADFGMA 149

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 38/109 (34%), Positives = 64/109 (58%), Gaps = 3/109 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 188

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  ++D+WS+GC++  MI R    F G D+ DQ  +I + LGT
Sbjct: 189 ILGMG-YKENVDIWSVGCIMGEMI-RGTVLFPGTDHIDQWNKIIEQLGT 235

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 70.1 bits (171), Expect = 4e-13
 Identities = 34/112 (30%), Positives = 64/112 (57%), Gaps = 3/112 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
           +     Y  ++D+WS+GC++  ++ +    F G D+ DQ  ++ + LGT   
Sbjct: 194 ILGMG-YKENVDIWSVGCIMGELV-KGSVIFQGTDHIDQWNKVIEQLGTPSA 243

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 40/114 (35%), Positives = 65/114 (57%), Gaps = 7/114 (6%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH---PGQEY-NVRVASRYFK 65
           AL Y H+  + HRD+KP N++ +  + KL++ D+GLA       P   +    VA+R+++
Sbjct: 115 ALKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 66  GPELLAD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PEL    +  Y  ++D+WS+GC+ A ++  K P F G +   QL  I  +LGT
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLLGT 226

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 69.2 bits (169), Expect = 5e-13
 Identities = 73/300 (24%), Positives = 129/300 (43%), Gaps = 47/300 (15%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-PVKKKKIK----REIKILENLRG--G 225
           Y+ V ++G G Y  V++A +  S     +K ++    +  +     RE+ +L+ L     
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 226 TNIITLQAVVKDPVSRTP-----ALIFEHVNNTDFKQLYQT-----LTDYDIRYYLYELL 275
            NI+ L  V     SRT       L+FEHV+  D +          L    I+  + + L
Sbjct: 62  PNIVRLMDVCA--TSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL 118

Query: 276 KALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 335
           + LD+ H+  I+HRD+KP N+++     +++L D+GLA  Y         V + +++ PE
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177

Query: 336 LLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK--NILGRHSRK 393
           +L    Y   +D      +     +R   F         + EA D L K  +++G     
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG-------NSEA-DQLGKIFDLIGLPPED 229

Query: 394 RWERFVHTENQHLVSPEA---------------LDFLDKLLRYDHYERLTAREAMDHPYF 438
            W R V T  +   SP                    L ++L ++ ++R++A  A+ HP+F
Sbjct: 230 DWPRDV-TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 5e-13
 Identities = 43/136 (31%), Positives = 73/136 (53%), Gaps = 19/136 (13%)

Query: 11  LDYCHSMGIMHRDVKPHN--VMIDHENR-KLRLIDWGLAEFYH----PGQEYNVRVASRY 63
           + Y HS  ++HRD+KP N  VM +   R  +++ D GLA  ++    P  + +  V + +
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180

Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAK 114
           ++ PELL   + Y  ++D+W++GC+ A ++   EP F G +           DQL RI +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELL-TLEPIFKGREAKIKKSNPFQRDQLERIFE 239

Query: 115 VLG--TEELFEYLDKY 128
           VLG  TE+ +  + K 
Sbjct: 240 VLGTPTEKDWPDIKKM 255

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 69/308 (22%), Positives = 119/308 (38%), Gaps = 93/308 (30%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSD-------KCVVKILKPVKKKKIK---REIKILENL 222
           ++L+R +G+G + +V     VQ  D       K + K  K V+K  ++    E +IL+ L
Sbjct: 2   FELLRVIGKGAFGKVC---IVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQEL 57

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDY----DIRY--------- 269
                               P L+    +  D + +Y  + D     D+RY         
Sbjct: 58  N------------------HPFLVNLWYSFQDEENMY-LVVDLLLGGDLRYHLSQKVKFS 98

Query: 270 ------YLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN 323
                 ++ E++ AL+Y HS GI+HRD+KP N+++D E   + + D+ +A    P     
Sbjct: 99  EEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTT 157

Query: 324 VRVASRYFKGPELLADYQYHIELDPRFADIL------GR-----HSRKRWERFVHTENQH 372
               +  +  PE+L    Y + +D     +       G+     HSR   ++    +   
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA 217

Query: 373 LVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL--TAR 430
            V                    W            S EA+D ++KLL  D  +RL    +
Sbjct: 218 DV---------------LYPATW------------STEAIDAINKLLERDPQKRLGDNLK 250

Query: 431 EAMDHPYF 438
           +  +HPYF
Sbjct: 251 DLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 69.3 bits (170), Expect = 5e-13
 Identities = 77/306 (25%), Positives = 127/306 (41%), Gaps = 59/306 (19%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK--------REIKILENLR 223
           +++ + ++G G Y  V+ A +  S +   +  LK V+    +        REI +L NLR
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGE---IVALKKVRMDNERDGIPISSLREITLLLNLR 64

Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALD 279
              NI+ L+ VV      +  L+ E+    D   L        ++  ++  + +LL+ L 
Sbjct: 65  H-PNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELL- 337
           Y H   I+HRD+K  N+++  +   L++ D+GLA  Y  P +    +V + +++ PELL 
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181

Query: 338 ADYQYHIELDP-RFADILGRHSRKRWERFVH-------TENQHLVSPEALDFLDKNILGR 389
               Y   +D      IL        E   H       +E       E LD +   +LG 
Sbjct: 182 GCTTYTTAIDMWAVGCILA-------ELLAHKPLLPGKSE------IEQLDLI-IQLLGT 227

Query: 390 HSRKRWERFV---HTENQHL--------------VSPEALDFLDKLLRYDHYERLTAREA 432
            +   W  F          L              +S   L  L+ LL YD  +R TA EA
Sbjct: 228 PNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA 287

Query: 433 MDHPYF 438
           ++  YF
Sbjct: 288 LESSYF 293

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 42/126 (33%), Positives = 66/126 (52%), Gaps = 9/126 (7%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-----PGQEYNVRVASRYF 64
            L Y H   I+HRD+K  N++I  ++  L+L D+GLA  +          Y  RV + ++
Sbjct: 131 GLYYIHRNKILHRDMKAANILIT-KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189

Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEELF 122
           + PELL   + Y   +DMW  GC++A M  R  P   G+    QL  I+++ G  T E++
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWTR-SPIMQGNTEQHQLTLISQLCGSITPEVW 248

Query: 123 EYLDKY 128
             +DK 
Sbjct: 249 PGVDKL 254

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 15/193 (7%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK--KKIKREIKILENLRGGTNI 228
           D ++++  +G+G Y +V++  N +      VKIL P+    ++I+ E  IL++L    N+
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV 81

Query: 229 ITLQAVVKDP---VSRTPALIFEHVNNTDFKQLY-------QTLTDYDIRYYLYELLKAL 278
           +    +       V     L+ E  N     +L        Q L +  I Y LY  L  L
Sbjct: 82  VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELL 337
            + H+  I+HRDVK +N+++  E   ++L+D+G+ A+        N  V + ++  PE++
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200

Query: 338 A-DYQYHIELDPR 349
           A + QY    D R
Sbjct: 201 ACEQQYDYSYDAR 213

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 69.0 bits (169), Expect = 7e-13
 Identities = 36/108 (33%), Positives = 60/108 (55%), Gaps = 5/108 (4%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKG 66
           L Y HS  ++HRD+KP NV I+ E+  L++ D+GLA    P   +    +  + +++++ 
Sbjct: 127 LKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           P LL     Y  ++DMW+ GC+ A M+  K P F G    +Q+  I +
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-PLFAGAHELEQMQLILE 233

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 67.9 bits (167), Expect = 7e-13
 Identities = 36/164 (21%), Positives = 70/164 (42%), Gaps = 16/164 (9%)

Query: 174 QLVRKLGRGKYSEVFEAINVQSSDK----CVVKILKPVK----KKKIKREIKILENLRGG 225
            L +KLG G + EV++        K      VK LK        ++  RE +I+  L   
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYC 281
            N++ L  V  +       ++ E++   D     +     L+  D+  +  ++ + ++Y 
Sbjct: 61  PNVVKLLGVCTEE--EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR 325
            S   +HRD+   N ++  EN  +++ D+GL+   +    Y  R
Sbjct: 119 ESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYRKR 161

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 82/293 (27%), Positives = 134/293 (45%), Gaps = 50/293 (17%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITL 231
           +++L+R LG G Y +VF    V   D   +  +K +KK  I ++ K  E+ R  T    L
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTR--TERQVL 58

Query: 232 QAVVKDP--VSRTPA--------LIFEHVNNTD-FKQLYQT--LTDYDIRYYLYELLKAL 278
           +AV + P  V+   A        LI ++VN  + F  LYQ    T+ ++R Y+ E++ AL
Sbjct: 59  EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
           D+ H +GI++RD+K  N+++D E   + L D+GL++ +   +E     A  +    E +A
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEER---AYSFCGTIEYMA 174

Query: 339 DYQYHIELDPRFADILGRHSRKR------WERFVHT-ENQHLVSPEALDFLDKNILGRHS 391
                        +++   S         W   V T E     SP  +D        ++S
Sbjct: 175 ------------PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG------EQNS 216

Query: 392 RKRWERFVHTEN---QHLVSPEALDFLDKLLRYDHYERL---TAREAMDHPYF 438
           +    R +          +S EA DF+ KLL  D  +RL    A E  +HP+F
Sbjct: 217 QSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 69/294 (23%), Positives = 132/294 (44%), Gaps = 64/294 (21%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK--KKIKREIKILENLRGGTN 227
           ++ + ++ KLG G Y  V++AI+ ++     +K++ PV++  ++I +EI IL+       
Sbjct: 2   EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDS-PY 59

Query: 228 IITLQA-VVKDPVSRTPALIFEH-----VNNTDFKQLYQ-TLTDYDIRYYLYELLKALDY 280
           I+       K+       ++ E+     V+  D  ++   TLT+ +I   LY+ LK L+Y
Sbjct: 60  IVKYYGSYFKN---TDLWIVMEYCGAGSVS--DIMKITNKTLTEEEIAAILYQTLKGLEY 114

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLAD 339
            HS   +HRD+K  N++++ E  + +L D+G++ +      + N  + + ++  PE++ +
Sbjct: 115 LHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173

Query: 340 YQYH------------IEL---DPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK 384
             Y+            IE+    P ++DI   H  +      +     L  PE       
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDI---HPMRAIFMIPNKPPPTLSDPE------- 223

Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                    +W            SPE  DF+ K L  D  ER +A + + HP+ 
Sbjct: 224 ---------KW------------SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 35/164 (21%), Positives = 70/164 (42%), Gaps = 17/164 (10%)

Query: 175 LVRKLGRGKYSEVFEAINVQSSD----KCVVKILKPVK----KKKIKREIKILENLRGGT 226
           L +KLG G + EV++       D    +  VK LK        ++  RE +I+  L    
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH-P 61

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIR-----YYLYELLKALDYC 281
           NI+ L  V  +       ++ E++   D     +     ++       +  ++ + ++Y 
Sbjct: 62  NIVKLLGVCTEE--EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR 325
            S   +HRD+   N ++  EN  +++ D+GL+   +    Y V+
Sbjct: 120 ESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYKVK 162

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 68.6 bits (167), Expect = 1e-12
 Identities = 41/135 (30%), Positives = 76/135 (56%), Gaps = 8/135 (5%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT   E  + L  
Sbjct: 190 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247

Query: 127 --KYHIELDPRFADI 139
             + ++E  P++A +
Sbjct: 248 TVRNYVENRPKYAGL 262

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 32/89 (35%), Positives = 55/89 (61%), Gaps = 2/89 (2%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 70
           L++ H   I++RD+KP NV++D ++  +R+ D GLA     G++   R  +  +  PE+L
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL 166

Query: 71  ADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
              ++YD+S+D ++LGC L  MI  + PF
Sbjct: 167 QG-EVYDFSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 41/133 (30%), Positives = 74/133 (55%), Gaps = 8/133 (6%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  MI      F G D+ DQ  ++ + LGT   E  + L  
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254

Query: 127 --KYHIELDPRFA 137
             + ++E  P++A
Sbjct: 255 TVRTYVENRPKYA 267

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 40/152 (26%), Positives = 77/152 (50%), Gaps = 13/152 (8%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL---KPVKKKK---IKREIKILENLRG 224
           DD++ ++ LG G +  V    +  S     +KIL   K VK K+   +  E +IL+++R 
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYC 281
              ++ L    +D       L+ E+V   +            +   R+Y  +++ AL+Y 
Sbjct: 61  -PFLVNLYGSFQDD--SNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           HS+ I++RD+KP N+++D +   +++ D+G A
Sbjct: 118 HSLDIVYRDLKPENLLLDSDGY-IKITDFGFA 148

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 78/327 (23%), Positives = 134/327 (40%), Gaps = 56/327 (17%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP---VKKKKIKR---EIKILENLRG 224
             ++ ++ LG+G    VF      +     +K+L     +K+ K+KR   E +IL  L  
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALD 279
              + TL A  +        L+ ++    +  +L Q      L++   R+Y  E+L AL+
Sbjct: 61  -PFLPTLYASFQT--ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE 117

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           Y H +GI++RD+KP N+++ HE+  + L D+ L+      ++ +V          +    
Sbjct: 118 YLHLLGIVYRDLKPENILL-HESGHIMLSDFDLS------KQSDVEPPPVSKALRKGSRR 170

Query: 340 YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE---------ALDFLDKNIL--- 387
              +      F++     S      FV TE    ++PE         A+D+    IL   
Sbjct: 171 SSVNSIPSETFSEEPSFRSNS----FVGTE--EYIAPEVISGDGHGSAVDWWTLGILLYE 224

Query: 388 ---------GRHSRKRWERFVHTE----NQHLVSPEALDFLDKLLRYDHYERL-TAREAM 433
                    G +  + +   +  E        VS  A D + KLL  D  +RL + R A 
Sbjct: 225 MLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284

Query: 434 D---HPYFYPIVKDQSRHTLPSSSPTP 457
           +   HP+F  +     RHT P   P P
Sbjct: 285 EIKQHPFFRGVNWALIRHTTPPIIPRP 311

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 71/320 (22%), Positives = 128/320 (40%), Gaps = 80/320 (25%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK-----------------REIKILEN 221
           LG G Y +V +A +  +     +K +K ++                      RE+KI+  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKAL 278
           ++   NI+ L  V    V      +   +  +D K++      LT+  ++  L ++L  L
Sbjct: 77  IKH-ENIMGLVDVY---VEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGL 132

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA---------------EFYHPGQEYN 323
           +  H    MHRD+ P N+ I+ +    ++ D+GLA               E     +E  
Sbjct: 133 NVLHKWYFMHRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191

Query: 324 VRVASRYFKGPELL-ADYQYHIELDPR-----FADILGRHSRKRWERFVHTENQHLVSPE 377
            +V + +++ PELL    +YH  +D       FA++L                   + P 
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL---------------TGKPLFPG 236

Query: 378 A--LDFLDK--NILGRHSRKRWER---------FVHTENQHL------VSPEALDFLDKL 418
              +D L +   +LG  +   W +         F   + + L       S +A+D L  L
Sbjct: 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSL 296

Query: 419 LRYDHYERLTAREAMDHPYF 438
           L+ +  ER++A+EA+ H YF
Sbjct: 297 LKLNPLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 72/287 (25%), Positives = 125/287 (43%), Gaps = 57/287 (19%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR---------EIKILENLRGGTNII 229
           LG+G + EV  A  V+++ K  +   K + KK++K+         E KILE +     I+
Sbjct: 1   LGKGGFGEVC-ACQVKATGK--MYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIV 56

Query: 230 TLQAVVKDPVSRTPALIFEHVNNTDFK-QLYQT----LTDYDIRYYLYELLKALDYCHSM 284
           +L    +        L+   +N  D K  +Y        +    +Y  +++  L++ H  
Sbjct: 57  SLAYAFETKDDL--CLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR 114

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHI 344
            I++RD+KP NV++D ++  +R+ D GLA     G++   R  +  +  PE+L    Y  
Sbjct: 115 RIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173

Query: 345 ELDPRFA------DILGRHS--RKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE 396
            +D  FA      +++   S  R+R E+    E +      A+++ DK            
Sbjct: 174 SVD-WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKF----------- 221

Query: 397 RFVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYF 438
                      SPEA D  + LL+ D  +RL     +A E  +HP F
Sbjct: 222 -----------SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 65/301 (21%), Positives = 134/301 (44%), Gaps = 42/301 (13%)

Query: 173 YQLVRKLGRGKYSEVFEAIN-VQSSDKCVVKILKPVKK----KKIKREIKILE-----NL 222
           YQ ++ +G G    V  A + +   +  + K+ +P +     K+  RE+ +++     N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKALDYC 281
            G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  + + 
Sbjct: 86  IGLLNVFTPQKSLEE---FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE++    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201

Query: 342 YHIELDPRFADIL------------GRHSRKRWERFVH------TENQHLVSPEALDFLD 383
           Y   +D      +            G     +W + +        E    + P    +++
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261

Query: 384 KNILGRHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+ HP
Sbjct: 262 NR--PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319

Query: 437 Y 437
           Y
Sbjct: 320 Y 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
           AL++ HS  IMHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
            + +   Y++  D+WSLGC+L  M   + PF+
Sbjct: 177 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 78/320 (24%), Positives = 138/320 (43%), Gaps = 69/320 (21%)

Query: 178 KLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK----REIKILENLRGGTNIITLQA 233
           K+GRG Y  V++A      D      LK ++   I     REI +L  L+   N+I+LQ 
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYA-LKQIEGTGISMSACREIALLRELKH-PNVISLQK 65

Query: 234 VVKDPVSRTPALIFEHVNN-----TDFKQLYQT------LTDYDIRYYLYELLKALDYCH 282
           V      R   L+F++  +       F +  +       L    ++  LY++L  + Y H
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 283 SMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPE 335
           +  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 336 LLADYQYHIE------LDPRFADILGR----HSRKRWERFVHTENQHLVSPEALDFLDK- 384
           LL   +++ +      +   FA++L      H R+        E+    +P   D LD+ 
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ--------EDIKTSNPYHHDQLDRI 237

Query: 385 -NILGRHSRKRWE-----------------------RFVHTENQHLVSPE--ALDFLDKL 418
            N++G  + K WE                         +    +H V P+  A   L KL
Sbjct: 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 297

Query: 419 LRYDHYERLTAREAMDHPYF 438
           L  D  +R+T+ +AM  PYF
Sbjct: 298 LTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 36/103 (34%), Positives = 58/103 (56%), Gaps = 12/103 (11%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR------ 62
           +AL+Y HS GI+HRD+KP N++ID  N  L+L D+GL++     ++ N+    +      
Sbjct: 104 LALEYLHSNGIIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162

Query: 63  ---YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 102
               +  PE++   Q +  ++D WSLGC+L   +    P FHG
Sbjct: 163 GTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLV-GIPPFHG 203

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 45/184 (24%), Positives = 90/184 (48%), Gaps = 15/184 (8%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVK--ILKPVKKKKIKREIKILENLRGGTNIIT 230
           Y+ + K+G G   EV++A +  +  +  +K   L+   K+ I  EI I+++ +   NI+ 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH-PNIVD 79

Query: 231 LQAVVKDPVSRTPALIFEHVNN---TDFKQLYQT---LTDYDIRYYLYELLKALDYCHSM 284
                   V     ++ E+++    TD   + Q    + +  I Y   E+L+ L+Y HS 
Sbjct: 80  YYDSYL--VGDELWVVMEYMDGGSLTDI--ITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLADYQYH 343
            ++HRD+K  N+++  +   ++L D+G  A+      + N  V + Y+  PE++    Y 
Sbjct: 136 NVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG 194

Query: 344 IELD 347
            ++D
Sbjct: 195 PKVD 198

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 65.7 bits (161), Expect = 5e-12
 Identities = 38/116 (32%), Positives = 55/116 (47%), Gaps = 10/116 (8%)

Query: 2   RIATGASMALDYCH-----SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY- 55
           RI T   +AL  CH        ++HRD+KP N+ +D  N  ++L D+GLA+       + 
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFA 167

Query: 56  NVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 111
              V + Y+  PE L     YD   D+WSLGC++  +     P F    N  QL  
Sbjct: 168 KTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPP-FTAR-NQLQLAS 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 66.6 bits (162), Expect = 6e-12
 Identities = 69/304 (22%), Positives = 128/304 (42%), Gaps = 44/304 (14%)

Query: 173 YQLVRKLGRGKYSEVFEAIN-VQSSDKCVVKILKPVKK----KKIKREIKILE-----NL 222
           YQ ++ +G G    V  A + V   +  V K+ +P +     K+  RE+ +L+     N+
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCH 282
               N+ T Q  +++   +   L+ E ++    + ++  L    + Y LY++L  + + H
Sbjct: 83  ISLLNVFTPQKSLEE--FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 140

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE++    Y
Sbjct: 141 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGY 199

Query: 343 ---------------------------HIELDPRFADILGRHSRKRWERFVHTENQHLVS 375
                                      HI+   +  + LG  S +   R   T   ++ +
Sbjct: 200 KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN 259

Query: 376 PEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH 435
                     I        W     +E   L + +A D L K+L  D  +R++  EA+ H
Sbjct: 260 RPQY----PGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315

Query: 436 PYFY 439
           PY  
Sbjct: 316 PYIT 319

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 65.1 bits (159), Expect = 7e-12
 Identities = 29/89 (32%), Positives = 47/89 (52%), Gaps = 1/89 (1%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 70
           L+Y H    +HRD+K  N+++D  N  ++L D+G+A+             S Y+  PE++
Sbjct: 115 LEYLHDRNTVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVI 173

Query: 71  ADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           A    Y  + D+WSLGC +  M   K P+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPW 202

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 44/191 (23%), Positives = 90/191 (47%), Gaps = 18/191 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK------PVKKKKIKREIKILENLRG 224
            ++++ +K+G+G++S V++AI +       +K ++         ++   +EI +L+ L  
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKA 277
              I  L + +++       ++ E  +  D  ++ +        + +  I  Y  +L  A
Sbjct: 62  PNVIKYLASFIEN---NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPEL 336
           L++ HS  IMHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE 
Sbjct: 119 LEHMHSKRIMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 337 LADYQYHIELD 347
           + +  Y+ + D
Sbjct: 178 IHENGYNFKSD 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 46/151 (30%), Positives = 81/151 (53%), Gaps = 12/151 (7%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK---IKREIKILENLRGGT 226
           Q DY+L++++G G Y +V++A N+ + +   VKI+K         I++EI +++  +   
Sbjct: 8   QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK-HC 66

Query: 227 NIITLQAVVKDPVSRTPALI-FEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYCH 282
           NI+   A     +SR    I  E+      + +Y     L++  I Y   E L+ L Y H
Sbjct: 67  NIV---AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           S G MHRD+K  N+++  +N  ++L D+G+A
Sbjct: 124 SKGKMHRDIKGANILLT-DNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 50/181 (27%), Positives = 93/181 (51%), Gaps = 14/181 (7%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGGTNI 228
           D ++++  +G+G Y +VF+ +N ++  K  VKIL P+    ++I+ E  IL+ L    N+
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77

Query: 229 ITLQAVV--KDPVSRTPA-LIFEHVNN---TD----FKQLYQTLTDYDIRYYLYELLKAL 278
           +    +   KD  +     L+ E  N    TD    F +  + + +  I Y L+E L  L
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELL 337
            + H    +HRDVK +N+++  E   ++L+D+G+ A+        N  V + ++  PE++
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196

Query: 338 A 338
           A
Sbjct: 197 A 197

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 30/85 (35%), Positives = 49/85 (57%), Gaps = 2/85 (2%)

Query: 15  HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 74
           HSM I++RD+KP NV++D +    RL D GLA     G+    R  +  +  PE+L + +
Sbjct: 112 HSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE-E 169

Query: 75  MYDYSLDMWSLGCMLASMIFRKEPF 99
            Y Y +D +++GC +  M+  + PF
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 67/282 (23%), Positives = 128/282 (45%), Gaps = 35/282 (12%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIIT 230
           ++LV  +G G Y +V++  +V++     +K++     ++++IK+EI +L+      NI T
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 231 LQA--VVKDP--VSRTPALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYC 281
                + K+P  +     L+ E         L +     TL +  I Y   E+L+ L + 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLA-- 338
           H   ++HRD+K  NV++  EN +++L+D+G+ A+        N  + + Y+  PE++A  
Sbjct: 128 HQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186

Query: 339 ---DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW 395
              D  Y  + D      LG  + +  E      + H +   AL  + +N   R   K+W
Sbjct: 187 ENPDATYDFKSDLW---SLGITAIEMAEGAPPLCDMHPM--RALFLIPRNPAPRLKSKKW 241

Query: 396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
            +   +            F++  L  +H +R T  + M HP+
Sbjct: 242 SKKFQS------------FIESCLVKNHSQRPTTEQLMKHPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 70/301 (23%), Positives = 136/301 (45%), Gaps = 42/301 (13%)

Query: 173 YQLVRKLGRGKYSEVFEAIN-VQSSDKCVVKILKPVKK----KKIKREIKILE-----NL 222
           YQ ++ +G G    V  A + V   +  + K+ +P +     K+  RE+ +++     N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKALDYC 281
               N+ T Q  +++   +   L+ E + + +  Q+ Q   D++ + Y LY++L  + + 
Sbjct: 79  ISLLNVFTPQKSLEE--FQDVYLVME-LMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE++    
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194

Query: 342 YHIELDP-RFADILGRHSRKR-----------WERFVHTENQHLVSPEALDFLDKNILGR 389
           Y   +D      I+G   R +           W + +  E      PE +  L   +   
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQPTVRNY 252

Query: 390 -HSRKRWERFV------------HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
             +R ++                 +E+  L + +A D L K+L  D  +R++  EA+ HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312

Query: 437 Y 437
           Y
Sbjct: 313 Y 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 43/152 (28%), Positives = 82/152 (53%), Gaps = 13/152 (8%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK---KKIKREIKILENLRGGT 226
           Q+DY+L++++G G Y +V++A ++ + +   +K++K       + I++EI +L+  R   
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR-HP 60

Query: 227 NIITLQAVVKDPVSRTPALI-FEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYC 281
           NI+   A     + R    I  E+      + +YQ     L++  I Y   E LK L Y 
Sbjct: 61  NIV---AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           H  G +HRD+K  N+++  E+  ++L D+G++
Sbjct: 118 HETGKIHRDIKGANILLT-EDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 58/218 (26%)

Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL---------AEFYHP 318
           R+Y+ EL  A++  H MG +HRD+KP N++ID +   ++L D+GL         +++Y  
Sbjct: 104 RFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYYQK 162

Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWER-----FVHTENQHL 373
           G   + R  S   +  E  ++      +D      L R  +++ +R      V T N   
Sbjct: 163 GD--HHRQDS--MEPSEEWSE------IDRCRLKPLERRRKRQHQRCLAHSLVGTPN--Y 210

Query: 374 VSPEALD--------------------------FLDKNILG-RHSRKRWERFVHTENQHL 406
           ++PE L                           FL       +     WE  +H  +Q  
Sbjct: 211 IAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAK 270

Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMD---HPYFYPI 441
           +S EA D + +L      +RL    A +   HP+F  I
Sbjct: 271 LSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 39/122 (31%), Positives = 62/122 (50%), Gaps = 8/122 (6%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-----EFYHPGQEYNVRVASRYFK 65
           L Y H   I+HRDVK  N++ID   ++LR+ D+G A     +    G+     + +  F 
Sbjct: 116 LSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHDNYDQLV-RIAKVLGTEELFE 123
            PE+L   + Y  S D+WS+GC++  M   K P+    H N+  L+ +IA       + E
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234

Query: 124 YL 125
           +L
Sbjct: 235 HL 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 63.2 bits (153), Expect = 6e-11
 Identities = 77/324 (23%), Positives = 140/324 (43%), Gaps = 77/324 (23%)

Query: 178 KLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK----REIKILENLRGGTNIITLQA 233
           K+GRG Y  V++A      D+     LK ++   I     REI +L  L+   N+I LQ 
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYA-LKQIEGTGISMSACREIALLRELKH-PNVIALQK 65

Query: 234 VVKDPVSRTPALIFEHVN---------------NTDFKQLYQTLTDYDIRYYLYELLKAL 278
           V      R   L+F++                 N    QL +++    ++  LY++L  +
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSM----VKSLLYQILDGI 121

Query: 279 DYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYH----PGQEYNVRVASRYF 331
            Y H+  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + ++
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 332 KGPELLADYQYHIE------LDPRFADILGR----HSRKRWERFVHTENQHLVSPEALDF 381
           + PELL   +++ +      +   FA++L      H R+        E+    +P   D 
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ--------EDIKTSNPFHHDQ 233

Query: 382 LDK--NILGRHSRKRWE-----------------------RFVHTENQHLVSPEALDF-- 414
           LD+  +++G  + K WE                         +    +H V P++  F  
Sbjct: 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLL 293

Query: 415 LDKLLRYDHYERLTAREAMDHPYF 438
           L KLL  D  +R+T+ +A+  PYF
Sbjct: 294 LQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.0 bits (151), Expect = 9e-11
 Identities = 43/189 (22%), Positives = 88/189 (46%), Gaps = 18/189 (9%)

Query: 175 LVRKLGRGKYSEV----FEAINVQSSDKCVVKILK----PVKKKKIKREIKILENLRGGT 226
            +++LG G + +V    ++ +   + ++  VK L        +   +REI+IL  L    
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH-E 66

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDY--DIRYYLY--ELLKALDYCH 282
           NI+  + V + P  R+  LI E++ +   +   Q   D     R  L+  ++ K +DY  
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S   +HRD+   N++++ E+  +++ D+GLA+     ++Y        +  ++  PE L 
Sbjct: 127 SQRYIHRDLAARNILVESEDL-VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 339 DYQYHIELD 347
             ++    D
Sbjct: 186 TSKFSSASD 194

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 35/124 (28%), Positives = 67/124 (54%), Gaps = 17/124 (13%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYH----PGQEYNVRVASR 62
            + Y H+  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + 
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIA 113
           +++ PELL   + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI 
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIF 238

Query: 114 KVLG 117
            V+G
Sbjct: 239 NVMG 242

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 35/124 (28%), Positives = 67/124 (54%), Gaps = 17/124 (13%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYH----PGQEYNVRVASR 62
            + Y H+  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + 
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIA 113
           +++ PELL   + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI 
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPFHHDQLDRIF 238

Query: 114 KVLG 117
            V+G
Sbjct: 239 SVMG 242

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 30/107 (28%), Positives = 57/107 (53%), Gaps = 3/107 (2%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGP 67
           +AL Y H +G++HRD+K  N+++ +    ++L D+G+ A       + +  V + Y+  P
Sbjct: 112 VALKYIHKVGVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           E++ + + YD   D+WSLG  +  M     P +   D +  ++ I K
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMA-TGNPPYSDVDAFRAMMLIPK 216

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 61.0 bits (149), Expect = 2e-10
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 16/164 (9%)

Query: 174 QLVRKLGRGKYSEVFEAINVQSSD----KCVVKILKP----VKKKKIKREIKILENLRGG 225
           +L +KLG G + EV++       +    K  VK LK      ++++   E  I++ L   
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH- 60

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDF----KQLYQTLTDYDIRYYLYELLKALDYC 281
            NI+ L  V          ++ E++   D     ++  + LT  D+     ++ K ++Y 
Sbjct: 61  PNIVRLLGVCTQ--GEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR 325
            S   +HRD+   N ++  EN  +++ D+GL+   +    Y  R
Sbjct: 119 ESKNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKR 161

Length = 258

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 48/164 (29%), Positives = 89/164 (54%), Gaps = 17/164 (10%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDK---CVVKILKP---VKKKKI----KREIKILEN 221
           +++L++ LG G Y +VF    V   D      +K+L+    V+K K     + E  +LE+
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKAL 278
           +R    ++TL    +        LI ++V+  + F  LYQ    ++ ++R+Y  E++ AL
Sbjct: 61  VRQSPFLVTLHYAFQTEAKL--HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQE 321
           ++ H +GI++RD+K  N+++D E   + L D+GL+ EF    +E
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKE 161

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 43/159 (27%), Positives = 84/159 (52%), Gaps = 16/159 (10%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKI----------KREIKILEN 221
           +++L++ LG G Y +VF    V   D   +  +K +KK  I          + E ++LE+
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQT--LTDYDIRYYLYELLKAL 278
           +R    ++TL    +        LI +++N  + F  L Q     + +++ Y  E++ AL
Sbjct: 61  IRQSPFLVTLHYAFQTDTKL--HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH 317
           ++ H +GI++RD+K  N+++D  N  + L D+GL++ +H
Sbjct: 119 EHLHKLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEFH 156

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 60.7 bits (148), Expect = 2e-10
 Identities = 36/120 (30%), Positives = 67/120 (55%), Gaps = 6/120 (5%)

Query: 7   ASM--ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           A +  A +Y H+ GI++RD+KP N+++D     ++L+D+G A+    GQ+      +  +
Sbjct: 100 ACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWTFCGTPEY 158

Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEY 124
             PE++ + + YD+S+D WSLG +L  ++  + PF  G D+ D +     +L      E+
Sbjct: 159 VAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPF--GEDDEDPMEIYNDILKGNGKLEF 215

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 2/90 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L+  H   I++RD+KP N+++D ++  +R+ D GLA     GQ    RV +  +  PE+
Sbjct: 114 GLEDLHQERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 172

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           + + + Y +S D W+LGC+L  MI  + PF
Sbjct: 173 VKN-ERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 76/304 (25%), Positives = 120/304 (39%), Gaps = 38/304 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK------PVKKKKIKREIKILENLRG 224
            D+ +   +GRG + EV       + D   +K++K             + E  IL ++  
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDIL-SISN 59

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYD-IRYYLYELLKALDY 280
              I  LQ   +D       L+ E+    D   L   Y+   D D  ++YL EL+ A+  
Sbjct: 60  SPWIPQLQYAFQD--KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHS 117

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR--VASRYFKGPELLA 338
            H MG +HRD+KP NV+ID     ++L D+G A      +  N +  V +  +  PE+L 
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 339 DYQ------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR 392
                    Y +E D     ++       +E           SP       K      + 
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIA------YEMIYGR------SPFHEGTSAKTYNNIMNF 224

Query: 393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPS 452
           +R+ +F        VS + LD +  LL     ERL       HP+F  I  +  R++LP 
Sbjct: 225 QRFLKF---PEDPKVSSDFLDLIQSLL-CGQKERLGYEGLCCHPFFSKIDWNNIRNSLPP 280

Query: 453 SSPT 456
             PT
Sbjct: 281 FVPT 284

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 30/159 (18%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           + ++  H  GI+HRD+KP N++ID +   L+L D+GL+         N     ++   P+
Sbjct: 108 LGVEDLHQRGIIHRDIKPENLLID-QTGHLKLTDFGLSR--------NGLENKKFVGTPD 158

Query: 69  LLA--------DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGT 118
            LA        D +M D+    WSLGC++   +F   PF     +  +D ++   ++   
Sbjct: 159 YLAPETILGVGDDKMSDW----WSLGCVIFEFLFGYPPFHAETPDAVFDNILS-RRINWP 213

Query: 119 EELFEYLDKYHIELDPRFADI-----LGRARVYADVNSH 152
           EE+ E+     ++L  R   +     LG A  Y ++ SH
Sbjct: 214 EEVKEFCSPEAVDLINRLLCMDPAKRLG-ANGYQEIKSH 251

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 31/89 (34%), Positives = 51/89 (57%), Gaps = 2/89 (2%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 70
           L+  H   I++RD+KP N+++D +   +R+ D GLA     G+    RV +  +  PE++
Sbjct: 115 LEDLHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV 173

Query: 71  ADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
            + + Y +S D W LGC++  MI  K PF
Sbjct: 174 KN-ERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 36/150 (24%), Positives = 74/150 (49%), Gaps = 12/150 (8%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK----IKREIKILENLRGGT 226
           + + L+  +G+G + EV++AI+ +++    +K++   + +     I++EI+ L   R   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRS-P 59

Query: 227 NIIT-LQAVVKDPVSRTPALIFEHVNNTDFKQL--YQTLTDYDIRYYLYELLKALDYCHS 283
            I     + +K        +I E+        L     L +  I + L E+L  L+Y H 
Sbjct: 60  YITKYYGSFLKG---SKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHE 116

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            G +HRD+K  N+++  E   ++L D+G++
Sbjct: 117 EGKIHRDIKAANILLS-EEGDVKLADFGVS 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 36/113 (31%), Positives = 59/113 (52%), Gaps = 2/113 (1%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L+  H    ++RD+KP N+++D +   +R+ D GLA     G+    RV +  +  PE+
Sbjct: 114 GLEDLHRENTVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEV 172

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELF 122
           L + Q Y  S D W LGC++  MI  + PF    +   +     +VL TEE++
Sbjct: 173 LNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 60.5 bits (146), Expect = 4e-10
 Identities = 69/295 (23%), Positives = 129/295 (43%), Gaps = 38/295 (12%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVK---ILKPVKKKKIKREIKILENLRGGTNII 229
           Y    K+G+G    VF AI+V +  +  +K   + K  KK+ I  EI +++ L+   NI+
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKN-PNIV 79

Query: 230 TL--QAVVKDPVSRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCHSMG 285
                 +V D +     ++ E++       +     + +  I     E L+AL++ H+  
Sbjct: 80  NFLDSFLVGDEL----FVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 286 IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQYHI 344
           ++HRD+K  NV++  +   ++L D+G      P Q + +  V + Y+  PE++    Y  
Sbjct: 136 VIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 345 ELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQ 404
           ++D     I+                  +V  E   +L++N L              +N 
Sbjct: 195 KVDIWSLGIMA---------------IEMVEGEP-PYLNENPLRALYLIATNGTPELQNP 238

Query: 405 HLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIV 459
             +SP   DFL++ L  D  +R +A+E + HP+         +   P SS TP++
Sbjct: 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL--------KLAKPLSSLTPLI 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 59.6 bits (145), Expect = 5e-10
 Identities = 49/191 (25%), Positives = 86/191 (45%), Gaps = 24/191 (12%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVV------KILKPVKKKKIKREIKILENLRGG 225
           DY+++  +G+G +  V +     S  K +V        +   +K+++  E+ IL  L+  
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRK-SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH- 58

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLT--------DYDIRYYLYELLKA 277
            NI+     + D  ++T  ++ E+    D  QL Q           ++  R  L +LL A
Sbjct: 59  PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRI-LTQLLLA 117

Query: 278 LDYCH-----SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYF 331
           L  CH        ++HRD+KP N+ +D  N  ++L D+GLA+       +    V + Y+
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176

Query: 332 KGPELLADYQY 342
             PE L    Y
Sbjct: 177 MSPEQLNHMSY 187

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 48/178 (26%), Positives = 82/178 (46%), Gaps = 18/178 (10%)

Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQ 320
           L +  I      +L+AL Y HS G++HRD+K  ++++  + R ++L D+G  A+      
Sbjct: 114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVP 172

Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD 380
           +    V + Y+  PE+++   Y  E+D              W   +      +V  E   
Sbjct: 173 KRKSLVGTPYWMAPEVISRTPYGTEVDI-------------WSLGIMV--IEMVDGEPPY 217

Query: 381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           F D  +     R R       +N H +SP   DFL+++L  +  ER TA+E +DHP+ 
Sbjct: 218 FSDSPVQAM-KRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 22/168 (13%)

Query: 274 LLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFK 332
           +LKAL   H+ G++HRD+K  ++++ H+ R ++L D+G  A+           V + Y+ 
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWM 183

Query: 333 GPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP--EALDFLDKNILGRH 390
            PEL++   Y  E+D     I+           V  E  +   P  +A+  +  N+  + 
Sbjct: 184 APELISRLPYGPEVDIWSLGIM-------VIEMVDGEPPYFNEPPLKAMKMIRDNLPPK- 235

Query: 391 SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                      +N H VSP    FLD+LL  D  +R TA E + HP+ 
Sbjct: 236 ----------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 59.5 bits (145), Expect = 5e-10
 Identities = 35/165 (21%), Positives = 73/165 (44%), Gaps = 23/165 (13%)

Query: 177 RKLGRGKYSEVFEAI---NVQSSDKCVVKILK----PVKKKKIKREIKILENLRGGTNII 229
           +KLG G + EV++         + +  VK LK      ++K   +E ++++ L G  N++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVV 59

Query: 230 TLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ------------TLTDYDIRYYLYELLKA 277
            L  V  +       L+ E++   D     +            TL+  D+  +  ++ K 
Sbjct: 60  RLLGVCTEE--EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 322
           ++Y  S   +HRD+   N ++  E+  +++ D+GL+   +    Y
Sbjct: 118 MEYLASKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDDYY 161

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 35/100 (35%), Positives = 49/100 (49%), Gaps = 6/100 (6%)

Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           I  GA   L Y HS   +HRD+K  N+++  E   ++L D+G A    P   +   V + 
Sbjct: 120 ICHGALQGLAYLHSHERIHRDIKAGNILLT-EPGTVKLADFGSASLVSPANSF---VGTP 175

Query: 63  YFKGPE--LLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           Y+  PE  L  D   YD  +D+WSLG     +  RK P F
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 46/177 (25%), Positives = 93/177 (52%), Gaps = 13/177 (7%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK---IKREIKILENLRGGT 226
           Q+D++L++++G G Y +V++A NV + +   +K++K    +    +++EI ++++ +  +
Sbjct: 8   QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK-HS 66

Query: 227 NIITLQAVVKDPVSRTPALI-FEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYCH 282
           NI+   A     + R    I  E       + +Y     L++  I Y   E L+ L Y H
Sbjct: 67  NIV---AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLA 338
           S G MHRD+K  N+++  +N  ++L D+G+ A+      +    + + Y+  PE+ A
Sbjct: 124 SKGKMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.1 bits (145), Expect = 6e-10
 Identities = 36/104 (34%), Positives = 59/104 (56%), Gaps = 5/104 (4%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKG 66
           S+AL+Y H  GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  
Sbjct: 106 SLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 164

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQ 108
           PE+L   + Y +S+D W+LG ++  M+  + PF      DN DQ
Sbjct: 165 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 48/211 (22%), Positives = 97/211 (45%), Gaps = 36/211 (17%)

Query: 257 QLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF 315
           Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++  +   L+++D+GLA  
Sbjct: 109 QVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART 167

Query: 316 YHPGQEYNVRVASRYFKGPELLADYQYHIELDPR-----FADIL-------GRHSRKRWE 363
                     V +RY++ PE++    Y   +D         +++       G     +W 
Sbjct: 168 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN 227

Query: 364 RFVHTENQHLVSPEALDFLDK------NIL---GRHSRKRWERFV--------HTENQHL 406
           + +    + L +P   +F+ +      N +    +++   +E              +  L
Sbjct: 228 KII----EQLGTPSD-EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKL 282

Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
            + +A D L K+L  D  +R++  +A+ HPY
Sbjct: 283 KASQARDLLSKMLVIDPEKRISVDDALQHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 52/176 (29%), Positives = 88/176 (50%), Gaps = 18/176 (10%)

Query: 176 VRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVV 235
           ++ LG+G Y +VF+   V  +D   +  +K +KK  I R  K   + +   NI  L+A V
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNI--LEA-V 57

Query: 236 KDP--VSRTPA--------LIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKALDYCH 282
           K P  V    A        LI E+++  + F  L +     +    +YL E+  AL++ H
Sbjct: 58  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
             GI++RD+KP N+++D +   ++L D+GL  E  H G   +    +  +  PE+L
Sbjct: 118 QQGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL 172

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.3 bits (143), Expect = 7e-10
 Identities = 46/190 (24%), Positives = 90/190 (47%), Gaps = 18/190 (9%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVK------ILKPVKKKKIKREIKILENLRGG 225
           ++Q+ +K+GRG++SEV+ A  +       +K      ++    ++   +EI +L+ L   
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTD-------FKQLYQTLTDYDIRYYLYELLKAL 278
             I  L + ++D       ++ E  +  D       FK+  + + +  +  Y  +L  A+
Sbjct: 63  NVIKYLDSFIED---NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELL 337
           ++ HS  +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 338 ADYQYHIELD 347
            +  Y+ + D
Sbjct: 179 HENGYNFKSD 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 44/181 (24%), Positives = 89/181 (49%), Gaps = 19/181 (10%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGGTNIIT 230
           ++LV  +G G Y +V++  +V++     +K++   +  +++IK EI +L+      NI T
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 231 LQAVVKDPVSRTPA-------LIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKAL 278
                   + ++P        L+ E         L +      L +  I Y   E+L+ L
Sbjct: 78  YYGAF---IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELL 337
            + H+  ++HRD+K  NV++  EN +++L+D+G+ A+        N  + + Y+  PE++
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 338 A 338
           A
Sbjct: 194 A 194

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPE 68
           A+++ HS  +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
            + +   Y++  D+WSLGC+L  M   + PF+
Sbjct: 177 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 27/98 (27%), Positives = 46/98 (46%), Gaps = 3/98 (3%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS 61
           RI       L   H   I+HRD+K  N+++   N  +++ D G+++           + +
Sbjct: 107 RIFIQLLRGLQALHEQKILHRDLKSANILL-VANDLVKIGDLGISKVLKKNMAKTQ-IGT 164

Query: 62  RYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
            ++  PE+    + Y Y  D+WSLGC+L  M     PF
Sbjct: 165 PHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 30/85 (35%), Positives = 43/85 (50%), Gaps = 17/85 (20%)

Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRV 326
           I+  + ++L ALD  HS GI+HRDVKP N++    +   ++ID G A         ++RV
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAA--------DLRV 308

Query: 327 ASRYFKGPELLADYQYHIELDPRFA 351
              Y    E L        LDPR+A
Sbjct: 309 GINYIP-KEFL--------LDPRYA 324

Length = 566

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 34/90 (37%), Positives = 52/90 (57%), Gaps = 3/90 (3%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA-SRYFKGPEL 69
           L++ H   I++RD+KP NV++D++   +R+ D GLA     GQ      A +  F  PEL
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL 168

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           L   + YD+S+D ++LG  L  MI  + PF
Sbjct: 169 LQG-EEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 31/93 (33%), Positives = 55/93 (59%), Gaps = 3/93 (3%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKG 66
           S+AL++ H  GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  
Sbjct: 106 SLALNFLHERGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIA 164

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           PE+L   + Y +S+D W+LG ++  M+  + PF
Sbjct: 165 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 9/103 (8%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-----GQEYNVRVASRYF 64
            L Y HS GI+HRD+KP N+ +DH N  ++L D+G A          G+E      +  +
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFLDH-NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169

Query: 65  KGPE--LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 105
             PE       + +  + D+WSLGC++  M   K P +   DN
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDN 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 6/101 (5%)

Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           I  GA   L Y HS  ++HRD+K  N+++  E  +++L D+G A    P   +   V + 
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLT-EPGQVKLADFGSASIASPANSF---VGTP 185

Query: 63  YFKGPE--LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           Y+  PE  L  D   YD  +D+WSLG     +  RK P F+
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPE 68
           AL++ HS  +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
            + +   Y++  D+WSLGC+L  M   + PF+
Sbjct: 177 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 3/106 (2%)

Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    + L++ H+  +++RD+KP N+++D E+  +R+ D GLA  +   + +   V +  
Sbjct: 103 AAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHG 160

Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
           +  PE+L     YD S D +SLGCML  ++    P F  H   D+ 
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 33/105 (31%), Positives = 59/105 (56%), Gaps = 5/105 (4%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKG 66
            + L + H  GI++RD+K  NV++D E   +++ D+G+  E    G   +    +  +  
Sbjct: 106 VLGLQFLHERGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIA 164

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 111
           PE+L+ YQ Y  ++D W+LG +L  M+  + P F G D+ D+L +
Sbjct: 165 PEILS-YQPYGPAVDWWALGVLLYEMLAGQSP-FEG-DDEDELFQ 206

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 6/100 (6%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGP 67
             L Y H   ++HRD+K  N+++      ++L+D+G+ A+        N  + + Y+  P
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182

Query: 68  ELLA-DYQM---YDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E++A D Q    YD   D+WSLG     +   K P    H
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 33/122 (27%), Positives = 52/122 (42%), Gaps = 32/122 (26%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA---------------------- 46
           +ALD  H +G +HRD+KP N++ID +   ++L D+GL                       
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 47  ----EFYHPGQEYNVR----VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEP 98
                     ++  VR    V +  +  PE+L     Y    D WSLG +L  M++   P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPP 229

Query: 99  FF 100
           F+
Sbjct: 230 FY 231

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 8/101 (7%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR--VASRYFKG 66
           +A+   H MG +HRD+KP NV+ID     ++L D+G A      +  N +  V +  +  
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIA 171

Query: 67  PELLADYQ-----MYDYSLDMWSLGCMLASMIFRKEPFFHG 102
           PE+L          Y    D WSLG +   MI+ + PF  G
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 45/153 (29%), Positives = 79/153 (51%), Gaps = 20/153 (13%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR-------EIKILENLR 223
           +D+ +++ +GRG + EV    +  S     +K+L   K + IKR       E + +    
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS--KFEMIKRSDSAFFWEERDIMAHA 100

Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDI-----RYYLYELLKAL 278
               I+ L    +D   +   ++ E++   D   L   +++YDI     R+Y  E++ AL
Sbjct: 101 NSEWIVQLHYAFQDD--KYLYMVMEYMPGGDLVNL---MSNYDIPEKWARFYTAEVVLAL 155

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG 311
           D  HSMG +HRDVKP N+++D ++  L+L D+G
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 45/155 (29%), Positives = 79/155 (50%), Gaps = 20/155 (12%)

Query: 169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR-------EIKILEN 221
           + +DY++V+ +GRG + EV    +  +     +K+L   K + IKR       E + +  
Sbjct: 41  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMA 98

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDI-----RYYLYELLK 276
                 ++ L    +D   R   ++ E++   D   L   +++YD+     R+Y  E++ 
Sbjct: 99  FANSPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNL---MSNYDVPEKWARFYTAEVVL 153

Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG 311
           ALD  HSMG +HRDVKP N+++D     L+L D+G
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 26/94 (27%), Positives = 50/94 (53%), Gaps = 3/94 (3%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPEL 69
           L+Y HS   +HRD+K  N++++ E  + +L D+G++ +      + N  + + ++  PE+
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV 170

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           + +   Y+   D+WSLG     M   K P+   H
Sbjct: 171 IQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIH 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 56.8 bits (138), Expect = 5e-09
 Identities = 26/86 (30%), Positives = 46/86 (53%), Gaps = 3/86 (3%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGP 67
             L+Y HS  ++HRD+K  N+++  +   ++L D+G  A+      + N  V + Y+  P
Sbjct: 127 QGLEYLHSQNVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMI 93
           E++   + Y   +D+WSLG M   M 
Sbjct: 186 EVIKR-KDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 39/110 (35%), Positives = 60/110 (54%), Gaps = 7/110 (6%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
           AL Y HSM I+HRD+K  NV++  +   ++L D+G+ A+     Q  +  + + Y+  PE
Sbjct: 122 ALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180

Query: 69  LLADYQM----YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           ++    M    YDY  D+WSLG  L  M  + EP  H  +    L++IAK
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 229

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 56.9 bits (138), Expect = 5e-09
 Identities = 61/294 (20%), Positives = 111/294 (37%), Gaps = 60/294 (20%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI----LKPVKKKKIKREIKILENLRGGT 226
           DD + + +LG G    V + ++  +     VK     +    +K+I RE+ IL       
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNS-P 59

Query: 227 NIITL-QA-VVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYL----YELLKALDY 280
            I+    A      +S    +  E+++     ++ + +        L      +LK L Y
Sbjct: 60  YIVGFYGAFYNNGDIS----ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTY 115

Query: 281 CHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN----VRVASRYFKGPE 335
            H    I+HRDVKP N++++    +++L D+G++     GQ  N      V +  +  PE
Sbjct: 116 LHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPE 169

Query: 336 LLADYQYHIELDPRFADI-----------LGRHSRKRWERFVHTENQHLVSPEALDFLDK 384
            +    Y ++     +DI            GR             N         + L  
Sbjct: 170 RIQGNDYSVK-----SDIWSLGLSLIELATGRFPYPPE-------NDPPDGI--FELLQY 215

Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +     R    +F         SP+  DF++  L  D  ER + +E ++HP+ 
Sbjct: 216 IVNEPPPRLPSGKF---------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 6/101 (5%)

Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           I  GA   L Y HS  ++HRD+K  N+++  E  +++L D+G A    P   +   V + 
Sbjct: 126 ITHGALQGLAYLHSHNMIHRDIKAGNILLT-EPGQVKLADFGSASKSSPANSF---VGTP 181

Query: 63  YFKGPE--LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           Y+  PE  L  D   YD  +D+WSLG     +  RK P F+
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 9/95 (9%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           AL Y HS+ I++RD+KP N+++D +   + L D+GL +    G E++ +  S +   PE 
Sbjct: 108 ALGYLHSLNIIYRDLKPENILLDSQGH-VVLTDFGLCK---EGIEHS-KTTSTFCGTPEY 162

Query: 70  LAD----YQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           LA      Q YD ++D W LG +L  M++   PF+
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 56.3 bits (136), Expect = 7e-09
 Identities = 46/171 (26%), Positives = 78/171 (45%), Gaps = 30/171 (17%)

Query: 275 LKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKG 333
           LKAL + H+ G++HRD+K  ++++  + R ++L D+G  A+           V + Y+  
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183

Query: 334 PELLADYQYHIELDPRFADI--LGRHSRKRWERFVHTENQHLVSPEALD----FLDKNIL 387
           PE+++   Y  E      DI  LG                 ++  E +D    + ++  L
Sbjct: 184 PEVISRLPYGTE-----VDIWSLG-----------------IMVIEMVDGEPPYFNEPPL 221

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
               R R       +N H VSP    FLD++L  D  +R TA E ++HP+ 
Sbjct: 222 QAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
           AL Y HS+ I++RD+KP N+++D +   + L D+GL  E        +    +  +  PE
Sbjct: 108 ALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE 166

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           +L   Q YD ++D W LG +L  M++   PF+
Sbjct: 167 VLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY 197

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 56.0 bits (135), Expect = 8e-09
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 3/99 (3%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVA 60
           R      + L + HS  I+HRD+K  N+ +D     +++ D G+A+       + N  V 
Sbjct: 105 RFFIQILLGLAHLHSKKILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNTNFANTIVG 163

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           + Y+  PEL  D + Y+   D+W+LG +L      K PF
Sbjct: 164 TPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 6/101 (5%)

Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +  GA   L Y HS  ++HRDVK  N+++  E   ++L D+G A    P   +   V + 
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANXF---VGTP 175

Query: 63  YFKGPE--LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           Y+  PE  L  D   YD  +D+WSLG     +  RK P F+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 56.4 bits (136), Expect = 9e-09
 Identities = 35/109 (32%), Positives = 62/109 (56%), Gaps = 6/109 (5%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE--FYHPGQEYNVRVASRYFK 65
           ++ALD+ HS+GI++RD+KP N+++D E   ++L D+GL++    H  + Y+      Y  
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYM- 165

Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
            PE++ + + +  S D WS G ++  M+    P F G D  + +  I K
Sbjct: 166 APEVV-NRRGHTQSADWWSFGVLMFEMLTGSLP-FQGKDRKETMTMILK 212

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.5 bits (136), Expect = 9e-09
 Identities = 31/98 (31%), Positives = 55/98 (56%), Gaps = 3/98 (3%)

Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASR 62
           A   + A+ Y HS+ I++RD+KP N+++D +   + L D+GL  E   P +  +    + 
Sbjct: 102 AAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTP 160

Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
            +  PE+L   + YD ++D W LG +L  M++   PF+
Sbjct: 161 EYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFY 197

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 56.1 bits (136), Expect = 9e-09
 Identities = 29/140 (20%), Positives = 64/140 (45%), Gaps = 13/140 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK----PVKKKKIKREIKILENLRGGT 226
            D + V+ LG+G    V++  +  +     +K +        +K++ RE+K L      +
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTL--RSCES 58

Query: 227 -NIITLQAVVKDPVSRTPALIFEHVNN---TDFKQLYQTLTDYDIRYYLYELLKALDYCH 282
             ++              +++ E+++     D  +    + +  + Y   ++LK LDY H
Sbjct: 59  PYVVKCYGAFYKE--GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH 116

Query: 283 SM-GIMHRDVKPHNVMIDHE 301
           +   I+HRD+KP N++I+ +
Sbjct: 117 TKRHIIHRDIKPSNLLINSK 136

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 6/106 (5%)

Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVAS 61
           I  GA + L + H+  I+HRDVK +N+++  E   ++L+D+G+ A+        N  V +
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGT 191

Query: 62  RYFKGPELLADYQMYDYSL----DMWSLGCMLASMIFRKEPFFHGH 103
            ++  PE++A  Q YDYS     D+WSLG     +     P F  H
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 56.3 bits (135), Expect = 1e-08
 Identities = 38/134 (28%), Positives = 69/134 (51%), Gaps = 10/134 (7%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
           AL++ H+  ++HRD+K  NV++  +   ++L D+G      P Q + +  V + Y+  PE
Sbjct: 127 ALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY 128
           ++   + Y   +D+WSLG M   M+  + P+   ++N  + + +    GT EL     + 
Sbjct: 186 VVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPEL-----QN 237

Query: 129 HIELDPRFADILGR 142
             +L P F D L R
Sbjct: 238 PEKLSPIFRDFLNR 251

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 24/52 (46%), Positives = 41/52 (78%), Gaps = 1/52 (1%)

Query: 263 TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
           T+ D+++YL EL  ALD+ HS+GI++RD+KP N+++D E   ++L D+GL++
Sbjct: 96  TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 13/133 (9%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
           +AL++ H  GI++RD+K  NV++D +   ++L D+G+  E   PG   +    +  +  P
Sbjct: 107 IALNFLHERGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAP 165

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE-LFEYLD 126
           E+L   + Y +S+D W+LG ++  M+  + PF    DN D        + TE+ LF+ + 
Sbjct: 166 EILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD--------MNTEDYLFQVIL 216

Query: 127 KYHIELDPRFADI 139
           +  I + PRF  +
Sbjct: 217 EKPIRI-PRFLSV 228

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 54.9 bits (133), Expect = 2e-08
 Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 25/150 (16%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILKPVKK---------KKIKREIKILENLRGGTNII 229
           LG G +  V E + V+S ++     LK VKK         + I  E +ILE       I+
Sbjct: 1   LGVGGFGRV-ELVKVKSKNRTFA--LKCVKKRHIVETGQQEHIFSEKEILEECNH-PFIV 56

Query: 230 TLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTD------YDIRYYLYELLKALDYCHS 283
            L    KD   +   ++ E+       +L+  L D      Y  R+Y+  ++ A +Y H+
Sbjct: 57  KLYRTFKD--KKYIYMLMEYCLG---GELWTILRDRGLFDEYTARFYIACVVLAFEYLHN 111

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            GI++RD+KP N+++D     ++L+D+G A
Sbjct: 112 RGIIYRDLKPENLLLDSNGY-VKLVDFGFA 140

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 29/93 (31%), Positives = 53/93 (56%), Gaps = 3/93 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
           AL   H+ G++HRD+K  ++++ H+ R ++L D+G  A+           V + Y+  PE
Sbjct: 128 ALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE 186

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           L++    Y   +D+WSLG M+  M+  + P+F+
Sbjct: 187 LISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFN 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 4/97 (4%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGP 67
             L + HS GI++RD+K  N+++D +   +++ D+G+ +    G  +      +  +  P
Sbjct: 107 CGLQFLHSKGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAP 165

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           E+L   Q Y+ S+D WS G +L  M+  + P FHGHD
Sbjct: 166 EILLG-QKYNTSVDWWSFGVLLYEMLIGQSP-FHGHD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 28/81 (34%), Positives = 48/81 (59%), Gaps = 2/81 (2%)

Query: 19  IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDY 78
           I++RD+KP N+++D +   +R+ D GLA     G+    RV +  +  PE++ + + Y +
Sbjct: 123 IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN-EKYTF 180

Query: 79  SLDMWSLGCMLASMIFRKEPF 99
           S D W LGC++  MI  + PF
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 32/96 (33%), Positives = 55/96 (57%), Gaps = 2/96 (2%)

Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           AT   + L++ H+  +++RD+KP N+++D E+  +R+ D GLA  +   + +   V +  
Sbjct: 103 ATEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHG 160

Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +  PE+L     YD S D +SLGCML  ++    PF
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 4/104 (3%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKG 66
           S+ L + H   I+HRD+K  N+ +       +L D+G+A   +   E     V + Y+  
Sbjct: 111 SLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLS 170

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
           PE+  + + Y+   D+WSLGC+L  +   K PF    +N  QLV
Sbjct: 171 PEICQN-RPYNNKTDIWSLGCVLYELCTLKHPF--EGNNLHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 46/186 (24%), Positives = 89/186 (47%), Gaps = 17/186 (9%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL--KPVKKKKIKR------EIKILENLR 223
           +++L + LGRG + EV+   +  +  +  VK +   P  ++  K       EI++L+NLR
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFK---QLYQTLTDYDIRYYLYELLKALDY 280
               I+     ++DP  +  ++  E++     K   + Y  LT+   R Y  ++L+ + Y
Sbjct: 63  H-DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE----FYHPGQEYNVRVASRYFKGPEL 336
            HS  I+HRD+K  N++ D     ++L D+G ++        G        + Y+  PE+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180

Query: 337 LADYQY 342
           ++   Y
Sbjct: 181 ISGEGY 186

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 48/184 (26%), Positives = 88/184 (47%), Gaps = 19/184 (10%)

Query: 177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKI---------KREIKILENLRGGTN 227
           R +GRG Y++V   + ++ +++  +  +K VKK+ +         + E  + E       
Sbjct: 1   RVIGRGSYAKVL-LVRLKKTER--IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 57

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFK---QLYQTLTDYDIRYYLYELLKALDYCHSM 284
           ++ L +  +   SR    + E+VN  D     Q  + L +   R+Y  E+  AL+Y H  
Sbjct: 58  LVGLHSCFQTE-SRL-FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
           GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  PE+L    Y 
Sbjct: 116 GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174

Query: 344 IELD 347
             +D
Sbjct: 175 FSVD 178

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 43/151 (28%), Positives = 79/151 (52%), Gaps = 13/151 (8%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-----PVKKKKIKR---EIKILENLR 223
           +++L + LG+G +  V+   +  +  +  VK ++     P   K++     EI++L+NL 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFK-QL--YQTLTDYDIRYYLYELLKALDY 280
               I+     ++DP+ RT ++  EH+     K QL  Y  LT+   R Y  ++L+ + Y
Sbjct: 63  H-ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWG 311
            HS  I+HRD+K  N++ D     ++L D+G
Sbjct: 122 LHSNMIVHRDIKGANILRDSVG-NVKLGDFG 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 46/156 (29%), Positives = 83/156 (53%), Gaps = 22/156 (14%)

Query: 169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKC-VVKILKPVKKKKIKR-------EIKILE 220
           + +DY +V+ +GRG + EV + +  +SS K   +K+L   K + IKR       E + + 
Sbjct: 41  KAEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLS--KFEMIKRSDSAFFWEERDIM 97

Query: 221 NLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDI-----RYYLYELL 275
                  ++ L    +D   +   ++ E++   D   L   +++YD+     ++Y  E++
Sbjct: 98  AFANSPWVVQLFCAFQD--DKYLYMVMEYMPGGDLVNL---MSNYDVPEKWAKFYTAEVV 152

Query: 276 KALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG 311
            ALD  HSMG++HRDVKP N+++D     L+L D+G
Sbjct: 153 LALDAIHSMGLIHRDVKPDNMLLDKHGH-LKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 6/82 (7%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQ-EYNVR---VASRYF 64
            L+Y HS G +HRD+K  N+++  E+  +++ D+G+ A     G     VR   V +  +
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172

Query: 65  KGPELLADYQMYDYSLDMWSLG 86
             PE++     YD+  D+WS G
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFG 194

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 31/112 (27%), Positives = 58/112 (51%), Gaps = 13/112 (11%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR-------Y 63
           L+Y H+ GI+HRD+K  N+++D++   +++ D+G+++             +R       +
Sbjct: 119 LNYLHNRGIIHRDIKGANILVDNKG-GIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177

Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
           +  PE++     Y    D+WSLGC++  M+  K PF     +  QL  I K+
Sbjct: 178 WMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPF----PDCTQLQAIFKI 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 15/106 (14%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 66
            L + H  GI++RD+K  NV++D +   +++ D+G+ +     +  N    +  F G   
Sbjct: 108 GLQFLHKKGIIYRDLKLDNVLLDKDGH-IKIADFGMCK-----ENMNGEGKASTFCGTPD 161

Query: 67  ---PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
              PE+L   Q Y+ S+D WS G +L  M+  + P FHG D  D+L
Sbjct: 162 YIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSP-FHGEDE-DEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 47/179 (26%), Positives = 87/179 (48%), Gaps = 11/179 (6%)

Query: 176 VRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK----IKREIKILENLRGGTNIITL 231
           + K+G+G + EVF+ I+ ++     +KI+   + +     I++EI +L            
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 232 QAVVKDPVSRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCHSMGIMHR 289
            + +KD       +I E++       L +   L +  I   L E+LK LDY HS   +HR
Sbjct: 69  GSYLKDT---KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHR 125

Query: 290 DVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQYHIELD 347
           D+K  NV++  E+ +++L D+G+A      Q + N  V + ++  PE++    Y  + D
Sbjct: 126 DIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 54.0 bits (129), Expect = 5e-08
 Identities = 69/299 (23%), Positives = 128/299 (42%), Gaps = 46/299 (15%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVK---ILKPVKKKKIKREIKILENLRGGTNII 229
           Y    K+G+G    V+ AI++ +  +  +K   + +  KK+ I  EI ++   +    + 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 230 TLQAVVKDPVSRTPALIFEHVNNTDFKQLY-QTLTDY-DIRYYLYELLKALDYCHSMGIM 287
            L + +   V     ++ E++       +  +T  D   I     E L+ALD+ HS  ++
Sbjct: 81  YLDSYL---VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVI 137

Query: 288 HRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQYHIEL 346
           HRD+K  N+++  +   ++L D+G      P Q + +  V + Y+  PE++    Y  ++
Sbjct: 138 HRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 347 DPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQ-H 405
           D     I+                  +V  E   +L++N L      R    + T     
Sbjct: 197 DIWSLGIMA---------------IEMVEGEP-PYLNENPL------RALYLIATNGTPE 234

Query: 406 LVSPEAL-----DFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIV 459
           L +PE L     DFL++ L  D   R +A+E + HP+         +   P SS TP++
Sbjct: 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL--------KLAKPLSSLTPLI 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 30/93 (32%), Positives = 53/93 (56%), Gaps = 3/93 (3%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKG 66
           S+AL++ H  GI++RD+KP N+++D +   ++L D+GL  E  H G   +    +  +  
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMA 168

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           PE+L     +  ++D WSLG ++  M+    PF
Sbjct: 169 PEILMR-SGHGKAVDWWSLGALMYDMLTGAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 46/184 (25%), Positives = 89/184 (48%), Gaps = 19/184 (10%)

Query: 177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKI---------KREIKILENLRGGTN 227
           R +GRG Y++V   + ++ +D+  +  +K VKK+ +         + E  + E       
Sbjct: 1   RVIGRGSYAKVL-LVRLKKNDQ--IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF 57

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFK---QLYQTLTDYDIRYYLYELLKALDYCHSM 284
           ++ L +  +   +    L+ E+VN  D     Q  + L +   R+Y  E+  AL++ H  
Sbjct: 58  LVGLHSCFQ--TTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
           GI++RD+K  NV++D +   ++L D+G+  E   PG   +    +  +  PE+L   +Y 
Sbjct: 116 GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174

Query: 344 IELD 347
             +D
Sbjct: 175 FSVD 178

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 38/165 (23%), Positives = 76/165 (46%), Gaps = 23/165 (13%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK----PVKKKKIKREIKILENLRGGT 226
           DDY+L+  +G G  + V+ AI + +++K  +K +          ++++E++ + +     
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAM-SQCNHP 59

Query: 227 NIITLQA---------VVKDPVSRTPAL-IFEHVNNTDFKQLYQTLTDYDIRYYLYELLK 276
           N++             +V   +S    L I +             L +  I   L E+LK
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG------LDEAIIATVLKEVLK 113

Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQ 320
            L+Y HS G +HRD+K  N+++  E+  +++ D+G+ A     G 
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGD 157

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 54.0 bits (129), Expect = 6e-08
 Identities = 33/113 (29%), Positives = 61/113 (53%), Gaps = 5/113 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
           ALD+ HS  ++HRD+K  N+++  +   ++L D+G      P Q + +  V + Y+  PE
Sbjct: 127 ALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
           ++   + Y   +D+WSLG M   M+  + P+   ++N  + + +    GT EL
Sbjct: 186 VVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPEL 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 53.6 bits (129), Expect = 6e-08
 Identities = 32/117 (27%), Positives = 61/117 (52%), Gaps = 5/117 (4%)

Query: 2   RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           +IA     AL+Y HS + ++HRDVKP NV+I+  N +++L D+G++ +        +   
Sbjct: 107 KIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR-NGQVKLCDFGISGYLVDSVAKTIDAG 165

Query: 61  SRYFKGPELL---ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
            + +  PE +    + + YD   D+WSLG  +  +   + P+      + QL ++ +
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 53.8 bits (129), Expect = 6e-08
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 10/135 (7%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
           AL++ HS  ++HRD+K  N+++  +   ++L D+G      P Q + +  V + Y+  PE
Sbjct: 127 ALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY 128
           ++     Y   +D+WSLG M   M+  + P+   ++N  + + +    GT EL     + 
Sbjct: 186 VVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPEL-----QN 237

Query: 129 HIELDPRFADILGRA 143
             +L   F D L R 
Sbjct: 238 PEKLSAIFRDFLNRC 252

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 40/158 (25%), Positives = 83/158 (52%), Gaps = 17/158 (10%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKI-KRE----IKILENLRGG 225
           +D+  V+ +G+G + EV     VQ  D   +  +K + K ++ K++    +K   ++   
Sbjct: 1   EDFHTVKVIGKGAFGEVRL---VQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57

Query: 226 TN---IITLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALD 279
           ++   +++L    +D  ++   LI E +   D   +   Y T ++   R+Y+ E + A++
Sbjct: 58  SDSPWVVSLYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIE 115

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH 317
             H +G +HRD+KP N++ID     ++L D+GL+  +H
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFH 152

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 29/92 (31%), Positives = 53/92 (57%), Gaps = 3/92 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
           AL Y HS G++HRD+K  ++++  + R ++L D+G  A+      +    V + Y+  PE
Sbjct: 129 ALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 187

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           +++    Y   +D+WSLG M+  M+  + P+F
Sbjct: 188 VISR-TPYGTEVDIWSLGIMVIEMVDGEPPYF 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 27/92 (29%), Positives = 52/92 (56%), Gaps = 3/92 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
           AL + H+ G++HRD+K  ++++  + R ++L D+G  A+           V + Y+  PE
Sbjct: 127 ALSFLHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE 185

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           +++    Y   +D+WSLG M+  M+  + P+F
Sbjct: 186 VISR-LPYGTEVDIWSLGIMVIEMVDGEPPYF 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 53.3 bits (128), Expect = 7e-08
 Identities = 30/93 (32%), Positives = 53/93 (56%), Gaps = 3/93 (3%)

Query: 9   MALDYCH-SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           +AL Y H    I+HRD+ P+N+M+  E+ K+ + D+GLA+   P  +    V +  +  P
Sbjct: 124 LALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGTILYSCP 182

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           E++ + + Y    D+W+ GC+L  M   + PF+
Sbjct: 183 EIVKN-EPYGEKADVWAFGCILYQMCTLQPPFY 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 53.3 bits (129), Expect = 8e-08
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 18/100 (18%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFK--- 65
           +AL+Y HS+ I++RD+KP N+++D +   +++ D+G A           RV  R +    
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGY-IKITDFGFA----------KRVKGRTYTLCG 160

Query: 66  GPELLAD----YQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
            PE LA      + Y  ++D W+LG ++  M+    PFF 
Sbjct: 161 TPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 53.6 bits (129), Expect = 8e-08
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 3/93 (3%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKG 66
           ++ L + HS GI++RD+K  NVM+D E   +++ D+G+  E    G+       +  +  
Sbjct: 111 AIGLFFLHSKGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIA 169

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           PE++A YQ Y  S+D W+ G +L  M+  + PF
Sbjct: 170 PEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 29/93 (31%), Positives = 54/93 (58%), Gaps = 3/93 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
           AL Y H+ G++HRD+K  ++++  + R ++L D+G  A+      +    V + Y+  PE
Sbjct: 130 ALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPE 188

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +++    Y   +D+WSLG M+  MI  + P+F+
Sbjct: 189 VISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFN 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 9e-08
 Identities = 45/181 (24%), Positives = 85/181 (46%), Gaps = 14/181 (7%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK----PVKKKKIKREIKILENLRGG--T 226
           YQ +  +GRG Y  V+   +V +     +KI+           I+RE+ +L  LR     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 227 NIITLQ-AVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHS 283
           NI     + +K P      +I E+      + L     + +  I   + E+L AL Y H 
Sbjct: 63  NITKYYGSYLKGP---RLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHK 119

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLADYQY 342
           +G++HRD+K  N+++ +    ++L D+G+ A       + +  V + Y+  PE++ + +Y
Sbjct: 120 VGVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 343 H 343
           +
Sbjct: 179 Y 179

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 45/190 (23%), Positives = 88/190 (46%), Gaps = 18/190 (9%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVK------ILKPVKKKKIKREIKILENLRGG 225
           ++++ +K+GRG++SEV+ A  +       +K      ++    +    +EI +L+ L   
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTD-------FKQLYQTLTDYDIRYYLYELLKAL 278
             I    + ++D       ++ E  +  D       FK+  + + +  +  Y  +L  AL
Sbjct: 63  NVIKYYASFIED---NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELL 337
           ++ HS  +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 338 ADYQYHIELD 347
            +  Y+ + D
Sbjct: 179 HENGYNFKSD 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 42/186 (22%), Positives = 90/186 (48%), Gaps = 14/186 (7%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK----PVKKKKI-KREIKILENLRGGTN 227
           Y++++K+G G + +++ A     S+ CV+K +     PVK+K+  K+E+ +L  ++   N
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH-PN 60

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCH 282
           I+T  A  ++  +    ++ E+ +  D  +          ++  I  +  ++   L + H
Sbjct: 61  IVTFFASFQE--NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGPELLADYQ 341
              I+HRD+K  N+ +       +L D+G+A   +   E     V + Y+  PE+  +  
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP 178

Query: 342 YHIELD 347
           Y+ + D
Sbjct: 179 YNNKTD 184

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 70/299 (23%), Positives = 129/299 (43%), Gaps = 46/299 (15%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVK---ILKPVKKKKIKREIKILENLRGGTNII 229
           Y    K+G+G    V+ AI+V +  +  +K   + +  KK+ I  EI ++   +    + 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 230 TLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIM 287
            L + +   V     ++ E++       +     + +  I     E L+AL++ HS  ++
Sbjct: 81  YLDSYL---VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 137

Query: 288 HRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQYHIEL 346
           HRD+K  N+++  +   ++L D+G      P Q + +  V + Y+  PE++    Y  ++
Sbjct: 138 HRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 347 DPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQ-H 405
           D     I+                  +V  E   +L++N L      R    + T     
Sbjct: 197 DIWSLGIMA---------------IEMVEGEP-PYLNENPL------RALYLIATNGTPE 234

Query: 406 LVSPEAL-----DFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIV 459
           L +PE L     DFL++ L  D  +R +A+E + HP F  I K       P SS TP++
Sbjct: 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP-FLKIAK-------PLSSLTPLI 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGP 67
           + + + H   ++HRD+K  N+ +  +N K++L D+G A     PG      V + Y+  P
Sbjct: 111 LGVQHIHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPP 169

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           E+  +   Y+   D+WSLGC+L  +   K PF
Sbjct: 170 EIWENMP-YNNKSDIWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 5/104 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
           AL Y HS+ I++RD+KP N+++D +   + L D+GL  E             +  +  PE
Sbjct: 108 ALGYLHSINIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPE 166

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFF--HGHDNYDQLV 110
           ++   Q YD ++D W LG +L  M++   PF+     + YD ++
Sbjct: 167 VIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 33/100 (33%), Positives = 56/100 (56%), Gaps = 5/100 (5%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPEL 69
           L + HS GI++RD+K  NVM+D +   +++ D+G+  E        +    +  +  PE+
Sbjct: 109 LQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEI 167

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
           L   + Y +S+D WS G +L  M+  + P FHG D+ D+L
Sbjct: 168 LQGLK-YTFSVDWWSFGVLLYEMLIGQSP-FHG-DDEDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 20/154 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVV-------KILKPVKKKKIKREIKILENLR 223
           +D+++++ +GRG + EV   + ++++DK          ++LK  +    + E  +L N  
Sbjct: 1   EDFEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-- 57

Query: 224 GGTN--IITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDY---DI-RYYLYELLKA 277
            G N  I TL    +D       L+ ++    D   L     D    D+ R+YL E++ A
Sbjct: 58  -GDNQWITTLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIA 114

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG 311
           +D  H +  +HRD+KP N+++D  N  +RL D+G
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDM-NGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 25/103 (24%), Positives = 47/103 (45%), Gaps = 10/103 (9%)

Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVR 58
           I  G    +DY  S   +HRD+   N++++ E+  +++ D+GLA+     ++Y       
Sbjct: 118 ICKG----MDYLGSQRYIHRDLAARNILVESEDL-VKISDFGLAKVLPEDKDYYYVKEPG 172

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
            +  ++  PE L   +    S D+WS G  L  +    +P   
Sbjct: 173 ESPIFWYAPECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQS 214

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 38/157 (24%), Positives = 76/157 (48%), Gaps = 15/157 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKRE----IKILENLRGGT 226
           DD++ ++ +GRG + EV       +     +K L+  K + +++E    ++   ++    
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR--KSEMLEKEQVAHVRAERDILAEA 58

Query: 227 N---IITLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDY 280
           +   ++ L    +D       LI E++   D   L     T T+ + R+Y+ E + A+D 
Sbjct: 59  DNPWVVKLYYSFQDE--NYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH 317
            H +G +HRD+KP N+++D     ++L D+GL     
Sbjct: 117 IHKLGYIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLK 152

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 3/93 (3%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKG 66
           +MAL Y H   I+HRD+K  NV +   N  +++ D G+A       +  +  + + Y+  
Sbjct: 112 AMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMASTLIGTPYYMS 170

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           PEL ++ + Y+Y  D+W+LGC +  M   K  F
Sbjct: 171 PELFSN-KPYNYKSDVWALGCCVYEMATLKHAF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 29/94 (30%), Positives = 53/94 (56%), Gaps = 7/94 (7%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL----AEFYHPGQEYNVRVASRYFKG 66
           L Y HS GI+HRD+K  N+++D +    ++ D+G+     + Y   Q  +++  S ++  
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADG-ICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMA 178

Query: 67  PELLADYQM-YDYSLDMWSLGCMLASMIFRKEPF 99
           PE++  Y   Y   +D+WSLGC++  M   + P+
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 53.2 bits (127), Expect = 2e-07
 Identities = 36/125 (28%), Positives = 61/125 (48%), Gaps = 25/125 (20%)

Query: 10  ALDYCHSMG-------IMHRDVKPHNVMIDHENRKL----------------RLIDWGLA 46
           AL YCH++        ++HRD+KP N+ +    R +                ++ D+GL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 47  EFYHPGQEYNVRVASRYFKGPELLA-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 105
           +        +  V + Y+  PELL  + + YD   DMW+LGC++  +   K P FH  +N
Sbjct: 190 KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP-FHKANN 248

Query: 106 YDQLV 110
           + QL+
Sbjct: 249 FSQLI 253

Length = 1021

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 65/242 (26%), Positives = 97/242 (40%), Gaps = 50/242 (20%)

Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL---------AEFYHP 318
           R+Y+ EL  A++  H MG +HRD+KP N++ID +   ++L D+GL         +++Y  
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYYQS 162

Query: 319 GQEYNVRVASRYFKGP-ELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
           G   +VR  S  F       A+ +    L P       +H R      V T N   ++PE
Sbjct: 163 GD--HVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPN--YIAPE 218

Query: 378 AL--------------------------DFLDKNILGRHSRK-RWERFVHTENQHLVSPE 410
            L                           FL +  L    +   W+  +H   Q  +SPE
Sbjct: 219 VLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPE 278

Query: 411 ALDFLDKLLR--YDHYERLTAREAMDHPYFYPI--VKDQSRHTLPS----SSPTPIVNSV 462
           A D + KL R   D   +  A E   HP+F  I    D  + + P     + PT   N  
Sbjct: 279 ASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFD 338

Query: 463 PV 464
           PV
Sbjct: 339 PV 340

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 30/93 (32%), Positives = 53/93 (56%), Gaps = 7/93 (7%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKG 66
           A+ Y H  GI+HRD+K  N+ +      ++L D+G+++    G EY++    V + Y+  
Sbjct: 113 AVSYIHKAGILHRDIKTLNIFLTKAGL-IKLGDFGISKIL--GSEYSMAETVVGTPYYMS 169

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           PEL    + Y++  D+W+LGC+L  ++  K  F
Sbjct: 170 PELCQGVK-YNFKSDIWALGCVLYELLTLKRTF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 28/91 (30%), Positives = 53/91 (58%), Gaps = 4/91 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           AL+Y HS  I++RD+KP N+++D E   ++L D+G A+     + + +     Y   PE+
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLR-DRTWTLCGTPEYL-APEV 169

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           +   + ++ ++D W+LG ++  M+    PFF
Sbjct: 170 IQS-KGHNKAVDWWALGILIYEMLVGYPPFF 199

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 23/184 (12%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR---------EIKILENLRGGTNII 229
           LG+G + EV  A+ V+++ K  +   K + KK++K+         E +ILE +     I+
Sbjct: 1   LGKGGFGEVC-AVQVKNTGK--MYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIV 56

Query: 230 TLQAVVKDPVSRTP-ALIFEHVNNTDFK-QLYQT----LTDYDIRYYLYELLKALDYCHS 283
            L    +   S+T   L+   +N  D K  +Y      L    + +Y  ++   + + HS
Sbjct: 57  NLAYAFE---SKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYH 343
           M I++RD+KP NV++D +    RL D GLA     G+    R  +  +  PE+L +  Y 
Sbjct: 114 MDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYS 172

Query: 344 IELD 347
             +D
Sbjct: 173 YPVD 176

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 18/37 (48%), Positives = 24/37 (64%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 46
           ALD  HS GI+HRDVKP N++    +   ++ID G A
Sbjct: 267 ALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 25/91 (27%), Positives = 50/91 (54%), Gaps = 1/91 (1%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           +AL + H+  I+HRD+K  N+++D     +++ D+G+++      +    V +  +  PE
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE 171

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
            L + + Y+   D+W+LGC+L  +   K  F
Sbjct: 172 -LCEGKPYNQKSDIWALGCVLYELASLKRAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 33/113 (29%), Positives = 61/113 (53%), Gaps = 5/113 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
           AL++ HS  ++HRD+K  N+++  +   ++L D+G      P Q + +  V + Y+  PE
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
           ++   + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL
Sbjct: 187 VVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPEL 236

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 44/152 (28%), Positives = 79/152 (51%), Gaps = 15/152 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIIT 230
           DD++ ++ +GRG + EV     VQ  D   +  +K ++K  +  E + + ++R   +I+ 
Sbjct: 1   DDFESLKVIGRGAFGEVRL---VQKKDTGHIYAMKILRKADM-LEKEQVAHIRAERDILV 56

Query: 231 LQA---VVKDPVS----RTPALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDY 280
                 VVK   S    R   LI E +   D   L     TL++   ++Y+ E + A+D 
Sbjct: 57  EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA 116

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL 312
            H +G +HRD+KP N+++D +   ++L D+GL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGH-VKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 46/197 (23%), Positives = 86/197 (43%), Gaps = 36/197 (18%)

Query: 176 VRKLGRGKYSEV----FEAINVQSSDKCVVKILKPVKKKK----IKREIKILENLRGGTN 227
           +R LG G + +V    ++     + ++  VK LKP         +K+EI+IL NL    N
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-EN 67

Query: 228 IITLQAVVKDPVSRTPALIFE-------------HVNNTDFKQLYQTLTDYDIRYYLYEL 274
           I+  + +  +       LI E             + N  + KQ  +         Y  ++
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK---------YAVQI 118

Query: 275 LKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRY 330
            K +DY  S   +HRD+   NV+++ E++ +++ D+GL +     +EY        +  +
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEYYTVKDDLDSPVF 177

Query: 331 FKGPELLADYQYHIELD 347
           +  PE L   +++I  D
Sbjct: 178 WYAPECLIQSKFYIASD 194

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 66/290 (22%), Positives = 122/290 (42%), Gaps = 58/290 (20%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILKPVKK-------------KKIKREIKILENLRGG 225
           +G+G Y  V+ A+NV + +   VK ++                 K ++ EI+ L++L   
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH- 67

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD---IRYYLYELLKALDYCH 282
            NI+            +  +  E+V         +T   ++   +R++  ++L+ L Y H
Sbjct: 68  LNIVQYLGFETTEEYLS--IFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGL----AEFYHPGQEYNVRVASRYFKGPELLA 338
           S GI+HRD+K  N+++D +    ++ D+G+     + Y   Q  +++  S ++  PE++ 
Sbjct: 126 SKGILHRDLKADNLLVDADG-ICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEVIH 183

Query: 339 DYQ--YHIELD---------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
            Y   Y  ++D           FA       R+ W              EA+  + K  L
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFA------GRRPWSDE-----------EAIAAMFK--L 224

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
           G          +  +    +SP ALDFL+     +   R TARE + HP+
Sbjct: 225 GNKRSA---PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 15/103 (14%)

Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR-VASR 62
           A   S+ L + H  GI++RD+K  NVM+D E   +++ D+G+       +E+ V  V +R
Sbjct: 107 AAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH-IKIADFGMC------KEHMVDGVTTR 159

Query: 63  YFKG------PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
            F G      PE++A YQ Y  S+D W+ G +L  M+  + PF
Sbjct: 160 TFCGTPDYIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 51.5 bits (123), Expect = 5e-07
 Identities = 84/360 (23%), Positives = 136/360 (37%), Gaps = 96/360 (26%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK--KKIKREIKILENLRGGTNIIT 230
           ++++  LG G + +V EA + +  + C VKI++ V K  +  K EI+ +E +R       
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVR------- 183

Query: 231 LQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDY-----------------DIRYYLYE 273
            QA   DP  R P +  +     +   +   +  Y                  +   +++
Sbjct: 184 -QA---DPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQ 239

Query: 274 LLKALDYCHS-MGIMHRDVKPHNVMIDHE--------NRKL-------RLIDWGLAEFYH 317
              ALDY H+ + +MH D+KP N++++          NR L       R+ D G      
Sbjct: 240 TGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC---- 295

Query: 318 PGQEYNVR---VASRYFKGPE---------------------------LLADYQYHIELD 347
              E + R   V++R+++ PE                           LL D   ++E  
Sbjct: 296 -CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354

Query: 348 PRFADILGRHSRKRWERFVHTENQHLVSPEALDF---LDKNILGRHSRKRWERFVHTENQ 404
                 LGR   + W     TE   L+   A       D   L R +R R  R V  +  
Sbjct: 355 HLMEKTLGRLPSE-WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRD-- 411

Query: 405 HLVSPEALDFLDKLLRYDHYERLTAREAMDHPY---FYPIVKDQSRH--TLPSSSPTPIV 459
                   D +  LL YD  +RL AR+   HPY   +YP  +    +        PTPI+
Sbjct: 412 ----DLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYPDNRSMLRPTPIM 467

Length = 467

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 18/99 (18%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFK--- 65
           +A +Y HS  I++RD+KP N+++D++   +++ D+G A+          +V  R F    
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGH-VKVTDFGFAK----------KVPDRTFTLCG 177

Query: 66  GPELLA----DYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
            PE LA      + +  ++D W++G +L   I    PFF
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216

Length = 329

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 3/91 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
           AL + H  GI++RD+K  NV++DHE    +L D+G+  E    G+  +    +  +  PE
Sbjct: 108 ALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +L +  +Y  S+D W++G +L  M+    PF
Sbjct: 167 ILQE-MLYGPSVDWWAMGVLLYEMLCGHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 42/171 (24%), Positives = 86/171 (50%), Gaps = 16/171 (9%)

Query: 176 VRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK------IKREIKILENLRGGTNII 229
           +R++G G +  V+ A +V++S+   +K +    K+       I +E++ L+ LR    I 
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 230 TLQAVVKDPVSRTPALIFEHV--NNTDFKQLYQT-LTDYDIRYYLYELLKALDYCHSMGI 286
                +++    T  L+ E+   + +D  ++++  L + +I    +  L+ L Y HS  +
Sbjct: 80  YRGCYLRE---HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 287 MHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
           +HRDVK  N+++  E   ++L D+G A    P   +   V + Y+  PE++
Sbjct: 137 IHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVI 183

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 50.1 bits (119), Expect = 8e-07
 Identities = 44/177 (24%), Positives = 83/177 (46%), Gaps = 11/177 (6%)

Query: 178 KLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK----IKREIKILENLRGGTNIITLQA 233
           ++G+G + EVF+ I+ ++     +KI+   + +     I++EI +L             +
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 234 VVKDPVSRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCHSMGIMHRDV 291
            +K        +I E++       L +     ++ I   L E+LK LDY HS   +HRD+
Sbjct: 71  YLK---GTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127

Query: 292 KPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQYHIELD 347
           K  NV++  E   ++L D+G+A      Q + N  V + ++  PE++    Y  + D
Sbjct: 128 KAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 50/190 (26%), Positives = 89/190 (46%), Gaps = 23/190 (12%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR---------EIKILENLR 223
           ++  R LG+G + EV  A  V+++ K  +   K ++KK+IK+         E +ILE + 
Sbjct: 2   FRQYRVLGKGGFGEVC-ACQVRATGK--MYACKRLEKKRIKKRKGESMALNEKQILEKVN 58

Query: 224 GGTNIITLQAV-VKDPVSRTPALIFEHVNNTDFK-QLYQT----LTDYDIRYYLYELLKA 277
               +    A   KD +     L+   +N  D K  +Y        +    +Y  E+L  
Sbjct: 59  SQFVVNLAYAYETKDAL----CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG 114

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
           L+  H    ++RD+KP N+++D +   +R+ D GLA     G+    RV +  +  PE+L
Sbjct: 115 LEDLHRENTVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL 173

Query: 338 ADYQYHIELD 347
            + +Y +  D
Sbjct: 174 NNQRYTLSPD 183

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 72/286 (25%), Positives = 117/286 (40%), Gaps = 43/286 (15%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR---------EIKILENLR 223
           ++  R LG+G + EV  A  V+++ K  +   K ++KK+IK+         E +ILE + 
Sbjct: 2   FRQYRVLGKGGFGEVC-ACQVRATGK--MYACKKLEKKRIKKRKGESMALNEKQILEKVN 58

Query: 224 GGTNIITLQAV-VKDPVSRTPALIFEHVNNTDFK-QLYQT----LTDYDIRYYLYELLKA 277
               +    A   KD +     L+   +N  D K  +Y        +    +Y  E+   
Sbjct: 59  SRFVVSLAYAYETKDAL----CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
           L+  H   I++RD+KP N+++D ++  +R+ D GLA     GQ    RV +  +  PE++
Sbjct: 115 LEDLHQERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 173

Query: 338 ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER 397
            + +Y    D              W        + +          K I  R   +R  +
Sbjct: 174 KNERYTFSPD--------------WWALGCLLYEMIAGQSPFQQRKKKI-KREEVERLVK 218

Query: 398 FVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYF 438
            V  E     SP+A      LL  D  ERL      ARE  +HP F
Sbjct: 219 EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 45/184 (24%), Positives = 86/184 (46%), Gaps = 19/184 (10%)

Query: 177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK---------IKREIKILENLRGGTN 227
           R +GRG Y++V   + ++ + +  +  +K +KK+          ++ E  + E       
Sbjct: 1   RVIGRGSYAKVLL-VELKKTRR--IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPF 57

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFK---QLYQTLTDYDIRYYLYELLKALDYCHSM 284
           ++ L +  +   SR    + E V+  D     Q  + L +   R+Y  E+  AL++ H  
Sbjct: 58  LVGLHSCFQTE-SRL-FFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
           GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  PE+L    Y 
Sbjct: 116 GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174

Query: 344 IELD 347
             +D
Sbjct: 175 FSVD 178

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 10/99 (10%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----VASRYF 64
           +ALD  HSMG +HRDVKP N+++D     L+L D+G        +E  VR    V +  +
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTC--MKMNKEGMVRCDTAVGTPDY 209

Query: 65  KGPELLADY---QMYDYSLDMWSLGCMLASMIFRKEPFF 100
             PE+L        Y    D WS+G  L  M+    PF+
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 36/151 (23%), Positives = 70/151 (46%), Gaps = 19/151 (12%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVK--ILKPVKKKKIKREIKILENLRGGTNIITLQAVVK 236
           +G G +  V+  +N  S +   VK   L  V      R+  +L+ L      I L   ++
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE---IALLKELQ 64

Query: 237 DP---------VSRTPALIF-EHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYCHS 283
                      +      IF E+V       L   Y    +  +R ++ ++LK L+Y H+
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
            GI+HRD+K  N+++D++   +++ D+G+++
Sbjct: 125 RGIIHRDIKGANILVDNKG-GIKISDFGISK 154

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 38/153 (24%), Positives = 75/153 (49%), Gaps = 13/153 (8%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK---PVKKKK---IKREIKILENLRG 224
           DD + ++ +G G +  V    +  S     +K++     ++ K+   +  E ++L+ +  
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKALDYC 281
              II L     D   R   ++ E+V   + F  L      ++    +Y  E++ AL+Y 
Sbjct: 61  -PFIIRLFWTEHD--QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
           HS  I++RD+KP N+++D E   ++L D+G A+
Sbjct: 118 HSKEIVYRDLKPENILLDKEGH-IKLTDFGFAK 149

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 49/181 (27%), Positives = 83/181 (45%), Gaps = 40/181 (22%)

Query: 2   RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHE--------NRKL-------RLIDWGL 45
           +I     +ALDY H+ + +MH D+KP N++++          NR L       R+ D G 
Sbjct: 235 QIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGG 294

Query: 46  AEFYHPGQEYNVR---VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 102
                   E + R   V++R+++ PE++     + YS DMWS+GC++  + +  +  +  
Sbjct: 295 C-----CDERHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYEL-YTGKLLYDT 347

Query: 103 HDNYDQLVRIAKVL-----------GTEE---LFEYLDKYHIELDPRFADILGRARVYAD 148
           HDN + L  + K L           GTEE   L+    +     DP+    + RAR   +
Sbjct: 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVRE 407

Query: 149 V 149
           V
Sbjct: 408 V 408

Length = 467

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 31/161 (19%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIIT 230
           +++ +V+ + RG + +V+      +S    VK++K  K   I +   ++  ++   + + 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVK--KADMINK--NMVHQVQAERDALA 59

Query: 231 LQAVVKDPVSRTP---------------ALIFEHVNNTDFKQLYQTLTDYD---IRYYLY 272
           L        S++P                L+ E++   D K L      +D      Y+ 
Sbjct: 60  L--------SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS 111

Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           E+  ALDY H  GI+HRD+KP N++I +E   ++L D+GL+
Sbjct: 112 EVALALDYLHRHGIIHRDLKPDNMLISNEGH-IKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 43/179 (24%), Positives = 82/179 (45%), Gaps = 17/179 (9%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILK-----PVKKKKIKR---EIKILENLRGGTNIIT 230
           LG+G +  V+   +V +  +   K ++     P   K++     EI++L+NL+    I+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH-ERIVQ 68

Query: 231 LQAVVKDPVSRTPALIFEHVNNTDFK---QLYQTLTDYDIRYYLYELLKALDYCHSMGIM 287
               ++D   +T  +  E++     K   + Y  LT+   R Y  ++L+ + Y HS  I+
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIV 128

Query: 288 HRDVKPHNVMIDHENRKLRLIDWG----LAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
           HRD+K  N++ D     ++L D+G    L      G        + Y+  PE+++   Y
Sbjct: 129 HRDIKGANILRDSAG-NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 37/128 (28%), Positives = 65/128 (50%), Gaps = 17/128 (13%)

Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASR 62
           A   ++ L + HS GI++RD+K  NVM+D E   +++ D+G+  E    G        + 
Sbjct: 107 AAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTP 165

Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELF 122
            +  PE++A YQ Y  S+D W+ G +L  M+  + P F G D              +ELF
Sbjct: 166 DYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAP-FEGEDE-------------DELF 210

Query: 123 EYLDKYHI 130
           + + ++++
Sbjct: 211 QSIMEHNV 218

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 4/85 (4%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGP 67
           + + Y H   I+HRD+K  N+ +  +N  L++ D+G++       +       + Y+  P
Sbjct: 117 LGVHYMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174

Query: 68  ELLADYQMYDYSLDMWSLGCMLASM 92
           E L  +Q YD   D+WSLGC+L  M
Sbjct: 175 EALK-HQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 5/107 (4%)

Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASR 62
           A   ++AL + H  G+++RD+K  N+++D E    +L D+G+  E    G        + 
Sbjct: 102 AAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTP 160

Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
            +  PE+L +   Y  S+D W+LG ++  M+  + PF    DN D L
Sbjct: 161 DYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPF--EADNEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 7/98 (7%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG--LAEFYHPGQEYNVRVASRYFKG 66
           +A+D  H +G +HRD+KP NV++D +N  +RL D+G  L        + NV V +  +  
Sbjct: 113 LAIDSVHQLGYVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171

Query: 67  PELLADYQ----MYDYSLDMWSLGCMLASMIFRKEPFF 100
           PE+L   +     Y    D WSLG  +  M++ + PF+
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 28/93 (30%), Positives = 50/93 (53%), Gaps = 2/93 (2%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF-YHPGQEYNVRVASRYFKGP 67
           +AL++ H   I++RD+KP N+++D     + L D+GL++      +  N    +  +  P
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAP 165

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           E+L D + Y   +D WSLG ++  M     PF+
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 44/177 (24%), Positives = 84/177 (47%), Gaps = 11/177 (6%)

Query: 178 KLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK----IKREIKILENLRGGTNIITLQA 233
           ++G+G + EV++ I+ ++ +   +KI+   + +     I++EI +L             +
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70

Query: 234 VVKDPVSRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCHSMGIMHRDV 291
            +K        +I E++       L +   L +  I   L E+LK LDY HS   +HRD+
Sbjct: 71  YLK---GTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 127

Query: 292 KPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQYHIELD 347
           K  NV++  E   ++L D+G+A      Q + N  V + ++  PE++    Y  + D
Sbjct: 128 KAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 48.6 bits (115), Expect = 2e-06
 Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 6/99 (6%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
            L + H   ++HRD+K  NV++  EN +++L+D+G+ A+        N  + + Y+  PE
Sbjct: 123 GLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 181

Query: 69  LLADYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           ++A  +     YD+  D+WSLG     M     P    H
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 28/88 (31%), Positives = 49/88 (55%), Gaps = 6/88 (6%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
            L + H+  ++HRD+K  NV++  EN +++L+D+G+ A+        N  + + Y+  PE
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 191

Query: 69  LLADYQ----MYDYSLDMWSLGCMLASM 92
           ++A  +     YDY  D+WSLG     M
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 10/99 (10%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----VASRYF 64
           +ALD  HSMG +HRDVKP N+++D ++  L+L D+G            VR    V +  +
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMDANGMVRCDTAVGTPDY 209

Query: 65  KGPELL---ADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
             PE+L        Y    D WS+G  L  M+    PF+
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 6/97 (6%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEY-NVRVASRYFKG 66
           +ALD  HSMG++HRDVKP N+++D     L+L D+G   +    G    +  V +  +  
Sbjct: 153 LALDAIHSMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPDYIS 211

Query: 67  PELLADY---QMYDYSLDMWSLGCMLASMIFRKEPFF 100
           PE+L        Y    D WS+G  L  M+    PF+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 35/123 (28%), Positives = 62/123 (50%), Gaps = 13/123 (10%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG--LAEFYHPGQEYNVRVASRYFKG 66
           +A+D  H +  +HRD+KP N+++D  N  +RL D+G  L        + +V V +  +  
Sbjct: 113 IAIDSVHQLHYVHRDIKPDNILMDM-NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 67  PELLADYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI-AKVLGTEEL 121
           PE+L   +     Y    D WSLG  +  M++ + PF+      + LV    K++  +E 
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-----ESLVETYGKIMNHKER 226

Query: 122 FEY 124
           F++
Sbjct: 227 FQF 229

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 47/197 (23%), Positives = 89/197 (45%), Gaps = 24/197 (12%)

Query: 170 QDDYQLVRKLGRGKYSEVFEA-----INVQSSDKCVVKILKPV----KKKKIKREIKILE 220
           +++    + LG G + +V EA         +  K  VK+LKP     +++ +  E+KI+ 
Sbjct: 34  RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93

Query: 221 NLRGGTNIITLQA--VVKDPVSRTPALIFEHVNNTDF-----KQLYQTLTDYDIRYYLYE 273
           +L    NI+ L     +  P+     +I E+    D      ++    LT  D+  + Y+
Sbjct: 94  HLGNHENIVNLLGACTIGGPI----LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149

Query: 274 LLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY--- 330
           + K + +  S   +HRD+   NV++ H  + +++ D+GLA        Y V+  +R    
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208

Query: 331 FKGPELLADYQYHIELD 347
           +  PE + +  Y  E D
Sbjct: 209 WMAPESIFNCVYTFESD 225

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 28/94 (29%), Positives = 52/94 (55%), Gaps = 6/94 (6%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
           AL++ HS  ++HRD+K  N+++  +   ++L D+G+ A+     Q+ +  + + Y+  PE
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE 173

Query: 69  LLADYQM----YDYSLDMWSLGCMLASMIFRKEP 98
           ++A        YDY  D+WSLG  L  +   + P
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 11/102 (10%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN----V 57
           +IA      L Y HS  I+HRD+KP N+++     +++L D+G++     G+  N     
Sbjct: 109 KIAESVLKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLCDFGVS-----GELVNSLAGT 162

Query: 58  RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
              + ++  PE +   + Y  + D+WSLG  L  +   + PF
Sbjct: 163 FTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 36/123 (29%), Positives = 61/123 (49%), Gaps = 13/123 (10%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG--LAEFYHPGQEYNVRVASRYFKG 66
           +A+   H +  +HRD+KP NV++D  N  +RL D+G  L        + +V V +  +  
Sbjct: 113 LAIHSIHQLHYVHRDIKPDNVLLDM-NGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYIS 171

Query: 67  PELLADYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI-AKVLGTEEL 121
           PE+L   +     Y    D WSLG  +  M++ + PF+      + LV    K++  EE 
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-----ESLVETYGKIMNHEER 226

Query: 122 FEY 124
           F++
Sbjct: 227 FQF 229

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 31/123 (25%), Positives = 60/123 (48%), Gaps = 9/123 (7%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR-----YFK 65
           + Y HS   +HRD+   NV++D++ R +++ D+GLA+    G EY  RV        ++ 
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFWY 177

Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE-ELFEY 124
             E L + +   Y+ D+WS G  L  ++   +        +++++   +   T   L E 
Sbjct: 178 AVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236

Query: 125 LDK 127
           L++
Sbjct: 237 LER 239

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 35/110 (31%), Positives = 59/110 (53%), Gaps = 7/110 (6%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
           AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     Q  +  + + Y+  PE
Sbjct: 115 ALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 173

Query: 69  LL----ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           ++    +  + YDY  D+WSLG  L  M  + EP  H  +    L++IAK
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 222

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 39/171 (22%), Positives = 88/171 (51%), Gaps = 16/171 (9%)

Query: 176 VRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK------IKREIKILENLRGGTNII 229
           +R++G G +  V+ A +V++++   +K +    K+       I +E+K L+ ++   +I 
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 230 TLQAVVKDPVSRTPALIFEHV--NNTDFKQLYQT-LTDYDIRYYLYELLKALDYCHSMGI 286
                +++    T  L+ E+   + +D  ++++  L + +I    +  L+ L Y HS  +
Sbjct: 90  YKGCYLRE---HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146

Query: 287 MHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
           +HRD+K  N+++  E  +++L D+G A    P   +   V + Y+  PE++
Sbjct: 147 IHRDIKAGNILLT-EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVI 193

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 45/190 (23%), Positives = 88/190 (46%), Gaps = 21/190 (11%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR--------EIKILENLR 223
           D++++ K+G+G +  VF+   V+ +DK V   +K +   K+ R        E ++L  L 
Sbjct: 1   DFEILNKIGKGSFGVVFKV--VRKADKRVY-AMKQIDLSKMNRREREEAIDEARVLAKLD 57

Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY-----QTLTDYDIRYYLYELLKAL 278
               I   ++ +         ++ E+  N D  +L      + L +  +  +  ++L  L
Sbjct: 58  SSYIIRYYESFLDK---GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL 114

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGPELL 337
            + HS  I+HRD+K  N+ +D     +++ D G+A+       + N  V + Y+  PEL 
Sbjct: 115 AHLHSKKILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC 173

Query: 338 ADYQYHIELD 347
            D  Y+ + D
Sbjct: 174 EDKPYNEKSD 183

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 19/184 (10%)

Query: 177 RKLGRGKYSEVFEAINVQSSDKCVVKILKP---VKKKKIK---REIKILENLRGGTNIIT 230
           R LG+G + +V  A   +S     VK+LK    ++   ++    E +IL   R    +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 231 LQAVVKDPVSRTPALIF---EHVNNTDFKQLYQTLTDYD---IRYYLYELLKALDYCHSM 284
           L    +     TP  +F   E VN  D     Q    +D    R+Y  E+  AL + H  
Sbjct: 61  LYCCFQ-----TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
           GI++RD+K  NV++DHE    +L D+G+  E    G+  +    +  +  PE+L +  Y 
Sbjct: 116 GIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174

Query: 344 IELD 347
             +D
Sbjct: 175 PSVD 178

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 44/152 (28%), Positives = 79/152 (51%), Gaps = 15/152 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIIT 230
           +D++ ++ +GRG + EV     VQ  D   V  +K ++K  +  E + + ++R   +I+ 
Sbjct: 1   EDFESLKVIGRGAFGEVRL---VQKKDTGHVYAMKILRKADM-LEKEQVGHIRAERDILV 56

Query: 231 LQA---VVKDPVSRTPA----LIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDY 280
                 VVK   S        LI E +   D   L     TLT+ + ++Y+ E + A+D 
Sbjct: 57  EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL 312
            H +G +HRD+KP N+++D +   ++L D+GL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGH-VKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 27/93 (29%), Positives = 50/93 (53%), Gaps = 3/93 (3%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGP 67
            AL+  H   +++RD+KP N+++D++   + L D+GL +      +  N    +  +  P
Sbjct: 104 CALENLHKFNVIYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDDKTNTFCGTPEYLAP 162

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           ELL  +  Y  ++D W+LG +L  M+    PF+
Sbjct: 163 ELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFY 194

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 27/92 (29%), Positives = 48/92 (52%), Gaps = 3/92 (3%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
           + L Y H   I++RD+K  N+++D E   +++ D+GL  E    G   +    +  F  P
Sbjct: 112 LGLQYLHENKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAP 170

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           E+L +   Y  ++D W LG ++  M+  + PF
Sbjct: 171 EVLTE-TSYTRAVDWWGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 71/294 (24%), Positives = 123/294 (41%), Gaps = 59/294 (20%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR---------EIKILENLR 223
           ++  R LG+G + EV  A  V+++ K  +   K ++KK+IK+         E +ILE + 
Sbjct: 2   FRHYRVLGKGGFGEVC-ACQVRATGK--MYACKKLEKKRIKKRKGEAMALNEKQILEKVN 58

Query: 224 GGTNIITLQAV--VKDPVSRTPALIFEHVNNTDFK-QLYQT----LTDYDIRYYLYELLK 276
               +++L      KD +     L+   +N  D K  +Y        +    +Y  E+  
Sbjct: 59  S-RFVVSLAYAYETKDAL----CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113

Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 336
            L+  H   I++RD+KP N+++D +   +R+ D GLA     G+    RV +  +  PE+
Sbjct: 114 GLEDLHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEV 172

Query: 337 LADYQYHIELD-----PRFADILGRHS--RKRWERFVHTENQHLVSPEALDFLDKNILGR 389
           + + +Y    D         +++   S  R+R E+         V  E ++   K     
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK---------VKREEVERRVKEDQEE 223

Query: 390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYF 438
           +S    E+F         S  A     +LL  D   RL      A E   HP+F
Sbjct: 224 YS----EKF---------SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 46/192 (23%), Positives = 92/192 (47%), Gaps = 24/192 (12%)

Query: 160 YESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR---EI 216
           YE    D    + ++++ +LG G + +V++A N ++      K+++   +++++    EI
Sbjct: 1   YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEI 60

Query: 217 KILENLRGGTNIITLQAVVKD----------PVSRTPALIFEHVNNTDFKQLYQTLTDYD 266
           +IL        +  L A   D          P     A++ E         L + LT+  
Sbjct: 61  EILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE---------LDRGLTEPQ 111

Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVR 325
           I+    ++L+AL Y HSM I+HRD+K  NV++  +   ++L D+G+ A+     Q  +  
Sbjct: 112 IQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQRRDSF 170

Query: 326 VASRYFKGPELL 337
           + + Y+  PE++
Sbjct: 171 IGTPYWMAPEVV 182

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 40/154 (25%), Positives = 79/154 (51%), Gaps = 17/154 (11%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-----PVKKKKIKR---EIKILENLR 223
           +++  + LG+G +  V+   +V +  +  VK +      P  KK++     EI++L+NL+
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 224 GGTNIITLQAVVKDPVSRTPALIF-EHVNNTDFK---QLYQTLTDYDIRYYLYELLKALD 279
               I+     ++D  + +   IF E++     K   + Y  LT+   R Y  ++L+ ++
Sbjct: 63  H-ERIVQYYGCLRDDETLS---IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVE 118

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           Y HS  I+HRD+K  N++ D     ++L D+G +
Sbjct: 119 YLHSNMIVHRDIKGANILRD-SAGNVKLGDFGAS 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 38/162 (23%), Positives = 73/162 (45%), Gaps = 20/162 (12%)

Query: 169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV---VKILK----PVKKKKIKREIKILEN 221
           Q++D  L R +G G++ +V++ + +   ++ +   VK  K    P  ++K  +E  I+  
Sbjct: 4   QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63

Query: 222 LRGGTNIITLQAVVKDPVSRTPA-LIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLK 276
                +I+ L  V+ +     P  ++ E     + +   Q     L    +  Y Y+L  
Sbjct: 64  FDH-PHIVKLIGVITEN----PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118

Query: 277 ALDYCHSMGIMHRDVKPHNVMI-DHENRKLRLIDWGLAEFYH 317
           AL Y  S   +HRD+   NV++   +  KL   D+GL+ +  
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLG--DFGLSRYLE 158

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 47.6 bits (114), Expect = 5e-06
 Identities = 26/84 (30%), Positives = 44/84 (52%), Gaps = 13/84 (15%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ------EYNVRVASRY 63
            L+Y H  G +HRD+K  N+++  E   ++L D+G++     GQ      + N  V + +
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLS-EEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPF 163

Query: 64  FKGPELLADYQMYDYSLDMWSLGC 87
           +  PE++     YD   D+WSLG 
Sbjct: 164 WMAPEVIKQ-SGYDEKADIWSLGI 186

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 41/171 (23%), Positives = 84/171 (49%), Gaps = 16/171 (9%)

Query: 176 VRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKK------KIKREIKILENLRGGTNII 229
           + ++G G +  V+ A N  +++   VK +    K+       I +E+K L+ L+    I 
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 230 TLQAVVKDPVSRTPALIFEHV--NNTDFKQLYQT-LTDYDIRYYLYELLKALDYCHSMGI 286
                +K+    T  L+ E+   + +D  ++++  L + +I    +  L+ L Y HS  +
Sbjct: 86  YKGCYLKE---HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142

Query: 287 MHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
           +HRD+K  N+++  E  +++L D+G A    P   +   V + Y+  PE++
Sbjct: 143 IHRDIKAGNILLT-EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVI 189

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 47.8 bits (113), Expect = 5e-06
 Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
            LDY HS   +HRD+K  NV++  E+ +++L D+G+A      Q + N  V + ++  PE
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEP 98
           ++     YD   D+WSLG + A  + + EP
Sbjct: 172 VIKQ-SAYDSKADIWSLG-ITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 47.8 bits (113), Expect = 5e-06
 Identities = 68/299 (22%), Positives = 129/299 (43%), Gaps = 46/299 (15%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVK---ILKPVKKKKIKREIKILENLRGGTNII 229
           Y    K+G+G    V+ A++V +  +  ++   + +  KK+ I  EI ++   +    + 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 230 TLQAVVKDPVSRTPALIFEHVNNTDFKQLY-QTLTDY-DIRYYLYELLKALDYCHSMGIM 287
            L + +   V     ++ E++       +  +T  D   I     E L+AL++ HS  ++
Sbjct: 82  YLDSYL---VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 288 HRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQYHIEL 346
           HRD+K  N+++  +   ++L D+G      P Q + +  V + Y+  PE++    Y  ++
Sbjct: 139 HRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 347 DPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQ-H 405
           D     I+                  ++  E   +L++N L      R    + T     
Sbjct: 198 DIWSLGIMA---------------IEMIEGEP-PYLNENPL------RALYLIATNGTPE 235

Query: 406 LVSPEAL-----DFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIV 459
           L +PE L     DFL++ L  D  +R +A+E + H  F  I K       P SS TP++
Sbjct: 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ-FLKIAK-------PLSSLTPLI 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 42/174 (24%), Positives = 91/174 (52%), Gaps = 8/174 (4%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR---EIKILENLRGGTN 227
           D ++++ +LG G + +V++A + ++      KI++   +++++    EI IL   +   N
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH-PN 63

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTD--FKQLYQTLTDYDIRYYLYELLKALDYCHSMG 285
           I+ L             + F      D    +L + LT+  IRY   ++L+AL++ HS  
Sbjct: 64  IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123

Query: 286 IMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLA 338
           ++HRD+K  N+++  +   ++L D+G+ A+     Q+ +  + + Y+  PE++A
Sbjct: 124 VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 46.2 bits (110), Expect = 5e-06
 Identities = 25/127 (19%), Positives = 52/127 (40%), Gaps = 10/127 (7%)

Query: 200 VVKILKP-VKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
           V+KI     K    +RE+ IL+ L     +   + +          L+ E +      ++
Sbjct: 25  VLKINPSREKGADREREVAILQLLAR-KGLPVPKVLASGESDGWSYLLMEWIEGETLDEV 83

Query: 259 YQTLTDYDIRYYLYELLKALDYCHSM---GIMHRDVKPHNVMIDHENRKLRLIDWGLAEF 315
               ++ +      +L + L   H +    + H D+ P N+++D + + L +IDW  A +
Sbjct: 84  ----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEYAGY 138

Query: 316 YHPGQEY 322
             P  + 
Sbjct: 139 GPPAFDL 145

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 47.3 bits (113), Expect = 6e-06
 Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 12/103 (11%)

Query: 2   RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN---- 56
           +IA      L Y H    I+HRDVKP N++++    +++L D+G++     GQ  N    
Sbjct: 104 KIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVS-----GQLVNSLAK 157

Query: 57  VRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
             V +  +  PE +     Y    D+WSLG  L  +   + P+
Sbjct: 158 TFVGTSSYMAPERI-QGNDYSVKSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 47.2 bits (112), Expect = 7e-06
 Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 15/147 (10%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK---------IKREIKILENLRGGTNII 229
           LG G +S  ++A +V++     VK +  V+            +++EI+++  L     I 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 230 TLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYCHSMGI 286
            L A  +D       L  E +       L   Y    +  I  Y  +LL+ L Y H   I
Sbjct: 68  MLGATCEDSHFN---LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 287 MHRDVKPHNVMIDHENRKLRLIDWGLA 313
           +HRDVK  N++ID   ++LR+ D+G A
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAA 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 26/80 (32%), Positives = 44/80 (55%), Gaps = 2/80 (2%)

Query: 269 YYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA- 327
           +Y  +++  L++ H   I++RD+KP NV++D++   +R+ D GLA     GQ      A 
Sbjct: 101 FYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKGYAG 159

Query: 328 SRYFKGPELLADYQYHIELD 347
           +  F  PELL   +Y   +D
Sbjct: 160 TPGFMAPELLQGEEYDFSVD 179

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
            LDY HS   +HRD+K  NV++  E   ++L D+G+A      Q + N  V + ++  PE
Sbjct: 113 GLDYLHSERKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEP 98
           ++     YD+  D+WSLG + A  + + EP
Sbjct: 172 VIKQ-SAYDFKADIWSLG-ITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 3/93 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
           AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  PE
Sbjct: 107 ALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +L D   Y  ++D W LG ++  M+  + PF++
Sbjct: 166 VLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYN 197

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 46.9 bits (112), Expect = 8e-06
 Identities = 41/168 (24%), Positives = 80/168 (47%), Gaps = 21/168 (12%)

Query: 174 QLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTNIITL 231
           +L RKLG G++ EV+       + K  VK LKP  +  +   +E +I++ LR    ++ L
Sbjct: 9   KLERKLGAGQFGEVWMGT-WNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLR-HDKLVQL 66

Query: 232 QAVV--KDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELL-------KALDYCH 282
            AV   ++P+     ++ E+++        ++     +R  L +L+       + + Y  
Sbjct: 67  YAVCSEEEPIY----IVTEYMSKGSLLDFLKSGEGKKLR--LPQLVDMAAQIAEGMAYLE 120

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 330
           S   +HRD+   N+++  EN   ++ D+GLA       EY  R  +++
Sbjct: 121 SRNYIHRDLAARNILVG-ENLVCKIADFGLARLIED-DEYTAREGAKF 166

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 33/96 (34%), Positives = 42/96 (43%), Gaps = 9/96 (9%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-----EFYHPGQEYNVRVASRYF 64
           AL Y H  GI+HRDVK  N+ +D     + L D+G A         P Q Y     +   
Sbjct: 197 ALAYLHGRGIIHRDVKTENIFLDEPENAV-LGDFGAACKLDAHPDTP-QCYG-WSGTLET 253

Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
             PELLA    Y    D+WS G +L  M  +    F
Sbjct: 254 NSPELLA-LDPYCAKTDIWSAGLVLFEMSVKNVTLF 288

Length = 392

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 47.1 bits (112), Expect = 9e-06
 Identities = 53/191 (27%), Positives = 82/191 (42%), Gaps = 41/191 (21%)

Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R+Y  E+  AL Y HS+ I++RD+KP N+++D +   + L D+GL +    G E++ +  
Sbjct: 99  RFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH-VVLTDFGLCK---EGIEHS-KTT 153

Query: 328 SRYFKGPELLADYQYHIELDPRFAD--ILGRHSRKRWERFVHTENQHLVSP-------EA 378
           S +   PE LA      +   R  D   LG          V  E  + + P       E 
Sbjct: 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGA---------VLYEMLYGLPPFYSRDTAEM 204

Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAR----EAMD 434
            D    NIL +  R +            +S  A   L+ LL+ D  +RL A+    E  +
Sbjct: 205 YD----NILNKPLRLK----------PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKN 250

Query: 435 HPYFYPIVKDQ 445
           H +F  I  D 
Sbjct: 251 HVFFSSINWDD 261

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 46.8 bits (112), Expect = 9e-06
 Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 4/94 (4%)

Query: 10  ALDYCHSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGP 67
            LDY H+   I+HRD+KP N++I+ +  ++++ D+G+++      +  N  V +  +  P
Sbjct: 111 GLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           E +   + Y Y+ D+WSLG  L      K PF  
Sbjct: 170 ERI-QGESYSYAADIWSLGLTLLECALGKFPFLP 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 20/45 (44%), Positives = 32/45 (71%), Gaps = 1/45 (2%)

Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL 312
           R+Y+ EL  A++  H MG +HRD+KP N++ID +   ++L D+GL
Sbjct: 104 RFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH-IKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 20/50 (40%), Positives = 32/50 (64%), Gaps = 1/50 (2%)

Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY 316
           I+  + ++L  L+Y H  GI H D+KP N+M+D  NR   +ID+G+A  +
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYGIASHF 176

Length = 294

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.0 bits (111), Expect = 9e-06
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 3/93 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
           ALDY HS  I++RD+K  N+M+D +   +++ D+GL  E             +  +  PE
Sbjct: 107 ALDYLHSGKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE 165

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +L D   Y  ++D W LG ++  M+  + PF++
Sbjct: 166 VLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYN 197

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 32/135 (23%), Positives = 53/135 (39%), Gaps = 46/135 (34%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL---------AEFYHPGQEY---- 55
            A++  H MG +HRD+KP N++ID +   ++L D+GL         +++Y  G  +    
Sbjct: 112 CAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 56  ---------------------NVR----------VASRYFKGPELLADYQMYDYSLDMWS 84
                                  R          V +  +  PE+L     Y    D WS
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWS 229

Query: 85  LGCMLASMIFRKEPF 99
           +G +L  M+  + PF
Sbjct: 230 VGVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 68/294 (23%), Positives = 121/294 (41%), Gaps = 71/294 (24%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDP 238
           +GRG + EV+     + +D   +  +K + KK+IK        ++ G  +   + ++   
Sbjct: 2   IGRGGFGEVY---GCRKADTGKMYAMKCLDKKRIK--------MKQGETLALNERIMLSL 50

Query: 239 VS--------------RTP---ALIFEHVNNTDFK-QLYQ--TLTDYDIRYYLYELLKAL 278
           VS               TP   + I + +N  D    L Q    ++ ++R+Y  E++  L
Sbjct: 51  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGL 110

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL- 337
           ++ H+  +++RD+KP N+++D E+  +R+ D GLA  +   + +   V +  +  PE+L 
Sbjct: 111 EHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQ 168

Query: 338 --------ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGR 389
                   AD+     L      +L  HS  R         QH                +
Sbjct: 169 KGVAYDSSADW---FSLGCMLFKLLRGHSPFR---------QHKTK------------DK 204

Query: 390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYF 438
           H   R    +  E     SPE    L+ LL+ D   RL      A+E  +HP+F
Sbjct: 205 HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 41/168 (24%), Positives = 78/168 (46%), Gaps = 22/168 (13%)

Query: 274 LLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFK 332
           +L+AL Y H+ G++HRD+K  ++++  + R ++L D+G  A+      +    V + Y+ 
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWM 185

Query: 333 GPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP--EALDFLDKNILGRH 390
            PE+++   Y  E+D     I+           +  E  +   P  +A+  +  N+  R 
Sbjct: 186 APEVISRLPYGTEVDIWSLGIM-------VIEMIDGEPPYFNEPPLQAMRRIRDNLPPR- 237

Query: 391 SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                      ++ H VS     FLD +L  +  +R TA+E + HP+ 
Sbjct: 238 ----------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
            LDY HS   +HRD+K  NV++  E   ++L D+G+A      Q + N  V + ++  PE
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEP 98
           ++     YD   D+WSLG + A  + + EP
Sbjct: 172 VIQQ-SAYDSKADIWSLG-ITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 19/40 (47%), Positives = 30/40 (75%), Gaps = 1/40 (2%)

Query: 7   ASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 46
            ++ALDY H  GI+HRD+KP N++I +E   ++L D+GL+
Sbjct: 113 VALALDYLHRHGIIHRDLKPDNMLISNEGH-IKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 45/187 (24%), Positives = 80/187 (42%), Gaps = 28/187 (14%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQ 232
           Y +++ L  G    VF A      D  V+KI    +K     E  +L+N+   + I    
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---GQKGTTLIEAMLLQNVNHPSVIRMKD 124

Query: 233 AVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLY---ELLKALDYCHSMGIMHR 289
            +V   ++    ++  H ++  +  L +      I   L    ++L+ L Y H+  I+HR
Sbjct: 125 TLVSGAIT---CMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181

Query: 290 DVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---------PELLADY 340
           DVK  N+ I+  + ++ + D G A+F          V +  F G         PE+LA  
Sbjct: 182 DVKTENIFINDVD-QVCIGDLGAAQF---------PVVAPAFLGLAGTVETNAPEVLARD 231

Query: 341 QYHIELD 347
           +Y+ + D
Sbjct: 232 KYNSKAD 238

Length = 357

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 41/167 (24%), Positives = 72/167 (43%), Gaps = 32/167 (19%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK------PVKKKKIKREIKILENLRGGT 226
           Y ++R +G+G   EV+ A +   S +  +K ++      P+ KK+  RE KI  +L    
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL---- 59

Query: 227 NIITLQAVV--------KDPVSRTPALIFEHVNNTDFKQLYQTLT---DYDIRYYLYELL 275
                  +V         DPV  T   I  +   +  K ++Q  +   +   +  +   L
Sbjct: 60  ---IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116

Query: 276 KALD-------YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF 315
                      Y HS G++HRD+KP N+++      + ++DWG A F
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV-ILDWGAAIF 162

Length = 932

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 28/85 (32%), Positives = 46/85 (54%), Gaps = 6/85 (7%)

Query: 7   ASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFK 65
           A M L + H    +HRDVK +N+++  E   ++L+D+G+ A+        N  V + ++ 
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191

Query: 66  GPELLADYQM----YDYSLDMWSLG 86
            PE++A  Q     YD   D+WSLG
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLG 216

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 27/93 (29%), Positives = 52/93 (55%), Gaps = 3/93 (3%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVR-VASRYFKG 66
           +AL++ H +GI++RD+K  N+++D E   + L D+GL+ EF    +E       +  +  
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           PE++     +  ++D WSLG ++  ++    PF
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 44/177 (24%), Positives = 89/177 (50%), Gaps = 22/177 (12%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--------KKKKIKREIKILENLRG 224
           +  +R++G G +  V+ A +V++++  VV I K          K + I +E++ L+ LR 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNE--VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 225 GTNIITLQAV-VKDPVSRTPALIFEHV--NNTDFKQLYQT-LTDYDIRYYLYELLKALDY 280
             N I  +   +++    T  L+ E+   + +D  ++++  L + +I    +  L+ L Y
Sbjct: 75  -PNTIEYKGCYLRE---HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAY 130

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
            HS   +HRD+K  N+++  E   ++L D+G A    P   +   V + Y+  PE++
Sbjct: 131 LHSHERIHRDIKAGNILLT-EPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVI 183

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 70/293 (23%), Positives = 120/293 (40%), Gaps = 54/293 (18%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVK-ILKPVKKKKIKREIKILE-NLRGG--T 226
           DD +++ +LGRG Y  V +  +V +     VK I   V  ++ KR +  L+ ++R     
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRY-------YLYELLKALD 279
             +T    +          I   V +T   + Y+ + D  +             ++KAL+
Sbjct: 61  YTVTFYGAL---FREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117

Query: 280 YCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
           Y HS + ++HRDVKP NV+I+  N +++L D+G++ +        +    + +  PE + 
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINR-NGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERIN 176

Query: 339 DYQYHIELDPRFADI-----------LGRHSRKRWERFVHTENQHL--VSPEALDFLDKN 385
                   D + +D+            GR     W     T  Q L  V  E    L   
Sbjct: 177 PELNQKGYDVK-SDVWSLGITMIELATGRFPYDSW----KTPFQQLKQVVEEPSPQLPA- 230

Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                     E+F         SPE  DF++K L+ ++ ER    E + HP+F
Sbjct: 231 ----------EKF---------SPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 21/44 (47%), Positives = 33/44 (75%), Gaps = 1/44 (2%)

Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG 311
           R+YL E++ A+D  H +G +HRD+KP NV++D +N  +RL D+G
Sbjct: 105 RFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD-KNGHIRLADFG 147

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 35/149 (23%), Positives = 77/149 (51%), Gaps = 18/149 (12%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDP 238
           +G+G + +V++   V+  D   +  +K + KK+I  + ++   + G  NI+    + + P
Sbjct: 1   IGKGTFGQVYQ---VRKKDTRRIYAMKVLSKKEIVAKKEVAHTI-GERNILVRTLLDESP 56

Query: 239 VSRTPALIFEHVNN----TDFK---QLYQTL------TDYDIRYYLYELLKALDYCHSMG 285
                   F+  ++    TD+    +L+  L      ++   ++Y+ EL+ AL++ H   
Sbjct: 57  FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD 116

Query: 286 IMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
           I++RD+KP N+++D     + L D+GL++
Sbjct: 117 IVYRDLKPENILLD-ATGHIALCDFGLSK 144

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 40/153 (26%), Positives = 75/153 (49%), Gaps = 18/153 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVV-------KILKPVKKKKIKREIKILENLR 223
           DD+++++ +GRG + EV   + ++ +++          ++LK  +    + E  +L N  
Sbjct: 1   DDFEIIKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-- 57

Query: 224 GGTN-IITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDY---DI-RYYLYELLKAL 278
           G    I TL    +D       L+ ++    D   L     D    D+ R+Y+ E++ A+
Sbjct: 58  GDCQWITTLHYAFQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI 115

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG 311
              H +  +HRD+KP NV++D  N  +RL D+G
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDM-NGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 29/92 (31%), Positives = 45/92 (48%), Gaps = 20/92 (21%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---- 66
           L Y H+  I+HRDVK  N+ I+  + ++ + D G A+F          V +  F G    
Sbjct: 170 LRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQF---------PVVAPAFLGLAGT 219

Query: 67  -----PELLADYQMYDYSLDMWSLGCMLASMI 93
                PE+LA  + Y+   D+WS G +L  M+
Sbjct: 220 VETNAPEVLARDK-YNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
           AL Y HS  +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  PE
Sbjct: 107 ALGYLHSCDVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           +L D   Y  ++D W LG ++  M+  + PF+
Sbjct: 166 VLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 29/130 (22%), Positives = 60/130 (46%), Gaps = 13/130 (10%)

Query: 194 QSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF 247
            +  +  +K+L+        ++ + +RE  +   L    NI+ L    + P     A +F
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYH-PNIVALLDSGEAPPGLLFA-VF 58

Query: 248 EHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN-- 302
           E+V     +++      L   +    + ++L AL   H+ GI+HRD+KP N+M+      
Sbjct: 59  EYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118

Query: 303 RKLRLIDWGL 312
              +++D+G+
Sbjct: 119 PHAKVLDFGI 128

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 31/103 (30%), Positives = 53/103 (51%), Gaps = 5/103 (4%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGP 67
           +AL + H   I+HRD+K  N+ +  +   ++L D+G+A   +   E     + + Y+  P
Sbjct: 112 LALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLSP 170

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
           E+  + + Y+   D+W+LGC+L  M   K  F  G  N   LV
Sbjct: 171 EICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAG--NMKNLV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 11/115 (9%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN----V 57
           RIA      L Y  S+ I+HRDVKP N++++    +++L D+G++      Q  N     
Sbjct: 99  RIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLCDFGVST-----QLVNSIAKT 152

Query: 58  RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 112
            V +  +  PE ++  Q Y    D+WSLG     +   + P+     N   L+ +
Sbjct: 153 YVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL 206

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 21/168 (12%)

Query: 174 QLVRKLGRGKYSEVFEAI-NVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTNIIT 230
           QL+RKLG G++ EV+E + N  +     VK LKP  +  K    E +I++ LR    +I 
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLR-HPKLIQ 65

Query: 231 LQAV--VKDPVSRTPAL-----IFEHVNNTDFKQL-YQTLTDYDIRYYLYELLKALDYCH 282
           L AV  +++P+     L     + E++     + L    L D        ++   + Y  
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA-----QVASGMAYLE 120

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 330
           +   +HRD+   NV++  EN   ++ D+GLA        Y  R  +++
Sbjct: 121 AQNYIHRDLAARNVLVG-ENNICKVADFGLARVIKE-DIYEAREGAKF 166

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 16/107 (14%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE---------FYHPGQEYNVR- 58
           +AL+Y H+ GI+HRD+KP N++I      ++L D+GL++          Y    E + R 
Sbjct: 112 LALEYLHNYGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 59  -VASRYFKGPELLAD----YQMYDYSLDMWSLGCMLASMIFRKEPFF 100
            +  +    PE +A      Q Y   +D W++G +L   +    PFF
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 44.8 bits (107), Expect = 3e-05
 Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 4/89 (4%)

Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
            A   +  ++Y  S   +HRD+   N ++  EN  +++ D+GL+   +    Y  R    
Sbjct: 107 FALQIARGMEYLESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYRKRGGKL 165

Query: 63  YFK--GPELLADYQMYDYSLDMWSLGCML 89
             +   PE L     +    D+WS G +L
Sbjct: 166 PIRWMAPESL-KEGKFTSKSDVWSFGVLL 193

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 26/95 (27%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFK 65
           +AL++ H +GI++RD+K  N+++D  N  + L D+GL++ +H  +    Y+      Y  
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM- 173

Query: 66  GPELLADYQM-YDYSLDMWSLGCMLASMIFRKEPF 99
            P+++      +D ++D WS+G ++  ++    PF
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 32/154 (20%), Positives = 73/154 (47%), Gaps = 16/154 (10%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSD-----KCVVKILKPVKKKKIKREIKILENLRGGT 226
           D+++++KLG+G Y  V++   +  +      +  +  +   +++    EI+IL ++    
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-P 59

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDF-------KQLYQTLTDYDIRYYLYELLKALD 279
           NII+ +    D       ++ E+    D        K+  + + + +I     +LL+ L 
Sbjct: 60  NIISYKEAFLD--GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
             H   I+HRD+K  N+++   N  +++ D G++
Sbjct: 118 ALHEQKILHRDLKSANILL-VANDLVKIGDLGIS 150

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 31/110 (28%), Positives = 52/110 (47%), Gaps = 10/110 (9%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG----LAEFYHPGQEYNVRVASRYFK 65
            + Y HS  I+HRD+K  N++ D     ++L D+G    L      G        + Y+ 
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
            PE+++  + Y    D+WSLGC +  M+  K P+      Y+ +  I K+
Sbjct: 177 SPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPW----AEYEAMAAIFKI 221

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 32/196 (16%)

Query: 174 QLVRKLGRGKYSEV----FEAINVQSSDKCVVKILK----PVKKKKIKREIKILENLRGG 225
           + +R LG G + +V    ++  N  + +   VK LK           K+EI IL+ L   
Sbjct: 7   KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH- 65

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDY---------DIRYYLYELLK 276
            NI+  +    +   +   LI E+V          +L DY          +  +  ++ +
Sbjct: 66  ENIVKYKGCCSEQGGKGLQLIMEYVP-------LGSLRDYLPKHKLNLAQLLLFAQQICE 118

Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR-----YF 331
            + Y HS   +HRD+   NV++D++ R +++ D+GLA+    G EY  RV        ++
Sbjct: 119 GMAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFW 176

Query: 332 KGPELLADYQYHIELD 347
              E L + ++    D
Sbjct: 177 YAVECLKENKFSYASD 192

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 45/178 (25%), Positives = 73/178 (41%), Gaps = 24/178 (13%)

Query: 265 YDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YN 323
              R+Y  ELL AL+  H   +++RD+KP N+++D++   + L D+GL +      +  N
Sbjct: 93  SRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDDKTN 151

Query: 324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLD 383
               +  +  PELL  + Y   +D              W   V         P    F D
Sbjct: 152 TFCGTPEYLAPELLLGHGYTKAVD-------------WWTLGVLLYEMLTGLPP---FYD 195

Query: 384 KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL---TAREAMDHPYF 438
           +N+   + +   E     +       +A D L  LL  D   RL    A+E  +HP+F
Sbjct: 196 ENVNEMYRKILQEPLRFPDG---FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 20/47 (42%), Positives = 32/47 (68%), Gaps = 1/47 (2%)

Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
           R Y  E + AL+Y H+ GI+HRD+KP N++I      ++L D+GL++
Sbjct: 104 RMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH-IKLTDFGLSK 149

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 34/118 (28%), Positives = 60/118 (50%), Gaps = 10/118 (8%)

Query: 10  ALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
           ALDY HS   +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  P
Sbjct: 107 ALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAP 165

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQL-----VRIAKVLGTE 119
           E+L D   Y  ++D W LG ++  M+  + PF++  H+   +L     +R  + L  E
Sbjct: 166 EVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE 222

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 5/94 (5%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA---SRYFK 65
           +ALD  HS  +MHRD+K  N+ +      ++L D+G ++ Y      +V  +   + Y+ 
Sbjct: 180 LALDEVHSRKMMHRDLKSANIFL-MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
            PEL  + + Y    DMWSLG +L  ++    PF
Sbjct: 239 APELW-ERKRYSKKADMWSLGVILYELLTLHRPF 271

Length = 478

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 27/94 (28%), Positives = 52/94 (55%), Gaps = 4/94 (4%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKG 66
           +ALD+ H +GI++RD+K  N+++D E   + L D+GL++ +   +E        +  +  
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 67  PELL-ADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           PE++      +D ++D WSLG +   ++    PF
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 25/81 (30%), Positives = 42/81 (51%), Gaps = 2/81 (2%)

Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRV 326
           R+Y  E+  AL Y HS+ I++RD+KP N+++D +   + L D+GL  E        +   
Sbjct: 99  RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFC 157

Query: 327 ASRYFKGPELLADYQYHIELD 347
            +  +  PE+L    Y   +D
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVD 178

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 13/150 (8%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP---VKKKKIKREIKILENLRGGTNI 228
           ++ L RKLG G + EV+E +      +  +KILK    +K++  ++E++ L+ LR   ++
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRV-RVAIKILKSDDLLKQQDFQKEVQALKRLR-HKHL 64

Query: 229 ITLQAVVKDPVSRTPALIFEHVNNTDFKQLY-----QTLTDYDIRYYLYELLKALDYCHS 283
           I+L AV    V     +I E +              Q L    +     ++ + + Y   
Sbjct: 65  ISLFAVCS--VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
              +HRD+   N+++  E+   ++ D+GLA
Sbjct: 123 QNSIHRDLAARNILVG-EDLVCKVADFGLA 151

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 45/191 (23%), Positives = 85/191 (44%), Gaps = 21/191 (10%)

Query: 169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL----KPVKKKKIKREIKILENLRG 224
           + DD++ + +LG G    VF+  +  S      K++    KP  + +I RE+++L     
Sbjct: 3   KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS 62

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYC 281
              +    A   D      ++  EH++     Q+ +    + +  +      ++K L Y 
Sbjct: 63  PYIVGFYGAFYSDG---EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 119

Query: 282 HSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPEL 336
                IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE 
Sbjct: 120 REKHKIMHRDVKPSNILVNSRG-EIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPER 173

Query: 337 LADYQYHIELD 347
           L    Y ++ D
Sbjct: 174 LQGTHYSVQSD 184

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 44.5 bits (106), Expect = 5e-05
 Identities = 24/92 (26%), Positives = 48/92 (52%), Gaps = 3/92 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L Y H  G++HRD+K  N++   +   ++L D+G+A +     ++    V + Y+  PE
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           ++        + D+WSLGC +  ++    P++
Sbjct: 170 VIEM-SGASTASDIWSLGCTVIELLTGNPPYY 200

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 44.5 bits (106), Expect = 5e-05
 Identities = 22/89 (24%), Positives = 40/89 (44%), Gaps = 4/89 (4%)

Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
            A   +  ++Y  S   +HRD+   N ++  EN  +++ D+GL+   +    Y V+    
Sbjct: 108 FALQIARGMEYLESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYKVKGGKL 166

Query: 63  YFK--GPELLADYQMYDYSLDMWSLGCML 89
             +   PE L     +    D+WS G +L
Sbjct: 167 PIRWMAPESL-KEGKFTSKSDVWSFGVLL 194

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 44.4 bits (106), Expect = 5e-05
 Identities = 22/96 (22%), Positives = 41/96 (42%), Gaps = 15/96 (15%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS 61
             A   +  ++Y  S   +HRD+   N ++  E+  +++ D+GL+   +    Y  +   
Sbjct: 109 SFAIQIAKGMEYLASKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDDYYRKKT-- 165

Query: 62  RYFKG--------PELLADYQMYDYSLDMWSLGCML 89
               G        PE L D  ++    D+WS G +L
Sbjct: 166 ---GGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLL 197

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 3/92 (3%)

Query: 266 DIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR 325
           ++   L   L AL     + ++H D+ P N+++D   R   +ID+  A    P  +    
Sbjct: 147 ELWERLLAALLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGDPAYDLASL 206

Query: 326 VASRYFK-GPELLADY--QYHIELDPRFADIL 354
           + S   + G ELLA Y   Y    DP     L
Sbjct: 207 LRSLGEELGAELLAAYLAAYGAAPDPARLREL 238

This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 29/121 (23%), Positives = 52/121 (42%), Gaps = 32/121 (26%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL---------AEFYH---------P 51
           AL+Y H +GI++RD+KP N+++ HE+  + L D+ L                        
Sbjct: 115 ALEYLHLLGIVYRDLKPENILL-HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173

Query: 52  GQEYNVRVA------SRYFKG------PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               +   +      S  F G      PE+++    +  ++D W+LG +L  M++   PF
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPF 232

Query: 100 F 100
            
Sbjct: 233 K 233

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 49/187 (26%), Positives = 87/187 (46%), Gaps = 25/187 (13%)

Query: 177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR---------EIKILENLRGGTN 227
           R LG+G + EV  A  V+++ K  +   K ++KK+IK+         E +ILE +     
Sbjct: 6   RVLGKGGFGEVC-ACQVRATGK--MYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-RF 61

Query: 228 IITLQAV--VKDPVSRTPALIFEHVNNTDFK-QLYQT----LTDYDIRYYLYELLKALDY 280
           +++L      KD +     L+   +N  D K  +Y        +    +Y  EL   L+ 
Sbjct: 62  VVSLAYAYETKDAL----CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLED 117

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
                I++RD+KP N+++D +   +R+ D GLA     G+    RV +  +  PE++ + 
Sbjct: 118 LQRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNE 176

Query: 341 QYHIELD 347
           +Y    D
Sbjct: 177 KYTFSPD 183

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 49/194 (25%), Positives = 85/194 (43%), Gaps = 38/194 (19%)

Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP 318
           +  T+   R+Y  E++ AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    
Sbjct: 90  RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISD 148

Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELD------PRFADILGRHSRKRWERFVHTENQH 372
           G        +  +  PE+L D  Y   +D        +  + GR        F + +++ 
Sbjct: 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP------FYNQDHER 202

Query: 373 LVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL----- 427
           L     ++ +              RF  T     +SPEA   L  LL+ D  +RL     
Sbjct: 203 LFELILMEEI--------------RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPS 243

Query: 428 TAREAMDHPYFYPI 441
            A+E M+H +F  I
Sbjct: 244 DAKEVMEHRFFLSI 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 18/39 (46%), Positives = 26/39 (66%), Gaps = 1/39 (2%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY 49
           L+Y H  GI H D+KP N+M+D  NR   +ID+G+A  +
Sbjct: 139 LEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYGIASHF 176

Length = 294

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 28/84 (33%), Positives = 43/84 (51%), Gaps = 11/84 (13%)

Query: 19  IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQ 74
           IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE L    
Sbjct: 125 IMHRDVKPSNILVNSRG-EIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTH 178

Query: 75  MYDYSLDMWSLGCMLASMIFRKEP 98
            Y    D+WS+G  L  M   + P
Sbjct: 179 -YSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 44.1 bits (104), Expect = 7e-05
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 14/143 (9%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK----IKREIKILENLRGGTNIITLQAV 234
           LG+G Y  V+ A ++ +  +  +K + P +  +    +  EI +   L+   NI+  Q +
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHSYLKH-RNIV--QYL 71

Query: 235 VKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYD--IRYYLYELLKALDYCHSMGIMH 288
             D  +    +  E V       L ++    L D +  I +Y  ++L+ L Y H   I+H
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 289 RDVKPHNVMIDHENRKLRLIDWG 311
           RD+K  NV+++  +  +++ D+G
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFG 154

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 28/78 (35%), Positives = 41/78 (52%), Gaps = 11/78 (14%)

Query: 19  IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLADYQ 74
           IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE L    
Sbjct: 121 IMHRDVKPSNILVN-SRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTH 174

Query: 75  MYDYSLDMWSLGCMLASM 92
            Y    D+WSLG  L  M
Sbjct: 175 -YTVQSDIWSLGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 43.9 bits (104), Expect = 9e-05
 Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 5/106 (4%)

Query: 246 IFEHVNNTDFKQLYQTLTDYD---IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN 302
           + E+VN  D     Q    +D    R+Y  E++  L + H  GI++RD+K  NV++D E 
Sbjct: 74  VMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG 133

Query: 303 RKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
             +++ D+G+  E    G   +    +  +  PE+L+   Y   +D
Sbjct: 134 H-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVD 178

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 45/173 (26%), Positives = 86/173 (49%), Gaps = 21/173 (12%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNI-ITLQAVVKD 237
           +GRG + EV+     + +D   +  +K + KK+IK  +K  E L     I ++L +    
Sbjct: 2   IGRGGFGEVY---GCRKADTGKMYAMKCLDKKRIK--MKQGETLALNERIMLSLVSTGDC 56

Query: 238 P-------VSRTP---ALIFEHVNNTDFK-QLYQ--TLTDYDIRYYLYELLKALDYCHSM 284
           P          TP     I + +N  D    L Q    ++ ++R+Y  E++  L++ H+ 
Sbjct: 57  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
            +++RD+KP N+++D E+  +R+ D GLA  +   + +   V +  +  PE+L
Sbjct: 117 FVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVL 167

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 45/211 (21%)

Query: 246 IFEHVNNTDFKQLYQTLTDYDI---RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN 302
           + E++N  D     Q+   +D    R+Y  E++  L + H  GI++RD+K  NV++D + 
Sbjct: 74  VMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG 133

Query: 303 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKG------PELLADYQYHIELDPRFADILGR 356
             +++ D+G+ +     +  N    +  F G      PE+L   +Y+  +D         
Sbjct: 134 H-IKIADFGMCK-----ENMNGEGKASTFCGTPDYIAPEILKGQKYNESVD--------- 178

Query: 357 HSRKRWERFVHTENQHLV--SP---EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEA 411
                W  F     + L+  SP   E  D L  +I   + R  + R+        +S EA
Sbjct: 179 -----WWSFGVLLYEMLIGQSPFHGEDEDELFDSI--LNDRPHFPRW--------ISKEA 223

Query: 412 LDFLDKLLRYDHYERLTAR-EAMDHPYFYPI 441
            D L KL   D  +RL    +   HP+F  I
Sbjct: 224 KDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 36/176 (20%), Positives = 79/176 (44%), Gaps = 17/176 (9%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGT 226
           Y+ +R +GRG +  V            ++K + PV      ++   + E ++L+ L    
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 227 NIITLQAVVKDP-----VSRTPA-LIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDY 280
            I   +  ++D      +   P   + E++     K+    L +  I ++  ++L AL +
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQ----KRCNSLLDEDTILHFFVQILLALHH 116

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 336
            H+  I+HRD+K  N+++D     +++ D+G+++      +    V +  +  PEL
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPEL 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 6/93 (6%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG----LAEFYHPGQEYNVRVASRYFKG 66
           ++Y HS  I+HRD+K  N++ D     ++L D+G    L      G        + Y+  
Sbjct: 117 VEYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           PE+++  + Y    D+WS+GC +  M+  K P+
Sbjct: 176 PEVISG-EGYGRKADVWSVGCTVVEMLTEKPPW 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 20/171 (11%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTN 227
           ++  QL++KLG G++ EV+       + K  VK LKP  +  +    E +I++ LR    
Sbjct: 5   RESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLR-HDK 62

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRY--------YLYELLKALD 279
           ++ L AV    VS  P  I     +     L   L D + R            ++   + 
Sbjct: 63  LVQLYAV----VSEEPIYIVTEYMSKG--SLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 330
           Y   M  +HRD++  N+++  +    ++ D+GLA       EY  R  +++
Sbjct: 117 YIERMNYIHRDLRSANILVG-DGLVCKIADFGLARLIE-DNEYTARQGAKF 165

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 44/180 (24%), Positives = 82/180 (45%), Gaps = 15/180 (8%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKIL--KPVKKKKIKREIK-----ILENLRGGTNIITL 231
           +G+G + +V  A          VK+L  K + KKK +  I      +L+NL+    ++ L
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH-PFLVGL 61

Query: 232 QAVVKDPVSRTPALIFEHVNNTDF---KQLYQTLTDYDIRYYLYELLKALDYCHSMGIMH 288
               +         + ++VN  +     Q  +   +   R+Y  E+  A+ Y HS+ I++
Sbjct: 62  HYSFQTA--EKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119

Query: 289 RDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
           RD+KP N+++D +   + L D+GL  E   P +  +    +  +  PE+L    Y   +D
Sbjct: 120 RDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVD 178

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 28/107 (26%), Positives = 51/107 (47%), Gaps = 10/107 (9%)

Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE----FYHPGQEYNVRVASRYFKGPE 68
           Y HS  I+HRD+K  N++ D     ++L D+G ++        G        + Y+  PE
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
           +++  + Y    D+WS+ C +  M+  K P+      Y+ +  I K+
Sbjct: 180 VISG-EGYGRKADVWSVACTVVEMLTEKPPW----AEYEAMAAIFKI 221

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 19/47 (40%), Positives = 32/47 (68%), Gaps = 1/47 (2%)

Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
           R+Y  E+  AL Y HS+ I++RD+KP N+++D +   + L D+GL +
Sbjct: 99  RFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH-VVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 24/74 (32%), Positives = 42/74 (56%), Gaps = 14/74 (18%)

Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           ++Y  EL+ A +Y HS  I++RD+KP N+++D++   +++ D+G A+          +V 
Sbjct: 121 KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH-VKVTDFGFAK----------KVP 169

Query: 328 SRYFK---GPELLA 338
            R F     PE LA
Sbjct: 170 DRTFTLCGTPEYLA 183

Length = 329

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 42/189 (22%), Positives = 71/189 (37%), Gaps = 56/189 (29%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL---------AEFYHPGQEY--- 55
           ++A++  H MG +HRD+KP N++ID +   ++L D+GL         +++Y  G      
Sbjct: 111 TLAIESVHKMGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169

Query: 56  ------------NVRVASRY------------------------FKGPELLADYQMYDYS 79
                       N R   R                         +  PE+L   + Y   
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQL 228

Query: 80  LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADI 139
            D WS+G +L  M+  + PF        QL    KV+  E          ++L P   D+
Sbjct: 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQL----KVINWENTLHI--PPQVKLSPEAVDL 282

Query: 140 LGRARVYAD 148
           + +    A+
Sbjct: 283 ITKLCCSAE 291

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 42.8 bits (100), Expect = 2e-04
 Identities = 47/180 (26%), Positives = 82/180 (45%), Gaps = 16/180 (8%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKILKP---VKKKKIKR---EIKILENLRGG-TNIITL 231
           LG+G + +V       S     +KILK    + K ++     E ++L+N R      +  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 232 QAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMH 288
               KD +      + E+VN  + F  L +    ++   R+Y  E++ ALDY HS  I++
Sbjct: 63  SFQTKDRL----CFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVY 118

Query: 289 RDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
           RD+K  N+M+D +   +++ D+GL  E             +  +  PE+L D  Y   +D
Sbjct: 119 RDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVD 177

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 2/76 (2%)

Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRV 326
           R+Y  E++ AL Y HS  +++RD+K  N+M+D +   +++ D+GL  E    G       
Sbjct: 98  RFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFC 156

Query: 327 ASRYFKGPELLADYQY 342
            +  +  PE+L D  Y
Sbjct: 157 GTPEYLAPEVLEDNDY 172

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 12/96 (12%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---- 66
           L Y H   I+HRD+K  NV+++  +  +++ D+G ++     +   +   +  F G    
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQY 175

Query: 67  --PELLADYQM-YDYSLDMWSLGCMLASMIFRKEPF 99
             PE++      Y    D+WSLGC +  M   K PF
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 71/325 (21%), Positives = 121/325 (37%), Gaps = 92/325 (28%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQS----SDKCVVKILKPVKKKKIKREIKIL------- 219
           DD++ + +LG G    V + ++  S    + K +   +KP  + +I RE+K+L       
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 220 ------------------ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT 261
                             E++ GG+    L  V+K    R P  I   ++    + L   
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGS----LDQVLKK-AGRIPENILGKISIAVLRGLT-- 113

Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
                   YL E  K         IMHRDVKP N++++    +++L D+G++     GQ 
Sbjct: 114 --------YLREKHK---------IMHRDVKPSNILVN-SRGEIKLCDFGVS-----GQL 150

Query: 322 Y----NVRVASRYFKGPELLADYQYHIELDPRFADI-----------LGRH-----SRKR 361
                N  V +R +  PE L    Y ++     +DI           +GR+       K 
Sbjct: 151 IDSMANSFVGTRSYMSPERLQGTHYTVQ-----SDIWSLGLSLVEMAIGRYPIPPPDAKE 205

Query: 362 WERFVHTENQHLVSPEALDFLDKNIL-GRHSRKRWERFVHTENQH-------LVSPEALD 413
            E           + E+   +  +          +E   +  N+          S E  D
Sbjct: 206 LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQD 265

Query: 414 FLDKLLRYDHYERLTAREAMDHPYF 438
           F+DK L+ +  ER   +E   HP+ 
Sbjct: 266 FVDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 28/108 (25%), Positives = 50/108 (46%), Gaps = 5/108 (4%)

Query: 10  ALDYC-HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           AL Y     G++HRDVKP N+++D  +  ++L D+G++      +          +  PE
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPE 184

Query: 69  LL---ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 113
            +        YD   D+WSLG  L  +   + P+ +    ++ L +I 
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 29/97 (29%), Positives = 50/97 (51%), Gaps = 12/97 (12%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG----LAEFYHPGQEYNVRVASRYFKG 66
           + Y H   I+HRD+KP N++I+   + +++ D+G    LA+   P    N  V +  +  
Sbjct: 181 IAYLHRRHIVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMS 236

Query: 67  PELL---ADYQMYD-YSLDMWSLGCMLASMIFRKEPF 99
           PE +    ++  YD Y+ D+WSLG  +      + PF
Sbjct: 237 PERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273

Length = 353

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 6/91 (6%)

Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG----LAEFYHPGQEYNVRVASRYFKGPE 68
           Y HS  I+HRD+K  N++ D     ++L D+G    L      G        + Y+  PE
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVG-NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +++  + Y    D+WS+GC +  M+  K P+
Sbjct: 180 VISG-EGYGRKADIWSVGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 40/147 (27%), Positives = 58/147 (39%), Gaps = 14/147 (9%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSD----KCVVKILKPVKKKKIKREIKILENLRGGTNI 228
           Y ++  L  G   EVF  +  +  D    K +VK +     K   REI IL+ +     I
Sbjct: 94  YNILSSLTPGSEGEVF--VCTKHGDEQRKKVIVKAV--TGGKTPGREIDILKTISHRAII 149

Query: 229 ITLQAVVKDPVSRTPALIFEHVNNTDFKQL--YQTLTDYDIRYYLYELLKALDYCHSMGI 286
             + A        T  ++        F  +     L           LL+AL Y H  GI
Sbjct: 150 NLIHAYRWKS---TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGI 206

Query: 287 MHRDVKPHNVMIDHENRKLRLIDWGLA 313
           +HRDVK  N+ +D     + L D+G A
Sbjct: 207 IHRDVKTENIFLDEPENAV-LGDFGAA 232

Length = 392

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 52/286 (18%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL----KPVKKKKIKREIKILENLRGGTN 227
           D Q    LG G    V++A ++ +     VK++        +K+I  E++IL        
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPY 60

Query: 228 IITLQAV--VKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMG 285
           II       V++ +S    +  E ++      +Y+ + ++ +      ++K L Y  S+ 
Sbjct: 61  IIGFYGAFFVENRIS----ICTEFMDGGSL-DVYRKIPEHVLGRIAVAVVKGLTYLWSLK 115

Query: 286 IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN----VRVASRYFKGPELLADYQ 341
           I+HRDVKP N++++    +++L D+G++      Q  N      V +  +  PE ++  Q
Sbjct: 116 ILHRDVKPSNMLVNTRG-QVKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISGEQ 169

Query: 342 YHIELDPRFADI------LGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW 395
           Y I  D     I      LGR    + ++     NQ  + P  L  L             
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQK-----NQGSLMP--LQLL------------- 209

Query: 396 ERFVHTENQ----HLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
           +  V  +         S + + F+ + +R    ER      MDHP+
Sbjct: 210 QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 39/188 (20%)

Query: 268 RYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVR 325
           R+Y  E++ ALDY HS   +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 98  RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTF 156

Query: 326 VASRYFKGPELLADYQYHIELD------PRFADILGRHSRKRWERFVHTENQHLVSPEAL 379
             +  +  PE+L D  Y   +D        +  + GR        F + +++ L     +
Sbjct: 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP------FYNQDHEKLFELILM 210

Query: 380 DFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMD 434
           + +              RF  T     +SPEA   L  LL+ D  +RL      A+E M 
Sbjct: 211 EEI--------------RFPRT-----LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251

Query: 435 HPYFYPIV 442
           H +F  IV
Sbjct: 252 HKFFAGIV 259

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 43/188 (22%), Positives = 86/188 (45%), Gaps = 19/188 (10%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTNII 229
           D  +  KLG G+Y EV+E +  + S    VK LK   ++ ++  +E  +++ ++   N++
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 65

Query: 230 TLQAVVKDPVSRTPA--LIFEHVNNTDFKQLY-----QTLTDYDIRYYLYELLKALDYCH 282
            L  V     +R P   +I E +   +          Q +    + Y   ++  A++Y  
Sbjct: 66  QLLGV----CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY---FKGPELLAD 339
               +HRD+   N ++  EN  +++ D+GL+     G  Y     +++   +  PE LA 
Sbjct: 122 KKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 179

Query: 340 YQYHIELD 347
            ++ I+ D
Sbjct: 180 NKFSIKSD 187

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 24/79 (30%), Positives = 43/79 (54%), Gaps = 4/79 (5%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPEL 69
           L Y H  G +HRD+K  N+++  E+  ++L D+G+ A+      +    + + Y+  PE+
Sbjct: 114 LAYLHETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172

Query: 70  LADYQM--YDYSLDMWSLG 86
            A  +   YD   D+W+LG
Sbjct: 173 AAVERKGGYDGKCDIWALG 191

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.8 bits (100), Expect = 4e-04
 Identities = 36/164 (21%), Positives = 79/164 (48%), Gaps = 26/164 (15%)

Query: 154 PREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI-----LKPVK 208
           P +Y D ES +      ++Y++++K+G G++ EVF   + ++ +    K      LK  +
Sbjct: 2   PGKYDDGESRL------NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE 55

Query: 209 KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFK-------QLYQT 261
           K ++  E+ ++  L+   NI+       +  ++   ++ E  +  D         +++  
Sbjct: 56  KSQLVIEVNVMRELK-HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK 114

Query: 262 LTDYDIRYYLYELLKALDYCHSMG-------IMHRDVKPHNVMI 298
           + ++ I     +LL AL YCH++        ++HRD+KP N+ +
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158

Length = 1021

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 25/84 (29%), Positives = 49/84 (58%), Gaps = 6/84 (7%)

Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR- 325
           + +YL++++ A+ Y H  GI+HRD+K  N+ +      ++L D+G+++    G EY++  
Sbjct: 103 VLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL-IKLGDFGISKIL--GSEYSMAE 159

Query: 326 --VASRYFKGPELLADYQYHIELD 347
             V + Y+  PEL    +Y+ + D
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSD 183

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 16/37 (43%), Positives = 25/37 (67%), Gaps = 1/37 (2%)

Query: 275 LKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG 311
           LK L Y HS  I+HRD+KP N+++     +++L D+G
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLCDFG 150

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 11/84 (13%)

Query: 19  IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQ 74
           IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE L    
Sbjct: 125 IMHRDVKPSNILVNSRG-EIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTH 178

Query: 75  MYDYSLDMWSLGCMLASMIFRKEP 98
            Y    D+WS+G  L  +   + P
Sbjct: 179 -YSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 45/194 (23%), Positives = 93/194 (47%), Gaps = 31/194 (15%)

Query: 176 VRKLGRGKYSEV----FEAINVQSSDKCVVKILKPVKKKKI---KREIKILENLRGGTNI 228
           +++LG+G +  V    ++ +   + +   VK L+    + +   +REI+IL++L+   NI
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH-DNI 67

Query: 229 ITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRY-----------YLYELLKA 277
           +  + V      R   L+ E++        Y +L DY  ++           Y  ++ K 
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLP-------YGSLRDYLQKHRERLDHRKLLLYASQICKG 120

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YNVRVASR---YFKG 333
           ++Y  S   +HRD+   N++++ ENR +++ D+GL +     +E Y VR       ++  
Sbjct: 121 MEYLGSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179

Query: 334 PELLADYQYHIELD 347
           PE L + ++ +  D
Sbjct: 180 PESLTESKFSVASD 193

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 16/42 (38%), Positives = 29/42 (69%), Gaps = 1/42 (2%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH 50
           +A++  H +G +HRD+KP N++ID     ++L D+GL+  +H
Sbjct: 112 LAIEAVHKLGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFH 152

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 29/106 (27%), Positives = 51/106 (48%), Gaps = 5/106 (4%)

Query: 246 IFEHVNNTDFKQLYQTLTDYD---IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN 302
           + E+VN  D     Q    +D    R+Y  E+  AL + H  G+++RD+K  N+++D E 
Sbjct: 74  VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG 133

Query: 303 RKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
              +L D+G+  E    G        +  +  PE+L + +Y   +D
Sbjct: 134 H-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVD 178

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 36/186 (19%), Positives = 88/186 (47%), Gaps = 15/186 (8%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVK-----ILKPVKKKKIKREIKILENLRGGTN 227
           Y  V+K+G G + +     + +   + V+K      + P ++++ ++E+ +L N++   N
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH-PN 60

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQT----LTDYDIRYYLYELLKALDYCH 282
           I+  Q   ++  +    ++ ++    D +K++         +  I  +  ++  AL + H
Sbjct: 61  IVQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGPELLADYQ 341
              I+HRD+K  N+ +  +   ++L D+G+A   +   E     + + Y+  PE+  +  
Sbjct: 119 DRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP 177

Query: 342 YHIELD 347
           Y+ + D
Sbjct: 178 YNNKSD 183

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 18/92 (19%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRV-ASRYF---- 64
           A+ Y H   I+HRD+K  N+ I+H    + L D+G A        + V + A++Y+    
Sbjct: 194 AIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAA-------CFPVDINANKYYGWAG 245

Query: 65  ----KGPELLADYQMYDYSLDMWSLGCMLASM 92
                 PELLA    Y  ++D+WS G +L  M
Sbjct: 246 TIATNAPELLAR-DPYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 9/94 (9%)

Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG----LAEFYHPGQEYNVRVASR---YFK 65
           Y H+  ++HRD+K +NVM+   N  ++LID+G    LA     G   N+  +     Y+ 
Sbjct: 117 YLHNNCVVHRDIKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
            PE++ +   Y    D+WS+GC +  M   K P 
Sbjct: 176 APEVINE-SGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 41.0 bits (97), Expect = 6e-04
 Identities = 16/32 (50%), Positives = 20/32 (62%)

Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           +S EA DFL K LR D  +R TA E + HP+ 
Sbjct: 229 LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 41.3 bits (97), Expect = 6e-04
 Identities = 31/111 (27%), Positives = 50/111 (45%), Gaps = 8/111 (7%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMI-DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFK- 65
           S AL Y  S   +HRD+   NV++   +  KL   D+GL+ +      Y         K 
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPDCVKLG--DFGLSRYLEDESYYKASKGKLPIKW 174

Query: 66  -GPELLADYQMYDYSLDMWSLG-CMLASMIFRKEPFFHGHDNYDQLVRIAK 114
             PE + +++ +  + D+W  G CM   ++   +P F G  N D + RI  
Sbjct: 175 MAPESI-NFRRFTSASDVWMFGVCMWEILMLGVKP-FQGVKNNDVIGRIEN 223

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 26/89 (29%), Positives = 45/89 (50%), Gaps = 5/89 (5%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY---F 64
           S  + Y   M ++HRD+   NV++  E RK+++ D+GL+   +    Y  R   R    +
Sbjct: 137 SRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKW 195

Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMI 93
              E L D+ +Y    D+WS G +L  ++
Sbjct: 196 MAIESLFDH-IYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.5 bits (97), Expect = 7e-04
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 55/220 (25%)

Query: 274 LLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRV-ASRYF- 331
           +L+A+ Y H   I+HRD+K  N+ I+H    + L D+G A        + V + A++Y+ 
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAA-------CFPVDINANKYYG 242

Query: 332 -------KGPELLADYQYHIELDPRFADIL------------------GRHSRKRWERF- 365
                    PELLA   Y   +D   A I+                  G     R  +  
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI 302

Query: 366 -----VHTENQHLVSPEA-LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLD-KL 418
                 H  N+  +  +A LD +   +  + SRK   R + T    L  P  L++L  K+
Sbjct: 303 IRRSGTHP-NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL--PIDLEYLICKM 359

Query: 419 LRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPI 458
           L +D + R +A   +D   F           +P   P P+
Sbjct: 360 LAFDAHHRPSAEALLDFAAFQ---------DIPDPYPNPM 390

Length = 391

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 36/146 (24%), Positives = 67/146 (45%), Gaps = 15/146 (10%)

Query: 179 LGRGKYSEVFEAINVQSSDKCVVKI-LKPVKK-------KKIKREIKILENLRGGTNIIT 230
           LG+G Y  V+  +  Q     V ++ L            +K++ E+ +L++L+   NI+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH-VNIVQ 66

Query: 231 LQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYCHSMGIM 287
                 D    T ++  E V       +   +  L +     Y  ++L  + Y H+  ++
Sbjct: 67  YLGTCLD--DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124

Query: 288 HRDVKPHNVMIDHENRKLRLIDWGLA 313
           HRD+K +NVM+   N  ++LID+G A
Sbjct: 125 HRDIKGNNVML-MPNGIIKLIDFGCA 149

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 15/102 (14%)

Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENR--------KLRLIDWGL-AEFYHPGQ 53
           I  G   ALDY H MG +HR VK  +++I  + +         L +I+ G      H   
Sbjct: 106 ILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFP 165

Query: 54  EYNVRVASRYFKGPELL-ADYQMYDYSLDMWSLG---CMLAS 91
           +Y+V+V    +  PE+L  + Q YD   D++S+G   C LA+
Sbjct: 166 KYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVGITACELAN 205

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 40.9 bits (96), Expect = 8e-04
 Identities = 30/100 (30%), Positives = 53/100 (53%), Gaps = 4/100 (4%)

Query: 244 ALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCH-SMGIMHRDVKPHNVMIDHEN 302
           A + EH N+   K+  Q  T+  I     +++ AL Y H    I+HRD+ P+N+M+  E+
Sbjct: 94  APLGEHFNS--LKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-ED 150

Query: 303 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
            K+ + D+GLA+   P  +    V +  +  PE++ +  Y
Sbjct: 151 DKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPY 190

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|176751 cd08340, DED_c-FLIP_repeat2, Death Effector Domain, repeat 2, of cellular FLICE-Inhibitory Protein

 Score = 37.7 bits (88), Expect = 9e-04
 Identities = 15/48 (31%), Positives = 26/48 (54%), Gaps = 4/48 (8%)

Query: 377 EALDFLDKNILGRHSRKRWERFVH----TENQHLVSPEALDFLDKLLR 420
            +L FL K+++   S+ + + F+      E  +LVSP  +D L+  LR
Sbjct: 20  RSLIFLLKDLMPSGSKAKDKSFLELVLELEKLNLVSPNKVDLLEDCLR 67

Death Effector Domain (DED), repeat 2, similar to that found in cellular FLICE-inhibitory protein (c-FLIP/CASH, also known as Casper/iFLICE/FLAME-1/CLARP/MRIT/usurpin). c-FLIP is a catalytically inactive homolog of the initator procaspases-8 and -10. It negatively influences apoptotic signaling by interfering with the efficient formation of the Death Inducing Signalling Complex (DISC). At low levels, c-FLIP has been shown to enhance apoptotic signaling by allosterically activating caspase-8. As a modulator of the initiator caspases, c-FLIP regulates life and death in various types of cells and tissues. All members contain two N-terminal DEDs and a C-terminal pseudo-caspase domain. DEDs comprise a subfamily of the Death Domain (DD) superfamily. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including PYRIN and CARD (Caspase activation and recruitment domain). They serve as adaptors in signaling pathways and can recruit other proteins into signaling complexes. Length = 81

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 25/107 (23%), Positives = 55/107 (51%), Gaps = 5/107 (4%)

Query: 245 LIFEHVNNTDFKQLYQTLTDYDI---RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE 301
            + E++N  D     Q+   +D+    +Y  E++  L + HS GI++RD+K  N+++D +
Sbjct: 73  FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132

Query: 302 NRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQYHIELD 347
              +++ D+G+ +    G  +      +  +  PE+L   +Y+  +D
Sbjct: 133 GH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVD 178

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 35/126 (27%), Positives = 56/126 (44%), Gaps = 36/126 (28%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL---------AEFY-----HPGQE 54
           +A+D  H +G +HRD+KP N+++D +   ++L D+GL          EFY     +P  +
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170

Query: 55  YNV------RVASRYFKGPELLA-------DY--------QMYDYSLDMWSLGCMLASMI 93
           ++       R A  + K    LA       DY          Y+   D WSLG ++  M+
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 94  FRKEPF 99
               PF
Sbjct: 231 IGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 34/155 (21%), Positives = 71/155 (45%), Gaps = 14/155 (9%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGT-NIITL 231
           Y L ++LG+G +  V+   + ++  +  +K+LK +   ++     +  N      + +  
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 232 QAVVKDPVS----RTPALIFEHVNNTD-------FKQLYQTLTDYDIRYYLYELLKALDY 280
            A+VK   S        +I E+    D        K   +TL++  +  +  +LL  + Y
Sbjct: 62  PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF 315
            H   I+HRD+K  N+ +  +N  L++ D+G++  
Sbjct: 122 MHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRL 154

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.9 bits (91), Expect = 0.001
 Identities = 11/40 (27%), Positives = 22/40 (55%), Gaps = 1/40 (2%)

Query: 16  SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 55
            + + H D+ P N+++D + + L +IDW  A +  P  + 
Sbjct: 107 LLVLCHGDLHPGNILVD-DGKILGIIDWEYAGYGPPAFDL 145

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 15/38 (39%), Positives = 26/38 (68%), Gaps = 1/38 (2%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF 48
           ++Y HS G++HRD+KP N+++      + ++DWG A F
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVV-ILDWGAAIF 162

Length = 932

>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 13/64 (20%), Positives = 25/64 (39%)

Query: 18  GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYD 77
            ++H D+ P N+++D   R   +ID+  A    P  +    + S   +    L    +  
Sbjct: 166 VLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGDPAYDLASLLRSLGEELGAELLAAYLAA 225

Query: 78  YSLD 81
           Y   
Sbjct: 226 YGAA 229

This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 29/117 (24%), Positives = 55/117 (47%), Gaps = 8/117 (6%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           M     A MA  Y   M  +HRD++  N+++  +    ++ D+GLA       EY  R  
Sbjct: 107 MAAQVAAGMA--YIERMNYIHRDLRSANILVG-DGLVCKIADFGLARLIE-DNEYTARQG 162

Query: 61  SRY---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +++   +  PE  A Y  +    D+WS G +L  ++ +    + G +N + L ++ +
Sbjct: 163 AKFPIKWTAPE-AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 16/43 (37%), Positives = 29/43 (67%), Gaps = 2/43 (4%)

Query: 272 YELLKALDYC-HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
             ++KAL Y     G++HRDVKP N+++D  +  ++L D+G++
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 17/37 (45%), Positives = 25/37 (67%)

Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI 298
           +++  I Y L  +LKALDY H MG +HR VK  +++I
Sbjct: 98  MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 134

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.0 bits (97), Expect = 0.001
 Identities = 15/71 (21%), Positives = 36/71 (50%), Gaps = 7/71 (9%)

Query: 245 LIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRK 304
           ++ E++   D K + +   +      + ++ + +   H  GI+H D+   N ++   + +
Sbjct: 413 IVMEYIGGKDLKDVLEGNPEL-----VRKVGEIVAKLHKAGIVHGDLTTSNFIVR--DDR 465

Query: 305 LRLIDWGLAEF 315
           L LID+GL ++
Sbjct: 466 LYLIDFGLGKY 476

Length = 535

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 40.2 bits (95), Expect = 0.001
 Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 4/90 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           AL+  H   I+H D+K  NV+ D    ++ L D+GL +    G          YF  PE 
Sbjct: 121 ALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTPSCYDGTLDYFS-PEK 177

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +     YD S D W++G +   ++  K PF
Sbjct: 178 IKG-HNYDVSFDWWAVGVLTYELLTGKHPF 206

Length = 267

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 7/84 (8%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFK 65
            ++Y  S   +HRD+   NV++  +N  +++ D+GLA   H    Y    N R+  ++  
Sbjct: 152 GMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWM- 209

Query: 66  GPELLADYQMYDYSLDMWSLGCML 89
            PE L D ++Y +  D+WS G +L
Sbjct: 210 APEALFD-RIYTHQSDVWSFGVLL 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 18/127 (14%)

Query: 10  ALDYC-HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN-----VRVASRY 63
           AL+Y    + I+HRDVKP N+++D  N  ++L D+G++     GQ  +          R 
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILLD-RNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRP 172

Query: 64  FKGPELLA--DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK----VLG 117
           +  PE +       YD   D+WSLG  L  +   K P+   +  +DQL ++ K    +L 
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232

Query: 118 TEELFEY 124
             E  E+
Sbjct: 233 NSEEREF 239

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 22/149 (14%)

Query: 178 KLGRGKYSEVF----EAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQA 233
           ++GRG + EVF     A N   + K   + L P  K K  +E +IL+      NI+ L  
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIG 60

Query: 234 VV--KDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLK-------ALDYCHSM 284
           V   K P+     ++ E V   DF    +T      R  + EL++        ++Y  S 
Sbjct: 61  VCTQKQPIY----IVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK 113

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
             +HRD+   N ++  +N  L++ D+G++
Sbjct: 114 HCIHRDLAARNCLVTEKN-VLKISDFGMS 141

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 27/97 (27%), Positives = 49/97 (50%), Gaps = 4/97 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
            L Y HS G MHRD+K  N+++  +N  ++L D+G+ A+      +    + + Y+  PE
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE 176

Query: 69  LLADYQM--YDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           + A  +   Y+   D+W++G     +   + P F  H
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 43/185 (23%), Positives = 72/185 (38%), Gaps = 34/185 (18%)

Query: 265 YDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYN 323
           Y   +Y  E++  L + HS GI++RD+K  NVM+D +   +++ D+G+  E        +
Sbjct: 96  YRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRAS 154

Query: 324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLD 383
               +  +  PE+L   +Y   +D              W  F     + L+        D
Sbjct: 155 TFCGTPDYIAPEILQGLKYTFSVD--------------WWSFGVLLYEMLIGQSPFHGDD 200

Query: 384 KNILGRHSRK------RWERFVHTENQHLVSPEALDFLDKLLRYDHYERL-TAREAMDHP 436
           ++ L    R       RW           ++ E+ D L+KL   D   RL        HP
Sbjct: 201 EDELFESIRVDTPHYPRW-----------ITKESKDILEKLFERDPTRRLGVVGNIRGHP 249

Query: 437 YFYPI 441
           +F  I
Sbjct: 250 FFKTI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 40/174 (22%), Positives = 86/174 (49%), Gaps = 8/174 (4%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR---EIKILENLRGGT 226
           ++ ++++ +LG G + +V++A N ++      K++    +++++    EI IL +     
Sbjct: 4   EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHP 62

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTD--FKQLYQTLTDYDIRYYLYELLKALDYCHSM 284
           NI+ L        +    + F      D    +L + LT+  IR    + L+AL+Y H  
Sbjct: 63  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELL 337
            I+HRD+K  N++   +   ++L D+G+ A+     Q  +  + + Y+  PE++
Sbjct: 123 KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 175

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 7/84 (8%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFK 65
            ++Y  S   +HRD+   NV++  +N  +++ D+GLA   H    Y    N R+  ++  
Sbjct: 146 GMEYLASQKCIHRDLAARNVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWM- 203

Query: 66  GPELLADYQMYDYSLDMWSLGCML 89
            PE L D ++Y +  D+WS G +L
Sbjct: 204 APEALFD-RVYTHQSDVWSFGVLL 226

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 27/115 (23%), Positives = 55/115 (47%), Gaps = 6/115 (5%)

Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD++  N+++  +N   ++ D+GLA       EY  R  ++
Sbjct: 107 MAAQIADGMAYIERMNYIHRDLRAANILVG-DNLVCKIADFGLARLIE-DNEYTARQGAK 164

Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  ++ +    + G  N + L ++ +
Sbjct: 165 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER 218

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 30/116 (25%), Positives = 56/116 (48%), Gaps = 10/116 (8%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS 61
           +IA+G    + Y   M  +HRD++  N+++  EN   ++ D+GLA       EY  R  +
Sbjct: 110 QIASG----MAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGA 163

Query: 62  RY---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           ++   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 164 KFPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 39.6 bits (93), Expect = 0.002
 Identities = 14/33 (42%), Positives = 22/33 (66%)

Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMID 299
           I + L ++L ALDY HS G +HR VK  ++++ 
Sbjct: 103 IAFILKDVLNALDYIHSKGFIHRSVKASHILLS 135

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 39.0 bits (92), Expect = 0.003
 Identities = 25/96 (26%), Positives = 43/96 (44%), Gaps = 17/96 (17%)

Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---- 58
           +A   +  ++Y  S   +HRD+   N ++  EN  +++ D+GL+   +    Y  R    
Sbjct: 107 MALQIAKGMEYLESKNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGGK 165

Query: 59  -----VASRYFKGPELLADYQMYDYSLDMWSLGCML 89
                +A      PE L D +    S D+WS G +L
Sbjct: 166 LPIKWMA------PESLKDGKFTSKS-DVWSFGVLL 194

Length = 258

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 42/189 (22%), Positives = 83/189 (43%), Gaps = 20/189 (10%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-----PVKKKKIKREIKILENLRGGTN 227
           Y  VR +G+G Y EV    +     + V+K L        ++K  ++E ++L  L+   N
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH-PN 60

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--------QTLTDYDIRYYLYELLKALD 279
           I+      ++       L++  +   +   LY        + L +  +  +  ++  AL 
Sbjct: 61  IVAY----RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGPELLA 338
           Y H   I+HRD+K  NV +   N  +++ D G+A       +  +  + + Y+  PEL +
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175

Query: 339 DYQYHIELD 347
           +  Y+ + D
Sbjct: 176 NKPYNYKSD 184

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 16/36 (44%), Positives = 26/36 (72%), Gaps = 1/36 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL 45
           A++  H MG +HRD+KP N++ID +   ++L D+GL
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 39.7 bits (92), Expect = 0.003
 Identities = 16/47 (34%), Positives = 32/47 (68%), Gaps = 1/47 (2%)

Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           I+  + ++L  L   H +GI+HRD+KP N+++  +  ++++ID+G A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAA 356

Length = 507

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 39.3 bits (91), Expect = 0.003
 Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 12/98 (12%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV--- 57
           +  A   +  +DY      +HRD+   N+++  EN   ++ D+GL+     GQE  V   
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSR----GQEVYVKKT 169

Query: 58  --RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMI 93
             R+  R+     L  +Y +Y  + D+WS G +L  ++
Sbjct: 170 MGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 33/115 (28%), Positives = 57/115 (49%), Gaps = 8/115 (6%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV-RV 59
           ++  T  +  ++Y  S   +HRD+   N M++ EN  + + D+GL++  + G  Y   R+
Sbjct: 115 VKFMTDIASGMEYLSSKSFIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRI 173

Query: 60  ASRYFK--GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN---YDQL 109
           A    K    E LAD ++Y    D+WS G  +  +  R +  + G +N   YD L
Sbjct: 174 AKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 25/84 (29%), Positives = 45/84 (53%), Gaps = 7/84 (8%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFK 65
            ++Y  S   +HRD+   NV++  EN  +++ D+GLA   +    Y    N R+  ++  
Sbjct: 149 GMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWM- 206

Query: 66  GPELLADYQMYDYSLDMWSLGCML 89
            PE L D ++Y +  D+WS G ++
Sbjct: 207 APEALFD-RVYTHQSDVWSFGVLM 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 33/126 (26%), Positives = 59/126 (46%), Gaps = 22/126 (17%)

Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           IA+G    ++Y  S   +HRD+   N M++ EN  + + D+GL++  + G  Y    AS+
Sbjct: 122 IASG----MEYLSSKNFIHRDLAARNCMLN-ENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
               +   E LAD  +Y    D+W+ G  +  ++ R +  + G +N              
Sbjct: 177 LPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-------------S 222

Query: 120 ELFEYL 125
           E++ YL
Sbjct: 223 EIYNYL 228

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)

Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLA 71
           Y HS G MHRD+K  N+++  +N  ++L D+G+ A+      +    + + Y+  PE+ A
Sbjct: 121 YLHSKGKMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179

Query: 72  DYQM--YDYSLDMWSLGCMLASMIFRKEPFFHGH 103
             +   Y+   D+W++G     +   + P F  H
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 25/97 (25%), Positives = 48/97 (49%), Gaps = 6/97 (6%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV--- 57
           ++ A      +DY  S   +HRD+   NV+++ E++ +++ D+GL +     +EY     
Sbjct: 112 LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEYYTVKD 170

Query: 58  -RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMI 93
              +  ++  PE L   + Y  S D+WS G  L  ++
Sbjct: 171 DLDSPVFWYAPECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 38.5 bits (90), Expect = 0.004
 Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 10/94 (10%)

Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           IA G  MA  Y  S   +HRD+   N+++  EN   ++ D+GLA       EY  R  ++
Sbjct: 112 IAEG--MA--YLESRNYIHRDLAARNILVG-ENLVCKIADFGLARLIED-DEYTAREGAK 165

Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMI 93
           +   +  PE  A+Y  +    D+WS G +L  ++
Sbjct: 166 FPIKWTAPE-AANYGRFTIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 39.4 bits (92), Expect = 0.004
 Identities = 17/50 (34%), Positives = 27/50 (54%), Gaps = 7/50 (14%)

Query: 3   IATGASM-----ALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGL 45
             TG  M     AL   H+ GI+HRD+KP N+M+         +++D+G+
Sbjct: 79  GETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 44/191 (23%), Positives = 85/191 (44%), Gaps = 21/191 (10%)

Query: 169 QQDDYQLVRKLGRGKYSEVFEAINVQS----SDKCVVKILKPVKKKKIKREIKILENLRG 224
           + DD++ + +LG G    V +  +  S    + K +   +KP  + +I RE+++L     
Sbjct: 3   KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS 62

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYC 281
              +    A   D      ++  EH++     Q+ +    + +  +      +L+ L Y 
Sbjct: 63  PYIVGFYGAFYSDG---EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119

Query: 282 HSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPEL 336
                IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE 
Sbjct: 120 REKHQIMHRDVKPSNILVNSRG-EIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPER 173

Query: 337 LADYQYHIELD 347
           L    Y ++ D
Sbjct: 174 LQGTHYSVQSD 184

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 35/123 (28%), Positives = 58/123 (47%), Gaps = 20/123 (16%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKG 66
           ++Y  S   +HRD+   NV++  +N  +++ D+GLA   H    Y    N R+  ++   
Sbjct: 147 MEYLESRRCIHRDLAARNVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWM-A 204

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLD 126
           PE L D ++Y +  D+WS G ++       E F  G   Y         +  EELF+ L 
Sbjct: 205 PEALFD-RVYTHQSDVWSFGILMW------EIFTLGGSPY-------PGIPVEELFKLLR 250

Query: 127 KYH 129
           + H
Sbjct: 251 EGH 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 23/92 (25%), Positives = 49/92 (53%), Gaps = 4/92 (4%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           +  +Y  S+ I++RD+KP N+++D +   +++ D+G A+     + Y +     Y   PE
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVVDT-RTYTLCGTPEYI-APE 198

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           +L +   +  + D W+LG  +  ++    PF+
Sbjct: 199 ILLNVG-HGKAADWWTLGIFIYEILVGCPPFY 229

Length = 340

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 39.1 bits (91), Expect = 0.004
 Identities = 14/27 (51%), Positives = 21/27 (77%)

Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMID 299
           +LL A+DY H  GI+HRD+K  NV+++
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVN 294

Length = 461

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 38.9 bits (91), Expect = 0.004
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 15/96 (15%)

Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA------EFYHPGQEYN 56
           IA G  MA  Y  +   +HRD+   N M+  E+  +++ D+G+       ++Y  G +  
Sbjct: 128 IADG--MA--YLAAKKFVHRDLAARNCMV-AEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182

Query: 57  VRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASM 92
           + V  R+   PE L D  ++    D+WS G +L  M
Sbjct: 183 LPV--RWM-APESLKD-GVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 38.9 bits (91), Expect = 0.004
 Identities = 41/177 (23%), Positives = 83/177 (46%), Gaps = 31/177 (17%)

Query: 169 QQDDYQLVRKLGRGKYSEVF--EAINVQSSDK---CVVKILKPVKKKK----IKREIKIL 219
            +D   L + LG G + +V   EA+ + + ++     VK+LK    +K    +  E++++
Sbjct: 10  PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMM 69

Query: 220 ENLRGGTNIITLQAVV--KDPV-----------------SRTPALIFEHVNNTDFKQLYQ 260
           + +    NII L  V   + P+                 +R P    E+ +  D +   +
Sbjct: 70  KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRP--PGEYASPDDPRPPEE 127

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH 317
           TLT  D+  + Y++ + +++  S   +HRD+   NV++  E+  +++ D+GLA   H
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT-EDHVMKIADFGLARDIH 183

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 38.5 bits (89), Expect = 0.004
 Identities = 44/175 (25%), Positives = 83/175 (47%), Gaps = 27/175 (15%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTN 227
           ++  +LV+KLG G++ EV+      +S K  VK LKP  +  +    E  +++ L+    
Sbjct: 5   RESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQ-HDK 62

Query: 228 IITLQAVV--KDPVSRTPALIFEHVNN---TDF-------KQLYQTLTDYDIRYYLYELL 275
           ++ L AVV  ++P+     +I E++      DF       K L   L D+       ++ 
Sbjct: 63  LVRLYAVVTKEEPIY----IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIA 113

Query: 276 KALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 330
           + + Y      +HRD++  NV++  E+   ++ D+GLA       EY  R  +++
Sbjct: 114 EGMAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIE-DNEYTAREGAKF 166

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 27/116 (23%), Positives = 54/116 (46%), Gaps = 13/116 (11%)

Query: 7   ASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA------EFYHPGQEYNVRVA 60
            +  ++Y  S   +HRD+   N M+D E+  +++ D+GLA      E+Y        ++ 
Sbjct: 107 VAKGMEYLASKKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165

Query: 61  SRYFKGPELLADYQMYDYSL--DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
            ++      L   Q   ++   D+WS G +L  ++ R  P +   D++D  V + +
Sbjct: 166 VKWMA----LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ 217

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 39.1 bits (91), Expect = 0.004
 Identities = 27/94 (28%), Positives = 50/94 (53%), Gaps = 5/94 (5%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFK 65
           +A+ + HS  ++HRD+K  N+++   N  ++L D+G ++ Y      +V      + Y+ 
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILL-CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
            PE+    + Y    DM+SLG +L  ++  K PF
Sbjct: 213 APEIWRR-KPYSKKADMFSLGVLLYELLTLKRPF 245

Length = 496

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	467
KOG0668|consensus	338		100.0
KOG0615|consensus	475		100.0
KOG0603|consensus	612		100.0
KOG0598|consensus	357		100.0
KOG0592|consensus	604		100.0
KOG0581|consensus	364		100.0
KOG0575|consensus	592		100.0
KOG0605|consensus	550		100.0
KOG0663|consensus	419		100.0
KOG0661|consensus	538		100.0
KOG0593|consensus	396		100.0
KOG0659|consensus	318		100.0
KOG0660|consensus	359		100.0
KOG0616|consensus	355		100.0
KOG0600|consensus	560		100.0
KOG0033|consensus	355		100.0
KOG0658|consensus	364		100.0
KOG0694|consensus	694		100.0
KOG0595|consensus	429		100.0
KOG0583|consensus	370		100.0
KOG0588|consensus	786		100.0
KOG0599|consensus	411		100.0
KOG0032|consensus	382		100.0
KOG0585|consensus	576		100.0
KOG0594|consensus	323		100.0
KOG0610|consensus	459		100.0
KOG0578|consensus	550		100.0
KOG0198|consensus	313		100.0
KOG0667|consensus	586		100.0
KOG0604|consensus	400		100.0
KOG0591|consensus	375		100.0
KOG0597|consensus	808		100.0
KOG0580|consensus	281		100.0
KOG0611|consensus	668		100.0
KOG0690|consensus	516		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0662|consensus	292		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0582|consensus	516		100.0
KOG4717|consensus	864		100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0986|consensus	591		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0612|consensus	1317		100.0
KOG0666|consensus	438		100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG4236|consensus	888		100.0
KOG0607|consensus	463		100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0201|consensus	467		100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0608|consensus	1034		100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0579|consensus	1187		100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0574|consensus	502		100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0589|consensus	426		100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0586|consensus	596		100.0
KOG0671|consensus	415		100.0
KOG0577|consensus	948		100.0
KOG0696|consensus	683		100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0695|consensus	593		100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG1035|consensus	1351		100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0669|consensus	376		100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0590|consensus	601		100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0614|consensus	732		100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0192|consensus	362		100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG1989|consensus	738		100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG4279|consensus	1226		100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG1167|consensus	418		100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0665|consensus	369		100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0670|consensus	752		100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0983|consensus	391		100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0596|consensus	677		100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG1151|consensus	775		100.0
KOG0584|consensus	632		100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0587|consensus	953		100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0664|consensus	449		100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG4645|consensus	1509		100.0
KOG1290|consensus	590		100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0197|consensus	468		100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG4250|consensus	732		100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG2345|consensus	302		100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.98
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.98
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.98
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.98
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.98
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.98
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.98
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.98
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.98
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.98
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.98
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.98
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.98
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
KOG0668|consensus	338		99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
KOG4721|consensus	904		99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
KOG0193|consensus	678		99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
KOG1006|consensus	361		99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
KOG0194|consensus	474		99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
KOG0593|consensus	396		99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
KOG1187|consensus	361		99.97
KOG1027|consensus	903		99.97
KOG1026|consensus	774		99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.97
KOG4257|consensus	974		99.96
KOG0576|consensus	829		99.96
KOG0658|consensus	364		99.96
KOG1152|consensus	772		99.96
KOG1095|consensus	1025		99.95
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.95
KOG1094|consensus	807		99.95
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.95
KOG4278|consensus	1157		99.95
KOG0199|consensus	1039		99.95
KOG0594|consensus	323		99.95
KOG0659|consensus	318		99.94
KOG0984|consensus	282		99.94
KOG0661|consensus	538		99.94
KOG0598|consensus	357		99.94
KOG0600|consensus	560		99.94
KOG1345|consensus	378		99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0196|consensus	996		99.93
KOG0660|consensus	359		99.93
KOG0667|consensus	586		99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0200|consensus	609		99.93
KOG0663|consensus	419		99.93
KOG0581|consensus	364		99.93
KOG3653|consensus	534		99.92
KOG0616|consensus	355		99.92
KOG0595|consensus	429		99.92
KOG0588|consensus	786		99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
KOG0615|consensus	475		99.91
KOG0592|consensus	604		99.91
KOG2052|consensus	513		99.91
KOG0591|consensus	375		99.91
KOG0578|consensus	550		99.91
KOG0192|consensus	362		99.9
KOG0575|consensus	592		99.9
KOG0694|consensus	694		99.9
KOG0583|consensus	370		99.9
KOG1025|consensus	1177		99.9
KOG0033|consensus	355		99.9
KOG0984|consensus	282		99.9
KOG0664|consensus	449		99.89
KOG0599|consensus	411		99.89
KOG0603|consensus	612		99.89
KOG0983|consensus	391		99.89
KOG0198|consensus	313		99.89
PTZ00036	440	glycogen synthase kinase; Provisional	99.88
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.88
KOG0662|consensus	292		99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
KOG0585|consensus	576		99.87
KOG0606|consensus	1205		99.87
KOG1163|consensus	341		99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
KOG0665|consensus	369		99.87
KOG0614|consensus	732		99.87
KOG0986|consensus	591		99.86
KOG0604|consensus	400		99.86
KOG0197|consensus	468		99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG0597|consensus	808		99.86
KOG0611|consensus	668		99.86
KOG0576|consensus	829		99.86
KOG0605|consensus	550		99.86
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.86
KOG4721|consensus	904		99.85
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.85
KOG0666|consensus	438		99.85
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.85
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.84
KOG1164|consensus	322		99.84
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.84
KOG0193|consensus	678		99.84
PRK10345	210	hypothetical protein; Provisional	99.84
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.84
PHA02882	294	putative serine/threonine kinase; Provisional	99.84
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.84
KOG0582|consensus	516		99.84
KOG1006|consensus	361		99.84
KOG0669|consensus	376		99.84
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.84
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.84
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.84
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.84
PHA03212	391	serine/threonine kinase US3; Provisional	99.84
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.84
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.84
PTZ00284	467	protein kinase; Provisional	99.84
KOG0696|consensus	683		99.83
KOG0671|consensus	415		99.83
KOG4717|consensus	864		99.83
KOG0589|consensus	426		99.83
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.83
KOG0580|consensus	281		99.83
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.83
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.83
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.83
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.83
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.83
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.83
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG0032|consensus	382		99.83
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.83
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.82
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.82
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.82
KOG1187|consensus	361		99.82
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.82
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.82
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.82
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.82

>KOG0668|consensus

Probab=100.00  E-value=1.7e-62  Score=426.28  Aligned_cols=308  Identities=73%  Similarity=1.188  Sum_probs=285.7

Q ss_pred             cccccccccccCCCCCcccccCccccccCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHH
Q psy3714         140 LGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKIL  219 (467)
Q Consensus       140 ~~~~~v~~~~~~~~p~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il  219 (467)
                      .+.+|++..++...|+++|+|.+..++|+.+++|++++++|+|.|+.||.|.+..++++++||++++++++.+.||+.||
T Consensus         7 ~s~ARvya~vn~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL   86 (338)
T KOG0668|consen    7 PSVARVYADVNEERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKIL   86 (338)
T ss_pred             chhhhhhhhccccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHH
Confidence            45689999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCeeEEEEEEeCCCCCccEEEEeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEe
Q psy3714         220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID  299 (467)
Q Consensus       220 ~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~  299 (467)
                      ++|.++|||++|.++..++....+.+++||+++.|+.+++..++..+++++++|++.||.||||+||+|||+||.|+|+|
T Consensus        87 ~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId  166 (338)
T KOG0668|consen   87 QNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID  166 (338)
T ss_pred             HhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCcEEEEecccceecCCCCCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCc-------
Q psy3714         300 HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQ-------  371 (467)
Q Consensus       300 ~~~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~-------  371 (467)
                      .....++|+|+|+|.++.++.+++.++.+++|..||++.+.+ |+.+.|.|+.+++.....+..+|||.+.++       
T Consensus       167 h~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkI  246 (338)
T KOG0668|consen  167 HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKI  246 (338)
T ss_pred             hhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHH
Confidence            988899999999999999999999999999999999999987 899999998888777777888999998764       


Q ss_pred             --ccCChhhhhhhhh----------hccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         372 --HLVSPEALDFLDK----------NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       372 --~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                        .+++.+...+..+          ++++++++++|..|...++...+|++|.|||.++|.+|..+|+||.|++.||||.
T Consensus       247 akVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~  326 (338)
T KOG0668|consen  247 AKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA  326 (338)
T ss_pred             HHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence              3445555444433          5678899999999999999999999999999999999999999999999999999


Q ss_pred             Cccccccc
Q psy3714         440 PIVKDQSR  447 (467)
Q Consensus       440 ~~~~~~~~  447 (467)
                      ++..++++
T Consensus       327 ~~~~~~~~  334 (338)
T KOG0668|consen  327 PVREAESS  334 (338)
T ss_pred             HHHHHhhc
Confidence            87755443

>KOG0615|consensus

Probab=100.00  E-value=1.3e-54  Score=406.54  Aligned_cols=257  Identities=25%  Similarity=0.388  Sum_probs=213.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----------KKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      ..+.|.+.+.||+|+||.|-+|..+.|++.||||++++.+          ...+.+|++||++|+ |||||+++++|..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFEVP  248 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeeecC
Confidence            4578999999999999999999999999999999997532          234679999999996 89999999999875


Q ss_pred             CCCccEEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC--CCcEEEEecccc
Q psy3714         239 VSRTPALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLA  313 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~--~~~ikl~DFGla  313 (467)
                        .+.||||||+.||+|.+..   +.+.+...+.+++|++.|+.|||++||+||||||+|||+..+  ...+||+|||+|
T Consensus       249 --ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  249 --DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             --CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence              4579999999999998765   357888899999999999999999999999999999999743  357999999999


Q ss_pred             eecCCCCCcceeeeccCccCCcccccCCC---CccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCC
Q psy3714         314 EFYHPGQEYNVRVASRYFKGPELLADYQY---HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRH  390 (467)
Q Consensus       314 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (467)
                      +....++...+.||||.|.|||++...++   ..++|+|+.+++.+.++.|..||......    +.+.+.+-   .+++
T Consensus       327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~----~sl~eQI~---~G~y  399 (475)
T KOG0615|consen  327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD----PSLKEQIL---KGRY  399 (475)
T ss_pred             hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC----ccHHHHHh---cCcc
Confidence            99887888888999999999999998763   34789999999988888888887543321    11222111   1222


Q ss_pred             CcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         391 SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       391 ~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ..       .+..|..+|++++|||++||..||++|+|++|+|+||||++..
T Consensus       400 ~f-------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  400 AF-------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             cc-------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            21       1223456899999999999999999999999999999999765

>KOG0603|consensus

Probab=100.00  E-value=2.4e-54  Score=426.45  Aligned_cols=398  Identities=25%  Similarity=0.337  Sum_probs=294.0

Q ss_pred             HHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeeeEEc
Q psy3714           5 TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDMWS   84 (467)
Q Consensus         5 ~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~ws   84 (467)
                      ..+|.|++++|+.||+|||+|++||+++. .+++++.|||+++.....+.   .||+..|||||++.   .+..++|+||
T Consensus       104 aelaLald~lh~l~iiyrd~k~enilld~-~Ghi~~tdfglske~v~~~~---~cgt~eymApEI~~---gh~~a~D~ws  176 (612)
T KOG0603|consen  104 AELALALDHLHKLGIAYRDYKLENVLLLL-EGHIKLTDFGLSKEAVKEKI---ACGTYEYRAPEIIN---GHLSAADWWS  176 (612)
T ss_pred             HHHHHHHhhcchhHHHHhcccccceeecc-cCccccCCchhhhHhHhhhh---cccchhhhhhHhhh---ccCCcccchh
Confidence            46789999999999999999999999995 45999999999987654332   28899999999986   3567899999


Q ss_pred             hhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---------------------------HhCC--ch--------hHhhhhh
Q psy3714          85 LGCMLASMIFRKEPFFHGHDNYDQLVRIAK---------------------------VLGT--EE--------LFEYLDK  127 (467)
Q Consensus        85 ~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~---------------------------~~~~--~~--------~~~~~~~  127 (467)
                      ||++.++|++|..||..     +....|.+                           .+|.  ..        ++.-+++
T Consensus       177 ~gvl~felltg~~pf~~-----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~  251 (612)
T KOG0603|consen  177 FGVLAFELLTGTLPFGG-----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDW  251 (612)
T ss_pred             hhhhHHHHhhCCCCCch-----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeH
Confidence            99999999999999864     22233322                           1111  00        1111111


Q ss_pred             ---hccCCCchhhhhcccccccc----cccCCCCCc---------------ccccCcccc-c----cCCccceeeeEeec
Q psy3714         128 ---YHIELDPRFADILGRARVYA----DVNSHKPRE---------------YWDYESYVV-D----WGQQDDYQLVRKLG  180 (467)
Q Consensus       128 ---~~~~~~p~~~~~~~~~~v~~----~~~~~~p~~---------------~~~~~~~~~-~----~~~~~~y~~~~~lG  180 (467)
                         +.-..+|.|++.....+...    ...+..|..               .+.+....+ .    ....+.|++...+|
T Consensus       252 ~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P~dsp~~~~~~s~~~if~g~sfva~~il~~~~~~~~~~~y~~~~~~~  331 (612)
T KOG0603|consen  252 NELEARSRPPPFKPGSITERDVAQFDPEFTSQVPADSPLLSASGSDHTIFSGPSFVAPGVLEDAVTAPFTESYEFREELG  331 (612)
T ss_pred             hhHhhcCCCCCCCCcccchhhhhhcCchhccCCcccCCCCCCCccccchhcCCCccChHHhhccccCCcchhhccccccC
Confidence               11122344444433322111    111122211               111111111 1    12367899999999


Q ss_pred             ccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCCccHHHHhh
Q psy3714         181 RGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ  260 (467)
Q Consensus       181 ~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~  260 (467)
                      .|+||.|-.+.+..+++..++|++.+. .....+|+.++....+|+||+.+++.+.+.  ...|+|||.+.++.+...+.
T Consensus       332 ~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~--~~~~~v~e~l~g~ell~ri~  408 (612)
T KOG0603|consen  332 EGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDG--KEIYLVMELLDGGELLRRIR  408 (612)
T ss_pred             CCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCC--ceeeeeehhccccHHHHHHH
Confidence            999999999999999999999998765 445678888888888999999999999874  56899999999988765443


Q ss_pred             c--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcceeeeccCccCCcccc
Q psy3714         261 T--LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA  338 (467)
Q Consensus       261 ~--~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~  338 (467)
                      .  ....++..++.||+.|+.|||++|||||||||+|||++.+.++++|+|||.++.....  ..+.+-|..|.|||++.
T Consensus       409 ~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~  486 (612)
T KOG0603|consen  409 SKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLA  486 (612)
T ss_pred             hcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhc
Confidence            2  2235777899999999999999999999999999999534447999999999876544  33456789999999999


Q ss_pred             cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhh
Q psy3714         339 DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKL  418 (467)
Q Consensus       339 ~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~l  418 (467)
                      ..+|+.++|+|..+++.+.++.|..++...+.+            .++..+....++        ...+|++|+|||++|
T Consensus       487 ~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------~ei~~~i~~~~~--------s~~vS~~AKdLl~~L  546 (612)
T KOG0603|consen  487 IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------IEIHTRIQMPKF--------SECVSDEAKDLLQQL  546 (612)
T ss_pred             cCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------HHHHHhhcCCcc--------ccccCHHHHHHHHHh
Confidence            999999999999999988888888777655433            111111111111        146999999999999


Q ss_pred             cCcCCCCCCCHHHHhCCCCCC
Q psy3714         419 LRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       419 L~~dp~~R~ta~e~l~Hp~f~  439 (467)
                      |+.||++|+|+.|++.||||.
T Consensus       547 L~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  547 LQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             ccCChhhCcChhhhccCcchh
Confidence            999999999999999999993

>KOG0598|consensus

Probab=100.00  E-value=1e-52  Score=391.09  Aligned_cols=264  Identities=26%  Similarity=0.403  Sum_probs=221.6

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ...++|++++.||+|+||+||.++.+.|++.+|+|.+++.      ..+++..|..||..++ ||.||.+...|+++  .
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~--~   98 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTE--E   98 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccC--C
Confidence            3468999999999999999999999999999999998753      2456789999999985 89999999999875  5


Q ss_pred             ccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec-C
Q psy3714         242 TPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-H  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~-~  317 (467)
                      .+|+|++|++||+|..+++   .++|+.+++|+.+|+.||+|||++|||||||||||||||..| +++|+|||||+.. .
T Consensus        99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G-Hi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG-HIKLTDFGLCKEDLK  177 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC-cEEEeccccchhccc
Confidence            7999999999999987776   699999999999999999999999999999999999999665 8999999999954 3


Q ss_pred             CCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       318 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      .+....+.|||+.|||||++.+.+|+.++|+|..+++.+.++.|+.||...        ......+....++        
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~--------~~~~~~~~I~~~k--------  241 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE--------DVKKMYDKILKGK--------  241 (357)
T ss_pred             CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc--------cHHHHHHHHhcCc--------
Confidence            444455679999999999999999999999999999988888999887543        2222222221111        


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCC----CHHHHhCCCCCCCcccccccCCCCCC
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERL----TAREAMDHPYFYPIVKDQSRHTLPSS  453 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~----ta~e~l~Hp~f~~~~~~~~~~~~~~~  453 (467)
                        ....+..+|.+++|||++||++||++|+    +++++.+||||.+++|+.......++
T Consensus       242 --~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~P  299 (357)
T KOG0598|consen  242 --LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSP  299 (357)
T ss_pred             --CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCC
Confidence              0112334899999999999999999997    68999999999999998766555443

>KOG0592|consensus

Probab=100.00  E-value=2.5e-50  Score=389.56  Aligned_cols=263  Identities=26%  Similarity=0.404  Sum_probs=221.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ...||...+.||+|+|++|++|+++.+++.||||++.+.      +.+.+.+|-.+|..|.+||.|++|+..|+|.  ..
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~--~s  148 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE--ES  148 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--cc
Confidence            347899999999999999999999999999999988642      3356788999999999999999999999874  57


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      +|+|+||+++|+|..+++   .|++..+++|+.||+.||+|||++|||||||||||||||.+ +++||+|||.|+.+.+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d-mhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD-GHIKITDFGSAKILSPS  227 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC-CcEEEeeccccccCChh
Confidence            999999999999887764   58999999999999999999999999999999999999955 58999999999987432


Q ss_pred             CC--------------cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhh
Q psy3714         320 QE--------------YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN  385 (467)
Q Consensus       320 ~~--------------~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (467)
                      ..              ....|||-.|.+||+|.+...+.+.|+|..+++.+.++.|..||-.+....+    ...++.  
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli----FqkI~~--  301 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI----FQKIQA--  301 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH----HHHHHH--
Confidence            11              1447999999999999999999999999998888888888777654432111    111111  


Q ss_pred             ccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccccccCCCCCC
Q psy3714         386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSS  453 (467)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~~~~~~~~~  453 (467)
                                   ...+.++..+++++|||+|+|..||.+|+|+.|+.+||||.+++|+..++..|+.
T Consensus       302 -------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~  356 (604)
T KOG0592|consen  302 -------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPK  356 (604)
T ss_pred             -------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCc
Confidence                         1223345688999999999999999999999999999999999999887777653

>KOG0581|consensus

Probab=100.00  E-value=3.2e-50  Score=374.43  Aligned_cols=257  Identities=18%  Similarity=0.292  Sum_probs=208.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEec----cchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK----PVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~----~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .++.+.++.||+|..|+||+|+++.|++.+|+|.+.    ...++++.+|+++++.. .+|+||.+++.|..+.. ..++
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~-~isI  155 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGE-EISI  155 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCc-eEEe
Confidence            357888999999999999999999999999999983    34567899999999999 58999999999987654 6899


Q ss_pred             EEeccCCccHHHHhhc---CCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         246 IFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~~---~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      +||||++|+|...+..   ++|..+..++.+|++||.|||+ ++||||||||+|||++..| .|||||||.|+..... .
T Consensus       156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lvnS-~  233 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILVNS-I  233 (364)
T ss_pred             ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhhhh-h
Confidence            9999999999988764   9999999999999999999995 9999999999999999654 8999999999977544 5


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ..+.+||..|||||.+.+..|+...|+|..++.......|..|+.....   .....+..++....+..+          
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~---~~~~~~~Ll~~Iv~~ppP----------  300 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP---PYLDIFELLCAIVDEPPP----------  300 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC---CCCCHHHHHHHHhcCCCC----------
Confidence            5678999999999999999999999999888765555555555433211   011222222222211111          


Q ss_pred             cCCC-CCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         402 ENQH-LVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       402 ~~~~-~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      .-+. ..|+|+++||.+||++||.+|+|++|+++|||+.....
T Consensus       301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            1112 36999999999999999999999999999999986543

>KOG0575|consensus

Probab=100.00  E-value=4e-49  Score=387.25  Aligned_cols=254  Identities=26%  Similarity=0.410  Sum_probs=213.7

Q ss_pred             ccccccCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEecc------chHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q psy3714         162 SYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP------VKKKKIKREIKILENLRGGTNIITLQAVV  235 (467)
Q Consensus       162 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~------~~~~~~~~Ei~il~~l~~~~~iv~l~~~~  235 (467)
                      ..+.+-.. ..|+..+.||+|+|+.||.+++..+|+.||+|++.+      ..++++.+||+|++.|+ |||||+++.+|
T Consensus        10 ~~i~D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~F   87 (592)
T KOG0575|consen   10 EVIEDPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFF   87 (592)
T ss_pred             CeeecCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEe
Confidence            33444444 789999999999999999999999999999999865      24578899999999996 89999999999


Q ss_pred             eCCCCCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccc
Q psy3714         236 KDPVSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL  312 (467)
Q Consensus       236 ~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGl  312 (467)
                      ++.  .++|+|+|.|..+++..+.+   .++|.+++++++||+.||.|||+++|||||||..|++|+ ++.+|||+||||
T Consensus        88 EDs--~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~-~~~~VKIgDFGL  164 (592)
T KOG0575|consen   88 EDS--NNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN-ENMNVKIGDFGL  164 (592)
T ss_pred             ecC--CceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec-CcCcEEecccce
Confidence            974  67999999999999988875   599999999999999999999999999999999999999 556899999999


Q ss_pred             ceecCCC-CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         313 AEFYHPG-QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       313 a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      |...... +...+.||||.|.|||++...++++.+|+|+.+++-+..+.|..||-..        ...+.......    
T Consensus       165 At~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk--------~vkety~~Ik~----  232 (592)
T KOG0575|consen  165 ATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK--------TVKETYNKIKL----  232 (592)
T ss_pred             eeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------hHHHHHHHHHh----
Confidence            9987644 5567789999999999999999999999999999877777766665211        11111111111    


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                             .++..|..+|.+|+|||.+||+.||.+|||++++|.|+||.
T Consensus       233 -------~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  233 -------NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             -------cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence                   12223446899999999999999999999999999999994

>KOG0605|consensus

Probab=100.00  E-value=2.6e-49  Score=382.79  Aligned_cols=267  Identities=26%  Similarity=0.386  Sum_probs=222.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||+|+||.||+|+.+.||..+|+|++++..      ..+++.|-.+|... ..+.||+|+..|++.  .+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~--~~  215 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDK--EY  215 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCC--Ce
Confidence            5689999999999999999999999999999999998642      35678899999885 589999999999875  67


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-  318 (467)
                      +||||||++|||+..++.   .|++..+++|+.+++.|++.+|+.|+|||||||+|+|||..| ++||+|||||..+.. 
T Consensus       216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-HiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG-HIKLSDFGLSTGLDKK  294 (550)
T ss_pred             eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC-CEeeccccccchhhhh
Confidence            999999999999998874   599999999999999999999999999999999999999665 899999999864311 


Q ss_pred             ---------------------CCC--------------------------cceeeeccCccCCcccccCCCCccchhHHH
Q psy3714         319 ---------------------GQE--------------------------YNVRVASRYFKGPELLADYQYHIELDPRFA  351 (467)
Q Consensus       319 ---------------------~~~--------------------------~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~  351 (467)
                                           .+.                          ....+|||-|||||++.+.+|+..+|+|+.
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                 000                          012489999999999999999999999999


Q ss_pred             hhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCC---
Q psy3714         352 DILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT---  428 (467)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~t---  428 (467)
                      +.+-+.++.|+.||.....        ..... .+      ..|......+....+|++|+|||.+||+ ||++|+.   
T Consensus       375 G~ImyEmLvGyPPF~s~tp--------~~T~r-kI------~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G  438 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETP--------QETYR-KI------VNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKG  438 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCH--------HHHHH-HH------HHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence            9888888888888754322        11111 11      2344444445556689999999999999 9999994   


Q ss_pred             HHHHhCCCCCCCcccccccCCCCCCCC
Q psy3714         429 AREAMDHPYFYPIVKDQSRHTLPSSSP  455 (467)
Q Consensus       429 a~e~l~Hp~f~~~~~~~~~~~~~~~~~  455 (467)
                      ++|+.+||||.+++|+..+..-++..|
T Consensus       439 ~~EIK~HPfF~~v~W~~l~~~~apfvP  465 (550)
T KOG0605|consen  439 AEEIKKHPFFKGVDWDHLREMPAPFVP  465 (550)
T ss_pred             HHHHhcCCccccCCcchhhcCCCCCCC
Confidence            899999999999999988877766655

>KOG0663|consensus

Probab=100.00  E-value=2.5e-49  Score=361.75  Aligned_cols=265  Identities=28%  Similarity=0.466  Sum_probs=206.9

Q ss_pred             ccCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHH-----HHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         166 DWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKK-----KIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       166 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .+...++|+.+..|++|+||.||+|++++|++.||+|.++..+.+     .-.|||.+|.+++ |||||.+.++......
T Consensus        71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR-HPNIVEVKEVVVGSNM  149 (419)
T ss_pred             CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC-CCCeeeeEEEEecccc
Confidence            455678999999999999999999999999999999999875432     3579999999996 9999999999988778


Q ss_pred             CccEEEEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         241 RTPALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      +.+|+|||||+. ||..+.    +.+...++++++.|++.|++|||.+.|+||||||+|+|++..| .+||+|||+|+.+
T Consensus       150 d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  150 DKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-ILKIADFGLAREY  227 (419)
T ss_pred             ceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC-cEEecccchhhhh
Confidence            889999999976 555554    4688999999999999999999999999999999999999776 6999999999988


Q ss_pred             C-CCCCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhh--hccCCCCc
Q psy3714         317 H-PGQEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK--NILGRHSR  392 (467)
Q Consensus       317 ~-~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  392 (467)
                      . +-..++..+.|.||+|||++.+.. |++++|.|+.+.+-...+ ...|++.+..+       .+.++.  ..++....
T Consensus       228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l-~~kPlf~G~sE-------~dQl~~If~llGtPte  299 (419)
T KOG0663|consen  228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELL-TQKPLFPGKSE-------IDQLDKIFKLLGTPSE  299 (419)
T ss_pred             cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHH-hcCCCCCCCch-------HHHHHHHHHHhCCCcc
Confidence            5 345578889999999999999876 999999997765532222 22344444322       111111  01111111


Q ss_pred             ccccccccc-----------------cCCC--CCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         393 KRWERFVHT-----------------ENQH--LVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       393 ~~~~~~~~~-----------------~~~~--~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      ..|..+...                 ..+.  .+|+.+.||+++||.+||++|+||+|+|+|+||.+.
T Consensus       300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence            222211110                 0111  267999999999999999999999999999999873

>KOG0661|consensus

Probab=100.00  E-value=2.4e-50  Score=383.99  Aligned_cols=265  Identities=26%  Similarity=0.452  Sum_probs=207.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .++|.++++||.|+||.||+|....+++.||||.+++..    ...-.||+..|++|+.|||||++.+++.++.. .+|+
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEee
Confidence            478999999999999999999999999999999987642    23357999999999889999999999988653 8999


Q ss_pred             EEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         246 IFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      ||||++. +|.++.+    .|++.+++.|++||++||+|+|.+|+.|||+||||||+.. +..|||+|||+|+.......
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~-~~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG-NDVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc-cceeEecccccccccccCCC
Confidence            9999864 5666654    4899999999999999999999999999999999999984 34799999999999988888


Q ss_pred             cceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc---
Q psy3714         322 YNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER---  397 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  397 (467)
                      ++.+|.|+||||||+|.... |+..+|+|.++.+-... ....|+|.|.++.   .+...+  ..++|......|.+   
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl-~sLrPLFPG~sE~---Dqi~KI--c~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAEL-YSLRPLFPGASEI---DQIYKI--CEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHH-HHhcccCCCCcHH---HHHHHH--HHHhCCCccccchhHHH
Confidence            99999999999999987765 89999999777653321 2234555543320   000000  12233322222222   


Q ss_pred             -----------ccccc---CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         398 -----------FVHTE---NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       398 -----------~~~~~---~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                                 +....   --+..|+++.+||.+||.|||.+||||+|+|+||||.....
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence                       00000   01226899999999999999999999999999999986543

>KOG0593|consensus

Probab=100.00  E-value=2.8e-50  Score=363.43  Aligned_cols=265  Identities=28%  Similarity=0.480  Sum_probs=204.2

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      +.|+.+.++|+|+||+||+|+++.||+.||||.+....     ++-..|||.+|+.|+ |+|+|.|.++|..  ....++
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrr--krklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK-HENLVNLIEVFRR--KRKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHh--cceeEE
Confidence            57899999999999999999999999999999886432     455789999999996 8999999999975  467899


Q ss_pred             EEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-CCCC
Q psy3714         246 IFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~~~~  321 (467)
                      |+|||+..-|.++.   +.+++..++.+++|++.|+.|||+++||||||||||||++..+ .+||||||+|+... +++.
T Consensus        79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-VVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-cEEeccchhhHhhcCCcch
Confidence            99999987766554   3588999999999999999999999999999999999999655 89999999999876 8888


Q ss_pred             cceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCC---ccc--------CChhhhhhhhhhccCC
Q psy3714         322 YNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTEN---QHL--------VSPEALDFLDKNILGR  389 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~~~~~~~  389 (467)
                      |+.++.|+||+|||++.+ .+|...+|+|..+.+-..... ..|++.+..   |..        ..+........+..  
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~-G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~--  234 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLT-GEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF--  234 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhc-CCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc--
Confidence            999999999999999998 579999999977765433333 334433321   100        01111111111000  


Q ss_pred             CCcccccccc----cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         390 HSRKRWERFV----HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       390 ~~~~~~~~~~----~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ..........    .....+.+|.-+.||+++||.+||.+|++-+|+|.||||++..
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            0000000000    0112345789999999999999999999999999999997543

>KOG0659|consensus

Probab=100.00  E-value=7.3e-49  Score=348.61  Aligned_cols=264  Identities=30%  Similarity=0.516  Sum_probs=198.5

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++|...+.+|+|+||.||+|++.+||+.||||.++..+     .....|||..|+.++ |+||+.+.++|.+  ...+.+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~-h~nIi~LiD~F~~--~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK-HPNIIELIDVFPH--KSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc-CcchhhhhhhccC--CCceEE
Confidence            56888999999999999999999999999999987543     245789999999996 8999999999865  456899


Q ss_pred             EEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-
Q psy3714         246 IFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-  320 (467)
                      |+||++. ||...++    .++..+++.|+.+++.||+|||++.|+||||||.|+|++.+| .+||+|||+|+.+.+.. 
T Consensus        79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG-QLKIADFGLARFFGSPNR  156 (318)
T ss_pred             EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-cEEeecccchhccCCCCc
Confidence            9999974 6666654    488999999999999999999999999999999999999665 89999999999886433 


Q ss_pred             CcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCc---------ccCChhhhhhhhhhccCCC
Q psy3714         321 EYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQ---------HLVSPEALDFLDKNILGRH  390 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~  390 (467)
                      ..+..+.|+||+|||++.+.. |...+|+|.++++-.... -..|++.+...         .+++|....+.+-..+..+
T Consensus       157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELl-lr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELL-LRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHH-ccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            344458999999999998875 999999997766533221 12345444321         1222221111111101000


Q ss_pred             Cccc-ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         391 SRKR-WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       391 ~~~~-~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      ...+ ........-.+..|+++.||+.+||.+||.+|+||.|+|+||||..
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence            0000 0000000123446899999999999999999999999999999984

>KOG0660|consensus

Probab=100.00  E-value=3e-48  Score=359.83  Aligned_cols=267  Identities=30%  Similarity=0.528  Sum_probs=207.5

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEecc-----chHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC---C
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP-----VKKKKIKREIKILENLRGGTNIITLQAVVKDP---V  239 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~-----~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~---~  239 (467)
                      .-...|..++.||+|+||.|+.|.++.+|+.||||.+..     ...++..||+.+|+.++ |+||+.+.+++..+   .
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccccccc
Confidence            345667778999999999999999999999999998763     23578899999999997 89999999988652   2


Q ss_pred             CCccEEEEeccCCccHHHHhh--c-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ--T-LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~--~-~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      .+.+|+|+|++ +.||.+.++  . ++++.++++++|++.||+|+|+.||+||||||+|+|++ .++.+||||||+|+..
T Consensus        98 f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n-~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN-ADCDLKICDFGLARYL  175 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeec-cCCCEEeccccceeec
Confidence            35679999988 568887764  3 89999999999999999999999999999999999999 4568999999999987


Q ss_pred             CC---CCCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCc---------ccCChh--hhhh
Q psy3714         317 HP---GQEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQ---------HLVSPE--ALDF  381 (467)
Q Consensus       317 ~~---~~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~--~~~~  381 (467)
                      .+   ....+.++.|+||+|||++... .|+.++|+|++|.+-...+. ..|+|.+.+.         .++++.  ....
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~-gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLT-GKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHc-CCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            53   4456889999999999998665 49999999977665443332 3445555442         222222  2222


Q ss_pred             hhhh-------ccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         382 LDKN-------ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       382 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      +...       .+...++..|...     .+..+++|.|||.|||++||.+|+||+|+|+|||++....
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~-----fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd  318 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSI-----FPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD  318 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHH-----cCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence            2110       1122233333322     3468999999999999999999999999999999987654

>KOG0616|consensus

Probab=100.00  E-value=4.7e-48  Score=348.34  Aligned_cols=257  Identities=21%  Similarity=0.374  Sum_probs=217.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||.|+||.|.+++.+.++..+|+|++++.+      .++..+|..+|+.+. ||.++++...+.+.  ..
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~--~~  118 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDN--SN  118 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccC--Ce
Confidence            3589999999999999999999999999999999987642      345778999999997 89999999998874  67


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      .||||||++||.+..+++   ++++..+++|+.||+.||+|||+++||+|||||||||||..| ++||+|||+|+.... 
T Consensus       119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G-~iKitDFGFAK~v~~-  196 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG-HIKITDFGFAKRVSG-  196 (355)
T ss_pred             EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC-cEEEEeccceEEecC-
Confidence            999999999999887764   699999999999999999999999999999999999999655 899999999998643 


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                       ...+.||||.|+|||++...+|..++|+|..+++.+.++.|..||+....        ...-++...+..         
T Consensus       197 -rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~~~v---------  258 (355)
T KOG0616|consen  197 -RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILEGKV---------  258 (355)
T ss_pred             -cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHhCcc---------
Confidence             24567999999999999999999999999999998888888888764321        222222211111         


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccccCCC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSRHTL  450 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~~~~  450 (467)
                        ..|..+|++++|||++||+.|-.+|.     ..+++..||||.+++|+...+..
T Consensus       259 --~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~  312 (355)
T KOG0616|consen  259 --KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRK  312 (355)
T ss_pred             --cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhcc
Confidence              12456899999999999999999995     57899999999999997655443

>KOG0600|consensus

Probab=100.00  E-value=3.1e-48  Score=372.15  Aligned_cols=265  Identities=30%  Similarity=0.513  Sum_probs=204.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..+.|+.+++||+|+||.||+|++..||+.||+|.++...     .....|||.||++|. ||||++|.+++.+.....+
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD-HPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC-CCcccceeeEEEecCCceE
Confidence            3588999999999999999999999999999999987532     345789999999996 8999999999987766789


Q ss_pred             EEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      |||+||++. ||.-+..    +|++.++++||.||+.||+|||++||+|||||.+|||||..| .+||+|||||+++...
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G-~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG-VLKIADFGLARFYTPS  271 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC-CEEeccccceeeccCC
Confidence            999999986 4433332    599999999999999999999999999999999999999665 8999999999988654


Q ss_pred             C--CcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcc---------cCChhhhhhhhhhcc
Q psy3714         320 Q--EYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQH---------LVSPEALDFLDKNIL  387 (467)
Q Consensus       320 ~--~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~  387 (467)
                      .  .++..|.|.||+|||+|.+.. |+.+||.|..+.+..... ...|++.+.++.         .+++....+. ...+
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~-~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kL  349 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELF-LGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKL  349 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHH-cCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccC
Confidence            4  578899999999999999875 999999997776643322 234444444321         1111111111 0000


Q ss_pred             CC----CCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         388 GR----HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       388 ~~----~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                      ..    .+.....+.+. +....+++.+.+|+.+||..||.+|.||.++|+|+||.
T Consensus       350 P~~~~~kp~~~y~r~l~-E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLR-ETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             CcccccCCCCcccchHH-HHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence            00    00001111111 12345799999999999999999999999999999994

>KOG0033|consensus

Probab=100.00  E-value=1.5e-49  Score=348.73  Aligned_cols=255  Identities=24%  Similarity=0.414  Sum_probs=210.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..+.|++.+.||+|.|++|+++.+..||+.+|+|++...     ..+.+.+|+.|-+.|+ ||||++|++.+..  ....
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~--~~~~   85 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQE--ESFH   85 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC-CCcEeehhhhhcc--ccee
Confidence            357899999999999999999999999999999987532     3577899999999997 8999999998875  3567


Q ss_pred             EEEEeccCCccHHH-Hhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC--CCcEEEEecccceecCC
Q psy3714         244 ALIFEHVNNTDFKQ-LYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       244 ~lv~e~~~~~~l~~-~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~--~~~ikl~DFGla~~~~~  318 (467)
                      |+|+|.+.|+++.. ..+  -++|..+..+++||+.||.|||.+||||||+||+|+|+...  +..+||+|||+|.....
T Consensus        86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            99999999999753 333  37889999999999999999999999999999999999753  34699999999999887


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      +......+|||.|||||++...+|+..+|+|..+++.+..+.|..||......     .....   ...+.+       -
T Consensus       166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-----rlye~---I~~g~y-------d  230 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYEQ---IKAGAY-------D  230 (355)
T ss_pred             ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-----HHHHH---Hhcccc-------C
Confidence            77778899999999999999999999999999998876666666666542211     11111   111111       1


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      .+.+.|+.+|++|+|||++||+.||++|+||.|+|+|||+.+.
T Consensus       231 ~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  231 YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            2334567799999999999999999999999999999999654

>KOG0658|consensus

Probab=100.00  E-value=3.3e-48  Score=360.22  Aligned_cols=267  Identities=27%  Similarity=0.486  Sum_probs=206.8

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC---ccEEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSR---TPALIF  247 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~---~~~lv~  247 (467)
                      -.|+-.+.+|.|+||.||+|....+++.+|||.+-..+ +.-.+|+++|+.+. |||||+|..+|....+.   +..+||
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-r~knrEl~im~~l~-HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-RYKNRELQIMRKLD-HPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-CcCcHHHHHHHhcC-CcCeeeEEEEEEecCCCchhHHHHHH
Confidence            45888899999999999999999999999999876543 24468999999885 89999999888654443   567899


Q ss_pred             eccCCccHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         248 EHVNNTDFKQLY-------QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       248 e~~~~~~l~~~~-------~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ||++.. |.+..       ++++.-+++.|++||++||.|||+.||+||||||+|||+|++.+.+||||||.|+...+++
T Consensus       102 eymP~t-L~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  102 EYMPET-LYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             HhchHH-HHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            999874 43332       3577888999999999999999999999999999999999998899999999999999999


Q ss_pred             CcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCc---------ccCChhh--hhhhhhhcc-
Q psy3714         321 EYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQ---------HLVSPEA--LDFLDKNIL-  387 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~--~~~~~~~~~-  387 (467)
                      ...++..|++|||||.|.+.. |+.++|+|+++.+-.....+ .|+|.+...         .++.+..  ...+..+.. 
T Consensus       181 pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g-~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~  259 (364)
T KOG0658|consen  181 PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKG-QPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE  259 (364)
T ss_pred             CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcC-CcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence            888999999999999998875 99999999877654333332 344444321         1222221  111111110 


Q ss_pred             ---CCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccccc
Q psy3714         388 ---GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ  445 (467)
Q Consensus       388 ---~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~  445 (467)
                         .......|.++    ....+++|+.||+.++|+++|++|.||.|+|.||||+.+..+.
T Consensus       260 ~~~p~ik~~~~~~~----~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~  316 (364)
T KOG0658|consen  260 FKFPQIKAHPWHKV----FFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN  316 (364)
T ss_pred             ccCcccccccceee----cccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence               11122233331    1234799999999999999999999999999999999887653

>KOG0694|consensus

Probab=100.00  E-value=7.5e-47  Score=375.29  Aligned_cols=258  Identities=24%  Similarity=0.369  Sum_probs=218.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|.++++||+|+||+|++|..+.+++.+|||++++.      .-.....|..|+.....||.+++++..|++  ..+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~~~  443 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--KEH  443 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--CCe
Confidence            468999999999999999999999999999999999864      235678899999988889999999999986  467


Q ss_pred             cEEEEeccCCccHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec-CCC
Q psy3714         243 PALIFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~-~~~  319 (467)
                      +++||||++|||+....  +.+++..+++|+.+|+.||+|||++|||+||||.+|||||.+| ++||+|||+|+.. ..+
T Consensus       444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG-h~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG-HVKIADFGLCKEGMGQG  522 (694)
T ss_pred             EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC-cEEecccccccccCCCC
Confidence            99999999999965443  4699999999999999999999999999999999999999776 8999999999954 356


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      ...++.||||.|||||++.+..|+.+||+|..+++.+.++.|.+||-+....     +.++    .|+.          .
T Consensus       523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----e~Fd----sI~~----------d  583 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----EVFD----SIVN----------D  583 (694)
T ss_pred             CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHH----HHhc----------C
Confidence            6677889999999999999999999999999999999888888887533211     1111    1111          1


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCcccccccC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKDQSRH  448 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~~~~~  448 (467)
                      +...|..+|.|+.+++++||++||++|+.     ++++.+||||..++|+...+
T Consensus       584 ~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~  637 (694)
T KOG0694|consen  584 EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLN  637 (694)
T ss_pred             CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhh
Confidence            12234468999999999999999999995     68999999999999964433

>KOG0595|consensus

Probab=100.00  E-value=8.2e-47  Score=354.55  Aligned_cols=253  Identities=25%  Similarity=0.407  Sum_probs=211.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ...+|.+.+.||+|+||+||+|+++.++..||||.+.+.     ..+.+..|+.||+.++ |||||.+.+++.++  +.+
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~--~~i   84 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLDCIEDD--DFI   84 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecC--CeE
Confidence            357899999999999999999999999999999988654     2345678999999997 89999999999875  479


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC--C---CcEEEEeccccee
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--N---RKLRLIDWGLAEF  315 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~--~---~~ikl~DFGla~~  315 (467)
                      |+|||||+||||..+++   .+++..++.++.||+.||++||+++||||||||+||||+..  +   ..+||+|||+|+.
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            99999999999988875   58999999999999999999999999999999999999864  2   3599999999999


Q ss_pred             cCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         316 YHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       316 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      ..++....+.|||+.|||||++....|+.++|.|..+.+.+.+..+..||.....     .+++.+.....         
T Consensus       165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~-----~eL~~~~~k~~---------  230 (429)
T KOG0595|consen  165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP-----KELLLYIKKGN---------  230 (429)
T ss_pred             CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH-----HHHHHHHhccc---------
Confidence            9888888889999999999999999999999999999888777777666543221     12222221110         


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                        ......+..+|+...+|+..+|..||+.|.+..+.+.||+...
T Consensus       231 --~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  231 --EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             --cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence              0011112346888889999999999999999999999999864

>KOG0583|consensus

Probab=100.00  E-value=6.7e-46  Score=365.00  Aligned_cols=251  Identities=29%  Similarity=0.444  Sum_probs=211.3

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--------KKKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      ....|++.+.||+|+||.|+.|.+..++..||+|+++..        ..+.+.||+.+++.+.+||||+++++++..+. 
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~-   93 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT-   93 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence            457899999999999999999999999999999987653        23467799999999988999999999998764 


Q ss_pred             CccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec-
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-  316 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~-  316 (467)
                       ..++||||+.+|+|.+.+.   .++|.+++.+++|++.|++|||++||+||||||||||++.....+||+|||+|... 
T Consensus        94 -~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   94 -KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             -eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence             4899999999999887763   68999999999999999999999999999999999999966258999999999987 


Q ss_pred             CCCCCcceeeeccCccCCcccccCC-CC-ccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         317 HPGQEYNVRVASRYFKGPELLADYQ-YH-IELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       317 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ..+....+.|||+.|+|||++.+.. |+ .++|+|+.+++.+...+|..||.....     +.....+.   .+.     
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----~~l~~ki~---~~~-----  239 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----PNLYRKIR---KGE-----  239 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----HHHHHHHh---cCC-----
Confidence            4666678899999999999999988 96 679999999998888888888754211     01111110   111     


Q ss_pred             ccccccccCCCCC-ChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         395 WERFVHTENQHLV-SPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       395 ~~~~~~~~~~~~~-s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                            ...+..+ |+++++||++||..||.+|+|+.++++||||..
T Consensus       240 ------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  240 ------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                  1223346 999999999999999999999999999999986

>KOG0588|consensus

Probab=100.00  E-value=1.3e-46  Score=370.82  Aligned_cols=260  Identities=24%  Similarity=0.379  Sum_probs=216.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..-|++.+.||+|+-|.|.+|++..||+.+|||++.+.      ....+.+||.||+.+. ||||+.+++++++.  .++
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~--~~l   87 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENK--QHL   87 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccC--ceE
Confidence            35689999999999999999999999999999998653      2357899999999886 89999999999864  578


Q ss_pred             EEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      |+|+||+++|.|.+++   +.+++.++..+++||+.|+.|||..+|+||||||+|+|||..+. |||+|||+|..-.++.
T Consensus        88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n-IKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN-IKIADFGMASLEVPGK  166 (786)
T ss_pred             EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC-EeeeccceeecccCCc
Confidence            9999999999987765   46999999999999999999999999999999999999997774 9999999999887888


Q ss_pred             CcceeeeccCccCCcccccCCCC-ccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYH-IELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~-~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      -..+.||+|+|.|||++.+.+|+ .+.|+|..+++.+-.+.|..||.                |.++....-+.+-..  
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd----------------DdNir~LLlKV~~G~--  228 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD----------------DDNIRVLLLKVQRGV--  228 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC----------------CccHHHHHHHHHcCc--
Confidence            88889999999999999999995 56899999998665555555543                222211111111111  


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccccccCCCCC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPS  452 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~~~~~~~~  452 (467)
                       ++.+..+|++|+|||++||+.||.+|+|.+|+++|||+.+.........++.
T Consensus       229 -f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~  280 (786)
T KOG0588|consen  229 -FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRP  280 (786)
T ss_pred             -ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCC
Confidence             2345679999999999999999999999999999999998776555433333

>KOG0599|consensus

Probab=100.00  E-value=3.6e-47  Score=338.57  Aligned_cols=262  Identities=26%  Similarity=0.445  Sum_probs=214.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----------KKKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      ...|+-.+.||.|..++|.+|.++.+++.+|+|++...           -.+...+|+.||+++.+||+|+.+.++|+.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            46678888999999999999999999999999998531           1234578999999999999999999999875


Q ss_pred             CCCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                        ..+++|+|.++-|.|.+++.   .+++.+++.+|+|++.|++|||.++||||||||+|||++ ++..+||+|||+|+.
T Consensus        96 --sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld-dn~~i~isDFGFa~~  172 (411)
T KOG0599|consen   96 --AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD-DNMNIKISDFGFACQ  172 (411)
T ss_pred             --chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec-cccceEEeccceeec
Confidence              45789999999999988775   489999999999999999999999999999999999999 566899999999999


Q ss_pred             cCCCCCcceeeeccCccCCcccc------cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCC
Q psy3714         316 YHPGQEYNVRVASRYFKGPELLA------DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGR  389 (467)
Q Consensus       316 ~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (467)
                      +.+++.....||||.|.|||.+.      ..+|+..+|.|..+++-+..+.|-.||.+.....     ++..+..   +.
T Consensus       173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml-----MLR~Ime---Gk  244 (411)
T KOG0599|consen  173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML-----MLRMIME---GK  244 (411)
T ss_pred             cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-----HHHHHHh---cc
Confidence            99999999999999999999984      2358889999999988666666555554432110     1111111   11


Q ss_pred             CCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccccccCC
Q psy3714         390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHT  449 (467)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~~~~~  449 (467)
                      +.       ...+.|..+|.+++|||++||+.||.+|+|++|+|+||||..+...+.++-
T Consensus       245 yq-------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~m  297 (411)
T KOG0599|consen  245 YQ-------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQM  297 (411)
T ss_pred             cc-------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccccc
Confidence            11       122345678999999999999999999999999999999988776666543

>KOG0032|consensus

Probab=100.00  E-value=2.2e-45  Score=361.06  Aligned_cols=256  Identities=28%  Similarity=0.506  Sum_probs=217.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..+.|++.+.||+|.||.||+|..+.||+.+|+|++++..      ...+.+|+.||+.+.+|||||.+++.|++.  ..
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~~  110 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--DS  110 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--Ce
Confidence            3467999999999999999999999999999999987543      247899999999999899999999999875  47


Q ss_pred             cEEEEeccCCccHHHHhh-c-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC---CcEEEEecccceecC
Q psy3714         243 PALIFEHVNNTDFKQLYQ-T-LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN---RKLRLIDWGLAEFYH  317 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~-~-~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~---~~ikl~DFGla~~~~  317 (467)
                      .++|||++.||+|.+.+. . +++.++..++.|++.|++|||+.||+||||||+|+|+....   ..+|++|||+|....
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~  190 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK  190 (382)
T ss_pred             EEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence            899999999999876554 3 99999999999999999999999999999999999997553   369999999999988


Q ss_pred             CCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       318 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      .+......+||++|+|||++...+|...+|+|.++++.+..++|..||........    ..    ....+.     +  
T Consensus       191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~----~~----~i~~~~-----~--  255 (382)
T KOG0032|consen  191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI----FL----AILRGD-----F--  255 (382)
T ss_pred             CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH----HH----HHHcCC-----C--
Confidence            76677888999999999999999999999999999999888888888765432111    01    111111     1  


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      -...+.|+.+|+.|+|||++||..||.+|+||.++|+|||+.+.
T Consensus       256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            12334566789999999999999999999999999999998865

>KOG0585|consensus

Probab=100.00  E-value=1.8e-45  Score=350.33  Aligned_cols=254  Identities=26%  Similarity=0.419  Sum_probs=203.5

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----------------HHHHHHHHHHHHHhcCCCCeeEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----------------KKKIKREIKILENLRGGTNIITL  231 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----------------~~~~~~Ei~il~~l~~~~~iv~l  231 (467)
                      ..+.|++.+.||+|+||.|.+|++..+++.||||++.+.+                 -+++.+||.||++|. |+|||+|
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~L  173 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVKL  173 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeEE
Confidence            4578999999999999999999999999999999986432                 136789999999995 7999999


Q ss_pred             EEEEeCCCCCccEEEEeccCCccHHHHh--hc-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEE
Q psy3714         232 QAVVKDPVSRTPALIFEHVNNTDFKQLY--QT-LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLI  308 (467)
Q Consensus       232 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~-~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~  308 (467)
                      .++..+|....+|||+|||..|.+...-  .. +++.+++.|++.++.||+|||.+|||||||||+|+||+.+ +.+||+
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~-g~VKIs  252 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD-GTVKIS  252 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC-CcEEee
Confidence            9999999999999999999998765432  23 8899999999999999999999999999999999999966 589999


Q ss_pred             ecccceecCCC------CCcceeeeccCccCCcccccC---CC-CccchhHHHhhhccccccccccccccCCcccCChhh
Q psy3714         309 DWGLAEFYHPG------QEYNVRVASRYFKGPELLADY---QY-HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEA  378 (467)
Q Consensus       309 DFGla~~~~~~------~~~~~~~gt~~y~aPE~l~~~---~~-~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (467)
                      |||.+.....+      ......+|||.|+|||.+.+.   .| ..++|+|..++-.+-.+++..||+...        .
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--------~  324 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--------E  324 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--------H
Confidence            99999876322      223447899999999999873   23 567999988886555556666665432        1


Q ss_pred             hhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      +...++.+-..         +..+..+.++++++|||.+||++||++|+|..++..|||...-
T Consensus       325 ~~l~~KIvn~p---------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  325 LELFDKIVNDP---------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHHHHHhcCc---------ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            22222211100         1112223579999999999999999999999999999998753

>KOG0594|consensus

Probab=100.00  E-value=5.8e-45  Score=339.12  Aligned_cols=270  Identities=27%  Similarity=0.478  Sum_probs=199.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCC-eeEEEEEEeCCC----
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTN-IITLQAVVKDPV----  239 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~-iv~l~~~~~~~~----  239 (467)
                      .+.|+.+++||+|+||+||+|+++.+|+.||+|.++-..     .....||+.+|+.|+ |+| |+.+++++....    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccc
Confidence            466888899999999999999999999999999987542     245689999999997 666 999999987643    


Q ss_pred             CCccEEEEeccCCccHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccc
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQT-------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL  312 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGl  312 (467)
                      ....++|+||++. ||..+...       ++...++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-~lKlaDFGl  166 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-VLKLADFGL  166 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-cEeeeccch
Confidence            1267899999864 56655433       45568999999999999999999999999999999999754 899999999


Q ss_pred             ceecC-CCCCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCc---------ccCChhhhhh
Q psy3714         313 AEFYH-PGQEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQ---------HLVSPEALDF  381 (467)
Q Consensus       313 a~~~~-~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~  381 (467)
                      |+.+. +...++..++|.+|+|||++.+. .|+..+|+|..+++-..... ..++|.+...         .++++....+
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~-~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT-RRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            99776 56668889999999999999988 59999999966655332222 2334433221         1111211111


Q ss_pred             hhhhccCCCC--cccccc-cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         382 LDKNILGRHS--RKRWER-FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       382 ~~~~~~~~~~--~~~~~~-~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      ........+.  ...|.. .......+..++++.||+.+||++||++|+||+.+|+||||.....
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            1111111110  011110 0001112335679999999999999999999999999999998753

>KOG0610|consensus

Probab=100.00  E-value=1.9e-44  Score=338.75  Aligned_cols=268  Identities=26%  Similarity=0.356  Sum_probs=217.3

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||.|.-|+||+|..+.++..+|+|++.+.      +..+++.|-+||+.+. ||.++.|+..++.  ..+
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet--~~~  151 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFET--DKY  151 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeec--cce
Confidence            347899999999999999999999999999999999753      2356778999999885 8999999999986  467


Q ss_pred             cEEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         243 PALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      .+++||||+||||..+.+     .+++..+++|+.+|+.||+|||-.|||.|||||||||+-.+ ++|-|+||.|+....
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvred-GHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRED-GHIMLSDFDLSLRCP  230 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecC-CcEEeeeccccccCC
Confidence            899999999999988765     48999999999999999999999999999999999999855 489999998764210


Q ss_pred             ----------------------------------CCC-----------------------CcceeeeccCccCCcccccC
Q psy3714         318 ----------------------------------PGQ-----------------------EYNVRVASRYFKGPELLADY  340 (467)
Q Consensus       318 ----------------------------------~~~-----------------------~~~~~~gt~~y~aPE~l~~~  340 (467)
                                                        ...                       .....|||-.|.|||+|.+.
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~  310 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE  310 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence                                              000                       01225899999999999999


Q ss_pred             CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcC
Q psy3714         341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR  420 (467)
Q Consensus       341 ~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~  420 (467)
                      +++.+||+|..+++.+.++.|.-||-+..+..    ...     +++++..     +|   +..+.+|.+|+|||++||.
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~----Tl~-----NIv~~~l-----~F---p~~~~vs~~akDLIr~LLv  373 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE----TLR-----NIVGQPL-----KF---PEEPEVSSAAKDLIRKLLV  373 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCCCCchh----hHH-----HHhcCCC-----cC---CCCCcchhHHHHHHHHHhc
Confidence            99999999999998887777777775543221    111     2222211     11   1223589999999999999


Q ss_pred             cCCCCCCC----HHHHhCCCCCCCcccccccCCCCCCCCCC
Q psy3714         421 YDHYERLT----AREAMDHPYFYPIVKDQSRHTLPSSSPTP  457 (467)
Q Consensus       421 ~dp~~R~t----a~e~l~Hp~f~~~~~~~~~~~~~~~~~~~  457 (467)
                      +||++|+.    |+|+.+||||.+++|+-.+...|+.-|.+
T Consensus       374 KdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~  414 (459)
T KOG0610|consen  374 KDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKP  414 (459)
T ss_pred             cChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCc
Confidence            99999997    99999999999999997777777655433

>KOG0578|consensus

Probab=100.00  E-value=5e-45  Score=355.66  Aligned_cols=251  Identities=23%  Similarity=0.403  Sum_probs=209.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEecc---chHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP---VKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~---~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ...|....+||+|+.|.||.|....+++.||||.+..   .+++-+.+|+.+|+.++ |+|||.+.+.|.-.  ..++.|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~--deLWVV  348 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLH-HPNIVNFLDSYLVG--DELWVV  348 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhcc-chHHHHHHHHhccc--ceeEEE
Confidence            4678889999999999999999999999999998854   24567899999999995 89999998876542  568999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-Ccc
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYN  323 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~~~  323 (467)
                      |||+++|+|.+...  .++|.++..+++++|.||+|||.+||||||||.+|||++.++ .+||+|||+|..+.... ..+
T Consensus       349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC-cEEEeeeeeeeccccccCccc
Confidence            99999999887765  488999999999999999999999999999999999999776 69999999998876554 456


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      +.+|||||||||++....|+.++|+|..+++...+..|..||+......     ++..+..+  +.         .....
T Consensus       428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-----AlyLIa~n--g~---------P~lk~  491 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLIATN--GT---------PKLKN  491 (550)
T ss_pred             cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-----HHHHHhhc--CC---------CCcCC
Confidence            7899999999999999999999999999998887777777776532110     11111110  11         11123


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      ++.+|++++|||.+||++||.+|+||.|+|+||||..
T Consensus       492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             ccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence            5679999999999999999999999999999999954

>KOG0198|consensus

Probab=100.00  E-value=1.9e-43  Score=334.53  Aligned_cols=255  Identities=25%  Similarity=0.355  Sum_probs=196.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..+|...+.||+|+||.||++.+.+++..+|||.+....   .+.+.+|+.+|.+++ |||||++++..........++.
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEee
Confidence            456788899999999999999999999999999987554   455899999999998 9999999986433222357899


Q ss_pred             EeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC----
Q psy3714         247 FEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP----  318 (467)
Q Consensus       247 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~----  318 (467)
                      |||+++|++.++..    .+++..++.+++|+++||+|||++|||||||||+|||++..++.+||+|||+|+....    
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            99999999988764    4899999999999999999999999999999999999997455899999999987652    


Q ss_pred             CCCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      ........||+.|||||++.+.. -..++|+|..++.-..+..+..||...    ........   ..  +...      
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~---~i--g~~~------  239 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALL---LI--GRED------  239 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHH---HH--hccC------
Confidence            12233468999999999999622 234899998776544444443343221    00000000   00  0000      


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                       ..++.+..+|++++|||.+||.+||++||||+++|+|||....
T Consensus       240 -~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  240 -SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             -CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence             0113345689999999999999999999999999999998653

>KOG0667|consensus

Probab=100.00  E-value=1.5e-42  Score=344.48  Aligned_cols=263  Identities=24%  Similarity=0.432  Sum_probs=197.2

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchH--HHHHHHHHHHHHhcC-----CCCeeEEEEEEeCCCCCccE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK--KKIKREIKILENLRG-----GTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~Ei~il~~l~~-----~~~iv~l~~~~~~~~~~~~~  244 (467)
                      +|++++.||+|+||+|.+|.+..|++.||||++++.+.  .....|+.||..|+.     ..|+|+++++|..  ..+.+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--cccee
Confidence            78999999999999999999999999999999987643  567789999999982     3589999998875  46789


Q ss_pred             EEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC-CCcEEEEecccceecCC
Q psy3714         245 LIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~-~~~ikl~DFGla~~~~~  318 (467)
                      +|+|.+.. +|.++++     .++...++.++.||+.||.+||+.||||+|||||||||... ...|||+|||+|++...
T Consensus       265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence            99997754 5666653     48899999999999999999999999999999999999754 34799999999998643


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCc---------ccCC--hhhhh-------
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQ---------HLVS--PEALD-------  380 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~--~~~~~-------  380 (467)
                        ...+++.|++|||||+|.+.+|+.++|+|+.+.+......| +|+|.+.+.         .++.  +.+++       
T Consensus       344 --~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG-~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k  420 (586)
T KOG0667|consen  344 --RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTG-EPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK  420 (586)
T ss_pred             --cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcC-ccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence              33479999999999999999999999999888776666565 455555432         1111  11111       


Q ss_pred             hhhh-hccCC---------CC--ccccc-------ccccc-cCC------C-CCChHHHHHHHhhcCcCCCCCCCHHHHh
Q psy3714         381 FLDK-NILGR---------HS--RKRWE-------RFVHT-ENQ------H-LVSPEALDFLDKLLRYDHYERLTAREAM  433 (467)
Q Consensus       381 ~~~~-~~~~~---------~~--~~~~~-------~~~~~-~~~------~-~~s~~~~dli~~lL~~dp~~R~ta~e~l  433 (467)
                      |.+. .-..+         ..  ...+.       ....+ ...      . .-...+.|||++||++||.+|+|+.|+|
T Consensus       421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal  500 (586)
T KOG0667|consen  421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL  500 (586)
T ss_pred             ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence            1111 00000         00  00000       00000 000      0 1124679999999999999999999999


Q ss_pred             CCCCCCC
Q psy3714         434 DHPYFYP  440 (467)
Q Consensus       434 ~Hp~f~~  440 (467)
                      +||||.+
T Consensus       501 ~Hpfl~~  507 (586)
T KOG0667|consen  501 NHPFLTG  507 (586)
T ss_pred             cCccccc
Confidence            9999984

>KOG0604|consensus

Probab=100.00  E-value=8.6e-44  Score=320.91  Aligned_cols=259  Identities=24%  Similarity=0.387  Sum_probs=213.4

Q ss_pred             Cccceeee-EeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC--CCccEE
Q psy3714         169 QQDDYQLV-RKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPV--SRTPAL  245 (467)
Q Consensus       169 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~--~~~~~l  245 (467)
                      -.++|.+- ++||-|-.|.|..|.++.|++++|+|++..  ..+..||+++.-..++|+|||.+.++|++..  ...+.+
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi  136 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI  136 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence            34777765 569999999999999999999999999864  4567889998888889999999999986532  345678


Q ss_pred             EEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC--CCcEEEEecccceecCC
Q psy3714         246 IFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       246 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~--~~~ikl~DFGla~~~~~  318 (467)
                      |||.++||+|.+.++     .++|.++..++.||+.|+.|||+.+|.||||||||+|....  +..+||+|||+|+....
T Consensus       137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            999999999876653     49999999999999999999999999999999999998643  45799999999997655


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      .....+.|-||||.|||++-...|+..+|.|..+++-+..++|..||...-. ...+++....+..   +.+      .|
T Consensus       217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~aispgMk~rI~~---gqy------~F  286 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKRRIRT---GQY------EF  286 (400)
T ss_pred             CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCChhHHhHhhc---cCc------cC
Confidence            5556677899999999999999999999999999888888888888755433 2334444432221   221      11


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                       ..+.|..+|++++|+|++||..+|.+|+|++|++.|||+..
T Consensus       287 -P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~  327 (400)
T KOG0604|consen  287 -PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ  327 (400)
T ss_pred             -CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence             23456679999999999999999999999999999999875

>KOG0591|consensus

Probab=100.00  E-value=1.1e-44  Score=324.26  Aligned_cols=249  Identities=23%  Similarity=0.360  Sum_probs=194.5

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEecc-----chHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP-----VKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~-----~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ....+|+++++||+|+||.||++.+..++..+|.|.++-     ..++.+..|+.+|+.|+ |||||+++..-.......
T Consensus        16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~ev   94 (375)
T KOG0591|consen   16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEV   94 (375)
T ss_pred             ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchh
Confidence            345789999999999999999999999999999998752     24567889999999997 899999987332223445


Q ss_pred             cEEEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHH--CC--ccccCCCCCceEEeCCCCcEEEEecc
Q psy3714         243 PALIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHS--MG--IMHRDVKPHNVMIDHENRKLRLIDWG  311 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~--~~--IiHrDlKp~Nill~~~~~~ikl~DFG  311 (467)
                      +++|||+|..|||.++++       .++|..++.++.|+|.||.+||+  .+  |+||||||.||+|+..| .+||.|||
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfG  173 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFG  173 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccch
Confidence            899999999999988864       37999999999999999999999  55  99999999999999655 89999999


Q ss_pred             cceecCCCCC-cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhcc-CC
Q psy3714         312 LAEFYHPGQE-YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL-GR  389 (467)
Q Consensus       312 la~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  389 (467)
                      +++++..... ..+.+|||+||+||++.+.+|+.++|+|..+.+.+.+..-..||.+.        ..... ...|. +.
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L-~~KI~qgd  244 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSL-CKKIEQGD  244 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHH-HHHHHcCC
Confidence            9998865443 45689999999999999999999999998887655443334444322        11111 11111 11


Q ss_pred             CCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      ++. .|        ....|.++..||.-|+..||..||+.     ||++.++
T Consensus       245 ~~~-~p--------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di  282 (375)
T KOG0591|consen  245 YPP-LP--------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDI  282 (375)
T ss_pred             CCC-Cc--------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHH
Confidence            110 11        03469999999999999999999974     5555443

>KOG0597|consensus

Probab=100.00  E-value=2.1e-43  Score=341.91  Aligned_cols=246  Identities=23%  Similarity=0.397  Sum_probs=205.7

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchH-----HHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK-----KKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..+     +.+.+|++|++.|+ |||||.+++.|+.  ...+++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt--~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK-HPNIVEMLESFET--SAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC-CcchhhHHHhhcc--cceEEE
Confidence            578899999999999999999999999999999876433     45889999999997 8999999999986  457899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-  321 (467)
                      |.||+.| +|.+++.   +++|+.++.++++++.||.|||+++|+|||+||.|||++. ++.+|+||||+|+-+..+.. 
T Consensus        79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~-~~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEK-GGTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecC-CCceeechhhhhhhcccCcee
Confidence            9999988 8877764   6999999999999999999999999999999999999995 55899999999998765443 


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      .+..-|||.|||||++.+.+|+..+|.|..+++.+....|..||+...        ..... +.|..  ...+|      
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv-~~I~~--d~v~~------  219 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLV-KSILK--DPVKP------  219 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHH-HHHhc--CCCCC------
Confidence            344569999999999999999999999999998887777777765322        11111 11111  11112      


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                        +...|+++++||..+|++||.+|+|+.+++.|||.++
T Consensus       220 --p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  220 --PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             --cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence              2358999999999999999999999999999999875

>KOG0580|consensus

Probab=100.00  E-value=3.1e-43  Score=308.43  Aligned_cols=249  Identities=25%  Similarity=0.381  Sum_probs=206.7

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ...++|++.+.||+|.||.||+|+.++++-.||+|++.+..      .+.+.||++|-.+|+ ||||.+++.+|.+.  .
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~--~   95 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDS--K   95 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheecc--c
Confidence            34689999999999999999999999999999999986432      356789999999996 89999999999874  5


Q ss_pred             ccEEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         242 TPALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      ..|+++||...|++.+.++     ++++..+..|++|++.||.|||.++||||||||+|+|++..+ .+||+|||++...
T Consensus        96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHA  174 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC-CeeccCCCceeec
Confidence            6899999999999876654     588999999999999999999999999999999999999666 7999999999865


Q ss_pred             CCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         317 HPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       317 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      . .....+.|||.-|.+||+..+..++..||.|..+++.+..+.+..||-...    . .+...    .+..        
T Consensus       175 p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~----~-~etYk----rI~k--------  236 (281)
T KOG0580|consen  175 P-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS----H-SETYK----RIRK--------  236 (281)
T ss_pred             C-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh----h-HHHHH----HHHH--------
Confidence            4 445567899999999999999999999999999998776666655542211    0 01111    1100        


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                        .....+..+|.+|+|||++||.++|.+|++..|++.|||+..
T Consensus       237 --~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  237 --VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             --ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence              111223569999999999999999999999999999999853

>KOG0611|consensus

Probab=100.00  E-value=8.8e-43  Score=325.56  Aligned_cols=247  Identities=21%  Similarity=0.392  Sum_probs=206.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      -..+|++.+.||+|+||.|-+|+....|+.||||.+++.+      .-++.|||+||..|+ ||||+.++++|+.  ...
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFEN--kdK  127 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFEN--KDK  127 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcC--Cce
Confidence            3468999999999999999999999999999999887542      246889999999996 8999999999986  456


Q ss_pred             cEEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      +++||||..+|+|.+++   +.+++.+++.+++||++|+.|||.++++|||||.+|||+|. ++.+||+|||++-.+..+
T Consensus       128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~-N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQ-NNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecC-CCCeeeeccchhhhhccc
Confidence            89999999999998886   46999999999999999999999999999999999999995 558999999999999888


Q ss_pred             CCcceeeeccCccCCcccccCCC-CccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQY-HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~-~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      ...++.||+|.|.+||++.+.+| ...+|.|..+++.+....|..||.+-.        ....+ .++    ....+   
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~lv-rQI----s~GaY---  270 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKRLV-RQI----SRGAY---  270 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHHHH-HHh----hcccc---
Confidence            88889999999999999999998 467999999998776655555553211        11111 111    11111   


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                      ..+    --+++|.-||+.||..||++|.|.+|+-.|=|..
T Consensus       271 rEP----~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  271 REP----ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             cCC----CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence            111    1367999999999999999999999999999974

>KOG0690|consensus

Probab=100.00  E-value=1.8e-43  Score=321.83  Aligned_cols=259  Identities=22%  Similarity=0.351  Sum_probs=211.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|+.++.||+|.||.|-+|+.+.+++.+|+|++++.      ...+...|-.+|++.+ ||.+..|...|+.  ...
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt--~dr  242 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQT--QDR  242 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhcc--Cce
Confidence            358899999999999999999999999999999999763      2245577889999886 7988888877765  467


Q ss_pred             cEEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec-CC
Q psy3714         243 PALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~-~~  318 (467)
                      +++||||.+||+|.-.+   ..++++.+++|-.+|++||.|||+++||.||||.+|+|+|.+| +|||+|||+++.- ..
T Consensus       243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG-HIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG-HIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC-ceEeeecccchhcccc
Confidence            89999999999975444   3599999999999999999999999999999999999999776 8999999999853 44


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      +....+.||||.|.|||++.+..|..++|+|-.+++-+.+.+|..||.......     ++..+-..   .   .     
T Consensus       322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-----LFeLIl~e---d---~-----  385 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-----LFELILME---D---L-----  385 (516)
T ss_pred             cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-----HHHHHHhh---h---c-----
Confidence            555677899999999999999999999999988877777777777765432211     11111100   0   0     


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccccCCC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSRHTL  450 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~~~~  450 (467)
                         ..+..+|++|+.||..+|.+||++|+     .|.|+.+|+||++++|+..-..+
T Consensus       386 ---kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kk  439 (516)
T KOG0690|consen  386 ---KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKK  439 (516)
T ss_pred             ---cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhc
Confidence               11335899999999999999999998     48999999999999996554443

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.1e-41  Score=324.46  Aligned_cols=260  Identities=27%  Similarity=0.543  Sum_probs=194.9

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      +..++|++++.||+|+||.||+|.+..+++.||+|.++..    ....+.+|+.+++.++ |+||+++++.+.+.  ...
T Consensus         2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~   78 (288)
T cd07871           2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK-HANIVTLHDIIHTE--RCL   78 (288)
T ss_pred             CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCC--CeE
Confidence            4568899999999999999999999999999999988642    2346779999999996 89999999988753  468


Q ss_pred             EEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ++||||+.+ ++.+...    .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus        79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~~~  156 (288)
T cd07871          79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-ELKLADFGLARAKSVP  156 (288)
T ss_pred             EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEECcCcceeeccCC
Confidence            999999986 6766543    367889999999999999999999999999999999998655 7999999999865322


Q ss_pred             -CCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc-
Q psy3714         320 -QEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE-  396 (467)
Q Consensus       320 -~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  396 (467)
                       ......++|+.|+|||++.+ ..|+.++|+|..+++.+....+..+|......     +...... ...+......|. 
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-----~~~~~~~-~~~~~~~~~~~~~  230 (288)
T cd07871         157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-----EELHLIF-RLLGTPTEETWPG  230 (288)
T ss_pred             CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH-HHhCCCChHHhhc
Confidence             22344678999999999876 45889999998887765555555444322110     0000000 000000000010 


Q ss_pred             --------ccc--------cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         397 --------RFV--------HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       397 --------~~~--------~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                              .+.        .....+.++++++|||++||++||++|+||+|+|+||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                    000        011123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0662|consensus

Probab=100.00  E-value=3.9e-42  Score=288.98  Aligned_cols=261  Identities=27%  Similarity=0.536  Sum_probs=199.3

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      +.|.-.++||+|.||+||+|++..+++.||+|.++-..     .....|||-+|+.|+ |.|||+++++....  +...+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelk-hknivrl~dvlhsd--kkltl   78 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSD--KKLTL   78 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-hcceeehhhhhccC--ceeEE
Confidence            35666789999999999999999999999999886432     356899999999997 89999999987653  56889


Q ss_pred             EEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-CCC
Q psy3714         246 IFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQ  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~~~  320 (467)
                      |+|||.. ++..++.    .++...++.++.|++.||.|+|++++.|||+||.|+|++. ++.+||+|||+|+.+. +-.
T Consensus        79 vfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~-ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   79 VFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR-NGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             eHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc-CCcEEecccchhhhcCCceE
Confidence            9999975 5655554    4678889999999999999999999999999999999995 4589999999999764 333


Q ss_pred             CcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      -++..+.|.+|++|.++.+.. |++++|.|+++.+-........|+|.+.+-.   .....+.  ..++......|....
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd---dqlkrif--~~lg~p~ed~wps~t  231 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIF--RLLGTPTEDQWPSMT  231 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH---HHHHHHH--HHhCCCccccCCccc
Confidence            466778999999999998865 9999999988876554444455665554310   0000000  011222222232211


Q ss_pred             c------------ccC----CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         400 H------------TEN----QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       400 ~------------~~~----~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      .            ...    -+.++...+||++++|.-+|.+|++|+++|+||||++.
T Consensus       232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            1            001    13467889999999999999999999999999999864

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-40  Score=321.03  Aligned_cols=259  Identities=22%  Similarity=0.280  Sum_probs=203.7

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....      ...+.+|+.+++.+. |+||+.+...+.+.  ...++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~--~~~~l   77 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETK--DALCL   77 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccC--CeEEE
Confidence            3788999999999999999999999999999876432      234678999999995 89999999888754  46899


Q ss_pred             EEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         246 IFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      +|||++++++.....     .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|.......
T Consensus        78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-HIRISDLGLAVQIPEGE  156 (285)
T ss_pred             EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcCCCC
Confidence            999999999875542     478889999999999999999999999999999999998554 79999999998765444


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      .....+||..|+|||++.+..|+.++|+|..+++.+....+..||.......     ........+..    .      .
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~----~------~  221 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-----KREEVDRRVKE----D------Q  221 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-----hHHHHHHHhhc----c------c
Confidence            4455679999999999999899999999988887655555555553322110     00111111000    0      0


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCcccccccCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKDQSRHT  449 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~~~~~~  449 (467)
                      ...+..+|+++.+||++||+.||++|+|     ++++++||||.+++++.....
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~  275 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEAN  275 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhC
Confidence            1122347999999999999999999997     899999999999988766544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0582|consensus

Probab=100.00  E-value=6.5e-41  Score=317.35  Aligned_cols=261  Identities=21%  Similarity=0.314  Sum_probs=200.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ..++|++...||.|..++||+|+...+++.||||++.-.+    -..+.+|+..|..+ +||||+.++..|..  ...+|
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv--~~~LW  100 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVV--DSELW  100 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEe--cceeE
Confidence            3589999999999999999999999999999999986432    36789999999877 59999999998865  35689


Q ss_pred             EEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec-CC
Q psy3714         245 LIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HP  318 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~-~~  318 (467)
                      .||.++.+|++.++..     .+.|..+..++++++.||.|||++|-||||||+.||||+.+| .|||+|||.+..+ ..
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG-~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG-TVKLADFGVSASLFDS  179 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC-cEEEcCceeeeeeccc
Confidence            9999999999887764     488999999999999999999999999999999999999665 8999999987644 33


Q ss_pred             CCCc----ceeeeccCccCCcccccC--CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         319 GQEY----NVRVASRYFKGPELLADY--QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       319 ~~~~----~~~~gt~~y~aPE~l~~~--~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      +...    ...+||++|||||+++..  +|+.+.|+|+.++.......|..||...+..        ...-..+.+..+.
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--------kvLl~tLqn~pp~  251 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--------KVLLLTLQNDPPT  251 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--------HHHHHHhcCCCCC
Confidence            3322    334899999999997654  5999999999998766555555555433211        1000011111110


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ... .....+.....+..++.+|..||.+||.+||||+++|+||||....
T Consensus       252 ~~t-~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  252 LLT-SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             ccc-ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            000 0001111123577999999999999999999999999999997543

>KOG4717|consensus

Probab=100.00  E-value=3.6e-41  Score=322.99  Aligned_cols=254  Identities=22%  Similarity=0.362  Sum_probs=216.6

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .-|.+-+.||+|-|.+|-+|++.-||.+||||++.+.+     ..++..|+..|+.++ |||||+|+++...+  ..+|+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQ--TKlyL   94 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQ--TKLYL   94 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc-CcCeeeeeehhccc--ceEEE
Confidence            34788899999999999999999999999999998654     457889999998775 89999999998765  45899


Q ss_pred             EEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         246 IFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      |+|..++|||.+++    ..+.|+-++.|+.||+.|+.|||+..+|||||||+|+.+-..-+-|||+|||++-.+.+++.
T Consensus        95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence            99999999998876    35889999999999999999999999999999999998876666899999999999999999


Q ss_pred             cceeeeccCccCCcccccCCCC-ccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYH-IELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~-~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      .++.||+..|-|||++.+..|+ .++|+|..+++.+...+|..||....+..    .+.-+++..               
T Consensus       175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----TLTmImDCK---------------  235 (864)
T KOG4717|consen  175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----TLTMIMDCK---------------  235 (864)
T ss_pred             hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----hhhhhhccc---------------
Confidence            9999999999999999999996 57999999999888778777775544321    111222221               


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccccc
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~~  446 (467)
                      +.-+..+|.+++|||..||..||++|.|.+++-.|+|++.++...+
T Consensus       236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~s  281 (864)
T KOG4717|consen  236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLS  281 (864)
T ss_pred             ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcc
Confidence            1224568999999999999999999999999999999998875433

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-40  Score=338.43  Aligned_cols=269  Identities=26%  Similarity=0.424  Sum_probs=197.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC------CCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDP------VSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~------~~~~  242 (467)
                      ...+|++.+.||+|+||.||+|.+..+++.||||.+... .....+|+.+|+.++ |+||+++.+++...      ....
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIMKNLN-HINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHhcC-CCCCcceeeeEeecccccCCCceE
Confidence            346899999999999999999999999999999987543 234568999999996 89999998876432      1124


Q ss_pred             cEEEEeccCCccHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         243 PALIFEHVNNTDFKQLY-------QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                      .++||||++++ +.+..       ..+++..++.++.||+.||+|||++||+||||||+|||++..+..+||+|||+|+.
T Consensus       142 l~lvmE~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~  220 (440)
T PTZ00036        142 LNVVMEFIPQT-VHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN  220 (440)
T ss_pred             EEEEEecCCcc-HHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence            67899999875 33322       24788899999999999999999999999999999999986665799999999987


Q ss_pred             cCCCCCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCc--------ccCChh--hhhhhhh
Q psy3714         316 YHPGQEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQ--------HLVSPE--ALDFLDK  384 (467)
Q Consensus       316 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~--~~~~~~~  384 (467)
                      ...+......+||+.|+|||++.+. .|+.++|+|..+++.+....+..+|......        .++.+.  .......
T Consensus       221 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~  300 (440)
T PTZ00036        221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP  300 (440)
T ss_pred             ccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence            7555555557899999999998765 5899999998888766655555554332110        000000  0000000


Q ss_pred             hcc----CCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         385 NIL----GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       385 ~~~----~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                      +..    .......+..    ..+...|++++|||++||++||.+|+||.|+|+||||..+...
T Consensus       301 ~~~~~~~~~~~~~~l~~----~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~  360 (440)
T PTZ00036        301 NYADIKFPDVKPKDLKK----VFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP  360 (440)
T ss_pred             hhhcccCCccCchhHHH----HhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence            000    0000011111    1123468899999999999999999999999999999877543

>KOG0986|consensus

Probab=100.00  E-value=1e-41  Score=322.84  Aligned_cols=265  Identities=23%  Similarity=0.318  Sum_probs=216.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..+.|..-++||+|+||.||-|.-+.||+.+|+|.+.+..      .....+|-.||++++ .+.||.+-..|+.+  ..
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTk--d~  259 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETK--DA  259 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCC--Cc
Confidence            4578889999999999999999999999999999875432      234678999999996 68999999888864  56


Q ss_pred             cEEEEeccCCccHHHHh---h--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         243 PALIFEHVNNTDFKQLY---Q--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~---~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      +++||..++||||.-++   .  .+++..+++|+.||+.||++||+.+||.||+||+|||||..| +++|+|+|||..+.
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G-hvRISDLGLAvei~  338 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG-HVRISDLGLAVEIP  338 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC-CeEeeccceEEecC
Confidence            89999999999985332   1  589999999999999999999999999999999999999555 89999999999998


Q ss_pred             CCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       318 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      .++..+..+||..|||||++.+..|+.++|+|..+.+.+.++.+..||.......     -...++.-++.         
T Consensus       339 ~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-----k~eEvdrr~~~---------  404 (591)
T KOG0986|consen  339 EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-----KREEVDRRTLE---------  404 (591)
T ss_pred             CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-----hHHHHHHHHhc---------
Confidence            8888888899999999999999999999999988888887777777775433210     00111111110         


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccccCCCCC
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSRHTLPS  452 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~~~~~~  452 (467)
                       ...+.++..|++|++|.+.+|++||++|+     +++++.+||||.+++|.......-.
T Consensus       405 -~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~  463 (591)
T KOG0986|consen  405 -DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLE  463 (591)
T ss_pred             -chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCC
Confidence             11223356899999999999999999998     5889999999999999766554433

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.7e-40  Score=322.58  Aligned_cols=271  Identities=26%  Similarity=0.440  Sum_probs=196.2

Q ss_pred             cCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       167 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      |+..++|++++.||+|+||.||+|.+..+++.+|+|+++...    .....+|+.+++.+. |+||+.+++++.+.  ..
T Consensus         1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~   77 (303)
T cd07869           1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK-HANIVLLHDIIHTK--ET   77 (303)
T ss_pred             CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCC-CCCcCeEEEEEecC--Ce
Confidence            356789999999999999999999999999999999986432    245678999999996 89999999998764  46


Q ss_pred             cEEEEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .++||||+.+ ++.+..    ..+++..++.++.|++.||+|||++||+||||||+|||++..+ .+||+|||+|+....
T Consensus        78 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~  155 (303)
T cd07869          78 LTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-ELKLADFGLARAKSV  155 (303)
T ss_pred             EEEEEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECCCCcceeccC
Confidence            8999999975 454433    2478899999999999999999999999999999999998554 799999999975432


Q ss_pred             -CCCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcc---------cCChhhhhhhhhhcc
Q psy3714         319 -GQEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQH---------LVSPEALDFLDKNIL  387 (467)
Q Consensus       319 -~~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~  387 (467)
                       .......+||+.|+|||++.+. .|+.++|+|..+++.+....+..||....+..         +..+....+......
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence             2223446789999999998764 47888999988887665555555553221100         000000000000000


Q ss_pred             CCCCcccccccc-----cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         388 GRHSRKRWERFV-----HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       388 ~~~~~~~~~~~~-----~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .......+....     ..-.....+++++|||++||++||++|+|++|+|+||||..+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            000000000000     0001113568999999999999999999999999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.4e-40  Score=326.04  Aligned_cols=247  Identities=23%  Similarity=0.344  Sum_probs=196.2

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      +.||+|+||.||+|.+..+++.+|+|+++...      .....+|+.+++.++ ||||+.+...+...  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~--~~~~lv~e~~   77 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTH--DRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcC--CEEEEEEeCC
Confidence            36899999999999999999999999987431      235678999999995 89999999888764  5689999999


Q ss_pred             CCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-CCCCcceee
Q psy3714         251 NNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRV  326 (467)
Q Consensus       251 ~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~~~~~~~~~  326 (467)
                      +++++...+.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+... .+......+
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~  156 (323)
T cd05571          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCCCccccee
Confidence            9999876653   478999999999999999999999999999999999998655 79999999998542 223334567


Q ss_pred             eccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       327 gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      ||+.|+|||++.+..|+.++|+|..+++.+....+..||.....        ...... +...          ....+..
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~-~~~~----------~~~~p~~  217 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFEL-ILME----------EIRFPRT  217 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHHH-HHcC----------CCCCCCC
Confidence            99999999999998999999999888876666555555532211        011110 1000          0011235


Q ss_pred             CChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccc
Q psy3714         407 VSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~  446 (467)
                      +++++++||++||+.||++|+     +++|+++||||..+.|...
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~  262 (323)
T cd05571         218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDV  262 (323)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence            799999999999999999999     8999999999998776433

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.9e-40  Score=329.03  Aligned_cols=257  Identities=21%  Similarity=0.348  Sum_probs=200.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++++.||+|+||.||+|.+..+++.||+|+++...      ...+.+|+.++..++ |+||++++..+.+.  ...+
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~--~~~~   77 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDK--LNLY   77 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecC--CeEE
Confidence            57999999999999999999999999999999986431      245678999999995 89999999988764  5689


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-  320 (467)
                      +||||+++++|.+++.   .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+...... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~-~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-CEEEeeccCccccccccc
Confidence            9999999999987763   588999999999999999999999999999999999998655 79999999997542210 


Q ss_pred             -----------------------------------CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccc
Q psy3714         321 -----------------------------------EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERF  365 (467)
Q Consensus       321 -----------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~  365 (467)
                                                         .....+||+.|+|||++.+..|+.++|+|..+++.+....+..||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                               012357999999999999999999999999888876666666665


Q ss_pred             cccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCC---CCHHHHhCCCCCCCcc
Q psy3714         366 VHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYER---LTAREAMDHPYFYPIV  442 (467)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R---~ta~e~l~Hp~f~~~~  442 (467)
                      .....        ..... .+..      |......+....+|++++|||.+|+. +|++|   +|++|+++||||.+++
T Consensus       237 ~~~~~--------~~~~~-~i~~------~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~  300 (363)
T cd05628         237 CSETP--------QETYK-KVMN------WKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD  300 (363)
T ss_pred             CCCCH--------HHHHH-HHHc------CcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence            32211        11111 1110      10001111122479999999999886 56654   7999999999999998


Q ss_pred             ccccc
Q psy3714         443 KDQSR  447 (467)
Q Consensus       443 ~~~~~  447 (467)
                      |+..+
T Consensus       301 ~~~~~  305 (363)
T cd05628         301 WEHIR  305 (363)
T ss_pred             HHHHH
Confidence            86553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.8e-40  Score=324.75  Aligned_cols=252  Identities=22%  Similarity=0.346  Sum_probs=202.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|+++...      ...+.+|+.+++.++ ||||+++++.+.+.  ..
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~   92 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDE--NR   92 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcC--CE
Confidence            3578999999999999999999999999999999986432      245788999999995 89999999988764  56


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      .+++|||+.+++|.+.+.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG-HVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC-CEEEeeccCceEcCCC
Confidence            899999999999877653   478889999999999999999999999999999999998654 7999999999876432


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                        ....+||+.|+|||++.+..++.++|+|..+++.+....+..||....        ...... .+...    .     
T Consensus       172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~-~i~~~----~-----  231 (329)
T PTZ00263        172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--------PFRIYE-KILAG----R-----  231 (329)
T ss_pred             --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC--------HHHHHH-HHhcC----C-----
Confidence              234579999999999999999999999988887666555555553221        111111 11100    0     


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCccccc
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKDQ  445 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~~  445 (467)
                       ...+..++++++|||++||+.||++|++     ++|+++||||.+..++.
T Consensus       232 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~  281 (329)
T PTZ00263        232 -LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDK  281 (329)
T ss_pred             -cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHH
Confidence             0112347899999999999999999997     79999999999876653

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=321.12  Aligned_cols=251  Identities=22%  Similarity=0.341  Sum_probs=201.2

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++++.||+|+||.||+|.+..+++.+|+|.++..      ....+.+|+.+++.+. ||||+++++.+.+.  ...+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~~~   77 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQ--RFLY   77 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccC--CeEE
Confidence            4799999999999999999999999999999998642      1345778999999996 89999998887653  5689


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      +||||+++++|.+++.   .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....  
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-HIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEEecCcchhccCC--
Confidence            9999999999987653   478899999999999999999999999999999999998654 7999999999876432  


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+||+.|+|||++.+..++.++|+|..+++.+....+..||....        ..........+.           .
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~-----------~  215 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--------PFGIYEKILAGK-----------L  215 (291)
T ss_pred             cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-----------c
Confidence            234579999999999999889999999998887666555555543221        111111111000           0


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCcccccc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~~~  446 (467)
                      ..+..++++++|||++||+.||.+|++     ++|+++||||..+.+...
T Consensus       216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~  265 (291)
T cd05612         216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDV  265 (291)
T ss_pred             CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHH
Confidence            112346899999999999999999995     999999999998877543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.1e-40  Score=332.11  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=198.1

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .|++++.||+|+||.||+|.+..+++.||+|+++...      ...+.+|+.+++.++ |+||++++..+.+.  ...++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~--~~~~l   78 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDK--DNLYF   78 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecC--CEEEE
Confidence            6899999999999999999999999999999986421      245778999999985 89999999998764  56899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC--
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~--  320 (467)
                      ||||+++++|.+++.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+....  
T Consensus        79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC-CEEEeeCcCCccccccccc
Confidence            999999999987763   478899999999999999999999999999999999998654 79999999986431000  


Q ss_pred             ----------------------------------------------CcceeeeccCccCCcccccCCCCccchhHHHhhh
Q psy3714         321 ----------------------------------------------EYNVRVASRYFKGPELLADYQYHIELDPRFADIL  354 (467)
Q Consensus       321 ----------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~  354 (467)
                                                                    .....+||+.|+|||++.+..|+.++|+|..+++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                          0123479999999999999889999999988887


Q ss_pred             ccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCC--CCCCHHHH
Q psy3714         355 GRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHY--ERLTAREA  432 (467)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~--~R~ta~e~  432 (467)
                      .+....+..||......    .....     +.      .|......+....+|++++|||.+||..+++  +|+|++|+
T Consensus       238 l~elltG~~Pf~~~~~~----~~~~~-----i~------~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         238 LFEMLVGQPPFLAPTPT----ETQLK-----VI------NWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             HHHHHhCCCCCcCCCHH----HHHHH-----HH------ccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            76666666665432110    00000     10      1111111122335799999999998766555  49999999


Q ss_pred             hCCCCCCCccccc
Q psy3714         433 MDHPYFYPIVKDQ  445 (467)
Q Consensus       433 l~Hp~f~~~~~~~  445 (467)
                      ++||||.++++..
T Consensus       303 l~hp~f~~~~~~~  315 (381)
T cd05626         303 KAHPFFSEVDFSS  315 (381)
T ss_pred             hcCcccCCCChhH
Confidence            9999999887643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=330.69  Aligned_cols=256  Identities=23%  Similarity=0.400  Sum_probs=201.6

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++++.||+|+||.||+|.+..+++.||||+++...      ...+.+|+.+|+.++ |+||+.+++.+.+.  ...+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~--~~~~   77 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDE--NYLY   77 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcC--CeEE
Confidence            47999999999999999999999999999999987431      235678999999996 89999999998864  5689


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-  320 (467)
                      +||||+.+++|.+++.   .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++...... 
T Consensus        78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEeecccceecccccc
Confidence            9999999999987653   488999999999999999999999999999999999998655 79999999987542211 


Q ss_pred             --------------------------------------CcceeeeccCccCCcccccCCCCccchhHHHhhhcccccccc
Q psy3714         321 --------------------------------------EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRW  362 (467)
Q Consensus       321 --------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~  362 (467)
                                                            .....+||+.|+|||++....|+.++|+|..+++.+....+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence                                                  001246999999999999989999999999888776666665


Q ss_pred             ccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCC---HHHHhCCCCCC
Q psy3714         363 ERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT---AREAMDHPYFY  439 (467)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~t---a~e~l~Hp~f~  439 (467)
                      .||.....        ..... .+.      .|......+....+|++++|||++||. ||.+|++   ++|+++||||.
T Consensus       237 ~Pf~~~~~--------~~~~~-~i~------~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~  300 (364)
T cd05599         237 PPFCSDNP--------QETYR-KII------NWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK  300 (364)
T ss_pred             CCCCCCCH--------HHHHH-HHH------cCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcC
Confidence            55532211        11110 111      111111111223479999999999997 9999998   99999999999


Q ss_pred             Ccccccc
Q psy3714         440 PIVKDQS  446 (467)
Q Consensus       440 ~~~~~~~  446 (467)
                      ..+++..
T Consensus       301 ~~~~~~~  307 (364)
T cd05599         301 GVDWEHI  307 (364)
T ss_pred             CCCHHHH
Confidence            8877543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0612|consensus

Probab=100.00  E-value=9e-42  Score=353.59  Aligned_cols=275  Identities=25%  Similarity=0.352  Sum_probs=216.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..+||++++.||+|+||.|..++++.|++.||+|++++-      ...-+..|-.+|..-. .+=|+.++..|+|  .++
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD--~~~  149 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQD--ERY  149 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcC--ccc
Confidence            358999999999999999999999999999999998752      1233556777776554 5668999998887  478


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      +||||||++||||..+..   .++++-+++|+.+|+.||.-||+.|.|||||||+|||||..| +|||+|||.|-.+..+
T Consensus       150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G-HikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG-HIKLADFGSCLKMDAD  228 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC-cEeeccchhHHhcCCC
Confidence            999999999999887764   578999999999999999999999999999999999999665 8999999998776543


Q ss_pred             CC--cceeeeccCccCCccccc-----CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         320 QE--YNVRVASRYFKGPELLAD-----YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       320 ~~--~~~~~gt~~y~aPE~l~~-----~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      ..  ....||||-|.+||++..     ..|+..+|+|+.|++.+.++.|.-||....        ..+. ...|+..   
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--------lveT-Y~KIm~h---  296 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--------LVET-YGKIMNH---  296 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--------HHHH-HHHHhch---
Confidence            33  344689999999999953     348899999999999888777766664321        1110 0011111   


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCC---HHHHhCCCCCCCcccccccCCCCCCCC---CCCCCCCC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT---AREAMDHPYFYPIVKDQSRHTLPSSSP---TPIVNSVP  463 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~t---a~e~l~Hp~f~~~~~~~~~~~~~~~~~---~~~~~~~~  463 (467)
                         ...+..+....||++|+|||+++|+ +|..|++   ++|+..||||.+++|+..|...|+..|   .+..+|.+
T Consensus       297 ---k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnF  369 (1317)
T KOG0612|consen  297 ---KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNF  369 (1317)
T ss_pred             ---hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccccc
Confidence               0111122233599999999999997 8999998   999999999999999999999888765   44555544

>KOG0666|consensus

Probab=100.00  E-value=2.2e-41  Score=306.69  Aligned_cols=265  Identities=26%  Similarity=0.504  Sum_probs=196.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCC----eEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSD----KCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      ...|+++..||+|+||.||+|..+.++.    .+|+|.++..+     .....||+.+++.++ |+|++.|..++-.. .
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~-d  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK-HPNVISLVKVFLSH-D  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc-CCcchhHHHHHhcc-C
Confidence            4679999999999999999997766654    68999887653     356789999999996 89999999888654 4


Q ss_pred             CccEEEEeccCCccHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC---CCcEEEEe
Q psy3714         241 RTPALIFEHVNNTDFKQLY--------QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE---NRKLRLID  309 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~---~~~ikl~D  309 (467)
                      ..+++++||.+. ||.+.+        +.++...++.++.||+.|+.|||++-|+||||||.|||+..+   .+.|||+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence            678999999986 444433        247778899999999999999999999999999999999765   24799999


Q ss_pred             cccceecCCC----CCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCccc------CChhh
Q psy3714         310 WGLAEFYHPG----QEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHL------VSPEA  378 (467)
Q Consensus       310 FGla~~~~~~----~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~  378 (467)
                      ||+|+.+...    -.....+.|.||+|||++.+.. |+.++|.|..+++-.. +...+|+|.+....+      .....
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaE-lLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAE-LLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHH-HHccCccccchhhhcccCCCchHHHH
Confidence            9999987532    1234468899999999999876 8999999966554222 123445555432211      11111


Q ss_pred             hhhhhhhccCCCCcccccccccccC------------------------CCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         379 LDFLDKNILGRHSRKRWERFVHTEN------------------------QHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ..+.  ++++..+...|+.+...++                        ...-|+.+.|||.+||++||.+|+||+|+|+
T Consensus       259 ~rIf--~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  259 DRIF--EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHH--HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            1111  2344444444543322111                        1223667999999999999999999999999


Q ss_pred             CCCCCC
Q psy3714         435 HPYFYP  440 (467)
Q Consensus       435 Hp~f~~  440 (467)
                      |+||..
T Consensus       337 h~yF~~  342 (438)
T KOG0666|consen  337 HPYFTE  342 (438)
T ss_pred             cccccc
Confidence            999975

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-40  Score=328.44  Aligned_cols=257  Identities=23%  Similarity=0.401  Sum_probs=199.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++++.||+|+||.||+|.+..+++.||||.+....      ...+.+|+++++.+. ||||+++++.+.+.  ...+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~--~~~~   77 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDA--QYLY   77 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcC--CeeE
Confidence            47999999999999999999999999999999885421      245678999999985 89999999998764  4689


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      +||||+++++|.+++.   .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.+.....
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~-~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEEeecccccccccccc
Confidence            9999999999987653   478899999999999999999999999999999999998554 799999999964321000


Q ss_pred             ------------------------------------------------cceeeeccCccCCcccccCCCCccchhHHHhh
Q psy3714         322 ------------------------------------------------YNVRVASRYFKGPELLADYQYHIELDPRFADI  353 (467)
Q Consensus       322 ------------------------------------------------~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~  353 (467)
                                                                      ....+||+.|+|||++.+..|+.++|+|..++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence                                                            01246999999999999988999999999888


Q ss_pred             hccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCC---CCHH
Q psy3714         354 LGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYER---LTAR  430 (467)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R---~ta~  430 (467)
                      +.+....+..||.....        ..... .+.      .|......+....+|++++|||++||+ +|.+|   +|++
T Consensus       237 il~elltG~~Pf~~~~~--------~~~~~-~i~------~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         237 IMFECLIGWPPFCSENS--------HETYR-KII------NWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             hhhhhhcCCCCCCCCCH--------HHHHH-HHH------ccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            87776666666532211        01111 111      011111112223479999999999998 77765   5999


Q ss_pred             HHhCCCCCCCccccccc
Q psy3714         431 EAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       431 e~l~Hp~f~~~~~~~~~  447 (467)
                      |+++||||.+++++..+
T Consensus       301 ~~l~hp~~~~~~~~~~~  317 (377)
T cd05629         301 EIKSHPFFRGVDWDTIR  317 (377)
T ss_pred             HHhcCCCcCCCCHHHHc
Confidence            99999999987765443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-40  Score=323.45  Aligned_cols=264  Identities=24%  Similarity=0.374  Sum_probs=205.5

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .+|++++.||+|+||.||+|.+..+++.||+|+++..      ....+.+|+.++..++ |+||++++..+.+.  ...+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~--~~~~   77 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDD--EYLY   77 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcC--CEEE
Confidence            3699999999999999999999999999999998743      2345678999999996 89999999988764  5689


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      +||||+++++|.+++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+....  .
T Consensus        78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~~~~--~  154 (333)
T cd05600          78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG-HIKLTDFGLSKGIVT--Y  154 (333)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEEEeCcCCccccc--c
Confidence            9999999999988764   478899999999999999999999999999999999998654 799999999986543  2


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+||+.|+|||++.+..|+.++|+|..+++.+....+..||.....     .+....+    ............  .
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i----~~~~~~~~~~~~--~  223 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-----NETWENL----KYWKETLQRPVY--D  223 (333)
T ss_pred             cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-----HHHHHHH----HhccccccCCCC--C
Confidence            3446799999999999998999999999888876666555555432211     0000100    000000000000  0


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccccccCCCC
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLP  451 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~~~~~~~  451 (467)
                      .....+|+++.+||.+||..+|.+|+|++|+++||||.+..++......+
T Consensus       224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~~~~~~~  273 (333)
T cd05600         224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKP  273 (333)
T ss_pred             ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHHHhhCCC
Confidence            00124699999999999999999999999999999999887765553333

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.3e-40  Score=322.24  Aligned_cols=256  Identities=23%  Similarity=0.336  Sum_probs=196.8

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      +.||+|+||.||+|.+..+++.||+|+++...      ...+.+|+.+++.+.+||||+.+++.+.+.  ...++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence            36899999999999999999999999987531      234678999999998899999999988764  5689999999


Q ss_pred             CCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec-CCCCCcceee
Q psy3714         251 NNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQEYNVRV  326 (467)
Q Consensus       251 ~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~-~~~~~~~~~~  326 (467)
                      ++++|....   ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.. ..+......+
T Consensus        79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEECcCccccccccCCCcccccc
Confidence            999987654   3589999999999999999999999999999999999998654 7999999999753 2233344567


Q ss_pred             eccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       327 gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      ||+.|+|||++.+..|+.++|+|..+++.+....+..||.......-............+...          ....+..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~p~~  227 (329)
T cd05588         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK----------QIRIPRS  227 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC----------CCCCCCC
Confidence            999999999999988999999998887766555555555321100000000001111111110          0011235


Q ss_pred             CChHHHHHHHhhcCcCCCCCCC------HHHHhCCCCCCCccccc
Q psy3714         407 VSPEALDFLDKLLRYDHYERLT------AREAMDHPYFYPIVKDQ  445 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~t------a~e~l~Hp~f~~~~~~~  445 (467)
                      +|+++.+||++||+.||.+|+|      ++|+++||||..+.|..
T Consensus       228 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~  272 (329)
T cd05588         228 LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL  272 (329)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHH
Confidence            7899999999999999999997      78999999999877643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.7e-40  Score=319.98  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=196.0

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      +.||+|+||.||+|.+..+++.||+|+++..      ......+|+.++..+.+||||+.+++.+.+.  ...++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcCC
Confidence            3689999999999999999999999998642      1244567888888877799999999988764  5689999999


Q ss_pred             CCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-CCCCcceee
Q psy3714         251 NNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRV  326 (467)
Q Consensus       251 ~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~~~~~~~~~  326 (467)
                      ++++|...+.   .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++... .+......+
T Consensus        79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCCCcccccc
Confidence            9999876653   588999999999999999999999999999999999998655 79999999988542 222234457


Q ss_pred             eccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       327 gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      ||+.|+|||++.+..|+.++|+|..+++.+....+..||.....     .....    .+...          ....+..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~----~i~~~----------~~~~~~~  218 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFE----AILND----------EVVYPTW  218 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHH----HHhcC----------CCCCCCC
Confidence            99999999999988899999999888876655555555432110     01111    11100          0011234


Q ss_pred             CChHHHHHHHhhcCcCCCCCCCH------HHHhCCCCCCCccccccc
Q psy3714         407 VSPEALDFLDKLLRYDHYERLTA------REAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~ta------~e~l~Hp~f~~~~~~~~~  447 (467)
                      +++++++||++||+.||++|+|+      +++++||||..+.|+...
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~  265 (320)
T cd05590         219 LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLN  265 (320)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence            79999999999999999999998      999999999988775543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2e-39  Score=318.10  Aligned_cols=252  Identities=22%  Similarity=0.301  Sum_probs=199.7

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      +|++++.||+|+||.||+|.+..+++.||+|+++..      ....+.+|+.++..+.++++|+.++..+.+.  ...++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence            589999999999999999999999999999998642      2345678999999998777899998888753  46899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-CCCC
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~~~~  321 (467)
                      ||||+++++|...+.   .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ....
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-HIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-CEEEeecCcceecCCCCCc
Confidence            999999999977653   478899999999999999999999999999999999998654 79999999987532 2223


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ....... +...          ..
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~-i~~~----------~~  218 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--------EDELFQS-IMEH----------NV  218 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHH-HHcC----------CC
Confidence            344679999999999999889999999988887665555555543211        0111111 1100          01


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCH-----HHHhCCCCCCCccccc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTA-----REAMDHPYFYPIVKDQ  445 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta-----~e~l~Hp~f~~~~~~~  445 (467)
                      ..+..+|+++++||++||+.||.+|+++     +++++||||..+++..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~  267 (324)
T cd05587         219 SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEK  267 (324)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence            1123579999999999999999999976     8999999999887743

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.2e-40  Score=321.28  Aligned_cols=260  Identities=26%  Similarity=0.383  Sum_probs=202.8

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|+++...      .+.+.+|+.+++.+ +|+||+.+...+.+.  ...+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~--~~~~   77 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDK--DNLY   77 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecC--CeEE
Confidence            47999999999999999999999999999999987532      24567888988877 489999999888753  4689


Q ss_pred             EEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      +||||+++++|.+++.    .+++..++.++.|++.||+|||++||+||||||+|||++..+ .+||+|||+|.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-HIKLADFGSAARLTANK  156 (330)
T ss_pred             EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC-CEEeccCCCCeECCCCC
Confidence            9999999999987763    478899999999999999999999999999999999998554 79999999998764433


Q ss_pred             Cc--ceeeeccCccCCcccc------cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         321 EY--NVRVASRYFKGPELLA------DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       321 ~~--~~~~gt~~y~aPE~l~------~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      ..  ...+||+.|+|||++.      ...|+.++|+|..+++.+....+..||......     ...    ..+...   
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~----~~i~~~---  224 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTY----NNIMNF---  224 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHH----HHHHcC---
Confidence            22  2346899999999987      345778899999998876666665555322110     000    111110   


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccccccCCC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTL  450 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~~~~~~  450 (467)
                         ......+....+++++++||++||+ ||++|+|++++++||||..+.++..+...
T Consensus       225 ---~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~~~~~  278 (330)
T cd05601         225 ---QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNIRNSL  278 (330)
T ss_pred             ---CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHHhhCC
Confidence               1111122234589999999999998 99999999999999999988776554433

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.4e-40  Score=329.42  Aligned_cols=254  Identities=25%  Similarity=0.370  Sum_probs=198.2

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .|++++.||+|+||.||+|.+..+++.+|+|++....      ...+.+|+.+++.+. |+||++++..+.+.  ...++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~--~~~~l   78 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDK--DNLYF   78 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeC--CEEEE
Confidence            5899999999999999999999999999999986432      245778999999995 89999999998764  56899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC--
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~--  320 (467)
                      ||||+++++|.+++.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..+....  
T Consensus        79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEeECCCCccccccccc
Confidence            999999999987763   478899999999999999999999999999999999998654 79999999985321000  


Q ss_pred             ----------------------------------------------CcceeeeccCccCCcccccCCCCccchhHHHhhh
Q psy3714         321 ----------------------------------------------EYNVRVASRYFKGPELLADYQYHIELDPRFADIL  354 (467)
Q Consensus       321 ----------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~  354 (467)
                                                                    .....+||+.|+|||++.+..|+.++|+|..+++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                          0112479999999999999999999999988877


Q ss_pred             ccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCC---HHH
Q psy3714         355 GRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT---ARE  431 (467)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~t---a~e  431 (467)
                      .+....+..||.....        ..... .+.      .|......+....+|++++|||.+|+ .||++|++   ++|
T Consensus       238 l~elltG~~Pf~~~~~--------~~~~~-~i~------~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         238 LYEMLVGQPPFLAQTP--------LETQM-KVI------NWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             HHHHHhCCCCCCCCCH--------HHHHH-HHH------ccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            6665555555532211        01000 011      01111111223458999999999987 59999997   999


Q ss_pred             HhCCCCCCCccccc
Q psy3714         432 AMDHPYFYPIVKDQ  445 (467)
Q Consensus       432 ~l~Hp~f~~~~~~~  445 (467)
                      +++||||..+++..
T Consensus       302 i~~hp~f~~~~~~~  315 (382)
T cd05625         302 IKAHPFFKTIDFSS  315 (382)
T ss_pred             HhcCCCcCCcChHH
Confidence            99999999887654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-39  Score=320.85  Aligned_cols=254  Identities=20%  Similarity=0.293  Sum_probs=202.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCC-CeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSS-DKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ..++|++.+.||+|+||.||+|.+..++ ..+|+|.+...      ....+.+|+.+++.++ ||||+++++.+.+.  .
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~--~  104 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDE--S  104 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeC--C
Confidence            4578999999999999999999876655 68999988542      2345678999999995 89999999998764  5


Q ss_pred             ccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      ..++||||+.+++|.+++.   .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-FIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEecCCCCeecCC
Confidence            6899999999999987764   488899999999999999999999999999999999998554 899999999987643


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      .  ....+||+.|+|||++.+..++.++|+|..+++.+....+..||.....        ..... .+...    .    
T Consensus       184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~-~i~~~----~----  244 (340)
T PTZ00426        184 R--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQ-KILEG----I----  244 (340)
T ss_pred             C--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHH-HHhcC----C----
Confidence            2  2346799999999999988899999999888877666666666543211        11111 11110    0    


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCccccccc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~  447 (467)
                        ...+..+++++++||++||+.||++|+     |++|+++||||..++|....
T Consensus       245 --~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~  296 (340)
T PTZ00426        245 --IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLL  296 (340)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence              011234789999999999999999996     89999999999998876544

>KOG4236|consensus

Probab=100.00  E-value=1.3e-40  Score=319.95  Aligned_cols=248  Identities=23%  Similarity=0.424  Sum_probs=203.7

Q ss_pred             eeee--EeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         173 YQLV--RKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       173 y~~~--~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      |++.  +.||+|.||+||-|.++++|+.||||++.+.     ....+.+|+.||+++. ||.||.+..+++.+  ..++.
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~-HPGiV~le~M~ET~--ervFV  640 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH-HPGIVNLECMFETP--ERVFV  640 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC-CCCeeEEEEeecCC--ceEEE
Confidence            5554  6799999999999999999999999998753     2356788999999995 89999999999876  45889


Q ss_pred             EEeccCCccHHHH----hhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC--CcEEEEecccceecCCC
Q psy3714         246 IFEHVNNTDFKQL----YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       246 v~e~~~~~~l~~~----~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~--~~ikl~DFGla~~~~~~  319 (467)
                      |||-+.|.-|.-.    ..++++...++++.||+.||+|||-+||+|+||||+|||+....  ..+||||||+|+++...
T Consensus       641 VMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  641 VMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             EehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            9999987554322    34799999999999999999999999999999999999997543  37999999999999777


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      +.....+|||.|.|||++.+.+|....|+|..+++.+..+.|..||-...+       ..+.++. ...-++...|    
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-------IndQIQN-AaFMyPp~PW----  788 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-------INDQIQN-AAFMYPPNPW----  788 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-------hhHHhhc-cccccCCCch----
Confidence            667778999999999999999999999999999998877777666533221       1111111 0112233333    


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                           ..+|++|.|||.++|+..=.+|.|++++|.|||+++
T Consensus       789 -----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  789 -----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             -----hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence                 458999999999999999999999999999999975

>KOG0607|consensus

Probab=100.00  E-value=3.5e-41  Score=306.36  Aligned_cols=266  Identities=24%  Similarity=0.374  Sum_probs=210.4

Q ss_pred             ccceeee-EeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLV-RKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .|-|++. +.||+|+|+.|--|.+..++.+||||++.+.   .+.++.||++++...++|+||+.|.++|++.  ..+|+
T Consensus        76 ~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd--~~FYL  153 (463)
T KOG0607|consen   76 EDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD--TRFYL  153 (463)
T ss_pred             HHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc--ceEEE
Confidence            3556665 4689999999999999999999999999865   3678999999999999999999999999875  46899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC--CcEEEEecccceecCCC-
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYHPG-  319 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~--~~ikl~DFGla~~~~~~-  319 (467)
                      |||-+.||.+.+.++   .+++.++..++..|..||+|||.+||.||||||+|||-...+  ..||||||.++..+.-. 
T Consensus       154 VfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~  233 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN  233 (463)
T ss_pred             EEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence            999999999877654   499999999999999999999999999999999999987554  25999999887543211 


Q ss_pred             -------CCcceeeeccCccCCcccc---cC--CCCccchhHHHhhhccccccccccccccCCcccCCh------hhhhh
Q psy3714         320 -------QEYNVRVASRYFKGPELLA---DY--QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP------EALDF  381 (467)
Q Consensus       320 -------~~~~~~~gt~~y~aPE~l~---~~--~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~  381 (467)
                             ....+.||+..|||||+..   +.  -|+..+|.|+.+++.+.++.|..||.+.-+...+..      .....
T Consensus       234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~  313 (463)
T KOG0607|consen  234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK  313 (463)
T ss_pred             CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence                   1234568999999999863   33  389999999999998888888888766443322211      11110


Q ss_pred             hhhhcc-CCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         382 LDKNIL-GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       382 ~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                      +-..|. +.+      . .+..+|..+|++++|||++||..|+.+|++|.++++|||+..+..+
T Consensus       314 LFesIQEGkY------e-FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  314 LFESIQEGKY------E-FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHHHhccCC------c-CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            001111 111      1 1223566799999999999999999999999999999999988755

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2e-39  Score=322.56  Aligned_cols=272  Identities=26%  Similarity=0.406  Sum_probs=199.3

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC---
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS---  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~---  240 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|.++..     ....+.+|+.+++.++ |+||+++.+++.....   
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCccc
Confidence            357899999999999999999999999999999998642     2356778999999995 8999999998754321   


Q ss_pred             -CccEEEEeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         241 -RTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       241 -~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                       ...++||||+.++........+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~  176 (359)
T cd07876          98 FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTN  176 (359)
T ss_pred             cceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEecCCCccccccC
Confidence             34689999998764444445688999999999999999999999999999999999998655 7999999999865444


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCc--------ccCCh--hhhhhhh---hhc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQ--------HLVSP--EALDFLD---KNI  386 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~---~~~  386 (467)
                      .......||+.|+|||++.+..|+.++|+|..+++.+....+..+|......        .+..+  .......   ...
T Consensus       177 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (359)
T cd07876         177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY  256 (359)
T ss_pred             ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence            3445567899999999999989999999998888766555555554322110        00000  0000000   000


Q ss_pred             c---CCCCcccccc----cc---cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         387 L---GRHSRKRWER----FV---HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       387 ~---~~~~~~~~~~----~~---~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .   .......+..    +.   ........+++++|||.+||++||++|||++|+|+||||....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  322 (359)
T cd07876         257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY  322 (359)
T ss_pred             HhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence            0   0000000000    00   0011223578999999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-39  Score=323.96  Aligned_cols=258  Identities=22%  Similarity=0.382  Sum_probs=202.0

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++++.||+|+||.||+|.+..+++.+|+|+++..      ....+.+|+.++..+. |+||++++..+.+.  ...+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~--~~~~   77 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDK--RNLY   77 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcC--CEEE
Confidence            5799999999999999999999999999999998642      2345678999999985 89999999988764  5689


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-  320 (467)
                      +||||+++++|.+++.   .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+...... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~-~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEeeccCCcccccccc
Confidence            9999999999987753   488999999999999999999999999999999999998655 79999999987542110 


Q ss_pred             -----------------------------------CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccc
Q psy3714         321 -----------------------------------EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERF  365 (467)
Q Consensus       321 -----------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~  365 (467)
                                                         .....+||+.|+|||++.+..|+.++|+|..+++.+....+..||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                               012347999999999999999999999999998877766666665


Q ss_pred             cccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCC---CHHHHhCCCCCCCcc
Q psy3714         366 VHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL---TAREAMDHPYFYPIV  442 (467)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~---ta~e~l~Hp~f~~~~  442 (467)
                      .....        ..... .+..      |......+....+|++++|||.+|+. ||.+|+   +++|+++||||.+++
T Consensus       237 ~~~~~--------~~~~~-~i~~------~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~  300 (360)
T cd05627         237 CSETP--------QETYR-KVMN------WKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVD  300 (360)
T ss_pred             CCCCH--------HHHHH-HHHc------CCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCC
Confidence            33211        01000 1110      11111111122479999999999885 999998   489999999999998


Q ss_pred             cccccC
Q psy3714         443 KDQSRH  448 (467)
Q Consensus       443 ~~~~~~  448 (467)
                      |...+.
T Consensus       301 ~~~~~~  306 (360)
T cd05627         301 WGHIRE  306 (360)
T ss_pred             HHHHhc
Confidence            865543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-39  Score=326.92  Aligned_cols=259  Identities=22%  Similarity=0.306  Sum_probs=193.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      ..+|++++.||+|+||.||+|.+..+++.||+|...   ...+.+|+++++.++ ||||+++++.+...  ...+++|++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l~-HpnIv~~~~~~~~~--~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAIN-HPSIIQLKGTFTYN--KFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhCC-CCCCCCEeEEEEEC--CeeEEEEec
Confidence            467999999999999999999999999999999754   346789999999996 89999999988753  467899999


Q ss_pred             cCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC--CCcce
Q psy3714         250 VNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG--QEYNV  324 (467)
Q Consensus       250 ~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~--~~~~~  324 (467)
                      +. +++....   ..++..++..++.||+.||+|||++|||||||||+|||++..+ .+||+|||+|+.....  .....
T Consensus       165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~~~~~~  242 (391)
T PHA03212        165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINANKYYG  242 (391)
T ss_pred             CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-CEEEEeCCccccccccccccccc
Confidence            86 4555443   3478889999999999999999999999999999999998655 7999999999754221  22334


Q ss_pred             eeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcc--cCChhhhhhh-------------------h
Q psy3714         325 RVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQH--LVSPEALDFL-------------------D  383 (467)
Q Consensus       325 ~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-------------------~  383 (467)
                      .+||+.|+|||++.+..|+.++|+|..+++.+....+..+++......  .........+                   .
T Consensus       243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~  322 (391)
T PHA03212        243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD  322 (391)
T ss_pred             ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence            579999999999999899999999988887666555555554321100  0000000000                   0


Q ss_pred             hh---ccCC-----CCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         384 KN---ILGR-----HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       384 ~~---~~~~-----~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ..   ....     ..+..|..      ...++.++.+||++||++||++||||+|+|+||||..+.
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        323 EIYIGLAKKSSRKPGSRPLWTN------LYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             HHHHHHHhccCCCCCCCCCHHH------HhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence            00   0000     00001110      112567899999999999999999999999999998653

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.6e-39  Score=325.44  Aligned_cols=255  Identities=24%  Similarity=0.356  Sum_probs=199.7

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .+|++++.||+|+||.||+|.+..+++.||+|++...      ....+.+|+.+|+.+. |+||++++..+.+.  ...+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~--~~~~   77 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDK--DNLY   77 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcC--CEEE
Confidence            3799999999999999999999999999999998642      2345778999999996 89999999998764  5789


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC--
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG--  319 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~--  319 (467)
                      +||||+++++|.+++.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..+...  
T Consensus        78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC-CEEEEeCCCCcccccccc
Confidence            9999999999988764   478888999999999999999999999999999999998655 7999999998532100  


Q ss_pred             ------------------------------------------CCcceeeeccCccCCcccccCCCCccchhHHHhhhccc
Q psy3714         320 ------------------------------------------QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRH  357 (467)
Q Consensus       320 ------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~  357 (467)
                                                                ......+||+.|+|||++.+..|+.++|+|..+++.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                      00112479999999999999999999999999988776


Q ss_pred             cccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCC---CHHHHhC
Q psy3714         358 SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL---TAREAMD  434 (467)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~---ta~e~l~  434 (467)
                      ...+..||.....        ...... +.      .|......+....+|+++++||.+|+ .||.+|+   |++|+++
T Consensus       237 ll~G~~Pf~~~~~--------~~~~~~-i~------~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         237 MLVGQPPFLADTP--------AETQLK-VI------NWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             hhhCCCCCCCCCH--------HHHHHH-Hh------ccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            6666666533211        010000 10      11111111223357999999999987 5999999   9999999


Q ss_pred             CCCCCCccccc
Q psy3714         435 HPYFYPIVKDQ  445 (467)
Q Consensus       435 Hp~f~~~~~~~  445 (467)
                      ||||..+++..
T Consensus       301 h~~~~~~~~~~  311 (376)
T cd05598         301 HPFFKGIDFAS  311 (376)
T ss_pred             CCCcCCCCHHH
Confidence            99999876543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.9e-39  Score=311.75  Aligned_cols=260  Identities=25%  Similarity=0.464  Sum_probs=190.1

Q ss_pred             cceeeeEeecccCCcceEEEEEcc-CCCeEEEEEeccch-----HHHHHHHHHHHHHhc--CCCCeeEEEEEEeC---CC
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQ-SSDKCVVKILKPVK-----KKKIKREIKILENLR--GGTNIITLQAVVKD---PV  239 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~--~~~~iv~l~~~~~~---~~  239 (467)
                      ++|++++.||+|+||.||+|.+.. ++..+|+|.++...     .....+|+.+++.+.  .||||+++++++..   ..
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            369999999999999999999865 46789999876421     235678888888775  48999999988742   22


Q ss_pred             CCccEEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccce
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE  314 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~  314 (467)
                      ....++||||+++ ++.++..     .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus        81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~~  158 (290)
T cd07862          81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLAR  158 (290)
T ss_pred             CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-CEEEccccceE
Confidence            3467999999975 6666553     378889999999999999999999999999999999998655 79999999998


Q ss_pred             ecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         315 FYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       315 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ............||+.|+|||++.+..++.++|+|..+++.+....+..+|.......    ......+.  .+......
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~----~~~~i~~~--~~~~~~~~  232 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD----QLGKILDV--IGLPGEED  232 (290)
T ss_pred             eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH----HHHHHHHH--hCCCChhh
Confidence            7654444455679999999999988889999999988877555444433332221100    00000000  00000001


Q ss_pred             ccc--------c---c---cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         395 WER--------F---V---HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       395 ~~~--------~---~---~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      |..        +   .   .....+.++++++|||.+||+.||++|||+.|+|+||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            100        0   0   000113478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.9e-39  Score=317.09  Aligned_cols=254  Identities=24%  Similarity=0.389  Sum_probs=196.8

Q ss_pred             ceeeeEeecccCCcceEEEEEc---cCCCeEEEEEeccch-------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINV---QSSDKCVVKILKPVK-------KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~-------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      +|++++.||+|+||.||++.+.   .+++.+|+|++++..       .+...+|+.+++.+.+|+||+.++..+...  .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--A   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--C
Confidence            5899999999999999998864   478899999986421       235678999999998899999999888653  4


Q ss_pred             ccEEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         242 TPALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      ..++||||+.++++.+.+   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+..
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-~~kl~DfG~~~~~~~  157 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-CEEEeeCcCCccccc
Confidence            689999999999987765   3588999999999999999999999999999999999998655 799999999986533


Q ss_pred             CC--CcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         319 GQ--EYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       319 ~~--~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      ..  .....+||+.|+|||++.+.. ++.++|+|..+++.+....+..||.......     ........+...      
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~~~~~~~~~~~------  226 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-----TQSEVSRRILKC------  226 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-----CHHHHHHHHhcC------
Confidence            22  223457999999999998754 7888999988887666656555543211100     000011111100      


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCccc
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVK  443 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~  443 (467)
                          ....+..+++++++||.+||+.||++|+     +++|+++||||.+..+
T Consensus       227 ----~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         227 ----DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                1112235799999999999999999999     7889999999987654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.1e-39  Score=318.42  Aligned_cols=257  Identities=23%  Similarity=0.333  Sum_probs=196.6

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      +.||+|+||.||+|.+..+++.+|+|++++..      ...+.+|+.++..+.+||||+.+++.+.+.  ...++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeCC
Confidence            36899999999999999999999999987531      235678999988887799999999988764  5689999999


Q ss_pred             CCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-CCCCcceee
Q psy3714         251 NNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRV  326 (467)
Q Consensus       251 ~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~~~~~~~~~  326 (467)
                      ++++|....   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ........+
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCCCcccccc
Confidence            999987654   3588999999999999999999999999999999999998655 79999999997532 222334467


Q ss_pred             eccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       327 gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      ||+.|+|||++.+..|+.++|+|..+++.+....+..||....................+...          ....+..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----------~~~~p~~  227 (329)
T cd05618         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------QIRIPRS  227 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC----------CCCCCCC
Confidence            999999999999988999999998887766655565555321100000000001111111110          0112335


Q ss_pred             CChHHHHHHHhhcCcCCCCCCC------HHHHhCCCCCCCcccccc
Q psy3714         407 VSPEALDFLDKLLRYDHYERLT------AREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~t------a~e~l~Hp~f~~~~~~~~  446 (467)
                      +++++++||++||+.||++|+|      ++|+++||||..++|...
T Consensus       228 ~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~  273 (329)
T cd05618         228 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLM  273 (329)
T ss_pred             CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHH
Confidence            7899999999999999999998      479999999998877533

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=323.04  Aligned_cols=258  Identities=26%  Similarity=0.463  Sum_probs=204.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++++.||+|+||.||+|.+..+++.||+|+++..      ....+.+|+.++..+. |+||+.++..+.+.  ...+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~--~~~~   77 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDE--EHLY   77 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecC--CeEE
Confidence            4799999999999999999999999999999998643      2345678999999986 89999999888753  5689


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-  320 (467)
                      +||||+.+++|.+.+.   .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++...... 
T Consensus        78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEeecCCCCccCcccCc
Confidence            9999999999987753   588999999999999999999999999999999999998655 79999999998654332 


Q ss_pred             -----------------------------CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCc
Q psy3714         321 -----------------------------EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQ  371 (467)
Q Consensus       321 -----------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~  371 (467)
                                                   .....+||+.|+|||++.+..++.++|+|..+++.+....+..||..... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-  235 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL-  235 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH-
Confidence                                         22345799999999999999999999999988887666666656543211 


Q ss_pred             ccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCC-HHHHhCCCCCCCcccccccC
Q psy3714         372 HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-AREAMDHPYFYPIVKDQSRH  448 (467)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~t-a~e~l~Hp~f~~~~~~~~~~  448 (467)
                             ..... .+.      .|......+....+++++++||.+||. ||.+|++ ++|+++||||.+++++....
T Consensus       236 -------~~~~~-~i~------~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~~~~  298 (350)
T cd05573         236 -------QETYN-KII------NWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENLRE  298 (350)
T ss_pred             -------HHHHH-HHh------ccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHHHhh
Confidence                   00000 111      011111111222379999999999998 9999999 99999999999988765543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.6e-39  Score=311.58  Aligned_cols=262  Identities=26%  Similarity=0.479  Sum_probs=194.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|+++..     ..+.+.+|+++++.++ |+||+++.+.+...  ...++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENIVELKEAFRRR--GKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC-CccccchhhhEecC--CEEEE
Confidence            4799999999999999999999999999999988643     2346788999999996 89999999888653  56899


Q ss_pred             EEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC--
Q psy3714         246 IFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~--  320 (467)
                      ||||+.++.+..+.   ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+|.......  
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccCcccccccccc
Confidence            99999988765543   2478889999999999999999999999999999999998554 79999999998764322  


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcc-c---------CChhhhhhhhhhccCCC
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQH-L---------VSPEALDFLDKNILGRH  390 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~-~---------~~~~~~~~~~~~~~~~~  390 (467)
                      ......||+.|+|||++.+..++.++|+|..+++.+....+..||....... +         ...........+.  ..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  234 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP--RF  234 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc--hh
Confidence            2234578999999999998889999999988887665555544442211100 0         0000000000000  00


Q ss_pred             Ccccccccc-----cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         391 SRKRWERFV-----HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       391 ~~~~~~~~~-----~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ....+....     .......+|++++|||++||++||++|+|++|+|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            000000000     001112478999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2e-39  Score=318.49  Aligned_cols=245  Identities=24%  Similarity=0.330  Sum_probs=193.5

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      +.||+|+||.||+|.+..+++.||+|+++..      ....+.+|+.+++.+. ||||+.+...+...  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~~~lv~Ey~   77 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTK--DRLCFVMEYV   77 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcC--CEEEEEEeCC
Confidence            3689999999999999999999999998643      1245678999999985 89999999888754  5689999999


Q ss_pred             CCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-CCCcceee
Q psy3714         251 NNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRV  326 (467)
Q Consensus       251 ~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~~~~~~~~  326 (467)
                      +++++.....   .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus        78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~  156 (328)
T cd05593          78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDAATMKTFC  156 (328)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCccccccccc
Confidence            9999876553   478999999999999999999999999999999999998554 799999999986422 22233457


Q ss_pred             eccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       327 gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      ||+.|+|||++.+..++.++|+|..+++.+....+..||.....        ..... .+...          ....+..
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~~~~~-~~~~~----------~~~~p~~  217 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFE-LILME----------DIKFPRT  217 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--------HHHHH-HhccC----------CccCCCC
Confidence            99999999999988899999999888776655555555432110        11111 11000          0011235


Q ss_pred             CChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccc
Q psy3714         407 VSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKD  444 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~  444 (467)
                      +++++++||++||+.||++|+     |++|+++||||.+..+.
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            799999999999999999997     89999999999987764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6.3e-39  Score=319.63  Aligned_cols=272  Identities=24%  Similarity=0.385  Sum_probs=198.3

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC----
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPV----  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~----  239 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.+|||.++..     ....+.+|+.+++.++ |+||+.+.+++....    
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC-CCCccccceeecccccccc
Confidence            357899999999999999999999999999999998642     2346778999999985 899999988775422    


Q ss_pred             CCccEEEEeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ....++||||+.++....+...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus       101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~  179 (364)
T cd07875         101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTS  179 (364)
T ss_pred             cCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-cEEEEeCCCccccCCC
Confidence            235799999998754444444688889999999999999999999999999999999998654 7999999999876544


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCc--------ccC--Chhhhhhhhhh---c
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQ--------HLV--SPEALDFLDKN---I  386 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~~---~  386 (467)
                      ......+||+.|+|||++.+..++.++|+|..+++.+....+..+|......        .+.  .+.........   .
T Consensus       180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (364)
T cd07875         180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY  259 (364)
T ss_pred             CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHH
Confidence            3344567999999999999989999999998888766555555554322110        000  01110000000   0


Q ss_pred             c---CCCCcccccccc-------cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         387 L---GRHSRKRWERFV-------HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       387 ~---~~~~~~~~~~~~-------~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .   .......+....       ........+++++|||.+||++||.+|||++|+|+||||....
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~  325 (364)
T cd07875         260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  325 (364)
T ss_pred             HhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence            0   000000000000       0111123467899999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4e-39  Score=314.89  Aligned_cols=259  Identities=26%  Similarity=0.479  Sum_probs=184.1

Q ss_pred             EeecccCCcceEEEEEc--cCCCeEEEEEeccch-HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCCc
Q psy3714         177 RKLGRGKYSEVFEAINV--QSSDKCVVKILKPVK-KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNT  253 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~~-~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~~  253 (467)
                      ++||+|+||.||+|.+.  .+++.+|+|.++... ...+.+|+.+++.++ ||||+++.+.+........+++|||+.+ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEH-   84 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence            57999999999999865  466889999887542 356789999999996 8999999998876555678999999876 


Q ss_pred             cHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC---CCCcEEEEecccceecCC
Q psy3714         254 DFKQLYQ------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH---ENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       254 ~l~~~~~------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~---~~~~ikl~DFGla~~~~~  318 (467)
                      ++..+..            .+++..++.++.||+.||+|||++||+||||||+|||++.   ..+.+||+|||+|+....
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence            4544321            3788889999999999999999999999999999999942   334799999999987643


Q ss_pred             CC----CcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccC-Chhhhhhhhh--hccCCC
Q psy3714         319 GQ----EYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLV-SPEALDFLDK--NILGRH  390 (467)
Q Consensus       319 ~~----~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~  390 (467)
                      ..    .....+||+.|+|||++.+. .|+.++|+|+.+++......+..+|......... .+........  ...+..
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T cd07868         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP  244 (317)
T ss_pred             CCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCC
Confidence            21    22346789999999999875 4888999998887766555555444322111000 0000000000  000000


Q ss_pred             Cccccc--------------------------ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         391 SRKRWE--------------------------RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       391 ~~~~~~--------------------------~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ....|.                          .+.. ......+++++|||++||++||++|+||+|+|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME-KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             ChHHhHHHhhccchhhhhhhhhccccCcccccchHH-hcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            000000                          0000 1112346789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.2e-39  Score=309.02  Aligned_cols=259  Identities=24%  Similarity=0.456  Sum_probs=191.0

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhc--CCCCeeEEEEEEeCC---CCC
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLR--GGTNIITLQAVVKDP---VSR  241 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~--~~~~iv~l~~~~~~~---~~~  241 (467)
                      +|++++.||+|+||.||+|.+..+++.+|+|.++...     .....+|+.+++.+.  .|+||+++.+++...   ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4899999999999999999999999999999886421     235678888888775  589999999887542   234


Q ss_pred             ccEEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         242 TPALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      ..+++|||+.+ ++.++..     .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~kl~dfg~~~~~  158 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLARIY  158 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccCccccc
Confidence            57899999986 6655543     378899999999999999999999999999999999998655 7999999999876


Q ss_pred             CCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         317 HPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       317 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      ..........||..|+|||++.+..++.++|+|..+++.+....+..+| .+...    ........ ...+......|.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f-~~~~~----~~~~~~~~-~~~~~~~~~~~~  232 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF-CGNSE----ADQLGKIF-DLIGLPPEDDWP  232 (288)
T ss_pred             cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCc-CCCCH----HHHHHHHH-HHhCCCChhhCc
Confidence            5444444567899999999999888999999998887755444333332 21110    00000000 000000000110


Q ss_pred             c--------cc------cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         397 R--------FV------HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       397 ~--------~~------~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      .        +.      .....+.++++++|||.+||++||++|||+.|+++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0        00      001113478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.3e-39  Score=317.35  Aligned_cols=246  Identities=23%  Similarity=0.357  Sum_probs=193.8

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      +.||+|+||.||++.+..+++.||+|+++..      ....+.+|+.+++.++ ||||+.+++.+...  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~--~~~~lv~E~~   77 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTH--DRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecC--CEEEEEEeCC
Confidence            3689999999999999999999999998643      1234568999999995 89999999888764  4689999999


Q ss_pred             CCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-CCCcceee
Q psy3714         251 NNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRV  326 (467)
Q Consensus       251 ~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~~~~~~~~  326 (467)
                      ++++|.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCCCcccccc
Confidence            9999876553   478999999999999999999999999999999999998655 799999999875422 22233457


Q ss_pred             eccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       327 gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      ||+.|+|||++.+..|+.++|+|..+++.+....+..||.....        ...........           ...+..
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~~~~-----------~~~p~~  217 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEE-----------IRFPRT  217 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCC-----------CCCCCC
Confidence            99999999999988899999999888876555555555432211        01111000000           011235


Q ss_pred             CChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCccccc
Q psy3714         407 VSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQ  445 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~  445 (467)
                      +++++++||.+||+.||++|+     +++++++||||....|..
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~  261 (323)
T cd05595         218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD  261 (323)
T ss_pred             CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence            799999999999999999998     899999999999877643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=315.15  Aligned_cols=242  Identities=22%  Similarity=0.345  Sum_probs=192.0

Q ss_pred             ecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCC
Q psy3714         179 LGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNN  252 (467)
Q Consensus       179 lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~  252 (467)
                      ||+|+||.||+|.+..+++.||+|+++..      ....+.+|+.+++.++ ||||+.+...+.+.  ...++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e~~~~   77 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSP--EKLYLVLAFING   77 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecC--CeEEEEEcCCCC
Confidence            69999999999999999999999998642      1245678999999995 89999999888754  568999999999


Q ss_pred             ccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-CCCcceeeec
Q psy3714         253 TDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVAS  328 (467)
Q Consensus       253 ~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~~~~~~~~gt  328 (467)
                      ++|.+.+.   .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.... .......+||
T Consensus        78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCccccccCC
Confidence            99977653   488899999999999999999999999999999999998555 799999999986432 2223446799


Q ss_pred             cCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCC
Q psy3714         329 RYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVS  408 (467)
Q Consensus       329 ~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  408 (467)
                      +.|+|||++.+..|+.++|+|..+++.+....+..||....        ...... .+...          ....+..++
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~-~~~~~----------~~~~~~~~~  217 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYR-KILQE----------PLRFPDGFD  217 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHH-HHHcC----------CCCCCCcCC
Confidence            99999999999899999999988887666555555553211        111111 11100          011123578


Q ss_pred             hHHHHHHHhhcCcCCCCCC---CHHHHhCCCCCCCccc
Q psy3714         409 PEALDFLDKLLRYDHYERL---TAREAMDHPYFYPIVK  443 (467)
Q Consensus       409 ~~~~dli~~lL~~dp~~R~---ta~e~l~Hp~f~~~~~  443 (467)
                      +++++||.+||+.||++|+   +|.|+|+||||....+
T Consensus       218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~  255 (312)
T cd05585         218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW  255 (312)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence            9999999999999999997   5899999999998754

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.3e-39  Score=314.13  Aligned_cols=248  Identities=22%  Similarity=0.286  Sum_probs=195.6

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      +.||+|+||.||+|.+..+++.||+|+++...      ......|.+++..+.+||||+.+++.+.+.  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeCC
Confidence            36899999999999999999999999986431      234567888888877899999999998764  4689999999


Q ss_pred             CCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-CCCCcceee
Q psy3714         251 NNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRV  326 (467)
Q Consensus       251 ~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~~~~~~~~~  326 (467)
                      ++++|...+.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+... ........+
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeecccceecccCCccccccc
Confidence            9999876553   578899999999999999999999999999999999998655 79999999998643 222234457


Q ss_pred             eccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       327 gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      ||+.|+|||++.+..|+.++|+|..+++.+....+..||.....        ...... +...          ....+..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~-i~~~----------~~~~p~~  218 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFES-ILHD----------DVLYPVW  218 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHH-HHcC----------CCCCCCC
Confidence            99999999999988899999999888876655555555432211        111111 1100          0011234


Q ss_pred             CChHHHHHHHhhcCcCCCCCC-------CHHHHhCCCCCCCcccccc
Q psy3714         407 VSPEALDFLDKLLRYDHYERL-------TAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~-------ta~e~l~Hp~f~~~~~~~~  446 (467)
                      +++++++||++||+.||++|+       |++++++||||..++|+..
T Consensus       219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~  265 (321)
T cd05591         219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL  265 (321)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHH
Confidence            789999999999999999999       9999999999998877543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.9e-39  Score=319.26  Aligned_cols=257  Identities=22%  Similarity=0.316  Sum_probs=200.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|.++..      ....+.+|+.+++.++ ||||+.+++.+.+.  ..
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~--~~  117 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDD--KY  117 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecC--CE
Confidence            357899999999999999999999999999999998642      1234678999999885 89999999988763  56


Q ss_pred             cEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      .++||||+++++|.++..  .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC-CEEEEeccceeeccCCC
Confidence            899999999999988764  478888999999999999999999999999999999998554 79999999998764332


Q ss_pred             C--cceeeeccCccCCcccccC----CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         321 E--YNVRVASRYFKGPELLADY----QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       321 ~--~~~~~gt~~y~aPE~l~~~----~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      .  ....+||+.|+|||++.+.    .++.++|+|..+++.+....+..||.....     ....    ..+....... 
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~----~~i~~~~~~~-  266 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTY----SKIMDHKNSL-  266 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----HHHH----HHHHcCCCcC-
Confidence            1  2345799999999998754    378899999888876666566555533211     0011    1111100000 


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCCcccc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYE--RLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~--R~ta~e~l~Hp~f~~~~~~  444 (467)
                           ..+....+|++++|||++||+.+|++  |+|++|+++||||....|.
T Consensus       267 -----~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~  313 (370)
T cd05596         267 -----TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT  313 (370)
T ss_pred             -----CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence                 11122347999999999999999998  9999999999999876543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.1e-38  Score=313.08  Aligned_cols=256  Identities=23%  Similarity=0.335  Sum_probs=198.8

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      +.||+|+||.||+|.+..+++.+|+|+++...      ...+.+|+.++..+.+|+||+.+++.+.+.  ...++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeCC
Confidence            36899999999999999999999999987532      234678999999998899999999988764  4689999999


Q ss_pred             CCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec-CCCCCcceee
Q psy3714         251 NNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQEYNVRV  326 (467)
Q Consensus       251 ~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~-~~~~~~~~~~  326 (467)
                      ++++|...+   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.. .........+
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCCCceeccc
Confidence            999997665   3589999999999999999999999999999999999999655 7999999999853 2233334567


Q ss_pred             eccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       327 gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      ||+.|+|||++.+..|+.++|+|..+++.+....+..||...........  .......+...          ....+..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~--~~~~~~~~~~~----------~~~~p~~  225 (327)
T cd05617         158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT--EDYLFQVILEK----------PIRIPRF  225 (327)
T ss_pred             CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc--HHHHHHHHHhC----------CCCCCCC
Confidence            99999999999998999999999888876665556555532211110000  00011111100          0112335


Q ss_pred             CChHHHHHHHhhcCcCCCCCCC------HHHHhCCCCCCCccccccc
Q psy3714         407 VSPEALDFLDKLLRYDHYERLT------AREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~t------a~e~l~Hp~f~~~~~~~~~  447 (467)
                      +|+++++||++||+.||++|+|      .+++++||||..++|+...
T Consensus       226 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~  272 (327)
T cd05617         226 LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLE  272 (327)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHH
Confidence            7899999999999999999998      4799999999998876443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9.3e-39  Score=312.16  Aligned_cols=247  Identities=21%  Similarity=0.305  Sum_probs=194.3

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      +.||+|+||.||+|.+..+++.||+|+++..      ......+|..++..+.+|+||+++++.+.+.  ...++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECCC
Confidence            3689999999999999999999999998753      2244667888887776799999999988763  5789999999


Q ss_pred             CCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-CCCcceee
Q psy3714         251 NNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRV  326 (467)
Q Consensus       251 ~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~~~~~~~~  326 (467)
                      .+++|...+.   .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus        79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCCCceeccC
Confidence            9999876653   478899999999999999999999999999999999998655 799999999975322 22234467


Q ss_pred             eccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       327 gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      ||+.|+|||++.+..|+.++|+|..+++.+....+..||.....     .........   .           ....+..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~~~~---~-----------~~~~~~~  218 (316)
T cd05620         158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFESIRV---D-----------TPHYPRW  218 (316)
T ss_pred             CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh---C-----------CCCCCCC
Confidence            99999999999998999999999888876665555555532211     011111100   0           0111234


Q ss_pred             CChHHHHHHHhhcCcCCCCCCCH-HHHhCCCCCCCccccc
Q psy3714         407 VSPEALDFLDKLLRYDHYERLTA-REAMDHPYFYPIVKDQ  445 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~ta-~e~l~Hp~f~~~~~~~  445 (467)
                      +++++++||++||..||++|+|+ +++++||||..+++..
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~~  258 (316)
T cd05620         219 ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTA  258 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHHH
Confidence            79999999999999999999997 5899999999887643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.2e-38  Score=317.66  Aligned_cols=255  Identities=22%  Similarity=0.305  Sum_probs=197.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++++.||+|+||.||+|.+..+++.+|+|++++.      ....+.+|+.+++.+. ||||+++.+.+.+.  ...
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~--~~~  118 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDD--KYL  118 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcC--CEE
Confidence            47899999999999999999999999999999998642      1234678999998885 89999999988764  568


Q ss_pred             EEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      ++||||+++++|.++..  .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|........
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-HLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEEecccceecccCCc
Confidence            99999999999988764  478889999999999999999999999999999999998554 799999999987643222


Q ss_pred             --cceeeeccCccCCcccccCC----CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         322 --YNVRVASRYFKGPELLADYQ----YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       322 --~~~~~gt~~y~aPE~l~~~~----~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                        ....+||+.|+|||++....    |+.++|+|..+++.+....+..||.....        ..... .+........ 
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~~-~i~~~~~~~~-  267 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTYS-KIMDHKNSLN-  267 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHHH-HHHhCCcccC-
Confidence              23457999999999997643    77889999888776666566666533211        01111 1111000011 


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCCccc
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYE--RLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~--R~ta~e~l~Hp~f~~~~~  443 (467)
                           .+....+|+.+++||.+||+.++.+  |+|++|+++||||....+
T Consensus       268 -----~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         268 -----FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             -----CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence                 1122347999999999999866654  889999999999987543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0201|consensus

Probab=100.00  E-value=1.8e-40  Score=314.20  Aligned_cols=249  Identities=22%  Similarity=0.344  Sum_probs=199.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ...|..++.||+|+||.||+|.+..+++.||+|++.-.    .-..+++|+.+|..+. ++||..++..|...  ..+++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~-~~~it~yygsyl~g--~~Lwi   88 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKG--TKLWI   88 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcC-cchHHhhhhheeec--ccHHH
Confidence            35577789999999999999999999999999998743    2356889999999997 69999998887653  45889


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-  321 (467)
                      +||||.||....+++   .+.+..+..++++++.||.|||+++.+|||||+.|||+..+ +.+||+|||+|........ 
T Consensus        89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES-GDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc-CcEEEEecceeeeeechhhc
Confidence            999999999887765   24788899999999999999999999999999999999966 5799999999987654333 


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ..+.+|||+|||||++....|+.++|+|..++.......|..|+...-....     +-     +..+......      
T Consensus       168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-----lf-----lIpk~~PP~L------  231 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-----LF-----LIPKSAPPRL------  231 (467)
T ss_pred             cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-----EE-----eccCCCCCcc------
Confidence            3567999999999999988999999999999877666666555432211000     00     0001111111      


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                        ....|+.+++||..||++||+.||||.++|+|+|+..
T Consensus       232 --~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  232 --DGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             --ccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence              1136899999999999999999999999999999976

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.4e-38  Score=312.00  Aligned_cols=254  Identities=21%  Similarity=0.283  Sum_probs=200.0

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      +|++++.||+|+||.||+|.+..+++.||+|++++..      ......|..++..+.+|++|+.+...+.+.  ...++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEE
Confidence            5899999999999999999999999999999987431      234567888888887889999999888753  56899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-CCC
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~~~  321 (467)
                      ||||+++++|.....   .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... ...
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-cEEEccCCCceecCCCCCc
Confidence            999999999976653   588999999999999999999999999999999999999655 799999999985432 223


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+||+.|+|||++.+..|+.++|+|..+++.+....+..||.....        ..... .+...    .      .
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~-~i~~~----~------~  218 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQ-SIMEH----N------V  218 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHH-HHHhC----C------C
Confidence            3446799999999999999999999999888776655555555432111        11111 11100    0      0


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCccccccc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~~~~  447 (467)
                      ..+..+|+++++||.+||++||.+|++     .+++++||||..++|....
T Consensus       219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~  269 (323)
T cd05616         219 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE  269 (323)
T ss_pred             CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence            112347999999999999999999997     4899999999988875443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.6e-39  Score=317.97  Aligned_cols=272  Identities=24%  Similarity=0.384  Sum_probs=198.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC----
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPV----  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~----  239 (467)
                      ..++|++++.||+|+||.||+|.+..+++.+|+|.++..     ......+|+.+++.++ |+||+.+.+.+....    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccccccc
Confidence            357999999999999999999999999999999988642     2346678999999985 899999999875432    


Q ss_pred             CCccEEEEeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ....+++|||++++....+...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus        94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-~~kl~Dfg~~~~~~~~  172 (355)
T cd07874          94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTS  172 (355)
T ss_pred             cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-CEEEeeCcccccCCCc
Confidence            134689999998754444445688899999999999999999999999999999999998554 7999999999876544


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcc--------c--CChhhhhhhhh---hc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQH--------L--VSPEALDFLDK---NI  386 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~--~~~~~~~~~~~---~~  386 (467)
                      ......+||+.|+|||++.+..|+.++|+|..+++.+....+..+|.......        +  ..++.......   ..
T Consensus       173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (355)
T cd07874         173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY  252 (355)
T ss_pred             cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHH
Confidence            33445679999999999999889999999988877655544444443211000        0  00000000000   00


Q ss_pred             c---CCCCccccccc-----c--cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         387 L---GRHSRKRWERF-----V--HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       387 ~---~~~~~~~~~~~-----~--~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .   .......+...     .  ........+++++|||.+||+.||++|||++|+|+||||....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             HhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence            0   00000000000     0  0111233578899999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.9e-39  Score=314.87  Aligned_cols=247  Identities=23%  Similarity=0.359  Sum_probs=194.3

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      +.||+|+||.||+|.+..+++.+|+|+++...      .....+|+++++.+. |+||+.+...+...  ...++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~--~~~~lv~E~~   77 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTH--DRLCFVMEYA   77 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcC--CEEEEEEeCC
Confidence            36899999999999999999999999987531      234567889998885 89999999888764  4689999999


Q ss_pred             CCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCCcEEEEecccceecC-CCCCccee
Q psy3714         251 NNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVR  325 (467)
Q Consensus       251 ~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~~~~~~~~  325 (467)
                      +++++.....   .+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|+... ........
T Consensus        78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~  156 (325)
T cd05594          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTF  156 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCcccccc
Confidence            9999876653   47899999999999999999997 7999999999999998655 79999999998542 22233445


Q ss_pred             eeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCC
Q psy3714         326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQH  405 (467)
Q Consensus       326 ~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (467)
                      +||+.|+|||++.+..|+.++|+|..+++.+....+..||.....     .......   ...           ....+.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i---~~~-----------~~~~p~  217 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELI---LME-----------EIRFPR  217 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHH---hcC-----------CCCCCC
Confidence            799999999999988899999999988876666666555532211     0111110   000           001123


Q ss_pred             CCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccc
Q psy3714         406 LVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       406 ~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~  446 (467)
                      .+++++.+||++||++||++|+     |++++++||||.++.+...
T Consensus       218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~  263 (325)
T cd05594         218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDV  263 (325)
T ss_pred             CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence            4799999999999999999997     8999999999998776533

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-38  Score=313.70  Aligned_cols=267  Identities=29%  Similarity=0.514  Sum_probs=193.6

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC---CCcc
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPV---SRTP  243 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~---~~~~  243 (467)
                      +|++.+.||+|+||.||+|.+..+++.||||.++..     ....+.+|+.+++.++ ||||+++.+++....   ....
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCceE
Confidence            489999999999999999999999999999988642     2345788999999996 899999988775432   1347


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++||||+. +++.+.+.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEccCcccccccccc
Confidence            99999996 46766553   488999999999999999999999999999999999998655 79999999998542211


Q ss_pred             ----CcceeeeccCccCCccccc--CCCCccchhHHHhhhccccccccccccccCCcc--------cCC--hhhhhhhhh
Q psy3714         321 ----EYNVRVASRYFKGPELLAD--YQYHIELDPRFADILGRHSRKRWERFVHTENQH--------LVS--PEALDFLDK  384 (467)
Q Consensus       321 ----~~~~~~gt~~y~aPE~l~~--~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~  384 (467)
                          .....+||+.|+|||++.+  ..|+.++|+|..+++.+....+..+|.......        ...  +........
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence                1234579999999999876  568889999988887665555544442211000        000  000000000


Q ss_pred             h----ccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         385 N----ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       385 ~----~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      .    ........  .........+.+++++++||.+||+.||++|||++|+|+||||.....
T Consensus       238 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         238 EKARRYLSSMRKK--QPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhHHHHHHhhccc--CCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            0    00000000  000001112346889999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.1e-38  Score=310.87  Aligned_cols=250  Identities=22%  Similarity=0.324  Sum_probs=195.7

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhc--CCCCeeEEEEEEeCCCCCccE
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLR--GGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~--~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      |++++.||+|+||.||+|.+..+++.||||+++...      .+.+.+|+.++..++  .||||+++++.+.+.  ...+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEEE
Confidence            788999999999999999999999999999987431      245667777765443  489999999988764  5689


Q ss_pred             EEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-CCC
Q psy3714         245 LIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQE  321 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~~~  321 (467)
                      +||||++++++.....  .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus        79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-FVKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-cEEeCcccCCccCCCCCCc
Confidence            9999999999877654  588999999999999999999999999999999999999655 799999999875422 222


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+||+.|+|||++.+..++.++|+|..+++.+....+..||....        ....... +...          ..
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--------~~~~~~~-i~~~----------~~  218 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--------EEEVFDS-IVND----------EV  218 (324)
T ss_pred             ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--------HHHHHHH-HHhC----------CC
Confidence            334679999999999999889999999988887655555555543211        1111111 1100          00


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKD  444 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~  444 (467)
                      ..+..+++++.+||++||+.||.+|+     +++++++||||..+.+.
T Consensus       219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~  266 (324)
T cd05589         219 RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD  266 (324)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence            11235799999999999999999999     79999999999887654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.1e-38  Score=309.64  Aligned_cols=248  Identities=20%  Similarity=0.271  Sum_probs=194.7

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      +.||+|+||.||+|.+..+++.||+|+++...      .....+|..++..+.+||||+++++.+.+.  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCC
Confidence            36899999999999999999999999987531      234567888887766799999999988764  4689999999


Q ss_pred             CCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-CCCcceee
Q psy3714         251 NNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRV  326 (467)
Q Consensus       251 ~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~~~~~~~~  326 (467)
                      ++++|...+.   .+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.... .......+
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCCCceeeec
Confidence            9999987764   478889999999999999999999999999999999998654 799999999985422 22334467


Q ss_pred             eccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       327 gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      ||+.|+|||++.+..|+.++|+|..+++.+....+..||.....     ........   ..           ....+..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~i~---~~-----------~~~~~~~  218 (316)
T cd05619         158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQSIR---MD-----------NPCYPRW  218 (316)
T ss_pred             CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH---hC-----------CCCCCcc
Confidence            99999999999988899999999888876655555555432110     01111110   00           0011234


Q ss_pred             CChHHHHHHHhhcCcCCCCCCCHH-HHhCCCCCCCcccccc
Q psy3714         407 VSPEALDFLDKLLRYDHYERLTAR-EAMDHPYFYPIVKDQS  446 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~ta~-e~l~Hp~f~~~~~~~~  446 (467)
                      ++.+++|||.+||+.||++|+|+. ++++||||..+++...
T Consensus       219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~  259 (316)
T cd05619         219 LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSAL  259 (316)
T ss_pred             CCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHHHH
Confidence            789999999999999999999996 9999999999887543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0608|consensus

Probab=100.00  E-value=7.3e-39  Score=313.61  Aligned_cols=264  Identities=24%  Similarity=0.366  Sum_probs=217.3

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      +...|..++.||-|+||+|+++....|...||+|.+++..      ..+++.|-.||.... .+=||+|+..|++.  ..
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDk--dn  703 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDK--DN  703 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccC--Cc
Confidence            3467889999999999999999999999999999987532      235678889998875 67799999998874  57


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC--
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH--  317 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~--  317 (467)
                      +|+||+|++|||+..++-   .|.|+-+++|+.+|..|+++.|..|.|||||||+|||||.+| +|||+|||||..+.  
T Consensus       704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG-HIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC-ceeeeeccccccceec
Confidence            999999999999988763   588999999999999999999999999999999999999776 89999999996531  


Q ss_pred             -------CCCC----------------------------------cceeeeccCccCCcccccCCCCccchhHHHhhhcc
Q psy3714         318 -------PGQE----------------------------------YNVRVASRYFKGPELLADYQYHIELDPRFADILGR  356 (467)
Q Consensus       318 -------~~~~----------------------------------~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~  356 (467)
                             .+.+                                  ....+||+.|+|||+|...+|+-.+|+|+.+++.+
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                   1100                                  01238999999999999999999999999999988


Q ss_pred             ccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCC---CHHHHh
Q psy3714         357 HSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL---TAREAM  433 (467)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~---ta~e~l  433 (467)
                      .++.|..||.....               .-..+..+.|+.++.......+|.|+.|||.+|.. ++..|+   .++|+.
T Consensus       863 em~~g~~pf~~~tp---------------~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vK  926 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTP---------------GETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVK  926 (1034)
T ss_pred             HHhhCCCCccCCCC---------------CcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhcccchhhhh
Confidence            87777766543211               01234456788888877777899999999999875 999999   478899


Q ss_pred             CCCCCCCcccccccCCCCC
Q psy3714         434 DHPYFYPIVKDQSRHTLPS  452 (467)
Q Consensus       434 ~Hp~f~~~~~~~~~~~~~~  452 (467)
                      .||||.+|++...|....+
T Consensus       927 aHpfFkgIDfsslRkq~Ap  945 (1034)
T KOG0608|consen  927 AHPFFKGIDFSSLRKQRAP  945 (1034)
T ss_pred             cCccccccchHhhhhccCC
Confidence            9999999998876665544

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-38  Score=315.38  Aligned_cols=262  Identities=20%  Similarity=0.269  Sum_probs=189.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      ..+|++++.||+|+||.||+|.+..+++.||+|+...   ....+|+.+++.++ |+||+++++++...  ...++||++
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---GTTLIEAMLLQNVN-HPSVIRMKDTLVSG--AITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---cccHHHHHHHHhCC-CCCCcChhheEEeC--CeeEEEEEc
Confidence            4679999999999999999999999999999997543   34467999999996 89999999988754  457899999


Q ss_pred             cCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCccee
Q psy3714         250 VNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR  325 (467)
Q Consensus       250 ~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~  325 (467)
                      +.+ ++.++.    ..+++..+..++.||+.||.|||++|||||||||+|||++..+ .+||+|||+++...........
T Consensus       139 ~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~  216 (357)
T PHA03209        139 YSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGL  216 (357)
T ss_pred             cCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEecCccccccccCcccccc
Confidence            865 554443    2478899999999999999999999999999999999998655 7999999999864333333446


Q ss_pred             eeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCC------hhhhhhhhh------hc-------
Q psy3714         326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVS------PEALDFLDK------NI-------  386 (467)
Q Consensus       326 ~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~------~~-------  386 (467)
                      .||+.|+|||++.+..|+.++|+|..+++.+.......+++.........      .........      ..       
T Consensus       217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  296 (357)
T PHA03209        217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR  296 (357)
T ss_pred             cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence            79999999999999899999999988776544333222332221110000      000000000      00       


Q ss_pred             -------cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         387 -------LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       387 -------~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                             .....+..+..+.. .....++.++.+||++||++||++||||+|+|+||||+.
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        297 LVRGFIEYASLERQPYTRYPC-FQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHHHhhcccCCCcccccHH-HhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                   00000001111000 011246889999999999999999999999999999975

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.9e-38  Score=308.70  Aligned_cols=247  Identities=22%  Similarity=0.319  Sum_probs=192.6

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      +.||+|+||.||+|.+..+++.||+|.++...      .....+|..++..+.+||||+++++.+...  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence            36899999999999999999999999987431      234566777777776799999999988753  4689999999


Q ss_pred             CCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CCcceee
Q psy3714         251 NNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRV  326 (467)
Q Consensus       251 ~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~~~~~~  326 (467)
                      ++++|.....   .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+..... ......+
T Consensus        79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCCCcccccc
Confidence            9999876653   588999999999999999999999999999999999998655 7999999999864322 2234457


Q ss_pred             eccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       327 gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      ||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ...... .+...          ....+..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~--------~~~~~~-~i~~~----------~~~~~~~  218 (316)
T cd05592         158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED--------EDELFD-SILND----------RPHFPRW  218 (316)
T ss_pred             CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC--------HHHHHH-HHHcC----------CCCCCCC
Confidence            9999999999998889999999988877655555555543211        011111 11100          0111234


Q ss_pred             CChHHHHHHHhhcCcCCCCCCCH-HHHhCCCCCCCccccc
Q psy3714         407 VSPEALDFLDKLLRYDHYERLTA-REAMDHPYFYPIVKDQ  445 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~ta-~e~l~Hp~f~~~~~~~  445 (467)
                      +++++.+||++||..||++|+|+ +++++||||..+.+..
T Consensus       219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~  258 (316)
T cd05592         219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWER  258 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHHH
Confidence            78999999999999999999986 5899999999887643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.1e-38  Score=308.58  Aligned_cols=254  Identities=21%  Similarity=0.283  Sum_probs=199.3

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      +|+..+.||+|+||.||+|.+..+++.||+|+++...      .+...+|+.++..+.+|++|+.+...+.+.  ...++
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEE
Confidence            4788999999999999999999999999999986431      234667888998888888999998888764  46899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CC
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~  321 (467)
                      ||||+++++|.+...   .+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus        79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeccccccccCCCCcc
Confidence            999999999987653   588999999999999999999999999999999999999654 7999999999854322 22


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+||+.|+|||++.+..++.++|+|..+++......+..||.....        ..... .+...    .      .
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~-~i~~~----~------~  218 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQ-SIMEH----N------V  218 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHH-HHHhC----C------C
Confidence            2345699999999999988899999999888776555555555432110        01111 11100    0      0


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCccccccc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~~~~  447 (467)
                      ..+..+|+++++|+.+||+.||.+|++     ++++++||||..++|....
T Consensus       219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~  269 (323)
T cd05615         219 SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLE  269 (323)
T ss_pred             CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHh
Confidence            112347899999999999999999997     5799999999998875443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=309.03  Aligned_cols=259  Identities=25%  Similarity=0.358  Sum_probs=197.2

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++++.||+|+||.||++.+..+++.||+|++++.      ..+.+.+|+.++..+ +|+||+.+++.+.+.  ...+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~   77 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDE--NNLY   77 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecC--CeEE
Confidence            5799999999999999999999999999999998642      123467888998888 489999999988764  5689


Q ss_pred             EEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      +||||+++++|.+++.    .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.......
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRLLADG  156 (331)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC-CEEEEECCceeecCCCC
Confidence            9999999999987763    478899999999999999999999999999999999998554 79999999997654332


Q ss_pred             Cc--ceeeeccCccCCccccc-----CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         321 EY--NVRVASRYFKGPELLAD-----YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       321 ~~--~~~~gt~~y~aPE~l~~-----~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ..  ...+||+.|+|||++..     ..++.++|+|..+++.+....+..||....        ...... .+.....  
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~--------~~~~~~-~i~~~~~--  225 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYG-KIMNHKE--  225 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC--------HHHHHH-HHHcCCC--
Confidence            22  23569999999999974     346788999988887666555555543211        001000 1111000  


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCCccccccc
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYE--RLTAREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~--R~ta~e~l~Hp~f~~~~~~~~~  447 (467)
                      .+   ........+|+++++||++||..++++  |++++++++||||.+.+|....
T Consensus       226 ~~---~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~  278 (331)
T cd05597         226 HF---QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIR  278 (331)
T ss_pred             cc---cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHHh
Confidence            00   011112347999999999999876655  7899999999999988765443

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.2e-38  Score=303.04  Aligned_cols=249  Identities=23%  Similarity=0.315  Sum_probs=192.3

Q ss_pred             ecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCC
Q psy3714         179 LGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNN  252 (467)
Q Consensus       179 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~  252 (467)
                      ||+|+||+||++.+..+++.+|+|.+....      ...+.+|+.+++.+ +|+||+.+...+...  ...++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTK--TDLCLVMTIMNG   77 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCC--CeEEEEEeCCCC
Confidence            699999999999999999999999986431      13456899999999 489999999888653  468999999999


Q ss_pred             ccHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-cce
Q psy3714         253 TDFKQLY-------QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YNV  324 (467)
Q Consensus       253 ~~l~~~~-------~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-~~~  324 (467)
                      ++|....       ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++........ ...
T Consensus        78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCccccc
Confidence            9987654       2378889999999999999999999999999999999998654 799999999986543322 233


Q ss_pred             eeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCC
Q psy3714         325 RVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQ  404 (467)
Q Consensus       325 ~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (467)
                      ..||+.|+|||++.+..++.+.|+|..+++.+....+..||...... .   .... ....+...          ....+
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~---~~~~-~~~~~~~~----------~~~~~  221 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-V---ENKE-LKQRILND----------SVTYP  221 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc-h---hHHH-HHHhhccc----------CCCCc
Confidence            57899999999999999999999998887765555555454321110 0   0000 00011000          00112


Q ss_pred             CCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccc
Q psy3714         405 HLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       405 ~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~  446 (467)
                      ..+|+++++|+.+||+.||++|+     |++++++||||.+..|...
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~  268 (280)
T cd05608         222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL  268 (280)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH
Confidence            35799999999999999999999     8899999999998877654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.7e-38  Score=306.27  Aligned_cols=264  Identities=26%  Similarity=0.546  Sum_probs=195.6

Q ss_pred             cCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       167 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      |+..++|++++.||+|+||.||+|.+..+++.+|+|.++...    .....+|+++++.++ |+||+.+++.+...  ..
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~   78 (309)
T cd07872           2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIVHTD--KS   78 (309)
T ss_pred             CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCC-CCCcceEEEEEeeC--Ce
Confidence            456789999999999999999999999999999999886432    235678999999996 89999999998754  46


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .++||||+.+ ++.+...    .++...++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~  156 (309)
T cd07872          79 LTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSV  156 (309)
T ss_pred             EEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECccccceecCC
Confidence            8999999986 5555442    367888999999999999999999999999999999998654 799999999976432


Q ss_pred             C-CCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         319 G-QEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       319 ~-~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      . ......++|+.|+|||++.+. .++.++|+|..+++......+..+|......     +....... ..+......|.
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-----~~~~~~~~-~~~~~~~~~~~  230 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-----DELHLIFR-LLGTPTEETWP  230 (309)
T ss_pred             CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHH-HhCCCCHHHHh
Confidence            2 223345789999999998764 4788999998887765555554444322110     00000000 00000000000


Q ss_pred             cc-----------c------cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         397 RF-----------V------HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       397 ~~-----------~------~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      .+           .      .....+.+|++++|||.+||++||++|+|++|+|+||||..+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            00           0      001123478999999999999999999999999999999765

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-38  Score=302.82  Aligned_cols=257  Identities=21%  Similarity=0.274  Sum_probs=200.8

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .|++.+.||+|+||.||++.+..+++.||+|.++...      ...+.+|+.+++.++ |+||+.+.+.+...  ...++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~l   77 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETK--DALCL   77 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCC--CeEEE
Confidence            4889999999999999999999999999999886421      234578999999995 89999999888654  46899


Q ss_pred             EEeccCCccHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         246 IFEHVNNTDFKQLY-----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~-----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ||||+.+++|....     ..+++..+..++.|++.||.|||++||+||||||+||+++.. +.++|+|||++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC-CCEEEeeCCCceecCCCC
Confidence            99999999987654     247888999999999999999999999999999999999855 479999999998765444


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      .....+||+.|+|||++.+..++...|+|..+++.+....+..||......     .........+...          .
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~----------~  221 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-----VKREEVERRVKED----------Q  221 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-----hHHHHHHHHhhhc----------c
Confidence            444567999999999999888999999998887755555555554322110     0001111111000          0


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCccccccc
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~  447 (467)
                      ...+..+++.+++||.+||..||++|+     |++++++||||...+++...
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~  273 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLE  273 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHh
Confidence            111234789999999999999999999     99999999999987776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.6e-38  Score=307.59  Aligned_cols=246  Identities=22%  Similarity=0.315  Sum_probs=194.4

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      +.||+|+||.||+|.+..+++.||+|+++..      ......+|+.+++.+.+|+||+++++.+.+.  ...++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence            3689999999999999999999999998743      1244668889998887899999999988764  4689999999


Q ss_pred             CCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-CCCCcceee
Q psy3714         251 NNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRV  326 (467)
Q Consensus       251 ~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~~~~~~~~~  326 (467)
                      ++++|.....   .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++... ........+
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCCCccccee
Confidence            9999876553   588999999999999999999999999999999999998655 79999999997532 222233457


Q ss_pred             eccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       327 gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      ||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ...... .+....          ...+..
T Consensus       158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--------~~~~~~-~i~~~~----------~~~~~~  218 (318)
T cd05570         158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------EDELFQ-SILEDE----------VRYPRW  218 (318)
T ss_pred             cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--------HHHHHH-HHHcCC----------CCCCCc
Confidence            9999999999999899999999988887655555555542211        001111 111100          011234


Q ss_pred             CChHHHHHHHhhcCcCCCCCCCH-----HHHhCCCCCCCcccc
Q psy3714         407 VSPEALDFLDKLLRYDHYERLTA-----REAMDHPYFYPIVKD  444 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~ta-----~e~l~Hp~f~~~~~~  444 (467)
                      ++++++|||++||..||++|+|+     .++++||||...+|.
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~  261 (318)
T cd05570         219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD  261 (318)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            78999999999999999999999     999999999887764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-38  Score=308.38  Aligned_cols=245  Identities=22%  Similarity=0.369  Sum_probs=189.6

Q ss_pred             ecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhc--CCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         179 LGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLR--GGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       179 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~--~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      ||+|+||.||+|.+..+++.||+|++....      .....+|..++..+.  +||||+.+...+.+.  ...++||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcCC
Confidence            699999999999999999999999986421      123445667776554  799999999988764  4689999999


Q ss_pred             CCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-CCCcceee
Q psy3714         251 NNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRV  326 (467)
Q Consensus       251 ~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~~~~~~~~  326 (467)
                      .++++...+.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCCCCccCcc
Confidence            9999876553   488999999999999999999999999999999999998654 799999999975432 22234467


Q ss_pred             eccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCC
Q psy3714         327 ASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQH  405 (467)
Q Consensus       327 gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (467)
                      ||+.|+|||++.+.. |+.++|+|..+++.+....+..||.....        .........+.   ..+       ...
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~---~~~-------~~~  219 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNIAFGK---VRF-------PKN  219 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHHHcCC---CCC-------CCc
Confidence            999999999997654 88899999999887777777666543211        11111110010   000       012


Q ss_pred             CCChHHHHHHHhhcCcCCCCCC----CHHHHhCCCCCCCcccc
Q psy3714         406 LVSPEALDFLDKLLRYDHYERL----TAREAMDHPYFYPIVKD  444 (467)
Q Consensus       406 ~~s~~~~dli~~lL~~dp~~R~----ta~e~l~Hp~f~~~~~~  444 (467)
                      .+++++++||++||+.||++|+    +++|+++||||....+.
T Consensus       220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~  262 (330)
T cd05586         220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWD  262 (330)
T ss_pred             cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHH
Confidence            3789999999999999999998    79999999999877653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.9e-38  Score=322.05  Aligned_cols=270  Identities=20%  Similarity=0.333  Sum_probs=190.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcC-----CCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRG-----GTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~-----~~~iv~l~~~~~~~~~~~  242 (467)
                      .++|++++.||+|+||.||+|.+..+++.||||+++...  .....+|+++++.+.+     +.+++.+..++... ...
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~~~  206 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-TGH  206 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-Cce
Confidence            478999999999999999999999999999999987532  3446778888887753     34688888887654 346


Q ss_pred             cEEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCC---------------
Q psy3714         243 PALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENR---------------  303 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~---------------  303 (467)
                      .++||+++. +++.+++   ..+++..++.++.||+.||+|||+ .|||||||||+|||++..+.               
T Consensus       207 ~~iv~~~~g-~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~  285 (467)
T PTZ00284        207 MCIVMPKYG-PCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC  285 (467)
T ss_pred             EEEEEeccC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence            788999874 4554443   258899999999999999999998 59999999999999985442               


Q ss_pred             cEEEEecccceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcc--------cC-
Q psy3714         304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQH--------LV-  374 (467)
Q Consensus       304 ~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~~-  374 (467)
                      .+||+|||++....  ......+||+.|+|||++.+..|+.++|+|..+++.+....+..+|.......        ++ 
T Consensus       286 ~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~  363 (467)
T PTZ00284        286 RVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR  363 (467)
T ss_pred             eEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Confidence            49999999986532  22345689999999999999999999999998887766666655543221100        00 


Q ss_pred             -Chhhh---------hhhhhh-c-cCCCCccccccccccc--CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         375 -SPEAL---------DFLDKN-I-LGRHSRKRWERFVHTE--NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       375 -~~~~~---------~~~~~~-~-~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                       ...+.         .+.... . ........+..+....  ....-++.+.|||++||++||++|+||+|+|+||||..
T Consensus       364 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence             00000         000000 0 0000000000000000  00112577899999999999999999999999999987


Q ss_pred             ccc
Q psy3714         441 IVK  443 (467)
Q Consensus       441 ~~~  443 (467)
                      ...
T Consensus       444 ~~~  446 (467)
T PTZ00284        444 YYP  446 (467)
T ss_pred             cCC
Confidence            543

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.3e-38  Score=302.99  Aligned_cols=258  Identities=24%  Similarity=0.326  Sum_probs=200.3

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .|++.+.||+|+||.||+|.+..+++.+|+|.+....      ...+.+|+.+++.++ |++++.+...+.+.  ...++
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~--~~~~l   77 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETK--DALCL   77 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecC--CEEEE
Confidence            3788899999999999999999999999999876431      234678999999996 79999998887653  46899


Q ss_pred             EEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         246 IFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      +|||+.+++|.....     .+++..+..++.|++.||.|||++||+||||||+||+++..+ .++|+|||++.....+.
T Consensus        78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeccceeecCCCc
Confidence            999999999976652     378889999999999999999999999999999999998655 79999999998765444


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      ......||..|+|||++.+..++.+.|+|..+++......+..||...... ........... .             ..
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-~~~~~~~~~~~-~-------------~~  221 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-IKREEVERLVK-E-------------VQ  221 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc-chHHHHHhhhh-h-------------hh
Confidence            444457999999999999888999999998887755555555554322110 00000000000 0             00


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCcccccccC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKDQSRH  448 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~~~~~  448 (467)
                      ...+..+++++++||++||+.||++|+|     ++|+++||||.++.+.....
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~  274 (285)
T cd05630         222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEA  274 (285)
T ss_pred             hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhc
Confidence            0112347899999999999999999999     99999999999887764443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.9e-38  Score=305.90  Aligned_cols=245  Identities=26%  Similarity=0.370  Sum_probs=191.7

Q ss_pred             eEeecccCCcceEEEEEc---cCCCeEEEEEeccch-------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         176 VRKLGRGKYSEVFEAINV---QSSDKCVVKILKPVK-------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       176 ~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~-------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++.||+|+||.||+|.+.   .+++.+|+|+++...       ...+.+|+.+|+.++ ||||+++++.+...  ...++
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~--~~~~l   77 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTG--GKLYL   77 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecC--CeEEE
Confidence            367999999999999864   467899999986421       234678999999996 89999999888753  46899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-CCC
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~~~  321 (467)
                      ||||+++++|.+.+.   .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          78 ILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-HVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             EEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEeeCcCCeecccCCCc
Confidence            999999999877653   477888999999999999999999999999999999998654 799999999975432 222


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+||+.|+|||++.+..++.++|+|..+++.+....+..||....        ..........+.           .
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--------~~~~~~~~~~~~-----------~  217 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--------RKKTIDKILKGK-----------L  217 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC-----------C
Confidence            334579999999999998889999999988887666555555543211        111111110000           0


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCccc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVK  443 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~  443 (467)
                      ..+..++++++|||++||+.||++|+     +++++++||||....+
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            11335789999999999999999999     8999999999987654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0579|consensus

Probab=100.00  E-value=9.3e-40  Score=319.68  Aligned_cols=254  Identities=22%  Similarity=0.349  Sum_probs=192.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ..+.|+++..||.|+||.||+|.++.++-..|.|.+....   .....-||+||..+. ||+||+|++.|..  .+.+++
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~--enkLwi  106 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECD-HPVIVKLLSAYYF--ENKLWI  106 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhc--cCceEE
Confidence            4577899999999999999999999888888888876443   345677999999986 9999999987764  456899


Q ss_pred             EEeccCCccHHHH----hhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-CCC
Q psy3714         246 IFEHVNNTDFKQL----YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQ  320 (467)
Q Consensus       246 v~e~~~~~~l~~~----~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~~~  320 (467)
                      +.|||.||-....    -..+++++++.+++|+|.||.|||+++|||||||..|||++.+| .|+|+|||.+.... .-+
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC-cEeeecccccccchhHHh
Confidence            9999999976543    35699999999999999999999999999999999999999776 79999999875432 223


Q ss_pred             CcceeeeccCccCCccc-----ccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         321 EYNVRVASRYFKGPELL-----ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l-----~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      ...+.+|||||||||+.     .+.+|++..|+|..++....+..+..|. +..     ++ +.-.+ + +....+    
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH-hel-----np-MRVll-K-iaKSeP----  252 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH-HEL-----NP-MRVLL-K-IAKSEP----  252 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc-ccc-----ch-HHHHH-H-HhhcCC----
Confidence            34567899999999986     4678999999998887543332222221 110     00 00000 0 000000    


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ..+..   +...|..+.|||.+||.+||..||+|+|+|+||||..+.
T Consensus       253 PTLlq---PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  253 PTLLQ---PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             CcccC---cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            11111   234588999999999999999999999999999998544

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-37  Score=305.96  Aligned_cols=261  Identities=23%  Similarity=0.315  Sum_probs=198.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++++.||+|+||.||++.+..+++.+|+|+++...      ...+.+|+.++..+. |+||+.++..+.+.  ...+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~--~~~~   77 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDE--NYLY   77 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcC--CEEE
Confidence            57999999999999999999999999999999986421      233567888888774 89999999988764  5789


Q ss_pred             EEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      +||||+.+++|.+++.    .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus        78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-CEEEEeccceeeccCCC
Confidence            9999999999987763    478889999999999999999999999999999999998555 79999999998764332


Q ss_pred             Cc--ceeeeccCccCCccccc-----CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         321 EY--NVRVASRYFKGPELLAD-----YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       321 ~~--~~~~gt~~y~aPE~l~~-----~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ..  ...+||+.|+|||++.+     ..++.++|+|..+++.+....+..||....        ...... .+.....+.
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~-~i~~~~~~~  227 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYG-KIMNHEERF  227 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC--------HHHHHH-HHHcCCCcc
Confidence            22  23469999999999876     357888999988887666666655553221        011111 111100001


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCCcccccccCC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYE--RLTAREAMDHPYFYPIVKDQSRHT  449 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~--R~ta~e~l~Hp~f~~~~~~~~~~~  449 (467)
                      .+     ......+|++++|||.+||..++++  |++++++++||||.+++|+..+..
T Consensus       228 ~~-----p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~~~~  280 (331)
T cd05624         228 QF-----PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNL  280 (331)
T ss_pred             cC-----CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHHhhC
Confidence            11     1112347899999999999977655  469999999999998877554433

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-37  Score=309.64  Aligned_cols=253  Identities=17%  Similarity=0.257  Sum_probs=193.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .++|+.++.||+|+||.||+|.+..+++.||||++....    ...+.+|+++++.++ |+||+++.+++.+.  ...++
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~l  149 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN-HPNVVKCHDMFDHN--GEIQV  149 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccC--CeEEE
Confidence            478899999999999999999999999999999986432    356789999999996 89999999988653  56899


Q ss_pred             EEeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-Ccce
Q psy3714         246 IFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNV  324 (467)
Q Consensus       246 v~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~~~~  324 (467)
                      ||||+.++++... ...++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... ....
T Consensus       150 v~e~~~~~~L~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~  227 (353)
T PLN00034        150 LLEFMDGGSLEGT-HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNS  227 (353)
T ss_pred             EEecCCCCccccc-ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEcccccceecccccccccc
Confidence            9999999987543 2356777888999999999999999999999999999998554 79999999998764332 2234


Q ss_pred             eeeccCccCCcccccC-----CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         325 RVASRYFKGPELLADY-----QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       325 ~~gt~~y~aPE~l~~~-----~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      .+||..|+|||++...     .++.++|+|..+++.+....+..+|.....     .+...........          .
T Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~----------~  292 (353)
T PLN00034        228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----GDWASLMCAICMS----------Q  292 (353)
T ss_pred             cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhcc----------C
Confidence            6799999999988532     234579999888876655555555432110     0111111110000          0


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ....+..+++++++||.+||+.||++|||++|+++||||....
T Consensus       293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            1112235789999999999999999999999999999998754

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.8e-37  Score=305.21  Aligned_cols=259  Identities=23%  Similarity=0.332  Sum_probs=196.6

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++++.||+|+||.||++.+..+++.+|+|++.+..      ...+.+|+.++..+. |+||+.++..+.+.  ...+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~--~~~~   77 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDE--NNLY   77 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecC--CEEE
Confidence            47999999999999999999999999999999986421      233667888888874 89999999988764  4689


Q ss_pred             EEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      +||||+.+++|.+++.    .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.......
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEeecchheecccCC
Confidence            9999999999987764    478889999999999999999999999999999999998554 79999999997653322


Q ss_pred             C--cceeeeccCccCCccccc-----CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         321 E--YNVRVASRYFKGPELLAD-----YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       321 ~--~~~~~gt~~y~aPE~l~~-----~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      .  ....+||+.|+|||++..     ..|+.++|+|..+++.+....+..||....        ...... .+.......
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~--------~~~~~~-~i~~~~~~~  227 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYG-KIMNHKERF  227 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC--------HHHHHH-HHhCCCccc
Confidence            2  223579999999999863     357889999988877665555555553221        111111 111110000


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCCccccccc
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYE--RLTAREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~--R~ta~e~l~Hp~f~~~~~~~~~  447 (467)
                      .+     +.....+|++++|||++||..++.+  |+|++|+++||||.+++|+...
T Consensus       228 ~~-----p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~~  278 (332)
T cd05623         228 QF-----PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIR  278 (332)
T ss_pred             cC-----CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHHh
Confidence            11     1112357999999999999876655  6799999999999988765433

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.7e-38  Score=317.20  Aligned_cols=257  Identities=21%  Similarity=0.253  Sum_probs=189.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||...   .....+|+++|++++ |+||+++++++...  ...+++|++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L~-HpnIv~l~~~~~~~--~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRLS-HPAVLALLDVRVVG--GLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHCC-CCCCCcEEEEEEEC--CEEEEEEEc
Confidence            457999999999999999999999999999999643   234678999999996 89999999987653  467899999


Q ss_pred             cCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC---c
Q psy3714         250 VNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---Y  322 (467)
Q Consensus       250 ~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~---~  322 (467)
                      +.+ ++...+.    .++..++..++.|++.||.|||++|||||||||+|||++..+ .+||+|||+|+.......   .
T Consensus       242 ~~~-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        242 YRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-CEEEcccCCceecccccccccc
Confidence            864 5554432    478899999999999999999999999999999999998654 799999999986543221   1


Q ss_pred             ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCccc---CChhhhhhhhhhc-------------
Q psy3714         323 NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHL---VSPEALDFLDKNI-------------  386 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-------------  386 (467)
                      ...+||+.|+|||++.+..++.++|+|..+++.+....+..+++.......   ........+....             
T Consensus       320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~  399 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR  399 (461)
T ss_pred             cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence            234699999999999998899999999888765544333333332211100   0000111110000             


Q ss_pred             -------------cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         387 -------------LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       387 -------------~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                                   ........|.+      ...++++++|||++||++||++|||++|+|+||||..
T Consensus       400 l~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        400 LVSQYRHRAARNRRPAYTRPAWTR------YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHhhhhcccCCccCCcchhh------hccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                         00000011111      1246789999999999999999999999999999964

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.3e-37  Score=298.32  Aligned_cols=252  Identities=22%  Similarity=0.264  Sum_probs=192.9

Q ss_pred             ecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCC
Q psy3714         179 LGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNN  252 (467)
Q Consensus       179 lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~  252 (467)
                      ||+|+||.||++.+..+++.+|+|.+...      ....+..|+++++.++ ||||+.+...+.+.  ...++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~--~~~~lv~e~~~g   77 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESK--THLCLVMSLMNG   77 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecC--CeEEEEEecCCC
Confidence            69999999999999999999999988642      1234567999999995 89999999888754  468999999999


Q ss_pred             ccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcceeee
Q psy3714         253 TDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA  327 (467)
Q Consensus       253 ~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~g  327 (467)
                      ++|.....     .+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.............|
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCceeeccCC
Confidence            99876542     367788889999999999999999999999999999998654 799999999987654444444578


Q ss_pred             ccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCC
Q psy3714         328 SRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLV  407 (467)
Q Consensus       328 t~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (467)
                      |..|+|||++.+..++..+|+|..+++.+....+..|+...... .   ...... ......    .    .. .....+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~---~~~~~~-~~~~~~----~----~~-~~~~~~  222 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-V---AKEELK-RRTLED----E----VK-FEHQNF  222 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-h---hHHHHH-HHhhcc----c----cc-cccccC
Confidence            99999999999888999999998887765555554444221100 0   000000 000000    0    00 011247


Q ss_pred             ChHHHHHHHhhcCcCCCCCCCH----HHHhCCCCCCCcccccccC
Q psy3714         408 SPEALDFLDKLLRYDHYERLTA----REAMDHPYFYPIVKDQSRH  448 (467)
Q Consensus       408 s~~~~dli~~lL~~dp~~R~ta----~e~l~Hp~f~~~~~~~~~~  448 (467)
                      +++++|||++||++||++|+|+    +++++||||..++++....
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~  267 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEA  267 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhc
Confidence            9999999999999999999999    6788999999988765543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-37  Score=305.05  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=189.2

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHH-HHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKI-LENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~i-l~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      +.||+|+||.||+|.+..+++.||+|++....      ...+.+|..+ ++.+ +||||++++..+.+.  ...++||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~--~~~~lv~e~   77 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTA--DKLYFVLDY   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeC--CEEEEEEcC
Confidence            36899999999999999999999999986421      2334555554 4556 589999999888754  568999999


Q ss_pred             cCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-CCCccee
Q psy3714         250 VNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVR  325 (467)
Q Consensus       250 ~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~~~~~~~  325 (467)
                      +++++|...+.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~  156 (323)
T cd05575          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHSKTTSTF  156 (323)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCCCccccc
Confidence            99999876653   478899999999999999999999999999999999998655 799999999975422 2223445


Q ss_pred             eeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCC
Q psy3714         326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQH  405 (467)
Q Consensus       326 ~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (467)
                      +||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ...... .+...    .      ...++
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~-~i~~~----~------~~~~~  217 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYD-NILNK----P------LRLKP  217 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHH-HHHcC----C------CCCCC
Confidence            79999999999999889999999988887666555555543211        111111 11110    0      01123


Q ss_pred             CCChHHHHHHHhhcCcCCCCCCCH----HHHhCCCCCCCcccc
Q psy3714         406 LVSPEALDFLDKLLRYDHYERLTA----REAMDHPYFYPIVKD  444 (467)
Q Consensus       406 ~~s~~~~dli~~lL~~dp~~R~ta----~e~l~Hp~f~~~~~~  444 (467)
                      .+++++.+||++||+.||++|+++    +|+++||||..+.+.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~  260 (323)
T cd05575         218 NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWD  260 (323)
T ss_pred             CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence            479999999999999999999998    699999999887664

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7e-38  Score=309.59  Aligned_cols=267  Identities=28%  Similarity=0.483  Sum_probs=194.9

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC---
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPV---  239 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~---  239 (467)
                      ...++|++++.||+|+||.||+|.+..+++.||+|.++..     ....+.+|+.+++.++ |+||+++++++....   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhccccccc
Confidence            3457899999999999999999999999999999998642     2245678999999996 899999988764321   


Q ss_pred             -CCccEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         240 -SRTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       240 -~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                       ....+++++++ ++++.+...  .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~  168 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQA  168 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-CEEEcCCccceec
Confidence             13468888877 567766653  589999999999999999999999999999999999998554 7999999999875


Q ss_pred             CCCCCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcc--------c--CChhhhhhhhhh
Q psy3714         317 HPGQEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQH--------L--VSPEALDFLDKN  385 (467)
Q Consensus       317 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~--~~~~~~~~~~~~  385 (467)
                      ..  .....+||+.|+|||++.+ ..++.++|+|..+++.+....+..+|.......        .  ..+.........
T Consensus       169 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             CC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence            43  2344679999999999987 458889999988877655544444442211000        0  000000000000


Q ss_pred             ----c---cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         386 ----I---LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       386 ----~---~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                          .   ........+.     ......++.++|||.+||+.||++|||++|+|+||||......
T Consensus       247 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         247 HARKYIQSLPHMPQQDLK-----KIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             hHHHHhhccccccchhHH-----HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence                0   0000000000     0112367889999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.3e-37  Score=308.69  Aligned_cols=254  Identities=22%  Similarity=0.309  Sum_probs=195.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++++.||+|+||.||+|.+..+++.+|+|+++...      ...+.+|+.+++.++ ||||++++..+.+.  ...
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~--~~~  118 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDD--RYL  118 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcC--CEE
Confidence            478999999999999999999999999999999986421      234668899998885 89999999988753  568


Q ss_pred             EEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      ++||||+++++|.++..  .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus       119 ~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-CEEEEeCCceeEcCcCCc
Confidence            99999999999987764  478888999999999999999999999999999999998654 799999999987643222


Q ss_pred             --cceeeeccCccCCcccccCC----CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         322 --YNVRVASRYFKGPELLADYQ----YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       322 --~~~~~gt~~y~aPE~l~~~~----~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                        ....+||+.|+|||++....    |+.++|+|+.+++.+....+..||....        ..... ..+.......  
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~-~~i~~~~~~~--  266 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTY-SKIMNHKNSL--  266 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC--------HHHHH-HHHHcCCCcc--
Confidence              23457999999999997643    7789999988887666666655553221        11111 1111110000  


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCCcc
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYE--RLTAREAMDHPYFYPIV  442 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~--R~ta~e~l~Hp~f~~~~  442 (467)
                          ..+....+|+++++||.+||+.++.+  |++++|+++||||....
T Consensus       267 ----~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         267 ----TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             ----cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence                11122358999999999999844443  77999999999998744

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.4e-38  Score=307.09  Aligned_cols=245  Identities=23%  Similarity=0.346  Sum_probs=188.8

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHH-HHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKI-LENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~i-l~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      +.||+|+||.||+|.+..+++.+|+|+++..      ....+.+|..+ ++.+ +||||++++..+...  ...++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~--~~~~lv~e~   77 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTT--EKLYFVLDF   77 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecC--CEEEEEEcC
Confidence            3689999999999999999999999998643      12344556554 4555 589999999888753  568999999


Q ss_pred             cCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-CCCccee
Q psy3714         250 VNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVR  325 (467)
Q Consensus       250 ~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~~~~~~~  325 (467)
                      +.++++.....   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~  156 (325)
T cd05604          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQSDTTTTF  156 (325)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCCCCcccc
Confidence            99999876553   488999999999999999999999999999999999998655 799999999975322 2223446


Q ss_pred             eeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCC
Q psy3714         326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQH  405 (467)
Q Consensus       326 ~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (467)
                      +||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ....... +...    .      ....+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~-~~~~----~------~~~~~  217 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------VAEMYDN-ILHK----P------LVLRP  217 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------HHHHHHH-HHcC----C------ccCCC
Confidence            79999999999999889999999988887666655555543221        1111111 1100    0      01123


Q ss_pred             CCChHHHHHHHhhcCcCCCCCCCH----HHHhCCCCCCCcccc
Q psy3714         406 LVSPEALDFLDKLLRYDHYERLTA----REAMDHPYFYPIVKD  444 (467)
Q Consensus       406 ~~s~~~~dli~~lL~~dp~~R~ta----~e~l~Hp~f~~~~~~  444 (467)
                      ..+.++.+||++||+.||++|+++    +++++||||....+.
T Consensus       218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~  260 (325)
T cd05604         218 GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWT  260 (325)
T ss_pred             CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHH
Confidence            478999999999999999999987    599999999987653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.9e-37  Score=303.63  Aligned_cols=263  Identities=19%  Similarity=0.291  Sum_probs=198.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .++|++++.||+|+||.||++.+..++..+|+|.++..    ....+.+|+++|+.++ |+||+++++.+.+.  ...++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSD--GEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEEC--CEEEE
Confidence            57899999999999999999999999999999988643    2356889999999996 89999999988753  46899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~-~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      ||||+++++|.++..   .+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++...... .
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-~  158 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M  158 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccccccc-c
Confidence            999999999988764   478889999999999999999986 699999999999998655 7999999999865332 2


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhcc----------C---
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL----------G---  388 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~---  388 (467)
                      ....+||+.|+|||++.+..++.++|+|..+++.+....+..||......     +..........          .   
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHhcccccccccCCccccCccc
Confidence            33457999999999999888999999998887655544454444211100     00000000000          0   


Q ss_pred             -------------CCCccc----ccccc----cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         389 -------------RHSRKR----WERFV----HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       389 -------------~~~~~~----~~~~~----~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                                   ......    .....    ........++++++||.+||++||++|||++|+++||||....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                         000000    00000    0001124689999999999999999999999999999997643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0574|consensus

Probab=100.00  E-value=6.9e-40  Score=295.65  Aligned_cols=251  Identities=20%  Similarity=0.329  Sum_probs=200.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEecc-chHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP-VKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~-~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      .+-|.++.+||+|+||.||+|.++.+|+.+|||.+.- ...+.+..||.||+.+. .+.||++++.|...  ..+++|||
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~--sDLWIVME  108 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCK-SKYVVKYYGSYFKH--SDLWIVME  108 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcC-CchhhhhhhhhccC--CceEeehh
Confidence            3568899999999999999999999999999998764 35678999999999996 79999999877543  35799999


Q ss_pred             ccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CCcc
Q psy3714         249 HVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYN  323 (467)
Q Consensus       249 ~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~~~  323 (467)
                      ||..|+..+..    +.+++.++..+++.-+.||+|||...-||||||..|||++.++ ..||+|||.|...... ....
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTMAKRN  187 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTMAKRN  187 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc-hhhhhhccccchhhhhHHhhC
Confidence            99999887665    3589999999999999999999999999999999999999776 7999999999765322 2345


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      +.+|||+|||||++.+.+|++..|+|..++....+..|..|+...-..       ..+..   ....+..   .|   ..
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-------RAIFM---IPT~PPP---TF---~K  251 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-------RAIFM---IPTKPPP---TF---KK  251 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-------ceeEe---ccCCCCC---CC---CC
Confidence            678999999999999999999999999888766555555554221100       00000   0001111   11   12


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      ++..|+++-|||++||.++|++|.||-++++|||+..
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn  288 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN  288 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence            3345999999999999999999999999999999864

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.7e-37  Score=298.07  Aligned_cols=265  Identities=26%  Similarity=0.544  Sum_probs=196.5

Q ss_pred             cCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       167 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ++..++|++++.||+|+||.||+|.+..+++.||+|.++...    .....+|+.+++.++ |+||+.+++.+...  ..
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~--~~   78 (301)
T cd07873           2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTE--KS   78 (301)
T ss_pred             CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcC-CCCcceEEEEEecC--Ce
Confidence            456789999999999999999999999999999999886432    345778999999996 89999999998764  56


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .++||||+.+ ++.+.+.    .+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus        79 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~  156 (301)
T cd07873          79 LTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSI  156 (301)
T ss_pred             EEEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC-cEEECcCcchhccCC
Confidence            8999999985 6665543    377888999999999999999999999999999999998654 799999999976432


Q ss_pred             C-CCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         319 G-QEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       319 ~-~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      . .......+++.|+|||++.+. .++.+.|+|..+++.+....+..+|.....     .+....... ..+......|.
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-----~~~~~~~~~-~~~~~~~~~~~  230 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-----EEQLHFIFR-ILGTPTEETWP  230 (301)
T ss_pred             CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHH-HcCCCChhhch
Confidence            2 223345679999999998764 477889999888776655555444432110     000000000 00000000010


Q ss_pred             cc---------c--------cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         397 RF---------V--------HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       397 ~~---------~--------~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .+         .        .......++++++|||.+||+.||.+|||++|+|+||||..+-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            00         0        0011235789999999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.9e-37  Score=301.96  Aligned_cols=245  Identities=25%  Similarity=0.373  Sum_probs=192.0

Q ss_pred             EeecccCCcceEEEEEc---cCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         177 RKLGRGKYSEVFEAINV---QSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      +.||+|+||.||++.+.   .+++.+|+|+++...     .....+|+++++.++ |+||+++++.+.+.  ...++|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTE--GKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcC--CEEEEEEc
Confidence            57999999999998763   578899999987532     345678999999996 89999999988764  46899999


Q ss_pred             ccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CCcce
Q psy3714         249 HVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNV  324 (467)
Q Consensus       249 ~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~~~~  324 (467)
                      |+.+++|.+.+.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... .....
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~  157 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYS  157 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCCCCceec
Confidence            999999877653   478999999999999999999999999999999999998655 7999999999865433 22334


Q ss_pred             eeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCC
Q psy3714         325 RVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQ  404 (467)
Q Consensus       325 ~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (467)
                      .+||+.|+|||++.+..++.+.|+|..+++.+....+..||....        ....... +..    ..      ...+
T Consensus       158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--------~~~~~~~-i~~----~~------~~~p  218 (318)
T cd05582         158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--------RKETMTM-ILK----AK------LGMP  218 (318)
T ss_pred             ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--------HHHHHHH-HHc----CC------CCCC
Confidence            579999999999998889999999988887666555555542211        1111111 100    00      0112


Q ss_pred             CCCChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCcccc
Q psy3714         405 HLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKD  444 (467)
Q Consensus       405 ~~~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~  444 (467)
                      ..+++++++||++||+.||++|+|     ++++++||||..+.+.
T Consensus       219 ~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~  263 (318)
T cd05582         219 QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN  263 (318)
T ss_pred             CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence            347899999999999999999999     6779999999887654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0589|consensus

Probab=100.00  E-value=4.3e-38  Score=305.46  Aligned_cols=251  Identities=21%  Similarity=0.344  Sum_probs=203.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .++|+.++.+|+|+||.++.++++..+..+++|.+.-.     .+.....|+.+++++. |||||.+.+.+... ..+.+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~-~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL-HPNIVEYKDSFEED-GQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc-CCCeeeeccchhcC-CceEE
Confidence            47899999999999999999999999999999998642     2446788999999985 89999999988764 34589


Q ss_pred             EEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      +||+||+||++.+.+.     .++++.+..++.|++.|+.|||+++|+|||||+.||+++.++ .|||.|||+|+...+.
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK-KVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC-ceeecchhhhhhcCCc
Confidence            9999999999988764     389999999999999999999999999999999999999776 6899999999998776


Q ss_pred             C-CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         320 Q-EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       320 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      . ...+.+||++||.||++.+.+|..+.|+|..+.+-+.......+ |.+.       +......+...+.         
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~a-F~a~-------~m~~Li~ki~~~~---------  222 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPA-FKAS-------NMSELILKINRGL---------  222 (426)
T ss_pred             hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccc-cCcc-------chHHHHHHHhhcc---------
Confidence            6 56678999999999999999999999999766553332222222 2222       1222222221111         


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                       ..+-+...|.+++.||+.||..+|..||+|.++|.+|.....
T Consensus       223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence             112234579999999999999999999999999999998743

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-37  Score=305.27  Aligned_cols=246  Identities=24%  Similarity=0.366  Sum_probs=189.4

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHH-HHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKI-LENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~i-l~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      +.||+|+||.||+|.+..+++.+|+|++....      ...+.+|... ++.+ .|+||++++..+...  ...++||||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~--~~~~lv~e~   77 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTA--DKLYFVLDY   77 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcC--CeEEEEEeC
Confidence            36899999999999999999999999986432      1234445443 4556 589999999988764  568999999


Q ss_pred             cCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-CCCCccee
Q psy3714         250 VNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVR  325 (467)
Q Consensus       250 ~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~~~~~~~~  325 (467)
                      ++++++.+...   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+... ........
T Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~~~~~~~  156 (325)
T cd05602          78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNGTTSTF  156 (325)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCCCCcccc
Confidence            99999877654   478889999999999999999999999999999999998654 79999999997542 22233446


Q ss_pred             eeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCC
Q psy3714         326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQH  405 (467)
Q Consensus       326 ~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (467)
                      +||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ...... .+...    .      ....+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~-~i~~~----~------~~~~~  217 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYD-NILNK----P------LQLKP  217 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC--------HHHHHH-HHHhC----C------cCCCC
Confidence            79999999999999889999999988887666555555543211        111111 11100    0      01123


Q ss_pred             CCChHHHHHHHhhcCcCCCCCCCHH----HHhCCCCCCCccccc
Q psy3714         406 LVSPEALDFLDKLLRYDHYERLTAR----EAMDHPYFYPIVKDQ  445 (467)
Q Consensus       406 ~~s~~~~dli~~lL~~dp~~R~ta~----e~l~Hp~f~~~~~~~  445 (467)
                      .+++++++||.+||+.||.+|+++.    ++++||||...+|+.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~  261 (325)
T cd05602         218 NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDD  261 (325)
T ss_pred             CCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence            5799999999999999999999876    899999998877643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0586|consensus

Probab=100.00  E-value=1.5e-37  Score=305.95  Aligned_cols=251  Identities=22%  Similarity=0.407  Sum_probs=209.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ....|.+.+.||+|.|+.|.+|++..|+..||||++.+.     ..+...+|+++|+.|. |||||+++.+...+  ..+
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~-HPnIvkl~~v~~t~--~~l  130 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN-HPNIVKLFSVIETE--ATL  130 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC-Ccceeeeeeeeeec--cee
Confidence            346799999999999999999999999999999999764     2356889999999996 89999999998764  579


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      |+||||+.++++.+++.   ...+..++.++.|+++|++|||+++|||||||++||||+. +..+||+|||++.++..+.
T Consensus       131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~-~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDE-NMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccc-ccceeeeccccceeecccc
Confidence            99999999999887764   4677899999999999999999999999999999999984 4579999999999998888


Q ss_pred             CcceeeeccCccCCcccccCCCC-ccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYH-IELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~-~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      ...+.||++.|.|||++.+..|+ ..+|.|+.+++.+....+..||.+..-.        .....-+.++     +    
T Consensus       210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------~Lr~rvl~gk-----~----  272 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------ELRPRVLRGK-----Y----  272 (596)
T ss_pred             cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--------cccchheeee-----e----
Confidence            88889999999999999999985 5699999999877766666665432211        1011111111     1    


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                        .-+-.+|.++.+||++||..+|.+|++.+|+++|+|.....
T Consensus       273 --rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  273 --RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             --cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence              11234899999999999999999999999999999987544

>KOG0671|consensus

Probab=100.00  E-value=6.7e-38  Score=291.95  Aligned_cols=266  Identities=21%  Similarity=0.411  Sum_probs=188.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcCC-C----CeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGG-T----NIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~~-~----~iv~l~~~~~~~~~~~  242 (467)
                      ..+|++++.+|+|+||.|..|.+..++..||+|+++.+.  ++...-|+++|+++..+ |    -++.+.++|+.  ..+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy--rgh  165 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY--RGH  165 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--cCc
Confidence            578999999999999999999999999999999999875  45677899999999532 2    25666666653  467


Q ss_pred             cEEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC----------------
Q psy3714         243 PALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE----------------  301 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~----------------  301 (467)
                      .++|+|.+.. +..+++.     .++.+.++.+.+|++.++++||+.+++|-||||||||+..+                
T Consensus       166 iCivfellG~-S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r  244 (415)
T KOG0671|consen  166 ICIVFELLGL-STFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR  244 (415)
T ss_pred             eEEEEeccCh-hHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence            8899997753 3333433     48999999999999999999999999999999999998422                


Q ss_pred             ---CCcEEEEecccceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCc--c----
Q psy3714         302 ---NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQ--H----  372 (467)
Q Consensus       302 ---~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~--~----  372 (467)
                         +..|||+|||.|+....  ..+..+.|..|+|||+|.+.+|+..+|+|+.+.+......|.. +|++-+.  .    
T Consensus       245 ~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~-LFqtHen~EHLaMM  321 (415)
T KOG0671|consen  245 PLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET-LFQTHENLEHLAMM  321 (415)
T ss_pred             cCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce-ecccCCcHHHHHHH
Confidence               12499999999997543  3466789999999999999999999999988876544333332 2222211  0    


Q ss_pred             --cCChhhhhhhhhh---ccCCCCccccccccccc---------CC-----CCCC---hHHHHHHHhhcCcCCCCCCCHH
Q psy3714         373 --LVSPEALDFLDKN---ILGRHSRKRWERFVHTE---------NQ-----HLVS---PEALDFLDKLLRYDHYERLTAR  430 (467)
Q Consensus       373 --~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~---------~~-----~~~s---~~~~dli~~lL~~dp~~R~ta~  430 (467)
                        +.++-....+.+.   -.....+..|..-....         .+     ...+   -++.|||++||++||.+|+|+.
T Consensus       322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~  401 (415)
T KOG0671|consen  322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR  401 (415)
T ss_pred             HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence              0000000000000   00000011221111000         00     0011   2678999999999999999999


Q ss_pred             HHhCCCCCCCc
Q psy3714         431 EAMDHPYFYPI  441 (467)
Q Consensus       431 e~l~Hp~f~~~  441 (467)
                      |+|+||||+..
T Consensus       402 EAL~HpFF~~~  412 (415)
T KOG0671|consen  402 EALSHPFFARL  412 (415)
T ss_pred             HHhcCHHhhcC
Confidence            99999999865

>KOG0577|consensus

Probab=100.00  E-value=1.8e-38  Score=308.79  Aligned_cols=246  Identities=24%  Similarity=0.334  Sum_probs=189.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEecc------chHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP------VKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~------~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .-|.-++.||.|+||.||-|++..+.+.||||.+.-      .+.+.+..|+..|+.|+ |||+|.+.+.|...  ...+
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre--~TaW  102 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLRE--HTAW  102 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeecc--chHH
Confidence            346667899999999999999999999999998852      24567999999999997 89999999988753  4579


Q ss_pred             EEEeccCCc--cHHHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         245 LIFEHVNNT--DFKQLY-QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       245 lv~e~~~~~--~l~~~~-~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      +|||||-|.  |+.+.. +.+.+.++..++.+.+.||.|||+.+.||||||..|||++..+ .|||+|||.|....+   
T Consensus       103 LVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  103 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG-LVKLADFGSASIMAP---  178 (948)
T ss_pred             HHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC-eeeeccccchhhcCc---
Confidence            999999764  344433 4688999999999999999999999999999999999998554 899999999987654   


Q ss_pred             cceeeeccCccCCccccc---CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         322 YNVRVASRYFKGPELLAD---YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~---~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      ..+.+|||||||||+|..   ..|+.++|+|+.++..........|+|..        +...-.... . .+....+   
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM--------NAMSALYHI-A-QNesPtL---  245 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHI-A-QNESPTL---  245 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc--------hHHHHHHHH-H-hcCCCCC---
Confidence            456799999999999864   35999999998876433222223343322        111111110 0 0000000   


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                       .   ....|+.+++||..||++-|.+|||++++|+|+|...
T Consensus       246 -q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  246 -Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             -C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence             0   1124899999999999999999999999999999864

>KOG0696|consensus

Probab=100.00  E-value=1.5e-38  Score=297.91  Aligned_cols=256  Identities=21%  Similarity=0.288  Sum_probs=206.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ...+|..+.+||+|+||.|.+|..+.+.+.+|||++++.-      -+-...|-++|......|.++.++..|+.  ...
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDR  424 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDR  424 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhh
Confidence            4578999999999999999999999999999999987531      12234566777655567888999998876  467


Q ss_pred             cEEEEeccCCccHHHH---hhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec-CC
Q psy3714         243 PALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~---~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~-~~  318 (467)
                      +|+||||++||||.-.   ++++.|..+.+|+.+|+-||=+||++|||.||||.+||||+.++ +|||+|||+++.. -.
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG-HiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIFD  503 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC-ceEeeecccccccccC
Confidence            8999999999998644   34789999999999999999999999999999999999999776 8999999999853 34


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      +....+.||||-|+|||+++..+|..++|+|..+++.+.++.+..||-+....     +.+.-+....            
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-----elF~aI~ehn------------  566 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELFQAIMEHN------------  566 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHcc------------
Confidence            44556789999999999999999999999999999988877777666433211     1111111111            


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCH-----HHHhCCCCCCCcccccc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTA-----REAMDHPYFYPIVKDQS  446 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta-----~e~l~Hp~f~~~~~~~~  446 (467)
                        ...+..+|.||.++.+.+|++.|.+|+..     +++..||||..++|+..
T Consensus       567 --vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~  617 (683)
T KOG0696|consen  567 --VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL  617 (683)
T ss_pred             --CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence              11234589999999999999999999953     78999999999999643

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.1e-36  Score=297.48  Aligned_cols=260  Identities=25%  Similarity=0.441  Sum_probs=182.1

Q ss_pred             EeecccCCcceEEEEEcc--CCCeEEEEEeccch-HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCCc
Q psy3714         177 RKLGRGKYSEVFEAINVQ--SSDKCVVKILKPVK-KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNT  253 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~-~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~~  253 (467)
                      .+||+|+||.||+|.+..  ++..+|+|.++... ...+.+|+++++.++ |+||+.+...+........+++|||+.+ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            579999999999998654  55789999886542 346789999999996 8999999998866555678999999876 


Q ss_pred             cHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC---CCCcEEEEecccceecCC
Q psy3714         254 DFKQLYQ------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH---ENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       254 ~l~~~~~------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~---~~~~ikl~DFGla~~~~~  318 (467)
                      ++.+...            .+++..++.++.||+.||.|||++||+||||||+|||+..   .++.+||+|||+|+....
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence            4433321            3678888999999999999999999999999999999942   335799999999987643


Q ss_pred             CC----CcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChh-hhhhhhh--hccCCC
Q psy3714         319 GQ----EYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE-ALDFLDK--NILGRH  390 (467)
Q Consensus       319 ~~----~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~  390 (467)
                      ..    .....+||+.|+|||++.+. .++.++|+|..+++.+....+..+|............ .......  ...+..
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T cd07867         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP  244 (317)
T ss_pred             CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCC
Confidence            21    22345789999999999775 4788999998887765555554444322111000000 0000000  000000


Q ss_pred             Cccccccc-------------------------ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         391 SRKRWERF-------------------------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       391 ~~~~~~~~-------------------------~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ....|...                         .........++.++|||.+||+.||++||||+|+|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             ChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            00001000                         0001112356789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.2e-37  Score=308.21  Aligned_cols=265  Identities=24%  Similarity=0.434  Sum_probs=192.7

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC---Ccc
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS---RTP  243 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~---~~~  243 (467)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...     ..+++.+|+.+++.++ |+||+.+.+++..+..   ...
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccceE
Confidence            578899999999999999999999999999988642     2356789999999996 8999999998865431   257


Q ss_pred             EEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++||||+.+ ++.+..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          80 YVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDE  157 (372)
T ss_pred             EEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-CEEeccccceeecccCc
Confidence            899999875 555544   3488999999999999999999999999999999999999654 79999999998654322


Q ss_pred             --CcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCc--------ccCChhhhhhh------h
Q psy3714         321 --EYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQ--------HLVSPEALDFL------D  383 (467)
Q Consensus       321 --~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~------~  383 (467)
                        .....++|+.|+|||++.+.. |+.+.|+|..+++......+..+|......        .++.+......      .
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence              223456899999999998754 788999998887765555554444221110        00000000000      0


Q ss_pred             hhccCC-CCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         384 KNILGR-HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       384 ~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      ..+... .....+...  .......+++++|||.+||++||++|||++|+|+||||.+.
T Consensus       238 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         238 AHILRGPHKPPSLPVL--YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHhCCCCCCchHHh--cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            000000 000000000  01122358899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0695|consensus

Probab=100.00  E-value=1.5e-37  Score=284.27  Aligned_cols=262  Identities=23%  Similarity=0.360  Sum_probs=210.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ...+|.++++||+|+|+.|.+++.++|.+.+|+|++++.      .-..++.|-.+.+..+++|.+|.++..|+.  +..
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esr  325 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESR  325 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cce
Confidence            357899999999999999999999999999999999863      124578888899999899999999999875  467


Q ss_pred             cEEEEeccCCccHH---HHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee-cCC
Q psy3714         243 PALIFEHVNNTDFK---QLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF-YHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~---~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~-~~~  318 (467)
                      +++|.||++||+|.   +...+++++.+++|..+|+.||.|||++|||.||||.+|+|+|.++ ++||+|+|+++. +.+
T Consensus       326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg-hikltdygmcke~l~~  404 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC-ceeecccchhhcCCCC
Confidence            89999999999974   3445799999999999999999999999999999999999999776 899999999985 456


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccC-Cc-ccCChhhhhhhhhhccCCCCccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTE-NQ-HLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      ++..++.||||.|.|||++.+..|.+.+|+|..+++-..+..+.+||..-. ++ ...+++   +.-.-++.+..     
T Consensus       405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nted---ylfqvilekqi-----  476 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTED---YLFQVILEKQI-----  476 (593)
T ss_pred             CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhH---HHHHHHhhhcc-----
Confidence            777788999999999999999999999999988877555555666653211 11 011111   11011111100     


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCC------CHHHHhCCCCCCCcccccc
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERL------TAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~------ta~e~l~Hp~f~~~~~~~~  446 (467)
                           ..+..+|-.|...++..|++||++|+      ..+++..||||..++|+..
T Consensus       477 -----riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~l  527 (593)
T KOG0695|consen  477 -----RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLL  527 (593)
T ss_pred             -----cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHH
Confidence                 11234678889999999999999998      4789999999999999643

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-36  Score=298.35  Aligned_cols=245  Identities=24%  Similarity=0.348  Sum_probs=188.6

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHH-HHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIK-ILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~-il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      +.||+|+||.||+|.+..+++.+|+|++....      ...+.+|.. +++.+ +|+||+++...+.+.  ...++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~--~~~~lv~e~   77 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTA--EKLYFVLDY   77 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcC--CEEEEEEcC
Confidence            36899999999999999999999999986421      233455554 45666 589999999888764  468999999


Q ss_pred             cCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-CCCCccee
Q psy3714         250 VNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVR  325 (467)
Q Consensus       250 ~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~~~~~~~~  325 (467)
                      ++++++...+.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ........
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05603          78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPEETTSTF  156 (321)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCCCccccc
Confidence            99999876553   478899999999999999999999999999999999998655 79999999997532 22223445


Q ss_pred             eeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCC
Q psy3714         326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQH  405 (467)
Q Consensus       326 ~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (467)
                      +||+.|+|||++.+..|+.+.|+|..+++.+....+..||....        .....+ .+...          ....+.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~-~i~~~----------~~~~~~  217 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYD-NILHK----------PLQLPG  217 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHH-HHhcC----------CCCCCC
Confidence            79999999999998889999999988887666655555543211        111111 11110          001123


Q ss_pred             CCChHHHHHHHhhcCcCCCCCCCH----HHHhCCCCCCCcccc
Q psy3714         406 LVSPEALDFLDKLLRYDHYERLTA----REAMDHPYFYPIVKD  444 (467)
Q Consensus       406 ~~s~~~~dli~~lL~~dp~~R~ta----~e~l~Hp~f~~~~~~  444 (467)
                      ..+.++.+||.+||+.||.+|+++    .|+++||||.++.+.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~  260 (321)
T cd05603         218 GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD  260 (321)
T ss_pred             CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence            468899999999999999999976    599999999887764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-36  Score=305.18  Aligned_cols=266  Identities=21%  Similarity=0.233  Sum_probs=193.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEc--cCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINV--QSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ..+|++++.||+|+||.||+|...  .++..|++|.+...  ....+|+++|+.++ |+||+++...+...  ...+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l~-h~~iv~~~~~~~~~--~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTIS-HRAIINLIHAYRWK--STVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhcC-CCCccceeeeEeeC--CEEEEEe
Confidence            457999999999999999999754  34578999987643  34578999999996 89999999888653  4689999


Q ss_pred             eccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC---
Q psy3714         248 EHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---  321 (467)
Q Consensus       248 e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~---  321 (467)
                      +++.+ ++.+++   ..+++.++..++.||+.||.|||++|||||||||+|||++..+ .+||+|||+|+.......   
T Consensus       166 e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~~~~~~  243 (392)
T PHA03207        166 PKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAHPDTPQ  243 (392)
T ss_pred             hhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEccCccccccCccccccc
Confidence            99875 555443   3588999999999999999999999999999999999998655 799999999976543221   


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhh---hc------------
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK---NI------------  386 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~------------  386 (467)
                      ....+||+.|+|||++....|+.++|+|..+++.+....+..||+...... ...........   ..            
T Consensus       244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~~~~~~~~~~~~~~~~~  322 (392)
T PHA03207        244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCMQVHPLEFPQNGSTNLC  322 (392)
T ss_pred             ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHhccCccccCCccchhHH
Confidence            123579999999999998889999999988887666656666654432210 00000000000   00            


Q ss_pred             --cCCC---CcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         387 --LGRH---SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       387 --~~~~---~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                        ...+   .+..+. ....-.....+.++++||++||++||++||||+|+|+||||....++
T Consensus       323 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~  384 (392)
T PHA03207        323 KHFKQYAIVLRPPYT-IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN  384 (392)
T ss_pred             HHHHhhcccccCCcc-ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence              0000   000000 00000012357899999999999999999999999999999865544

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-36  Score=312.51  Aligned_cols=251  Identities=21%  Similarity=0.284  Sum_probs=195.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC----
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS----  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~----  240 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||||.++..     ....+.+|+.++..+. |+|++.++..+.....    
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC-CCcEEEeecceecccccCcc
Confidence            47899999999999999999999999999999998642     2345778999998885 8999998876643211    


Q ss_pred             --CccEEEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecc
Q psy3714         241 --RTPALIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG  311 (467)
Q Consensus       241 --~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFG  311 (467)
                        ...++||||+++++|.+.+.       .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~-~vkL~DFG  188 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG-LVKLGDFG  188 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC-CEEEEecc
Confidence              13679999999999987653       478889999999999999999999999999999999999654 79999999


Q ss_pred             cceecCCC---CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccC
Q psy3714         312 LAEFYHPG---QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILG  388 (467)
Q Consensus       312 la~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (467)
                      +++.+...   ......+||+.|+|||++.+..|+.++|+|..+++.+....+..||...        ...........+
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--------~~~~~~~~~~~~  260 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--------NMEEVMHKTLAG  260 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHhcC
Confidence            99875422   1223457999999999999988999999998887755544444444211        111111111111


Q ss_pred             CCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         389 RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       389 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      ..          .+.+..+++++++||.+||+.||.+|||+.++++|||+..
T Consensus       261 ~~----------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        261 RY----------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             CC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            10          0123457899999999999999999999999999999864

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-36  Score=299.11  Aligned_cols=268  Identities=21%  Similarity=0.307  Sum_probs=196.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .++|++.+.||+|+||.||+|.+..++..+|+|+++..    ....+.+|+++++.++ |+||+.+++.+.+.  ...++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~l   80 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSD--GEISI   80 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCcccceeEEEEEC--CEEEE
Confidence            47899999999999999999999999999999987643    2356789999999996 89999999998764  46899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~-~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      ||||+.+++|.+++.   .+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++...... .
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~-~  158 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M  158 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhhhhh-c
Confidence            999999999988764   477888899999999999999985 799999999999998655 7999999999765322 2


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCccc---------CChhhhhhhhhh-----cc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHL---------VSPEALDFLDKN-----IL  387 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~-----~~  387 (467)
                      ....+||..|+|||++.+..++.+.|+|..+++.+....+..|+.......+         ............     ..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence            2345789999999999988899999999888765544444444422110000         000000000000     00


Q ss_pred             ---CCCCccc------ccccccc----cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         388 ---GRHSRKR------WERFVHT----ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       388 ---~~~~~~~------~~~~~~~----~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                         ....+..      .......    ......++++++||.+||++||++|||++|+++||||....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence               0000000      0000000    00113578999999999999999999999999999997643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-36  Score=322.80  Aligned_cols=256  Identities=20%  Similarity=0.311  Sum_probs=199.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..++|++++.||+|+||.||+|.+..++..+|+|+++..     ....+.+|+.+|+.|. ||||+.+++.+.+.....+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecCCCEE
Confidence            347899999999999999999999999999999988642     2356788999999996 8999999998866555678


Q ss_pred             EEEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC-------CccccCCCCCceEEeCC--------
Q psy3714         244 ALIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSM-------GIMHRDVKPHNVMIDHE--------  301 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~-------~IiHrDlKp~Nill~~~--------  301 (467)
                      ++||||+.+++|..++.       .+++..++.++.||+.||.|||+.       +||||||||+|||++..        
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            99999999999977653       478999999999999999999984       49999999999999642        


Q ss_pred             --------CCcEEEEecccceecCCCCCcceeeeccCccCCcccccC--CCCccchhHHHhhhccccccccccccccCCc
Q psy3714         302 --------NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY--QYHIELDPRFADILGRHSRKRWERFVHTENQ  371 (467)
Q Consensus       302 --------~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~  371 (467)
                              ...+||+|||++............+||+.|+|||++.+.  .|+.++|+|..+++.+....+..||..... 
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-  248 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-  248 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-
Confidence                    124899999999876544444456799999999998653  478899999888876666565555532211 


Q ss_pred             ccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         372 HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                            ...... .+. ...         .......++++.+||.+||..||.+|||+.|+|+||||..+..
T Consensus       249 ------~~qli~-~lk-~~p---------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        249 ------FSQLIS-ELK-RGP---------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             ------HHHHHH-HHh-cCC---------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence                  001110 000 000         0011235889999999999999999999999999999986643

>KOG1035|consensus

Probab=100.00  E-value=1.4e-36  Score=317.57  Aligned_cols=412  Identities=22%  Similarity=0.291  Sum_probs=245.4

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCC---cEEEecCCCcEEEE--ecccceecCCCCcccccccccccccccccccccCCC
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPH---NVMIDHENRKLRLI--DWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~---Nil~~~~~~~~kl~--dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      ...+...||.|+|+....|.-+...   +-..+.. ..+...  ||+.++.+..............+.++|.... ....
T Consensus       291 ~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-~~~~  368 (1351)
T KOG1035|consen  291 LHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-NTAK  368 (1351)
T ss_pred             HHHHHhhhHHHHHHhccceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCcccccccccccc-ccch
Confidence            4567889999999985555554443   1212211 234444  7777766544333333344445667777654 2223


Q ss_pred             --CeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchhHhhhhh-------hccCCCchhhhhcccccc---
Q psy3714          78 --YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDK-------YHIELDPRFADILGRARV---  145 (467)
Q Consensus        78 --~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~p~~~~~~~~~~v---  145 (467)
                        ...|+|.+|.++..+..+..+.....    ............+......+       ......+-+...+-+...   
T Consensus       369 ~~r~~dL~~lgll~~~~~~~~~i~~~~~----~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~  444 (1351)
T KOG1035|consen  369 KSRLTDLWCLGLLLLQLSQGEDISEKSA----VPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNE  444 (1351)
T ss_pred             hhhhhHHHHHHHHHhhhhhcCccccccc----chhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccccc
Confidence              23699999999999887754322111    00000000000000000000       000000000000000000   


Q ss_pred             ---cccccCCCCCcccccCcccccc------CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHH
Q psy3714         146 ---YADVNSHKPREYWDYESYVVDW------GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKI  212 (467)
Q Consensus       146 ---~~~~~~~~p~~~~~~~~~~~~~------~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~  212 (467)
                         +........+.++........+      .-..+|+.++.||+|+||.||+++++-+|..||||.+.-.    ...++
T Consensus       445 ~~~~~~~~~~~~~~~~~r~~~~~s~~~r~~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI  524 (1351)
T KOG1035|consen  445 SSEFAPNDETSVPQFRLRFSGAMSPLQRQFSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKI  524 (1351)
T ss_pred             cccccCccccccCccCCCCccccCccccchhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHH
Confidence               0000000001111111111111      1236889999999999999999999999999999987643    23578


Q ss_pred             HHHHHHHHHhcCCCCeeEEEEEEeCC------------------------------------------------------
Q psy3714         213 KREIKILENLRGGTNIITLQAVVKDP------------------------------------------------------  238 (467)
Q Consensus       213 ~~Ei~il~~l~~~~~iv~l~~~~~~~------------------------------------------------------  238 (467)
                      .||+.+|.+|+ |||||+++..+-..                                                      
T Consensus       525 ~rEVk~LArLn-HpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~ss  603 (1351)
T KOG1035|consen  525 LREVKLLARLN-HPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSS  603 (1351)
T ss_pred             HHHHHHHhhcC-CcceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCcccc
Confidence            99999999996 89999887422100                                                      


Q ss_pred             -------------------------------------------------------CC--------CccEEEEeccCCccH
Q psy3714         239 -------------------------------------------------------VS--------RTPALIFEHVNNTDF  255 (467)
Q Consensus       239 -------------------------------------------------------~~--------~~~~lv~e~~~~~~l  255 (467)
                                                                             .+        ..+|+=||||+...+
T Consensus       604 s~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll  683 (1351)
T KOG1035|consen  604 SYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLL  683 (1351)
T ss_pred             ccccccccccccCCcccccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHH
Confidence                                                                   00        123566788887777


Q ss_pred             HHHhh--cC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC--------------
Q psy3714         256 KQLYQ--TL--TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH--------------  317 (467)
Q Consensus       256 ~~~~~--~~--~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~--------------  317 (467)
                      ..+..  .+  ....++.+++||+.||.|+|++|||||||||.||+++..+ .|||.|||+|+...              
T Consensus       684 ~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~  762 (1351)
T KOG1035|consen  684 RDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFST  762 (1351)
T ss_pred             HHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccc
Confidence            66653  23  2567789999999999999999999999999999999554 79999999998711              


Q ss_pred             -----CCCCcceeeeccCccCCcccccCC---CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhcc-C
Q psy3714         318 -----PGQEYNVRVASRYFKGPELLADYQ---YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL-G  388 (467)
Q Consensus       318 -----~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  388 (467)
                           .....+..+||..|+|||++.+..   |+.++|+...|++-..   .+.|| .+      +.+....+. +.. +
T Consensus       763 ~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFE---M~yPF-~T------sMERa~iL~-~LR~g  831 (1351)
T KOG1035|consen  763 NRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFE---MLYPF-GT------SMERASILT-NLRKG  831 (1351)
T ss_pred             cccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHH---HhccC-Cc------hHHHHHHHH-hcccC
Confidence                 111345679999999999998765   9999999988887432   23332 11      111111111 111 0


Q ss_pred             CCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         389 RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       389 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      ..+. . ..|..     .--+....+|+.||+.||++||||.|+|++.||-+
T Consensus       832 ~iP~-~-~~f~~-----~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  832 SIPE-P-ADFFD-----PEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             CCCC-C-ccccc-----ccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence            0000 0 11111     11246678999999999999999999999999974

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-36  Score=310.33  Aligned_cols=248  Identities=20%  Similarity=0.281  Sum_probs=195.0

Q ss_pred             cceeeeEeecccCCcceEEEEEccC-CCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQS-SDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..|.+.+.||+|+||.||+|.+..+ ++.+|+|.+....   ...+.+|+.+|+.++ ||||+++++.+...  ...++|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~--~~~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD-HFGIVKHFDDFKSD--DKLLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEEC--CEEEEE
Confidence            4599999999999999999998877 7788888764322   245678999999995 89999999998764  568999


Q ss_pred             EeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         247 FEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      |||+++++|.+.+.       .+++.++..++.|++.||.|||++||+||||||+|||++..+ .+||+|||+|+.+...
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-cEEEEeCcCceecCCc
Confidence            99999999976542       378889999999999999999999999999999999999655 7999999999876432


Q ss_pred             CC---cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         320 QE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       320 ~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      ..   ....+||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ..........+..      
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~~~~~~~------  288 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQVLYGKY------  288 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC------
Confidence            21   234579999999999999889999999988887655555555543211        1111111111110      


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                          .+.+..+|+++++||.+||..||++|||++|+++|||+..
T Consensus       289 ----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        289 ----DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             ----CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence                0112347899999999999999999999999999999853

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7e-36  Score=287.58  Aligned_cols=254  Identities=23%  Similarity=0.303  Sum_probs=197.3

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      |+..+.||+|+||.||+|.+..+++.+|+|.++...      .....+|+++|+.++ |+||+.+...+...  ...+++
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~--~~~~lv   78 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETK--DALCLV   78 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecC--CEEEEE
Confidence            778899999999999999999999999999886432      234678999999995 79999998887653  468999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      |||+.++++.....     .+++..+..++.|++.||.|||++||+||||||+||+++..+ .+||+|||++........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG-HIRISDLGLAVKIPEGES  157 (285)
T ss_pred             EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC-CEEEecCCcceecCCCCc
Confidence            99999999875542     478899999999999999999999999999999999998554 799999999976644444


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      .....|+..|+|||++.+..++.+.|+|..+++......+..||......     .............    .      .
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-----~~~~~~~~~~~~~----~------~  222 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-----VKREEVDRRVLET----E------E  222 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhhhcc----c------c
Confidence            44567999999999998888999999998887755544454454322110     0001111111000    0      0


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCccccc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKDQ  445 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~~  445 (467)
                      ..+..+++++.+|+.+||..||++|+|     ++++++||||....++.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~  271 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR  271 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHH
Confidence            112347889999999999999999999     89999999999876553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0669|consensus

Probab=100.00  E-value=8.5e-39  Score=282.15  Aligned_cols=267  Identities=27%  Similarity=0.434  Sum_probs=187.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeC---CC--
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKD---PV--  239 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~---~~--  239 (467)
                      ...|+-+.++|+|.||.||+|+...++++||+|++-..     ......||+.+|..|+ |+|++.+.+++..   +.  
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk-Henv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCccc
Confidence            45688888999999999999999999999998865321     1245789999999996 8999888776532   22  


Q ss_pred             -CCccEEEEeccCCccHHHH----hhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccce
Q psy3714         240 -SRTPALIFEHVNNTDFKQL----YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE  314 (467)
Q Consensus       240 -~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~  314 (467)
                       ...+|+||++|+. ||.-+    ..+++..+++.++.+++.||.|+|++.|+|||+||+|+||+.++ .+||+|||+|+
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-ilklADFGlar  172 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-ILKLADFGLAR  172 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-eEEeecccccc
Confidence             2347999999875 33333    34689999999999999999999999999999999999999665 89999999997


Q ss_pred             ecCC-----CCCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCc---------cc--CChh
Q psy3714         315 FYHP-----GQEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQ---------HL--VSPE  377 (467)
Q Consensus       315 ~~~~-----~~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~---------~~--~~~~  377 (467)
                      .+..     ...++.++.|.+|++||.+.+.. |...+|+|.++.+-..+ ...+|++.+..+         ..  .+++
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeM-wtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEM-WTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHH-HccCccccCChHHHHHHHHHHHhccCCcc
Confidence            6532     22366788999999999999876 99999999655432111 111333333211         00  0111


Q ss_pred             hhhhhhh-----hc-cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         378 ALDFLDK-----NI-LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       378 ~~~~~~~-----~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      ..+..++     .+ +...+.....+......+-.-.++|.||+.+||.+||.+|++++|+|.|.||..
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            1111110     00 000111111111111111223679999999999999999999999999999963

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.8e-36  Score=286.71  Aligned_cols=257  Identities=20%  Similarity=0.263  Sum_probs=196.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ++|++++.||+|+||.||+|.+..+++.+|+|.+...    ....+.+|+++++.+. |+||+.+++.+...  ...+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCD-SPYIIGFYGAFFVE--NRISIC   77 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEEC--CEEEEE
Confidence            4688999999999999999999999999999988543    1345778999999995 89999999988764  457899


Q ss_pred             EeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcceee
Q psy3714         247 FEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRV  326 (467)
Q Consensus       247 ~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~  326 (467)
                      |||++++++... ..+++..+..++.|++.||.|||++||+|+||||+|||++.++ .+||+|||++...... .....+
T Consensus        78 ~e~~~~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~~-~~~~~~  154 (279)
T cd06619          78 TEFMDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNS-IAKTYV  154 (279)
T ss_pred             EecCCCCChHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-CEEEeeCCcceecccc-cccCCC
Confidence            999999988543 5678889999999999999999999999999999999999654 7999999999865432 233457


Q ss_pred             eccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       327 gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      ||..|+|||.+.+..++.+.|+|..+++......+..||........ ........... ...    ...    ......
T Consensus       155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~-~~~----~~~----~~~~~~  224 (279)
T cd06619         155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG-SLMPLQLLQCI-VDE----DPP----VLPVGQ  224 (279)
T ss_pred             CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccc-ccchHHHHHHH-hcc----CCC----CCCCCc
Confidence            99999999999988899999999888765555455555432110000 00000000000 000    000    001123


Q ss_pred             CChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      .++++++||.+||..||++|||++|+++||||...+.
T Consensus       225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         225 FSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             CCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence            6889999999999999999999999999999976643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.3e-36  Score=296.81  Aligned_cols=270  Identities=24%  Similarity=0.384  Sum_probs=194.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC----
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPV----  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~----  239 (467)
                      -.++|++++.||+|+||.||+|.+..+++.+|+|.+...     ....+.+|+.+++.++ |+||+++.+.+....    
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCccc
Confidence            357899999999999999999999999999999988632     2345678999999995 899999998875432    


Q ss_pred             CCccEEEEeccCCccHHHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         240 SRTPALIFEHVNNTDFKQLY-QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      ....++||||+.+ ++.+.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~  170 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGT  170 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCccceeCCC
Confidence            1356999999976 555443 3588899999999999999999999999999999999998655 799999999987654


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCc--------ccCC--hhhhhhhhhh---
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQ--------HLVS--PEALDFLDKN---  385 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~--~~~~~~~~~~---  385 (467)
                      ........+|+.|+|||.+.+..++.++|+|..+++......+..+|......        .+..  ..........   
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN  250 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence            43334456899999999999989999999998887655544444443221100        0000  0000000000   


Q ss_pred             cc---CCCCccccccccc--------ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         386 IL---GRHSRKRWERFVH--------TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       386 ~~---~~~~~~~~~~~~~--------~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      ..   .......+.....        ...+...+++++|||.+||+.||++|||+.|+|+||||..-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence            00   0000001111000        00122356789999999999999999999999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0590|consensus

Probab=100.00  E-value=8.6e-38  Score=324.01  Aligned_cols=422  Identities=23%  Similarity=0.316  Sum_probs=265.9

Q ss_pred             hHHHHHHHHHHHHH-hCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCc---cccccc-ccccccccccccccC
Q psy3714           2 RIATGASMALDYCH-SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQE---YNVRVA-SRYFKGPELLADYQM   75 (467)
Q Consensus         2 ~i~~~i~~al~~lH-~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~---~~~~~~-~~~~~~pe~~~~~~~   75 (467)
                      +...|+..|+.|+| ..++.|||+||+|.+++..+..+++.|||+|..+.. +..   ....+| +..|+|||...+...
T Consensus       127 ~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~  206 (601)
T KOG0590|consen  127 RYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAY  206 (601)
T ss_pred             hhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhh
Confidence            35688999999999 999999999999999985433799999999987655 222   344577 899999999987555


Q ss_pred             CCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHH---hCCc-------hhHhhhhhhccCCCchh----hhhcc
Q psy3714          76 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV---LGTE-------ELFEYLDKYHIELDPRF----ADILG  141 (467)
Q Consensus        76 ~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~---~~~~-------~~~~~~~~~~~~~~p~~----~~~~~  141 (467)
                      .....|+||+|+++..+++|..|+............+...   +...       .....+.+.-. ..|..    +++. 
T Consensus       207 ~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~-~~~~~r~s~~~~~-  284 (601)
T KOG0590|consen  207 RGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILK-ENPSNRLSIEELK-  284 (601)
T ss_pred             cCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhccccccc-CCchhcccccccc-
Confidence            6778999999999999999999886433221111111000   0000       00111111000 01110    0000 


Q ss_pred             ccccccc-ccCCCCCc-ccccCccc-cccCCccce-eeeEeecccCCcceEEEEEccCCCeEEEEEec----cch--H--
Q psy3714         142 RARVYAD-VNSHKPRE-YWDYESYV-VDWGQQDDY-QLVRKLGRGKYSEVFEAINVQSSDKCVVKILK----PVK--K--  209 (467)
Q Consensus       142 ~~~v~~~-~~~~~p~~-~~~~~~~~-~~~~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~----~~~--~--  209 (467)
                      ....+.. .+...... ........ ...+..+.| .....+|.|++|.|+.+......+.++.|..+    ...  .  
T Consensus       285 ~d~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~  364 (601)
T KOG0590|consen  285 LDNWLSSKRNGFSKSNPCADSLTIAKSPIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKY  364 (601)
T ss_pred             ccccccccccccccccccccccccccCccccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHH
Confidence            0011111 00000000 00000000 001122334 45677999999988888777666655555433    111  1  


Q ss_pred             -HHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC
Q psy3714         210 -KKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMG  285 (467)
Q Consensus       210 -~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~  285 (467)
                       ..+..|..+-..+. |+|++.....+.+...  .+-.||||++ ||..+..   .++..++-+++.|++.|++|+|+.|
T Consensus       365 ~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~~--~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G  440 (601)
T KOG0590|consen  365 NYNITSEFCIGSSLS-HPNIIETLDIVQEIDG--ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG  440 (601)
T ss_pred             hhhhhhheeeccccc-CCchhhhHHHHhhccc--chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC
Confidence             11344555555564 7888665554443222  2233999999 8877654   4888999999999999999999999


Q ss_pred             ccccCCCCCceEEeCCCCcEEEEecccceecCCC-C----CcceeeeccCccCCcccccCCCCc-cchhHHHhhhccccc
Q psy3714         286 IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-Q----EYNVRVASRYFKGPELLADYQYHI-ELDPRFADILGRHSR  359 (467)
Q Consensus       286 IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~----~~~~~~gt~~y~aPE~l~~~~~~~-~~D~~~~~~~~~~~~  359 (467)
                      |.|||+||+|+++...+ .+||+|||.+..+... +    .....+|+..|+|||++.+..|+. .+|+|..+++..-+.
T Consensus       441 iahrdlK~enll~~~~g-~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~  519 (601)
T KOG0590|consen  441 LAHRDLKLENLLVTENG-ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMI  519 (601)
T ss_pred             ceeccCccccEEEecCC-ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEe
Confidence            99999999999999554 8999999998765322 2    234568999999999999999975 489998877655555


Q ss_pred             cccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc--cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q psy3714         360 KRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT--ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY  437 (467)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~  437 (467)
                      .+..+|.....+.-    .+  .+...      ..+......  .-...++.+.+.+|.+||+.||++|+|++++++.||
T Consensus       520 ~~~~~Wk~a~~~~~----~~--~~~~~------~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W  587 (601)
T KOG0590|consen  520 LGRFPWKVAKKSDN----SF--KTNNY------SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW  587 (601)
T ss_pred             cCCCcccccccccc----ch--hhhcc------ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence            55444433221100    00  00000      001000000  011236788999999999999999999999999999


Q ss_pred             CCCcc
Q psy3714         438 FYPIV  442 (467)
Q Consensus       438 f~~~~  442 (467)
                      |..+.
T Consensus       588 ~~~i~  592 (601)
T KOG0590|consen  588 IRSIE  592 (601)
T ss_pred             hhhcc
Confidence            98765

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.2e-36  Score=295.07  Aligned_cols=246  Identities=22%  Similarity=0.322  Sum_probs=183.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEc-----cCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINV-----QSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|+++...    ...+.+|+.++..+.+||||+++++.+..+ .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-N   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-C
Confidence            478999999999999999999753     345679999986432    346788999999997799999999987654 3


Q ss_pred             CccEEEEeccCCccHHHHhhc-----------------------------------------------------------
Q psy3714         241 RTPALIFEHVNNTDFKQLYQT-----------------------------------------------------------  261 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~~-----------------------------------------------------------  261 (467)
                      ...+++|||+++|+|.+++..                                                           
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            457899999999999766532                                                           


Q ss_pred             ------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc---ceeeeccCcc
Q psy3714         262 ------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY---NVRVASRYFK  332 (467)
Q Consensus       262 ------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~---~~~~gt~~y~  332 (467)
                            ++..++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+........   ....+|+.|+
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCcccc
Confidence                  55667788999999999999999999999999999998654 7999999999865322211   1234567899


Q ss_pred             CCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHH
Q psy3714         333 GPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEA  411 (467)
Q Consensus       333 aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  411 (467)
                      |||++.+..|+.++|+|..+++.+.... +..||.....    ..........   +    ..      ...+..+++++
T Consensus       244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~----~~~~~~~~~~---~----~~------~~~~~~~~~~l  306 (338)
T cd05102         244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----NEEFCQRLKD---G----TR------MRAPENATPEI  306 (338)
T ss_pred             CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc----cHHHHHHHhc---C----CC------CCCCCCCCHHH
Confidence            9999998889999999988876544332 3333321110    0111111000   0    00      01123578899


Q ss_pred             HHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         412 LDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       412 ~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .+||.+||..||++|||+.|+++
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9.1e-36  Score=290.12  Aligned_cols=263  Identities=26%  Similarity=0.437  Sum_probs=193.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.++...     .....+|+.+++.++ |+|++++.+.+.+......
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeE
Confidence            4688999999999999999999999999999999886432     224568999999996 7999999998876544568


Q ss_pred             EEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ++||||+.+ ++.+++.    .+++.++..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++......
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~~~~~  161 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLARTYGLP  161 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccceeeecCCc
Confidence            999999975 5554433    478899999999999999999999999999999999998655 7999999999876433


Q ss_pred             -CCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc-
Q psy3714         320 -QEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE-  396 (467)
Q Consensus       320 -~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  396 (467)
                       .......+++.|+|||++.+. .++.+.|+|..+++.+....+..++......     +....... ..+......|. 
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-----~~~~~~~~-~~~~~~~~~~~~  235 (309)
T cd07845         162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-----EQLDLIIQ-LLGTPNESIWPG  235 (309)
T ss_pred             cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHH-hcCCCChhhchh
Confidence             223334568899999998764 4788999998887655544444443221110     00000000 00000000000 


Q ss_pred             --------cccc--------ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         397 --------RFVH--------TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       397 --------~~~~--------~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                              .+..        ......++++++|||++||.+||++|||++|+++||||.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~  295 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE  295 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence                    0000        0011236899999999999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.2e-36  Score=288.02  Aligned_cols=258  Identities=25%  Similarity=0.483  Sum_probs=190.8

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++.+.||+|+||.||+|.+..+++.+++|.++...     ...+.+|+.+++.++ |+||+++.+.+.+.  ...+++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~--~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLYDVLHSD--KKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcC-CCCeeeHHHHhccC--CceEEE
Confidence            4889999999999999999999999999999886421     245678999999995 89999999988754  468999


Q ss_pred             EeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CC
Q psy3714         247 FEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~  321 (467)
                      +||+.+ ++.+..    ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          78 FEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-cEEECccchhhccCCCCCC
Confidence            999986 554443    2478999999999999999999999999999999999998655 7999999999865432 22


Q ss_pred             cceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhh-----------hccCC
Q psy3714         322 YNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK-----------NILGR  389 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~  389 (467)
                      .....+++.|+|||.+.+.. ++.+.|+|..+++......+..|++.+.+.    ......+..           .....
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH----HHHHHHHHHHhCCCChHHhHHhhhc
Confidence            33456789999999987754 788999998887766555555555433221    000000000           00000


Q ss_pred             CCccccccccc----ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         390 HSRKRWERFVH----TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       390 ~~~~~~~~~~~----~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      .....+..+..    .+..+.+|++++|||.+||..||.+|||++|+++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            00000000000    01123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0614|consensus

Probab=100.00  E-value=3.6e-38  Score=302.10  Aligned_cols=260  Identities=22%  Similarity=0.322  Sum_probs=213.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..+++++..||-|+||.|=++........+|+|++++.      ..+++..|-.||..++ .+.||+++-.|.+  .+++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd--~kyv  495 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRD--SKYV  495 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhcc--chhh
Confidence            46778889999999999988876665556899988753      2356788999999986 7999999999987  4789


Q ss_pred             EEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ||+||-|-||++...+   +.|.+..+++++..+++|++|||++|||.|||||+|+||+..| .+||.|||+|+.+..+.
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G-y~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG-YLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC-ceEEeehhhHHHhccCC
Confidence            9999999999987765   3699999999999999999999999999999999999999665 79999999999998888


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      ..-+.||||.|.|||++.+.+++.++|.|..+++-+..+.|..||. +.+++...        ..|+.......|     
T Consensus       575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs-~~dpmktY--------n~ILkGid~i~~-----  640 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS-GVDPMKTY--------NLILKGIDKIEF-----  640 (732)
T ss_pred             ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC-CCchHHHH--------HHHHhhhhhhhc-----
Confidence            8888999999999999999999999999999887666656555543 33322111        112222222222     


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCcccccccCCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKDQSRHTL  450 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~~~~~~~  450 (467)
                         |..++..|.|||+++...+|.+|+.     +.|+.+|-||.+.+|+-.+...
T Consensus       641 ---Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~  692 (732)
T KOG0614|consen  641 ---PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRT  692 (732)
T ss_pred             ---ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhcc
Confidence               3458999999999999999999995     8999999999999998665443

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=288.86  Aligned_cols=265  Identities=26%  Similarity=0.341  Sum_probs=205.1

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+...      ..+.+.+|+++++.+. |+||+++++.+.+.  ...+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~   77 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTE--TYLC   77 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecC--CEEE
Confidence            4799999999999999999999999999999988643      2245778999999996 89999999888653  5689


Q ss_pred             EEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ++|||+.+++|.+++.     .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~  156 (316)
T cd05574          78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-HIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC-CEEEeecchhhccccc
Confidence            9999999999987763     478888999999999999999999999999999999998654 7999999998754321


Q ss_pred             CC------------------------------cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccC
Q psy3714         320 QE------------------------------YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTE  369 (467)
Q Consensus       320 ~~------------------------------~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~  369 (467)
                      ..                              ....+||..|+|||++.+..++.+.|+|..+++.+....+..||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            11                              112368899999999998889999999988887665555555543221


Q ss_pred             CcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCC----HHHHhCCCCCCCccccc
Q psy3714         370 NQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT----AREAMDHPYFYPIVKDQ  445 (467)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~t----a~e~l~Hp~f~~~~~~~  445 (467)
                      ..    .........    .   ..+      .....+++++++||.+||..||++|||    ++|+|+||||....|..
T Consensus       237 ~~----~~~~~~~~~----~---~~~------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~  299 (316)
T cd05574         237 RD----ETFSNILKK----E---VTF------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL  299 (316)
T ss_pred             hH----HHHHHHhcC----C---ccC------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence            10    000000000    0   001      111226899999999999999999999    99999999999988887


Q ss_pred             ccCCCCCCCCC
Q psy3714         446 SRHTLPSSSPT  456 (467)
Q Consensus       446 ~~~~~~~~~~~  456 (467)
                      .+...++..|+
T Consensus       300 ~~~~~~~~~~~  310 (316)
T cd05574         300 IRHTTPPIIPR  310 (316)
T ss_pred             cccCCCCCCCC
Confidence            77644444443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.3e-36  Score=286.17  Aligned_cols=250  Identities=30%  Similarity=0.476  Sum_probs=190.5

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccchH-----HHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK-----KKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      |++++.||+|+||.||++.+..+++.+|+|++.....     ....+|+.+++.+ .|+||+++.+++.+  ....+++|
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQD--DNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEE--SSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccc--cccccccc
Confidence            8899999999999999999999999999999876532     2235699999999 58999999998876  45688999


Q ss_pred             eccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec-CCCCCcc
Q psy3714         248 EHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQEYN  323 (467)
Q Consensus       248 e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~-~~~~~~~  323 (467)
                      +++.++++.+++.   .+++..+..++.|++.||.+||++||+||||||+||+++. ++.++|+|||.+... .......
T Consensus        78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~-~~~~~l~Dfg~~~~~~~~~~~~~  156 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDE-NGEVKLIDFGSSVKLSENNENFN  156 (260)
T ss_dssp             EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEEST-TSEEEESSGTTTEESTSTTSEBS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccc
Confidence            9999999887654   5888999999999999999999999999999999999994 458999999999863 2233344


Q ss_pred             eeeeccCccCCcccc-cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccccc
Q psy3714         324 VRVASRYFKGPELLA-DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE  402 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~-~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
                      ...+|..|+|||++. +..++.+.|+|..+++......+..++....     ................. ..      ..
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~-~~------~~  224 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-----SDDQLEIIEKILKRPLP-SS------SQ  224 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-----HHHHHHHHHHHHHTHHH-HH------TT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccc-----chhhhhhhhhccccccc-cc------cc
Confidence            567899999999998 7778999999988877554444433332210     00111111111000000 00      00


Q ss_pred             CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       403 ~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      .....++++++||.+||..||++|||++|+++||||
T Consensus       225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            001124799999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-35  Score=284.95  Aligned_cols=256  Identities=28%  Similarity=0.533  Sum_probs=188.4

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++++.||+|+||.||+|.+..+++.||+|.++..     ....+.+|+.+++.+. |+||+++++.+.+.  ...++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQE--SRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeC--CeEEEE
Confidence            589999999999999999999999999999988642     1346788999999996 89999999998763  468999


Q ss_pred             EeccCCccHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-
Q psy3714         247 FEHVNNTDFKQLY------QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-  319 (467)
Q Consensus       247 ~e~~~~~~l~~~~------~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-  319 (467)
                      |||+.+ ++.+..      ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++...... 
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          78 FEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFGIPV  155 (285)
T ss_pred             EecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-cEEECcccceeecCCCc
Confidence            999984 565544      2478889999999999999999999999999999999998654 7999999999765322 


Q ss_pred             CCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc------
Q psy3714         320 QEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR------  392 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  392 (467)
                      .......+++.|+|||++.+.. ++.+.|+|..+++......+..++......    ........  ..+....      
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~----~~~~~~~~--~~~~~~~~~~~~~  229 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI----DQLFRIFR--ILGTPTEDVWPGV  229 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHH--HhCCCChhhhhcc
Confidence            2223346789999999987654 788899998887655444443333211100    00000000  0000000      


Q ss_pred             ----------ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         393 ----------KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       393 ----------~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                                ..|...........+|+++++||++||+.||++|||++++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                      0010000011123479999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7e-36  Score=285.18  Aligned_cols=251  Identities=23%  Similarity=0.379  Sum_probs=192.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC----CCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPV----SRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~----~~~~  243 (467)
                      ...|++.+.||+|+||.||+|.+..+++.+|+|.+...  ....+.+|+.+++.+.+|+||+++.+.+....    ....
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            35688899999999999999999999999999998643  24567889999999977999999999876432    2357


Q ss_pred             EEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      +++|||+.++++.+++.     .+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++.....
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~~~  163 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDR  163 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-CEEEccCCCceeccc
Confidence            89999999999887654     367888899999999999999999999999999999998654 799999999986532


Q ss_pred             C-CCcceeeeccCccCCcccc-----cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         319 G-QEYNVRVASRYFKGPELLA-----DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       319 ~-~~~~~~~gt~~y~aPE~l~-----~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      . .......|+..|+|||++.     +..|+..+|+|..+++......+..|+.....      ......    ..... 
T Consensus       164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~------~~~~~~----~~~~~-  232 (272)
T cd06637         164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFL----IPRNP-  232 (272)
T ss_pred             ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH------HHHHHH----HhcCC-
Confidence            2 2233457899999999986     33578889999888775554444444321110      000000    00000 


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                            ........++.+++|||.+||..||.+|||++|+++||||
T Consensus       233 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 ------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                  0001122468899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4e-35  Score=282.97  Aligned_cols=252  Identities=23%  Similarity=0.394  Sum_probs=200.2

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++.+.||+|+||.||++.+..+++.+|+|.++..      ....+.+|+++++.+. |+||+.+.+.+.+.  ...+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~   77 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDD--SNLY   77 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcC--CeEE
Confidence            4799999999999999999999999999999988642      2345778999999996 89999999988763  5689


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      ++|||++++++.+.+.   .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.....  
T Consensus        78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG-YIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEeeCCCccccCCC--
Confidence            9999999999877753   488899999999999999999999999999999999998654 7999999999876443  


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+|++.|+|||.+.+..++.+.|+|..+++......+..|+....        ..........+.           .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~-----------~  215 (290)
T cd05580         155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--------PIQIYEKILEGK-----------V  215 (290)
T ss_pred             CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCC-----------c
Confidence            233468999999999988888899999988877555444444432211        000010000000           0


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCccccccc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~  447 (467)
                      ..+..+++.+++||++||+.||.+|+     +++|+++||||..+.|....
T Consensus       216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~  266 (290)
T cd05580         216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALL  266 (290)
T ss_pred             cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHh
Confidence            11234689999999999999999999     99999999999998875443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2e-35  Score=285.56  Aligned_cols=262  Identities=27%  Similarity=0.514  Sum_probs=192.1

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC---Cc
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVS---RT  242 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~---~~  242 (467)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++...     ...+.+|+.+++.+.+|+||+++.+.+.....   ..
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47999999999999999999999999999999876432     24678899999999888999999988764321   23


Q ss_pred             cEEEEeccCCccHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccce
Q psy3714         243 PALIFEHVNNTDFKQLYQ--------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE  314 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~  314 (467)
                      .+++|||+.+ ++.++..        .+++..+..++.||+.||.|||++||+||||||+||+++..++.+||+|||++.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            6899999986 5655432        368889999999999999999999999999999999999746689999999998


Q ss_pred             ecCC-CCCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         315 FYHP-GQEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       315 ~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      .+.. ...+....+++.|+|||++.+. .++.+.|+|..+++.+....+..++......    .........  .+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~--~~~~~~  233 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL----QQLLHIFKL--LGTPTE  233 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHHH--hCCCCh
Confidence            6532 2223345678999999988764 4788999998887765555554444321110    000000000  000000


Q ss_pred             c---------------cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         393 K---------------RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       393 ~---------------~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                      .               .+.........+.+++++.+||.+||..||++|||++|+++||||.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            0               0000000111234789999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-36  Score=309.23  Aligned_cols=266  Identities=18%  Similarity=0.241  Sum_probs=179.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCe-EEEE------------------Eeccc--hHHHHHHHHHHHHHhcCCCCe
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDK-CVVK------------------ILKPV--KKKKIKREIKILENLRGGTNI  228 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~-~avK------------------~~~~~--~~~~~~~Ei~il~~l~~~~~i  228 (467)
                      .++|++++.||+|+||.||+|..+..... .+.|                  .++..  ....+.+|+.+|+.++ |+||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-HENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-CCCc
Confidence            47899999999999999999875433221 1111                  11111  1235678999999996 8999


Q ss_pred             eEEEEEEeCCCCCccEEEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC
Q psy3714         229 ITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE  301 (467)
Q Consensus       229 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~  301 (467)
                      +++++++.+.  ...|++++++.+..+..+..       .....+++.++.||+.||+|||++|||||||||+|||++.+
T Consensus       226 v~l~~~~~~~--~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        226 LKIEEILRSE--ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             CcEeEEEEEC--CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            9999998764  45789999886543332221       12356678899999999999999999999999999999865


Q ss_pred             CCcEEEEecccceecCCCCC--cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccc-cCCccc-----
Q psy3714         302 NRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVH-TENQHL-----  373 (467)
Q Consensus       302 ~~~ikl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~-~~~~~~-----  373 (467)
                      + .+||+|||+|+.+.....  ....+||..|+|||++.+..|+.++|+|..+++.+....+..+++. ......     
T Consensus       304 ~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        304 G-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             C-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            5 799999999987653322  2235799999999999999999999999888765544333222111 110000     


Q ss_pred             -------CCh-------hhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         374 -------VSP-------EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       374 -------~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                             ...       ....++...... ........+.   ....+++++.+||.+||++||++||||.|+|+||||.
T Consensus       383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~-~~~~~~~~~~---~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        383 IIDSLSVCDEEFPDPPCKLFDYIDSAEID-HAGHSVPPLI---RNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHHhcccChhhcCCcHHHHHHHhhhhhcc-cCccchhhHH---HhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence                   000       000000000000 0000000000   1123578899999999999999999999999999998


Q ss_pred             Cccc
Q psy3714         440 PIVK  443 (467)
Q Consensus       440 ~~~~  443 (467)
                      ....
T Consensus       459 ~~~~  462 (501)
T PHA03210        459 AEEE  462 (501)
T ss_pred             cCCc
Confidence            7554

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=279.84  Aligned_cols=247  Identities=21%  Similarity=0.316  Sum_probs=193.1

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ++|++.+.||+|++|.||.|.+..+++.+++|.+....        ...+.+|+++++.+. |+||+++++.+.+.  ..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~   78 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDD--ET   78 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccC--Ce
Confidence            57899999999999999999999999999999875321        235778999999995 89999999998764  47


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      .++++||++++++.+...   .+++..++.++.|++.||.|||++||+||||||+||+++.+ +.++|+|||+++.....
T Consensus        79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecccc
Confidence            899999999999887654   47788899999999999999999999999999999999854 47999999999865332


Q ss_pred             CC----cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         320 QE----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       320 ~~----~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      ..    .....|+..|+|||.+.+..++.+.|+|..+++.+....+..||....        ............      
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~------  223 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE--------AMAAIFKIATQP------  223 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc--------hHHHHHHHhccC------
Confidence            11    123467889999999999889999999988877555444444432211        111000000000      


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                         .....+..+++++++||++||..||.+|||++|+++||||
T Consensus       224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 ---TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ---CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence               0011223578999999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0192|consensus

Probab=100.00  E-value=1.6e-35  Score=288.87  Aligned_cols=243  Identities=20%  Similarity=0.300  Sum_probs=184.9

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++..+.+.+|+|+||+||++....+ ..||+|++....     .+.+.+|+.+|.+++ |||||.+.+++.++.. ...+
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~-~~~i  117 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLR-HPNIVQFYGACTSPPG-SLCI  117 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCC-ceEE
Confidence            4445556699999999999987533 239999987543     457899999999996 8999999999987542 5789


Q ss_pred             EEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         246 IFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMG-IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       246 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~-IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ||||+++|+|.+++.     .++...+..++.||+.|+.|||+++ ||||||||+|||++....++||+|||+|+.....
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            999999999988763     4788888999999999999999999 9999999999999965448999999999876543


Q ss_pred             -CCcceeeeccCccCCcccc--cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         320 -QEYNVRVASRYFKGPELLA--DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       320 -~~~~~~~gt~~y~aPE~l~--~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                       ...+...||+.|||||++.  ...|+.++|+++.+++......+..||-....     .....   ..... .      
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~---~v~~~-~------  262 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVAS---AVVVG-G------  262 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHH---HHHhc-C------
Confidence             3344468999999999999  55899999999888875444444444322111     00000   00000 0      


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHh
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM  433 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l  433 (467)
                        ..+..+...++...+||.+|..-||.+||+..+++
T Consensus       263 --~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~  297 (362)
T KOG0192|consen  263 --LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIV  297 (362)
T ss_pred             --CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence              01111223678999999999999999999987654

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.1e-35  Score=280.72  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=186.5

Q ss_pred             eecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHh--cCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         178 KLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENL--RGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       178 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l--~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      .||+|+||.||++.+..+++.+|+|.+....      .....+|..+++.+  .+|+||+.+...+...  ...++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEec
Confidence            3799999999999999999999999885421      12234555444443  2589999998888653  468999999


Q ss_pred             cCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcceee
Q psy3714         250 VNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRV  326 (467)
Q Consensus       250 ~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~  326 (467)
                      +++++|...+.   .+++..+..++.|++.||+|||++||+||||||+|||++..+ .+||+|||++....... .....
T Consensus        79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC-CEEEccCCcceeccccC-ccCcC
Confidence            99999976653   488999999999999999999999999999999999998554 79999999997654322 23356


Q ss_pred             eccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCC
Q psy3714         327 ASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQH  405 (467)
Q Consensus       327 gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (467)
                      ||..|+|||.+.. ..++.+.|+|..+++......+..||......     .. .........          .....+.
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~-~~~~~~~~~----------~~~~~~~  220 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DK-HEIDRMTLT----------VNVELPD  220 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----CH-HHHHHHhhc----------CCcCCcc
Confidence            8999999999864 55888999998887755555555554321110     00 001100000          0011223


Q ss_pred             CCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCccccccc
Q psy3714         406 LVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       406 ~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~  447 (467)
                      .+++++++||++||..||++|+     |++|+++||||.++.+.+..
T Consensus       221 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~  267 (279)
T cd05633         221 SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVY  267 (279)
T ss_pred             ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHh
Confidence            4789999999999999999999     69999999999998876554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.3e-35  Score=281.78  Aligned_cols=257  Identities=30%  Similarity=0.506  Sum_probs=192.8

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++.+.||+|+||.||+|.+..+++.+++|.+....     ...+.+|+.+++.++ |+|++.+.+.+.+  ....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDVFPH--GSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC-CCCCcceeeEEec--CCeeEEE
Confidence            5899999999999999999999999999999986432     356789999999996 8999999998876  3568999


Q ss_pred             EeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC--
Q psy3714         247 FEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--  320 (467)
Q Consensus       247 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~--  320 (467)
                      |||+ ++++.+.+.    .+++.+++.++.|++.||.|||++||+|+||||+||+++.. +.++|+|||++.......  
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCCC
Confidence            9999 899887653    37889999999999999999999999999999999999965 479999999998764332  


Q ss_pred             CcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc-------
Q psy3714         321 EYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR-------  392 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  392 (467)
                      ......|+..|+|||.+.+.. ++.+.|+|..+++......+ .+++.+....    ........ ..+....       
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg-~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~  229 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG-SPLFPGENDI----EQLAIVFR-TLGTPNEETWPGLT  229 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcC-CcCcCCCCHH----HHHHHHHH-HcCCCChHHHhhcc
Confidence            234467899999999987654 68899999888776555554 3333222110    00000000 0000000       


Q ss_pred             --cccccccc--------ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         393 --KRWERFVH--------TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       393 --~~~~~~~~--------~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                        ..|.....        ....+..++++.+||++||..||++|||++++++||||.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence              00000000        011234678999999999999999999999999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.3e-35  Score=279.96  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=191.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcCCCCeeEEEEEEeC---CCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGGTNIITLQAVVKD---PVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~~~~iv~l~~~~~~---~~~~~~  243 (467)
                      ..++|++++.||+|+||.||+|.+..+++.+|+|+++...  ...+.+|+.+++.+.+|+||+++.+.+..   ......
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            3578999999999999999999999999999999886532  35678899999999779999999987632   223568


Q ss_pred             EEEEeccCCccHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         244 ALIFEHVNNTDFKQLY-------QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      +++|||+++++|.+..       ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||+++..
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~  174 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQL  174 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-CEEEccCCceeec
Confidence            9999999999987654       2467788899999999999999999999999999999998655 6999999999865


Q ss_pred             CCCC-CcceeeeccCccCCccccc-----CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCC
Q psy3714         317 HPGQ-EYNVRVASRYFKGPELLAD-----YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRH  390 (467)
Q Consensus       317 ~~~~-~~~~~~gt~~y~aPE~l~~-----~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (467)
                      .... ......|++.|+|||++..     ..|+.+.|+|..+++......+..|+.....        ...... .. . 
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~--------~~~~~~-~~-~-  243 (286)
T cd06638         175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP--------MRALFK-IP-R-  243 (286)
T ss_pred             ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch--------hHHHhh-cc-c-
Confidence            4322 2233568999999999853     3478889999888765444333333321110        000000 00 0 


Q ss_pred             CcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         391 SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       391 ~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                        ....   ....+...+.++++||.+||..||.+|||+.|+++||||
T Consensus       244 --~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         244 --NPPP---TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             --cCCC---cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence              0000   001123357899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-35  Score=290.98  Aligned_cols=264  Identities=21%  Similarity=0.258  Sum_probs=186.9

Q ss_pred             eeEeeccc--CCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         175 LVRKLGRG--KYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       175 ~~~~lG~G--~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ++++||+|  +||+||++.+..+++.||+|.++..     ....+.+|+.+++.++ ||||+++++.+..+  ...++||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~--~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN-HPNIVPYRATFIAD--NELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEEC--CEEEEEE
Confidence            56789999  6789999999999999999998643     2245778999999885 89999999988764  4689999


Q ss_pred             eccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-CCC
Q psy3714         248 EHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQE  321 (467)
Q Consensus       248 e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~~~  321 (467)
                      ||++++++.++..     .+++..++.++.|++.||+|||++||+||||||+|||++.++ .++++|||.+..... +..
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-cEEEcccchhhcccccccc
Confidence            9999999887653     378889999999999999999999999999999999998655 799999986543211 110


Q ss_pred             -------cceeeeccCccCCccccc--CCCCccchhHHHhhhccccccccccccccCCcccCChh-------hhh---hh
Q psy3714         322 -------YNVRVASRYFKGPELLAD--YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE-------ALD---FL  382 (467)
Q Consensus       322 -------~~~~~gt~~y~aPE~l~~--~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~---~~  382 (467)
                             ....+++..|+|||++.+  ..|+.++|+|..+++......+..||............       ...   ..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence                   112356778999999976  35889999998887765555555554322110000000       000   00


Q ss_pred             hhhccCCCCc-----------------ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         383 DKNILGRHSR-----------------KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       383 ~~~~~~~~~~-----------------~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ..........                 .........+....+++++++||++||++||++|||++|+++||||..+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence            0000000000                 00000000011123578999999999999999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG1989|consensus

Probab=100.00  E-value=1.4e-35  Score=303.75  Aligned_cols=251  Identities=20%  Similarity=0.263  Sum_probs=188.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEE-EEeC---CC-CC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQA-VVKD---PV-SR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~-~~~~---~~-~~  241 (467)
                      ...+++.+.|.+|+|+.||+|.+...+..||+|.+-...   .+.+.+||++|+.|++|+|||.+.+ ....   .. ..
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            356889999999999999999999988999999875433   3567899999999999999999988 3221   11 24


Q ss_pred             ccEEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEeCCCCcEEEEecccce
Q psy3714         242 TPALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAE  314 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~--IiHrDlKp~Nill~~~~~~ikl~DFGla~  314 (467)
                      .+.++||||.++.|.++..     .|++.++..|++|+++|+.+||...  |||||||-|||||+.++ ..||||||.|.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g-~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG-NYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC-CEEeCcccccc
Confidence            5688999999888766543     5999999999999999999999998  99999999999999665 79999999987


Q ss_pred             ecC--CCCCcc--------eeeeccCccCCcccc---cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhh
Q psy3714         315 FYH--PGQEYN--------VRVASRYFKGPELLA---DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDF  381 (467)
Q Consensus       315 ~~~--~~~~~~--------~~~gt~~y~aPE~l~---~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (467)
                      -..  +.....        ..-.|+.|||||+|.   +.+-+.++|+|..+++.+.......||-...        .+.+
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------~laI  266 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------KLAI  266 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------ceeE
Confidence            432  111100        124799999999874   5567889999999887654322223332211        1111


Q ss_pred             hhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC--------CCCCCCcc
Q psy3714         382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD--------HPYFYPIV  442 (467)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~--------Hp~f~~~~  442 (467)
                      +.    +.+.         .+..+..|+.+++||+.||+.||.+||++-|++.        ++++.++.
T Consensus       267 ln----g~Y~---------~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  267 LN----GNYS---------FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             Ee----cccc---------CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence            11    1111         1223457999999999999999999999877664        56666555

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.6e-34  Score=273.28  Aligned_cols=246  Identities=20%  Similarity=0.335  Sum_probs=190.7

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++++.||+|+||.||++.+..+++.+++|.+...     ..+.+.+|+++++.++ |+|++.+...+... ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~-~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGE-DGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCC-CCEEEEE
Confidence            589999999999999999999999999999988532     2345778999999996 89999998876532 2357899


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-C
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-Q  320 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~  320 (467)
                      |||++++++.+...     .+++.++..++.|++.||++||++||+||||||+||+++.++ .++|+|||++...... .
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC-cEEEecccceEEecccCC
Confidence            99999999876653     378899999999999999999999999999999999998654 7999999999866422 2


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      ......+++.|+|||++.+..++.+.|+|..+++......+..++...        +..........+..          
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~--------~~~~~~~~~~~~~~----------  219 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK--------DMNSLVYRIIEGKL----------  219 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhcCC----------
Confidence            223356899999999999888999999998887655444444333211        11111111000000          


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ...+..+++++.+||.+||+.||++|||+.++++||||
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            01123478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9.6e-35  Score=278.75  Aligned_cols=257  Identities=30%  Similarity=0.483  Sum_probs=188.0

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      |++++.||+|+||.||+|.+..+++.+|+|.++...    .....+|+.+++++.+|+|++++.+.+.+......++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            678999999999999999999999999999886531    2234579999999988999999999988764467899999


Q ss_pred             ccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcce
Q psy3714         249 HVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV  324 (467)
Q Consensus       249 ~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~  324 (467)
                      |+++ ++.+...    .+++.++..++.|++.||+|||++||+||||||+||+++.  +.+||+|||+++..........
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~~~  157 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSKPPYTE  157 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccCCCcCC
Confidence            9986 4444332    3788999999999999999999999999999999999996  5899999999987654444444


Q ss_pred             eeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCC-----------CCc
Q psy3714         325 RVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGR-----------HSR  392 (467)
Q Consensus       325 ~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~  392 (467)
                      ..++..|+|||.+... .++.+.|+|..+++......+..+|.. .+.    .+...... ...+.           ...
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~-~~~----~~~~~~~~-~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG-TNE----LDQIAKIH-DVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC-CCH----HHHHHHHH-HHcCCCCHHHHHhhccccc
Confidence            5689999999987544 467889999888775544443333321 110    00000000 00000           000


Q ss_pred             ccc--ccccc---ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         393 KRW--ERFVH---TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       393 ~~~--~~~~~---~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ..+  .....   ......+|+++++||.+||.+||++|||++|+++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            000  00000   00012468999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-34  Score=282.36  Aligned_cols=261  Identities=21%  Similarity=0.313  Sum_probs=193.9

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ++|++.+.||+|+||.||++.+..++..+++|.++..    ....+.+|+++++.++ |+||+++++.+.+.  ...+++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSD--GEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeC--CEEEEE
Confidence            4799999999999999999999999999999987643    2345788999999995 89999999988764  468999


Q ss_pred             EeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc
Q psy3714         247 FEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       247 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~  322 (467)
                      |||+++++|.++..   .+++..+..++.|++.||.|||+ .+++||||||+|||++.++ .+||+|||++...... ..
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~-~~  155 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MA  155 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccccc-cc
Confidence            99999999987764   47888899999999999999997 5999999999999998654 7999999998765322 22


Q ss_pred             ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhcc-------------CC
Q psy3714         323 NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL-------------GR  389 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~  389 (467)
                      ...+|++.|+|||.+.+..++.+.|+|..+++......+..|+......     ...........             ..
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-----ELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-----hHHHhhcCccccccccCCcccccCCC
Confidence            3457899999999998888889999998887655444444443211100     00000000000             00


Q ss_pred             CCccc-------cccccc----ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         390 HSRKR-------WERFVH----TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       390 ~~~~~-------~~~~~~----~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      .....       .+....    ......+++++++||.+||..||++|||++|+++||||...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence            00000       000000    00112368899999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.4e-35  Score=280.74  Aligned_cols=251  Identities=21%  Similarity=0.352  Sum_probs=191.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcCCCCeeEEEEEEeCC----CCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGGTNIITLQAVVKDP----VSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~----~~~~~  243 (467)
                      ...|++.+.||+|+||.||+|.+..+++.+|+|.+....  ...+.+|+.+++.+.+|+||+++.+.+...    .....
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            467999999999999999999999999999999876542  346778999999997899999999887432    23567


Q ss_pred             EEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      +++|||+.++++.++..     .+++..+..++.||+.||.|||++||+||||||+||+++.++ .++|+|||++.....
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~~~  173 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCcchhhhhc
Confidence            99999999999877663     267778889999999999999999999999999999999655 799999999875432


Q ss_pred             -CCCcceeeeccCccCCcccc-----cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         319 -GQEYNVRVASRYFKGPELLA-----DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       319 -~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                       ........|++.|+|||.+.     ...|+.+.|+|..+++......+..|+.....      . ....  . ......
T Consensus       174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~------~-~~~~--~-~~~~~~  243 (282)
T cd06636         174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP------M-RALF--L-IPRNPP  243 (282)
T ss_pred             cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH------H-hhhh--h-HhhCCC
Confidence             12233457899999999986     34578889999888775555444444422110      0 0000  0 000000


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                             .......+++++.+||++||..||.+|||+.|+++||||
T Consensus       244 -------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 -------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                   000112468899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4279|consensus

Probab=100.00  E-value=1.3e-35  Score=293.46  Aligned_cols=245  Identities=21%  Similarity=0.336  Sum_probs=194.4

Q ss_pred             eecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCCcc
Q psy3714         178 KLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTD  254 (467)
Q Consensus       178 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~~~  254 (467)
                      +||+|+||+||.|++..|....|||-+....   .+-+..||.+.+.|+ |.|||++.+.+...  ..+-+.||.++||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~sen--Gf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLR-HKNIVRYLGSVSEN--GFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHh-hHhHHHHhhccCCC--CeEEEEeecCCCCc
Confidence            5999999999999999999999999876543   345678999999997 89999999987643  46778899999999


Q ss_pred             HHHHhh----cC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-cceeee
Q psy3714         255 FKQLYQ----TL--TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YNVRVA  327 (467)
Q Consensus       255 l~~~~~----~~--~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-~~~~~g  327 (467)
                      |..++.    .+  .|..+.+|.+||++||+|||++.|||||||-+|+|++.-.+.+||+|||-++....-.. ..+..|
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            988764    35  67788999999999999999999999999999999998778999999999986532222 234569


Q ss_pred             ccCccCCcccccCC--CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCC
Q psy3714         328 SRYFKGPELLADYQ--YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQH  405 (467)
Q Consensus       328 t~~y~aPE~l~~~~--~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (467)
                      |..|||||+|...+  |..+.|+|+.+.--..+..|..||...     +++.+.- ......+          ..++.+.
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El-----gspqAAM-FkVGmyK----------vHP~iPe  802 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL-----GSPQAAM-FKVGMYK----------VHPPIPE  802 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec-----CChhHhh-hhhccee----------cCCCCcH
Confidence            99999999998764  899999998887655566666665432     2222111 1111111          1233445


Q ss_pred             CCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       406 ~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      .+|.+|++||.+|++.||.+||+|.++|+.||++.-
T Consensus       803 elsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            689999999999999999999999999999999865

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-35  Score=280.48  Aligned_cols=261  Identities=27%  Similarity=0.535  Sum_probs=189.4

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|.+....    .....+|+++++.++ |+||+.+++++.+.  ...
T Consensus         2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~   78 (291)
T cd07844           2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK-HANIVTLHDIIHTK--KTL   78 (291)
T ss_pred             CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCC-CcceeeEEEEEecC--CeE
Confidence            45689999999999999999999999899999999886432    234678999999995 89999999988753  578


Q ss_pred             EEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-
Q psy3714         244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-  318 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-  318 (467)
                      ++||||+.+ ++.+...    .+++..++.++.|++.||.|||++||+||||||+||+++..+ .+||+|||+++.... 
T Consensus        79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~  156 (291)
T cd07844          79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVP  156 (291)
T ss_pred             EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-CEEECccccccccCCC
Confidence            999999985 7766543    468889999999999999999999999999999999998655 799999999875421 


Q ss_pred             CCCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc--
Q psy3714         319 GQEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW--  395 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  395 (467)
                      ........++..|+|||++.+. .++.+.|+|..+++......+..+|......    .+....... .++......|  
T Consensus       157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~  231 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV----EDQLHKIFR-VLGTPTEETWPG  231 (291)
T ss_pred             CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH----HHHHHHHHH-hcCCCChhhhhh
Confidence            1222334578899999998764 4788899998887655444443333211100    000000000 0000000000  


Q ss_pred             ------------cccc---cccCCCCCC--hHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         396 ------------ERFV---HTENQHLVS--PEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       396 ------------~~~~---~~~~~~~~s--~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                                  ....   .......++  +++.+||.+||+.||++|||+.|+++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                        0000   001112244  899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.6e-35  Score=276.98  Aligned_cols=247  Identities=23%  Similarity=0.352  Sum_probs=187.9

Q ss_pred             cceeeeEee--cccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         171 DDYQLVRKL--GRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       171 ~~y~~~~~l--G~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      ++|++.+.+  |+|+||.||++.+..++..+|+|.++......  .|+.....+.+|+|++++++.+..+  ...++|||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~e~~~~~~~~~h~~iv~~~~~~~~~--~~~~iv~e   89 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--IEPMVHQLMKDNPNFIKLYYSVTTL--KGHVLIMD   89 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--hhHHHHHHhhcCCCEEEEEEEEecC--CeeEEEEE
Confidence            456666665  99999999999999999999999986532222  2343444345799999999998764  46899999


Q ss_pred             ccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCccee
Q psy3714         249 HVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR  325 (467)
Q Consensus       249 ~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~  325 (467)
                      |+++++|.+++.   .+++.++..++.|++.||.|||++||+||||||+||+++..+..++|+|||+++.....   ...
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~  166 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCY  166 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccC
Confidence            999999987763   47899999999999999999999999999999999999966547999999999865422   234


Q ss_pred             eeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCC
Q psy3714         326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQH  405 (467)
Q Consensus       326 ~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (467)
                      .++..|+|||++.+..++...|+|..+++......+..|+.......+...   ...     ... .      .....+.
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~---~~~-----~~~-~------~~~~~~~  231 (267)
T PHA03390        167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE---SLL-----KRQ-Q------KKLPFIK  231 (267)
T ss_pred             CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH---HHH-----Hhh-c------ccCCccc
Confidence            688999999999988899999999888876655555555532211110000   000     000 0      0011123


Q ss_pred             CCChHHHHHHHhhcCcCCCCCCC-HHHHhCCCCCC
Q psy3714         406 LVSPEALDFLDKLLRYDHYERLT-AREAMDHPYFY  439 (467)
Q Consensus       406 ~~s~~~~dli~~lL~~dp~~R~t-a~e~l~Hp~f~  439 (467)
                      .+|+++++||.+||+.||.+|++ ++|+|+||||.
T Consensus       232 ~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        232 NVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             ccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            57999999999999999999996 59999999995

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.4e-34  Score=279.25  Aligned_cols=266  Identities=26%  Similarity=0.429  Sum_probs=187.7

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      +...+|++++.||+|+||.||+|.+..+++.+++|.++...    .....+|+.+++.+. |+||+.+++.+.+.  ...
T Consensus         2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~--~~~   78 (291)
T cd07870           2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK-HANIVLLHDIIHTK--ETL   78 (291)
T ss_pred             CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecC--CeE
Confidence            34578999999999999999999999999999999986432    235678999999996 89999999988753  468


Q ss_pred             EEEEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-
Q psy3714         244 ALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-  318 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-  318 (467)
                      +++|||+.+ ++.+..    ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        79 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          79 TFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIP  156 (291)
T ss_pred             EEEEecccC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-cEEEeccccccccCCC
Confidence            999999974 554433    2367788899999999999999999999999999999998655 799999999975432 


Q ss_pred             CCCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcc---------cCChhhhhhhhhhccC
Q psy3714         319 GQEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQH---------LVSPEALDFLDKNILG  388 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~  388 (467)
                      ........+++.|+|||.+.+. .++...|+|..+++......+..+|....+..         +..+....+.......
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence            2223345679999999998764 47888999988877555444444442211100         0000000000000000


Q ss_pred             CCCcccccc-----cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         389 RHSRKRWER-----FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       389 ~~~~~~~~~-----~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      .+....+..     +.........++++.|||.+||+.||++|||++|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            000000000     00000001136789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8e-35  Score=279.55  Aligned_cols=252  Identities=21%  Similarity=0.347  Sum_probs=188.8

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ++|++++.||+|+||.||++.+..+++.||+|.++...    ...+..|+.++.+..+|+||+++.+.+...  ...+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEEE
Confidence            57999999999999999999999999999999886432    235566777655566799999999988753  468999


Q ss_pred             EeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         247 FEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~-~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      |||+++ ++.+++.       .+++..+..++.|++.||.|||++ +++||||||+||+++.++ .+||+|||++..+..
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~~  156 (283)
T cd06617          79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVD  156 (283)
T ss_pred             hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeeccccccccc
Confidence            999975 4544332       378889999999999999999997 999999999999998654 799999999986643


Q ss_pred             CCCcceeeeccCccCCccccc----CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         319 GQEYNVRVASRYFKGPELLAD----YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~----~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ....+...|+..|+|||.+.+    ..++...|+|..+++......+..|+.....       ........ ...    .
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~-~~~----~  224 (283)
T cd06617         157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-------PFQQLKQV-VEE----P  224 (283)
T ss_pred             ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-------CHHHHHHH-Hhc----C
Confidence            333333568899999999865    4568889999888775555555545421110       00000000 000    0


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ...+    ....+|+++++||.+||..||.+|||++|+++||||....
T Consensus       225 ~~~~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         225 SPQL----PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             CCCC----CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            0000    0123689999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.3e-34  Score=278.44  Aligned_cols=259  Identities=27%  Similarity=0.483  Sum_probs=192.7

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+....     .+.+.+|+.+++.++ |+|++.+.+.+...  ...++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~--~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRK--RKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeC--CEEEE
Confidence            47999999999999999999999899999999875421     245678999999996 89999999988753  46799


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-C
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-E  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~  321 (467)
                      +|||++++.+.....   .+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++....... .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG-QIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC-cEEECccccceecCCCccc
Confidence            999999988876653   478899999999999999999999999999999999998655 79999999998764433 2


Q ss_pred             cceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccC-------CCCcc
Q psy3714         322 YNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILG-------RHSRK  393 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~  393 (467)
                      .....++..|+|||.+.+. .++.+.|+|..+++......+..||.....     .+...........       .....
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD-----VDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChHHhhhcccc
Confidence            3345688999999998764 478899999888775555555444422111     0000000000000       00000


Q ss_pred             cccc---ccc-------ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         394 RWER---FVH-------TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       394 ~~~~---~~~-------~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      .+..   ...       ......+++++.|||.+||..||++|||+.|+++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            0000   000       00123468999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.3e-34  Score=280.35  Aligned_cols=253  Identities=21%  Similarity=0.350  Sum_probs=197.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..+|++++.||+|+||.||+|.+..+++.||+|.+...   ....+.+|+.+++.+. |+||+.+.+.+...  ...++|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~--~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLVG--DELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCC-CCCEeeEEEEEecC--CEEEEe
Confidence            47899999999999999999999999999999988642   2356778999999885 89999999988753  468999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-cc
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YN  323 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-~~  323 (467)
                      |||++++++.++..  .+++.++..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             ecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEECcCccceEccCCccCcC
Confidence            99999999988764  478889999999999999999999999999999999998554 799999999986543322 23


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      ...+++.|+|||.+.+..++.+.|+|..+++.+....+..||......        .....  ......      .....
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~--------~~~~~--~~~~~~------~~~~~  237 (297)
T cd06656         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYL--IATNGT------PELQN  237 (297)
T ss_pred             cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc--------hheee--eccCCC------CCCCC
Confidence            356899999999999888889999998887655544444444321100        00000  000000      00112


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      +..+++.+++||.+||..||++|||++++++||||....
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            234788999999999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=286.20  Aligned_cols=267  Identities=28%  Similarity=0.507  Sum_probs=193.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC---CCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV---SRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~---~~~  242 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.++..    ......+|+.+++.++ |+||+.+.+++....   ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccccce
Confidence            47899999999999999999999999999999988642    2345678999999997 899999988765432   235


Q ss_pred             cEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      .++++||+.+ ++.+...  .+++..++.++.|++.||.|||++||+||||||+||+++..+ .+||+|||++.......
T Consensus        83 ~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          83 VYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEH  160 (336)
T ss_pred             EEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEECcccceeeccccc
Confidence            7899999975 5655543  488999999999999999999999999999999999998554 79999999998653322


Q ss_pred             C----cceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcc--------cCC--hhhhhhhhh-
Q psy3714         321 E----YNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQH--------LVS--PEALDFLDK-  384 (467)
Q Consensus       321 ~----~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~-  384 (467)
                      .    ....+||+.|+|||.+.+ ..++...|+|..+++......+..+|.......        +..  ++....+.. 
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence            1    123468999999998765 457888999988877555444444442211000        000  000000000 


Q ss_pred             ---hccC---CCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         385 ---NILG---RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       385 ---~~~~---~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                         ....   ......+.     ...+.+++++.|||.+||+.||++|||+.|+++||||......
T Consensus       241 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         241 RARNYIKSLPFKPKVPWN-----KLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             hhhhHHhhcCcCCcccHH-----HHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence               0000   00000010     0112468899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.1e-35  Score=278.54  Aligned_cols=251  Identities=21%  Similarity=0.359  Sum_probs=191.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|.++...   ...+.+|+.+++.++ |+||+++.+.+...  ...++
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~--~~~~l   83 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRR--DKLWI   83 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC--CEEEE
Confidence            3568999999999999999999999999999999987542   235678999999995 89999999988653  56899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-C
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-E  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~  321 (467)
                      +|||+++++|.+++.   .+++.++..++.|++.||.|||++||+||||||+||+++..+ .+||+|||++....... .
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-HVKLADFGVSAQITATIAK  162 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECcceeeeEccCcccc
Confidence            999999999987653   578999999999999999999999999999999999998554 79999999987653221 1


Q ss_pred             cceeeeccCccCCcccc---cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         322 YNVRVASRYFKGPELLA---DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~---~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      .....||..|+|||++.   ...++.++|+|..+++.+....+..|+......    ........    .......+   
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~----~~~~~~~~----~~~~~~~~---  231 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM----RALFLMTK----SNFQPPKL---  231 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch----hhHHhhhc----cCCCCCcc---
Confidence            23457899999999985   345888999998887755544444443221100    00000000    00000000   


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY  437 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~  437 (467)
                         .....+++.+.+||.+||..||++|||++++++|||
T Consensus       232 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         232 ---KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ---cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence               111236789999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.2e-34  Score=273.90  Aligned_cols=246  Identities=19%  Similarity=0.281  Sum_probs=193.0

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++++.||+|+||.||+|.+..+++.+++|.+...     ....+.+|+++++.++ |+|++.+++.+..  ....++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYENFLE--DKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC-CCchhheeeeEec--CCEEEEE
Confidence            589999999999999999999999999999987542     2356788999999996 8999999988764  3568999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      |||++++++.+...     .+++..+..++.|++.||.|||++||+||||||+||+++.++..+||+|||++........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999887653     2678889999999999999999999999999999999986666789999999987654443


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      .....|+..|+|||.+.+..++.+.|+|..+++......+..++....        ....... +...    .     ..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--------~~~~~~~-~~~~----~-----~~  219 (256)
T cd08220         158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--------LPALVLK-IMSG----T-----FA  219 (256)
T ss_pred             ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc--------hHHHHHH-HHhc----C-----CC
Confidence            344578999999999988888899999988876544333333321110        0000100 0000    0     00


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ..+..+++++++||.+||..||.+|||++|+++||||
T Consensus       220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            1123478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.6e-34  Score=278.95  Aligned_cols=258  Identities=21%  Similarity=0.316  Sum_probs=196.2

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ...+.|++++.||+|+||.||+|.+..++..+++|.+....   .+.+.+|+.+++.++ |+||+.+.+.+...  ...+
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~   85 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCN-HPYIVKLLGAFYWD--GKLW   85 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeC--CeEE
Confidence            34578999999999999999999999999999999986543   345678999999996 89999999987653  4689


Q ss_pred             EEEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-
Q psy3714         245 LIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-  319 (467)
Q Consensus       245 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-  319 (467)
                      +||||++++++....    ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++...... 
T Consensus        86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC-CCEEEccCccceeccccc
Confidence            999999999987654    247889999999999999999999999999999999999854 47999999998754322 


Q ss_pred             CCcceeeeccCccCCcccc-----cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         320 QEYNVRVASRYFKGPELLA-----DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~-----~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      .......+++.|+|||.+.     ...++.++|+|..+++.+....+..++....      +  ..... .....    .
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~------~--~~~~~-~~~~~----~  231 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN------P--MRVLL-KIAKS----E  231 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc------H--HHHHH-HHhcC----C
Confidence            2223456889999999985     3447788999988877554444433331110      0  00000 00000    0


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccccc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ  445 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~  445 (467)
                      ..   ....+..++.++.+||++||..||.+|||++|+++||||..+.++.
T Consensus       232 ~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         232 PP---TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             Cc---cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence            00   0111234688999999999999999999999999999998776543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.9e-34  Score=278.36  Aligned_cols=253  Identities=23%  Similarity=0.361  Sum_probs=193.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC---CCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPV---SRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~---~~~~~  244 (467)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+...  ....+.+|+.+++++.+|+|++++++.+....   ....+
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            57899999999999999999999999999999998653  23567789999999977999999999876432   24579


Q ss_pred             EEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         245 LIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      +||||++++++.++..       .+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||++....
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~~  179 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLT  179 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeecccchhcc
Confidence            9999999999876542       478888999999999999999999999999999999998655 79999999988654


Q ss_pred             CCC-CcceeeeccCccCCcccccCC-----CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         318 PGQ-EYNVRVASRYFKGPELLADYQ-----YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       318 ~~~-~~~~~~gt~~y~aPE~l~~~~-----~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      ... ......|+..|+|||++....     ++.++|+|..+++......+..|+.....        ..........  .
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--------~~~~~~~~~~--~  249 (291)
T cd06639         180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--------VKTLFKIPRN--P  249 (291)
T ss_pred             cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--------HHHHHHHhcC--C
Confidence            322 123356889999999986432     67889999888775554445444432110        0000000000  0


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                      .   ..   ...+...+.++++||.+||..||++|||+.|+++||||.
T Consensus       250 ~---~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         250 P---PT---LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             C---CC---CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            0   00   011234678899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.7e-34  Score=274.59  Aligned_cols=251  Identities=20%  Similarity=0.315  Sum_probs=193.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ++|++.+.||.|+||.||+|....++..+++|.+...    ....+.+|+.+++.++ |+|++.+...+...  ...+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN-HPNVVKYYTSFVVG--DELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeC--CEEEEE
Confidence            5799999999999999999998888999999988642    2356789999999985 89999999887653  568999


Q ss_pred             EeccCCccHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         247 FEHVNNTDFKQLYQ------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       247 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ||+++++++.....      .+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++..+....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED-GSVKIADFGVSASLADGG  156 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccchHHHhccCc
Confidence            99999999887763      36788899999999999999999999999999999999965 479999999987654332


Q ss_pred             Cc-----ceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         321 EY-----NVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       321 ~~-----~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ..     ...+|+..|+|||++... .++...|.|..+++......+..|+......        ..... ....    .
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~-~~~~----~  223 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLML-TLQN----D  223 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--------hhHHH-HhcC----C
Confidence            21     234689999999998877 6888999998887755555555554221110        00000 0000    0


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ...+........++++++|||.+||..||++|||++|+++||||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            00111111123578999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG1167|consensus

Probab=100.00  E-value=1.3e-35  Score=280.29  Aligned_cols=271  Identities=28%  Similarity=0.483  Sum_probs=208.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEcc---CCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQ---SSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ...|.++.+||+|+|++||+|.+..   ....||+|.+... ...++.+|+++|..+.++.||+.+...+..  .....+
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd~v~i  112 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRN--NDQVAI  112 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhcc--CCeeEE
Confidence            3678899999999999999999887   7788999988654 457899999999999999999999998875  457899


Q ss_pred             EEeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC--------
Q psy3714         246 IFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH--------  317 (467)
Q Consensus       246 v~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~--------  317 (467)
                      ||+|++..++.+++..++-.+++.|++.++.||.++|.+|||||||||+|+|.+...+.-.|+|||+|....        
T Consensus       113 vlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s  192 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS  192 (418)
T ss_pred             EecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence            999999999999999999999999999999999999999999999999999999877778999999997211        


Q ss_pred             ---------C--CC--------------C------------cceeeeccCccCCcccccCC-CCccchhHHHhhhccccc
Q psy3714         318 ---------P--GQ--------------E------------YNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSR  359 (467)
Q Consensus       318 ---------~--~~--------------~------------~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~  359 (467)
                               +  +.              .            .....||+.|+|||++...+ -+.++|+|.++++-...+
T Consensus       193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll  272 (418)
T KOG1167|consen  193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL  272 (418)
T ss_pred             hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence                     0  00              0            01147999999999999887 588999999999877777


Q ss_pred             cccccccccCCcc---------cCChhhhhh---------hhhhccCC--CCcccccccc------------c-ccCCCC
Q psy3714         360 KRWERFVHTENQH---------LVSPEALDF---------LDKNILGR--HSRKRWERFV------------H-TENQHL  406 (467)
Q Consensus       360 ~~~~~~~~~~~~~---------~~~~~~~~~---------~~~~~~~~--~~~~~~~~~~------------~-~~~~~~  406 (467)
                      ....|||...+..         ++..+....         .++.....  .....|+...            . ......
T Consensus       273 s~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~  352 (418)
T KOG1167|consen  273 SRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDV  352 (418)
T ss_pred             ccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccccc
Confidence            7778888776541         111111110         00000000  0001111110            0 011123


Q ss_pred             CChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .+..+.||+.|||+.||.+|+||+++|+||||.+..
T Consensus       353 ~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  353 FPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence            466899999999999999999999999999998655

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.9e-34  Score=276.50  Aligned_cols=255  Identities=21%  Similarity=0.329  Sum_probs=189.0

Q ss_pred             eecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHh--cCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         178 KLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENL--RGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       178 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l--~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      .||+|+||.||+|.+..+++.||+|.+....      ......|..+++.+  .+|++|+.+...+.+.  ...++||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence            3799999999999999999999999876421      11233444444333  2589999999888764  468999999


Q ss_pred             cCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcceee
Q psy3714         250 VNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRV  326 (467)
Q Consensus       250 ~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~  326 (467)
                      +.+++|.....   .+++..++.++.|++.||.|||+++|+||||||+||+++.++ .+||+|||+++..... .....+
T Consensus        79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~-~~~~~~  156 (278)
T cd05606          79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK-KPHASV  156 (278)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCcc-CCcCcC
Confidence            99999977653   478999999999999999999999999999999999998554 7999999999865332 223457


Q ss_pred             eccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCC
Q psy3714         327 ASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQH  405 (467)
Q Consensus       327 gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (467)
                      ||..|+|||.+.+. .++.++|+|..+++.+....+..||......     .... .......          ...+.+.
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-----~~~~-~~~~~~~----------~~~~~~~  220 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHE-IDRMTLT----------MAVELPD  220 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-----chHH-HHHHhhc----------cCCCCCC
Confidence            99999999999754 5888999998887755544444444322110     0000 0000000          0111223


Q ss_pred             CCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccccCCCCC
Q psy3714         406 LVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSRHTLPS  452 (467)
Q Consensus       406 ~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~~~~~~  452 (467)
                      .+|+++.|||.+||..||.+|+     |++++++||||.+..+++......+
T Consensus       221 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~  272 (278)
T cd05606         221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYP  272 (278)
T ss_pred             cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhcccC
Confidence            4689999999999999999999     9999999999999988766544433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2e-34  Score=274.49  Aligned_cols=252  Identities=23%  Similarity=0.354  Sum_probs=190.9

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ...++|++.+.||+|+||.||+|.+..+++.+|+|+++..   ....+.+|+.+++.+. |+||+.+.+.+...  ...+
T Consensus         6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~--~~~~   82 (267)
T cd06646           6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSR--EKLW   82 (267)
T ss_pred             CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeC--CEEE
Confidence            3457899999999999999999999999999999998643   2345778999999985 89999999888653  4679


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-  320 (467)
                      +||||+++++|.+.+.   .+++.++..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++....... 
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIA  161 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEECcCccceeeccccc
Confidence            9999999999987653   478889999999999999999999999999999999998555 69999999998653221 


Q ss_pred             CcceeeeccCccCCccccc---CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         321 EYNVRVASRYFKGPELLAD---YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~---~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      ......|++.|+|||.+..   ..++.+.|+|..+++......+..|+......        ...    . ......+..
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~--------~~~----~-~~~~~~~~~  228 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--------RAL----F-LMSKSNFQP  228 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--------hhh----e-eeecCCCCC
Confidence            2234568999999999853   34778899998887654444444443221100        000    0 000000000


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY  437 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~  437 (467)
                       ........+++++.|||++||..||++|||++++++|+|
T Consensus       229 -~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         229 -PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             -CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence             000112246889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.8e-34  Score=275.02  Aligned_cols=261  Identities=20%  Similarity=0.285  Sum_probs=195.5

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+...    ....+.+|+++++.++ |+||+.+.+.+.+......++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEEEE
Confidence            4789999999999999999999999999999988643    2356789999999995 8999999998866555578999


Q ss_pred             EeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         247 FEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      |||+++++|.+++.       .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~  158 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-eEEEeecccccccccc
Confidence            99999999876543       367888899999999999999999999999999999998655 7999999998765322


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      .. ....++..|+|||.+.+..++...|+|..+++.+....+..|+.....+.....+.......     ........  
T Consensus       159 ~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~--  230 (287)
T cd06621         159 LA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-----MPNPELKD--  230 (287)
T ss_pred             cc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-----CCchhhcc--
Confidence            21 23457889999999988889999999988877555444444443221110000111111000     00000000  


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      ........++++++||.+||..||.+|||+.|+++||||...
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence            000011246789999999999999999999999999999644

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-34  Score=274.98  Aligned_cols=251  Identities=23%  Similarity=0.317  Sum_probs=193.2

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      +|+..+.||+|+||.||++.+..+++.+|+|.++...         .+.+.+|+.+++.++ |+|++++.+.+.+.  ..
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~   77 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCED--SH   77 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccC--Ce
Confidence            4778899999999999999999999999999886422         346788999999996 89999999998764  46


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      .+++|||++++++.+++.   .+++..+..++.|++.||.|||++|++||||||+||+++..+..+||+|||++......
T Consensus        78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            799999999999887653   47888999999999999999999999999999999999866557999999999765432


Q ss_pred             C-----CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         320 Q-----EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       320 ~-----~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      .     ......||..|+|||.+.+..++.+.|.|..+++......+..|+......     ...........       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-------  225 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-----NHLALIFKIAS-------  225 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-----chHHHHHHHhc-------
Confidence            1     112246788999999998888999999998887655544444443211100     00011100000       


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                        .......+..+++++++||.+||..||.+|||+.|+++||||.
T Consensus       226 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         226 --ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             --cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence              0001122335789999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.9e-34  Score=276.26  Aligned_cols=253  Identities=24%  Similarity=0.324  Sum_probs=194.3

Q ss_pred             ecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCC
Q psy3714         179 LGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNN  252 (467)
Q Consensus       179 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~  252 (467)
                      ||+|+||.||+|.+..+++.+++|.+....      ...+.+|+++++.++ |+||+.+...+...  ...++||||+++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETK--DDLCLVMTLMNG   77 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecC--CeEEEEEecCCC
Confidence            689999999999999999999999886421      234567999999996 89999999888754  468999999999


Q ss_pred             ccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcceeee
Q psy3714         253 TDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA  327 (467)
Q Consensus       253 ~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~g  327 (467)
                      ++|.+.+.     .+++.++..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.............+
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCccccccC
Confidence            99976642     478889999999999999999999999999999999998655 799999999986654434444568


Q ss_pred             ccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCC
Q psy3714         328 SRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLV  407 (467)
Q Consensus       328 t~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (467)
                      +..|+|||.+.+..++...|+|..+++......+..||......     ............          .....+...
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~----------~~~~~~~~~  221 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-----VEKEELKRRTLE----------MAVEYPDKF  221 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-----ccHHHHHhcccc----------ccccCCccC
Confidence            88999999998888899999998887655444444443221110     000000000000          011122346


Q ss_pred             ChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccccCCC
Q psy3714         408 SPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSRHTL  450 (467)
Q Consensus       408 s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~~~~  450 (467)
                      ++++++||.+||..||.+||     |+.++++||||..++|+......
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~  269 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGM  269 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCC
Confidence            89999999999999999999     99999999999999887665433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-34  Score=281.39  Aligned_cols=263  Identities=26%  Similarity=0.478  Sum_probs=187.8

Q ss_pred             ceeeeEeecccCCcceEEEEEcc--CCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQ--SSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .|++.+.||+|+||.||+|.+..  ++..+|+|.+....      ...+.+|+.+++.++ ||||+++++.+.+......
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence            48899999999999999999988  78999999987522      356788999999996 8999999999987655678


Q ss_pred             EEEEeccCCccHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC---CCCcEEEEeccc
Q psy3714         244 ALIFEHVNNTDFKQLY--------QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH---ENRKLRLIDWGL  312 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~---~~~~ikl~DFGl  312 (467)
                      ++||||+.+. +.+..        ..+++..++.++.|++.||.|||+++|+||||||+|||++.   ..+.+||+|||+
T Consensus        80 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAEHD-LWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEEeCCCcC-HHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            9999999864 43332        14678889999999999999999999999999999999986   134799999999


Q ss_pred             ceecCCCCC----cceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcc-cCCh----hhhhhh
Q psy3714         313 AEFYHPGQE----YNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQH-LVSP----EALDFL  382 (467)
Q Consensus       313 a~~~~~~~~----~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~  382 (467)
                      ++.......    ....++|..|+|||++.+. .++...|+|..+++......+..++....... ...+    ......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            986532211    2234688999999988764 47888999988776544444433332211110 0000    000000


Q ss_pred             hhhccCCCCcccc---------cc---------cc------cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         383 DKNILGRHSRKRW---------ER---------FV------HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       383 ~~~~~~~~~~~~~---------~~---------~~------~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                        ..++......|         ..         +.      ..+.+...++++.|||.+||+.||++|||+.|+++||||
T Consensus       239 --~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 --EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             --HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence              00000000000         00         00      001112467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4e-34  Score=278.04  Aligned_cols=260  Identities=21%  Similarity=0.318  Sum_probs=197.7

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++++.||+|+||.||++.+..+++.|++|.++...      ...+.+|+++++.++ |+||+.++..+...  ...+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~--~~~~   77 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETK--RHLC   77 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecC--CEEE
Confidence            47999999999999999999999999999999886432      235678999999885 89999999888653  4689


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-  320 (467)
                      ++|||++++++.+++.   .+++..+..++.|++.||.|||++||+||||||+||+++..+ .+||+|||+++...... 
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-CEEEeeCCCccccCcCcc
Confidence            9999999999987764   478888899999999999999999999999999999998554 79999999987421000 


Q ss_pred             ---------------CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhh
Q psy3714         321 ---------------EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN  385 (467)
Q Consensus       321 ---------------~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (467)
                                     ......++..|+|||.+....++.++|+|..+++......+..|+.....     .+...   ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~~---~~  228 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFG---QV  228 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH---HH
Confidence                           00123578889999999888899999999888765554445445432111     01111   10


Q ss_pred             ccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCC---HHHHhCCCCCCCcccccccCCC
Q psy3714         386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT---AREAMDHPYFYPIVKDQSRHTL  450 (467)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~t---a~e~l~Hp~f~~~~~~~~~~~~  450 (467)
                      ....        .........+++++++||.+||..||++|||   +.++|+||||...+++.....+
T Consensus       229 ~~~~--------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~  288 (305)
T cd05609         229 ISDD--------IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQK  288 (305)
T ss_pred             Hhcc--------cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcC
Confidence            0000        0001111247889999999999999999997   7999999999888776554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.2e-34  Score=278.13  Aligned_cols=266  Identities=26%  Similarity=0.444  Sum_probs=190.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .++|++.+.||+|+||.||+|.+..+++.+++|.++...     ...+.+|+.+++.+. |+||+.+.+.+........+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEE
Confidence            468999999999999999999999899999999886432     234578999999996 89999999988765456889


Q ss_pred             EEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-
Q psy3714         245 LIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-  319 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-  319 (467)
                      ++|||+.+ ++.++..    .+++..+..++.||+.||+|||++||+||||||+||+++.. +.+||+|||++...... 
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CcEEEeecCceeeccCCc
Confidence            99999985 6665543    37889999999999999999999999999999999999965 47999999999866432 


Q ss_pred             CCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcc--------cCChhhhhhhhhhccCCC
Q psy3714         320 QEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQH--------LVSPEALDFLDKNILGRH  390 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~  390 (467)
                      .......+++.|+|||.+.+.. ++...|+|..+++......+..++.......        +..+....+.....+...
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            2334456889999999987654 6788999987766444333333321111000        000000000000000000


Q ss_pred             Cccccccc----ccccCCCC-CChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         391 SRKRWERF----VHTENQHL-VSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       391 ~~~~~~~~----~~~~~~~~-~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ....+...    .....+.. +++.++|||++||+.||++|||++|+++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            00000000    00011112 58899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0665|consensus

Probab=100.00  E-value=1.2e-35  Score=271.01  Aligned_cols=267  Identities=24%  Similarity=0.379  Sum_probs=193.9

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEecc-----chHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC---
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP-----VKKKKIKREIKILENLRGGTNIITLQAVVKDPV---  239 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~-----~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~---  239 (467)
                      ....+|.-++.+|.|+- .|..|.+.-+++.||+|.+..     ...++..||..++..+. |+||+++..++.-..   
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccHH
Confidence            34567888999999998 788999999999999997643     23467889999999996 899999999884321   


Q ss_pred             -CCccEEEEeccCCccHHHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         240 -SRTPALIFEHVNNTDFKQLY-QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       240 -~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                       ....|+|||++.. ++.+.. -.++...++++++|++.|++|||+.||+||||||+||+++.+ +.+||.|||+|+.-.
T Consensus        92 ~~~e~y~v~e~m~~-nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~-~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   92 EFQEVYLVMELMDA-NLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD-CTLKILDFGLARTED  169 (369)
T ss_pred             HHHhHHHHHHhhhh-HHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch-hheeeccchhhcccC
Confidence             2356899999875 444443 468888999999999999999999999999999999999854 589999999999766


Q ss_pred             CCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCc---------ccCChhhh--hhhhh--
Q psy3714         318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQ---------HLVSPEAL--DFLDK--  384 (467)
Q Consensus       318 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~--~~~~~--  384 (467)
                      ..-..+.++.|++|+|||++.+.+|...+|+|..|++-.....+.- +|.+.+.         .+++++..  ..+..  
T Consensus       170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~V-lf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~  248 (369)
T KOG0665|consen  170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTV-LFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV  248 (369)
T ss_pred             cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceE-EecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence            5545678999999999999999999999999977665332222211 1222211         12222211  10000  


Q ss_pred             -h---ccCCCCcccccccccc-------cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         385 -N---ILGRHSRKRWERFVHT-------ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       385 -~---~~~~~~~~~~~~~~~~-------~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                       +   ...++....+.+....       +..+.-+..|+||+.+||..||++|++++++|+||||.
T Consensus       249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence             0   0111111111111111       11123467899999999999999999999999999996

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.5e-34  Score=278.30  Aligned_cols=253  Identities=21%  Similarity=0.328  Sum_probs=197.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..+|++++.||+|+||.||+|.+..+++.+++|.+...   ....+.+|+.+++.+. |+||+.+.+.+...  ...++|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~--~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLVG--DELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCC-CCCEeeEEEEEEeC--CEEEEe
Confidence            36899999999999999999999999999999988643   2356788999999885 89999999888753  468999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-cc
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YN  323 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-~~  323 (467)
                      |||++++++..+..  .+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........ ..
T Consensus        96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEECccccchhccccccccC
Confidence            99999999987764  378889999999999999999999999999999999998554 799999999876543222 23


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      ...|++.|+|||.+.+..++.+.|+|..+++......+..||.....        ............        .....
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--------~~~~~~~~~~~~--------~~~~~  238 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGT--------PELQN  238 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH--------HHhHHHHhcCCC--------CCCCC
Confidence            35789999999999888888999999888776555555555432211        000000000000        00112


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      +..+++.+.+||.+||..||++|||++|+++||||....
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             ccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence            235788999999999999999999999999999997643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=9.4e-35  Score=302.30  Aligned_cols=264  Identities=22%  Similarity=0.293  Sum_probs=167.2

Q ss_pred             CccceeeeEeecccCCcceEEEEEccC----CCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEE----EeCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQS----SDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAV----VKDPVS  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~----~~~~~~  240 (467)
                      ..++|++.+.||+|+||.||+|.+..+    +..||+|.++.........+.. ++... +.++..+...    ......
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~-l~~~~-~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER-VRRAC-PNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHH-HHhhc-hhhHHHHHHhhhcccccccC
Confidence            457899999999999999999999988    8999999876432211111111 11111 1111111111    111234


Q ss_pred             CccEEEEeccCCccHHHHhhcC-----------------------CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceE
Q psy3714         241 RTPALIFEHVNNTDFKQLYQTL-----------------------TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVM  297 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~~~-----------------------~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nil  297 (467)
                      ...++||+|+.+++|.++....                       ....++.++.||+.||+|||++|||||||||+|||
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL  287 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII  287 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence            5679999999999987765321                       12345679999999999999999999999999999


Q ss_pred             EeCCCCcEEEEecccceecCCCCC--cceeeeccCccCCcccccCC----------------------CCccchhHHHhh
Q psy3714         298 IDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQ----------------------YHIELDPRFADI  353 (467)
Q Consensus       298 l~~~~~~ikl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~----------------------~~~~~D~~~~~~  353 (467)
                      ++.+++.+||+|||+|+....+..  ....++|+.|+|||.+....                      +..++|+|..++
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            986556899999999986543322  23467899999999764322                      334569998887


Q ss_pred             hccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc----------cCCCCCChHHHHHHHhhcCcCC
Q psy3714         354 LGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT----------ENQHLVSPEALDFLDKLLRYDH  423 (467)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~s~~~~dli~~lL~~dp  423 (467)
                      +.+....+..+   ..      .....+...-.........|......          +.....+.++.|||++||++||
T Consensus       368 iL~el~~~~~~---~~------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        368 IFLQMAFPNLR---SD------SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             HHHHHHhCcCC---Cc------hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            75443321111   00      00000000000000001111111000          0011124567799999999999


Q ss_pred             CCCCCHHHHhCCCCCCCccc
Q psy3714         424 YERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       424 ~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      ++|||++|+|+||||.+...
T Consensus       439 ~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        439 RQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999987543

>KOG0670|consensus

Probab=100.00  E-value=1.6e-35  Score=284.63  Aligned_cols=267  Identities=23%  Similarity=0.401  Sum_probs=194.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcC-----CCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRG-----GTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~-----~~~iv~l~~~~~~~~~~~  242 (467)
                      ...|.+....|+|-||+|.+|.+...++.|||||+.+..  .+.-++|++||++|+.     -.+.++++..|..  ..+
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h--knH  508 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH--KNH  508 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--cce
Confidence            578999999999999999999999999999999998764  4667899999999974     2356666666553  467


Q ss_pred             cEEEEeccCCccHHHHhhc------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         243 PALIFEHVNNTDFKQLYQT------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      ++||+|-+.. +|.+.+++      |....++.|+.|+..||..|-..||+|.||||+|||++.....+||||||.|...
T Consensus       509 LClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~  587 (752)
T KOG0670|consen  509 LCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFA  587 (752)
T ss_pred             eEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccc
Confidence            8999996643 45555432      5667889999999999999999999999999999999977778999999999876


Q ss_pred             CCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccC--Chhhh---------------
Q psy3714         317 HPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLV--SPEAL---------------  379 (467)
Q Consensus       317 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---------------  379 (467)
                      .. ...+.+..+.+|+|||+|.+.+|++.+|.|++++..+..+.|.-.|.+..+..+.  ..+..               
T Consensus       588 ~e-neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~d  666 (752)
T KOG0670|consen  588 SE-NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKD  666 (752)
T ss_pred             cc-ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhh
Confidence            54 3456788899999999999999999999999888766655554333332222110  00000               


Q ss_pred             -------hhhhh---hccCCC---------Cccccc-cccc----ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         380 -------DFLDK---NILGRH---------SRKRWE-RFVH----TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       380 -------~~~~~---~~~~~~---------~~~~~~-~~~~----~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                             +|+..   .+.++.         +.+.+. .+..    +.....+=.+++|||.+||..||++|+|..|+|+|
T Consensus       667 qHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  667 QHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             hhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence                   00000   000000         000000 0000    01111233578999999999999999999999999


Q ss_pred             CCCCC
Q psy3714         436 PYFYP  440 (467)
Q Consensus       436 p~f~~  440 (467)
                      |||..
T Consensus       747 pFi~~  751 (752)
T KOG0670|consen  747 PFITE  751 (752)
T ss_pred             CcccC
Confidence            99964

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.8e-34  Score=272.56  Aligned_cols=249  Identities=21%  Similarity=0.327  Sum_probs=189.9

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      .+|+..+.||+|+||.||+|.+..++..+++|.++..        ....+.+|+.+++.++ |+||+.+.+.+.+.....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKT   80 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCE
Confidence            3688999999999999999999999999999987532        1245778999999995 899999999887654567


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-  318 (467)
                      .++++||+++++|.+.+.   .+++.....++.|++.||+|||+++|+||||||+||+++.++ .+||+|||+++.... 
T Consensus        81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~~~~~~~  159 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCCCccccccc
Confidence            889999999999877653   478888889999999999999999999999999999998554 799999999975432 


Q ss_pred             ---CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         319 ---GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       319 ---~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                         ........++..|+|||.+.+..++.+.|+|..+++......+..||...        ......... .....    
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~--------~~~~~~~~~-~~~~~----  226 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY--------EAMAAIFKI-ATQPT----  226 (266)
T ss_pred             cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc--------chHHHHHHH-hcCCC----
Confidence               11122345888999999999888899999998887655544444443211        001101000 00000    


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                          ....+..+++++++||+ |+..||++|||++|+++||||.
T Consensus       227 ----~~~~~~~~~~~~~~li~-~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 ----NPQLPSHISEHARDFLG-CIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ----CCCCchhcCHHHHHHHH-HhcCChhhCcCHHHHhcCcccc
Confidence                01112346889999995 6668999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=277.79  Aligned_cols=254  Identities=22%  Similarity=0.323  Sum_probs=195.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ..++|++++.||.|+||.||++.+..++..+|+|.++...   .+.+.+|++++++++ |+||+++.+.+..+  ...++
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~l   79 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK-HPNIVGLYEAYFYE--NKLWI   79 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecC--CeEEE
Confidence            3578999999999999999999998889999999986543   245778999999997 89999999988754  46899


Q ss_pred             EEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-C
Q psy3714         246 IFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-Q  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~  320 (467)
                      ||||++++++..+..    .+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||++...... .
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC-CEEEccCccchhhccccc
Confidence            999999999987753    478999999999999999999999999999999999998654 7999999998754322 2


Q ss_pred             CcceeeeccCccCCccccc-----CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         321 EYNVRVASRYFKGPELLAD-----YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~-----~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      ......+|+.|+|||.+..     ..++..+|+|..+++......+..|+....        ...... .+...    ..
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~--------~~~~~~-~~~~~----~~  225 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN--------PMRVLL-KILKS----EP  225 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC--------HHHHHH-HHhcC----CC
Confidence            2234568999999999853     346778999988876555444444432110        000000 00000    00


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .   ....+..++.++.+||.+||+.||.+|||++++++||||....
T Consensus       226 ~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         226 P---TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             C---CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence            0   0112235788999999999999999999999999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0983|consensus

Probab=100.00  E-value=3.8e-35  Score=261.97  Aligned_cols=256  Identities=18%  Similarity=0.286  Sum_probs=194.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      +.++.+.+..||.|+.|+|+++..+++|...|||.+...    ..+++.+.+.++....+.|.||+.+++|-.+.  .++
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--dV~  167 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT--DVF  167 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc--hHH
Confidence            346778889999999999999999999999999998753    34678888888877777899999999886543  355


Q ss_pred             EEEeccCC---ccHHHHhhcCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         245 LIFEHVNN---TDFKQLYQTLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       245 lv~e~~~~---~~l~~~~~~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      +.||.+.-   .-+....+.++|.-+-.+...++.||.||.+ +||||||+||+|||+|..| .|||||||+|-.+-...
T Consensus       168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeecccccceeeccc
Confidence            66664422   2233444568898889999999999999985 5999999999999999655 79999999998776555


Q ss_pred             CcceeeeccCccCCcccccC---CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         321 EYNVRVASRYFKGPELLADY---QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~---~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      ..+...|.+.|||||.|...   .|+...|.|..++-......+..||-+....       ++.+.+ ++...+ ..   
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-------Fe~ltk-vln~eP-P~---  314 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-------FEVLTK-VLNEEP-PL---  314 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-------HHHHHH-HHhcCC-CC---
Confidence            55667899999999999754   4999999999888766666666666432211       111111 111000 01   


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                       ...  ....|+++++|+..||++|+.+||...++|+|||+....
T Consensus       315 -L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  315 -LPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             -CCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence             111  123799999999999999999999999999999986543

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5e-34  Score=270.70  Aligned_cols=247  Identities=23%  Similarity=0.340  Sum_probs=193.0

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++++.||.|+||.||+|.+..+++.+++|.++..     ..+.+.+|+++++.++ |+||+++.+.+........+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEEE
Confidence            589999999999999999999999999999988632     2346778999999996 8999999987765545667999


Q ss_pred             EeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH-----HCCccccCCCCCceEEeCCCCcEEEEecccce
Q psy3714         247 FEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCH-----SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE  314 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH-----~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~  314 (467)
                      |||+++++|.+.+.       .+++..+..++.|++.||.|||     +.+|+|+||||+||+++.+ +.+||+|||++.
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~g~~~  158 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAK  158 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC-CCEEEecccccc
Confidence            99999999877653       4678889999999999999999     9999999999999999955 489999999998


Q ss_pred             ecCCCCC-cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         315 FYHPGQE-YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       315 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ....... .....+++.|+|||.+.+..++...|.|..+++......+..|+....     ...........        
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~--------  225 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASKIKEG--------  225 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHHHhcC--------
Confidence            7654332 334578999999999988888889999988876544444433332111     01111111100        


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ..     ...+...++++.+|+.+||..||++|||++|+++|||+
T Consensus       226 ~~-----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 KF-----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             CC-----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            00     01122468899999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.9e-34  Score=275.28  Aligned_cols=262  Identities=29%  Similarity=0.516  Sum_probs=191.9

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++|++.+.||+|++|.||+|.+..+++.+|+|.++..     ....+.+|+++++.+. |+||+++++.+.+.  ...++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSE--KRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc-CCCEeeEEEEEecC--CeEEE
Confidence            5799999999999999999999999999999987542     1245778999999995 89999999998754  57899


Q ss_pred             EEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-
Q psy3714         246 IFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-  319 (467)
Q Consensus       246 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-  319 (467)
                      ||||+++ ++.+...     .+++..+..++.||+.||+|||++||+||||||+||+++..+..+||+|||++...... 
T Consensus        79 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         79 VFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             EEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9999975 5554442     24677888999999999999999999999999999999866667999999999765322 


Q ss_pred             CCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc-
Q psy3714         320 QEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER-  397 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  397 (467)
                      .......+++.|+|||.+.+. .++.+.|+|..+++......+..++......    ........  ..+......|.. 
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~----~~~~~~~~--~~~~~~~~~~~~~  231 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI----DELFKIFR--ILGTPNEETWPGV  231 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHH--HhCCCChhhcccc
Confidence            223445688999999998764 4788899998887755544444443221100    00000000  000000011100 


Q ss_pred             ---------------cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         398 ---------------FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       398 ---------------~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                                     .......+.+++++.+||.+||+.||++|||++++++||||.+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                           000011234789999999999999999999999999999998754

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.2e-34  Score=276.10  Aligned_cols=253  Identities=23%  Similarity=0.390  Sum_probs=198.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..+|++.+.||.|+||.||+|.+..+++.+++|.+...   ....+.+|+.+++.++ |+|++.+.+.+...  ...++|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv   94 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK-NPNIVNFLDSFLVG--DELFVV   94 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcC-CCceeeeeeeEecC--ceEEEE
Confidence            36799999999999999999999999999999987542   2456788999999995 89999999988753  568999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-cc
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YN  323 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-~~  323 (467)
                      +||++++++..+..  .+++.++..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655          95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccchhcccccccCC
Confidence            99999999987764  478899999999999999999999999999999999998655 799999999886543322 22


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      ...++..|+|||.+.+..++.+.|+|..+++.+....+..||......     .........   .  .      .....
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-----~~~~~~~~~---~--~------~~~~~  237 (296)
T cd06655         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----RALYLIATN---G--T------PELQN  237 (296)
T ss_pred             CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhc---C--C------cccCC
Confidence            346889999999998888899999998887765555554444321100     000000000   0  0      00112


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      +..+++++++||++||..||.+|||+.++++||||....
T Consensus       238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             cccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            335789999999999999999999999999999997544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.4e-34  Score=276.51  Aligned_cols=256  Identities=27%  Similarity=0.522  Sum_probs=188.6

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++++.||+|+||.||+|.+..+++.++||.++...     ...+.+|++++++++ |+||+++.+.+.+.  ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTE--NKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC-CCCCcchhhhcccC--CcEEEE
Confidence            5889999999999999999999999999999876421     246788999999996 89999999988653  568999


Q ss_pred             EeccCCccHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-C
Q psy3714         247 FEHVNNTDFKQLY-----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-Q  320 (467)
Q Consensus       247 ~e~~~~~~l~~~~-----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~  320 (467)
                      |||+. +++....     ..+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++...... .
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR  155 (284)
T ss_pred             eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEeeccchhhcccCcc
Confidence            99996 4666554     2478889999999999999999999999999999999999655 7999999998765432 2


Q ss_pred             CcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCC--------
Q psy3714         321 EYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS--------  391 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  391 (467)
                      ......++..|+|||.+.+.. ++...|+|..+++.+....+..++......    ........  ..+...        
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~--~~~~~~~~~~~~~~  229 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI----DQLFRIFR--TLGTPDEVVWPGVT  229 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHH--HhCCCChhhhhhhh
Confidence            233446788999999987655 577899998888765555554444221110    00000000  000000        


Q ss_pred             --------cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         392 --------RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       392 --------~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                              ...|..-......+.++++++|||.+||+.||.+|||++|+++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                    00000000001123478999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.4e-34  Score=270.31  Aligned_cols=249  Identities=22%  Similarity=0.339  Sum_probs=191.6

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      .+|++.+.||+|+||.||.+.+..++..+++|.+...        ..+.+.+|+.+++.+. |+||+.+.+.+.++....
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence            5799999999999999999999999999999987521        1245778999999995 899999999887655567


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      .+++|||++++++.+...   .+++..+..++.|++.||+|||++||+|+||||+||+++.++ .+||+|||++......
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-NVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC-CEEECcCccccccccc
Confidence            889999999999987653   467888899999999999999999999999999999998554 7999999999754321


Q ss_pred             ----CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         320 ----QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       320 ----~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                          .......|+..|+|||.+.+..++...|+|..+++.+....+..|+....       ...... .. .....    
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~~~-~~-~~~~~----  226 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-------AMAAIF-KI-ATQPT----  226 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-------hHHHHH-HH-hcCCC----
Confidence                12233468899999999988888899999988876554444444432110       011111 10 00000    


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                          ....+..++..+.++|++|+. +|++|||++|+++|||+.
T Consensus       227 ----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                011223478899999999995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.1e-34  Score=282.80  Aligned_cols=269  Identities=29%  Similarity=0.509  Sum_probs=193.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC---C
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS---R  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~---~  241 (467)
                      ..+|++.+.||+|+||.||+|.+..+++.||||.++..     ....+.+|+.+++.++ |+||+++.+++.....   .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC-CCCccchHHheecccccccC
Confidence            35799999999999999999999999999999987642     2345678999999985 8999999887654321   3


Q ss_pred             ccEEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         242 TPALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      ..++++||+. +++.+..   ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++....
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~  160 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSE  160 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcCccccccCC
Confidence            5799999996 4666554   3578999999999999999999999999999999999998654 799999999986643


Q ss_pred             C-CCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcc---------cC--Chhhhhhhhhh
Q psy3714         319 G-QEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQH---------LV--SPEALDFLDKN  385 (467)
Q Consensus       319 ~-~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~---------~~--~~~~~~~~~~~  385 (467)
                      . .......+|..|+|||.+.+ ..++.+.|+|..+++.+....+..+|. +.+..         ..  ..+...+....
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP-GKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC-CCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            3 22334568999999998875 358889999988876554444444432 11100         00  00000000000


Q ss_pred             cc----CCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         386 IL----GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       386 ~~----~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                      ..    ..........+  ....+.+|++++|||++||+.||++|||++|+++||||..+...
T Consensus       240 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         240 KARRYIRSLPYTPRQSF--ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             hhhHHHHhcCcccccCH--HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            00    00000000000  01123579999999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-34  Score=271.50  Aligned_cols=252  Identities=22%  Similarity=0.348  Sum_probs=192.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC----CCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGGTNIITLQAVVKDPV----SRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~----~~~~  243 (467)
                      .++|++.+.||+|+||.||+|.+..+++.+++|++....  ...+.+|+.+++++..|+||+++.+.+....    ....
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            478999999999999999999999889999999987543  3568899999999977999999999886533    3457


Q ss_pred             EEEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         244 ALIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      +++|||++++++.++..       .+++..++.++.|++.||.|||++||+|+||+|+||+++.++ .+||+|||++...
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~  163 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-EVKLVDFGVSAQL  163 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-eEEECCCccceec
Confidence            99999999998876542       477888999999999999999999999999999999998654 7999999998765


Q ss_pred             CCCC-CcceeeeccCccCCcccccC-----CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCC
Q psy3714         317 HPGQ-EYNVRVASRYFKGPELLADY-----QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRH  390 (467)
Q Consensus       317 ~~~~-~~~~~~gt~~y~aPE~l~~~-----~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (467)
                      .... ......|+..|+|||++...     .++.+.|+|..+++......+..|+.....     ..........   . 
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~---~-  234 (275)
T cd06608         164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-----MRALFKIPRN---P-  234 (275)
T ss_pred             ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-----HHHHHHhhcc---C-
Confidence            3222 22345689999999998542     367789999888765554444444422110     0000000000   0 


Q ss_pred             CcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         391 SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       391 ~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                       ...      .......++++++||++||..||++|||++|+++|||+
T Consensus       235 -~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         235 -PPT------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             -CCC------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence             000      01112367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0596|consensus

Probab=100.00  E-value=1e-34  Score=281.53  Aligned_cols=251  Identities=22%  Similarity=0.359  Sum_probs=185.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ...|++++.||+|+.+.||++... ..+.+|+|.+...     .-.....||..|.+|++|.+||.|+++--.  ..++|
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~lY  436 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYLY  436 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceEE
Confidence            357999999999999999999864 3456777655421     234568999999999999999999987544  46899


Q ss_pred             EEEeccCCccHHHHhhc----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         245 LIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      |||||.+ .||.+++++    .+...+++|..|+|+|+.++|.+||||.||||.|+|+- .| .+||+|||+|..+.+++
T Consensus       437 mvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG-~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  437 MVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KG-RLKLIDFGIANAIQPDT  513 (677)
T ss_pred             EEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-ee-eEEeeeechhcccCccc
Confidence            9999764 477766643    45568999999999999999999999999999999996 44 79999999999876543


Q ss_pred             C---cceeeeccCccCCcccccCCCC-----------ccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhc
Q psy3714         321 E---YNVRVASRYFKGPELLADYQYH-----------IELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI  386 (467)
Q Consensus       321 ~---~~~~~gt~~y~aPE~l~~~~~~-----------~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (467)
                      .   ....+||+.||+||.+....++           ...|+|..+.+.+.+..+..||....+.   ......+.+   
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~---~aKl~aI~~---  587 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ---IAKLHAITD---  587 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH---HHHHHhhcC---
Confidence            2   2346899999999999765544           4679998888877666555554322110   000001111   


Q ss_pred             cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                        ......+...   +    -..++.|++++||.+||++|+|..++|+|||+...
T Consensus       588 --P~~~Iefp~~---~----~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  588 --PNHEIEFPDI---P----ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             --CCccccccCC---C----CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence              0011111111   0    12349999999999999999999999999999863

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.8e-34  Score=269.62  Aligned_cols=247  Identities=23%  Similarity=0.369  Sum_probs=192.1

Q ss_pred             ecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCC
Q psy3714         179 LGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNN  252 (467)
Q Consensus       179 lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~  252 (467)
                      ||.|+||.||+|.+..+++.+++|.+...      ..+.+.+|+.+++.++ |+||+.+.+.+.+.  ...++++||+++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDK--KYIYMLMEYCLG   77 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcC--CccEEEEecCCC
Confidence            69999999999999999999999998642      2356788999999995 89999999988754  568999999999


Q ss_pred             ccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcceeeecc
Q psy3714         253 TDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR  329 (467)
Q Consensus       253 ~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~gt~  329 (467)
                      ++|.+.+.   .+++..+..++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++.............+++
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCcccccccccCCc
Confidence            99987764   478888999999999999999999999999999999998655 79999999998765433333457899


Q ss_pred             CccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCCh
Q psy3714         330 YFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSP  409 (467)
Q Consensus       330 ~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  409 (467)
                      .|+|||.+.+..++...|.|..+++.+....+..|+.....      +....... +....        .....+...++
T Consensus       157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~--------~~~~~~~~~~~  221 (262)
T cd05572         157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYND-ILKGN--------GKLEFPNYIDK  221 (262)
T ss_pred             CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHH-HhccC--------CCCCCCcccCH
Confidence            99999999888889999999888765544444444432211      01111111 11000        00111233588


Q ss_pred             HHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCcccc
Q psy3714         410 EALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKD  444 (467)
Q Consensus       410 ~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~  444 (467)
                      ++++||.+||..||.+|+|     ++|+++||||.+.+|+
T Consensus       222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             HHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence            9999999999999999999     9999999999987765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-34  Score=273.53  Aligned_cols=259  Identities=30%  Similarity=0.501  Sum_probs=192.8

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++|++.+.||+|+||.||+|.+..+++.+++|.++..     ....+.+|+++++.+. |+||+.+.+.+.+  ....++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~i   77 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR-HENIVNLKEAFRR--KGRLYL   77 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC-CCCeeehhheEEE--CCEEEE
Confidence            4699999999999999999999999999999987642     2356889999999997 8999999998876  346899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC--
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~--  320 (467)
                      +|||++++.+..+..   .+++.++..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++.......  
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES-GVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEEeeecccccCCCccc
Confidence            999999877765443   37889999999999999999999999999999999999964 479999999998765433  


Q ss_pred             CcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhh----------hhhccC-
Q psy3714         321 EYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFL----------DKNILG-  388 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~-  388 (467)
                      .....+++..|+|||++.+. .++.+.|+|..+++......+..++.....     .+.....          ...... 
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-----IDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHhhhccc
Confidence            33446789999999999888 788999999888765444444333221100     0000000          000000 


Q ss_pred             --CCCcccc-----cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         389 --RHSRKRW-----ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       389 --~~~~~~~-----~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                        ......+     ........+..+++++++||++||..||++|||++++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence              0000000     0000001122358999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.5e-34  Score=276.00  Aligned_cols=260  Identities=31%  Similarity=0.504  Sum_probs=191.8

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      +|++.+.||+|+||.||+|.+..+++.|++|.++...        ...+.+|+++++.++ |+||+++.+.+.+  ....
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~~   77 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGH--KSNI   77 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeec--CCEE
Confidence            4888999999999999999999999999999986532        234568999999996 8999999998876  4578


Q ss_pred             EEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ++||||+ +++|.+++.    .+++..+..++.||+.||.|||++||+|+||||+||+++.+ +.+||+|||+++.....
T Consensus        78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC-CCEEEccceeeeeccCC
Confidence            9999999 888887763    37888999999999999999999999999999999999965 47999999999876433


Q ss_pred             -CCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc-
Q psy3714         320 -QEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE-  396 (467)
Q Consensus       320 -~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  396 (467)
                       .......+++.|+|||.+.+. .++...|+|..+++......+ .+++.....    .......... .+......|. 
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g-~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~  229 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPFLPGDSD----IDQLGKIFEA-LGTPTEENWPG  229 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcC-CccccCCcc----HHHHHHHHHH-cCCCchhhhhh
Confidence             223344678899999988653 478889999888765544444 232222111    0000000000 0000000000 


Q ss_pred             -----------c---cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         397 -----------R---FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       397 -----------~---~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                                 .   ..........++++++||.+||+.||++|||++|+++||||.+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence                       0   000011234688999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.7e-34  Score=269.86  Aligned_cols=249  Identities=23%  Similarity=0.384  Sum_probs=195.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      .++|++.+.||+|+||.||+|....+++.+++|.++... .+.+.+|+++++.+ .|+||+.+.+.+...  ...++++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQC-DSPYIVKYYGSYFKN--TDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecC--CcEEEEEe
Confidence            478999999999999999999999889999999987543 56788999999999 589999999988764  56899999


Q ss_pred             ccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-Ccc
Q psy3714         249 HVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYN  323 (467)
Q Consensus       249 ~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~~~  323 (467)
                      |++++++.+.+.    .+++..+..++.|++.||.|||+.||+||||+|+||+++.++ .+||+|||++....... ...
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-cEEEcccccchhcccCccccc
Confidence            999999987753    478889999999999999999999999999999999999655 79999999998654332 223


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      ...++..|+|||++.+..++.++|+|..+++......+..|+.....      . ....  .+ .......      ...
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~------~-~~~~--~~-~~~~~~~------~~~  221 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP------M-RAIF--MI-PNKPPPT------LSD  221 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch------h-hhhh--hh-ccCCCCC------CCc
Confidence            34588999999999888899999999888765544444333321110      0 0000  00 0000000      111


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      +..+++++.+||.+||+.||++|||+.|+|+||||
T Consensus       222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            23468899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=8.1e-34  Score=276.11  Aligned_cols=261  Identities=27%  Similarity=0.447  Sum_probs=185.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC----
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPV----  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~----  239 (467)
                      ..++|++++.||+|+||.||+|.+..+++.+|+|.+....     .....+|+++++.++ ||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC-CCCccceEEEEeccccccc
Confidence            3478999999999999999999999999999999875321     234578999999995 899999998876532    


Q ss_pred             --CCccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccc
Q psy3714         240 --SRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA  313 (467)
Q Consensus       240 --~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla  313 (467)
                        ....++||||+.+ ++.+.+.    .+++.++..++.|++.||.|||++||+||||||+||+++..+ .+||+|||++
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~  166 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLA  166 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-cEEECcCCCc
Confidence              2346999999976 5554432    478999999999999999999999999999999999998554 7999999999


Q ss_pred             eecCCCC-----CcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhcc
Q psy3714         314 EFYHPGQ-----EYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL  387 (467)
Q Consensus       314 ~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (467)
                      .......     ......++..|+|||.+.+.. ++.++|+|..+++......+..++......     .....+.. +.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-----~~~~~~~~-~~  240 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-----HQLTLISQ-LC  240 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHH-Hh
Confidence            8653221     112346788999999887654 688899998887654433333332211100     00000000 00


Q ss_pred             CCCCcc---------cccc----------cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         388 GRHSRK---------RWER----------FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       388 ~~~~~~---------~~~~----------~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      +.....         .+..          ....-.....++.++|||.+||..||.+|||++|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            000000         0000          00000011246789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.5e-34  Score=285.50  Aligned_cols=246  Identities=20%  Similarity=0.302  Sum_probs=182.8

Q ss_pred             ccceeeeEeecccCCcceEEEEE-----ccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAIN-----VQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++.+.||+|+||.||+|..     ..++..||+|+++..    ..+.+.+|+.+|+.+.+||||+++.+.+.+.  
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~--  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG--  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence            46899999999999999999964     345668999998743    2346788999999997799999999988764  


Q ss_pred             CccEEEEeccCCccHHHHhh------------------------------------------------------------
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ------------------------------------------------------------  260 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  260 (467)
                      ...++||||+++|+|.+++.                                                            
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            46799999999999876653                                                            


Q ss_pred             ------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc
Q psy3714         261 ------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       261 ------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~  322 (467)
                                        .++...+..++.||+.||.|||++||+||||||+|||++.. ..+||+|||+|+........
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC-CcEEEecCccceeccCcccc
Confidence                              14556778899999999999999999999999999999854 47999999999866433221


Q ss_pred             c---eeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         323 N---VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       323 ~---~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      .   ...++..|+|||++.+..++.+.|+|..+++...... +..|+.....    ...........         +   
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~----~~~~~~~~~~~---------~---  334 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV----DSKFYKMIKEG---------Y---  334 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc----hHHHHHHHHhC---------c---
Confidence            1   1234567999999999899999999988876443322 2223211110    00111111110         0   


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                       ....+...++++++||.+||..||++|||+.|+++.
T Consensus       335 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         335 -RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             -cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence             011123467899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=9.2e-34  Score=270.13  Aligned_cols=247  Identities=19%  Similarity=0.307  Sum_probs=186.4

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      ......||+|+||.||+|.+..++..+++|.+...   ..+.+.+|+.+++.++ |+||+++.+.+...  ...++++||
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e~   86 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK-HRNIVQYLGSDSEN--GFFKIFMEQ   86 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccC--CEEEEEEec
Confidence            33446799999999999999999999999987654   2346789999999996 89999999987653  568999999


Q ss_pred             cCCccHHHHhh----cC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-c
Q psy3714         250 VNNTDFKQLYQ----TL--TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-Y  322 (467)
Q Consensus       250 ~~~~~l~~~~~----~~--~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-~  322 (467)
                      +++++|.....    .+  ++..+..++.|++.||.|||++||+||||||+||+++.+++.+||+|||++........ .
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  166 (268)
T cd06624          87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT  166 (268)
T ss_pred             CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence            99999987653    23  67778889999999999999999999999999999986556899999999876532221 2


Q ss_pred             ceeeeccCccCCcccccCC--CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         323 NVRVASRYFKGPELLADYQ--YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~~--~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      ....|++.|+|||++....  ++.++|+|..+++......+..|+.....     ..... ......        .  ..
T Consensus       167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~-----~~~~~-~~~~~~--------~--~~  230 (268)
T cd06624         167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE-----PQAAM-FKVGMF--------K--IH  230 (268)
T ss_pred             ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC-----hhhhH-hhhhhh--------c--cC
Confidence            2345889999999986644  77889999888765544444444321110     00000 000000        0  00


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ...+..+++++++|+++||..||++|||+.|++.||||
T Consensus       231 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         231 PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            11123478899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.3e-34  Score=284.83  Aligned_cols=245  Identities=21%  Similarity=0.280  Sum_probs=182.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCC-----CeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSS-----DKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++.+.||+|+||.||+|.+..++     ..||+|.++...    ...+.+|+++++.+..|+||+++++.+...  
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~--  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG--  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence            478999999999999999999865443     479999986432    345788999999996699999999988764  


Q ss_pred             CccEEEEeccCCccHHHHhh------------------------------------------------------------
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ------------------------------------------------------------  260 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  260 (467)
                      ...++||||+.+++|.++..                                                            
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            46899999999999876542                                                            


Q ss_pred             -------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcc---e
Q psy3714         261 -------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN---V  324 (467)
Q Consensus       261 -------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~---~  324 (467)
                                   .++...+..++.|++.||.|||++||+||||||+|||++.+ ..+||+|||+|+....+....   .
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEEeeceeeeeccCCcceeeccC
Confidence                         24566788999999999999999999999999999999854 479999999998654332211   1


Q ss_pred             eeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         325 RVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       325 ~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      ..++..|+|||++.+..|+.++|+|..+++.+.... +..||.....    ..........         .    .....
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~----~~~~~~~~~~---------~----~~~~~  336 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV----NSKFYKMVKR---------G----YQMSR  336 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc----cHHHHHHHHc---------c----cCccC
Confidence            234567999999988889999999988876544332 3333321100    0001111100         0    01112


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      +..+++++++||.+||+.||++|||++|+++
T Consensus       337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            2346899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-34  Score=271.90  Aligned_cols=250  Identities=22%  Similarity=0.335  Sum_probs=197.8

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ++|++.+.||.|+||.||+|.+..+++.+++|.+....    ...+.+|+++++.++ |+|++.+.+.+.+.  ...+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKG--SKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEEC--CeEEEE
Confidence            46889999999999999999999999999999886432    345788999999996 89999999987754  578999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CCcc
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYN  323 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~~~  323 (467)
                      +||+.++++.+.+.  .+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||+++..... ....
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEcccccceeecccccccc
Confidence            99999999988765  478899999999999999999999999999999999999654 7999999999876533 2233


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      ...++..|+|||.+.+..++.+.|+|..+++......+..|+....        ....... +..     .+.    ...
T Consensus       157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~--------~~~~~~~-~~~-----~~~----~~~  218 (274)
T cd06609         157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH--------PMRVLFL-IPK-----NNP----PSL  218 (274)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc--------hHHHHHH-hhh-----cCC----CCC
Confidence            4578899999999998889999999988887665555554442111        0010000 000     000    000


Q ss_pred             CC-CCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         404 QH-LVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       404 ~~-~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .. .+++++.+||.+||..||.+|||++++++||||....
T Consensus       219 ~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         219 EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             cccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence            11 2688999999999999999999999999999998654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.2e-34  Score=271.54  Aligned_cols=245  Identities=24%  Similarity=0.388  Sum_probs=189.5

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------------KKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      .|.+.+.||+|+||.||+|.+..+++.+|+|.+....            .+.+.+|+.+++.++ |+||+++.+.+... 
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-   78 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDA-   78 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeC-
Confidence            3677889999999999999998889999999875321            135678999999995 89999999987653 


Q ss_pred             CCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                       ...+++|||++++++..+..   .+++..+..++.|++.||+|||++|++||||||+||+++..+ .+||+|||+++..
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~-~~~l~dfg~~~~~  156 (267)
T cd06628          79 -DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-GIKISDFGISKKL  156 (267)
T ss_pred             -CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC-CEEecccCCCccc
Confidence             57899999999999887764   478888999999999999999999999999999999998554 7999999999866


Q ss_pred             CCCC-------CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCC
Q psy3714         317 HPGQ-------EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGR  389 (467)
Q Consensus       317 ~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (467)
                      ....       ......|+..|+|||.+.+..++...|.|..+++......+..||....       .......  +.. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~--~~~-  226 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT-------QLQAIFK--IGE-  226 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc-------HHHHHHH--Hhc-
Confidence            4211       1112357889999999998888889999988877555444444442211       0000000  000 


Q ss_pred             CCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                              ......+..+++++++||++||+.||++|||+.|+++||||
T Consensus       227 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         227 --------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             --------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                    00111223478999999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.3e-34  Score=281.72  Aligned_cols=270  Identities=29%  Similarity=0.429  Sum_probs=191.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC------
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVS------  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~------  240 (467)
                      ..+|++.+.||.|+||.||+|.+..+++.||+|.+....   .+.+.+|+++++.++ |+||+++.+.+.....      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcC-CCcchhhHhhhccccccccccc
Confidence            478999999999999999999999999999999876432   356788999999995 8999998876654321      


Q ss_pred             ------CccEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccc
Q psy3714         241 ------RTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL  312 (467)
Q Consensus       241 ------~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGl  312 (467)
                            ...+++|||+.+ ++.+...  .+++..++.++.|++.||.|||++||+||||||+||+++.++..+||+|||+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~  161 (342)
T cd07854          83 GSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL  161 (342)
T ss_pred             ccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence                  246899999974 6766553  5889999999999999999999999999999999999986666799999999


Q ss_pred             ceecCCCCC----cceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCc----------ccCChh
Q psy3714         313 AEFYHPGQE----YNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQ----------HLVSPE  377 (467)
Q Consensus       313 a~~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~  377 (467)
                      ++.......    .....++..|+|||.+.. ..++.++|+|..+++......+..+|......          ....+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE  241 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            986532211    122467899999998755 45788899998887755544444444221100          000000


Q ss_pred             hhhhhhhhccCCCCcccccc-cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         378 ALDFLDKNILGRHSRKRWER-FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      .................+.. .......+.++.++++||++||+.||++|||++|+++||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            00000000000000000000 00000123478999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.3e-34  Score=273.89  Aligned_cols=251  Identities=22%  Similarity=0.295  Sum_probs=189.9

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      +-|++++.||+|+||.||+|.+..++..+++|.+....   .....+|+++++.+. |+|++.+.+.+...  ...+++|
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~--~~~~~v~   81 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYYE--NNLWILI   81 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeC--CEEEEEE
Confidence            45788999999999999999999999999999886432   345678999999995 89999999988653  4689999


Q ss_pred             eccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CCc
Q psy3714         248 EHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEY  322 (467)
Q Consensus       248 e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~~  322 (467)
                      ||++++++....    ..+++..+..++.|++.||.|||++||+||||||+|||++..+ .+||+|||++...... ...
T Consensus        82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-CEEEcccccccccccccccc
Confidence            999999987654    2478889999999999999999999999999999999998554 7999999998754322 122


Q ss_pred             ceeeeccCccCCcccc-----cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         323 NVRVASRYFKGPELLA-----DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~-----~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      ....+|..|+|||++.     +..++...|+|..+++......+..|+.. .     .  ............     .. 
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~-~-----~--~~~~~~~~~~~~-----~~-  226 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE-L-----N--PMRVLLKIAKSE-----PP-  226 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc-c-----C--HHHHHHHHhhcC-----CC-
Confidence            3356899999999984     34477889999888765444333333211 1     0  001000000000     00 


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                        ....+..++.++++||.+||..||.+|||++++++||||...
T Consensus       227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         227 --TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             --CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence              011123478899999999999999999999999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-34  Score=270.31  Aligned_cols=250  Identities=24%  Similarity=0.414  Sum_probs=193.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      .++|++.+.||+|+||.||+|.+..+++.+++|.+...   ..+.+.+|+++++.++ |+||+++.+.+.+  ....+++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR-HPNIVAYFGSYLR--RDKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCC-CCChhceEEEEEe--CCEEEEE
Confidence            47899999999999999999999999999999998753   2456789999999995 8999999988765  3568999


Q ss_pred             EeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-C
Q psy3714         247 FEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-E  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~  321 (467)
                      |||+.++++.++.    ..+++.++..++.|++.||.|||++||+|+||||+||+++.++ .+||+|||++....... .
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-CEEECccccchhhhhhhhc
Confidence            9999999988765    3578899999999999999999999999999999999999654 79999999997654322 2


Q ss_pred             cceeeeccCccCCcccccC---CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         322 YNVRVASRYFKGPELLADY---QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~---~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      .....++..|+|||.+...   .++..+|+|..+++......+..|+......     ........   ......     
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-----~~~~~~~~---~~~~~~-----  224 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-----RALFLISK---SNFPPP-----  224 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh---ccCCCc-----
Confidence            2345688999999999877   7888999998887755554454444321100     00000000   000000     


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY  437 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~  437 (467)
                       .......++.++++||++||..||.+|||+.|++.|||
T Consensus       225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         225 -KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             -cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence             00112235789999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.5e-34  Score=280.66  Aligned_cols=266  Identities=28%  Similarity=0.510  Sum_probs=194.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC----
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPV----  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~----  239 (467)
                      -.++|.+.+.||+|+||.||+|.+..+++.+|+|.++..     ....+.+|+.+++.+. |+||+++.+++....    
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC-CCCccchhheecccccCCC
Confidence            347899999999999999999999999999999988642     1245778999999995 899999998875432    


Q ss_pred             CCccEEEEeccCCccHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ-TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      ....+++++|+.. ++..... .+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~~~~  169 (342)
T cd07879          92 FQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLARHADA  169 (342)
T ss_pred             CceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCCCCcCCCC
Confidence            1245899999864 5655544 688999999999999999999999999999999999999655 799999999986532


Q ss_pred             CCCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcc----------cCChhhhhhhhhh--
Q psy3714         319 GQEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQH----------LVSPEALDFLDKN--  385 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~--  385 (467)
                        ......+|+.|+|||++.+. .++.++|+|..+++......+..+|.......          ...+.........  
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (342)
T cd07879         170 --EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA  247 (342)
T ss_pred             --CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence              23345789999999998764 57889999988877655545544443211000          0000000000000  


Q ss_pred             --c---cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         386 --I---LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       386 --~---~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                        .   ........+.     ...+..++++++||.+||+.||++|||++|++.||||.+..+.
T Consensus       248 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         248 KSYIKSLPKYPRKDFS-----TLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             HHHHhhcCCcccchHH-----HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence              0   0000000000     0112468899999999999999999999999999999887643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.6e-34  Score=280.68  Aligned_cols=271  Identities=27%  Similarity=0.484  Sum_probs=195.2

Q ss_pred             cCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC-
Q psy3714         167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS-  240 (467)
Q Consensus       167 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~-  240 (467)
                      |...++|++++.||+|+||.||+|.+..++..||+|.++..     ....+.+|+.+++.++ |+||+.+.+.+..... 
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCccc
Confidence            34568899999999999999999999999999999988532     1345778999999995 8999999988764321 


Q ss_pred             ---CccEEEEeccCCccHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         241 ---RTPALIFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       241 ---~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                         ...++||+|+ ++++..+.  ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||++..
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~~  167 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  167 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccccc
Confidence               2358999998 56776665  3588999999999999999999999999999999999998654 799999999986


Q ss_pred             cCCCCCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCccc---------C-Chhhhhhhhh
Q psy3714         316 YHPGQEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHL---------V-SPEALDFLDK  384 (467)
Q Consensus       316 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~---------~-~~~~~~~~~~  384 (467)
                      ....  .....+++.|+|||.+.+. .++...|+|..+++......+..+|........         . ..........
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         168 TDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             cccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence            5432  2334678999999998763 477889999888765544444444422110000         0 0000000000


Q ss_pred             ----hccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         385 ----NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       385 ----~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                          .............+  ....+.+++++.+||.+||+.||++|||+.++++||||......
T Consensus       246 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDF--RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             hhHHHHHHhccccCcchH--HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence                00000000000000  01123578899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.8e-34  Score=274.72  Aligned_cols=252  Identities=19%  Similarity=0.300  Sum_probs=192.1

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ++|++++.||+|+||.||+|.+..++..+|+|.++..    ....+.+|+.+++.++ |+||+++++.+...  ...+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~--~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAV-SPYIVDFYGAFFIE--GAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecC--CeEEEE
Confidence            5789999999999999999999989999999987642    1346778999999985 89999999887653  568999


Q ss_pred             EeccCCccHHHHhh------cCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         247 FEHVNNTDFKQLYQ------TLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       247 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      |||++++++.++..      .+++..+..++.|++.||.|||+ .||+||||||+||+++.+ +.+||+|||++..+...
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC-CCEEEeecCCcccccCC
Confidence            99999999987653      47888999999999999999997 599999999999999864 47999999999765322


Q ss_pred             CCcceeeeccCccCCcccccC------CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         320 QEYNVRVASRYFKGPELLADY------QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~------~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                       .....++++.|+|||.+.+.      .++...|+|..+++......+..||.....     ............+.    
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~----  226 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQLSAIVDGD----  226 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hhHHHHHHHHhhcC----
Confidence             22334688899999998543      357789999888765544444444422110     01111111000000    


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                            ....+..+++++.+||.+||+.||.+|||++++++||||....
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         227 ------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             ------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence                  0111234789999999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7e-34  Score=270.41  Aligned_cols=246  Identities=21%  Similarity=0.311  Sum_probs=189.1

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      +|++.+.||+|+||.||+|.+ .+++.+|+|.++...         ...+.+|+++++.++ |+||+++.+.+.+.  ..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~   76 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDD--NT   76 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecC--Ce
Confidence            478889999999999999986 478889999876321         245788999999996 79999999988764  57


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-  318 (467)
                      .++++||+++++|.+++.   .+++..+..++.|++.||+|||+.||+|+||||+||+++.++ .+||+|||++..... 
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~  155 (265)
T cd06631          77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG-IIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-eEEeccchhhHhhhhc
Confidence            899999999999988764   478889999999999999999999999999999999998554 799999999875421 


Q ss_pred             ------CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         319 ------GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       319 ------~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                            ........|+..|+|||.+.+..++...|.|..+++......+..||....       .......  +.. .. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~--~~~-~~-  224 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD-------RLAAMFY--IGA-HR-  224 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC-------hHHHHHH--hhh-cc-
Confidence                  111223468999999999998889999999988877555444444442211       0000000  000 00 


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ..     ....+..+++++++||++||..||.+|||++|+++||||
T Consensus       225 ~~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         225 GL-----MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CC-----CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            00     011123478999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.5e-33  Score=271.97  Aligned_cols=258  Identities=23%  Similarity=0.366  Sum_probs=195.8

Q ss_pred             ceeeeEeecccCCcceEEEEEc---cCCCeEEEEEeccc-------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINV---QSSDKCVVKILKPV-------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~-------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      +|++.+.||+|+||.||.|.+.   .++..+|+|.++..       ..+.+.+|+.+++.+.+|+||+.++..+...  .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--T   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--C
Confidence            4889999999999999999875   47889999998642       1345778999999998899999999888653  4


Q ss_pred             ccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      ..++||||++++++.+.+.   .+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~  157 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFHE  157 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-CEEEeeCccceeccc
Confidence            6789999999999877653   478889999999999999999999999999999999998654 799999999986543


Q ss_pred             CC--CcceeeeccCccCCcccccC--CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         319 GQ--EYNVRVASRYFKGPELLADY--QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       319 ~~--~~~~~~gt~~y~aPE~l~~~--~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ..  ......|+..|+|||.+...  .++...|+|..+++.+....+..|+......    ....... ......     
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~-~~~~~~-----  227 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK----NSQAEIS-RRILKS-----  227 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc----ccHHHHH-HHhhcc-----
Confidence            22  12235689999999998753  4678899998887655444444443211100    0000100 011000     


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCccccccc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~  447 (467)
                           ..+.+..+++.+.+||++||..||++|+     ++++++.||||..+.|+...
T Consensus       228 -----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~  280 (290)
T cd05613         228 -----EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLA  280 (290)
T ss_pred             -----CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHh
Confidence                 0111234788999999999999999997     89999999999999886653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1151|consensus

Probab=100.00  E-value=8.6e-35  Score=274.80  Aligned_cols=258  Identities=22%  Similarity=0.379  Sum_probs=204.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----------KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      .++|-++..||+|+|+.||+|.+...++.||||+-.-.          ..+...||-.|.+.|. ||-||++++++.-+ 
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYDyfslD-  539 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYDYFSLD-  539 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeeeeeeec-
Confidence            47799999999999999999999999999999985321          2356789999999995 89999999998654 


Q ss_pred             CCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCceEEeCC--CCcEEEEeccc
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSM--GIMHRDVKPHNVMIDHE--NRKLRLIDWGL  312 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~--~IiHrDlKp~Nill~~~--~~~ikl~DFGl  312 (467)
                      ...++-|+|||+|.||.-+++   .+++.+++.++.||+.||.||.+.  -|||-||||.||||-..  .+.|||+|||+
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            357899999999999876654   489999999999999999999976  59999999999999632  24799999999


Q ss_pred             ceecCCCCCc--------ceeeeccCccCCcccccC--C--CCccchhHHHhhhccccccccccccccCCcccCChhhhh
Q psy3714         313 AEFYHPGQEY--------NVRVASRYFKGPELLADY--Q--YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD  380 (467)
Q Consensus       313 a~~~~~~~~~--------~~~~gt~~y~aPE~l~~~--~--~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (467)
                      ++.+..+...        +-..||.||.+||.+.-.  +  .+.++|+|..+++-+.++.|..||.+.-.+       .+
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-------Qd  692 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-------QD  692 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-------HH
Confidence            9988543321        224699999999987533  2  567899999999988888888887554321       12


Q ss_pred             hhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ++..+..-....      +..+..+.+|++|++||++||.+.-+.|+.+.|+-.||||-+..
T Consensus       693 ILqeNTIlkAtE------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~  748 (775)
T KOG1151|consen  693 ILQENTILKATE------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI  748 (775)
T ss_pred             HHhhhchhccee------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence            222221111111      22334567999999999999999999999999999999998744

>KOG0584|consensus

Probab=100.00  E-value=4.9e-35  Score=288.61  Aligned_cols=248  Identities=21%  Similarity=0.326  Sum_probs=195.5

Q ss_pred             eeeEeecccCCcceEEEEEccCCCeEEEEEecc-------chHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         174 QLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP-------VKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       174 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~-------~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +...+||+|+|=+||+|.|..+|-.||--.++-       ...+++..|+.+|+.|+ |+||++++..+.+.......+|
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCceeeee
Confidence            344679999999999999999998888543321       12477889999999997 8999999999988777889999


Q ss_pred             EeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~--IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      .|.+..|+|.++.+   ..+..-++.|++||+.||.|||++.  |||||||.+||+++...+.|||.|+|||...... .
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-~  200 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-H  200 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-c
Confidence            99999999988865   4677888999999999999999985  9999999999999987789999999999977543 3


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+|||.|||||++. ..|+..+|++..+|+-..+..+.+|+.-..+        ...+.+.+.+......+.+    
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--------~AQIYKKV~SGiKP~sl~k----  267 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--------PAQIYKKVTSGIKPAALSK----  267 (632)
T ss_pred             cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--------HHHHHHHHHcCCCHHHhhc----
Confidence            45579999999999987 6799999999888875555555555432211        1112222222211111111    


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                          .-.+++++||.+||.- ..+|+||.|+|+||||+.-
T Consensus       268 ----V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  268 ----VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ----cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                1268999999999998 9999999999999999864

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.7e-34  Score=270.51  Aligned_cols=247  Identities=21%  Similarity=0.397  Sum_probs=195.2

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      +|++.+.||.|+||.||+|.+..+++.+++|.+...      ..+.+.+|+++++.++ ||||+.+...+.+.  ...++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~l   77 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDE--ENMYL   77 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCC--CeEEE
Confidence            589999999999999999999999999999988642      2356788999999995 89999998887653  56899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~  322 (467)
                      ++||+.+++|...+.   .+++..+..++.|+++||.|||++||+|+||||+||+++.++ .++|+|||++.........
T Consensus        78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-HVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-CEEEeecccccccCCCccc
Confidence            999999999887653   578889999999999999999999999999999999998654 7999999999876544333


Q ss_pred             ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccccc
Q psy3714         323 NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE  402 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
                      ....|+..|+|||.+....++.+.|.|..+++......+..|+......   ...  .+.... .    .      ....
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~--~~~~~~-~----~------~~~~  220 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRD--QIRAKQ-E----T------ADVL  220 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHH--HHHHHh-c----c------cccc
Confidence            4456889999999998888999999998887755554454444322110   000  111000 0    0      0111


Q ss_pred             CCCCCChHHHHHHHhhcCcCCCCCCCH--HHHhCCCCC
Q psy3714         403 NQHLVSPEALDFLDKLLRYDHYERLTA--REAMDHPYF  438 (467)
Q Consensus       403 ~~~~~s~~~~dli~~lL~~dp~~R~ta--~e~l~Hp~f  438 (467)
                      .+..+++++.+||++||+.||.+|+|+  +|+++||||
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             CcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            223468999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.8e-33  Score=276.76  Aligned_cols=264  Identities=29%  Similarity=0.472  Sum_probs=187.7

Q ss_pred             ceeeeEeecccCCcceEEEEEccC--CCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeC--CCCCc
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQS--SDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKD--PVSRT  242 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~--~~~~~  242 (467)
                      +|++.+.||+|+||.||++.+..+  +..+|+|.+...     ..+...+|+.+++++.+|+||+++.+....  .....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            488999999999999999999888  889999987642     234677899999999889999999876432  12245


Q ss_pred             cEEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      .+++++++. ++|.+.+   ..+++..++.++.||+.||+|||++||+||||||+|||++..+ .+||+|||+|+.....
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-CEEeCcCCCceecccc
Confidence            678888876 4666554   3578899999999999999999999999999999999998654 7999999999865322


Q ss_pred             C-----CcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcc--------cCCh--hhhhhhh
Q psy3714         320 Q-----EYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQH--------LVSP--EALDFLD  383 (467)
Q Consensus       320 ~-----~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~--~~~~~~~  383 (467)
                      .     .....+||+.|+|||.+.+ ..++..+|+|..+++......+..++.......        ++.+  +......
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            1     1223478999999998766 458889999988876544433333332111000        0000  0000000


Q ss_pred             hh-------ccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         384 KN-------ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       384 ~~-------~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ..       .........+.     ...+.++.++++||.+||+.||++|||++|+++||||....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFE-----SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             hhhHHHHHHhccccCCcchH-----hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence            00       00000000110     11233688999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.5e-33  Score=263.36  Aligned_cols=245  Identities=24%  Similarity=0.362  Sum_probs=192.1

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++++.||.|+||.||.+.+..+++.+++|.+...     ....+.+|++++++++ |+||+.+.+.+.+.  ...+++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~--~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDD--NTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecC--CeEEEE
Confidence            589999999999999999999999999999987532     2345788999999995 89999999998763  568999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-  320 (467)
                      |||++++++.+...     .+++.++..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGDFGISKILGSEYS  156 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-CEEECcCcceEEcccccc
Confidence            99999999987763     377888999999999999999999999999999999999654 79999999998764332 


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      ......|++.|+|||.+.+..++...|+|..+++......+..++...        ...........+     .+.    
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--------~~~~~~~~~~~~-----~~~----  219 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT--------NPLNLVVKIVQG-----NYT----  219 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHcC-----CCC----
Confidence            233456899999999998888888999998887654433333333111        011111111111     111    


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                       .....++.++.+||.+||..||.+|||++|+++|||+
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         220 -PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence             0113468999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.5e-34  Score=274.61  Aligned_cols=256  Identities=18%  Similarity=0.294  Sum_probs=190.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ++|+..+.||+|+||.||++.+..+++.+|+|.+...    ....+.+|+.++.++.+|+||+++++.+..+  ...+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEE
Confidence            5777888999999999999999999999999988643    2346788999999997789999999987653  457899


Q ss_pred             EeccCCc--cHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         247 FEHVNNT--DFKQLY-----QTLTDYDIRYYLYELLKALDYCHSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       247 ~e~~~~~--~l~~~~-----~~~~~~~~~~~~~qll~al~~lH~~-~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      |||+...  ++....     ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++ .+||+|||+|+....
T Consensus        82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQLVD  160 (288)
T ss_pred             EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHhcc
Confidence            9998652  222221     3478889999999999999999974 999999999999998654 799999999976543


Q ss_pred             CCCcceeeeccCccCCcccccC---CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADY---QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~---~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      ........||..|+|||++...   .++.++|+|..+++......+..||....       ...........+...    
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~----  229 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKGDPP----  229 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCCCCC----
Confidence            3333445689999999999876   58889999988876554444444432111       001111100000000    


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                       . .....+..+++++.+||++||+.||++|||++|+++||||....
T Consensus       230 -~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         230 -I-LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             -c-CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence             0 01111234789999999999999999999999999999997644

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.2e-34  Score=272.51  Aligned_cols=252  Identities=19%  Similarity=0.317  Sum_probs=194.1

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ++|++.+.||+|+||.||+|.+..+++.+++|.+...    ....+.+|+++++.+. |+||+.+.+.+...  ...+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~--~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN-SPYIVGFYGAFYNN--GDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC-CCchhhhheeeecC--CEEEEE
Confidence            4688899999999999999999999999999987643    2346788999999997 89999999887654  568999


Q ss_pred             EeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      +||+.+++|.++..    .+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .+||+|||++........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhHHHHh
Confidence            99999999987764    46888889999999999999999 9999999999999999654 799999999876532222


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      . ...++..|+|||.+.+..++.+.|+|..+++......+..|+......   ........... ....         ..
T Consensus       157 ~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~-~~~~---------~~  222 (265)
T cd06605         157 K-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYI-VNEP---------PP  222 (265)
T ss_pred             h-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHHH-hcCC---------CC
Confidence            1 256888999999998888999999998887655444444444322110   00111111111 0000         00


Q ss_pred             cCCC-CCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         402 ENQH-LVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       402 ~~~~-~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      ..+. .+++++++||.+||..||++|||+.|++.||||..
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            0011 26889999999999999999999999999999965

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.8e-33  Score=263.63  Aligned_cols=245  Identities=21%  Similarity=0.354  Sum_probs=192.1

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++.+.||+|+||.||+|.+..+++.+++|.+...     ....+.+|+.+++.++ |+|++++.+.+...  ...+++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYIIRYYESFLDK--GKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC-CCCeehheeeeccC--CEEEEE
Confidence            588999999999999999999999999999987532     2456778999999996 89999999887653  568999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      |||++++++.+++.     .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-CEEEcccccceeccCccc
Confidence            99999999887653     367788889999999999999999999999999999999654 799999999987643322


Q ss_pred             -cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         322 -YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       322 -~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                       .....|++.|+|||++.+..++.+.|+|..+++......+..|+....      .  .........+.     .     
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~--~~~~~~~~~~~-----~-----  218 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN------Q--GALILKIIRGV-----F-----  218 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC------H--HHHHHHHHcCC-----C-----
Confidence             233468899999999998889999999988877555444544442211      0  01111100000     0     


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ......++++++++|.+|++.||++||++.++++|||+
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            01112468899999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.3e-33  Score=274.21  Aligned_cols=249  Identities=18%  Similarity=0.249  Sum_probs=179.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEcc----------------CCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCee
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQ----------------SSDKCVVKILKPVK----KKKIKREIKILENLRGGTNII  229 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv  229 (467)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|.++...    ...+.+|+.++..++ |+||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK-DPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC-CCCee
Confidence            4689999999999999999997532                23469999886532    346789999999995 89999


Q ss_pred             EEEEEEeCCCCCccEEEEeccCCccHHHHhhc----------------------CCHHHHHHHHHHHHHHHHHHHHCCcc
Q psy3714         230 TLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----------------------LTDYDIRYYLYELLKALDYCHSMGIM  287 (467)
Q Consensus       230 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----------------------~~~~~~~~~~~qll~al~~lH~~~Ii  287 (467)
                      ++++.+.+.  ...+++|||+.+++|.++...                      ++...+..++.||+.||.|||++||+
T Consensus        83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          83 RLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             EEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            999988764  458999999999998776532                      34566788999999999999999999


Q ss_pred             ccCCCCCceEEeCCCCcEEEEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc--cc
Q psy3714         288 HRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK--RW  362 (467)
Q Consensus       288 HrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~--~~  362 (467)
                      ||||||+|||++.++ .+||+|||+++........   ....++..|+|||++....++.+.|+|..+++.+....  +.
T Consensus       161 H~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         161 HRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             ccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            999999999999554 7999999999865433221   12345778999999988889999999988776433211  11


Q ss_pred             ccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHh
Q psy3714         363 ERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM  433 (467)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l  433 (467)
                      .|+....     ............. ...     .......++..++++++||.+|+..||++|||++|+.
T Consensus       240 ~p~~~~~-----~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         240 QPYGELT-----DEQVIENAGEFFR-DQG-----RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCCcCC-----HHHHHHHHHHHhh-hcc-----ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            1221111     0111110000000 000     0000112234688999999999999999999999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-33  Score=278.60  Aligned_cols=270  Identities=29%  Similarity=0.477  Sum_probs=194.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+...     ......+|+.+++.+.+|+||+++.+.+........+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            47899999999999999999999989999999987432     2345678999999996699999999988665455689


Q ss_pred             EEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC--
Q psy3714         245 LIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~--  320 (467)
                      +||||+.+ ++.+...  .+++.....++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......  
T Consensus        86 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~~~~~~~~  163 (337)
T cd07852          86 LVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEEN  163 (337)
T ss_pred             EEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccchhcccccccc
Confidence            99999985 7776654  467788888999999999999999999999999999999655 79999999998653221  


Q ss_pred             ----CcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcc----------cCChhhhhhh---
Q psy3714         321 ----EYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQH----------LVSPEALDFL---  382 (467)
Q Consensus       321 ----~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~---  382 (467)
                          .....+||..|+|||.+.+. .++..+|+|..+++......+..++.......          ....+.....   
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
T cd07852         164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP  243 (337)
T ss_pred             ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence                22335789999999988654 47888999988876554444444432111000          0000000000   


Q ss_pred             -hhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         383 -DKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       383 -~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                       ................  ....+.+++++.+||.+||+.||.+|||++++++||||.....
T Consensus       244 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         244 FAATMLDSLPSRPRKPL--DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             hHHHhhhhcccccccch--hhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence             0000000000000000  0111236899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.4e-33  Score=268.39  Aligned_cols=256  Identities=25%  Similarity=0.513  Sum_probs=187.9

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      +|++++.||.|++|.||+|.+..++..+|+|.++..    ....+.+|+.+++.++ |+||+++.+.+.+.  ...++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK-HENIVRLHDVIHTE--NKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeC--CcEEEEE
Confidence            589999999999999999999999999999988643    2346678999999995 89999999988764  4679999


Q ss_pred             eccCCccHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-C
Q psy3714         248 EHVNNTDFKQLYQ------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-Q  320 (467)
Q Consensus       248 e~~~~~~l~~~~~------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~  320 (467)
                      ||+.+ ++..+..      .+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++...... .
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVN  155 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcCCcc
Confidence            99986 5655432      378889999999999999999999999999999999998554 7999999999754322 2


Q ss_pred             CcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      ......+|..|++||.+.+.. ++...|+|..+++......+..++.....     .+....... .........|....
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~~~~~~  229 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN-----EDQLLKIFR-IMGTPTESTWPGIS  229 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHHH-HhCCCChhhHHHHh
Confidence            223456789999999987654 68889999888765544444444322111     000000000 00000000000000


Q ss_pred             ----------------cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         400 ----------------HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       400 ----------------~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                                      .....+.+++++++||.+||+.||.+|||++|+++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                            000112468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.7e-33  Score=263.98  Aligned_cols=245  Identities=17%  Similarity=0.318  Sum_probs=191.3

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++++.||+|+||.||++.+..+++.+++|.+...     ....+.+|+.+++.++ |+||+.+.+.+...  ...++|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK-HPNIVQYQESFEEN--GNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCC--CeEEEE
Confidence            589999999999999999999999999999987532     2346788999999996 89999999988653  568999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      +||+.++++.+...     .+++.++..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++........
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEEeeccceeecCcchh
Confidence            99999999877653     367888899999999999999999999999999999998654 799999999986543222


Q ss_pred             -cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         322 -YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       322 -~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                       .....|++.|+|||++.+..++.+.|.|..+++......+..++...        ...........+..          
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--------~~~~~~~~~~~~~~----------  218 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--------NMKNLVLKIIRGSY----------  218 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC--------CHHHHHHHHhcCCC----------
Confidence             22345888999999998888888999998887655444443333211        11111111111110          


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ...+...+.+++++|.+||+.||.+|||++|+++||||
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            01123468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.5e-34  Score=279.74  Aligned_cols=269  Identities=30%  Similarity=0.545  Sum_probs=194.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC--CCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDP--VSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~--~~~~  242 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+...     ....+.+|+.+|+.++ |+||+++++.+...  ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCce
Confidence            47899999999999999999999999999999988643     2345778999999996 89999998876532  2346


Q ss_pred             cEEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      .++||||+. +++.+..   ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~  160 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSS  160 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEecccccceeeccc
Confidence            799999996 4676665   3478999999999999999999999999999999999999654 7999999999765322


Q ss_pred             CC-----cceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCc--------ccCCh--hhhhhhh
Q psy3714         320 QE-----YNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQ--------HLVSP--EALDFLD  383 (467)
Q Consensus       320 ~~-----~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~  383 (467)
                      ..     ....+|+..|+|||.+.+. .++.+.|+|..+++.+....+..+|......        ..+.+  .......
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            11     1234789999999998763 4788999998887655444444443211100        00000  0000000


Q ss_pred             hh-------ccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccccc
Q psy3714         384 KN-------ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       384 ~~-------~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~~  446 (467)
                      ..       .........|..     ..+.+++++++||++||+.||.+|||++++++||||.....+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~  305 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSK-----IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD  305 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHH-----HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence            00       000000011110     11346899999999999999999999999999999987654443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1e-33  Score=272.31  Aligned_cols=263  Identities=25%  Similarity=0.442  Sum_probs=190.1

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++|++++.||+|+||.||+|.+..+++.+|+|.+....     .+.+.+|+++++.+. |+||+++.+.+.+  ....++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-HENLVNLIEVFRR--KKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC-CcchhhHHHhccc--CCeEEE
Confidence            47999999999999999999999899999999875421     345678999999995 8999999988865  356899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CC
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~  321 (467)
                      |+||++++.+..+..   .++...+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++...... ..
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-cEEEEeeeeeeeccCCccc
Confidence            999999988876643   478899999999999999999999999999999999998554 7999999999865432 22


Q ss_pred             cceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCccc-----------CChhhhhhhhh-hccC
Q psy3714         322 YNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHL-----------VSPEALDFLDK-NILG  388 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~-~~~~  388 (467)
                      .....++..|+|||++.+.. ++.+.|+|..+++......+..++. .....-           ..+........ .+..
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC-CCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            34457899999999987644 6778999988876544444432221 111000           00000000000 0000


Q ss_pred             CCCcccccc-cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         389 RHSRKRWER-FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       389 ~~~~~~~~~-~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ......... .......+.+++++++||++||..||++|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            000000000 00001123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.4e-34  Score=275.43  Aligned_cols=252  Identities=19%  Similarity=0.327  Sum_probs=194.5

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      +.|.....||+|+||.||++.+..++..+|||.+...   ....+.+|+.+++.++ |+|++.+.+.+...  ...+++|
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~--~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH-HENVVDMYNSYLVG--DELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCC-CCcHHHHHHheecC--CeEEEEE
Confidence            4566667899999999999999989999999987643   2345788999999985 89999998887653  4679999


Q ss_pred             eccCCccHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CCcce
Q psy3714         248 EHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNV  324 (467)
Q Consensus       248 e~~~~~~l~~~~--~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~~~~  324 (467)
                      ||++++++..+.  ..+++.++..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++...... .....
T Consensus        99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658          99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccccccCce
Confidence            999999988765  3578889999999999999999999999999999999998654 7999999998754322 22234


Q ss_pred             eeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCC
Q psy3714         325 RVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQ  404 (467)
Q Consensus       325 ~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (467)
                      ..|+..|+|||.+.+..++.+.|+|..+++......+..|+.....        ...... +....     ..  .....
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~-~~~~~-----~~--~~~~~  241 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--------LQAMRR-IRDNL-----PP--RVKDS  241 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH-HHhcC-----CC--ccccc
Confidence            5789999999999888899999999888776555555444432111        010000 00000     00  00112


Q ss_pred             CCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         405 HLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       405 ~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ..++++.++||.+||..||++|||++|+++||||....
T Consensus       242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~  279 (292)
T cd06658         242 HKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG  279 (292)
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence            24688999999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.6e-34  Score=278.46  Aligned_cols=265  Identities=32%  Similarity=0.550  Sum_probs=196.4

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC---CCcc
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPV---SRTP  243 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~---~~~~  243 (467)
                      +|++.+.||+|+||.||+|.+..+++.+++|.+...     ..+.+.+|+.+++.++ |+||+.+.+++....   ....
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccce
Confidence            588999999999999999999988999999988653     2356888999999996 899999998876542   2367


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      +++|+|+.+ ++.+.+.   .+++..+..++.|++.||+|||++||+||||||+|||++.. +.++|+|||++.......
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDE  157 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEeecccc
Confidence            999999985 6665543   47889999999999999999999999999999999999965 589999999998765432


Q ss_pred             ----CcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcc--------cC--Chhhhhhhhhh
Q psy3714         321 ----EYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQH--------LV--SPEALDFLDKN  385 (467)
Q Consensus       321 ----~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~~--~~~~~~~~~~~  385 (467)
                          ......+|+.|+|||.+.+. .++.+.|+|..+++......+..+|.......        ..  .+.........
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence                23445689999999999888 78999999988877555555544442211000        00  00000000000


Q ss_pred             c-------cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         386 I-------LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       386 ~-------~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                      .       ........+..     ..+.+++++.+||.+||++||.+|||++++++||||.....+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSK-----LFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             chhhHHhhcccCCcchhHH-----hcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            0       00000111111     122368999999999999999999999999999999876654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1e-33  Score=267.74  Aligned_cols=246  Identities=19%  Similarity=0.341  Sum_probs=191.7

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++.+.||+|+||.||++.+..++..+|+|.+...     ....+.+|+++++.++ |+||+++.+.+...  ...+++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~--~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPNIVTFFASFQEN--GRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC-CCChhhhhheeccC--CeEEEE
Confidence            588999999999999999999999999999988542     3356778999999996 89999999887653  568999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      +||+.++++.+.+.     .+++..+..++.|++.||.|||+++|+|+||||+||+++.++..+||+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999987663     2678889999999999999999999999999999999987655679999999976543322


Q ss_pred             -cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         322 -YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       322 -~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                       .....|++.|+|||.+.+..++.+.|.|..+++......+..|+...        ........ ....    .+     
T Consensus       158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~~~-~~~~----~~-----  219 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN--------NLHQLVLK-ICQG----YF-----  219 (257)
T ss_pred             cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHH-Hhcc----cC-----
Confidence             22346899999999998888899999998887654443333333211        01111110 0000    00     


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      .+....++.+++++|++||..||++|||++|+++||||
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            01123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=267.77  Aligned_cols=247  Identities=25%  Similarity=0.345  Sum_probs=186.6

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      +.||+|+||.||+|.+..+++.+|+|.++...      ......|..++....+|+|++++++.+...  ...++++||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEEecc
Confidence            56899999999999999999999999986432      122345555555555789999999988753  5689999999


Q ss_pred             CCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcceeee
Q psy3714         251 NNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA  327 (467)
Q Consensus       251 ~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~g  327 (467)
                      ++++|..+..   .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++....   .....+
T Consensus        80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEeecccceeccc---cccCCC
Confidence            9999988764   478899999999999999999999999999999999998654 799999999986432   223458


Q ss_pred             ccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCC
Q psy3714         328 SRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLV  407 (467)
Q Consensus       328 t~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (467)
                      +..|+|||.+.+..++...|+|..+++.+....+..|+.....     .........   +   ...|.    ......+
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~---~---~~~~~----~~~~~~~  220 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILS---R---RINWP----EEVKEFC  220 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHh---c---ccCCC----CcccccC
Confidence            8899999999888888999999888765554444444422110     011110100   0   00111    0112247


Q ss_pred             ChHHHHHHHhhcCcCCCCCCCH---HHHhCCCCCCCcccc
Q psy3714         408 SPEALDFLDKLLRYDHYERLTA---REAMDHPYFYPIVKD  444 (467)
Q Consensus       408 s~~~~dli~~lL~~dp~~R~ta---~e~l~Hp~f~~~~~~  444 (467)
                      ++++.+||.+||+.||++|||+   +|+|.||||..+.|+
T Consensus       221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         221 SPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD  260 (260)
T ss_pred             CHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence            8999999999999999999955   799999999887764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.4e-33  Score=268.48  Aligned_cols=252  Identities=17%  Similarity=0.271  Sum_probs=186.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEcc-----CCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQ-----SSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++.+.||+|+||.||+|..+.     .+..+|+|.++...    ...+.+|+.+++.+. |+||+++++.+.+.  
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--   81 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-CHHVVRLLGVVSKG--   81 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCC--
Confidence            4789999999999999999997642     24479999876432    234678999999995 89999999988764  


Q ss_pred             CccEEEEeccCCccHHHHhhc-------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEE
Q psy3714         241 RTPALIFEHVNNTDFKQLYQT-------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRL  307 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl  307 (467)
                      ...+++|||+.+++|.++...             .+...+..++.|++.||.|||++||+||||||+|||++.+ +.+||
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~-~~~~L  160 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKI  160 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC-CcEEE
Confidence            468999999999999877642             2345678899999999999999999999999999999955 47999


Q ss_pred             EecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhh
Q psy3714         308 IDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLD  383 (467)
Q Consensus       308 ~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  383 (467)
                      +|||+++.......   .....++..|+|||.+.+..++.+.|+|..+++...... +..++...     ...+...+..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~-----~~~~~~~~~~  235 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-----SNEQVLKFVM  235 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHH
Confidence            99999986532221   112245678999999988889999999988876443222 22222111     1111111111


Q ss_pred             hhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC------CCCCCCccc
Q psy3714         384 KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD------HPYFYPIVK  443 (467)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~------Hp~f~~~~~  443 (467)
                      .   +.    .      .+.+...+++++++|.+||+.||++|||+.|+++      ||||.+++|
T Consensus       236 ~---~~----~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         236 D---GG----Y------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             c---CC----C------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence            0   00    0      0112245789999999999999999999999987      999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-33  Score=276.84  Aligned_cols=267  Identities=26%  Similarity=0.446  Sum_probs=191.4

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC---
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPV---  239 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~---  239 (467)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.++...     .+.+.+|+.+++.++ |+||+++.+++....   
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~~~   92 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLE   92 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeeccccc
Confidence            34588999999999999999999999999999999886421     345778999999996 899999998875432   


Q ss_pred             -CCccEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         240 -SRTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       240 -~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                       ....+++++++ ++++.+...  .+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++..
T Consensus        93 ~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~~  170 (345)
T cd07877          93 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHT  170 (345)
T ss_pred             ccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-CEEEecccccccc
Confidence             13356777765 667766553  488999999999999999999999999999999999999655 7999999999865


Q ss_pred             CCCCCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCccc----------CChhhhhhhhh-
Q psy3714         317 HPGQEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQHL----------VSPEALDFLDK-  384 (467)
Q Consensus       317 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~-  384 (467)
                      ..  ......+|..|+|||.+.+ ..++.+.|+|..+++......+..++........          ..+........ 
T Consensus       171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (345)
T cd07877         171 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  248 (345)
T ss_pred             cc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence            32  2334578999999999876 4578889999888765544444333321110000          00000000000 


Q ss_pred             ---hc---cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         385 ---NI---LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       385 ---~~---~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                         ..   ........+.     ......+++++|||.+||+.||.+|+|+.+++.||||.....+
T Consensus       249 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         249 SARNYIQSLTQMPKMNFA-----NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             hHHHHHHHhcccCCcchh-----hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence               00   0000000000     0112358899999999999999999999999999999875443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.7e-33  Score=267.41  Aligned_cols=250  Identities=23%  Similarity=0.374  Sum_probs=187.8

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-------------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-------------KKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-------------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      .|.+.+.||+|+||.||+|.+..+++.+|+|.++...             .+.+.+|+.+++.++ |+|++++.+.+...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence            4778899999999999999998899999999875311             134678999999995 89999999988754


Q ss_pred             CCCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                        ...++||||++++++.+...   .+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++.
T Consensus        81 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~  157 (272)
T cd06629          81 --EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKK  157 (272)
T ss_pred             --CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-CeEEEeecccccc
Confidence              46899999999999887654   47888899999999999999999999999999999999854 4899999999976


Q ss_pred             cCCCC---CcceeeeccCccCCcccccCC--CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCC
Q psy3714         316 YHPGQ---EYNVRVASRYFKGPELLADYQ--YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRH  390 (467)
Q Consensus       316 ~~~~~---~~~~~~gt~~y~aPE~l~~~~--~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (467)
                      .....   ......|+..|+|||.+....  ++.+.|.|..+++......+..|+....        ....... .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~~-~~~~~  228 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE--------AIAAMFK-LGNKR  228 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc--------hHHHHHH-hhccc
Confidence            43211   122345788999999987755  7888999988876544444444432111        0000000 00000


Q ss_pred             CcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         391 SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       391 ~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ....+    .......+++++++||.+||..||.+|||++|+++||||
T Consensus       229 ~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         229 SAPPI----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cCCcC----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            00000    111123468999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0587|consensus

Probab=100.00  E-value=2.5e-33  Score=284.85  Aligned_cols=255  Identities=20%  Similarity=0.350  Sum_probs=199.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeC---CCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKD---PVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~---~~~~~~  243 (467)
                      ..+-|++.+.||.|.||.||+++++++++..|+||+...  ....+..|.+||+.+.+|||++.+++++..   .....+
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            357799999999999999999999999999999998764  356788899999999999999999988742   234678


Q ss_pred             EEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      +||||||.+|+.-++.+     ++.+.-+.+++++++.||.|||.+.+||||||=.|||++.++ .|||+|||++.....
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDS  175 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-cEEEeeeeeeeeeec
Confidence            99999999999877764     467888899999999999999999999999999999999665 799999999987643


Q ss_pred             CC-CcceeeeccCccCCcccccC-----CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         319 GQ-EYNVRVASRYFKGPELLADY-----QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       319 ~~-~~~~~~gt~~y~aPE~l~~~-----~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      +- ...+.+|||+|||||+++-.     .|+..+|.|..++.......|-.|++..-.       ......   ..+++.
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-------mraLF~---IpRNPP  245 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFL---IPRNPP  245 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-------hhhhcc---CCCCCC
Confidence            32 34557899999999999643     377788999888765554444444432110       000000   011111


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      .+.   .   .+.+-|.++.|||+.||.+|-.+||+..++|+|||+.+
T Consensus       246 PkL---k---rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  246 PKL---K---RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             ccc---c---chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            111   1   12234899999999999999999999999999999973

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.8e-33  Score=264.72  Aligned_cols=242  Identities=17%  Similarity=0.273  Sum_probs=189.5

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      +|++.+.||+|+||.||++.+..+++.+++|.++..    ..+.+.+|+.+++.++ |+||+.+.+.+.+.  ...+++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEAD--GHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEEC--CEEEEEE
Confidence            589999999999999999999999999999987532    2356778999999996 89999999988753  5789999


Q ss_pred             eccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-
Q psy3714         248 EHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-  321 (467)
Q Consensus       248 e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-  321 (467)
                      ||++++++.+...     .+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||++........ 
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC-cEEEcccCcceeecccccc
Confidence            9999999877653     368888999999999999999999999999999999998654 799999999986643222 


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      .....|++.|+|||++.+..++...|+|..+++......+..||....        ..........+..          .
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~----------~  218 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------WKNLILKVCQGSY----------K  218 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--------HHHHHHHHhcCCC----------C
Confidence            234568999999999988889999999988887665555555543211        1111110000000          0


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ..+..++.++++||.+||+.||++|||+++++.-
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            1123478899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.2e-33  Score=273.21  Aligned_cols=267  Identities=29%  Similarity=0.482  Sum_probs=187.8

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC---
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPV---  239 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~---  239 (467)
                      ...++|++.+.||+|+||.||+|.+..+++.+++|.+....     .....+|+++++.++ |+||+++.+.+....   
T Consensus         5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC-CCCccchhhheecccccc
Confidence            34689999999999999999999999999999999875321     235678999999996 799999988765432   


Q ss_pred             ---CCccEEEEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccc
Q psy3714         240 ---SRTPALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL  312 (467)
Q Consensus       240 ---~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGl  312 (467)
                         ....+++|+|+.+. +...+    ..+++..++.++.|++.||+|||++||+||||||+||+++.. +.+||+|||+
T Consensus        84 ~~~~~~~~lv~~~~~~~-l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~  161 (311)
T cd07866          84 KRKRGSVYMVTPYMDHD-LSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ-GILKIADFGL  161 (311)
T ss_pred             cccCceEEEEEecCCcC-HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECcCcc
Confidence               23468999998764 44333    248899999999999999999999999999999999999855 4799999999


Q ss_pred             ceecCCCC------------CcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCccc------
Q psy3714         313 AEFYHPGQ------------EYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHL------  373 (467)
Q Consensus       313 a~~~~~~~------------~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~------  373 (467)
                      ++......            ..+...+++.|+|||.+.+. .++.+.|+|..+++.+....+..++........      
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            97653211            12234678999999988764 478889999888776555444444321111000      


Q ss_pred             --CChhhhhhhhhhccCC----CCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         374 --VSPEALDFLDKNILGR----HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       374 --~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                        ..+....+........    .......... .......++++.|||++||+.||++|||+.|++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTL-EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccH-HHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence              0000000000000000    0000000000 00123356889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.5e-33  Score=277.80  Aligned_cols=247  Identities=20%  Similarity=0.276  Sum_probs=184.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEcc-----CCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQ-----SSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++.+.||+|+||.||+|....     +++.||+|+++...    .+.+.+|+.+++++.+|+||+.+.+.+... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~   84 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G   84 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence            4689999999999999999997543     45789999886421    245678999999997799999999887653 3


Q ss_pred             CccEEEEeccCCccHHHHhh------------------------------------------------------------
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ------------------------------------------------------------  260 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  260 (467)
                      ...+++|||++++++.+.+.                                                            
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            46789999999999876642                                                            


Q ss_pred             ----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC---cceeeeccCccC
Q psy3714         261 ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG  333 (467)
Q Consensus       261 ----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~a  333 (467)
                          .++...+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.......   .....++..|+|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCccccC
Confidence                356777889999999999999999999999999999999654 799999999986532221   122345678999


Q ss_pred             CcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHH
Q psy3714         334 PELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEAL  412 (467)
Q Consensus       334 PE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  412 (467)
                      ||++.+..++.+.|+|..+++.+.... +..|+.....    ............             ....+...++++.
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~----~~~~~~~~~~~~-------------~~~~~~~~~~~~~  306 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----DEEFCRRLKEGT-------------RMRAPEYATPEIY  306 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc----cHHHHHHHhccC-------------CCCCCccCCHHHH
Confidence            999999999999999988876544332 3333321100    011111111000             0111234688999


Q ss_pred             HHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         413 DFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       413 dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      +++.+||+.+|++|||++|+++|
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.5e-33  Score=273.85  Aligned_cols=246  Identities=17%  Similarity=0.221  Sum_probs=183.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCe--EEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDK--CVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++.+.||+|+||.||+|.+..++..  +++|.++..    ....+.+|++++.++.+|+||+++++.+..  ...
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~   82 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY   82 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCC
Confidence            347899999999999999999998877754  466665532    234577899999999779999999998865  356


Q ss_pred             cEEEEeccCCccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR  303 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~  303 (467)
                      .+++|||+++++|.+++.                   .+++.++..++.|++.||+|||++||+||||||+|||++.++ 
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~-  161 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-  161 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC-
Confidence            899999999999887653                   357788999999999999999999999999999999998655 


Q ss_pred             cEEEEecccceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhh
Q psy3714         304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFL  382 (467)
Q Consensus       304 ~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  382 (467)
                      .+||+|||++.............++..|+|||.+....++.++|+|..+++...... +..||....     ..+.....
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~~~~~  236 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEKL  236 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC-----hHHHHHHH
Confidence            799999999874322111112234567999999988888999999988876444332 333332111     00111100


Q ss_pred             hhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         383 DKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                          ....         ....+..+++++.+||.+||..||.+|||+++++++
T Consensus       237 ----~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         237 ----PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             ----hcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                0000         001123468899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-33  Score=269.03  Aligned_cols=258  Identities=19%  Similarity=0.275  Sum_probs=194.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .++|++++.||+|+||.||++.+..+++.+|+|++...    ..+.+.+|+++++.++ |+||+++.+.+...  ...++
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~l   80 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR-SPYIVSFYGAFLNE--NNICM   80 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcC-CCCcceEeeeEecC--CEEEE
Confidence            47899999999999999999999999999999987543    2356789999999995 89999999988764  56899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      ||||++++++.....   .++...+..++.|++.||.|||+ ++|+||||||+||+++.++ .++|+|||++....... 
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSI-  158 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchhhhc-
Confidence            999999999977653   47888899999999999999997 6999999999999998554 79999999987543221 


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCccc---CChhhhhhhhhhccCCCCccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHL---VSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      ....+||..|+|||++.+..++.++|+|..+++......+..||.......-   ............+...     ...+
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~  233 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-----PPRL  233 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----CCCC
Confidence            2235789999999999888889999999888765444444444432111000   0000111111111000     0000


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                          ....++.++.+||++||..||.+|||++|+++||||...
T Consensus       234 ----~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         234 ----PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             ----CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                011257899999999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.6e-33  Score=296.48  Aligned_cols=141  Identities=27%  Similarity=0.482  Sum_probs=124.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++++.||+|+||.||+|.+..+++.||||+++...      ...+.+|+.++..++ |+||+.++..+...  ...
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~--~~~   79 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSA--NNV   79 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEEC--CEE
Confidence            478999999999999999999999999999999986432      256788999998885 89999999887653  568


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccce
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE  314 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~  314 (467)
                      ++||||+.+++|..++.   .+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+++
T Consensus        80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g-~vkL~DFGls~  152 (669)
T cd05610          80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSK  152 (669)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence            99999999999987764   478888999999999999999999999999999999998655 79999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0664|consensus

Probab=100.00  E-value=1.7e-35  Score=264.09  Aligned_cols=269  Identities=26%  Similarity=0.452  Sum_probs=185.3

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC---c
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR---T  242 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~---~  242 (467)
                      .|.+--+.||.|+||+||.+.+..+++.|++|.+.+.     ..+++.+|+.+|...+ |.||....+..+-+...   .
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHH
Confidence            3445567899999999999999999999999988654     3578899999998886 78998888776544321   1


Q ss_pred             cEEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      .|.+.|.+ ..||...+   +.++.+.++-+++||+.||+|||+.||.||||||.|+|++ +++.+||||||+|+-.+..
T Consensus       132 iYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  132 LYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN-SNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec-cCceEEecccccccccchh
Confidence            23333433 23444433   3588899999999999999999999999999999999998 7789999999999976544


Q ss_pred             CC--cceeeeccCccCCcccccCC-CCccchhHHHh-----hhccccccccccccc---cCCcccCChh--hhhhhhh--
Q psy3714         320 QE--YNVRVASRYFKGPELLADYQ-YHIELDPRFAD-----ILGRHSRKRWERFVH---TENQHLVSPE--ALDFLDK--  384 (467)
Q Consensus       320 ~~--~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~-----~~~~~~~~~~~~~~~---~~~~~~~~~~--~~~~~~~--  384 (467)
                      +.  .+..+.|.||+|||++++.. |+.++|+|+.+     ++++..++.-.....   .....++++.  ......+  
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            33  45568899999999999876 89999999554     444433221110000   0001122221  1111111  


Q ss_pred             --hcc-CCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         385 --NIL-GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       385 --~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                        .++ +......+..+.....+..-..++.+++.+||..||.+|++.++++.|+|..+.+
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence              111 1111112222222222223356899999999999999999999999999987543

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.2e-33  Score=270.16  Aligned_cols=253  Identities=21%  Similarity=0.356  Sum_probs=196.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      .++|++++.||+|+||.||++.+..+++.+++|.+...   ....+.+|+.+++.++ ||||+.+++.+...  ...++|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~--~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK-HPNIVNYLDSYLVG--DELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcC-CCCeeehhheeeeC--CcEEEE
Confidence            47899999999999999999999889999999987532   2356788999999996 89999999988653  468999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-cc
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YN  323 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-~~  323 (467)
                      +||++++++.++..  .+++.++..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++....+... ..
T Consensus        95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-CEEEccCcceecccccccccc
Confidence            99999999988764  478888999999999999999999999999999999998654 799999999876543322 23


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      ...|++.|+|||.+.+..++...|.|..+++......+..||......        ...  .........      ....
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--------~~~--~~~~~~~~~------~~~~  237 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RAL--YLIATNGTP------ELQN  237 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--------hhe--eehhcCCCC------CCCC
Confidence            346889999999998888889999998887655544454444321110        000  000000000      0112


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      +..++++.++||++||..||.+|||++++++||||....
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            234688999999999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-33  Score=266.46  Aligned_cols=260  Identities=26%  Similarity=0.451  Sum_probs=187.8

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhc--CCCCeeEEEEEEeCCCC---Cc
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLR--GGTNIITLQAVVKDPVS---RT  242 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~--~~~~iv~l~~~~~~~~~---~~  242 (467)
                      |++.+.||+|+||.||+|.+..+++.+|+|.++..     ....+.+|+.+++.+.  .|+|++++.+.+.+...   ..
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            67899999999999999999888999999998632     1235667888888775  48999999998865422   23


Q ss_pred             cEEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         243 PALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      .+++|||+++ ++.++..     .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++..+.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~~~~  158 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLARIYS  158 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCcceecc
Confidence            7899999985 5655432     37889999999999999999999999999999999999966 579999999998765


Q ss_pred             CCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhcc---------C
Q psy3714         318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL---------G  388 (467)
Q Consensus       318 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~  388 (467)
                      .........++..|+|||.+.+..++.+.|+|..+++......+..++. .....   .....+.+....         .
T Consensus       159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR-GTSEA---DQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCccc-CCChH---HHHHHHHHHcCCCChHhcCCCc
Confidence            4444444568899999999998889999999988876554433322222 11100   000000000000         0


Q ss_pred             CCCccccccccc---ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         389 RHSRKRWERFVH---TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       389 ~~~~~~~~~~~~---~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ......+.....   ....+.+++++.+||.+||+.||.+|||++|+++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            000000000000   01112367899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.2e-33  Score=264.38  Aligned_cols=246  Identities=24%  Similarity=0.342  Sum_probs=190.6

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      +|+..+.||+|+||.||+|.+..+++.+++|.+...        ..+.+.+|+.+++.++ |+||+++.+.+.+.  ...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~--~~~   77 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREE--DNL   77 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecC--CeE
Confidence            367778999999999999999888999999987542        2246788999999995 89999999887653  568


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++++||++++++.+++.   .+++..+..++.|++.||.|||++||+|+||||+||+++.++ .+||+|||++.......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-VVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccceeccccc
Confidence            99999999999987764   377888889999999999999999999999999999998655 79999999998654433


Q ss_pred             CcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      ......|+..|+|||.+.... ++...|.|..+++......+..|+....       . ....... ...   ..     
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-------~-~~~~~~~-~~~---~~-----  219 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-------G-VAAVFKI-GRS---KE-----  219 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-------H-HHHHHHH-Hhc---cc-----
Confidence            334456899999999988776 8889999988876554444444432111       0 0100000 000   00     


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ....+..+++++++||++||..||.+|||++++++|||+
T Consensus       220 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         220 LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            011123578999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-33  Score=273.11  Aligned_cols=252  Identities=21%  Similarity=0.349  Sum_probs=194.8

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      +.|+....||+|+||.||+|.+..+++.+|+|.++..   ..+.+.+|+.+++.+. |+|++++.+.+...  ...+++|
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~--~~~~iv~   97 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVG--EELWVLM   97 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCC-CCchhhhhhheeeC--CeEEEEE
Confidence            4455566899999999999999989999999998542   2456788999999995 89999999887653  5689999


Q ss_pred             eccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-Ccce
Q psy3714         248 EHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNV  324 (467)
Q Consensus       248 e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~~~~  324 (467)
                      ||++++++..+..  .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....... ....
T Consensus        98 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659          98 EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             ecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-cEEEeechhHhhcccccccccc
Confidence            9999999987754  478899999999999999999999999999999999998655 79999999987553322 2334


Q ss_pred             eeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCC
Q psy3714         325 RVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQ  404 (467)
Q Consensus       325 ~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (467)
                      .+|+..|+|||++.+..++.+.|+|..+++......+..|+.....     .+.......     .....+      ...
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~-----~~~~~~------~~~  240 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-----VQAMKRLRD-----SPPPKL------KNA  240 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhc-----cCCCCc------ccc
Confidence            6789999999999888899999999888775554445445432211     011111100     000001      112


Q ss_pred             CCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         405 HLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       405 ~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ..+++++.+||++||+.||++|||++++++||||....
T Consensus       241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         241 HKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence            34688999999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8.2e-33  Score=262.48  Aligned_cols=253  Identities=21%  Similarity=0.346  Sum_probs=198.7

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+....    ...+.+|+.++..++ |+|++++.+.+...  ...+++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKE--GEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccC--CeEEEE
Confidence            47899999999999999999999999999999886542    456889999999997 89999999988764  568999


Q ss_pred             EeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc
Q psy3714         247 FEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       247 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~  322 (467)
                      |||+++++|.+...   .+++..+..++.|++.||+|||+ +|++||||+|+||+++..+ .++|+|||++.........
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecccCCCc
Confidence            99999999988764   48889999999999999999999 9999999999999998654 7999999999876443332


Q ss_pred             -ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         323 -NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       323 -~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                       ....++..|+|||.+....++...|.|..+++.+....+..|+.....     ........ .+...         ...
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~-~~~~~---------~~~  221 (264)
T cd06623         157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQ-AICDG---------PPP  221 (264)
T ss_pred             ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHH-HHhcC---------CCC
Confidence             245789999999999888889999999888775555444444322210     00111111 10000         000


Q ss_pred             cCCCC-CChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         402 ENQHL-VSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       402 ~~~~~-~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ..... +++.+.+||++||..+|++|||++|+++||||..++
T Consensus       222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            11122 688999999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-32  Score=261.54  Aligned_cols=248  Identities=22%  Similarity=0.348  Sum_probs=192.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      .+|++.+.||+|+||.||+|.+..+++.+++|.+...        ....+.+|+++++.++ |+||+++.+.+.+.....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence            5799999999999999999999999999999987421        1246788999999996 899999999887655566


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-  318 (467)
                      .++++||++++++.+.+.   .+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||+++.... 
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~  159 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECccccccccccc
Confidence            889999999999887754   477888999999999999999999999999999999998554 799999999986532 


Q ss_pred             ---CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         319 ---GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       319 ---~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                         ........|+..|+|||.+.+..++.+.|+|..+++......+..||....       ....... . .....    
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~-~-~~~~~----  226 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-------AMAAIFK-I-ATQPT----  226 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-------HHHHHHH-H-HcCCC----
Confidence               111233468999999999988888899999988877555444544442110       0111111 1 00000    


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                          ....+..++++++|||++||+ +|.+|||+.+++.|||.
T Consensus       227 ----~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         227 ----KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ----CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                011234578999999999999 67999999999999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.2e-33  Score=277.67  Aligned_cols=263  Identities=19%  Similarity=0.261  Sum_probs=181.2

Q ss_pred             Eeeccc--CCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         177 RKLGRG--KYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       177 ~~lG~G--~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      ..||+|  +||+||+|.+..+++.||+|+++...     .+.+.+|+.+++.++ |+||+++++++...  ...+++|||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~--~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTG--SWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecC--CceEEEEec
Confidence            456666  99999999999999999999986422     245778999888885 89999999998764  467999999


Q ss_pred             cCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-CCCc-
Q psy3714         250 VNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEY-  322 (467)
Q Consensus       250 ~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~~~~-  322 (467)
                      +.++++..++.     .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+|++|||.+..... +... 
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhccCcccc
Confidence            99999877654     377888899999999999999999999999999999998655 799999985532211 1110 


Q ss_pred             ------ceeeeccCccCCcccccC--CCCccchhHHHhhhccccccccccccccCCccc-----CCh------------h
Q psy3714         323 ------NVRVASRYFKGPELLADY--QYHIELDPRFADILGRHSRKRWERFVHTENQHL-----VSP------------E  377 (467)
Q Consensus       323 ------~~~~gt~~y~aPE~l~~~--~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~------------~  377 (467)
                            ....++..|+|||++.+.  .|+..+|+|..+++......+..||........     ..+            .
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                  112345679999999764  478889999877665444444444322110000     000            0


Q ss_pred             hhhh------hhhhccCCCCccccccc-----ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         378 ALDF------LDKNILGRHSRKRWERF-----VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       378 ~~~~------~~~~~~~~~~~~~~~~~-----~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      ...+      .+..+........+...     ...+.....+++++|||++||++||++|||++|+|+||||..+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence            0000      00000000000000000     011112236789999999999999999999999999999976653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7e-33  Score=261.62  Aligned_cols=245  Identities=22%  Similarity=0.362  Sum_probs=192.3

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++.+.||+|+||.||++.+..+++.+++|.+...     ....+.+|+++++.++ |+|++.+.+.+...  ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~--~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFEEK--GKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC-CCChhheEEEEecC--CEEEEE
Confidence            588999999999999999999989999999998643     3456788999999997 89999999887654  578999


Q ss_pred             EeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         247 FEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      +|+++++++.+.+.       .+++..+..++.|++.||.|||++|++|+||+|+||+++..+ .++|+|||++......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~  156 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSST  156 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC-cEEECCccceeecccC
Confidence            99999999877653       377889999999999999999999999999999999998554 7999999999876433


Q ss_pred             C-CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         320 Q-EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       320 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      . ......|++.|+|||.+.+..++...|.|..+++......+..++....        ........ ..    ..+.  
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~-~~----~~~~--  221 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKI-LK----GQYP--  221 (258)
T ss_pred             cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHH-hc----CCCC--
Confidence            2 2233578999999999988889999999988876444333333332111        01111110 00    0011  


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                         ..+..++.++.++|.+||..||.+|||++|+|+||||
T Consensus       222 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         222 ---PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence               1122468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5e-33  Score=295.42  Aligned_cols=244  Identities=19%  Similarity=0.287  Sum_probs=185.7

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++..      ..+++.+|+++++.++ ||||+.+++.+.+.  ...+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~--~~ly   78 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDG--DPVY   78 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeC--CEEE
Confidence            5799999999999999999999999999999998642      2356788999999996 89999999988753  5689


Q ss_pred             EEEeccCCccHHHHhhc--------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEec
Q psy3714         245 LIFEHVNNTDFKQLYQT--------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW  310 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~~--------------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DF  310 (467)
                      ++|||+++++|.+++..              ++...+..++.||+.||+|||++||+||||||+|||++..+ .+||+||
T Consensus        79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-~vKLiDF  157 (932)
T PRK13184         79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG-EVVILDW  157 (932)
T ss_pred             EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC-CEEEEec
Confidence            99999999999876532              23345678899999999999999999999999999998655 7999999


Q ss_pred             ccceecCCCC-------------------CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCc
Q psy3714         311 GLAEFYHPGQ-------------------EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQ  371 (467)
Q Consensus       311 Gla~~~~~~~-------------------~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~  371 (467)
                      |+|+......                   .....+||+.|+|||++.+..++.++|+|..+++......+..||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9998652100                   011246999999999999989999999998888766655565555321110


Q ss_pred             ccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         372 HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                              ...........        ........+++.+.+++.+||..||++|++..+.+.
T Consensus       238 --------ki~~~~~i~~P--------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        238 --------KISYRDVILSP--------IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             --------hhhhhhhccCh--------hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                    00000000000        000111247889999999999999999997665554

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=263.69  Aligned_cols=251  Identities=22%  Similarity=0.352  Sum_probs=192.1

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhc--CCCCeeEEEEEEeCCCCCccEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLR--GGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~--~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .|++++.||+|+||.||+|.+..+++.+++|.++..    ....+.+|+.+++.+.  .|+|++.+.+.+..  ....++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence            478889999999999999999999999999987642    2346788999999996  48999999988765  346799


Q ss_pred             EEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-Cc
Q psy3714         246 IFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EY  322 (467)
Q Consensus       246 v~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~~  322 (467)
                      +|||+++++|.++..  .+++..+..++.|++.||.|||++||+||||+|+||+++.++ .++|+|||++....... ..
T Consensus        80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-CEEEccCCceeecCCCcccc
Confidence            999999999887654  477888999999999999999999999999999999999654 79999999998764332 22


Q ss_pred             ceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         323 NVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....|+..|+|||.+.+. .++...|.|..+++......+..|+....        .......  ........+      
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~--------~~~~~~~--~~~~~~~~~------  222 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD--------AFRAMML--IPKSKPPRL------  222 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC--------hhhhhhc--cccCCCCCC------
Confidence            334689999999998654 46888999988876554444444432111        0000000  000000000      


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                       .....++++.+|+++||+.||++|||+.|+++||||....
T Consensus       223 -~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         223 -EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             -CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence             0112678999999999999999999999999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=9e-33  Score=266.19  Aligned_cols=257  Identities=27%  Similarity=0.397  Sum_probs=192.3

Q ss_pred             ceeeeEeecccCCcceEEEEEc---cCCCeEEEEEeccch-------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINV---QSSDKCVVKILKPVK-------KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~-------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      +|++.+.||+|+||.||++.+.   .++..+|+|.++...       ...+.+|+.+++.+.+|+||+.+...+...  .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--T   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--C
Confidence            4889999999999999999864   456789999886421       245678999999998899999998887653  4


Q ss_pred             ccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      ..++||||+.++++.....   .+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++....
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~  157 (288)
T cd05583          79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-HVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEEECcccccccc
Confidence            6789999999999877653   477889999999999999999999999999999999998654 799999999886543


Q ss_pred             CCC--cceeeeccCccCCcccccCC--CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         319 GQE--YNVRVASRYFKGPELLADYQ--YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       319 ~~~--~~~~~gt~~y~aPE~l~~~~--~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ...  .....|+..|+|||.+.+..  ++...|+|..+++......+..|+......  ..  ..... ......     
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~--~~~~~-~~~~~~-----  227 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NS--QSEIS-RRILKS-----  227 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--ch--HHHHH-HHHHcc-----
Confidence            322  12245889999999987654  677899998777654444444443211100  00  00111 111000     


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCC---HHHHhCCCCCCCcccccc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLT---AREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~t---a~e~l~Hp~f~~~~~~~~  446 (467)
                           ....+..+++++++||.+||+.||++|||   ++++|+||||..+.|+..
T Consensus       228 -----~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~  277 (288)
T cd05583         228 -----KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL  277 (288)
T ss_pred             -----CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHH
Confidence                 01122347889999999999999999998   577899999999988644

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG4645|consensus

Probab=100.00  E-value=2e-34  Score=302.86  Aligned_cols=252  Identities=22%  Similarity=0.318  Sum_probs=196.3

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      -+++-...||.|.||.||-|.+..+|...|+|-++-..     -+.+.+|..+|+.++ |||+|+++++-.+.  ..+++
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHR--ekv~I 1311 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHR--EKVYI 1311 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc-CccccccCceeecH--HHHHH
Confidence            34556678999999999999999999999999765321     245789999999996 89999999986653  45789


Q ss_pred             EEeccCCccHHHHhhc---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC--
Q psy3714         246 IFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~~---~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~--  320 (467)
                      .||||.+|+|..+.+.   .++.-.+.|..|++.|+.|||++|||||||||+||+|+..| .+|+.|||.|....+..  
T Consensus      1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cEEeecccceeEecCchhc
Confidence            9999999999887653   56666788999999999999999999999999999999655 89999999998765332  


Q ss_pred             ---CcceeeeccCccCCcccccC---CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         321 ---EYNVRVASRYFKGPELLADY---QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       321 ---~~~~~~gt~~y~aPE~l~~~---~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                         .....+||+.|||||+|.+.   +...+.|+|..+.+-..+..|..||....++       +.++..--.+..    
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~gh~---- 1459 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAGHK---- 1459 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhccCC----
Confidence               23457899999999999764   4667789998887766666666665432211       111111111111    


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                            ++.|..+|++++|||.+||+-||++|.||.|+|+|.|-+....
T Consensus      1460 ------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1460 ------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred             ------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence                  1223458999999999999999999999999999999765443

>KOG1290|consensus

Probab=100.00  E-value=7.6e-33  Score=264.93  Aligned_cols=129  Identities=29%  Similarity=0.511  Sum_probs=110.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCC-------CCeeEEEEEEe--CC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGG-------TNIITLQAVVK--DP  238 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~-------~~iv~l~~~~~--~~  238 (467)
                      ..+|.++++||-|-|++||+|.|.++.+.||+|+++..  ..+....||.+|+.++.+       ..||+|.+.|.  .+
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            37899999999999999999999999999999999864  457788999999988743       36999998874  56


Q ss_pred             CCCccEEEEeccCCccHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEe
Q psy3714         239 VSRTPALIFEHVNNTDFKQLY-----QTLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMID  299 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~  299 (467)
                      +..+++||+|++.. +|..++     +.++...++.+++|||.||.|||+ .||||-||||+|||+.
T Consensus       157 NG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  157 NGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            67789999998854 444433     468999999999999999999996 5999999999999984

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.2e-33  Score=269.87  Aligned_cols=244  Identities=15%  Similarity=0.233  Sum_probs=182.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCe----EEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDK----CVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      ...+|++.+.||+|+||.||+|.+..++..    ||+|.++..    ..+.+.+|+.+++.+. |+||+++++.+...  
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~--   81 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS--   81 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC--
Confidence            457899999999999999999987766554    899988643    2356778999999995 89999999988653  


Q ss_pred             CccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                       ..+++++|++++++.+...    .++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-~~kl~DfG~a~~~  159 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL  159 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-cEEEccccccccc
Confidence             4689999999999887654    367778889999999999999999999999999999998554 7999999999876


Q ss_pred             CCCCCcc---eeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         317 HPGQEYN---VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       317 ~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      .......   ...++..|+|||.+.+..++.++|+|..+++.+.... +..|+....     ..+........       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-----~~~~~~~~~~~-------  227 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEKG-------  227 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHhCC-------
Confidence            4333211   1234567999999998889999999988876443222 233321110     00111111000       


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                            ...+.+...+.++.+++.+|+..||.+|||+.+++.+
T Consensus       228 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         228 ------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                  0011123467899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-33  Score=265.62  Aligned_cols=257  Identities=30%  Similarity=0.540  Sum_probs=187.8

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      |++++.||.|++|.||+|.+..++..+++|.+....     ...+.+|+++++.++ |+|++++.+.+.+.  ...+++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~--~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN-HPNIVRLLDVVHSE--NKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC-CCCccCHhheeccC--CeEEEEE
Confidence            678899999999999999999999999999886431     245778999999996 89999999988754  5789999


Q ss_pred             eccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CC
Q psy3714         248 EHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QE  321 (467)
Q Consensus       248 e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~  321 (467)
                      ||++ +++.++..     .+++..+..++.|++.||+|||+++++||||+|+||+++.+ +.++|+|||++...... ..
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CcEEEeecccccccCCCccc
Confidence            9996 46766543     36788899999999999999999999999999999999964 57999999999765322 22


Q ss_pred             cceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhh----------hc--cC
Q psy3714         322 YNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK----------NI--LG  388 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~--~~  388 (467)
                      .....++..|+|||++.+. .++...|+|..+++......+..+|......    .........          ..  ..
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI----DQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCChHHhhhhhhch
Confidence            3334678999999988765 4688899998887765554444443221100    000000000          00  00


Q ss_pred             --CCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         389 --RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       389 --~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                        ......+.........+.+++++.+||.+||+.||++|||++|+++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence              00000010000111234578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.2e-33  Score=268.68  Aligned_cols=244  Identities=17%  Similarity=0.225  Sum_probs=181.7

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCC--eEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSD--KCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++.+.||+|+||.||+|....++.  .+++|.++..    ..+.+.+|++++.++.+||||+++.+.+...  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccce
Confidence            689999999999999999999877664  4688877642    2346788999999997799999999987653  4689


Q ss_pred             EEEeccCCccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcE
Q psy3714         245 LIFEHVNNTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKL  305 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~i  305 (467)
                      ++|||++++++.+++.                   .+++..+..++.|++.||+|||++||+||||||+|||++.+ ..+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~  158 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN-LAS  158 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC-CeE
Confidence            9999999999877653                   26677889999999999999999999999999999999855 479


Q ss_pred             EEEecccceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhh
Q psy3714         306 RLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDK  384 (467)
Q Consensus       306 kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  384 (467)
                      ||+|||++..............+..|+|||.+....++.++|+|..+++.+.... +..||.....     .........
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----~~~~~~~~~  233 (297)
T cd05089         159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----AELYEKLPQ  233 (297)
T ss_pred             EECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHhc
Confidence            9999999864321111111223456999999988889999999988876544332 3333321110     011110000


Q ss_pred             hccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      .             .....+..+++++++||.+||..||.+|||++++++.
T Consensus       234 ~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 G-------------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             C-------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0             0111223478999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.8e-33  Score=266.62  Aligned_cols=250  Identities=22%  Similarity=0.330  Sum_probs=194.3

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..|+.++.||+|+||.||+|.+..++..+|+|.++...    ...+.+|+.+++.+. |+||+.+.+.+.+.  ...++|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKG--TKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEC--CEEEEE
Confidence            46888899999999999999999899999999886432    346788999999995 89999999988764  468999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-cc
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YN  323 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-~~  323 (467)
                      |||+.++++.++..  .+++.++..++.|++.||+|||+++++|+||+|+||+++.++ .++|+|||++........ ..
T Consensus        81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-CEEEcccccceeccCCccccc
Confidence            99999999887654  478888999999999999999999999999999999998654 799999999976543322 23


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      ...++..|+|||.+.+..++.+.|.|..+++......+..|+.....        ..... .+ ....        ....
T Consensus       160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--------~~~~~-~~-~~~~--------~~~~  221 (277)
T cd06640         160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP--------MRVLF-LI-PKNN--------PPTL  221 (277)
T ss_pred             cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh--------HhHhh-hh-hcCC--------CCCC
Confidence            34688899999999888889999999888776554444444321110        00000 00 0000        0011


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ...++.++.+||.+||+.||++|||++++++||||....
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             chhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence            123578899999999999999999999999999997543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.1e-33  Score=266.24  Aligned_cols=252  Identities=21%  Similarity=0.339  Sum_probs=194.0

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ..|...+.||+|++|.||++.+..+++.+++|.++..   ..+.+.+|+.+++.+. |+||+.+.+.+...  ...++++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~--~~~~~v~   95 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVG--DELWVVM   95 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcC-CCChheEEEEEEcC--CeEEEEE
Confidence            4566678999999999999999989999999987532   2345788999999985 89999999987653  5679999


Q ss_pred             eccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-Ccce
Q psy3714         248 EHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNV  324 (467)
Q Consensus       248 e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~~~~  324 (467)
                      ||+.++++.+...  .++..++..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++....... ....
T Consensus        96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~  174 (285)
T cd06648          96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVPRRKS  174 (285)
T ss_pred             eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-cEEEcccccchhhccCCccccc
Confidence            9999999987764  478888999999999999999999999999999999998554 79999999887543221 1223


Q ss_pred             eeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCC
Q psy3714         325 RVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQ  404 (467)
Q Consensus       325 ~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (467)
                      ..|+..|+|||.+.+..++.+.|+|..+++......+..++....        ...... .+... ..      ......
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--------~~~~~~-~~~~~-~~------~~~~~~  238 (285)
T cd06648         175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--------PLQAMK-RIRDN-LP------PKLKNL  238 (285)
T ss_pred             ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--------HHHHHH-HHHhc-CC------CCCccc
Confidence            468999999999988889999999988877655555444443211        001110 00000 00      001112


Q ss_pred             CCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         405 HLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       405 ~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ..+++++.+||++||..||++|||+.++++||||....
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence            23788999999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.4e-33  Score=272.06  Aligned_cols=261  Identities=26%  Similarity=0.437  Sum_probs=187.9

Q ss_pred             ccceee-eEeecccCCcceEEEEEccCCCeEEEEEeccchH-----------------HHHHHHHHHHHHhcCCCCeeEE
Q psy3714         170 QDDYQL-VRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK-----------------KKIKREIKILENLRGGTNIITL  231 (467)
Q Consensus       170 ~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----------------~~~~~Ei~il~~l~~~~~iv~l  231 (467)
                      .++|.. .+.||+|+||.||+|.+..+++.||+|.++....                 ..+.+|+++++.++ |+||+.+
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~   85 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMGL   85 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccceeee
Confidence            466765 4679999999999999999999999998864321                 13678999999996 8999999


Q ss_pred             EEEEeCCCCCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEE
Q psy3714         232 QAVVKDPVSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLI  308 (467)
Q Consensus       232 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~  308 (467)
                      .+.+...  ...+++|||+.+ ++.+.+.   .+++..+..++.|++.||+|||++||+||||||+||+++..+ .+||+
T Consensus        86 ~~~~~~~--~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~-~~kl~  161 (335)
T PTZ00024         86 VDVYVEG--DFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG-ICKIA  161 (335)
T ss_pred             eEEEecC--CcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC-CEEEC
Confidence            9988653  568999999974 6666553   478899999999999999999999999999999999998654 79999


Q ss_pred             ecccceecCC---------------CCCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcc
Q psy3714         309 DWGLAEFYHP---------------GQEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQH  372 (467)
Q Consensus       309 DFGla~~~~~---------------~~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~  372 (467)
                      |||++.....               ........++..|+|||.+.+.. ++...|+|..+++......+..++...... 
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-  240 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI-  240 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence            9999976541               11122345788999999987654 688899998887655544444443221110 


Q ss_pred             cCChhhhhhhhhhccCCCCcccccc---------cc------cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q psy3714         373 LVSPEALDFLDKNILGRHSRKRWER---------FV------HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY  437 (467)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~------~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~  437 (467)
                          +....... ..+......|..         +.      ........++++.+||.+||..||.+|||++|+|.|||
T Consensus       241 ----~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        241 ----DQLGRIFE-LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             ----HHHHHHHH-HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence                00000000 000000000100         00      00111245889999999999999999999999999999


Q ss_pred             CCCc
Q psy3714         438 FYPI  441 (467)
Q Consensus       438 f~~~  441 (467)
                      |...
T Consensus       316 ~~~~  319 (335)
T PTZ00024        316 FKSD  319 (335)
T ss_pred             cCCC
Confidence            9753

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.2e-32  Score=267.06  Aligned_cols=260  Identities=26%  Similarity=0.509  Sum_probs=188.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC-----
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPV-----  239 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~-----  239 (467)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.++...     ...+.+|+++++.++ ||||+++++++.+..     
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhhhc
Confidence            478999999999999999999999999999999986432     245678999999995 899999998876532     


Q ss_pred             ---CCccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccc
Q psy3714         240 ---SRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL  312 (467)
Q Consensus       240 ---~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGl  312 (467)
                         ....++++||+++. +.....    .+++..+..++.|++.||.|||++||+||||||+||+++..+ .+||+|||+
T Consensus        85 ~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~kl~dfg~  162 (302)
T cd07864          85 KKDKGAFYLVFEYMDHD-LMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGL  162 (302)
T ss_pred             cccCCcEEEEEcccCcc-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-cEEeCcccc
Confidence               23679999999874 433332    478899999999999999999999999999999999998554 799999999


Q ss_pred             ceecCCCC--CcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCC
Q psy3714         313 AEFYHPGQ--EYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGR  389 (467)
Q Consensus       313 a~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (467)
                      +.......  .+....++..|+|||.+.+. .++.+.|+|..+++......+..++.....     ......+... .+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-----~~~~~~~~~~-~~~  236 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-----LAQLELISRL-CGS  236 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHH-hCC
Confidence            98664332  22334578889999988654 468889999887765443334333321110     0000000000 000


Q ss_pred             CCccccccc-----------------ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         390 HSRKRWERF-----------------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       390 ~~~~~~~~~-----------------~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      .....|...                 ........+++++++||.+||..||.+|||+++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            000000000                 0001123478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-33  Score=277.70  Aligned_cols=266  Identities=27%  Similarity=0.488  Sum_probs=192.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC---
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS---  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~---  240 (467)
                      -.++|++.+.||+|+||.||+|.+..+++.||+|.+...     ....+.+|+.+++.+. |+|++.+.+.+.....   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhccccccc
Confidence            357899999999999999999999999999999987642     2245678999999995 8999988876643221   


Q ss_pred             -CccEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         241 -RTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       241 -~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                       ...++|++|+ ++++.++..  .+++.++..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~~~  169 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARHTD  169 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEcccccccccc
Confidence             3478999998 457776653  588999999999999999999999999999999999998654 79999999998654


Q ss_pred             CCCCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcc--------cC--Chhhhhhhhhh-
Q psy3714         318 PGQEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQH--------LV--SPEALDFLDKN-  385 (467)
Q Consensus       318 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~~--~~~~~~~~~~~-  385 (467)
                      ..  .....+|..|+|||.+... .++.+.|+|..+++......+..+|.......        ..  .+....-.... 
T Consensus       170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07851         170 DE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES  247 (343)
T ss_pred             cc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence            32  3445688999999998654 57888999988876554444444432211100        00  00000000000 


Q ss_pred             ---c---cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         386 ---I---LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       386 ---~---~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                         .   ........+.     ......|+++.|||++||..||++|||+.|+++||||.....+
T Consensus       248 ~~~~~~~~~~~~~~~~~-----~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         248 ARNYIQSLPQMPKKDFK-----EVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             HHHHHHhccccCCCCHH-----HHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence               0   0000000010     1112358999999999999999999999999999999875443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.8e-32  Score=258.75  Aligned_cols=249  Identities=27%  Similarity=0.387  Sum_probs=195.7

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++.+.||+|++|.||+|.+..+++.+++|.++...     .+.+.+|+.+++++. |+||+.+.+.+.+......+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEEE
Confidence            4788899999999999999999899999999886543     456789999999996 8999999988876433568999


Q ss_pred             EeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC--
Q psy3714         247 FEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~--  321 (467)
                      +|+++++++.++..   .+++.++..++.|++.||.|||++|++|+||+|+||+++.. +.+||+|||.+........  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEcccccEEecccccccc
Confidence            99999999887764   47888999999999999999999999999999999999964 4799999999987654432  


Q ss_pred             -cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         322 -YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       322 -~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                       .....++..|+|||.+....++.+.|+|..+++......+..++....+       ....... ...   ...     .
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~-~~~---~~~-----~  222 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYK-IGS---SGE-----P  222 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHh-ccc---cCC-----C
Confidence             3345688999999999888889999999888775554444444422110       0000000 000   000     0


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ...+..+++++++||.+||+.||.+|||+.|+++||||
T Consensus       223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            11223468999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-33  Score=266.09  Aligned_cols=255  Identities=34%  Similarity=0.570  Sum_probs=188.6

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      |++.+.||+|++|.||+|.+..+++.+++|.++...     ...+.+|+++++.++ |+||+++++.+.+.  ...++++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKLLDVFRHK--GDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCcchHHHhhccC--CCEEEEE
Confidence            678899999999999999999899999999886532     346778999999996 89999999987754  5689999


Q ss_pred             eccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-Cc
Q psy3714         248 EHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EY  322 (467)
Q Consensus       248 e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~~  322 (467)
                      ||+.+ ++.+.+.    .+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||.+....... ..
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~~  155 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPY  155 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcccc
Confidence            99986 5554432    57888999999999999999999999999999999999855 479999999998765433 33


Q ss_pred             ceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc-
Q psy3714         323 NVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH-  400 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  400 (467)
                      ....++..|+|||.+.+. .++.+.|+|..+++......+..+|.. .+.    .+....... ..+......|..+.. 
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~-~~~----~~~~~~~~~-~~~~~~~~~~~~~~~~  229 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG-KSE----IDQLFKIFR-TLGTPDPEVWPKFTSL  229 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CCH----HHHHHHHHH-HcCCCchHhcccchhh
Confidence            445688999999999876 688899999888765544444333321 110    000000000 000000000000000 


Q ss_pred             ----------------ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         401 ----------------TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       401 ----------------~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                                      ....+.+++++++||.+||+.||.+||+++++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                            01123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.6e-33  Score=266.30  Aligned_cols=244  Identities=15%  Similarity=0.243  Sum_probs=185.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCC-----CeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSS-----DKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++++.||+|+||.||+|.....+     ..+++|.++...    ...+.+|+.+++.++ |+||+.+.+.+.+.  
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~--   80 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKE--   80 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCC--
Confidence            368999999999999999999876554     679999886432    345788999999995 89999999988653  


Q ss_pred             CccEEEEeccCCccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE  301 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~  301 (467)
                      ...+++|||++++++.+++.                   .++...+..++.|++.||.|||++||+||||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            46789999999999887653                   25667888999999999999999999999999999999855


Q ss_pred             CCcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChh
Q psy3714         302 NRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPE  377 (467)
Q Consensus       302 ~~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  377 (467)
                      + .+||+|||+++.......   .....+++.|+|||.+.+..++.+.|+|..+++.+.... +..|+.....     .+
T Consensus       161 ~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-----~~  234 (283)
T cd05048         161 L-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-----QE  234 (283)
T ss_pred             C-cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-----HH
Confidence            4 799999999986533221   223456888999999988889999999988876544332 3344332111     11


Q ss_pred             hhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ....    +....         ....+...++++.+|+.+|++.||++|||+.|+++|
T Consensus       235 ~~~~----i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         235 VIEM----IRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHH----HHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1111    11000         001123578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1e-32  Score=272.71  Aligned_cols=247  Identities=21%  Similarity=0.324  Sum_probs=181.5

Q ss_pred             ccceeeeEeecccCCcceEEEEE-----ccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAIN-----VQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++.+.||+|+||.||+|.+     ..+++.||||.++...    ...+.+|+.++..+.+|+||+++.+.+... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-C
Confidence            47899999999999999999984     3456789999986422    245778999999998899999999877543 3


Q ss_pred             CccEEEEeccCCccHHHHhh------------------------------------------------------------
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ------------------------------------------------------------  260 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  260 (467)
                      ...+++|||+++++|.++..                                                            
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            46789999999999876542                                                            


Q ss_pred             ----------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc---ceeee
Q psy3714         261 ----------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY---NVRVA  327 (467)
Q Consensus       261 ----------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~---~~~~g  327 (467)
                                .++..++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.........   ....+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCCCCC
Confidence                      145566778999999999999999999999999999998554 7999999999865322211   11234


Q ss_pred             ccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         328 SRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       328 t~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      +..|+|||.+.+..++.+.|+|..+++...... +..|+....     ...  .+.. ..... .        ....+..
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~--~~~~-~~~~~-~--------~~~~~~~  306 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-----IDE--EFCR-RLKEG-T--------RMRAPDY  306 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc-----ccH--HHHH-HHhcc-C--------CCCCCCC
Confidence            567999999988889999999987765433221 222221110     000  0000 00000 0        0111234


Q ss_pred             CChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         407 VSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      .++++.+++.+|+..||++|||+.|+++|
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            68899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2e-32  Score=274.86  Aligned_cols=246  Identities=22%  Similarity=0.275  Sum_probs=181.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEccC-----CCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQS-----SDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++.+.||+|+||.||+|.+...     +..||||.++...    .+.+.+|+++|+.+..||||+++.+.+.+. 
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-  113 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-  113 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-
Confidence            357899999999999999999987433     3469999986432    356789999999997799999999988653 


Q ss_pred             CCccEEEEeccCCccHHHHhh-----------------------------------------------------------
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ-----------------------------------------------------------  260 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~-----------------------------------------------------------  260 (467)
                       ...++||||+++++|.+++.                                                           
T Consensus       114 -~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         114 -GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             -CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence             56899999999999876542                                                           


Q ss_pred             ----------------------------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC
Q psy3714         261 ----------------------------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH  300 (467)
Q Consensus       261 ----------------------------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~  300 (467)
                                                              .++..++..++.|++.||.|||++||+||||||+|||++.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~  272 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence                                                    1455667789999999999999999999999999999996


Q ss_pred             CCCcEEEEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCCh
Q psy3714         301 ENRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSP  376 (467)
Q Consensus       301 ~~~~ikl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  376 (467)
                      ++ .+||+|||+++........   ....++..|+|||.+.+..++.++|+|..+++...... +..|+....    ...
T Consensus       273 ~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~----~~~  347 (400)
T cd05105         273 GK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI----VDS  347 (400)
T ss_pred             CC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc----hhH
Confidence            54 7999999999865332221   22346778999999998889999999988876443221 223322110    000


Q ss_pred             hhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ....    .+....         ....+..+++++++||.+||+.||++|||+.++.+
T Consensus       348 ~~~~----~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         348 TFYN----KIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHH----HHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            0111    010000         01112347889999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0197|consensus

Probab=100.00  E-value=5e-33  Score=271.04  Aligned_cols=239  Identities=21%  Similarity=0.338  Sum_probs=188.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .+.+.+++.||+|.||.|+.|.... ...||+|.++..  ..+.+.+|+++|++|+ |+|||++++++...  ..+||||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~--~piyIVt  280 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLR-HEKLVKLYGVCTKQ--EPIYIVT  280 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCc-ccCeEEEEEEEecC--CceEEEE
Confidence            3567788999999999999998754 357999998863  3467789999999997 89999999999864  3689999


Q ss_pred             eccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc
Q psy3714         248 EHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       248 e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~  322 (467)
                      ||+..|+|.++++     .+...+...++.||++|++||+++++|||||...|||++.+. .+||+|||||+.. .++.+
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~-~d~~Y  358 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL-VVKISDFGLARLI-GDDEY  358 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc-eEEEccccccccc-CCCce
Confidence            9999999988875     367788999999999999999999999999999999999554 8999999999944 34445


Q ss_pred             ceeeec---cCccCCcccccCCCCccchhHHHhhhccccccccccccccC--CcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         323 NVRVAS---RYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTE--NQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       323 ~~~~gt---~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      +...|+   ..|.|||.+....++.++|+|+.+++.      |+.+..+.  .......+....++..            
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL------~E~fT~G~~py~~msn~ev~~~le~G------------  420 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLL------WELFTYGRVPYPGMSNEEVLELLERG------------  420 (468)
T ss_pred             eecCCCCCCceecCHHHHhhCCcccccceeehhhhH------HHHhccCCCCCCCCCHHHHHHHHhcc------------
Confidence            544443   349999999999999999999888863      33332221  1122223333333322            


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHh
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM  433 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l  433 (467)
                       ...+.|+..+++..+++..|-..+|++|||.+.+.
T Consensus       421 -yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  421 -YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             -CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence             12234567899999999999999999999987554

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.9e-33  Score=269.39  Aligned_cols=250  Identities=22%  Similarity=0.316  Sum_probs=192.5

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +.|+.++.||+|+||.||+|.+..++..+|+|.++...    .+.+.+|+.+++.+. |+||+.+.+.+...  ...++|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv   80 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKG--TKLWII   80 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCC-CCccHhhhcccccC--CceEEE
Confidence            45778889999999999999998889999999876332    346788999999995 89999999988653  468999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-cc
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YN  323 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-~~  323 (467)
                      |||++++++.+...  .+++..+..++.|++.|+.|||++||+|+||||+||+++.++ .+||+|||++........ ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-CEEEccccccccccCcchhhh
Confidence            99999999887764  478888999999999999999999999999999999998554 799999999986543221 22


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      ...|+..|+|||.+.+..++.+.|.|..+++......+..|+......     .......     ..   ..     ...
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~~-----~~---~~-----~~~  221 (277)
T cd06642         160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----RVLFLIP-----KN---SP-----PTL  221 (277)
T ss_pred             cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----hHHhhhh-----cC---CC-----CCC
Confidence            345889999999999888899999998887655444444333211100     0000000     00   00     001


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ....+.++.|||.+||..||.+|||+.|+++||||....
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            123678999999999999999999999999999997543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.9e-32  Score=260.14  Aligned_cols=248  Identities=26%  Similarity=0.394  Sum_probs=190.9

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++.+.||+|+||.||+|.+..+++.+++|.++..     ..+.+.+|+.+++.++ |+||+.+.+...+  ....+++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~--~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLVKYYGVEVH--REKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC-CCChhheeeeEec--CCEEEEE
Confidence            488999999999999999999889999999998643     2356789999999995 7999999988754  3568999


Q ss_pred             EeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC--
Q psy3714         247 FEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~--  321 (467)
                      +||+.++++.+...   .+++..+..++.|++.||.|||++||+|+||||+||+++.. +.+||+|||++........  
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEcccccccccCCCCCcc
Confidence            99999999988764   37788889999999999999999999999999999999964 4799999999886543222  


Q ss_pred             ---cceeeeccCccCCcccccCC---CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         322 ---YNVRVASRYFKGPELLADYQ---YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       322 ---~~~~~gt~~y~aPE~l~~~~---~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                         .....++..|+|||.+.+..   ++...|+|..+++......+..||.....     .....+.   +.. ...   
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-----~~~~~~~---~~~-~~~---  224 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----EFQIMFH---VGA-GHK---  224 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-----hHHHHHH---Hhc-CCC---
Confidence               11245788999999998766   78889999888765555445445432110     0000000   000 000   


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                         ...+....+++++.+||.+||+.||.+|||++|+++|||+
T Consensus       225 ---~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         225 ---PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             ---CCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence               0011122468999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-32  Score=263.38  Aligned_cols=255  Identities=19%  Similarity=0.249  Sum_probs=185.0

Q ss_pred             cce-eeeEeecccCCcceEEEE----EccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         171 DDY-QLVRKLGRGKYSEVFEAI----NVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       171 ~~y-~~~~~lG~G~~g~V~~~~----~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ++| ++++.||+|+||+||++.    ...++..+|+|.++..    ....+.+|+++++.+. |+||+++.+.+......
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQGGK   81 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCc
Confidence            344 899999999999998764    3356778999998753    2346778999999995 89999999987665455


Q ss_pred             ccEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ..+++|||++++++.+...  .+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....+
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~  160 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEG  160 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-cEEEeecccccccCCc
Confidence            6899999999999987754  588999999999999999999999999999999999998654 7999999999876432


Q ss_pred             CC----cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         320 QE----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       320 ~~----~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      ..    .....++..|+|||.+.+..++.+.|+|..+++......+..|+......      ....... ..+......+
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~------~~~~~~~-~~~~~~~~~~  233 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK------FEEMIGP-KQGQMTVVRL  233 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch------hhhhhcc-cccccchhhh
Confidence            22    11234567799999998888899999998887655444444333211100      0000000 0000000000


Q ss_pred             c----ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         396 E----RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       396 ~----~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .    .....+.+...+.++++|+.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0    00011123346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG4250|consensus

Probab=100.00  E-value=1e-33  Score=282.51  Aligned_cols=195  Identities=23%  Similarity=0.376  Sum_probs=171.8

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEecc----chHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC----CCcc
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP----VKKKKIKREIKILENLRGGTNIITLQAVVKDPV----SRTP  243 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~----~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~----~~~~  243 (467)
                      .+..-+.||+|+||.||+++++.+|+.+|||..++    ....+..+|+++|++|+ |+|||++.++-++..    ....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCcccccc
Confidence            45666789999999999999999999999999875    24567889999999998 999999998876655    5678


Q ss_pred             EEEEeccCCccHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC--C-CcEEEEecccce
Q psy3714         244 ALIFEHVNNTDFKQLYQ------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--N-RKLRLIDWGLAE  314 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~--~-~~ikl~DFGla~  314 (467)
                      .++||||.+|+|...++      .+++.+...++..+..||.|||++|||||||||+||++-..  + ..-||+|||.|+
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            99999999999988875      38999999999999999999999999999999999998532  2 246999999999


Q ss_pred             ecCCCCCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccc
Q psy3714         315 FYHPGQEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVH  367 (467)
Q Consensus       315 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~  367 (467)
                      ....++..++.+||+.|.+||++.+ ..|+..+|-|+.++..+.+..|..||..
T Consensus       173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            9988888888999999999999986 6689999999999998888888887744

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-32  Score=261.54  Aligned_cols=257  Identities=31%  Similarity=0.546  Sum_probs=188.0

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      |++++.||+|+||.||+|.+..+++.+++|.++...     ...+.+|+++++.+. |+|++.+.+.+.+......+++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEEe
Confidence            678999999999999999999999999999987542     345778999999996 89999999988765335789999


Q ss_pred             eccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC--C
Q psy3714         248 EHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--E  321 (467)
Q Consensus       248 e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~--~  321 (467)
                      +|+++ ++.....    .+++..+..++.||+.||+|||++|++|+||||+||+++.+ +.+||+|||++.......  .
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-CCEEEccccceeeccCCCccc
Confidence            99985 6665542    47888999999999999999999999999999999999965 479999999998764432  2


Q ss_pred             cceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc---
Q psy3714         322 YNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER---  397 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  397 (467)
                      .+...++..|+|||.+.+. .++.+.|+|..+++......+..++.... .    ......... ..+......|..   
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~-~----~~~~~~~~~-~~~~~~~~~~~~~~~  231 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST-E----LEQLEKIFE-LCGSPTDENWPGVSK  231 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC-h----HHHHHHHHH-HhCCCchhhcccccc
Confidence            3345678899999987654 47888999987776544444433332111 0    000000000 000000000000   


Q ss_pred             ---------------cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         398 ---------------FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       398 ---------------~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                                     ..........++++.+||++||..||.+|||++++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                           00000011148899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=263.04  Aligned_cols=262  Identities=27%  Similarity=0.462  Sum_probs=186.3

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      |++.+.||+|+||.||+|....+++.+++|.+....    .....+|+..++++.+|+|++.+.+.+.+  ....++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence            678899999999999999998889999999876431    23446799999999768999999988766  356899999


Q ss_pred             ccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcc
Q psy3714         249 HVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN  323 (467)
Q Consensus       249 ~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~  323 (467)
                      |+ ++++.+.+.     .+++..+..++.|++.||.|||++|++|+||||+||+++.. +.++|+|||++..........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~  156 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYT  156 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CCEEEeecccceeccCCCCcC
Confidence            99 667765542     46888999999999999999999999999999999999954 479999999998765544445


Q ss_pred             eeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCc--------ccCChhhhhhhhhhccCCCCccc
Q psy3714         324 VRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQ--------HLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ...++..|+|||++... .++...|+|..+++......+..++......        .+..+....+.............
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07830         157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR  236 (283)
T ss_pred             CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence            56789999999988654 4788999998877654443443332111100        00000000000000000000000


Q ss_pred             cccc---ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         395 WERF---VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       395 ~~~~---~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      +...   ......+..++++++||++||+.||++|||++|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            0000   0001112237899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.9e-32  Score=254.19  Aligned_cols=246  Identities=28%  Similarity=0.434  Sum_probs=193.0

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      +|++.+.||+|++|.||++.+..+++.+++|.+...   ....+.+|+++++.+. |+|++.+.+.+...  ...++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK-HPNIVKYYGSYLKK--DELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCC-CCCEeEEEEEEecC--CeEEEEEe
Confidence            588999999999999999999988999999998654   3467889999999997 89999999988764  56799999


Q ss_pred             ccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcce
Q psy3714         249 HVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV  324 (467)
Q Consensus       249 ~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~  324 (467)
                      |++++++.+...    .+++..+..++.|++.||.+||++|++||||+|+||+++.+ +.++|+|||.+...........
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~  156 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNT  156 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC-CeEEEeeccccccccccccccc
Confidence            999999987753    46888999999999999999999999999999999999965 4799999999987654432344


Q ss_pred             eeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCC
Q psy3714         325 RVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQ  404 (467)
Q Consensus       325 ~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (467)
                      ..++..|+|||.+.+..++.+.|.|..+++......+..++....        ...........     ....   ....
T Consensus       157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-----~~~~---~~~~  220 (253)
T cd05122         157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP--------PMKALFKIATN-----GPPG---LRNP  220 (253)
T ss_pred             eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc--------hHHHHHHHHhc-----CCCC---cCcc
Confidence            578999999999988888889999988876554444444432211        00000000000     0000   0111


Q ss_pred             CCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q psy3714         405 HLVSPEALDFLDKLLRYDHYERLTAREAMDHPY  437 (467)
Q Consensus       405 ~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~  437 (467)
                      ..++.++.+||++||+.||++|||++|+++|||
T Consensus       221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             cccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            224889999999999999999999999999999

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.5e-32  Score=265.70  Aligned_cols=266  Identities=27%  Similarity=0.500  Sum_probs=191.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..++|++++.||.|+||.||+|.+..+++.+|+|.+...     ..+.+.+|+++++.+. |||++++.+.+..+ ....
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~-~~~~   85 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-HENIISLSDIFISP-LEDI   85 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecC-CCcE
Confidence            457899999999999999999999999999999987531     2356788999999996 89999999988653 3467


Q ss_pred             EEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      ++++||+. +++.+...  .+++..+..++.|++.||.|||++||+||||||+|||++.. +.+||+|||++......  
T Consensus        86 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~~--  161 (328)
T cd07856          86 YFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN-CDLKICDFGLARIQDPQ--  161 (328)
T ss_pred             EEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC-CCEEeCccccccccCCC--
Confidence            89999985 57776654  47778888999999999999999999999999999999854 47999999999865322  


Q ss_pred             cceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCc--------ccC--Chhhhhh-hhh---hc
Q psy3714         322 YNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQ--------HLV--SPEALDF-LDK---NI  386 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~-~~~---~~  386 (467)
                      .....++..|+|||.+.+ ..++.+.|+|..+++......+..+|......        .+.  ..+.... ...   ..
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF  241 (328)
T ss_pred             cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence            233567889999999866 45888999998887655544444443211100        000  0000000 000   00


Q ss_pred             cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ........  ........+.+++++++||++||+.||++|||+++++.||||....
T Consensus       242 ~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         242 VQSLPKRE--PVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             HhhccccC--CCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence            00000000  0000011234688999999999999999999999999999997544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.1e-32  Score=264.79  Aligned_cols=254  Identities=19%  Similarity=0.307  Sum_probs=189.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.+|||.++..    ....+.+|+.++..+.+|+||+.+++.+.+.  ...+
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~   90 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDVF   90 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC--CeEE
Confidence            357899999999999999999999988999999998643    2345667888787777799999999988763  4689


Q ss_pred             EEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ++|||+.+ .+..+..    .+++..+..++.|++.||.|||+ .||+||||||+||+++.+ +.+||+|||++..+...
T Consensus        91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~-~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDS  168 (296)
T ss_pred             EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC-CCEEECccccchhccCC
Confidence            99999865 4544432    47888888999999999999997 599999999999999854 47999999999866433


Q ss_pred             CCcceeeeccCccCCcccccCC----CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQ----YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~----~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      .......++..|+|||.+.+..    ++.+.|+|..+++......+..|+.....       ....... +.... ... 
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~-~~~~~-~~~-  238 (296)
T cd06618         169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-------EFEVLTK-ILQEE-PPS-  238 (296)
T ss_pred             CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-------HHHHHHH-HhcCC-CCC-
Confidence            3333446788999999987653    77889999888765554444444321110       0010100 00000 000 


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                           .+....+++++++||.+||..||.+|||++++++||||...
T Consensus       239 -----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         239 -----LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence                 01112368899999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-32  Score=257.17  Aligned_cols=245  Identities=24%  Similarity=0.401  Sum_probs=192.3

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++.+.||+|++|.||++.+..+++.+++|.+....     ...+.+|+++++++. |+|++.+.+.+.+.  ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETS--DSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeC--CEEEEE
Confidence            5889999999999999999999899999999886542     346789999999995 89999999888753  568999


Q ss_pred             EeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-c
Q psy3714         247 FEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-Y  322 (467)
Q Consensus       247 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-~  322 (467)
                      |+|+++++|.+...   .+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++........ .
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~  156 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDD  156 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC-CCEEEeccccceecCCCcccc
Confidence            99999999987764   47888999999999999999999999999999999999964 4799999999987643332 2


Q ss_pred             ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccccc
Q psy3714         323 NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE  402 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
                      ....++..|+|||.+.+..++...|+|..+++......+..++....        ............          ...
T Consensus       157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~----------~~~  218 (254)
T cd06627         157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN--------PMAALFRIVQDD----------HPP  218 (254)
T ss_pred             cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhccC----------CCC
Confidence            33568899999999988778889999988776544433333332111        001000000000          011


Q ss_pred             CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       403 ~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      .+..+++++++||.+||..||++|||++|++.||||
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            223578999999999999999999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.6e-32  Score=260.67  Aligned_cols=257  Identities=18%  Similarity=0.289  Sum_probs=183.4

Q ss_pred             ccceeeeEeecccCCcceEEEE----EccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAI----NVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..+|++++.||+|+||.||+|.    +..++..|++|.++...   .+.+.+|+++++.++ |+||+++.+.+.......
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCCCc
Confidence            3589999999999999999987    44578899999986543   346788999999996 899999998876554556


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .++||||+++++|.+++.    .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~  160 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-RVKIGDFGLTKVLPQ  160 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-eEEECCCcccccccC
Confidence            899999999999988763    367888899999999999999999999999999999998554 799999999987643


Q ss_pred             CCCcc----eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         319 GQEYN----VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       319 ~~~~~----~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      .....    ...++..|+|||.+.+..++.+.|+|..+++......+..+..... .     ..................
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPP-A-----EFMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcc-h-----hhhhhcccccccccchHH
Confidence            32211    1123456999999988889999999988776433222111110000 0     000000000000000000


Q ss_pred             ----ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         395 ----WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       395 ----~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                          .......+.+..+++++.+||.+||..||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                0000011123457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.8e-32  Score=262.70  Aligned_cols=243  Identities=19%  Similarity=0.299  Sum_probs=185.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEcc-----CCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQ-----SSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|.+.+.||+|+||.||+|....     ++..+|+|.++...    .+.+.+|+++++.+. |+||+.+.+.+...  
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ-HENIVKFYGVCTEG--   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC-CCCchheeeEEecC--
Confidence            4679999999999999999998753     35789999987532    356889999999996 89999999988764  


Q ss_pred             CccEEEEeccCCccHHHHhh-----------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ-----------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR  303 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~-----------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~  303 (467)
                      ...+++|||+++++|.+++.                 .+++.++..++.|++.||.|||++||+||||||+||+++.++ 
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-  159 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL-  159 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC-
Confidence            56899999999999987653                 256778889999999999999999999999999999998654 


Q ss_pred             cEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhh
Q psy3714         304 KLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEAL  379 (467)
Q Consensus       304 ~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  379 (467)
                      .+||+|||+++.......   .....++..|+|||++.+..++.++|+|..+++...... +..|+....     .....
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-----~~~~~  234 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-----NEEVI  234 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-----HHHHH
Confidence            899999999986532221   122345778999999999889999999988876544332 333432211     11111


Q ss_pred             hhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         380 DFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .....   +.          ....+..++.++++||++||..||++|||++|+++
T Consensus       235 ~~~~~---~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         235 ECITQ---GR----------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHc---CC----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            11110   00          00112347899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-32  Score=264.32  Aligned_cols=254  Identities=20%  Similarity=0.281  Sum_probs=184.4

Q ss_pred             cceeeeEeecccCCcceEEEEE----ccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAIN----VQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~----~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      .-|++++.||+|+||.||+|..    ..++..+|+|.++..    ....+.+|+++++.+. |+|++.+.+.+.+.....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCCc
Confidence            3578999999999999999974    456788999998643    2346788999999995 899999999887654567


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .+++|||+++++|.++..    .++..++..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~  161 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIET  161 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC-CEEECCCcccccccc
Confidence            899999999999987763    367888899999999999999999999999999999998654 799999999986643


Q ss_pred             CCCc----ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCC---cccC---ChhhhhhhhhhccC
Q psy3714         319 GQEY----NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTEN---QHLV---SPEALDFLDKNILG  388 (467)
Q Consensus       319 ~~~~----~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~---~~~~---~~~~~~~~~~~~~~  388 (467)
                      ....    ....++..|+|||.+.+..++.+.|+|..+++.+....+..+......   ....   ........... ..
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  240 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-LE  240 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH-HH
Confidence            3221    224567789999999888899999999888764433221111100000   0000   00000000000 00


Q ss_pred             CCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         389 RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       389 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      .   .     ...+.+..+++++.+||.+||+.||++|||++|++++
T Consensus       241 ~---~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         241 E---G-----KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             c---C-----ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            0   0     0011233478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.3e-33  Score=265.61  Aligned_cols=246  Identities=29%  Similarity=0.469  Sum_probs=191.2

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++.+.||+|+||.||+|.+..+++.+++|++...      ....+.+|+++++.+..|+||+++++.+.+.  ...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceEE
Confidence            4799999999999999999999999999999988642      1345778999999997689999999887653  4689


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-  320 (467)
                      ++||++.++++.+.+.   .++...+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++....... 
T Consensus        79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEecCCccccccCCccc
Confidence            9999999999987764   478899999999999999999999999999999999998655 79999999987653221 


Q ss_pred             --------------------CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhh
Q psy3714         321 --------------------EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD  380 (467)
Q Consensus       321 --------------------~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (467)
                                          ......++..|+|||++....++.+.|+|..+++......+..|+....       ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~  230 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-------EYLT  230 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-------HHHH
Confidence                                1122357889999999988888889999987766444333333332111       0000


Q ss_pred             hhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCH----HHHhCCCCC
Q psy3714         381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTA----REAMDHPYF  438 (467)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta----~e~l~Hp~f  438 (467)
                      + ....     ...+      ..+..+++++.+||.+||+.||.+|||+    +|+|+||||
T Consensus       231 ~-~~~~-----~~~~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         231 F-QKIL-----KLEY------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             H-HHHH-----hcCC------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            0 0000     0011      1123468899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.1e-32  Score=257.27  Aligned_cols=244  Identities=18%  Similarity=0.301  Sum_probs=190.4

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +|++.+.||+|+||.||++.+..+++.+++|.++..     ....+.+|+.+++.++ |+||+++.+.+.+.  ...+++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKEAFLDG--NKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccC--CEEEEE
Confidence            588999999999999999999999999999987642     2345678999999997 89999998887654  568999


Q ss_pred             EeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         247 FEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      |||++++++.+...       .+++..+..++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~~~~  156 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGISKVLKKN  156 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC-cEEEeeccchhhhccC
Confidence            99999999987653       377888899999999999999999999999999999999654 7999999999876543


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                       ......++..|+|||.+.+..++...|.|..+++......+..|+...        +...+......     ..+.   
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~--------~~~~~~~~~~~-----~~~~---  219 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR--------SMQDLRYKVQR-----GKYP---  219 (256)
T ss_pred             -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHhc-----CCCC---
Confidence             233356889999999999888888999998776654433333333211        11111111000     0110   


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                        ......+++++++|.+||..||++|||++|+++||++
T Consensus       220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         220 --PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             --CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence              1112468899999999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.2e-32  Score=259.20  Aligned_cols=246  Identities=20%  Similarity=0.310  Sum_probs=187.6

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++.+.||+|+||.||+|.+..+++.+|||.++..      ....+.+|+++++.++ |+||+.+.+.+.+.  ...+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~   78 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIED--NELN   78 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEEC--CeEE
Confidence            5799999999999999999999999999999977532      1245678999999995 89999999888754  4678


Q ss_pred             EEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         245 LIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      +++||++++++..+..       .+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||++....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~~~  157 (267)
T cd08228          79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-CEEECccccceecc
Confidence            9999999999876652       267888899999999999999999999999999999998655 79999999998764


Q ss_pred             CCCC-cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         318 PGQE-YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       318 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      .... .....|++.|+|||.+.+..++...|+|..+++......+..|+.....      ...............     
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~-----  226 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLFSLCQKIEQCDYP-----  226 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc------cHHHHHHHHhcCCCC-----
Confidence            3221 2234688899999999888888999999888765544444444432111      011111110000000     


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                          .......+.++++||++|+..||.+|||++++++.
T Consensus       227 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         227 ----PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             ----CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence                00112367899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.9e-32  Score=262.51  Aligned_cols=249  Identities=23%  Similarity=0.325  Sum_probs=191.9

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +-|++++.||+|+||.||+|.+..++..+|+|......    ...+.+|+.+++.+. |+||+.+++.+...  ...++|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv   80 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKD--TKLWII   80 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeC--CeEEEE
Confidence            45788899999999999999998889999999876322    345778999999995 89999999988753  467999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-Ccc
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYN  323 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~~~  323 (467)
                      |||+.++++.++..  .++...+..++.|++.|+.|||++||+|+||||+||+++.++ .++|+|||++....... ...
T Consensus        81 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          81 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC-CEEEeecccceecccchhhhc
Confidence            99999999887764  478888999999999999999999999999999999998654 79999999997654322 122


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      ...++..|+|||.+.+..++...|.|..+++......+..|+....      +.  .... .+...    ..     ...
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~------~~--~~~~-~~~~~----~~-----~~~  221 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH------PM--KVLF-LIPKN----NP-----PTL  221 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc------hH--HHHH-HHhcC----CC-----CCC
Confidence            3468899999999988778888999988876544444433332110      00  0000 00000    00     011


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      ...++.++.|+|.+||..||.+||++.++++||||...
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            12468899999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.2e-32  Score=262.11  Aligned_cols=245  Identities=20%  Similarity=0.298  Sum_probs=183.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCC-----CeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSS-----DKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++.+.||+|+||.||++......     ..+|+|.++...    ...+.+|+++++.+..|+||+++.+.+...  
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--   88 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE--   88 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC--
Confidence            468999999999999999999876433     679999886532    235778999999996699999999988653  


Q ss_pred             CccEEEEeccCCccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE  301 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~  301 (467)
                      ...+++|||+.++++..++.                   .+++..+..++.|++.||+|||++||+||||||+||+++.+
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~  168 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED  168 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence            46899999999999887653                   36777888999999999999999999999999999999865


Q ss_pred             CCcEEEEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChh
Q psy3714         302 NRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPE  377 (467)
Q Consensus       302 ~~~ikl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  377 (467)
                      + .+||+|||+++........   ....++..|+|||.+.+..++.++|+|..+++.+.... +..++....     ...
T Consensus       169 ~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~  242 (293)
T cd05053         169 H-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VEE  242 (293)
T ss_pred             C-eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-----HHH
Confidence            4 7999999999876433221   11224567999999988889999999987766433221 222321110     111


Q ss_pred             hhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      .........             ....+...++++.+|+.+||..||++|||++|++++
T Consensus       243 ~~~~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         243 LFKLLKEGY-------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHcCC-------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            111111100             011223468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.2e-33  Score=269.52  Aligned_cols=256  Identities=19%  Similarity=0.222  Sum_probs=179.5

Q ss_pred             CCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCCccHHH
Q psy3714         183 KYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQ  257 (467)
Q Consensus       183 ~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~  257 (467)
                      ++|.||.+.+..+++.+|+|.++..     ....+.+|+++++.++ |+||+.+.+.+.+.  ...+++|||+.++++.+
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~~   88 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVD--SELYVVSPLMAYGSCED   88 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC-CcchhhhhheeecC--CeEEEEEeccCCCCHHH
Confidence            4566777777779999999998643     2356889999999996 89999999888753  46799999999999887


Q ss_pred             Hhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC--------cce
Q psy3714         258 LYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--------YNV  324 (467)
Q Consensus       258 ~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~--------~~~  324 (467)
                      ++.     .+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||.+........        ...
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~  167 (314)
T cd08216          89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQRVVHDFPKS  167 (314)
T ss_pred             HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC-ceEEecCccceeecccccccccccccccc
Confidence            654     377888999999999999999999999999999999999554 799999999875532111        122


Q ss_pred             eeeccCccCCcccccC--CCCccchhHHHhhhccccccccccccccCCcccCChhhhh----hhhhhccC----CCCc--
Q psy3714         325 RVASRYFKGPELLADY--QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD----FLDKNILG----RHSR--  392 (467)
Q Consensus       325 ~~gt~~y~aPE~l~~~--~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----~~~~--  392 (467)
                      ..++..|+|||++...  .|+.+.|+|..+++-.....+..||...............    ........    ....  
T Consensus       168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
T cd08216         168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSR  247 (314)
T ss_pred             ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccc
Confidence            4577889999998763  5888999998887755555555554332111000000000    00000000    0000  


Q ss_pred             --ccccc---cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         393 --KRWER---FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       393 --~~~~~---~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                        .....   .........+++++.+||++||++||++|||++|+|+||||..+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         248 SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             ccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence              00000   000011123467999999999999999999999999999998765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.2e-32  Score=262.82  Aligned_cols=244  Identities=15%  Similarity=0.250  Sum_probs=182.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEc----cCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINV----QSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      .++|++.+.||+|+||.||+|...    .++..+++|.++...    ...+.+|+++++.++ |+||+++.+.+...  .
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~   80 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQE--Q   80 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecC--C
Confidence            478999999999999999999853    355789999886422    245788999999995 89999999987653  4


Q ss_pred             ccEEEEeccCCccHHHHhh--------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ--------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE  301 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~--------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~  301 (467)
                      ..+++|||+++++|.+++.                    .+++.++..++.|++.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            6799999999999987652                    25677788899999999999999999999999999999965


Q ss_pred             CCcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChh
Q psy3714         302 NRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPE  377 (467)
Q Consensus       302 ~~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  377 (467)
                      + .+||+|||+++.......   .....++..|+|||.+.+..++.+.|+|..+++...... +..|+.....     ..
T Consensus       161 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-----~~  234 (283)
T cd05090         161 L-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-----QE  234 (283)
T ss_pred             C-cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----HH
Confidence            4 799999999986533221   122345667999999988889999999988776443332 2223221110     01


Q ss_pred             hhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      .......    .    ..     ...+..+++++++|+.+||+.||++||++++++++
T Consensus       235 ~~~~~~~----~----~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         235 VIEMVRK----R----QL-----LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHc----C----Cc-----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            1111110    0    00     01223478999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-32  Score=264.02  Aligned_cols=235  Identities=14%  Similarity=0.141  Sum_probs=180.5

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeC--CCCCccEEEEe
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKD--PVSRTPALIFE  248 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~--~~~~~~~lv~e  248 (467)
                      ..||+|++|.||+|..  +++.||+|.++...      .+.+.+|+.+|++++ ||||+++++++.+  ......+++||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence            5689999999999987  68899999987532      245669999999996 7899999998865  33456799999


Q ss_pred             ccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcce
Q psy3714         249 HVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV  324 (467)
Q Consensus       249 ~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~  324 (467)
                      |+++++|.+.+.   .++......++.|++.||.|||+ .+++||||||+|||++.++ .+||+|||+++.....  ...
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~--~~~  179 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSP--PFK  179 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhccc--ccc
Confidence            999999988764   47778888999999999999998 4999999999999999654 7999999999865322  223


Q ss_pred             eeeccCccCCccccc--CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccccc
Q psy3714         325 RVASRYFKGPELLAD--YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE  402 (467)
Q Consensus       325 ~~gt~~y~aPE~l~~--~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
                      .+||..|+|||++.+  ..|+.++|+|+.+++.+....+..||.....     .+...    .+......        ..
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~~----~i~~~~~~--------~~  242 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIYD----LIINKNNS--------LK  242 (283)
T ss_pred             ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHHH----HHHhcCCC--------CC
Confidence            568999999999976  5789999999888876655555555532210     11111    11100000        01


Q ss_pred             CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       403 ~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .+...++++++||.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        243 LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            12246899999999999999999999999985

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.9e-32  Score=259.86  Aligned_cols=244  Identities=27%  Similarity=0.410  Sum_probs=187.6

Q ss_pred             ecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCC
Q psy3714         179 LGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNN  252 (467)
Q Consensus       179 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~  252 (467)
                      ||+|+||.||++.+..+++.+++|.++...      ...+.+|+++++.+. |+|++++.+.+..  ....+++|||+.+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~~~lv~e~~~~   77 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQG--KKNLYLVMEYLPG   77 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheec--CcEEEEEEecCCC
Confidence            689999999999999899999999986432      346788999999996 8999999887764  3568999999999


Q ss_pred             ccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC---------
Q psy3714         253 TDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---------  320 (467)
Q Consensus       253 ~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~---------  320 (467)
                      ++|..++.   .+++..+..++.||+.||.|||++||+||||+|+||+++.++ .+||+|||++.......         
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCcccccccccc
Confidence            99877654   478889999999999999999999999999999999999655 79999999987543221         


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      ......++..|+|||.+....++...|+|..+++......+..++....        ....... ...  ....+.    
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~-~~~--~~~~~~----  221 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQN-ILN--GKIEWP----  221 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH-Hhc--CCcCCC----
Confidence            1223467889999999988888889999988876554444444432211        0011100 000  000111    


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCH---HHHhCCCCCCCccc
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTA---REAMDHPYFYPIVK  443 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta---~e~l~Hp~f~~~~~  443 (467)
                        ....+++++.+||++||+.||++|||+   .|+|+||||..++|
T Consensus       222 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         222 --EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             --ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence              111258999999999999999999999   99999999998765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.7e-32  Score=256.72  Aligned_cols=226  Identities=18%  Similarity=0.240  Sum_probs=172.5

Q ss_pred             cCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCCccHHHHhh-
Q psy3714         182 GKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ-  260 (467)
Q Consensus       182 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-  260 (467)
                      |.||.||++.+..+++.+|+|.++...  ...+|...+... .|||++.+++.+.+.  ...+++|||+++++|.+.+. 
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~-~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPH-CVPNMVCLHKYIVSE--DSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhc-CCCceeehhhheecC--CeEEEEEecCCCCCHHHHHHH
Confidence            899999999999999999999987532  233444444444 379999999988753  56899999999999877653 


Q ss_pred             --cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcceeeeccCccCCcccc
Q psy3714         261 --TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA  338 (467)
Q Consensus       261 --~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~  338 (467)
                        .+++..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++......  .....++..|+|||.+.
T Consensus        79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG  155 (237)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCccccCCcccC
Confidence              478899999999999999999999999999999999999665 7999999988765432  22345678899999998


Q ss_pred             cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhh
Q psy3714         339 DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKL  418 (467)
Q Consensus       339 ~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~l  418 (467)
                      ...++...|.|..+++.+....+..++....              ....         .......+..+++++++||.+|
T Consensus       156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~~--------------~~~~---------~~~~~~~~~~~~~~~~~li~~~  212 (237)
T cd05576         156 ISEETEACDWWSLGAILFELLTGKTLVECHP--------------SGIN---------THTTLNIPEWVSEEARSLLQQL  212 (237)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCcchhhcCc--------------hhcc---------cccccCCcccCCHHHHHHHHHH
Confidence            8888899999988876544333322211000              0000         0000112234789999999999


Q ss_pred             cCcCCCCCCCH-----HHHhCCCCC
Q psy3714         419 LRYDHYERLTA-----REAMDHPYF  438 (467)
Q Consensus       419 L~~dp~~R~ta-----~e~l~Hp~f  438 (467)
                      |+.||++|+|+     +|+++||||
T Consensus       213 l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         213 LQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             ccCCHHHhcCCCccchHHHHcCCCC
Confidence            99999999986     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.5e-32  Score=262.70  Aligned_cols=245  Identities=21%  Similarity=0.311  Sum_probs=184.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEc-----cCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINV-----QSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++.+.||+|+||.||+|.+.     .++..+|+|.++...    .+.+.+|+.+++++.+|+||+++.+.+...  
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--  111 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG--  111 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence            478999999999999999999753     344579999886432    345788999999996699999999988654  


Q ss_pred             CccEEEEeccCCccHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         241 RTPALIFEHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                      ...+++|||+.+++|.++...     +++.++..++.|++.||+|||++||+|+||||+|||++.. ..+||+|||+++.
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~dfg~~~~  190 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDFGLARD  190 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC-CeEEECCCccccc
Confidence            468999999999999877642     6888999999999999999999999999999999999854 4799999999986


Q ss_pred             cCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         316 YHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       316 ~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      .......   ....++..|+|||.+.+..++.+.|+|..+++...... +..|+.....    .+.........      
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~----~~~~~~~~~~~------  260 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV----DSKFYKLIKEG------  260 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc----hHHHHHHHHcC------
Confidence            5332211   11245678999999998889999999988876443332 3333321110    00111111000      


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                         +    ....+..+++++.+|+.+||..||++|||+.|+++
T Consensus       261 ---~----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         261 ---Y----RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ---C----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence               0    11122346899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.8e-32  Score=263.12  Aligned_cols=247  Identities=22%  Similarity=0.324  Sum_probs=187.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ...|++.+.||+|+||.||+|.+..+++.||+|.+...      ..+.+.+|+++++.++ |+||+++.+.+.+.  ...
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~--~~~   90 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLRE--HTA   90 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeC--CeE
Confidence            35689999999999999999999989999999987532      1245788999999996 89999999988764  457


Q ss_pred             EEEEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         244 ALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ++||||+.+. +.+..    +.+++..+..++.|++.||.|||++||+||||+|+||+++.++ .+||+|||++......
T Consensus        91 ~lv~e~~~g~-l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~~~~  168 (307)
T cd06607          91 WLVMEYCLGS-ASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSASLVSPA  168 (307)
T ss_pred             EEEHHhhCCC-HHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC-CEEEeecCcceecCCC
Confidence            9999999854 43332    3578889999999999999999999999999999999998654 7999999999765432


Q ss_pred             CCcceeeeccCccCCcccc---cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         320 QEYNVRVASRYFKGPELLA---DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~---~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                         ....+++.|+|||++.   ...++.+.|+|..+++......+..++....        ............  ...  
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~--------~~~~~~~~~~~~--~~~--  233 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQND--SPT--  233 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc--------HHHHHHHHhcCC--CCC--
Confidence               2346888999999884   3457889999988877554444444432211        000000000000  000  


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                           ......++++++||.+||..||++|||+.++++||||..-
T Consensus       234 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         234 -----LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             -----CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence                 0011257899999999999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.6e-32  Score=263.62  Aligned_cols=251  Identities=22%  Similarity=0.342  Sum_probs=192.1

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      .|+....||+|+||.||++....+++.+|+|.+...   ....+.+|+.+++.+. |+|++.+.+.+...  ...+++||
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e   97 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVG--DELWVVME   97 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcC-CcchhheeeEEEeC--CEEEEEEe
Confidence            344456799999999999999999999999987532   2345788999999986 79999999988754  56899999


Q ss_pred             ccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-Cccee
Q psy3714         249 HVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVR  325 (467)
Q Consensus       249 ~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~~~~~  325 (467)
                      |++++++.+...  .+++..+..++.|++.||+|||++||+|+||||+||+++.++ .++|+|||++....... .....
T Consensus        98 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657          98 FLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             cCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEcccccceeccccccccccc
Confidence            999999887653  478888999999999999999999999999999999998554 79999999987653222 22335


Q ss_pred             eeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCC
Q psy3714         326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQH  405 (467)
Q Consensus       326 ~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (467)
                      .|++.|+|||.+.+..++.+.|.|..+++......+..|+.....     ...........     ...+      ....
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-----~~~~~~~~~~~-----~~~~------~~~~  240 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIRDNL-----PPKL------KNLH  240 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhhC-----Cccc------CCcc
Confidence            689999999999888888899999888775554444444322110     00001110000     0000      0112


Q ss_pred             CCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       406 ~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .+++++.+||.+||..||.+|+|++|+++||||....
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence            4688999999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.6e-32  Score=261.49  Aligned_cols=245  Identities=15%  Similarity=0.264  Sum_probs=180.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEcc-----CCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQ-----SSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++.+.||+|+||.||+|.+..     ++..+|+|.++..    ....+.+|+.+++.++ |+||+++.+.+... 
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~-   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG-   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCC-
Confidence            34789999999999999999998642     3467999987542    2345778999999985 89999999987653 


Q ss_pred             CCccEEEEeccCCccHHHHhhc-------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEE
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQT-------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLR  306 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ik  306 (467)
                       ...++||||+++++|.++...             ++...+..++.|++.||.|||++|++||||||+||+++.+ +.+|
T Consensus        82 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~-~~~~  159 (277)
T cd05062          82 -QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVK  159 (277)
T ss_pred             -CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC-CCEE
Confidence             468999999999999877642             2445678899999999999999999999999999999955 4799


Q ss_pred             EEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhh
Q psy3714         307 LIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFL  382 (467)
Q Consensus       307 l~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  382 (467)
                      |+|||+++........   ....++..|+|||++.+..++...|+|..+++.+.... +..++....     ........
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-----~~~~~~~~  234 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-----NEQVLRFV  234 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Confidence            9999999755322211   12345778999999988889999999988876443332 222221110     01111111


Q ss_pred             hhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         383 DKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ..   ..     .     ...+...++++++||.+||+.||++|||+.|++++
T Consensus       235 ~~---~~-----~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         235 ME---GG-----L-----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             Hc---CC-----c-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            00   00     0     01123467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.5e-32  Score=256.83  Aligned_cols=243  Identities=13%  Similarity=0.178  Sum_probs=182.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEc---cCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINV---QSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..+|++.+.||+|+||.||+|...   ..+..+|+|.++...    ...+.+|+.+++.++ ||||+++.+.+...  ..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~   80 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRG--NT   80 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecC--CC
Confidence            467999999999999999999765   345689999887532    245778999999985 89999999988753  56


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .++||||++++++.++..    .+++.++..++.|++.||+|||++||+||||||+|||++.++ .+|++|||.+.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~-~~~l~dfg~~~~~~~  159 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQEDKS  159 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC-cEEECCCcccccccc
Confidence            899999999999987653    478889999999999999999999999999999999998654 799999998765422


Q ss_pred             CCCcc--eeeeccCccCCcccccCCCCccchhHHHhhhccccc-cccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         319 GQEYN--VRVASRYFKGPELLADYQYHIELDPRFADILGRHSR-KRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       319 ~~~~~--~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      .....  ...++..|+|||.+.+..++.+.|+|..+++..... .+..||.....     .+........          
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----~~~~~~~~~~----------  224 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----QDVIKAVEDG----------  224 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHHHHCC----------
Confidence            21111  123467899999999888999999998876644322 23333322110     1111111000          


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                         ...+.+...+..+.+|+.+|+..||.+|||++|+++
T Consensus       225 ---~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         225 ---FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence               001123346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8.1e-32  Score=256.06  Aligned_cols=243  Identities=17%  Similarity=0.290  Sum_probs=185.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ..+|++.+.||+|+||.||+|.+..+++.+++|.++...  ...+.+|+++++.+. |+||+++.+.+...  ...+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~   81 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE--PPFYIIT   81 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCC-CCChhheEEEEcCC--CCcEEEE
Confidence            357999999999999999999999999999999987543  346788999999996 89999999987653  4679999


Q ss_pred             eccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc
Q psy3714         248 EHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       248 e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~  322 (467)
                      ||+++++|.+.+.     .++...+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.........
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-cEEeCCCccccccccceee
Confidence            9999999987653     367788889999999999999999999999999999998554 7999999999865432211


Q ss_pred             c--eeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         323 N--VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       323 ~--~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      .  ...++..|+|||.+.+..++...|+|..+++...... +..++....     .........    ..         .
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~----~~---------~  222 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLE----KG---------Y  222 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH----CC---------C
Confidence            1  1123567999999988889999999988876544432 223321110     011111111    00         0


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ....+..+++++.+||.+||..||++|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            11223457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-31  Score=254.78  Aligned_cols=245  Identities=22%  Similarity=0.337  Sum_probs=187.6

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++.+.||+|+||.||+|.+..+++.+++|.++..      ....+.+|+++++.++ |+|++.+...+...  ...+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~--~~~~   78 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIEN--NELN   78 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecC--CeEE
Confidence            5799999999999999999999989999999987531      2456789999999995 89999999988764  4679


Q ss_pred             EEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         245 LIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ++|||+++++|..++.       .+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||++....
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~~~~  157 (267)
T cd08224          79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-VVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-cEEEeccceeeecc
Confidence            9999999999987653       267888899999999999999999999999999999998655 79999999998654


Q ss_pred             CCC-CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         318 PGQ-EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       318 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      ... ......++..|+|||.+.+..++...|+|..+++......+..|+.....      ......+....+     .+.
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-----~~~  226 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEKC-----DYP  226 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhhcC-----CCC
Confidence            322 22335688999999999888899999999888765444444444322110      011111110000     000


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .    ......+.+.+++|.+||..||.+|||+.++++
T Consensus       227 ~----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         227 P----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             C----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            0    011246789999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-32  Score=257.25  Aligned_cols=243  Identities=20%  Similarity=0.281  Sum_probs=180.1

Q ss_pred             eeeeEeecccCCcceEEEEEccC---CCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC----
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQS---SDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVS----  240 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~----  240 (467)
                      |++.+.||+|+||.||+|....+   +..+|+|.++...     ...+.+|+++++.++ |+||+++.+.+.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCccccC
Confidence            56789999999999999987653   4789999887431     245788999999985 8999999987754322    


Q ss_pred             CccEEEEeccCCccHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecc
Q psy3714         241 RTPALIFEHVNNTDFKQLY---------QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG  311 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFG  311 (467)
                      ...+++|||++++++....         ..+++..+..++.|++.||+|||++||+||||||+||+++.. +.+||+|||
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg  158 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED-MTVCVADFG  158 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC-CeEEECCcc
Confidence            3478999999999987665         146788889999999999999999999999999999999855 479999999


Q ss_pred             cceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhcc
Q psy3714         312 LAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNIL  387 (467)
Q Consensus       312 la~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (467)
                      +++........   ....++..|+|||.+....++.+.|+|..+++.+.... +..|+....     ..........   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-----~~~~~~~~~~---  230 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-----NHEIYDYLRH---  230 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHc---
Confidence            99876433221   11234668999999988889999999988876544333 222321111     1111111110   


Q ss_pred             CCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      +.          ....+...++++.++|.+||+.||++|||+.|++++
T Consensus       231 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         231 GN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            00          011123478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-32  Score=260.02  Aligned_cols=261  Identities=29%  Similarity=0.488  Sum_probs=187.7

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      |++.+.||+|+||.||+|.+..+++.+++|.++...     .+...+|+.+++.++ |+|++++.+.+.+.  ...++++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~--~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK-HPNIVKLLDVIHTE--RKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcC--CceEEEe
Confidence            677889999999999999999999999999987532     245678999999996 89999999887754  5789999


Q ss_pred             eccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-Cc
Q psy3714         248 EHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EY  322 (467)
Q Consensus       248 e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~~  322 (467)
                      ||+++ ++.+.+.    .+++..+..++.|++.||.|||++||+||||+|+||+++.. +.+||+|||+++...... ..
T Consensus        78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-CCEEEecCCcccccCCCcccc
Confidence            99985 7776653    47889999999999999999999999999999999999864 479999999998654322 23


Q ss_pred             ceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCc--------ccCCh--hhhhhhhhhccCCCC
Q psy3714         323 NVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQ--------HLVSP--EALDFLDKNILGRHS  391 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~~~~~  391 (467)
                      ....++..|+|||.+.+. .++.+.|+|..+++......+..++......        .+..+  ...............
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            345568889999998776 6888999998887655444443332111100        00000  000000000000000


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ...+.........+.+++++.+||++||..||++|||++|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            00110000011122358899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.4e-32  Score=256.79  Aligned_cols=236  Identities=19%  Similarity=0.296  Sum_probs=176.7

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCC
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNN  252 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~  252 (467)
                      +.||+|+||.||+|.+..+++.+|+|.+...    ....+.+|+++++.+. |+||+++.+.+...  ...++||||+.+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQK--QPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCC--CCeEEEEeeccC
Confidence            3689999999999999999999999987542    2356789999999995 89999999988753  568999999999


Q ss_pred             ccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcc---ee
Q psy3714         253 TDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN---VR  325 (467)
Q Consensus       253 ~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~---~~  325 (467)
                      +++.+...    .+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.....+....   ..
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-cEEECccccCcccccccccccCCCC
Confidence            99987763    367888999999999999999999999999999999998655 79999999987543221111   11


Q ss_pred             eeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCC
Q psy3714         326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQ  404 (467)
Q Consensus       326 ~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (467)
                      .++..|+|||.+.+..++...|+|..+++.+.... +..|+....     ...........             .....+
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~-----~~~~~~~~~~~-------------~~~~~~  218 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS-----NQQTREAIEQG-------------VRLPCP  218 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC-----HHHHHHHHHcC-------------CCCCCc
Confidence            22456999999988889999999988876443222 222221110     00111111100             001112


Q ss_pred             CCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         405 HLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       405 ~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ...++++.+|+.+||+.||++|||+.|+++
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.7e-32  Score=254.74  Aligned_cols=242  Identities=14%  Similarity=0.209  Sum_probs=181.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .++|++.+.||+|+||.||++... .+..+|+|.++..  ....+.+|+.+++.++ ||||+++++.+...  ...+++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~iv~   78 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQ--KPLYIVT   78 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCC-CCCceeEEEEEccC--CCEEEEE
Confidence            367999999999999999999765 4567999987643  2456788999999996 89999999988653  4689999


Q ss_pred             eccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc-
Q psy3714         248 EHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-  322 (467)
Q Consensus       248 e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~-  322 (467)
                      ||++++++.+.+.    .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++........ 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC-CeEEECCCCCccccCCCceec
Confidence            9999999987663    36788889999999999999999999999999999999854 47999999999865322211 


Q ss_pred             -ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         323 -NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       323 -~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                       ....++..|+|||.+....++.++|+|..+++...... +..|+....     ..........   +.          .
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-----~~~~~~~i~~---~~----------~  219 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-----NYEVVEMISR---GF----------R  219 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHC---CC----------C
Confidence             11234567999999988889999999988876443332 222321111     0011111100   00          0


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ...+...++++.+|+.+|+..||++|||++++++
T Consensus       220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            0112346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.7e-32  Score=256.16  Aligned_cols=241  Identities=18%  Similarity=0.235  Sum_probs=181.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .++|++.+.||+|+||.||+|.+..+ ..+|+|.++..  ....+.+|+++++.++ |+||+++.+.+..   ...+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~---~~~~lv~   79 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE---EPIYIVT   79 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCC-CCCcceEEEEECC---CCcEEEE
Confidence            46799999999999999999987655 46999998753  2456789999999995 8999999887643   4579999


Q ss_pred             eccCCccHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc
Q psy3714         248 EHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       248 e~~~~~~l~~~~~~-----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~  322 (467)
                      ||+.++++.+++..     ++...+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||.+.........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC-cEEeccCCceeeccccccc
Confidence            99999999877642     67788899999999999999999999999999999998654 7999999999866433221


Q ss_pred             --ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         323 --NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       323 --~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                        ....++..|+|||.+.+..++...|+|..+++.+.... +..|+....     ......    .+....         
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-----~~~~~~----~~~~~~---------  220 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLD----QVERGY---------  220 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----hHHHHH----HHhcCC---------
Confidence              12345678999999988889999999988876544333 222221111     011111    110000         


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .......+++++.+||.+||+.||++|||++++++
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            00112346889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.8e-32  Score=258.44  Aligned_cols=243  Identities=16%  Similarity=0.253  Sum_probs=181.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCC----eEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSD----KCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      ..++|++++.||+|+||.||+|.+..++.    .||+|.++...    ...+.+|+.+++.+. |+||+.+.+.+..   
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~---   80 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG-SPYVCRLLGICLT---   80 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC---
Confidence            45789999999999999999999877766    47999876432    345778999998885 8999999988764   


Q ss_pred             CccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      ...+++++|++++++.+...    .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~~~~  159 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-HVKITDFGLARLL  159 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCCCceeec
Confidence            34689999999999887753    378889999999999999999999999999999999998554 7999999999876


Q ss_pred             CCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         317 HPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       317 ~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      ......   ....+++.|+|||.+.+..++.++|+|..+++.+.... +..|+....     ...........       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~~-------  227 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----AREIPDLLEKG-------  227 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHCC-------
Confidence            432221   11234678999999988889999999988776443222 233321110     00111111100       


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                            ...+.+...++++.++|.+||..||++|||+.++++
T Consensus       228 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         228 ------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                  001112346889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=7.7e-32  Score=255.76  Aligned_cols=243  Identities=19%  Similarity=0.242  Sum_probs=183.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..++|+++++||+|+||.||+|.+. ++..+++|.++..  ..+.+.+|+.+++.++ |+||+++.+.+.+.  ...+++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv   79 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKE--EPIYII   79 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCC--CCcEEE
Confidence            3578999999999999999999864 5667999987643  3457789999999996 89999999887653  567999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      |||+.++++.+++.     .++...+..++.|++.||+|||+++++||||||+||+++.++ .+||+|||++........
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEY  158 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-cEEECCCccceecCCCce
Confidence            99999999887753     366778888999999999999999999999999999999655 799999999987643221


Q ss_pred             --cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         322 --YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       322 --~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                        .....++..|+|||.+....++...|+|..+++.+.... +..|+....     ........    ...     +   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~----~~~-----~---  221 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-----NSDVMSAL----QRG-----Y---  221 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-----HHHHHHHH----HcC-----C---
Confidence              112235667999999988888889999988876544332 333332111     00111111    000     0   


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                       ..+....++.++.+||.+||+.||++|||++++++
T Consensus       222 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         222 -RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence             01122347889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG2345|consensus

Probab=100.00  E-value=5e-33  Score=245.38  Aligned_cols=250  Identities=18%  Similarity=0.189  Sum_probs=186.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeC---CCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKD---PVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~---~~~~~  242 (467)
                      ...+|.+.+.||+|+|+.||++.+..++..||+|.+.-.   ..+.+.+|++..++++ ||||+++.+..-.   +....
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCcee
Confidence            457899999999999999999999999999999987543   3467889999999997 6999988764321   13456


Q ss_pred             cEEEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEeCCCCcEEEEecccc
Q psy3714         243 PALIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLA  313 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~--IiHrDlKp~Nill~~~~~~ikl~DFGla  313 (467)
                      .|+++.|...|++.+.++       .+++.++..++.+|++||++||+..  ..||||||.|||+..++ .++|.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-LPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-ceEEEeccCc
Confidence            799999999998876653       3789999999999999999999999  99999999999998654 7999999998


Q ss_pred             eecCC---C-------CCcceeeeccCccCCcccccCC---CCccchhHHHhhhccccccccccccccCCcccCChhhhh
Q psy3714         314 EFYHP---G-------QEYNVRVASRYFKGPELLADYQ---YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD  380 (467)
Q Consensus       314 ~~~~~---~-------~~~~~~~gt~~y~aPE~l~~~~---~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (467)
                      +...-   +       ++......|..|+|||++.=..   -+.++|+|+.+...+....+..||-....+  +..-.+.
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--GgSlaLA  254 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--GGSLALA  254 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--CCeEEEe
Confidence            75321   1       1122235688999999986443   467899998887666555555555322111  0000011


Q ss_pred             hhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ...       ....|      +.....|+...+||+.||+.||.+|||+.+++.+
T Consensus       255 v~n-------~q~s~------P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  255 VQN-------AQISI------PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eec-------ccccc------CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            000       01111      1122379999999999999999999999998864

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7.2e-32  Score=260.83  Aligned_cols=250  Identities=18%  Similarity=0.249  Sum_probs=182.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCC----------------CeEEEEEeccch----HHHHHHHHHHHHHhcCCCCee
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSS----------------DKCVVKILKPVK----KKKIKREIKILENLRGGTNII  229 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----------------~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv  229 (467)
                      ..+|++++.||+|+||.||+|.+..++                ..+|+|.+....    ...+.+|+++++.++ |+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS-DPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC-CCCEe
Confidence            468999999999999999999876543                457899876432    346778999999996 89999


Q ss_pred             EEEEEEeCCCCCccEEEEeccCCccHHHHhh--------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q psy3714         230 TLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ--------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHN  295 (467)
Q Consensus       230 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~N  295 (467)
                      ++.+.+...  ...+++||++.+++|.+++.              .+++..+..++.|++.||+|||++||+||||||+|
T Consensus        83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          83 RLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            999988754  56899999999999887653              36778889999999999999999999999999999


Q ss_pred             eEEeCCCCcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc--ccccccccCC
Q psy3714         296 VMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK--RWERFVHTEN  370 (467)
Q Consensus       296 ill~~~~~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~--~~~~~~~~~~  370 (467)
                      |+++.+ +.++|+|||+++.......   .....++..|+|||.+....++.++|+|..+++.+....  +..|+.... 
T Consensus       161 ili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-  238 (296)
T cd05051         161 CLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-  238 (296)
T ss_pred             eeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC-
Confidence            999865 4799999999986533221   122345778999999988889999999988765432211  122221111 


Q ss_pred             cccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         371 QHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                          .......... ..   .....  ....+.+...++++.+||.+||..||++|||+.|+++
T Consensus       239 ----~~~~~~~~~~-~~---~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         239 ----DQQVIENAGH-FF---RDDGR--QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             ----hHHHHHHHHh-cc---ccccc--cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence                0111110000 00   00000  0011122346789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.3e-31  Score=258.18  Aligned_cols=243  Identities=19%  Similarity=0.253  Sum_probs=183.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEc-----cCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINV-----QSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      .++|.+.+.||+|+||.||++...     .++..+|+|.++...   .+.+.+|++++++++ |+||+++.+.+...  .
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG--D   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecC--C
Confidence            468999999999999999999753     344568899876432   346789999999996 79999999988753  5


Q ss_pred             ccEEEEeccCCccHHHHhh----------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcE
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKL  305 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~i  305 (467)
                      ..+++|||+++++|.+++.                .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~-~~  159 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-LV  159 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-cE
Confidence            6899999999999987653                278888999999999999999999999999999999998654 79


Q ss_pred             EEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhh
Q psy3714         306 RLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDF  381 (467)
Q Consensus       306 kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  381 (467)
                      ||+|||+++.......   .....++..|+|||++.+..++.+.|+|..+++...... +..|+....        ....
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~--------~~~~  231 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEV  231 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHH
Confidence            9999999986533221   112345778999999988889999999988876554433 333332111        0111


Q ss_pred             hhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ......+..          ...+...++++.+|+.+||+.||.+|||++|+++
T Consensus       232 ~~~i~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         232 IECITQGRV----------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHHHcCCc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            111111100          0112246889999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-31  Score=261.28  Aligned_cols=245  Identities=20%  Similarity=0.262  Sum_probs=182.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEcc-------CCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQ-------SSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      .++|.+.+.||+|+||.||+|.+..       +...+|+|.++...    ...+.+|+++++.+..|+||+++.+.+...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4789999999999999999998643       23469999887532    245778999999997799999999988754


Q ss_pred             CCCccEEEEeccCCccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEe
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID  299 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~  299 (467)
                        ...+++|||+++++|.+++.                   .++..++..++.|++.||+|||++|++||||||+||+++
T Consensus        97 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  174 (307)
T cd05098          97 --GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  174 (307)
T ss_pred             --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence              46899999999999987763                   256677889999999999999999999999999999998


Q ss_pred             CCCCcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCC
Q psy3714         300 HENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVS  375 (467)
Q Consensus       300 ~~~~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  375 (467)
                      .++ .+||+|||+|+.......   .....++..|+|||.+.+..++.+.|+|..+++.+.... +..|+....     .
T Consensus       175 ~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-----~  248 (307)
T cd05098         175 EDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----V  248 (307)
T ss_pred             CCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----H
Confidence            654 799999999976532211   111224568999999988889999999988876544332 222221110     0


Q ss_pred             hhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         376 PEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      .+.......    ..         ..+.+..+++++++||.+||..||++|||+.+++++
T Consensus       249 ~~~~~~~~~----~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         249 EELFKLLKE----GH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHHc----CC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            111111110    00         011223468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.5e-32  Score=257.24  Aligned_cols=244  Identities=20%  Similarity=0.327  Sum_probs=184.1

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      +|.+.+.||+|+||.||++.+..++..+++|+++..        ....+.+|+.+++.++ ||||+++.+.+.+.  ...
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~   77 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLER--DAF   77 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcC--Cce
Confidence            488999999999999999999888777777776532        2234667899999985 89999998887653  457


Q ss_pred             EEEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         244 ALIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      ++++||+.++++.....       .+++..+..++.|++.||.|||++|++|+||||+||+++ ++ .+||+|||+++..
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~-~~-~~~l~d~g~~~~~  155 (260)
T cd08222          78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-NN-LLKIGDFGVSRLL  155 (260)
T ss_pred             EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee-cC-CEeecccCceeec
Confidence            99999999999876542       478889999999999999999999999999999999997 34 6999999999876


Q ss_pred             CCCCC-cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         317 HPGQE-YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       317 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      ..... .....|++.|+|||.+.+..++.+.|.|..+++......+..++...        ...........+.      
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--------~~~~~~~~~~~~~------  221 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ--------NFLSVVLRIVEGP------  221 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHcCC------
Confidence            43322 22345788999999998888888999998887644333333232110        0001000000000      


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                          ....+...++++.|||.+||+.||.+|||++|+++||||
T Consensus       222 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         222 ----TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ----CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                001122468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.4e-31  Score=261.20  Aligned_cols=244  Identities=20%  Similarity=0.263  Sum_probs=180.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEcc-------CCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQ-------SSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      .++|.+.+.||+|+||.||+|.+..       ....+|+|.++...    ...+.+|+.+++.+.+|+||+++.+.+.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            4789999999999999999997642       23468999877432    235678999999997799999999988653


Q ss_pred             CCCccEEEEeccCCccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEe
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID  299 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~  299 (467)
                        ...+++|||+++++|.+++.                   .++..++..++.|++.||.|||++||+||||||+|||++
T Consensus        91 --~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  168 (314)
T cd05099          91 --GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             --CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence              46799999999999987763                   256677888999999999999999999999999999998


Q ss_pred             CCCCcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCC
Q psy3714         300 HENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVS  375 (467)
Q Consensus       300 ~~~~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  375 (467)
                      .++ .+||+|||+++.......   .....++..|+|||.+.+..++.+.|+|..+++.+.... +..|+....     .
T Consensus       169 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-----~  242 (314)
T cd05099         169 EDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-----V  242 (314)
T ss_pred             CCC-cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-----H
Confidence            654 799999999986542211   111224467999999988889999999988876433222 222221110     1


Q ss_pred             hhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         376 PEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .+........       ..      ...+..++.++++||.+||..||++|||+.|+++
T Consensus       243 ~~~~~~~~~~-------~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         243 EELFKLLREG-------HR------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHHcC-------CC------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            1111111110       00      0112346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-31  Score=256.24  Aligned_cols=242  Identities=18%  Similarity=0.258  Sum_probs=177.7

Q ss_pred             eeeEeecccCCcceEEEEEccCCC--eEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC----CCc
Q psy3714         174 QLVRKLGRGKYSEVFEAINVQSSD--KCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPV----SRT  242 (467)
Q Consensus       174 ~~~~~lG~G~~g~V~~~~~~~~~~--~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~----~~~  242 (467)
                      .+.+.||+|+||.||+|.+..++.  .+|+|.++..     ....+.+|+++++.++ |+||+++.+.+....    ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCCCC
Confidence            467889999999999999877665  5899987642     2345778999999995 899999998764321    235


Q ss_pred             cEEEEeccCCccHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccc
Q psy3714         243 PALIFEHVNNTDFKQLYQ---------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA  313 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla  313 (467)
                      .+++|+|+.++++.+...         .+++..+..++.|++.||+|||++||+||||||+|||++.. ..+||+|||++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~  159 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADFGLS  159 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC-CCEEECCCCcc
Confidence            689999999999876541         26788889999999999999999999999999999999855 47999999999


Q ss_pred             eecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCC
Q psy3714         314 EFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGR  389 (467)
Q Consensus       314 ~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (467)
                      +........   ....+++.|+|||.+.+..++.+.|+|..+++...... +..|+.. .    ............   .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~----~~~~~~~~~~~~---~  231 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-V----ENSEIYDYLRQG---N  231 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-C----CHHHHHHHHHcC---C
Confidence            876433221   12245678999999998889999999988776443332 2223211 1    011111111100   0


Q ss_pred             CCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                             .   ...+..++++++++|.+||+.||.+|||+++++++
T Consensus       232 -------~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         232 -------R---LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             -------C---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                   0   01123467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.3e-32  Score=257.69  Aligned_cols=245  Identities=22%  Similarity=0.339  Sum_probs=187.0

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++.+.||+|+||.||+|.+..++..++||.+...      ....+.+|+.+++.+. |+||+.++..+...  ...+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~--~~~~   78 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIED--NELN   78 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeC--CeEE
Confidence            5789999999999999999999999999999987532      2245778999999985 89999999888653  4689


Q ss_pred             EEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         245 LIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ++|||++++++.++..       .+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||++....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  157 (267)
T cd08229          79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEECcchhhhccc
Confidence            9999999999887653       367888999999999999999999999999999999998654 79999999988654


Q ss_pred             CCCC-cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         318 PGQE-YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       318 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      .... .....|+..|+|||.+.+..++.+.|+|..+++......+..|+.....      +....... +.    ...+ 
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~----~~~~-  225 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKK-IE----QCDY-  225 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc------hHHHHhhh-hh----cCCC-
Confidence            3222 2334689999999999888889999999888775554444444432111      00011000 00    0000 


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                         ....+...++++++||.+||..||.+|||++++++
T Consensus       226 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         226 ---PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ---CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence               00112246889999999999999999999997653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.98  E-value=1.6e-31  Score=255.99  Aligned_cols=245  Identities=18%  Similarity=0.275  Sum_probs=183.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEcc-----CCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQ-----SSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++.+.||+|+||.||+|.+..     ++..+++|.+....    ...+.+|+.+++.++ |+||+++.+.+.+.  
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN-HQNIVRLIGVSFER--   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC--
Confidence            4679999999999999999999877     67789999876432    245788999999996 89999999987653  


Q ss_pred             CccEEEEeccCCccHHHHhh----------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC--CcEEEE
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ----------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLI  308 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~--~~ikl~  308 (467)
                      ...+++|||+.+++|.++..          .+++.++..++.||+.||+|||+++++||||||+||+++..+  ..+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            45789999999999987653          367788889999999999999999999999999999998543  359999


Q ss_pred             ecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhh
Q psy3714         309 DWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDK  384 (467)
Q Consensus       309 DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  384 (467)
                      |||+++........   .....+..|+|||++.+..++.++|+|..+++.+.... +..||.....     .........
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-----~~~~~~~~~  236 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-----QEVMEFVTG  236 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHc
Confidence            99999865322111   11223467999999988889999999988876443222 2233221110     111111110


Q ss_pred             hccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      .     .  .+      ..+..++.++.+|+.+||+.||++|||++++++|
T Consensus       237 ~-----~--~~------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         237 G-----G--RL------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             C-----C--cC------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0     0  01      1123478899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.98  E-value=2.4e-31  Score=254.60  Aligned_cols=244  Identities=16%  Similarity=0.262  Sum_probs=183.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCC-----CeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSS-----DKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++.+.||+|+||.||+|.+....     ..+++|.+....    ...+.+|+.+++.+. |+||+++++.+... 
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-   81 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSTG-   81 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcCC-
Confidence            3578999999999999999999876443     789999986432    345778999999985 89999999988764 


Q ss_pred             CCccEEEEeccCCccHHHHhhc-------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEE
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQT-------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLR  306 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ik  306 (467)
                       ...+++|||+++++|.+++..             +++..+..++.|++.||.|||++||+||||||+||+++.++ .+|
T Consensus        82 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~-~~k  159 (277)
T cd05032          82 -QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVK  159 (277)
T ss_pred             -CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC-CEE
Confidence             568999999999999877632             45567888999999999999999999999999999999654 799


Q ss_pred             EEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhh
Q psy3714         307 LIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFL  382 (467)
Q Consensus       307 l~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  382 (467)
                      |+|||+++.......   .....+|..|+|||.+.+..++.+.|+|..+++.+.... +..++....     ........
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-----~~~~~~~~  234 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-----NEEVLKFV  234 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-----HHHHHHHH
Confidence            999999976533221   123346788999999988889999999988876544332 223321110     01111111


Q ss_pred             hhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         383 DKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ..   +.          ....+...++++.+||.+||+.||++|||+.++++
T Consensus       235 ~~---~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         235 ID---GG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             hc---CC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            10   00          01112346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=1.1e-31  Score=272.84  Aligned_cols=261  Identities=21%  Similarity=0.317  Sum_probs=170.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEc----------------cCCCeEEEEEeccchH-----------------HHHHHH
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINV----------------QSSDKCVVKILKPVKK-----------------KKIKRE  215 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~~~~avK~~~~~~~-----------------~~~~~E  215 (467)
                      ..++|++.++||+|+||.||+|...                ..++.||||.++....                 +....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4689999999999999999999753                2345799998764211                 112346


Q ss_pred             HHHHHHhcCCCC----eeEEEEEEeCC------CCCccEEEEeccCCccHHHHhhc------------------------
Q psy3714         216 IKILENLRGGTN----IITLQAVVKDP------VSRTPALIFEHVNNTDFKQLYQT------------------------  261 (467)
Q Consensus       216 i~il~~l~~~~~----iv~l~~~~~~~------~~~~~~lv~e~~~~~~l~~~~~~------------------------  261 (467)
                      +.++.+++++++    ++.+..++...      .....++||||+.+++|.+++..                        
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777764432    23333333221      12357999999999998766431                        


Q ss_pred             ---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCccee--eeccCccCCcc
Q psy3714         262 ---LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR--VASRYFKGPEL  336 (467)
Q Consensus       262 ---~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~--~gt~~y~aPE~  336 (467)
                         ++...++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+|+....+......  .+|+.|+|||.
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence               23455778999999999999999999999999999998655 7999999999765433322222  34889999999


Q ss_pred             cccCC--------------------CC--ccchhHHHhhhccccccccc-cccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         337 LADYQ--------------------YH--IELDPRFADILGRHSRKRWE-RFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       337 l~~~~--------------------~~--~~~D~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      +....                    |.  ...|+|..+++......+.. ++...   .....+....       .....
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~---~~f~~~~~~~-------~~~~~  451 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANI---RLFNTELRQY-------DNDLN  451 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccch---hhhhhHHhhc-------cchHH
Confidence            86432                    21  23688877776544332211 11100   0000000000       00001


Q ss_pred             ccccc----ccccCCCCCChHHHHHHHhhcCcCC---CCCCCHHHHhCCCCCCC
Q psy3714         394 RWERF----VHTENQHLVSPEALDFLDKLLRYDH---YERLTAREAMDHPYFYP  440 (467)
Q Consensus       394 ~~~~~----~~~~~~~~~s~~~~dli~~lL~~dp---~~R~ta~e~l~Hp~f~~  440 (467)
                      .|...    .....+..+|++++|||++||+.+|   .+|+||+|+|+||||..
T Consensus       452 ~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        452 RWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             HHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            11111    1122234579999999999999876   68999999999999965

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.98  E-value=1.3e-31  Score=268.87  Aligned_cols=247  Identities=21%  Similarity=0.255  Sum_probs=182.5

Q ss_pred             CccceeeeEeecccCCcceEEEEEc-----cCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINV-----QSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|.+.+.||+|+||.||+|.+.     .++..||+|+++...    .+.+.+|+.+|..+..|+||+++.+.+... 
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-  113 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-  113 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence            4578999999999999999999853     345689999987532    235778999999997789999999988754 


Q ss_pred             CCccEEEEeccCCccHHHHhhc----------------------------------------------------------
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQT----------------------------------------------------------  261 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~~----------------------------------------------------------  261 (467)
                       ...++||||+.+++|.+++..                                                          
T Consensus       114 -~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         114 -GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             -CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence             468999999999998766531                                                          


Q ss_pred             -------------------------------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE
Q psy3714         262 -------------------------------------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI  298 (467)
Q Consensus       262 -------------------------------------------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill  298 (467)
                                                                 ++..++..++.|++.||+|||+++|+||||||+|||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl  272 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI  272 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence                                                       3345567789999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccC
Q psy3714         299 DHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLV  374 (467)
Q Consensus       299 ~~~~~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~  374 (467)
                      +.. ..+||+|||+++.......   .....++..|+|||.+.+..++...|+|..+++...... +..|+....     
T Consensus       273 ~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~-----  346 (401)
T cd05107         273 CEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP-----  346 (401)
T ss_pred             eCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC-----
Confidence            854 4899999999986532221   122356788999999988888999999988776443222 222321111     


Q ss_pred             ChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         375 SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ..+.   ....+...     +    ....+..+++++.+||.+|+..||.+|||++|+++.
T Consensus       347 ~~~~---~~~~~~~~-----~----~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         347 MNEQ---FYNAIKRG-----Y----RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             chHH---HHHHHHcC-----C----CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            0000   00000000     0    011233578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.98  E-value=5.9e-32  Score=259.75  Aligned_cols=244  Identities=14%  Similarity=0.233  Sum_probs=181.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEccC-----CCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQS-----SDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++++.||+|+||.||+|.+..+     ++.+|+|.++...    ...+.+|+.++..++ |+||+++.+.+.+.  
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~--   80 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKE--   80 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCC--
Confidence            45788999999999999999987543     4679999987432    245778999999886 89999999988764  


Q ss_pred             CccEEEEeccCCccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE  301 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~  301 (467)
                      ...+++++|+.++++.+++.                   .++...+..++.|++.||+|||++||+||||||+|||++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            45789999999998877652                   25677788999999999999999999999999999999855


Q ss_pred             CCcEEEEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChh
Q psy3714         302 NRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPE  377 (467)
Q Consensus       302 ~~~ikl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  377 (467)
                      + .+||+|||+++........   ....+++.|+|||.+.+..++.+.|+|..+++...... +..++....     ..+
T Consensus       161 ~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~  234 (283)
T cd05091         161 L-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQD  234 (283)
T ss_pred             C-ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-----HHH
Confidence            4 7999999998865332211   22345778999999988889999999988766443322 222322111     111


Q ss_pred             hhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ........   .          ....+...++++.+|+.+||+.||++|||++++++.
T Consensus       235 ~~~~i~~~---~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         235 VIEMIRNR---Q----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHcC---C----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            11111100   0          001123468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.98  E-value=1.2e-31  Score=254.30  Aligned_cols=241  Identities=19%  Similarity=0.261  Sum_probs=181.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..++|++++.||+|+||.||+|.+. ++..+|+|.++..  ....+.+|+.+++.++ |+|++.++..+..   ...+++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~---~~~~lv   78 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLR-HDKLVQLYAVVSE---EPIYIV   78 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcC-CCceEEEEeEECC---CCcEEE
Confidence            3478999999999999999999765 5667999988753  3456889999999996 8999999987743   347899


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      |||+.++++.++..     .+++.++..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG-LVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC-ceEEeCCceeeeeccCccc
Confidence            99999999988763     37888899999999999999999999999999999999854 4799999999986543221


Q ss_pred             c--ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         322 Y--NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       322 ~--~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      .  ....++..|+|||.+.+..++.+.|+|..+++...... +..|+....     ..+.......    .         
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~~~~~~~~~~----~---------  219 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-----NREVLEQVER----G---------  219 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHc----C---------
Confidence            1  11234567999999988888999999988876544333 222321110     0111111110    0         


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHh
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM  433 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l  433 (467)
                      ...+.+...+.++++||.+||..||.+|||++++.
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence            00111234688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.98  E-value=3.1e-31  Score=258.74  Aligned_cols=246  Identities=22%  Similarity=0.308  Sum_probs=184.8

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      +-|...+.||+|+||.||+|.+..+++.+++|.+...      ....+.+|+++++.++ |+|++.+.+.+.+.  ...+
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~   97 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKE--HTAW   97 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeC--CEEE
Confidence            4477788899999999999999999999999988632      1245778999999996 89999999988764  5679


Q ss_pred             EEEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         245 LIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++|||+.+ ++...+    ..+++.++..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.....  
T Consensus        98 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~~--  173 (313)
T cd06633          98 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASKSSP--  173 (313)
T ss_pred             EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-CEEEeecCCCcccCC--
Confidence            99999975 444433    2478888999999999999999999999999999999998554 799999999865322  


Q ss_pred             CcceeeeccCccCCcccc---cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         321 EYNVRVASRYFKGPELLA---DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~---~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                       .....|+..|+|||++.   ...++.+.|+|..+++......+..|+.....        .............      
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~~~------  238 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNDSP------  238 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHhcCCC------
Confidence             23456899999999984   34578889999888765444334444322110        0100000000000      


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                         ......+++.+++||.+||+.||++|||++++++||||...
T Consensus       239 ---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         239 ---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             ---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence               00112357789999999999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.98  E-value=1.2e-31  Score=258.82  Aligned_cols=243  Identities=20%  Similarity=0.281  Sum_probs=183.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEcc-----CCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQ-----SSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ..+|.+.+.||+|+||.||+|.+..     ++..+++|.++...   .+.+.+|+++++.++ |+||+++.+.+...  .
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~   80 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDG--D   80 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCC-CCCcceEEEEEccC--C
Confidence            3579999999999999999997543     44568888876542   346789999999996 89999999988753  5


Q ss_pred             ccEEEEeccCCccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN  302 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~  302 (467)
                      ..++||||+++++|.+++.                   .+++..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence            6899999999999987763                   257788899999999999999999999999999999999655


Q ss_pred             CcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhh
Q psy3714         303 RKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEA  378 (467)
Q Consensus       303 ~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  378 (467)
                       .+||+|||+++.......   .....++..|+|||.+.+..++.+.|+|..+++.+.... +..|+.....     ...
T Consensus       161 -~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~~  234 (291)
T cd05094         161 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-----TEV  234 (291)
T ss_pred             -cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHH
Confidence             799999999976533221   123456788999999998889999999988876544333 3344322110     111


Q ss_pred             hhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ......   +     .+.     ..+...+.++.+|+.+||+.||++|||++++++
T Consensus       235 ~~~~~~---~-----~~~-----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         235 IECITQ---G-----RVL-----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHhC---C-----CCC-----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            111110   0     010     112235789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.98  E-value=2.3e-31  Score=258.52  Aligned_cols=246  Identities=19%  Similarity=0.255  Sum_probs=181.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEc-------cCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINV-------QSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKD  237 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~  237 (467)
                      ..++|++.+.||+|+||.||+|...       ..+..+|+|.++..    ....+.+|+.+++.+.+|+||+++.+.+..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3578999999999999999999753       23347899988642    235678999999999779999999998876


Q ss_pred             CCCCccEEEEeccCCccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE
Q psy3714         238 PVSRTPALIFEHVNNTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI  298 (467)
Q Consensus       238 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill  298 (467)
                      .  ...+++|||+++++|.+++.                   .++..++..++.|++.||.|||++||+||||||+|||+
T Consensus        93 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili  170 (304)
T cd05101          93 D--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV  170 (304)
T ss_pred             C--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence            4  46899999999999887653                   24556778899999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccC
Q psy3714         299 DHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLV  374 (467)
Q Consensus       299 ~~~~~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~  374 (467)
                      +.++ .+||+|||+|+.......   .....+++.|+|||++.+..|+.+.|+|..+++...... +..++...     .
T Consensus       171 ~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~  244 (304)
T cd05101         171 TENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----P  244 (304)
T ss_pred             cCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----C
Confidence            8554 799999999986643221   122345678999999988889999999988876433222 12222110     0


Q ss_pred             ChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         375 SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ..+........    .   .      ...+...+.++++||.+||..+|.+|||+.|+++.
T Consensus       245 ~~~~~~~~~~~----~---~------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         245 VEELFKLLKEG----H---R------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHHcC----C---c------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            01111111100    0   0      01123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.98  E-value=1.2e-31  Score=256.06  Aligned_cols=236  Identities=17%  Similarity=0.216  Sum_probs=173.7

Q ss_pred             eecccCCcceEEEEEccCCC--eEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccC
Q psy3714         178 KLGRGKYSEVFEAINVQSSD--KCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVN  251 (467)
Q Consensus       178 ~lG~G~~g~V~~~~~~~~~~--~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~  251 (467)
                      .||+|+||.||+|.+..++.  .+++|.++..    ....+.+|++++.++.+||||+++++.+...  ...+++|||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEEeCC
Confidence            58999999999999887775  4578877642    2346778999999997799999999988753  46799999999


Q ss_pred             CccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccc
Q psy3714         252 NTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL  312 (467)
Q Consensus       252 ~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGl  312 (467)
                      +++|..++.                   .++..++..++.|++.||+|||++|++||||||+|||++.++ .+||+|||+
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-~~kl~dfgl  158 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGL  158 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-eEEECCCCC
Confidence            999887653                   257788899999999999999999999999999999998554 799999999


Q ss_pred             ceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         313 AEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       313 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      +..............+..|+|||++....++.++|+|..+++...... +..||....     ..+.....    .... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~~~----~~~~-  228 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEKL----PQGY-  228 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----HHHHHHHH----hCCC-
Confidence            864321111111233567999999988889999999988766443322 223332111     00111100    0000 


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                              ..+.+..+++++.+|+.+|+..||.+|||++|+++
T Consensus       229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 --------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             --------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                    00112246889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.98  E-value=2.1e-31  Score=253.56  Aligned_cols=244  Identities=16%  Similarity=0.224  Sum_probs=182.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccC---CCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQS---SDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      .++|++.+.||+|+||.||+|....+   ...+++|.++...    ...+.+|+.+++.++ |+||+++.+.+...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKS--RP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecC--Cc
Confidence            46799999999999999999987644   4578999876432    345778999999996 89999999988653  46


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .+++|||+++++|.++..    .++...+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~  158 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRLED  158 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-CEEECccchhhcccc
Confidence            899999999999987753    478889999999999999999999999999999999998654 799999999987642


Q ss_pred             -CCCcce--eeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         319 -GQEYNV--RVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       319 -~~~~~~--~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                       ......  ..++..|+|||.+.+..++...|+|..+++.+.... +..|+....     ........    ...     
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-----~~~~~~~~----~~~-----  224 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-----NQDVIKAV----EDG-----  224 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH----HcC-----
Confidence             111111  234567999999988889999999987766433221 222322111     01111111    000     


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      +    ..+.+...++++.+|+.+||+.||++|||++|++++
T Consensus       225 ~----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         225 Y----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             C----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0    011123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.98  E-value=1.2e-31  Score=258.15  Aligned_cols=255  Identities=24%  Similarity=0.383  Sum_probs=196.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..+.|++.+.||+|+||.||++.+..+++.+++|.++...  ...+.+|+++++.++ |+|++++++.+...  ...+++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCK-HPNIVDYYDSYLVG--DELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCC-CCCeeEEEEEEEEC--CEEEEE
Confidence            3467889999999999999999999889999999987544  456788999999996 79999999988764  568999


Q ss_pred             EeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-C
Q psy3714         247 FEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-E  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~  321 (467)
                      +||+++++|.+++.    .++...+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||++....... .
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC-CEEECccchhhhhccchhh
Confidence            99999999987764    478888899999999999999999999999999999998554 79999999987543221 1


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      .....++..|+|||++.+..++.+.|.|..+++.+....+..|+.....     ......    +...    .   ....
T Consensus       173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-----~~~~~~----~~~~----~---~~~~  236 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-----LRALFL----ITTK----G---IPPL  236 (286)
T ss_pred             hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH----HHhc----C---CCCC
Confidence            2234578899999999888899999999888775554444434321100     000000    0000    0   0011


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      .....++.++++||++||+.||.+|||++++++||||....+
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence            112236889999999999999999999999999999987443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.98  E-value=4.2e-31  Score=250.05  Aligned_cols=240  Identities=16%  Similarity=0.269  Sum_probs=180.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      .++|++.+.||+|+||.||++...  +..+++|..+... .+.+.+|+.+++.++ |+|++++.+.+... ....+++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~-~~~~~lv~e   80 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVEE-KGGLYIVTE   80 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCC-CCCeeeEEEEEEcC-CCceEEEEE
Confidence            468999999999999999999754  6789999887543 456789999999995 89999999875432 345799999


Q ss_pred             ccCCccHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcc
Q psy3714         249 HVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN  323 (467)
Q Consensus       249 ~~~~~~l~~~~~~-----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~  323 (467)
                      |++++++.+....     +++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++......  .
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~--~  157 (256)
T cd05082          81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ--D  157 (256)
T ss_pred             CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC-cEEecCCccceeccccC--C
Confidence            9999999877642     66788899999999999999999999999999999998554 79999999998653222  2


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccccccc
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE  402 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
                      ...++..|+|||++.+..++.+.|+|..+++.+.... +..|+....     .........    ..     +    ...
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~~----~~-----~----~~~  219 (256)
T cd05082         158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVE----KG-----Y----KMD  219 (256)
T ss_pred             CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHh----cC-----C----CCC
Confidence            2345668999999988889999999988766443221 222221110     001111110    00     0    011


Q ss_pred             CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       403 ~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .+..+++++++||.+||+.||++|||++++++
T Consensus       220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            22357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.98  E-value=5.6e-31  Score=249.35  Aligned_cols=243  Identities=16%  Similarity=0.219  Sum_probs=182.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .++|++.+.||+|+||.||+|.... +..+|+|.++...  ...+.+|+.+++.+. ||||+++++++...  ...+++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~   78 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQ--RPIYIVT   78 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCC-CCCeeeEEEEEccC--CCcEEEE
Confidence            4689999999999999999997643 4569999877532  356788999999996 89999999988653  4579999


Q ss_pred             eccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcc
Q psy3714         248 EHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN  323 (467)
Q Consensus       248 e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~  323 (467)
                      ||+.++++.++..    .+++..+..++.|++.||.|||++||+|+||||+||+++.++ .+||+|||+++.........
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-CEEECCCccceecCCCceee
Confidence            9999999887653    478888999999999999999999999999999999998554 79999999998654322111


Q ss_pred             --eeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         324 --VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       324 --~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                        ...++..|+|||.+.+..++...|+|..+++...... +..|+....     .+....   . +...    .+     
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~~~~~~---~-~~~~----~~-----  219 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-----NSETVE---K-VSQG----LR-----  219 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC-----HHHHHH---H-HhcC----CC-----
Confidence              1234567999999988889999999988876443322 222321110     011111   1 1000    00     


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ...+...++++++++.+||..||.+|||+.+++++
T Consensus       220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            01122358899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.98  E-value=1.7e-31  Score=258.38  Aligned_cols=250  Identities=18%  Similarity=0.265  Sum_probs=178.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCC--------------CeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSS--------------DKCVVKILKPVK----KKKIKREIKILENLRGGTNIITL  231 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~--------------~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l  231 (467)
                      ..+|++.+.||+|+||.||+|.+..++              ..||+|.++...    ...+.+|+++++.++ |+|++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK-NPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCcCeE
Confidence            468999999999999999999875432              358999886531    345788999999996 8999999


Q ss_pred             EEEEeCCCCCccEEEEeccCCccHHHHhhc---------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCce
Q psy3714         232 QAVVKDPVSRTPALIFEHVNNTDFKQLYQT---------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNV  296 (467)
Q Consensus       232 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---------------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Ni  296 (467)
                      .+.+...  ...++||||+.++++.+++..               ++...+..++.|++.||.|||++|++||||||+||
T Consensus        83 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          83 LGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             EEEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            9988653  568999999999998776531               45667788999999999999999999999999999


Q ss_pred             EEeCCCCcEEEEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc--ccccccccCCc
Q psy3714         297 MIDHENRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK--RWERFVHTENQ  371 (467)
Q Consensus       297 ll~~~~~~ikl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~--~~~~~~~~~~~  371 (467)
                      +++.+ ..+||+|||++.........   ....++..|+|||.+.+..++.++|+|..+++......  +..++....  
T Consensus       161 ll~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~--  237 (295)
T cd05097         161 LVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS--  237 (295)
T ss_pred             EEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC--
Confidence            99855 47999999999865332211   11234678999999988889999999987765432211  111211100  


Q ss_pred             ccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         372 HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                         .......... ..    ..... ......++..++.++||+++|+..||++|||++++++
T Consensus       238 ---~~~~~~~~~~-~~----~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         238 ---DEQVIENTGE-FF----RNQGR-QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             ---hHHHHHHHHH-hh----hhccc-cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence               0000000000 00    00000 0001123346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=3.8e-31  Score=260.49  Aligned_cols=245  Identities=19%  Similarity=0.255  Sum_probs=180.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccC-------CCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQS-------SDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      .+|++.+.||+|+||.||+|.+...       +..+|+|.++..    ..+.+.+|+++++.+.+|+||+++.+.+... 
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-   90 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-   90 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC-
Confidence            5799999999999999999986432       236899987642    1346788999999997799999999988653 


Q ss_pred             CCccEEEEeccCCccHHHHhhc-------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQT-------------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH  300 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~~-------------------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~  300 (467)
                       ...+++|||+++++|.+++..                   ++..++..++.|++.||.|||++||+||||||+|||++.
T Consensus        91 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~  169 (334)
T cd05100          91 -GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE  169 (334)
T ss_pred             -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence             468999999999999876532                   455667789999999999999999999999999999986


Q ss_pred             CCCcEEEEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCCh
Q psy3714         301 ENRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSP  376 (467)
Q Consensus       301 ~~~~ikl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  376 (467)
                      ++ .+||+|||+++........   ....++..|+|||++.+..++.+.|+|..+++.+.... +..++....     ..
T Consensus       170 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~  243 (334)
T cd05100         170 DN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VE  243 (334)
T ss_pred             CC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----HH
Confidence            54 7999999999865432211   11234567999999998889999999987766433222 222221110     01


Q ss_pred             hhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCC
Q psy3714         377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP  436 (467)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp  436 (467)
                      +......    ...         ....+...+.++.+||.+||..+|++|||+.|++++-
T Consensus       244 ~~~~~~~----~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         244 ELFKLLK----EGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHHHHHH----cCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            1111110    000         0111234688999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.2e-31  Score=251.99  Aligned_cols=242  Identities=16%  Similarity=0.231  Sum_probs=181.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      .+|++.+.||+|+||.||++.+. ++..+|+|.++..  ....+.+|+++++.++ |+||+++++.+...  ...+++||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv~e   79 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQ--RPIFIVTE   79 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCC-CCCEEEEEEEEcCC--CceEEEEe
Confidence            56889999999999999999875 4668999988643  3456788999999995 89999999887653  46899999


Q ss_pred             ccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcc-
Q psy3714         249 HVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN-  323 (467)
Q Consensus       249 ~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~-  323 (467)
                      |++++++.++..    .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++......... 
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-cEEECCcccceeccccccccc
Confidence            999999887653    367888899999999999999999999999999999998654 79999999998654222111 


Q ss_pred             -eeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         324 -VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       324 -~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                       ...++..|+|||.+.+..++.+.|+|..+++.+.... +..|+.....     .+...    .+...         ...
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~----~~~~~---------~~~  220 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-----SEVVE----SVSAG---------YRL  220 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH----HHHcC---------CcC
Confidence             1123447999999998889999999988776443332 2223211100     01111    11000         011


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ..+...++++++++.+||..+|++|||++|+++.
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            1223478999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=4.1e-31  Score=250.06  Aligned_cols=237  Identities=20%  Similarity=0.308  Sum_probs=183.2

Q ss_pred             EeecccCCcceEEEEEccC---CCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         177 RKLGRGKYSEVFEAINVQS---SDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      +.||+|+||.||+|.+...   +..+++|.++...    ...+.+|+.+++.++ |+|++++++.+.+  ....+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGVCTE--EEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC-CCChheeeeeecC--CCceEEEEEe
Confidence            3689999999999998866   8899999987542    456788999999997 8999999998876  4568999999


Q ss_pred             cCCccHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         250 VNNTDFKQLYQ------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       250 ~~~~~l~~~~~------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ++++++.+...            .+++.++..++.|++.||.|||++||+||||||+||+++.. +.+||+|||.+....
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~  156 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVY  156 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC-CcEEEcccccccccc
Confidence            99999887653            36788999999999999999999999999999999999965 479999999998765


Q ss_pred             CCC---CcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         318 PGQ---EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       318 ~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ...   ......++..|+|||.+....++.+.|+|..+++.+.... +..|+....     ..........   +     
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~---~-----  223 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----NEEVLEYLRK---G-----  223 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHc---C-----
Confidence            432   1233457889999999988889999999988876443332 233332110     0111111110   0     


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                           .....+..+|+++.++|.+||+.||.+|||++|+++|
T Consensus       224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         224 -----YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             -----CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                 0112234568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=3e-31  Score=251.60  Aligned_cols=241  Identities=18%  Similarity=0.254  Sum_probs=182.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .++|+++++||+|+||.||+|... +++.+|+|.+...  ....+.+|+.+++.++ |+|++.+.+.+..   ...+++|
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~---~~~~~v~   79 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQ-HPRLVRLYAVVTQ---EPIYIIT   79 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcC-CcCeeeEEEEEcc---CCcEEEE
Confidence            478999999999999999999854 5678999988753  2457889999999996 8999999988643   4579999


Q ss_pred             eccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-
Q psy3714         248 EHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-  321 (467)
Q Consensus       248 e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-  321 (467)
                      ||+.++++.+...     .++..++..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++........ 
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-CEEEccCcceeecCCCCcc
Confidence            9999999887653     367788889999999999999999999999999999999654 799999999987642221 


Q ss_pred             -cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         322 -YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       322 -~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                       .....++..|+|||.+....++.+.|+|..+++.+.... +..|+....     .+.........             .
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~-------------~  220 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-----NPEVIQNLERG-------------Y  220 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC-----hHHHHHHHHcC-------------C
Confidence             112345678999999988888999999988876443332 333332111     11111111100             0


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ..+.+...++++++||.+||+.||++|||++++++
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            01122346789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.5e-31  Score=250.51  Aligned_cols=239  Identities=18%  Similarity=0.263  Sum_probs=182.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .++|++.+.||+|+||.||+|...  ++.+|+|.++...  .+++.+|+.+++.++ |+||+++.+.+.+  ....+++|
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLR-HPNLVQLLGVVLQ--GNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcC-CcceeeeEEEEcC--CCCeEEEE
Confidence            468999999999999999999864  7889999987553  457888999999996 8999999998875  45689999


Q ss_pred             eccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc
Q psy3714         248 EHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       248 e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~  322 (467)
                      ||++++++.+...     .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++......  
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-CEEEccccccccccccc--
Confidence            9999999987763     478889999999999999999999999999999999998554 79999999998763222  


Q ss_pred             ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         323 NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      .....+..|+|||.+....++.+.|+|..+++...... +..|+....     ........    ...     +    ..
T Consensus       157 ~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~----~~~-----~----~~  218 (256)
T cd05039         157 DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPHV----EKG-----Y----RM  218 (256)
T ss_pred             ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHH----hcC-----C----CC
Confidence            12334567999999988888889999988765332221 222221110     00111100    000     0    00


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ..+...++++.+||++||..||++|||++|+++
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            112346899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=5.6e-31  Score=252.61  Aligned_cols=242  Identities=15%  Similarity=0.240  Sum_probs=179.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCC----eEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSD----KCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      .++|++++.||+|+||.||+|....+++    .+++|.+....    ...+..|+.+++.+. |+||+++++++..   .
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~~---~   81 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD-HAYIVRLLGICPG---A   81 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCC-CCCcceEEEEECC---C
Confidence            4789999999999999999999877776    46777765322    234566777888885 8999999998753   3


Q ss_pred             ccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..++++||++++++.++..    .+++..+..++.||+.||.|||++|++||||||+|||++.+ ..+||+|||+++...
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~  160 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD-SIVQIADFGVADLLY  160 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEEcCCccceecc
Confidence            4689999999999987763    46788899999999999999999999999999999999854 479999999998654


Q ss_pred             CCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         318 PGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       318 ~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      +...   .....++..|+|||.+....|+.+.|+|..+++.+.... +..|+.....     ..........     .  
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~-----~--  228 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----HEVPDLLEKG-----E--  228 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCC-----C--
Confidence            3321   122346778999999988889999999988876443332 3333321110     0011111100     0  


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                            ....+...+.+..+++.+|+..||++|||++|+++
T Consensus       229 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         229 ------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                  01112235778999999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=7.8e-31  Score=256.37  Aligned_cols=246  Identities=23%  Similarity=0.329  Sum_probs=186.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ..|+..+.||+|+||.||++.+..++..+|+|.+...      ....+.+|+++++.++ |+|++.+.+.+.+.  ...+
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~  101 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLRE--HTAW  101 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeC--CeEE
Confidence            4578889999999999999999999999999988632      1245778999999995 89999999988754  4579


Q ss_pred             EEEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         245 LIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      +||||+.+ ++.+..    ..+++.++..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++...... 
T Consensus       102 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         102 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASIASPA-  178 (317)
T ss_pred             EEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC-CEEEecCCCccccCCc-
Confidence            99999986 444443    2478889999999999999999999999999999999998654 7999999998765432 


Q ss_pred             CcceeeeccCccCCcccc---cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         321 EYNVRVASRYFKGPELLA---DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~---~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                        ....|++.|+|||.+.   ...++.++|+|..+++......+..|+....        .............       
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~~-------  241 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES-------  241 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHhccC-------
Confidence              2346889999999984   3457888999988877555444444443211        0000000000000       


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                        ........++.+++||.+||+.||.+|||++|+++|||+...
T Consensus       242 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         242 --PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             --CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence              001112367899999999999999999999999999999643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=2.4e-31  Score=252.28  Aligned_cols=243  Identities=17%  Similarity=0.251  Sum_probs=185.3

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ...+|++++.||.|+||.||+|.+.. +..+++|.++...   ...+.+|+.+++.++ |+||+++.+.+.+.  ...++
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~l   79 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLR-HKHLISLFAVCSVG--EPVYI   79 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCC-CcchhheeeeEecC--CCeEE
Confidence            34689999999999999999999877 8889999987543   356788999999996 89999999988754  46899


Q ss_pred             EEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         246 IFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      +|||+++++|.++..     .++...+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDV  158 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-eEEEccccchhhcCCcc
Confidence            999999999988764     367888899999999999999999999999999999998654 79999999997653221


Q ss_pred             C-cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         321 E-YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       321 ~-~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      . .....++..|+|||.+.+..++.+.|+|..+++.+.... +..|+....     ..+........    .        
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-----~~~~~~~~~~~----~--------  221 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-----NHEVYDQITAG----Y--------  221 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-----HHHHHHHHHhC----C--------
Confidence            1 112235667999999988889999999988876443332 222321111     01111111100    0        


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                       ....+...++++.++|.+||+.||.+|||++++++
T Consensus       222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         222 -RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             -cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence             01122357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=4.8e-31  Score=250.30  Aligned_cols=241  Identities=18%  Similarity=0.234  Sum_probs=180.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .++|++.+.||+|+||.||+|.+..+ ..+|+|.+...  ....+.+|+.+++.+. |+|++.++..+..   ...+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~---~~~~~v~   79 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLR-HDKLVPLYAVVSE---EPIYIVT   79 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCC-CCCeeeEEEEEcC---CCcEEEE
Confidence            46799999999999999999987654 46899987643  2356788999999996 8999999887753   4578999


Q ss_pred             eccCCccHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-
Q psy3714         248 EHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-  321 (467)
Q Consensus       248 e~~~~~~l~~~~~~-----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-  321 (467)
                      ||+.++++.+.+..     ++...+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++........ 
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-eEEECCCccceEccCCccc
Confidence            99999998877642     57788889999999999999999999999999999998554 799999999986543221 


Q ss_pred             -cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         322 -YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       322 -~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                       .....++..|+|||.+.+..++...|+|..+++.+.... +..|+....     ......    .+....         
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~----~~~~~~---------  220 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-----NREVLE----QVERGY---------  220 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHH----HHHcCC---------
Confidence             112235677999999988888999999988876544333 222322111     001111    110000         


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ....+...+..+++|+++||..||++|||++++++
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         221 RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            01112346889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.3e-31  Score=249.52  Aligned_cols=237  Identities=25%  Similarity=0.409  Sum_probs=185.4

Q ss_pred             ecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCC
Q psy3714         179 LGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNN  252 (467)
Q Consensus       179 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~  252 (467)
                      ||.|+||.||++.+..+++.+++|.++...      ...+.+|+.+++.+. |+|++.++..+..  ....+++|||+.+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~e~~~~   77 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQT--EEKLYLVLEYAPG   77 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeec--CCeeEEEEecCCC
Confidence            699999999999998889999999886432      236788999999996 8999999888765  3568999999999


Q ss_pred             ccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CCcceeeec
Q psy3714         253 TDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVAS  328 (467)
Q Consensus       253 ~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~~~~~~gt  328 (467)
                      +++.+.+.   .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++...... .......++
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCcccCCcCC
Confidence            99887764   478899999999999999999999999999999999998655 7999999999876433 223345688


Q ss_pred             cCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCC
Q psy3714         329 RYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVS  408 (467)
Q Consensus       329 ~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  408 (467)
                      ..|+|||.+.+..++...|.|..+++......+..++.....        ..... .+..    .      ....+..++
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~-~~~~----~------~~~~~~~~~  217 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYE-KILK----D------PLRFPEFLS  217 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHH-HHhc----C------CCCCCCCCC
Confidence            899999999888888899999877765444444444422110        00010 1100    0      111233468


Q ss_pred             hHHHHHHHhhcCcCCCCCCCH---HHHhCCCCC
Q psy3714         409 PEALDFLDKLLRYDHYERLTA---REAMDHPYF  438 (467)
Q Consensus       409 ~~~~dli~~lL~~dp~~R~ta---~e~l~Hp~f  438 (467)
                      ++..+||++||..||.+|||+   +++++||||
T Consensus       218 ~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         218 PEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            899999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=6.4e-31  Score=248.99  Aligned_cols=234  Identities=18%  Similarity=0.294  Sum_probs=174.9

Q ss_pred             eecccCCcceEEEEE--ccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         178 KLGRGKYSEVFEAIN--VQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       178 ~lG~G~~g~V~~~~~--~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      .||+|+||.||+|..  ..++..+|+|+++...     .+.+.+|+.+++.+. |+||+++.+.+..   ...+++|||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVRMIGICEA---ESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcC---CCcEEEEecC
Confidence            589999999999964  4567889999986432     346788999999985 8999999988753   3568999999


Q ss_pred             CCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc----c
Q psy3714         251 NNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----N  323 (467)
Q Consensus       251 ~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~----~  323 (467)
                      +++++.++..   .+++..+..++.|++.||+|||++||+||||||+||+++.+ ..+||+|||+++........    .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC-CeEEECCCccccccCCCCCeeeecC
Confidence            9999887663   47888999999999999999999999999999999999865 47999999999865433221    1


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccccccc
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE  402 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
                      ...++..|+|||.+....++...|+|..+++.+.... +..||.....     ..........   .          ..+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~i~~~---~----------~~~  218 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----NEVTQMIESG---E----------RME  218 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHCC---C----------CCC
Confidence            1234578999999988788899999988876544332 3333321110     0111111110   0          011


Q ss_pred             CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       403 ~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .+..+++++.|||.+|++.||++|||++++.+
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence            23457899999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=8.6e-31  Score=247.59  Aligned_cols=240  Identities=20%  Similarity=0.273  Sum_probs=182.4

Q ss_pred             eeeeEeecccCCcceEEEEEccCC----CeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSS----DKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~----~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      +++.+.||.|+||.||+|.+...+    ..+|+|.++...    .+.+..|+.+++.+ +|+||+.+...+.+.  ...+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEE--EPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC--CeeE
Confidence            356789999999999999998766    889999987543    45778899999999 589999999988764  5689


Q ss_pred             EEEeccCCccHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         245 LIFEHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ++|||++++++.+....     +++..+..++.|++.||.|||++|++||||||+||+++..+ .++|+|||++......
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~  156 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-eEEEcccCCceecccc
Confidence            99999999998876532     88899999999999999999999999999999999998654 7999999999876543


Q ss_pred             CCcce--eeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         320 QEYNV--RVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       320 ~~~~~--~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      .....  ..+++.|+|||.+....++.+.|+|..+++...... +..++.. .       ........ +....      
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~-------~~~~~~~~-~~~~~------  221 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-M-------SNEEVLEY-LKKGY------  221 (258)
T ss_pred             cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-C-------CHHHHHHH-HhcCC------
Confidence            22221  236788999999987788999999988766433222 2222211 0       00111111 00000      


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                         ....+...++++.+++.+||+.||++|||+.|+++
T Consensus       222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      222 ---RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ---CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence               01112337899999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=4.3e-31  Score=254.80  Aligned_cols=241  Identities=18%  Similarity=0.273  Sum_probs=178.0

Q ss_pred             ceeeeEeecccCCcceEEEEEcc-----CCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQ-----SSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+....    ...+.+|+.+++.+. ||||+++.+.+...  ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQD--GP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecC--CC
Confidence            47889999999999999998753     22568888876432    346788999999995 89999999987653  46


Q ss_pred             cEEEEeccCCccHHHHhh---------------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q psy3714         243 PALIFEHVNNTDFKQLYQ---------------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHN  295 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~N  295 (467)
                      .+++|||+.++++..++.                           .++...+..++.|++.||+|||++||+||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            799999999999887643                           25567788999999999999999999999999999


Q ss_pred             eEEeCCCCcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCc
Q psy3714         296 VMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQ  371 (467)
Q Consensus       296 ill~~~~~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~  371 (467)
                      ||++.+ +.+||+|||+++.......   .....++..|+|||.+.+..++...|+|..+++...... +..|+....  
T Consensus       158 ill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--  234 (290)
T cd05045         158 VLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--  234 (290)
T ss_pred             EEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC--
Confidence            999855 4799999999986532221   122345678999999988889999999988876443332 222321110  


Q ss_pred             ccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         372 HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                         ...........         +    ....+...++++++|+.+||+.||++|||++|+++
T Consensus       235 ---~~~~~~~~~~~---------~----~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         235 ---PERLFNLLKTG---------Y----RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             ---HHHHHHHHhCC---------C----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence               00111111100         0    11123357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=1.5e-31  Score=253.57  Aligned_cols=234  Identities=14%  Similarity=0.184  Sum_probs=172.7

Q ss_pred             EeecccCCcceEEEEEccCCC-------eEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         177 RKLGRGKYSEVFEAINVQSSD-------KCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~-------~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +.||+|+||.||+|.+..++.       .+++|.+....   .+.+.+|+.+++.+. |+||+.+++.+..+  ...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~--~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS-HKHLVLNYGVCVCG--DESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCC-CCChhheeeEEEeC--CCcEEE
Confidence            368999999999998865443       37788765432   245677889998885 89999999988764  457999


Q ss_pred             EeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCc-------EEEEeccccee
Q psy3714         247 FEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRK-------LRLIDWGLAEF  315 (467)
Q Consensus       247 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~-------ikl~DFGla~~  315 (467)
                      |||+++++|.+++.    .+++..+..++.||+.||+|||++||+||||||+|||++.++..       ++++|||++..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999988764    36788888999999999999999999999999999999866532       79999999876


Q ss_pred             cCCCCCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         316 YHPGQEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       316 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ..+.   ....++..|+|||++.+. .++...|+|..+++.+....+..+++....       .....  .....     
T Consensus       158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-------~~~~~--~~~~~-----  220 (258)
T cd05078         158 VLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-------SQKKL--QFYED-----  220 (258)
T ss_pred             cCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-------HHHHH--HHHHc-----
Confidence            5432   234688899999999874 478889999888764443333222211110       00000  00000     


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                           ....+...++++.+||++||+.||++|||++++++.
T Consensus       221 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 -----RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             -----cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                 001122356889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=4.1e-31  Score=252.78  Aligned_cols=245  Identities=16%  Similarity=0.235  Sum_probs=182.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccC-----CCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQS-----SDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++++.||+|+||.||+|....+     .+.+++|.+....    ...+.+|++++++++ |+||++++..+.+.  
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--   80 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS-HKNVVRLLGLCREA--   80 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC-CcceeeeEEEECCC--
Confidence            47899999999999999999996543     4578999876432    346788999999995 89999999987653  


Q ss_pred             CccEEEEeccCCccHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEE
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLI  308 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~  308 (467)
                      ...++||||+++++|.+++.            .+++..+..++.|++.||+|||++||+||||||+||+++.++ .++|+
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~  159 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR-EVKVS  159 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC-cEEEc
Confidence            56799999999999987753            367888999999999999999999999999999999998655 79999


Q ss_pred             ecccceecCCCC--CcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhh
Q psy3714         309 DWGLAEFYHPGQ--EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKN  385 (467)
Q Consensus       309 DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  385 (467)
                      |||++.......  ......++..|+|||.+.+..++.+.|+|..+++...... +..++.....     .   ......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----~---~~~~~~  231 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----E---EVLNRL  231 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-----H---HHHHHH
Confidence            999987542211  1233456788999999988888889999988766433222 2222211110     0   111110


Q ss_pred             ccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ..   ....|      ..+...++++.++|.+||..||.+|||+.|++++
T Consensus       232 ~~---~~~~~------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         232 QA---GKLEL------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             Hc---CCcCC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            00   00111      1123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=7.4e-31  Score=249.10  Aligned_cols=241  Identities=22%  Similarity=0.285  Sum_probs=181.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .++|++.+.||+|+||.||+|.+. +++.+|+|.++..  ..+.+.+|+.++++++ |+||++++..+...  ...+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLR-HPKLIQLYAVCTLE--EPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCC-CCCccceeEEEecC--CCeeeee
Confidence            467999999999999999999865 4568999998753  2456789999999996 89999999987653  4679999


Q ss_pred             eccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc
Q psy3714         248 EHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       248 e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~  322 (467)
                      ||+.+++|.+.+.     .++...+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++...... .
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~-~  158 (261)
T cd05068          81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKEDI-Y  158 (261)
T ss_pred             ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-CEEECCcceEEEccCCc-c
Confidence            9999999987763     367888999999999999999999999999999999999655 79999999998764221 1


Q ss_pred             ceeee---ccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         323 NVRVA---SRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       323 ~~~~g---t~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      ....|   +..|+|||.+.+..++...|+|..+++...... +..|+.. ..    ..........    .     +   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~----~~~~~~~~~~----~-----~---  221 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG-MT----NAEVLQQVDQ----G-----Y---  221 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC-CC----HHHHHHHHHc----C-----C---
Confidence            11222   347999999988889999999988766443332 2222211 10    0111111110    0     0   


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                       ....+...++++.+|+.+||+.||.+|||++++++
T Consensus       222 -~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         222 -RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             -CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence             00112346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=5.5e-31  Score=254.84  Aligned_cols=250  Identities=18%  Similarity=0.256  Sum_probs=178.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEcc----------------CCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCee
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQ----------------SSDKCVVKILKPVK----KKKIKREIKILENLRGGTNII  229 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv  229 (467)
                      .++|++.+.||+|+||.||++.+..                ++..+|+|.++...    ...+.+|+++++.++ |+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK-DPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcc
Confidence            3579999999999999999986432                23468999886432    346789999999995 89999


Q ss_pred             EEEEEEeCCCCCccEEEEeccCCccHHHHhhc--------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q psy3714         230 TLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT--------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHN  295 (467)
Q Consensus       230 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~N  295 (467)
                      ++++.+.+.  ...+++|||+.+++|.+++..              ++...+..++.|++.||+|||++||+||||||+|
T Consensus        83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          83 RLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             eEEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            999988764  457999999999999877542              4456789999999999999999999999999999


Q ss_pred             eEEeCCCCcEEEEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc--ccccccccCC
Q psy3714         296 VMIDHENRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK--RWERFVHTEN  370 (467)
Q Consensus       296 ill~~~~~~ikl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~--~~~~~~~~~~  370 (467)
                      ||++.. +.+||+|||+|+........   ....++..|+|||......++.+.|+|..+++.+....  +..|+.....
T Consensus       161 ili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         161 CLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             EEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            999854 47999999999865432211   11234678999999888889999999988776443322  2222221111


Q ss_pred             cccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         371 QHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .     .............     ... ...+.+...++.+++|+.+||..||++|||+.|+.+
T Consensus       240 ~-----~~~~~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         240 E-----QVIENTGEFFRDQ-----GRQ-VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             H-----HHHHHHHHHHhhc-----ccc-ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            0     0000000000000     000 001122346789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=1.2e-30  Score=248.64  Aligned_cols=243  Identities=16%  Similarity=0.248  Sum_probs=181.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCC---eEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSD---KCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..+|++.+.||+|+||.||+|.+..++.   .+|+|.++..    ....+.+|+.+++.++ ||||+++++.+...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~   79 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKS--KP   79 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecC--Cc
Confidence            3679999999999999999998865543   6899987643    2346788999999995 89999999988653  56


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .+++|||+++++|.+...    .++..++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~~l~dfg~~~~~~~  158 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLED  158 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC-eEEeCCCCccccccc
Confidence            899999999999987764    367888899999999999999999999999999999998554 799999999986643


Q ss_pred             CCCc--c--eeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         319 GQEY--N--VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       319 ~~~~--~--~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ....  .  ...++..|+|||.+.+..++.+.|.|..+++...... +..|+.....     .+......    ..    
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-----~~~~~~~~----~~----  225 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-----QDVIKAIE----EG----  225 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-----HHHHHHHh----CC----
Confidence            2211  1  1123467999999988889999999987765433221 3333322110     11111110    00    


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                       +    ..+.+..+++++.+|+.+||+.||.+|||++++++
T Consensus       226 -~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         226 -Y----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             -C----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence             0    01122346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=7.7e-31  Score=251.75  Aligned_cols=242  Identities=18%  Similarity=0.271  Sum_probs=180.6

Q ss_pred             cceeeeEeecccCCcceEEEEEc-----cCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINV-----QSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      .+|++.++||+|+||.||++...     .++..+++|.++...   ...+.+|+++++.++ |+||+++.+.+.+.  ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ-HQHIVRFYGVCTEG--RP   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecC--Cc
Confidence            57889999999999999999643     345678888876432   356889999999995 89999999887653  45


Q ss_pred             cEEEEeccCCccHHHHhh------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCc
Q psy3714         243 PALIFEHVNNTDFKQLYQ------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRK  304 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~  304 (467)
                      .+++|||+.+++|.+++.                  .++...+..++.|++.||+|||++||+||||||+|||++.+ ..
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~-~~  160 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG-LV  160 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC-CC
Confidence            799999999999887653                  25677888999999999999999999999999999999855 47


Q ss_pred             EEEEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhh
Q psy3714         305 LRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALD  380 (467)
Q Consensus       305 ikl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  380 (467)
                      +||+|||+++........   ....+++.|+|||.+.+..++.++|+|..+++.+.... +..|+....        ...
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~  232 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS--------NTE  232 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC--------HHH
Confidence            999999999865432221   12335678999999998889999999988776443332 333332111        011


Q ss_pred             hhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .......+.          ....+..+++++.+||.+||..||.+|||++|+++
T Consensus       233 ~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         233 AIECITQGR----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHHcCc----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            111110000          01122347899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=1e-30  Score=247.78  Aligned_cols=234  Identities=16%  Similarity=0.293  Sum_probs=173.8

Q ss_pred             eecccCCcceEEEEEc--cCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccC
Q psy3714         178 KLGRGKYSEVFEAINV--QSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVN  251 (467)
Q Consensus       178 ~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~  251 (467)
                      .||+|+||.||+|...  .++..+|+|+++...    .+.+.+|+.+++.++ |+||+++.+.+..   ...++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~---~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD-NPYIVRMIGVCEA---EALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEcC---CCeEEEEEeCC
Confidence            3899999999999765  344568999886542    245788999999995 8999999998753   35799999999


Q ss_pred             CccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc----c
Q psy3714         252 NTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----N  323 (467)
Q Consensus       252 ~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~----~  323 (467)
                      +++|.+++.    .+++.++..++.|++.||.|||++|++||||||+|||++.++ .+||+|||++.........    .
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEeccCCccccccCCccceeccC
Confidence            999987663    478899999999999999999999999999999999998554 7999999999865432221    1


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccccccc
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE  402 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
                      ...++..|+|||.+....++.+.|+|..+++...... +..|+.....     .+........     .        ...
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~-----~--------~~~  218 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-----PEVMSFIEQG-----K--------RLD  218 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHHHHCC-----C--------CCC
Confidence            1223568999999988888999999988876443322 3333322110     1111111100     0        011


Q ss_pred             CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       403 ~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .+...++++.+||.+|+..||++|||+.++.+
T Consensus       219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            22346899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.2e-30  Score=250.46  Aligned_cols=254  Identities=18%  Similarity=0.267  Sum_probs=186.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEc----cCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINV----QSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ..+|++++.||+|+||.||+|...    .++..+|+|.++...    ...+.+|+++++.+. |+||+++.+++......
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD-HENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC-CCChheEEeeeecCCCC
Confidence            367889999999999999999854    347889999987542    346889999999995 89999999988765566


Q ss_pred             ccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..+++|||++++++.++..    .++...+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~  160 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE-DLVKISDFGLAKVLP  160 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccccccccc
Confidence            7899999999999987764    37888889999999999999999999999999999999865 479999999998764


Q ss_pred             CCCCc----ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccC--Ch----hhhhhhhhhcc
Q psy3714         318 PGQEY----NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLV--SP----EALDFLDKNIL  387 (467)
Q Consensus       318 ~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~----~~~~~~~~~~~  387 (467)
                      .....    ....++..|+|||.+....++...|+|..+++......+..++.........  .+    ......... .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  239 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL-L  239 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH-H
Confidence            32221    1123456799999998888899999998887755544444333221111000  00    000000000 0


Q ss_pred             CCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ..        ......+...++++.+|+.+||..||++|||+.|+++
T Consensus       240 ~~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         240 KE--------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             Hc--------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            00        0011112345789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=9.5e-31  Score=252.08  Aligned_cols=243  Identities=16%  Similarity=0.225  Sum_probs=181.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEcc-----CCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQ-----SSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++.+.||+|+||.||+|.+..     ++..+|+|.++...    ...+.+|+.+++.+. |+||+++.+.+.+.  
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~--   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-HPNIVKLLGVCAVG--   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCC--
Confidence            4789999999999999999998743     56789999886432    345788999999995 89999999988753  


Q ss_pred             CccEEEEeccCCccHHHHhh-------------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ-------------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHN  295 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~-------------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~N  295 (467)
                      ...+++|||+++++|.++..                         .+++..+..++.|++.||.|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            46799999999999987764                         24566778999999999999999999999999999


Q ss_pred             eEEeCCCCcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCc
Q psy3714         296 VMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQ  371 (467)
Q Consensus       296 ill~~~~~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~  371 (467)
                      |+++.++ .+||+|||++........   .....++..|+|||.+.+..++.+.|+|..+++.+.... +..++....  
T Consensus       161 il~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~--  237 (288)
T cd05050         161 CLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA--  237 (288)
T ss_pred             eEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--
Confidence            9998654 799999999876532221   112234567999999988889999999988876443221 222332111  


Q ss_pred             ccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         372 HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                         ..+........   .    .      ...+...++++.+||.+||+.||.+|||++|+++
T Consensus       238 ---~~~~~~~~~~~---~----~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         238 ---HEEVIYYVRDG---N----V------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             ---HHHHHHHHhcC---C----C------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence               01111111100   0    0      0112346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0668|consensus

Probab=99.97  E-value=3.9e-32  Score=236.92  Aligned_cols=140  Identities=86%  Similarity=1.469  Sum_probs=135.3

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeeeE
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDM   82 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~   82 (467)
                      ...+++.||+||||+||+|||+||.|++|+.....++|+|+|+|.++.++..++.++.|++|..||.+...+.|+.+.|+
T Consensus       137 Y~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~  216 (338)
T KOG0668|consen  137 YIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDM  216 (338)
T ss_pred             HHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHH
Confidence            46789999999999999999999999999988889999999999999999999999999999999999999999999999


Q ss_pred             EchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchhHhhhhhhccCCCchhhhhccc
Q psy3714          83 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADILGR  142 (467)
Q Consensus        83 ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  142 (467)
                      |||||++..|+..+.|||.|+++++|+.+|++++|+.++..++.++.+.++|++.+++++
T Consensus       217 WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~  276 (338)
T KOG0668|consen  217 WSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGR  276 (338)
T ss_pred             HHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhc
Confidence            999999999999999999999999999999999999999999999999999999998865

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=8.6e-31  Score=249.92  Aligned_cols=243  Identities=19%  Similarity=0.313  Sum_probs=181.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccC---CCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQS---SDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      .++|.+.+.||+|+||.||+|.+...   ...+++|.....    ..+.+.+|+.+++.+. |+||+++.+.+.+   ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~---~~   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE---NP   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC---CC
Confidence            46799999999999999999987654   346888987643    2346788999999996 8999999998765   34


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .+++|||++++++.+++.    .++...+..++.|++.||+|||++|++||||||+||+++..+ .+||+|||+++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~  159 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLED  159 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC-CeEEccCceeeeccc
Confidence            689999999999988764    378888999999999999999999999999999999998554 799999999986543


Q ss_pred             CCCcc--eeeeccCccCCcccccCCCCccchhHHHhhhccccc-cccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         319 GQEYN--VRVASRYFKGPELLADYQYHIELDPRFADILGRHSR-KRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       319 ~~~~~--~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      ...+.  ...++..|+|||.+....++.+.|+|..+++..... .+..||.....     .+.......   +.      
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~~~~---~~------  225 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-----NDVIGRIEN---GE------  225 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHc---CC------
Confidence            32221  122346799999998888999999998776643322 13333322111     111110000   00      


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                          ....+..+++++.+||.+|+..||.+|||+.+++..
T Consensus       226 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         226 ----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             ----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                001223578999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=1.1e-30  Score=254.24  Aligned_cols=247  Identities=23%  Similarity=0.318  Sum_probs=185.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ...|+..+.||+|+||.||+|.+..+++.+++|.+...      ....+.+|+++++.++ |+|++.+.+.+...  ...
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~   90 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLRE--HTA   90 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcC--Cee
Confidence            35588889999999999999999999999999987532      1235678999999995 89999999988764  467


Q ss_pred             EEEEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         244 ALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ++||||+.+ ++....    ..+++.++..++.|++.||.|||+++++||||||+||+++.++ .+||+|||++....+.
T Consensus        91 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~  168 (308)
T cd06634          91 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA  168 (308)
T ss_pred             EEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-cEEECCcccceeecCc
Confidence            999999975 554433    2478889999999999999999999999999999999998654 7999999999865432


Q ss_pred             CCcceeeeccCccCCccccc---CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         320 QEYNVRVASRYFKGPELLAD---YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~---~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                         ....+++.|+|||.+..   ..++.+.|+|..+++......+..|+....        ..........+..      
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~------  231 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES------  231 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc--------HHHHHHHHhhcCC------
Confidence               23468899999999853   457888999988876544433433332110        0000000000000      


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                         ........+..+++||++||..+|++|||++++++|||+...
T Consensus       232 ---~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         232 ---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             ---CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence               000112468899999999999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1e-30  Score=247.53  Aligned_cols=235  Identities=18%  Similarity=0.265  Sum_probs=176.4

Q ss_pred             EeecccCCcceEEEEEccCC---CeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         177 RKLGRGKYSEVFEAINVQSS---DKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      +.||+|+||.||+|....++   ..+|+|.++...    .+.+.+|+.+++.+. |+||+++.+.+..   ...+++|+|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~---~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD-HPCIVRLIGVCKG---EPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEcC---CceEEEEEe
Confidence            36899999999999876655   689999886432    346788999999995 8999999987753   357999999


Q ss_pred             cCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc-ce-
Q psy3714         250 VNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NV-  324 (467)
Q Consensus       250 ~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~-~~-  324 (467)
                      ++++++.+.+.   .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++........ .. 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-cEEeccccccceeecCCcccccc
Confidence            99999987764   378889999999999999999999999999999999998654 7999999999866433221 11 


Q ss_pred             --eeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         325 --RVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       325 --~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                        ..++..|+|||.+....++.+.|+|..+++...... +..|+....     ..........    .         ...
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-----~~~~~~~~~~----~---------~~~  217 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-----GAEVIAMLES----G---------ERL  217 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHHHc----C---------CcC
Confidence              112457999999988889999999988876444332 333332111     1111111110    0         001


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ..+..++++++|||.+||..||++|||+.++++
T Consensus       218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            123357889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=1.9e-30  Score=246.65  Aligned_cols=233  Identities=18%  Similarity=0.178  Sum_probs=167.8

Q ss_pred             EeecccCCcceEEEEEcc------------CCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         177 RKLGRGKYSEVFEAINVQ------------SSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~------------~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      +.||+|+||.||+|....            ....+++|.+....   ...+.+|+.+++.++ ||||+++++++...  .
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~--~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS-HKHIVLLYGVCVRD--V   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC--C
Confidence            358999999999997432            12357888876433   235677888998885 89999999988754  4


Q ss_pred             ccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC------cEEEEecc
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR------KLRLIDWG  311 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~------~ikl~DFG  311 (467)
                      ..+++|||++++++..+..    .+++..+..++.|++.||+|||++||+||||||+|||++..+.      .+|++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            5689999999998876653    3788889999999999999999999999999999999975432      38999999


Q ss_pred             cceecCCCCCcceeeeccCccCCccccc-CCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCC
Q psy3714         312 LAEFYHPGQEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGR  389 (467)
Q Consensus       312 la~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (467)
                      ++......   ....++..|+|||.+.+ ..++.++|+|..+++.+.... +..|+....     ..+...+...     
T Consensus       158 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~~~~~~~~~~-----  224 (262)
T cd05077         158 IPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-----LAEKERFYEG-----  224 (262)
T ss_pred             CCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-----hhHHHHHHhc-----
Confidence            98765322   23467889999999874 558889999988776433221 111211100     0000000000     


Q ss_pred             CCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                          ..      ......++++.+||++||+.||++|||..+++++
T Consensus       225 ----~~------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 ----QC------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ----Cc------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                00      0011135789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=1.2e-30  Score=250.17  Aligned_cols=244  Identities=18%  Similarity=0.245  Sum_probs=182.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEcc----CCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQ----SSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      .++|++.+.||+|+||.||+|.+..    ++..+++|.++...    ...+.+|+.+++.+ .|+||+++.+.+... ..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIED-GE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC-CC
Confidence            5789999999999999999999876    35788999876432    34577899999999 489999999876543 34


Q ss_pred             ccEEEEeccCCccHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEec
Q psy3714         242 TPALIFEHVNNTDFKQLYQ-----------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW  310 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DF  310 (467)
                      ..+++++|+.++++..++.           .+++.++..++.|++.||+|||+++|+||||||+||+++.+ ..+||+||
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kl~d~  161 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE-LQVKITDN  161 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC-CcEEECCC
Confidence            6789999999999877653           36788889999999999999999999999999999999855 47999999


Q ss_pred             ccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhc
Q psy3714         311 GLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNI  386 (467)
Q Consensus       311 Gla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (467)
                      |+++.+.+....   ....++..|+|||.+.+..++.++|+|..+++...... +..|+....     ..+.......  
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~--  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-----PFEMAAYLKD--  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-----HHHHHHHHHc--
Confidence            999866433211   12335677999999988889999999988876433322 222321110     0011111100  


Q ss_pred             cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                        ..         .......+++++++++.+|+..||++|||+.|+++
T Consensus       235 --~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         235 --GY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             --CC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence              00         00112246789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.7e-30  Score=246.83  Aligned_cols=242  Identities=15%  Similarity=0.248  Sum_probs=181.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCC----eEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSD----KCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      .++|++.+.||+|+||.||+|.+..++.    .+++|..+...    ...+.+|+.+++.+. |+|++++.+.+..   .
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---~   81 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-HPHVVRLLGICLS---S   81 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec---C
Confidence            4689999999999999999999876654    58888776432    346778999999995 8999999998875   4


Q ss_pred             ccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..+++|||+.++++.+.+.    .+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++...
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kL~dfg~~~~~~  160 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLD  160 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC-eEEECCCccccccc
Confidence            6799999999999887653    378889999999999999999999999999999999998554 79999999998764


Q ss_pred             CCCCcce---eeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         318 PGQEYNV---RVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       318 ~~~~~~~---~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      .......   ..++..|+|||.+....++.+.|+|..+++...... +..|+....     ..+.......   +     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~---~-----  227 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-----AVEIPDLLEK---G-----  227 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHhC---C-----
Confidence            3322111   123567999999988889999999988766433322 333321110     0111111100   0     


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                           .....+...+.++.+++.+|+..||++|||+.++++
T Consensus       228 -----~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         228 -----ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                 001122346789999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=1.1e-30  Score=252.53  Aligned_cols=250  Identities=16%  Similarity=0.214  Sum_probs=168.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccC---CCeEEEEEeccchHHHH------------HHHH---HHHHHhcCCCCeeEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQS---SDKCVVKILKPVKKKKI------------KREI---KILENLRGGTNIITL  231 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~------------~~Ei---~il~~l~~~~~iv~l  231 (467)
                      ..+|++.+.||+|+||.||+|....+   +..+++|+..... ...            ..++   ..+..+ .|+|++.+
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~-~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~   88 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN-ETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKY   88 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccC-CchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcE
Confidence            36899999999999999999998777   5667777543211 111            1122   223333 47899988


Q ss_pred             EEEEeCCC--CCccEEEEeccCCccHHHH---hhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEE
Q psy3714         232 QAVVKDPV--SRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLR  306 (467)
Q Consensus       232 ~~~~~~~~--~~~~~lv~e~~~~~~l~~~---~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ik  306 (467)
                      ++......  ....+++++++.. ++...   ....++..++.++.|++.||+|||+++|+||||||+|||++..+ .+|
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~-~~~  166 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN-RGY  166 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-cEE
Confidence            87654322  1234677776643 23222   23467788899999999999999999999999999999998654 799


Q ss_pred             EEecccceecCCCC--------CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhh
Q psy3714         307 LIDWGLAEFYHPGQ--------EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEA  378 (467)
Q Consensus       307 l~DFGla~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (467)
                      |+|||+|+.+....        ......||+.|+|||++.+..|+.++|+|+.+++......+..||......    ...
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~----~~~  242 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN----GNL  242 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc----hHH
Confidence            99999998653211        112346999999999999988999999998887765555555555332110    011


Q ss_pred             hhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ......+...+.....       ......++++.++++.|++.||.+||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        243 IHAAKCDFIKRLHEGK-------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHhHHHHHHHhhhhh-------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            0000001000000000       011235789999999999999999999999874

>KOG4721|consensus

Probab=99.97  E-value=1.3e-31  Score=260.21  Aligned_cols=236  Identities=17%  Similarity=0.217  Sum_probs=180.0

Q ss_pred             eEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCCccH
Q psy3714         176 VRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDF  255 (467)
Q Consensus       176 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~~~l  255 (467)
                      ++-||+|+.|.||+|+.  .++.||||.++..+    ..+|.-|++|+ |+||+.+.++|...  -.+++|||||..|.|
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~elk----ETdIKHLRkLk-H~NII~FkGVCtqs--PcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRELK----ETDIKHLRKLK-HPNIITFKGVCTQS--PCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHhhhh----hhhHHHHHhcc-CcceeeEeeeecCC--ceeEEeeeccccccH
Confidence            45589999999999975  36799999876432    34577789996 89999999999653  346899999999999


Q ss_pred             HHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcceeeeccCcc
Q psy3714         256 KQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFK  332 (467)
Q Consensus       256 ~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~  332 (467)
                      .+.++   .++..-...+..+|+.|+.|||.+.|||||||.-||||..++ .|||+|||-++........-..+||..||
T Consensus       200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFaGTVaWM  278 (904)
T KOG4721|consen  200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFAGTVAWM  278 (904)
T ss_pred             HHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhhhhHhhh
Confidence            88875   478888899999999999999999999999999999999665 89999999998765444444578999999


Q ss_pred             CCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHH
Q psy3714         333 GPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEAL  412 (467)
Q Consensus       333 aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  412 (467)
                      |||+|...+.+.+||+|.++++...++.+.-|+.... +            ..|.......    .+..+-+.-.++-++
T Consensus       279 APEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd-s------------sAIIwGVGsN----sL~LpvPstcP~Gfk  341 (904)
T KOG4721|consen  279 APEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD-S------------SAIIWGVGSN----SLHLPVPSTCPDGFK  341 (904)
T ss_pred             CHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc-h------------heeEEeccCC----cccccCcccCchHHH
Confidence            9999999999999999999987544433333321110 0            0000000000    001112223566778


Q ss_pred             HHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         413 DFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       413 dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      =||+.|++-.|..||+.+|+|.|==+
T Consensus       342 lL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  342 LLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             HHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            89999999999999999999999443

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=2.3e-30  Score=245.04  Aligned_cols=231  Identities=16%  Similarity=0.165  Sum_probs=170.9

Q ss_pred             EeecccCCcceEEEEEccCC----------CeEEEEEeccch--HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         177 RKLGRGKYSEVFEAINVQSS----------DKCVVKILKPVK--KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~----------~~~avK~~~~~~--~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      +.||+|+||.||+|.+..++          ..+++|.++...  ...+.+|+.+++.++ |+||+.+.+.+..   ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLS-HKHLVKLYGVCVR---DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCC-CcchhheeeEEec---CCcE
Confidence            36899999999999998776          347778765433  456788999999995 8999999998765   3468


Q ss_pred             EEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC------cEEEEecccce
Q psy3714         245 LIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR------KLRLIDWGLAE  314 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~------~ikl~DFGla~  314 (467)
                      ++|||+.+++|.++..    .++...+..++.||+.||+|||++||+||||||+|||++.++.      .+||+|||++.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            9999999999987764    4778888899999999999999999999999999999986542      59999999998


Q ss_pred             ecCCCCCcceeeeccCccCCcccccC--CCCccchhHHHhhhccccccc-cccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         315 FYHPGQEYNVRVASRYFKGPELLADY--QYHIELDPRFADILGRHSRKR-WERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       315 ~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~D~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      ....   .....++..|+|||.+...  .++.+.|+|..+++......+ ..++....     .........        
T Consensus       157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-----~~~~~~~~~--------  220 (259)
T cd05037         157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-----SSEKERFYQ--------  220 (259)
T ss_pred             cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-----chhHHHHHh--------
Confidence            6543   2234577889999999877  688899999887653332221 11111100     000000000        


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                         .    ....+...+.++.+||.+||+.||.+|||+.|+++
T Consensus       221 ---~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         221 ---D----QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ---c----CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence               0    00001112479999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=3e-30  Score=245.86  Aligned_cols=243  Identities=17%  Similarity=0.277  Sum_probs=181.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCC---eEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSD---KCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      .++|+..+.||+|+||.||+|.+..+++   .+++|.++..    ..+.+.+|+++++.+. |+|++++.+.+.+.  ..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKF--KP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccC--CC
Confidence            3578899999999999999999876654   6899987643    2345778999999995 89999999988754  46


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .+++|||+++++|..+..    .+++.++..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~  159 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVLED  159 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC-cEEECCCccceeccc
Confidence            899999999999987763    367888999999999999999999999999999999998554 799999999986532


Q ss_pred             CCCc--ce--eeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         319 GQEY--NV--RVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       319 ~~~~--~~--~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ....  ..  ...+..|+|||.+....++.+.|+|..+++.+.... +..|+.....     ......+.    ..    
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~~i~----~~----  226 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAIN----DG----  226 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHHh----cC----
Confidence            2111  11  112456999999988888999999988876443322 3334322110     11111111    00    


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                           ...+.....++++.+|+.+|+..||++||+++++++
T Consensus       227 -----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         227 -----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                 011112346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.6e-30  Score=245.15  Aligned_cols=243  Identities=19%  Similarity=0.241  Sum_probs=183.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..++|++.+.||+|+||.||+|.+. ++..+++|.++..  ....+.+|+.+++.++ |+|++++++.+...  ...+++
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~~v   79 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLR-HDKLVQLYAVCSEE--EPIYIV   79 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCC-CCCEeeeeeeeecC--CceEEE
Confidence            3578999999999999999999865 4578999988753  3467889999999996 89999999987653  467999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      |||+++++|.+...     .++...+..++.|++.||.|||++||+|+||||+||+++.++ .+||+|||++........
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL-VCKIADFGLARLIEDDEY  158 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC-CEEECccccceeccchhh
Confidence            99999999987763     367888999999999999999999999999999999998654 799999999986643211


Q ss_pred             c--ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         322 Y--NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       322 ~--~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      .  ....++..|+|||.+.+..++.+.|+|..+++...... +..|+....        .....+. +....        
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--------~~~~~~~-~~~~~--------  221 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--------NREVLEQ-VERGY--------  221 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHH-HHcCC--------
Confidence            1  11223567999999988888999999988876443332 233321110        0111111 11000        


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                       ....+...++++++++.+||+.||.+|||++++.+
T Consensus       222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         222 -RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence             11112335789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=5.7e-30  Score=242.90  Aligned_cols=241  Identities=17%  Similarity=0.243  Sum_probs=180.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .++|++.+.||+|+||.||++.+. .+..+++|.++...  ...+.+|+++++.++ |+||+++++.+.+   ...+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~---~~~~~v~   79 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK---EPIYIIT   79 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC---CCeEEEE
Confidence            478999999999999999999754 45679999876543  356788999999995 8999999988765   4579999


Q ss_pred             eccCCccHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc
Q psy3714         248 EHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       248 e~~~~~~l~~~~~~-----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~  322 (467)
                      ||++++++.+++..     ++...+..++.|++.||.|||++|++||||||+||+++..+ .+||+|||++.........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCCcceeeccCCCcc
Confidence            99999999877642     56677888999999999999999999999999999998554 7999999999865432211


Q ss_pred             --ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         323 --NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       323 --~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                        ....++..|+|||++....++...|+|..+++...... +..|+....     .........    ...         
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~~----~~~---------  220 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRALE----RGY---------  220 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHh----CCC---------
Confidence              12234567999999988888889999988876443332 222321110     111111110    000         


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ..+.....+.++.+++.+||..||++|||++++++
T Consensus       221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            01112346889999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=2.4e-30  Score=251.33  Aligned_cols=244  Identities=16%  Similarity=0.239  Sum_probs=181.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCC----eEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSD----KCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      ..++|+..+.||+|+||.||+|.+..++.    .+|+|.+....    ...+.+|+.+++.+. |+||+++++.+..+  
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~--   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP--   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC--
Confidence            45789999999999999999999887776    46888776432    235678999999995 89999999988643  


Q ss_pred             CccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                       ..+++++|++++++.+...    .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++..
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-~~kL~Dfg~~~~~  159 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-HVKITDFGLARLL  159 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-ceEEccccccccc
Confidence             3578999999999887654    367888899999999999999999999999999999998554 7999999999865


Q ss_pred             CCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         317 HPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       317 ~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      .....   .....++..|+|||.+.+..++.+.|+|..+++.+.... +..|+....     ...........     . 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~~-----~-  228 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREIPDLLEKG-----E-  228 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHCC-----C-
Confidence            43222   112345678999999988889999999988876443221 223321110     01111111100     0 


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                             ....+...+.++.+++.+|+..||++|||++++++.
T Consensus       229 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         229 -------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                   011123457899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=2.3e-30  Score=246.82  Aligned_cols=242  Identities=17%  Similarity=0.240  Sum_probs=180.7

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCC---eEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSD---KCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .+|++.+.||+|+||.||+|....+++   .+++|.++..    ....+.+|+.+++.+. ||||+++.+.+.+  ....
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~--~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTK--SRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CcCcceEEEEECC--CCce
Confidence            568999999999999999999877664   5999988643    2346788999999995 8999999998865  3467


Q ss_pred             EEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      +++|||++++++.++..    .++..++..++.|++.||.|||++|++||||||+||+++.. ..+||+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC-CcEEECCCccccccccC
Confidence            99999999999887654    36788899999999999999999999999999999999854 47999999998765432


Q ss_pred             CCc---ceee---eccCccCCcccccCCCCccchhHHHhhhccccc-cccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         320 QEY---NVRV---ASRYFKGPELLADYQYHIELDPRFADILGRHSR-KRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       320 ~~~---~~~~---gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      ...   ....   .+..|+|||.+....++.+.|+|..+++..... .+..|+....        ....... +...   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~--------~~~~~~~-i~~~---  227 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--------NQDVINA-IEQD---  227 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--------HHHHHHH-HHcC---
Confidence            211   1111   134699999998888999999998876643322 2333332111        0111111 0000   


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                        +    ..+.+...++++.+++.+||..||.+|||++++++
T Consensus       228 --~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         228 --Y----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             --C----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence              0    01112346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=3.2e-30  Score=243.84  Aligned_cols=243  Identities=14%  Similarity=0.259  Sum_probs=181.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .++|++.+.||+|+||.||+|.+. .+..+++|.++..  ....+.+|+++++.+. |+|++++++.+...  ...+++|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~~v~   78 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLS-HPKLVQLYGVCTER--SPICLVF   78 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCC-CCCeeeEEEEEccC--CceEEEE
Confidence            368999999999999999999875 4678999988643  2456888999999995 89999999887653  4679999


Q ss_pred             eccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC--
Q psy3714         248 EHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--  321 (467)
Q Consensus       248 e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~--  321 (467)
                      ||+.+++|.+...    .+++..+..++.|++.||+|||++|++||||||+||+++.+ ..+||+|||++........  
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC-CeEEECCCcceeecccCcccc
Confidence            9999999887653    36788889999999999999999999999999999999854 4799999999876532211  


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      .....++..|+|||.+.+..++.+.|+|..+++-+.... +..|+...        ........ +..     .+.    
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--------~~~~~~~~-~~~-----~~~----  219 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR--------SNSEVVET-INA-----GFR----  219 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC--------CHHHHHHH-HhC-----CCC----
Confidence            112234568999999988889999999988765433222 22222111        00111111 000     000    


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ...+...++++.+|+++||+.||++|||++|++++
T Consensus       220 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            01122358899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=3e-30  Score=243.33  Aligned_cols=235  Identities=19%  Similarity=0.278  Sum_probs=175.6

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCC
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNN  252 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~  252 (467)
                      +.||+|+||.||+|.+.. ++.+++|.++..    ....+.+|+++++.+. |+||+.+.+.+.+.  ...+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQK--QPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecC--CCeEEEEEcCCC
Confidence            368999999999999877 899999987643    2346788999999996 89999999987653  568999999999


Q ss_pred             ccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc---cee
Q psy3714         253 TDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY---NVR  325 (467)
Q Consensus       253 ~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~---~~~  325 (467)
                      +++.+.+.    .++...+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++........   ...
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcceeccccC
Confidence            99987753    367788889999999999999999999999999999998655 7999999999865322111   112


Q ss_pred             eeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCC
Q psy3714         326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQ  404 (467)
Q Consensus       326 ~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (467)
                      .++..|+|||.+.+..++...|+|..+++.+.... +..++....     .........    ..         .....+
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~-----~~~~~~~~~----~~---------~~~~~~  217 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS-----NQQTRERIE----SG---------YRMPAP  217 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC-----HHHHHHHHh----cC---------CCCCCC
Confidence            23566999999988889999999988876543332 222221110     000111110    00         011122


Q ss_pred             CCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         405 HLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       405 ~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ...+.++.||+.+||+.||.+|||++|+++
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            346889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=3.2e-30  Score=242.98  Aligned_cols=235  Identities=20%  Similarity=0.266  Sum_probs=174.7

Q ss_pred             EeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCC
Q psy3714         177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNN  252 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~  252 (467)
                      +.||+|+||.||+|... ++..+|+|.++...    ...+.+|+++++.+. |+||+++.+.+...  ...++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYD-HPNIVKLIGVCTQR--QPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecC--CccEEEEECCCC
Confidence            36899999999999854 67889999876432    235778999999995 89999999988754  468999999999


Q ss_pred             ccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc--ceee
Q psy3714         253 TDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY--NVRV  326 (467)
Q Consensus       253 ~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~--~~~~  326 (467)
                      +++.+...    .+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.....+...  ....
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-eEEECCCccceeccccccccCCCCC
Confidence            99987653    367888899999999999999999999999999999998554 7999999999754322211  1123


Q ss_pred             eccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCC
Q psy3714         327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQH  405 (467)
Q Consensus       327 gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (467)
                      ++..|+|||++....++.+.|+|..+++...... +..||....     ......    .+...         .....+.
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~-----~~~~~~----~~~~~---------~~~~~~~  217 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT-----NQQARE----QVEKG---------YRMSCPQ  217 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH----HHHcC---------CCCCCCC
Confidence            4567999999988888999999988876443322 222321110     001111    11000         0011223


Q ss_pred             CCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         406 LVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       406 ~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .+++++.+|+.+||..||++|||+.|+++
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            47899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0193|consensus

Probab=99.97  E-value=3.8e-31  Score=259.63  Aligned_cols=242  Identities=17%  Similarity=0.249  Sum_probs=179.8

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++..+...||+|+||+||+|+.-   ..||||+++..     ..+.+++|+.++++-+ |.||+-+.+++..+.   ..+
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~---~AI  464 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR-HENILLFMGACMNPP---LAI  464 (678)
T ss_pred             HHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCc---eee
Confidence            45678899999999999999863   47999999753     3467889999999997 799999999987653   378


Q ss_pred             EEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec---CC
Q psy3714         246 IFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY---HP  318 (467)
Q Consensus       246 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~---~~  318 (467)
                      |..+|.|.+|..+++    +|...+++.|++|+++|+.|||.++|||||||..||+|..+ ..|||+||||+..-   ..
T Consensus       465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~w~g  543 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATVKTRWSG  543 (678)
T ss_pred             eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceeeeeeecc
Confidence            889999999987764    57788899999999999999999999999999999999855 48999999998632   22


Q ss_pred             CCCcceeeeccCccCCcccccC---CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADY---QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~---~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      ...+....|...|||||++..+   +|++..|++..+++-+....+-.||.....             +.|+....+...
T Consensus       544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-------------dqIifmVGrG~l  610 (678)
T KOG0193|consen  544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-------------DQIIFMVGRGYL  610 (678)
T ss_pred             ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-------------hheEEEeccccc
Confidence            2233344688899999999754   589999999777765555555555531110             111110000000


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .. ...........+.++|+..|+++++++||+..++|.
T Consensus       611 ~p-d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  611 MP-DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             Cc-cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            00 000001123458999999999999999999888775

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=5.3e-30  Score=242.18  Aligned_cols=238  Identities=14%  Similarity=0.251  Sum_probs=179.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      ..+|++.+.||+|+||.||++.  .+++.+|+|.++.. ....+.+|+.+++.++ |+|++++.+.+..   ...+++||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~---~~~~~v~e   78 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLH-HKNLVRLLGVILH---NGLYIVME   78 (254)
T ss_pred             HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhCC-CCCcCeEEEEEcC---CCcEEEEE
Confidence            4689999999999999999986  46788999988653 3456789999999996 8999999988754   34699999


Q ss_pred             ccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcc
Q psy3714         249 HVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN  323 (467)
Q Consensus       249 ~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~  323 (467)
                      |+.++++.+.+.     .++...+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++......  ..
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~--~~  155 (254)
T cd05083          79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG--VD  155 (254)
T ss_pred             CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-cEEECCCccceecccc--CC
Confidence            999999987764     257778889999999999999999999999999999998654 7999999999864322  12


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccccccc
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE  402 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
                      ....+..|+|||.+.+..++...|+|..+++...... +..|+....     ..+.......    .     +    ...
T Consensus       156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~----~-----~----~~~  217 (254)
T cd05083         156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVKECVEK----G-----Y----RME  217 (254)
T ss_pred             CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHHHhC----C-----C----CCC
Confidence            2334567999999988889999999988766443322 223322111     0111111110    0     0    011


Q ss_pred             CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       403 ~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ....+++++.+|+++||+.+|++|||++++++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            12346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG1006|consensus

Probab=99.97  E-value=7.4e-32  Score=240.08  Aligned_cols=256  Identities=18%  Similarity=0.276  Sum_probs=188.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ++.+-+..||.|+||+|++-.++.+|+..|||.++..    ..+++.+|.+...+-...||||++++....  +.-.++.
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcWiC  141 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCWIC  141 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCceeee
Confidence            5566678899999999999999999999999998743    346788898888777789999999987643  3446888


Q ss_pred             EeccCCccHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         247 FEHVNNTDFKQLYQ--------TLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--------~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ||.++. ++..+++        .++|.-+-.+....+.||.||-. ..|||||+||+|||++..| .+||||||.+-...
T Consensus       142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQLV  219 (361)
T ss_pred             HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhHH
Confidence            887754 4544442        47787778888888999999985 5899999999999999776 69999999987654


Q ss_pred             CCCCcceeeeccCccCCcccccC--CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         318 PGQEYNVRVASRYFKGPELLADY--QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       318 ~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      ..-..+..+|...|||||.|...  +|+..+|.|+.++-...-..|..|+...       ...++.+.--..+..     
T Consensus       220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-------~svfeql~~Vv~gdp-----  287 (361)
T KOG1006|consen  220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-------DSVFEQLCQVVIGDP-----  287 (361)
T ss_pred             HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-------HHHHHHHHHHHcCCC-----
Confidence            33333556799999999999654  5999999998887654444444443211       111111111111111     


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ..+.....--..|..++.||.-||.+|-..||...+++++||+....
T Consensus       288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence            11111111224689999999999999999999999999999986543

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=2.6e-30  Score=247.32  Aligned_cols=232  Identities=14%  Similarity=0.159  Sum_probs=167.3

Q ss_pred             eecccCCcceEEEEEccC------------------------CCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeE
Q psy3714         178 KLGRGKYSEVFEAINVQS------------------------SDKCVVKILKPVK---KKKIKREIKILENLRGGTNIIT  230 (467)
Q Consensus       178 ~lG~G~~g~V~~~~~~~~------------------------~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~  230 (467)
                      .||+|+||.||+|....+                        ...+++|.++...   ...+.+|+.+++.++ |+||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~-h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVS-HIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCC-CCCeee
Confidence            589999999999874321                        1347888876432   234667888888885 899999


Q ss_pred             EEEEEeCCCCCccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC----
Q psy3714         231 LQAVVKDPVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN----  302 (467)
Q Consensus       231 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~----  302 (467)
                      +++++.+.  ...++||||++++++.....    .+++..+..++.|++.||+|||++||+||||||+|||++..+    
T Consensus        81 ~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          81 VHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEEeC--CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            99988754  46789999999999877653    378888899999999999999999999999999999997432    


Q ss_pred             --CcEEEEecccceecCCCCCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccc-cccccccccCCcccCChhh
Q psy3714         303 --RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSR-KRWERFVHTENQHLVSPEA  378 (467)
Q Consensus       303 --~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  378 (467)
                        ..+|++|||++......   ....++..|+|||.+.+ ..++..+|+|..+++..... .+..|+....     ....
T Consensus       159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~  230 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-----PSEK  230 (274)
T ss_pred             ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC-----hHHH
Confidence              24899999998654222   22457888999998876 45788999998776533221 1222221110     0010


Q ss_pred             hhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ..+...         .+      ..+...++++.+||.+||+.||++|||+++++++
T Consensus       231 ~~~~~~---------~~------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         231 ERFYEK---------KH------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHHh---------cc------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            111000         00      0112246789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0194|consensus

Probab=99.97  E-value=4.9e-30  Score=253.92  Aligned_cols=242  Identities=19%  Similarity=0.285  Sum_probs=177.3

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCC---e-EEEEEecc------chHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSD---K-CVVKILKP------VKKKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~-~avK~~~~------~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      ++-.+.++||+|+||.||+|..+..+.   . ||+|..+.      .....+.+|+++|+.++ |+|||+++++..+  .
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~--~  233 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVL--E  233 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcC--C
Confidence            455566999999999999998766432   3 89998874      12456789999999996 8999999998865  3


Q ss_pred             CccEEEEeccCCccHHHHhhc----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         241 RTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      ..+++|||+|+||+|.+++++    ++..+-..++.+.+.||+|||++++|||||-.+|+|++..+ .+||+|||+|+.-
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~-~vKISDFGLs~~~  312 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG-VVKISDFGLSRAG  312 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC-eEEeCccccccCC
Confidence            568999999999999988864    67788889999999999999999999999999999998544 6899999999854


Q ss_pred             CCCCCcc-eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhc-cCCCCccc
Q psy3714         317 HPGQEYN-VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI-LGRHSRKR  394 (467)
Q Consensus       317 ~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  394 (467)
                      ....... ..--...|+|||.+....|+.+.|+|+.+++.      |+-|..+.. ++....... ....+ ...+    
T Consensus       313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~------~Eif~~g~~-Py~g~~~~~-v~~kI~~~~~----  380 (474)
T KOG0194|consen  313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLL------WEIFENGAE-PYPGMKNYE-VKAKIVKNGY----  380 (474)
T ss_pred             cceeeccccccCcceecChhhhccCccccccchhheeeeE------EeeeccCCC-CCCCCCHHH-HHHHHHhcCc----
Confidence            2111111 11134569999999999999999999888863      444432221 111111111 11111 1110    


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHh
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM  433 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l  433 (467)
                           ....+...+.+...++.+|...||++|+|..++.
T Consensus       381 -----r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~  414 (474)
T KOG0194|consen  381 -----RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK  414 (474)
T ss_pred             -----cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence                 1112234567888999999999999999987654

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=7.4e-30  Score=243.40  Aligned_cols=240  Identities=14%  Similarity=0.157  Sum_probs=168.0

Q ss_pred             EeecccCCcceEEEEEc--cCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         177 RKLGRGKYSEVFEAINV--QSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      +.||+|+||.||+|...  .++..+++|.++...    ...+.+|+.+++.++ |+||+++.+.+.+.  ...++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEV--TPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCC--CCcEEEEECC
Confidence            35899999999999754  345678999876432    245778999999996 89999999988654  4579999999


Q ss_pred             CCccHHHHhhc--------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-
Q psy3714         251 NNTDFKQLYQT--------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-  321 (467)
Q Consensus       251 ~~~~l~~~~~~--------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-  321 (467)
                      +++++.++...        .+...+..++.|++.||+|||++|++||||||+||+++.+ ..+||+|||+++....... 
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEECCccccccccCccee
Confidence            99999876532        3445677899999999999999999999999999999865 4799999999975432211 


Q ss_pred             --cceeeeccCccCCcccccC-------CCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         322 --YNVRVASRYFKGPELLADY-------QYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       322 --~~~~~gt~~y~aPE~l~~~-------~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                        .....++..|+|||++.+.       .++.++|+|..+++...... +..||....     ..+...+.   +.... 
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-----~~~~~~~~---~~~~~-  227 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS-----DEQVLTYT---VREQQ-  227 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC-----hHHHHHHH---hhccc-
Confidence              1123567889999998643       35678999988776443321 333332111     11111110   00000 


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                       .   .+.........++.+.+++.+|+ .||++|||++|+++
T Consensus       228 -~---~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         228 -L---KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             -C---CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence             0   00111111236788999999998 69999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0593|consensus

Probab=99.97  E-value=3.1e-31  Score=240.24  Aligned_cols=133  Identities=35%  Similarity=0.720  Sum_probs=118.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC-CCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      ++..|++.|+.|||+++||||||||||||++. ++.+||||||+|+... ++..++.++.|+||+|||.+.+...|+.++
T Consensus       105 ~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~-~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pV  183 (396)
T KOG0593|consen  105 KYLYQLLKAIHFCHKNNCIHRDIKPENILITQ-NGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPV  183 (396)
T ss_pred             HHHHHHHHHhhhhhhcCeecccCChhheEEec-CCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcc
Confidence            57899999999999999999999999999995 4599999999999887 888899999999999999999877799999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchhHhhhhhhccCCCchhhhhcccccccccc
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADILGRARVYADV  149 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~~~  149 (467)
                      ||||+||++.||++| .|+++|.++.+|++.|.+.+|.             +.|+...+++++..+..+
T Consensus       184 DiWAiGCv~aEl~~G-~pL~PG~SDiDQLy~I~ktLG~-------------L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  184 DIWAIGCVFAELLTG-EPLWPGRSDIDQLYLIRKTLGN-------------LIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             cchhhhHHHHHHhcC-CcCCCCcchHHHHHHHHHHHcc-------------cCHHHHHHhccCCceeee
Confidence            999999999999999 5888999999999999999984             566766676666655543

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=5.9e-30  Score=242.87  Aligned_cols=238  Identities=17%  Similarity=0.227  Sum_probs=171.6

Q ss_pred             EeecccCCcceEEEEEccC---CCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         177 RKLGRGKYSEVFEAINVQS---SDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      +.||+|+||.||+|.+...   +..+|+|.+...    ....+.+|+.+++.++ |+||+.+.+.+... ....+++|+|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~-~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPS-EGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCC-CCCcceEEEEeecC-CCCcEEEEec
Confidence            3689999999999986543   356999987542    1346678999999885 89999999876543 3457899999


Q ss_pred             cCCccHHHHhhc----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC----
Q psy3714         250 VNNTDFKQLYQT----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----  321 (467)
Q Consensus       250 ~~~~~l~~~~~~----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~----  321 (467)
                      +.++++.++...    .+...+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++.......    
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCccccccccCCcceeec
Confidence            999999887642    45667788899999999999999999999999999998655 799999999975432111    


Q ss_pred             -cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         322 -YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       322 -~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                       .....++..|+|||.+....++.+.|+|..+++......+..+.+...       ....... ....      ..   .
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-------~~~~~~~-~~~~------~~---~  220 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------DSFDITV-YLLQ------GR---R  220 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHH-HHhc------CC---C
Confidence             112345678999999988889999999988876443323222221111       0011110 0000      00   0


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ...+..+++.+.+++.+||..||++|||+.|+++
T Consensus       221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            1112346889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1187|consensus

Probab=99.97  E-value=4.3e-30  Score=252.40  Aligned_cols=253  Identities=17%  Similarity=0.233  Sum_probs=178.9

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ++|.--..||+|+||.||+|.-.. +..||||.+....   .+.+.+|++++.+++ |+|+|+|.++|.+... ...||+
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~-~~~LVY  151 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLR-HPNLVKLLGYCLEGGE-HRLLVY  151 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCC-CcCcccEEEEEecCCc-eEEEEE
Confidence            677777899999999999998654 4899999887543   456999999999997 9999999999986432 589999


Q ss_pred             eccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCceEEeCCCCcEEEEecccceecCC-
Q psy3714         248 EHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMG---IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-  318 (467)
Q Consensus       248 e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~---IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-  318 (467)
                      ||+++|+|.+.+.     .++...-..|+.+++.||+|||+..   ||||||||+||||| ++...||+|||+|+.... 
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCcccCCcc
Confidence            9999999987753     3456666789999999999999853   99999999999999 455899999999976543 


Q ss_pred             CCCccee-eeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         319 GQEYNVR-VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       319 ~~~~~~~-~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      ....... .||..|+|||.+.....+.+.|++..+++....+.+..+..........  ....+.......    .....
T Consensus       231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~--~l~~w~~~~~~~----~~~~e  304 (361)
T KOG1187|consen  231 DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGEL--SLVEWAKPLLEE----GKLRE  304 (361)
T ss_pred             ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccc--cHHHHHHHHHHC----cchhh
Confidence            3333333 7999999999998877888999997777543333333332211100000  011111110000    01222


Q ss_pred             cccccCC-CCCC-----hHHHHHHHhhcCcCCCCCCCHHHHh
Q psy3714         398 FVHTENQ-HLVS-----PEALDFLDKLLRYDHYERLTAREAM  433 (467)
Q Consensus       398 ~~~~~~~-~~~s-----~~~~dli~~lL~~dp~~R~ta~e~l  433 (467)
                      ++++.-. ...+     ..+..+-.+|++.+|++||+..|+.
T Consensus       305 iiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv  346 (361)
T KOG1187|consen  305 IVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV  346 (361)
T ss_pred             eeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence            2222111 1111     2346678899999999999998864

>KOG1027|consensus

Probab=99.97  E-value=8e-31  Score=265.56  Aligned_cols=243  Identities=23%  Similarity=0.285  Sum_probs=178.7

Q ss_pred             eEeecccCCcc-eEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCCcc
Q psy3714         176 VRKLGRGKYSE-VFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTD  254 (467)
Q Consensus       176 ~~~lG~G~~g~-V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~~~  254 (467)
                      .+.+|.|+-|+ ||+|..  .++.||||.+-......+.|||..|+.-..|||||+++..-.++  ...|+..|.|.. +
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~--qF~YIalELC~~-s  588 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDR--QFLYIALELCAC-S  588 (903)
T ss_pred             HHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCC--ceEEEEehHhhh-h
Confidence            35689999986 588875  57899999887766778999999999999999999998876654  457888887753 4


Q ss_pred             HHHHhhc-------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC---C-CcEEEEecccceecCCCCC--
Q psy3714         255 FKQLYQT-------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE---N-RKLRLIDWGLAEFYHPGQE--  321 (467)
Q Consensus       255 l~~~~~~-------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~---~-~~ikl~DFGla~~~~~~~~--  321 (467)
                      |.++...       ...-+.+..+.|++.||+|||+.+||||||||.||||+..   + ..++|+|||+|+....+..  
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~  668 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF  668 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence            5555432       1113457889999999999999999999999999999863   2 4699999999998765443  


Q ss_pred             --cceeeeccCccCCcccccCCCCccchhHHHhhhcccccccc-ccccccCCcccCChhhhhhhhhhccC-CCCcccccc
Q psy3714         322 --YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRW-ERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWER  397 (467)
Q Consensus       322 --~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  397 (467)
                        .....||-.|+|||++....-..++|+...+.+-++...+. .|| +..         . ..+.+|+. .+...... 
T Consensus       669 ~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpF-Gd~---------~-~R~~NIl~~~~~L~~L~-  736 (903)
T KOG1027|consen  669 SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPF-GDS---------L-ERQANILTGNYTLVHLE-  736 (903)
T ss_pred             hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCC-Cch---------H-HhhhhhhcCccceeeec-
Confidence              23457999999999999888888999997776654443332 232 111         0 11223322 11111111 


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                        .     ....+|+|||.+||..||..||+|.++|.||||.+-.
T Consensus       737 --~-----~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e  774 (903)
T KOG1027|consen  737 --P-----LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE  774 (903)
T ss_pred             --c-----CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence              0     0112999999999999999999999999999997543

>KOG1026|consensus

Probab=99.97  E-value=1.9e-30  Score=265.00  Aligned_cols=241  Identities=21%  Similarity=0.342  Sum_probs=189.2

Q ss_pred             CccceeeeEeecccCCcceEEEEEcc-----CCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQ-----SSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ...+-+..+.||+|+||+||+|+...     ....||||.+|..    .++.++||+++|..++ |||||++++++..  
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~--  560 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ-HPNIVRLLGVCRE--  560 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEcc--
Confidence            34667788999999999999997543     3457999999864    3467899999999996 8999999999976  


Q ss_pred             CCccEEEEeccCCccHHHHhh-------------c----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ-------------T----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN  302 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~-------------~----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~  302 (467)
                      .+..+||+||+..|||.+++.             .    ++..+...++.||+.|++||-++..|||||-..|+|++ ++
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg-e~  639 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG-EN  639 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec-cc
Confidence            457899999999999998863             1    56678889999999999999999999999999999998 66


Q ss_pred             CcEEEEecccceecCCCCCccee---eeccCccCCcccccCCCCccchhHHHhhhccccccccccccccC--CcccCChh
Q psy3714         303 RKLRLIDWGLAEFYHPGQEYNVR---VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTE--NQHLVSPE  377 (467)
Q Consensus       303 ~~ikl~DFGla~~~~~~~~~~~~---~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  377 (467)
                      ..|||+||||++.....+.|...   .-...|||||.|....|++++|+|.++++      .|+-|..+.  ...+...+
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVv------LWEIFsyG~QPy~glSn~E  713 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVV------LWEIFSYGKQPYYGLSNQE  713 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhh------hhhhhccccCcccccchHH
Confidence            78999999999976544433322   12456999999999999999999999986      355554442  11223334


Q ss_pred             hhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHH
Q psy3714         378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREA  432 (467)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~  432 (467)
                      ....+....+             .+-++..+++..+|+..|-+.+|++|||..|+
T Consensus       714 VIe~i~~g~l-------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  714 VIECIRAGQL-------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HHHHHHcCCc-------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            4443332211             12345678999999999999999999997765

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=1.4e-29  Score=239.56  Aligned_cols=236  Identities=18%  Similarity=0.224  Sum_probs=176.0

Q ss_pred             EeecccCCcceEEEEEccC-CC--eEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         177 RKLGRGKYSEVFEAINVQS-SD--KCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~~~-~~--~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      +.||+|+||.||+|.+..+ +.  .+|+|.++...    .+.+.+|+.+++.++ |+||+++.+.+.+   ...+++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~---~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIRLYGVVLT---HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcC-CCCccceeEEEcC---CeEEEEEEe
Confidence            3689999999999987653 32  58999887542    346788999999996 8999999998865   568999999


Q ss_pred             cCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc--
Q psy3714         250 VNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY--  322 (467)
Q Consensus       250 ~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~--  322 (467)
                      ++++++.+.+.     .++...+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||+++........  
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEEecccccccccccccccee
Confidence            99999987653     367788899999999999999999999999999999999664 7999999999876432111  


Q ss_pred             --ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         323 --NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       323 --~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                        ....++..|+|||.+....++.+.|+|..+++...... +..|+....     ..+.......    .  ...     
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~----~--~~~-----  219 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-----GSQILKKIDK----E--GER-----  219 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHh----c--CCc-----
Confidence              12346778999999988889999999988876443332 333332110     0111111110    0  000     


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                       ...+...++++.+|+.+||..+|++|||++|+++
T Consensus       220 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         220 -LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             -CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence             0112346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=6.5e-30  Score=243.69  Aligned_cols=239  Identities=15%  Similarity=0.161  Sum_probs=165.0

Q ss_pred             eecccCCcceEEEEEcc--CCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccC
Q psy3714         178 KLGRGKYSEVFEAINVQ--SSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVN  251 (467)
Q Consensus       178 ~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~  251 (467)
                      .||+|+||.||+|....  ....+++|.+....    ...+.+|+.+++.++ |+||+++.+.+.+.  ...++||||++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~--~~~~lv~e~~~   78 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIES--IPYLLVLEFCP   78 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCC--CceEEEEEeCC
Confidence            58999999999996433  33467888765332    235678999999885 89999999987653  46899999999


Q ss_pred             CccHHHHhhc--------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC--
Q psy3714         252 NTDFKQLYQT--------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--  321 (467)
Q Consensus       252 ~~~l~~~~~~--------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~--  321 (467)
                      +++|.+++..        .++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........  
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-cEEEeccccccccccchhee
Confidence            9999876532        34567788999999999999999999999999999999655 799999999875432211  


Q ss_pred             -cceeeeccCccCCccccc-------CCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         322 -YNVRVASRYFKGPELLAD-------YQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       322 -~~~~~gt~~y~aPE~l~~-------~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                       .....++..|+|||++..       ..++.+.|+|..+++...... +..++....        ........+....  
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~~~~~--  227 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS--------DEQVLKQVVREQD--  227 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC--------HHHHHHHHhhccC--
Confidence             122345677999998753       346778999988766443222 222221110        0011111111000  


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .   .+.........+++.++++..|+ .||++|||++|+++
T Consensus       228 ~---~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         228 I---KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             c---cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            0   01111122347888999998887 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=1.2e-29  Score=241.71  Aligned_cols=244  Identities=19%  Similarity=0.310  Sum_probs=183.2

Q ss_pred             ceeeeEeecccCCcceEEEEEcc-CCCeEEEEEeccc-------------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeC
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQ-SSDKCVVKILKPV-------------KKKKIKREIKILENLRGGTNIITLQAVVKD  237 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~-------------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~  237 (467)
                      +|++.+.||+|+||.||++.+.. +++.+|+|.+...             ....+.+|+.++.+...|+||+.+...+..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48889999999999999999887 6788999987521             113456788888765569999999998865


Q ss_pred             CCCCccEEEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCCcEEEEe
Q psy3714         238 PVSRTPALIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLID  309 (467)
Q Consensus       238 ~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~~ikl~D  309 (467)
                      .  ...+++|||++++++.+.+.       .+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|
T Consensus        81 ~--~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l~d  157 (269)
T cd08528          81 N--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTITD  157 (269)
T ss_pred             C--CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEEec
Confidence            3  56899999999998876542       37788899999999999999996 7899999999999998655 799999


Q ss_pred             cccceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCC
Q psy3714         310 WGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGR  389 (467)
Q Consensus       310 FGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (467)
                      ||++.............|+..|+|||.+.+..++...|+|..+++......+..|+...        ........ +.. 
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~--------~~~~~~~~-~~~-  227 (269)
T cd08528         158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST--------NMLSLATK-IVE-  227 (269)
T ss_pred             ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc--------CHHHHHHH-Hhh-
Confidence            99998765443444567899999999999888889999998887655444443333211        11111100 000 


Q ss_pred             CCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                         ..+.    .......++++.+||.+||..||++|||+.|+..+
T Consensus       228 ---~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         228 ---AVYE----PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ---ccCC----cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence               0000    00112468899999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=9.4e-30  Score=242.98  Aligned_cols=243  Identities=19%  Similarity=0.251  Sum_probs=176.3

Q ss_pred             eeeeEeecccCCcceEEEEEcc---CCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC----
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQ---SSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS----  240 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~----  240 (467)
                      |++.+.||+|+||.||+|....   +++.+|+|.++..     ..+.+.+|+++++.+. ||||+++.+.+.....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCcc
Confidence            5678899999999999998653   5678999988642     2345788999999995 8999999997754321    


Q ss_pred             CccEEEEeccCCccHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecc
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ---------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG  311 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFG  311 (467)
                      ...+++++|+.++++..+..         .++...+..++.|++.||+|||++||+||||||+||+++.+ ..+||+|||
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~-~~~kl~dfg  158 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-MTVCVADFG  158 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC-CCEEECccc
Confidence            23478889999999865531         35778889999999999999999999999999999999854 479999999


Q ss_pred             cceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhcc
Q psy3714         312 LAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNIL  387 (467)
Q Consensus       312 la~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (467)
                      +++.......   .....+++.|++||.+....++...|+|..+++...... +..++. ..+    ..+......    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~-~~~----~~~~~~~~~----  229 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA-GVE----NSEIYNYLI----  229 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCC-CCC----HHHHHHHHH----
Confidence            9986533221   112235678999999988888999999988876443322 222221 110    001111100    


Q ss_pred             CCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      .      ...   .......++++.+|+.+||..+|.+|||+.|++++
T Consensus       230 ~------~~~---~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         230 K------GNR---LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             c------CCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0      000   01112467899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=1.2e-29  Score=241.66  Aligned_cols=236  Identities=20%  Similarity=0.269  Sum_probs=173.8

Q ss_pred             eecccCCcceEEEEEccCC------CeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         178 KLGRGKYSEVFEAINVQSS------DKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       178 ~lG~G~~g~V~~~~~~~~~------~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .||+|+||.||+|......      +.+++|.+...    ....+.+|+.+++.+. |+||+++.+.+.+.  ...+++|
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~~v~   78 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLN--EPQYIIM   78 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCC--CCeEEEE
Confidence            5899999999999876433      67899987543    2446788999999995 89999999987653  4689999


Q ss_pred             eccCCccHHHHhhc----------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC----CcEEEEecccc
Q psy3714         248 EHVNNTDFKQLYQT----------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN----RKLRLIDWGLA  313 (467)
Q Consensus       248 e~~~~~~l~~~~~~----------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~----~~ikl~DFGla  313 (467)
                      ||++++++.+.+..          ++..++..++.|++.||+|||+++++|+||||+||+++..+    ..+||+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            99999998876532          56678888999999999999999999999999999998543    26999999999


Q ss_pred             eecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCC
Q psy3714         314 EFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGR  389 (467)
Q Consensus       314 ~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (467)
                      +........   ....++..|+|||.+.+..++.+.|+|..+++.+.... +..|+....     ..+........    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~-----~~~~~~~~~~~----  229 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-----NQEVLQHVTAG----  229 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC-----HHHHHHHHhcC----
Confidence            765322211   12245678999999998889999999988876443322 333321110     01111111000    


Q ss_pred             CCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                         .      ....+..+++++.+||.+||+.||.+|||++++++
T Consensus       230 ---~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         230 ---G------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ---C------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence               0      01112347889999999999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=2.4e-29  Score=239.78  Aligned_cols=239  Identities=15%  Similarity=0.160  Sum_probs=164.5

Q ss_pred             eecccCCcceEEEEEccCC--CeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccC
Q psy3714         178 KLGRGKYSEVFEAINVQSS--DKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVN  251 (467)
Q Consensus       178 ~lG~G~~g~V~~~~~~~~~--~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~  251 (467)
                      .||+|+||.||++.....+  ..+++|.++..    ....+.+|+.+++.++ ||||+++.+.+.+.  ...++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~--~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEA--IPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccC-CcchhheEEEecCC--CccEEEEecCC
Confidence            5899999999999754332  34566665532    2356788999999885 89999999988753  46799999999


Q ss_pred             CccHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC---C
Q psy3714         252 NTDFKQLYQT-------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---E  321 (467)
Q Consensus       252 ~~~l~~~~~~-------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~---~  321 (467)
                      +++|.++...       .+...+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++.......   .
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-cEEecccccccccCcchhhhc
Confidence            9999876542       34556788999999999999999999999999999998654 79999999986432111   1


Q ss_pred             cceeeeccCccCCccccc-------CCCCccchhHHHhhhccccccc-cccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         322 YNVRVASRYFKGPELLAD-------YQYHIELDPRFADILGRHSRKR-WERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~-------~~~~~~~D~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ....+++..|+|||++..       ..++.+.|+|..+++......+ ..|+....        ..........+     
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~~~-----  224 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--------DREVLNHVIKD-----  224 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhh-----
Confidence            123467889999999853       2356789999877664332211 22221110        00111100000     


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ..............+++..+++.+|+ .||.+|||++|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         225 QQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            00011111122346889999999998 68999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.97  E-value=1e-29  Score=241.21  Aligned_cols=239  Identities=21%  Similarity=0.336  Sum_probs=172.9

Q ss_pred             eeeEeecccCCcceEEEEEc----cCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         174 QLVRKLGRGKYSEVFEAINV----QSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       174 ~~~~~lG~G~~g~V~~~~~~----~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++.+.||.|+||.||+|...    ..+..|+||.++..    ....+.+|+++++++ .||||+++.+++..  ....++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~--~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIE--NEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEES--SSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccc--cccccc
Confidence            46789999999999999987    34567999999653    245788999999999 59999999999984  345899


Q ss_pred             EEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         246 IFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      |+||+++++|.+.+.     .++......++.|++.||.|||+++|+|+||+|+||+++..+ .+||+|||++.......
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-EEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccc
Confidence            999999999987653     377888899999999999999999999999999999999554 89999999998763222


Q ss_pred             Cc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         321 EY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       321 ~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      ..   ........|+|||.+....++.+.|+|..+++...... +..++..     .............           
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~-----~~~~~~~~~~~~~-----------  221 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD-----YDNEEIIEKLKQG-----------  221 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT-----SCHHHHHHHHHTT-----------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccccccc-----------
Confidence            21   22356778999999998889999999988887443322 1122110     0001111111000           


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                        .....+...+.+..++|.+|+..||++|||++++++
T Consensus       222 --~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  222 --QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             --EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             --ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence              011123357889999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG4257|consensus

Probab=99.96  E-value=1.5e-29  Score=248.14  Aligned_cols=234  Identities=20%  Similarity=0.351  Sum_probs=180.7

Q ss_pred             eeeEeecccCCcceEEEEEccC--C--CeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         174 QLVRKLGRGKYSEVFEAINVQS--S--DKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       174 ~~~~~lG~G~~g~V~~~~~~~~--~--~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .+.+.||.|.||.||+|....-  |  -.||||+.|..    .++.+..|..+|+++. |||||+|.+++.+   ...++
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfd-HphIikLIGv~~e---~P~Wi  467 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVE---QPMWI  467 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCC-Ccchhheeeeeec---cceeE
Confidence            3446799999999999986543  2  24889988753    4678999999999996 8999999999975   45799


Q ss_pred             EEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         246 IFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      |||.++.|.|..+++    .++......|++||+.||.|||+.+.|||||-..|||+....+ +||+|||+++..+....
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C-VKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC-VKLADFGLSRYLEDDAY  546 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce-eeecccchhhhccccch
Confidence            999999999998876    3778888999999999999999999999999999999986664 99999999998877666


Q ss_pred             cceeee--ccCccCCcccccCCCCccchhHHHhhhccccccccccccccCC--cccCChhhhhhhhhhccCCCCcccccc
Q psy3714         322 YNVRVA--SRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTEN--QHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       322 ~~~~~g--t~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      |+...|  ..-|||||.+.-..++.++|.|+.+++      .|+-+..+..  +.+.+.        ++.+..     +.
T Consensus       547 YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVC------mWEIl~lGvkPfqgvkNs--------DVI~~i-----En  607 (974)
T KOG4257|consen  547 YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVC------MWEILSLGVKPFQGVKNS--------DVIGHI-----EN  607 (974)
T ss_pred             hhccccccceeecCccccchhcccchhhHHHHHHH------HHHHHHhcCCcccccccc--------ceEEEe-----cC
Confidence            655555  345999999988889999999988874      3443322221  111111        111111     11


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHH
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTARE  431 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e  431 (467)
                      --..+.++..++.+..|+++|-.+||.+||+..+
T Consensus       608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrfte  641 (974)
T KOG4257|consen  608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTE  641 (974)
T ss_pred             CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHH
Confidence            1122345678999999999999999999997543

>KOG0576|consensus

Probab=99.96  E-value=6e-31  Score=260.11  Aligned_cols=255  Identities=24%  Similarity=0.368  Sum_probs=191.3

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ..+++|+++..+|.|+||.||+|+++.+++..|+|+++-..   -+-++.|+-+++..+ |+|||-++..|-..  ...+
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~-h~nivay~gsylr~--dklw   88 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRR--DKLW   88 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCC-CcChHHHHhhhhhh--cCcE
Confidence            45789999999999999999999999999999999998543   355788999999886 89999988877543  4589


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-C
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-Q  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~  320 (467)
                      +.||||.+|++.+.++   .+++.++.+.+++.+.||+|||++|-+|||||=.|||++..+ .+|++|||.+..+... .
T Consensus        89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g-DvklaDfgvsaqitati~  167 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG-DVKLADFGVSAQITATIA  167 (829)
T ss_pred             EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC-ceeecccCchhhhhhhhh
Confidence            9999999999988765   589999999999999999999999999999999999999665 7999999998765321 1


Q ss_pred             CcceeeeccCccCCcccc---cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         321 EYNVRVASRYFKGPELLA---DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~---~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      ......||++|||||+-.   ..+|...+|+|..++-.........|.|..-.     ...+..+.+.   .+....   
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-----mr~l~LmTkS---~~qpp~---  236 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-----MRALFLMTKS---GFQPPT---  236 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-----HHHHHHhhcc---CCCCCc---
Confidence            234578999999999863   34588899999776432211111111111000     0000001000   000000   


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                         -.++..-|+.+-+|++.+|.++|++||||+-+|+|||...
T Consensus       237 ---lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  237 ---LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             ---ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence               0112234889999999999999999999999999999864

>KOG0658|consensus

Probab=99.96  E-value=3.8e-29  Score=233.12  Aligned_cols=119  Identities=38%  Similarity=0.676  Sum_probs=111.6

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeeeE
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDM   82 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~   82 (467)
                      +..||.+||.|||++||+||||||+|+|+|.+++.+||||||.|+....++....+..|++|+|||.+.+...|+.++|+
T Consensus       130 Yt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDi  209 (364)
T KOG0658|consen  130 YTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDI  209 (364)
T ss_pred             HHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEE
Confidence            46799999999999999999999999999998889999999999999888888888999999999999999999999999


Q ss_pred             EchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchhH
Q psy3714          83 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELF  122 (467)
Q Consensus        83 ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  122 (467)
                      ||.||++.||+-| .|+|+|++..+|+..|.+++|++.-.
T Consensus       210 WSaGCV~aELl~g-~plFpG~s~~dQL~eIik~lG~Pt~e  248 (364)
T KOG0658|consen  210 WSAGCVMAELLKG-QPLFPGDSSVDQLVEIIKVLGTPTRE  248 (364)
T ss_pred             hhhhHHHHHHhcC-CcccCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999999999998 48889999999999999999987643

>KOG1152|consensus

Probab=99.96  E-value=5.7e-29  Score=242.50  Aligned_cols=188  Identities=25%  Similarity=0.377  Sum_probs=158.4

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----------HHHHHHHHHHHHHhc--CCCCeeEEEEE
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----------KKKIKREIKILENLR--GGTNIITLQAV  234 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----------~~~~~~Ei~il~~l~--~~~~iv~l~~~  234 (467)
                      .+..+|..++.+|+|+||.|++|.+++....|+||.+.+.+           ...+..||+||..|+  .|+||+++.++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            34578999999999999999999999999999999887532           123568999999887  47899999999


Q ss_pred             EeCCCCCccEEEEec-cCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEec
Q psy3714         235 VKDPVSRTPALIFEH-VNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW  310 (467)
Q Consensus       235 ~~~~~~~~~~lv~e~-~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DF  310 (467)
                      |+++  .+.|++||- -++-||..++   ..++|.+++.+++||..|+++||+.||||||||-+|+.++..| -+||+||
T Consensus       638 FEdd--d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g-~~klidf  714 (772)
T KOG1152|consen  638 FEDD--DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG-FVKLIDF  714 (772)
T ss_pred             eecC--CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC-eEEEeec
Confidence            9875  567899984 4555666555   3689999999999999999999999999999999999999555 7999999


Q ss_pred             ccceecCCCCCcceeeeccCccCCcccccCCCC-ccchhHHHhhhccccc
Q psy3714         311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYH-IELDPRFADILGRHSR  359 (467)
Q Consensus       311 Gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~D~~~~~~~~~~~~  359 (467)
                      |.|.... .......+||.-|.|||++.+..|- ...|+|..+++.+...
T Consensus       715 gsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytiv  763 (772)
T KOG1152|consen  715 GSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIV  763 (772)
T ss_pred             cchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEE
Confidence            9987653 4456778999999999999999984 5689999998866543

>KOG1095|consensus

Probab=99.95  E-value=1.2e-27  Score=253.14  Aligned_cols=242  Identities=22%  Similarity=0.348  Sum_probs=185.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCC-----eEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSD-----KCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .+.-++.+.||+|+||.||.|.......     .||+|.+++.    +...+.+|..+|++++ ||||+++.+++-+  .
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~--~  767 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLD--S  767 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecC--C
Confidence            4567788999999999999998765443     3899988764    3457889999999996 8999999999876  4


Q ss_pred             CccEEEEeccCCccHHHHhhc----------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEec
Q psy3714         241 RTPALIFEHVNNTDFKQLYQT----------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW  310 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DF  310 (467)
                      ...++++||+.+|||..+++.          ++..+...++.+|+.|..||++++.|||||-..|+||+.. ..+||+||
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VKIaDF  846 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVKIADF  846 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEEEccc
Confidence            567999999999999988752          6778999999999999999999999999999999999966 58999999


Q ss_pred             ccceecCCCCCcceee-e--ccCccCCcccccCCCCccchhHHHhhhccccccccccccccCC--cccCChhhhhhhhhh
Q psy3714         311 GLAEFYHPGQEYNVRV-A--SRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTEN--QHLVSPEALDFLDKN  385 (467)
Q Consensus       311 Gla~~~~~~~~~~~~~-g--t~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  385 (467)
                      |+|+.+...+.+.... +  ..-|||||.+.+..++.+.|+|..+++.      |+-|..+..  ...-+.+.+......
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVll------WEifslG~~PY~~~~n~~v~~~~~~g  920 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLL------WEIFSLGATPYPSRSNFEVLLDVLEG  920 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHH------HHHHhCCCCCCCCcchHHHHHHHHhC
Confidence            9999554333332211 1  2459999999999999999999999873      444332211  000011111111000


Q ss_pred             ccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                        +           ..+.+...++...+++..|.+-+|++||+...+++
T Consensus       921 --g-----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  921 --G-----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             --C-----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence              0           12334568889999999999999999999988886

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.95  E-value=1.3e-27  Score=222.99  Aligned_cols=237  Identities=31%  Similarity=0.495  Sum_probs=181.1

Q ss_pred             CCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCCccHHHH
Q psy3714         183 KYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL  258 (467)
Q Consensus       183 ~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~  258 (467)
                      +||.||+|....+++.+++|.+....    .+.+.+|++.++.+ +|+|++++.+.+...  ...++++|++.++++...
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence            58999999998889999999986542    46788999999999 589999998887653  467999999999998877


Q ss_pred             hhc---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcceeeeccCccCCc
Q psy3714         259 YQT---LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE  335 (467)
Q Consensus       259 ~~~---~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE  335 (467)
                      ...   ++...+..++.+++.++.+||+.||+|+||+|+||+++.. +.++|+|||.+.............++..|++||
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE  156 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE  156 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCCCCHH
Confidence            643   6788899999999999999999999999999999999865 479999999998765443445567889999999


Q ss_pred             ccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHH
Q psy3714         336 LLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFL  415 (467)
Q Consensus       336 ~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli  415 (467)
                      .+.+..++.+.|+|..+++......+..++.....    ...........        ...   .......++.++.+++
T Consensus       157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----~~~~~~~~~~~--------~~~---~~~~~~~~~~~~~~~i  221 (244)
T smart00220      157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----LLELFKKIGKP--------KPP---FPPPEWKISPEAKDLI  221 (244)
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHhcc--------CCC---CccccccCCHHHHHHH
Confidence            99888888899999877664433333333321100    00001100000        000   0000111678999999


Q ss_pred             HhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         416 DKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       416 ~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      .+||..||++|||+.++++||||
T Consensus       222 ~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      222 RKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             HHHccCCchhccCHHHHhhCCCC
Confidence            99999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1094|consensus

Probab=99.95  E-value=4.9e-28  Score=236.20  Aligned_cols=251  Identities=21%  Similarity=0.300  Sum_probs=181.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .+...++++||+|.||.|.+|.- ..+..||||+++..    .++.+.+||++|.+|+ ||||+.|.++|..+  +.+.+
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~D--ePicm  612 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLK-HPNIVELLGVCVQD--DPLCM  612 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccC-CCCeeEEEeeeecC--CchHH
Confidence            35667889999999999999974 44689999999864    2466889999999995 89999999998653  46789


Q ss_pred             EEeccCCccHHHHhhcC-----CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         246 IFEHVNNTDFKQLYQTL-----TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++||++.|||.+++...     .......++.||.+|++||.+.++|||||.+.|+|++.+ .++||+|||+|+....+.
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e-~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE-FTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-ccEEecCcccccccccCC
Confidence            99999999999987542     233456699999999999999999999999999999955 489999999999765555


Q ss_pred             Cccee---eeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         321 EYNVR---VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       321 ~~~~~---~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      .+...   +-...|||||.|....++++.|.|..++-      .|+.+.....+++.........+ + .+......-..
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvT------lwE~~~~C~e~Py~~lt~e~vve-n-~~~~~~~~~~~  763 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVT------LWEVFMLCREQPYSQLTDEQVVE-N-AGEFFRDQGRQ  763 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHH------HHHHHHHHhhCchhhhhHHHHHH-h-hhhhcCCCCcc
Confidence            54432   34677999999999999999999977652      23332222111111000000000 0 00000000000


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                       .-...+...+..+..|+.+|..+|-++|||.+++-.
T Consensus       764 -~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  764 -VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             -eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence             011223456788999999999999999999998743

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.95  E-value=2e-27  Score=265.73  Aligned_cols=251  Identities=15%  Similarity=0.160  Sum_probs=180.3

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccC
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVN  251 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~  251 (467)
                      .|...+.||+|+||.||+|.+..++..||+|.++.... ....|++++++++ ||||+++++++.+.  ...++||||++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~-HpnIv~~~~~~~~~--~~~~lv~Ey~~  766 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQ-HPNIVKLIGLCRSE--KGAYLIHEYIE  766 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCC-CCCcceEEEEEEcC--CCCEEEEeCCC
Confidence            45666789999999999999988999999998865322 2345788899995 89999999999764  45799999999


Q ss_pred             CccHHHHhhcCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcceeeec
Q psy3714         252 NTDFKQLYQTLTDYDIRYYLYELLKALDYCH---SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS  328 (467)
Q Consensus       252 ~~~l~~~~~~~~~~~~~~~~~qll~al~~lH---~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~gt  328 (467)
                      +++|.++++.++......++.|++.||+|||   +.+|+||||||+||+++.++ ..++. ||.+......   ....||
T Consensus       767 ~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~~---~~~~~t  841 (968)
T PLN00113        767 GKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCTD---TKCFIS  841 (968)
T ss_pred             CCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-ceEEE-eccccccccC---CCcccc
Confidence            9999999888999999999999999999999   67999999999999998554 55654 6665543221   224689


Q ss_pred             cCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc-ccccc--CCC
Q psy3714         329 RYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER-FVHTE--NQH  405 (467)
Q Consensus       329 ~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~  405 (467)
                      +.|+|||++.+..|+.++|+|..+++-+....+..|+......   ......+.... ........|.. .....  ...
T Consensus       842 ~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  917 (968)
T PLN00113        842 SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV---HGSIVEWARYC-YSDCHLDMWIDPSIRGDVSVNQ  917 (968)
T ss_pred             ccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC---CCcHHHHHHHh-cCccchhheeCccccCCCCccH
Confidence            9999999999988999999998888766555555554221111   00111111100 00000000100 00000  000


Q ss_pred             CCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         406 LVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       406 ~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ....++.+++.+|++.||++|||++|+++.
T Consensus       918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        918 NEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            112367899999999999999999999875

>KOG4278|consensus

Probab=99.95  E-value=2.9e-27  Score=231.94  Aligned_cols=241  Identities=19%  Similarity=0.336  Sum_probs=187.2

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      .+..+..+||-|.||.||.+..++-.-.||||.++..  ....++.|+.+|+.++ |||+|+|.++|..  +-.+|+|.|
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeik-HpNLVqLLGVCT~--EpPFYIiTE  343 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTH--EPPFYIITE  343 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhc-CccHHHHhhhhcc--CCCeEEEEe
Confidence            4566778999999999999999999999999999864  3567899999999995 8999999999975  346899999


Q ss_pred             ccCCccHHHHhhcC-----CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcc
Q psy3714         249 HVNNTDFKQLYQTL-----TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN  323 (467)
Q Consensus       249 ~~~~~~l~~~~~~~-----~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~  323 (467)
                      |+..|+|.+++...     +.--+.+++.||.+|++||..++.|||||-..|.|+. ++..||++||||++++. ++.|+
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg-EnhiVKvADFGLsRlMt-gDTYT  421 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHIVKVADFGLSRLMT-GDTYT  421 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc-ccceEEeeccchhhhhc-CCcee
Confidence            99999998887643     3334567889999999999999999999999999998 55689999999999884 44555


Q ss_pred             eeeecc---CccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         324 VRVASR---YFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       324 ~~~gt~---~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      ...|..   -|.|||.++...++.+.|.|..+++......    +.+.+...+--....+.+.+.             ..
T Consensus       422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIAT----YGMsPYPGidlSqVY~LLEkg-------------yR  484 (1157)
T KOG4278|consen  422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDLSQVYGLLEKG-------------YR  484 (1157)
T ss_pred             cccCccCcccccCcccccccccccchhhHHHHHHHHHHHh----cCCCCCCCccHHHHHHHHhcc-------------cc
Confidence            555643   4999999999999999999988887422111    111111111112222322222             12


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHh
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAM  433 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l  433 (467)
                      ...++..++....|++.|-+++|.+||+.+|+-
T Consensus       485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence            234567899999999999999999999987653

>KOG0199|consensus

Probab=99.95  E-value=3.9e-27  Score=234.04  Aligned_cols=241  Identities=20%  Similarity=0.297  Sum_probs=186.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCC---eEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSD---KCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      .++..+.+.||+|+||+|++|.....+.   .||||+++...    ...+.+|+.+|.+|+ |+|+++|++++.++   .
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~-H~hliRLyGvVl~q---p  184 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ-HPHLIRLYGVVLDQ---P  184 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhcc-CcceeEEeeeeccc---h
Confidence            3556677899999999999998776443   48999997543    457899999999996 89999999999863   4


Q ss_pred             cEEEEeccCCccHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         243 PALIFEHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..||+|.++.|+|.+-+.+     |.......|+.||+.|+.||.+++.|||||-..|+|+... ..||||||||.+...
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp-rtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP-RTVKICDFGLMRALG  263 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc-ceeeeecccceeccC
Confidence            6899999999998765543     5566778899999999999999999999999999999864 489999999999886


Q ss_pred             CCCCcceeee----ccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChh--hhhhhhhhccCCCC
Q psy3714         318 PGQEYNVRVA----SRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE--ALDFLDKNILGRHS  391 (467)
Q Consensus       318 ~~~~~~~~~g----t~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  391 (467)
                      .++.+....+    ...|.|||.|....++.+.|.|++++-      .|+.|..+.....+...  .+..+++       
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVT------iWEMFtyGEePW~G~~g~qIL~~iD~-------  330 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVT------IWEMFTYGEEPWVGCRGIQILKNIDA-------  330 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhh------HHhhhccCCCCCCCCCHHHHHHhccc-------
Confidence            6665543322    445999999999999999999999884      46666555433222221  1121111       


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ..++      +.+...|++..+++.+|-..+|++|||..++.+
T Consensus       331 ~erL------pRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  331 GERL------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             cccC------CCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            1111      234567999999999999999999999877653

>KOG0594|consensus

Probab=99.95  E-value=6.4e-28  Score=225.18  Aligned_cols=118  Identities=39%  Similarity=0.746  Sum_probs=108.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC-CCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      ++..||+.||+|||+++|+||||||+|||++. .+.+||+|||+|+... +...++..++|.+|+|||++.+...|++.+
T Consensus       124 ~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~-~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~v  202 (323)
T KOG0594|consen  124 SFMRQLLRGLAFLHSHGILHRDLKPQNLLISS-SGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSV  202 (323)
T ss_pred             HHHHHHHHHHHHHHhCCeecccCCcceEEECC-CCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCc
Confidence            47899999999999999999999999999995 5699999999999765 556678889999999999999988899999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchh
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL  121 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~  121 (467)
                      |+||+||+++||+++ .|.|+|..+.+|+.+|.+.+|++..
T Consensus       203 DiWs~GcIfaEm~~~-~~LFpG~se~~ql~~If~~lGtP~e  242 (323)
T KOG0594|consen  203 DIWSLGCIFAEMFTR-RPLFPGDSEIDQLFRIFRLLGTPNE  242 (323)
T ss_pred             chHhHHHHHHHHHhC-CCCCCCCcHHHHHHHHHHHcCCCCc
Confidence            999999999999996 5888999999999999999998764

>KOG0659|consensus

Probab=99.94  E-value=9.1e-28  Score=214.23  Aligned_cols=123  Identities=37%  Similarity=0.762  Sum_probs=109.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC-CCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.++++||+|||++.|+||||||.|+|++. ++.+||+|||+|+.+. ++...+..+.|+||+|||.+.+.+.|+..+
T Consensus       105 ~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~-~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~V  183 (318)
T KOG0659|consen  105 SYMLMTLKGLAYCHSKWILHRDLKPNNLLISS-DGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGV  183 (318)
T ss_pred             HHHHHHHHHHHHHHhhhhhcccCCccceEEcC-CCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcc
Confidence            36789999999999999999999999999994 5699999999999764 444455568899999999999999999999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchhHhhhh
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLD  126 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  126 (467)
                      |+||.||++.||+.| .|+++|.++.+|+..|.+.+|++...++.+
T Consensus       184 DmWavGCI~AELllr-~P~fpG~sDidQL~~If~~LGTP~~~~WP~  228 (318)
T KOG0659|consen  184 DMWAVGCIFAELLLR-VPFFPGDSDIDQLSKIFRALGTPTPDQWPE  228 (318)
T ss_pred             hhhhHHHHHHHHHcc-CCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence            999999999999977 699999999999999999999987655544

>KOG0984|consensus

Probab=99.94  E-value=1.9e-27  Score=204.69  Aligned_cols=181  Identities=20%  Similarity=0.374  Sum_probs=147.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEecc----chHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP----VKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~----~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .++...+..||+|+||.|-+-++..+|...|+|.++.    ...++..+|+.+..+...+|.+|++++.+.+  +..+++
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvwI  122 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVWI  122 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEEE
Confidence            4667778889999999999999999999999998764    2356788899988888889999999987654  345788


Q ss_pred             EEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         246 IFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       246 v~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~-~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      .||.+.. ++..++.       ..+|.-+-.++..++.||.|||++ .|||||+||+|||++.+| ++|+||||.+-...
T Consensus       123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISGYLV  200 (282)
T ss_pred             eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccceeeh
Confidence            8887653 4554442       478888899999999999999976 899999999999999776 79999999998765


Q ss_pred             CCCCcceeeeccCccCCcccccC----CCCccchhHHHhhh
Q psy3714         318 PGQEYNVRVASRYFKGPELLADY----QYHIELDPRFADIL  354 (467)
Q Consensus       318 ~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~D~~~~~~~  354 (467)
                      ..-..+...|...|||||.+...    +|+.++|+|+.++-
T Consensus       201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGIt  241 (282)
T KOG0984|consen  201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGIT  241 (282)
T ss_pred             hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhh
Confidence            43333446788999999998643    69999999987764

>KOG0661|consensus

Probab=99.94  E-value=1.6e-27  Score=228.20  Aligned_cols=119  Identities=33%  Similarity=0.641  Sum_probs=110.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .|+.||++||+|+|++|++|||+||||||+. .+..+||+|||+||.......++.++.|+||+|||++.+...|+.++|
T Consensus       114 nim~QilqGL~hiHk~GfFHRDlKPENiLi~-~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD  192 (538)
T KOG0661|consen  114 NIMYQILQGLAHIHKHGFFHRDLKPENILIS-GNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVD  192 (538)
T ss_pred             HHHHHHHHHHHHHHhcCcccccCChhheEec-ccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchH
Confidence            5899999999999999999999999999998 355899999999999887788999999999999999999899999999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchhH
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELF  122 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  122 (467)
                      +||+||+++|+.+- .|.|+|.++.+|+.+|..++|++.-.
T Consensus       193 ~wA~GcI~aEl~sL-rPLFPG~sE~Dqi~KIc~VLGtP~~~  232 (538)
T KOG0661|consen  193 MWAVGCIMAELYSL-RPLFPGASEIDQIYKICEVLGTPDKD  232 (538)
T ss_pred             HHHHHHHHHHHHHh-cccCCCCcHHHHHHHHHHHhCCCccc
Confidence            99999999999877 58889999999999999999987543

>KOG0598|consensus

Probab=99.94  E-value=2.5e-27  Score=221.45  Aligned_cols=107  Identities=33%  Similarity=0.591  Sum_probs=89.8

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC-CCCcccccccccccccccccccccCCCCeee
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .+.+|+.||+|||++|||||||||||||++.. ++++|+|||+|+... .+....+.|||+.|||||++.+ ..|+.++|
T Consensus       130 YlaEi~lAL~~LH~~gIiyRDlKPENILLd~~-GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~-~gy~~~vD  207 (357)
T KOG0598|consen  130 YLAEIVLALGYLHSKGIIYRDLKPENILLDEQ-GHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLG-KGYDKAVD  207 (357)
T ss_pred             HHHHHHHHHHHHHhCCeeeccCCHHHeeecCC-CcEEEeccccchhcccCCCccccccCCccccChHHHhc-CCCCcccc
Confidence            36789999999999999999999999999955 599999999999553 3445566799999999999987 56899999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      +||+|+++|||++|..||. +.+.......+
T Consensus       208 WWsLGillYeML~G~pPF~-~~~~~~~~~~I  237 (357)
T KOG0598|consen  208 WWSLGILLYEMLTGKPPFY-AEDVKKMYDKI  237 (357)
T ss_pred             hHhHHHHHHHHhhCCCCCc-CccHHHHHHHH
Confidence            9999999999999998885 44444444444

>KOG0600|consensus

Probab=99.94  E-value=5.2e-27  Score=226.25  Aligned_cols=119  Identities=38%  Similarity=0.759  Sum_probs=107.9

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC--cccccccccccccccccccccCCCCee
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +.+|++.||+|||++||+|||||.+||||+. ++.+||+|||||+++....  .++.++.|.||++||.+.+...|+.++
T Consensus       223 ~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn-~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aV  301 (560)
T KOG0600|consen  223 YMKQLLEGLEYCHSRGVLHRDIKGSNILIDN-NGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAV  301 (560)
T ss_pred             HHHHHHHHHHHHhhcCeeeccccccceEEcC-CCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccce
Confidence            6899999999999999999999999999995 4599999999999876544  477889999999999999999999999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchhHh
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFE  123 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  123 (467)
                      |+||+||+|.||+.|+ |+++|.++.+|+..|.+..|.+.-..
T Consensus       302 DlWS~GCIl~El~~gk-PI~~G~tEveQl~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  302 DLWSVGCILAELFLGK-PILQGRTEVEQLHKIFKLCGSPTEDY  343 (560)
T ss_pred             eehhhhHHHHHHHcCC-CCcCCccHHHHHHHHHHHhCCCChhc
Confidence            9999999999999995 77799999999999999999876433

>KOG1345|consensus

Probab=99.94  E-value=3e-27  Score=211.27  Aligned_cols=256  Identities=19%  Similarity=0.229  Sum_probs=185.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .|.|.+.+.||+|.||.+-+|+++.++..+++|.+...  ..+.+.||-.---.|.+|.||+.-+++.. ......+++|
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHh-hcCceEEEee
Confidence            47899999999999999999999999999999998653  34678888776666778899987766432 2345678999


Q ss_pred             eccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC-CCCcEEEEecccceecCCCCCcce
Q psy3714         248 EHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH-ENRKLRLIDWGLAEFYHPGQEYNV  324 (467)
Q Consensus       248 e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~-~~~~ikl~DFGla~~~~~~~~~~~  324 (467)
                      ||++.|||..-..  .+.|...+.++.|+++|++|+|++++||||||.+|||+-. +-..|||||||+.+.....-.  -
T Consensus       102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~--~  179 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK--Y  179 (378)
T ss_pred             ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh--h
Confidence            9999999987664  4778888999999999999999999999999999999853 335799999999876432111  1


Q ss_pred             eeeccCccCCcccccC---C--CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         325 RVASRYFKGPELLADY---Q--YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       325 ~~gt~~y~aPE~l~~~---~--~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      .--+..|-+||+....   .  .....|+|..+++...++.|-.||....-.   .+....+..  ..++... .     
T Consensus       180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~---d~~Y~~~~~--w~~rk~~-~-----  248 (378)
T KOG1345|consen  180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM---DKPYWEWEQ--WLKRKNP-A-----  248 (378)
T ss_pred             hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc---CchHHHHHH--HhcccCc-c-----
Confidence            2246678899976432   2  356789999999888777777666432110   111111111  0111000 0     


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCC---CCHHHHhCCCCCC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYER---LTAREAMDHPYFY  439 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R---~ta~e~l~Hp~f~  439 (467)
                      .+..+...|+.|..+.+|-|..+|++|   -+++.-.+.-|..
T Consensus       249 ~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  249 LPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             CchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            111223479999999999999999999   4666666666653

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=4.3e-25  Score=200.84  Aligned_cols=205  Identities=31%  Similarity=0.532  Sum_probs=172.7

Q ss_pred             ecccCCcceEEEEEccCCCeEEEEEeccchH----HHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEeccCCcc
Q psy3714         179 LGRGKYSEVFEAINVQSSDKCVVKILKPVKK----KKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTD  254 (467)
Q Consensus       179 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~~~  254 (467)
                      ||+|++|.||++....+++.+++|+......    ..+.+|++.++.+. |++++.+...+...  ...++++|++.+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~--~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGVFEDE--NHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcC-CCCeeeEeeeeecC--CeEEEEEecCCCCc
Confidence            6899999999999988899999999886543    67899999999997 69999999988754  56899999999999


Q ss_pred             HHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-Ccceeeecc
Q psy3714         255 FKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASR  329 (467)
Q Consensus       255 l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~~~~~~gt~  329 (467)
                      +.++..    .++...+..++.+++.++.+||++|++|+||+|.||+++..+..++|+|||.+....... ......++.
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  157 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP  157 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence            988764    368888999999999999999999999999999999999623479999999998764332 123356788


Q ss_pred             CccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCC
Q psy3714         330 YFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVS  408 (467)
Q Consensus       330 ~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  408 (467)
                      .|++||.+... .+....|.|..+++...                                                 + 
T Consensus       158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~-------------------------------------------------l-  187 (215)
T cd00180         158 AYMAPEVLLGKGYYSEKSDIWSLGVILYE-------------------------------------------------L-  187 (215)
T ss_pred             CccChhHhcccCCCCchhhhHHHHHHHHH-------------------------------------------------H-
Confidence            99999999876 67788899977765110                                                 0 


Q ss_pred             hHHHHHHHhhcCcCCCCCCCHHHHhCCC
Q psy3714         409 PEALDFLDKLLRYDHYERLTAREAMDHP  436 (467)
Q Consensus       409 ~~~~dli~~lL~~dp~~R~ta~e~l~Hp  436 (467)
                      +.+.+++.+||..||.+|||++++++||
T Consensus       188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            5778999999999999999999999986

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0196|consensus

Probab=99.93  E-value=5.9e-26  Score=228.42  Aligned_cols=243  Identities=17%  Similarity=0.252  Sum_probs=185.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCC---CeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSS---DKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ...-.+.++||.|.||.||+|+.+..+   ..||||.+|.-    .+..++.|+.||-+.. ||||++|.++...  .+.
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTk--s~P  704 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTK--SKP  704 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEec--Cce
Confidence            345678899999999999999887665   36999999863    3456889999999995 8999999999875  356


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      +++|.||+++|.|+.++.    +|+.-++..+++.|+.|++||-++|.|||||-..|||++ ++-..|++|||+++..+.
T Consensus       705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN-snLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec-cceEEEeccccceeeccc
Confidence            788899999999998875    477778899999999999999999999999999999999 566899999999998754


Q ss_pred             CC--Ccceeee--ccCccCCcccccCCCCccchhHHHhhhccc-cccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         319 GQ--EYNVRVA--SRYFKGPELLADYQYHIELDPRFADILGRH-SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       319 ~~--~~~~~~g--t~~y~aPE~l~~~~~~~~~D~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      +.  .+++..|  ...|.|||.|....++.++|.|+++++-.. +..|..|+....+|     +..+-++...       
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-----dVIkaIe~gy-------  851 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DVIKAIEQGY-------  851 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-----HHHHHHHhcc-------
Confidence            43  2333333  356999999999999999999999875110 11112222222222     2222222211       


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                            ..+.+-..+..+-.|+..|-++|-++||+..|+..
T Consensus       852 ------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  852 ------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             ------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                  11223356788899999999999999999888765

>KOG0660|consensus

Probab=99.93  E-value=1.1e-26  Score=216.42  Aligned_cols=116  Identities=36%  Similarity=0.696  Sum_probs=104.7

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC---CCcccccccccccccccccccccCCCCe
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP---GQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +..||++||.|+||.||+||||||+|+|++. +..+|+||||+|+....   ....+..+.|+||+|||.+.....|+.+
T Consensus       130 f~YQiLrgLKyiHSAnViHRDLKPsNll~n~-~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~a  208 (359)
T KOG0660|consen  130 FLYQILRGLKYIHSANVIHRDLKPSNLLLNA-DCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKA  208 (359)
T ss_pred             HHHHHHHhcchhhcccccccccchhheeecc-CCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccch
Confidence            5689999999999999999999999999985 45899999999998753   3345678899999999999998899999


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCch
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE  120 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~  120 (467)
                      +||||.||+++||++|+ |.|+|.+..+|+..|...+|+++
T Consensus       209 iDiWSvGCI~AEmL~gk-plFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  209 IDIWSVGCILAEMLTGK-PLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             hhhhhhhHHHHHHHcCC-CCCCCCchHHHHHHHHHhcCCCC
Confidence            99999999999999995 77899999999999999999874

>KOG0667|consensus

Probab=99.93  E-value=2.6e-26  Score=228.89  Aligned_cols=115  Identities=38%  Similarity=0.786  Sum_probs=103.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCC-cEEEEecccceecCCCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~-~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .|+.||+.||.+||++||||.|||||||||...+. .|||+|||.|+......  .+++-|++|+|||++.+.+ |+.+.
T Consensus       293 ~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v--ytYiQSRfYRAPEVILGlp-Y~~~I  369 (586)
T KOG0667|consen  293 KFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV--YTYIQSRFYRAPEVILGLP-YDTAI  369 (586)
T ss_pred             HHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc--eeeeeccccccchhhccCC-CCCcc
Confidence            58999999999999999999999999999975433 79999999999876443  3789999999999999855 89999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCch
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE  120 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~  120 (467)
                      |+|||||+++||++| .|+|+|++.++|++.|+..+|.+.
T Consensus       370 DmWSLGCIlAEL~tG-~PLfpG~ne~DQl~~I~e~lG~Pp  408 (586)
T KOG0667|consen  370 DMWSLGCILAELFTG-EPLFPGDNEYDQLARIIEVLGLPP  408 (586)
T ss_pred             ceeehhhhHHhHhcC-ccccCCCCHHHHHHHHHHHhCCCC
Confidence            999999999999999 799999999999999999999643

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=2.5e-25  Score=217.35  Aligned_cols=160  Identities=19%  Similarity=0.268  Sum_probs=124.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEcc-CCCeEEEEEeccc--------hHHHHHHHHHHHHHhcCCCCee-EEEEEEeCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQ-SSDKCVVKILKPV--------KKKKIKREIKILENLRGGTNII-TLQAVVKDPV  239 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~--------~~~~~~~Ei~il~~l~~~~~iv-~l~~~~~~~~  239 (467)
                      .++|++.+.||+|+||+||+|.+.. +++.+|||.+...        ....+.+|+++|+.++ |+|++ .+...     
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~-----   90 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT-----   90 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc-----
Confidence            4789999999999999999998876 6777899986422        1345889999999997 66776 44432     


Q ss_pred             CCccEEEEeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCceEEeCCCCcEEEEecccceecCC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDV-KPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDl-Kp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                       ...++||||+++++|... ...   ....++.|++.||.|||++||+|||| ||+|||++.++ .+||+|||+|+.+..
T Consensus        91 -~~~~LVmE~~~G~~L~~~-~~~---~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~-~ikLiDFGlA~~~~~  164 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLA-RPH---GDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG-EAAVIDFQLASVFRR  164 (365)
T ss_pred             -CCcEEEEEccCCCCHHHh-Ccc---chHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC-CEEEEECccceeccc
Confidence             246999999999988632 211   12567899999999999999999999 99999998554 799999999996643


Q ss_pred             CC---------CcceeeeccCccCCcccccCC
Q psy3714         319 GQ---------EYNVRVASRYFKGPELLADYQ  341 (467)
Q Consensus       319 ~~---------~~~~~~gt~~y~aPE~l~~~~  341 (467)
                      ..         ..+...+++.|+|||.+....
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~  196 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPRE  196 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence            22         113346888899999997643

>KOG0200|consensus

Probab=99.93  E-value=6.4e-25  Score=230.90  Aligned_cols=241  Identities=25%  Similarity=0.390  Sum_probs=181.8

Q ss_pred             cceeeeEeecccCCcceEEEEEcc-------CCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQ-------SSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ++.++.+.||+|.||.|++|.-..       ....||||.++..    ..+.+..|+++|+.+..|+||+.+.+.+..  
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--  373 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--  373 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence            344666799999999999987431       1457999998753    346788999999999999999999998876  


Q ss_pred             CCccEEEEeccCCccHHHHhh--c-----------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ--T-----------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH  300 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~--~-----------------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~  300 (467)
                      ....++|+||+..|+|..++.  +                 ++..+...++.||+.|++||+++.+|||||-..|||+. 
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~-  452 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT-  452 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec-
Confidence            467899999999999987653  3                 67788899999999999999999999999999999998 


Q ss_pred             CCCcEEEEecccceecCCCCCccee--eec--cCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcc--cC
Q psy3714         301 ENRKLRLIDWGLAEFYHPGQEYNVR--VAS--RYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQH--LV  374 (467)
Q Consensus       301 ~~~~ikl~DFGla~~~~~~~~~~~~--~gt--~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--~~  374 (467)
                      .+..+||+|||+|+...+...+...  .++  ..|||||.+.+..|+.+.|+|+.+++.      |+-|..+....  +.
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L------~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILL------WEIFTLGGTPYPGIP  526 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHH------HHHhhCCCCCCCCCC
Confidence            4568999999999966544444322  222  239999999998899999999999863      33222221111  11


Q ss_pred             -ChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHh
Q psy3714         375 -SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM  433 (467)
Q Consensus       375 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l  433 (467)
                       .++...++...             .....+...+++..++++.|-+.+|++||+..|+.
T Consensus       527 ~~~~l~~~l~~G-------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~  573 (609)
T KOG0200|consen  527 PTEELLEFLKEG-------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECV  573 (609)
T ss_pred             cHHHHHHHHhcC-------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence             12222222111             11123455799999999999999999999987654

>KOG0663|consensus

Probab=99.93  E-value=3.6e-26  Score=210.06  Aligned_cols=117  Identities=36%  Similarity=0.666  Sum_probs=106.2

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC-CCCcccccccccccccccccccccCCCCeee
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +..|+++|++|||.+.|+||||||+|+|+... +.+|++|||+||.+. +-+.++..+-|.||+|||.+.+...|++++|
T Consensus       182 L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iD  260 (419)
T KOG0663|consen  182 LMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK-GILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVD  260 (419)
T ss_pred             HHHHHHHHHHHHhhceeEecccchhheeeccC-CcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchh
Confidence            56799999999999999999999999999854 589999999999764 4455777889999999999999999999999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchh
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL  121 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~  121 (467)
                      +||+||++.||++++ |.|+|.+..+|+.+|.+.+|++.-
T Consensus       261 MWSvGCI~aE~l~~k-Plf~G~sE~dQl~~If~llGtPte  299 (419)
T KOG0663|consen  261 MWSVGCIFAELLTQK-PLFPGKSEIDQLDKIFKLLGTPSE  299 (419)
T ss_pred             hhhHHHHHHHHHhcC-CCCCCCchHHHHHHHHHHhCCCcc
Confidence            999999999999985 788999999999999999998753

>KOG0581|consensus

Probab=99.93  E-value=2.2e-26  Score=215.19  Aligned_cols=98  Identities=27%  Similarity=0.527  Sum_probs=88.9

Q ss_pred             hHHHHHHHHHHHHHh-CCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~-~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +||.+|++||.|||. ++||||||||+|||++. .+.|||||||.+....+. ...+.+||..|||||.+.+ ..|+.++
T Consensus       182 ~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs-kGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g-~~Ys~~s  258 (364)
T KOG0581|consen  182 KIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS-KGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISG-ESYSVKS  258 (364)
T ss_pred             HHHHHHHHHHHHHhhccCeeeccCCHHHeeecc-CCCEEeccccccHHhhhh-hcccccccccccChhhhcC-CcCCccc
Confidence            589999999999995 99999999999999995 569999999999987655 5677899999999999986 6699999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHG  102 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~  102 (467)
                      ||||||..++|+.+|+.|+.+.
T Consensus       259 DIWSLGLsllE~a~GrfP~~~~  280 (364)
T KOG0581|consen  259 DIWSLGLSLLELAIGRFPYPPP  280 (364)
T ss_pred             ceecccHHHHHHhhCCCCCCCc
Confidence            9999999999999999998764

>KOG3653|consensus

Probab=99.92  E-value=2.6e-25  Score=212.99  Aligned_cols=262  Identities=19%  Similarity=0.217  Sum_probs=179.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhc-CCCCeeEEEEEEeCCC--CCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLR-GGTNIITLQAVVKDPV--SRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~-~~~~iv~l~~~~~~~~--~~~~~lv  246 (467)
                      .+..++++.+|+|.||.||+|..  .++.||||++....++..+.|-+|.+... .|+||+++...-+...  ...++||
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            45667888999999999999975  45899999999888888888888876432 4899998877654332  3357899


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSM---------GIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~---------~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                      ++|.+.|+|.+++.  ..+-.+...++..++.||+|||+-         .|+|||||..|||+..+. +.-|+|||||..
T Consensus       287 t~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFGLAl~  365 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFGLALR  365 (534)
T ss_pred             eeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccceeEE
Confidence            99999999998876  477888999999999999999963         599999999999998554 799999999998


Q ss_pred             cCCCCC---cceeeeccCccCCcccccCC-CC-----ccchhHHHhhhc-----ccccc--ccccccccC-CcccCChhh
Q psy3714         316 YHPGQE---YNVRVASRYFKGPELLADYQ-YH-----IELDPRFADILG-----RHSRK--RWERFVHTE-NQHLVSPEA  378 (467)
Q Consensus       316 ~~~~~~---~~~~~gt~~y~aPE~l~~~~-~~-----~~~D~~~~~~~~-----~~~~~--~~~~~~~~~-~~~~~~~~~  378 (467)
                      +.++..   ....+||..|||||+|.+-- ..     ..+|+...+++.     +-...  +-.+-++.+ .+.++...-
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            876543   33479999999999997642 22     235666544431     10000  111111111 112222222


Q ss_pred             hhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHH------HHhCCCC
Q psy3714         379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAR------EAMDHPY  437 (467)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~------e~l~Hp~  437 (467)
                      ++.+....+....+..|...-..+  . --.-+++.+..|-.-||+.|+||.      ..|.|+|
T Consensus       446 ~e~mq~~VV~kK~RP~~p~~W~~h--~-~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPDAWRKH--A-GMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HHHHHHHHHhhccCCCChhhhhcC--c-cHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            333333333222233332211111  1 124678899999999999999984      3456666

>KOG0616|consensus

Probab=99.92  E-value=1e-25  Score=204.00  Aligned_cols=96  Identities=28%  Similarity=0.598  Sum_probs=87.0

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeeeE
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDM   82 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~   82 (467)
                      +|.||+.||+|||+++||+|||||||||++. ++.+||+|||+|+.....  .-+.|||+.|+|||++.. ..|+.++|+
T Consensus       149 YAAeivlAleylH~~~iiYRDLKPENiLlD~-~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~s-k~ynkavDW  224 (355)
T KOG0616|consen  149 YAAEIVLALEYLHSLDIIYRDLKPENLLLDQ-NGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQS-KGYNKAVDW  224 (355)
T ss_pred             HHHHHHHHHHHHHhcCeeeccCChHHeeecc-CCcEEEEeccceEEecCc--EEEecCCccccChHHhhc-CCCCcchhH
Confidence            5889999999999999999999999999995 569999999999988644  556799999999999986 668999999


Q ss_pred             EchhHHHHHHHhcCCCCCCC
Q psy3714          83 WSLGCMLASMIFRKEPFFHG  102 (467)
Q Consensus        83 ws~G~~l~~~l~g~~~~~~~  102 (467)
                      |||||+.|||+.|..||+..
T Consensus       225 WalGVLIYEMlaG~pPF~~~  244 (355)
T KOG0616|consen  225 WALGVLIYEMLAGYPPFYDD  244 (355)
T ss_pred             HHHHHHHHHHHcCCCCCcCC
Confidence            99999999999999999743

>KOG0595|consensus

Probab=99.92  E-value=8.2e-26  Score=213.20  Aligned_cols=98  Identities=33%  Similarity=0.647  Sum_probs=88.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC--C---CcEEEEecccceecCCCCcccccccccccccccccccccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE--N---RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~--~---~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~   76 (467)
                      .+..|||.||++||+++||||||||+||||+..  +   ..+||+|||+|+.+.++...++.+||+.|||||++.. +.|
T Consensus       113 ~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~Y  191 (429)
T KOG0595|consen  113 HFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQY  191 (429)
T ss_pred             HHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHh-ccc
Confidence            467899999999999999999999999999853  1   3589999999999998888888999999999999975 668


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +.|+|+||+|+++|++++|+.||.
T Consensus       192 dAKADLWSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  192 DAKADLWSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             cchhhHHHHHHHHHHHHhCCCCcc
Confidence            999999999999999999998874

>KOG0588|consensus

Probab=99.91  E-value=4.9e-25  Score=218.67  Aligned_cols=110  Identities=28%  Similarity=0.553  Sum_probs=100.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.|+.|||..+|+|||+||+|+|++..+ .+||+|||+|.+..+++...+.||++.|.+||++.+..+.+.++|
T Consensus       116 ~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~-nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sD  194 (786)
T KOG0588|consen  116 HFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN-NIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSD  194 (786)
T ss_pred             HHHHHHHHHHHHHhhhcceeccCCchhhhhhccc-CEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccc
Confidence            5789999999999999999999999999999766 599999999999999999999999999999999999888889999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      ||||||+|+.+|+|+.||.  +++..++...++
T Consensus       195 VWSCGVILfALLtG~LPFd--DdNir~LLlKV~  225 (786)
T KOG0588|consen  195 VWSCGVILFALLTGKLPFD--DDNIRVLLLKVQ  225 (786)
T ss_pred             cchhHHHHHHHHhCCCCCC--CccHHHHHHHHH
Confidence            9999999999999999994  667777655543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=2.8e-25  Score=242.35  Aligned_cols=180  Identities=12%  Similarity=0.095  Sum_probs=124.6

Q ss_pred             CccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC---------------
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE---------------  301 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~---------------  301 (467)
                      ..++++||++ +++|.+.+.    .+++.+++.+++||+.||.|||++|||||||||+|||++..               
T Consensus        53 ~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~  131 (793)
T PLN00181         53 DSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG  131 (793)
T ss_pred             chhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence            3467778876 457877763    38899999999999999999999999999999999999532               


Q ss_pred             ---CCcEEEEecccceecCCC-----------------CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccc
Q psy3714         302 ---NRKLRLIDWGLAEFYHPG-----------------QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKR  361 (467)
Q Consensus       302 ---~~~ikl~DFGla~~~~~~-----------------~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~  361 (467)
                         +..+||+|||+++.....                 ......+||++|||||++.+..|+.++|+|..+++.+....+
T Consensus       132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~  211 (793)
T PLN00181        132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP  211 (793)
T ss_pred             ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC
Confidence               235677777777642110                 001124689999999999999999999999888875443332


Q ss_pred             cccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         362 WERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      ..++.          ....... ......        .. +....-.+++.+++.+||..||.+|||++|+|+||||...
T Consensus       212 ~~~~~----------~~~~~~~-~~~~~~--------~~-~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        212 VSSRE----------EKSRTMS-SLRHRV--------LP-PQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             CCchh----------hHHHHHH-HHHHhh--------cC-hhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            22110          0000000 000000        00 0001124677899999999999999999999999999764

>KOG0615|consensus

Probab=99.91  E-value=1.5e-25  Score=211.29  Aligned_cols=99  Identities=32%  Similarity=0.617  Sum_probs=86.9

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecC--CCcEEEEecccceecCCCCccccccccccccccccccccc--CCCC
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ--MYDY   78 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~--~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~   78 (467)
                      +++|++.|+.|||++||+||||||+|||+...  ...+||+|||+|+....++...+.|||+.|.|||++.+..  .+..
T Consensus       281 ~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~  360 (475)
T KOG0615|consen  281 LFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPS  360 (475)
T ss_pred             HHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccc
Confidence            68999999999999999999999999999743  2368999999999988777788999999999999997632  2345


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      ++|+||+||+||-+|+|..||..
T Consensus       361 kVDiWSlGcvLfvcLsG~pPFS~  383 (475)
T KOG0615|consen  361 KVDIWSLGCVLFVCLSGYPPFSE  383 (475)
T ss_pred             hheeeeccceEEEEeccCCCccc
Confidence            78999999999999999988853

>KOG0592|consensus

Probab=99.91  E-value=4.3e-25  Score=214.76  Aligned_cols=110  Identities=35%  Similarity=0.650  Sum_probs=91.8

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC--------------ccccccccccccccc
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--------------EYNVRVASRYFKGPE   68 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~--------------~~~~~~~~~~~~~pe   68 (467)
                      +|.||+.||+|||++|||||||||||||++ .+.+++|+|||-|+.+.+..              .....+||-.|++||
T Consensus       179 YAAeIldAleylH~~GIIHRDlKPENILLd-~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPE  257 (604)
T KOG0592|consen  179 YAAEILDALEYLHSNGIIHRDLKPENILLD-KDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPE  257 (604)
T ss_pred             HHHHHHHHHHHHHhcCceeccCChhheeEc-CCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHH
Confidence            689999999999999999999999999999 55699999999998764321              114468999999999


Q ss_pred             ccccccCCCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q psy3714          69 LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV  115 (467)
Q Consensus        69 ~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~  115 (467)
                      ++.. ...+..+|+|+|||++|.|+.|+.|| .+.+.+....+|++.
T Consensus       258 lL~~-~~~~~~sDiWAlGCilyQmlaG~PPF-ra~NeyliFqkI~~l  302 (604)
T KOG0592|consen  258 LLND-SPAGPSSDLWALGCILYQMLAGQPPF-RAANEYLIFQKIQAL  302 (604)
T ss_pred             HhcC-CCCCcccchHHHHHHHHHHhcCCCCC-ccccHHHHHHHHHHh
Confidence            9976 55788999999999999999998777 566666666666553

>KOG2052|consensus

Probab=99.91  E-value=4.3e-24  Score=203.21  Aligned_cols=181  Identities=22%  Similarity=0.284  Sum_probs=145.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHH--hcCCCCeeEEEEEEeC--CCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILEN--LRGGTNIITLQAVVKD--PVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~--l~~~~~iv~l~~~~~~--~~~~~~~l  245 (467)
                      ...-.+++.||+|.||.||+|..+  |+.||||++.........||.+|.+.  | .|+||..+.+....  .....++|
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmL-RHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVML-RHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             hheeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHh-ccchhhhhhhccccCCCceEEEEE
Confidence            466789999999999999999875  78999999998888888999988763  4 48999988765422  23356799


Q ss_pred             EEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         246 IFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSM--------GIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       246 v~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~--------~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                      |.+|.+.|+|.+++.  .++.+....++..++.||+|||-.        .|.|||||..|||+.. ++..-|+|+|||..
T Consensus       287 vTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk-n~~C~IADLGLAv~  365 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVR  365 (513)
T ss_pred             eeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc-CCcEEEeeceeeEE
Confidence            999999999999886  477888899999999999999953        4999999999999985 45899999999976


Q ss_pred             cCCCC-----CcceeeeccCccCCcccccCCC--C----ccchhHHHhhh
Q psy3714         316 YHPGQ-----EYNVRVASRYFKGPELLADYQY--H----IELDPRFADIL  354 (467)
Q Consensus       316 ~~~~~-----~~~~~~gt~~y~aPE~l~~~~~--~----~~~D~~~~~~~  354 (467)
                      .....     ..+..|||..|||||+|.+.--  +    ...|+|..+++
T Consensus       366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLV  415 (513)
T KOG2052|consen  366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLV  415 (513)
T ss_pred             ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHH
Confidence            64332     2345799999999999976421  1    23588866654

>KOG0591|consensus

Probab=99.91  E-value=8.8e-25  Score=196.56  Aligned_cols=109  Identities=33%  Similarity=0.640  Sum_probs=92.3

Q ss_pred             hHHHHHHHHHHHHHh--CC--CcccCCCCCcEEEecCCCcEEEEecccceecCCCCc-ccccccccccccccccccccCC
Q psy3714           2 RIATGASMALDYCHS--MG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLADYQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~--~~--iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~   76 (467)
                      +++.|+|.||.+||+  ..  |+||||||.||+++. ++.|||+|||+++++..... ....+|||+||+||.+.. +.|
T Consensus       128 k~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~-~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y  205 (375)
T KOG0591|consen  128 KYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA-NGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHE-SGY  205 (375)
T ss_pred             HHHHHHHHHHHHHhccccccceeeccCcchheEEcC-CCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhc-CCC
Confidence            578999999999999  44  999999999999994 56999999999998876544 345799999999999986 669


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      +.++||||+||++|||+.-..||+ |+ ++..+.+.+.
T Consensus       206 ~~kSDiWslGCllyEMcaL~~PF~-g~-n~~~L~~KI~  241 (375)
T KOG0591|consen  206 NFKSDIWSLGCLLYEMCALQSPFY-GD-NLLSLCKKIE  241 (375)
T ss_pred             CcchhHHHHHHHHHHHHhcCCCcc-cc-cHHHHHHHHH
Confidence            999999999999999999988885 33 5656554443

>KOG0578|consensus

Probab=99.91  E-value=1.8e-24  Score=211.99  Aligned_cols=136  Identities=28%  Similarity=0.526  Sum_probs=108.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-cccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .|+.+++.||+|||.+||||||||.+|||++.+ +.+||+|||+|..+.... ...+.+||++|||||++.+ ..|+.++
T Consensus       373 ~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~-g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr-k~YG~KV  450 (550)
T KOG0578|consen  373 AICREILQGLKFLHARGIIHRDIKSDNILLTMD-GSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR-KPYGPKV  450 (550)
T ss_pred             HHHHHHHHHHHHHHhcceeeeccccceeEeccC-CcEEEeeeeeeeccccccCccccccCCCCccchhhhhh-cccCccc
Confidence            478999999999999999999999999999965 479999999998776554 5677899999999999986 5589999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchhHhhhhhhccCCCchhhhhccccccc
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADILGRARVY  146 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~  146 (467)
                      ||||||++.+||+.|..||+. ++...-++.| ..-|++++..     .-.+.|.|++++.++...
T Consensus       451 DIWSLGIMaIEMveGEPPYln-E~PlrAlyLI-a~ng~P~lk~-----~~klS~~~kdFL~~cL~~  509 (550)
T KOG0578|consen  451 DIWSLGIMAIEMVEGEPPYLN-ENPLRALYLI-ATNGTPKLKN-----PEKLSPELKDFLDRCLVV  509 (550)
T ss_pred             cchhhhhHHHHHhcCCCCccC-CChHHHHHHH-hhcCCCCcCC-----ccccCHHHHHHHHHHhhc
Confidence            999999999999999999986 3344444444 3346665522     223567777777665544

>KOG0192|consensus

Probab=99.90  E-value=2.4e-24  Score=210.49  Aligned_cols=143  Identities=24%  Similarity=0.362  Sum_probs=107.9

Q ss_pred             ChHHHHHHHHHHHHHhCC-CcccCCCCCcEEEecCCCcEEEEecccceecCCC-Cccccccccccccccccccc-ccCCC
Q psy3714           1 MRIATGASMALDYCHSMG-IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLAD-YQMYD   77 (467)
Q Consensus         1 ~~i~~~i~~al~~lH~~~-iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~-~~~~~   77 (467)
                      ++||.|||+||+|||+++ ||||||||+|||++....++||+|||+++..... ...+...||..|||||++.+ ...|+
T Consensus       145 l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~  224 (362)
T KOG0192|consen  145 LRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYT  224 (362)
T ss_pred             HHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCC
Confidence            479999999999999999 9999999999999954349999999999877643 33444689999999999985 25689


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCCCCCCCHHHH-HHHHHHhCCc-----------hhHhhhhhhccCCCchhhhhcccccc
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL-VRIAKVLGTE-----------ELFEYLDKYHIELDPRFADILGRARV  145 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~-~~~~~~~~~~-----------~~~~~~~~~~~~~~p~~~~~~~~~~v  145 (467)
                      .++||||||+++||++||+.||- +... .+. ..+......+           .+.+.|.......+|.|.++....+.
T Consensus       225 ~K~DvySFgIvlWEl~t~~~Pf~-~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~  302 (362)
T KOG0192|consen  225 EKSDVYSFGIVLWELLTGEIPFE-DLAP-VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES  302 (362)
T ss_pred             ccchhhhHHHHHHHHHHCCCCCC-CCCH-HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence            99999999999999999999984 3333 333 2222211111           23455555666677888877665443

>KOG0575|consensus

Probab=99.90  E-value=3e-24  Score=212.07  Aligned_cols=108  Identities=28%  Similarity=0.555  Sum_probs=92.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .+..||+.||.|||+++|||||||..|++++ ++.+|||+|||||..... ++...+.|||+.|.|||++.. .+++..+
T Consensus       122 y~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~-~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEv  199 (592)
T KOG0575|consen  122 YFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN-ENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEV  199 (592)
T ss_pred             HHHHHHHHHHHHHHhcCceecccchhheeec-CcCcEEecccceeeeecCcccccceecCCCcccChhHhcc-CCCCCch
Confidence            4789999999999999999999999999998 566999999999987764 466778899999999999985 6689999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      ||||+||++|.||.|++||. ..+-.+.+.+|
T Consensus       200 DiWSlGcvmYtLL~G~PPFe-tk~vkety~~I  230 (592)
T KOG0575|consen  200 DIWSLGCVMYTLLVGRPPFE-TKTVKETYNKI  230 (592)
T ss_pred             hhhhhhhHHHhhhhCCCCcc-cchHHHHHHHH
Confidence            99999999999999998873 33333444444

>KOG0694|consensus

Probab=99.90  E-value=2.1e-24  Score=215.61  Aligned_cols=106  Identities=29%  Similarity=0.564  Sum_probs=92.1

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC-CCCcccccccccccccccccccccCCCCeee
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +|..|+.||.|||++|||+||||.+|||+|.+ +++||+|||+++..- .+...++.|||+-|+|||++.+ ..|+.++|
T Consensus       473 yaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e-~~Yt~aVD  550 (694)
T KOG0694|consen  473 YAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE-GHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE-QSYTRAVD  550 (694)
T ss_pred             HHHHHHHHHHHHHhcCceeeecchhheEEccc-CcEEecccccccccCCCCCccccccCChhhcChhhhcc-Ccccchhh
Confidence            58899999999999999999999999999965 599999999999654 4556788899999999999986 66999999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHH
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVR  111 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~  111 (467)
                      +|||||++||||.|..|| +|++..+.-..
T Consensus       551 WW~lGVLlyeML~Gq~PF-~gddEee~Fds  579 (694)
T KOG0694|consen  551 WWGLGVLLYEMLVGESPF-PGDDEEEVFDS  579 (694)
T ss_pred             HHHHHHHHHHHHcCCCCC-CCCCHHHHHHH
Confidence            999999999999998887 66665444333

>KOG0583|consensus

Probab=99.90  E-value=2.3e-24  Score=212.40  Aligned_cols=100  Identities=31%  Similarity=0.562  Sum_probs=89.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceec-CCCCccccccccccccccccccccc-CCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLADYQ-MYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~-~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~   79 (467)
                      +++.|+++|++|||++||+||||||||||++.....+||+|||++... ..+....+.+||+.|+|||++.+.. ..+.+
T Consensus       124 ~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~  203 (370)
T KOG0583|consen  124 KYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKA  203 (370)
T ss_pred             HHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCch
Confidence            578999999999999999999999999999955368999999999988 5666788899999999999998766 44688


Q ss_pred             eeEEchhHHHHHHHhcCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|+|||||+||.|++|..||..
T Consensus       204 aDvWS~GViLy~ml~G~~PF~d  225 (370)
T KOG0583|consen  204 ADVWSLGVILYVLLCGRLPFDD  225 (370)
T ss_pred             hhhhhhHHHHHHHHhCCCCCCC
Confidence            9999999999999999999953

>KOG1025|consensus

Probab=99.90  E-value=1e-23  Score=213.11  Aligned_cols=237  Identities=19%  Similarity=0.318  Sum_probs=179.0

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCC----eEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSD----KCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..+..++||+|+||+||+|.....++    +||+|++...    ....+..|+-+|.+|. |||++++.+++...   .+
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s---~~  772 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLD-HPNLLRLLGVCMLS---TL  772 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCC-CchHHHHhhhcccc---hH
Confidence            34456789999999999998766554    5788877543    2457889999999995 89999999998754   37


Q ss_pred             EEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      .+|.+|+++|.|.++++    .+...+...+.+||++|+.|||.+++|||||-..|+|+...+ ++||+|||+|+...++
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~-hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN-HVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC-eEEEEecchhhccCcc
Confidence            78999999999988765    366677888999999999999999999999999999999766 8999999999987654


Q ss_pred             CC-cceeee--ccCccCCcccccCCCCccchhHHHhhhccccccccccccc--cCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         320 QE-YNVRVA--SRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVH--TENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       320 ~~-~~~~~g--t~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      +. ++...|  .+-|||=|.+....|+...|+|++++.      .|+....  .+...+...+..+++...         
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVt------iWElmTFGa~Py~gi~~~eI~dlle~g---------  916 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVT------IWELMTFGAKPYDGIPAEEIPDLLEKG---------  916 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhh------HHHHHhcCCCccCCCCHHHhhHHHhcc---------
Confidence            43 433333  456889999988899999999999874      3432211  111222222222322221         


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHH
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREA  432 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~  432 (467)
                       ++   ...++..+-|..-++.+|+..|++.||+++++
T Consensus       917 -eR---LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel  950 (1177)
T KOG1025|consen  917 -ER---LSQPPICTIDVYMVMVKCWMIDADSRPTFKEL  950 (1177)
T ss_pred             -cc---CCCCCCccHHHHHHHHHHhccCcccCccHHHH
Confidence             11   12345578899999999999999999998765

>KOG0033|consensus

Probab=99.90  E-value=5.7e-24  Score=187.75  Aligned_cols=99  Identities=30%  Similarity=0.606  Sum_probs=88.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCC--CcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~--~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +...||+.||+|||.+||||||+||+|+|+....  ..+||+|||+|..+..+.....++||+.||+||+++. ..|+.+
T Consensus       114 H~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrk-dpy~kp  192 (355)
T KOG0033|consen  114 HCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKK-DPYSKP  192 (355)
T ss_pred             HHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhc-CCCCCc
Confidence            3578999999999999999999999999997533  3699999999998887777788899999999999986 558999


Q ss_pred             eeEEchhHHHHHHHhcCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|+|++||+|+-+|.|..||+.
T Consensus       193 vDiW~cGViLfiLL~G~~PF~~  214 (355)
T KOG0033|consen  193 VDIWACGVILYILLVGYPPFWD  214 (355)
T ss_pred             chhhhhhHHHHHHHhCCCCCCC
Confidence            9999999999999999999863

>KOG0984|consensus

Probab=99.90  E-value=3.8e-24  Score=184.45  Aligned_cols=112  Identities=25%  Similarity=0.533  Sum_probs=98.0

Q ss_pred             hHHHHHHHHHHHHHh-CCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCccccccccccccccccccc---ccCCC
Q psy3714           2 RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD---YQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~-~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~   77 (467)
                      +||..|..||+|||+ ..|||||+||+||||+.. +.||+||||++-.+.++-..+...|...|||||.+-.   ...|+
T Consensus       152 kIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~  230 (282)
T KOG0984|consen  152 KIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD-GQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYS  230 (282)
T ss_pred             HhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC-CcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccce
Confidence            689999999999997 689999999999999965 5999999999998876655565788899999999843   23688


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      .++|+||||+.+.||.+++.|+......++|+.++.+
T Consensus       231 vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  231 VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            9999999999999999999999888888999887754

>KOG0664|consensus

Probab=99.89  E-value=6.1e-24  Score=190.28  Aligned_cols=119  Identities=31%  Similarity=0.620  Sum_probs=102.9

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCee
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +..||++||+|||+.||+||||||.|+|++ +|-.+||||||+|+....++.  .+..+.|.+|+|||.+.+.+.|+.++
T Consensus       161 FlYQILRGLKYLHsA~ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~Av  239 (449)
T KOG0664|consen  161 FVYQILRGLKYLHTANILHRDIKPGNLLVN-SNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAV  239 (449)
T ss_pred             hHHHHHhhhHHHhhcchhhccCCCccEEec-cCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCcc
Confidence            467999999999999999999999999998 566899999999997655433  34457788999999999999999999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchhHh
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFE  123 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  123 (467)
                      ||||.||++.|++.+ ...|......+|+..|...+|++.+..
T Consensus       240 DiWSVGCIFaELLgR-rILFQAq~PiqQL~lItdLLGTPs~Ea  281 (449)
T KOG0664|consen  240 DIWSVGCIFAELLQR-KILFQAAGPIEQLQMIIDLLGTPSQEA  281 (449)
T ss_pred             ceehhhHHHHHHHhh-hhhhhccChHHHHHHHHHHhCCCcHHH
Confidence            999999999999865 456677788899999999999987643

>KOG0599|consensus

Probab=99.89  E-value=4.1e-24  Score=191.38  Aligned_cols=99  Identities=27%  Similarity=0.578  Sum_probs=92.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCccccccccccccccccccc-----ccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD-----YQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~   76 (467)
                      +|.+|+..|++|||.++|+||||||+|||++ ++..+||+|||+|+...+++.....|||+.|.|||.+..     .++|
T Consensus       127 ~iMrqlfegVeylHa~~IVHRDLKpENILld-dn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGY  205 (411)
T KOG0599|consen  127 RIMRQLFEGVEYLHARNIVHRDLKPENILLD-DNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGY  205 (411)
T ss_pred             HHHHHHHHHHHHHHHhhhhhcccChhheeec-cccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCc
Confidence            6899999999999999999999999999999 667999999999999999988888999999999999864     3568


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +..+|.||+||++|.+|.|..||++
T Consensus       206 s~EVD~Wa~GVImyTLLaGcpPFwH  230 (411)
T KOG0599|consen  206 SKEVDEWACGVIMYTLLAGCPPFWH  230 (411)
T ss_pred             cchhhHHHHHHHHHHHHcCCCchhH
Confidence            8889999999999999999999985

>KOG0603|consensus

Probab=99.89  E-value=2.1e-24  Score=214.38  Aligned_cols=246  Identities=24%  Similarity=0.333  Sum_probs=187.6

Q ss_pred             eecccCCcceEEEEE---ccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         178 KLGRGKYSEVFEAIN---VQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       178 ~lG~G~~g~V~~~~~---~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      .+|+|+||.|+++..   ...+.-+|+|.+++.     .+.+...|..++...+.++.++.++..++.+  ...++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~--~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD--GKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc--cchhHhhhh
Confidence            379999999987653   234566888876542     1234556888888888899999999998764  457899999


Q ss_pred             cCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcceee
Q psy3714         250 VNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRV  326 (467)
Q Consensus       250 ~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~  326 (467)
                      ..++++.....   .+++...+.+..+++.|++++|+.+|+|||+|++||+++..| ++|+.|||+++..-+.+.   .|
T Consensus        79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~~---~c  154 (612)
T KOG0603|consen   79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEKI---AC  154 (612)
T ss_pred             cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-ccccCCchhhhHhHhhhh---cc
Confidence            99998765443   467788899999999999999999999999999999999665 899999999997654333   28


Q ss_pred             eccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       327 gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      ||..|||||++.  ++..++|+|..+++......+-.+|..         +..    ..+++.          ....+..
T Consensus       155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---------~~~----~~Il~~----------~~~~p~~  209 (612)
T KOG0603|consen  155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---------DTM----KRILKA----------ELEMPRE  209 (612)
T ss_pred             cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------HHH----HHHhhh----------ccCCchh
Confidence            999999999998  678889999988876555555444432         111    122110          1123345


Q ss_pred             CChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCcccc--cccCCCCCCC
Q psy3714         407 VSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKD--QSRHTLPSSS  454 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~--~~~~~~~~~~  454 (467)
                      ++.+|++++..|+..+|.+|+.     +.|+++|+||..++|.  ..+...+..+
T Consensus       210 l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fk  264 (612)
T KOG0603|consen  210 LSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFK  264 (612)
T ss_pred             hhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCC
Confidence            7999999999999999999985     5899999999999998  4444444433

>KOG0983|consensus

Probab=99.89  E-value=3.4e-23  Score=185.65  Aligned_cols=112  Identities=24%  Similarity=0.500  Sum_probs=96.5

Q ss_pred             hHHHHHHHHHHHHHh-CCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCccccccccccccccccccc--ccCCCC
Q psy3714           2 RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD--YQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~-~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~   78 (467)
                      ++.+.+..||.||.+ +||||||+||+|||+|. .+.+||||||++-.+.+....+...|.+.|||||.+.-  ...|+.
T Consensus       195 k~tva~v~AL~YLKeKH~viHRDvKPSNILlDe-~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDi  273 (391)
T KOG0983|consen  195 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDI  273 (391)
T ss_pred             hhHHHHHHHHHHHHHhcceeecccCccceEEcc-CCCEEeecccccceeecccccccccCCccccCccccCCCCCCccch
Confidence            356778999999985 89999999999999995 45999999999988877777777889999999999853  345788


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      ++||||||+.++|+.||..|+...+.+++.+..+..
T Consensus       274 RaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln  309 (391)
T KOG0983|consen  274 RADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN  309 (391)
T ss_pred             hhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence            999999999999999999999766777888877765

>KOG0198|consensus

Probab=99.89  E-value=7.2e-24  Score=201.20  Aligned_cols=100  Identities=30%  Similarity=0.551  Sum_probs=83.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC----CCcccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP----GQEYNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +.++||++||+|||++|||||||||+|||++..++.+||+|||+++....    ........||+.|||||++......+
T Consensus       121 ~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~  200 (313)
T KOG0198|consen  121 RYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVAR  200 (313)
T ss_pred             HHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCC
Confidence            57899999999999999999999999999996456899999999986652    11233468999999999998522233


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      .++|+|||||++.||+||+.||..
T Consensus       201 ~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  201 RESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             ccchhhhcCCEEEeccCCCCcchh
Confidence            489999999999999999888853

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.88  E-value=3.6e-23  Score=210.86  Aligned_cols=119  Identities=40%  Similarity=0.663  Sum_probs=100.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||+|||++||+||||||+|||++..+..+||+|||+|+............||+.|+|||++.+...++.++|
T Consensus       174 ~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  253 (440)
T PTZ00036        174 LYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHID  253 (440)
T ss_pred             HHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHH
Confidence            47889999999999999999999999999986555799999999987654444445678999999999876666889999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchh
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL  121 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~  121 (467)
                      +|||||++|+|++|..|| .+.+..+++.++.+.+|++..
T Consensus       254 iwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        254 LWSLGCIIAEMILGYPIF-SGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             HHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCH
Confidence            999999999999998766 566777888888888776543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.88  E-value=1.3e-21  Score=180.66  Aligned_cols=189  Identities=31%  Similarity=0.551  Sum_probs=154.8

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      |.+.+.||+|++|.||++.+..+++.+++|.....    ..+.+.+|++.++.+. |+|++.+...+...  ...++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~--~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLK-HPNIVKLYGVFEDP--EPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCChhhheeeeecC--CceEEEEe
Confidence            56788999999999999999888999999998754    3557788999999995 79999999887653  46789999


Q ss_pred             ccCCccHHHHhhc----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC--Cc
Q psy3714         249 HVNNTDFKQLYQT----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--EY  322 (467)
Q Consensus       249 ~~~~~~l~~~~~~----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~--~~  322 (467)
                      ++.++++.+....    +++..+..++.|++.++.+||+++++|+||+|+||+++.. ..++|+|||++.......  ..
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccccc
Confidence            9999998887643    7888889999999999999999999999999999999965 479999999998765432  33


Q ss_pred             ceeeeccCccCCccc-ccCCCCccchhHHHhhhccccccccccc
Q psy3714         323 NVRVASRYFKGPELL-ADYQYHIELDPRFADILGRHSRKRWERF  365 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l-~~~~~~~~~D~~~~~~~~~~~~~~~~~~  365 (467)
                      ....++..|++||.+ ....++...|+|..+++......+..+|
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf  200 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPF  200 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCc
Confidence            446788899999998 5566777899998776544333333343

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0662|consensus

Probab=99.87  E-value=6.7e-23  Score=172.99  Aligned_cols=119  Identities=37%  Similarity=0.732  Sum_probs=107.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC-CCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .+..|+++||.|||++++.|||+||.|+||+ .++.+|++|||+|+.+. +-.+++..+.|.+|++|.++.+..-|++..
T Consensus       105 sfmlqllrgl~fchshnvlhrdlkpqnllin-~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsi  183 (292)
T KOG0662|consen  105 SFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI  183 (292)
T ss_pred             HHHHHHHhhhhhhhhhhhhhccCCcceEEec-cCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccch
Confidence            3567999999999999999999999999998 56699999999999664 444667778899999999999999999999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchh
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL  121 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~  121 (467)
                      |+||-||++.|+...+.|.|+|.+-.+|+.+|.+.+|++.-
T Consensus       184 dmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~e  224 (292)
T KOG0662|consen  184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  224 (292)
T ss_pred             HhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcc
Confidence            99999999999998888999999999999999999997654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=3.8e-22  Score=179.38  Aligned_cols=133  Identities=17%  Similarity=0.286  Sum_probs=102.0

Q ss_pred             eEeecccCCcceEEEEEccCCCeEEEEEeccchH-----------------------------HHHHHHHHHHHHhcCCC
Q psy3714         176 VRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK-----------------------------KKIKREIKILENLRGGT  226 (467)
Q Consensus       176 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----------------------------~~~~~Ei~il~~l~~~~  226 (467)
                      ...||+|+||.||+|.+. +|+.||+|+++....                             ....+|+.++..+. ++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence            457999999999999986 899999999864311                             12235999999996 34


Q ss_pred             CeeEEEEEEeCCCCCccEEEEeccCCccHHHH-h--hcCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCceEEeCCC
Q psy3714         227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQL-Y--QTLTDYDIRYYLYELLKALDYC-HSMGIMHRDVKPHNVMIDHEN  302 (467)
Q Consensus       227 ~iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~~~~~~~~~~~~qll~al~~l-H~~~IiHrDlKp~Nill~~~~  302 (467)
                      ++........    ...++||||++++++... .  ..+++.++..++.|++.+|+++ |+.||+||||||+|||++ ++
T Consensus        80 ~v~~p~~~~~----~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          80 GIPCPEPILL----KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCCCcEEEe----cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence            4322111111    123899999998765432 2  3578889999999999999999 799999999999999998 44


Q ss_pred             CcEEEEecccceec
Q psy3714         303 RKLRLIDWGLAEFY  316 (467)
Q Consensus       303 ~~ikl~DFGla~~~  316 (467)
                       .++|+|||+|...
T Consensus       155 -~v~LiDFG~a~~~  167 (190)
T cd05147         155 -KLYIIDVSQSVEH  167 (190)
T ss_pred             -cEEEEEccccccC
Confidence             6999999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0585|consensus

Probab=99.87  E-value=6e-23  Score=196.77  Aligned_cols=99  Identities=29%  Similarity=0.669  Sum_probs=83.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC------Ccccccccccccccccccccc--
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG------QEYNVRVASRYFKGPELLADY--   73 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~------~~~~~~~~~~~~~~pe~~~~~--   73 (467)
                      .+..+++.||+|||.+|||||||||+|+|++. ++.|||+|||.+.....+      ......+||+.|+|||.....  
T Consensus       214 ~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~-~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~  292 (576)
T KOG0585|consen  214 KYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSS-DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS  292 (576)
T ss_pred             HHHHHHHHHHHHHHhcCeeccccchhheEEcC-CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCC
Confidence            47889999999999999999999999999995 469999999999766221      123346899999999999762  


Q ss_pred             -cCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          74 -QMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        74 -~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                       ...+.+.||||+||+||.|+.|+.||+.
T Consensus       293 ~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  293 FSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             ccccchhhhhhhhhhhHHHhhhccCCccc
Confidence             2345789999999999999999999973

>KOG0606|consensus

Probab=99.87  E-value=5.9e-23  Score=213.61  Aligned_cols=229  Identities=24%  Similarity=0.384  Sum_probs=162.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      ..++|+.++.+..|+||.||..+++.+.+.+|+|+-++.   -+.|-  |+... +.|.+|                   
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~---lilRn--ilt~a-~npfvv-------------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN---LILRN--ILTFA-GNPFVV-------------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccccc---hhhhc--ccccc-CCccee-------------------
Confidence            358899999999999999999999999999999654322   12211  11111 222222                   


Q ss_pred             ccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-------
Q psy3714         249 HVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-------  318 (467)
Q Consensus       249 ~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-------  318 (467)
                          ||...+.+   .++.        +++.|++|||+-||+|||+||+|+||+.-| ++|++|||+++....       
T Consensus       136 ----gDc~tllk~~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  136 ----GDCATLLKNIGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             ----chhhhhcccCCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecc-cccccchhhhhhhhhhccchhh
Confidence                33333322   2332        227899999999999999999999999655 899999999875310       


Q ss_pred             -CC------C--cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhh-hhhhhccC
Q psy3714         319 -GQ------E--YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD-FLDKNILG  388 (467)
Q Consensus       319 -~~------~--~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  388 (467)
                       +.      +  ....||||.|+|||++..++|...||||..+++.+..+.+..+||+...+.     +++ ++.+.   
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-----lfg~visd~---  274 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-----LFGQVISDD---  274 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-----HHhhhhhhh---
Confidence             00      0  012489999999999999999999999999999888888888887764321     222 11111   


Q ss_pred             CCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCC---CHHHHhCCCCCCCcccccccCCCCC
Q psy3714         389 RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL---TAREAMDHPYFYPIVKDQSRHTLPS  452 (467)
Q Consensus       389 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~---ta~e~l~Hp~f~~~~~~~~~~~~~~  452 (467)
                          ..|.+     .-+.+.+|++|+|.+||+.+|..|.   .+-++.+|+||..++|...-..+..
T Consensus       275 ----i~wpE-----~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkae  332 (1205)
T KOG0606|consen  275 ----IEWPE-----EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAE  332 (1205)
T ss_pred             ----ccccc-----cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhcc
Confidence                12321     1234789999999999999999997   4678999999999999844333333

>KOG1163|consensus

Probab=99.87  E-value=1.2e-21  Score=172.88  Aligned_cols=183  Identities=22%  Similarity=0.391  Sum_probs=139.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEecc-chHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP-VKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~-~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ....|.++++||+|+||.+|.|....+|..||||.-++ .....+..|..+.+.|++...|..+..+..+  ..+-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccc--cccceeee
Confidence            35789999999999999999999999999999998654 3456788999999999988888877766543  45678999


Q ss_pred             eccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC--CCcEEEEecccceecCCCC-
Q psy3714         248 EHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       248 e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~--~~~ikl~DFGla~~~~~~~-  320 (467)
                      +.+ |.+|.++++    .++..++.-++-|++.-++|+|.++.|||||||+|.|+.-.  ...+.|+|||+|+.+.... 
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t  169 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT  169 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence            976 456666653    58888888899999999999999999999999999998632  3479999999999874322 


Q ss_pred             -------CcceeeeccCccCCcccccCCCCccchhHHHhhh
Q psy3714         321 -------EYNVRVASRYFKGPELLADYQYHIELDPRFADIL  354 (467)
Q Consensus       321 -------~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~  354 (467)
                             +.....||..|.+=-...+..-+..-|..+.+.+
T Consensus       170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYv  210 (341)
T KOG1163|consen  170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYV  210 (341)
T ss_pred             cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcce
Confidence                   1122468888877544433333333455444433

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=9.5e-21  Score=183.98  Aligned_cols=259  Identities=27%  Similarity=0.414  Sum_probs=183.1

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      |.+.+.||.|+||.||++.+.   ..+++|.+....      ...+.+|+.++..+.++++++.+...+...  ...+++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~   76 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYLV   76 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEEE
Confidence            788999999999999999987   678889876432      456789999999998666899999988543  337999


Q ss_pred             EeccCCccHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         247 FEHVNNTDFKQLYQ------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       247 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++++.++++.+...      .+++.....++.|++.+++|+|+.+++|||+||+||+++..+..++++|||+++......
T Consensus        77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999999886654      578889999999999999999999999999999999999655469999999998554322


Q ss_pred             -------CcceeeeccCccCCccccc---CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCC
Q psy3714         321 -------EYNVRVASRYFKGPELLAD---YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRH  390 (467)
Q Consensus       321 -------~~~~~~gt~~y~aPE~l~~---~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (467)
                             .....+||..|+|||.+.+   ..+....|.|..++.......+..|+ ........................
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF-EGEKNSSATSQTLKIILELPTPSL  235 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCC-CCCCccccHHHHHHHHHhcCCccc
Confidence                   2356789999999999988   46788899996664433222233331 111100000111111111100000


Q ss_pred             CcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         391 SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       391 ~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                       .....    .......+..+.+++.+++..+|..|.+..+...++|.....
T Consensus       236 -~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~  282 (384)
T COG0515         236 -ASPLS----PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK  282 (384)
T ss_pred             -ccccC----ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence             00000    000011235789999999999999999999999987775433

>KOG0665|consensus

Probab=99.87  E-value=1.2e-22  Score=185.97  Aligned_cols=116  Identities=32%  Similarity=0.655  Sum_probs=102.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .|..|++.|++|||+.||+||||||+||++..+ ..+|++|||+|+....+-..+..+.+++|+|||++.+.+ +...+|
T Consensus       122 ~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~-~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vd  199 (369)
T KOG0665|consen  122 YILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD-CTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVD  199 (369)
T ss_pred             HHHHHHHHHHHHHHhcceeecccCcccceecch-hheeeccchhhcccCcccccCchhheeeccCchheeccC-Ccccch
Confidence            478899999999999999999999999999854 589999999998765543456678999999999999877 888999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCch
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE  120 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~  120 (467)
                      |||+||++.||++|+ .+|+|.+..+|..++...+|++.
T Consensus       200 iwSvGci~gEli~~~-Vlf~g~d~idQ~~ki~~~lgtpd  237 (369)
T KOG0665|consen  200 IWSVGCIMGELILGT-VLFPGKDHIDQWNKIIEQLGTPD  237 (369)
T ss_pred             hhhhhhHHHHHhhce-EEecCchHHHHHHHHHHHhcCCC
Confidence            999999999999986 56689999999999999999864

>KOG0614|consensus

Probab=99.87  E-value=1.3e-22  Score=195.66  Aligned_cols=111  Identities=27%  Similarity=0.512  Sum_probs=96.9

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeeeE
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDM   82 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~   82 (467)
                      ++..++.|++|||++|||.|||||+|++++.. +.+||.|||+|+....+...-+.|||+.|+|||++.. .+++.++|.
T Consensus       525 ~~acv~EAfeYLH~k~iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILn-KGHD~avDy  602 (732)
T KOG0614|consen  525 YVACVLEAFEYLHRKGIIYRDLKPENLLLDNR-GYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILN-KGHDRAVDY  602 (732)
T ss_pred             hHHHHHHHHHHHHhcCceeccCChhheeeccC-CceEEeehhhHHHhccCCceeeecCCcccccchhhhc-cCcchhhHH
Confidence            46678999999999999999999999999954 5899999999999888877778899999999999986 568899999


Q ss_pred             EchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHh
Q psy3714          83 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL  116 (467)
Q Consensus        83 ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~  116 (467)
                      ||||+++||+++|++|| .+-|.....+.|.+.+
T Consensus       603 WaLGIli~ELL~G~pPF-s~~dpmktYn~ILkGi  635 (732)
T KOG0614|consen  603 WALGILIYELLTGSPPF-SGVDPMKTYNLILKGI  635 (732)
T ss_pred             HHHHHHHHHHHcCCCCC-CCCchHHHHHHHHhhh
Confidence            99999999999998777 5666666666666643

>KOG0986|consensus

Probab=99.86  E-value=1.4e-22  Score=193.19  Aligned_cols=96  Identities=35%  Similarity=0.594  Sum_probs=89.4

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeeeE
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDM   82 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~   82 (467)
                      .|.+|+.||++||+.+||.||+||+|||+|. .++|+|+|+|+|..+..++....++||..|||||++.. +.|+.++|+
T Consensus       292 YAAEi~cGLehlH~~~iVYRDLKPeNILLDd-~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dw  369 (591)
T KOG0986|consen  292 YAAEIICGLEHLHRRRIVYRDLKPENILLDD-HGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDW  369 (591)
T ss_pred             HHHHHHhhHHHHHhcceeeccCChhheeecc-CCCeEeeccceEEecCCCCccccccCcccccCHHHHcC-CcccCCccH
Confidence            5889999999999999999999999999994 56999999999999988888888899999999999986 459999999


Q ss_pred             EchhHHHHHHHhcCCCCC
Q psy3714          83 WSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        83 ws~G~~l~~~l~g~~~~~  100 (467)
                      ||+||++|||+.|..||-
T Consensus       370 f~lGCllYemi~G~sPFr  387 (591)
T KOG0986|consen  370 FSLGCLLYEMIAGHSPFR  387 (591)
T ss_pred             HHHHhHHHHHHcccCchh
Confidence            999999999999999984

>KOG0604|consensus

Probab=99.86  E-value=2e-22  Score=182.91  Aligned_cols=101  Identities=35%  Similarity=0.643  Sum_probs=88.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEec--CCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~--~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      .|.+||+.|+.|||+++|.||||||||+|...  .+..+||+|||+|+.........+.+.|++|.|||++.. +.|+..
T Consensus       165 eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~-eKydks  243 (400)
T KOG0604|consen  165 EIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGP-EKYDKS  243 (400)
T ss_pred             HHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCc-hhcCCC
Confidence            47899999999999999999999999999874  234789999999998765566778899999999999864 669999


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGH  103 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~  103 (467)
                      +|+||+||++|-||.|-.||+..+
T Consensus       244 cdmwSlgVimYIlLCGyPPFYS~h  267 (400)
T KOG0604|consen  244 CDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_pred             CCccchhHHHHHhhcCCCcccccC
Confidence            999999999999999999998543

>KOG0197|consensus

Probab=99.86  E-value=3.5e-22  Score=195.38  Aligned_cols=111  Identities=23%  Similarity=0.431  Sum_probs=91.8

Q ss_pred             ChHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccc---cccccccccccccCCC
Q psy3714           1 MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS---RYFKGPELLADYQMYD   77 (467)
Q Consensus         1 ~~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~---~~~~~pe~~~~~~~~~   77 (467)
                      +.+|.|||+|++||+++++|||||.+.|||++. +..+||+|||+|+...++ .+....+.   ..|.|||.+.. ..++
T Consensus       306 l~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~-~~~vKIsDFGLAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~-~~FS  382 (468)
T KOG0197|consen  306 LDFAAQIAEGMAYLESKNYIHRDLAARNILVDE-DLVVKISDFGLARLIGDD-EYTASEGGKFPIKWTAPEALNY-GKFS  382 (468)
T ss_pred             HHHHHHHHHHHHHHHhCCccchhhhhhheeecc-CceEEEcccccccccCCC-ceeecCCCCCCceecCHHHHhh-CCcc
Confidence            468999999999999999999999999999994 559999999999954433 34444443   33899999975 6689


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      .++|||||||+|+|++|-+...+++.++.+.+..+.+
T Consensus       383 ~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~  419 (468)
T KOG0197|consen  383 SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER  419 (468)
T ss_pred             cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc
Confidence            9999999999999999866666788888777777765

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=4e-21  Score=173.25  Aligned_cols=134  Identities=16%  Similarity=0.223  Sum_probs=103.9

Q ss_pred             eEeecccCCcceEEEEEccCCCeEEEEEeccch-----------------------------HHHHHHHHHHHHHhcCCC
Q psy3714         176 VRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----------------------------KKKIKREIKILENLRGGT  226 (467)
Q Consensus       176 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----------------------------~~~~~~Ei~il~~l~~~~  226 (467)
                      .+.||+|+||.||+|.+. +|+.||||+++...                             .....+|...+.++. ++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence            468999999999999987 89999999987431                             112357888898886 56


Q ss_pred             CeeEEEEEEeCCCCCccEEEEeccCCccHHH-Hh--hcCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCC
Q psy3714         227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQ-LY--QTLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHEN  302 (467)
Q Consensus       227 ~iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~-~~--~~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~  302 (467)
                      ++.....+...    ..++||||++++++.. ..  ..+++.++..++.|++.++.++|+ +||+||||||+|||++ + 
T Consensus        80 ~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~-  153 (190)
T cd05145          80 GVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D-  153 (190)
T ss_pred             CCCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C-
Confidence            65333332221    2489999999875322 12  246778889999999999999999 9999999999999998 4 


Q ss_pred             CcEEEEecccceecC
Q psy3714         303 RKLRLIDWGLAEFYH  317 (467)
Q Consensus       303 ~~ikl~DFGla~~~~  317 (467)
                      +.++|+|||+|+...
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            479999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0597|consensus

Probab=99.86  E-value=1.3e-22  Score=198.05  Aligned_cols=98  Identities=36%  Similarity=0.675  Sum_probs=87.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc-ccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .||.|++.||.|||+++|+|||+||.|||++ .++.+|+||||+|+.+..+.. .+..-||+.|||||.+.+ +.|+..+
T Consensus       104 ~~a~~LVsaL~yLhs~rilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e-~pyd~~s  181 (808)
T KOG0597|consen  104 AIAYDLVSALYYLHSNRILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEE-QPYDHTS  181 (808)
T ss_pred             HHHHHHHHHHHHHHhcCcccccCCcceeeec-CCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcC-CCccchh
Confidence            5899999999999999999999999999999 456999999999998765543 455579999999999985 6799999


Q ss_pred             eEEchhHHHHHHHhcCCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      |.||+||++||+..|+.||+.
T Consensus       182 DlWslGcilYE~~~G~PPF~a  202 (808)
T KOG0597|consen  182 DLWSLGCILYELYVGQPPFYA  202 (808)
T ss_pred             hHHHHHHHHHHHhcCCCCchH
Confidence            999999999999999999974

>KOG0611|consensus

Probab=99.86  E-value=3e-22  Score=188.29  Aligned_cols=109  Identities=27%  Similarity=0.583  Sum_probs=96.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      ++++||.+|+.|||.++++|||||.+|||++ .|.++||+|||++-++..+....+.||++.|.+||++-+..+-+..+|
T Consensus       157 hfFRQIvSAVhYCHknrVvHRDLKLENILLD-~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVD  235 (668)
T KOG0611|consen  157 HFFRQIVSAVHYCHKNRVVHRDLKLENILLD-QNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVD  235 (668)
T ss_pred             HHHHHHHHHHHHHhhccceecccchhheeec-CCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccc
Confidence            6899999999999999999999999999999 456999999999999988888889999999999999988777788999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      .|||||+||.+.+|..|| .|.|......+|
T Consensus       236 sWsLGvLLYtLVyGtMPF-DG~Dhk~lvrQI  265 (668)
T KOG0611|consen  236 SWSLGVLLYTLVYGTMPF-DGRDHKRLVRQI  265 (668)
T ss_pred             hhhHHHHHHHHhhccccc-CCchHHHHHHHh
Confidence            999999999999999988 565544444444

>KOG0576|consensus

Probab=99.86  E-value=1e-22  Score=202.08  Aligned_cols=364  Identities=16%  Similarity=0.185  Sum_probs=231.3

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-Cccccccccccccccccccc--ccCCCCe
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLAD--YQMYDYS   79 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~~   79 (467)
                      +++....||+|||+.|=+|||||-.|||++. .+.+|+.|||.+-..... ......+||++|||||+...  ...|...
T Consensus       117 vcRetl~gl~ylhs~gk~hRdiKGanilltd-~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynql  195 (829)
T KOG0576|consen  117 VCRETLQGLKYLHSQGKIHRDIKGANILLTD-EGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQL  195 (829)
T ss_pred             HHhhhhccchhhhcCCcccccccccceeecc-cCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhccccccc
Confidence            4567789999999999999999999999985 458999999997654322 22455799999999999753  3457789


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchhHhhhhhhccCCCchhhhhcccccccccccCCCCCcccc
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWD  159 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~~~~~~~p~~~~~  159 (467)
                      +|+|++|+...|+-.-..|.|.-+ ..+.+..+.+. +            . -.|.+++-                    
T Consensus       196 cdiwa~gitAiel~eLqpplfdlh-pmr~l~LmTkS-~------------~-qpp~lkDk--------------------  240 (829)
T KOG0576|consen  196 CDIWALGITAIELGELQPPLFDLH-PMRALFLMTKS-G------------F-QPPTLKDK--------------------  240 (829)
T ss_pred             ccccccccchhhhhhcCCcccccc-hHHHHHHhhcc-C------------C-CCCcccCC--------------------
Confidence            999999999999866666655221 11111111110 0            0 01111110                    


Q ss_pred             cCccccccCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCC-eeEEEEEEeCC
Q psy3714         160 YESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTN-IITLQAVVKDP  238 (467)
Q Consensus       160 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~-iv~l~~~~~~~  238 (467)
                                ..-|.....+++|+++.+++++...+.... .+.+...  ....-++++|.+++ ||| .+...+  ...
T Consensus       241 ----------~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~n-~P~~~v~~~~--d~~  304 (829)
T KOG0576|consen  241 ----------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKVN-NPNPVVRYLE--DYD  304 (829)
T ss_pred             ----------ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHcc-CCCCcccccc--cCC
Confidence                      011223345689999999999877665444 6665543  34456788999997 687 443333  333


Q ss_pred             CCCccEEEEeccCCc-c-HHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccc
Q psy3714         239 VSRTPALIFEHVNNT-D-FKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA  313 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~-~-l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla  313 (467)
                      .+.+..++++++..+ + .....   ..+.+-+.....+.=..+++++|+--=+|||    ||+... + ..|..||+..
T Consensus       305 ~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~-~~~~~~~~v~  378 (829)
T KOG0576|consen  305 GEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-E-EVKLLDFAVP  378 (829)
T ss_pred             cccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-c-ccccccccCC
Confidence            456788899998776 1 11000   0123334445566667899999998889999    888863 3 6899999999


Q ss_pred             eecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccc--cCCcccCChhhhhhhhhhccCCCC
Q psy3714         314 EFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVH--TENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       314 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      ..+......+...+|+.++|||+..+..++...|.|..+.-......+..|-..  ......+...       +......
T Consensus       379 ~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~~~~g~~p-------~s~~L~~  451 (829)
T KOG0576|consen  379 PQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVLPMIGNGP-------NSPMLTD  451 (829)
T ss_pred             cccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccccCCCCCCC-------Cccccch
Confidence            877665555667899999999999998898888888554311010111111000  0000000000       0000000


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ...|.         .+  .=.|+...++..-|..|.++..++.|-+|.++.
T Consensus       452 ~~aw~---------~~--~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  452 KSAWS---------PV--FHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             hhhcC---------cc--cccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence            01121         11  112688999999999999999999999998753

>KOG0605|consensus

Probab=99.86  E-value=4.1e-22  Score=194.13  Aligned_cols=109  Identities=28%  Similarity=0.538  Sum_probs=86.6

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC----------------------CCcc-----
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP----------------------GQEY-----   55 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~----------------------~~~~-----   55 (467)
                      .+.+.+.|++-+|++|+|||||||+|+|||. .+++||+|||||.-+..                      .+..     
T Consensus       246 YiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~-~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (550)
T KOG0605|consen  246 YIAETVLAIESIHQLGYIHRDIKPDNLLIDA-KGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTP  324 (550)
T ss_pred             HHHHHHHHHHHHHHcCcccccCChhheeecC-CCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccc
Confidence            3567889999999999999999999999995 45999999999842100                      0000     


Q ss_pred             ---------------------cccccccccccccccccccCCCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          56 ---------------------NVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        56 ---------------------~~~~~~~~~~~pe~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                                           ...+|||-|+|||++.+ ..|+..+|+|||||++||||.|-+|| .+++..+...+|..
T Consensus       325 ~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG~ImyEmLvGyPPF-~s~tp~~T~rkI~n  402 (550)
T KOG0605|consen  325 RSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLGCIMYEMLVGYPPF-CSETPQETYRKIVN  402 (550)
T ss_pred             cchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHH
Confidence                                 01379999999999987 55899999999999999999998776 56666666666654

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.86  E-value=8.6e-22  Score=189.78  Aligned_cols=114  Identities=33%  Similarity=0.668  Sum_probs=94.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++............|+..|+|||.+.+ ..++.++|
T Consensus       114 ~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  191 (290)
T cd07862         114 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVD  191 (290)
T ss_pred             HHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcC-CCCEEEccccceEeccCCcccccccccccccChHHHhC-CCCCCccc
Confidence            58999999999999999999999999999985 45899999999987654444445678899999999875 45788999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      +|||||++|+|++|+.|| .+....+.+..+....+.
T Consensus       192 iwslG~il~el~~g~~~f-~~~~~~~~~~~i~~~~~~  227 (290)
T cd07862         192 LWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGL  227 (290)
T ss_pred             hHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHHhCC
Confidence            999999999999997666 555666667666665543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG4721|consensus

Probab=99.85  E-value=2.3e-22  Score=196.10  Aligned_cols=97  Identities=22%  Similarity=0.429  Sum_probs=86.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .+.+|||.|+.|||.+.|||||||.=||||..+ ..|||+|||-++...........+||..|||||+++. +..+.++|
T Consensus       216 ~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrn-ePcsEKVD  293 (904)
T KOG4721|consen  216 DWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRN-EPCSEKVD  293 (904)
T ss_pred             HHHHHhhhhhHHHHHhhHhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhc-CCcccccc
Confidence            467899999999999999999999999999955 4899999999987765555566799999999999986 66899999


Q ss_pred             EEchhHHHHHHHhcCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~  100 (467)
                      ||||||+|||||||..|+.
T Consensus       294 IwSfGVVLWEmLT~EiPYk  312 (904)
T KOG4721|consen  294 IWSFGVVLWEMLTGEIPYK  312 (904)
T ss_pred             eehhHHHHHHHHhcCCCcc
Confidence            9999999999999998874

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.85  E-value=9.7e-22  Score=190.83  Aligned_cols=117  Identities=35%  Similarity=0.571  Sum_probs=93.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.... ........+++.|+|||.+.+...++.++
T Consensus       107 ~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  185 (303)
T cd07869         107 LFLFQLLRGLSYIHQRYILHRDLKPQNLLISD-TGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCL  185 (303)
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHEEECC-CCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHH
Confidence            57899999999999999999999999999984 45899999999875432 22234457788999999987656678889


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      |+||+||++++|++|..||....+..+++..+...++.+
T Consensus       186 DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  224 (303)
T cd07869         186 DMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTP  224 (303)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCC
Confidence            999999999999999998864444455566665555443

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0666|consensus

Probab=99.85  E-value=6e-22  Score=180.62  Aligned_cols=121  Identities=31%  Similarity=0.620  Sum_probs=100.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC---CCcEEEEecccceecCCC-C---ccccccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE---NRKLRLIDWGLAEFYHPG-Q---EYNVRVASRYFKGPELLADYQ   74 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~---~~~~kl~dfG~a~~~~~~-~---~~~~~~~~~~~~~pe~~~~~~   74 (467)
                      +|.-||+.|+.|||++=|+||||||.|||+..+   .+.|||+|||+||.+.+. .   .....+.|.||+|||.+.+..
T Consensus       136 silwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~  215 (438)
T KOG0666|consen  136 SILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR  215 (438)
T ss_pred             HHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccc
Confidence            477899999999999999999999999999743   258999999999987532 1   123357789999999999999


Q ss_pred             CCCCeeeEEchhHHHHHHHhcCCCCCCCCC---------CHHHHHHHHHHhCCchhHh
Q psy3714          75 MYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLGTEELFE  123 (467)
Q Consensus        75 ~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~  123 (467)
                      .|+.++|+||.||++.||++-. |.|.|..         ..+|+.+|.+.+|++.-..
T Consensus       216 hYT~AiDvWAiGCIfaElLtl~-PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~  272 (438)
T KOG0666|consen  216 HYTKAIDVWAIGCIFAELLTLE-PLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKD  272 (438)
T ss_pred             cccchhhhHHHHHHHHHHHccC-ccccchhhhcccCCCchHHHHHHHHHHcCCCcccc
Confidence            9999999999999999999875 6665542         2578999999999876543

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.85  E-value=1.7e-21  Score=187.45  Aligned_cols=98  Identities=31%  Similarity=0.561  Sum_probs=85.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.++|+|||++.............|+..|+|||++.+ ..++.++|
T Consensus       106 ~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~D  183 (285)
T cd05631         106 FYAAELCCGLEDLQRERIVYRDLKPENILLDD-RGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN-EKYTFSPD  183 (285)
T ss_pred             HHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC-CCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcC-CCCCcccC
Confidence            57899999999999999999999999999984 45899999999987654444455678999999999975 45788999


Q ss_pred             EEchhHHHHHHHhcCCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|||||++|+|++|+.||..
T Consensus       184 vwslGvil~el~~g~~pf~~  203 (285)
T cd05631         184 WWGLGCLIYEMIQGQSPFRK  203 (285)
T ss_pred             chhHHHHHHHHHhCCCCCCC
Confidence            99999999999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.84  E-value=1.5e-21  Score=188.13  Aligned_cols=116  Identities=32%  Similarity=0.616  Sum_probs=93.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-CcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..... .......++..|+|||.+.+...++.++
T Consensus       107 ~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  185 (288)
T cd07871         107 IFMFQLLRGLSYCHKRKILHRDLKPQNLLINE-KGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI  185 (288)
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCCHHHEEECC-CCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHH
Confidence            47899999999999999999999999999985 458999999999765322 2233456788999999987656678899


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      |+||+||++|+|++|+.|| .+.+..+.+..+.+.++.+
T Consensus       186 DiwslG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~  223 (288)
T cd07871         186 DMWGVGCILYEMATGRPMF-PGSTVKEELHLIFRLLGTP  223 (288)
T ss_pred             HHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCC
Confidence            9999999999999998777 4555556666666665543

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG1164|consensus

Probab=99.84  E-value=7.6e-20  Score=178.83  Aligned_cols=177  Identities=21%  Similarity=0.317  Sum_probs=138.9

Q ss_pred             ceeeeEeecccCCcceEEEEEccCC-CeEEEEEeccch---HHHHHHHHHHHHHhc---CCCCeeEEEEEEeCCCCCccE
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSS-DKCVVKILKPVK---KKKIKREIKILENLR---GGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~-~~~avK~~~~~~---~~~~~~Ei~il~~l~---~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .|.+.+.||+|+||.||.+.+..++ ..+|+|......   ...+..|+.++..+.   +..++..+..... ....+-+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence            8999999999999999999988775 578888766432   226889999999887   3457788877764 2234568


Q ss_pred             EEEeccCCccHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC----CcEEEEecccce-
Q psy3714         245 LIFEHVNNTDFKQLY-----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN----RKLRLIDWGLAE-  314 (467)
Q Consensus       245 lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~----~~ikl~DFGla~-  314 (467)
                      +||+.+ |.+|.++.     +.++..++..++.|++.+|++||+.|+|||||||+|++++...    ..+.|.|||+|+ 
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            888755 56676665     4688999999999999999999999999999999999998653    469999999998 


Q ss_pred             -ecCCCC--------C-cceeeeccCccCCcccccCCCCccchhHH
Q psy3714         315 -FYHPGQ--------E-YNVRVASRYFKGPELLADYQYHIELDPRF  350 (467)
Q Consensus       315 -~~~~~~--------~-~~~~~gt~~y~aPE~l~~~~~~~~~D~~~  350 (467)
                       .+....        . .....||..|.++..-.+......-|.|+
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles  222 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLES  222 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhh
Confidence             331111        1 12345999999999888887777778774

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.84  E-value=2.8e-21  Score=188.79  Aligned_cols=99  Identities=24%  Similarity=0.598  Sum_probs=83.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEec---CCCcEEEEecccceecCCCC----ccccccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDH---ENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQ   74 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~---~~~~~kl~dfG~a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~   74 (467)
                      .++.||+.||+|||++||+||||||+|||+..   .++.+||+|||+|+......    ......+|+.|+|||++.+..
T Consensus       112 ~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  191 (317)
T cd07868         112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR  191 (317)
T ss_pred             HHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCC
Confidence            47899999999999999999999999999952   33579999999998654321    223457889999999997766


Q ss_pred             CCCCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          75 MYDYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        75 ~~~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      .++.++|+||+||++++|++|+.||.
T Consensus       192 ~~~~~~DiwslG~il~el~~g~~~f~  217 (317)
T cd07868         192 HYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             CcCchhhHHHHHHHHHHHHhCCCCcc
Confidence            68889999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0193|consensus

Probab=99.84  E-value=8.2e-22  Score=194.27  Aligned_cols=139  Identities=23%  Similarity=0.423  Sum_probs=104.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC---CCCcccccccccccccccccccc--cCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH---PGQEYNVRVASRYFKGPELLADY--QMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~---~~~~~~~~~~~~~~~~pe~~~~~--~~~   76 (467)
                      .||.|||+|+.|||.++|||||||..||++.. +.+|||+|||++....   ..+-.....|+..|||||+++..  ..|
T Consensus       492 dIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~-~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPf  570 (678)
T KOG0193|consen  492 DIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHE-DLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPF  570 (678)
T ss_pred             HHHHHHHHhhhhhhhhhhhhhhccccceEEcc-CCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCC
Confidence            69999999999999999999999999999984 4699999999986432   22334556788889999999753  347


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHH------------HHhCCc---hhHhhhhhhccCCCchhhhhcc
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA------------KVLGTE---ELFEYLDKYHIELDPRFADILG  141 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~------------~~~~~~---~~~~~~~~~~~~~~p~~~~~~~  141 (467)
                      +..+|||||||++|||++|..|+.  ..+-+|+.-++            ...+..   ++...|.++..+-+|-|..++.
T Consensus       571 S~qSDVYaFGiV~YELltg~lPys--i~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  571 SFQSDVYAFGIVWYELLTGELPYS--IQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             CcccchhhhhHHHHHHHhCcCCcC--CCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            889999999999999999999985  33444432111            111221   3445556666677888887776


Q ss_pred             cc
Q psy3714         142 RA  143 (467)
Q Consensus       142 ~~  143 (467)
                      +.
T Consensus       649 ~l  650 (678)
T KOG0193|consen  649 KL  650 (678)
T ss_pred             HH
Confidence            43

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=1.8e-20  Score=170.10  Aligned_cols=133  Identities=19%  Similarity=0.241  Sum_probs=103.0

Q ss_pred             eEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhc----CCCCeeEEEEEEeCCCC-Cc-cEEE
Q psy3714         176 VRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLR----GGTNIITLQAVVKDPVS-RT-PALI  246 (467)
Q Consensus       176 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~----~~~~iv~l~~~~~~~~~-~~-~~lv  246 (467)
                      .+.||+|+||.||.  +..++.. +||++...   ..+.+.+|+.+++.+.    .||||+++++++.+... .. ..+|
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            46799999999995  7777666 68887643   3467899999999995    37999999999987532 22 2368


Q ss_pred             Eec--cCCccHHHHhhc--CCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCCceEEeCC---CCcEEEEecccc
Q psy3714         247 FEH--VNNTDFKQLYQT--LTDYDIRYYLYELLKAL-DYCHSMGIMHRDVKPHNVMIDHE---NRKLRLIDWGLA  313 (467)
Q Consensus       247 ~e~--~~~~~l~~~~~~--~~~~~~~~~~~qll~al-~~lH~~~IiHrDlKp~Nill~~~---~~~ikl~DFGla  313 (467)
                      +||  +.+++|.++.+.  +++.  ..++.|++.++ +|||+++||||||||+|||++..   +..++|+||+-+
T Consensus        84 ~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            999  557899888753  3443  45678888888 99999999999999999999742   237999995433

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.84  E-value=2.9e-21  Score=192.11  Aligned_cols=115  Identities=30%  Similarity=0.590  Sum_probs=94.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....+.......++..|+|||.+.+ ..++.++|
T Consensus       127 ~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~D  204 (359)
T cd07876         127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG-MGYKENVD  204 (359)
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCCHHHEEECC-CCCEEEecCCCccccccCccCCCCcccCCCCCchhccC-CCCCcchh
Confidence            47899999999999999999999999999985 45899999999986544433445578889999999976 45788999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      +|||||++|+|++|+.||. +.+..+++..+.+.++.+
T Consensus       205 iwSlG~il~el~tg~~pf~-~~~~~~~~~~~~~~~~~~  241 (359)
T cd07876         205 IWSVGCIMGELVKGSVIFQ-GTDHIDQWNKVIEQLGTP  241 (359)
T ss_pred             hHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCC
Confidence            9999999999999998874 555566666666666543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.84  E-value=2.6e-21  Score=187.01  Aligned_cols=98  Identities=27%  Similarity=0.408  Sum_probs=82.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC--------cccccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--------EYNVRVASRYFKGPELLADY   73 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~--------~~~~~~~~~~~~~pe~~~~~   73 (467)
                      .|+.||+.||+|||++||+||||||+|||++. +..++|+|||+|+....+.        ......||+.|+|||...+ 
T Consensus       130 ~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~-~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-  207 (294)
T PHA02882        130 NIMKDMLTTLEYIHEHGISHGDIKPENIMVDG-NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-  207 (294)
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-
Confidence            58999999999999999999999999999984 4589999999998653211        1123468999999999875 


Q ss_pred             cCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          74 QMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        74 ~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      ..++.++|+|||||++++|++|+.||..
T Consensus       208 ~~~~~~~DiwSlG~~l~el~~g~~P~~~  235 (294)
T PHA02882        208 ACVTRRGDLESLGYCMLKWAGIKLPWKG  235 (294)
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence            5578999999999999999999999853

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.84  E-value=1.8e-21  Score=193.87  Aligned_cols=97  Identities=28%  Similarity=0.537  Sum_probs=81.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC----------------------------
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----------------------------   53 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~----------------------------   53 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......                            
T Consensus       105 ~~~~qi~~aL~~lH~~givHrDlKp~NILi~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (363)
T cd05628         105 FYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS-KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE  183 (363)
T ss_pred             HHHHHHHHHHHHHHhCCeEecCCCHHHeEECC-CCCEEEeeccCcccccccccccccccccccccccccccccccccccc
Confidence            47899999999999999999999999999985 4589999999987542110                            


Q ss_pred             --------cccccccccccccccccccccCCCCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          54 --------EYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        54 --------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                              .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.
T Consensus       184 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         184 TWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             hhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                    0123478999999999975 557889999999999999999999884

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0582|consensus

Probab=99.84  E-value=1.7e-21  Score=185.73  Aligned_cols=97  Identities=32%  Similarity=0.612  Sum_probs=83.3

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceec-CCCCcc----cccccccccccccc-cccccCC
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQEY----NVRVASRYFKGPEL-LADYQMY   76 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~-~~~~~~----~~~~~~~~~~~pe~-~~~~~~~   76 (467)
                      |.+++++||+|||.+|.||||||+.||||+. ++.|||+|||.+-.+ ..+...    .+.+|+++|||||+ .....+|
T Consensus       131 iLre~LkaL~YLH~~G~IHRdvKAgnILi~~-dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GY  209 (516)
T KOG0582|consen  131 ILREVLKALDYLHQNGHIHRDVKAGNILIDS-DGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGY  209 (516)
T ss_pred             HHHHHHHHHHHHHhcCceecccccccEEEcC-CCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCc
Confidence            6789999999999999999999999999994 569999999986543 333322    44589999999999 5556779


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +.|+||||||+...|+.+|..||-
T Consensus       210 dfKaDIwSfGITA~ELA~G~aPf~  233 (516)
T KOG0582|consen  210 DFKADIWSFGITACELAHGHAPFS  233 (516)
T ss_pred             cchhhhhhhhHHHHHHhcCCCCcc
Confidence            999999999999999999998884

>KOG1006|consensus

Probab=99.84  E-value=1.5e-22  Score=180.88  Aligned_cols=111  Identities=29%  Similarity=0.509  Sum_probs=91.4

Q ss_pred             HHHHHHHHHHHHHh-CCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccC-CCCee
Q psy3714           3 IATGASMALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQM-YDYSL   80 (467)
Q Consensus         3 i~~~i~~al~~lH~-~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~~   80 (467)
                      |++-.+.||+||.+ +.||||||||+|||++.. +.+||||||++-.+.++-..+.-+|...|||||.+..... |+.++
T Consensus       172 ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~-G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRS  250 (361)
T KOG1006|consen  172 ITVATVDALDYLKEELKIIHRDVKPSNILLDRH-GDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRS  250 (361)
T ss_pred             eeeeehhHHHHHHHHhhhhhccCChhheEEecC-CCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhh
Confidence            45556899999986 799999999999999955 5899999999987765545566689999999999976444 88999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      |+||||++|+|+.||..|+..-++.++|+..+..
T Consensus       251 DvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~  284 (361)
T KOG1006|consen  251 DVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI  284 (361)
T ss_pred             hhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc
Confidence            9999999999999999998655556666665543

>KOG0669|consensus

Probab=99.84  E-value=2.2e-21  Score=172.08  Aligned_cols=122  Identities=34%  Similarity=0.656  Sum_probs=102.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-----CcccccccccccccccccccccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-----QEYNVRVASRYFKGPELLADYQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~   76 (467)
                      ++.+++..||.|+|++.|+|||+||+|+||+.+ +.+||+|||+++.++..     ..++.++.|.+|++||.+.+...|
T Consensus       128 k~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d-gilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~y  206 (376)
T KOG0669|consen  128 KVMKGLMNGLYYIHRNKILHRDMKAANVLITKD-GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREY  206 (376)
T ss_pred             HHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC-ceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhccccc
Confidence            467899999999999999999999999999954 58999999999865422     125567789999999999999999


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhC--CchhHhhh
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEELFEYL  125 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  125 (467)
                      +.+.|+|.-||++.||.+| .|.+.|+.+..++..|...+|  +.++++.+
T Consensus       207 g~~iDiWgAgCimaeMwtr-spimqgnteqqql~~Is~LcGs~tkevWP~~  256 (376)
T KOG0669|consen  207 GPPIDIWGAGCIMAEMWTR-SPIMQGNTEQQQLHLISQLCGSITKEVWPNV  256 (376)
T ss_pred             CCcchhHhHHHHHHHHHcc-CccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence            9999999999999999998 577789999999988887776  33444333

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.84  E-value=2.9e-21  Score=192.52  Aligned_cols=114  Identities=32%  Similarity=0.605  Sum_probs=94.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++............++..|+|||.+.+ ..++.++|
T Consensus       130 ~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~D  207 (364)
T cd07875         130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVD  207 (364)
T ss_pred             HHHHHHHHHHHHHhhCCeecCCCCHHHEEECC-CCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhC-CCCCchhh
Confidence            47899999999999999999999999999984 45899999999987644333345578899999999976 55788999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      +|||||++|+|++|+.|| .+.+..+....+...++.
T Consensus       208 iwSlG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~  243 (364)
T cd07875         208 IWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGT  243 (364)
T ss_pred             HHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCC
Confidence            999999999999999887 455666666666665554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.84  E-value=4.3e-21  Score=191.39  Aligned_cols=99  Identities=32%  Similarity=0.597  Sum_probs=83.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC--ccccccccccccccccccccc---CC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLADYQ---MY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~---~~   76 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|.......  ......||+.|+|||++....   .+
T Consensus       146 ~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  224 (370)
T cd05621         146 FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK-HGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYY  224 (370)
T ss_pred             HHHHHHHHHHHHHHHCCeEecCCCHHHEEECC-CCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCC
Confidence            47899999999999999999999999999984 4589999999998764322  123557899999999986532   36


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +.++|+||+||++|+|++|+.||..
T Consensus       225 ~~~~DiwSlG~ilyell~G~~Pf~~  249 (370)
T cd05621         225 GRECDWWSVGVFLFEMLVGDTPFYA  249 (370)
T ss_pred             CcccCEEeehHHHHHHHhCCCCCCC
Confidence            7899999999999999999999853

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.84  E-value=4e-21  Score=171.07  Aligned_cols=155  Identities=21%  Similarity=0.194  Sum_probs=110.1

Q ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcceeeeccCccCCcccccC
Q psy3714         261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY  340 (467)
Q Consensus       261 ~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~  340 (467)
                      .+++.++..++.|++.||.|||+++      ||+|||++.++ .+|+  ||+++......    ..||+.|||||++.+.
T Consensus        13 ~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~~----~~g~~~y~aPE~~~~~   79 (176)
T smart00750       13 PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPEQ----SRVDPYFMAPEVIQGQ   79 (176)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeecccc----CCCcccccChHHhcCC
Confidence            4899999999999999999999998      99999998554 7888  99998764322    3689999999999999


Q ss_pred             CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCCh--HHHHHHHhh
Q psy3714         341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSP--EALDFLDKL  418 (467)
Q Consensus       341 ~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~dli~~l  418 (467)
                      .|+.++|+|..+++.+....+..|+......   . ...........    .....   .......+++  ++++||.+|
T Consensus        80 ~~~~~~DiwSlG~il~elltg~~p~~~~~~~---~-~~~~~~~~~~~----~~~~~---~~~~~~~~~~~~~~~~~i~~c  148 (176)
T smart00750       80 SYTEKADIYSLGITLYEALDYELPYNEEREL---S-AILEILLNGMP----ADDPR---DRSNLESVSAARSFADFMRVC  148 (176)
T ss_pred             CCcchhhHHHHHHHHHHHHhCCCCccccchh---c-HHHHHHHHHhc----cCCcc---ccccHHHHHhhhhHHHHHHHH
Confidence            9999999998888766555555554221110   0 00000000000    00000   0001112344  799999999


Q ss_pred             cCcCCCCCCCHHHHhCCCCCC
Q psy3714         419 LRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       419 L~~dp~~R~ta~e~l~Hp~f~  439 (467)
                      |..||++|||+.|+++|+|+.
T Consensus       149 l~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      149 ASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HhcccccccCHHHHHHHHHHH
Confidence            999999999999999999975

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.84  E-value=2.5e-21  Score=189.75  Aligned_cols=98  Identities=28%  Similarity=0.534  Sum_probs=83.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC-CCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++... ........+|++.|+|||.+.+ ..++.++
T Consensus        99 ~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  176 (323)
T cd05571          99 FYGAEIVSALGYLHSCDVVYRDLKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAV  176 (323)
T ss_pred             HHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC-CCCEEEeeCCCCcccccCCCcccceecCccccChhhhcC-CCCCccc
Confidence            47899999999999999999999999999985 4589999999987542 2223344578999999999875 4578899


Q ss_pred             eEEchhHHHHHHHhcCCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      |+|||||++|+|++|+.||..
T Consensus       177 DiwSlG~il~elltg~~Pf~~  197 (323)
T cd05571         177 DWWGLGVVMYEMMCGRLPFYN  197 (323)
T ss_pred             cCcccchhhhhhhcCCCCCCC
Confidence            999999999999999999853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.84  E-value=3.5e-21  Score=193.24  Aligned_cols=115  Identities=30%  Similarity=0.445  Sum_probs=91.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC--CcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      .|+.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+.....  .......||+.|+|||++.+ ..++.+
T Consensus       186 ~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~-~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~  263 (391)
T PHA03212        186 AIERSVLRAIQYLHENRIIHRDIKAENIFINH-PGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR-DPYGPA  263 (391)
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCChHhEEEcC-CCCEEEEeCCcccccccccccccccccCccCCCChhhhcC-CCCCcH
Confidence            58899999999999999999999999999984 458999999999754321  12334578999999999876 457889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCCC------CHHHHHHHHHHhCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGHD------NYDQLVRIAKVLGT  118 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~~------~~~~~~~~~~~~~~  118 (467)
                      +|+|||||++|+|++|+.|++....      ...++..+.+..|.
T Consensus       264 ~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~  308 (391)
T PHA03212        264 VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT  308 (391)
T ss_pred             HHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence            9999999999999999999875432      23455555555553

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.84  E-value=3.7e-21  Score=191.05  Aligned_cols=114  Identities=32%  Similarity=0.612  Sum_probs=93.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++............++..|+|||.+.+ ..++.++|
T Consensus       123 ~~~~qi~~aL~~LH~~givHrDikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~D  200 (355)
T cd07874         123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVD  200 (355)
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCChHHEEECC-CCCEEEeeCcccccCCCccccCCccccCCccCHHHHcC-CCCCchhh
Confidence            47899999999999999999999999999984 45899999999987644333445678899999999875 45788999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      +|||||++++|++|+.|| .+.+..+....+.+.++.
T Consensus       201 iwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~  236 (355)
T cd07874         201 IWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGT  236 (355)
T ss_pred             HHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCC
Confidence            999999999999999887 455555556666555553

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.84  E-value=3.8e-21  Score=188.47  Aligned_cols=97  Identities=30%  Similarity=0.506  Sum_probs=83.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.... ........|++.|+|||++.+ ..++.++
T Consensus       105 ~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~-~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  182 (323)
T cd05616         105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS-EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSV  182 (323)
T ss_pred             HHHHHHHHHHHHHHHCCEEecCCCHHHeEECC-CCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC-CCCCCcc
Confidence            57899999999999999999999999999985 45899999999975432 222344578999999999976 5578999


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+|||||++|+|++|+.||.
T Consensus       183 DiwSlGvil~elltg~~Pf~  202 (323)
T cd05616         183 DWWAFGVLLYEMLAGQAPFE  202 (323)
T ss_pred             chhchhHHHHHHHhCCCCCC
Confidence            99999999999999999884

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00284 protein kinase; Provisional

Probab=99.84  E-value=3.1e-21  Score=198.57  Aligned_cols=113  Identities=31%  Similarity=0.598  Sum_probs=92.2

Q ss_pred             hHHHHHHHHHHHHHh-CCCcccCCCCCcEEEecCCC---------------cEEEEecccceecCCCCcccccccccccc
Q psy3714           2 RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHENR---------------KLRLIDWGLAEFYHPGQEYNVRVASRYFK   65 (467)
Q Consensus         2 ~i~~~i~~al~~lH~-~~iiHrDlkp~Nil~~~~~~---------------~~kl~dfG~a~~~~~~~~~~~~~~~~~~~   65 (467)
                      .|+.||+.||+|||+ .|||||||||+|||++..+.               .+||+|||++.....  .....+||+.|+
T Consensus       235 ~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~  312 (467)
T PTZ00284        235 QIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYR  312 (467)
T ss_pred             HHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc--ccccccCCcccc
Confidence            588999999999998 59999999999999985432               489999998864322  234457899999


Q ss_pred             cccccccccCCCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          66 GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        66 ~pe~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      |||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+.+.+|.
T Consensus       313 APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~g~  363 (467)
T PTZ00284        313 SPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLY-DTHDNLEHLHLMEKTLGR  363 (467)
T ss_pred             CcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHcCC
Confidence            9999976 45888999999999999999998776 566667777777776663

>KOG0696|consensus

Probab=99.83  E-value=4.1e-21  Score=181.08  Aligned_cols=107  Identities=32%  Similarity=0.585  Sum_probs=91.5

Q ss_pred             HHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceec-CCCCcccccccccccccccccccccCCCCeee
Q psy3714           3 IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         3 i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~-~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .|..||-||-|||++|||.||||.+|||++.+ +++||+|||+++.. ..+....+.+||+.|+|||++. ++.|+.++|
T Consensus       455 YAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~-YqPYgksvD  532 (683)
T KOG0696|consen  455 YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKSVD  532 (683)
T ss_pred             hhHHHHHHhhhhhcCCeeeeeccccceEeccC-CceEeeecccccccccCCcceeeecCCCcccccceEE-ecccccchh
Confidence            58899999999999999999999999999965 59999999999854 3445567789999999999997 688999999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      +||+||+||||+.|..|| .|+|..+-...|
T Consensus       533 WWa~GVLLyEmlaGQpPF-dGeDE~elF~aI  562 (683)
T KOG0696|consen  533 WWAFGVLLYEMLAGQPPF-DGEDEDELFQAI  562 (683)
T ss_pred             HHHHHHHHHHHHcCCCCC-CCCCHHHHHHHH
Confidence            999999999999998776 676665444444

>KOG0671|consensus

Probab=99.83  E-value=2.5e-21  Score=181.46  Aligned_cols=113  Identities=25%  Similarity=0.591  Sum_probs=96.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC-------------------CCcEEEEecccceecCCCCccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE-------------------NRKLRLIDWGLAEFYHPGQEYNVRVASR   62 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~-------------------~~~~kl~dfG~a~~~~~~~~~~~~~~~~   62 (467)
                      .|+.|++.|+.|||+++++|.||||||||+..+                   +..|+++|||.|......  .+..+.|.
T Consensus       196 ~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTR  273 (415)
T KOG0671|consen  196 HMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTR  273 (415)
T ss_pred             HHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC--cceeeecc
Confidence            489999999999999999999999999998532                   124799999999876433  46668899


Q ss_pred             ccccccccccccCCCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          63 YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        63 ~~~~pe~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      .|+|||++.+ -+++.++||||+||+|.|+.+|.. .|.++++.++++.+.+.+|.
T Consensus       274 HYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~-LFqtHen~EHLaMMerIlGp  327 (415)
T KOG0671|consen  274 HYRAPEVILG-LGWSQPCDVWSIGCILVELYTGET-LFQTHENLEHLAMMERILGP  327 (415)
T ss_pred             ccCCchheec-cCcCCccCceeeeeEEEEeeccce-ecccCCcHHHHHHHHHhhCC
Confidence            9999999997 458999999999999999999965 55788899999888888883

>KOG4717|consensus

Probab=99.83  E-value=4.4e-21  Score=185.31  Aligned_cols=111  Identities=28%  Similarity=0.585  Sum_probs=97.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.|+.|||+.-+|||||||+|+.+-..-+-|||.|||++-.+.+++..++.||+..|-|||++.+..+..+++|
T Consensus       122 kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVD  201 (864)
T KOG4717|consen  122 KYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVD  201 (864)
T ss_pred             HHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchh
Confidence            46789999999999999999999999998876666899999999999999999999999999999999998776678999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA  113 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~  113 (467)
                      ||||||+||.+..|+.||.+.+|. +.+..|+
T Consensus       202 iWSLGVILyMLVCGq~PFqeANDS-ETLTmIm  232 (864)
T KOG4717|consen  202 IWSLGVILYMLVCGQPPFQEANDS-ETLTMIM  232 (864)
T ss_pred             hhHHHHHHHHHHhCCCccccccch-hhhhhhh
Confidence            999999999999999999766543 4454444

>KOG0589|consensus

Probab=99.83  E-value=4.4e-21  Score=186.99  Aligned_cols=111  Identities=30%  Similarity=0.569  Sum_probs=93.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-cccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +++.||+.|++|||++.|+|||||+.||++...+ .|||.|||+|+.+.+.. ...+.+||++||+||.+.+ ..|+.++
T Consensus       110 ~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KS  187 (426)
T KOG0589|consen  110 KWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK-KVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSD-IPYNEKS  187 (426)
T ss_pred             HHHHHHHHHHHHHHhhhhhcccchhhhhhccccC-ceeecchhhhhhcCCchhhhheecCCCcccCHHHhCC-CCCCccC
Confidence            5789999999999999999999999999999655 77999999999887665 5677899999999999987 5589999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV  115 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~  115 (467)
                      |+|||||++|||++-+.+| .+.+...-..++.+.
T Consensus       188 DiWsLGC~~yEm~~lk~aF-~a~~m~~Li~ki~~~  221 (426)
T KOG0589|consen  188 DIWSLGCCLYEMCTLKPAF-KASNMSELILKINRG  221 (426)
T ss_pred             cchhhcchHHHHHhccccc-CccchHHHHHHHhhc
Confidence            9999999999999998777 444443334455443

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.83  E-value=8e-21  Score=189.90  Aligned_cols=118  Identities=34%  Similarity=0.667  Sum_probs=97.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC--cccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......  ......++..|+|||.+.+...++.+
T Consensus       107 ~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  185 (372)
T cd07853         107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVNS-NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSA  185 (372)
T ss_pred             HHHHHHHHHHHHHHhCCeeCCCCChHHEEECC-CCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcH
Confidence            57899999999999999999999999999985 4589999999998654322  22334678889999999876667889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchh
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL  121 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~  121 (467)
                      +|+||+||++++|++|+.|| .+.+..+++..+...+|.+..
T Consensus       186 ~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~g~~~~  226 (372)
T cd07853         186 VDIWSVGCIFAELLGRRILF-QAQSPIQQLDLITDLLGTPSL  226 (372)
T ss_pred             HHHHhHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCH
Confidence            99999999999999998777 566667778888777776554

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0580|consensus

Probab=99.83  E-value=3.3e-21  Score=170.06  Aligned_cols=109  Identities=25%  Similarity=0.470  Sum_probs=90.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .+..|+|.||.|||.++||||||||+|+|++.. +.+|++|||.+.... .....+.|||.-|.+||...+ ..++..+|
T Consensus       128 ~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd  204 (281)
T KOG0580|consen  128 TYIKQLANALLYCHLKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEG-RGHDKFVD  204 (281)
T ss_pred             HHHHHHHHHHHHhccCCcccCCCCHHHhccCCC-CCeeccCCCceeecC-CCCceeeecccccCCHhhcCC-CCccchhh
Confidence            367899999999999999999999999999954 589999999997765 445677899999999999976 56889999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      +|++|++.||++.|..||. .....+...+|.+
T Consensus       205 ~w~lgvl~yeflvg~ppFe-s~~~~etYkrI~k  236 (281)
T KOG0580|consen  205 LWSLGVLCYEFLVGLPPFE-SQSHSETYKRIRK  236 (281)
T ss_pred             HHHHHHHHHHHHhcCCchh-hhhhHHHHHHHHH
Confidence            9999999999999988874 3333344444433

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.83  E-value=9.2e-21  Score=189.17  Aligned_cols=98  Identities=33%  Similarity=0.602  Sum_probs=82.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC--ccccccccccccccccccccc---CC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLADYQ---MY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~---~~   76 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......  .....+||+.|+|||++....   .+
T Consensus       146 ~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~-~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~  224 (371)
T cd05622         146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY  224 (371)
T ss_pred             HHHHHHHHHHHHHHHCCEEeCCCCHHHEEECC-CCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccC
Confidence            46889999999999999999999999999985 4589999999998764322  123457899999999986532   36


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +.++|+|||||++|+|++|+.||.
T Consensus       225 ~~~~DiwSlGvilyell~G~~Pf~  248 (371)
T cd05622         225 GRECDWWSVGVFLYEMLVGDTPFY  248 (371)
T ss_pred             CCccceeehhHHHHHHHhCCCCCC
Confidence            789999999999999999999985

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.83  E-value=1.1e-20  Score=186.82  Aligned_cols=113  Identities=38%  Similarity=0.733  Sum_probs=92.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....  .....+++.|+|||++.+...++.++|
T Consensus       122 ~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~D  198 (343)
T cd07878         122 FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE-DCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVD  198 (343)
T ss_pred             HHHHHHHHHHHHHHHCCeecccCChhhEEECC-CCCEEEcCCccceecCCC--cCCccccccccCchHhcCCccCCchhh
Confidence            58899999999999999999999999999984 458999999999875432  334578889999999876556788999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      +|||||++++|++|+.|| .+.+..+.+..+....+.
T Consensus       199 iwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~  234 (343)
T cd07878         199 IWSVGCIMAELLKGKALF-PGNDYIDQLKRIMEVVGT  234 (343)
T ss_pred             hHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHhCC
Confidence            999999999999998877 444555555555555443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.83  E-value=1.1e-20  Score=181.80  Aligned_cols=114  Identities=33%  Similarity=0.649  Sum_probs=92.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++............++..|+|||++.+ ..++.++|
T Consensus       112 ~~~~qi~~al~~lH~~~ivH~dikp~Nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  189 (288)
T cd07863         112 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS-GGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ-STYATPVD  189 (288)
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCHHHEEECC-CCCEEECccCccccccCcccCCCccccccccCchHhhC-CCCCCcch
Confidence            57899999999999999999999999999985 45899999999987654433444567888999999875 45788999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      +||+||++++|++|+.|| .+....+.+..+....+.
T Consensus       190 iwslG~~l~~l~~g~~~f-~~~~~~~~~~~~~~~~~~  225 (288)
T cd07863         190 MWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGL  225 (288)
T ss_pred             hhhHHHHHHHHHhCCcCc-CCCCHHHHHHHHHHHhCC
Confidence            999999999999987665 555555556666555443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.83  E-value=6.5e-21  Score=187.20  Aligned_cols=98  Identities=29%  Similarity=0.522  Sum_probs=83.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.... ........|++.|+|||.+.+ ..++.++
T Consensus        99 ~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~-~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  176 (328)
T cd05593          99 FYGAEIVSALDYLHSGKIVYRDLKLENLMLDK-DGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGRAV  176 (328)
T ss_pred             HHHHHHHHHHHHHHhCCeEecccCHHHeEECC-CCcEEEecCcCCccCCCcccccccccCCcCccChhhhcC-CCCCccC
Confidence            57899999999999999999999999999984 45899999999875422 222334578999999999875 4578899


Q ss_pred             eEEchhHHHHHHHhcCCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      |+|||||++|+|++|+.||..
T Consensus       177 DiwslGvil~elltG~~Pf~~  197 (328)
T cd05593         177 DWWGLGVVMYEMMCGRLPFYN  197 (328)
T ss_pred             CccccchHHHHHhhCCCCCCC
Confidence            999999999999999999853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.83  E-value=5.9e-21  Score=188.12  Aligned_cols=116  Identities=33%  Similarity=0.626  Sum_probs=91.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC----cccccccccccccccccccc-cCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADY-QMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~----~~~~~~~~~~~~~pe~~~~~-~~~   76 (467)
                      .++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++......    ......|+..|+|||++.+. ..+
T Consensus       107 ~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  185 (338)
T cd07859         107 FFLYQLLRALKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY  185 (338)
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHeEECC-CCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhcccccc
Confidence            57899999999999999999999999999984 4589999999997543211    12345788999999998642 457


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      +.++|+|||||++|+|++|+.|| .+.+...++..+....|.+
T Consensus       186 ~~~~DvwSlGvvl~el~tg~~pf-~~~~~~~~~~~~~~~~~~~  227 (338)
T cd07859         186 TPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLITDLLGTP  227 (338)
T ss_pred             CchhHHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCC
Confidence            88999999999999999998776 4555555665555555543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.83  E-value=5.3e-21  Score=188.14  Aligned_cols=98  Identities=23%  Similarity=0.430  Sum_probs=83.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC--cccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......  ......||..|+|||.+.+...++.+
T Consensus       109 ~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  187 (332)
T cd05614         109 FYSGEIILALEHLHKLGIVYRDIKLENILLDS-EGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKA  187 (332)
T ss_pred             HHHHHHHHHHHHHHHCCcEecCCCHHHeEECC-CCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCc
Confidence            47889999999999999999999999999985 4589999999998653322  12335689999999999765557789


Q ss_pred             eeEEchhHHHHHHHhcCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +|+|||||++|+|++|+.||.
T Consensus       188 ~DiwslG~il~elltg~~pf~  208 (332)
T cd05614         188 VDWWSLGILIFELLTGASPFT  208 (332)
T ss_pred             cccccchhhhhhhhcCCCCCC
Confidence            999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.83  E-value=9.9e-21  Score=184.92  Aligned_cols=97  Identities=29%  Similarity=0.559  Sum_probs=83.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-CcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..... ......+||..|+|||.+.+ ..++.++
T Consensus       100 ~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  177 (316)
T cd05592         100 FYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK-DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG-QKYNESV  177 (316)
T ss_pred             HHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC-CCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcC-CCCCCcc
Confidence            47899999999999999999999999999985 458999999999865322 22344578999999999875 4578899


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+|||||++++|++|+.||.
T Consensus       178 DvwslG~il~ell~G~~Pf~  197 (316)
T cd05592         178 DWWSFGVLLYEMLIGQSPFH  197 (316)
T ss_pred             cchhHHHHHHHHHhCCCCCC
Confidence            99999999999999999884

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=8.1e-20  Score=162.91  Aligned_cols=131  Identities=19%  Similarity=0.161  Sum_probs=103.8

Q ss_pred             eeEeecccCCcceEEEEEccCCCeEEEEEeccch-------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         175 LVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       175 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      +...|++|+||+|+.+..  .+.+++.+-++...       ...+.+|+++|++|.++++++.+.++      ...+++|
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm   77 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR   77 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence            567899999999997754  56777766665432       22578999999999888889988775      2358999


Q ss_pred             eccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCceEEeCCCCcEEEEecccceecCC
Q psy3714         248 EHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDV-KPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       248 e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDl-Kp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      +|+.|.+|.+...   .. ...++.|++.+|+++|++||+|||| ||+|||++.++ .++|+|||+|....+
T Consensus        78 eyI~G~~L~~~~~---~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~~~~  144 (218)
T PRK12274         78 SYLAGAAMYQRPP---RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVRGNP  144 (218)
T ss_pred             eeecCccHHhhhh---hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-CEEEEECCCceecCC
Confidence            9999988864421   12 2457789999999999999999999 79999998554 799999999986543

>KOG0032|consensus

Probab=99.83  E-value=1e-20  Score=186.54  Aligned_cols=109  Identities=32%  Similarity=0.717  Sum_probs=93.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCC---CcEEEEecccceecCCCCcccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHEN---RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~---~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      .++.||+.|+.|||+.||+||||||||+|+....   ..+|++|||+|....+.......+||+.|+|||++.. ..|+.
T Consensus       139 ~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~  217 (382)
T KOG0032|consen  139 GIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGD  217 (382)
T ss_pred             HHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC-CCCCc
Confidence            5789999999999999999999999999997543   3799999999999887666788899999999999975 56899


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      .+|+||+||++|.|+.|..||+ +.+.......+
T Consensus       218 ~~DiWS~Gvi~yiLL~G~~PF~-~~~~~~~~~~i  250 (382)
T KOG0032|consen  218 EVDVWSIGVILYILLSGVPPFW-GETEFEIFLAI  250 (382)
T ss_pred             ccchhHHHHHHHHHhhCCCCCc-CCChhHHHHHH
Confidence            9999999999999999998885 44443333333

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.83  E-value=9.3e-21  Score=185.87  Aligned_cols=97  Identities=32%  Similarity=0.586  Sum_probs=83.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.... .......+|++.|+|||++.+ ..++.++
T Consensus       100 ~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~-~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  177 (325)
T cd05602         100 FYAAEIASALGYLHSLNIVYRDLKPENILLDS-QGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK-QPYDRTV  177 (325)
T ss_pred             HHHHHHHHHHHHHHHCCeEecCCCHHHeEECC-CCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcC-CCCCCcc
Confidence            47899999999999999999999999999985 45899999999975422 222344578999999999876 5578899


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+|||||++|+|++|..||.
T Consensus       178 DiwslG~il~el~~g~~pf~  197 (325)
T cd05602         178 DWWCLGAVLYEMLYGLPPFY  197 (325)
T ss_pred             ccccccHHHHHHhcCCCCCC
Confidence            99999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.82  E-value=1.4e-20  Score=188.86  Aligned_cols=97  Identities=30%  Similarity=0.556  Sum_probs=80.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-----------------------------
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-----------------------------   52 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-----------------------------   52 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|......                             
T Consensus       105 ~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~-~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (382)
T cd05625         105 FYIAELTCAVESVHKMGFIHRDIKPDNILIDR-DGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC  183 (382)
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCHHHEEECC-CCCEEEeECCCCccccccccccccccccccccccccccccccccccc
Confidence            46889999999999999999999999999984 558999999997532100                             


Q ss_pred             -------------------CcccccccccccccccccccccCCCCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          53 -------------------QEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        53 -------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                                         ......+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~  249 (382)
T cd05625         184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFL  249 (382)
T ss_pred             cccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHHHHHHhCCCCCC
Confidence                               00112368899999999975 457899999999999999999999885

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.82  E-value=2.7e-21  Score=190.04  Aligned_cols=99  Identities=28%  Similarity=0.500  Sum_probs=84.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC-CCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.++|+|||+++... ........+|+..|+|||.+.+...++.++
T Consensus       100 ~~~~qil~al~~LH~~~ivHrDlkp~Nili~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  178 (330)
T cd05586         100 FYIAELVLALEHLHKYDIVYRDLKPENILLDA-TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV  178 (330)
T ss_pred             HHHHHHHHHHHHHHHCCeEeccCCHHHeEECC-CCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCcc
Confidence            57899999999999999999999999999985 4589999999987532 222334557899999999987655578899


Q ss_pred             eEEchhHHHHHHHhcCCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      |+|||||++|+|++|+.||..
T Consensus       179 DvwslGvil~elltG~~Pf~~  199 (330)
T cd05586         179 DFWSLGVLVFEMCCGWSPFYA  199 (330)
T ss_pred             ceeccccEEEEeccCCCCCCC
Confidence            999999999999999999853

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.82  E-value=1e-20  Score=185.51  Aligned_cols=97  Identities=30%  Similarity=0.517  Sum_probs=82.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC-CCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++... ........+|+..|+|||++.+ ..++.++
T Consensus       105 ~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  182 (324)
T cd05587         105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA-EGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY-QPYGKSV  182 (324)
T ss_pred             HHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC-CCCEEEeecCcceecCCCCCceeeecCCccccChhhhcC-CCCCccc
Confidence            47899999999999999999999999999985 4589999999987532 2222344578999999999976 4578899


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+||+||++|+|++|+.||.
T Consensus       183 DiwslGvil~elltG~~pf~  202 (324)
T cd05587         183 DWWAFGVLLYEMLAGQPPFD  202 (324)
T ss_pred             chhhhHHHHHHHHhCCCCCC
Confidence            99999999999999998884

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG1187|consensus

Probab=99.82  E-value=7.7e-21  Score=187.01  Aligned_cols=99  Identities=27%  Similarity=0.459  Sum_probs=84.4

Q ss_pred             ChHHHHHHHHHHHHHhCC---CcccCCCCCcEEEecCCCcEEEEecccceecCC-CCccccc-ccccccccccccccccC
Q psy3714           1 MRIATGASMALDYCHSMG---IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVR-VASRYFKGPELLADYQM   75 (467)
Q Consensus         1 ~~i~~~i~~al~~lH~~~---iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~-~~~~~~~~pe~~~~~~~   75 (467)
                      ++||.++|+||+|||+..   ||||||||+|||+| ++...||+|||+|+.... ....... .||..|++||+... ..
T Consensus       177 ~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~  254 (361)
T KOG1187|consen  177 LKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GK  254 (361)
T ss_pred             HHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCcccCCccccceeeecCCCCccCChhhhcc-CC
Confidence            489999999999999844   99999999999999 678999999999976654 3333333 78999999999976 45


Q ss_pred             CCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          76 YDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        76 ~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      .+.++|||||||+++|+++|+.+...
T Consensus       255 lt~KsDVySFGVvllElitgr~~~d~  280 (361)
T KOG1187|consen  255 LTEKSDVYSFGVVLLELITGRKAVDQ  280 (361)
T ss_pred             cCcccccccchHHHHHHHhCCcccCC
Confidence            78899999999999999999987753

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.82  E-value=9.3e-21  Score=186.02  Aligned_cols=97  Identities=30%  Similarity=0.605  Sum_probs=83.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceec-CCCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~-~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.. .........+|++.|+|||.+.+ ..++.++
T Consensus       100 ~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  177 (327)
T cd05617         100 FYAAEICIALNFLHERGIIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSV  177 (327)
T ss_pred             HHHHHHHHHHHHHHHCCeeccCCCHHHEEEeC-CCCEEEeccccceeccCCCCceecccCCcccCCHHHHCC-CCCCchh
Confidence            58899999999999999999999999999985 458999999999753 22333445678999999999875 5578899


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+|||||++|+|++|+.||.
T Consensus       178 DiwslGvil~ell~g~~pf~  197 (327)
T cd05617         178 DWWALGVLMFEMMAGRSPFD  197 (327)
T ss_pred             eeehhHHHHHHHHhCCCCCC
Confidence            99999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.82  E-value=1.3e-20  Score=184.50  Aligned_cols=97  Identities=27%  Similarity=0.486  Sum_probs=82.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.... ........|+..|+|||.+.+ ..++.++
T Consensus       100 ~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  177 (321)
T cd05591         100 FYAAEVTLALMFLHRHGVIYRDLKLDNILLDA-EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSV  177 (321)
T ss_pred             HHHHHHHHHHHHHHHCCeeccCCCHHHeEECC-CCCEEEeecccceecccCCccccccccCccccCHHHHcC-CCCCCcc
Confidence            47899999999999999999999999999985 45899999999875432 222344568899999999875 5578899


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+|||||++|+|++|+.||.
T Consensus       178 DvwslG~il~el~tg~~Pf~  197 (321)
T cd05591         178 DWWALGVLMYEMMAGQPPFE  197 (321)
T ss_pred             ceechhHHHHHHhcCCCCCC
Confidence            99999999999999998884

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.82  E-value=1.7e-20  Score=187.18  Aligned_cols=98  Identities=33%  Similarity=0.607  Sum_probs=82.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC--cccccccccccccccccccc---cCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLADY---QMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~---~~~   76 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......  .....+||+.|+|||++.+.   ..+
T Consensus       146 ~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~-~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  224 (370)
T cd05596         146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYY  224 (370)
T ss_pred             HHHHHHHHHHHHHHHCCeeccCCCHHHEEEcC-CCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCC
Confidence            47889999999999999999999999999984 5689999999998654322  22345789999999998643   236


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +.++|+|||||++|+|++|+.||.
T Consensus       225 ~~~~DiwSlGvilyelltG~~Pf~  248 (370)
T cd05596         225 GRECDWWSVGVFLYEMLVGDTPFY  248 (370)
T ss_pred             CCceeeeehhHHHHHHHhCCCCcC
Confidence            789999999999999999999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.82  E-value=1.2e-20  Score=184.01  Aligned_cols=98  Identities=28%  Similarity=0.530  Sum_probs=83.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.... .......+|++.|+|||.+.+ ..++.++
T Consensus        97 ~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  174 (312)
T cd05585          97 FYTAELLCALENLHKFNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG-HGYTKAV  174 (312)
T ss_pred             HHHHHHHHHHHHHHhCCeEeCCCCHHHeEECC-CCcEEEEECcccccCccCCCccccccCCcccCCHHHHcC-CCCCCcc
Confidence            47889999999999999999999999999984 45899999999985432 222344578999999999976 5578899


Q ss_pred             eEEchhHHHHHHHhcCCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      |+|||||++++|++|+.||..
T Consensus       175 DvwslGvil~el~tg~~pf~~  195 (312)
T cd05585         175 DWWTLGVLLYEMLTGLPPFYD  195 (312)
T ss_pred             ceechhHHHHHHHhCCCCcCC
Confidence            999999999999999999853

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	467
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-119
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-119
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-119
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-119
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-119
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-119
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-119
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-119
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-119
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-118
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-118
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-118
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-118
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-117
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-117
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-109
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-109
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-95
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-95
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-95
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-95
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		4e-95
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		6e-95
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-95
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-95
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		9e-95
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-94
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-22
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-19
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-22
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-16
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-21
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-15
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-21
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-15
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-21
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-15
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-21
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-15
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-21
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-15
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-21
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-15
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-21
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-15
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-21
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-15
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-21
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		9e-15
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-21
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-15
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-21
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-14
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-21
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-15
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-21
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-15
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-21
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-15
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-21
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-14
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-21
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-14
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-21
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-21
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-21
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-14
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-21
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-15
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-21
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-14
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-21
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-14
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		8e-21
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-20
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-14
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-19
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-16
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-19
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-16
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-19
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-14
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-19
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-19
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-18
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-18
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-18
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-18
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-18
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-18
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-18
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-18
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-18
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-18
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-18
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-18
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-18
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-18
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-18
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-18
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-18
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-18
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-18
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-18
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-18
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-18
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-18
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-18
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-18
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-18
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-18
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-18
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-18
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-18
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-18
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-18
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-18
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-18
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-18
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-18
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-18
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-18
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-18
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-18
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-16
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-18
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-17
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-17
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-15
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-17
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-15
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-17
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-15
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-17
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-15
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-17
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-17
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-17
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-17
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-15
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-17
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-17
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-17
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-17
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-17
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-17
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-17
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-17
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-17
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-17
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-14
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-17
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-14
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-17
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-14
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-17
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-17
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-17
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-16
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-14
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-16
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-14
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-16
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-16
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-16
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-16
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-16
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-16
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-14
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-16
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-16
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-16
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-16
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-16
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-14
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-16
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-14
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-16
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-14
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-16
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-16
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-14
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-16
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-14
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-16
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-14
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-16
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-14
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-16
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-14
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-16
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-14
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-16
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-14
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-16
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-14
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-16
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-16
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-16
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-16
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-16
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-14
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-16
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-16
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-16
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-14
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-16
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-14
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-16
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-16
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-13
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-16
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-16
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		9e-16
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-16
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-16
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-15
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-15
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-15
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-15
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-15
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-15
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-14
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-13
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-14
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-13
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-14
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-13
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-13
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-12
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-13
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-12
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-12
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-13
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		9e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-12
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-12
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-13
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		9e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-13
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-13
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		5e-13
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-13
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-13
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-13
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-12
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-12
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-13
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-13
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-13
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		9e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-07
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-12
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-11
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-11
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-09
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-11
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		8e-11
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-11
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-07
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-07
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-10
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-10
2oza_A	356	Structure Of P38alpha Complex Length = 356		7e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-10
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-10
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-06
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-10
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-06
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-10
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-10
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-10
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		7e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-10
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-10
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-06
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-06
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-06
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-06
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-10
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-06
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-06
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-06
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-06
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-06
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-09
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-09
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-09
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-05
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-09
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-09
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-06
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-09
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-09
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-06
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-09
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-07
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-07
3soa_A	444	Full-Length Human Camkii Length = 444		1e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-05
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-04
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-06
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-08
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-06
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-08
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-06
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-08
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		7e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-06
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-04
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-05
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-05
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-06
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-06
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-04
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-05
2jam_B	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-07
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-05
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-05
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-06
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-04
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		3e-07
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		8e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-04
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-07
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-07
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		7e-07
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-04
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-04
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		7e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-04
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-04
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-04
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-04
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-04
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-06
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-04
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		4e-06
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		5e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-04
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-04
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		8e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		8e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-06
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-06
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-06
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-06
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-05
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-05
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-05
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-05
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-05
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-04
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-05
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-05
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-05
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-05
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-05
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		8e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-04
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-04
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-04
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-04
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-04
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-04
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-04
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-04
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-04
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-04
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-04
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-04
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-04
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-04
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-04
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-04
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-04
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-04
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-04
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-04
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-04
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-04
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-04
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-04
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-04
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-04
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-04
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-04
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-04
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-04
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-04
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-04
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-04
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-04
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-04
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-04
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-04
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-04
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-04
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-04
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-04
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-04

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  426 bits (1094), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 222/362 (61%), Positives = 243/362 (67%), Gaps = 86/362 (23%)
Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDX 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++ 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 199 XXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
                               LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 299
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                       FLDKLLRYDH  RLTAREAM+HPYFYP+VK+Q
Sbjct: 300 ----------------------------FLDKLLRYDHQSRLTAREAMEHPYFYPVVKEQ 331
Query: 446 SR 447
           S+
Sbjct: 332 SQ 333

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  424 bits (1091), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 222/362 (61%), Positives = 242/362 (66%), Gaps = 86/362 (23%)
Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDX 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++ 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 199 XXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
                               LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 299
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                       FLDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 300 ----------------------------FLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331
Query: 446 SR 447
           +R
Sbjct: 332 AR 333

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  424 bits (1091), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 222/362 (61%), Positives = 242/362 (66%), Gaps = 86/362 (23%)
Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDX 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++ 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 199 XXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
                               LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 299
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                       FLDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 300 ----------------------------FLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331
Query: 446 SR 447
           +R
Sbjct: 332 AR 333

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  424 bits (1090), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 222/362 (61%), Positives = 242/362 (66%), Gaps = 86/362 (23%)
Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDX 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++ 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 199 XXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
                               LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 299
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                       FLDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 300 ----------------------------FLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331
Query: 446 SR 447
           +R
Sbjct: 332 AR 333

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  424 bits (1090), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 222/362 (61%), Positives = 242/362 (66%), Gaps = 86/362 (23%)
Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDX 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++ 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 199 XXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
                               LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 299
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                       FLDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 300 ----------------------------FLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331
Query: 446 SR 447
           +R
Sbjct: 332 AR 333

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  424 bits (1090), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 222/362 (61%), Positives = 242/362 (66%), Gaps = 86/362 (23%)
Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDX 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++ 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 199 XXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
                               LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 299
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                       FLDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 300 ----------------------------FLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331
Query: 446 SR 447
           +R
Sbjct: 332 AR 333

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  424 bits (1089), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 222/362 (61%), Positives = 242/362 (66%), Gaps = 86/362 (23%)
Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDX 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++ 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 199 XXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
                               LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 299
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                       FLDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 300 ----------------------------FLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331
Query: 446 SR 447
           +R
Sbjct: 332 AR 333

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  424 bits (1089), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 222/362 (61%), Positives = 242/362 (66%), Gaps = 86/362 (23%)
Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDX 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++ 
Sbjct: 10  VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 69
Query: 199 XXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
                               LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 70  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 129
Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 130 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 189
Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 190 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 249
Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 250 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 304
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                       FLDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 305 ----------------------------FLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 336
Query: 446 SR 447
           +R
Sbjct: 337 AR 338

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  424 bits (1089), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 222/362 (61%), Positives = 242/362 (66%), Gaps = 86/362 (23%)
Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDX 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++ 
Sbjct: 4   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 63
Query: 199 XXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
                               LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 64  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 123
Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 124 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183
Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 243
Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 244 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 298
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                       FLDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 299 ----------------------------FLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 330
Query: 446 SR 447
           +R
Sbjct: 331 AR 332

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  423 bits (1088), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 221/362 (61%), Positives = 242/362 (66%), Gaps = 86/362 (23%)
Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDX 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++ 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 199 XXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
                               LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VAVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNV+IDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHP 184
Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 299
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                       FLDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 300 ----------------------------FLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331
Query: 446 SR 447
           +R
Sbjct: 332 AR 333

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  421 bits (1082), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 221/362 (61%), Positives = 241/362 (66%), Gaps = 86/362 (23%)
Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDX 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++ 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 199 XXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
                               LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
            QTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 RQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 299
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                       FLDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 300 ----------------------------FLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331
Query: 446 SR 447
           +R
Sbjct: 332 AR 333

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  421 bits (1082), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 221/360 (61%), Positives = 240/360 (66%), Gaps = 86/360 (23%)
Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDX 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++ 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 199 XXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
                               LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 299
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                       FLDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 300 ----------------------------FLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  421 bits (1081), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 221/360 (61%), Positives = 240/360 (66%), Gaps = 86/360 (23%)
Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDX 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++ 
Sbjct: 4   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 63
Query: 199 XXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
                               LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 64  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 123
Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 124 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183
Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 243
Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 244 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 298
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                                       FLDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 299 ----------------------------FLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 330

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  418 bits (1075), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 220/359 (61%), Positives = 239/359 (66%), Gaps = 86/359 (23%)
Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDX 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++ 
Sbjct: 3   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 62
Query: 199 XXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
                               LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 63  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 122
Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 123 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182
Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242
Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 297
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD 444
                                       FLDKLLRYDH  RLTAREAM+HPYFY +VKD
Sbjct: 298 ----------------------------FLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 328

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  418 bits (1074), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 218/358 (60%), Positives = 237/358 (66%), Gaps = 86/358 (24%)
Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDX 198
           +  RARVY DVN+H+PREYWDY S+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++ 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 199 XXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
                               LENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 65  VVVKILKPVKKNKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 319 GQEYNVRVASRYFKGPELLADYQ------------------------------------- 341
           GQEYNVRVASRYFKGPELL DYQ                                     
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 ----------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
                           Y+IELDPRF DILGRHSRKRWERFVH+ENQHLVSPEALD     
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD----- 299
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
                                       FLDKLLRYDH  RLTAREAM+HPYFY +VK
Sbjct: 300 ----------------------------FLDKLLRYDHQSRLTAREAMEHPYFYTVVK 329

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  392 bits (1007), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 204/360 (56%), Positives = 232/360 (64%), Gaps = 86/360 (23%)
Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXX 200
            RARVYA+VNS + REYWDYE++V  WG QDDYQLVRKLGRGKYSEVFEAIN+ +++   
Sbjct: 8   SRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVV 67
Query: 201 XXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
                             LENLRGGTNII L   VKDPVS+TPAL+FE++NNTDFKQLYQ
Sbjct: 68  VKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQ 127
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
            LTD+DIR+Y+YELLKALDYCHS GIMHRDVKPHNVMIDH+ +KLRLIDWGLAEFYHP Q
Sbjct: 128 ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQ 187
Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL DYQ                                       
Sbjct: 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIA 247
Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         YHI+LDP F DILG+HSRKRWE F+H+EN+HLVSPEAL        
Sbjct: 248 KVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEAL-------- 299
Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                                    D LDKLLRYDH +RLTA+EAM+HPYFYP+VK+QS+
Sbjct: 300 -------------------------DLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQ 334

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  391 bits (1004), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 204/360 (56%), Positives = 232/360 (64%), Gaps = 86/360 (23%)
Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXX 200
            RARVYA+VNS + REYWDYE++V  WG QDDYQLVRKLGRGKYSEVFEAIN+ +++   
Sbjct: 13  SRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVV 72
Query: 201 XXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
                             LENLRGGTNII L   VKDPVS+TPAL+FE++NNTDFKQLYQ
Sbjct: 73  VKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQ 132
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
            LTD+DIR+Y+YELLKALDYCHS GIMHRDVKPHNVMIDH+ +KLRLIDWGLAEFYHP Q
Sbjct: 133 ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQ 192
Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL DYQ                                       
Sbjct: 193 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIA 252
Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         YHI+LDP F DILG+HSRKRWE F+H+EN+HLVSPEAL        
Sbjct: 253 KVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEAL-------- 304
Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                                    D LDKLLRYDH +RLTA+EAM+HPYFYP+VK+QS+
Sbjct: 305 -------------------------DLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQ 339

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  346 bits (888), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 186/363 (51%), Positives = 218/363 (60%), Gaps = 86/363 (23%)
Query: 140 LGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXX 199
           + +ARVYADVN  +P+EYWDYE+  V WG+QDDY++VRK+GRGKYSEVFE INV +++  
Sbjct: 1   MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60
Query: 200 XXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY 259
                              L+NL GG NI+ L  +V+D  S+TP+LIFE+VNNTDFK LY
Sbjct: 61  IIKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
            TLTDYDIRYY+YELLKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180
Query: 320 QEYNVRVASRYFKGPELLADYQ-------------------------------------- 341
           +EYNVRVASRYFKGPELL D Q                                      
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 342 ---------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI 386
                          Y IELDP+   ++GRHSRK W +F++ +NQHLVSPEA+D      
Sbjct: 241 AKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAID------ 294
Query: 387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS 446
                                      FLDKLLRYDH ERLTA EAM HPYF  +   ++
Sbjct: 295 ---------------------------FLDKLLRYDHQERLTALEAMTHPYFQQVRAAEN 327
Query: 447 RHT 449
             T
Sbjct: 328 SRT 330

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  346 bits (887), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 186/363 (51%), Positives = 218/363 (60%), Gaps = 86/363 (23%)
Query: 140 LGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXX 199
           + +ARVYADVN  +P+EYWDYE+  V WG+QDDY++VRK+GRGKYSEVFE INV +++  
Sbjct: 1   MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60
Query: 200 XXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY 259
                              L+NL GG NI+ L  +V+D  S+TP+LIFE+VNNTDFK LY
Sbjct: 61  IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
            TLTDYDIRYY+YELLKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180
Query: 320 QEYNVRVASRYFKGPELLADYQ-------------------------------------- 341
           +EYNVRVASRYFKGPELL D Q                                      
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 342 ---------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI 386
                          Y IELDP+   ++GRHSRK W +F++ +NQHLVSPEA+D      
Sbjct: 241 AKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAID------ 294
Query: 387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS 446
                                      FLDKLLRYDH ERLTA EAM HPYF  +   ++
Sbjct: 295 ---------------------------FLDKLLRYDHQERLTALEAMTHPYFQQVRAAEN 327
Query: 447 RHT 449
             T
Sbjct: 328 SRT 330

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  345 bits (886), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 186/363 (51%), Positives = 218/363 (60%), Gaps = 86/363 (23%)
Query: 140 LGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXX 199
           + +ARVYADVN  +P+EYWDYE+  V WG+QDDY++VRK+GRGKYSEVFE INV +++  
Sbjct: 21  MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 80
Query: 200 XXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY 259
                              L+NL GG NI+ L  +V+D  S+TP+LIFE+VNNTDFK LY
Sbjct: 81  IIKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 140
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
            TLTDYDIRYY+YELLKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 141 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 200
Query: 320 QEYNVRVASRYFKGPELLADYQ-------------------------------------- 341
           +EYNVRVASRYFKGPELL D Q                                      
Sbjct: 201 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 260
Query: 342 ---------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI 386
                          Y IELDP+   ++GRHSRK W +F++ +NQHLVSPEA+D      
Sbjct: 261 AKVLGTDGLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAID------ 314
Query: 387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS 446
                                      FLDKLLRYDH ERLTA EAM HPYF  +   ++
Sbjct: 315 ---------------------------FLDKLLRYDHQERLTALEAMTHPYFQQVRAAEN 347
Query: 447 RHT 449
             T
Sbjct: 348 SRT 350

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  345 bits (885), Expect = 3e-95,   Method: Compositional matrix adjust.
 Identities = 186/362 (51%), Positives = 217/362 (59%), Gaps = 86/362 (23%)
Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXX 200
            +ARVYADVN  +P+EYWDYE+  V WG+QDDY++VRK+GRGKYSEVFE INV +++   
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 201 XXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
                             L+NL GG NI+ L  +V+D  S+TP+LIFE+VNNTDFK LY 
Sbjct: 61  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TLTDYDIRYY+YELLKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL D Q                                       
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         Y IELDP+   ++GRHSRK W +F++ +NQHLVSPEA+D       
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAID------- 293
Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                                     FLDKLLRYDH ERLTA EAM HPYF  +   ++ 
Sbjct: 294 --------------------------FLDKLLRYDHQERLTALEAMTHPYFQQVRAAENS 327
Query: 448 HT 449
            T
Sbjct: 328 RT 329

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  345 bits (884), Expect = 4e-95,   Method: Compositional matrix adjust.
 Identities = 186/362 (51%), Positives = 217/362 (59%), Gaps = 86/362 (23%)
Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXX 200
            +ARVYADVN  +P+EYWDYE+  V WG+QDDY++VRK+GRGKYSEVFE INV +++   
Sbjct: 3   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 62
Query: 201 XXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
                             L+NL GG NI+ L  +V+D  S+TP+LIFE+VNNTDFK LY 
Sbjct: 63  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 122
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TLTDYDIRYY+YELLKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+
Sbjct: 123 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 182
Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL D Q                                       
Sbjct: 183 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 242
Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         Y IELDP+   ++GRHSRK W +F++ +NQHLVSPEA+D       
Sbjct: 243 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAID------- 295
Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                                     FLDKLLRYDH ERLTA EAM HPYF  +   ++ 
Sbjct: 296 --------------------------FLDKLLRYDHQERLTALEAMTHPYFQQVRAAENS 329
Query: 448 HT 449
            T
Sbjct: 330 RT 331

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  344 bits (882), Expect = 6e-95,   Method: Compositional matrix adjust.
 Identities = 185/351 (52%), Positives = 213/351 (60%), Gaps = 86/351 (24%)
Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXX 200
            +ARVYADVN  +P+EYWDYE+  V WG+QDDY++VRK+GRGKYSEVFE INV +++   
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 201 XXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
                             L+NL GG NI+ L  +V+D  S+TP+LIFE+VNNTDFK LY 
Sbjct: 61  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TLTDYDIRYY+YELLKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL D Q                                       
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         Y IELDP+   ++GRHSRK W +F++ +NQHLVSPEA+D       
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAID------- 293
Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                                     FLDKLLRYDH ERLTA EAM HPYF
Sbjct: 294 --------------------------FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  344 bits (882), Expect = 7e-95,   Method: Compositional matrix adjust.
 Identities = 185/351 (52%), Positives = 213/351 (60%), Gaps = 86/351 (24%)
Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXX 200
            +ARVYADVN  +P+EYWDYE+  V WG+QDDY++VRK+GRGKYSEVFE INV +++   
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 201 XXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
                             L+NL GG NI+ L  +V+D  S+TP+LIFE+VNNTDFK LY 
Sbjct: 61  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TLTDYDIRYY+YELLKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL D Q                                       
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         Y IELDP+   ++GRHSRK W +F++ +NQHLVSPEA+D       
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAID------- 293
Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                                     FLDKLLRYDH ERLTA EAM HPYF
Sbjct: 294 --------------------------FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  344 bits (882), Expect = 7e-95,   Method: Compositional matrix adjust.
 Identities = 185/351 (52%), Positives = 213/351 (60%), Gaps = 86/351 (24%)
Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXX 200
            +ARVYADVN  +P+EYWDYE+  V WG+QDDY++VRK+GRGKYSEVFE INV +++   
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 201 XXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
                             L+NL GG NI+ L  +V+D  S+TP+LIFE+VNNTDFK LY 
Sbjct: 61  IKILKPVKKKKIKREIKILQNLMGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TLTDYDIRYY+YELLKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL D Q                                       
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         Y IELDP+   ++GRHSRK W +F++ +NQHLVSPEA+D       
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAID------- 293
Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                                     FLDKLLRYDH ERLTA EAM HPYF
Sbjct: 294 --------------------------FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  343 bits (881), Expect = 9e-95,   Method: Compositional matrix adjust.
 Identities = 185/351 (52%), Positives = 213/351 (60%), Gaps = 86/351 (24%)
Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXX 200
            +ARVYADVN  +P+EYWDYE+  V WG+QDDY++VRK+GRGKYSEVFE INV +++   
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 201 XXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
                             L+NL GG NI+ L  +V+D  S+TP+LIFE+VNNTDFK LY 
Sbjct: 61  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TLTDYDIRYY+YELLKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL D Q                                       
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         Y IELDP+   ++GRHSRK W +F++ +NQHLVSPEA+D       
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAID------- 293
Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                                     FLDKLLRYDH ERLTA EAM HPYF
Sbjct: 294 --------------------------FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  343 bits (881), Expect = 1e-94,   Method: Compositional matrix adjust.
 Identities = 185/351 (52%), Positives = 213/351 (60%), Gaps = 86/351 (24%)
Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXX 200
            +ARVYADVN  +P+EYWDYE+  V WG+QDDY++VRK+GRGKYSEVFE INV +++   
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 201 XXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 260
                             L+NL GG NI+ L  +V+D  S+TP+LIFE+VNNTDFK LY 
Sbjct: 61  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TLTDYDIRYY+YELLKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 321 EYNVRVASRYFKGPELLADYQ--------------------------------------- 341
           EYNVRVASRYFKGPELL D Q                                       
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 342 --------------YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
                         Y IELDP+   ++GRHSRK W +F++ +NQHLVSPEA+D       
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAID------- 293
Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                                     FLDKLLRYDH ERLTA EAM HPYF
Sbjct: 294 --------------------------FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 46/109 (42%), Positives = 70/109 (64%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS+GI HRD+KP N+++D  +  L+LID+G A+    G+     + SRY++ PEL
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPEL 212
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  ++D+WS GC++A ++ + +P F G    DQLV I KVLGT
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELM-QGQPLFPGESGIDQLVEIIKVLGT 260

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 27/216 (12%)
Query: 245 LIFEHVNNTDFK------QLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI 298
           L+ E+V  T ++      +L QT+    I+ Y+Y+LL++L Y HS+GI HRD+KP N+++
Sbjct: 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL 174
Query: 299 DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL---ADYQYHIEL--------- 346
           D  +  L+LID+G A+    G+     + SRY++ PEL+    +Y  +I++         
Sbjct: 175 DPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAE 234
Query: 347 ----DPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE 402
                P F    G        + + T ++  +     ++++     +  + R   F    
Sbjct: 235 LMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEH----KFPQIRPHPFSKVF 290
Query: 403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                 P+A+D + +LL Y    RLTA EA+ HP+F
Sbjct: 291 RPR-TPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 78/130 (60%), Gaps = 6/130 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ + HS+GI HRD+KP N++++ ++  L+L D+G A+   P +     + SR+++ PEL
Sbjct: 153 AVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPEL 212
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYH 129
           +     Y  S+D+WS+GC+   +I  K P F G  + DQLVRI +++GT        +  
Sbjct: 213 MLGATEYTPSIDLWSIGCVFGELILGK-PLFSGETSIDQLVRIIQIMGTPT-----KEQM 266
Query: 130 IELDPRFADI 139
           I ++P + ++
Sbjct: 267 IRMNPHYTEV 276

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 94/191 (49%), Gaps = 27/191 (14%)
Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRV 326
           I  Y+Y+L +A+ + HS+GI HRD+KP N++++ ++  L+L D+G A+   P +     +
Sbjct: 143 ISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXI 202
Query: 327 ASRYFKGPELL---ADYQYHIEL---DPRFADIL-------GRHSRKRWERFVHTENQHL 373
            SR+++ PEL+    +Y   I+L      F +++       G  S  +  R +    Q +
Sbjct: 203 CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRII----QIM 258
Query: 374 VSPEALDFLDKNILGRHSR------KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL 427
            +P     +  N      R      K W + +      L    A+D L+++LRY+   R+
Sbjct: 259 GTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSL----AIDLLEQILRYEPDLRI 314
Query: 428 TAREAMDHPYF 438
              EAM HP+F
Sbjct: 315 NPYEAMAHPFF 325

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 227
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 275

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 27/203 (13%)
Query: 255 FKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
           + +  QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+
Sbjct: 146 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205
Query: 315 FYHPGQEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHS 358
               G+     + SRY++ PEL+    DY   I++              P F    G   
Sbjct: 206 QLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 265
Query: 359 RKRWERFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFL 415
                + + T  +  +   +P   +F    I        W +           PEA+   
Sbjct: 266 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALC 317
Query: 416 DKLLRYDHYERLTAREAMDHPYF 438
            +LL Y    RLT  EA  H +F
Sbjct: 318 SRLLEYTPTARLTPLEACAHSFF 340

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 146 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 205
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 253

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 129 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 188
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 189 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 248
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 249 KVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 300
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 301 YTPTARLTPLEACAHSFF 318

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 142 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 201
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 202 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 249

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 125 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 184
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 185 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 244
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 245 KVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 296
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 297 YTPTARLTPLEACAHSFF 314

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 153 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 212
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 213 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 260

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 136 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 195
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 196 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 255
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 256 KVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 307
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 308 YTPTARLTPLEACAHSFF 325

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 146 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 205
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 253

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 129 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 188
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 189 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 248
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 249 KVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 300
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 301 YTPTARLTPLEACAHSFF 318

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 241

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 177 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 288
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 289 YTPTARLTPLEACAHSFF 306

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 241

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 177 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 237 KVLGTPTREQIREMNPNYTEFAFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 288
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 289 YTPTARLTPLEACAHSFF 306

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 138 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 197
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 198 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 245

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 121 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 180
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 181 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 240
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 241 KVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 292
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 293 YTPTARLTPLEACAHSFF 310

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 135 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 194
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 195 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 242

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 118 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 177
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 178 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 237
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 238 KVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 289
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 290 YTPTARLTPLEACAHSFF 307

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 241

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 177 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 288
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 289 YTPTARLTPLEACAHSFF 306

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 162 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 221
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 222 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 269

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 145 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 204
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 205 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 264
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 265 KVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 316
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 317 YTPTARLTPLEACAHSFF 334

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 172 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 231
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 232 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 279

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 27/203 (13%)
Query: 255 FKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
           + +  QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+
Sbjct: 150 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 209
Query: 315 FYHPGQEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHS 358
               G+     + SRY++ PEL+    DY   I++              P F    G   
Sbjct: 210 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 269
Query: 359 RKRWERFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFL 415
                + + T  +  +   +P   +F    I        W +           PEA+   
Sbjct: 270 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALC 321
Query: 416 DKLLRYDHYERLTAREAMDHPYF 438
            +LL Y    RLT  EA  H +F
Sbjct: 322 SRLLEYTPTARLTPLEACAHSFF 344

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 241

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 177 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 288
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 289 YTPTARLTPLEACAHSFF 306

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 170 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 229
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 230 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 277

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 27/203 (13%)
Query: 255 FKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
           + +  QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+
Sbjct: 148 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 207
Query: 315 FYHPGQEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHS 358
               G+     + SRY++ PEL+    DY   I++              P F    G   
Sbjct: 208 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 267
Query: 359 RKRWERFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFL 415
                + + T  +  +   +P   +F    I        W +           PEA+   
Sbjct: 268 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALC 319
Query: 416 DKLLRYDHYERLTAREAMDHPYF 438
            +LL Y    RLT  EA  H +F
Sbjct: 320 SRLLEYTPTARLTPLEACAHSFF 342

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 139 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 198
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 199 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 246

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 122 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 181
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 182 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 241
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 242 KVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 293
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 294 YTPTARLTPLEACAHSFF 311

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 227
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 275

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 27/203 (13%)
Query: 255 FKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
           + +  QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+
Sbjct: 146 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205
Query: 315 FYHPGQEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHS 358
               G+     + SRY++ PEL+    DY   I++              P F    G   
Sbjct: 206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 265
Query: 359 RKRWERFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFL 415
                + + T  +  +   +P   +F    I        W +           PEA+   
Sbjct: 266 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALC 317
Query: 416 DKLLRYDHYERLTAREAMDHPYF 438
            +LL Y    RLT  EA  H +F
Sbjct: 318 SRLLEYTPTARLTPLEACAHSFF 340

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 213 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 272
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 273 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 320

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 27/203 (13%)
Query: 255 FKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
           + +  QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+
Sbjct: 191 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 250
Query: 315 FYHPGQEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHS 358
               G+     + SRY++ PEL+    DY   I++              P F    G   
Sbjct: 251 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 310
Query: 359 RKRWERFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFL 415
                + + T  +  +   +P   +F    I        W +           PEA+   
Sbjct: 311 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALC 362
Query: 416 DKLLRYDHYERLTAREAMDHPYF 438
            +LL Y    RLT  EA  H +F
Sbjct: 363 SRLLEYTPTARLTPLEACAHSFF 385

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 74/110 (67%), Gaps = 3/110 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE 68
            L+Y H   I+HRD+KP+N+++D EN  L+L D+GLA+ F  P + Y  +V +R+++ PE
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPE 182
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           LL   +MY   +DMW++GC+LA ++ R  PF  G  + DQL RI + LGT
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDLDQLTRIFETLGT 231

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID 299
           +L+F+ +  TD + + +     LT   I+ Y+   L+ L+Y H   I+HRD+KP+N+++D
Sbjct: 88  SLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD 146
Query: 300 HENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLADYQYH-------------IE 345
            EN  L+L D+GLA+ F  P + Y  +V +R+++ PELL   + +              E
Sbjct: 147 -ENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAE 205
Query: 346 LDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQH 405
           L  R   + G     +  R   T    L +P    + D   L  +    ++ F      H
Sbjct: 206 LLLRVPFLPGDSDLDQLTRIFET----LGTPTEEQWPDMCSLPDYV--TFKSFPGIPLHH 259
Query: 406 LVSPEA---LDFLDKLLRYDHYERLTAREAMDHPYF 438
           + S      LD +  L  ++   R+TA +A+   YF
Sbjct: 260 IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 147 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 206
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 207 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 254

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 130 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 189
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 190 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 249
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 250 KVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 301
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 302 YTPTARLTPLEACAHSFF 319

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 241

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 237 KVLGTPTREQIREMNPNYTEFAFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 288
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 289 YTPTARLTPLEACAHSFF 306

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 241

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 288
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 289 YTPTARLTPLEACAHSFF 306

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGT 241

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L D+G A+    G
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 320 QEYNVRVASRYFKGPELL---ADYQYHIEL-------------DPRFADILGRHSRKRWE 363
           +     + SRY++ PEL+    DY   I++              P F    G        
Sbjct: 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 364 RFVHTENQHLV---SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLR 420
           + + T  +  +   +P   +F    I        W +           PEA+    +LL 
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHP----WTKVFRPRT----PPEAIALCSRLLE 288
Query: 421 YDHYERLTAREAMDHPYF 438
           Y    RLT  EA  H +F
Sbjct: 289 YTPTARLTPLEACAHSFF 306

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 92/162 (56%), Gaps = 3/162 (1%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           S+   +  S+ + HRD+KPHNV+++  +  L+L D+G A+   P +     + SRY++ P
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAP 200
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEELFEYL 125
           EL+   Q Y  ++D+WS+GC+ A M+   EP F G ++  QL  I +VLG  + E+   L
Sbjct: 201 ELIFGNQHYTTAVDIWSVGCIFAEMML-GEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259
Query: 126 DKYHIELDPRFADILGRARVYADVNSHKPREYWDYESYVVDW 167
           +  H ++D   +  +  + V++D +    +E +D  S ++ +
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQY 301

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 26/193 (13%)
Query: 267 IRYYLYELLKALDYCH--SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV 324
           I+ +L++L++++   H  S+ + HRD+KPHNV+++  +  L+L D+G A+   P +    
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 325 RVASRYFKGPELLADYQYHI------ELDPRFADIL-------GRHSRKRWERFVHT--- 368
            + SRY++ PEL+   Q++        +   FA+++       G +S  +    V     
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250
Query: 369 ---ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYE 425
              E    ++P   D    N  G      W   V +++    + EA D L  LL+Y   E
Sbjct: 251 PSREVLRKLNPSHTDVDLYNSKG----IPWSN-VFSDHSLKDAKEAYDLLSALLQYLPEE 305
Query: 426 RLTAREAMDHPYF 438
           R+   EA+ HPYF
Sbjct: 306 RMKPYEALCHPYF 318

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/110 (40%), Positives = 71/110 (64%), Gaps = 2/110 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+  N +L+L D+GLA  F  P + Y+  V + +++ P+
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINR-NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPD 171
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +L   ++Y  S+DMWS GC+ A +     P F G+D  DQL RI ++LGT
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGT 221

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 132/295 (44%), Gaps = 41/295 (13%)
Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXX-----XXXXXXXXXXXXXLENLRGGTN 227
           Y+ + K+G G Y  VF+A N ++ +                          L+ L+   N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KN 62
Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLT-DYD---IRYYLYELLKALDYCHS 283
           I+ L  V+      T  L+FE  +  D K+ + +   D D   ++ +L++LLK L +CHS
Sbjct: 63  IVRLHDVLHSDKKLT--LVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLADYQ- 341
             ++HRD+KP N++I+  N +L+L D+GLA  F  P + Y+  V + +++ P++L   + 
Sbjct: 120 RNVLHRDLKPQNLLINR-NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 342 YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK--NILGRHSRKRWERFV 399
           Y   +D   A  +       +    +         +  D L +   +LG  + ++W    
Sbjct: 179 YSTSIDMWSAGCI-------FAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 400 H------------TENQHLVSPE----ALDFLDKLLRYDHYERLTAREAMDHPYF 438
                        T +   V P+      D L  LL+ +  +R++A EA+ HPYF
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 44/109 (40%), Positives = 75/109 (68%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS GI+HRD+KP NV ++ E+ +LR++D+GLA      +E    VA+R+++ PE+
Sbjct: 143 GLKYIHSAGIIHRDLKPSNVAVN-EDSELRILDFGLAR--QADEEMTGYVATRWYRAPEI 199
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++ + +  F G D  DQL RI +V+GT
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELL-QGKALFPGSDYIDQLKRIMEVVGT 247

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 39/243 (16%)
Query: 220 ENLRGGTNIITLQAVVKD--PVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKA 277
           EN+ G  ++ T    ++D   V     L+   +NN    Q    L+D  +++ +Y+LL+ 
Sbjct: 87  ENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQ---ALSDEHVQFLVYQLLRG 143
Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
           L Y HS GI+HRD+KP NV ++ E+ +LR++D+GLA      +E    VA+R+++ PE++
Sbjct: 144 LKYIHSAGIIHRDLKPSNVAVN-EDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIM 200
Query: 338 ADYQYHIE------LDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
            ++ ++ +      +    A++L   +           KR    V T      SPE L  
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTP-----SPEVL-- 253
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVS------PEALDFLDKLLRYDHYERLTAREAMDH 435
               I   H+R   +       + L S      P A+D L ++L  D  +R++A EA+ H
Sbjct: 254 --AKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAH 311
Query: 436 PYF 438
            YF
Sbjct: 312 AYF 314

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 44/109 (40%), Positives = 75/109 (68%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS GI+HRD+KP NV ++ E+ +LR++D+GLA      +E    VA+R+++ PE+
Sbjct: 143 GLKYIHSAGIIHRDLKPSNVAVN-EDSELRILDFGLAR--QADEEMTGYVATRWYRAPEI 199
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++ + +  F G D  DQL RI +V+GT
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELL-QGKALFPGSDYIDQLKRIMEVVGT 247

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 39/243 (16%)
Query: 220 ENLRGGTNIITLQAVVKD--PVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKA 277
           EN+ G  ++ T    ++D   V     L+   +NN       Q L+D  +++ +Y+LL+ 
Sbjct: 87  ENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNI---VKCQALSDEHVQFLVYQLLRG 143
Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
           L Y HS GI+HRD+KP NV ++ E+ +LR++D+GLA      +E    VA+R+++ PE++
Sbjct: 144 LKYIHSAGIIHRDLKPSNVAVN-EDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIM 200
Query: 338 ADYQYHIE------LDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
            ++ ++ +      +    A++L   +           KR    V T      SPE L  
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTP-----SPEVL-- 253
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVS------PEALDFLDKLLRYDHYERLTAREAMDH 435
               I   H+R   +       + L S      P A+D L ++L  D  +R++A EA+ H
Sbjct: 254 --AKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAH 311
Query: 436 PYF 438
            YF
Sbjct: 312 AYF 314

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 44/110 (40%), Positives = 71/110 (64%), Gaps = 2/110 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+  N +L+L ++GLA  F  P + Y+  V + +++ P+
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +L   ++Y  S+DMWS GC+ A +     P F G+D  DQL RI ++LGT
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 132/295 (44%), Gaps = 41/295 (13%)
Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXX-----XXXXXXXXXXXXXLENLRGGTN 227
           Y+ + K+G G Y  VF+A N ++ +                          L+ L+   N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KN 62
Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLT-DYD---IRYYLYELLKALDYCHS 283
           I+ L  V+      T  L+FE  +  D K+ + +   D D   ++ +L++LLK L +CHS
Sbjct: 63  IVRLHDVLHSDKKLT--LVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLADYQ- 341
             ++HRD+KP N++I+  N +L+L ++GLA  F  P + Y+  V + +++ P++L   + 
Sbjct: 120 RNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 342 YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK--NILGRHSRKRWERFV 399
           Y   +D   A  +       +    +         +  D L +   +LG  + ++W    
Sbjct: 179 YSTSIDMWSAGCI-------FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 400 H------------TENQHLVSPE----ALDFLDKLLRYDHYERLTAREAMDHPYF 438
                        T +   V P+      D L  LL+ +  +R++A EA+ HPYF
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 44/109 (40%), Positives = 75/109 (68%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS GI+HRD+KP NV ++ E+ +LR++D+GLA      +E    VA+R+++ PE+
Sbjct: 135 GLKYIHSAGIIHRDLKPSNVAVN-EDCELRILDFGLAR--QADEEMTGYVATRWYRAPEI 191
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++ + +  F G D  DQL RI +V+GT
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELL-QGKALFPGSDYIDQLKRIMEVVGT 239

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 39/243 (16%)
Query: 220 ENLRGGTNIITLQAVVKD--PVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKA 277
           EN+ G  ++ T    ++D   V     L+   +NN       Q L+D  +++ +Y+LL+ 
Sbjct: 79  ENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNI---VKCQALSDEHVQFLVYQLLRG 135
Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
           L Y HS GI+HRD+KP NV ++ E+ +LR++D+GLA      +E    VA+R+++ PE++
Sbjct: 136 LKYIHSAGIIHRDLKPSNVAVN-EDCELRILDFGLAR--QADEEMTGYVATRWYRAPEIM 192
Query: 338 ADYQYHIE------LDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
            ++ ++ +      +    A++L   +           KR    V T      SPE L  
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTP-----SPEVL-- 245
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVS------PEALDFLDKLLRYDHYERLTAREAMDH 435
               I   H+R   +       + L S      P A+D L ++L  D  +R++A EA+ H
Sbjct: 246 --AKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAH 303
Query: 436 PYF 438
            YF
Sbjct: 304 AYF 306

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 115 GLSFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 224

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 63  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 237
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 238 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 224

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 63  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGX 178
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 237
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 238 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 231

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 70  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 127 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGX 185
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 244
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 245 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 299

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 223

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FEHV+  D K       LT      I+ YL++LL+ L +C
Sbjct: 62  NIVKLLDVIH--TENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 119 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 236
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 237 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 223

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 62  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 119 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 236
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 237 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 231

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 70  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 127 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 185
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 244
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 245 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 299

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 174
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 225

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L
Sbjct: 61  NHPNIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 176
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 235
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 236 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291
Query: 442 VK 443
            K
Sbjct: 292 TK 293

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 224

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 135/299 (45%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 63  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 237
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 238 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 119 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 177
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 228

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 67  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 124 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 182
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 241
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 242 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 296

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 223

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 135/299 (45%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 62  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 119 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 236
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 237 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 224

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 63  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 237
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 238 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 224

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 63  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 237
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 238 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 223

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 62  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 119 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 236
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 237 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 224

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 63  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 237
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 238 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 226

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L
Sbjct: 62  NHPNIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 236
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 237 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292
Query: 442 VK 443
            K
Sbjct: 293 TK 294

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 227

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L
Sbjct: 63  NHPNIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 237
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 238 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 442 VK 443
            K
Sbjct: 294 TK 295

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 226

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L
Sbjct: 62  NHPNIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 236
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 237 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292
Query: 442 VK 443
            K
Sbjct: 293 TK 294

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 227

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 136/302 (45%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FEHV+  D K+      LT      I+ YL++LL+ L
Sbjct: 63  NHPNIVKLLDVIH--TENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 237
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 238 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 442 VK 443
            K
Sbjct: 294 TK 295

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 227

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FE ++  D K       LT      I+ YL++LL+ L
Sbjct: 63  NHPNIVKLLDVIH--TENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 237
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 238 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 442 VK 443
            K
Sbjct: 294 TK 295

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 172
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 223

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 62  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 119 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 236
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 237 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 119 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 177
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 228

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L
Sbjct: 64  NHPNIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 121 AFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 179
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 238
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 239 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 294
Query: 442 VK 443
            K
Sbjct: 295 TK 296

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 224

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 63  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 237
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 238 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 226

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FE ++  D K       LT      I+ YL++LL+ L
Sbjct: 62  NHPNIVKLLDVIH--TENKLYLVFEFLS-MDLKDFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 236
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 237 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292
Query: 442 VK 443
            K
Sbjct: 293 TK 294

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 227

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L
Sbjct: 63  NHPNIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 237
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 238 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 442 VK 443
            K
Sbjct: 294 TK 295

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 224

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 63  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 237
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 238 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 172
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 223

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 35/299 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 62  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 119 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 236
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 237 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 225

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L
Sbjct: 61  NHPNIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 235
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 236 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291
Query: 442 VK 443
            K
Sbjct: 292 TK 293

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 227

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FE ++  D K       LT      I+ YL++LL+ L
Sbjct: 63  NHPNIVKLLDVIH--TENKLYLVFEFLS-MDLKDFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 237
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 238 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 442 VK 443
            K
Sbjct: 294 TK 295

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 224

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 132/294 (44%), Gaps = 35/294 (11%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRGGT 226
           +++Q V K+G G Y  V++A N  + +                         L       
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKALDYC 281
           NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L +C
Sbjct: 63  NIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 237
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F
Sbjct: 238 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 118 GLAFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 227

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L
Sbjct: 63  NHPNIVKLLDVIH--TENKLYLVFEFLS-MDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 237
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 238 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 442 VK 443
            K
Sbjct: 294 TK 295

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 225

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 1   GHMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L
Sbjct: 61  NHPNIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 235
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 236 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291
Query: 442 VK 443
            K
Sbjct: 292 TK 293

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 117 GLAFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 226

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L
Sbjct: 62  NHPNIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 119 AFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 236
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 237 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292
Query: 442 VK 443
            K
Sbjct: 293 TK 294

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 116 GLAFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 225

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L
Sbjct: 61  NHPNIVKLLDVIH--TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 118 AFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 235
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 236 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291
Query: 442 VK 443
            K
Sbjct: 292 TK 293

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 116 GLAFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 225

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 35/302 (11%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLR 223
           G  +++Q V K+G G Y  V++A N  + +                         L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYD---IRYYLYELLKAL 278
              NI+ L  V+         L+FE ++  D K+      LT      I+ YL++LL+ L
Sbjct: 61  NHPNIVKLLDVIH--TENKLYLVFEFLS-MDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 118 AFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 338 ADYQYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDF 381
              +Y+        L   FA+++ R +            R  R + T ++ +V P     
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSM 235
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            D     + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  +
Sbjct: 236 PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291
Query: 442 VK 443
            K
Sbjct: 292 TK 293

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 69/112 (61%), Gaps = 3/112 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE
Sbjct: 115 GLAFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPD 224

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 130/299 (43%), Gaps = 31/299 (10%)
Query: 169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX----XXXXXXXXXXXXXXXLENLRG 224
             +++Q V K+G G Y  V++A N  + +                         L     
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
             NI+ L  V+           F H +  DF      LT      I+ YL++LL+ L +C
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMD-ASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L   
Sbjct: 120 HSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 341 QYHI------ELDPRFADILGRHS----------RKRWERFVHTENQHLVSPEALDFLDK 384
           +Y+        L   FA+++ R +            R  R + T ++ +V P      D 
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE-VVWPGVTSMPDY 237
Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
               + S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 238 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 80/148 (54%), Gaps = 16/148 (10%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE 68
            + +CHS  I+HRD+KP N+++  ++  ++L D+G A     PG+ Y+  VA+R+++ PE
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY 128
           LL     Y  ++D+W++GC++  M F  EP F G  + DQL  I   LG           
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHIMMCLGN---------- 243
Query: 129 HIELDPRFADILGRARVYADVNSHKPRE 156
              L PR  ++  +  V+A V   + +E
Sbjct: 244 ---LIPRHQELFNKNPVFAGVRLPEIKE 268

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 76/126 (60%), Gaps = 8/126 (6%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT--DFKQLYQTLTDYDI-RYYLYELLKALDYCHS 283
           N++ L  V K    +   L+FE V++T  D  +L+    DY + + YL++++  + +CHS
Sbjct: 85  NLVNLLEVCKK--KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELL-ADYQ 341
             I+HRD+KP N+++  ++  ++L D+G A     PG+ Y+  VA+R+++ PELL  D +
Sbjct: 143 HNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 342 YHIELD 347
           Y   +D
Sbjct: 202 YGKAVD 207

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 41/110 (37%), Positives = 70/110 (63%), Gaps = 3/110 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE 68
            + YCH   ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   V + +++ P+
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPD 170
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +L   + Y  ++D+WS+GC+ A M+    P F G    DQL+RI ++LGT
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGT 219

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 113/235 (48%), Gaps = 32/235 (13%)
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKALDYC 281
           +NI+ L  V+     +   L+FEH++  D K+L       L     + +L +LL  + YC
Sbjct: 60  SNIVKLYDVIH--TKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE-LLAD 339
           H   ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   V + +++ P+ L+  
Sbjct: 117 HDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 340 YQYHIELD---------------PRFADILGRHSRKRWERFVHTEN-QHLVSPEALDFLD 383
            +Y   +D               P F  +       R  R + T N ++  +   L   D
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 384 KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            N    +    WE F+   ++       +D L K+L+ D  +R+TA++A++H YF
Sbjct: 236 PN-FTVYEPLPWESFLKGLDE-----SGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 41/110 (37%), Positives = 70/110 (63%), Gaps = 3/110 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE 68
            + YCH   ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   V + +++ P+
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPD 170
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +L   + Y  ++D+WS+GC+ A M+    P F G    DQL+RI ++LGT
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMV-NGAPLFPGVSEADQLMRIFRILGT 219

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 113/235 (48%), Gaps = 32/235 (13%)
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKALDYC 281
           +NI+ L  V+     +   L+FEH++  D K+L       L     + +L +LL  + YC
Sbjct: 60  SNIVKLYDVIH--TKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE-LLAD 339
           H   ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   V + +++ P+ L+  
Sbjct: 117 HDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 340 YQYHIELD---------------PRFADILGRHSRKRWERFVHTEN-QHLVSPEALDFLD 383
            +Y   +D               P F  +       R  R + T N ++  +   L   D
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 384 KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            N    +    WE F+   ++       +D L K+L+ D  +R+TA++A++H YF
Sbjct: 236 PN-FTVYEPLPWESFLKGLDE-----SGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 42/109 (38%), Positives = 70/109 (64%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS G++HRD+KP N+ ++ E+ +L+++D+GLA   H   E    V +R+++ PE+
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVN-EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEV 194
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +  +  Y+ ++D+WS+GC++A M+  K   F G D  DQL +I KV G 
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQILKVTGV 242

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 108/204 (52%), Gaps = 19/204 (9%)
Query: 252 NTDFKQLYQ-TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
            TD +++     ++  I+Y +Y++LK L Y HS G++HRD+KP N+ ++ E+ +L+++D+
Sbjct: 112 QTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN-EDCELKILDF 170
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRHSRKRWER 364
           GLA   H   E    V +R+++ PE++  + ++ +      +    A++L   +  + + 
Sbjct: 171 GLAR--HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228
Query: 365 FVHTENQHL--VSPEALDFLDKNILGRHSRKRWERFVHTENQHLV------SPEALDFLD 416
           ++    Q L        +F+ K +  + ++   +    T  +         SP+A D L+
Sbjct: 229 YLDQLTQILKVTGVPGTEFVQK-LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLE 287
Query: 417 KLLRYDHYERLTAREAMDHPYFYP 440
           K+L  D  +RLTA +A+ HP+F P
Sbjct: 288 KMLELDVDKRLTAAQALTHPFFEP 311

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 40/110 (36%), Positives = 70/110 (63%), Gaps = 3/110 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE 68
            + YCH   ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   + + +++ P+
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +L   + Y  ++D+WS+GC+ A M+    P F G    DQL+RI ++LGT
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGT 219

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 113/235 (48%), Gaps = 32/235 (13%)
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKALDYC 281
           +NI+ L  V+     +   L+FEH++  D K+L       L     + +L +LL  + YC
Sbjct: 60  SNIVKLYDVIH--TKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE-LLAD 339
           H   ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   + + +++ P+ L+  
Sbjct: 117 HDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 340 YQYHIELD---------------PRFADILGRHSRKRWERFVHTEN-QHLVSPEALDFLD 383
            +Y   +D               P F  +       R  R + T N ++  +   L   D
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 384 KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            N    +    WE F+   ++       +D L K+L+ D  +R+TA++A++H YF
Sbjct: 236 PN-FTVYEPLPWESFLKGLDE-----SGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 42/109 (38%), Positives = 70/109 (64%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS G++HRD+KP N+ ++ E+ +L+++D+GLA   H   E    V +R+++ PE+
Sbjct: 156 GLKYIHSAGVVHRDLKPGNLAVN-EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEV 212
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +  +  Y+ ++D+WS+GC++A M+  K   F G D  DQL +I KV G 
Sbjct: 213 ILSWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQILKVTGV 260

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 108/204 (52%), Gaps = 19/204 (9%)
Query: 252 NTDFKQLY-QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
            TD +++     ++  I+Y +Y++LK L Y HS G++HRD+KP N+ ++ E+ +L+++D+
Sbjct: 130 QTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN-EDCELKILDF 188
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRHSRKRWER 364
           GLA   H   E    V +R+++ PE++  + ++ +      +    A++L   +  + + 
Sbjct: 189 GLAR--HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246
Query: 365 FVHTENQHL--VSPEALDFLDKNILGRHSRKRWERFVHTENQHLV------SPEALDFLD 416
           ++    Q L        +F+ K +  + ++   +    T  +         SP+A D L+
Sbjct: 247 YLDQLTQILKVTGVPGTEFVQK-LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLE 305
Query: 417 KLLRYDHYERLTAREAMDHPYFYP 440
           K+L  D  +RLTA +A+ HP+F P
Sbjct: 306 KMLELDVDKRLTAAQALTHPFFEP 329

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 43/109 (39%), Positives = 70/109 (64%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y H+ GI+HRD+KP N+ ++ E+ +L+++D+GLA       E    V +R+++ PE+
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--QADSEMXGXVVTRWYRAPEV 196
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y  ++D+WS+GC++A MI  K   F G D+ DQL  I KV GT
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKT-LFKGSDHLDQLKEIMKVTGT 244

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 106/209 (50%), Gaps = 32/209 (15%)
Query: 252 NTDFKQL--YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLID 309
            TD  +L  ++ L +  I++ +Y++LK L Y H+ GI+HRD+KP N+ + +E+ +L+++D
Sbjct: 113 GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV-NEDCELKILD 171
Query: 310 WGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADIL-------GR 356
           +GLA       E    V +R+++ PE++ ++  + +      +    A+++       G 
Sbjct: 172 FGLAR--QADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229
Query: 357 HSRKRWERFVHTEN-------QHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSP 409
               + +  +           Q L S EA +++    L    +K +   +        SP
Sbjct: 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG--LPELEKKDFASILTN-----ASP 282
Query: 410 EALDFLDKLLRYDHYERLTAREAMDHPYF 438
            A++ L+K+L  D  +R+TA EA+ HPYF
Sbjct: 283 LAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 128/307 (41%), Gaps = 56/307 (18%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGG-- 225
           G  + YQ + K+G G Y  V++A + Q                          +L     
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 226 -TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDY 280
             NI++L  V+     R   L+FE +   D K++       L D  I+ YLY+LL+ + +
Sbjct: 78  HPNIVSLIDVIHS--ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE-LLA 338
           CH   I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++ P+ L+ 
Sbjct: 135 CHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 339 DYQYHIELD---------------------------PRFADILGRHSRKRWERFVHTENQ 371
             +Y   +D                           P+   ILG  + + W +       
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV------ 247
Query: 372 HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTARE 431
                + L    +       +K W   +    Q     E +D L  +L +D  +R++AR+
Sbjct: 248 -----QELPLWKQRTFQVFEKKPWSSIIPGFCQ-----EGIDLLSNMLCFDPNKRISARD 297
Query: 432 AMDHPYF 438
           AM+HPYF
Sbjct: 298 AMNHPYF 304

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 128/307 (41%), Gaps = 56/307 (18%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGG-- 225
           G  + YQ + K+G G Y  V++A + Q                          +L     
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 226 -TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDY 280
             NI++L  V+     R   L+FE +   D K++       L D  I+ YLY+LL+ + +
Sbjct: 78  HPNIVSLIDVIHS--ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE-LLA 338
           CH   I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++ P+ L+ 
Sbjct: 135 CHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 339 DYQYHIELD---------------------------PRFADILGRHSRKRWERFVHTENQ 371
             +Y   +D                           P+   ILG  + + W +       
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV------ 247
Query: 372 HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTARE 431
                + L    +       +K W   +    Q     E +D L  +L +D  +R++AR+
Sbjct: 248 -----QELPLWKQRTFQVFEKKPWSSIIPGFCQ-----EGIDLLSNMLCFDPNKRISARD 297
Query: 432 AMDHPYF 438
           AM+HPYF
Sbjct: 298 AMNHPYF 304

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTADEMTGYVATRWYRAPEI 200
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 248

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 169
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 170 ELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 225
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 226 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 283
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 284 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTADEMTGYVATRWYRAPEI 200
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 248

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 169
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 170 ELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 225
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 226 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 283
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 284 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTADEMTGYVATRWYRAPEI 200
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 248

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 169
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 170 ELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 225
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 226 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 283
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 284 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVN-EDSELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 195
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 243

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDS 164
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 165 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 220
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 221 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 278
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 279 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDX 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVN-EDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 198
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 246

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDX 167
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 168 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 223
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 224 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 281
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 282 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVN-EDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 198
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 246

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDX 167
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 168 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 223
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 224 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 281
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 282 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVN-EDSELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 199
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 247

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDS 168
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 169 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 224
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 225 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 282
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 283 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGXVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDFGLAR--HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 42/110 (38%), Positives = 68/110 (61%), Gaps = 3/110 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE 68
            L +CH   I+HRD+KP N++I+    +L+L D+GLA  F  P   ++  V + +++ P+
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +L   + Y  S+D+WS GC+LA MI  K P F G ++ +QL  I  ++GT
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIMGT 227

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 130/297 (43%), Gaps = 37/297 (12%)
Query: 173 YQLVRKLGRGKYSEVFEAIN----VQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNI 228
           ++ + KLG G Y+ V++ +N    V  +                      ++ L+   NI
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH-ENI 65
Query: 229 ITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD---------IRYYLYELLKALD 279
           + L  V+      T  L+FE ++N D K+   + T  +         ++Y+ ++LL+ L 
Sbjct: 66  VRLYDVIHTENKLT--LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE-LL 337
           +CH   I+HRD+KP N++I+    +L+L D+GLA  F  P   ++  V + +++ P+ L+
Sbjct: 123 FCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM 181
Query: 338 ADYQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHL-VSPEALDF 381
               Y   +D               P F         K     + T N+ L  S   L  
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241
Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            + NI  R  R    + +    +  +    +DFL  LL+ +   RL+A++A+ HP+F
Sbjct: 242 YNPNIQQRPPRD-LRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVN-EDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 204
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 252

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 115 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDX 173
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 174 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 229
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 230 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 287
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 288 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDYGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDYGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 195
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 243

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 164
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 165 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 220
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 221 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 278
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 279 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 198
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 246

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 167
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 168 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 223
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 224 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 281
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 282 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 136 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 192
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 193 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 240

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 103 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 161
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 162 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 217
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 218 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 275
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 276 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 307

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLAQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 147 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 203
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 204 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 251

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 114 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 172
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 173 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 228
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 229 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLAQMPKMNFANVFIG 286
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 287 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 318

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 200
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 248

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 169
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 170 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 225
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 226 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 283
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 284 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 205
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 253

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 116 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 174
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 175 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 230
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 231 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 288
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 289 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 205
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 253

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 116 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 174
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 175 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 230
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 231 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 288
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 289 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 190
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 238

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 101 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 159
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 160 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 215
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 216 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 273
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 274 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 195
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 243

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 164
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 165 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 220
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 221 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 278
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 279 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 205
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 253

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 116 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 174
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 175 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 230
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 231 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 288
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 289 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 189
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 237

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 158
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 159 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 214
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 215 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 272
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 198
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 246

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 167
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 168 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 223
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 224 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 281
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 282 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 195
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 243

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 164
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 165 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 220
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 221 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 278
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 279 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 190
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 238

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 101 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 159
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 160 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 215
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 216 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 273
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 274 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 135 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 191
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 239

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 102 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 160
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 161 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 216
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 217 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 274
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 275 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 306

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 189
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 237

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   + +   LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 100 LVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 158
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 159 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 214
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 215 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLAQMPKMNFANVFIG 272
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 199
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 247

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 168
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 169 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 224
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 225 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 282
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 283 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 189
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 237

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 158
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 159 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 214
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 215 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLAQMPKMNFANVFIG 272
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 199
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 247

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 168
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 169 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 224
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 225 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 282
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 283 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 204
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 252

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 115 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 173
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 174 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 229
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 230 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 287
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 288 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 212
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 260

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 123 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 181
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 182 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 237
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 238 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 295
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 296 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMXGXVATRWYRAPEI 213
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 261

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 124 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 182
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 183 ELKILDFGLAR--HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 238
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 239 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLAQMPKMNFANVFIG 296
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 297 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 216
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 264

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 127 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 185
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 186 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 241
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 242 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 299
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 300 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 212
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 260

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 123 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 181
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 182 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 237
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 238 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLAQMPKMNFANVFIG 295
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 296 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 213
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 261

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 124 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 182
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 183 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 238
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 239 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 296
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 297 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 199
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 247

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 168
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 169 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 224
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 225 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLAQMPKMNFANVFIG 282
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 283 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 213
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 261

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 124 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 182
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 183 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 238
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 239 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLAQMPKMNFANVFIG 296
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 297 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMXGYVATRWYRAPEI 216
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 264

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 127 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 185
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 186 ELKILDFGLAR--HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 241
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 242 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 299
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 300 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 72/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GL    H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDSELKILDFGLCR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDS 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GL    H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDFGLCR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLAQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 166 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 222
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ +QL +I ++ GT
Sbjct: 223 MLNWMHYNMTVDIWSVGCIMAELLTGRT-LFPGTDHINQLQQIMRLTGT 270

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 87/325 (26%), Positives = 147/325 (45%), Gaps = 54/325 (16%)
Query: 151 SHKPR-EYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXX 209
           SHK R  ++  E     W   + YQ +  +G G Y  V  + +V+S              
Sbjct: 30  SHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQ 89
Query: 210 XXXXXXXXXLENLR-----GGTNIITLQAVVKDPVSRTPALIFE---------HVNNTDF 255
                     E LR        N+I L  V       TPA   E         H+   D 
Sbjct: 90  SIIHAKRTYRE-LRLLKHMKHENVIGLLDVF------TPATSLEEFNDVYLVTHLMGADL 142
Query: 256 KQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
             +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA
Sbjct: 143 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLA 201
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQ-YHIELD-----PRFADIL-GR---------H 357
              H   E    VA+R+++ PE++ ++  Y++ +D        A++L GR         +
Sbjct: 202 R--HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHIN 259
Query: 358 SRKRWERFVHTENQHLVSP----EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALD 413
             ++  R   T    ++S     EA +++  N L +  ++ +       N     P A+D
Sbjct: 260 QLQQIMRLTGTPPASVISRMPSHEARNYI--NSLPQMPKRNFADVFIGAN-----PLAVD 312
Query: 414 FLDKLLRYDHYERLTAREAMDHPYF 438
            L+K+L  D  +R+TA EA+ HPYF
Sbjct: 313 LLEKMLVLDTDKRITASEALAHPYF 337

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 73/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEI 189
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 237

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 158
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 159 ELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 214
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 215 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLAQMPKMNFANVFIG 272
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/328 (24%), Positives = 149/328 (45%), Gaps = 70/328 (21%)
Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDXXXXXX-----XXXXXXXXXXXXXXXLENLRGGTN 227
           Y+LV+KLG+G Y  V+++I+ ++ +                          L  L G  N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCHSMG 285
           I+ L  V++    R   L+F+++  TD   + +   L     +Y +Y+L+K + Y HS G
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 286 IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR-------------------- 325
           ++HRD+KP N++++ E   +++ D+GL+  +      N+R                    
Sbjct: 130 LLHRDMKPSNILLNAECH-VKVADFGLSRSF-----VNIRRVTNNIPLSINENTENFDDD 183
Query: 326 -------VASRYFKGPELL---ADYQYHIE---LDPRFADIL-------GRHSRKRWERF 365
                  VA+R+++ PE+L     Y   I+   L     +IL       G  +  + ER 
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 366 V-------HTENQHLVSPEA---LDFLDKNILGRHSRKR-----WERFVHTENQHL-VSP 409
           +       + + + + SP A   ++ L + +  R S KR     W+  +   N     + 
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 410 EALDFLDKLLRYDHYERLTAREAMDHPY 437
           EALD LDKLL+++  +R++A +A+ HP+
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPF 331

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 72/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDGGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDGGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 72/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + +   Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNAMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+GLA   H   E    VA+R+++ PE++ +  ++ +      +    A++L   
Sbjct: 163 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 72/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDAGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDAGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 72/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDRGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDRGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 64/108 (59%), Gaps = 3/108 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           L     Y   +D+WS+GC+ A M FR++P F G  + DQL +I  V+G
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIG 236

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 133/336 (39%), Gaps = 68/336 (20%)
Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLR--------G 224
           Y+ V ++G G Y +VF+A ++++                       +  +          
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 225 GTNIITLQAVVKDPVSRTP-----ALIFEHVNNTDFKQLYQTLTDY------------DI 267
             N++ L  V    VSRT       L+FEHV+        Q LT Y             I
Sbjct: 73  HPNVVRLFDVCT--VSRTDRETKLTLVFEHVD--------QDLTTYLDKVPEPGVPTETI 122
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           +  +++LL+ LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V 
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQMALTSVVV 181
Query: 328 SRYFKGPELLADYQYHIELD-----PRFADILGRHSRKRWERFVHTENQHLVSPEALDFL 382
           + +++ PE+L    Y   +D       FA++  R    R    V    + L         
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL--------- 232
Query: 383 DKNILGRHSRKRWERFVHTENQHLVSPEAL--------------DFLDKLLRYDHYERLT 428
             +++G    + W R V    Q   S  A               D L K L ++  +R++
Sbjct: 233 --DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290
Query: 429 AREAMDHPYFYPI--VKDQSRHTLPSSSPTPIVNSV 462
           A  A+ HPYF  +   K+     LP S  T  +N+ 
Sbjct: 291 AYSALSHPYFQDLERCKENLDSHLPPSQNTSELNTA 326

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 64/108 (59%), Gaps = 3/108 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           L     Y   +D+WS+GC+ A M FR++P F G  + DQL +I  V+G
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIG 236

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 123/310 (39%), Gaps = 66/310 (21%)
Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLR--------G 224
           Y+ V ++G G Y +VF+A ++++                       +  +          
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 225 GTNIITLQAVVKDPVSRTP-----ALIFEHVNNTDFKQLYQTLTDY------------DI 267
             N++ L  V    VSRT       L+FEHV+        Q LT Y             I
Sbjct: 73  HPNVVRLFDVCT--VSRTDRETKLTLVFEHVD--------QDLTTYLDKVPEPGVPTETI 122
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           +  +++LL+ LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V 
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQMALTSVVV 181
Query: 328 SRYFKGPELLADYQYHIELD-----PRFADILGRHSRKRWERFVHTENQHLVSPEALDFL 382
           + +++ PE+L    Y   +D       FA++  R    R    V    + L         
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL--------- 232
Query: 383 DKNILGRHSRKRWERFVHTENQHLVSPEAL--------------DFLDKLLRYDHYERLT 428
             +++G    + W R V    Q   S  A               D L K L ++  +R++
Sbjct: 233 --DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290
Query: 429 AREAMDHPYF 438
           A  A+ HPYF
Sbjct: 291 AYSALSHPYF 300

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 64/108 (59%), Gaps = 3/108 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           L     Y   +D+WS+GC+ A M FR++P F G  + DQL +I  V+G
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIG 236

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 123/310 (39%), Gaps = 66/310 (21%)
Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLR--------G 224
           Y+ V ++G G Y +VF+A ++++                       +  +          
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 225 GTNIITLQAVVKDPVSRTP-----ALIFEHVNNTDFKQLYQTLTDY------------DI 267
             N++ L  V    VSRT       L+FEHV+        Q LT Y             I
Sbjct: 73  HPNVVRLFDVCT--VSRTDRETKLTLVFEHVD--------QDLTTYLDKVPEPGVPTETI 122
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           +  +++LL+ LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V 
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQMALTSVVV 181
Query: 328 SRYFKGPELLADYQYHIELD-----PRFADILGRHSRKRWERFVHTENQHLVSPEALDFL 382
           + +++ PE+L    Y   +D       FA++  R    R    V    + L         
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL--------- 232
Query: 383 DKNILGRHSRKRWERFVHTENQHLVSPEAL--------------DFLDKLLRYDHYERLT 428
             +++G    + W R V    Q   S  A               D L K L ++  +R++
Sbjct: 233 --DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290
Query: 429 AREAMDHPYF 438
           A  A+ HPYF
Sbjct: 291 AYSALSHPYF 300

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++I+     L++ D+GLA    P  ++       VA+R+++
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLIN-TTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYR 214
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 266

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 109/219 (49%), Gaps = 34/219 (15%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           I + +  TD  +L   Q L++  I Y+LY++L+ L Y HS  ++HRD+KP N++I+    
Sbjct: 123 IVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLIN-TTC 181
Query: 304 KLRLIDWGLAEFYHPGQEYNV----RVASRYFKGPELLADYQYHIE------LDPRFADI 353
            L++ D+GLA    P  ++       VA+R+++ PE++ + + + +      +    A++
Sbjct: 182 DLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 241
Query: 354 L-------GRHSRKRWERFV-------HTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
           L       G+H   +    +         +   +++ +A ++L    L   ++  W +  
Sbjct: 242 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQS--LPSKTKVAWAKLF 299
Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
              +      +ALD LD++L ++  +R+T  EA+ HPY 
Sbjct: 300 PKSDS-----KALDLLDRMLTFNPNKRITVEEALAHPYL 333

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 72/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++ +GLA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILGFGLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++ +GLA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILGFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 123/252 (48%), Gaps = 35/252 (13%)
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQ----LYQTLTDYDIRYYLYELLKALDYC 281
            NI+TL  ++    S T  L+FE+++  D KQ        +  ++++ +L++LL+ L YC
Sbjct: 60  ANIVTLHDIIHTEKSLT--LVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE-LLAD 339
           H   ++HRD+KP N++I+ E  +L+L D+GLA     P + Y+  V + +++ P+ LL  
Sbjct: 117 HRQKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 340 YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
             Y  ++D      +          F  +  +     E L F+ + ILG  + + W   +
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-----EQLHFIFR-ILGTPTEETWPGIL 229
Query: 400 HTEN-----------QHLVS------PEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV 442
             E            + L+S       +  D L KLL+++   R++A +AM HP+F  + 
Sbjct: 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL- 288
Query: 443 KDQSRHTLPSSS 454
             +  H LP ++
Sbjct: 289 -GERIHKLPDTT 299

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 89/180 (49%), Gaps = 30/180 (16%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE--FYHPGQ------EYNVRVAS 61
            L Y HS  ++HRD+KP N++++ EN +L++ D+G+A      P +      EY   VA+
Sbjct: 171 GLKYMHSAQVIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEY---VAT 226
Query: 62  RYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
           R+++ PEL+     Y  ++D+WS+GC+   M+ R++  F G +   QL  I  VLGT   
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ-LFPGKNYVHQLQLIMMVLGTP-- 283
Query: 122 FEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGR 181
                       P     +G  RV A + S  PR+   +E+         D Q +  LGR
Sbjct: 284 -----------SPAVIQAVGAERVRAYIQSLPPRQPVPWETVY----PGADRQALSLLGR 328

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 35/205 (17%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE--FYH 317
           Q LT   +RY+LY+LL+ L Y HS  ++HRD+KP N++++ EN +L++ D+G+A      
Sbjct: 154 QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTS 212
Query: 318 PGQ------EYNVRVASRYFKGPEL---LADYQYHIEL---DPRFADILGRHSRKRWERF 365
           P +      EY   VA+R+++ PEL   L +Y   I+L      F ++L R      + +
Sbjct: 213 PAEHQYFMTEY---VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY 269
Query: 366 VH----------TENQHLVSPEALDFLDKNILGRHSRK--RWERFVHTENQHLVSPEALD 413
           VH          T +  ++     + +   I     R+   WE      ++     +AL 
Sbjct: 270 VHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADR-----QALS 324
Query: 414 FLDKLLRYDHYERLTAREAMDHPYF 438
            L ++LR++   R++A  A+ HP+ 
Sbjct: 325 LLGRMLRFEPSARISAAAALRHPFL 349

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 41/115 (35%), Positives = 69/115 (60%), Gaps = 6/115 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN----VRVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 192
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+ E
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPE 246

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 116/238 (48%), Gaps = 32/238 (13%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 140 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 339 D---YQYHIEL---DPRFADILGRHSRKRWERFVHTENQ---HLVSPEALDF-LDKNILG 388
           +   Y   I++       A++L        + ++   N     L SPE  D     N+  
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKA 258
Query: 389 RH--------SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           R+        ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 259 RNYLLSLPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 89/180 (49%), Gaps = 30/180 (16%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE--FYHPGQ------EYNVRVAS 61
            L Y HS  ++HRD+KP N++++ EN +L++ D+G+A      P +      EY   VA+
Sbjct: 170 GLKYMHSAQVIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEY---VAT 225
Query: 62  RYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
           R+++ PEL+     Y  ++D+WS+GC+   M+ R++  F G +   QL  I  VLGT   
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ-LFPGKNYVHQLQLIMMVLGTP-- 282
Query: 122 FEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGR 181
                       P     +G  RV A + S  PR+   +E+         D Q +  LGR
Sbjct: 283 -----------SPAVIQAVGAERVRAYIQSLPPRQPVPWETVY----PGADRQALSLLGR 327

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 35/205 (17%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE--FYH 317
           Q LT   +RY+LY+LL+ L Y HS  ++HRD+KP N++++ EN +L++ D+G+A      
Sbjct: 153 QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTS 211
Query: 318 PGQ------EYNVRVASRYFKGPEL---LADYQYHIEL---DPRFADILGRHSRKRWERF 365
           P +      EY   VA+R+++ PEL   L +Y   I+L      F ++L R      + +
Sbjct: 212 PAEHQYFMTEY---VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY 268
Query: 366 VH----------TENQHLVSPEALDFLDKNILGRHSRK--RWERFVHTENQHLVSPEALD 413
           VH          T +  ++     + +   I     R+   WE      ++     +AL 
Sbjct: 269 VHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADR-----QALS 323
Query: 414 FLDKLLRYDHYERLTAREAMDHPYF 438
            L ++LR++   R++A  A+ HP+ 
Sbjct: 324 LLGRMLRFEPSARISAAAALRHPFL 348

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 72/109 (66%), Gaps = 4/109 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+ LA   H   E    VA+R+++ PE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFYLAR--HTDDEMTGYVATRWYRAPEI 193
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGT 241

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 246 IFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           +  H+   D   +   Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 162
Query: 304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE------LDPRFADILGRH 357
           +L+++D+ LA   H   E    VA+R+++ PE++ ++ ++ +      +    A++L   
Sbjct: 163 ELKILDFYLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-- 218
Query: 358 SRKRWERFVHTENQHLV-----SPEALDFLDKNILGRHSRKRWERFVHTENQHL------ 406
            R  +    H +   L+     +P A   L K I    +R   +        +       
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +P A+D L+K+L  D  +R+TA +A+ H YF
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN----VRVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 246

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 142 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 261 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLN-TTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 248

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 32/238 (13%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 144 SANVLHRDLKPSNLLLN-TTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 339 D---YQYHIEL---DPRFADILGRHSRKRWERFVHTENQ---HLVSPEALDF-LDKNILG 388
           +   Y   I++       A++L        + ++   N     L SP   D     N+  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKA 262
Query: 389 RH--------SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           R+        ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 250

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 146 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 265 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYR 198
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 250

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN----VRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 146 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 265 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYR 199
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 251

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN----VRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 147 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 266 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 318

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN----VRVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 246

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 142 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 261 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN----VRVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 250

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 146 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 265 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 214
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 266

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 117/240 (48%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         +  H+   D  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 161
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 162 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 281 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 333

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN----VRVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLN-TTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 246

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 142 SANVLHRDLKPSNLLLN-TTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 261 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 64/108 (59%), Gaps = 3/108 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y      +  V + +++ PE+
Sbjct: 124 GLDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEV 182
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           L     Y   +DMWS+GC+ A M FR++P F G+   DQL +I  ++G
Sbjct: 183 LLQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 228

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 31/217 (14%)
Query: 244 ALIFEHVNNTDF-----KQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI 298
            L+FEHV+  D      K     L    I+  + + L+ LD+ H+  I+HRD+KP N+++
Sbjct: 87  TLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 145
Query: 299 DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHS 358
                 ++L D+GLA  Y      +  V + +++ PE+L    Y   +D      +    
Sbjct: 146 T-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204
Query: 359 RKRWERFVHTENQHLVSPEALDFLDK--NILGRHSRKRWERFVHTENQHL---------- 406
            +R   F              D L K  +++G      W R V                 
Sbjct: 205 FRRKPLFCGNSEA--------DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQS 256
Query: 407 VSPE----ALDFLDKLLRYDHYERLTAREAMDHPYFY 439
           V PE        L ++L ++ ++R++A  A+ H Y +
Sbjct: 257 VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 293

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN----VRVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 246

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 142 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 261 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 199
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 251

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 147 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 266 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 318

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN----VRVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 248

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 144 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 263 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 142 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 200
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 201 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 252

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 88  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 147
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 148 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 266
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 267 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 319

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 133 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 191
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 192 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 243

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 79  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 138
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 139 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 257
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 258 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 310

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 250

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 146 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 265 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN----VRVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 250

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 146 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 265 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 63/108 (58%), Gaps = 3/108 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+
Sbjct: 132 GLDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEV 190
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           L     Y   +DMWS+GC+ A M FR++P F G+   DQL +I  ++G
Sbjct: 191 LLQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 236

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 31/217 (14%)
Query: 244 ALIFEHVNNTDF-----KQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI 298
            L+FEHV+  D      K     L    I+  + + L+ LD+ H+  I+HRD+KP N+++
Sbjct: 95  TLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 153
Query: 299 DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHS 358
                 ++L D+GLA  Y         V + +++ PE+L    Y   +D      +    
Sbjct: 154 T-SGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212
Query: 359 RKRWERFVHTENQHLVSPEALDFLDK--NILGRHSRKRWERFVHTENQHL---------- 406
            +R   F              D L K  +++G      W R V                 
Sbjct: 213 FRRKPLFCGNSEA--------DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQS 264
Query: 407 VSPE----ALDFLDKLLRYDHYERLTAREAMDHPYFY 439
           V PE        L ++L ++ ++R++A  A+ H Y +
Sbjct: 265 VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 192
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 244

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 140 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 258
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 259 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 144 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 202
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 203 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 254

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 149
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 150 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 268
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 269 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 321

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 246

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 142 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 261 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 248

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 144 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 263 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 214
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 266

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 118/240 (49%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L +T  L++  I Y+LY++L+ L Y H
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 161
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 162 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 281 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 333

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 250

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 117/240 (48%), Gaps = 36/240 (15%)
Query: 227 NIITLQAVVKDPV--SRTPALIFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P         I + +  TD  +L   Q L++  I Y+LY++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH 145
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 146 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 339 D---YQYHIEL---DPRFADIL-------GRHSRKRWERFV-------HTENQHLVSPEA 378
           +   Y   I++       A++L       G+H   +    +         +   +++ +A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            ++L    L   ++  W R     +      +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 265 RNYLLS--LPHKNKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 63/108 (58%), Gaps = 3/108 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+
Sbjct: 124 GLDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEV 182
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           L     Y   +DMWS+GC+ A M FR++P F G+   DQL +I  ++G
Sbjct: 183 LLQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 228

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 31/217 (14%)
Query: 244 ALIFEHVNNTDF-----KQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI 298
            L+FEHV+  D      K     L    I+  + + L+ LD+ H+  I+HRD+KP N+++
Sbjct: 87  TLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 145
Query: 299 DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHS 358
                 ++L D+GLA  Y         V + +++ PE+L    Y   +D      +    
Sbjct: 146 T-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204
Query: 359 RKRWERFVHTENQHLVSPEALDFLDK--NILGRHSRKRWERFVHTENQHL---------- 406
            +R   F              D L K  +++G      W R V                 
Sbjct: 205 FRRKPLFCGNSEA--------DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQS 256
Query: 407 VSPE----ALDFLDKLLRYDHYERLTAREAMDHPYFY 439
           V PE        L ++L ++ ++R++A  A+ H Y +
Sbjct: 257 VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 293

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMID----HENRKLRLIDWGLAE-FYHPGQEYNVRVASRYF 64
            +++CHS   +HRD+KP N+++      E   L++ D+GLA  F  P +++   + + ++
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           + PE+L   + Y  S+D+WS+ C+ A M+  K P F G    DQL +I +VLG
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPLFPGDSEIDQLFKIFEVLG 255

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 18/191 (9%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXX-----XXXXXXXXXXXXXXXLENLRGG 225
           D Y+ + KLG G Y EV++AI+  +++                          L+ L+  
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH- 92
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRY---YLYELLKALDYCH 282
            NII L++V+    +    LIFE+  N D K+      D  +R    +LY+L+  +++CH
Sbjct: 93  RNIIELKSVIHH--NHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 283 SMGIMHRDVKPHNVMID----HENRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE-L 336
           S   +HRD+KP N+++      E   L++ D+GLA  F  P +++   + + +++ PE L
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209
Query: 337 LADYQYHIELD 347
           L    Y   +D
Sbjct: 210 LGSRHYSTSVD 220

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 64/109 (58%), Gaps = 3/109 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE 68
           A+++CH    +HRDVKP N++I  ++  ++L D+G A     P   Y+  VA+R+++ PE
Sbjct: 114 AVNFCHKHNCIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPE 172
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           LL     Y   +D+W++GC+ A ++    P + G  + DQL  I K LG
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLG 220

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 129/303 (42%), Gaps = 52/303 (17%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXX-----XXXXXXXXXXLENLRGG 225
           + Y+ + K+G G Y  VF+  N  +                            L+ L+  
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH- 61
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL--YQ-TLTDYDIRYYLYELLKALDYCH 282
            N++ L  V +    R   L+FE+ ++T   +L  YQ  + ++ ++   ++ L+A+++CH
Sbjct: 62  PNLVNLLEVFRR--KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELL-ADY 340
               +HRDVKP N++I  ++  ++L D+G A     P   Y+  VA+R+++ PELL  D 
Sbjct: 120 KHNCIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 341 QYHIELD-----PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW 395
           QY   +D       FA++L       W      +  +L+     D     ++ RH +   
Sbjct: 179 QYGPPVDVWAIGCVFAELLS--GVPLWPGKSDVDQLYLIRKTLGD-----LIPRHQQ--- 228
Query: 396 ERFVHTENQHL--------------------VSPEALDFLDKLLRYDHYERLTAREAMDH 435
              V + NQ+                     +S  AL  L   L  D  ERLT  + + H
Sbjct: 229 ---VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285
Query: 436 PYF 438
           PYF
Sbjct: 286 PYF 288

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 63/108 (58%), Gaps = 3/108 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+
Sbjct: 124 GLDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEV 182
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           L     Y   +DMWS+GC+ A M FR++P F G+   DQL +I  ++G
Sbjct: 183 LLQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 228

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 31/217 (14%)
Query: 244 ALIFEHVNNTDF-----KQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI 298
            L+FEHV+  D      K     L    I+  + + L+ LD+ H+  I+HRD+KP N+++
Sbjct: 87  TLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 145
Query: 299 DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHS 358
                 ++L D+GLA  Y         V + +++ PE+L    Y   +D      +    
Sbjct: 146 T-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204
Query: 359 RKRWERFVHTENQHLVSPEALDFLDK--NILGRHSRKRWERFVHTENQHL---------- 406
            +R   F              D L K  +++G      W R V                 
Sbjct: 205 FRRKPLFCGNSEA--------DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQS 256
Query: 407 VSPE----ALDFLDKLLRYDHYERLTAREAMDHPYFY 439
           V PE        L ++L ++ ++R++A  A+ H Y +
Sbjct: 257 VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 293

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 67/120 (55%), Gaps = 13/120 (10%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH---------PGQEYNVR-- 58
           A+   H   ++HRD+KP N++I+  N  L++ D+GLA              GQ+  +   
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEX 182
Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           VA+R+++ PE++     Y  ++D+WS GC+LA +  R+ P F G D   QL+ I  ++GT
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIGT 241

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 42/227 (18%)
Query: 246 IFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           I + +  TD  ++  T  L+D  I+Y++Y+ L+A+   H   ++HRD+KP N++I+  N 
Sbjct: 91  IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN-SNC 149
Query: 304 KLRLIDWGLAEFYH---------PGQEYNVR--VASRYFKGPE-LLADYQYHIELD---- 347
            L++ D+GLA              GQ+  +   VA+R+++ PE +L   +Y   +D    
Sbjct: 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 348 -----------PRFADILGRHSRKRWERFV---HTEN--QHLVSPEALDFLDKNILGRHS 391
                      P F     RH        +   H++N  + + SP A +++    L  + 
Sbjct: 210 GCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKS--LPMYP 267
Query: 392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
               E+         V+P+ +D L ++L +D  +R+TA+EA++HPY 
Sbjct: 268 AAPLEKMFPR-----VNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 67/120 (55%), Gaps = 13/120 (10%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH---------PGQEYNVR-- 58
           A+   H   ++HRD+KP N++I+  N  L++ D+GLA              GQ+  +   
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEY 182
Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           VA+R+++ PE++     Y  ++D+WS GC+LA +  R+ P F G D   QL+ I  ++GT
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIGT 241

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 42/227 (18%)
Query: 246 IFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           I + +  TD  ++  T  L+D  I+Y++Y+ L+A+   H   ++HRD+KP N++I+  N 
Sbjct: 91  IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN-SNC 149
Query: 304 KLRLIDWGLAEFYH---------PGQEYNVR--VASRYFKGPE-LLADYQYHIELD---- 347
            L++ D+GLA              GQ+  +   VA+R+++ PE +L   +Y   +D    
Sbjct: 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 348 -----------PRFADILGRHSRKRWERFV---HTEN--QHLVSPEALDFLDKNILGRHS 391
                      P F     RH        +   H++N  + + SP A +++    L  + 
Sbjct: 210 GCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKS--LPMYP 267
Query: 392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
               E+         V+P+ +D L ++L +D  +R+TA+EA++HPY 
Sbjct: 268 AAPLEKMFPR-----VNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 67/120 (55%), Gaps = 13/120 (10%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH---------PGQEYNVR-- 58
           A+   H   ++HRD+KP N++I+  N  L++ D+GLA              GQ+  +   
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           VA+R+++ PE++     Y  ++D+WS GC+LA +  R+ P F G D   QL+ I  ++GT
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIGT 241

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 42/227 (18%)
Query: 246 IFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           I + +  TD  ++  T  L+D  I+Y++Y+ L+A+   H   ++HRD+KP N++I+  N 
Sbjct: 91  IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN-SNC 149
Query: 304 KLRLIDWGLAEFYH---------PGQEYNVR--VASRYFKGPE-LLADYQYHIELD---- 347
            L++ D+GLA              GQ+  +   VA+R+++ PE +L   +Y   +D    
Sbjct: 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 348 -----------PRFADILGRHSRKRWERFV---HTEN--QHLVSPEALDFLDKNILGRHS 391
                      P F     RH        +   H++N  + + SP A +++    L  + 
Sbjct: 210 GCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKS--LPMYP 267
Query: 392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
               E+         V+P+ +D L ++L +D  +R+TA+EA++HPY 
Sbjct: 268 AAPLEKMFPR-----VNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 64/113 (56%), Gaps = 2/113 (1%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           + L   H  G++HRD+ P N+++  +N  + + D+ LA            V  R+++ PE
Sbjct: 145 LGLHVLHEAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHYVTHRWYRAPE 203
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
           L+  ++ +   +DMWS GC++A M F ++  F G   Y+QL +I +V+GT ++
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEM-FNRKALFRGSTFYNQLNKIVEVVGTPKI 255

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 31/210 (14%)
Query: 253 TDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLI 308
           TD  Q+       ++   I+Y++Y +L  L   H  G++HRD+ P N+++  +N  + + 
Sbjct: 118 TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA-DNNDITIC 176
Query: 309 DWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIEL------DPRFADILGRHSRKRW 362
           D+ LA            V  R+++ PEL+  ++   +L          A++  R +  R 
Sbjct: 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236
Query: 363 ERFVHTENQ--------------HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVS 408
             F +  N+                 SP A D+L +N L     + W   V T +     
Sbjct: 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYL-RNSLSNVPARAWTAVVPTAD----- 290
Query: 409 PEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           P ALD + K+L ++   R++  +A+ HPYF
Sbjct: 291 PVALDLIAKMLEFNPQRRISTEQALRHPYF 320

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 64/113 (56%), Gaps = 2/113 (1%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           + L   H  G++HRD+ P N+++  +N  + + D+ LA            V  R+++ PE
Sbjct: 145 LGLHVLHEAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHYVTHRWYRAPE 203
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
           L+  ++ +   +DMWS GC++A M F ++  F G   Y+QL +I +V+GT ++
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEM-FNRKALFRGSTFYNQLNKIVEVVGTPKI 255

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 31/210 (14%)
Query: 253 TDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLI 308
           TD  Q+       ++   I+Y++Y +L  L   H  G++HRD+ P N+++  +N  + + 
Sbjct: 118 TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA-DNNDITIC 176
Query: 309 DWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIEL------DPRFADILGRHSRKRW 362
           D+ LA            V  R+++ PEL+  ++   +L          A++  R +  R 
Sbjct: 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236
Query: 363 ERFVHTENQ--------------HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVS 408
             F +  N+                 SP A D+L +N L     + W   V T +     
Sbjct: 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYL-RNSLSNVPARAWTAVVPTAD----- 290
Query: 409 PEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           P ALD + K+L ++   R++  +A+ HPYF
Sbjct: 291 PVALDLIAKMLEFNPQRRISTEQALRHPYF 320

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 76/134 (56%), Gaps = 8/134 (5%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           + + + HS GI+HRD+KP N+++   +  L+++D+GLA            V +RY++ PE
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD 126
           ++     Y  ++D+WS+GC++  MI +    F G D+ DQ  ++ + LGT   E  + L 
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 127 ---KYHIELDPRFA 137
              + ++E  P++A
Sbjct: 254 PTVRTYVENRPKYA 267

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKAL 278
           +N+ G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  +
Sbjct: 83  KNIIGLLNVFTPQKSLEE---FQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            + HS GI+HRD+KP N+++   +  L+++D+GLA            V +RY++ PE++ 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 339 DYQYHIELDP-RFADILGRHSRK-----------RWERFVHTENQHLVSPEALDFLDKNI 386
              Y   +D      I+G   +            +W + +  E     SPE +  L   +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPSPEFMKKLQPTV 256
Query: 387 LG------RHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                   +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 434 DHPYF 438
            HPY 
Sbjct: 317 QHPYI 321

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 76/135 (56%), Gaps = 8/135 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++   +  L+++D+GLA            V +RY++ PE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT   E  + L  
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 127 --KYHIELDPRFADI 139
             + ++E  P++A +
Sbjct: 255 TVRNYVENRPKYAGL 269

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 252 NTDFKQLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
           + +  Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++   +  L+++D+
Sbjct: 112 DANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDF 170
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKR-------- 361
           GLA            V +RY++ PE++    Y   +D      I+G   R +        
Sbjct: 171 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 230
Query: 362 ---WERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWERFVH------------TENQH 405
              W + +  E      PE +  L   +     +R ++                 +E+  
Sbjct: 231 IDQWNKVI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 288
Query: 406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L + +A D L K+L  D  +R++  +A+ HPY 
Sbjct: 289 LKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 62/102 (60%), Gaps = 5/102 (4%)
Query: 17  MGIMHRDVKPHNVMIDHENRK-LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQM 75
           + I+H D+KP N+++ +  R  ++++D+G +     GQ     + SR+++ PE+L     
Sbjct: 159 LSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGMP- 215
Query: 76  YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           YD ++DMWSLGC+L  M    EP F G +  DQ+ +I +VLG
Sbjct: 216 YDLAIDMWSLGCILVEM-HTGEPLFSGANEVDQMNKIVEVLG 256

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 58/105 (55%), Gaps = 9/105 (8%)
Query: 246 IFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHS--MGIMHRDVKPHNVMIDHENR 303
           +++ + NT+F+ +   LT    R +  ++  AL +  +  + I+H D+KP N+++ +  R
Sbjct: 123 LYDLLRNTNFRGVSLNLT----RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 178
Query: 304 K-LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
             ++++D+G +     GQ     + SR+++ PE+L    Y + +D
Sbjct: 179 SAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGMPYDLAID 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 75/133 (56%), Gaps = 8/133 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEV 196
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  MI +    F G D+ DQ  ++ + LGT   E  + L  
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 127 --KYHIELDPRFA 137
             + ++E  P++A
Sbjct: 255 TVRTYVENRPKYA 267

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 111/245 (45%), Gaps = 32/245 (13%)
Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKAL 278
           +N+ G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  +
Sbjct: 83  KNIIGLLNVFTPQKSLEE---FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE++ 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVIL 198
Query: 339 DYQYHIELDP-RFADILGRHSRK-----------RWERFVHTENQHLVSPEALDFLDKNI 386
              Y   +D      I+G   +            +W + +  E      PE +  L   +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPCPEFMKKLQPTV 256
Query: 387 LG------RHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                   +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 434 DHPYF 438
            HPY 
Sbjct: 317 QHPYI 321

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 76/135 (56%), Gaps = 8/135 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++   +  L+++D+GLA            V +RY++ PE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT   E  + L  
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 127 --KYHIELDPRFADI 139
             + ++E  P++A +
Sbjct: 255 TVRNYVENRPKYAGL 269

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 252 NTDFKQLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
           + +  Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++   +  L+++D+
Sbjct: 112 DANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDF 170
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKR-------- 361
           GLA            V +RY++ PE++    Y   +D      I+G   R +        
Sbjct: 171 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 230
Query: 362 ---WERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWERFVH------------TENQH 405
              W + +  E      PE +  L   +     +R ++                 +E+  
Sbjct: 231 IDQWNKVI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 288
Query: 406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L + +A D L K+L  D  +R++  +A+ HPY 
Sbjct: 289 LKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 76/135 (56%), Gaps = 8/135 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++   +  L+++D+GLA            V +RY++ PE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT   E  + L  
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 127 --KYHIELDPRFADI 139
             + ++E  P++A +
Sbjct: 255 TVRNYVENRPKYAGL 269

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 252 NTDFKQLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
           + +  Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++   +  L+++D+
Sbjct: 112 DANLXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDF 170
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKR-------- 361
           GLA            V +RY++ PE++    Y   +D      I+G   R +        
Sbjct: 171 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 230
Query: 362 ---WERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWERFVH------------TENQH 405
              W + +  E      PE +  L   +     +R ++                 +E+  
Sbjct: 231 IDQWNKVI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 288
Query: 406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L + +A D L K+L  D  +R++  +A+ HPY 
Sbjct: 289 LKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 62/102 (60%), Gaps = 5/102 (4%)
Query: 17  MGIMHRDVKPHNVMIDHENRK-LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQM 75
           + I+H D+KP N+++ +  R  ++++D+G +     GQ     + SR+++ PE+L     
Sbjct: 178 LSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGMP- 234
Query: 76  YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           YD ++DMWSLGC+L  M    EP F G +  DQ+ +I +VLG
Sbjct: 235 YDLAIDMWSLGCILVEM-HTGEPLFSGANEVDQMNKIVEVLG 275

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 58/105 (55%), Gaps = 9/105 (8%)
Query: 246 IFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHS--MGIMHRDVKPHNVMIDHENR 303
           +++ + NT+F+ +   LT    R +  ++  AL +  +  + I+H D+KP N+++ +  R
Sbjct: 142 LYDLLRNTNFRGVSLNLT----RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197
Query: 304 K-LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
             ++++D+G +     GQ     + SR+++ PE+L    Y + +D
Sbjct: 198 SAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGMPYDLAID 240

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 75/133 (56%), Gaps = 8/133 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++   +  L+++D+GLA            V +RY++ PE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  MI +    F G D+ DQ  ++ + LGT   E  + L  
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 127 --KYHIELDPRFA 137
             + ++E  P++A
Sbjct: 255 TVRTYVENRPKYA 267

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKAL 278
           +N+ G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  +
Sbjct: 83  KNIIGLLNVFTPQKSLEE---FQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            + HS GI+HRD+KP N+++   +  L+++D+GLA            V +RY++ PE++ 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 339 DYQYHIELDP-RFADILGRHSRK-----------RWERFVHTENQHLVSPEALDFLDKNI 386
              Y   +D      I+G   +            +W + +  E     SPE +  L   +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPSPEFMKKLQPTV 256
Query: 387 LG------RHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                   +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 434 DHPYF 438
            HPY 
Sbjct: 317 QHPYI 321

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 76/135 (56%), Gaps = 8/135 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++   +  L+++D+GLA            V +RY++ PE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT   E  + L  
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 127 --KYHIELDPRFADI 139
             + ++E  P++A +
Sbjct: 255 TVRNYVENRPKYAGL 269

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 252 NTDFKQLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
           + +  Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++   +  L+++D+
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDF 170
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKR-------- 361
           GLA            V +RY++ PE++    Y   +D      I+G   R +        
Sbjct: 171 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 230
Query: 362 ---WERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWERFVH------------TENQH 405
              W + +  E      PE +  L   +     +R ++                 +E+  
Sbjct: 231 IDQWNKVI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 288
Query: 406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L + +A D L K+L  D  +R++  +A+ HPY 
Sbjct: 289 LKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 76/135 (56%), Gaps = 8/135 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++   +  L+++D+GLA            V +RY++ PE+
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT   E  + L  
Sbjct: 190 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 127 --KYHIELDPRFADI 139
             + ++E  P++A +
Sbjct: 248 TVRNYVENRPKYAGL 262

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 252 NTDFKQLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
           + +  Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++   +  L+++D+
Sbjct: 105 DANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDF 163
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKR-------- 361
           GLA            V +RY++ PE++    Y   +D      I+G   R +        
Sbjct: 164 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
Query: 362 ---WERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWERFVH------------TENQH 405
              W + +  E      PE +  L   +     +R ++                 +E+  
Sbjct: 224 IDQWNKVI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281
Query: 406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L + +A D L K+L  D  +R++  +A+ HPY 
Sbjct: 282 LKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKAL 278
           +N+ G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  +
Sbjct: 83  KNIIGLLNVFTPQKSLEE---FQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            + HS GI+HRD+KP N+++   +  L+++D+GLA            V +RY++ PE++ 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 339 DYQYHIELDP-RFADILGRHSRK-----------RWERFVHTENQHLVSPEALDFLDKNI 386
              Y   +D      I+G   +            +W + +  E     SPE +  L   +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPSPEFMKKLQPTV 256
Query: 387 LG------RHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                   +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 434 DHPYF 438
            HPY 
Sbjct: 317 QHPYI 321

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 62/102 (60%), Gaps = 5/102 (4%)
Query: 17  MGIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQM 75
           + I+H D+KP N+++ +  R  ++++D+G +     GQ     + SR+++ PE+L     
Sbjct: 178 LSIIHCDLKPENILLCNPKRXAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGMP- 234
Query: 76  YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           YD ++DMWSLGC+L  M    EP F G +  DQ+ +I +VLG
Sbjct: 235 YDLAIDMWSLGCILVEM-HTGEPLFSGANEVDQMNKIVEVLG 275

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 58/105 (55%), Gaps = 9/105 (8%)
Query: 246 IFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHS--MGIMHRDVKPHNVMIDHENR 303
           +++ + NT+F+ +   LT    R +  ++  AL +  +  + I+H D+KP N+++ +  R
Sbjct: 142 LYDLLRNTNFRGVSLNLT----RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197
Query: 304 -KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
             ++++D+G +     GQ     + SR+++ PE+L    Y + +D
Sbjct: 198 XAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGMPYDLAID 240

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 111/245 (45%), Gaps = 32/245 (13%)
Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKAL 278
           +N+ G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  +
Sbjct: 83  KNIIGLLNVFTPQKSLEE---FQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            + HS GI+HRD+KP N+++   +  L+++D+GLA            V +RY++ PE++ 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 339 DYQYHIELDPRFADIL------------GRHSRKRWERFVHTENQHLVSPEALDFLDKNI 386
              Y   +D     ++            G     +W + +  E     SPE +  L   +
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPSPEFMKKLQPTV 256
Query: 387 LG------RHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                   +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 434 DHPYF 438
            HPY 
Sbjct: 317 QHPYI 321

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 111/245 (45%), Gaps = 32/245 (13%)
Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKAL 278
           +N+ G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  +
Sbjct: 83  KNIIGLLNVFTPQKSLEE---FQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            + HS GI+HRD+KP N+++   +  L+++D+GLA            V +RY++ PE++ 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 339 DYQYHIELDPRFADIL------------GRHSRKRWERFVHTENQHLVSPEALDFLDKNI 386
              Y   +D     ++            G     +W + +  E     SPE +  L   +
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPSPEFMKKLQPTV 256
Query: 387 LG------RHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                   +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 434 DHPYF 438
            HPY 
Sbjct: 317 QHPYI 321

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 74/133 (55%), Gaps = 8/133 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEV 196
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  M+  K   F G D  DQ  ++ + LGT   E  + L  
Sbjct: 197 ILGMG-YKENVDLWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 127 --KYHIELDPRFA 137
             + ++E  P++A
Sbjct: 255 TVRTYVENRPKYA 267

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 110/245 (44%), Gaps = 32/245 (13%)
Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKAL 278
           +N+ G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  +
Sbjct: 83  KNIIGLLNVFTPQKSLEE---FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE++ 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVIL 198
Query: 339 DYQYHIELDPRFADIL------------GRHSRKRWERFVHTENQHLVSPEALDFLDKNI 386
              Y   +D      +            GR    +W + +  E      PE +  L   +
Sbjct: 199 GMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQPTV 256
Query: 387 LG------RHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                   +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 434 DHPYF 438
            HPY 
Sbjct: 317 QHPYI 321

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKAL 278
           +N+ G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  +
Sbjct: 83  KNIIGLLNVFTPQKSLEE---FQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE++ 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 339 DYQYHIELDP-RFADILGRHSRK-----------RWERFVHTENQHLVSPEALDFLDKNI 386
              Y   +D      I+G   +            +W + +  E     SPE +  L   +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPSPEFMKKLQPTV 256
Query: 387 LG------RHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                   +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 434 DHPYF 438
            HPY 
Sbjct: 317 QHPYI 321

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 76/136 (55%), Gaps = 10/136 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++   +  L+++D+GLA            V +RY++ PE+
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY- 128
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT    E++ K  
Sbjct: 235 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGT-PCPEFMKKLQ 291
Query: 129 -----HIELDPRFADI 139
                ++E  P++A +
Sbjct: 292 PTVRNYVENRPKYAGL 307

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 252 NTDFKQLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
           + +  Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++   +  L+++D+
Sbjct: 150 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDF 208
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKR-------- 361
           GLA            V +RY++ PE++    Y   +D      I+G   R +        
Sbjct: 209 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 268
Query: 362 ---WERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWERFVH------------TENQH 405
              W + +  E      PE +  L   +     +R ++                 +E+  
Sbjct: 269 IDQWNKVI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 326
Query: 406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L + +A D L K+L  D  +R++  +A+ HPY 
Sbjct: 327 LKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 36/197 (18%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R ++Y+LL+ L Y HS  ++HRD+KP N+ I+ E+  L++ D+GLA    P   +   ++
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 328 ----SRYFKGPELLA---DYQYHIEL---DPRFADIL-------GRHSRKRWERF----- 365
               +++++ P LL    +Y   I++      FA++L       G H  ++ +       
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242
Query: 366 -VHTEN-QHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL--VSPEALDFLDKLLRY 421
            VH E+ Q L+S          ++  + R           Q L  +S EA+DFL+++L +
Sbjct: 243 VVHEEDRQELLS----------VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTF 292
Query: 422 DHYERLTAREAMDHPYF 438
              +RLTA EA+ HPY 
Sbjct: 293 SPMDRLTAEEALSHPYM 309

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 76/136 (55%), Gaps = 10/136 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY- 128
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT    E++ K  
Sbjct: 198 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGT-PCPEFMKKLQ 254
Query: 129 -----HIELDPRFADI 139
                ++E  P++A +
Sbjct: 255 PTVRNYVENRPKYAGL 270

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 252 NTDFKQLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
           + +  Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++  +   L+++D+
Sbjct: 113 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDF 171
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKR-------- 361
           GLA            V +RY++ PE++    Y   +D      I+G   R +        
Sbjct: 172 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 231
Query: 362 ---WERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWERFVH------------TENQH 405
              W + +  E      PE +  L   +     +R ++                 +E+  
Sbjct: 232 IDQWNKVI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 289
Query: 406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L + +A D L K+L  D  +R++  +A+ HPY 
Sbjct: 290 LKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 76/136 (55%), Gaps = 10/136 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 137 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 195
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY- 128
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT    E++ K  
Sbjct: 196 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGT-PCPEFMKKLQ 252
Query: 129 -----HIELDPRFADI 139
                ++E  P++A +
Sbjct: 253 PTVRNYVENRPKYAGL 268

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 252 NTDFKQLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
           + +  Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++  +   L+++D+
Sbjct: 111 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDF 169
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKR-------- 361
           GLA            V +RY++ PE++    Y   +D      I+G   R +        
Sbjct: 170 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 229
Query: 362 ---WERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWERFVH------------TENQH 405
              W + +  E      PE +  L   +     +R ++                 +E+  
Sbjct: 230 IDQWNKVI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 287
Query: 406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L + +A D L K+L  D  +R++  +A+ HPY 
Sbjct: 288 LKASQARDLLSKMLVIDPAKRISVDDALQHPYI 320

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 76/136 (55%), Gaps = 10/136 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY- 128
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT    E++ K  
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGT-PCPEFMKKLQ 253
Query: 129 -----HIELDPRFADI 139
                ++E  P++A +
Sbjct: 254 PTVRNYVENRPKYAGL 269

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 252 NTDFKQLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
           + +  Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++  +   L+++D+
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDF 170
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKR-------- 361
           GLA            V +RY++ PE++    Y   +D      I+G   R +        
Sbjct: 171 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 230
Query: 362 ---WERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWERFVH------------TENQH 405
              W + +  E      PE +  L   +     +R ++                 +E+  
Sbjct: 231 IDQWNKVI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 288
Query: 406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L + +A D L K+L  D  +R++  +A+ HPY 
Sbjct: 289 LKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 76/136 (55%), Gaps = 10/136 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY- 128
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT    E++ K  
Sbjct: 235 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGT-PCPEFMKKLQ 291
Query: 129 -----HIELDPRFADI 139
                ++E  P++A +
Sbjct: 292 PTVRNYVENRPKYAGL 307

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 252 NTDFKQLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
           + +  Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++  +   L+++D+
Sbjct: 150 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDF 208
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKR-------- 361
           GLA            V +RY++ PE++    Y   +D      I+G   R +        
Sbjct: 209 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 268
Query: 362 ---WERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWERFVH------------TENQH 405
              W + +  E      PE +  L   +     +R ++                 +E+  
Sbjct: 269 IDQWNKVI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 326
Query: 406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L + +A D L K+L  D  +R++  +A+ HPY 
Sbjct: 327 LKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 76/136 (55%), Gaps = 10/136 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY- 128
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT    E++ K  
Sbjct: 198 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGT-PCPEFMKKLQ 254
Query: 129 -----HIELDPRFADI 139
                ++E  P++A +
Sbjct: 255 PTVRNYVENRPKYAGL 270

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 252 NTDFKQLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
           + +  Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++  +   L+++D+
Sbjct: 113 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDF 171
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKR-------- 361
           GLA            V +RY++ PE++    Y   +D      I+G   R +        
Sbjct: 172 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 231
Query: 362 ---WERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWERFVH------------TENQH 405
              W + +  E      PE +  L   +     +R ++                 +E+  
Sbjct: 232 IDQWNKVI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 289
Query: 406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L + +A D L K+L  D  +R++  +A+ HPY 
Sbjct: 290 LKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 76/135 (56%), Gaps = 8/135 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT   E  + L  
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 127 --KYHIELDPRFADI 139
             + ++E  P++A +
Sbjct: 255 TVRNYVENRPKYAGL 269

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 252 NTDFKQLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
           + +  Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++  +   L+++D+
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDF 170
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKR-------- 361
           GLA            V +RY++ PE++    Y   +D      I+G   R +        
Sbjct: 171 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 230
Query: 362 ---WERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWERFVH------------TENQH 405
              W + +  E      PE +  L   +     +R ++                 +E+  
Sbjct: 231 IDQWNKVI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 288
Query: 406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L + +A D L K+L  D  +R++  +A+ HPY 
Sbjct: 289 LKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 76/136 (55%), Gaps = 10/136 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY- 128
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT    E++ K  
Sbjct: 190 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGT-PCPEFMKKLQ 246
Query: 129 -----HIELDPRFADI 139
                ++E  P++A +
Sbjct: 247 PTVRNYVENRPKYAGL 262

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 252 NTDFKQLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
           + +  Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++  +   L+++D+
Sbjct: 105 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDF 163
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKR-------- 361
           GLA            V +RY++ PE++    Y   +D      I+G   R +        
Sbjct: 164 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
Query: 362 ---WERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWERFVH------------TENQH 405
              W + +  E      PE +  L   +     +R ++                 +E+  
Sbjct: 224 IDQWNKVI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281
Query: 406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L + +A D L K+L  D  +R++  +A+ HPY 
Sbjct: 282 LKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 76/136 (55%), Gaps = 10/136 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 190
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY- 128
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT    E++ K  
Sbjct: 191 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGT-PCPEFMKKLQ 247
Query: 129 -----HIELDPRFADI 139
                ++E  P++A +
Sbjct: 248 PTVRNYVENRPKYAGL 263

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 252 NTDFKQLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
           + +  Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++  +   L+++D+
Sbjct: 106 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDF 164
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKR-------- 361
           GLA            V +RY++ PE++    Y   +D      I+G   R +        
Sbjct: 165 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 224
Query: 362 ---WERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWERFVH------------TENQH 405
              W + +  E      PE +  L   +     +R ++                 +E+  
Sbjct: 225 IDQWNKVI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 282
Query: 406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L + +A D L K+L  D  +R++  +A+ HPY 
Sbjct: 283 LKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 63/109 (57%), Gaps = 3/109 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEV 196
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  ++D+WS+GC++  M+  K   F G D  DQ  ++ + LGT
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGT 243

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 109/245 (44%), Gaps = 32/245 (13%)
Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKAL 278
           +N+ G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  +
Sbjct: 83  KNIIGLLNVFTPQKSLEE---FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE++ 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVIL 198
Query: 339 DYQYHIELDPRFADIL------------GRHSRKRWERFVHTENQHLVSPEALDFLDKNI 386
              Y   +D      +            GR    +W + +  E      P  +  L   +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVI--EQLGTPCPAFMKKLQPTV 256
Query: 387 LG------RHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                   +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+
Sbjct: 257 RNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 434 DHPYF 438
            HPY 
Sbjct: 317 QHPYI 321

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 76/136 (55%), Gaps = 10/136 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 190
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY- 128
           +     Y  ++D+WS+GC++  M+ R +  F G D  DQ  ++ + LGT    E++ K  
Sbjct: 191 ILGMG-YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGT-PCPEFMKKLQ 247
Query: 129 -----HIELDPRFADI 139
                ++E  P++A +
Sbjct: 248 PTVRNYVENRPKYAGL 263

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 252 NTDFKQLYQTLTDYD-IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW 310
           + +  Q+ Q   D++ + Y LY++L  + + HS GI+HRD+KP N+++  +   L+++D+
Sbjct: 106 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDF 164
Query: 311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKR-------- 361
           GLA            V +RY++ PE++    Y   +D      I+G   R +        
Sbjct: 165 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 224
Query: 362 ---WERFVHTENQHLVSPEALDFLDKNILG-RHSRKRWERFVH------------TENQH 405
              W + +  E      PE +  L   +     +R ++                 +E+  
Sbjct: 225 IDQWNKVI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 282
Query: 406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L + +A D L K+L  D  +R++  +A+ HPY 
Sbjct: 283 LKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 75/133 (56%), Gaps = 8/133 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  MI +    F G D+ DQ  ++ + LGT   E  + L  
Sbjct: 198 ILGMG-YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255
Query: 127 --KYHIELDPRFA 137
             + ++E  P++A
Sbjct: 256 TVRTYVENRPKYA 268

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 111/245 (45%), Gaps = 32/245 (13%)
Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKAL 278
           +N+ G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  +
Sbjct: 84  KNIIGLLNVFTPQKSLEE---FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE++ 
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 339 DYQYHIELDP-RFADILGRHSRK-----------RWERFVHTENQHLVSPEALDFLDKNI 386
              Y   +D      I+G   +            +W + +  E      PE +  L   +
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPCPEFMKKLQPTV 257
Query: 387 LG------RHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                   +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317
Query: 434 DHPYF 438
            HPY 
Sbjct: 318 QHPYI 322

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 75/133 (56%), Gaps = 8/133 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  MI +    F G D+ DQ  ++ + LGT   E  + L  
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 127 --KYHIELDPRFA 137
             + ++E  P++A
Sbjct: 255 TVRTYVENRPKYA 267

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKAL 278
           +N+ G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  +
Sbjct: 83  KNIIGLLNVFTPQKSLEE---FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE++ 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 339 DYQYHIELDP-RFADILGRHSRK-----------RWERFVHTENQHLVSPEALDFLDKNI 386
              Y   +D      I+G   +            +W + +  E     SPE +  L   +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPSPEFMKKLQPTV 256
Query: 387 LG------RHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                   +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 434 DHPYF 438
            HPY 
Sbjct: 317 QHPYI 321

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 75/133 (56%), Gaps = 8/133 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  MI +    F G D+ DQ  ++ + LGT   E  + L  
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 127 --KYHIELDPRFA 137
             + ++E  P++A
Sbjct: 255 TVRTYVENRPKYA 267

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 111/245 (45%), Gaps = 32/245 (13%)
Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKAL 278
           +N+ G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  +
Sbjct: 83  KNIIGLLNVFTPQKSLEE---FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE++ 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 339 DYQYHIELDP-RFADILGRHSRK-----------RWERFVHTENQHLVSPEALDFLDKNI 386
              Y   +D      I+G   +            +W + +  E      PE +  L   +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPCPEFMKKLQPTV 256
Query: 387 LG------RHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                   +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 434 DHPYF 438
            HPY 
Sbjct: 317 QHPYI 321

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 74/133 (55%), Gaps = 8/133 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 143 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 201
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  M+  K   F G D  DQ  ++ + LGT   E  + L  
Sbjct: 202 ILGMG-YKENVDLWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 259
Query: 127 --KYHIELDPRFA 137
             + ++E  P++A
Sbjct: 260 TVRTYVENRPKYA 272

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 110/245 (44%), Gaps = 32/245 (13%)
Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKAL 278
           +N+ G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  +
Sbjct: 88  KNIIGLLNVFTPQKSLEE---FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 144
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE++ 
Sbjct: 145 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 203
Query: 339 DYQYHIELDPRFADIL------------GRHSRKRWERFVHTENQHLVSPEALDFLDKNI 386
              Y   +D      +            GR    +W + +  E      PE +  L   +
Sbjct: 204 GMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQPTV 261
Query: 387 LG------RHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                   +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+
Sbjct: 262 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 321
Query: 434 DHPYF 438
            HPY 
Sbjct: 322 QHPYI 326

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 64/109 (58%), Gaps = 3/109 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 136 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEV 194
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  ++D+WS+GC++  ++ +    F G D+ DQ  ++ + LGT
Sbjct: 195 ILGMG-YKENVDIWSVGCIMGELV-KGSVIFQGTDHIDQWNKVIEQLGT 241

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 95/217 (43%), Gaps = 24/217 (11%)
Query: 245 LIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRK 304
           L+ E ++    + ++  L    + Y LY++L  + + HS GI+HRD+KP N+++  +   
Sbjct: 104 LVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-T 162
Query: 305 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRK--- 360
           L+++D+GLA            V +RY++ PE++    Y   +D      I+G   +    
Sbjct: 163 LKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVI 222
Query: 361 --------RWERFVH------TENQHLVSPEALDFLDK-----NILGRHSRKRWERFVHT 401
                   +W + +        E    + P   ++++       I        W     +
Sbjct: 223 FQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSES 282
Query: 402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           E   + + +A D L K+L  D  +R++  EA+ HPY 
Sbjct: 283 ERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 63/109 (57%), Gaps = 3/109 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 190
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  ++D+WS+GC++  M+  K   F G D  DQ  ++ + LGT
Sbjct: 191 ILGMG-YKENVDLWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGT 237

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 110/245 (44%), Gaps = 32/245 (13%)
Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKAL 278
           +N+ G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  +
Sbjct: 77  KNIIGLLNVFTPQKSLEE---FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE++ 
Sbjct: 134 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 339 DYQYHIELDPRFADIL------------GRHSRKRWERFVHTENQHLVSPEALDFLDKNI 386
              Y   +D      +            GR    +W + +  E      PE +  L   +
Sbjct: 193 GMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQPTV 250
Query: 387 LG------RHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                   +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+
Sbjct: 251 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 310
Query: 434 DHPYF 438
            HPY 
Sbjct: 311 QHPYI 315

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 75/133 (56%), Gaps = 8/133 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 140 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEV 198
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFEYLD- 126
           +     Y  ++D+WS+GC++  MI +    F G D+ DQ  ++ + LGT   E  + L  
Sbjct: 199 ILGMG-YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 256
Query: 127 --KYHIELDPRFA 137
             + ++E  P++A
Sbjct: 257 TVRTYVENRPKYA 269

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 111/245 (45%), Gaps = 32/245 (13%)
Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD-IRYYLYELLKAL 278
           +N+ G  N+ T Q  +++        I   + + +  Q+ Q   D++ + Y LY++L  +
Sbjct: 85  KNIIGLLNVFTPQKSLEE---FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 141
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE++ 
Sbjct: 142 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVIL 200
Query: 339 DYQYHIELDP-RFADILGRHSRK-----------RWERFVHTENQHLVSPEALDFLDKNI 386
              Y   +D      I+G   +            +W + +  E      PE +  L   +
Sbjct: 201 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPCPEFMKKLQPTV 258
Query: 387 LG------RHSRKRWERF-------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                   +++   +E+          +E+  L + +A D L K+L  D  +R++  EA+
Sbjct: 259 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 318
Query: 434 DHPYF 438
            HPY 
Sbjct: 319 QHPYI 323

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 63/109 (57%), Gaps = 5/109 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRK-LRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
            LD  H   I+H D+KP N+++  + R  +++ID+G + + H  Q     + SR+++ PE
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--QRVYTXIQSRFYRAPE 269
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           ++   + Y   +DMWSLGC+LA ++    P   G D  DQL  + ++LG
Sbjct: 270 VILGAR-YGMPIDMWSLGCILAELL-TGYPLLPGEDEGDQLACMIELLG 316

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/93 (26%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 256 KQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRK-LRLIDWGLAE 314
           K  +Q  +   +R + + +L+ LD  H   I+H D+KP N+++  + R  +++ID+G + 
Sbjct: 191 KNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250
Query: 315 FYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
           + H  Q     + SR+++ PE++   +Y + +D
Sbjct: 251 YEH--QRVYTXIQSRFYRAPEVILGARYGMPID 281

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 63/109 (57%), Gaps = 5/109 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRK-LRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
            LD  H   I+H D+KP N+++  + R  +++ID+G + + H  Q     + SR+++ PE
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--QRVYTXIQSRFYRAPE 269
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           ++   + Y   +DMWSLGC+LA ++    P   G D  DQL  + ++LG
Sbjct: 270 VILGAR-YGMPIDMWSLGCILAELL-TGYPLLPGEDEGDQLACMIELLG 316

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/93 (26%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 256 KQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRK-LRLIDWGLAE 314
           K  +Q  +   +R + + +L+ LD  H   I+H D+KP N+++  + R  +++ID+G + 
Sbjct: 191 KNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250
Query: 315 FYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
           + H  Q     + SR+++ PE++   +Y + +D
Sbjct: 251 YEH--QRVYTXIQSRFYRAPEVILGARYGMPID 281

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 63/109 (57%), Gaps = 5/109 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRK-LRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
            LD  H   I+H D+KP N+++  + R  +++ID+G + + H  Q     + SR+++ PE
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--QRVYXXIQSRFYRAPE 269
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           ++   + Y   +DMWSLGC+LA ++    P   G D  DQL  + ++LG
Sbjct: 270 VILGAR-YGMPIDMWSLGCILAELL-TGYPLLPGEDEGDQLACMIELLG 316

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 25/93 (26%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 256 KQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRK-LRLIDWGLAE 314
           K  +Q  +   +R + + +L+ LD  H   I+H D+KP N+++  + R  +++ID+G + 
Sbjct: 191 KNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250
Query: 315 FYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
           + H  Q     + SR+++ PE++   +Y + +D
Sbjct: 251 YEH--QRVYXXIQSRFYRAPEVILGARYGMPID 281

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 64/109 (58%), Gaps = 3/109 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 196
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  ++D+WS+GC++  ++ +    F G D+ DQ  ++ + LGT
Sbjct: 197 ILGMG-YAANVDIWSVGCIMGELV-KGCVIFQGTDHIDQWNKVIEQLGT 243

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 95/217 (43%), Gaps = 24/217 (11%)
Query: 245 LIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRK 304
           L+ E ++    + ++  L    + Y LY++L  + + HS GI+HRD+KP N+++  +   
Sbjct: 106 LVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-T 164
Query: 305 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRK--- 360
           L+++D+GLA            V +RY++ PE++    Y   +D      I+G   +    
Sbjct: 165 LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVI 224
Query: 361 --------RWERFVH------TENQHLVSPEALDFLDK-----NILGRHSRKRWERFVHT 401
                   +W + +        E    + P   ++++       I        W     +
Sbjct: 225 FQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSES 284
Query: 402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           E   + + +A D L K+L  D  +R++  EA+ HPY 
Sbjct: 285 ERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 321

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYF 64
            L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   +      Y  RV + ++
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEELF 122
           + PELL   + Y   +D+W  GC++A M + + P   G+    QL  I+++ G  T E++
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQLCGSITPEVW 254
Query: 123 EYLDKYHIELDPRFADILGRARVYAD 148
             +D Y  EL  +   + G+ R   D
Sbjct: 255 PNVDNY--ELYEKLELVKGQKRKVKD 278

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 70/303 (23%), Positives = 121/303 (39%), Gaps = 41/303 (13%)
Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLE----NLRGGTNI 228
           Y+ + K+G+G + EVF+A + ++                        E     L    N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 229 ITLQAVVK---DPVSRTPALIF------EHVNNTDFKQLYQTLTDYDIRYYLYELLKALD 279
           + L  + +    P +R    I+      EH        +    T  +I+  +  LL  L 
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYFKGP 334
           Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   +      Y  RV + +++ P
Sbjct: 140 YIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 335 ELL-ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHL----------VSPEALDFLD 383
           ELL  +  Y   +D   A  +      R         QH           ++PE    +D
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 384 K-------NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                    ++    RK  +R       ++  P ALD +DKLL  D  +R+ + +A++H 
Sbjct: 259 NYELYEKLELVKGQKRKVKDRL----KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 314
Query: 437 YFY 439
           +F+
Sbjct: 315 FFW 317

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMI--DHENRKLRLIDWGLAEFYHPGQEYNVRV 59
           RI      A+ YCH + + HRD+KP N +   D  +  L+LID+GLA  + PG+    +V
Sbjct: 127 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 186
Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
            + Y+  P++L    +Y    D WS G M+  ++    PF    D  + +++I      E
Sbjct: 187 GTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDX-EVMLKI-----RE 238
Query: 120 ELFEYLDKYHIELDPRFADILGR 142
             F + +K  + + P+   ++ R
Sbjct: 239 GTFTFPEKDWLNVSPQAESLIRR 261

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 20/190 (10%)
Query: 264 DYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI--DHENRKLRLIDWGLAEFYHPGQE 321
           + D    + ++L A+ YCH + + HRD+KP N +   D  +  L+LID+GLA  + PG+ 
Sbjct: 122 ESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 181
Query: 322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDF 381
              +V + Y+  P++L    Y  E D              W   V         P     
Sbjct: 182 MRTKVGTPYYVSPQVLEGL-YGPECD-------------EWSAGVMMYVLLCGYPPFSAP 227
Query: 382 LDKNILGRHSRKRWERFVHTENQHL-VSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP 440
            D  ++    + R   F   E   L VSP+A   + +LL     +R+T+ +A++H +F  
Sbjct: 228 TDXEVM---LKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 284
Query: 441 IVKDQSRHTL 450
            +    R+ L
Sbjct: 285 QLSSSPRNLL 294

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMI--DHENRKLRLIDWGLAEFYHPGQEYNVRV 59
           RI      A+ YCH + + HRD+KP N +   D  +  L+LID+GLA  + PG+    +V
Sbjct: 110 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 169
Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
            + Y+  P++L    +Y    D WS G M+  ++    PF    D  + +++I      E
Sbjct: 170 GTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDX-EVMLKI-----RE 221
Query: 120 ELFEYLDKYHIELDPRFADILGR 142
             F + +K  + + P+   ++ R
Sbjct: 222 GTFTFPEKDWLNVSPQAESLIRR 244

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 264 DYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI--DHENRKLRLIDWGLAEFYHPGQE 321
           + D    + ++L A+ YCH + + HRD+KP N +   D  +  L+LID+GLA  + PG+ 
Sbjct: 105 ESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164
Query: 322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDF 381
              +V + Y+  P++L    Y  E D   A ++       +  F    +  ++       
Sbjct: 165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVM------- 216
Query: 382 LDKNILGRHSRKRWERFVHTENQHL-VSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP 440
                     + R   F   E   L VSP+A   + +LL     +R+T+ +A++H +F  
Sbjct: 217 ---------LKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267
Query: 441 IVKDQSRHTL 450
            +    R+ L
Sbjct: 268 QLSSSPRNLL 277

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYF 64
            L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   +      Y  RV + ++
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEELF 122
           + PELL   + Y   +D+W  GC++A M + + P   G+    QL  I+++ G  T E++
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQLCGSITPEVW 254
Query: 123 EYLDKYHIELDPRFADILGRARVYAD 148
             +D Y  EL  +   + G+ R   D
Sbjct: 255 PNVDNY--ELYEKLELVKGQKRKVKD 278

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 41/303 (13%)
Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLE----NLRGGTNI 228
           Y+ + K+G+G + EVF+A + ++                        E     L    N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 229 ITLQAVVK---DPVSRTPALIF------EHVNNTDFKQLYQTLTDYDIRYYLYELLKALD 279
           + L  + +    P +R  A I+      EH        +    T  +I+  +  LL  L 
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYFKGP 334
           Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   +      Y  RV + +++ P
Sbjct: 140 YIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 335 ELL-ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHL----------VSPEALDFLD 383
           ELL  +  Y   +D   A  +      R         QH           ++PE    +D
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 384 K-------NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                    ++    RK  +R       ++  P ALD +DKLL  D  +R+ + +A++H 
Sbjct: 259 NYELYEKLELVKGQKRKVKDRL----KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 314
Query: 437 YFY 439
           +F+
Sbjct: 315 FFW 317

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYF 64
            L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   +      Y  RV + ++
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEELF 122
           + PELL   + Y   +D+W  GC++A M + + P   G+    QL  I+++ G  T E++
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQLCGSITPEVW 254
Query: 123 EYLDKYHIELDPRFADILGRARVYAD 148
             +D Y  EL  +   + G+ R   D
Sbjct: 255 PNVDNY--ELYEKLELVKGQKRKVKD 278

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/303 (23%), Positives = 121/303 (39%), Gaps = 41/303 (13%)
Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLE----NLRGGTNI 228
           Y+ + K+G+G + EVF+A + ++                        E     L    N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 229 ITLQAVVK---DPVSRTPALIF------EHVNNTDFKQLYQTLTDYDIRYYLYELLKALD 279
           + L  + +    P +R    I+      EH        +    T  +I+  +  LL  L 
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYFKGP 334
           Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   +      Y  RV + +++ P
Sbjct: 140 YIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 335 ELL-ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHL----------VSPEALDFLD 383
           ELL  +  Y   +D   A  +      R         QH           ++PE    +D
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 384 K-------NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                    ++    RK  +R       ++  P ALD +DKLL  D  +R+ + +A++H 
Sbjct: 259 NYELYEKLELVKGQKRKVKDRL----KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 314
Query: 437 YFY 439
           +F+
Sbjct: 315 FFW 317

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYF 64
            L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   +      Y  RV + ++
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 194
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEELF 122
           + PELL   + Y   +D+W  GC++A M + + P   G+    QL  I+++ G  T E++
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQLCGSITPEVW 253
Query: 123 EYLDKYHIELDPRFADILGRARVYAD 148
             +D Y  EL  +   + G+ R   D
Sbjct: 254 PNVDNY--ELYEKLELVKGQKRKVKD 277

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/303 (23%), Positives = 121/303 (39%), Gaps = 41/303 (13%)
Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLE----NLRGGTNI 228
           Y+ + K+G+G + EVF+A + ++                        E     L    N+
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 229 ITLQAVVK---DPVSRTPALIF------EHVNNTDFKQLYQTLTDYDIRYYLYELLKALD 279
           + L  + +    P +R    I+      EH        +    T  +I+  +  LL  L 
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 138
Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYFKGP 334
           Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   +      Y  RV + +++ P
Sbjct: 139 YIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 335 ELL-ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHL----------VSPEALDFLD 383
           ELL  +  Y   +D   A  +      R         QH           ++PE    +D
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 257
Query: 384 K-------NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                    ++    RK  +R       ++  P ALD +DKLL  D  +R+ + +A++H 
Sbjct: 258 NYELYEKLELVKGQKRKVKDRL----KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313
Query: 437 YFY 439
           +F+
Sbjct: 314 FFW 316

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 68/122 (55%), Gaps = 5/122 (4%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQEYNVRV 59
           RI       + Y H   I+HRD+KP N++++ +++   +R+ID+GL+  +   ++   ++
Sbjct: 130 RIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI 189
Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
            + Y+  PE+L  +  YD   D+WS G +L  ++    P F+G + YD L ++ K   T 
Sbjct: 190 GTAYYIAPEVL--HGTYDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEKGKYTF 246
Query: 120 EL 121
           EL
Sbjct: 247 EL 248

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 92/200 (46%), Gaps = 32/200 (16%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPG 319
            ++ D    + ++L  + Y H   I+HRD+KP N++++ +++   +R+ID+GL+  +   
Sbjct: 123 FSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFV-----HTENQHLV 374
           ++   ++ + Y+  PE+L     H   D +  D+        W   V      +      
Sbjct: 183 KKXKDKIGTAYYIAPEVL-----HGTYDEK-CDV--------WSTGVILYILLSGCPPFN 228
Query: 375 SPEALDFLDKNILGRHSRK--RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREA 432
                D L K   G+++ +  +W++         VS  A D + K L Y    R++AR+A
Sbjct: 229 GANEYDILKKVEKGKYTFELPQWKK---------VSESAKDLIRKXLTYVPSXRISARDA 279
Query: 433 MDHPYFYPIVKDQSRHTLPS 452
           +DH +     K+Q    +PS
Sbjct: 280 LDHEWIQTYTKEQISVDVPS 299

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 61/113 (53%), Gaps = 5/113 (4%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQEYNVRV 59
           RI       + Y H   I+HRD+KP N++++ + +   +++ID+GL+  +    +   R+
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184
Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 112
            + Y+  PE+L     YD   D+WS G +L  ++    P F+G + YD L R+
Sbjct: 185 GTAYYIAPEVLRG--TYDEKCDVWSAGVILY-ILLSGTPPFYGKNEYDILKRV 234

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/205 (20%), Positives = 89/205 (43%), Gaps = 31/205 (15%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPG 319
            +++D    + ++   + Y H   I+HRD+KP N++++ + +   +++ID+GL+  +   
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEAL 379
            +   R+ + Y+  PE+L    Y  + D   A ++                 +++     
Sbjct: 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVI----------------LYILLSGTP 220
Query: 380 DFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            F  KN      R    ++     Q   +S +A D + K+L +    R+TA + ++HP+ 
Sbjct: 221 PFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280
Query: 439 YPIVKDQSRHTLPSSSPTPIVNSVP 463
                         SS TP ++ +P
Sbjct: 281 QKY-----------SSETPTISDLP 294

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 68/122 (55%), Gaps = 5/122 (4%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQEYNVRV 59
           RI       + Y H   I+HRD+KP N++++ +++   +R+ID+GL+  +   ++   ++
Sbjct: 136 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 195
Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
            + Y+  PE+L  +  YD   D+WS G +L  ++    P F+G + YD L ++ K   T 
Sbjct: 196 GTAYYIAPEVL--HGTYDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEKGKYTF 252
Query: 120 EL 121
           EL
Sbjct: 253 EL 254

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/193 (23%), Positives = 90/193 (46%), Gaps = 32/193 (16%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPG 319
            ++ D    + ++L  + Y H   I+HRD+KP N++++ +++   +R+ID+GL+  +   
Sbjct: 129 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 188
Query: 320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFV-----HTENQHLV 374
           ++   ++ + Y+  PE+L     H   D +  D+        W   V      +      
Sbjct: 189 KKMKDKIGTAYYIAPEVL-----HGTYDEK-CDV--------WSTGVILYILLSGCPPFN 234
Query: 375 SPEALDFLDKNILGRHSRK--RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREA 432
                D L K   G+++ +  +W++         VS  A D + K+L Y    R++AR+A
Sbjct: 235 GANEYDILKKVEKGKYTFELPQWKK---------VSESAKDLIRKMLTYVPSMRISARDA 285
Query: 433 MDHPYFYPIVKDQ 445
           +DH +     K+Q
Sbjct: 286 LDHEWIQTYTKEQ 298

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 68/122 (55%), Gaps = 5/122 (4%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQEYNVRV 59
           RI       + Y H   I+HRD+KP N++++ +++   +R+ID+GL+  +   ++   ++
Sbjct: 130 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 189
Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
            + Y+  PE+L  +  YD   D+WS G +L  ++    P F+G + YD L ++ K   T 
Sbjct: 190 GTAYYIAPEVL--HGTYDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEKGKYTF 246
Query: 120 EL 121
           EL
Sbjct: 247 EL 248

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 93/200 (46%), Gaps = 32/200 (16%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPG 319
            ++ D    + ++L  + Y H   I+HRD+KP N++++ +++   +R+ID+GL+  +   
Sbjct: 123 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFV-----HTENQHLV 374
           ++   ++ + Y+  PE+L     H   D +  D+        W   V      +      
Sbjct: 183 KKMKDKIGTAYYIAPEVL-----HGTYDEK-CDV--------WSTGVILYILLSGCPPFN 228
Query: 375 SPEALDFLDKNILGRHSRK--RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREA 432
                D L K   G+++ +  +W++         VS  A D + K+L Y    R++AR+A
Sbjct: 229 GANEYDILKKVEKGKYTFELPQWKK---------VSESAKDLIRKMLTYVPSMRISARDA 279
Query: 433 MDHPYFYPIVKDQSRHTLPS 452
           +DH +     K+Q    +PS
Sbjct: 280 LDHEWIQTYTKEQISVDVPS 299

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 61/113 (53%), Gaps = 5/113 (4%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQEYNVRV 59
           RI       + Y H   I+HRD+KP N++++ + +   +++ID+GL+  +    +   R+
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184
Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 112
            + Y+  PE+L     YD   D+WS G +L  ++    P F+G + YD L R+
Sbjct: 185 GTAYYIAPEVLRG--TYDEKCDVWSAGVILY-ILLSGTPPFYGKNEYDILKRV 234

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/180 (20%), Positives = 81/180 (45%), Gaps = 20/180 (11%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPG 319
            +++D    + ++   + Y H   I+HRD+KP N++++ + +   +++ID+GL+  +   
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEAL 379
            +   R+ + Y+  PE+L    Y  + D   A ++                 +++     
Sbjct: 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVI----------------LYILLSGTP 220
Query: 380 DFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            F  KN      R    ++     Q   +S +A D + K+L +    R+TA + ++HP+ 
Sbjct: 221 PFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 61/113 (53%), Gaps = 5/113 (4%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQEYNVRV 59
           RI       + Y H   I+HRD+KP N++++ + +   +++ID+GL+  +    +   R+
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184
Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 112
            + Y+  PE+L     YD   D+WS G +L  ++    P F+G + YD L R+
Sbjct: 185 GTAYYIAPEVLRG--TYDEKCDVWSAGVILY-ILLSGTPPFYGKNEYDILKRV 234

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/180 (20%), Positives = 81/180 (45%), Gaps = 20/180 (11%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPG 319
            +++D    + ++   + Y H   I+HRD+KP N++++ + +   +++ID+GL+  +   
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEAL 379
            +   R+ + Y+  PE+L    Y  + D   A ++                 +++     
Sbjct: 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVI----------------LYILLSGTP 220
Query: 380 DFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            F  KN      R    ++     Q   +S +A D + K+L +    R+TA + ++HP+ 
Sbjct: 221 PFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 68/122 (55%), Gaps = 5/122 (4%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQEYNVRV 59
           RI       + Y H   I+HRD+KP N++++ +++   +R+ID+GL+  +   ++   ++
Sbjct: 153 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 212
Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
            + Y+  PE+L  +  YD   D+WS G +L  ++    P F+G + YD L ++ K   T 
Sbjct: 213 GTAYYIAPEVL--HGTYDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEKGKYTF 269
Query: 120 EL 121
           EL
Sbjct: 270 EL 271

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 93/200 (46%), Gaps = 32/200 (16%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPG 319
            ++ D    + ++L  + Y H   I+HRD+KP N++++ +++   +R+ID+GL+  +   
Sbjct: 146 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 205
Query: 320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFV-----HTENQHLV 374
           ++   ++ + Y+  PE+L     H   D +  D+        W   V      +      
Sbjct: 206 KKMKDKIGTAYYIAPEVL-----HGTYDEK-CDV--------WSTGVILYILLSGCPPFN 251
Query: 375 SPEALDFLDKNILGRHSRK--RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREA 432
                D L K   G+++ +  +W++         VS  A D + K+L Y    R++AR+A
Sbjct: 252 GANEYDILKKVEKGKYTFELPQWKK---------VSESAKDLIRKMLTYVPSMRISARDA 302
Query: 433 MDHPYFYPIVKDQSRHTLPS 452
           +DH +     K+Q    +PS
Sbjct: 303 LDHEWIQTYTKEQISVDVPS 322

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 68/122 (55%), Gaps = 5/122 (4%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQEYNVRV 59
           RI       + Y H   I+HRD+KP N++++ +++   +R+ID+GL+  +   ++   ++
Sbjct: 154 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 213
Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
            + Y+  PE+L  +  YD   D+WS G +L  ++    P F+G + YD L ++ K   T 
Sbjct: 214 GTAYYIAPEVL--HGTYDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEKGKYTF 270
Query: 120 EL 121
           EL
Sbjct: 271 EL 272

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 93/200 (46%), Gaps = 32/200 (16%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPG 319
            ++ D    + ++L  + Y H   I+HRD+KP N++++ +++   +R+ID+GL+  +   
Sbjct: 147 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 206
Query: 320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFV-----HTENQHLV 374
           ++   ++ + Y+  PE+L     H   D +  D+        W   V      +      
Sbjct: 207 KKMKDKIGTAYYIAPEVL-----HGTYDEK-CDV--------WSTGVILYILLSGCPPFN 252
Query: 375 SPEALDFLDKNILGRHSRK--RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREA 432
                D L K   G+++ +  +W++         VS  A D + K+L Y    R++AR+A
Sbjct: 253 GANEYDILKKVEKGKYTFELPQWKK---------VSESAKDLIRKMLTYVPSMRISARDA 303
Query: 433 MDHPYFYPIVKDQSRHTLPS 452
           +DH +     K+Q    +PS
Sbjct: 304 LDHEWIQTYTKEQISVDVPS 323

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 62/148 (41%), Gaps = 29/148 (19%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG----------------- 52
           AL   H  GI+HRDVKP N + +   +K  L+D+GLA+  H                   
Sbjct: 129 ALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERC 188
Query: 53  ------------QEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
                       Q+   R  +  F+ PE+L        ++DMWS G +  S++  + PF+
Sbjct: 189 SQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248
Query: 101 HGHDNYDQLVRIAKVLGTEELFEYLDKY 128
              D+   L +I  + G+ E  +    +
Sbjct: 249 KASDDLTALAQIMTIRGSRETIQAAKTF 276

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/64 (39%), Positives = 38/64 (59%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            F  +  +L+  ++R Y+  L KAL   H  GI+HRDVKP N + +   +K  L+D+GLA
Sbjct: 106 SFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165
Query: 314 EFYH 317
           +  H
Sbjct: 166 QGTH 169

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 227 NIITLQAVVKDPVSRTPA-LIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCH 282
           N+ITL  V ++   RT   LI E V+     DF    ++L++ +   ++ ++L  ++Y H
Sbjct: 76  NVITLHDVYEN---RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 283 SMGIMHRDVKPHNVMIDHENRK---LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           +  I H D+KP N+M+  +N     ++LID+GLA     G E+     +  F  PE++  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 340 YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
               +E D     ++          F+    Q  ++         NI         E F 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------NITSVSYDFDEEFFS 243
Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS 446
           HT      S  A DF+ KLL  +  +RLT +EA+ HP+  P+   Q+
Sbjct: 244 HT------SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 67/124 (54%), Gaps = 17/124 (13%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYH----PGQEYNVRVASR 62
            + Y H+  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + 
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIA 113
           +++ PELL   + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI 
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIF 258
Query: 114 KVLG 117
            V+G
Sbjct: 259 NVMG 262

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 115/269 (42%), Gaps = 67/269 (24%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVN---------------NTDFKQLYQTLTDYDIRYYL 271
           N+I+LQ V      R   L+F++                 N    QL + +    ++  L
Sbjct: 79  NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM----VKSLL 134
Query: 272 YELLKALDYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYH----PGQEYNV 324
           Y++L  + Y H+  ++HRD+KP N+++     E  ++++ D G A  ++    P  + + 
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 325 RVASRYFKGPELLADYQYHIE------LDPRFADILGRHSRKRWERFVHTENQHLVS--P 376
            V + +++ PELL   +++ +      +   FA++L        E   H   + + +  P
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS------EPIFHCRQEDIKTSNP 248
Query: 377 EALDFLDK--NILGRHSRKRWE-----------------------RFVHTENQHLVSPEA 411
              D LD+  N++G  + K WE                         +    +H V P++
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 308
Query: 412 LDF--LDKLLRYDHYERLTAREAMDHPYF 438
             F  L KLL  D  +R+T+ +AM  PYF
Sbjct: 309 KAFHLLQKLLTMDPIKRITSEQAMQDPYF 337

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVS 200
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 201 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANA 191
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 192 FVGTAQYVSPELLTE 206

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 57/99 (57%), Gaps = 5/99 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 105
           PELL +      S D+W+LGC++  ++    PF  G++ 
Sbjct: 203 PELLTEKSAXKSS-DLWALGCIIYQLVAGLPPFRAGNEG 240

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 249 HVNNTDFKQLYQTLTDYD---IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKL 305
           +  N +  +  + +  +D    R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +
Sbjct: 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHI 171
Query: 306 RLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLAD 339
           ++ D+G A+   P  +    N  V +  +  PELL +
Sbjct: 172 QITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 56/98 (57%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKL--RLIDWGLAEFYHP-GQEYNVRVASRYFKG 66
           A+ + H +G++HRD+KP N++   EN  L  ++ID+G A    P  Q       + ++  
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +   YD S D+WSLG +L +M+  + P F  HD
Sbjct: 178 PELL-NQNGYDESCDLWSLGVILYTMLSGQVP-FQSHD 213

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/259 (22%), Positives = 110/259 (42%), Gaps = 20/259 (7%)
Query: 177 RKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQAVVK 236
           + LG G +S   + ++ +S+                      L+   G  NI+ L  V  
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 237 DPVSRTPALIFEHVNNTD-FKQLYQT--LTDYDIRYYLYELLKALDYCHSMGIMHRDVKP 293
           D +     L+ E +N  + F+++ +    ++ +  Y + +L+ A+ + H +G++HRD+KP
Sbjct: 77  DQLHTF--LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 294 HNVMIDHENRKL--RLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQYHIELDPRF 350
            N++   EN  L  ++ID+G A    P  Q       + ++  PELL    Y    D   
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWS 194
Query: 351 ADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS--RKRWERFVHTENQHLVS 408
             ++  ++    +    + ++ L    A++ + K   G  S   + W+          VS
Sbjct: 195 LGVI-LYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN---------VS 244
Query: 409 PEALDFLDKLLRYDHYERL 427
            EA D +  LL  D  +RL
Sbjct: 245 QEAKDLIQGLLTVDPNKRL 263

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 57/99 (57%), Gaps = 5/99 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 105
           PELL +      S D+W+LGC++  ++    PF  G++ 
Sbjct: 203 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEG 240

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 249 HVNNTDFKQLYQTLTDYD---IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKL 305
           +  N +  +  + +  +D    R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +
Sbjct: 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHI 171
Query: 306 RLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLAD 339
           ++ D+G A+   P  +    N  V +  +  PELL +
Sbjct: 172 QITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHEN---RKLRLIDWGLAEFYHPGQEYNVRVASRY- 63
           +  ++Y H+ G++HRD+KP N++   E+     +R+ D+G A+      E  + +   Y 
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA--ENGLLMTPCYT 183
Query: 64  --FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
             F  PE+L + Q YD + D+WSLG +L +M+    PF +G D+  +   I   +G+ + 
Sbjct: 184 ANFVAPEVL-ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE--EILARIGSGK- 239
Query: 122 FEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRK--- 178
           F     Y   +     D++ +  ++ D +            ++V W Q   YQL R+   
Sbjct: 240 FSLSGGYWNSVSDTAKDLVSKM-LHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAP 298
Query: 179 -LGRGKYSEVFEAINVQSS 196
            L +G  +  + A+N   S
Sbjct: 299 HLVKGAMAATYSALNRNQS 317

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDF--KQLYQTL-TDYDIRYYLYELLKALDYCHS 283
           NIITL+ V  D   +   ++ E +   +   K L Q   ++ +    L+ + K ++Y H+
Sbjct: 77  NIITLKDVYDD--GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 284 MGIMHRDVKPHNVMIDHEN---RKLRLIDWGLAEFYHPGQEYNVRVASRY---FKGPELL 337
            G++HRD+KP N++   E+     +R+ D+G A+      E  + +   Y   F  PE+L
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVL 192
Query: 338 ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER 397
               Y    D     +L       +  F +  +    +PE        IL R    ++  
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD---TPE-------EILARIGSGKFSL 242
Query: 398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                N   VS  A D + K+L  D ++RLTA   + HP+ 
Sbjct: 243 SGGYWNS--VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 227 NIITLQAVVKDPVSRTPA-LIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCH 282
           N+ITL  V ++   RT   LI E V+     DF    ++L++ +   ++ ++L  ++Y H
Sbjct: 76  NVITLHDVYEN---RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 283 SMGIMHRDVKPHNVMIDHENRK---LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           +  I H D+KP N+M+  +N     ++LID+GLA     G E+     +  F  PE++  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 340 YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
               +E D     ++          F+    Q  ++         NI         E F 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------NITSVSYDFDEEFFS 243
Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS 446
           HT      S  A DF+ KLL  +  +RLT +EA+ HP+  P+   Q+
Sbjct: 244 HT------SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 122 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 180
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 181 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 217

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 113 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANX 171
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 172 FVGTAQYVSPELLTE 186

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDY 198
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 199 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 257
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 258 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 301

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 34  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 93
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 94  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 150
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 151 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 208
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 209 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 253
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 254 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 227 NIITLQAVVKDPVSRTPA-LIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCH 282
           N+ITL  V ++   RT   LI E V+     DF    ++L++ +   ++ ++L  ++Y H
Sbjct: 76  NVITLHDVYEN---RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 283 SMGIMHRDVKPHNVMIDHENRK---LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           +  I H D+KP N+M+  +N     ++LID+GLA     G E+     +  F  PE++  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 340 YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
               +E D     ++          F+    Q  ++         NI         E F 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------NITSVSYDFDEEFFS 243
Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS 446
           HT      S  A DF+ KLL  +  +RLT +EA+ HP+  P+   Q+
Sbjct: 244 HT------SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 201 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANX 191
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 192 FVGTAQYVSPELLTE 206

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 178
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 179 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 215

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 111 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANX 169
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 170 FVGTAQYVSPELLTE 184

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 201 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANX 191
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 192 FVGTAQYVSPELLTE 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 119 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 177
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 178 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 214

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 110 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANX 168
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 169 FVGTAQYVSPELLTE 183

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 203 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANX 193
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 194 FVGTAQYVSPELLTE 208

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 201 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANX 191
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 192 FVGTAQYVSPELLTE 206

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 147 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 205
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 206 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 242

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 247 FEHVNNTDFKQLYQTLTDYD---IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
             +  N +  +  + +  +D    R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+ 
Sbjct: 114 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDM 172
Query: 304 KLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLAD 339
            +++ D+G A+   P  +    N  V +  +  PELL +
Sbjct: 173 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 203 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANX 193
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 194 FVGTAQYVSPELLTE 208

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 145 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 203
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 204 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 136 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANX 194
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 195 FVGTAQYVSPELLTE 209

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 121 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 179
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 180 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 216

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 112 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANX 170
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 171 FVGTAQYVSPELLTE 185

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 203 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANX 193
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 194 FVGTAQYVSPELLTE 208

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 63/121 (52%), Gaps = 19/121 (15%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-------------PGQEYN 56
           AL Y HS GI+HRD+KP N+ ID E+R +++ D+GLA+  H             PG   N
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 57  VR--VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   + +  +   E+L     Y+  +DM+SLG +   MI+   PF  G +  + L ++  
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRS 243
Query: 115 V 115
           V
Sbjct: 244 V 244

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 35/45 (77%), Gaps = 1/45 (2%)
Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH 317
           ++L+AL Y HS GI+HRD+KP N+ ID E+R +++ D+GLA+  H
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVH 167

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 132 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDY 189
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 190 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 248
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 249 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 292

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 25  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 84
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 85  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 141
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 142 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 199
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 200 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 244
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 245 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 277

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 63/121 (52%), Gaps = 19/121 (15%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-------------PGQEYN 56
           AL Y HS GI+HRD+KP N+ ID E+R +++ D+GLA+  H             PG   N
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 57  VR--VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   + +  +   E+L     Y+  +DM+SLG +   MI+   PF  G +  + L ++  
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRS 243
Query: 115 V 115
           V
Sbjct: 244 V 244

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 35/45 (77%), Gaps = 1/45 (2%)
Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH 317
           ++L+AL Y HS GI+HRD+KP N+ ID E+R +++ D+GLA+  H
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVH 167

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 126 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 184
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 185 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 221

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 117 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANX 175
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 176 FVGTAQYVSPELLTE 190

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 202
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL + +    S D+W+LGC++  ++    PF  G++
Sbjct: 203 PELLTE-KSASKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANS 193
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 194 FVGTAQYVSPELLTE 208

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 145 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 203
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 204 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 136 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANS 194
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 195 FVGTAQYVSPELLTE 209

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 141 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 199
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 200 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 132 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANX 190
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 191 FVGTAQYVSPELLTE 205

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 149 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 207
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 208 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 244

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 140 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANX 198
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 199 FVGTAQYVSPELLTE 213

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N  V +  +  
Sbjct: 141 ALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 199
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           PELL +      S D+W+LGC++  ++    PF  G++
Sbjct: 200 PELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 4/75 (5%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 324
           R+Y  E++ AL+Y H  GI+HRD+KP N++++ E+  +++ D+G A+   P  +    N 
Sbjct: 132 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANS 190
Query: 325 RVASRYFKGPELLAD 339
            V +  +  PELL +
Sbjct: 191 FVGTAQYVSPELLTE 205

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDY 175
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 176 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 235 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 278

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 71  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 128 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 230
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 231 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 246 IFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN-RK 304
           +F+ +   D+K     +++ ++  Y+ +  + L + H   I+H D+KP N+M + +    
Sbjct: 135 LFDRIAAEDYK-----MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS 189
Query: 305 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWER 364
           +++ID+GLA   +P +   V  A+  F  PE++         D     +LG         
Sbjct: 190 VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
Query: 365 FVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHY 424
           F   +             D   L    R  WE     +    VSPEA DF+  LL+ +  
Sbjct: 250 FAGED-------------DLETLQNVKRCDWE--FDEDAFSSVSPEAKDFIKNLLQKEPR 294
Query: 425 ERLTAREAMDHPYF 438
           +RLT  +A++HP+ 
Sbjct: 295 KRLTVHDALEHPWL 308

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P    +    +  +
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRDTLCGTLDY 173
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 174 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 232
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 233 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 276

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 115/280 (41%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 69  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 125
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P    +    +  +  PE++    
Sbjct: 126 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRM 183
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 228
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 229 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+             + Y+  P
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 188
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E+L   + YD S DMWSLG ++  ++    PF+  H
Sbjct: 189 EVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 223

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 78/182 (42%), Gaps = 15/182 (8%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYH 317
           Q  T+ +    +  + +A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+   
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171
Query: 318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
                     + Y+  PE+L   +Y    D     ++       +  F ++ +   +SP 
Sbjct: 172 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISP- 229
Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                     G  +R R  ++     +   VS E    +  LL+ +  +R+T  E M+HP
Sbjct: 230 ----------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 279
Query: 437 YF 438
           + 
Sbjct: 280 WI 281

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+             + Y+  P
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 188
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E+L   + YD S DMWSLG ++  ++    PF+  H
Sbjct: 189 EVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 223

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 78/182 (42%), Gaps = 15/182 (8%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYH 317
           Q  T+ +    +  + +A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+   
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171
Query: 318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
                     + Y+  PE+L   +Y    D     ++       +  F ++ +   +SP 
Sbjct: 172 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISP- 229
Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                     G  +R R  ++     +   VS E    +  LL+ +  +R+T  E M+HP
Sbjct: 230 ----------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 279
Query: 437 YF 438
           + 
Sbjct: 280 WI 281

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+             + Y+  P
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 186
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E+L   + YD S DMWSLG ++  ++    PF+  H
Sbjct: 187 EVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 221

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 78/182 (42%), Gaps = 15/182 (8%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYH 317
           Q  T+ +    +  + +A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+   
Sbjct: 110 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 169
Query: 318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
                     + Y+  PE+L   +Y    D     ++       +  F ++ +   +SP 
Sbjct: 170 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISP- 227
Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                     G  +R R  ++     +   VS E    +  LL+ +  +R+T  E M+HP
Sbjct: 228 ----------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 277
Query: 437 YF 438
           + 
Sbjct: 278 WI 279

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+             + Y+  P
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E+L   + YD S DMWSLG ++  ++    PF+  H
Sbjct: 233 EVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 78/182 (42%), Gaps = 15/182 (8%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYH 317
           Q  T+ +    +  + +A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+   
Sbjct: 156 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
                     + Y+  PE+L   +Y    D     ++       +  F ++ +   +SP 
Sbjct: 216 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISP- 273
Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                     G  +R R  ++     +   VS E    +  LL+ +  +R+T  E M+HP
Sbjct: 274 ----------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323
Query: 437 YF 438
           + 
Sbjct: 324 WI 325

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDY 172
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 173 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 275

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 68  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 125 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 182
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 227
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 228 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+             + Y+  P
Sbjct: 128 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 187
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E+L   + YD S DMWSLG ++  ++    PF+  H
Sbjct: 188 EVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 222

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 78/182 (42%), Gaps = 15/182 (8%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYH 317
           Q  T+ +    +  + +A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+   
Sbjct: 111 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 170
Query: 318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
                     + Y+  PE+L   +Y    D     ++       +  F ++ +   +SP 
Sbjct: 171 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISP- 228
Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                     G  +R R  ++     +   VS E    +  LL+ +  +R+T  E M+HP
Sbjct: 229 ----------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 278
Query: 437 YF 438
           + 
Sbjct: 279 WI 280

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDY 177
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 178 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 236
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 237 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 280

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 73  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 129
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 130 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 232
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 233 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDY 177
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 178 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 236
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 237 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 280

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/279 (21%), Positives = 111/279 (39%), Gaps = 37/279 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD---IRYYLYELLKALDYCH 282
            NI+ L     D  +R   LI E+    +  +  Q L+ +D      Y+ EL  AL YCH
Sbjct: 73  PNILRLYGYFHD-ATRV-YLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCH 130
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
           S  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    +
Sbjct: 131 SKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 343 HIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
             ++D     +L       +  +E   + E    +S     F D                
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD---------------- 232
Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                  V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 233 ------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+             + Y+  P
Sbjct: 134 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 193
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E+L   + YD S DMWSLG ++  ++    PF+  H
Sbjct: 194 EVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 228

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 78/182 (42%), Gaps = 15/182 (8%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYH 317
           Q  T+ +    +  + +A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+   
Sbjct: 117 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 176
Query: 318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
                     + Y+  PE+L   +Y    D     ++       +  F ++ +   +SP 
Sbjct: 177 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISP- 234
Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                     G  +R R  ++     +   VS E    +  LL+ +  +R+T  E M+HP
Sbjct: 235 ----------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 284
Query: 437 YF 438
           + 
Sbjct: 285 WI 286

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+             + Y+  P
Sbjct: 133 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 192
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E+L   + YD S DMWSLG ++  ++    PF+  H
Sbjct: 193 EVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 227

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 78/182 (42%), Gaps = 15/182 (8%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYH 317
           Q  T+ +    +  + +A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+   
Sbjct: 116 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 175
Query: 318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
                     + Y+  PE+L   +Y    D     ++       +  F ++ +   +SP 
Sbjct: 176 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISP- 233
Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                     G  +R R  ++     +   VS E    +  LL+ +  +R+T  E M+HP
Sbjct: 234 ----------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 283
Query: 437 YF 438
           + 
Sbjct: 284 WI 285

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+             + Y+  P
Sbjct: 179 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 238
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E+L   + YD S DMWSLG ++  ++    PF+  H
Sbjct: 239 EVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 273

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/187 (23%), Positives = 79/187 (42%), Gaps = 15/187 (8%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYH 317
           Q  T+ +    +  + +A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+   
Sbjct: 162 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 221
Query: 318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
                     + Y+  PE+L   +Y    D     ++       +  F ++ +   +SP 
Sbjct: 222 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISP- 279
Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                     G  +R R  ++     +   VS E    +  LL+ +  +R+T  E M+HP
Sbjct: 280 ----------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 329
Query: 437 YFYPIVK 443
           +     K
Sbjct: 330 WIMQSTK 336

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+             + Y+  P
Sbjct: 135 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 194
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E+L   + YD S DMWSLG ++  ++    PF+  H
Sbjct: 195 EVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 229

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 78/182 (42%), Gaps = 15/182 (8%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYH 317
           Q  T+ +    +  + +A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+   
Sbjct: 118 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 177
Query: 318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
                     + Y+  PE+L   +Y    D     ++       +  F ++ +   +SP 
Sbjct: 178 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISP- 235
Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                     G  +R R  ++     +   VS E    +  LL+ +  +R+T  E M+HP
Sbjct: 236 ----------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 285
Query: 437 YF 438
           + 
Sbjct: 286 WI 287

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+             + Y+  P
Sbjct: 143 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 202
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E+L   + YD S DMWSLG ++  ++    PF+  H
Sbjct: 203 EVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 237

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/187 (23%), Positives = 79/187 (42%), Gaps = 15/187 (8%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYH 317
           Q  T+ +    +  + +A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+   
Sbjct: 126 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 185
Query: 318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
                     + Y+  PE+L   +Y    D     ++       +  F ++ +   +SP 
Sbjct: 186 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISP- 243
Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                     G  +R R  ++     +   VS E    +  LL+ +  +R+T  E M+HP
Sbjct: 244 ----------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 293
Query: 437 YFYPIVK 443
           +     K
Sbjct: 294 WIMQSTK 300

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 51/90 (56%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A++YCH   I+HRD+KP N+++D E+  +++ D+GL+     G        S  +  PE+
Sbjct: 124 AVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 182
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           ++        +D+WS G +L  M+ R+ PF
Sbjct: 183 ISGKLYAGPEVDVWSCGVILYVMLCRRLPF 212

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 84/190 (44%), Gaps = 12/190 (6%)
Query: 161 ESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXX----- 215
           +S + D     +YQ+V+ LG G + +V  A +  +                         
Sbjct: 3   KSSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER 62
Query: 216 -XXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLY 272
               L  LR   +II L  V+K        ++ E+  N  F  + Q   +++ + R +  
Sbjct: 63  EISYLRLLRH-PHIIKLYDVIKS--KDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQ 119
Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 332
           +++ A++YCH   I+HRD+KP N+++D E+  +++ D+GL+     G        S  + 
Sbjct: 120 QIISAVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 178
Query: 333 GPELLADYQY 342
            PE+++   Y
Sbjct: 179 APEVISGKLY 188

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 59/104 (56%), Gaps = 5/104 (4%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKG 66
           S+AL+Y H  GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  
Sbjct: 163 SLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQ 108
           PE+L   + Y +S+D W+LG ++  M+  + PF      DN DQ
Sbjct: 222 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 54/107 (50%), Gaps = 5/107 (4%)
Query: 245 LIFEHVNNTDFK---QLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE 301
            + E+VN  D     Q  + L +   R+Y  E+  AL+Y H  GI++RD+K  NV++D E
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 189
Query: 302 NRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
              ++L D+G+  E   PG   +    +  +  PE+L    Y   +D
Sbjct: 190 GH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 235

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 51/90 (56%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A++YCH   I+HRD+KP N+++D E+  +++ D+GL+     G        S  +  PE+
Sbjct: 115 AVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 173
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           ++        +D+WS G +L  M+ R+ PF
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPF 203

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 12/179 (6%)
Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXX------XXXLENLRGG 225
           +YQ+V+ LG G + +V  A +  +                             L  LR  
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH- 63
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHS 283
            +II L  V+K        ++ E+  N  F  + Q   +++ + R +  +++ A++YCH 
Sbjct: 64  PHIIKLYDVIKS--KDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 121
Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
             I+HRD+KP N+++D E+  +++ D+GL+     G        S  +  PE+++   Y
Sbjct: 122 HKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 179

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 51/90 (56%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A++YCH   I+HRD+KP N+++D E+  +++ D+GL+     G        S  +  PE+
Sbjct: 119 AVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 177
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           ++        +D+WS G +L  M+ R+ PF
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPF 207

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 82/187 (43%), Gaps = 12/187 (6%)
Query: 164 VVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXX------XX 217
           + D     +YQ+V+ LG G + +V  A +  +                            
Sbjct: 1   LADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREIS 60
Query: 218 XLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELL 275
            L  LR   +II L  V+K        ++ E+  N  F  + Q   +++ + R +  +++
Sbjct: 61  YLRLLRH-PHIIKLYDVIKS--KDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 117
Query: 276 KALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 335
            A++YCH   I+HRD+KP N+++D E+  +++ D+GL+     G        S  +  PE
Sbjct: 118 SAVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 176
Query: 336 LLADYQY 342
           +++   Y
Sbjct: 177 VISGKLY 183

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/281 (22%), Positives = 114/281 (40%), Gaps = 28/281 (9%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLR---- 223
           G  D YQ V+KLG G Y EV    +  +                       L+ +     
Sbjct: 18  GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 77
Query: 224 -GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQ---LYQTLTDYDIRYYLYELLKALD 279
               NI+ L    +D   R   L+ E     +      L Q  ++ D    + ++L    
Sbjct: 78  LDHPNIMKLYEFFED--KRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT 135
Query: 280 YCHSMGIMHRDVKPHNVMIDHENRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
           Y H   I+HRD+KP N++++ ++R   ++++D+GL+  +  G +   R+ + Y+  PE+L
Sbjct: 136 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 195
Query: 338 ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER 397
              +Y  + D              W   V         P      D+ IL R  + ++  
Sbjct: 196 RK-KYDEKCDV-------------WSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFS- 240
Query: 398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                +   VS EA   +  +L Y+  +R++A EA++HP+ 
Sbjct: 241 -FDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 51/90 (56%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A++YCH   I+HRD+KP N+++D E+  +++ D+GL+     G        S  +  PE+
Sbjct: 125 AVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 183
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           ++        +D+WS G +L  M+ R+ PF
Sbjct: 184 ISGKLYAGPEVDVWSCGVILYVMLCRRLPF 213

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 84/190 (44%), Gaps = 12/190 (6%)
Query: 161 ESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXX----- 215
           +S + D     +YQ+V+ LG G + +V  A +  +                         
Sbjct: 4   KSSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER 63
Query: 216 -XXXLENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLY 272
               L  LR   +II L  V+K        ++ E+  N  F  + Q   +++ + R +  
Sbjct: 64  EISYLRLLRH-PHIIKLYDVIKS--KDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQ 120
Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 332
           +++ A++YCH   I+HRD+KP N+++D E+  +++ D+GL+     G        S  + 
Sbjct: 121 QIISAVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 179
Query: 333 GPELLADYQY 342
            PE+++   Y
Sbjct: 180 APEVISGKLY 189

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 18/178 (10%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQ 320
           L +  I      +L+AL Y H+ G++HRD+K  ++++  + R ++L D+G  A+      
Sbjct: 138 LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVP 196
Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD 380
           +    V + Y+  PE+++   Y  E+D              W   +      +V  E   
Sbjct: 197 KRKXLVGTPYWMAPEVISRSLYATEVDI-------------WSLGIMV--IEMVDGEPPY 241
Query: 381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           F D  +     R R       +N H VSP   DFL+++L  D  ER TA+E +DHP+ 
Sbjct: 242 FSDSPVQA-MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P    +    +  +
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRDDLCGTLDY 198
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 199 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 257
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 258 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 301

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 115/280 (41%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 34  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 93
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 94  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 150
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P    +    +  +  PE++    
Sbjct: 151 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRM 208
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 209 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 253
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 254 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 115 TELANALSYCHSKKVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRAALCGTLDY 172
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      D Y ++ R+          
Sbjct: 173 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTE 231
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKP 154
           G  +L   L K++    P   ++L    + A  NS KP
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKP 267

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/279 (22%), Positives = 114/279 (40%), Gaps = 37/279 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A    S                            +++    
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  S    LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 68  PNILRLYGYFHD--STRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 125 HSKKVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM 182
Query: 342 YHIELDPRFADILGRHSRKRWERFVHTENQHLVSP--EALDFLDKNILGRHSRKRWERFV 399
           +  ++D              W   V      +  P  EA  + D       + KR  R V
Sbjct: 183 HDEKVD-------------LWSLGVLCYEFLVGKPPFEANTYQD-------TYKRISR-V 221
Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                  V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 222 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-CHAPSSRRTTLSGTLDY 173
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 174 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 232
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 233 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNSQNKES 276

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 122/296 (41%), Gaps = 45/296 (15%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 69  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 125
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 126 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMIEGRM 183
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 228
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSS 454
                   V+  A D + +LL+++  +R   RE ++HP+   I  + S+   PS+S
Sbjct: 229 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPW---ITANSSK---PSNS 271

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 22/180 (12%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQ 320
           + +  I      +L+AL   H+ G++HRD+K  ++++ H+ R ++L D+G  A+      
Sbjct: 244 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVP 302
Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP--EA 378
                V + Y+  PEL++   Y  E+D     I+           V  E  +   P  +A
Sbjct: 303 RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM-------VIEMVDGEPPYFNEPPLKA 355
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           +  +  N+  R            +N H VSP    FLD+LL  D  +R TA E + HP+ 
Sbjct: 356 MKMIRDNLPPR-----------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRAALCGTLDY 175
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 176 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 235 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 278

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 71  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 128 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM 185
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 230
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 231 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 22/180 (12%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQ 320
           + +  I      +L+AL   H+ G++HRD+K  ++++ H+ R ++L D+G  A+      
Sbjct: 167 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVP 225
Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP--EA 378
                V + Y+  PEL++   Y  E+D     I+           V  E  +   P  +A
Sbjct: 226 RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM-------VIEMVDGEPPYFNEPPLKA 278
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           +  +  N+  R            +N H VSP    FLD+LL  D  +R TA E + HP+ 
Sbjct: 279 MKMIRDNLPPR-----------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 59/104 (56%), Gaps = 5/104 (4%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKG 66
           S+AL+Y H  GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  
Sbjct: 131 SLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 189
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQ 108
           PE+L   + Y +S+D W+LG ++  M+  + PF      DN DQ
Sbjct: 190 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 232

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 54/107 (50%), Gaps = 5/107 (4%)
Query: 245 LIFEHVNNTDFK---QLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE 301
            + E+VN  D     Q  + L +   R+Y  E+  AL+Y H  GI++RD+K  NV++D E
Sbjct: 98  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 157
Query: 302 NRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
              ++L D+G+  E   PG   +    +  +  PE+L    Y   +D
Sbjct: 158 GH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVD 203

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 59/104 (56%), Gaps = 5/104 (4%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKG 66
           S+AL+Y H  GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  
Sbjct: 116 SLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 174
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQ 108
           PE+L   + Y +S+D W+LG ++  M+  + PF      DN DQ
Sbjct: 175 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 217

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 54/107 (50%), Gaps = 5/107 (4%)
Query: 245 LIFEHVNNTDFK---QLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE 301
            + E+VN  D     Q  + L +   R+Y  E+  AL+Y H  GI++RD+K  NV++D E
Sbjct: 83  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 142
Query: 302 NRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
              ++L D+G+  E   PG   +    +  +  PE+L    Y   +D
Sbjct: 143 GH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVD 188

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTELCGTLDY 172
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 173 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 275

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 68  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 125 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGRM 182
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 227
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 228 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 117 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRXXLCGTLDY 174
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 175 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 233
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 234 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 277

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 69
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 70  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 126
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 127 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM 184
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 229
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 230 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 59/104 (56%), Gaps = 5/104 (4%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKG 66
           S+AL+Y H  GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 178
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQ 108
           PE+L   + Y +S+D W+LG ++  M+  + PF      DN DQ
Sbjct: 179 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 54/107 (50%), Gaps = 5/107 (4%)
Query: 245 LIFEHVNNTDFK---QLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE 301
            + E+VN  D     Q  + L +   R+Y  E+  AL+Y H  GI++RD+K  NV++D E
Sbjct: 87  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 146
Query: 302 NRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
              ++L D+G+  E   PG   +    +  +  PE+L    Y   +D
Sbjct: 147 GH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVD 192

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+             + Y+  P
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAP 186
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E+L   + YD S DMWSLG ++  ++    PF+  H
Sbjct: 187 EVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 221

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 78/182 (42%), Gaps = 15/182 (8%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYH 317
           Q  T+ +    +  + +A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+   
Sbjct: 110 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 169
Query: 318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
                     + Y+  PE+L   +Y    D     ++       +  F ++ +   +SP 
Sbjct: 170 SHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISP- 227
Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                     G  +R R  ++     +   VS E    +  LL+ +  +R+T  E M+HP
Sbjct: 228 ----------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 277
Query: 437 YF 438
           + 
Sbjct: 278 WI 279

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 22/180 (12%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQ 320
           + +  I      +L+AL   H+ G++HRD+K  ++++ H+ R ++L D+G  A+      
Sbjct: 124 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVP 182
Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP--EA 378
                V + Y+  PEL++   Y  E+D     I+           V  E  +   P  +A
Sbjct: 183 RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM-------VIEMVDGEPPYFNEPPLKA 235
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           +  +  N+  R            +N H VSP    FLD+LL  D  +R TA E + HP+ 
Sbjct: 236 MKMIRDNLPPR-----------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 284

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 25/227 (11%)
Query: 227 NIITLQAVVKDPVSRTPA-LIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCH 282
           N+ITL  V ++   RT   LI E V+     DF    ++L++ +   ++ ++L  ++Y H
Sbjct: 76  NVITLHDVYEN---RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 283 SMGIMHRDVKPHNVMIDHENRK---LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           +  I H D+KP N+M+  +N     ++LID+GLA     G E+     +  F  PE++  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 340 YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
               +E D     ++          F+    Q  ++         NI         E F 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------NITAVSYDFDEEFFS 243
Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS 446
            T      S  A DF+ KLL  +  +RLT +EA+ HP+  P+   Q+
Sbjct: 244 QT------SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 22/180 (12%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQ 320
           + +  I      +L+AL   H+ G++HRD+K  ++++ H+ R ++L D+G  A+      
Sbjct: 122 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVP 180
Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP--EA 378
                V + Y+  PEL++   Y  E+D     I+           V  E  +   P  +A
Sbjct: 181 RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM-------VIEMVDGEPPYFNEPPLKA 233
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           +  +  N+  R            +N H VSP    FLD+LL  D  +R TA E + HP+ 
Sbjct: 234 MKMIRDNLPPR-----------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 282

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 62/107 (57%), Gaps = 5/107 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
            + Y H   I+HRD+KP N++++++N    ++++D+GL+ F+    +   R+ + Y+  P
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           E+L   + Y+   D+WS G ++  ++    P F G ++ D + ++ K
Sbjct: 218 EVLK--KKYNEKCDVWSCGVIMYILLCGYPP-FGGQNDQDIIKKVEK 261

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 81/171 (47%), Gaps = 28/171 (16%)
Query: 271 LYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQEYNVRVAS 328
           + ++L  + Y H   I+HRD+KP N++++++N    ++++D+GL+ F+    +   R+ +
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 329 RYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEA-----LDFLD 383
            Y+  PE+L   +Y+ + D     ++       +  F    +Q ++          DF D
Sbjct: 212 AYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270
Query: 384 KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD 434
                      W+          +S EA + +  +L YD+ +R TA EA++
Sbjct: 271 -----------WKN---------ISDEAKELIKLMLTYDYNKRCTAEEALN 301

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 25/227 (11%)
Query: 227 NIITLQAVVKDPVSRTPA-LIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCH 282
           N+ITL  V ++   RT   LI E V+     DF    ++L++ +   ++ ++L  ++Y H
Sbjct: 76  NVITLHDVYEN---RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 283 SMGIMHRDVKPHNVMIDHENRK---LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           +  I H D+KP N+M+  +N     ++LID+GLA     G E+     +  F  PE++  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 340 YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
               +E D     ++          F+    Q  ++         NI         E F 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------NITAVSYDFDEEFFS 243
Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS 446
            T      S  A DF+ KLL  +  +RLT +EA+ HP+  P+   Q+
Sbjct: 244 QT------SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 60/104 (57%), Gaps = 5/104 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 70
           Y H   I+HRD+KP N++++ ++R   ++++D+GL+  +  G +   R+ + Y+  PE+L
Sbjct: 119 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 178
Query: 71  ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
              + YD   D+WS G +L  ++    P F G  + + L R+ K
Sbjct: 179 R--KKYDEKCDVWSCGVILYILLCGYPP-FGGQTDQEILKRVEK 219

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/300 (22%), Positives = 119/300 (39%), Gaps = 32/300 (10%)
Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLR---- 223
           G  D YQ V+KLG G Y EV    +  +                       L+ +     
Sbjct: 1   GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 60
Query: 224 -GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQ---LYQTLTDYDIRYYLYELLKALD 279
               NI+ L    +D   R   L+ E     +      L Q  ++ D    + ++L    
Sbjct: 61  LDHPNIMKLYEFFEDK--RNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT 118
Query: 280 YCHSMGIMHRDVKPHNVMIDHENRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
           Y H   I+HRD+KP N++++ ++R   ++++D+GL+  +  G +   R+ + Y+  PE+L
Sbjct: 119 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 178
Query: 338 ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER 397
              +Y  + D              W   V         P      D+ IL R  + ++  
Sbjct: 179 RK-KYDEKCDV-------------WSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFS- 223
Query: 398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK----DQSRHTLPSS 453
                +   VS EA   +  +L Y+  +R++A EA++HP+          D  +H L  +
Sbjct: 224 -FDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVKFCSQKHTDVGKHALTGA 282

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 22/180 (12%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQ 320
           + +  I      +L+AL   H+ G++HRD+K  ++++ H+ R ++L D+G  A+      
Sbjct: 117 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVP 175
Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP--EA 378
                V + Y+  PEL++   Y  E+D     I+           V  E  +   P  +A
Sbjct: 176 RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM-------VIEMVDGEPPYFNEPPLKA 228
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           +  +  N+  R            +N H VSP    FLD+LL  D  +R TA E + HP+ 
Sbjct: 229 MKMIRDNLPPR-----------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 277

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 25/227 (11%)
Query: 227 NIITLQAVVKDPVSRTPA-LIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCH 282
           NIITL  V ++   RT   LI E V+     DF    ++L++ +   ++ ++L  ++Y H
Sbjct: 76  NIITLHDVYEN---RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 283 SMGIMHRDVKPHNVMIDHENRK---LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           +  I H D+KP N+M+  +N     ++LID+GLA     G E+     +  F  PE++  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 340 YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
               +E D     ++          F+    Q  ++         NI         E F 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------NITAVSYDFDEEFFS 243
Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS 446
            T      S  A DF+ KLL  +  +RLT +EA+ HP+  P+   Q+
Sbjct: 244 QT------SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQA 284

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ ++G +  + P         +  +
Sbjct: 117 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIANFGWS-VHAPSSRRTTLCGTLDY 174
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 175 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 233
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 234 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 277

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 69
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 70  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 126
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ ++G +  + P         +  +  PE++    
Sbjct: 127 HSKRVIHRDIKPENLLLGSAG-ELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 184
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 229
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 230 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 22/180 (12%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQ 320
           + +  I      +L+AL   H+ G++HRD+K  ++++ H+ R ++L D+G  A+      
Sbjct: 113 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVP 171
Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP--EA 378
                V + Y+  PEL++   Y  E+D     I+           V  E  +   P  +A
Sbjct: 172 RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM-------VIEMVDGEPPYFNEPPLKA 224
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           +  +  N+  R            +N H VSP    FLD+LL  D  +R TA E + HP+ 
Sbjct: 225 MKMIRDNLPPR-----------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 85/179 (47%), Gaps = 16/179 (8%)
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVM-IDHENRKLRLIDWGLAEFYHPG 319
            LT+ D   ++ ++ + + + H M I+H D+KP N++ ++ + +++++ID+GLA  Y P 
Sbjct: 183 NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242
Query: 320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEAL 379
           ++  V   +  F  PE++         D     ++          F+   +   ++    
Sbjct: 243 EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN---- 298
Query: 380 DFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                NIL      RW+  +  E    +S EA +F+ KLL  +   R++A EA+ HP+ 
Sbjct: 299 -----NILAC----RWD--LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHEN---RKLRLIDWGLA-EFYHPGQEYNVRVASRY 63
           +  ++Y H+ G++HRD+KP N++   E+     +R+ D+G A +             +  
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTAN 185
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFE 123
           F  PE+L + Q YD + D+WSLG +L + +    PF +G D+  +   I   +G+ + F 
Sbjct: 186 FVAPEVL-ERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPE--EILARIGSGK-FS 241
Query: 124 YLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRK----L 179
               Y   +     D++ +  ++ D +            ++V W Q   YQL R+    L
Sbjct: 242 LSGGYWNSVSDTAKDLVSKX-LHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHL 300
Query: 180 GRGKYSEVFEAINVQSS 196
            +G  +  + A+N   S
Sbjct: 301 VKGAXAATYSALNRNQS 317

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 16/172 (9%)
Query: 271 LYELLKALDYCHSMGIMHRDVKPHNVMIDHEN---RKLRLIDWGLA-EFYHPGQEYNVRV 326
           L+ + K ++Y H+ G++HRD+KP N++   E+     +R+ D+G A +            
Sbjct: 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPC 181
Query: 327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI 386
            +  F  PE+L    Y    D     +L       +  F +  +    +PE        I
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDD---TPE-------EI 231
Query: 387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           L R    ++       N   VS  A D + K L  D ++RLTA   + HP+ 
Sbjct: 232 LARIGSGKFSLSGGYWNS--VSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTDLCGTLDY 173
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 174 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 232
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 233 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 276

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 69  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 125
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 126 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 228
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 229 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTDLCGTLDY 172
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 173 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 275

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 68  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 125 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM 182
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 227
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 228 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRXXLXGTLDY 177
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 178 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 236
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 237 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 280

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/279 (21%), Positives = 111/279 (39%), Gaps = 37/279 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD---IRYYLYELLKALDYCH 282
            NI+ L     D  +R   LI E+    +  +  Q L+ +D      Y+ EL  AL YCH
Sbjct: 73  PNILRLYGYFHD-ATRV-YLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCH 130
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
           S  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    +
Sbjct: 131 SKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRMH 188
Query: 343 HIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
             ++D     +L       +  +E   + E    +S     F D                
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD---------------- 232
Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                  V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 233 ------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 114 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDY 171
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 172 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 230
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKP 154
           G  +L   L K++    P   ++L    + A  NS KP
Sbjct: 231 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKP 266

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 7   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 66
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 67  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 123
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 124 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 181
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 182 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 226
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 227 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 259

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTDLCGTLDY 172
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 173 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 275

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 68  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 125 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM 182
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 227
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 228 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTDLCGTLDY 177
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 178 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 236
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 237 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKPSNCQNKES 280

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 73  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 129
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 130 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM 187
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 232
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 233 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 26/199 (13%)
Query: 245 LIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI-DHENR 303
           L FE V   D   +Y   ++    +Y+ ++L+AL YCH   I+HRDVKP NV++   EN 
Sbjct: 113 LCFEIVKRADAGFVY---SEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENS 169
Query: 304 K-LRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKR 361
             ++L D+G+A +    G     RV + +F  PE++    Y   +D     ++       
Sbjct: 170 APVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
Query: 362 WERFVHTENQHLVSPEALDFLDKNILGRH--SRKRWERFVHTENQHLVSPEALDFLDKLL 419
              F  T+ +           +  I G++  + ++W           +S  A D + ++L
Sbjct: 230 CLPFYGTKER---------LFEGIIKGKYKMNPRQWSH---------ISESAKDLVRRML 271
Query: 420 RYDHYERLTAREAMDHPYF 438
             D  ER+T  EA++HP+ 
Sbjct: 272 MLDPAERITVYEALNHPWL 290

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDY 176
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 177 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 235
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKP 154
           G  +L   L K++    P   ++L    + A  NS KP
Sbjct: 236 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKP 271

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 12  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 71
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 72  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 128
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 129 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 186
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 231
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 232 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 264

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 38/222 (17%)
Query: 234 VVKDPVSRTPALIFEHVNNT--------DFKQLYQTLTDYDIRYYLYELLKALDYCHSMG 285
           VVK  +   P    E +N +        DF Q  + +++      + ++  AL Y H+ G
Sbjct: 134 VVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI-----MRQIFSALHYLHNQG 188
Query: 286 IMHRDVKPHNVMID-HENRKLRLIDWGLA-EFY--HPGQEYNV--RVASRYFKGPELL-- 337
           I HRD+KP N +   +++ +++L+D+GL+ EFY  + G+ Y +  +  + YF  PE+L  
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248
Query: 338 ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER 397
            +  Y  + D   A +L                 HL+   A+ F   N     S+   ++
Sbjct: 249 TNESYGPKCDAWSAGVL----------------LHLLLMGAVPFPGVNDADTISQVLNKK 292
Query: 398 FV-HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                 N +++SP A D L  LL  +  ER  A  A+ HP+ 
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N+ITL  V ++       LI E V      DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 75  NVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 284 MGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           + I H D+KP N+M+   N    ++++ID+GLA     G E+     +  F  PE++   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFL---DKNILGRHSRKRWER 397
              +E D              W   V T   +++   A  FL    +  L   S   +E 
Sbjct: 193 PLGLEAD-------------MWSIGVIT---YILLSGASPFLGDTKQETLANVSAVNYE- 235
Query: 398 FVHTENQHLVSPEAL--DFLDKLLRYDHYERLTAREAMDHPYFYP 440
               E+++  +  AL  DF+ +LL  D  +R+T ++++ HP+  P
Sbjct: 236 ---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 15/159 (9%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++   N +L++ D+G +  + P    +    +  +
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLG-SNGELKIADFGWS-VHAPSSRRDTLCGTLDY 176
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV--------- 115
             PE++ + +M+D  +D+WSLG +    +    P F  H   +   RI++V         
Sbjct: 177 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGMPP-FEAHTYQETYRRISRVEFTFPDFVT 234
Query: 116 LGTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKP 154
            G  +L   L K++       A++L    + A  NS KP
Sbjct: 235 EGARDLISRLLKHNASQRLTLAEVLEHPWIKA--NSSKP 271

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/280 (22%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+ + R LG+GK+  V+ A   QS                            +++    
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +    LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 72  PNILRLYGYFHD--ATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYITELANALSYC 128
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++   N +L++ D+G +  + P    +    +  +  PE++    
Sbjct: 129 HSKRVIHRDIKPENLLLG-SNGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRM 186
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L          +E   + E    +S     F D               
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD--------------- 231
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +RLT  E ++HP+ 
Sbjct: 232 -------FVTEGARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTXLCGTLDY 172
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 173 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKP 154
           G  +L   L K++    P   ++L    + A  NS KP
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKP 267

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 68  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 125 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGRM 182
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 227
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 228 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N+ITL  V ++       LI E V      DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 75  NVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 284 MGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           + I H D+KP N+M+   N    ++++ID+GLA     G E+     +  F  PE++   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYE 192
Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFL---DKNILGRHSRKRWER 397
              +E D              W   V T   +++   A  FL    +  L   S   +E 
Sbjct: 193 PLGLEAD-------------MWSIGVIT---YILLSGASPFLGDTKQETLANVSAVNYE- 235
Query: 398 FVHTENQHLVSPEAL--DFLDKLLRYDHYERLTAREAMDHPYFYP 440
               E+++  +  AL  DF+ +LL  D  +R+T ++++ HP+  P
Sbjct: 236 ---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRAALCGTLDY 172
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 173 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKP 154
           G  +L   L K++    P   ++L    + A  NS KP
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKP 267

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 68  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 125 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM 182
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 227
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 228 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CHS G++HRD+K  N++ID      +LID+G     H  + Y     +R +  PE 
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFDGTRVYSPPEW 209
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           ++ +Q +     +WSLG +L  M+    PF
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPF 239

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 44/76 (57%), Gaps = 1/76 (1%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R +  +++ A+ +CHS G++HRD+K  N++ID      +LID+G     H  + Y     
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFDG 200
Query: 328 SRYFKGPELLADYQYH 343
           +R +  PE ++ +QYH
Sbjct: 201 TRVYSPPEWISRHQYH 216

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 3/103 (2%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVA 60
           I      A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+             
Sbjct: 166 IXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 225
Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           + Y+  PE+L   + YD S D WSLG +   ++    PF+  H
Sbjct: 226 TPYYVAPEVLGP-EKYDKSCDXWSLGVIXYILLCGYPPFYSNH 267

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 2/90 (2%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYH 317
           Q  T+ +       + +A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+   
Sbjct: 156 QAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 318 PGQEYNVRVASRYFKGPELLADYQYHIELD 347
                     + Y+  PE+L   +Y    D
Sbjct: 216 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 77/159 (48%), Gaps = 15/159 (9%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++   N +L++ D+G +  + P         +  +
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLG-SNGELKIADFGWS-VHAPSSRRTTLCGTLDY 176
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV--------- 115
             PE++ + +M+D  +D+WSLG +    +    P F  H   +   RI++V         
Sbjct: 177 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGMPP-FEAHTYQETYRRISRVEFTFPDFVT 234
Query: 116 LGTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKP 154
            G  +L   L K++       A++L    + A  NS KP
Sbjct: 235 EGARDLISRLLKHNASQRLTLAEVLEHPWIKA--NSSKP 271

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/280 (22%), Positives = 113/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+ + R LG+GK+  V+ A   QS                            +++    
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +    LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 72  PNILRLYGYFHD--ATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYITELANALSYC 128
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++   N +L++ D+G +  + P         +  +  PE++    
Sbjct: 129 HSKRVIHRDIKPENLLLG-SNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 186
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L          +E   + E    +S     F D               
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD--------------- 231
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +RLT  E ++HP+ 
Sbjct: 232 -------FVTEGARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 87/194 (44%), Gaps = 21/194 (10%)
Query: 246 IFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID-HENRK 304
           IFE +N + F+     L + +I  Y++++ +AL + HS  I H D++P N++     +  
Sbjct: 88  IFERINTSAFE-----LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSST 142
Query: 305 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWER 364
           +++I++G A    PG  + +   +  +  PE+          D      L          
Sbjct: 143 IKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
Query: 365 FVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHY 424
           F+   NQ ++         +NI+        E F        +S EA+DF+D+LL  +  
Sbjct: 203 FLAETNQQII---------ENIMNAEYTFDEEAFKE------ISIEAMDFVDRLLVKERK 247
Query: 425 ERLTAREAMDHPYF 438
            R+TA EA+ HP+ 
Sbjct: 248 SRMTASEALQHPWL 261

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N+ITL  V ++       LI E V      DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 75  NVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 284 MGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           + I H D+KP N+M+   N    ++++ID+GLA     G E+     +  F  PE++   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFL---DKNILGRHSRKRWER 397
              +E D              W   V T   +++   A  FL    +  L   S   +E 
Sbjct: 193 PLGLEAD-------------MWSIGVIT---YILLSGASPFLGDTKQETLANVSAVNYE- 235
Query: 398 FVHTENQHLVSPEAL--DFLDKLLRYDHYERLTAREAMDHPYFYP 440
               E+++  +  AL  DF+ +LL  D  +R+T ++++ HP+  P
Sbjct: 236 ---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N+ITL  V ++       LI E V      DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 75  NVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 284 MGIMHRDVKPHNVMIDHEN---RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           + I H D+KP N+M+   N    ++++ID+GLA     G E+     +  F  PE++   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFL---DKNILGRHSRKRWER 397
              +E D              W   V T   +++   A  FL    +  L   S   +E 
Sbjct: 193 PLGLEAD-------------MWSIGVIT---YILLSGASPFLGDTKQETLANVSAVNYE- 235
Query: 398 FVHTENQHLVSPEAL--DFLDKLLRYDHYERLTAREAMDHPYFYP 440
               E+++  +  AL  DF+ +LL  D  +R+T ++++ HP+  P
Sbjct: 236 ---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N+ITL  V ++       LI E V      DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 75  NVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 284 MGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           + I H D+KP N+M+   N    ++++ID+GLA     G E+     +  F  PE++   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFL---DKNILGRHSRKRWER 397
              +E D              W   V T   +++   A  FL    +  L   S   +E 
Sbjct: 193 PLGLEAD-------------MWSIGVIT---YILLSGASPFLGDTKQETLANVSAVNYE- 235
Query: 398 FVHTENQHLVSPEAL--DFLDKLLRYDHYERLTAREAMDHPYFYP 440
               E+++  +  AL  DF+ +LL  D  +R+T ++++ HP+  P
Sbjct: 236 ---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N+ITL  V ++       LI E V      DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 75  NVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 284 MGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           + I H D+KP N+M+   N    ++++ID+GLA     G E+     +  F  PE++   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFL---DKNILGRHSRKRWER 397
              +E D              W   V T   +++   A  FL    +  L   S   +E 
Sbjct: 193 PLGLEAD-------------MWSIGVIT---YILLSGASPFLGDTKQETLANVSAVNYE- 235
Query: 398 FVHTENQHLVSPEAL--DFLDKLLRYDHYERLTAREAMDHPYFYP 440
               E+++  +  AL  DF+ +LL  D  +R+T ++++ HP+  P
Sbjct: 236 ---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N+ITL  V ++       LI E V      DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 75  NVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 284 MGIMHRDVKPHNVMIDHEN---RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           + I H D+KP N+M+   N    ++++ID+GLA     G E+     +  F  PE++   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFL---DKNILGRHSRKRWER 397
              +E D              W   V T   +++   A  FL    +  L   S   +E 
Sbjct: 193 PLGLEAD-------------MWSIGVIT---YILLSGASPFLGDTKQETLANVSAVNYE- 235
Query: 398 FVHTENQHLVSPEAL--DFLDKLLRYDHYERLTAREAMDHPYFYP 440
               E+++  +  AL  DF+ +LL  D  +R+T ++++ HP+  P
Sbjct: 236 ---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 71/139 (51%), Gaps = 20/139 (14%)
Query: 10  ALDYCHSMGIMHRDVKPHNVM---IDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 66
           A+ Y H +GI+HRD+KP N++   +D E+ K+ + D+GL++   PG   +    +  +  
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 186
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLD 126
           PE+LA  + Y  ++D WS+G +   ++    PF+  +D               +LFE + 
Sbjct: 187 PEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDEND--------------AKLFEQIL 231
Query: 127 KYHIELD-PRFADILGRAR 144
           K   E D P + DI   A+
Sbjct: 232 KAEYEFDSPYWDDISDSAK 250

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 85/185 (45%), Gaps = 31/185 (16%)
Query: 263 TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVM---IDHENRKLRLIDWGLAEFYHPG 319
           T+ D    ++++L A+ Y H +GI+HRD+KP N++   +D E+ K+ + D+GL++   PG
Sbjct: 114 TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPG 172
Query: 320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEAL 379
              +    +  +  PE+LA   Y   +D     ++                 +++     
Sbjct: 173 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA----------------YILLCGYP 216
Query: 380 DFLDKNILGRHSRKRWERFVHTENQ------HLVSPEALDFLDKLLRYDHYERLTAREAM 433
            F D+N       K +E+ +  E +        +S  A DF+  L+  D  +R T  +A+
Sbjct: 217 PFYDEN-----DAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 271
Query: 434 DHPYF 438
            HP+ 
Sbjct: 272 QHPWI 276

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 71/139 (51%), Gaps = 20/139 (14%)
Query: 10  ALDYCHSMGIMHRDVKPHNVM---IDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 66
           A+ Y H +GI+HRD+KP N++   +D E+ K+ + D+GL++   PG   +    +  +  
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 186
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLD 126
           PE+LA  + Y  ++D WS+G +   ++    PF+  +D               +LFE + 
Sbjct: 187 PEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------------KLFEQIL 231
Query: 127 KYHIELD-PRFADILGRAR 144
           K   E D P + DI   A+
Sbjct: 232 KAEYEFDSPYWDDISDSAK 250

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 85/185 (45%), Gaps = 31/185 (16%)
Query: 263 TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVM---IDHENRKLRLIDWGLAEFYHPG 319
           T+ D    ++++L A+ Y H +GI+HRD+KP N++   +D E+ K+ + D+GL++   PG
Sbjct: 114 TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPG 172
Query: 320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEAL 379
              +    +  +  PE+LA   Y   +D     ++                 +++     
Sbjct: 173 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA----------------YILLCGYP 216
Query: 380 DFLDKNILGRHSRKRWERFVHTENQ------HLVSPEALDFLDKLLRYDHYERLTAREAM 433
            F D+N       K +E+ +  E +        +S  A DF+  L+  D  +R T  +A+
Sbjct: 217 PFYDEN-----DAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 271
Query: 434 DHPYF 438
            HP+ 
Sbjct: 272 QHPWI 276

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 71/139 (51%), Gaps = 20/139 (14%)
Query: 10  ALDYCHSMGIMHRDVKPHNVM---IDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 66
           A+ Y H +GI+HRD+KP N++   +D E+ K+ + D+GL++   PG   +    +  +  
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 186
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLD 126
           PE+LA  + Y  ++D WS+G +   ++    PF+  +D               +LFE + 
Sbjct: 187 PEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------------KLFEQIL 231
Query: 127 KYHIELD-PRFADILGRAR 144
           K   E D P + DI   A+
Sbjct: 232 KAEYEFDSPYWDDISDSAK 250

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 85/185 (45%), Gaps = 31/185 (16%)
Query: 263 TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVM---IDHENRKLRLIDWGLAEFYHPG 319
           T+ D    ++++L A+ Y H +GI+HRD+KP N++   +D E+ K+ + D+GL++   PG
Sbjct: 114 TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPG 172
Query: 320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEAL 379
              +    +  +  PE+LA   Y   +D     ++                 +++     
Sbjct: 173 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA----------------YILLCGYP 216
Query: 380 DFLDKNILGRHSRKRWERFVHTENQ------HLVSPEALDFLDKLLRYDHYERLTAREAM 433
            F D+N       K +E+ +  E +        +S  A DF+  L+  D  +R T  +A+
Sbjct: 217 PFYDEN-----DAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 271
Query: 434 DHPYF 438
            HP+ 
Sbjct: 272 QHPWI 276

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 125/282 (44%), Gaps = 74/282 (26%)
Query: 246 IFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN 302
           I   + ++D K+L++T   LT+  I+  LY LL   ++ H  GI+HRD+KP N +++ ++
Sbjct: 107 IVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN-QD 165
Query: 303 RKLRLIDWGLAEFYHPGQEYNV-----------------------RVASRYFKGPELL-- 337
             +++ D+GLA   +  ++ N+                        V +R+++ PEL+  
Sbjct: 166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225
Query: 338 -ADYQYHIEL-------------------DP--RFADILGRH----SRKRWERFVHTENQ 371
             +Y   I++                   DP  RF    G      S  R  + VH ++ 
Sbjct: 226 QENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSN 285
Query: 372 --------HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL------VSPEALDFLDK 417
                   +++     D L KNI      K  + F H +  +L      +S + ++ L+ 
Sbjct: 286 RDQLNIIFNIIGTPTEDDL-KNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLES 344
Query: 418 LLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIV 459
           +L+++  +R+T  +A+DHPY    +KD  +  L + S   I+
Sbjct: 345 MLKFNPNKRITIDQALDHPY----LKDVRKKKLENFSTKKII 382

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 55/97 (56%), Gaps = 6/97 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ + H+  I+HRD+KP N+++D +N ++RL D+G +    PG++      +  +  PE+
Sbjct: 212 AVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 70  LA-----DYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           L       +  Y   +D+W+ G +L +++    PF+H
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 44/195 (22%)
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
            L++ + R  +  LL+A+ + H+  I+HRD+KP N+++D +N ++RL D+G +    PG+
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGE 254
Query: 321 EYNVRVASRYFKGPELLADYQ------YHIELDPRFADI----LGRHSRKRWERFVHTEN 370
           +      +  +  PE+L          Y  E+D     +    L   S   W R      
Sbjct: 255 KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR------ 308
Query: 371 QHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPE-------ALDFLDKLLRYDH 423
                        + IL         R +        SPE         D + +LL+ D 
Sbjct: 309 -------------RQIL-------MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDP 348
Query: 424 YERLTAREAMDHPYF 438
             RLTA +A+ HP+F
Sbjct: 349 EARLTAEQALQHPFF 363

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N+ITL  V ++       LI E V      DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 74  NVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 284 MGIMHRDVKPHNVMIDHEN---RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           + I H D+KP N+M+   N    ++++ID+GLA     G E+     +  F  PE++   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFL---DKNILGRHSRKRWER 397
              +E D              W   V T   +++   A  FL    +  L   S   +E 
Sbjct: 192 PLGLEAD-------------MWSIGVIT---YILLSGASPFLGDTKQETLANVSAVNYE- 234
Query: 398 FVHTENQHLVSPEAL--DFLDKLLRYDHYERLTAREAMDHPYFYP 440
               E+++  +  AL  DF+ +LL  D  +R+T ++++ HP+  P
Sbjct: 235 ---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N+ITL  V ++       LI E V      DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 75  NVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 284 MGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           + I H D+KP N+M+   N    ++++ID+GLA     G E+     +  F  PE++   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFL---DKNILGRHSRKRWER 397
              +E D              W   V T   +++   A  FL    +  L   S   +E 
Sbjct: 193 PLGLEAD-------------MWSIGVIT---YILLSGASPFLGDTKQETLANVSAVNYE- 235
Query: 398 FVHTENQHLVSPEAL--DFLDKLLRYDHYERLTAREAMDHPYFYP 440
               E+++  +  AL  DF+ +LL  D  +R+T ++++ HP+  P
Sbjct: 236 ---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N+ITL  V ++       LI E V      DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 74  NVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 284 MGIMHRDVKPHNVMIDHEN---RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           + I H D+KP N+M+   N    ++++ID+GLA     G E+     +  F  PE++   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFL---DKNILGRHSRKRWER 397
              +E D              W   V T   +++   A  FL    +  L   S   +E 
Sbjct: 192 PLGLEAD-------------MWSIGVIT---YILLSGASPFLGDTKQETLANVSAVNYE- 234
Query: 398 FVHTENQHLVSPEAL--DFLDKLLRYDHYERLTAREAMDHPYFYP 440
               E+++  +  AL  DF+ +LL  D  +R+T ++++ HP+  P
Sbjct: 235 ---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 71/139 (51%), Gaps = 20/139 (14%)
Query: 10  ALDYCHSMGIMHRDVKPHNVM---IDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 66
           A+ Y H +GI+HRD+KP N++   +D E+ K+ + D+GL++   PG   +    +  +  
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 186
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLD 126
           PE+LA  + Y  ++D WS+G +   ++    PF+  +D               +LFE + 
Sbjct: 187 PEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------------KLFEQIL 231
Query: 127 KYHIELD-PRFADILGRAR 144
           K   E D P + DI   A+
Sbjct: 232 KAEYEFDSPYWDDISDSAK 250

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 85/185 (45%), Gaps = 31/185 (16%)
Query: 263 TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVM---IDHENRKLRLIDWGLAEFYHPG 319
           T+ D    ++++L A+ Y H +GI+HRD+KP N++   +D E+ K+ + D+GL++   PG
Sbjct: 114 TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPG 172
Query: 320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEAL 379
              +    +  +  PE+LA   Y   +D     ++                 +++     
Sbjct: 173 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA----------------YILLCGYP 216
Query: 380 DFLDKNILGRHSRKRWERFVHTENQ------HLVSPEALDFLDKLLRYDHYERLTAREAM 433
            F D+N       K +E+ +  E +        +S  A DF+  L+  D  +R T  +A+
Sbjct: 217 PFYDEN-----DAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 271
Query: 434 DHPYF 438
            HP+ 
Sbjct: 272 QHPWI 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N+ITL  V ++       LI E V      DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 75  NVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 284 MGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           + I H D+KP N+M+   N    ++++ID+GLA     G E+     +  F  PE++   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFL---DKNILGRHSRKRWER 397
              +E D              W   V T   +++   A  FL    +  L   S   +E 
Sbjct: 193 PLGLEAD-------------MWSIGVIT---YILLSGASPFLGDTKQETLANVSAVNYE- 235
Query: 398 FVHTENQHLVSPEAL--DFLDKLLRYDHYERLTAREAMDHPYFYP 440
               E+++  +  AL  DF+ +LL  D  +R+T ++++ HP+  P
Sbjct: 236 ---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N+ITL  V ++       LI E V      DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 75  NVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 284 MGIMHRDVKPHNVMIDHEN---RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           + I H D+KP N+M+   N    ++++ID+GLA     G E+     +  F  PE++   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFL---DKNILGRHSRKRWER 397
              +E D              W   V T   +++   A  FL    +  L   S   +E 
Sbjct: 193 PLGLEAD-------------MWSIGVIT---YILLSGASPFLGDTKQETLANVSAVNYE- 235
Query: 398 FVHTENQHLVSPEAL--DFLDKLLRYDHYERLTAREAMDHPYFYP 440
               E+++  +  AL  DF+ +LL  D  +R+T ++++ HP+  P
Sbjct: 236 ---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N+ITL  V ++       LI E V      DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 75  NVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 284 MGIMHRDVKPHNVMIDHEN---RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           + I H D+KP N+M+   N    ++++ID+GLA     G E+     +  F  PE++   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFL---DKNILGRHSRKRWER 397
              +E D              W   V T   +++   A  FL    +  L   S   +E 
Sbjct: 193 PLGLEAD-------------MWSIGVIT---YILLSGASPFLGDTKQETLANVSAVNYE- 235
Query: 398 FVHTENQHLVSPEAL--DFLDKLLRYDHYERLTAREAMDHPYFYP 440
               E+++  +  AL  DF+ +LL  D  +R+T ++++ HP+  P
Sbjct: 236 ---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 2/96 (2%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A      L+  H   I++RD+KP N+++D ++  +R+ D GLA     GQ    RV +  
Sbjct: 292 AAEICCGLEDLHRERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +  PE++ + + Y +S D W+LGC+L  MI  + PF
Sbjct: 351 YMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 21/175 (12%)
Query: 269 YYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS 328
           +Y  E+   L+  H   I++RD+KP N+++D ++  +R+ D GLA     GQ    RV +
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 329 RYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILG 388
             +  PE++ + +Y    D              W        + +          K I  
Sbjct: 349 VGYMAPEVVKNERYTFSPD--------------WWALGCLLYEMIAGQSPFQQRKKKI-K 393
Query: 389 RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYF 438
           R   +R  + V  E     SP+A     +LL  D  ERL     +ARE  +HP F
Sbjct: 394 REEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRXXLCGTLDY 172
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 173 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKP 154
           G  +L   L K++    P   ++L    + A  NS KP
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKP 267

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 68  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 125 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM 182
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 227
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 228 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A++YCH   I+HRD+KP N+++D +N  +++ D+GL+     G        S  +  PE+
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 178
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +         +D+WS G +L  M+  + PF
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/117 (25%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYCHSMG 285
           II L  V+  P      ++ E+     F  + +   +T+ + R +  +++ A++YCH   
Sbjct: 71  IIKLYDVITTPTD--IVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 286 IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
           I+HRD+KP N+++D +N  +++ D+GL+     G        S  +  PE++    Y
Sbjct: 129 IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 2/96 (2%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A      L+  H   I++RD+KP N+++D ++  +R+ D GLA     GQ    RV +  
Sbjct: 292 AAEICCGLEDLHRERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +  PE++ + + Y +S D W+LGC+L  MI  + PF
Sbjct: 351 YMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 21/175 (12%)
Query: 269 YYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS 328
           +Y  E+   L+  H   I++RD+KP N+++D ++  +R+ D GLA     GQ    RV +
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 329 RYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILG 388
             +  PE++ + +Y    D              W        + +          K I  
Sbjct: 349 VGYMAPEVVKNERYTFSPD--------------WWALGCLLYEMIAGQSPFQQRKKKI-K 393
Query: 389 RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYF 438
           R   +R  + V  E     SP+A     +LL  D  ERL     +ARE  +HP F
Sbjct: 394 REEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ ++G +  + P         +  +
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIANFGWS-VHAPSSRRTTLCGTLDY 175
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 176 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKP 154
           G  +L   L K++    P   ++L    + A  NS KP
Sbjct: 235 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKP 270

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 71  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ ++G +  + P         +  +  PE++    
Sbjct: 128 HSKRVIHRDIKPENLLLGSAG-ELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 230
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 231 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDY 177
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE + + + +D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 178 LPPEXI-EGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 236
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           G  +L   L K++    P   ++L    + A  NS KP    + ES
Sbjct: 237 GARDLISRLLKHNPSQRPXLREVLEHPWITA--NSSKPSNCQNKES 280

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 113/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 73  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 129
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +    
Sbjct: 130 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGRX 187
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 232
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 233 -------FVTEGARDLISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/301 (21%), Positives = 124/301 (41%), Gaps = 50/301 (16%)
Query: 173 YQLVRKLGRGKYSEVF----EAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNI 228
           YQ V+KLG G Y EV     +  +V+ +                      +  L    NI
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 229 ITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQTL--TDYDIRYYLYELLKALDYCHSMG 285
           + L    +D   R   L+ E     + F ++   +   + D    + ++L  + Y H   
Sbjct: 99  MKLYDFFEDK--RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 286 IMHRDVKPHNVMIDHENRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYH 343
           I+HRD+KP N++++ + +   ++++D+GL+  +   ++   R+ + Y+  PE+L   +Y 
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYD 215
Query: 344 IELDPRFADIL-----------GRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR 392
            + D     ++           G  + +   R V        SPE               
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE--------------- 260
Query: 393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV-KDQSRHTLP 451
             W+          VS  A D + ++L++D   R++A++A++HP+   +  K +S   LP
Sbjct: 261 --WKN---------VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELP 309
Query: 452 S 452
           S
Sbjct: 310 S 310

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 60/109 (55%), Gaps = 4/109 (3%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKG 66
           SMAL + H  GI++RD+KP N+M++H+   ++L D+GL  E  H G   +    +  +  
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
           PE+L     ++ ++D WSLG ++  M+    P F G +    + +I K 
Sbjct: 190 PEILM-RSGHNRAVDWWSLGALMYDMLTGAPP-FTGENRKKTIDKILKC 236

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 114/287 (39%), Gaps = 46/287 (16%)
Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQ 232
           ++L+R LG+G Y +VF+   V  ++                       + +   NI+   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL--- 75
Query: 233 AVVKDP----------VSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKALD 279
             VK P                LI E+++  + F QL +     +    +YL E+  AL 
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLA 338
           + H  GI++RD+KP N+M++H+   ++L D+GL  E  H G   +    +  +  PE+L 
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 339 DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
              ++  +D              W       +    +P           G + +K  ++ 
Sbjct: 195 RSGHNRAVD-------------WWSLGALMYDMLTGAPP--------FTGENRKKTIDKI 233
Query: 399 VHTENQ--HLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYF 438
           +  +      ++ EA D L KLL+ +   RL      A E   HP+F
Sbjct: 234 LKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P    +    +  +
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRDDLCGTLDY 175
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 176 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKP 154
           G  +L   L K++    P   ++L    + A  NS KP
Sbjct: 235 GARDLISRLLKHNPSQRPMLREVLEHPWITA--NSSKP 270

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 115/280 (41%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 71  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P    +    +  +  PE++    
Sbjct: 128 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRM 185
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 230
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 231 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMID-HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           A+DYCH   ++HRD+KP NV++D H N K+   D+GL+     G+       S  +  PE
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIA--DFGLSNMMSDGEFLRTSCGSPNYAAPE 180
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +++        +D+WS G +L +++    PF
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 61/120 (50%), Gaps = 8/120 (6%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           +II L  V+  P      ++ E+V+     D+   +  + + + R    ++L A+DYCH 
Sbjct: 72  HIIKLYQVISTPTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 284 MGIMHRDVKPHNVMID-HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
             ++HRD+KP NV++D H N K+   D+GL+     G+       S  +  PE+++   Y
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIA--DFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 6/110 (5%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE--FYHPGQEYNVRVASRYFK 65
           ++ LD+ HS+GI++RD+KP N+++D E   ++L D+GL++    H  + Y+      Y  
Sbjct: 140 ALGLDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYM- 197
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
            PE++ + Q + +S D WS G ++  M+    P F G D  + +  I K 
Sbjct: 198 APEVV-NRQGHSHSADWWSYGVLMFEMLTGSLP-FQGKDRKETMTLILKA 245

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 23/53 (43%), Positives = 40/53 (75%), Gaps = 1/53 (1%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
            T+ D+++YL EL   LD+ HS+GI++RD+KP N+++D E   ++L D+GL++
Sbjct: 127 FTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSK 178

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 26/199 (13%)
Query: 245 LIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI-DHENR 303
           L FE V   D   +Y   ++    +Y+ ++L+AL YCH   I+HRDVKPH V++   EN 
Sbjct: 115 LCFEIVKRADAGFVY---SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENS 171
Query: 304 K-LRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKR 361
             ++L  +G+A +    G     RV + +F  PE++    Y   +D     ++       
Sbjct: 172 APVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231
Query: 362 WERFVHTENQHLVSPEALDFLDKNILGRH--SRKRWERFVHTENQHLVSPEALDFLDKLL 419
              F  T+ +           +  I G++  + ++W           +S  A D + ++L
Sbjct: 232 CLPFYGTKER---------LFEGIIKGKYKMNPRQWSH---------ISESAKDLVRRML 273
Query: 420 RYDHYERLTAREAMDHPYF 438
             D  ER+T  EA++HP+ 
Sbjct: 274 MLDPAERITVYEALNHPWL 292

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 10/157 (6%)
Query: 166 DWGQQDDYQLVRKLGRGKYSEVFEAIN-----VQSSDXXXXXXXXXXXXXXXXXXXXXLE 220
           DW   D Y++   +G G Y  V EA +     V +                       L 
Sbjct: 48  DWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILN 107
Query: 221 NLRGGTNIITLQAVVKDPVSRTPAL-IFEHVNNTDFKQLYQT---LTDYDIRYYLYELLK 276
            L     +  L  V+   V +   L +   + ++DFK+L++T   LT+  I+  LY LL 
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            + Y HS GI+HRD+KP N +++ ++  +++ D+GLA
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVN-QDCSVKVCDFGLA 203

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQL--YQTLTDYDIRYYLYELLKALDYCHSM 284
           N++ L  V+ DP      ++FE VN     ++   + L++   R+Y  +L+K ++Y H  
Sbjct: 97  NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ 156
Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
            I+HRD+KP N+++  E+  +++ D+G++ EF       +  V +  F  PE L++ +  
Sbjct: 157 KIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR-- 213
Query: 344 IELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN 403
                    I    +   W   V     +        F+D+ I+  HS+ +  + +   +
Sbjct: 214 --------KIFSGKALDVWAMGV---TLYCFVFGQCPFMDERIMCLHSKIK-SQALEFPD 261
Query: 404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
           Q  ++ +  D + ++L  +   R+   E   HP+
Sbjct: 262 QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 6/110 (5%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE--FYHPGQEYNVRVASRYFK 65
           ++ALD+ HS+GI++RD+KP N+++D E   ++L D+GL++    H  + Y+      Y  
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYM- 193
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
            PE++ + + +  S D WS G ++  M+    P F G D  + +  I K 
Sbjct: 194 APEVV-NRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMILKA 241

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 41/53 (77%), Gaps = 1/53 (1%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
            T+ D+++YL EL  ALD+ HS+GI++RD+KP N+++D E   ++L D+GL++
Sbjct: 123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSK 174

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 3/103 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPE 68
           AL++ HS  +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE
Sbjct: 148 ALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 111
            + +   Y++  D+WSLGC+L  M   + PF+    N   L +
Sbjct: 207 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 248

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 80/190 (42%), Gaps = 18/190 (9%)
Query: 172 DYQLVRKLGRGKYSEVFEA------INVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           ++++ +K+GRG++SEV+ A      + V                         L+ L   
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTD-------FKQLYQTLTDYDIRYYLYELLKAL 278
             I    + ++D       ++ E  +  D       FK+  + + +  +  Y  +L  AL
Sbjct: 93  NVIKYYASFIED---NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELL 337
           ++ HS  +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE +
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 338 ADYQYHIELD 347
            +  Y+ + D
Sbjct: 209 HENGYNFKSD 218

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N+ITL  V ++       LI E V      DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 75  NVITLHEVYENKTDVI--LIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 284 MGIMHRDVKPHNVMIDHEN---RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           + I H D+KP N+M+   N    ++++ID+GLA     G E+     +  F  PE++   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFL---DKNILGRHSRKRWER 397
              +E D              W   V T   +++   A  FL    +  L   S   +E 
Sbjct: 193 PLGLEAD-------------MWSIGVIT---YILLSGASPFLGDTKQETLANVSAVNYE- 235
Query: 398 FVHTENQHLVSPEAL--DFLDKLLRYDHYERLTAREAMDHPYFYP 440
               E+++  +  AL  DF+ +LL  D  +R+T ++++ HP+  P
Sbjct: 236 ---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 60/109 (55%), Gaps = 4/109 (3%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKG 66
           SMAL + H  GI++RD+KP N+M++H+   ++L D+GL  E  H G   +    +  +  
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHXFCGTIEYMA 189
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
           PE+L     ++ ++D WSLG ++  M+    P F G +    + +I K 
Sbjct: 190 PEILM-RSGHNRAVDWWSLGALMYDMLTGAPP-FTGENRKKTIDKILKC 236

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 114/287 (39%), Gaps = 46/287 (16%)
Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQ 232
           ++L+R LG+G Y +VF+   V  ++                       + +   NI+   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL--- 75
Query: 233 AVVKDP----------VSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKALD 279
             VK P                LI E+++  + F QL +     +    +YL E+  AL 
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLA 338
           + H  GI++RD+KP N+M++H+   ++L D+GL  E  H G   +    +  +  PE+L 
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 339 DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
              ++  +D              W       +    +P           G + +K  ++ 
Sbjct: 195 RSGHNRAVD-------------WWSLGALMYDMLTGAPP--------FTGENRKKTIDKI 233
Query: 399 VHTENQ--HLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYF 438
           +  +      ++ EA D L KLL+ +   RL      A E   HP+F
Sbjct: 234 LKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 26/199 (13%)
Query: 245 LIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI-DHENR 303
           L FE V   D   +Y   ++    +Y+ ++L+AL YCH   I+HRDVKPH V++   EN 
Sbjct: 113 LCFEIVKRADAGFVY---SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENS 169
Query: 304 K-LRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKR 361
             ++L  +G+A +    G     RV + +F  PE++    Y   +D     ++       
Sbjct: 170 APVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
Query: 362 WERFVHTENQHLVSPEALDFLDKNILGRH--SRKRWERFVHTENQHLVSPEALDFLDKLL 419
              F  T+ +           +  I G++  + ++W           +S  A D + ++L
Sbjct: 230 CLPFYGTKER---------LFEGIIKGKYKMNPRQWSH---------ISESAKDLVRRML 271
Query: 420 RYDHYERLTAREAMDHPYF 438
             D  ER+T  EA++HP+ 
Sbjct: 272 MLDPAERITVYEALNHPWL 290

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 120/285 (42%), Gaps = 39/285 (13%)
Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLE----NLRGG 225
           Q  YQL  +LG+G +S V   + V +                        E     L   
Sbjct: 21  QSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 80
Query: 226 TNIITLQAVVKDPVSRTPA--LIFEHVNNTD-FKQLY--QTLTDYDIRYYLYELLKALDY 280
            NI+ L     D +S      LIF+ V   + F+ +   +  ++ D  + + ++L+A+ +
Sbjct: 81  PNIVRLH----DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 136
Query: 281 CHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 337
           CH MG++HRD+KP N+++    +   ++L D+GLA E     Q +     +  +  PE+L
Sbjct: 137 CHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 196
Query: 338 ADYQYHIELDPRFADILGRHSRKRWERFVHTENQH----LVSPEALDFLDKNILGRHSRK 393
               Y   +D     ++       +  F   E+QH     +   A DF            
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVGYPPF-WDEDQHRLYQQIKAGAYDF---------PSP 246
Query: 394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            W+          V+PEA D ++K+L  +  +R+TA EA+ HP+ 
Sbjct: 247 EWDT---------VTPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 6/110 (5%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE--FYHPGQEYNVRVASRYFK 65
           ++ALD+ HS+GI++RD+KP N+++D E   ++L D+GL++    H  + Y+      Y  
Sbjct: 137 ALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYM- 194
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
            PE++ + + +  S D WS G ++  M+    P F G D  + +  I K 
Sbjct: 195 APEVV-NRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMILKA 242

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 41/53 (77%), Gaps = 1/53 (1%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
            T+ D+++YL EL  ALD+ HS+GI++RD+KP N+++D E   ++L D+GL++
Sbjct: 124 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSK 175

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 6/110 (5%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE--FYHPGQEYNVRVASRYFK 65
           ++ALD+ HS+GI++RD+KP N+++D E   ++L D+GL++    H  + Y+      Y  
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYM- 193
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
            PE++ + + +  S D WS G ++  M+    P F G D  + +  I K 
Sbjct: 194 APEVV-NRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMILKA 241

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 41/53 (77%), Gaps = 1/53 (1%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
            T+ D+++YL EL  ALD+ HS+GI++RD+KP N+++D E   ++L D+GL++
Sbjct: 123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSK 174

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 123/284 (43%), Gaps = 39/284 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLE----NLRGGT 226
           D+YQL  +LG+G +S V   + + +                        E     L    
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 227 NIITLQAVVKDPVSRTPA--LIFEHVNNTD-FKQLY--QTLTDYDIRYYLYELLKALDYC 281
           NI+ L     D +S      L+F+ V   + F+ +   +  ++ D  + + ++L+++++C
Sbjct: 64  NIVRLH----DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 282 HSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLA 338
           H  GI+HRD+KP N+++  +++   ++L D+GLA E     Q +     +  +  PE+L 
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 339 DYQYHIELDPRFADILGRHSRKRWERFVHTENQH----LVSPEALDFLDKNILGRHSRKR 394
              Y   +D     ++       +  F   E+QH     +   A DF             
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYPPF-WDEDQHRLYQQIKAGAYDF---------PSPE 229
Query: 395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           W+          V+PEA D ++K+L  +  +R+TA EA+ HP+ 
Sbjct: 230 WDT---------VTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 6/101 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +  GA   L Y HS  ++HRDVK  N+++  E   ++L D+G A    P    N  V + 
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPA---NXFVGTP 175
Query: 63  YFKGPE--LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           Y+  PE  L  D   YD  +D+WSLG     +  RK P F+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 6/101 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +  GA   L Y HS  ++HRDVK  N+++  E   ++L D+G A    P    N  V + 
Sbjct: 159 VTHGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPA---NXFVGTP 214
Query: 63  YFKGPE--LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           Y+  PE  L  D   YD  +D+WSLG     +  RK P F+
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 123/284 (43%), Gaps = 39/284 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLE----NLRGGT 226
           D+YQL  +LG+G +S V   + + +                        E     L    
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 227 NIITLQAVVKDPVSRTPA--LIFEHVNNTD-FKQLY--QTLTDYDIRYYLYELLKALDYC 281
           NI+ L     D +S      L+F+ V   + F+ +   +  ++ D  + + ++L+++++C
Sbjct: 64  NIVRLH----DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 282 HSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLA 338
           H  GI+HRD+KP N+++  +++   ++L D+GLA E     Q +     +  +  PE+L 
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 339 DYQYHIELDPRFADILGRHSRKRWERFVHTENQH----LVSPEALDFLDKNILGRHSRKR 394
              Y   +D     ++       +  F   E+QH     +   A DF             
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYPPF-WDEDQHRLYQQIKAGAYDF---------PSPE 229
Query: 395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           W+          V+PEA D ++K+L  +  +R+TA EA+ HP+ 
Sbjct: 230 WDT---------VTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDY 175
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 176 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYAD 148
           G  +L   L K++    P   ++L    + A+
Sbjct: 235 GARDLISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 71  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 128 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 230
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 231 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +AL+Y HS  I++RD+KP N+++D +N  +++ D+G A+ Y P   Y +     Y
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLD-KNGHIKITDFGFAK-YVPDVTYXLCGTPDY 169
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE+++  + Y+ S+D WS G ++  M+    PF+
Sbjct: 170 I-APEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY 204

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 83/182 (45%), Gaps = 31/182 (17%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           ++Y  E+  AL+Y HS  I++RD+KP N+++D +N  +++ D+G A+ Y P   Y +   
Sbjct: 109 KFYAAEVCLALEYLHSKDIIYRDLKPENILLD-KNGHIKITDFGFAK-YVPDVTYXLCGT 166
Query: 328 SRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL 387
             Y   PE+++   Y+  +D              W  F     + L       F D N +
Sbjct: 167 PDYI-APEVVSTKPYNKSID--------------WWSFGILIYEMLAG--YTPFYDSNTM 209
Query: 388 GRHSRKRWERFVHTENQH--LVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYP 440
                K +E+ ++ E +     + +  D L +L+  D  +RL        +  +HP+F  
Sbjct: 210 -----KTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
Query: 441 IV 442
           +V
Sbjct: 265 VV 266

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 112 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDY 169
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 170 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 228
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYAD 148
           G  +L   L K++    P   ++L    + A+
Sbjct: 229 GARDLISRLLKHNPSQRPMLREVLEHPWITAN 260

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/280 (21%), Positives = 113/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQ-----SSDXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   Q     +                       +++    
Sbjct: 5   EDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 64
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +    LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 65  PNILRLYGYFHD--ATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 121
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 122 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 179
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 180 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 224
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 225 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 257

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDF--KQLYQTL-TDYDIRYYLYELLKALDYCHS 283
           NIITL+ V  D   +   L+ E +   +   K L Q   ++ +  + L+ + K ++Y HS
Sbjct: 82  NIITLKDVYDD--GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 284 MGIMHRDVKPHNVMIDHENRK---LRLIDWGLAEFYHPGQEYNVRVASRY---FKGPELL 337
            G++HRD+KP N++   E+     LR+ D+G A+      E  + +   Y   F  PE+L
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVL 197
Query: 338 ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER 397
               Y    D     IL       +  F +  +    +PE        IL R    ++  
Sbjct: 198 KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD---TPE-------EILTRIGSGKFT- 246
Query: 398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
            +   N + VS  A D + K+L  D ++RLTA++ + HP+
Sbjct: 247 -LSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 5/106 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           Y HS  I H D+KP N+M+   +  N +++LID+G+A     G E+     +  F  PE+
Sbjct: 130 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 189
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
           + +Y+      DMWS+G +   ++    PF  G    + L  I+ V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAV 233

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 61/117 (52%), Gaps = 8/117 (6%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           NIITL  + ++       LI E V+     DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 76  NIITLHDIFENKTD--VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 284 MGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
             I H D+KP N+M+   +  N +++LID+G+A     G E+     +  F  PE++
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 190

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 5/106 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           Y HS  I H D+KP N+M+   +  N +++LID+G+A     G E+     +  F  PE+
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
           + +Y+      DMWS+G +   ++    PF  G    + L  I+ V
Sbjct: 183 V-NYEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAV 226

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 27/229 (11%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           NIITL  + ++       LI E V+     DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 69  NIITLHDIFENKTD--VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 284 MGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
             I H D+KP N+M+   +  N +++LID+G+A     G E+     +  F  PE++   
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186
Query: 341 QYHIELDPRFADILGRHSRKRWERFV-HTENQHLVSPEALDF-LDKNILGRHSRKRWERF 398
              +E D     ++          F+  T+ + L +  A+++  D+           E F
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE-----------EYF 235
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
            +T      S  A DF+ +LL  D   R+T  ++++H +   I +   R
Sbjct: 236 SNT------SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVR 278

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDF--KQLYQTL-TDYDIRYYLYELLKALDYCHS 283
           NIITL+ V  D   +   L+ E +   +   K L Q   ++ +  + L+ + K ++Y HS
Sbjct: 82  NIITLKDVYDD--GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 284 MGIMHRDVKPHNVMIDHENRK---LRLIDWGLAEFYHPGQEYNVRVASRY---FKGPELL 337
            G++HRD+KP N++   E+     LR+ D+G A+      E  + +   Y   F  PE+L
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVL 197
Query: 338 ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER 397
               Y    D     IL       +  F +  +    +PE        IL R    ++  
Sbjct: 198 KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD---TPE-------EILTRIGSGKFT- 246
Query: 398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
            +   N + VS  A D + K+L  D ++RLTA++ + HP+
Sbjct: 247 -LSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 5/106 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           Y HS  I H D+KP N+M+   +  N +++LID+G+A     G E+     +  F  PE+
Sbjct: 144 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 203
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
           + +Y+      DMWS+G +   ++    PF  G    + L  I+ V
Sbjct: 204 V-NYEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAV 247

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 61/117 (52%), Gaps = 8/117 (6%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           NIITL  + ++       LI E V+     DF    ++LT+ +   +L ++L  + Y HS
Sbjct: 90  NIITLHDIFENKTD--VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 284 MGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
             I H D+KP N+M+   +  N +++LID+G+A     G E+     +  F  PE++
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 204

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMID-HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           A+DYCH   ++HRD+KP NV++D H N K+   D+GL+     G+       S  +  PE
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIA--DFGLSNMMSDGEFLRDSCGSPNYAAPE 180
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +++        +D+WS G +L +++    PF
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 61/120 (50%), Gaps = 8/120 (6%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           +II L  V+  P      ++ E+V+     D+   +  + + + R    ++L A+DYCH 
Sbjct: 72  HIIKLYQVISTPTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 284 MGIMHRDVKPHNVMID-HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
             ++HRD+KP NV++D H N K+   D+GL+     G+       S  +  PE+++   Y
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIA--DFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLY 187

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 61/121 (50%), Gaps = 19/121 (15%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-------------PGQEYN 56
           AL Y HS GI+HR++KP N+ ID E+R +++ D+GLA+  H             PG   N
Sbjct: 128 ALSYIHSQGIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 57  VR--VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   + +  +   E+L     Y+  +D +SLG +    I+   PF  G +  + L ++  
Sbjct: 187 LTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTGXERVNILKKLRS 243
Query: 115 V 115
           V
Sbjct: 244 V 244

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 22/45 (48%), Positives = 35/45 (77%), Gaps = 1/45 (2%)
Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH 317
           ++L+AL Y HS GI+HR++KP N+ ID E+R +++ D+GLA+  H
Sbjct: 124 QILEALSYIHSQGIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVH 167

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 68/138 (49%), Gaps = 18/138 (13%)
Query: 10  ALDYCHSMGIMHRDVKPHNVM--IDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y H MGI+HRD+KP N++     E  K+ + D+GL++    G   +    +  +  P
Sbjct: 132 AVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAP 191
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDK 127
           E+LA  + Y  ++D WS+G +   ++    PF+  +D+              +LFE + K
Sbjct: 192 EVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDS--------------KLFEQILK 236
Query: 128 YHIELD-PRFADILGRAR 144
              E D P + DI   A+
Sbjct: 237 AEYEFDSPYWDDISDSAK 254

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 79/184 (42%), Gaps = 29/184 (15%)
Query: 263 TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVM--IDHENRKLRLIDWGLAEFYHPGQ 320
           T+ D    + ++L A+ Y H MGI+HRD+KP N++     E  K+ + D+GL++    G 
Sbjct: 118 TEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD 177
Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD 380
             +    +  +  PE+LA   Y   +D     ++                 +++      
Sbjct: 178 VMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA----------------YILLCGYPP 221
Query: 381 FLDKNILGRHSRKRWERFVHTENQH------LVSPEALDFLDKLLRYDHYERLTAREAMD 434
           F D+N       K +E+ +  E +        +S  A DF+  L+  D  +R T  +A  
Sbjct: 222 FYDEN-----DSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAAR 276
Query: 435 HPYF 438
           HP+ 
Sbjct: 277 HPWI 280

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 184
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 216

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 103 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 162
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 163 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 191

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 58/105 (55%), Gaps = 8/105 (7%)
Query: 1   MRIATGASMALDYCHSMG-----IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 55
           +R+ T  ++AL  CH        ++HRD+KP NV +D + + ++L D+GLA   +  +++
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDEDF 172
Query: 56  NVR-VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               V + Y+  PE + +   Y+   D+WSLGC+L  +     PF
Sbjct: 173 AKEFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 199
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 231

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 118 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 177
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 178 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 206

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 227
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 259

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 146 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 205
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 206 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 234

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 200
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 119 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 178
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 179 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 207

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 185
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 217

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 104 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 163
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 164 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 192

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 185
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 217

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 104 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 163
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 164 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 192

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 64/125 (51%), Gaps = 3/125 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 213
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYH 129
           +  ++ +  S  +WSLG +L  M+    PF H  +     V   + + +E   ++L ++ 
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSE--CQHLIRWC 271
Query: 130 IELDP 134
           + L P
Sbjct: 272 LALRP 276

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 191
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 192 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 220

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 199
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 231

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 118 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 177
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 178 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 206

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 185
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 217

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 104 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 163
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 164 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 192

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 200
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 119 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 178
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 179 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 207

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 212
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 131 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 190
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 191 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 219

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 227
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 259

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 146 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 205
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 206 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 234

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 184
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 216

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 103 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 162
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 163 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 191

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 64/125 (51%), Gaps = 3/125 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 212
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYH 129
           +  ++ +  S  +WSLG +L  M+    PF H  +     V   + + +E   ++L ++ 
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSE--CQHLIRWC 270
Query: 130 IELDP 134
           + L P
Sbjct: 271 LALRP 275

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 131 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 190
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 191 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 219

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 200
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 119 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 178
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 179 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 207

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 213
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 191
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 192 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 220

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 64/125 (51%), Gaps = 3/125 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 213
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYH 129
           +  ++ +  S  +WSLG +L  M+    PF H  +     V   + + +E   ++L ++ 
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSE--CQHLIRWC 271
Query: 130 IELDP 134
           + L P
Sbjct: 272 LALRP 276

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 191
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 192 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 220

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 180
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 99  DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 158
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 159 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 187

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 212
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 131 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 190
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 191 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 219

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 125 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 183
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 184 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 215

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 102 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 161
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 162 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 190

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 227
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 259

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 146 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 205
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 206 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 234

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 64/125 (51%), Gaps = 3/125 (2%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 212
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYH 129
           +  ++ +  S  +WSLG +L  M+    PF H  +     V   + + +E   ++L ++ 
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSE--CQHLIRWC 270
Query: 130 IELDP 134
           + L P
Sbjct: 271 LALRP 275

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 131 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 190
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 191 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 219

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 174 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 232
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 233 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 264

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 151 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 210
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 211 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 239

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 213
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 191
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 192 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 220

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 180
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 99  DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 158
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 159 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 187

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 149 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 207
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 208 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 239

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 126 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 185
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 186 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 214

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 180
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 99  DFITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSG 158
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 159 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 187

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 219
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +  ++ +  S  +WSLG +L  M+    PF H
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 254 DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 138 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197
Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
                   Y     +R +  PE +  ++YH
Sbjct: 198 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYH 226

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 39/284 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLE----NLRGGT 226
           ++YQL  +LG+G +S V   + V +                        E     L    
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 227 NIITLQAVVKDPVSRTPA--LIFEHVNNTD-FKQLY--QTLTDYDIRYYLYELLKALDYC 281
           NI+ L     D +S      LIF+ V   + F+ +   +  ++ D  + + ++L+A+ +C
Sbjct: 71  NIVRLH----DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 282 HSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLA 338
           H MG++HR++KP N+++    +   ++L D+GLA E     Q +     +  +  PE+L 
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 339 DYQYHIELDPRFADILGRHSRKRWERFVHTENQH----LVSPEALDFLDKNILGRHSRKR 394
              Y   +D     ++       +  F   E+QH     +   A DF             
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPF-WDEDQHRLYQQIKAGAYDF---------PSPE 236
Query: 395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           W+          V+PEA D ++K+L  +  +R+TA EA+ HP+ 
Sbjct: 237 WD---------TVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 5   TGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
           T  + AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRXXLCGTLDY 175
Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVL------ 116
             PE++ + +M+D  +D+WSLG +    +  K PF      + Y ++ R+          
Sbjct: 176 LPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYAD 148
           G  +L   L K++    P   ++L    + A+
Sbjct: 235 GARDLISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           +D+++ R LG+GK+  V+ A   QS                            +++    
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVN-NTDFKQLYQTLTDYD---IRYYLYELLKALDYC 281
            NI+ L     D  +R   LI E+    T +++L Q L+ +D      Y+ EL  AL YC
Sbjct: 71  PNILRLYGYFHD-ATRV-YLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE++    
Sbjct: 128 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM 185
Query: 342 YHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +  ++D     +L       +  +E   + E    +S     F D               
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 230
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                   V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 231 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 9/101 (8%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A   + AL Y HS+ I++RD+KP N+++D +   + L D+GL +      E+N    S +
Sbjct: 145 AAEIASALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCK---ENIEHN-STTSTF 199
Query: 64  FKGPELLAD----YQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE LA      Q YD ++D W LG +L  M++   PF+
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 42/76 (55%), Gaps = 5/76 (6%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R+Y  E+  AL Y HS+ I++RD+KP N+++D +   + L D+GL +      E+N    
Sbjct: 142 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCK---ENIEHN-STT 196
Query: 328 SRYFKGPELLADYQYH 343
           S +   PE LA    H
Sbjct: 197 STFCGTPEYLAPEVLH 212

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 3/95 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMID-HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
            +DYCH   ++HRD+KP NV++D H N K  + D+GL+     G+       S  +  PE
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAK--IADFGLSNMMSDGEFLRXSCGSPNYAAPE 185
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           +++        +D+WS G +L +++    PF   H
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 9/111 (8%)
Query: 239 VSRTPALIFEHVNNTDFKQLYQ------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVK 292
           V  TP+ IF  +      +L+        L + + R    ++L  +DYCH   ++HRD+K
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143
Query: 293 PHNVMID-HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
           P NV++D H N K  + D+GL+     G+       S  +  PE+++   Y
Sbjct: 144 PENVLLDAHMNAK--IADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLY 192

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 8/105 (7%)
Query: 1   MRIATGASMALDYCHSMG-----IMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQE 54
           +R+ T  ++AL  CH        ++HRD+KP NV +D + + ++L D+GLA    H    
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSF 172
Query: 55  YNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               V + Y+  PE + +   Y+   D+WSLGC+L  +     PF
Sbjct: 173 AKTFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 51/242 (21%)
Query: 244 ALIFEHVNNTDFKQLYQTLTDYDIRYYLY-------------------ELLKALDYCHSM 284
           +L +     TD   +   +   DIRY++Y                   +++  L++ H  
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR-YFKGPELLADYQYH 343
            I++RD+KP NV++D +   +R+ D GLA     GQ      A    F  PELL   +Y 
Sbjct: 309 NIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 344 IELD------PRFADILGRHS-RKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE 396
             +D        +  I  R   R R E+  + E +  V  +A+ + DK            
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK------------ 415
Query: 397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTARE-AMDHPYFYPIVKDQSRHTLPSSSP 455
                      SP + DF + LL+ D  +RL  R+ + D    +P+ +D S   L +   
Sbjct: 416 ----------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGML 465
Query: 456 TP 457
           TP
Sbjct: 466 TP 467

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 8/105 (7%)
Query: 1   MRIATGASMALDYCHSMG-----IMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQE 54
           +R+ T  ++AL  CH        ++HRD+KP NV +D + + ++L D+GLA    H    
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSF 172
Query: 55  YNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               V + Y+  PE + +   Y+   D+WSLGC+L  +     PF
Sbjct: 173 AKAFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 51/242 (21%)
Query: 244 ALIFEHVNNTDFKQLYQTLTDYDIRYYLY-------------------ELLKALDYCHSM 284
           +L +     TD   +   +   DIRY++Y                   +++  L++ H  
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR-YFKGPELLADYQYH 343
            I++RD+KP NV++D +   +R+ D GLA     GQ      A    F  PELL   +Y 
Sbjct: 309 NIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 344 IELD------PRFADILGRHS-RKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE 396
             +D        +  I  R   R R E+  + E +  V  +A+ + DK            
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK------------ 415
Query: 397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTARE-AMDHPYFYPIVKDQSRHTLPSSSP 455
                      SP + DF + LL+ D  +RL  R+ + D    +P+ +D S   L +   
Sbjct: 416 ----------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGML 465
Query: 456 TP 457
           TP
Sbjct: 466 TP 467

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 51/242 (21%)
Query: 244 ALIFEHVNNTDFKQLYQTLTDYDIRYYLY-------------------ELLKALDYCHSM 284
           +L +     TD   +   +   DIRY++Y                   +++  L++ H  
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR-YFKGPELLADYQYH 343
            I++RD+KP NV++D +   +R+ D GLA     GQ      A    F  PELL   +Y 
Sbjct: 309 NIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 344 IELD------PRFADILGRHS-RKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE 396
             +D        +  I  R   R R E+  + E +  V  +A+ + DK            
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK------------ 415
Query: 397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTARE-AMDHPYFYPIVKDQSRHTLPSSSP 455
                      SP + DF + LL+ D  +RL  R+ + D    +P+ +D S   L +   
Sbjct: 416 ----------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGML 465
Query: 456 TP 457
           TP
Sbjct: 466 TP 467

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 51/242 (21%)
Query: 244 ALIFEHVNNTDFKQLYQTLTDYDIRYYLY-------------------ELLKALDYCHSM 284
           +L +     TD   +   +   DIRY++Y                   +++  L++ H  
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR-YFKGPELLADYQYH 343
            I++RD+KP NV++D +   +R+ D GLA     GQ      A    F  PELL   +Y 
Sbjct: 309 NIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 344 IELD------PRFADILGRHS-RKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE 396
             +D        +  I  R   R R E+  + E +  V  +A+ + DK            
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK------------ 415
Query: 397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTARE-AMDHPYFYPIVKDQSRHTLPSSSP 455
                      SP + DF + LL+ D  +RL  R+ + D    +P+ +D S   L +   
Sbjct: 416 ----------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGML 465
Query: 456 TP 457
           TP
Sbjct: 466 TP 467

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 120/283 (42%), Gaps = 39/283 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLE----NLRGGT 226
           D+YQL   +G+G +S V   + + +                        E     L   +
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHS 63
Query: 227 NIITLQAVVKDPVSRTPA--LIFEHVNNTD-FKQLY--QTLTDYDIRYYLYELLKALDYC 281
           NI+ L     D +S      L+F+ V   + F+ +   +  ++ D  + + ++L+A+ +C
Sbjct: 64  NIVRLH----DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 282 HSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLA 338
           H MG++HRD+KP N+++  + +   ++L D+GLA E     Q +     +  +  PE+L 
Sbjct: 120 HQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 339 DYQYHIELDPRFAD----ILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR 394
              Y   +D         IL       W+   H   Q  +   A DF             
Sbjct: 180 KEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQ-IKAGAYDF---------PSPE 229
Query: 395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
           W+          V+PEA + ++++L  +  +R+TA EA+ HP+
Sbjct: 230 WDT---------VTPEAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 119 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEIXINK 59
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 120 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 179 KRREFHAE 186

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 61/110 (55%), Gaps = 7/110 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
           AL++ HS  I+HRD+K  NV++  E   +RL D+G+ A+     Q+ +  + + Y+  PE
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 69  LLADYQM----YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           ++    M    YDY  D+WSLG  L  M  + EP  H  +    L++IAK
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 236

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/82 (31%), Positives = 50/82 (60%), Gaps = 2/82 (2%)
Query: 257 QLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEF 315
           +L + LT+  I+    ++L+AL++ HS  I+HRD+K  NV++  E   +RL D+G+ A+ 
Sbjct: 109 ELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKN 167
Query: 316 YHPGQEYNVRVASRYFKGPELL 337
               Q+ +  + + Y+  PE++
Sbjct: 168 LKTLQKRDSFIGTPYWMAPEVV 189

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 119 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 4/87 (4%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQ 320
           + + D + + ++L+  + Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNR 159
Query: 321 E--YNVRVASRYFKGPELLADYQYHIE 345
           E   N    +  +  PELL   ++H E
Sbjct: 160 ERLLNKMCGTLPYVAPELLKRREFHAE 186

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 120 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 60
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 180 KRREFHAE 187

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 119 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 59
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 120 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 179 KRREFHAE 186

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 61/110 (55%), Gaps = 7/110 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
           AL++ HS  I+HRD+K  NV++  E   +RL D+G+ A+     Q+ +  + + Y+  PE
Sbjct: 121 ALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 179
Query: 69  LLADYQM----YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           ++    M    YDY  D+WSLG  L  M  + EP  H  +    L++IAK
Sbjct: 180 VVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 228

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/82 (31%), Positives = 50/82 (60%), Gaps = 2/82 (2%)
Query: 257 QLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEF 315
           +L + LT+  I+    ++L+AL++ HS  I+HRD+K  NV++  E   +RL D+G+ A+ 
Sbjct: 101 ELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKN 159
Query: 316 YHPGQEYNVRVASRYFKGPELL 337
               Q+ +  + + Y+  PE++
Sbjct: 160 LKTLQKRDSFIGTPYWMAPEVV 181

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 118 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 58
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 59  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 119 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 178 KRREFHAE 185

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 1/101 (0%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ Y     I+HRD+K  N++I  E+  ++LID+G A +   G+ +     +  +  PE+
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVI-AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
           L         L+MWSLG  L +++F + PF    +  +  +
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAI 241

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 119 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 59
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 120 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 179 KRREFHAE 186

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 120 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 60
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 180 KRREFHAE 187

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 120 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 60
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 180 KRREFHAE 187

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 120 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 60
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 180 KRREFHAE 187

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 63/126 (50%), Gaps = 22/126 (17%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDH------------------ENRKLRLIDWGLAEFYHP 51
           AL + H   + H D+KP N++  +                  +N  +R+ D+G A F H 
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH- 193
Query: 52  GQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 111
            + +   VA+R+++ PE++ +   +    D+WS+GC+L    +R    F  H+N + LV 
Sbjct: 194 -EHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEY-YRGFTLFQTHENREHLVM 250
Query: 112 IAKVLG 117
           + K+LG
Sbjct: 251 MEKILG 256

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 104/234 (44%), Gaps = 48/234 (20%)
Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH------------------ENRKLRLI 308
           +R+  Y+L  AL + H   + H D+KP N++  +                  +N  +R+ 
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 309 DWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKRWERFVH 367
           D+G A F H  + +   VA+R+++ PE++ +  +    D      IL  + R       H
Sbjct: 185 DFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242
Query: 368 TENQHLVSPEA-LDFLDKNILGRHSRKR--------WE------RFVHTENQHLVS---- 408
              +HLV  E  L  +  +++ R  +++        W+      R+V    + L S    
Sbjct: 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQ 302
Query: 409 -----PEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV-KDQSRHTLPSSSPT 456
                 +  D + ++L +D  +R+T  EA+ HP+F  +  +++S HT  S +P+
Sbjct: 303 DSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT--SRNPS 354

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 119 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 59
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 120 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 179 KRREFHAE 186

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 63/126 (50%), Gaps = 22/126 (17%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDH------------------ENRKLRLIDWGLAEFYHP 51
           AL + H   + H D+KP N++  +                  +N  +R+ D+G A F H 
Sbjct: 167 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH- 225
Query: 52  GQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 111
            + +   VA+R+++ PE++ +   +    D+WS+GC+L    +R    F  H+N + LV 
Sbjct: 226 -EHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEY-YRGFTLFQTHENREHLVM 282
Query: 112 IAKVLG 117
           + K+LG
Sbjct: 283 MEKILG 288

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 100/227 (44%), Gaps = 46/227 (20%)
Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH------------------ENRKLRLI 308
           +R+  Y+L  AL + H   + H D+KP N++  +                  +N  +R+ 
Sbjct: 157 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 216
Query: 309 DWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKRWERFVH 367
           D+G A F H  + +   VA+R+++ PE++ +  +    D      IL  + R       H
Sbjct: 217 DFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 274
Query: 368 TENQHLVSPEA-LDFLDKNILGRHSRKR--------WE------RFVHTENQHLVS---- 408
              +HLV  E  L  +  +++ R  +++        W+      R+V    + L S    
Sbjct: 275 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQ 334
Query: 409 -----PEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV-KDQSRHT 449
                 +  D + ++L +D  +R+T  EA+ HP+F  +  +++S HT
Sbjct: 335 DSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT 381

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 15  HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA--- 71
           H + I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  PE++    
Sbjct: 141 HKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSM 199
Query: 72  --DYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
             ++  Y   +DMWS G ++ +++    PF+H
Sbjct: 200 NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/201 (21%), Positives = 83/201 (41%), Gaps = 36/201 (17%)
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TL++ + R  +  LL+ +   H + I+HRD+KP N+++D ++  ++L D+G +    PG+
Sbjct: 120 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGE 178
Query: 321 EYNVRVASRYFKGPELLADYQ------YHIELDPRFADILGRHSRKRWERFVHTENQHLV 374
           +      +  +  PE++          Y  E+D     ++          F H +   ++
Sbjct: 179 KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 375 SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPE-------ALDFLDKLLRYDHYERL 427
                                 R + + N    SPE         D + + L     +R 
Sbjct: 239 ----------------------RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 276
Query: 428 TAREAMDHPYFYPIVKDQSRH 448
           TA EA+ HP+F   V ++ RH
Sbjct: 277 TAEEALAHPFFQQYVVEEVRH 297

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 119 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 59
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 120 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 179 KRREFHAE 186

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 120/286 (41%), Gaps = 79/286 (27%)
Query: 246 IFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN 302
           I   + ++D K+L++T   LT+  ++  LY LL    + H  GI+HRD+KP N +++ ++
Sbjct: 109 IVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLN-QD 167
Query: 303 RKLRLIDWGLAEFYH-------------------PG-------QEYNVRVASRYFKGPEL 336
             +++ D+GLA   +                   PG       ++    V +R+++ PEL
Sbjct: 168 CSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL 227
Query: 337 L---ADYQYHIEL---DPRFADILG---RHSRKRWERF-------------------VHT 368
           +    +Y   I++      FA++L     H      RF                   VH 
Sbjct: 228 ILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCFPLSPDHNSKKVHE 287
Query: 369 ENQH---------LVSPEALDFLDKNILGRHSRKRWERFVHTENQHL------VSPEALD 413
           ++           + +P   D   K I  +   K  + F   +   L      +S E +D
Sbjct: 288 KSNRDQLNIIFNVIGTPPEEDL--KCITKQEVIKYIKLFPTRDGIDLSKKYSSISKEGID 345
Query: 414 FLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIV 459
            L+ +LR++  +R+T  +A+ HPY    +KD  +  L + S   I+
Sbjct: 346 LLESMLRFNAQKRITIDKALSHPY----LKDVRKENLENFSTEKII 387

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 120 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 60
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 180 KRREFHAE 187

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 63/126 (50%), Gaps = 22/126 (17%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDH------------------ENRKLRLIDWGLAEFYHP 51
           AL + H   + H D+KP N++  +                  +N  +R+ D+G A F H 
Sbjct: 144 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH- 202
Query: 52  GQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 111
            + +   VA+R+++ PE++ +   +    D+WS+GC+L    +R    F  H+N + LV 
Sbjct: 203 -EHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEY-YRGFTLFQTHENREHLVM 259
Query: 112 IAKVLG 117
           + K+LG
Sbjct: 260 MEKILG 265

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 96/222 (43%), Gaps = 45/222 (20%)
Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH------------------ENRKLRLI 308
           +R+  Y+L  AL + H   + H D+KP N++  +                  +N  +R+ 
Sbjct: 134 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 193
Query: 309 DWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKRWERFVH 367
           D+G A F H  + +   VA+R+++ PE++ +  +    D      IL  + R       H
Sbjct: 194 DFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 251
Query: 368 TENQHLVSPEA-LDFLDKNILGRHSRKR--------WE------RFVHTENQHLVS---- 408
              +HLV  E  L  +  +++ R  +++        W+      R+V    + L S    
Sbjct: 252 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQ 311
Query: 409 -----PEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                 +  D + ++L +D  +R+T  EA+ HP+F  +  ++
Sbjct: 312 DSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 353

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 120 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINA 60
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 180 KRREFHAE 187

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 119 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEIXINK 59
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 120 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 179 KRREFHAE 186

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 119 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 59
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 120 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 179 KRREFHAE 186

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 119 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQE 216

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 59
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 120 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 179 KRREFHAE 186

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 119 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 59
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 120 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 179 KRREFHAE 186

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 4/106 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
            L + H    +H D+KP N+M   + + +L+LID+GL     P Q   V   +  F  PE
Sbjct: 161 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 220
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
            +A+ +   Y  DMWS+G +   ++    PF  G +N D+ +R  K
Sbjct: 221 -VAEGKPVGYYTDMWSVGVLSYILLSGLSPF--GGENDDETLRNVK 263

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 79/194 (40%), Gaps = 16/194 (8%)
Query: 270 YLYELLKALDYCHSMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHPGQEYNVRVAS 328
           Y+ ++ K L + H    +H D+KP N+M   + + +L+LID+GL     P Q   V   +
Sbjct: 154 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 213
Query: 329 RYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILG 388
             F  PE+          D     +L          ++          E  D   +N+  
Sbjct: 214 AEFAAPEVAEGKPVGYYTDMWSVGVLS---------YILLSGLSPFGGENDDETLRNV-- 262
Query: 389 RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRH 448
               K  +  +       +S +  DF+ KLL  D   R+T  +A++HP+  P        
Sbjct: 263 ----KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 318
Query: 449 TLPSSSPTPIVNSV 462
            +PSS  T I +S+
Sbjct: 319 QIPSSRYTKIRDSI 332

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 4/106 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
            L + H    +H D+KP N+M   + + +L+LID+GL     P Q   V   +  F  PE
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 326
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
            +A+ +   Y  DMWS+G +   ++    PF  G +N D+ +R  K
Sbjct: 327 -VAEGKPVGYYTDMWSVGVLSYILLSGLSPF--GGENDDETLRNVK 369

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 79/194 (40%), Gaps = 16/194 (8%)
Query: 270 YLYELLKALDYCHSMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHPGQEYNVRVAS 328
           Y+ ++ K L + H    +H D+KP N+M   + + +L+LID+GL     P Q   V   +
Sbjct: 260 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 319
Query: 329 RYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILG 388
             F  PE+          D     +L          ++          E  D   +N+  
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLS---------YILLSGLSPFGGENDDETLRNV-- 368
Query: 389 RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRH 448
               K  +  +       +S +  DF+ KLL  D   R+T  +A++HP+  P        
Sbjct: 369 ----KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 424
Query: 449 TLPSSSPTPIVNSV 462
            +PSS  T I +S+
Sbjct: 425 QIPSSRYTKIRDSI 438

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 120 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 60
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 180 KRREFHAE 187

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ YCH   I+HRD+K  N+++D +   +++ D+G +  +  G + +    S  +  PEL
Sbjct: 126 AVQYCHQKYIVHRDLKAENLLLDGD-MNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPEL 184
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               +     +D+WSLG +L +++    PF
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/119 (23%), Positives = 60/119 (50%), Gaps = 6/119 (5%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           NI+ L  V++    +T  L+ E+ +     D+   +  + + + R    +++ A+ YCH 
Sbjct: 75  NIVKLFEVIE--TEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
             I+HRD+K  N+++D +   +++ D+G +  +  G + +    S  +  PEL    +Y
Sbjct: 133 KYIVHRDLKAENLLLDGD-MNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKY 190

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 119 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 59
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 120 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 179 KRREFHAE 186

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 120 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEIXINK 60
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 180 KRREFHAE 187

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 15  HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA--- 71
           H + I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  PE++    
Sbjct: 141 HKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSM 199
Query: 72  --DYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
             ++  Y   +DMWS G ++ +++    PF+H
Sbjct: 200 NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/201 (21%), Positives = 83/201 (41%), Gaps = 36/201 (17%)
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TL++ + R  +  LL+ +   H + I+HRD+KP N+++D ++  ++L D+G +    PG+
Sbjct: 120 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGE 178
Query: 321 EYNVRVASRYFKGPELLADYQ------YHIELDPRFADILGRHSRKRWERFVHTENQHLV 374
           +      +  +  PE++          Y  E+D     ++          F H +   ++
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 375 SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPE-------ALDFLDKLLRYDHYERL 427
                                 R + + N    SPE         D + + L     +R 
Sbjct: 239 ----------------------RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 276
Query: 428 TAREAMDHPYFYPIVKDQSRH 448
           TA EA+ HP+F   V ++ RH
Sbjct: 277 TAEEALAHPFFQQYVVEEVRH 297

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ YCH   I+HRD+K  N+++D  +  +++ D+G +  +  G + +    S  +  PEL
Sbjct: 123 AVQYCHQKRIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPEL 181
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               +     +D+WSLG +L +++    PF
Sbjct: 182 FQGKKYDGPEVDVWSLGVILYTLVSGSLPF 211

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/119 (24%), Positives = 60/119 (50%), Gaps = 6/119 (5%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           NI+ L  V++    +T  LI E+ +     D+   +  + + + R    +++ A+ YCH 
Sbjct: 72  NIVKLFEVIE--TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
             I+HRD+K  N+++D  +  +++ D+G +  +  G + +    S  +  PEL    +Y
Sbjct: 130 KRIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKY 187

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPEL 69
           Y H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PEL
Sbjct: 119 YLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           L   + +   +D+WS G +L +M+  + P+    D+  +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIIT 230
           +D+ LV+ LG G Y EV  A+N  + +                      EN++    I  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINK 59
Query: 231 L---QAVVKDPVSRTPA----LIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDY 280
           +   + VVK    R       L  E+ +  +     +    + + D + + ++L+  + Y
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE-FYHPGQE--YNVRVASRYFKGPELL 337
            H +GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL
Sbjct: 120 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 338 ADYQYHIE 345
              ++H E
Sbjct: 179 KRREFHAE 186

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 15  HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA--- 71
           H + I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  PE++    
Sbjct: 128 HKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSM 186
Query: 72  --DYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
             ++  Y   +DMWS G ++ +++    PF+H
Sbjct: 187 NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 218

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/191 (21%), Positives = 78/191 (40%), Gaps = 36/191 (18%)
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           TL++ + R  +  LL+ +   H + I+HRD+KP N+++D ++  ++L D+G +    PG+
Sbjct: 107 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGE 165
Query: 321 EYNVRVASRYFKGPELLADYQ------YHIELDPRFADILGRHSRKRWERFVHTENQHLV 374
           +      +  +  PE++          Y  E+D     ++          F H +   ++
Sbjct: 166 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 225
Query: 375 SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPE-------ALDFLDKLLRYDHYERL 427
                                 R + + N    SPE         D + + L     +R 
Sbjct: 226 ----------------------RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 263
Query: 428 TAREAMDHPYF 438
           TA EA+ HP+F
Sbjct: 264 TAEEALAHPFF 274

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 57/102 (55%), Gaps = 4/102 (3%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASR 62
           A    + L + HS GI++RD+K  N+++D +   +++ D+G+ +    G  + N    + 
Sbjct: 124 AAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTP 182
Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
            +  PE+L   Q Y++S+D WS G +L  M+  + P FHG D
Sbjct: 183 DYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQD 222

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/107 (24%), Positives = 56/107 (52%), Gaps = 5/107 (4%)
Query: 245 LIFEHVNNTDFKQLYQTLTDYDIR---YYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE 301
            + E++N  D     Q+   +D+    +Y  E++  L + HS GI++RD+K  N+++D +
Sbjct: 95  FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD 154
Query: 302 NRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQYHIELD 347
              +++ D+G+ +    G  + N    +  +  PE+L   +Y+  +D
Sbjct: 155 GH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVD 200

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ YCH   I+HRD+K  N+++D  +  +++ D+G +  +  G + +    S  +  PEL
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPEL 183
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               +     +D+WSLG +L +++    PF
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/119 (23%), Positives = 60/119 (50%), Gaps = 6/119 (5%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           NI+ L  V++    +T  L+ E+ +     D+   +  + + + R    +++ A+ YCH 
Sbjct: 74  NIVKLFEVIE--TEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
             I+HRD+K  N+++D  +  +++ D+G +  +  G + +    S  +  PEL    +Y
Sbjct: 132 KFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ YCH   I+HRD+K  N+++D  +  +++ D+G +  +  G + +    S  +  PEL
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPEL 183
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               +     +D+WSLG +L +++    PF
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/119 (23%), Positives = 60/119 (50%), Gaps = 6/119 (5%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           NI+ L  V++    +T  L+ E+ +     D+   +  + + + R    +++ A+ YCH 
Sbjct: 74  NIVKLFEVIE--TEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
             I+HRD+K  N+++D  +  +++ D+G +  +  G + +    S  +  PEL    +Y
Sbjct: 132 KFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ YCH   I+HRD+K  N+++D  +  +++ D+G +  +  G + +    S  +  PEL
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPEL 183
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               +     +D+WSLG +L +++    PF
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/119 (23%), Positives = 60/119 (50%), Gaps = 6/119 (5%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           NI+ L  V++    +T  L+ E+ +     D+   +  + + + R    +++ A+ YCH 
Sbjct: 74  NIVKLFEVIE--TEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
             I+HRD+K  N+++D  +  +++ D+G +  +  G + +    S  +  PEL    +Y
Sbjct: 132 KFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ YCH   I+HRD+K  N+++D  +  +++ D+G +  +  G + +    +  +  PEL
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLD-ADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPEL 183
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               +     +D+WSLG +L +++    PF
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 27/119 (22%), Positives = 59/119 (49%), Gaps = 6/119 (5%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           NI+ L  V++    +T  L+ E+ +     D+   +    + + R    +++ A+ YCH 
Sbjct: 74  NIVKLFEVIE--TEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQ 131
Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
             I+HRD+K  N+++D  +  +++ D+G +  +  G + +    +  +  PEL    +Y
Sbjct: 132 KFIVHRDLKAENLLLD-ADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
           AL Y H+ G++HRD+K  ++++  + R ++L D+G  A+      +    V + Y+  PE
Sbjct: 153 ALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPE 211
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           +++    Y   +D+WSLG M+  MI  + P+F+
Sbjct: 212 VISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFN 243

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/178 (23%), Positives = 77/178 (43%), Gaps = 18/178 (10%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQ 320
           + +  I      +L+AL Y H+ G++HRD+K  ++++  + R ++L D+G  A+      
Sbjct: 138 MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVP 196
Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD 380
           +    V + Y+  PE+++   Y  E+D              W   +         P    
Sbjct: 197 KRKXLVGTPYWMAPEVISRLPYGTEVD-------------IWSLGIMVIEMIDGEPP--- 240
Query: 381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           + ++  L    R R       ++ H VS     FLD +L  +  +R TA+E + HP+ 
Sbjct: 241 YFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRATAQELLGHPFL 298

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG----LAEFYHPGQEYN 56
           + +   A  AL++ H  GI+HRDVKP N+MI   N  ++++D+G    +A+  +   +  
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTA 177
Query: 57  VRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
             + +  +  PE  A     D   D++SLGC+L  ++  + PF
Sbjct: 178 AVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/82 (29%), Positives = 45/82 (54%), Gaps = 4/82 (4%)
Query: 235 VKDPVSRTPALIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYCHSMGIMHRDV 291
            + P    P ++ E+V+    + +  T   +T       + +  +AL++ H  GI+HRDV
Sbjct: 83  AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDV 142
Query: 292 KPHNVMIDHENRKLRLIDWGLA 313
           KP N+MI   N  ++++D+G+A
Sbjct: 143 KPANIMISATN-AVKVMDFGIA 163

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG----LAEFYHPGQEYN 56
           + +   A  AL++ H  GI+HRDVKP N+MI   N  ++++D+G    +A+  +   +  
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTA 177
Query: 57  VRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
             + +  +  PE  A     D   D++SLGC+L  ++  + PF
Sbjct: 178 AVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/82 (29%), Positives = 45/82 (54%), Gaps = 4/82 (4%)
Query: 235 VKDPVSRTPALIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYCHSMGIMHRDV 291
            + P    P ++ E+V+    + +  T   +T       + +  +AL++ H  GI+HRDV
Sbjct: 83  AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDV 142
Query: 292 KPHNVMIDHENRKLRLIDWGLA 313
           KP N+MI   N  ++++D+G+A
Sbjct: 143 KPANIMISATN-AVKVMDFGIA 163

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG----LAEFYHPGQEYN 56
           + +   A  AL++ H  GI+HRDVKP N+MI   N  ++++D+G    +A+  +   +  
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTA 177
Query: 57  VRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
             + +  +  PE  A     D   D++SLGC+L  ++  + PF
Sbjct: 178 AVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/82 (29%), Positives = 45/82 (54%), Gaps = 4/82 (4%)
Query: 235 VKDPVSRTPALIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYCHSMGIMHRDV 291
            + P    P ++ E+V+    + +  T   +T       + +  +AL++ H  GI+HRDV
Sbjct: 83  AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDV 142
Query: 292 KPHNVMIDHENRKLRLIDWGLA 313
           KP N+MI   N  ++++D+G+A
Sbjct: 143 KPANIMISATN-AVKVMDFGIA 163

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ YCH   I+HRD+K  N+++D  +  +++ D+G +  +  G + +    S  +  PEL
Sbjct: 118 AVQYCHQKFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPEL 176
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               +     +D+WSLG +L +++    PF
Sbjct: 177 FQGKKYDGPEVDVWSLGVILYTLVSGSLPF 206

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/178 (19%), Positives = 80/178 (44%), Gaps = 10/178 (5%)
Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLE----NLRGGTN 227
           +Y+L++ +G+G +++V  A ++ +                        E     +    N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 228 IITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHSM 284
           I+ L  V++    +T  L+ E+ +     D+   +  + + + R    +++ A+ YCH  
Sbjct: 68  IVKLFEVIE--TEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQK 125
Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
            I+HRD+K  N+++D  +  +++ D+G +  +  G + +    S  +  PEL    +Y
Sbjct: 126 FIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 182

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 7   ASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG----LAEFYHPGQEYNVRVASR 62
           A  AL++ H  GI+HRDVKP N+MI   N  ++++D+G    +A+  +   +    + + 
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
            +  PE  A     D   D++SLGC+L  ++  + PF
Sbjct: 184 QYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/82 (29%), Positives = 45/82 (54%), Gaps = 4/82 (4%)
Query: 235 VKDPVSRTPALIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYCHSMGIMHRDV 291
            + P    P ++ E+V+    + +  T   +T       + +  +AL++ H  GI+HRDV
Sbjct: 83  AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDV 142
Query: 292 KPHNVMIDHENRKLRLIDWGLA 313
           KP N+MI   N  ++++D+G+A
Sbjct: 143 KPANIMISATN-AVKVMDFGIA 163

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 57/102 (55%), Gaps = 4/102 (3%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASR 62
           A    + L + HS GI++RD+K  N+++D +   +++ D+G+ +    G  + N    + 
Sbjct: 125 AAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTP 183
Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
            +  PE+L   Q Y++S+D WS G +L  M+  + P FHG D
Sbjct: 184 DYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQD 223

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/107 (24%), Positives = 56/107 (52%), Gaps = 5/107 (4%)
Query: 245 LIFEHVNNTDFKQLYQTLTDYDIR---YYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE 301
            + E++N  D     Q+   +D+    +Y  E++  L + HS GI++RD+K  N+++D +
Sbjct: 96  FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD 155
Query: 302 NRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQYHIELD 347
              +++ D+G+ +    G  + N    +  +  PE+L   +Y+  +D
Sbjct: 156 GH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVD 201

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG----LAEFYHPGQEYN 56
           + +   A  AL++ H  GI+HRDVKP N+MI   N  ++++D+G    +A+  +   +  
Sbjct: 136 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTA 194
Query: 57  VRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
             + +  +  PE  A     D   D++SLGC+L  ++  + PF
Sbjct: 195 AVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPF 236

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/82 (29%), Positives = 45/82 (54%), Gaps = 4/82 (4%)
Query: 235 VKDPVSRTPALIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYCHSMGIMHRDV 291
            + P    P ++ E+V+    + +  T   +T       + +  +AL++ H  GI+HRDV
Sbjct: 100 AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDV 159
Query: 292 KPHNVMIDHENRKLRLIDWGLA 313
           KP N+MI   N  ++++D+G+A
Sbjct: 160 KPANIMISATN-AVKVMDFGIA 180

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-----QEY 55
           + +   A  AL++ H  GI+HRDVKP N++I   N  ++++D+G+A           Q  
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANILISATN-AVKVVDFGIARAIADSGNSVXQTA 177
Query: 56  NVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
            V   ++Y    +   D    D   D++SLGC+L  ++  + PF
Sbjct: 178 AVIGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/82 (28%), Positives = 45/82 (54%), Gaps = 4/82 (4%)
Query: 235 VKDPVSRTPALIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYCHSMGIMHRDV 291
            + P    P ++ E+V+    + +  T   +T       + +  +AL++ H  GI+HRDV
Sbjct: 83  AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDV 142
Query: 292 KPHNVMIDHENRKLRLIDWGLA 313
           KP N++I   N  ++++D+G+A
Sbjct: 143 KPANILISATN-AVKVVDFGIA 163

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ YCH   I+HRD+K  N+++D  +  +++ D+G +  +  G + +    +  +  PEL
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPEL 184
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               +     +D+WSLG +L +++    PF
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/119 (23%), Positives = 60/119 (50%), Gaps = 6/119 (5%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           NI+ L  V++    +T  LI E+ +     D+   +  + + + R    +++ A+ YCH 
Sbjct: 75  NIVKLFEVIE--TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
             I+HRD+K  N+++D  +  +++ D+G +  +  G + +    +  +  PEL    +Y
Sbjct: 133 KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP---GQEYNVRVASRYFKG 66
            + + H M I+HRD+KP N++ID  N+ L++ D+G+A+        Q  +V    +YF  
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILID-SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF-S 180
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           PE  A  +  D   D++S+G +L  M+  + PF
Sbjct: 181 PE-QAKGEATDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 17/45 (37%), Positives = 32/45 (71%), Gaps = 1/45 (2%)
Query: 270 YLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE 314
           +  ++L  + + H M I+HRD+KP N++ID  N+ L++ D+G+A+
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILID-SNKTLKIFDFGIAK 159

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ YCH   I+HRD+K  N+++D  +  +++ D+G +  +  G + +    S  +  PEL
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPEL 183
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               +     +D+WSLG +L +++    PF
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/119 (23%), Positives = 60/119 (50%), Gaps = 6/119 (5%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           NI+ L  V++    +T  L+ E+ +     D+   +  + + + R    +++ A+ YCH 
Sbjct: 74  NIVKLFEVIE--TEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
             I+HRD+K  N+++D  +  +++ D+G +  +  G + +    S  +  PEL    +Y
Sbjct: 132 KFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKY 189

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDY------DIRYYLYELLKALDY 280
           NI+  + V+  P     A+I E+ +     +LY+ + +       + R++  +LL  + Y
Sbjct: 77  NIVRFKEVILTPTHL--AIIMEYASG---GELYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 281 CHSMGIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           CHSM I HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L  
Sbjct: 132 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 191
Query: 340 YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
            +Y    D + AD+        W   V     +++   A  F D     R  RK  +R +
Sbjct: 192 QEY----DGKIADV--------WSCGV---TLYVMLVGAYPFEDPE-EPRDYRKTIQRIL 235
Query: 400 HTE----NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
             +    +   +SPE    + ++   D   R++  E   H +F
Sbjct: 236 SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ YCH   I+HRD+K  N+++D  +  +++ D+G +  +  G + +    +  +  PEL
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPEL 183
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               +     +D+WSLG +L +++    PF
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/119 (22%), Positives = 60/119 (50%), Gaps = 6/119 (5%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           NI+ L  V++    +T  L+ E+ +     D+   +  + + + R    +++ A+ YCH 
Sbjct: 74  NIVKLFEVIE--TEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
             I+HRD+K  N+++D  +  +++ D+G +  +  G + +    +  +  PEL    +Y
Sbjct: 132 KFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 61/113 (53%), Gaps = 5/113 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
           AL++ HS  ++HRD+K  N+++  +   ++L D+G      P Q + +  V + Y+  PE
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
           ++   + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL
Sbjct: 187 VVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPEL 236

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 38/203 (18%)
Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVR 325
           I     E L+AL++ HS  ++HRD+K  N+++  +   ++L D+G      P Q + +  
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTM 176
Query: 326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
           V + Y+  PE++    Y  ++D     I+                  ++  E   +L++N
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAI---------------EMIEGEP-PYLNEN 220
Query: 386 ILGRHSRKRWERFVHTENQ-HLVSPEAL-----DFLDKLLRYDHYERLTAREAMDHPYFY 439
            L      R    + T     L +PE L     DFL++ L  D  +R +A+E + H  F 
Sbjct: 221 PL------RALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH-QFL 273
Query: 440 PIVKDQSRHTLPSSSPTPIVNSV 462
            I K       P SS TP++ + 
Sbjct: 274 KIAK-------PLSSLTPLIAAA 289

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 53/91 (58%), Gaps = 2/91 (2%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           + L++ H+  +++RD+KP N+++D E+  +R+ D GLA  +   + +   V +  +  PE
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +L     YD S D +SLGCML  ++    PF
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/77 (28%), Positives = 47/77 (61%), Gaps = 2/77 (2%)
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
             ++ D+R+Y  E++  L++ H+  +++RD+KP N+++D E+  +R+ D GLA  +   +
Sbjct: 288 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKK 346
Query: 321 EYNVRVASRYFKGPELL 337
            +   V +  +  PE+L
Sbjct: 347 PH-ASVGTHGYMAPEVL 362

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 53/91 (58%), Gaps = 2/91 (2%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           + L++ H+  +++RD+KP N+++D E+  +R+ D GLA  +   + +   V +  +  PE
Sbjct: 302 LGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPE 359
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +L     YD S D +SLGCML  ++    PF
Sbjct: 360 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/77 (28%), Positives = 47/77 (61%), Gaps = 2/77 (2%)
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
             ++ D+R+Y  E++  L++ H+  +++RD+KP N+++D E+  +R+ D GLA  +   +
Sbjct: 287 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKK 345
Query: 321 EYNVRVASRYFKGPELL 337
            +   V +  +  PE+L
Sbjct: 346 PH-ASVGTHGYMAPEVL 361

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 53/91 (58%), Gaps = 2/91 (2%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           + L++ H+  +++RD+KP N+++D E+  +R+ D GLA  +   + +   V +  +  PE
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +L     YD S D +SLGCML  ++    PF
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/77 (28%), Positives = 47/77 (61%), Gaps = 2/77 (2%)
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
             ++ D+R+Y  E++  L++ H+  +++RD+KP N+++D E+  +R+ D GLA  +   +
Sbjct: 288 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKK 346
Query: 321 EYNVRVASRYFKGPELL 337
            +   V +  +  PE+L
Sbjct: 347 PH-ASVGTHGYMAPEVL 362

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 53/91 (58%), Gaps = 2/91 (2%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           + L++ H+  +++RD+KP N+++D E+  +R+ D GLA  +   + +   V +  +  PE
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +L     YD S D +SLGCML  ++    PF
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/77 (28%), Positives = 47/77 (61%), Gaps = 2/77 (2%)
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
             ++ D+R+Y  E++  L++ H+  +++RD+KP N+++D E+  +R+ D GLA  +   +
Sbjct: 288 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKK 346
Query: 321 EYNVRVASRYFKGPELL 337
            +   V +  +  PE+L
Sbjct: 347 PH-ASVGTHGYMAPEVL 362

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 14/106 (13%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYH--------PGQEYNV 57
           + ALD+ H+ GI HRD+KP N++ +H N+   +++ D+GL                E   
Sbjct: 121 ASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLT 180
Query: 58  RVASRYFKGPELLADY----QMYDYSLDMWSLGCMLASMIFRKEPF 99
              S  +  PE++  +     +YD   D+WSLG +L  ++    PF
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 92/226 (40%), Gaps = 48/226 (21%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYH-- 317
             + +    + ++  ALD+ H+ GI HRD+KP N++ +H N+   +++ D+GL       
Sbjct: 108 FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLN 167
Query: 318 ------PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADI-----------------L 354
                    E      S  +  PE++  +     +  +  D+                 +
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227
Query: 355 GR-HSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALD 413
           GR  S   W+R           P   + L ++I       ++E F   +  H +S  A D
Sbjct: 228 GRCGSDCGWDR-------GEACPACQNMLFESI----QEGKYE-FPDKDWAH-ISCAAKD 274
Query: 414 FLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIV 459
            + KLL  D  +RL+A + + HP+      +   +TL    PTP+V
Sbjct: 275 LISKLLVRDAKQRLSAAQVLQHPWVQGCAPE---NTL----PTPMV 313

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 79/182 (43%), Gaps = 19/182 (10%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPG 319
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++    E+  +++ D+G ++     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 320 QEYNVRVASRYFKGPELLADY---QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP 376
                   +  +  PE+L       Y+  +D     ++       +  F     Q     
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----- 225
Query: 377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
             +   D+   G+++      F+  E    VS +ALD + KLL  D   R T  EA+ HP
Sbjct: 226 --VSLKDQITSGKYN------FI-PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 437 YF 438
           + 
Sbjct: 277 WL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 79/182 (43%), Gaps = 19/182 (10%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPG 319
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++    E+  +++ D+G ++     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 320 QEYNVRVASRYFKGPELLADY---QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP 376
                   +  +  PE+L       Y+  +D     ++       +  F     Q     
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----- 225
Query: 377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
             +   D+   G+++      F+  E    VS +ALD + KLL  D   R T  EA+ HP
Sbjct: 226 --VSLKDQITSGKYN------FI-PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 437 YF 438
           + 
Sbjct: 277 WL 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 79/182 (43%), Gaps = 19/182 (10%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPG 319
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++    E+  +++ D+G ++     
Sbjct: 117 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 176
Query: 320 QEYNVRVASRYFKGPELLADY---QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP 376
                   +  +  PE+L       Y+  +D     ++       +  F     Q     
Sbjct: 177 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----- 231
Query: 377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
             +   D+   G+++      F+  E    VS +ALD + KLL  D   R T  EA+ HP
Sbjct: 232 --VSLKDQITSGKYN------FI-PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 282
Query: 437 YF 438
           + 
Sbjct: 283 WL 284

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 79/182 (43%), Gaps = 19/182 (10%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPG 319
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++    E+  +++ D+G ++     
Sbjct: 110 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 169
Query: 320 QEYNVRVASRYFKGPELLADY---QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP 376
                   +  +  PE+L       Y+  +D     ++       +  F     Q     
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----- 224
Query: 377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
             +   D+   G+++      F+  E    VS +ALD + KLL  D   R T  EA+ HP
Sbjct: 225 --VSLKDQITSGKYN------FI-PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 275
Query: 437 YF 438
           + 
Sbjct: 276 WL 277

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 79/182 (43%), Gaps = 19/182 (10%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPG 319
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++    E+  +++ D+G ++     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 320 QEYNVRVASRYFKGPELLADY---QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP 376
                   +  +  PE+L       Y+  +D     ++       +  F     Q     
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----- 225
Query: 377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
             +   D+   G+++      F+  E    VS +ALD + KLL  D   R T  EA+ HP
Sbjct: 226 --VSLKDQITSGKYN------FI-PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 437 YF 438
           + 
Sbjct: 277 WL 278

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 61/113 (53%), Gaps = 5/113 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
           AL++ HS  ++HRD+K  N+++  +   ++L D+G      P Q + +  V + Y+  PE
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE 186
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
           ++   + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL
Sbjct: 187 VVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPEL 236

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 38/203 (18%)
Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVR 325
           I     E L+AL++ HS  ++HRD+K  N+++  +   ++L D+G      P Q + +  
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSXM 176
Query: 326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
           V + Y+  PE++    Y  ++D     I+                  ++  E   +L++N
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAI---------------EMIEGEP-PYLNEN 220
Query: 386 ILGRHSRKRWERFVHTENQ-HLVSPEAL-----DFLDKLLRYDHYERLTAREAMDHPYFY 439
            L      R    + T     L +PE L     DFL++ L  D  +R +A+E + H  F 
Sbjct: 221 PL------RALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH-QFL 273
Query: 440 PIVKDQSRHTLPSSSPTPIVNSV 462
            I K       P SS TP++ + 
Sbjct: 274 KIAK-------PLSSLTPLIAAA 289

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 61/113 (53%), Gaps = 5/113 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
           AL++ HS  ++HRD+K  N+++  +   ++L D+G      P Q + +  V + Y+  PE
Sbjct: 129 ALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE 187
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
           ++   + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL
Sbjct: 188 VVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPEL 237

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 38/202 (18%)
Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVR 325
           I     E L+AL++ HS  ++HRD+K  N+++  +   ++L D+G      P Q + +  
Sbjct: 119 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSXM 177
Query: 326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
           V + Y+  PE++    Y  ++D     I+                  ++  E   +L++N
Sbjct: 178 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAI---------------EMIEGEP-PYLNEN 221
Query: 386 ILGRHSRKRWERFVHTENQ-HLVSPEAL-----DFLDKLLRYDHYERLTAREAMDHPYFY 439
            L      R    + T     L +PE L     DFL++ L  D  +R +A+E + H  F 
Sbjct: 222 PL------RALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQH-QFL 274
Query: 440 PIVKDQSRHTLPSSSPTPIVNS 461
            I K       P SS TP++ +
Sbjct: 275 KIAK-------PLSSLTPLIAA 289

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 79/182 (43%), Gaps = 19/182 (10%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPG 319
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++    E+  +++ D+G ++     
Sbjct: 250 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 309
Query: 320 QEYNVRVASRYFKGPELLADY---QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP 376
                   +  +  PE+L       Y+  +D     ++       +  F     Q     
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----- 364
Query: 377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
             +   D+   G+++      F+  E    VS +ALD + KLL  D   R T  EA+ HP
Sbjct: 365 --VSLKDQITSGKYN------FI-PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 415
Query: 437 YF 438
           + 
Sbjct: 416 WL 417

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ + HS  I HRDVKP N++   + +   L+L D+G A+             + Y+  P
Sbjct: 121 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAP 179
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           E+L   + YD S DMWSLG ++  ++    PF+
Sbjct: 180 EVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFY 211

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 16/182 (8%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRK--LRLIDWGLAEFYH 317
           Q  T+ +    + ++  A+ + HS  I HRDVKP N++   + +   L+L D+G A+   
Sbjct: 104 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ET 162
Query: 318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
                     + Y+  PE+L   +Y    D     ++       +  F     Q  +SP 
Sbjct: 163 TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ-AISP- 220
Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                     G   R R  ++     +   VS +A   +  LL+ D  ERLT  + M+HP
Sbjct: 221 ----------GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 270
Query: 437 YF 438
           + 
Sbjct: 271 WI 272

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 79/182 (43%), Gaps = 19/182 (10%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPG 319
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++    E+  +++ D+G ++     
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
Query: 320 QEYNVRVASRYFKGPELLADY---QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP 376
                   +  +  PE+L       Y+  +D     ++       +  F     Q     
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----- 350
Query: 377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
             +   D+   G+++      F+  E    VS +ALD + KLL  D   R T  EA+ HP
Sbjct: 351 --VSLKDQITSGKYN------FI-PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401
Query: 437 YF 438
           + 
Sbjct: 402 WL 403

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ + HS  I HRDVKP N++   + +   L+L D+G A+             + Y+  P
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAP 198
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           E+L   + YD S DMWSLG ++  ++    PF+
Sbjct: 199 EVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFY 230

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 16/182 (8%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRK--LRLIDWGLAEFYH 317
           Q  T+ +    + ++  A+ + HS  I HRDVKP N++   + +   L+L D+G A+   
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ET 181
Query: 318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
                     + Y+  PE+L   +Y    D     ++       +  F     Q  +SP 
Sbjct: 182 TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ-AISP- 239
Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQ-HLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                     G   R R  ++     +   VS +A   +  LL+ D  ERLT  + M+HP
Sbjct: 240 ----------GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289
Query: 437 YF 438
           + 
Sbjct: 290 WI 291

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 61/131 (46%), Gaps = 28/131 (21%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMID------------------------HENRKLRLIDWGL 45
           AL+Y   M + H D+KP N+++D                         ++  ++LID+G 
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 46  AEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 105
           A F      +   + +R ++ PE++ +   +D S DMWS GC+LA + +     F  H++
Sbjct: 209 ATF--KSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAEL-YTGSLLFRTHEH 264
Query: 106 YDQLVRIAKVL 116
            + L  +  ++
Sbjct: 265 MEHLAMMESII 275

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 74/171 (43%), Gaps = 28/171 (16%)
Query: 266 DIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID------------------------HE 301
           DI+ Y  E+LKAL+Y   M + H D+KP N+++D                         +
Sbjct: 138 DIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 302 NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRK 360
           +  ++LID+G A F      +   + +R ++ PE++ +  + +  D   F  +L      
Sbjct: 198 STGIKLIDFGCATF--KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
Query: 361 RWERFVHTENQHLVSPEA-LDFLDKNILGRHSRKRWERFVHTENQHLVSPE 410
                 H   +HL   E+ +  + KN+L   ++    ++V+ +   L  PE
Sbjct: 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPE 306

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 59/113 (52%), Gaps = 5/113 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPE 68
           AL++ HS  ++HRD+K  N+++  +   ++L D+G      P Q      V + Y+  PE
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPE 186
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
           ++   + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL
Sbjct: 187 VVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPEL 236

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 38/203 (18%)
Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR- 325
           I     E L+AL++ HS  ++HRD+K  N+++  +   ++L D+G      P Q      
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSEM 176
Query: 326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
           V + Y+  PE++    Y  ++D     I+                  ++  E   +L++N
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAI---------------EMIEGEP-PYLNEN 220
Query: 386 ILGRHSRKRWERFVHTENQ-HLVSPEAL-----DFLDKLLRYDHYERLTAREAMDHPYFY 439
            L      R    + T     L +PE L     DFL++ L  D  +R +A+E + H  F 
Sbjct: 221 PL------RALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH-QFL 273
Query: 440 PIVKDQSRHTLPSSSPTPIVNSV 462
            I K       P SS TP++ + 
Sbjct: 274 KIAK-------PLSSLTPLIAAA 289

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 55/97 (56%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N+MID +   +++ D+GLA+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGLAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/80 (28%), Positives = 47/80 (58%), Gaps = 3/80 (3%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R+Y  +++   +Y HS+ +++RD+KP N+MID +   +++ D+GLA+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGLAKRVK-GRTWXLCGT 201
Query: 328 SRYFKGPELLADYQYHIELD 347
             Y   PE++    Y+  +D
Sbjct: 202 PEYL-APEIILSKGYNKAVD 220

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 49/88 (55%), Gaps = 3/88 (3%)
Query: 13  YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLA 71
           Y HS GI+HRD+   N+++   N  +++ D+GLA +   P +++     +  +  PE+ A
Sbjct: 127 YLHSHGILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI-A 184
Query: 72  DYQMYDYSLDMWSLGCMLASMIFRKEPF 99
               +    D+WSLGCM  +++  + PF
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPF 212

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/199 (21%), Positives = 86/199 (43%), Gaps = 25/199 (12%)
Query: 245 LIFEHVNNTD----FKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH 300
           L+ E  +N +     K   +  ++ + R+++++++  + Y HS GI+HRD+   N+++  
Sbjct: 88  LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT- 146
Query: 301 ENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSR 359
            N  +++ D+GLA +   P +++     +  +  PE+     + +E D            
Sbjct: 147 RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDV----------- 195
Query: 360 KRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLL 419
             W          +  P       KN L +     +E          +S EA D + +LL
Sbjct: 196 --WSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM------PSFLSIEAKDLIHQLL 247
Query: 420 RYDHYERLTAREAMDHPYF 438
           R +  +RL+    +DHP+ 
Sbjct: 248 RRNPADRLSLSSVLDHPFM 266

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 13/102 (12%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A   S+ L + H  GI++RD+K  NVM+D E   +++ D+G+ +     +     V +R 
Sbjct: 126 AAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGH-IKIADFGMCK-----EHMMDGVTTRE 179
Query: 64  FKG------PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           F G      PE++A YQ Y  S+D W+ G +L  M+  + PF
Sbjct: 180 FCGTPDYIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPF 220

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 61/113 (53%), Gaps = 5/113 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
           AL++ HS  ++HR++K  N+++  +   ++L D+G      P Q + +  V + Y+  PE
Sbjct: 129 ALEFLHSNQVIHRNIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 187
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
           ++   + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL
Sbjct: 188 VVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPEL 237

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 38/202 (18%)
Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVR 325
           I     E L+AL++ HS  ++HR++K  N+++  +   ++L D+G      P Q + +  
Sbjct: 119 IAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTM 177
Query: 326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
           V + Y+  PE++    Y  ++D     I+                  ++  E   +L++N
Sbjct: 178 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAI---------------EMIEGEP-PYLNEN 221
Query: 386 ILGRHSRKRWERFVHTENQ-HLVSPEAL-----DFLDKLLRYDHYERLTAREAMDHPYFY 439
            L      R    + T     L +PE L     DFL++ L  D  +R +A+E + H  F 
Sbjct: 222 PL------RALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQH-QFL 274
Query: 440 PIVKDQSRHTLPSSSPTPIVNS 461
            I K       P SS TP++ +
Sbjct: 275 KIAK-------PLSSLTPLIAA 289

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 55/97 (56%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N+MID +   +++ D+GLA+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IQVTDFGLAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/80 (28%), Positives = 47/80 (58%), Gaps = 3/80 (3%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R+Y  +++   +Y HS+ +++RD+KP N+MID +   +++ D+GLA+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IQVTDFGLAKRVK-GRTWXLCGT 201
Query: 328 SRYFKGPELLADYQYHIELD 347
             Y   PE++    Y+  +D
Sbjct: 202 PEYL-APEIILSKGYNKAVD 220

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/117 (27%), Positives = 57/117 (48%), Gaps = 5/117 (4%)
Query: 2   RIATGASMALDYC-HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           +I      AL++   ++ I+HRD+KP N+++D     ++L D+G++              
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN-IKLCDFGISGQLVDSIAKTRDAG 187
Query: 61  SRYFKGPELL---ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
            R +  PE +   A  Q YD   D+WSLG  L  +   + P+   +  +DQL ++ K
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 10/99 (10%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----VASRYF 64
           +ALD  HSMG +HRDVKP N+++D     L+L D+G        +E  VR    V +  +
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTC--MKMNKEGMVRCDTAVGTPDY 235
Query: 65  KGPELLADY---QMYDYSLDMWSLGCMLASMIFRKEPFF 100
             PE+L        Y    D WS+G  L  M+    PF+
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/74 (36%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 245 LIFEHVNNTDFKQLYQTLTDYDI-----RYYLYELLKALDYCHSMGIMHRDVKPHNVMID 299
           ++ E++   D   L   +++YD+     R+Y  E++ ALD  HSMG +HRDVKP N+++D
Sbjct: 146 MVMEYMPGGDLVNL---MSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 202
Query: 300 HENRKLRLIDWGLA 313
                L+L D+G  
Sbjct: 203 KSGH-LKLADFGTC 215

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 10/99 (10%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----VASRYF 64
           +ALD  HSMG +HRDVKP N+++D     L+L D+G        +E  VR    V +  +
Sbjct: 184 LALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTC--MKMNKEGMVRCDTAVGTPDY 240
Query: 65  KGPELLADY---QMYDYSLDMWSLGCMLASMIFRKEPFF 100
             PE+L        Y    D WS+G  L  M+    PF+
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/74 (36%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 245 LIFEHVNNTDFKQLYQTLTDYDI-----RYYLYELLKALDYCHSMGIMHRDVKPHNVMID 299
           ++ E++   D   L   +++YD+     R+Y  E++ ALD  HSMG +HRDVKP N+++D
Sbjct: 151 MVMEYMPGGDLVNL---MSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 207
Query: 300 HENRKLRLIDWGLA 313
                L+L D+G  
Sbjct: 208 KSGH-LKLADFGTC 220

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 10/99 (10%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----VASRYF 64
           +ALD  HSMG +HRDVKP N+++D     L+L D+G        +E  VR    V +  +
Sbjct: 184 LALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTC--MKMNKEGMVRCDTAVGTPDY 240
Query: 65  KGPELLADY---QMYDYSLDMWSLGCMLASMIFRKEPFF 100
             PE+L        Y    D WS+G  L  M+    PF+
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/74 (36%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 245 LIFEHVNNTDFKQLYQTLTDYDI-----RYYLYELLKALDYCHSMGIMHRDVKPHNVMID 299
           ++ E++   D   L   +++YD+     R+Y  E++ ALD  HSMG +HRDVKP N+++D
Sbjct: 151 MVMEYMPGGDLVNL---MSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 207
Query: 300 HENRKLRLIDWGLA 313
                L+L D+G  
Sbjct: 208 KSGH-LKLADFGTC 220

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASR 62
           A   ++ L +  S GI++RD+K  NVM+D E   +++ D+G+  E    G        + 
Sbjct: 127 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTP 185
Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
            +  PE++A YQ Y  S+D W+ G +L  M+  + P F G D
Sbjct: 186 DYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAP-FEGED 225

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 26/93 (27%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           ++ YCHS GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  P
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           E+L     Y   +D+W+ G +L  ++    PF+
Sbjct: 177 EVLKK-DPYSKPVDIWACGVILYILLVGYPPFW 208

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/178 (21%), Positives = 82/178 (46%), Gaps = 17/178 (9%)
Query: 263 TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQ 320
           ++ D  + + ++L+++ YCHS GI+HR++KP N+++  + +   ++L D+GLA   +  +
Sbjct: 103 SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162
Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD 380
            ++    +  +  PE+L    Y   +D     ++       +  F   +   L +     
Sbjct: 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 222
Query: 381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
             D      +    W+          V+PEA   +D +L  +  +R+TA +A+  P+ 
Sbjct: 223 AYD------YPSPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/133 (24%), Positives = 66/133 (49%), Gaps = 22/133 (16%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMI---DHE---------------NRKLRLIDWG 44
           +A     A+ + H   + H D+KP N++    D+E               +  +R++D+G
Sbjct: 142 MAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFG 201
Query: 45  LAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
            A F H  + ++  V++R+++ PE++ +   +    D+WS+GC++    +     F  HD
Sbjct: 202 SATFDH--EHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEY-YVGFTLFQTHD 257
Query: 105 NYDQLVRIAKVLG 117
           N + L  + ++LG
Sbjct: 258 NREHLAMMERILG 270

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/220 (21%), Positives = 96/220 (43%), Gaps = 51/220 (23%)
Query: 265 YDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI---DHE---------------NRKLR 306
           + +R+  ++L +A+ + H   + H D+KP N++    D+E               +  +R
Sbjct: 137 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVR 196
Query: 307 LIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD----------------YQYHIELDPRF 350
           ++D+G A F H  + ++  V++R+++ PE++ +                ++Y++     F
Sbjct: 197 VVDFGSATFDH--EHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGF-TLF 253
Query: 351 ADILGRHSRKRWERFV---------HTENQHLVSPEALDFLDKNILGRHSR---KRWERF 398
                R      ER +          T  Q       LD+ +    GR+ R   K   R+
Sbjct: 254 QTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRY 313
Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           + +E +     +  D ++ +L Y+  +RLT  EA+ HP+F
Sbjct: 314 LTSEAEE--HHQLFDLIESMLEYEPAKRLTLGEALQHPFF 351

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 66
            L+Y H  G +HRDVK  N+++  E+  +++ D+G++ F   G +       + F G   
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 67  ---PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
              PE++   + YD+  D+WS G     +     P+
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/73 (30%), Positives = 39/73 (53%), Gaps = 1/73 (1%)
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
            L +  I   L E+L+ L+Y H  G +HRDVK  N+++  E+  +++ D+G++ F   G 
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGG 175
Query: 321 EYNVRVASRYFKG 333
           +       + F G
Sbjct: 176 DITRNKVRKTFVG 188

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
           +   Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA +  + G+   V   +  +  P
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           E+L+  + + + +D+WS+GC++ +++  K PF
Sbjct: 185 EVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 215

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 52/89 (58%), Gaps = 2/89 (2%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP 318
           + LT+ + RYYL +++    Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA +  + 
Sbjct: 110 KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYD 168
Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELD 347
           G+   V   +  +  PE+L+   +  E+D
Sbjct: 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVD 197

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
           +   Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA +  + G+   V   +  +  P
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           E+L+  + + + +D+WS+GC++ +++  K PF
Sbjct: 211 EVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 241

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 52/89 (58%), Gaps = 2/89 (2%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP 318
           + LT+ + RYYL +++    Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA +  + 
Sbjct: 136 KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYD 194
Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELD 347
           G+   V   +  +  PE+L+   +  E+D
Sbjct: 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVD 223

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
           +   Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA +  + G+   V   +  +  P
Sbjct: 150 LGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 208
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           E+L+  + + + +D+WS+GC++ +++  K PF
Sbjct: 209 EVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 239

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 52/89 (58%), Gaps = 2/89 (2%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP 318
           + LT+ + RYYL +++    Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA +  + 
Sbjct: 134 KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYD 192
Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELD 347
           G+   V   +  +  PE+L+   +  E+D
Sbjct: 193 GERKKVLCGTPNYIAPEVLSKKGHSFEVD 221

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 26/93 (27%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           ++ YCHS GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  P
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           E+L     Y   +D+W+ G +L  ++    PF+
Sbjct: 177 EVLKK-DPYSKPVDIWACGVILYILLVGYPPFW 208

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/178 (21%), Positives = 82/178 (46%), Gaps = 17/178 (9%)
Query: 263 TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQ 320
           ++ D  + + ++L+++ YCHS GI+HR++KP N+++  + +   ++L D+GLA   +  +
Sbjct: 103 SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162
Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD 380
            ++    +  +  PE+L    Y   +D     ++       +  F   +   L +     
Sbjct: 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 222
Query: 381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
             D      +    W+          V+PEA   +D +L  +  +R+TA +A+  P+ 
Sbjct: 223 AYD------YPSPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 66
            L+Y H  G +HRDVK  N+++  E+  +++ D+G++ F   G +       + F G   
Sbjct: 128 GLEYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 67  ---PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
              PE++   + YD+  D+WS G     +     P+
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 222

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/73 (30%), Positives = 39/73 (53%), Gaps = 1/73 (1%)
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
            L +  I   L E+L+ L+Y H  G +HRDVK  N+++  E+  +++ D+G++ F   G 
Sbjct: 112 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGG 170
Query: 321 EYNVRVASRYFKG 333
           +       + F G
Sbjct: 171 DITRNKVRKTFVG 183

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 26/93 (27%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           ++ YCHS GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  P
Sbjct: 116 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 175
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           E+L     Y   +D+W+ G +L  ++    PF+
Sbjct: 176 EVLKK-DPYSKPVDIWACGVILYILLVGYPPFW 207

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/178 (21%), Positives = 82/178 (46%), Gaps = 17/178 (9%)
Query: 263 TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQ 320
           ++ D  + + ++L+++ YCHS GI+HR++KP N+++  + +   ++L D+GLA   +  +
Sbjct: 102 SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 161
Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD 380
            ++    +  +  PE+L    Y   +D     ++       +  F   +   L +     
Sbjct: 162 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 221
Query: 381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
             D      +    W+          V+PEA   +D +L  +  +R+TA +A+  P+ 
Sbjct: 222 AYD------YPSPEWD---------TVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEY-NVRVASRYFKG 66
           +ALD  HSMG++HRDVKP N+++D     L+L D+G   +    G  + +  V +  +  
Sbjct: 185 LALDAIHSMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTAVGTPDYIS 243
Query: 67  PELLADY---QMYDYSLDMWSLGCMLASMIFRKEPFF 100
           PE+L        Y    D WS+G  L  M+    PF+
Sbjct: 244 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 280

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 45/74 (60%), Gaps = 9/74 (12%)
Query: 245 LIFEHVNNTDFKQLYQTLTDYDI-----RYYLYELLKALDYCHSMGIMHRDVKPHNVMID 299
           ++ E++   D   L   +++YD+     ++Y  E++ ALD  HSMG++HRDVKP N+++D
Sbjct: 152 MVMEYMPGGDLVNL---MSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD 208
Query: 300 HENRKLRLIDWGLA 313
                L+L D+G  
Sbjct: 209 KHGH-LKLADFGTC 221

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 85/182 (46%), Gaps = 25/182 (13%)
Query: 263 TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQ 320
           ++ D  + + ++L+++ YCHS GI+HR++KP N+++  + +   ++L D+GLA   +  +
Sbjct: 126 SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185
Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQH----LVSP 376
            ++    +  +  PE+L    Y   +D     ++       +  F   E+QH     +  
Sbjct: 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQIKA 244
Query: 377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
            A D+             W+          V+PEA   +D +L  +  +R+TA +A+  P
Sbjct: 245 GAYDY---------PSPEWD---------TVTPEAKSLIDSMLTVNPKKRITADQALKVP 286
Query: 437 YF 438
           + 
Sbjct: 287 WI 288

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYH--------P 51
           R+    + ALD+ H+ GI HRD+KP N++ +   +   +++ D+ L              
Sbjct: 115 RVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPIT 174
Query: 52  GQEYNVRVASRYFKGPELLADY----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 107
             E      S  +  PE++  +      YD   D+WSLG +L  M+    PF  GH   D
Sbjct: 175 TPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFV-GHCGAD 233
Query: 108 ------QLVRIAKVLGTEELFEYLDKYHIEL-DPRFADILGRAR 144
                 ++ R+ +     +LFE + +   E  D  +A I   A+
Sbjct: 234 CGWDRGEVCRVCQ----NKLFESIQEGKYEFPDKDWAHISSEAK 273

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/296 (19%), Positives = 114/296 (38%), Gaps = 36/296 (12%)
Query: 170 QDDYQLVRKL-GRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENL---RGG 225
           +D Y+L  +L G G Y++V  A+++Q+                       +E L   +G 
Sbjct: 11  EDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGN 70
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIR---YYLYELLKALDYCH 282
            NI+ L    +D       L+FE +         Q    ++ R     + ++  ALD+ H
Sbjct: 71  KNILELIEFFEDDTRFY--LVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLH 128
Query: 283 SMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           + GI HRD+KP N++ +   +   +++ D+ L      G    +  +      PEL    
Sbjct: 129 TKGIAHRDLKPENILCESPEKVSPVKICDFDL------GSGMKLNNSCTPITTPELTTPC 182
Query: 341 QYHIELDPRFADILGRHSR---KRWERFVHTENQHLVSPEALDFL---------DKNILG 388
                + P   ++    +    KR + +      +++      F+         D+  + 
Sbjct: 183 GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVC 242
Query: 389 RHSRKRWERFVHTENQHL-------VSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
           R  + +    +              +S EA D + KLL  D  +RL+A + + HP+
Sbjct: 243 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPW 298

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N+MID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/80 (27%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R+Y  +++   +Y HS+ +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVK-GRTWXLCGT 201
Query: 328 SRYFKGPELLADYQYHIELD 347
             Y   PE++    Y+  +D
Sbjct: 202 PEYL-APEIILSKGYNKAVD 220

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N+MID +   +++ D+G A+    G+ + +     Y
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVK-GRTWXLCGTPEY 205
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 206 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/80 (27%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R+Y  +++   +Y HS+ +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVK-GRTWXLCGT 202
Query: 328 SRYFKGPELLADYQYHIELD 347
             Y   PE++    Y+  +D
Sbjct: 203 PEYL-APEIILSKGYNKAVD 221

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N+MID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/80 (27%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R+Y  +++   +Y HS+ +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVK-GRTWXLCGT 201
Query: 328 SRYFKGPELLADYQYHIELD 347
             Y   PE++    Y+  +D
Sbjct: 202 PEYL-APEIILSKGYNKAVD 220

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N+MID +   +++ D+G A+    G+ + +     Y
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVK-GRTWXLCGTPEY 205
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 206 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/80 (27%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R+Y  +++   +Y HS+ +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVK-GRTWXLCGT 202
Query: 328 SRYFKGPELLADYQYHIELD 347
             Y   PE++    Y+  +D
Sbjct: 203 PEYL-APEIILSKGYNKAVD 221

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N+MID +   +++ D+G A+    G+ + +     Y
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVK-GRTWXLCGTPEY 205
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 206 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/80 (27%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R+Y  +++   +Y HS+ +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVK-GRTWXLCGT 202
Query: 328 SRYFKGPELLADYQYHIELD 347
             Y   PE++    Y+  +D
Sbjct: 203 PEYL-APEIILSKGYNKAVD 221

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 3/97 (3%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASR 62
           A   ++ L +  S GI++RD+K  NVM+D E   +++ D+G+  E    G        + 
Sbjct: 448 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTP 506
Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
            +  PE++A YQ Y  S+D W+ G +L  M+  + PF
Sbjct: 507 DYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPF 542

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N+MID +   +++ D+G A+    G+ + +     Y
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVK-GRTWXLCGTPEY 205
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 206 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/80 (27%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R+Y  +++   +Y HS+ +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVK-GRTWXLCGT 202
Query: 328 SRYFKGPELLADYQYHIELD 347
             Y   PE++    Y+  +D
Sbjct: 203 PEYL-APEIILSKGYNKAVD 221

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 82/184 (44%), Gaps = 24/184 (13%)
Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPG 319
           TL +  I Y   E+L+ L + H   ++HRD+K  NV++  EN +++L+D+G+ A+     
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTV 183
Query: 320 QEYNVRVASRYFKGPELLA-----DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLV 374
              N  + + Y+  PE++A     D  Y  + D      LG  + +  E      + H +
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS---LGITAIEMAEGAPPLCDMHPM 240
Query: 375 SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD 434
              AL  + +N   R   K+W +   +            F++  L  +H +R    + M 
Sbjct: 241 --RALFLIPRNPAPRLKSKKWSKKFQS------------FIESCLVKNHSQRPATEQLMK 286
Query: 435 HPYF 438
           HP+ 
Sbjct: 287 HPFI 290

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQT--LTDYDIRYYLYELLKALDYCHS 283
           NII L+ + + P   +  L+ E V   + F ++ +    ++ D    + ++L+A+ Y H 
Sbjct: 109 NIIKLKEIFETPTEIS--LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 284 MGIMHRDVKPHNVM--IDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
            GI+HRD+KP N++      +  L++ D+GL++             +  +  PE+L    
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 342 YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT 401
           Y  E+D     I+       +E F               F+ + IL        E +  +
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPFYDERGDQ--------FMFRRIL------NCEYYFIS 272
Query: 402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
                VS  A D + KL+  D  +RLT  +A+ HP+
Sbjct: 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKL--RLIDWGLAEFYHPGQEYNVRVASRYFK 65
           S AL Y H   I+HRD+KP N+++    ++L  ++ID G A+    G+     V +  + 
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 190
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
            PELL + + Y  ++D WS G +    I    PF 
Sbjct: 191 APELL-EQKKYTVTVDYWSFGTLAFECITGFRPFL 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 54/113 (47%), Gaps = 8/113 (7%)
Query: 243 PALIFEHVNNTDFKQLYQT------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNV 296
           P L  E+    D ++          L +  IR  L ++  AL Y H   I+HRD+KP N+
Sbjct: 93  PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 152
Query: 297 MIDHENRKL--RLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
           ++    ++L  ++ID G A+    G+     V +  +  PELL   +Y + +D
Sbjct: 153 VLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVD 205

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 59/108 (54%), Gaps = 4/108 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
           AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  PE
Sbjct: 120 ALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVRIAKV 115
           +L D   Y  ++D W LG ++  M+  + PF++  H+   +L+ + ++
Sbjct: 179 VLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 225

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 26/188 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP 318
           +  T+   R+Y  E++ AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    
Sbjct: 103 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISD 161
Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEA 378
           G        +  +  PE+L D  Y   +D     ++          F + +++ L     
Sbjct: 162 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 221
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAM 433
           ++ +              RF  T     +SPEA   L  LL+ D  +RL      A+E M
Sbjct: 222 MEEI--------------RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 262
Query: 434 DHPYFYPI 441
           +H +F  I
Sbjct: 263 EHRFFLSI 270

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 59/108 (54%), Gaps = 4/108 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
           AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  PE
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVRIAKV 115
           +L D   Y  ++D W LG ++  M+  + PF++  H+   +L+ + ++
Sbjct: 176 VLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 26/188 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP 318
           +  T+   R+Y  E++ AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISD 158
Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEA 378
           G        +  +  PE+L D  Y   +D     ++          F + +++ L     
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAM 433
           ++ +              RF  T     +SPEA   L  LL+ D  +RL      A+E M
Sbjct: 219 MEEI--------------RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
Query: 434 DHPYFYPI 441
           +H +F  I
Sbjct: 260 EHRFFLSI 267

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKL--RLIDWGLAEFYHPGQEYNVRVASRYFK 65
           S AL Y H   I+HRD+KP N+++    ++L  ++ID G A+    G+     V +  + 
Sbjct: 132 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 191
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
            PELL + + Y  ++D WS G +    I    PF 
Sbjct: 192 APELL-EQKKYTVTVDYWSFGTLAFECITGFRPFL 225

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 54/113 (47%), Gaps = 8/113 (7%)
Query: 243 PALIFEHVNNTDFKQLYQT------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNV 296
           P L  E+    D ++          L +  IR  L ++  AL Y H   I+HRD+KP N+
Sbjct: 94  PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 153
Query: 297 MIDHENRKL--RLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
           ++    ++L  ++ID G A+    G+     V +  +  PELL   +Y + +D
Sbjct: 154 VLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVD 206

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/292 (21%), Positives = 114/292 (39%), Gaps = 41/292 (14%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSS-----DXXXXXXXXXXXXXXXXXXXXXLENLRGG 225
           DD+ +VR LG+GK+  V+ A   Q+                            +++    
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIR---YYLYELLKALDYCH 282
            NI+ +     D   +   L+ E     +  +  Q    +D +    ++ EL  AL YCH
Sbjct: 74  PNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH 131
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
              ++HRD+KP N+++ ++  +L++ D+G +  + P         +  +  PE++    +
Sbjct: 132 ERKVIHRDIKPENLLMGYKG-ELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTH 189
Query: 343 HIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
             ++D   A +L          ++   HTE    +    L F                  
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF------------------ 231
Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLP 451
                  +S  + D + KLLRY   +RL  +  M+HP+    VK  SR  LP
Sbjct: 232 ----PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW----VKANSRRVLP 275

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 59/108 (54%), Gaps = 4/108 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
           AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  PE
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVRIAKV 115
           +L D   Y  ++D W LG ++  M+  + PF++  H+   +L+ + ++
Sbjct: 176 VLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 26/188 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP 318
           +  T+   R+Y  E++ AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISD 158
Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEA 378
           G        +  +  PE+L D  Y   +D     ++          F + +++ L     
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAM 433
           ++ +              RF  T     +SPEA   L  LL+ D  +RL      A+E M
Sbjct: 219 MEEI--------------RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
Query: 434 DHPYFYPI 441
           +H +F  I
Sbjct: 260 EHRFFLSI 267

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N+MID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 22/80 (27%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R+Y  +++   +Y HS+ +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IQVTDFGFAKRVK-GRTWXLCGT 201
Query: 328 SRYFKGPELLADYQYHIELD 347
             Y   PE++    Y+  +D
Sbjct: 202 PEYL-APEIILSKGYNKAVD 220

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/111 (27%), Positives = 52/111 (46%), Gaps = 14/111 (12%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYH--------PG 52
           +    + ALD+ H+ GI HRD+KP N++ +H N+   +++ D+ L               
Sbjct: 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 53  QEYNVRVASRYFKGPELLADY----QMYDYSLDMWSLGCMLASMIFRKEPF 99
            E      S  +  PE++  +     +YD   D+WSLG +L  ++    PF
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/226 (22%), Positives = 91/226 (40%), Gaps = 48/226 (21%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYH-- 317
             + +    + ++  ALD+ H+ GI HRD+KP N++ +H N+   +++ D+ L       
Sbjct: 108 FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 318 ------PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADI-----------------L 354
                    E      S  +  PE++  +     +  +  D+                 +
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227
Query: 355 GR-HSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALD 413
           GR  S   W+R           P   + L ++I       ++E F   +  H +S  A D
Sbjct: 228 GRCGSDCGWDR-------GEACPACQNMLFESI----QEGKYE-FPDKDWAH-ISCAAKD 274
Query: 414 FLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIV 459
            + KLL  D  +RL+A + + HP+      +   +TL    PTP+V
Sbjct: 275 LISKLLVRDAKQRLSAAQVLQHPWVQGCAPE---NTL----PTPMV 313

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 25/93 (26%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           MALDY  +  I+HRD+KP N+++D E+  + + D+ +A       +      ++ +  PE
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPE 184
Query: 69  LLADYQ--MYDYSLDMWSLGCMLASMIFRKEPF 99
           + +  +   Y +++D WSLG     ++  + P+
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/72 (26%), Positives = 41/72 (56%), Gaps = 1/72 (1%)
Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRV 326
           ++ ++ EL+ ALDY  +  I+HRD+KP N+++D E+  + + D+ +A       +     
Sbjct: 117 VKLFICELVMALDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMA 175
Query: 327 ASRYFKGPELLA 338
            ++ +  PE+ +
Sbjct: 176 GTKPYMAPEMFS 187

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 60/113 (53%), Gaps = 7/113 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF---YHPGQEYNVRV 59
           IA   +  +DY H+  I+HRD+K +N+ + HE   +++ D+GLA     +   Q+     
Sbjct: 137 IARQTAQGMDYLHAKNIIHRDMKSNNIFL-HEGLTVKIGDFGLATVKSRWSGSQQVEQPT 195
Query: 60  ASRYFKGPEL--LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
            S  +  PE+  + D   + +  D++S G +L  ++  + P+ H  +N DQ++
Sbjct: 196 GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH-INNRDQII 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 59/108 (54%), Gaps = 4/108 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
           AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  PE
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVRIAKV 115
           +L D   Y  ++D W LG ++  M+  + PF++  H+   +L+ + ++
Sbjct: 176 VLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 26/188 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP 318
           +  T+   R+Y  E++ AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISD 158
Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEA 378
           G        +  +  PE+L D  Y   +D     ++          F + +++ L     
Sbjct: 159 GATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAM 433
           ++ +              RF  T     +SPEA   L  LL+ D  +RL      A+E M
Sbjct: 219 MEEI--------------RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
Query: 434 DHPYFYPI 441
           +H +F  I
Sbjct: 260 EHRFFLSI 267

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 59/108 (54%), Gaps = 4/108 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
           AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  PE
Sbjct: 122 ALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVRIAKV 115
           +L D   Y  ++D W LG ++  M+  + PF++  H+   +L+ + ++
Sbjct: 181 VLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 227

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 26/188 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP 318
           +  T+   R+Y  E++ AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    
Sbjct: 105 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISD 163
Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEA 378
           G        +  +  PE+L D  Y   +D     ++          F + +++ L     
Sbjct: 164 GATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 223
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAM 433
           ++ +              RF  T     +SPEA   L  LL+ D  +RL      A+E M
Sbjct: 224 MEEI--------------RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 264
Query: 434 DHPYFYPI 441
           +H +F  I
Sbjct: 265 EHRFFLSI 272

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLXGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 21/80 (26%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R+Y  +++   +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLXGT 201
Query: 328 SRYFKGPELLADYQYHIELD 347
             Y   PE++    Y+  +D
Sbjct: 202 PEYL-APEIILSKGYNKAVD 220

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 9/102 (8%)
Query: 237 DPVSRTPALIFEHVNNTDFKQLY-QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHN 295
           DPV     ++ E+V     K+   Q L   +   YL E+L AL Y HS+G+++ D+KP N
Sbjct: 156 DPVGY---IVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPEN 212
Query: 296 VMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
           +M+  E  +L+LID G     +    +     +  F+ PE++
Sbjct: 213 IMLTEE--QLKLIDLGAVSRIN---SFGYLYGTPGFQAPEIV 249

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 59/108 (54%), Gaps = 4/108 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
           AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  PE
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVRIAKV 115
           +L D   Y  ++D W LG ++  M+  + PF++  H+   +L+ + ++
Sbjct: 176 VLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 26/188 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP 318
           +  T+   R+Y  E++ AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISD 158
Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEA 378
           G        +  +  PE+L D  Y   +D     ++          F + +++ L     
Sbjct: 159 GATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAM 433
           ++ +              RF  T     +SPEA   L  LL+ D  +RL      A+E M
Sbjct: 219 MEEI--------------RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
Query: 434 DHPYFYPI 441
           +H +F  I
Sbjct: 260 EHRFFLSI 267

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 59/108 (54%), Gaps = 4/108 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
           AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  PE
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVRIAKV 115
           +L D   Y  ++D W LG ++  M+  + PF++  H+   +L+ + ++
Sbjct: 176 VLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 26/188 (13%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP 318
           +  T+   R+Y  E++ AL+Y HS  +++RD+K  N+M+D +   +++ D+GL  E    
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISD 158
Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEA 378
           G        +  +  PE+L D  Y   +D     ++          F + +++ L     
Sbjct: 159 GATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAM 433
           ++ +              RF  T     +SPEA   L  LL+ D  +RL      A+E M
Sbjct: 219 MEEI--------------RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
Query: 434 DHPYFYPI 441
           +H +F  I
Sbjct: 260 EHRFFLSI 267

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 15/103 (14%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKG 66
           A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+   V +  +  
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 224
Query: 67  PELLADYQ----------MYDYSLDMWSLGCMLASMIFRKEPF 99
           PE + D                  D+WSLGC+L  M + K PF
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLAGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 21/80 (26%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R+Y  +++   +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLAGT 201
Query: 328 SRYFKGPELLADYQYHIELD 347
             Y   PE++    Y+  +D
Sbjct: 202 PEYL-APEIILSKGYNKAVD 220

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/159 (23%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDX----------XXXXXXXXXXXXXXXXXXXXLE 220
           ++++L++ LG G Y +VF    +   D                               LE
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 221 NLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQT--LTDYDIRYYLYELLKA 277
           ++R    ++TL    +        LI +++N  + F  L Q    T+++++ Y+ E++ A
Sbjct: 114 HIRQSPFLVTLHYAFQTETKL--HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY 316
           L++ H +GI++RD+K  N+++D  N  + L D+GL++ +
Sbjct: 172 LEHLHKLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEF 209

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 15/103 (14%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKG 66
           A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+   V +  +  
Sbjct: 120 AVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 67  PELLADYQ----------MYDYSLDMWSLGCMLASMIFRKEPF 99
           PE + D                  D+WSLGC+L  M + K PF
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 15/103 (14%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKG 66
           A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+   V +  +  
Sbjct: 123 AVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 180
Query: 67  PELLADYQ----------MYDYSLDMWSLGCMLASMIFRKEPF 99
           PE + D                  D+WSLGC+L  M + K PF
Sbjct: 181 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 223

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 15/103 (14%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKG 66
           A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+   V +  +  
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 224
Query: 67  PELLADYQ----------MYDYSLDMWSLGCMLASMIFRKEPF 99
           PE + D                  D+WSLGC+L  M + K PF
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 15/103 (14%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKG 66
           A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+   V +  +  
Sbjct: 139 AVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 67  PELLADYQ----------MYDYSLDMWSLGCMLASMIFRKEPF 99
           PE + D                  D+WSLGC+L  M + K PF
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 56/106 (52%), Gaps = 13/106 (12%)
Query: 6   GASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG---LAEFYHPG-------QEY 55
           G    L+  H+ G  HRD+KP N+++  E + + L+D G    A  +  G       Q++
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPV-LMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 56  NVRVASRYFKGPELLA--DYQMYDYSLDMWSLGCMLASMIFRKEPF 99
             +  +  ++ PEL +   + + D   D+WSLGC+L +M+F + P+
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 15/103 (14%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKG 66
           A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+   V +  +  
Sbjct: 139 AVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMP 196
Query: 67  PELLADYQ----------MYDYSLDMWSLGCMLASMIFRKEPF 99
           PE + D                  D+WSLGC+L  M + K PF
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 15/103 (14%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKG 66
           A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+   V +  +  
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 67  PELLADYQ----------MYDYSLDMWSLGCMLASMIFRKEPF 99
           PE + D                  D+WSLGC+L  M + K PF
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 15/103 (14%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKG 66
           A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+   V +  +  
Sbjct: 119 AVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 176
Query: 67  PELLADYQ----------MYDYSLDMWSLGCMLASMIFRKEPF 99
           PE + D                  D+WSLGC+L  M + K PF
Sbjct: 177 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 219

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 133 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWTLCGTPEY 190
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 191 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 225

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 21/80 (26%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R+Y  +++   +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 130 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWTLCGT 187
Query: 328 SRYFKGPELLADYQYHIELD 347
             Y   PE++    Y+  +D
Sbjct: 188 PEYL-APEIILSKGYNKAVD 206

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE---FYHPGQEYNVRVASRYFKG 66
            L Y H   I+HRD+K  NV+I+  +  L++ D+G ++     +P  E      +  +  
Sbjct: 134 GLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE--TFTGTLQYMA 191
Query: 67  PELL-ADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           PE++    + Y  + D+WSLGC +  M   K PF+ 
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 63/123 (51%), Gaps = 13/123 (10%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG-LAEFYHPGQ-EYNVRVASRYFKG 66
           +A+D  H +  +HRD+KP NV++D  N  +RL D+G   +    G  + +V V +  +  
Sbjct: 202 LAIDSIHQLHYVHRDIKPDNVLLD-VNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYIS 260
Query: 67  PELLADYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI-AKVLGTEEL 121
           PE+L   +     Y    D WSLG  +  M++ + PF+      + LV    K++  EE 
Sbjct: 261 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-----ESLVETYGKIMNHEER 315
Query: 122 FEY 124
           F++
Sbjct: 316 FQF 318

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 25/72 (34%), Positives = 43/72 (59%), Gaps = 3/72 (4%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG-LAEFYHPGQ-EYNVR 325
           R+Y+ E++ A+D  H +  +HRD+KP NV++D  N  +RL D+G   +    G  + +V 
Sbjct: 194 RFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLD-VNGHIRLADFGSCLKMNDDGTVQSSVA 252
Query: 326 VASRYFKGPELL 337
           V +  +  PE+L
Sbjct: 253 VGTPDYISPEIL 264

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/92 (26%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
           +   Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA +  + G+       +  +  P
Sbjct: 128 LGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           E+L+  + + + +D+WS+GC++ +++  K PF
Sbjct: 187 EVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/89 (26%), Positives = 51/89 (57%), Gaps = 2/89 (2%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP 318
           + LT+ + RYYL +++    Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA +  + 
Sbjct: 112 KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYD 170
Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELD 347
           G+       +  +  PE+L+   +  E+D
Sbjct: 171 GERKKTLCGTPNYIAPEVLSKKGHSFEVD 199

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 4/90 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
            LDY HS   +HRD+K  NV++  E+ +++L D+G+A      Q + N  V + ++  PE
Sbjct: 116 GLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 174
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEP 98
           ++     YD   D+WSLG + A  + R EP
Sbjct: 175 VIKQ-SAYDSKADIWSLG-ITAIELARGEP 202

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 2/87 (2%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ- 320
           L +  I   L E+LK LDY HS   +HRD+K  NV++  E+ +++L D+G+A      Q 
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQI 159
Query: 321 EYNVRVASRYFKGPELLADYQYHIELD 347
           + N  V + ++  PE++    Y  + D
Sbjct: 160 KRNTFVGTPFWMAPEVIKQSAYDSKAD 186

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/92 (26%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
           +   Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA +  + G+       +  +  P
Sbjct: 132 LGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 190
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           E+L+  + + + +D+WS+GC++ +++  K PF
Sbjct: 191 EVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 221

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/89 (26%), Positives = 51/89 (57%), Gaps = 2/89 (2%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP 318
           + LT+ + RYYL +++    Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA +  + 
Sbjct: 116 KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYD 174
Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELD 347
           G+       +  +  PE+L+   +  E+D
Sbjct: 175 GERKKTLCGTPNYIAPEVLSKKGHSFEVD 203

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/92 (26%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
           +   Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA +  + G+       +  +  P
Sbjct: 128 LGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           E+L+  + + + +D+WS+GC++ +++  K PF
Sbjct: 187 EVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/89 (26%), Positives = 51/89 (57%), Gaps = 2/89 (2%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP 318
           + LT+ + RYYL +++    Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA +  + 
Sbjct: 112 KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYD 170
Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELD 347
           G+       +  +  PE+L+   +  E+D
Sbjct: 171 GERKKTLCGTPNYIAPEVLSKKGHSFEVD 199

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 63/123 (51%), Gaps = 13/123 (10%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG-LAEFYHPGQ-EYNVRVASRYFKG 66
           +A+D  H +  +HRD+KP NV++D  N  +RL D+G   +    G  + +V V +  +  
Sbjct: 186 LAIDSIHQLHYVHRDIKPDNVLLD-VNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYIS 244
Query: 67  PELLADYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI-AKVLGTEEL 121
           PE+L   +     Y    D WSLG  +  M++ + PF+      + LV    K++  EE 
Sbjct: 245 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-----ESLVETYGKIMNHEER 299
Query: 122 FEY 124
           F++
Sbjct: 300 FQF 302

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 25/72 (34%), Positives = 43/72 (59%), Gaps = 3/72 (4%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG-LAEFYHPGQ-EYNVR 325
           R+Y+ E++ A+D  H +  +HRD+KP NV++D  N  +RL D+G   +    G  + +V 
Sbjct: 178 RFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLD-VNGHIRLADFGSCLKMNDDGTVQSSVA 236
Query: 326 VASRYFKGPELL 337
           V +  +  PE+L
Sbjct: 237 VGTPDYISPEIL 248

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 4/90 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
            LDY HS   +HRD+K  NV++  E+ +++L D+G+A      Q + N  V + ++  PE
Sbjct: 136 GLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 194
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEP 98
           ++     YD   D+WSLG + A  + R EP
Sbjct: 195 VIKQ-SAYDSKADIWSLG-ITAIELARGEP 222

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 2/87 (2%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ- 320
           L +  I   L E+LK LDY HS   +HRD+K  NV++  E+ +++L D+G+A      Q 
Sbjct: 121 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQI 179
Query: 321 EYNVRVASRYFKGPELLADYQYHIELD 347
           + N  V + ++  PE++    Y  + D
Sbjct: 180 KRNTFVGTPFWMAPEVIKQSAYDSKAD 206

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWTLCGTPEY 205
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 206 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 21/80 (26%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 327
           R+Y  +++   +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWTLCGT 202
Query: 328 SRYFKGPELLADYQYHIELD 347
             Y   PE++    Y+  +D
Sbjct: 203 PEYL-APEIILSKGYNKAVD 221

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE---FYHPGQEYNVRVASRYFKG 66
            L Y H   I+HRD+K  NV+I+  +  L++ D+G ++     +P  E      +  +  
Sbjct: 120 GLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE--TFTGTLQYMA 177
Query: 67  PELL-ADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
           PE++    + Y  + D+WSLGC +  M   K PF+ 
Sbjct: 178 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 79/185 (42%), Gaps = 31/185 (16%)
Query: 270 YLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 329
           ++ EL  AL YCH   ++HRD+KP N+++ ++  +L++ D+G +  + P         + 
Sbjct: 120 FMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGWS-VHAPSLRRRXMCGTL 177
Query: 330 YFKGPELLADYQYHIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNI 386
            +  PE++    +  ++D   A +L          ++   HTE    +    L F     
Sbjct: 178 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF----- 232
Query: 387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS 446
                               +S  + D + KLLRY   +RL  +  M+HP+    VK  S
Sbjct: 233 -----------------PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW----VKANS 271
Query: 447 RHTLP 451
           R  LP
Sbjct: 272 RRVLP 276

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IKVADFGFAKRVK-GRTWXLCGTPEY 205
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 206 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IKVADFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 142 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 199
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 200 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 234

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYQMAAGYPPFF 239

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IKVADFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IKVADFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 6/109 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVA--SRYFKG 66
            L+Y HS GI+H+D+KP N+++      L++   G+AE  HP   +   R +  S  F+ 
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 67  PELLADYQMYD-YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           PE+      +  + +D+WS G  L ++     P F G + Y     I K
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP-FEGDNIYKLFENIGK 227

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 76/195 (38%), Gaps = 28/195 (14%)
Query: 270 YLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVA- 327
           Y  +L+  L+Y HS GI+H+D+KP N+++      L++   G+AE  HP   +   R + 
Sbjct: 114 YFCQLIDGLEYLHSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 328 -SRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI 386
            S  F+ PE+               D         W   V   N   ++     F   NI
Sbjct: 173 GSPAFQPPEIANGL-----------DTFSGFKVDIWSAGVTLYN---ITTGLYPFEGDNI 218
Query: 387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS 446
                      +    +     P   D L  +L Y+  +R + R+   H +F      + 
Sbjct: 219 YKLFENIGKGSYAIPGD---CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF------RK 269
Query: 447 RHTLPSSSPTPIVNS 461
           +H  P+ +P PI  S
Sbjct: 270 KHP-PAEAPVPIPPS 283

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 140 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 197
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 198 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/117 (23%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 2   RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           +IA     AL++ HS + ++HRDVKP NV+I+   + +++ D+G++ +        +   
Sbjct: 157 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ-VKMCDFGISGYLVDSVAKTIDAG 215
Query: 61  SRYFKGPELL---ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
            + +  PE +    + + Y    D+WSLG  +  +   + P+      + QL ++ +
Sbjct: 216 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 272

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 75/190 (39%), Gaps = 34/190 (17%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           QT+ +  +      ++KAL++ HS + ++HRDVKP NV+I+   + +++ D+G++ +   
Sbjct: 148 QTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ-VKMCDFGISGYLVD 206
Query: 319 GQEYNVRVASRYFKGPEL----LADYQYHIELDPRFADI------LGRHSRKRWERFVHT 368
                +    + +  PE     L    Y ++ D     I      + R     W      
Sbjct: 207 SVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ 266
Query: 369 ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT 428
             Q +  P      DK                       S E +DF  + L+ +  ER T
Sbjct: 267 LKQVVEEPSPQLPADK----------------------FSAEFVDFTSQCLKKNSKERPT 304
Query: 429 AREAMDHPYF 438
             E M HP+F
Sbjct: 305 YPELMQHPFF 314

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 205
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 206 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 205
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 206 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 205
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 206 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 4/90 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
            LDY HS   +HRD+K  NV++  E+ +++L D+G+A      Q + N  V + ++  PE
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 189
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEP 98
           ++     YD   D+WSLG + A  + R EP
Sbjct: 190 VIKQ-SAYDSKADIWSLG-ITAIELARGEP 217

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 2/87 (2%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ- 320
           L +  I   L E+LK LDY HS   +HRD+K  NV++  E+ +++L D+G+A      Q 
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQI 174
Query: 321 EYNVRVASRYFKGPELLADYQYHIELD 347
           + N  V + ++  PE++    Y  + D
Sbjct: 175 KRNXFVGTPFWMAPEVIKQSAYDSKAD 201

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID E   +++ D+G A+    G+ + +     Y
Sbjct: 134 AAQIVLTFEYLHSLDLIYRDLKPENLLID-EQGYIQVTDFGFAKRVK-GRTWXLCGTPEY 191
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 192 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 226

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 4/90 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
            LDY HS   +HRD+K  NV++  E+ +++L D+G+A      Q + N  V + ++  PE
Sbjct: 116 GLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 174
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEP 98
           ++     YD   D+WSLG + A  + R EP
Sbjct: 175 VIKQ-SAYDSKADIWSLG-ITAIELARGEP 202

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 2/87 (2%)
Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ- 320
           L +  I   L E+LK LDY HS   +HRD+K  NV++  E+ +++L D+G+A      Q 
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQI 159
Query: 321 EYNVRVASRYFKGPELLADYQYHIELD 347
           + N  V + ++  PE++    Y  + D
Sbjct: 160 KRNXFVGTPFWMAPEVIKQSAYDSKAD 186

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 205
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 206 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 140 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 197
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 198 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIIIS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 63/123 (51%), Gaps = 13/123 (10%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG-LAEFYHPGQ-EYNVRVASRYFKG 66
           +A+D  H +  +HRD+KP N+++D  N  +RL D+G   +    G  + +V V +  +  
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDM-NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 67  PELLADYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI-AKVLGTEEL 121
           PE+L   +     Y    D WSLG  +  M++ + PF+      + LV    K++  +E 
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-----ESLVETYGKIMNHKER 299
Query: 122 FEY 124
           F++
Sbjct: 300 FQF 302

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/72 (34%), Positives = 43/72 (59%), Gaps = 3/72 (4%)
Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG-LAEFYHPGQ-EYNVR 325
           R+YL E++ A+D  H +  +HRD+KP N+++D  N  +RL D+G   +    G  + +V 
Sbjct: 178 RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM-NGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 326 VASRYFKGPELL 337
           V +  +  PE+L
Sbjct: 237 VGTPDYISPEIL 248

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G  + +     Y
Sbjct: 168 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GATWTLCGTPEY 225
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 226 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 168 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 225
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 226 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 205
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 206 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 205
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 206 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 61/118 (51%), Gaps = 10/118 (8%)
Query: 10  ALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
           ALDY HS   +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  P
Sbjct: 263 ALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAP 321
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQL-----VRIAKVLGTE 119
           E+L D   Y  ++D W LG ++  M+  + PF++  H+   +L     +R  + LG E
Sbjct: 322 EVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 378

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 39/188 (20%)
Query: 268 RYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVR 325
           R+Y  E++ ALDY HS   +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 254 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTF 312
Query: 326 VASRYFKGPELLADYQYHIELD------PRFADILGRHSRKRWERFVHTENQHLVSPEAL 379
             +  +  PE+L D  Y   +D        +  + GR        F + +++ L     +
Sbjct: 313 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP------FYNQDHEKLFELILM 366
Query: 380 DFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMD 434
           + +              RF  T     + PEA   L  LL+ D  +RL      A+E M 
Sbjct: 367 EEI--------------RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 407
Query: 435 HPYFYPIV 442
           H +F  IV
Sbjct: 408 HRFFAGIV 415

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 168 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 225
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
              PE++   + Y+ ++D W+LG ++  M     PFF
Sbjct: 226 L-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKG 66
            +AL + H   I+HRD+K  N+ +  +   ++L D+G+A   +   E     + + Y+  
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLS 193
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 102
           PE + + + Y+   D+W+LGC+L  +   K  F  G
Sbjct: 194 PE-ICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/279 (20%), Positives = 119/279 (42%), Gaps = 29/279 (10%)
Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRG--GTN 227
            D Y+LV+ +G G +  V   +  + S+                     + N R     N
Sbjct: 18  SDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPN 76
Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQT--LTDYDIRYYLYELLKALDYCHSM 284
           I+  + V+  P     A++ E+ +  + F+++      ++ + R++  +L+  + YCH+M
Sbjct: 77  IVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 285 GIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYH 343
            + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L   +Y 
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY- 193
Query: 344 IELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE- 402
              D + AD+        W   V     +++   A  F D     ++ RK   R ++ + 
Sbjct: 194 ---DGKVADV--------WSCGV---TLYVMLVGAYPFEDPE-EPKNFRKTIHRILNVQY 238
Query: 403 ---NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
              +   +SPE    + ++   D  +R++  E  +H +F
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/91 (27%), Positives = 53/91 (58%), Gaps = 3/91 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G+       +  +  PE
Sbjct: 154 GVQYLHNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPE 212
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +L   + + + +D+WSLGC+L +++  K PF
Sbjct: 213 VLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 61/118 (51%), Gaps = 10/118 (8%)
Query: 10  ALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
           ALDY HS   +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  P
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQL-----VRIAKVLGTE 119
           E+L D   Y  ++D W LG ++  M+  + PF++  H+   +L     +R  + LG E
Sbjct: 319 EVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 375

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 27/182 (14%)
Query: 268 RYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVR 325
           R+Y  E++ ALDY HS   +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTF 309
Query: 326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
             +  +  PE+L D  Y   +D     ++          F + +++ L     ++ +   
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--- 366
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYP 440
                      RF  T     + PEA   L  LL+ D  +RL      A+E M H +F  
Sbjct: 367 -----------RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
Query: 441 IV 442
           IV
Sbjct: 411 IV 412

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/220 (20%), Positives = 101/220 (45%), Gaps = 26/220 (11%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQT--LTDYDIRYYLYELLKALDYCHS 283
           NI+  + V+  P     A++ E+ +  + F+++      ++ + R++  +L+  + YCH+
Sbjct: 75  NIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 132
Query: 284 MGIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
           M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L   +Y
Sbjct: 133 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 192
Query: 343 HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE 402
               D + AD+        W   V     +++   A  F D     ++ RK   R ++ +
Sbjct: 193 ----DGKVADV--------WSCGV---TLYVMLVGAYPFEDPE-EPKNFRKTIHRILNVQ 236
Query: 403 ----NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
               +   +SPE    + ++   D  +R++  E  +H +F
Sbjct: 237 YAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
            LDY HS   +HRD+K  NV++  E   ++L D+G+A      Q + N  V + ++  PE
Sbjct: 128 GLDYLHSERKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 186
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEP 98
           ++     YD+  D+WSLG + A  + + EP
Sbjct: 187 VIKQ-SAYDFKADIWSLG-ITAIELAKGEP 214

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVR 325
           I   L E+LK LDY HS   +HRD+K  NV++  E   ++L D+G+A      Q + N  
Sbjct: 118 IATILREILKGLDYLHSERKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNXF 176
Query: 326 VASRYFKGPELLADYQYHIELD 347
           V + ++  PE++    Y  + D
Sbjct: 177 VGTPFWMAPEVIKQSAYDFKAD 198

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/117 (23%), Positives = 60/117 (51%), Gaps = 5/117 (4%)
Query: 2   RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           +IA     AL++ HS + ++HRDVKP NV+I+   + +++ D+G++ +       ++   
Sbjct: 113 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ-VKMCDFGISGYLVDDVAKDIDAG 171
Query: 61  SRYFKGPELL---ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
            + +  PE +    + + Y    D+WSLG  +  +   + P+      + QL ++ +
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 76/190 (40%), Gaps = 34/190 (17%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           QT+ +  +      ++KAL++ HS + ++HRDVKP NV+I+   + +++ D+G++ +   
Sbjct: 104 QTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ-VKMCDFGISGYLVD 162
Query: 319 GQEYNVRVASRYFKGPEL----LADYQYHIELDPRFADI------LGRHSRKRWERFVHT 368
               ++    + +  PE     L    Y ++ D     I      + R     W      
Sbjct: 163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ 222
Query: 369 ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT 428
             Q +  P      DK                       S E +DF  + L+ +  ER T
Sbjct: 223 LKQVVEEPSPQLPADK----------------------FSAEFVDFTSQCLKKNSKERPT 260
Query: 429 AREAMDHPYF 438
             E M HP+F
Sbjct: 261 YPELMQHPFF 270

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
           AL + H  GI++RD+K  NV++DHE    +L D+G+  E    G        +  +  PE
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +L +  +Y  ++D W++G +L  M+    PF
Sbjct: 195 ILQE-MLYGPAVDWWAMGVLLYEMLCGHAPF 224

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 5/107 (4%)
Query: 245 LIFEHVNNTDFKQLYQTLTDYD---IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE 301
            + E VN  D     Q    +D    R+Y  E++ AL + H  GI++RD+K  NV++DHE
Sbjct: 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE 160
Query: 302 NRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYHIELD 347
               +L D+G+  E    G        +  +  PE+L +  Y   +D
Sbjct: 161 GH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVD 206

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 74/155 (47%), Gaps = 7/155 (4%)
Query: 13  YCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 70
           Y H   I+H D+KP N+++   +    ++++D+G++       E    + +  +  PE+L
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL 205
Query: 71  ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEELFEYLDKY 128
            +Y     + DMW++G ++A M+      F G DN +  + I++V    +EE F  + + 
Sbjct: 206 -NYDPITTATDMWNIG-IIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263
Query: 129 HIELDPRFADILGRARVYADVN-SHKPREYWDYES 162
             +            R  A++  SH   + WD+E+
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 44/96 (45%), Gaps = 24/96 (25%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y HS+ I HRDVKP N++   +  N  L+L D+G A+                    
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------------- 169
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
                 + YD S DMWSLG ++  ++    PF+  H
Sbjct: 170 ---TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 74/349 (21%), Positives = 134/349 (38%), Gaps = 115/349 (32%)
Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQ 232
           Y++V  LG G + +V E I+ ++                            GG ++    
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKA----------------------------GGRHVAV-- 45
Query: 233 AVVKD-----PVSRTPALIFEHVNNTDFKQLYQT---------------------LTDYD 266
            +VK+       +R+   + EH+N TD    ++                      L+ YD
Sbjct: 46  KIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYD 105
Query: 267 --------------IRYYLYELLKALDYCHSMGIMHRDVKPHNVM-------------ID 299
                         IR   Y++ K++++ HS  + H D+KP N++             I 
Sbjct: 106 FIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165
Query: 300 HENRKL-----RLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADI 353
            + R L     +++D+G A +    + ++  V++R+++ PE++    +    D      I
Sbjct: 166 RDERTLINPDIKVVDFGSATY--DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCI 223
Query: 354 LGRHSRKRWERFVHTENQHLVSPE-ALDFLDKNILGR--------HSRKRWE------RF 398
           L  +         H   +HL   E  L  L K+++ +        H R  W+      R+
Sbjct: 224 LIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRY 283
Query: 399 VHTENQHL--------VSPEAL-DFLDKLLRYDHYERLTAREAMDHPYF 438
           V    + L        V  E L D + K+L YD  +R+T REA+ HP+F
Sbjct: 284 VSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 7/110 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
           AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     Q  +  + + Y+  PE
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 205
Query: 69  LL----ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           ++    +  + YDY  D+WSLG  L  M    EP  H  +    L++IAK
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAK 254

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/116 (25%), Positives = 62/116 (53%), Gaps = 7/116 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF---YHPGQEYNVRV 59
           IA   +  +DY H+  I+HRD+K +N+ + HE+  +++ D+GLA     +    ++    
Sbjct: 113 IARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDFGLATVKSRWSGSHQFEQLS 171
Query: 60  ASRYFKGPEL--LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 113
            S  +  PE+  + D   Y +  D+++ G +L  ++  + P+ +  +N DQ++ + 
Sbjct: 172 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN-INNRDQIIEMV 226

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 25/91 (27%), Positives = 53/91 (58%), Gaps = 3/91 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G+       +  +  PE
Sbjct: 154 GVQYLHNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPE 212
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +L   + + + +D+WSLGC+L +++  K PF
Sbjct: 213 VLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 7/110 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
           AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     Q  +  + + Y+  PE
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPE 205
Query: 69  LL----ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           ++    +  + YDY  D+WSLG  L  M    EP  H  +    L++IAK
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAK 254

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 3   IATGASMALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS 61
           I      +  Y H+   I HRDVKP N+++D +N +++L D+G +E Y   ++      +
Sbjct: 156 IIKSVLNSFSYIHNEKNICHRDVKPSNILMD-KNGRVKLSDFGESE-YMVDKKIKGSRGT 213
Query: 62  RYFKGPELLADYQMYDYS-LDMWSLGCMLASMIFRKEPF 99
             F  PE  ++   Y+ + +D+WSLG  L  M +   PF
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 87/186 (46%), Gaps = 26/186 (13%)
Query: 267 IRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR 325
           I+  +  +L +  Y H+   I HRDVKP N+++D +N +++L D+G +E Y   ++    
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-KNGRVKLSDFGESE-YMVDKKIKGS 210
Query: 326 VASRYFKGPELLAD-----------YQYHIELDPRFADILGRHSRKRW-ERFVHTENQHL 373
             +  F  PE  ++           +   I L   F +++    +    E F +   +++
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270
Query: 374 VSPEALDFLDKN-ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREA 432
             P     LD+N  L   + K+      T + + +S E +DFL   LR +  ER+T+ +A
Sbjct: 271 EYP-----LDRNHFLYPLTNKK-----STCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320
Query: 433 MDHPYF 438
           + H + 
Sbjct: 321 LKHEWL 326

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 61/118 (51%), Gaps = 10/118 (8%)
Query: 10  ALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
           ALDY HS   +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  P
Sbjct: 121 ALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAP 179
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQL-----VRIAKVLGTE 119
           E+L D   Y  ++D W LG ++  M+  + PF++  H+   +L     +R  + LG E
Sbjct: 180 EVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 236

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 27/182 (14%)
Query: 268 RYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVR 325
           R+Y  E++ ALDY HS   +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 112 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXF 170
Query: 326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
             +  +  PE+L D  Y   +D     ++          F + +++ L     ++ +   
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--- 227
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYP 440
                      RF  T     + PEA   L  LL+ D  +RL      A+E M H +F  
Sbjct: 228 -----------RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 271
Query: 441 IV 442
           IV
Sbjct: 272 IV 273

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 61/118 (51%), Gaps = 10/118 (8%)
Query: 10  ALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
           ALDY HS   +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  P
Sbjct: 122 ALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAP 180
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQL-----VRIAKVLGTE 119
           E+L D   Y  ++D W LG ++  M+  + PF++  H+   +L     +R  + LG E
Sbjct: 181 EVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 237

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 27/182 (14%)
Query: 268 RYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVR 325
           R+Y  E++ ALDY HS   +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 113 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXF 171
Query: 326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
             +  +  PE+L D  Y   +D     ++          F + +++ L     ++ +   
Sbjct: 172 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--- 228
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYP 440
                      RF  T     + PEA   L  LL+ D  +RL      A+E M H +F  
Sbjct: 229 -----------RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 272
Query: 441 IV 442
           IV
Sbjct: 273 IV 274

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
            LDY HS   +HRD+K  NV++  E   ++L D+G+A      Q + N  V + ++  PE
Sbjct: 132 GLDYLHSEKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 190
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEP 98
           ++     YD   D+WSLG + A  + + EP
Sbjct: 191 VIQQ-SAYDSKADIWSLG-ITAIELAKGEP 218

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 46/85 (54%), Gaps = 2/85 (2%)
Query: 264 DYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EY 322
           ++ I   L E+LK LDY HS   +HRD+K  NV++  E   ++L D+G+A      Q + 
Sbjct: 119 EFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKR 177
Query: 323 NVRVASRYFKGPELLADYQYHIELD 347
           N  V + ++  PE++    Y  + D
Sbjct: 178 NTFVGTPFWMAPEVIQQSAYDSKAD 202

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 61/118 (51%), Gaps = 10/118 (8%)
Query: 10  ALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
           ALDY HS   +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  P
Sbjct: 120 ALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAP 178
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQL-----VRIAKVLGTE 119
           E+L D   Y  ++D W LG ++  M+  + PF++  H+   +L     +R  + LG E
Sbjct: 179 EVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 235

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 27/182 (14%)
Query: 268 RYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVR 325
           R+Y  E++ ALDY HS   +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 111 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXF 169
Query: 326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
             +  +  PE+L D  Y   +D     ++          F + +++ L     ++ +   
Sbjct: 170 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--- 226
Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYP 440
                      RF  T     + PEA   L  LL+ D  +RL      A+E M H +F  
Sbjct: 227 -----------RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 270
Query: 441 IV 442
           IV
Sbjct: 271 IV 272

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 7/110 (6%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPE 68
           AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     Q  +  + + Y+  PE
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPE 205
Query: 69  LL----ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           ++    +  + YDY  D+WSLG  L  M    EP  H  +    L++IAK
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAK 254

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 64/122 (52%), Gaps = 10/122 (8%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YNVRV---ASRYFK 65
            + Y H+   +HRD+   NV++D+ +R +++ D+GLA+    G E Y VR    +  ++ 
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY 204
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK----VLGTEEL 121
            PE L +Y+ Y Y+ D+WS G  L  ++   +        + +L+ IA+    VL   EL
Sbjct: 205 APECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263
Query: 122 FE 123
            E
Sbjct: 264 LE 265

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 71/136 (52%), Gaps = 18/136 (13%)
Query: 2   RIATGASMALDYCHS-MGIMHRDVKPHNVMID----HENR-KLRLIDWGLAEFYHPGQEY 55
           +I+    + LDY H   GI+H D+KP NV+++     EN  ++++ D G A +Y   + Y
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHY 192
Query: 56  NVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMI---FRKEPFFHGHD---NYDQL 109
              + +R ++ PE+L     +    D+WS  C++  +I   F  EP   GH    + D +
Sbjct: 193 TNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEP-DEGHSYTKDDDHI 250
Query: 110 VRIAKVLGTEELFEYL 125
            +I ++LG  EL  YL
Sbjct: 251 AQIIELLG--ELPSYL 264

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 71/136 (52%), Gaps = 18/136 (13%)
Query: 2   RIATGASMALDYCHS-MGIMHRDVKPHNVMID----HENR-KLRLIDWGLAEFYHPGQEY 55
           +I+    + LDY H   GI+H D+KP NV+++     EN  ++++ D G A +Y   + Y
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHY 192
Query: 56  NVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMI---FRKEPFFHGHD---NYDQL 109
              + +R ++ PE+L     +    D+WS  C++  +I   F  EP   GH    + D +
Sbjct: 193 TNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEP-DEGHSYTKDDDHI 250
Query: 110 VRIAKVLGTEELFEYL 125
            +I ++LG  EL  YL
Sbjct: 251 AQIIELLG--ELPSYL 264

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 26/97 (26%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+    G+ + +     Y
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK-GRTWXLCGTPEY 204
Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
                +L+  + Y+ ++D W+LG ++  M     PFF
Sbjct: 205 LAPAIILS--KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 24/92 (26%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           AL Y HS  ++H+D+KP N++    +    +++ID+GLAE +   +       +  +  P
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           E+    +   +  D+WS G ++  ++    PF
Sbjct: 196 EVFK--RDVTFKCDIWSAGVVMYFLLTGCLPF 225

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/182 (18%), Positives = 79/182 (43%), Gaps = 21/182 (11%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYH 317
           + L++  +   + +++ AL Y HS  ++H+D+KP N++    +    +++ID+GLAE + 
Sbjct: 119 KALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178
Query: 318 PGQEYNVRVASRYFKGPELLA-DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP 376
             +       +  +  PE+   D  +  ++               W   V     + +  
Sbjct: 179 SDEHSTNAAGTALYMAPEVFKRDVTFKCDI---------------WSAGV---VMYFLLT 220
Query: 377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
             L F   ++     +  ++   +      ++P+A+D L ++L  D   R +A + + H 
Sbjct: 221 GCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280
Query: 437 YF 438
           +F
Sbjct: 281 WF 282

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/117 (23%), Positives = 58/117 (49%), Gaps = 5/117 (4%)
Query: 2   RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           +IA     AL++ HS + ++HRDVKP NV+I+   + ++  D+G++ +       ++   
Sbjct: 140 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ-VKXCDFGISGYLVDDVAKDIDAG 198
Query: 61  SRYFKGPELL---ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
            + +  PE +    + + Y    D+WSLG     +   + P+      + QL ++ +
Sbjct: 199 CKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVE 255

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 61/113 (53%), Gaps = 7/113 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF---YHPGQEYNVRV 59
           IA   +  +DY H+  I+HRD+K +N+ + HE+  +++ D+GLA     +    ++    
Sbjct: 137 IARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLS 195
Query: 60  ASRYFKGPEL--LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
            S  +  PE+  + D   Y +  D+++ G +L  ++  + P+ +  +N DQ++
Sbjct: 196 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN-INNRDQII 247

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 61/113 (53%), Gaps = 7/113 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF---YHPGQEYNVRV 59
           IA   +  +DY H+  I+HRD+K +N+ + HE+  +++ D+GLA     +    ++    
Sbjct: 136 IARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLS 194
Query: 60  ASRYFKGPEL--LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
            S  +  PE+  + D   Y +  D+++ G +L  ++  + P+ +  +N DQ++
Sbjct: 195 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN-INNRDQII 246

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 61/113 (53%), Gaps = 7/113 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF---YHPGQEYNVRV 59
           IA   +  +DY H+  I+HRD+K +N+ + HE+  +++ D+GLA     +    ++    
Sbjct: 114 IARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 60  ASRYFKGPEL--LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
            S  +  PE+  + D   Y +  D+++ G +L  ++  + P+ +  +N DQ++
Sbjct: 173 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN-INNRDQII 224

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 53/104 (50%), Gaps = 18/104 (17%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY 63
           A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+          RV  R 
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK----------RVKGRT 195
Query: 64  FK---GPELLAD----YQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           +     PE LA      + Y+ ++D W+LG ++  M     PFF
Sbjct: 196 WXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 60/113 (53%), Gaps = 7/113 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF---YHPGQEYNVRV 59
           IA   +  +DY H+  I+HRD+K +N+ + HE+  +++ D+GLA     +    ++    
Sbjct: 111 IARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLS 169
Query: 60  ASRYFKGPEL--LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
            S  +  PE+  + D   Y +  D+++ G +L  ++  + P +   +N DQ++
Sbjct: 170 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 221

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/115 (25%), Positives = 62/115 (53%), Gaps = 7/115 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA---EFYHPGQEYNVRV 59
           IA   +  +DY H+  I+HRD+K +N+ + HE+  +++ D+GLA     +    ++    
Sbjct: 125 IARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 60  ASRYFKGPEL--LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 112
            S  +  PE+  + D   Y +  D+++ G +L  ++  + P+ +  +N DQ++ +
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN-INNRDQIIEM 237

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/115 (25%), Positives = 62/115 (53%), Gaps = 7/115 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA---EFYHPGQEYNVRV 59
           IA   +  +DY H+  I+HRD+K +N+ + HE+  +++ D+GLA     +    ++    
Sbjct: 125 IARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 60  ASRYFKGPEL--LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 112
            S  +  PE+  + D   Y +  D+++ G +L  ++  + P+ +  +N DQ++ +
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN-INNRDQIIEM 237

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 60/113 (53%), Gaps = 7/113 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF---YHPGQEYNVRV 59
           IA   +  +DY H+  I+HRD+K +N+ + HE+  +++ D+GLA     +    ++    
Sbjct: 114 IARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 60  ASRYFKGPEL--LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
            S  +  PE+  + D   Y +  D+++ G +L  ++  + P +   +N DQ++
Sbjct: 173 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 224

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 54/122 (44%), Gaps = 24/122 (19%)
Query: 19  IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQ 74
           IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE L    
Sbjct: 145 IMHRDVKPSNILVNSRG-EIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTH 198
Query: 75  MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDP 134
            Y    D+WS+G  L  M   + P   G              G+  +FE LD    E  P
Sbjct: 199 -YSVQSDIWSMGLSLVEMAVGRYPIGSGS-------------GSMAIFELLDYIVNEPPP 244
Query: 135 RF 136
           + 
Sbjct: 245 KL 246

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 60/113 (53%), Gaps = 7/113 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF---YHPGQEYNVRV 59
           IA   +  +DY H+  I+HRD+K +N+ + HE+  +++ D+GLA     +    ++    
Sbjct: 109 IARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 60  ASRYFKGPEL--LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
            S  +  PE+  + D   Y +  D+++ G +L  ++  + P +   +N DQ++
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 219

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/91 (27%), Positives = 53/91 (58%), Gaps = 3/91 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G+       +  +  PE
Sbjct: 138 GVQYLHNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPE 196
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +L   + + + +D+WSLGC+L +++  K PF
Sbjct: 197 VLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 60/113 (53%), Gaps = 7/113 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF---YHPGQEYNVRV 59
           IA   +  +DY H+  I+HRD+K +N+ + HE+  +++ D+GLA     +    ++    
Sbjct: 109 IARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 60  ASRYFKGPEL--LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
            S  +  PE+  + D   Y +  D+++ G +L  ++  + P +   +N DQ++
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 219

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/91 (27%), Positives = 53/91 (58%), Gaps = 3/91 (3%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G+       +  +  PE
Sbjct: 154 GVQYLHNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPE 212
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +L   + + + +D+WSLGC+L +++  K PF
Sbjct: 213 VLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/283 (22%), Positives = 118/283 (41%), Gaps = 39/283 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLE----NLRGGT 226
           DDYQL  +LG+G +S V   +    +                       E     L    
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 227 NIITLQAVVKDPVSRTPA--LIFEHVNNTD-FKQLY--QTLTDYDIRYYLYELLKALDYC 281
           NI+ L     D +S      L+F+ V   + F+ +   +  ++ D  + ++++L+++++ 
Sbjct: 91  NIVRLH----DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHI 146
Query: 282 HSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLA 338
           H   I+HRD+KP N+++  + +   ++L D+GLA E     Q +     +  +  PE+L 
Sbjct: 147 HQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLR 206
Query: 339 DYQYHIELDPRFAD----ILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR 394
              Y   +D         IL       W+   H   Q  +   A DF             
Sbjct: 207 KDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQ-IKAGAYDF---------PSPE 256
Query: 395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
           W+          V+PEA + ++++L  +  +R+TA +A+ HP+
Sbjct: 257 WDT---------VTPEAKNLINQMLTINPAKRITADQALKHPW 290

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 64/122 (52%), Gaps = 10/122 (8%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YNVRV---ASRYFK 65
            + Y HS   +HR++   NV++D+ +R +++ D+GLA+    G E Y VR    +  ++ 
Sbjct: 129 GMAYLHSQHYIHRNLAARNVLLDN-DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 187
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK----VLGTEEL 121
            PE L +Y+ Y Y+ D+WS G  L  ++   +        + +L+ IA+    VL   EL
Sbjct: 188 APECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 246
Query: 122 FE 123
            E
Sbjct: 247 LE 248

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 49/89 (55%), Gaps = 2/89 (2%)
Query: 260 QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP 318
           +TLT+ +I   L   LK L+Y H M  +HRD+K  N++++ E    +L D+G+A +    
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHA-KLADFGVAGQLTDX 178
Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELD 347
             + N  + + ++  PE++ +  Y+   D
Sbjct: 179 MAKRNXVIGTPFWMAPEVIQEIGYNCVAD 207

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 64/130 (49%), Gaps = 24/130 (18%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMID------------HENRKLRLIDWGLAEFY 49
           +IA+G +    + HS+ I+HRD+KP N+++              EN ++ + D+GL +  
Sbjct: 141 QIASGVA----HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 196
Query: 50  HPGQ-----EYNVRVASRYFKGPELL--ADYQMYDYSLDMWSLGCMLASMIFR-KEPFFH 101
             GQ       N    +  ++ PELL  +  +    S+D++S+GC+   ++ + K PF  
Sbjct: 197 DSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256
Query: 102 GHDNYDQLVR 111
            +     ++R
Sbjct: 257 KYSRESNIIR 266

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 86/206 (41%), Gaps = 45/206 (21%)
Query: 264 DYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID------------HENRKLRLIDWG 311
           +Y+    L ++   + + HS+ I+HRD+KP N+++              EN ++ + D+G
Sbjct: 132 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 312 LAEFYHPGQ-----EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFV 366
           L +    GQ       N    +  ++ PELL +                  +++R  R +
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEE-----------------STKRRLTRSI 234
Query: 367 HTENQ-----HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL----VSPEALDFLDK 417
              +      +++S     F DK    R S      F   E + L    +  EA D + +
Sbjct: 235 DIFSMGCVFYYILSKGKHPFGDK--YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQ 292
Query: 418 LLRYDHYERLTAREAMDHPYFYPIVK 443
           ++ +D  +R TA + + HP F+P  K
Sbjct: 293 MIDHDPLKRPTAMKVLRHPLFWPKSK 318

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 64/130 (49%), Gaps = 24/130 (18%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMID------------HENRKLRLIDWGLAEFY 49
           +IA+G +    + HS+ I+HRD+KP N+++              EN ++ + D+GL +  
Sbjct: 141 QIASGVA----HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 196
Query: 50  HPGQ-----EYNVRVASRYFKGPELL--ADYQMYDYSLDMWSLGCMLASMIFR-KEPFFH 101
             GQ       N    +  ++ PELL  +  +    S+D++S+GC+   ++ + K PF  
Sbjct: 197 DSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256
Query: 102 GHDNYDQLVR 111
            +     ++R
Sbjct: 257 KYSRESNIIR 266

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 86/206 (41%), Gaps = 45/206 (21%)
Query: 264 DYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID------------HENRKLRLIDWG 311
           +Y+    L ++   + + HS+ I+HRD+KP N+++              EN ++ + D+G
Sbjct: 132 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 312 LAEFYHPGQ-----EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFV 366
           L +    GQ       N    +  ++ PELL +                  +++R  R +
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEE-----------------STKRRLTRSI 234
Query: 367 HTENQ-----HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL----VSPEALDFLDK 417
              +      +++S     F DK    R S      F   E + L    +  EA D + +
Sbjct: 235 DIFSMGCVFYYILSKGKHPFGDK--YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQ 292
Query: 418 LLRYDHYERLTAREAMDHPYFYPIVK 443
           ++ +D  +R TA + + HP F+P  K
Sbjct: 293 MIDHDPLKRPTAMKVLRHPLFWPKSK 318

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 74/349 (21%), Positives = 132/349 (37%), Gaps = 115/349 (32%)
Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGTNIITLQ 232
           Y++V  LG G + +V E I+ ++                            GG ++    
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKA----------------------------GGRHVAV-- 45
Query: 233 AVVKD-----PVSRTPALIFEHVNNTDFKQLYQT---------------------LTDYD 266
            +VK+       +R+   + EH+N TD    ++                      L+ YD
Sbjct: 46  KIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYD 105
Query: 267 --------------IRYYLYELLKALDYCHSMGIMHRDVKPHNVM-------------ID 299
                         IR   Y++ K++++ HS  + H D+KP N++             I 
Sbjct: 106 FIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165
Query: 300 HENRKL-----RLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDP-RFADI 353
            + R L     +++D+G A +    + ++  V  R+++ PE++    +    D      I
Sbjct: 166 RDERTLINPDIKVVDFGSATY--DDEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCI 223
Query: 354 LGRHSRKRWERFVHTENQHLVSPE-ALDFLDKNILGR--------HSRKRWE------RF 398
           L  +         H   +HL   E  L  L K+++ +        H R  W+      R+
Sbjct: 224 LIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRY 283
Query: 399 VHTENQHL--------VSPEAL-DFLDKLLRYDHYERLTAREAMDHPYF 438
           V    + L        V  E L D + K+L YD  +R+T REA+ HP+F
Sbjct: 284 VSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 60/113 (53%), Gaps = 7/113 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA---EFYHPGQEYNVRV 59
           IA   +  +DY H+  I+HRD+K +N+ + HE+  +++ D+GLA     +    ++    
Sbjct: 129 IARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLS 187
Query: 60  ASRYFKGPEL--LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
            S  +  PE+  + D   Y +  D+++ G +L  ++  + P +   +N DQ++
Sbjct: 188 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 239

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 61/113 (53%), Gaps = 7/113 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA---EFYHPGQEYNVRV 59
           IA   +  +DY H+  I+HRD+K +N+ + HE+  +++ D+GLA     +    ++    
Sbjct: 137 IARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLS 195
Query: 60  ASRYFKGPEL--LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
            S  +  PE+  + D   Y +  D+++ G +L  ++  + P+ +  +N DQ++
Sbjct: 196 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN-INNRDQII 247

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKG 66
           +  +DY HS  ++HRD+KP N+ +  + +++++ D+GL     + G+    +   RY   
Sbjct: 146 TKGVDYIHSKKLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM-S 203
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMI------FRKEPFF 100
           PE ++  Q Y   +D+++LG +LA ++      F    FF
Sbjct: 204 PEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFF 242

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 22/76 (28%), Positives = 43/76 (56%), Gaps = 3/76 (3%)
Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYF 331
           ++ K +DY HS  ++HRD+KP N+ +  + +++++ D+GL     + G+    +   RY 
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 202
Query: 332 KGPELLADYQYHIELD 347
             PE ++   Y  E+D
Sbjct: 203 -SPEQISSQDYGKEVD 217

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 60/113 (53%), Gaps = 7/113 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA---EFYHPGQEYNVRV 59
           IA   +  +DY H+  I+HRD+K +N+ + HE+  +++ D+GLA     +    ++    
Sbjct: 109 IARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLS 167
Query: 60  ASRYFKGPEL--LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
            S  +  PE+  + D   Y +  D+++ G +L  ++  + P +   +N DQ++
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 219

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/99 (25%), Positives = 50/99 (50%), Gaps = 5/99 (5%)
Query: 18  GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL----ADY 73
           G++HRDVKP N+++D E  +++L D+G++      +  +       +  PE +       
Sbjct: 145 GVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 74  QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 112
             YD   D+WSLG  L  +   + P+ +   +++ L ++
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 19/108 (17%)
Query: 4   ATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-----EFYHP------- 51
           A   +  + Y HSM I+HRD+  HN ++  EN+ + + D+GLA     E   P       
Sbjct: 114 AKDIASGMAYLHSMNIIHRDLNSHNCLV-RENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 52  ----GQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFR 95
                + Y V V + Y+  PE++ + + YD  +D++S G +L  +I R
Sbjct: 173 KPDRKKRYTV-VGNPYWMAPEMI-NGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 64/122 (52%), Gaps = 10/122 (8%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YNVRV---ASRYFK 65
            + Y H+   +HR++   NV++D+ +R +++ D+GLA+    G E Y VR    +  ++ 
Sbjct: 129 GMAYLHAQHYIHRNLAARNVLLDN-DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 187
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK----VLGTEEL 121
            PE L +Y+ Y Y+ D+WS G  L  ++   +        + +L+ IA+    VL   EL
Sbjct: 188 APECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 246
Query: 122 FE 123
            E
Sbjct: 247 LE 248

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/220 (20%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQT--LTDYDIRYYLYELLKALDYCHS 283
           NI+  + V+  P     A++ E+ +  + F+++      ++ + R++  +L+  + YCH+
Sbjct: 76  NIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 284 MGIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
           M + HRD+K  N ++D     +L++  +G ++      +    V +  +  PE+L   +Y
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 193
Query: 343 HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE 402
               D + AD+        W   V     +++   A  F D     ++ RK   R ++ +
Sbjct: 194 ----DGKVADV--------WSCGV---TLYVMLVGAYPFEDPE-EPKNFRKTIHRILNVQ 237
Query: 403 ----NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
               +   +SPE    + ++   D  +R++  E  +H +F
Sbjct: 238 YAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 63/134 (47%), Gaps = 28/134 (20%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMID------------HENRKLRLIDWGLAEFY 49
           +IA+G +    + HS+ I+HRD+KP N+++              EN ++ + D+GL +  
Sbjct: 123 QIASGVA----HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 50  HPGQE-----YNVRVASRYFKGPELLADYQMYDY------SLDMWSLGCMLASMIFR-KE 97
             GQ       N    +  ++ PELL +            S+D++S+GC+   ++ + K 
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 98  PFFHGHDNYDQLVR 111
           PF   +     ++R
Sbjct: 239 PFGDKYSRESNIIR 252

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 87/201 (43%), Gaps = 31/201 (15%)
Query: 264 DYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID------------HENRKLRLIDWG 311
           +Y+    L ++   + + HS+ I+HRD+KP N+++              EN ++ + D+G
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 312 LAEFYHPGQE-----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFV 366
           L +    GQ       N    +  ++ PELL +   +++   R    +   S      ++
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESN-NLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 367 HTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL----VSPEALDFLDKLLRYD 422
            ++ +H        F DK    R S      F   E + L    +  EA D + +++ +D
Sbjct: 233 LSKGKH-------PFGDK--YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 283
Query: 423 HYERLTAREAMDHPYFYPIVK 443
             +R TA + + HP F+P  K
Sbjct: 284 PLKRPTAMKVLRHPLFWPKSK 304

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 63/134 (47%), Gaps = 28/134 (20%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMID------------HENRKLRLIDWGLAEFY 49
           +IA+G +    + HS+ I+HRD+KP N+++              EN ++ + D+GL +  
Sbjct: 123 QIASGVA----HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 50  HPGQ-----EYNVRVASRYFKGPELLADYQMYDY------SLDMWSLGCMLASMIFR-KE 97
             GQ       N    +  ++ PELL +            S+D++S+GC+   ++ + K 
Sbjct: 179 DSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 98  PFFHGHDNYDQLVR 111
           PF   +     ++R
Sbjct: 239 PFGDKYSRESNIIR 252

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 87/201 (43%), Gaps = 31/201 (15%)
Query: 264 DYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID------------HENRKLRLIDWG 311
           +Y+    L ++   + + HS+ I+HRD+KP N+++              EN ++ + D+G
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 312 LAEFYHPGQ-----EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFV 366
           L +    GQ       N    +  ++ PELL +   +++   R    +   S      ++
Sbjct: 174 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESN-NLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 367 HTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL----VSPEALDFLDKLLRYD 422
            ++ +H        F DK    R S      F   E + L    +  EA D + +++ +D
Sbjct: 233 LSKGKH-------PFGDK--YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 283
Query: 423 HYERLTAREAMDHPYFYPIVK 443
             +R TA + + HP F+P  K
Sbjct: 284 PLKRPTAMKVLRHPLFWPKSK 304

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 4/101 (3%)
Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           +AL + HS G++H DVKP N+ +    R  +L D+GL           V+     +  PE
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226
Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
           LL     Y  + D++SLG  +  +    E   HG + + QL
Sbjct: 227 LLQGS--YGTAADVFSLGLTILEVACNME-LPHGGEGWQQL 264

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/220 (20%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQT--LTDYDIRYYLYELLKALDYCHS 283
           NI+  + V+  P     A++ E+ +  + F+++      ++ + R++  +L+  + YCH+
Sbjct: 76  NIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 284 MGIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
           M + HRD+K  N ++D     +L++  +G ++      +    V +  +  PE+L   +Y
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEY 193
Query: 343 HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE 402
               D + AD+        W   V     +++   A  F D     ++ RK   R ++ +
Sbjct: 194 ----DGKVADV--------WSCGV---TLYVMLVGAYPFEDPE-EPKNFRKTIHRILNVQ 237
Query: 403 ----NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
               +   +SPE    + ++   D  +R++  E  +H +F
Sbjct: 238 YAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 65/152 (42%), Gaps = 12/152 (7%)
Query: 169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLEN----LRG 224
           Q+DD+++++ +GRG +SEV      Q+                        E     + G
Sbjct: 59  QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 225 GTNIIT-LQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD----IRYYLYELLKALD 279
               IT L    +D       L+ E+    D   L     +       R+YL E++ A+D
Sbjct: 119 DRRWITQLHFAFQD--ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176
Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG 311
             H +G +HRD+KP N+++D     +RL D+G
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGH-IRLADFG 207

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 11/85 (12%)
Query: 19  IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQ 74
           IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE L    
Sbjct: 188 IMHRDVKPSNILVNSRG-EIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTH 241
Query: 75  MYDYSLDMWSLGCMLASMIFRKEPF 99
            Y    D+WS+G  L  M   + P 
Sbjct: 242 -YSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 7   ASMALDYCHSMGIMHRDVKPHNVMID----HENRKLRLIDWGLAEFYHPGQ-EYNVRVAS 61
            +  L + HS+ I+HRD+KPHN++I     H   K  + D+GL +    G+  ++ R   
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 62  RYFKG---PELLAD--YQMYDYSLDMWSLGCML 89
              +G   PE+L++   +   Y++D++S GC+ 
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF 219

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 239 VSRTPALIFEHVNNTDFKQL-YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVM 297
           +    A + E+V   DF  L  + +T       L +    L + HS+ I+HRD+KPHN++
Sbjct: 97  IELCAATLQEYVEQKDFAHLGLEPIT------LLQQTTSGLAHLHSLNIVHRDLKPHNIL 150
Query: 298 ID----HENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKG---PELLADYQYHIELDPR 349
           I     H   K  + D+GL +    G+  ++ R      +G   PE+L++     + +P 
Sbjct: 151 ISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE---DCKENPT 207
Query: 350 FA-DILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVS 408
           +  DI    S      +V +E  H    ++L      +LG  S       +H E    V 
Sbjct: 208 YTVDIF---SAGCVFYYVISEGSHPFG-KSLQRQANILLGACSLD----CLHPEKHEDVI 259
Query: 409 PEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
             A + ++K++  D  +R +A+  + HP+F+ + K
Sbjct: 260 --ARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKG 66
           +  +DY HS  +++RD+KP N+ +  + +++++ D+GL     + G+    +   RY   
Sbjct: 132 TKGVDYIHSKKLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYM-S 189
Query: 67  PELLADYQMYDYSLDMWSLGCMLASMI------FRKEPFF 100
           PE ++  Q Y   +D+++LG +LA ++      F    FF
Sbjct: 190 PEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFF 228

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 11/85 (12%)
Query: 19  IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQ 74
           IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE L    
Sbjct: 153 IMHRDVKPSNILVNSRG-EIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTH 206
Query: 75  MYDYSLDMWSLGCMLASMIFRKEPF 99
            Y    D+WS+G  L  M   + P 
Sbjct: 207 -YSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 11/85 (12%)
Query: 19  IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQ 74
           IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE L    
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTH 179
Query: 75  MYDYSLDMWSLGCMLASMIFRKEPF 99
            Y    D+WS+G  L  M   + P 
Sbjct: 180 -YSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 11/85 (12%)
Query: 19  IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQ 74
           IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE L    
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTH 179
Query: 75  MYDYSLDMWSLGCMLASMIFRKEPF 99
            Y    D+WS+G  L  M   + P 
Sbjct: 180 -YSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 11/85 (12%)
Query: 19  IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQ 74
           IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE L    
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTH 179
Query: 75  MYDYSLDMWSLGCMLASMIFRKEPF 99
            Y    D+WS+G  L  M   + P 
Sbjct: 180 -YSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/131 (22%), Positives = 66/131 (50%), Gaps = 10/131 (7%)
Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQT--LTDYDIRYYLYELLKALDYCHS 283
           NI+  + V+  P     A++ E+ +  + F+++      ++ + R++  +L+  + Y H+
Sbjct: 76  NIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHA 133
Query: 284 MGIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
           M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L   +Y
Sbjct: 134 MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEY 193
Query: 343 HIELDPRFADI 353
               D + AD+
Sbjct: 194 ----DGKVADV 200

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 11/85 (12%)
Query: 19  IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQ 74
           IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE L    
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTH 179
Query: 75  MYDYSLDMWSLGCMLASMIFRKEPF 99
            Y    D+WS+G  L  M   + P 
Sbjct: 180 -YSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 11/85 (12%)
Query: 19  IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQ 74
           IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE L    
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTH 179
Query: 75  MYDYSLDMWSLGCMLASMIFRKEPF 99
            Y    D+WS+G  L  M   + P 
Sbjct: 180 -YSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 45/102 (44%), Gaps = 10/102 (9%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 66
            L+Y HS  I+H DVK  NV++  +     L D+G A    P       +   Y  G   
Sbjct: 197 GLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTET 256
Query: 67  ---PELLADYQMYDYSLDMWSLGCMLASMIFRKEP---FFHG 102
              PE++   +  D  +D+WS  CM+  M+    P   FF G
Sbjct: 257 HMAPEVVLG-RSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG 297

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 40/94 (42%), Gaps = 3/94 (3%)
Query: 245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE 301
           +  E +      QL +    L +    YYL + L+ L+Y HS  I+H DVK  NV++  +
Sbjct: 162 IFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSD 221
Query: 302 NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 335
                L D+G A    P       +   Y  G E
Sbjct: 222 GSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTE 255

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 11/85 (12%)
Query: 19  IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQ 74
           IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE L    
Sbjct: 136 IMHRDVKPSNILVNSRG-EIKLCDFGVS-----GQLIDSMANSFVGTRSYMAPERLQGTH 189
Query: 75  MYDYSLDMWSLGCMLASMIFRKEPF 99
            Y    D+WS+G  L  +   + P 
Sbjct: 190 -YSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 43/84 (51%), Gaps = 11/84 (13%)
Query: 19  IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQ 74
           IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE L    
Sbjct: 129 IMHRDVKPSNILVNSRG-EIKLCDFGVS-----GQLIDEMANEFVGTRSYMSPERLQGTH 182
Query: 75  MYDYSLDMWSLGCMLASMIFRKEP 98
            Y    D+WS+G  L  M   + P
Sbjct: 183 -YSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 45/102 (44%), Gaps = 10/102 (9%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 66
            L+Y HS  I+H DVK  NV++  +     L D+G A    P       +   Y  G   
Sbjct: 178 GLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTET 237
Query: 67  ---PELLADYQMYDYSLDMWSLGCMLASMIFRKEP---FFHG 102
              PE++   +  D  +D+WS  CM+  M+    P   FF G
Sbjct: 238 HMAPEVVLG-RSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG 278

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 54/107 (50%), Gaps = 14/107 (13%)
Query: 4   ATGASMALDYCHS---MGIMHRDVKPHNVMI-------DHENRKLRLIDWGLAEFYHPGQ 53
           A   +  ++Y H    + I+HRD+K  N++I       D  N+ L++ D+GLA  +H  +
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--R 168
Query: 54  EYNVRVASRY-FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
              +  A  Y +  PE++    M+    D+WS G +L  ++  + PF
Sbjct: 169 TTKMSAAGAYAWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 44/96 (45%), Gaps = 7/96 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 66
            L+Y H+  I+H DVK  NV++  +  +  L D+G A    P       +   Y  G   
Sbjct: 178 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 237
Query: 67  ---PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
              PE++   +  D  +D+WS  CM+  M+    P+
Sbjct: 238 HMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 41/94 (43%), Gaps = 3/94 (3%)
Query: 245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE 301
           +  E +      QL +    L +    YYL + L+ L+Y H+  I+H DVK  NV++  +
Sbjct: 143 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD 202
Query: 302 NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 335
             +  L D+G A    P       +   Y  G E
Sbjct: 203 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 236

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 55/105 (52%), Gaps = 5/105 (4%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           AL YCH   ++HRD+KP N++      +L++ D+G +  + P         +  +  PE+
Sbjct: 135 ALMYCHGKKVIHRDIKPENLL-LGLKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEM 192
Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRI 112
           + + +M++  +D+W +G +   ++    PF     N  Y ++V++
Sbjct: 193 I-EGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV 236

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 65/295 (22%), Positives = 111/295 (37%), Gaps = 41/295 (13%)
Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDXXXXXXXXXXXXXXXXXXXXXLENLRGGT---- 226
           DD+++ R LG+GK+  V+ A   +S                          +        
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 227 -NIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQTLT--DYDIRYYLYELLKALDYCH 282
            NI+ L     D   R   LI E+    + +K+L ++ T  +      + EL  AL YCH
Sbjct: 83  PNILRLYNYFYD--RRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCH 140
Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
              ++HRD+KP N++      +L++ D+G +  + P         +  +  PE++    +
Sbjct: 141 GKKVIHRDIKPENLL-LGLKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEGRMH 198
Query: 343 HIELDPRFADILGRH---SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
           + ++D     +L          +E   H E    +    L F      G           
Sbjct: 199 NEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTG----------- 247
Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSS 454
                      A D + KLLR++  ERL   +   HP+    V+  SR  LP S+
Sbjct: 248 -----------AQDLISKLLRHNPSERLPLAQVSAHPW----VRANSRRVLPPSA 287

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 44/96 (45%), Gaps = 7/96 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 66
            L+Y H+  I+H DVK  NV++  +  +  L D+G A    P       +   Y  G   
Sbjct: 162 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 67  ---PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
              PE++   +  D  +D+WS  CM+  M+    P+
Sbjct: 222 HMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 41/94 (43%), Gaps = 3/94 (3%)
Query: 245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE 301
           +  E +      QL +    L +    YYL + L+ L+Y H+  I+H DVK  NV++  +
Sbjct: 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD 186
Query: 302 NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 335
             +  L D+G A    P       +   Y  G E
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD++  N+++  EN   ++ D+GLA       EY  R  ++
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAK 342
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 343 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 44/96 (45%), Gaps = 7/96 (7%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 66
            L+Y H+  I+H DVK  NV++  +  +  L D+G A    P       +   Y  G   
Sbjct: 176 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 235
Query: 67  ---PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
              PE++   +  D  +D+WS  CM+  M+    P+
Sbjct: 236 HMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 41/94 (43%), Gaps = 3/94 (3%)
Query: 245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE 301
           +  E +      QL +    L +    YYL + L+ L+Y H+  I+H DVK  NV++  +
Sbjct: 141 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD 200
Query: 302 NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 335
             +  L D+G A    P       +   Y  G E
Sbjct: 201 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 234

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD++  N+++  EN   ++ D+GLA       EY  R  ++
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAK 342
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 343 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRL-MTGDTYTAHAGAK 173
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 174 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 202

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD++  N+++  EN   ++ D+GLA       EY  R  ++
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAK 342
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 343 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 16/99 (16%)
Query: 19  IMHRDVKPHNVMIDHENRKLRLIDWGLAEF--YHPG-----------QEYNVRVASRYFK 65
           I+HRD+K  N+++ ++   ++L D+G A    ++P            +E   R  +  ++
Sbjct: 159 IIHRDLKVENLLLSNQG-TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYR 217
Query: 66  GPELLADYQMYDYS--LDMWSLGCMLASMIFRKEPFFHG 102
            PE++  Y  +      D+W+LGC+L  + FR+ PF  G
Sbjct: 218 TPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRL-MTGDTYTAHAGAK 173
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 174 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 202

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 129 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRL-MTGDTYTAHAGAK 186
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 187 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 215

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRL-MTGDTYTAHAGAK 173
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 174 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 202

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 135 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHVVKVADFGLSRL-MTGDTYTAHAGAK 192
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 193 FPIKWTAPESLA-YNTFSIKSDVWAFGVLL 221

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD++  N+++  EN   ++ D+GLA       EY  R  ++
Sbjct: 368 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAK 425
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 426 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRL-MTGDTYTAHAGAK 178
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 179 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRL-MTGDTYTAHAGAK 173
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 174 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 202

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRL-MTGDTYTAHAGAK 178
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 179 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 118 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLM-TGDTYTAHAGAK 175
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 176 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 204

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRL-MTGDTYTAHAGAK 178
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 179 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRL-MTGDTYTAHAGAK 173
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 174 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 202

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD++  N+++  EN   ++ D+GLA       EY  R  ++
Sbjct: 112 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAK 169
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 170 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 223

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 118 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRL-MTGDTYTAHAGAK 175
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 176 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 204

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRL-MTGDTYTAHAGAK 178
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 179 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRL-MTGDTYTAHAGAK 173
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 174 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD++  N+++  EN   ++ D+GLA       EY  R  ++
Sbjct: 110 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAK 167
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 168 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 221

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 120 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRL-MTGDTYTAHAGAK 177
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 178 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 206

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 56/116 (48%), Gaps = 10/116 (8%)
Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS 61
           +IA+G    + Y   M  +HRD++  N+++  EN   ++ D+GLA       EY  R  +
Sbjct: 119 QIASG----MAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGA 172
Query: 62  RY---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           ++   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 173 KFPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 227

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD++  N+++  EN   ++ D+GLA       EY  R  ++
Sbjct: 108 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAK 165
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 166 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 219

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 117 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRL-MTGDTYTAPAGAK 174
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 175 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 203

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 118 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRL-MTGDTYTAPAGAK 175
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 176 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 204

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD++  N+++  EN   ++ D+GLA       EY  R  ++
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAK 176
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 177 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD++  N+++  EN   ++ D+GLA       EY  R  ++
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAK 176
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 177 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD++  N+++  EN   ++ D+GLA       EY  R  ++
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAK 176
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 177 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD++  N+++  EN   ++ D+GLA       EY  R  ++
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAK 176
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 177 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD++  N+++  EN   ++ D+GLA       EY  R  ++
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAK 176
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 177 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD++  N+++  EN   ++ D+GLA       EY  R  ++
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAK 176
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 177 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 55/105 (52%), Gaps = 6/105 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YNVRV---ASRYFK 65
            + Y H+   +HR +   NV++D+ +R +++ D+GLA+    G E Y VR    +  ++ 
Sbjct: 123 GMAYLHAQHYIHRALAARNVLLDN-DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 181
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
            PE L + + Y Y+ D+WS G  L  ++   +     H  + +L+
Sbjct: 182 APECLKECKFY-YASDVWSFGVTLYELLTYCDSNQSPHTKFTELI 225

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 55/105 (52%), Gaps = 6/105 (5%)
Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YNVRV---ASRYFK 65
            + Y H+   +HR +   NV++D+ +R +++ D+GLA+    G E Y VR    +  ++ 
Sbjct: 124 GMAYLHAQHYIHRALAARNVLLDN-DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 182
Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
            PE L + + Y Y+ D+WS G  L  ++   +     H  + +L+
Sbjct: 183 APECLKECKFY-YASDVWSFGVTLYELLTYCDSNQSPHTKFTELI 226

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/90 (26%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HR++   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 323 MATQISSAMEYLEKKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLM-TGDTYTAHAGAK 380
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 381 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 409

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/90 (26%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HR++   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 362 MATQISSAMEYLEKKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLM-TGDTYTAHAGAK 419
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 420 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 448

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 24/90 (26%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+     G  +     ++
Sbjct: 114 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLM-TGDTFTAHAGAK 171
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCML 89
           +   +  PE LA Y  +    D+W+ G +L
Sbjct: 172 FPIKWTAPESLA-YNKFSIKSDVWAFGVLL 200

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/115 (23%), Positives = 53/115 (46%), Gaps = 6/115 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD++  N+++  EN   ++ D+GL        EY  R  ++
Sbjct: 286 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLGRLIE-DNEYTARQGAK 343
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 344 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 397

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 53/115 (46%), Gaps = 6/115 (5%)
Query: 3   IATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 62
           +A   +  + Y   M  +HRD+   N+++  EN   ++ D+GLA       EY  R  ++
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLAAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAK 176
Query: 63  Y---FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   +  PE  A Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 177 FPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 6/108 (5%)
Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFK-- 65
           S AL Y  S   +HRD+   NV++   N  ++L D+GL+ +      Y         K  
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 66  GPELLADYQMYDYSLDMWSLG-CMLASMIFRKEPFFHGHDNYDQLVRI 112
            PE + +++ +  + D+W  G CM   ++   +P F G  N D + RI
Sbjct: 560 APESI-NFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	467
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-152
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-82
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-44
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-32
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-43
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-31
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-42
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-30
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-38
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-38
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-27
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-38
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-24
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-37
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-27
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-37
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-24
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-37
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-31
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-37
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-37
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-20
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-36
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-36
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-27
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-36
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-25
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-36
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-26
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-36
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-25
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-36
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-36
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-26
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-36
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-35
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-35
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-35
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-35
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-35
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-25
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-35
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-35
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-35
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-35
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-27
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-34
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-34
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-27
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-34
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-34
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-19
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-34
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-34
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-19
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-17
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-34
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-34
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-25
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-34
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-34
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-34
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-29
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-33
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-33
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-27
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-33
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-22
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-18
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-33
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-33
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-33
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-32
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-32
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-26
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-32
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-31
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-18
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-31
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-19
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-31
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-31
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-16
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-31
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-31
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-22
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-16
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-31
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-30
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-16
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-30
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-30
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-30
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-19
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-19
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-19
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-16
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-20
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-28
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-18
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-19
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-28
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-27
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-17
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-27
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-26
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-16
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-05
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-16
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-25
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-18
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-25
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-25
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-15
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-15
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-25
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-21
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-25
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-04
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-14
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-14
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-24
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-13
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-12
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-12
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-23
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-23
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-12
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-11
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-16
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-22
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-22
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-11
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-11
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-12
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-22
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-17
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-21
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-21
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	9e-17
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-21
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-16
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-16
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-20
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-16
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-20
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-15
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-20
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-11
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-19
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-13
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-04
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-17
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-11
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-17
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-10
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-17
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-11
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-17
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-11
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-14
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-15
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-10
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-15
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-10
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-15
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-10
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-14
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-09
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-14
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-09
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-14
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-09
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-14
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-06
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-14
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-10
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-14
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-12
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-13
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-11
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-13
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-09
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-13
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-13
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-10
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-13
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-08
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-13
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-04
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-06
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-13
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-08
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-10
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-11
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-12
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-09
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-12
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-09
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-12
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-04
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-12
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-10
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-11
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-05
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-12
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-10
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-12
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-09
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-10
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-11
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-06
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-08
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-11
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-11
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-11
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-10
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-11
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-09
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-11
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-09
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-11
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-06
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-10
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-10
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-10
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-08
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-09
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-10
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-07
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-09
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-09
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-09
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-09
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-06
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-08
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-09
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-06
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-08
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-08
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-07
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-08
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-06
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-08
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-08
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-08
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-08
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-08
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-06
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-08
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-08
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-07
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-08
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-08
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-05
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-08
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-06
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-08
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-08
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-07
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-07
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-07
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-07
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-07
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-07
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-07
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-07
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-07
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-07
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-07
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-07
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-07
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-07
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-07
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-06
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-06
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-06
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-06
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-06
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-06
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-06
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-06
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-06
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-06
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-06
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-06
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-05
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-05
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-05
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-05
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-05
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-05
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-05
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-05
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-05
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-05
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-04
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	2e-04
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-04
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-04
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	6e-04
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-04
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-04

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  435 bits (1122), Expect = e-152
 Identities = 242/336 (72%), Positives = 263/336 (78%), Gaps = 38/336 (11%)

Query: 139 ILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDK 198
           +  RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++K
Sbjct: 4   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 63

Query: 199 CVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
            VVKILKPVKKKKIKREIKILENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQL
Sbjct: 64  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 123

Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
           YQTLTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHP
Sbjct: 124 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183

Query: 319 GQEYNVRVASRYFKGPELLADYQ-YHIELD----------------PRF----------- 350
           GQEYNVRVASRYFKGPELL DYQ Y   LD                P F           
Sbjct: 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 243

Query: 351 -ADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSP 409
            A +LG      +    +             F D  ILGRHSRKRWERFVH+ENQHLVSP
Sbjct: 244 IAKVLGTEDLYDYIDKYN-------IELDPRFND--ILGRHSRKRWERFVHSENQHLVSP 294

Query: 410 EALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
           EALDFLDKLLRYDH  RLTAREAM+HPYFY +VKDQ
Sbjct: 295 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 330

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  257 bits (659), Expect = 1e-82
 Identities = 125/133 (93%), Positives = 131/133 (98%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           ALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 201

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYH 129
           L DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE+L++Y+DKY+
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261

Query: 130 IELDPRFADILGR 142
           IELDPRF DILGR
Sbjct: 262 IELDPRFNDILGR 274

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  159 bits (404), Expect = 3e-44
 Identities = 86/358 (24%), Positives = 143/358 (39%), Gaps = 59/358 (16%)

Query: 138 DILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSD 197
              G  +V  D +  K            D  Q+  Y   + +G G +  V++A    S +
Sbjct: 21  SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 80

Query: 198 KCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA----LIFEHVNNT 253
              +K +   K+ K  RE++I+  L    NI+ L+        +       L+ ++V  T
Sbjct: 81  LVAIKKVLQDKRFKN-RELQIMRKLDH-CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET 138

Query: 254 ------DFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRL 307
                  + +  QTL    ++ Y+Y+L ++L Y HS GI HRD+KP N+++D +   L+L
Sbjct: 139 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKL 198

Query: 308 IDWGLAEFYHPGQEYNVRVASRYFKGPELL---ADYQYHI----------EL---DPRFA 351
            D+G A+    G+     + SRY++ PEL+    DY   I          EL    P F 
Sbjct: 199 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258

Query: 352 ------------DILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
                        +LG  +R++            ++P   +F       +     W +  
Sbjct: 259 GDSGVDQLVEIIKVLGTPTREQIRE---------MNPNYTEF----KFPQIKAHPWTKVF 305

Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTP 457
                    PEA+    +LL Y    RLT  EA  H +F  +     +  LP+   TP
Sbjct: 306 RPR----TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK--LPNGRDTP 357

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  125 bits (317), Expect = 4e-32
 Identities = 47/109 (43%), Positives = 67/109 (61%), Gaps = 1/109 (0%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 227

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS GC+LA ++  + P F G    DQLV I KVLGT
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGT 275

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  155 bits (394), Expect = 5e-43
 Identities = 84/330 (25%), Positives = 153/330 (46%), Gaps = 60/330 (18%)

Query: 166 DWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGG 225
              ++  Y   + +G G +  VF+A  V+S +  + K+L+   K+   RE++I+  ++  
Sbjct: 35  GEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD--KRFKNRELQIMRIVKH- 91

Query: 226 TNIITLQAVVKDPVSRTPA----LIFEHVNNT------DFKQLYQTLTDYDIRYYLYELL 275
            N++ L+A       +       L+ E+V  T       + +L QT+    I+ Y+Y+LL
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151

Query: 276 KALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 335
           ++L Y HS+GI HRD+KP N+++D  +  L+LID+G A+    G+     + SRY++ PE
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPE 211

Query: 336 LL---ADYQYHI----------EL---DPRFA------------DILGRHSRKRWERFVH 367
           L+    +Y  +I          EL    P F              +LG  SR++ +    
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT--- 268

Query: 368 TENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL 427
                 ++P  ++        +     + +           P+A+D + +LL Y    RL
Sbjct: 269 ------MNPNYMEHK----FPQIRPHPFSKVFRPR----TPPDAIDLISRLLEYTPSARL 314

Query: 428 TAREAMDHPYFYPIVKDQSRHTLPSSSPTP 457
           TA EA+ HP+F  +   ++R  +P+    P
Sbjct: 315 TAIEALCHPFFDELRTGEAR--MPNGRELP 342

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  124 bits (313), Expect = 1e-31
 Identities = 46/109 (42%), Positives = 69/109 (63%), Gaps = 1/109 (0%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           +L Y HS+GI HRD+KP N+++D  +  L+LID+G A+    G+     + SRY++ PEL
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPEL 212

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  ++D+WS GC++A ++  + P F G    DQLV I KVLGT
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKVLGT 260

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  151 bits (383), Expect = 9e-42
 Identities = 74/336 (22%), Positives = 136/336 (40%), Gaps = 60/336 (17%)

Query: 165 VDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVK--ILKPVKKKKIKREIKILENL 222
               + D +Q+ R  G+G +  V       +     +K  I  P  + +  + ++ L  L
Sbjct: 17  RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL 76

Query: 223 RGGTNIITLQAVVKDPVSRTP-----ALIFEHVNNT------DFKQLYQTLTDYDIRYYL 271
               NI+ LQ+       R        ++ E+V +T      ++ +         I+ +L
Sbjct: 77  HH-PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 272 YELLKALDYCH--SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 329
           ++L++++   H  S+ + HRD+KPHNV+++  +  L+L D+G A+   P +     + SR
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195

Query: 330 YFKGPELL---ADYQYHI----------EL---DPRFA------------DILGRHSRKR 361
           Y++ PEL+     Y   +          E+   +P F              +LG  SR+ 
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255

Query: 362 WERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRY 421
             +         ++P   D    N         W       +    + EA D L  LL+Y
Sbjct: 256 LRK---------LNPSHTDVDLYNS----KGIPWSNVFSDHSLKD-AKEAYDLLSALLQY 301

Query: 422 DHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTP 457
              ER+   EA+ HPYF  +    ++  LP++   P
Sbjct: 302 LPEERMKPYEALCHPYFDELHDPATK--LPNNKDLP 335

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  120 bits (303), Expect = 1e-30
 Identities = 40/111 (36%), Positives = 67/111 (60%), Gaps = 3/111 (2%)

Query: 10  ALDYCH--SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           ++   H  S+ + HRD+KPHNV+++  +  L+L D+G A+   P +     + SRY++ P
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAP 200

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           EL+   Q Y  ++D+WS+GC+ A M+  + P F G ++  QL  I +VLG 
Sbjct: 201 ELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PIFRGDNSAGQLHEIVRVLGC 250

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  141 bits (358), Expect = 1e-38
 Identities = 77/330 (23%), Positives = 135/330 (40%), Gaps = 70/330 (21%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK--------REIKILENL 222
             Y+ V ++G G Y +VF+A ++++  + V   LK V+ +  +        RE+ +L +L
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHL 68

Query: 223 RGGT--NIITLQAVVKDPVSRTPA---LIFEHVNNTDFKQL-----YQTLTDYDIRYYLY 272
                 N++ L  V     +       L+FEHV+  D            +    I+  ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMF 127

Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 332
           +LL+ LD+ HS  ++HRD+KP N+++    + ++L D+GLA  Y         V + +++
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYSFQMALTSVVVTLWYR 186

Query: 333 GPELLADYQYHIELD---------------PRFA------------DILGRHSRKRWERF 365
            PE+L    Y   +D               P F             D++G    + W R 
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246

Query: 366 VHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYE 425
           V               L +      S +  E+FV       +     D L K L ++  +
Sbjct: 247 VA--------------LPRQAFHSKSAQPIEKFVTD-----IDELGKDLLLKCLTFNPAK 287

Query: 426 RLTAREAMDHPYF--YPIVKDQSRHTLPSS 453
           R++A  A+ HPYF      K+     LP S
Sbjct: 288 RISAYSALSHPYFQDLERCKENLDSHLPPS 317

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  104 bits (262), Expect = 3e-25
 Identities = 39/109 (35%), Positives = 64/109 (58%), Gaps = 3/109 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            LD+ HS  ++HRD+KP N+++    + ++L D+GLA  Y         V + +++ PE+
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           L     Y   +D+WS+GC+ A M FR++P F G  + DQL +I  V+G 
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGL 237

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  140 bits (355), Expect = 3e-38
 Identities = 77/334 (23%), Positives = 134/334 (40%), Gaps = 77/334 (23%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK-------------REIK 217
           + Y+ + K+G G Y  VF+  N  +    +V I      KK               REI+
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQ--IVAI------KKFLESEDDPVIKKIALREIR 54

Query: 218 ILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY----QTLTDYDIRYYLYE 273
           +L+ L+   N++ L  V +        L+FE+ +            + + ++ ++   ++
Sbjct: 55  MLKQLKH-PNLVNLLEVFRRKRRLH--LVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQ 110

Query: 274 LLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFK 332
            L+A+++CH    +HRDVKP N++I   +  ++L D+G A     P   Y+  VA+R+++
Sbjct: 111 TLQAVNFCHKHNCIHRDVKPENILITKHSV-IKLCDFGFARLLTGPSDYYDDEVATRWYR 169

Query: 333 GPE-LLADYQYHIELD---------------PRFA------------DILGRHSRKRWER 364
            PE L+ D QY   +D               P +               LG    +  + 
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229

Query: 365 FVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHY 424
           F  + NQ         F    I      +  E          +S  AL  L   L  D  
Sbjct: 230 F--STNQ--------YFSGVKIPDPEDMEPLELKFPN-----ISYPALGLLKGCLHMDPT 274

Query: 425 ERLTAREAMDHPYF--YPIVKDQSR-HTLPSSSP 455
           ERLT  + + HPYF     ++D ++ H  P+ + 
Sbjct: 275 ERLTCEQLLHHPYFENIREIEDLAKEHDKPAENL 308

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  110 bits (278), Expect = 2e-27
 Identities = 39/110 (35%), Positives = 63/110 (57%), Gaps = 3/110 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
           A+++CH    +HRDVKP N++I   +  ++L D+G A     P   Y+  VA+R+++ PE
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSV-IKLCDFGFARLLTGPSDYYDDEVATRWYRSPE 172

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           LL     Y   +D+W++GC+ A ++    P + G  + DQL  I K LG 
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGD 221

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  141 bits (358), Expect = 3e-38
 Identities = 67/323 (20%), Positives = 136/323 (42%), Gaps = 40/323 (12%)

Query: 151 SHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVK-ILKPVKK 209
           S +   ++  E     +     YQ ++ +G G    V  A +        +K + +P + 
Sbjct: 5   SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 64

Query: 210 ----KKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA----LIFEHVNNTDFKQ-LYQ 260
               K+  RE+ +++ +    NII L  V     S        ++ E ++  +  Q +  
Sbjct: 65  QTHAKRAYRELVLMKCVNH-KNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM 122

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
            L    + Y LY++L  + + HS GI+HRD+KP N+++   +  L+++D+GLA       
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSF 181

Query: 321 EYNVRVASRYFKGPELLADYQYHIELDP-----RFADIL-------GRHSRKRWERFVHT 368
                V +RY++ PE++    Y   +D         +++       G     +W + +  
Sbjct: 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 241

Query: 369 ------ENQHLVSPEALDFLDKNILGRHSRKRWERF-------VHTENQHLVSPEALDFL 415
                 E    + P    +++     +++   +E+          +E+  L + +A D L
Sbjct: 242 LGTPCPEFMKKLQPTVRTYVEN--RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 299

Query: 416 DKLLRYDHYERLTAREAMDHPYF 438
            K+L  D  +R++  EA+ HPY 
Sbjct: 300 SKMLVIDASKRISVDEALQHPYI 322

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  101 bits (254), Expect = 7e-24
 Identities = 36/109 (33%), Positives = 63/109 (57%), Gaps = 3/109 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++   +  L+++D+GLA            V +RY++ PE+
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  ++D+WS+GC++  MI      F G D+ DQ  ++ + LGT
Sbjct: 198 ILGMG-YKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQLGT 244

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  139 bits (352), Expect = 1e-37
 Identities = 72/308 (23%), Positives = 134/308 (43%), Gaps = 53/308 (17%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL---KPVKKKKIKREIKILENLRGGTNII 229
           Y  ++ LG G    VF A++     +  +K +    P   K   REIKI+  L    NI+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH-DNIV 71

Query: 230 TLQAVVKDPVSRTPALIFEHVNNTDFKQLY----------------QTLTDYDIRYYLYE 273
            +  ++    S+      +  + T+   +Y                  L +   R ++Y+
Sbjct: 72  KVFEILGPSGSQLTD---DVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ 128

Query: 274 LLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----VASR 329
           LL+ L Y HS  ++HRD+KP N+ I+ E+  L++ D+GLA    P   +       + ++
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 330 YFKGPE-LLADYQYHIELDP-----RFADIL-------GRHSRKRWERFVHT------EN 370
           +++ P  LL+   Y   +D       FA++L       G H  ++ +  + +      E+
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248

Query: 371 QHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAR 430
           +  +      ++          K   + +       +S EA+DFL+++L +   +RLTA 
Sbjct: 249 RQELLSVIPVYIRN--DMTEPHKPLTQLLPG-----ISREAVDFLEQILTFSPMDRLTAE 301

Query: 431 EAMDHPYF 438
           EA+ HPY 
Sbjct: 302 EALSHPYM 309

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  109 bits (275), Expect = 5e-27
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 5/113 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----VASRYFK 65
            L Y HS  ++HRD+KP N+ I+ E+  L++ D+GLA    P   +       + +++++
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191

Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
            P LL     Y  ++DMW+ GC+ A M+  K   F G    +Q+  I + +  
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TLFAGAHELEQMQLILESIPV 243

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  142 bits (360), Expect = 1e-37
 Identities = 66/323 (20%), Positives = 138/323 (42%), Gaps = 40/323 (12%)

Query: 151 SHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVK-ILKPVKK 209
           S    +++  E     +     YQ ++ +G G    V  A +        +K + +P + 
Sbjct: 42  SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 101

Query: 210 ----KKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA----LIFEHVNNTDFKQ-LYQ 260
               K+  RE+ +++ +    NII+L  V     +        L+ E ++  +  Q +  
Sbjct: 102 QTHAKRAYRELVLMKCVNH-KNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM 159

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
            L    + Y LY++L  + + HS GI+HRD+KP N+++   +  L+++D+GLA       
Sbjct: 160 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSF 218

Query: 321 EYNVRVASRYFKGPELLADYQYHIELDP-----RFADIL-------GRHSRKRWERFVHT 368
                V +RY++ PE++    Y   +D         +++       GR    +W + +  
Sbjct: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

Query: 369 ------ENQHLVSPEALDFLDKNILGRHSRKRWERF-------VHTENQHLVSPEALDFL 415
                 E    + P   ++++     +++   + +          +E+  L + +A D L
Sbjct: 279 LGTPCPEFMKKLQPTVRNYVEN--RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 336

Query: 416 DKLLRYDHYERLTAREAMDHPYF 438
            K+L  D  +R++  +A+ HPY 
Sbjct: 337 SKMLVIDPAKRISVDDALQHPYI 359

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  103 bits (257), Expect = 6e-24
 Identities = 36/109 (33%), Positives = 63/109 (57%), Gaps = 3/109 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            + + HS GI+HRD+KP N+++   +  L+++D+GLA            V +RY++ PE+
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  ++D+WS+GC++  M+  K   F G D  DQ  ++ + LGT
Sbjct: 235 ILGMG-YKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIEQLGT 281

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  140 bits (355), Expect = 1e-37
 Identities = 73/340 (21%), Positives = 129/340 (37%), Gaps = 89/340 (26%)

Query: 169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNI 228
               Y L + LG G +  V E  +++S  +  +K +    + K  RE+ I++ L    NI
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-RELDIMKVLDH-VNI 62

Query: 229 ITLQAVVKDPVSRTPALIFEHV---------------------NNTDFKQLY-------- 259
           I L           P                            N +  K L         
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122

Query: 260 -------------QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLR 306
                        +++    I  Y+Y+L +A+ + HS+GI HRD+KP N++++ ++  L+
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLK 182

Query: 307 LIDWGLAEFYHPGQEYNVRVASRYFKGPELL---ADYQYHI----------EL---DPRF 350
           L D+G A+   P +     + SR+++ PEL+    +Y   I          EL    P F
Sbjct: 183 LCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242

Query: 351 ------------ADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
                         I+G  ++++  R         ++P   +            K W + 
Sbjct: 243 SGETSIDQLVRIIQIMGTPTKEQMIR---------MNPHYTEVR----FPTLKAKDWRKI 289

Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           +           A+D L+++LRY+   R+   EAM HP+F
Sbjct: 290 LPEGT----PSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  122 bits (309), Expect = 3e-31
 Identities = 42/109 (38%), Positives = 70/109 (64%), Gaps = 1/109 (0%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ + HS+GI HRD+KP N++++ ++  L+L D+G A+   P +     + SR+++ PEL
Sbjct: 153 AVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPEL 212

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +     Y  S+D+WS+GC+   +I  K P F G  + DQLVRI +++GT
Sbjct: 213 MLGATEYTPSIDLWSIGCVFGELILGK-PLFSGETSIDQLVRIIQIMGT 260

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  143 bits (363), Expect = 1e-37
 Identities = 65/306 (21%), Positives = 117/306 (38%), Gaps = 54/306 (17%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL---KPVKKKKIKREIKILENLRGGT 226
            D Y +  +LG G +  V       + +    K +       K+ +++EI+ +  LR   
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-P 214

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ---TLTDYDIRYYLYELLKALDYCH 282
            ++ L    +D       +I+E ++  + F+++      +++ +   Y+ ++ K L + H
Sbjct: 215 TLVNLHDAFEDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272

Query: 283 SMGIMHRDVKPHNVMI-DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
               +H D+KP N+M     + +L+LID+GL     P Q   V   +  F  PE+     
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332

Query: 342 YHIELDPRFAD---------IL--GRHSRKRWERFVHTENQHLVSPEALDFLDKN---IL 387
                     D         IL  G                  +SP    F  +N    L
Sbjct: 333 VGYY-----TDMWSVGVLSYILLSG------------------LSP----FGGENDDETL 365

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                  W     +     +S +  DF+ KLL  D   R+T  +A++HP+  P       
Sbjct: 366 RNVKSCDWN-MDDSAFSG-ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 423

Query: 448 HTLPSS 453
             +PSS
Sbjct: 424 SQIPSS 429

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 92.2 bits (229), Expect = 4e-20
 Identities = 26/81 (32%), Positives = 40/81 (49%), Gaps = 2/81 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMI-DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
            L + H    +H D+KP N+M     + +L+LID+GL     P Q   V   +  F  PE
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 326

Query: 69  LLADYQMYDYSLDMWSLGCML 89
           +  + +   Y  DMWS+G + 
Sbjct: 327 VA-EGKPVGYYTDMWSVGVLS 346

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  138 bits (350), Expect = 2e-37
 Identities = 59/314 (18%), Positives = 120/314 (38%), Gaps = 58/314 (18%)

Query: 170 QDDYQLV-RKLGRGKYSEVFEAINVQSSDKCVVKI-----LKPVKKKKIKREIKILENLR 223
            + Y L  ++LGRGK++ V + I+  +  +   K           + +I  EI +LE  +
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86

Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTD-F----KQLYQTLTDYDIRYYLYELLKAL 278
               +I L  V ++       LI E+    + F     +L + +++ D+   + ++L+ +
Sbjct: 87  SCPRVINLHEVYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144

Query: 279 DYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 336
            Y H   I+H D+KP N+++   +    ++++D+G++       E    + +  +  PE+
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204

Query: 337 LADYQYHIELDPRFAD---------IL--GRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
           L              D         +L                      SP    F+ ++
Sbjct: 205 LNYDPITTA-----TDMWNIGIIAYMLLTH------------------TSP----FVGED 237

Query: 386 ---ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV 442
                   S+   + +        VS  A DF+  LL  +  +R TA   + H +     
Sbjct: 238 NQETYLNISQVNVD-YSEETFSS-VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295

Query: 443 KDQSRHTLPSSSPT 456
            +   H   +SS +
Sbjct: 296 FENLFHPEETSSSS 309

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 89.2 bits (222), Expect = 8e-20
 Identities = 19/79 (24%), Positives = 40/79 (50%), Gaps = 3/79 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
            + Y H   I+H D+KP N+++   +    ++++D+G++       E    + +  +  P
Sbjct: 143 GVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202

Query: 68  ELLADYQMYDYSLDMWSLG 86
           E+L  Y     + DMW++G
Sbjct: 203 EILN-YDPITTATDMWNIG 220

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  136 bits (345), Expect = 1e-36
 Identities = 64/288 (22%), Positives = 119/288 (41%), Gaps = 53/288 (18%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL--KPVKKKKIKREIKILENLRGGTN 227
            + Y +   LGRG++  V   +   S    + K +  K   +  +K+EI IL       N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRN 62

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ---TLTDYDIRYYLYELLKALDYCHS 283
           I+ L    +        +IFE ++  D F+++      L + +I  Y++++ +AL + HS
Sbjct: 63  ILHLHESFESMEELV--MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 284 MGIMHRDVKPHNVM-IDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
             I H D++P N++     +  +++I++G A    PG  + +   +  +  PE+      
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 343 HIELDPRFAD---------IL--GRHSRKRWERFVHTENQHLVSPEALDFLDKN---ILG 388
                    D         +L  G                  ++P    FL +    I+ 
Sbjct: 181 STA-----TDMWSLGTLVYVLLSG------------------INP----FLAETNQQIIE 213

Query: 389 RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                 +  F     +  +S EA+DF+D+LL  +   R+TA EA+ HP
Sbjct: 214 NIMNAEYT-FDEEAFKE-ISIEAMDFVDRLLVKERKSRMTASEALQHP 259

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 92.3 bits (230), Expect = 6e-21
 Identities = 22/81 (27%), Positives = 43/81 (53%), Gaps = 2/81 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVM-IDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           AL + HS  I H D++P N++     +  +++I++G A    PG  + +   +  +  PE
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173

Query: 69  LLADYQMYDYSLDMWSLGCML 89
           +   + +   + DMWSLG ++
Sbjct: 174 VHQ-HDVVSTATDMWSLGTLV 193

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  136 bits (345), Expect = 1e-36
 Identities = 76/335 (22%), Positives = 128/335 (38%), Gaps = 74/335 (22%)

Query: 150 NSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK 209
           + H      D  +  + +   + Y+ +  +G G Y  V +  N  +    +V I      
Sbjct: 4   HHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGR--IVAI------ 55

Query: 210 KKIK-------------REIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFK 256
           KK               REIK+L+ LR   N++ L  V K        L+FE V+     
Sbjct: 56  KKFLESDDDKMVKKIAMREIKLLKQLRH-ENLVNLLEVCKKKKRWY--LVFEFVD-HTIL 111

Query: 257 QLYQT----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL 312
              +     L    ++ YL++++  + +CHS  I+HRD+KP N+++      ++L D+G 
Sbjct: 112 DDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV-VKLCDFGF 170

Query: 313 A-EFYHPGQEYNVRVASRYFKGPE-LLADYQYHIELD---------------PRFA---- 351
           A     PG+ Y+  VA+R+++ PE L+ D +Y   +D               P F     
Sbjct: 171 ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230

Query: 352 --------DILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN 403
                     LG    +  E F   +N          F    +     R+  ER      
Sbjct: 231 IDQLYHIMMCLGNLIPRHQELF--NKNP--------VFAGVRLPEIKEREPLERRYPK-- 278

Query: 404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
              +S   +D   K L  D  +R    E + H +F
Sbjct: 279 ---LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  111 bits (281), Expect = 1e-27
 Identities = 41/110 (37%), Positives = 65/110 (59%), Gaps = 3/110 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            + +CHS  I+HRD+KP N+++      ++L D+G A     PG+ Y+  VA+R+++ PE
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGV-VKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           LL     Y  ++D+W++GC++  M F  EP F G  + DQL  I   LG 
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHIMMCLGN 243

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  137 bits (347), Expect = 1e-36
 Identities = 76/321 (23%), Positives = 146/321 (45%), Gaps = 45/321 (14%)

Query: 150 NSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL----- 204
           +S +   ++  E     W   + YQ +  +G G Y  V  A + ++  +  VK L     
Sbjct: 8   HSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 67

Query: 205 KPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA----LIFEHVNNTDFKQL-- 258
             +  K+  RE+++L++++   N+I L  V     S        L+   +   D   +  
Sbjct: 68  SIIHAKRTYRELRLLKHMKH-ENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK 125

Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
            Q LTD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA     
Sbjct: 126 CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTAD 184

Query: 319 GQ-EYNVRVASRYFKGPE-LLADYQYHIELDP-----RFADIL-------GRHSRKRWER 364
               Y   VA+R+++ PE +L    Y+  +D        A++L       G     + + 
Sbjct: 185 EMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241

Query: 365 FVHT-------ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDK 417
            +           + + S  A +++    L +  +  +            +P A+D L+K
Sbjct: 242 ILRLVGTPGAELLKKISSESARNYIQS--LTQMPKMNFANVFIG-----ANPLAVDLLEK 294

Query: 418 LLRYDHYERLTAREAMDHPYF 438
           +L  D  +R+TA +A+ H YF
Sbjct: 295 MLVLDSDKRITAAQALAHAYF 315

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  105 bits (264), Expect = 3e-25
 Identities = 39/110 (35%), Positives = 72/110 (65%), Gaps = 6/110 (5%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
            L Y HS  I+HRD+KP N+ ++ E+ +L+++D+GLA         Y   VA+R+++ PE
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTADEMTGY---VATRWYRAPE 199

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           ++ ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFPGTDHIDQLKLILRLVGT 248

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  136 bits (345), Expect = 2e-36
 Identities = 79/317 (24%), Positives = 149/317 (47%), Gaps = 44/317 (13%)

Query: 153 KPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVK-ILKPVKK-- 209
           + + ++  +     W     Y     +G G Y  V  AI+ +S +K  +K + +P +   
Sbjct: 6   RKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI 65

Query: 210 --KKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA----LIFEHVNNTDFKQ-LYQTL 262
             K+  RE+ +L++++   N+I L  V     S        L+   +  TD ++ +    
Sbjct: 66  FAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLKF 123

Query: 263 TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-E 321
           ++  I+Y +Y++LK L Y HS G++HRD+KP N+ ++ E+ +L+++D+GLA         
Sbjct: 124 SEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTG 182

Query: 322 YNVRVASRYFKGPE-LLADYQYHIELDP-----RFADIL-------GRHSRKRWERFVHT 368
           Y   V +R+++ PE +L+   Y+  +D        A++L       G+    +  + +  
Sbjct: 183 Y---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239

Query: 369 -------ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRY 421
                    Q L    A  ++    L +  RK + +          SP+A D L+K+L  
Sbjct: 240 TGVPGTEFVQKLNDKAAKSYIQS--LPQTPRKDFTQLFPR-----ASPQAADLLEKMLEL 292

Query: 422 DHYERLTAREAMDHPYF 438
           D  +RLTA +A+ HP+F
Sbjct: 293 DVDKRLTAAQALTHPFF 309

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  106 bits (268), Expect = 7e-26
 Identities = 41/110 (37%), Positives = 69/110 (62%), Gaps = 6/110 (5%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
            L Y HS G++HRD+KP N+ ++ E+ +L+++D+GLA         Y   V +R+++ PE
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGY---VVTRWYRAPE 193

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           ++  +  Y+ ++D+WS+GC++A M+  K   F G D  DQL +I KV G 
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK-TLFKGKDYLDQLTQILKVTGV 242

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  135 bits (341), Expect = 3e-36
 Identities = 64/321 (19%), Positives = 116/321 (36%), Gaps = 82/321 (25%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK----------------R 214
             Y+ V ++G G Y  V++A +  S     V +      K ++                R
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGH--FVAL------KSVRVPNGGGGGGGLPISTVR 60

Query: 215 EIKILENLRGGT--NIITLQAVVKDPVSRTPA---LIFEHVNNTDFKQL-----YQTLTD 264
           E+ +L  L      N++ L  V     +       L+FEHV+  D +          L  
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPA 119

Query: 265 YDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV 324
             I+  + + L+ LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y        
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT-VKLADFGLARIYSYQMALTP 178

Query: 325 RVASRYFKGPELLADYQYHIELD---------------PRFA------------DILGRH 357
            V + +++ PE+L    Y   +D               P F             D++G  
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238

Query: 358 SRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDK 417
               W R V               L +        +  +  V       +       L +
Sbjct: 239 PEDDWPRDVS--------------LPRGAFPPRGPRPVQSVVPE-----MEESGAQLLLE 279

Query: 418 LLRYDHYERLTAREAMDHPYF 438
           +L ++ ++R++A  A+ H Y 
Sbjct: 280 MLTFNPHKRISAFRALQHSYL 300

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  104 bits (263), Expect = 2e-25
 Identities = 39/109 (35%), Positives = 63/109 (57%), Gaps = 3/109 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSGGT-VKLADFGLARIYSYQMALTPVVVTLWYRAPEV 190

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           L     Y   +DMWS+GC+ A M FR++P F G+   DQL +I  ++G 
Sbjct: 191 LLQST-YATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIGL 237

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  136 bits (344), Expect = 3e-36
 Identities = 80/315 (25%), Positives = 145/315 (46%), Gaps = 51/315 (16%)

Query: 165 VDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK----KKIKREIKILE 220
           + +    D+QL   LG G Y  V  A +  + +   +K ++P  K     +  REIKIL+
Sbjct: 5   IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK 64

Query: 221 NLRGGTNIITLQAVVKDPVSRTPA---LIFEHVNNTDFKQL--YQTLTDYDIRYYLYELL 275
           + +   NIIT+  + +           +I E +  TD  ++   Q L+D  I+Y++Y+ L
Sbjct: 65  HFKH-ENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTL 122

Query: 276 KALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---------- 325
           +A+   H   ++HRD+KP N++I+  N  L++ D+GLA         N            
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 326 -VASRYFKGPE-LLADYQYHIELDP-----RFADIL-------GRHSRKRWERFVHT--- 368
            VA+R+++ PE +L   +Y   +D        A++        GR  R +          
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 369 -----ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDH 423
                + + + SP A +++    L  +     E+         V+P+ +D L ++L +D 
Sbjct: 242 PHSDNDLRCIESPRAREYIKS--LPMYPAAPLEKMFPR-----VNPKGIDLLQRMLVFDP 294

Query: 424 YERLTAREAMDHPYF 438
            +R+TA+EA++HPY 
Sbjct: 295 AKRITAKEALEHPYL 309

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  103 bits (260), Expect = 9e-25
 Identities = 39/120 (32%), Positives = 64/120 (53%), Gaps = 13/120 (10%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----------- 58
           A+   H   ++HRD+KP N++I+  N  L++ D+GLA         N             
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           VA+R+++ PE++     Y  ++D+WS GC+LA +  R+ P F G D   QL+ I  ++GT
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIGT 241

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  134 bits (340), Expect = 5e-36
 Identities = 72/338 (21%), Positives = 138/338 (40%), Gaps = 81/338 (23%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK------------REIKI 218
             ++ + KLG G Y+ V++ +N  +     V +      K++K            REI +
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGV--YVAL------KEVKLDSEEGTPSTAIREISL 56

Query: 219 LENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL---------YQTLTDYDIRY 269
           ++ L+   NI+ L  V+      T  L+FE ++  D K+           + L    ++Y
Sbjct: 57  MKELKH-ENIVRLYDVIHTENKLT--LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKY 112

Query: 270 YLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVAS 328
           + ++LL+ L +CH   I+HRD+KP N++I+   + L+L D+GLA  +  P   ++  V +
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVNTFSSEVVT 171

Query: 329 RYFKGPE-LLADYQYHIELD---------------PRFA------------DILGRHSRK 360
            +++ P+ L+    Y   +D               P F             DI+G  +  
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231

Query: 361 RWERFVHTENQHLVSPEALDFLD-KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLL 419
            W             P           + +   +   + +    +  +    +DFL  LL
Sbjct: 232 LW-------------PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLL 278

Query: 420 RYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTP 457
           + +   RL+A++A+ HP+F     +   H     S + 
Sbjct: 279 QLNPDMRLSAKQALHHPWF----AEYYHHASMGGSRSH 312

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  107 bits (270), Expect = 2e-26
 Identities = 40/110 (36%), Positives = 68/110 (61%), Gaps = 3/110 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE 68
            L +CH   I+HRD+KP N++I+   + L+L D+GLA  +  P   ++  V + +++ P+
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +L   + Y  S+D+WS GC+LA MI   +P F G ++ +QL  I  ++GT
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMI-TGKPLFPGTNDEEQLKLIFDIMGT 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  135 bits (342), Expect = 6e-36
 Identities = 77/300 (25%), Positives = 147/300 (49%), Gaps = 45/300 (15%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVK-ILKPVKK----KKIKREIKILENLRGG 225
             Y+ ++ +G G Y  V  A++ ++  K  +K + +P +     K+  RE+++L+++R  
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH- 83

Query: 226 TNIITLQAVVKDPVSRTPA----LIFEHVNNTDFKQL--YQTLTDYDIRYYLYELLKALD 279
            N+I L  V     +        L+   +  TD  +L  ++ L +  I++ +Y++LK L 
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQFLVYQMLKGLR 142

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE-LL 337
           Y H+ GI+HRD+KP N+ ++ E+ +L+++D+GLA         Y   V +R+++ PE +L
Sbjct: 143 YIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQADSEMTGY---VVTRWYRAPEVIL 198

Query: 338 ADYQYHIELDP-----RFADIL-------GRHSRKRWERFVHT-------ENQHLVSPEA 378
              +Y   +D        A+++       G     + +  +           Q L S EA
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258

Query: 379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +++    L    +K +   +        SP A++ L+K+L  D  +R+TA EA+ HPYF
Sbjct: 259 KNYMKG--LPELEKKDFASILTN-----ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  106 bits (267), Expect = 1e-25
 Identities = 43/110 (39%), Positives = 70/110 (63%), Gaps = 6/110 (5%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPE 68
            L Y H+ GI+HRD+KP N+ ++ E+ +L+++D+GLA         Y   V +R+++ PE
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQADSEMTGY---VVTRWYRAPE 195

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           ++ ++  Y  ++D+WS+GC++A MI  K   F G D+ DQL  I KV GT
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGK-TLFKGSDHLDQLKEIMKVTGT 244

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  133 bits (338), Expect = 1e-35
 Identities = 75/296 (25%), Positives = 127/296 (42%), Gaps = 61/296 (20%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK---------PVKKKKIKREIKILE 220
           +D Y +  +LG G+++ V +     +  +   K +K          V +++I+RE+ IL 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 221 NLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKA 277
            +    N+ITL  V ++       LI E V+  + F  L Q  +L++ +   ++ ++L  
Sbjct: 71  QVLH-HNVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 278 LDYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 334
           ++Y H+  I H D+KP N+M+   +     ++LID+GLA     G E+     +  F  P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 335 ELLADYQYHIELDPRFAD---------IL--GRHSRKRWERFVHTENQHLVSPEALDFLD 383
           E++      +E     AD         IL  G                   SP    FL 
Sbjct: 188 EIVNYEPLGLE-----ADMWSIGVITYILLSG------------------ASP----FLG 220

Query: 384 KN---ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                 L   +   ++ F      H  S  A DF+ KLL  +  +RLT +EA+ HP
Sbjct: 221 DTKQETLANITSVSYD-FDEEFFSH-TSELAKDFIRKLLVKETRKRLTIQEALRHP 274

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 90.0 bits (224), Expect = 3e-20
 Identities = 26/83 (31%), Positives = 43/83 (51%), Gaps = 4/83 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 66
            ++Y H+  I H D+KP N+M+   +     ++LID+GLA     G E+     +  F  
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186

Query: 67  PELLADYQMYDYSLDMWSLGCML 89
           PE++  Y+      DMWS+G + 
Sbjct: 187 PEIVN-YEPLGLEADMWSIGVIT 208

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  135 bits (341), Expect = 2e-35
 Identities = 60/294 (20%), Positives = 113/294 (38%), Gaps = 59/294 (20%)

Query: 171 DDYQLV-RKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNII 229
           DDY++  + LG G   +V +  N ++ +K  +K+L+     K +RE+++        +I+
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 118

Query: 230 TLQAVVKDPVSRTPA--LIFEHVNNTD-----FKQLYQTLTDYDIRYYLYELLKALDYCH 282
            +  V ++  +      ++ E ++  +       +  Q  T+ +    +  + +A+ Y H
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178

Query: 283 SMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           S+ I HRDVKP N++      N  L+L D+G A+             + Y+  PE+L   
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 238

Query: 341 QYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
           +Y    D               P F                ++ +   +SP         
Sbjct: 239 KYDKSCDMWSLGVIMYILLCGYPPF----------------YSNHGLAISPGMK----TR 278

Query: 386 ILGRH---SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
           I           W           VS E    +  LL+ +  +R+T  E M+HP
Sbjct: 279 IRMGQYEFPNPEWSE---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 34/101 (33%), Positives = 50/101 (49%), Gaps = 3/101 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y HS+ I HRDVKP N++      N  L+L D+G A+             + Y+  P
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
           E+L   + YD S DMWSLG ++  ++    PF+  H     
Sbjct: 233 EVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 272

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  133 bits (337), Expect = 2e-35
 Identities = 65/295 (22%), Positives = 111/295 (37%), Gaps = 60/295 (20%)

Query: 170 QDDYQLVRK-LGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNI 228
            DDYQL ++ LG G   +V E  + ++  KC +K+L      K ++E+       GG +I
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHI 84

Query: 229 ITLQAVVKDPVSRTPA--LIFEHVNNTD-----FKQLYQTLTDYDIRYYLYELLKALDYC 281
           + +  V ++         +I E +   +      ++  Q  T+ +    + ++  A+ + 
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144

Query: 282 HSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           HS  I HRDVKP N++     ++  L+L D+G A+             + Y+  PE+L  
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGP 203

Query: 340 YQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK 384
            +Y    D               P F                       +SP       +
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYS----------------NTGQAISPGMK----R 243

Query: 385 NILGRH---SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
            I           W           VS +A   +  LL+ D  ERLT  + M+HP
Sbjct: 244 RIRLGQYGFPNPEWSE---------VSEDAKQLIRLLLKTDPTERLTITQFMNHP 289

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 31/109 (28%), Positives = 51/109 (46%), Gaps = 4/109 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ + HS  I HRDVKP N++     ++  L+L D+G A+             + Y+  P
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAP 198

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 116
           E+L   + YD S DMWSLG ++  ++    PF+             ++ 
Sbjct: 199 EVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  134 bits (339), Expect = 2e-35
 Identities = 69/289 (23%), Positives = 119/289 (41%), Gaps = 54/289 (18%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL---KPVKKKKIKREIKILENLRGGT 226
            D Y ++ +LG G +  V   +   +    V K +    P+ K  +K EI I+  L    
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-P 108

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ---TLTDYDIRYYLYELLKALDYCH 282
            +I L    +D       LI E ++  + F ++      +++ ++  Y+ +  + L + H
Sbjct: 109 KLINLHDAFEDKYEMV--LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166

Query: 283 SMGIMHRDVKPHNVMI-DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
              I+H D+KP N+M    +   +++ID+GLA   +P +   V  A+  F  PE++    
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 226

Query: 342 YHIELDPRFAD---------IL--GRHSRKRWERFVHTENQHLVSPEALDFLDKN---IL 387
                     D         +L  G                  +SP    F  ++    L
Sbjct: 227 VGFY-----TDMWAIGVLGYVLLSG------------------LSP----FAGEDDLETL 259

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
               R  WE F        VSPEA DF+  LL+ +  +RLT  +A++HP
Sbjct: 260 QNVKRCDWE-FDEDAFSS-VSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 90.5 bits (225), Expect = 5e-20
 Identities = 25/81 (30%), Positives = 44/81 (54%), Gaps = 2/81 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMI-DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
            L + H   I+H D+KP N+M    +   +++ID+GLA   +P +   V  A+  F  PE
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE 220

Query: 69  LLADYQMYDYSLDMWSLGCML 89
           ++ D +   +  DMW++G + 
Sbjct: 221 IV-DREPVGFYTDMWAIGVLG 240

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  133 bits (337), Expect = 3e-35
 Identities = 74/301 (24%), Positives = 140/301 (46%), Gaps = 43/301 (14%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK----KKIKREIKILENLRGGT 226
             Y  +  +G G Y  V  A +  +  +  +K + P +     ++  REIKIL   R   
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-E 85

Query: 227 NIITLQAVVKDPVSRTPA---LIFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYC 281
           NII +  +++ P         ++ + +  TD  +L   Q L++  I Y+LY++L+ L Y 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----VASRYFKGPE-L 336
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE +
Sbjct: 145 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203

Query: 337 LADYQYHIELDP-----RFADIL-------GRHSRKRWERFVHT-------ENQHLVSPE 377
           L    Y   +D        A++L       G+H   +    +         +   +++ +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263

Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
           A ++L    L   ++  W R            +ALD LDK+L ++ ++R+   +A+ HPY
Sbjct: 264 ARNYLLS--LPHKNKVPWNRLFPN-----ADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

Query: 438 F 438
            
Sbjct: 317 L 317

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  104 bits (262), Expect = 5e-25
 Identities = 41/122 (33%), Positives = 71/122 (58%), Gaps = 8/122 (6%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----VASRYFK 65
            L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198

Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EELFE 123
            PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG+  +E   
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLN 257

Query: 124 YL 125
            +
Sbjct: 258 CI 259

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  133 bits (336), Expect = 4e-35
 Identities = 68/326 (20%), Positives = 128/326 (39%), Gaps = 49/326 (15%)

Query: 153 KPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK--- 209
              E    +        Q  Y + R +  G Y  V   ++ +     + ++   V     
Sbjct: 4   AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRT 63

Query: 210 ----------KKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA---LIFEHVNNTDFK 256
                     K++ REI++L +     NI+ L+ +             L+ E +  TD  
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHFHH-PNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLA 121

Query: 257 QLYQT----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL 312
           Q+       ++   I+Y++Y +L  L   H  G++HRD+ P N+++  +N  + + D+ L
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA-DNNDITICDFNL 180

Query: 313 AEFYHPGQEYNVRVASRYFKGPELLADYQ-YHIELDP-----RFADIL-------GRHSR 359
           A            V  R+++ PEL+  ++ +   +D        A++        G    
Sbjct: 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240

Query: 360 KRWERFVHT-------ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEAL 412
            +  + V         +     SP A D+L +N L     + W   V T       P AL
Sbjct: 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYL-RNSLSNVPARAWTAVVPT-----ADPVAL 294

Query: 413 DFLDKLLRYDHYERLTAREAMDHPYF 438
           D + K+L ++   R++  +A+ HPYF
Sbjct: 295 DLIAKMLEFNPQRRISTEQALRHPYF 320

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  107 bits (269), Expect = 7e-26
 Identities = 36/109 (33%), Positives = 60/109 (55%), Gaps = 2/109 (1%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L   H  G++HRD+ P N+++  +N  + + D+ LA            V  R+++ PEL
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHYVTHRWYRAPEL 204

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +  ++ +   +DMWS GC++A M  RK   F G   Y+QL +I +V+GT
Sbjct: 205 VMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFRGSTFYNQLNKIVEVVGT 252

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  135 bits (342), Expect = 4e-35
 Identities = 60/294 (20%), Positives = 124/294 (42%), Gaps = 59/294 (20%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI-----LKPVKKKKIKREIKILENLRG 224
            + YQ V+KLG G Y EV    +  +  +  +KI     +      K+  E+ +L+ L  
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-D 94

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKALDYC 281
             NI+ L    +D  +    L+ E     + F ++       + D    + ++L  + Y 
Sbjct: 95  HPNIMKLYDFFEDKRNY--YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152

Query: 282 HSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           H   I+HRD+KP N++++   ++  ++++D+GL+  +   ++   R+ + Y+  PE+L  
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-R 211

Query: 340 YQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK 384
            +Y  + D               P F    G+  ++   +    +           F   
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPPFG---GQTDQEILRKVEKGK---------YTF--- 256

Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                     W+          VS  A D + ++L++D   R++A++A++HP+ 
Sbjct: 257 ------DSPEWKN---------VSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 95.9 bits (239), Expect = 2e-21
 Identities = 27/98 (27%), Positives = 55/98 (56%), Gaps = 4/98 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
            + Y H   I+HRD+KP N++++   ++  ++++D+GL+  +   ++   R+ + Y+  P
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAP 207

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 105
           E+L   + YD   D+WS+G +L  ++    PF    D 
Sbjct: 208 EVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ 243

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  135 bits (341), Expect = 6e-35
 Identities = 67/313 (21%), Positives = 129/313 (41%), Gaps = 60/313 (19%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK------PVKKKKIKREIKILENLR 223
            D Y+  R LG+G + EV    +  +  +C VK++          K+ + RE+++L+ L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL- 83

Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKALDY 280
              NI+ L    +D       L+ E     + F ++      ++ D    + ++L  + Y
Sbjct: 84  DHPNIMKLYEFFEDKGYF--YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141

Query: 281 CHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA 338
            H   I+HRD+KP N++++   ++  +R+ID+GL+  +   ++   ++ + Y+  PE+L 
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 200

Query: 339 DYQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLD 383
              Y  + D               P F      +    ++     E           F  
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPF------NGANEYDILKKVEKGK------YTF-- 246

Query: 384 KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
                     +W++         VS  A D + K+L Y    R++AR+A+DH +     K
Sbjct: 247 -------ELPQWKK---------VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290

Query: 444 DQSRHTLPSSSPT 456
           +Q    +PS    
Sbjct: 291 EQISVDVPSLDNA 303

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 92.8 bits (231), Expect = 2e-20
 Identities = 27/93 (29%), Positives = 52/93 (55%), Gaps = 4/93 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
            + Y H   I+HRD+KP N++++   ++  +R+ID+GL+  +   ++   ++ + Y+  P
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           E+L     YD   D+WS G +L  ++    PF 
Sbjct: 198 EVLH--GTYDEKCDVWSTGVILYILLSGCPPFN 228

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  130 bits (329), Expect = 2e-34
 Identities = 76/331 (22%), Positives = 143/331 (43%), Gaps = 76/331 (22%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK------------REIKI 218
           + Y  + KLG G Y+ V++  +  +           V  K+I+            RE+ +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTD--------NLVALKEIRLEHEEGAPCTAIREVSL 53

Query: 219 LENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYEL 274
           L++L+   NI+TL  ++    S T  L+FE+++  D KQ        +  ++++ +L++L
Sbjct: 54  LKDLKH-ANIVTLHDIIHTEKSLT--LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQL 109

Query: 275 LKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKG 333
           L+ L YCH   ++HRD+KP N++I+     L+L D+GLA     P + Y+  V + +++ 
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGE-LKLADFGLARAKSIPTKTYDNEVVTLWYRP 168

Query: 334 PE-LLADYQYHIELD---------------PRFA------------DILGRHSRKRWERF 365
           P+ LL    Y  ++D               P F              ILG  + + W   
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228

Query: 366 VHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYE 425
           +  E     +             ++  +             +  +  D L KLL+++   
Sbjct: 229 LSNEEFKTYNYP-----------KYRAEALLSHAPR-----LDSDGADLLTKLLQFEGRN 272

Query: 426 RLTAREAMDHPYFYPIVKDQSRHTLPSSSPT 456
           R++A +AM HP+F  +   +  H LP ++  
Sbjct: 273 RISAEDAMKHPFFLSL--GERIHKLPDTTSI 301

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  108 bits (271), Expect = 2e-26
 Identities = 38/110 (34%), Positives = 61/110 (55%), Gaps = 3/110 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE 68
            L YCH   ++HRD+KP N++I+     L+L D+GLA     P + Y+  V + +++ P+
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGE-LKLADFGLARAKSIPTKTYDNEVVTLWYRPPD 170

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +L     Y   +DMW +GC+   M   + P F G    +QL  I ++LGT
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGT 219

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  129 bits (326), Expect = 2e-34
 Identities = 77/315 (24%), Positives = 132/315 (41%), Gaps = 79/315 (25%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK-------------REIK 217
           + Y  + K+G G Y  V++A N            +    KKI+             REI 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN---------NYGETFALKKIRLEKEDEGIPSTTIREIS 52

Query: 218 ILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYE 273
           IL+ L+  +NI+ L  V+         L+FEH++  D K+L       L     + +L +
Sbjct: 53  ILKELKH-SNIVKLYDVIHTKKRLV--LVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 274 LLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFK 332
           LL  + YCH   ++HRD+KP N++I+ E   L++ D+GLA  +  P ++Y   + + +++
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYR 167

Query: 333 GPE-LLADYQYHIELD---------------PRFA------------DILGRHSRKRWER 364
            P+ L+   +Y   +D               P F              ILG  + K W  
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW-- 225

Query: 365 FVHTENQHLVSPEALDFLD-KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDH 423
                      P   +          +    WE F+       +    +D L K+L+ D 
Sbjct: 226 -----------PNVTELPKYDPNFTVYEPLPWESFLKG-----LDESGIDLLSKMLKLDP 269

Query: 424 YERLTAREAMDHPYF 438
            +R+TA++A++H YF
Sbjct: 270 NQRITAKQALEHAYF 284

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  110 bits (277), Expect = 2e-27
 Identities = 39/110 (35%), Positives = 69/110 (62%), Gaps = 3/110 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE 68
            + YCH   ++HRD+KP N++I+ E   L++ D+GLA  +  P ++Y   + + +++ P+
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +L   + Y  ++D+WS+GC+ A M+    P F G    DQL+RI ++LGT
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGT 219

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  130 bits (328), Expect = 3e-34
 Identities = 77/316 (24%), Positives = 132/316 (41%), Gaps = 61/316 (19%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK---------PVKKKKIKREIKILE 220
            D Y    +LG G+++ V +     +  +   K +K          V ++ I+RE+ IL+
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 221 NLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKA 277
            ++   N+ITL  V ++       LI E V   + F  L +  +LT+ +   +L ++L  
Sbjct: 70  EIQH-PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126

Query: 278 LDYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 334
           + Y HS+ I H D+KP N+M+   +    ++++ID+GLA     G E+     +  F  P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186

Query: 335 ELLADYQYHIELDPRFAD---------IL--GRHSRKRWERFVHTENQHLVSPEALDFLD 383
           E++      +E     AD         IL  G                   SP    FL 
Sbjct: 187 EIVNYEPLGLE-----ADMWSIGVITYILLSG------------------ASP----FLG 219

Query: 384 KN---ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP 440
                 L   S   +E F      +  S  A DF+ +LL  D  +R+T ++++ HP+  P
Sbjct: 220 DTKQETLANVSAVNYE-FEDEYFSN-TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

Query: 441 IVKDQSRHTLPSSSPT 456
               Q+     S+   
Sbjct: 278 KDTQQALSRKASAVNM 293

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 26/83 (31%), Positives = 44/83 (53%), Gaps = 4/83 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 66
            + Y HS+ I H D+KP N+M+   +    ++++ID+GLA     G E+     +  F  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185

Query: 67  PELLADYQMYDYSLDMWSLGCML 89
           PE++  Y+      DMWS+G + 
Sbjct: 186 PEIVN-YEPLGLEADMWSIGVIT 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  130 bits (330), Expect = 3e-34
 Identities = 75/296 (25%), Positives = 126/296 (42%), Gaps = 61/296 (20%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK---------PVKKKKIKREIKILE 220
           +D Y +  +LG G+++ V +     +  +   K +K          V +++I+RE+ IL 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 221 NLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKA 277
            +    NIITL  V ++       LI E V+  + F  L Q  +L++ +   ++ ++L  
Sbjct: 71  QVLH-PNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 278 LDYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 334
           ++Y H+  I H D+KP N+M+   +     ++LID+GLA     G E+     +  F  P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 335 ELLADYQYHIELDPRFAD---------IL--GRHSRKRWERFVHTENQHLVSPEALDFLD 383
           E++      +E     AD         IL  G                   SP    FL 
Sbjct: 188 EIVNYEPLGLE-----ADMWSIGVITYILLSG------------------ASP----FLG 220

Query: 384 KN---ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                 L   +   ++ F         S  A DF+ KLL  +  +RLT +EA+ HP
Sbjct: 221 DTKQETLANITAVSYD-FDEEFFSQ-TSELAKDFIRKLLVKETRKRLTIQEALRHP 274

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 26/83 (31%), Positives = 43/83 (51%), Gaps = 4/83 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 66
            ++Y H+  I H D+KP N+M+   +     ++LID+GLA     G E+     +  F  
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186

Query: 67  PELLADYQMYDYSLDMWSLGCML 89
           PE++  Y+      DMWS+G + 
Sbjct: 187 PEIVN-YEPLGLEADMWSIGVIT 208

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  129 bits (327), Expect = 3e-34
 Identities = 64/293 (21%), Positives = 118/293 (40%), Gaps = 53/293 (18%)

Query: 170 QDDYQL---VRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGT 226
              Y L    + LG G +S   + ++ +S+    VKI+    +   ++EI  L+   G  
Sbjct: 7   YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHP 66

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKALDYCHS 283
           NI+ L  V  D +     L+ E +N  + F+++ +    ++ +  Y + +L+ A+ + H 
Sbjct: 67  NIVKLHEVFHDQLHTF--LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124

Query: 284 MGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADY 340
           +G++HRD+KP N++     +N ++++ID+G A    P  Q       + ++  PELL   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184

Query: 341 QYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
            Y    D                 F                   ++ L    A++ + K 
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQS----------------HDRSLTCTSAVEIMKKI 228

Query: 386 ILGRHS--RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
             G  S   + W+          VS EA D +  LL  D  +RL       + 
Sbjct: 229 KKGDFSFEGEAWKN---------VSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 32/99 (32%), Positives = 56/99 (56%), Gaps = 4/99 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKG 66
           A+ + H +G++HRD+KP N++     +N ++++ID+G A    P  Q       + ++  
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 105
           PELL +   YD S D+WSLG +L +M+  + PF     +
Sbjct: 178 PELL-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRS 215

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  130 bits (329), Expect = 4e-34
 Identities = 64/294 (21%), Positives = 126/294 (42%), Gaps = 62/294 (21%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI-----LKPVKKKKIKREIKILENLRG 224
            D+Y +  +LG+G +S V   ++  +  +   KI     L     +K++RE +I   L+ 
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKALDYC 281
             NI+ L   +++       L+F+ V   + F+ +      ++ D  + + ++L+++ YC
Sbjct: 88  -PNIVRLHDSIQEESFHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144

Query: 282 HSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           HS GI+HR++KP N+++    +   ++L D+GLA   +  + ++    +  +  PE+L  
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 204

Query: 340 YQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK 384
             Y   +D               P F D                E+QH           +
Sbjct: 205 DPYSKPVDIWACGVILYILLVGYPPFWD----------------EDQH-------RLYAQ 241

Query: 385 NILGRHS--RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
              G +      W+          V+PEA   +D +L  +  +R+TA +A+  P
Sbjct: 242 IKAGAYDYPSPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALKVP 286

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 24/82 (29%), Positives = 47/82 (57%), Gaps = 3/82 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           ++ YCHS GI+HR++KP N+++    +   ++L D+GLA   +  + ++    +  +  P
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199

Query: 68  ELLADYQMYDYSLDMWSLGCML 89
           E+L     Y   +D+W+ G +L
Sbjct: 200 EVLK-KDPYSKPVDIWACGVIL 220

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  129 bits (326), Expect = 4e-34
 Identities = 60/313 (19%), Positives = 111/313 (35%), Gaps = 59/313 (18%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI-----LKPVKKKKIKREIKILENLRGG- 225
            Y +++++G G  S+VF+ +N +      +K               + EI  L  L+   
Sbjct: 29  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL--YQTLTDYDIRYYLYELLKALDYCHS 283
             II L         +   ++ E  N      L   +++  ++ + Y   +L+A+   H 
Sbjct: 88  DKIIRLYDYEITD--QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKGPELLADY 340
            GI+H D+KP N +I   +  L+LID+G+A    P     V+   V +  +  PE + D 
Sbjct: 146 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 341 QYHIELDPRF------ADILGRHSRKRWER-------------FVHTENQHLVSPEALDF 381
               E           +D+        W               F    NQ       +  
Sbjct: 204 SSSRENGKSKSKISPKSDV--------WSLGCILYYMTYGKTPFQQIINQ-------ISK 248

Query: 382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
           L   I   H  +  +         +   +  D L   L+ D  +R++  E + HPY    
Sbjct: 249 LHAIIDPNHEIEFPD---------IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299

Query: 442 VKDQSRHTLPSSS 454
               ++    ++ 
Sbjct: 300 THPVNQMAKGTTE 312

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 34/118 (28%), Positives = 51/118 (43%), Gaps = 15/118 (12%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKG 66
           A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+   V +  +  
Sbjct: 139 AVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

Query: 67  PELL----------ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           PE +                    D+WSLGC+L  M + K PF    +   +L  I  
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  132 bits (334), Expect = 5e-34
 Identities = 58/294 (19%), Positives = 123/294 (41%), Gaps = 59/294 (20%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI-----LKPVKKKKIKREIKILENLRG 224
            + Y +V  LG+G + EV +  +  +  +  VK+      K      I RE+++L+ L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKALDYC 281
             NI+ L  +++D  S    ++ E     + F ++ +    +++D    + ++   + Y 
Sbjct: 80  HPNIMKLFEILEDSSSFY--IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137

Query: 282 HSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           H   I+HRD+KP N++++   ++  +++ID+GL+  +    +   R+ + Y+  PE+L  
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-R 196

Query: 340 YQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK 384
             Y  + D               P F      + +  ++     E           F   
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPF------YGKNEYDILKRVETGK------YAF--- 241

Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                    +W           +S +A D + K+L +    R+TA + ++HP+ 
Sbjct: 242 ------DLPQWRT---------ISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 90.9 bits (226), Expect = 7e-20
 Identities = 25/82 (30%), Positives = 47/82 (57%), Gaps = 4/82 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
            + Y H   I+HRD+KP N++++   ++  +++ID+GL+  +    +   R+ + Y+  P
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 68  ELLADYQMYDYSLDMWSLGCML 89
           E+L     YD   D+WS G +L
Sbjct: 193 EVLR--GTYDEKCDVWSAGVIL 212

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  129 bits (327), Expect = 6e-34
 Identities = 76/342 (22%), Positives = 131/342 (38%), Gaps = 81/342 (23%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK-------------REIK 217
             Y+ + K+G+G + EVF+A + ++         + V  KK+              REIK
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTG--------QKVALKKVLMENEKEGFPITALREIK 68

Query: 218 ILENLRGGTNIITLQAVVKDPVSRTPA------LIFEHVNNTDFKQL----YQTLTDYDI 267
           IL+ L+   N++ L  + +   S          L+F+     D   L        T  +I
Sbjct: 69  ILQLLKH-ENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEI 126

Query: 268 RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-----PGQEY 322
           +  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +          Y
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRY 185

Query: 323 NVRVASRYFKGPE-LLADYQYHIELD---------------PRFA------------DIL 354
             RV + +++ PE LL +  Y   +D               P                + 
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245

Query: 355 GRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDF 414
           G  + + W    + E    +                 +KR  +       ++  P ALD 
Sbjct: 246 GSITPEVWPNVDNYELYEKLEL------------VKGQKR--KVKDRLKAYVRDPYALDL 291

Query: 415 LDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPT 456
           +DKLL  D  +R+ + +A++H +F+          + S+  T
Sbjct: 292 IDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLT 333

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  105 bits (265), Expect = 2e-25
 Identities = 37/114 (32%), Positives = 60/114 (52%), Gaps = 7/114 (6%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-----PGQEYNVRVASRYF 64
            L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +          Y  RV + ++
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194

Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + PELL   + Y   +D+W  GC++A M + + P   G+    QL  I+++ G+
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQLCGS 247

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  129 bits (326), Expect = 6e-34
 Identities = 77/319 (24%), Positives = 138/319 (43%), Gaps = 77/319 (24%)

Query: 169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK-------------RE 215
             D Y+ + KLG G Y EV++AI+  +++   V I      K+I+             RE
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNE--TVAI------KRIRLEHEEEGVPGTAIRE 83

Query: 216 IKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLY 272
           + +L+ L+   NII L++V+         LIFE+    D K+       ++   I+ +LY
Sbjct: 84  VSLLKELQH-RNIIELKSVIHHNHRLH--LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLY 139

Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHENRK----LRLIDWGLAEFYH-PGQEYNVRVA 327
           +L+  +++CHS   +HRD+KP N+++   +      L++ D+GLA  +  P +++   + 
Sbjct: 140 QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199

Query: 328 SRYFKGPE-LLADYQYHIELD---------------PRFA------------DILGRHSR 359
           + +++ PE LL    Y   +D               P F             ++LG    
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259

Query: 360 KRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLL 419
             W       +     P            +   K  +R +      L+  E LD L  +L
Sbjct: 260 TTWPGVTALPDWKQSFP------------KFRGKTLKRVLGA----LLDDEGLDLLTAML 303

Query: 420 RYDHYERLTAREAMDHPYF 438
             D  +R++A+ A++HPYF
Sbjct: 304 EMDPVKRISAKNALEHPYF 322

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  107 bits (269), Expect = 4e-26
 Identities = 37/114 (32%), Positives = 67/114 (58%), Gaps = 6/114 (5%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRK----LRLIDWGLAEFYH-PGQEYNVRVASRYF 64
            +++CHS   +HRD+KP N+++   +      L++ D+GLA  +  P +++   + + ++
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203

Query: 65  KGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + PE+L   + Y  S+D+WS+ C+ A M+  K P F G    DQL +I +VLG 
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEML-MKTPLFPGDSEIDQLFKIFEVLGL 256

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  127 bits (322), Expect = 7e-34
 Identities = 64/294 (21%), Positives = 126/294 (42%), Gaps = 62/294 (21%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI-----LKPVKKKKIKREIKILENLRG 224
            D+Y +  +LG+G +S V   ++  +  +   KI     L     +K++RE +I   L+ 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKALDYC 281
             NI+ L   +++       L+F+ V   + F+ +      ++ D  + + ++L+++ YC
Sbjct: 65  -PNIVRLHDSIQEESFHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121

Query: 282 HSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           HS GI+HR++KP N+++    +   ++L D+GLA   +  + ++    +  +  PE+L  
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181

Query: 340 YQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK 384
             Y   +D               P F D                E+QH           +
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWD----------------EDQH-------RLYAQ 218

Query: 385 NILGRHS--RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
              G +      W+          V+PEA   +D +L  +  +R+TA +A+  P
Sbjct: 219 IKAGAYDYPSPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALKVP 263

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 84.5 bits (210), Expect = 2e-18
 Identities = 24/82 (29%), Positives = 47/82 (57%), Gaps = 3/82 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           ++ YCHS GI+HR++KP N+++    +   ++L D+GLA   +  + ++    +  +  P
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176

Query: 68  ELLADYQMYDYSLDMWSLGCML 89
           E+L     Y   +D+W+ G +L
Sbjct: 177 EVLK-KDPYSKPVDIWACGVIL 197

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  127 bits (322), Expect = 8e-34
 Identities = 75/316 (23%), Positives = 134/316 (42%), Gaps = 79/316 (25%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK-------------REIK 217
             Y+ + K+G G Y  VF+A N ++ +  +V +      K+++             REI 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHE--IVAL------KRVRLDDDDEGVPSSALREIC 53

Query: 218 ILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYE 273
           +L+ L+   NI+ L  V+      T  L+FE  +  D K+ + +    L    ++ +L++
Sbjct: 54  LLKELKH-KNIVRLHDVLHSDKKLT--LVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 274 LLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFK 332
           LLK L +CHS  ++HRD+KP N++I+     L+L ++GLA  +  P + Y+  V + +++
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLARAFGIPVRCYSAEVVTLWYR 168

Query: 333 GPE-LLADYQYHIELD----------------PRFA------------DILGRHSRKRWE 363
            P+ L     Y   +D                P F              +LG  + ++W 
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW- 227

Query: 364 RFVHTENQHLVSPEALDFLD-KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYD 422
                       P      D K      +       V       ++    D L  LL+ +
Sbjct: 228 ------------PSMTKLPDYKPYPMYPATTSLVNVVPK-----LNATGRDLLQNLLKCN 270

Query: 423 HYERLTAREAMDHPYF 438
             +R++A EA+ HPYF
Sbjct: 271 PVQRISAEEALQHPYF 286

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  114 bits (287), Expect = 8e-29
 Identities = 42/110 (38%), Positives = 69/110 (62%), Gaps = 2/110 (1%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE 68
            L +CHS  ++HRD+KP N++I+     L+L ++GLA  +  P + Y+  V + +++ P+
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +L   ++Y  S+DMWS GC+ A +     P F G+D  DQL RI ++LGT
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  127 bits (321), Expect = 1e-33
 Identities = 68/301 (22%), Positives = 123/301 (40%), Gaps = 71/301 (23%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK---------PVKKKKIKREIKILE 220
           +D Y++  +LG G+++ V +     +  +   K +K          V +++I+RE+ IL 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 221 NLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKA 277
            +R   NIITL  + ++       LI E V+  + F  L +  +LT+ +   +L ++L  
Sbjct: 64  EIRH-PNIITLHDIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120

Query: 278 LDYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 334
           + Y HS  I H D+KP N+M+   +  N +++LID+G+A     G E+     +  F  P
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180

Query: 335 ELLADYQYHIELD---------------PRFADILGRHSRKRWERFVHTENQH----LVS 375
           E++      +E D                 F                  E +      +S
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLG----------------ETKQETLTNIS 224

Query: 376 PEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH 435
               DF           + +            S  A DF+ +LL  D   R+T  ++++H
Sbjct: 225 AVNYDF---------DEEYFSN---------TSELAKDFIRRLLVKDPKRRMTIAQSLEH 266

Query: 436 P 436
            
Sbjct: 267 S 267

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 27/83 (32%), Positives = 44/83 (53%), Gaps = 4/83 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 66
            + Y HS  I H D+KP N+M+   +  N +++LID+G+A     G E+     +  F  
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179

Query: 67  PELLADYQMYDYSLDMWSLGCML 89
           PE++  Y+      DMWS+G + 
Sbjct: 180 PEIVN-YEPLGLEADMWSIGVIT 201

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  128 bits (323), Expect = 1e-33
 Identities = 81/317 (25%), Positives = 137/317 (43%), Gaps = 76/317 (23%)

Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK-------------R 214
           G  + YQ + K+G G Y  V++A + Q          + V  K+I+             R
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQG---------RIVALKRIRLDAEDEGIPSTAIR 68

Query: 215 EIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYY 270
           EI +L+ L    NI++L  V+      T  L+FE +   D K++       L D  I+ Y
Sbjct: 69  EISLLKELHH-PNIVSLIDVIHSERCLT--LVFEFME-KDLKKVLDENKTGLQDSQIKIY 124

Query: 271 LYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASR 329
           LY+LL+ + +CH   I+HRD+KP N++I+ +   L+L D+GLA  +  P + Y   V + 
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSYTHEVVTL 183

Query: 330 YFKGPE-LLADYQYHIELD---------------PRFA------------DILGRHSRKR 361
           +++ P+ L+   +Y   +D               P F              ILG  + + 
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243

Query: 362 WERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRY 421
           W +          + +              +K W   +          E +D L  +L +
Sbjct: 244 WPQVQELPLWKQRTFQ-----------VFEKKPWSSIIPG-----FCQEGIDLLSNMLCF 287

Query: 422 DHYERLTAREAMDHPYF 438
           D  +R++AR+AM+HPYF
Sbjct: 288 DPNKRISARDAMNHPYF 304

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  109 bits (275), Expect = 5e-27
 Identities = 42/110 (38%), Positives = 68/110 (61%), Gaps = 3/110 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE 68
            + +CH   I+HRD+KP N++I+ +   L+L D+GLA  +  P + Y   V + +++ P+
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSYTHEVVTLWYRAPD 189

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           +L   + Y  S+D+WS+GC+ A MI  K P F G  + DQL +I  +LGT
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGT 238

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  129 bits (326), Expect = 1e-33
 Identities = 81/334 (24%), Positives = 149/334 (44%), Gaps = 60/334 (17%)

Query: 165 VDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVK-ILKPVKK----KKIKREIKIL 219
           VD      Y+LV+KLG+G Y  V+++I+ ++ +   VK I    +     ++  REI IL
Sbjct: 3   VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMIL 62

Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKA 277
             L G  NI+ L  V++    R   L+F+++  TD   +     L     +Y +Y+L+K 
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKV 121

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR------------ 325
           + Y HS G++HRD+KP N++++     +++ D+GL+  +   +                 
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180

Query: 326 ----------VASRYFKGPE-LLADYQYHIELDP-----RFADIL-------GRHSRKRW 362
                     VA+R+++ PE LL   +Y   +D         +IL       G  +  + 
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240

Query: 363 ERFVHT-------ENQHLVSPEALDFLDK---------NILGRHSRKRWERFVHTENQHL 406
           ER +         + + + SP A   ++          +       K     +    +  
Sbjct: 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300

Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP 440
            + EALD LDKLL+++  +R++A +A+ HP+   
Sbjct: 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 96.7 bits (241), Expect = 5e-22
 Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 24/131 (18%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----------- 58
            + Y HS G++HRD+KP N++++     +++ D+GL+  +   +                
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179

Query: 59  -----------VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 107
                      VA+R+++ PE+L     Y   +DMWSLGC+L  ++  K P F G    +
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PIFPGSSTMN 238

Query: 108 QLVRIAKVLGT 118
           QL RI  V+  
Sbjct: 239 QLERIIGVIDF 249

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  127 bits (322), Expect = 2e-33
 Identities = 59/309 (19%), Positives = 111/309 (35%), Gaps = 51/309 (16%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI-----LKPVKKKKIKREIKILENLRGG- 225
            Y +++++G G  S+VF+ +N +      +K               + EI  L  L+   
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNN--TDFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
             II L         +   ++ E  N     + +  +++  ++ + Y   +L+A+   H 
Sbjct: 69  DKIIRLYDYEITD--QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKGPELLADY 340
            GI+H D+KP N +I   +  L+LID+G+A    P     V+   V +  +  PE + D 
Sbjct: 127 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 341 QYHIELDPRFADILGRHSRKR--WER-------------FVHTENQHLVSPEALDFLDKN 385
                          + S K   W               F    NQ       +  L   
Sbjct: 185 SS----SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLHAI 233

Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
           I   H  +  +         +   +  D L   L+ D  +R++  E + HPY        
Sbjct: 234 IDPNHEIEFPD---------IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 284

Query: 446 SRHTLPSSS 454
           ++    ++ 
Sbjct: 285 NQMAKGTTE 293

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 34/118 (28%), Positives = 51/118 (43%), Gaps = 15/118 (12%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKG 66
           A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+   V +  +  
Sbjct: 120 AVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 67  PELL----------ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           PE +                    D+WSLGC+L  M + K PF    +   +L  I  
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  126 bits (319), Expect = 2e-33
 Identities = 60/294 (20%), Positives = 128/294 (43%), Gaps = 63/294 (21%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI-----LKPVKKKKIKREIKILENLRG 224
            + Y +V  LG+G + EV +  +  +  +  VK+      K      I RE+++L+ L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQL--YQTLTDYDIRYYLYELLKALDYC 281
             NI+ L  +++D  S    ++ E     + F ++   +  +++D    + ++   + Y 
Sbjct: 80  HPNIMKLFEILEDSSSFY--IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137

Query: 282 HSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           H   I+HRD+KP N++++   ++  +++ID+GL+  +    +   R+ + Y+  PE+L  
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-R 196

Query: 340 YQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK 384
             Y  + D               P F                + +N++       D L +
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPF----------------YGKNEY-------DILKR 233

Query: 385 NILGRHS--RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
              G+++    +W           +S +A D + K+L +    R+TA + ++HP
Sbjct: 234 VETGKYAFDLPQWRT---------ISDDAKDLIRKMLTFHPSLRITATQCLEHP 278

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 85.7 bits (213), Expect = 6e-19
 Identities = 25/82 (30%), Positives = 47/82 (57%), Gaps = 4/82 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
            + Y H   I+HRD+KP N++++   ++  +++ID+GL+  +    +   R+ + Y+  P
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 68  ELLADYQMYDYSLDMWSLGCML 89
           E+L     YD   D+WS G +L
Sbjct: 193 EVLR--GTYDEKCDVWSAGVIL 212

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  126 bits (318), Expect = 3e-33
 Identities = 65/318 (20%), Positives = 119/318 (37%), Gaps = 75/318 (23%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK------------PVKKKKIKREIK 217
            ++Y+    LGRG  S V   I+  +  +  VKI+                ++   +E+ 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 218 ILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYEL 274
           IL  + G  NII L+   +        L+F+ +   + F  L +  TL++ + R  +  L
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFF--LVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133

Query: 275 LKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY---- 330
           L+ +   H + I+HRD+KP N+++D ++  ++L D+G +    PG++      +      
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192

Query: 331 --FKGPELLADYQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHL 373
              +         Y  E+D               P F                    Q L
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH----------------RKQML 236

Query: 374 VSPEALDFLDKNILGRH---SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAR 430
           +         + I+  +       W+           S    D + + L     +R TA 
Sbjct: 237 ML--------RMIMSGNYQFGSPEWDD---------YSDTVKDLVSRFLVVQPQKRYTAE 279

Query: 431 EAMDHPYFYPIVKDQSRH 448
           EA+ HP+F   V ++ RH
Sbjct: 280 EALAHPFFQQYVVEEVRH 297

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 22/85 (25%), Positives = 46/85 (54%), Gaps = 6/85 (7%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            +   H + I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  PE+
Sbjct: 136 VICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194

Query: 70  LA-----DYQMYDYSLDMWSLGCML 89
           +      ++  Y   +DMWS G ++
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIM 219

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  127 bits (320), Expect = 5e-33
 Identities = 63/303 (20%), Positives = 114/303 (37%), Gaps = 73/303 (24%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK--------PVKKKKIKREIKILEN 221
           +D Y+L   +G+G +S V   IN ++  +  VKI+          +  + +KRE  I   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNN-------TDFKQLYQTLTDYDIRYYLYEL 274
           L    +I+ L             ++FE ++                  ++    +Y+ ++
Sbjct: 83  L-KHPHIVELLETYSSDGMLY--MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139

Query: 275 LKALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLA-EFYHPGQEYNVRVASRYF 331
           L+AL YCH   I+HRDVKPH V++     +  ++L  +G+A +    G     RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

Query: 332 KGPELLADYQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHL--- 373
             PE++    Y   +D                 F                    + L   
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG----------------TKERLFEG 243

Query: 374 VSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
           +                + ++W           +S  A D + ++L  D  ER+T  EA+
Sbjct: 244 IIKGKYKM---------NPRQWSH---------ISESAKDLVRRMLMLDPAERITVYEAL 285

Query: 434 DHP 436
           +HP
Sbjct: 286 NHP 288

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 87.0 bits (216), Expect = 6e-19
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 4/83 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKG 66
           AL YCH   I+HRDVKPH V++     +  ++L  +G+A +    G     RV + +F  
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201

Query: 67  PELLADYQMYDYSLDMWSLGCML 89
           PE++   + Y   +D+W  G +L
Sbjct: 202 PEVVK-REPYGKPVDVWGCGVIL 223

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  124 bits (313), Expect = 1e-32
 Identities = 65/296 (21%), Positives = 112/296 (37%), Gaps = 65/296 (21%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL---KPVKKKKIKREIKILENLRGGT 226
              Y L   +GRG + EV  A+   +  +   K +         + K+EI+I+++L    
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH-P 66

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           NII L    +D       L+ E        +     +   + D    + ++L A+ YCH 
Sbjct: 67  NIIRLYETFEDNTDIY--LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124

Query: 284 MGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           + + HRD+KP N +      +  L+LID+GLA  + PG+    +V + Y+  P++L +  
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGL 183

Query: 342 YHIELD---------------PRFADILGRHSRKRWERFVHTENQH----LVSPEALDFL 382
           Y  E D               P F                           +      F 
Sbjct: 184 YGPECDEWSAGVMMYVLLCGYPPF----------------SAPTDSEVMLKIREGTFTF- 226

Query: 383 DKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                     K W           VSP+A   + +LL     +R+T+ +A++H +F
Sbjct: 227 --------PEKDWLN---------VSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 29/82 (35%), Positives = 46/82 (56%), Gaps = 4/82 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ YCH + + HRD+KP N +      +  L+LID+GLA  + PG+    +V + Y+  P
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177

Query: 68  ELLADYQMYDYSLDMWSLGCML 89
           ++L    +Y    D WS G M+
Sbjct: 178 QVLE--GLYGPECDEWSAGVMM 197

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  125 bits (317), Expect = 1e-32
 Identities = 73/330 (22%), Positives = 131/330 (39%), Gaps = 68/330 (20%)

Query: 169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK--------REIKILE 220
           +   Y+ +  LG G+++ V++A +  ++    +K +K   + + K        REIK+L+
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67

Query: 221 NLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL----YQTLTDYDIRYYLYELLK 276
            L    NII L        + +  L+F+ +  TD + +       LT   I+ Y+   L+
Sbjct: 68  ELSH-PNIIGLLDAFGHKSNIS--LVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 335
            L+Y H   I+HRD+KP+N+++D     L+L D+GLA  F  P + Y  +V +R+++ PE
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 182

Query: 336 -LLADYQYHIELD---------------PRFA------------DILGRHSRKRWERFVH 367
            L     Y + +D               P               + LG  + ++W     
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW----- 237

Query: 368 TENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL 427
                   P+     D                          + LD +  L  ++   R+
Sbjct: 238 --------PDMCSLPDYVTFKSFPGIPLHHIFSA-----AGDDLLDLIQGLFLFNPCARI 284

Query: 428 TAREAMDHPYFYPIVKDQSRHTLPSSSPTP 457
           TA +A+   YF     ++   T     P P
Sbjct: 285 TATQALKMKYF----SNRPGPTPGCQLPRP 310

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  108 bits (271), Expect = 3e-26
 Identities = 47/110 (42%), Positives = 71/110 (64%), Gaps = 3/110 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 68
            L+Y H   I+HRD+KP+N+++D     L+L D+GLA  F  P + Y  +V +R+++ PE
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 182

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           LL   +MY   +DMW++GC+LA ++ R  PF  G  + DQL RI + LGT
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGT 231

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  124 bits (314), Expect = 6e-32
 Identities = 58/315 (18%), Positives = 111/315 (35%), Gaps = 63/315 (20%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI-----LKPVKKKKIKREIKILENLRG-G 225
            Y +++++G G  S+VF+ +N +      +K               + EI  L  L+   
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL--YQTLTDYDIRYYLYELLKALDYCHS 283
             II L         +   ++ E  N      L   +++  ++ + Y   +L+A+   H 
Sbjct: 116 DKIIRLYDYEITD--QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKGPELLADY 340
            GI+H D+KP N +I   +  L+LID+G+A    P     V+   V +  +  PE + D 
Sbjct: 174 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 341 QYHIELDPRF------ADI--LG-------------RHSRKRWERFVHTENQHLVSPEAL 379
               E           +D+  LG             +    +  +               
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--------------- 276

Query: 380 DFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY 439
             L   I   H  +  +         +   +  D L   L+ D  +R++  E + HPY  
Sbjct: 277 --LHAIIDPNHEIEFPD---------IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

Query: 440 PIVKDQSRHTLPSSS 454
                 ++    ++ 
Sbjct: 326 IQTHPVNQMAKGTTE 340

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 84.1 bits (208), Expect = 9e-18
 Identities = 34/118 (28%), Positives = 51/118 (43%), Gaps = 15/118 (12%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKG 66
           A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+   V +  +  
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 67  PELL----------ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           PE +                    D+WSLGC+L  M + K PF    +   +L  I  
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  123 bits (311), Expect = 1e-31
 Identities = 67/305 (21%), Positives = 119/305 (39%), Gaps = 72/305 (23%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKK-----------KIKREIKIL 219
             Y     +GRG  S V   ++  +  +  VKI++   ++             +RE  IL
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLK 276
             + G  +IITL    +        L+F+ +   + F  L +   L++ + R  +  LL+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMF--LVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211

Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF----- 331
           A+ + H+  I+HRD+KP N+++D +N ++RL D+G +    PG++      +  +     
Sbjct: 212 AVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270

Query: 332 -KGPELLADYQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVS 375
            K         Y  E+D               P F                    Q L+ 
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH----------------RRQILM- 313

Query: 376 PEALDFLDKNILGRHS--RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
                 L   + G++      W+           S    D + +LL+ D   RLTA +A+
Sbjct: 314 ------LRMIMEGQYQFSSPEWDD---------RSSTVKDLISRLLQVDPEARLTAEQAL 358

Query: 434 DHPYF 438
            HP+F
Sbjct: 359 QHPFF 363

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 6/85 (7%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ + H+  I+HRD+KP N+++D +N ++RL D+G +    PG++      +  +  PE+
Sbjct: 212 AVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270

Query: 70  L-----ADYQMYDYSLDMWSLGCML 89
           L       +  Y   +D+W+ G +L
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVIL 295

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  123 bits (311), Expect = 1e-31
 Identities = 66/296 (22%), Positives = 122/296 (41%), Gaps = 66/296 (22%)

Query: 170 QDDYQLVRK--LGRGKYSEVFEAINVQSSDKCVVKIL---KPVKKKKIKREIKILENLRG 224
              Y + +   LG G++ +V +     +  K   KI+       K+++K EI ++  L  
Sbjct: 86  NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145

Query: 225 GTNIITLQAVVKDPVSRTPALI---------FEHVNNTDFKQLYQTLTDYDIRYYLYELL 275
             N+I L    +        L+         F+ + +  +      LT+ D   ++ ++ 
Sbjct: 146 -ANLIQLYDAFESKNDIV--LVMEYVDGGELFDRIIDESYN-----LTELDTILFMKQIC 197

Query: 276 KALDYCHSMGIMHRDVKPHNVM-IDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 334
           + + + H M I+H D+KP N++ ++ + +++++ID+GLA  Y P ++  V   +  F  P
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257

Query: 335 ELLADYQYHIELDPRFAD---------IL--GRHSRKRWERFVHTENQHLVSPEALDFLD 383
           E++              D         +L  G                  +SP    FL 
Sbjct: 258 EVVNYDFVSFP-----TDMWSVGVIAYMLLSG------------------LSP----FLG 290

Query: 384 KN---ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
            N    L      RW+     E Q  +S EA +F+ KLL  +   R++A EA+ HP
Sbjct: 291 DNDAETLNNILACRWD-LEDEEFQD-ISEEAKEFISKLLIKEKSWRISASEALKHP 344

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 87.4 bits (217), Expect = 4e-19
 Identities = 25/78 (32%), Positives = 47/78 (60%), Gaps = 2/78 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVM-IDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
            + + H M I+H D+KP N++ ++ + +++++ID+GLA  Y P ++  V   +  F  PE
Sbjct: 199 GIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE 258

Query: 69  LLADYQMYDYSLDMWSLG 86
           ++  Y    +  DMWS+G
Sbjct: 259 VVN-YDFVSFPTDMWSVG 275

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  124 bits (313), Expect = 2e-31
 Identities = 71/372 (19%), Positives = 141/372 (37%), Gaps = 94/372 (25%)

Query: 150 NSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVK-ILKPVK 208
           + H       Y   + +    D+Y +   +GRG Y  V+ A +  +     +K + +  +
Sbjct: 5   HHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE 64

Query: 209 K----KKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA----LIFEHVNNTDFKQL-- 258
                K+I REI IL  L+    II L  ++  P          ++ E  + +D K+L  
Sbjct: 65  DLIDCKRILREITILNRLKS-DYIIRLYDLII-PDDLLKFDELYIVLEIAD-SDLKKLFK 121

Query: 259 -YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH 317
               LT+  I+  LY LL   ++ H  GI+HRD+KP N +++ ++  +++ D+GLA   +
Sbjct: 122 TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN-QDCSVKVCDFGLARTIN 180

Query: 318 PGQEYNVR-----------------------VASRYFKGPE-LLADYQYHIELD------ 347
             ++ N+                        V +R+++ PE +L    Y   +D      
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240

Query: 348 --------------------PRF----ADILGRHSRKRWERFVHTENQ------------ 371
                               P F       L      +        +Q            
Sbjct: 241 IFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPT 300

Query: 372 -----HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYER 426
                ++  PE + ++             ++   +     +S + ++ L+ +L+++  +R
Sbjct: 301 EDDLKNINKPEVIKYIKL--FPHRKPINLKQKYPS-----ISDDGINLLESMLKFNPNKR 353

Query: 427 LTAREAMDHPYF 438
           +T  +A+DHPY 
Sbjct: 354 ITIDQALDHPYL 365

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 37/159 (23%), Positives = 68/159 (42%), Gaps = 51/159 (32%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----------- 58
             ++ H  GI+HRD+KP N +++ ++  +++ D+GLA   +  ++ N+            
Sbjct: 141 GENFIHESGIIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199

Query: 59  ------------VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMI----------FRK 96
                       V +R+++ PEL+   + Y  S+D+WS GC+ A ++            +
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259

Query: 97  EPFFHG-----------------HDNYDQLVRIAKVLGT 118
            P F G                   N DQL  I  ++GT
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGT 298

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  121 bits (305), Expect = 3e-31
 Identities = 66/319 (20%), Positives = 127/319 (39%), Gaps = 51/319 (15%)

Query: 170 QDDYQLVRK-LGRGKYSEVFEAINVQSSDKCVVKIL---KPVKKKKIKREIKILENLRGG 225
           +D YQL    LG G ++ V   IN+ +S +  VKI+       + ++ RE+++L   +G 
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKALDYCH 282
            N++ L    ++       L+FE +        +++     + +    + ++  ALD+ H
Sbjct: 71  RNVLELIEFFEEEDRF--YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 283 SMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNV--------RVASRYFK 332
           + GI HRD+KP N++ +H  +   +++ D+ L        + +            S  + 
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 333 GPELLADYQYHIEL-DPRFADI--LGR------------HSRKRWERFVHTENQHLVSPE 377
            PE++  +     + D R  D+  LG               R   +              
Sbjct: 189 APEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247

Query: 378 ALDFLDKNILGRHS--RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH 435
            L   +    G++    K W           +S  A D + KLL  D  +RL+A + + H
Sbjct: 248 ML--FESIQEGKYEFPDKDWAH---------ISCAAKDLISKLLVRDAKQRLSAAQVLQH 296

Query: 436 PYFYPIVKDQSRHTLPSSS 454
           P+   +      +TLP+  
Sbjct: 297 PW---VQGCAPENTLPTPM 312

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 32/129 (24%), Positives = 56/129 (43%), Gaps = 15/129 (11%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNV--------RV 59
           ALD+ H+ GI HRD+KP N++ +H  +   +++ D+ L        + +           
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 60  ASRYFKGPELL----ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
            S  +  PE++     +  +YD   D+WSLG +L  ++    PF     +     R    
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242

Query: 116 LGTE-ELFE 123
              +  LFE
Sbjct: 243 PACQNMLFE 251

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  120 bits (303), Expect = 4e-31
 Identities = 54/302 (17%), Positives = 113/302 (37%), Gaps = 73/302 (24%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK----PVKKKKIKREIKILENLRGG 225
            D +   RKLG G + +V       S  + V+K +      V  ++I+ EI++L++L   
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DH 79

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNN-------TDFKQLYQTLTDYDIRYYLYELLKAL 278
            NII +  V +D  +    ++ E              +   + L++  +   + +++ AL
Sbjct: 80  PNIIKIFEVFEDYHNMY--IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137

Query: 279 DYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 336
            Y HS  ++H+D+KP N++      +  +++ID+GLAE +   +       +  +  PE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197

Query: 337 LADYQYHIELD---------------PRF-----ADILGRHSRKRWERFVHTENQHLVSP 376
                   + D                 F      ++  + + K      +      ++P
Sbjct: 198 F-KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN---YAVECRPLTP 253

Query: 377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
           +A+D L +                                 +L  D   R +A + + H 
Sbjct: 254 QAVDLLKQ---------------------------------MLTKDPERRPSAAQVLHHE 280

Query: 437 YF 438
           +F
Sbjct: 281 WF 282

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 88.4 bits (220), Expect = 7e-20
 Identities = 22/82 (26%), Positives = 43/82 (52%), Gaps = 4/82 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           AL Y HS  ++H+D+KP N++      +  +++ID+GLAE +   +       +  +  P
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195

Query: 68  ELLADYQMYDYSLDMWSLGCML 89
           E+    +   +  D+WS G ++
Sbjct: 196 EVFK--RDVTFKCDIWSAGVVM 215

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  122 bits (309), Expect = 4e-31
 Identities = 74/369 (20%), Positives = 136/369 (36%), Gaps = 88/369 (23%)

Query: 158 WDYESYVVDWGQ--QDDYQLVR-KLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK- 213
           +D++  +    +  +D ++    K+GRG Y  V++A      D     +      K+I+ 
Sbjct: 5   YDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYAL------KQIEG 58

Query: 214 --------REIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL------- 258
                   REI +L  L+   N+I+LQ V      R   L+F++    D   +       
Sbjct: 59  TGISMSACREIALLRELKH-PNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRAS 116

Query: 259 -----YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRK---LRLIDW 310
                   L    ++  LY++L  + Y H+  ++HRD+KP N+++  E  +   +++ D 
Sbjct: 117 KANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176

Query: 311 GLA-EFYHPGQEY---NVRVASRYFKGPE-LLADYQYHIELD---------------PRF 350
           G A  F  P +     +  V + +++ PE LL    Y   +D               P F
Sbjct: 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

Query: 351 A---------------------DILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGR 389
                                 +++G  + K WE            PE    +       
Sbjct: 237 HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKM-------PEHSTLMKDFRRNT 289

Query: 390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHT 449
           ++     +++          +A   L KLL  D  +R+T+ +AM  PYF     +    T
Sbjct: 290 YTNCSLIKYMEKHKVKP-DSKAFHLLQKLLTMDPIKRITSEQAMQDPYF----LEDPLPT 344

Query: 450 LPSSSPTPI 458
               +   I
Sbjct: 345 SDVFAGCQI 353

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 96.4 bits (240), Expect = 6e-22
 Identities = 36/125 (28%), Positives = 66/125 (52%), Gaps = 17/125 (13%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRK---LRLIDWGLA-EFYHPGQEY---NVRVASR 62
            + Y H+  ++HRD+KP N+++  E  +   +++ D G A  F  P +     +  V + 
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199

Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIA 113
           +++ PELL   + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI 
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIF 258

Query: 114 KVLGT 118
            V+G 
Sbjct: 259 NVMGF 263

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  121 bits (304), Expect = 4e-31
 Identities = 45/304 (14%), Positives = 93/304 (30%), Gaps = 42/304 (13%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK----IKREIKILENLRGGT 226
             + L   LG+G  + VF   + ++ D   +K+   +   +      RE ++L+ L    
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDF------KQLYQTLTDYDIRYYLYELLKALDY 280
           NI+ L A+ ++  +R   LI E                   L + +    L +++  +++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 281 CHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
               GI+HR++KP N+M    +      +L D+G A      +++     +  +  P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 338 ADY--------QYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLV 374
                      +Y   +D                 F    G    K     + T      
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 375 SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD 434
                   +  I                    +       L  +L  D  +     +   
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRG-----LQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 435 HPYF 438
               
Sbjct: 303 ETSD 306

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 23/135 (17%), Positives = 49/135 (36%), Gaps = 10/135 (7%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 66
            +++    GI+HR++KP N+M    +      +L D+G A      +++     +  +  
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183

Query: 67  PELLADY-------QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
           P++           + Y  ++D+WS+G           PF            + K++  +
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

Query: 120 ELFEYLDKYHIELDP 134
                      E  P
Sbjct: 244 PSGAISGVQKAENGP 258

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  119 bits (302), Expect = 8e-31
 Identities = 64/292 (21%), Positives = 116/292 (39%), Gaps = 61/292 (20%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL---KPVKKKKIKREIKILENLRGGT 226
           +  +  +  LG G +SEVF      +     +K +      +   ++ EI +L+ ++   
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-E 66

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTD-FKQL--YQTLTDYDIRYYLYELLKALDYCHS 283
           NI+TL+ + +        L+ + V+  + F ++      T+ D    + ++L A+ Y H 
Sbjct: 67  NIVTLEDIYESTTHY--YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE 124

Query: 284 MGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
            GI+HRD+KP N++     EN K+ + D+GL++    G   +    +  +  PE+LA   
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPEVLAQKP 183

Query: 342 YHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI 386
           Y   +D               P F +                E +           +K  
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPPFYE----------------ETES-------KLFEKIK 220

Query: 387 LGRHS--RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
            G +      W+          +S  A DF+  LL  D  ER T  +A+ HP
Sbjct: 221 EGYYEFESPFWDD---------ISESAKDFICHLLEKDPNERYTCEKALSHP 263

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 27/82 (32%), Positives = 46/82 (56%), Gaps = 4/82 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y H  GI+HRD+KP N++     EN K+ + D+GL++    G   +    +  +  P
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAP 176

Query: 68  ELLADYQMYDYSLDMWSLGCML 89
           E+LA  + Y  ++D WS+G + 
Sbjct: 177 EVLA-QKPYSKAVDCWSIGVIT 197

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  118 bits (299), Expect = 4e-30
 Identities = 61/288 (21%), Positives = 106/288 (36%), Gaps = 52/288 (18%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIIT 230
           D Y++   +G G YS     I+  ++ +  VKI+    K+    EI+IL       NIIT
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQHPNIIT 80

Query: 231 LQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIM 287
           L+ V  D       ++ E +   +   ++ +    ++ +    L+ + K ++Y H+ G++
Sbjct: 81  LKDVYDDGKYVY--VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138

Query: 288 HRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLADYQYH 343
           HRD+KP N++          +R+ D+G A+              +  F  PE+L    Y 
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD 198

Query: 344 IELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILG 388
              D                 FA+       +   R         +              
Sbjct: 199 AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR---------IGSGKFSLSGGY--- 246

Query: 389 RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
                 W           VS  A D + K+L  D ++RLTA   + HP
Sbjct: 247 ------WNS---------VSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 31/103 (30%), Positives = 53/103 (51%), Gaps = 5/103 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQE-YNVRVASRYFK 65
            ++Y H+ G++HRD+KP N++          +R+ D+G A+              +  F 
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187

Query: 66  GPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
            PE+L   Q YD + D+WSLG +L +M+    PF +G D+  +
Sbjct: 188 APEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE 229

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  117 bits (296), Expect = 5e-30
 Identities = 59/319 (18%), Positives = 116/319 (36%), Gaps = 72/319 (22%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK--PVKKKKIKREIKILENLRGGTN 227
             D++ +  LG+G + +V +A N   S    +K ++    K   I  E+ +L +L     
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH-QY 63

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--------QTLTDY-----------DIR 268
           ++   A   +  +    +      +T    L+         TL D            +  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKST----LFIQMEYCENGTLYDLIHSENLNQQRDEYW 119

Query: 269 YYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS 328
               ++L+AL Y HS GI+HRD+KP N+ ID E+R +++ D+GLA+  H   +     + 
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 329 RYFKG---------------PELLADYQYHIELDPRFADILGRHSRKRW-------ERFV 366
                                E+L    ++   + +  D+        +       E   
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHY---NEK-IDM--------YSLGIIFFE--- 223

Query: 367 HTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYER 426
                 ++ P +      NIL +  R     F    + +         +  L+ +D  +R
Sbjct: 224 ------MIYPFSTGMERVNIL-KKLRSVSIEFPPDFDDN-KMKVEKKIIRLLIDHDPNKR 275

Query: 427 LTAREAMDHPYFYPIVKDQ 445
             AR  ++  +     +D+
Sbjct: 276 PGARTLLNSGWLPVKHQDE 294

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 36/119 (30%), Positives = 57/119 (47%), Gaps = 19/119 (15%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 66
            AL Y HS GI+HRD+KP N+ ID E+R +++ D+GLA+  H   +     +        
Sbjct: 127 EALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185

Query: 67  -------------PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 112
                         E+L     Y+  +DM+SLG +   MI+   PF  G +  + L ++
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKL 241

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  120 bits (302), Expect = 6e-30
 Identities = 69/294 (23%), Positives = 126/294 (42%), Gaps = 63/294 (21%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI-----LKPVKKKKIKREIKILENLRGG 225
           ++YQL  +LG+G +S V   + V +  +    I     L     +K++RE +I   L   
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KH 69

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQL--YQTLTDYDIRYYLYELLKALDYCH 282
            NI+ L   + +       LIF+ V   + F+ +   +  ++ D  + + ++L+A+ +CH
Sbjct: 70  PNIVRLHDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127

Query: 283 SMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLAD 339
            MG++HR++KP N+++    +   ++L D+GLA       Q +     +  +  PE+L  
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187

Query: 340 YQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK 384
             Y   +D               P F D                E+QH           +
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWD----------------EDQH-------RLYQQ 224

Query: 385 NILGRHS--RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
              G +      W+          V+PEA D ++K+L  +  +R+TA EA+ HP
Sbjct: 225 IKAGAYDFPSPEWDT---------VTPEAKDLINKMLTINPSKRITAAEALKHP 269

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 24/83 (28%), Positives = 45/83 (54%), Gaps = 4/83 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKG 66
           A+ +CH MG++HR++KP N+++    +   ++L D+GLA       Q +     +  +  
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181

Query: 67  PELLADYQMYDYSLDMWSLGCML 89
           PE+L     Y   +D+W+ G +L
Sbjct: 182 PEVLR-KDPYGKPVDLWACGVIL 203

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  118 bits (297), Expect = 6e-30
 Identities = 64/343 (18%), Positives = 111/343 (32%), Gaps = 107/343 (31%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK--------PVKKKKIKREIKILEN 221
           Q  Y L   +G+G Y  V  AI  Q+     +KI+         P   ++IK E+++++ 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 222 LRGGTNIITLQAVVKD-----------------------------------------PVS 240
           L    NI  L  V +D                                         P  
Sbjct: 85  LHH-PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143

Query: 241 RTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH 300
                      +   + L     +  I   + ++  AL Y H+ GI HRD+KP N +   
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203

Query: 301 -ENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYFKGPELL--ADYQYHIELD----- 347
            ++ +++L+D+GL++ ++            +  + YF  PE+L   +  Y  + D     
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263

Query: 348 ----------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS--RKRW 395
                       F                   N         D + + +  +       +
Sbjct: 264 VLLHLLLMGAVPFPG----------------VNDA-------DTISQVLNKKLCFENPNY 300

Query: 396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                      +SP A D L  LL  +  ER  A  A+ HP+ 
Sbjct: 301 NV---------LSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 7/103 (6%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDH-ENRKLRLIDWGLAEFYHPGQE-----YNVRVASRY 63
           AL Y H+ GI HRD+KP N +    ++ +++L+D+GL++ ++            +  + Y
Sbjct: 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239

Query: 64  FKGPELL-ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 105
           F  PE+L    + Y    D WS G +L  ++    PF   +D 
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA 282

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  118 bits (298), Expect = 2e-29
 Identities = 55/293 (18%), Positives = 96/293 (32%), Gaps = 56/293 (19%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITL 231
            +     LG G    +     +  +    VK + P       RE+++L       N+I  
Sbjct: 25  SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRY 83

Query: 232 QAVVKDP------VSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMG 285
               KD       +    A + E+V   DF          +    L +    L + HS+ 
Sbjct: 84  FCTEKDRQFQYIAIELCAATLQEYVEQKDF-----AHLGLEPITLLQQTTSGLAHLHSLN 138

Query: 286 IMHRDVKPHNVMIDHEN----RKLRLIDWGLAEFYHPGQEYNVR----VASRYFKGPELL 337
           I+HRD+KPHN++I   N     K  + D+GL +    G+    R      +  +  PE+L
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 338 ADYQYHIELDPRFADI------------LGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
           ++            DI             G H                  P    F    
Sbjct: 199 SE-DCKENPTYT-VDIFSAGCVFYYVISEGSH------------------P----FGKSL 234

Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
               +             +      A + ++K++  D  +R +A+  + HP+F
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 88.7 bits (220), Expect = 3e-19
 Identities = 29/115 (25%), Positives = 53/115 (46%), Gaps = 10/115 (8%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHEN----RKLRLIDWGLAEFYHPGQEYNVR----VAS 61
            L + HS+ I+HRD+KPHN++I   N     K  + D+GL +    G+    R      +
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

Query: 62  RYFKGPELLAD--YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
             +  PE+L++   +   Y++D++S GC+   +I      F         + +  
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA 244

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  115 bits (289), Expect = 3e-29
 Identities = 57/313 (18%), Positives = 107/313 (34%), Gaps = 56/313 (17%)

Query: 162 SYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILEN 221
           ++ VD     D++ +  +G G + +VF+A +       V+K +K    +K +RE+K L  
Sbjct: 2   AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAEREVKALAK 60

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--------------------QT 261
           L    NI+                      +   K L+                    + 
Sbjct: 61  LDH-VNIVHYNGCWDGFDYDPETSSKNSSRSKT-KCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
           L          ++ K +DY HS  +++RD+KP N+ +  + +++++ D+GL        +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGK 177

Query: 322 YNVRVASRYFKGPELLADYQYHIELDPRFADI--LGRHSRKRWERFVHTENQHLVSP--E 377
                 +  +  PE ++   Y  E      D+  LG          +  E  H+     E
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKE-----VDLYALG---------LILAELLHVCDTAFE 223

Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
              F      G  S                  +    L KLL     +R    E +    
Sbjct: 224 TSKFFTDLRDGIISDI-------------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270

Query: 438 FYPIVKDQS-RHT 449
            +    +++ RHT
Sbjct: 271 VWKKSPEKNERHT 283

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 23/104 (22%), Positives = 51/104 (49%), Gaps = 2/104 (1%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
             +DY HS  +++RD+KP N+ +  + +++++ D+GL        +      +  +  PE
Sbjct: 133 KGVDYIHSKKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPE 191

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 112
            ++  Q Y   +D+++LG +LA ++   +  F     +  L   
Sbjct: 192 QISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 234

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  118 bits (296), Expect = 1e-28
 Identities = 58/314 (18%), Positives = 117/314 (37%), Gaps = 48/314 (15%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK----PVKKKKIKREIKILENLRGGT 226
             +++  +LG G +  V   I+  + ++  +K  +    P  +++   EI+I++ L    
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH-P 72

Query: 227 NIITLQAVVKDP----VSRTPALIFEHVNNTDF------KQLYQTLTDYDIRYYLYELLK 276
           N+++ + V         +  P L  E+    D        +    L +  IR  L ++  
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 277 ALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 334
           AL Y H   I+HRD+KP N+++    +    ++ID G A+    G+     V +  +  P
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192

Query: 335 ELLADYQYHIELD----------------PRFADILGRHSRKRWERFVHTENQHLVSPEA 378
           ELL   +Y + +D                P     L      +W        +       
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRP----FLPNWQPVQWHG--KVREKSNEHIVV 246

Query: 379 LDFLDKNILGRHSRKRWERFVHTENQ--HLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
            D L   +       ++   + T N    +++ +   +L  +L +   +R T  +  +  
Sbjct: 247 YDDLTGAV-------KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVG 299

Query: 437 YFYPIVKDQSRHTL 450
            F  +    S   L
Sbjct: 300 CFQALDSILSLKLL 313

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 80.9 bits (199), Expect = 2e-16
 Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 4/107 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           AL Y H   I+HRD+KP N+++    +    ++ID G A+    G+     V +  +  P
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           ELL   + Y  ++D WS G +    I    P F  +    Q     +
Sbjct: 193 ELLE-QKKYTVTVDYWSFGTLAFECITGFRP-FLPNWQPVQWHGKVR 237

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  115 bits (290), Expect = 2e-28
 Identities = 60/316 (18%), Positives = 108/316 (34%), Gaps = 61/316 (19%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNII 229
           ++     + LG G    V             VK +          EIK+L       N+I
Sbjct: 14  KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVI 72

Query: 230 TLQAVVKDPVSRTPAL------IFEHV-NNTDFKQLYQTLTDYDIRYYLYELLKALDYCH 282
                         AL      + + V +     +  +   +Y+    L ++   + + H
Sbjct: 73  RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 283 SMGIMHRDVKPHNVMID------------HENRKLRLIDWGLAEFYHPGQEY-----NVR 325
           S+ I+HRD+KP N+++              EN ++ + D+GL +    GQ       N  
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192

Query: 326 VASRYFKGPELLADYQYHIELDP--RFADI------------LGRHSRKRWERFVHTENQ 371
             +  ++ PELL +           R  DI             G+H       F    ++
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH------PFGDKYSR 246

Query: 372 HLVSPEALDFLDKNIL-GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAR 430
                      + NI+ G  S    +          +  EA D + +++ +D  +R TA 
Sbjct: 247 -----------ESNIIRGIFSLDEMKCLHDRS----LIAEATDLISQMIDHDPLKRPTAM 291

Query: 431 EAMDHPYFYPIVKDQS 446
           + + HP F+P  K   
Sbjct: 292 KVLRHPLFWPKSKKLE 307

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 84.8 bits (210), Expect = 6e-18
 Identities = 31/144 (21%), Positives = 64/144 (44%), Gaps = 25/144 (17%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID------------HENRKLRLIDWGLAEFYHPGQEY-- 55
            + + HS+ I+HRD+KP N+++              EN ++ + D+GL +    GQ    
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 56  ---NVRVASRYFKGPELLADYQM------YDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 106
              N    +  ++ PELL +            S+D++S+GC+   ++ + +  F   D Y
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKY 244

Query: 107 DQLVRIAKVLGTEELFEYLDKYHI 130
            +   I + + + +  + L    +
Sbjct: 245 SRESNIIRGIFSLDEMKCLHDRSL 268

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  115 bits (290), Expect = 5e-28
 Identities = 64/340 (18%), Positives = 120/340 (35%), Gaps = 100/340 (29%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK----------------PVKKKKIKR 214
           + Y  VRKLG G Y EV          +  +K++K                    ++I  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 215 EIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ--TLTDYDIRYYL 271
           EI +L++L    NII L  V +D       L+ E     + F+Q+       + D    +
Sbjct: 96  EISLLKSL-DHPNIIKLFDVFEDKKYFY--LVTEFYEGGELFEQIINRHKFDECDAANIM 152

Query: 272 YELLKALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASR 329
            ++L  + Y H   I+HRD+KP N++++  +    ++++D+GL+ F+    +   R+ + 
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212

Query: 330 YFKGPELLADYQYHIELD---------------PRFAD---------ILGRH---SRKRW 362
           Y+  PE+L   +Y+ + D               P F           +           W
Sbjct: 213 YYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271

Query: 363 ERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYD 422
           +          +S EA +                                  +  +L YD
Sbjct: 272 KN---------ISDEAKEL---------------------------------IKLMLTYD 289

Query: 423 HYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIVNSV 462
           + +R TA EA++  +       +      + S    +   
Sbjct: 290 YNKRCTAEEALNSRWI------KKYANNINKSDQKTLCGA 323

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 92.1 bits (229), Expect = 3e-20
 Identities = 25/93 (26%), Positives = 52/93 (55%), Gaps = 4/93 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
            + Y H   I+HRD+KP N++++  +    ++++D+GL+ F+    +   R+ + Y+  P
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           E+L   + Y+   D+WS G ++  ++    PF 
Sbjct: 218 EVLK--KKYNEKCDVWSCGVIMYILLCGYPPFG 248

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  112 bits (282), Expect = 5e-28
 Identities = 58/287 (20%), Positives = 98/287 (34%), Gaps = 52/287 (18%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-----PVKKKKIKREIKILENLRG 224
           Q  +Q + +LG G Y EVF+  + +      VK        P  + +   E+   E +  
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVN----------NTDFKQLYQTLTDYDIRYYLYEL 274
               + L+   ++            +               +    +L +  +  YL + 
Sbjct: 116 HPCCVRLEQAWEEG---------GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDT 166

Query: 275 LKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 334
           L AL + HS G++H DVKP N+ +    R  +L D+GL           V+     +  P
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225

Query: 335 ELL-ADYQYHIELDPRFADI--LGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS 391
           ELL   Y          AD+  LG                 L   E    ++    G   
Sbjct: 226 ELLQGSYGTA-------ADVFSLG-----------------LTILEVACNMELPHGGEGW 261

Query: 392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           ++  + ++  E    +S E    L  +L  D   R TA   +  P  
Sbjct: 262 QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 28/97 (28%), Positives = 43/97 (44%), Gaps = 3/97 (3%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
            +AL + HS G++H DVKP N+ +    R  +L D+GL           V+     +  P
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           ELL     Y  + D++SLG  +  +    E    G  
Sbjct: 226 ELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEG 260

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  113 bits (283), Expect = 6e-28
 Identities = 48/343 (13%), Positives = 88/343 (25%), Gaps = 86/343 (25%)

Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL------KPVKKKKIKREIKILEN 221
             +   +LV  L  G  S VF   +V+  +   +K+          + +++         
Sbjct: 59  QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118

Query: 222 LR-----------------------GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
           L                               L     D       L+    +  D + L
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELL 177

Query: 259 YQTLTDYDI----------RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLI 308
           + TL    +               +L++      S G++H    P N+ I  + R L L 
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR-LMLG 236

Query: 309 DWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADI--LG----------- 355
           D      +  G           +   E L              +   LG           
Sbjct: 237 DVSAL--WKVGTRGPASSVPVTYAPREFLN--ASTATFTHA-LNAWQLGLSIYRVWCLFL 291

Query: 356 --RHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALD 413
                    +      +  +   ++L F                     +   +      
Sbjct: 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAF--------------------GSCTPLPDFVKT 331

Query: 414 FLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPT 456
            + + L +D   RL   EAM+ P F      Q ++ + SS  T
Sbjct: 332 LIGRFLNFDRRRRLLPLEAMETPEF-----LQLQNEISSSLST 369

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 87.8 bits (217), Expect = 4e-19
 Identities = 20/107 (18%), Positives = 34/107 (31%), Gaps = 4/107 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
                 S G++H    P N+ I  + R L L D      +  G           +   E 
Sbjct: 206 LAANLQSKGLVHGHFTPDNLFIMPDGR-LMLGDVSAL--WKVGTRGPASSVPVTYAPREF 262

Query: 70  L-ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
           L A    + ++L+ W LG  +  +     PF           +   +
Sbjct: 263 LNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSL 309

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  113 bits (285), Expect = 6e-28
 Identities = 46/301 (15%), Positives = 94/301 (31%), Gaps = 42/301 (13%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGT 226
             + L   LG+G  + VF   + ++ D   +K+   +          RE ++L+ L    
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ-----TLTDYDIRYYLYELLKALDY 280
           NI+ L A+ ++  +R   LI E       +  L +      L + +    L +++  +++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 281 CHSMGIMHRDVKPHNVMIDH---ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 337
               GI+HR++KP N+M           +L D+G A      +++     +  +  P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 338 ADY--------QYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLV 374
                      +Y   +D                 F    G    K     + T      
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 375 SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD 434
                   +  I                    +       L  +L  D  +     +   
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSL-----SRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 435 H 435
            
Sbjct: 303 E 303

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 78.4 bits (193), Expect = 7e-16
 Identities = 23/135 (17%), Positives = 48/135 (35%), Gaps = 10/135 (7%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDH---ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 66
            +++    GI+HR++KP N+M           +L D+G A      +++     +  +  
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183

Query: 67  PELLADY-------QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
           P++           + Y  ++D+WS+G           PF            + K++  +
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

Query: 120 ELFEYLDKYHIELDP 134
                      E  P
Sbjct: 244 PSGAISGVQKAENGP 258

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  114 bits (287), Expect = 7e-28
 Identities = 76/378 (20%), Positives = 134/378 (35%), Gaps = 102/378 (26%)

Query: 152 HKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVK-ILKPVKK- 209
           H  +          DW   D Y++   +G G Y  V EA +        +K IL+  +  
Sbjct: 34  HSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL 93

Query: 210 ---KKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA---LIFEHVNNTDFKQL---YQ 260
              K+I REI IL  L    +++ +  +V            ++ E  + +DFK+L     
Sbjct: 94  IDCKRILREIAILNRLNH-DHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPV 151

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
            LT+  I+  LY LL  + Y HS GI+HRD+KP N +++ ++  +++ D+GLA      +
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPE 210

Query: 321 EYNVR----------------------------VASRYFKGPE-LLADYQYHIELD---- 347
             N +                            V +R+++ PE +L    Y   +D    
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270

Query: 348 ---------PRFADILGRHSRK----------RWERFVHTENQHLVSPEALDFLDK--NI 386
                        ++     R                    +    +    D L+   NI
Sbjct: 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330

Query: 387 LGRHSRKRWERFVHTENQHLVSPEALDFL--------------------------DKLLR 420
           LG  S +  E         L   +A  ++                           ++L 
Sbjct: 331 LGTPSEEDIEA--------LEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLV 382

Query: 421 YDHYERLTAREAMDHPYF 438
           ++  +R+T  E + HP+F
Sbjct: 383 FNPNKRITINECLAHPFF 400

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 39/167 (23%), Positives = 68/167 (40%), Gaps = 59/167 (35%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----------- 58
            + Y HS GI+HRD+KP N +++ ++  +++ D+GLA      +  N +           
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226

Query: 59  -----------------VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMI-------- 93
                            V +R+++ PEL+   + Y  ++D+WS+GC+ A ++        
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286

Query: 94  --FRKEPFFHGHD--------------------NYDQLVRIAKVLGT 118
               + P F G                      N DQL  I  +LGT
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGT 333

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  111 bits (280), Expect = 2e-27
 Identities = 67/304 (22%), Positives = 111/304 (36%), Gaps = 85/304 (27%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVK-ILKPVKKKKIKREIKILENLRGGTNI 228
            D +++  +LGRG  S V+      +     +K + K V KK ++ EI +L  L    NI
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNI 110

Query: 229 ITLQAVVKDPVSRTPALIFEHVNNTDF------KQLYQTLTDYDIRYYLYELLKALDYCH 282
           I L+ + + P   +  L+ E V   +       K  Y   ++ D    + ++L+A+ Y H
Sbjct: 111 IKLKEIFETPTEIS--LVLELVTGGELFDRIVEKGYY---SERDAADAVKQILEAVAYLH 165

Query: 283 SMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
             GI+HRD+KP N++      +  L++ D+GL++             +  +  PE+L   
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC 225

Query: 341 QYHIELD---------------PRFAD----------ILGRH---SRKRWERFVHTENQH 372
            Y  E+D                 F D          IL          W+         
Sbjct: 226 AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDE-------- 277

Query: 373 LVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREA 432
            VS  A D + K                                 L+  D  +RLT  +A
Sbjct: 278 -VSLNAKDLVRK---------------------------------LIVLDPKKRLTTFQA 303

Query: 433 MDHP 436
           + HP
Sbjct: 304 LQHP 307

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 24/82 (29%), Positives = 41/82 (50%), Gaps = 3/82 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y H  GI+HRD+KP N++      +  L++ D+GL++             +  +  P
Sbjct: 160 AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAP 219

Query: 68  ELLADYQMYDYSLDMWSLGCML 89
           E+L     Y   +DMWS+G + 
Sbjct: 220 EILR-GCAYGPEVDMWSVGIIT 240

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  112 bits (281), Expect = 3e-27
 Identities = 64/322 (19%), Positives = 117/322 (36%), Gaps = 77/322 (23%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL-----------KPVKKKKIKREIKI 218
           +D+Y + + LG G   EV  A   ++  K  ++I+           +      ++ EI+I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 219 LENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQL--YQTLTDYDIRYYLYELL 275
           L+ L     II ++            ++ E +   + F ++   + L +   + Y Y++L
Sbjct: 194 LKKLNH-PCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249

Query: 276 KALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 333
            A+ Y H  GI+HRD+KP NV++    E+  +++ D+G ++             +  +  
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309

Query: 334 PELLADYQ---YHIELD---------------PRFADILGRHS-----RKRWERFVHTEN 370
           PE+L       Y+  +D               P F++   + S           F+    
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369

Query: 371 QHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAR 430
              VS +ALD                                  + KLL  D   R T  
Sbjct: 370 AE-VSEKALDL---------------------------------VKKLLVVDPKARFTTE 395

Query: 431 EAMDHPYFYPIVKDQSRHTLPS 452
           EA+ HP+       +    L S
Sbjct: 396 EALRHPWLQDEDMKRKFQDLLS 417

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 84.0 bits (208), Expect = 9e-18
 Identities = 28/109 (25%), Positives = 49/109 (44%), Gaps = 4/109 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y H  GI+HRD+KP NV++    E+  +++ D+G ++             +  +  P
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310

Query: 68  ELLAD--YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           E+L       Y+ ++D WSLG +L   +    PF           +I  
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 359

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  110 bits (276), Expect = 4e-27
 Identities = 45/187 (24%), Positives = 84/187 (44%), Gaps = 17/187 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL---------KPVKKKKIKREIKILEN 221
             YQ+   LG G +  V+  I V  +    +K +         +     ++  E+ +L+ 
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 222 LR-GGTNIITLQAVVKDPVSRTPALIFEHVNNT----DFKQLYQTLTDYDIRYYLYELLK 276
           +  G + +I L    + P   +  LI E         DF      L +   R + +++L+
Sbjct: 103 VSSGFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 160

Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 336
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEW 219

Query: 337 LADYQYH 343
           +  ++YH
Sbjct: 220 IRYHRYH 226

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 3/91 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE 
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEW 219

Query: 70  LADYQMYD-YSLDMWSLGCMLASMIFRKEPF 99
           +  Y  Y   S  +WSLG +L  M+    PF
Sbjct: 220 IR-YHRYHGRSAAVWSLGILLYDMVCGDIPF 249

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  106 bits (267), Expect = 6e-26
 Identities = 42/189 (22%), Positives = 77/189 (40%), Gaps = 19/189 (10%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL---------KPVKKKKIKREIKILEN 221
            +Y+L   LG+G +  VF    +    +  +K++                   E+ +L  
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 222 LRGGT---NIITLQAVVKDPVSRTPALIFEHVNNT----DFKQLYQTLTDYDIRYYLYEL 274
           +  G     +I L    +        L+ E         D+      L +   R +  ++
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFM--LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQV 148

Query: 275 LKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 334
           + A+ +CHS G++HRD+K  N++ID      +LID+G     H    Y     +R +  P
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPP 207

Query: 335 ELLADYQYH 343
           E ++ +QYH
Sbjct: 208 EWISRHQYH 216

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 77.3 bits (191), Expect = 7e-16
 Identities = 30/103 (29%), Positives = 50/103 (48%), Gaps = 7/103 (6%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ +CHS G++HRD+K  N++ID      +LID+G     H    Y     +R +  PE 
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEW 209

Query: 70  LADYQMYD-YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 111
           ++    Y      +WSLG +L  M+    PF    +   +++ 
Sbjct: 210 IS-RHQYHALPATVWSLGILLYDMVCGDIPF----ERDQEILE 247

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  106 bits (267), Expect = 7e-26
 Identities = 43/189 (22%), Positives = 80/189 (42%), Gaps = 20/189 (10%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----------KKKIKREIKI 218
           +D+Y + + LG G   EV  A   ++  K  +KI+   K              ++ EI+I
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 219 LENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELL 275
           L+ L     II ++            ++ E +      D     + L +   + Y Y++L
Sbjct: 69  LKKLNH-PCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124

Query: 276 KALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 333
            A+ Y H  GI+HRD+KP NV++    E+  +++ D+G ++             +  +  
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184

Query: 334 PELLADYQY 342
           PE+L     
Sbjct: 185 PEVLVSVGT 193

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 25/84 (29%), Positives = 44/84 (52%), Gaps = 4/84 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y H  GI+HRD+KP NV++    E+  +++ D+G ++             +  +  P
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185

Query: 68  ELLA--DYQMYDYSLDMWSLGCML 89
           E+L       Y+ ++D WSLG +L
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVIL 209

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 17/46 (36%), Positives = 22/46 (47%)

Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPS 452
           VS +ALD + KLL  D   R T  EA+ HP+       +    L S
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLS 292

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  106 bits (266), Expect = 2e-25
 Identities = 48/343 (13%), Positives = 97/343 (28%), Gaps = 96/343 (27%)

Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK------KKIKREIKILEN 221
            +         LG+       EA + ++ +   V +    ++      K++K E+  L  
Sbjct: 70  ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDI-------------- 267
           LRG  N    +  ++      P  + +        ++     D  +              
Sbjct: 130 LRGIKNQKQAKVHLRFIF---PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186

Query: 268 ----------------------RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKL 305
                                      ++++ L   H  G++H  ++P ++++D     +
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-V 245

Query: 306 RLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERF 365
            L  +             V   SR F+ PEL A                   S  R  R 
Sbjct: 246 FLTGFEHL---VRDGARVVSSVSRGFEPPELEARRAT--------------ISYHRDRRT 288

Query: 366 VHTENQHLVSPEALD-----------------FLDKNILGRHSRKRWERFVHTENQHLVS 408
           + T         + D                       LG          +    ++ + 
Sbjct: 289 LMT--------FSFDAWALGLVIYWIWCADLPITKDAALGGSEW------IFRSCKN-IP 333

Query: 409 PEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLP 451
                 L+  LRY   +RL   +AM+ P +  + + +    LP
Sbjct: 334 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL-RTELSAALP 375

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 21/102 (20%), Positives = 38/102 (37%), Gaps = 14/102 (13%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L   H  G++H  ++P ++++D     + L  +             V   SR F+ PEL
Sbjct: 218 LLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEHL---VRDGARVVSSVSRGFEPPEL 273

Query: 70  LADYQ----------MYDYSLDMWSLGCMLASMIFRKEPFFH 101
            A             +  +S D W+LG ++  +     P   
Sbjct: 274 EARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  105 bits (263), Expect = 2e-25
 Identities = 54/348 (15%), Positives = 111/348 (31%), Gaps = 59/348 (16%)

Query: 140 LGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKC 199
           +G +  +   +S +   Y+     ++D      Y  ++KLG G +S V     +      
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGHMVIID---NKHYLFIQKLGEGGFSYVDLVEGLHDGHFY 57

Query: 200 VVKIL---KPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA--LIFEHVNNTD 254
            +K +   +   +++ +RE  +        NI+ L A             L+        
Sbjct: 58  ALKRILCHEQQDREEAQREADMHRLFNH-PNILRLVAYCLRERGAKHEAWLLLPFFKRGT 116

Query: 255 -------FKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRL 307
                   K     LT+  I + L  + + L+  H+ G  HRD+KP N+++  E +   L
Sbjct: 117 LWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ-PVL 175

Query: 308 IDWGLAEFYHPG----------QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRH 357
           +D G                  Q++  +  +  ++ PEL +   +   +D R  D+    
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHC-VIDER-TDV---- 229

Query: 358 SRKRWE------RFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEA 411
               W         +         P    +      G       +  +        S   
Sbjct: 230 ----WSLGCVLYAMM-----FGEGP----YDMVFQKGDSVALAVQNQLSIPQSPRHSSAL 276

Query: 412 LDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIV 459
              L+ ++  D ++R      +          +  +   P    T I+
Sbjct: 277 WQLLNSMMTVDPHQRPHIPLLLSQL-------EALQPPAPGQHTTQIL 317

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 83.9 bits (208), Expect = 4e-18
 Identities = 30/124 (24%), Positives = 56/124 (45%), Gaps = 13/124 (10%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-------- 52
           + +  G    L+  H+ G  HRD+KP N+++  E +   L+D G                
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ-PVLMDLGSMNQACIHVEGSRQAL 195

Query: 53  --QEYNVRVASRYFKGPELLAD--YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 108
             Q++  +  +  ++ PEL +   + + D   D+WSLGC+L +M+F + P+       D 
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255

Query: 109 LVRI 112
           +   
Sbjct: 256 VALA 259

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  103 bits (260), Expect = 2e-25
 Identities = 57/300 (19%), Positives = 109/300 (36%), Gaps = 52/300 (17%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI-----LKPVKKKKIKREIKILENLRGG 225
           +DY+++  +G G Y    +          V K      +   +K+ +  E+ +L  L+  
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 64

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTD-------FKQLYQTLTDYDIRYYLYELLKAL 278
            NI+     + D  + T  ++ E+    D         +  Q L +  +   + +L  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 279 DYCHSMG-----IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFK 332
             CH        ++HRD+KP NV +D   + ++L D+GLA   +    +    V + Y+ 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 333 GPELLADYQYHIELDPRFADILGRHSRKRW-------ERFVHTENQHLVSPEALDFLDKN 385
            PE +    Y    + + +DI        W       E           +  +   L   
Sbjct: 184 SPEQMNRMSY----NEK-SDI--------WSLGCLLYELCAL---MPPFTAFSQKELAGK 227

Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
           I     R+   R+         S E  + + ++L    Y R +  E +++P         
Sbjct: 228 IREGKFRRIPYRY---------SDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHH 278

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 32/109 (29%), Positives = 52/109 (47%), Gaps = 10/109 (9%)

Query: 9   MALDYCHSMG-----IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASR 62
           +AL  CH        ++HRD+KP NV +D   + ++L D+GLA   +    +    V + 
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTP 180

Query: 63  YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 111
           Y+  PE +     Y+   D+WSLGC+L  +     PF     +  +L  
Sbjct: 181 YYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT--AFSQKELAG 226

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  105 bits (263), Expect = 5e-25
 Identities = 74/327 (22%), Positives = 129/327 (39%), Gaps = 71/327 (21%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK--KKIKREIKILENLR------- 223
           Y LVRKLG G +S V+ A ++ ++    +KI++  K   +  + EIK+L+ +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 224 ---GGTNIITLQA--VVKDPVSRTPALIFE--HVNNTDF--KQLYQTLTDYDIRYYLYEL 274
              G  +I+ L      K P      ++FE    N      K  ++ +    ++    +L
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140

Query: 275 LKALDYCHSM-GIMHRDVKPHNVMIDHENR-----KLRLIDWGLAEFYHPGQEYNVRVAS 328
           L  LDY H   GI+H D+KP NV+++  +      ++++ D G A +Y   + Y   + +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQT 198

Query: 329 RYFKGPELL--ADYQYHI----------EL---DPRFADILGRHSRKRWERFVHTENQHL 373
           R ++ PE+L  A +              EL   D  F           + +    ++ H+
Sbjct: 199 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP----DEGHSYTK----DDDHI 250

Query: 374 V----------------SPEALDFLDKNILGRHSRK---RWERFVHTENQHLVSPEA--- 411
                                  F +   L R+  K        V TE       EA   
Sbjct: 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 310

Query: 412 LDFLDKLLRYDHYERLTAREAMDHPYF 438
            DFL  +L+ D  +R  A   ++HP+ 
Sbjct: 311 SDFLSPMLQLDPRKRADAGGLVNHPWL 337

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 31/120 (25%), Positives = 59/120 (49%), Gaps = 16/120 (13%)

Query: 10  ALDYCHSM-GIMHRDVKPHNVMIDHENR-----KLRLIDWGLAEFYHPGQEYNVRVASRY 63
            LDY H   GI+H D+KP NV+++  +      ++++ D G A +Y   + Y   + +R 
Sbjct: 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTRE 200

Query: 64  FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD------NYDQLVRIAKVLG 117
           ++ PE+L     +    D+WS  C++  +I      F   +      + D + +I ++LG
Sbjct: 201 YRSPEVLLGAP-WGCGADIWSTACLIFELITGD-FLFEPDEGHSYTKDDDHIAQIIELLG 258

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  104 bits (261), Expect = 5e-25
 Identities = 61/306 (19%), Positives = 131/306 (42%), Gaps = 44/306 (14%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI-----LKPVKKKKIKREIKILENLRGGT 226
           +Y+L++ +G+G +++V  A ++ +  +  +KI     L P   +K+ RE++I++ L    
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-P 74

Query: 227 NIITLQAVVKDPVSRTPA---LIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDY 280
           NI+ L  V++     T     LI E+ +     D+   +  + + + R    +++ A+ Y
Sbjct: 75  NIVKLFEVIE-----TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           CH   I+HRD+K  N+++D  +  +++ D+G +  +  G + +    +  +  PEL    
Sbjct: 130 CHQKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGK 188

Query: 341 QYHIELDPRFADILGRHSRKRWER----FVHTENQHLVSPEALDFLDKNILGRHSRKRWE 396
           +Y    D    D+        W      +       LVS  +L F  +N+  +  R+R  
Sbjct: 189 KY----DGPEVDV--------WSLGVILYT------LVS-GSLPFDGQNL--KELRERVL 227

Query: 397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPT 456
           R  +    ++ S +  + L + L  +  +R T  + M   +     ++            
Sbjct: 228 RGKYRIPFYM-STDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELD 286

Query: 457 PIVNSV 462
                 
Sbjct: 287 ISDQKR 292

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 27/91 (29%), Positives = 51/91 (56%), Gaps = 3/91 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ YCH   I+HRD+K  N+++D  +  +++ D+G +  +  G + +    +  +  PEL
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPEL 184

Query: 70  LADYQMYD-YSLDMWSLGCMLASMIFRKEPF 99
               + YD   +D+WSLG +L +++    PF
Sbjct: 185 FQG-KKYDGPEVDVWSLGVILYTLVSGSLPF 214

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  105 bits (265), Expect = 5e-25
 Identities = 61/325 (18%), Positives = 132/325 (40%), Gaps = 70/325 (21%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK--KKIKREIKILENLR-----GG 225
           Y++++ +G+G + +V +A + +      +K+++  K+  ++   EI+ILE+LR       
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 226 TNIITLQA---------VVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLK 276
            N+I +           +  + +S     ++E +    F+     L    +R + + +L+
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMN---LYELIKKNKFQGFSLPL----VRKFAHSILQ 211

Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 335
            LD  H   I+H D+KP N+++  + R  +++ID+G + + H  Q     + SR+++ PE
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--QRVYTYIQSRFYRAPE 269

Query: 336 LLADYQYHIELD---------------PRFA------------DILG-------RHSRKR 361
           ++   +Y + +D               P               ++LG         S++ 
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA 329

Query: 362 WERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEA--------LD 413
                 +   +          D +++    R R  +                      LD
Sbjct: 330 KNFV--SSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387

Query: 414 FLDKLLRYDHYERLTAREAMDHPYF 438
           FL + L +D   R+T  +A+ HP+ 
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWL 412

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 94.0 bits (234), Expect = 6e-21
 Identities = 37/109 (33%), Positives = 62/109 (56%), Gaps = 5/109 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
            LD  H   I+H D+KP N+++  + R  +++ID+G + + H  Q     + SR+++ PE
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--QRVYTYIQSRFYRAPE 269

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           ++   + Y   +DMWSLGC+LA +     P   G D  DQL  + ++LG
Sbjct: 270 VILGAR-YGMPIDMWSLGCILAEL-LTGYPLLPGEDEGDQLACMIELLG 316

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  102 bits (257), Expect = 9e-25
 Identities = 37/153 (24%), Positives = 75/153 (49%), Gaps = 12/153 (7%)

Query: 171 DDYQLV-RKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNII 229
           DDY++  + LG G   +V +  N ++ +K  +K+L+     K +RE+++        +I+
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 74

Query: 230 TLQAVVKDPVSRTPA--LIFEHVNNTD-----FKQLYQTLTDYDIRYYLYELLKALDYCH 282
            +  V ++  +      ++ E ++  +       +  Q  T+ +    +  + +A+ Y H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134

Query: 283 SMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLA 313
           S+ I HRDVKP N++      N  L+L D+G A
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 70.8 bits (174), Expect = 9e-14
 Identities = 28/82 (34%), Positives = 37/82 (45%), Gaps = 24/82 (29%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 67
           A+ Y HS+ I HRDVKP N++      N  L+L D+G A                     
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------K 168

Query: 68  ELLADYQMYDYSLDMWSLGCML 89
           E     + YD S DMWSLG ++
Sbjct: 169 ETTG--EKYDKSCDMWSLGVIM 188

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 11/30 (36%), Positives = 17/30 (56%)

Query: 407 VSPEALDFLDKLLRYDHYERLTAREAMDHP 436
           VS E    +  LL+ +  +R+T  E M+HP
Sbjct: 229 VSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  102 bits (256), Expect = 1e-24
 Identities = 39/169 (23%), Positives = 80/169 (47%), Gaps = 13/169 (7%)

Query: 162 SYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL------KPVKKKKIKRE 215
             +VD   +  Y   R LG+G +++ FE  +  + +    KI+      KP +++K+  E
Sbjct: 6   EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65

Query: 216 IKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNN---TDFKQLYQTLTDYDIRYYLY 272
           I I  +L    +++      +D       ++ E        +  +  + LT+ + RYYL 
Sbjct: 66  ISIHRSLAH-QHVVGFHGFFEDNDFVF--VVLELCRRRSLLELHKRRKALTEPEARYYLR 122

Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
           +++    Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA       E
Sbjct: 123 QIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGE 170

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 26/100 (26%), Positives = 52/100 (52%), Gaps = 21/100 (21%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----------YNVRV 59
              Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA       E          Y   +
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY---I 182

Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           A      PE+L+  + + + +D+WS+GC++ +++  K PF
Sbjct: 183 A------PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 215

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  102 bits (257), Expect = 2e-24
 Identities = 39/169 (23%), Positives = 80/169 (47%), Gaps = 13/169 (7%)

Query: 162 SYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL------KPVKKKKIKRE 215
             +VD   +  Y   R LG+G +++ FE  +  + +    KI+      KP +++K+  E
Sbjct: 32  EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 91

Query: 216 IKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNN---TDFKQLYQTLTDYDIRYYLY 272
           I I  +L    +++      +D       ++ E        +  +  + LT+ + RYYL 
Sbjct: 92  ISIHRSLAH-QHVVGFHGFFEDN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 148

Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
           +++    Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA       E
Sbjct: 149 QIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGE 196

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 26/100 (26%), Positives = 52/100 (52%), Gaps = 21/100 (21%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----------YNVRV 59
              Y H   ++HRD+K  N+ ++ E+ ++++ D+GLA       E          Y   +
Sbjct: 153 GCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY---I 208

Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           A      PE+L+  + + + +D+WS+GC++ +++  K PF
Sbjct: 209 A------PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 241

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  100 bits (252), Expect = 4e-24
 Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 17/154 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKK--------KIKREIKILENL 222
           +D+++ R LG+GK+  V+ A   QS     +K+L   K +        +++RE++I  +L
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 66

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQL--YQTLTDYDIRYYLYELLKALD 279
           R   NI+ L     D  +    LI E+      +++L       +     Y+ EL  AL 
Sbjct: 67  RH-PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           YCHS  ++HRD+KP N+++     +L++ D+G +
Sbjct: 124 YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWS 156

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 33/116 (28%), Positives = 59/116 (50%), Gaps = 24/116 (20%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---------EYNVRVA 60
           AL YCHS  ++HRD+KP N+++     +L++ D+G +  + P           +Y   + 
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSV-HAPSSRRTDLCGTLDY---LP 175

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV-RIAKV 115
                 PE++   +M+D  +D+WSLG +    +  K PF    + Y +   RI++V
Sbjct: 176 ------PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE--ANTYQETYKRISRV 222

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =   99 bits (250), Expect = 7e-24
 Identities = 34/153 (22%), Positives = 82/153 (53%), Gaps = 14/153 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL------KPVKKKKIKREIKILENLRG 224
           +D+++   LG+G ++ V+ A ++ +  +  +K++      K    ++++ E+KI   L+ 
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ---TLTDYDIRYYLYELLKALDY 280
             +I+ L    +D       L+ E  +N +  + L       ++ + R+++++++  + Y
Sbjct: 71  -PSILELYNYFEDS--NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            HS GI+HRD+   N+++   N  +++ D+GLA
Sbjct: 128 LHSHGILHRDLTLSNLLLT-RNMNIKIADFGLA 159

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 67.2 bits (165), Expect = 1e-12
 Identities = 25/99 (25%), Positives = 45/99 (45%), Gaps = 19/99 (19%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---------VA 60
            + Y HS GI+HRD+   N+++   N  +++ D+GLA        +            ++
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLT-RNMNIKIADFGLAT--QLKMPHEKHYTLCGTPNYIS 180

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
                 PE+      +    D+WSLGCM  +++  + PF
Sbjct: 181 ------PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPF 212

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 99.6 bits (249), Expect = 7e-24
 Identities = 57/284 (20%), Positives = 113/284 (39%), Gaps = 41/284 (14%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK----KKIKREIKILENLRGGT 226
           +D+ LV+ LG G Y EV  A+N  + +   VKI+   +     + IK+EI I + L    
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N++      ++       L  E+ +     D  +    + + D + + ++L+  + Y H 
Sbjct: 66  NVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV---RVASRYFKGPELLADY 340
           +GI HRD+KP N+++D E   L++ D+GLA  +       +      +  +  PELL   
Sbjct: 124 IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 341 QYHIELDPRFAD------ILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR 394
           ++         D      +L                  +++   L +   +   +     
Sbjct: 183 EF----HAEPVDVWSCGIVL----------TA------MLA-GELPWDQPSDSCQEYSDW 221

Query: 395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            E+  +      +    L  L K+L  +   R+T  +     ++
Sbjct: 222 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 64.5 bits (158), Expect = 8e-12
 Identities = 29/109 (26%), Positives = 54/109 (49%), Gaps = 6/109 (5%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV---RVASRYFKG 66
            + Y H +GI HRD+KP N+++D E   L++ D+GLA  +       +      +  +  
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 67  PELLADYQMYD-YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           PELL   + +    +D+WS G +L +M+  + P+    D+  +     +
Sbjct: 176 PELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 57/314 (18%), Positives = 104/314 (33%), Gaps = 81/314 (25%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK----PVKKKKIKREIKILENLRGGT 226
            D++ ++ LGRG +  VFEA N        +K ++     + ++K+ RE+K L  L    
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-P 63

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--------QTLTDY------------- 265
            I+       +  +       +   ++    LY        + L D+             
Sbjct: 64  GIVRYFNAWLEKNTTE-----KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118

Query: 266 DIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-------EFYHP 318
              +   ++ +A+++ HS G+MHRD+KP N+     +  +++ D+GL        E    
Sbjct: 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTV 177

Query: 319 GQEYNVRVASRYFKG------PELLADYQYHIELDPRFADILGRHSRKRW-------ERF 365
                         G      PE +    Y  +      DI        +       E  
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-----VDI--------FSLGLILFE-- 222

Query: 366 VHTENQHLVSPEALDFLDKNILGRHSRK-RWERFVHTENQHLVSPEALDFLDKLLRYDHY 424
                  L+ P    F  +    R     R  +F     Q    P     +  +L     
Sbjct: 223 -------LLYP----FSTQMERVRTLTDVRNLKFPPLFTQK--YPCEYVMVQDMLSPSPM 269

Query: 425 ERLTAREAMDHPYF 438
           ER  A   +++  F
Sbjct: 270 ERPEAINIIENAVF 283

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 82.8 bits (205), Expect = 9e-18
 Identities = 28/125 (22%), Positives = 52/125 (41%), Gaps = 18/125 (14%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-------EFYHPGQ 53
           + I    + A+++ HS G+MHRD+KP N+     +  +++ D+GL        E      
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 54  EYNVRVASRYFKG------PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 107
                       G      PE +     Y + +D++SLG +L  +++   PF    +   
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235

Query: 108 QLVRI 112
            L  +
Sbjct: 236 TLTDV 240

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  100 bits (250), Expect = 2e-23
 Identities = 61/284 (21%), Positives = 116/284 (40%), Gaps = 41/284 (14%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL--KPVKKKKIKREIKILENLRGGTNI 228
           D Y  V+ +G G +       +  + +   VK +       + ++REI    +LR   NI
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNI 78

Query: 229 ITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHSMG 285
           +  + V+  P     A+I E+ +     +        ++ + R++  +LL  + YCHSM 
Sbjct: 79  VRFKEVILTP--THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136

Query: 286 IMHRDVKPHNVMID-HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHI 344
           I HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L   +Y  
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEY-- 194

Query: 345 ELDPRFAD------ILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
             D + AD       L          +V      ++   A  F D      + RK  +R 
Sbjct: 195 --DGKIADVWSCGVTL----------YV------MLV-GAYPFEDPEEPRDY-RKTIQRI 234

Query: 399 VHTE----NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           +  +    +   +SPE    + ++   D   R++  E   H +F
Sbjct: 235 LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 3/92 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMID-HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
            + YCHSM I HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 187

Query: 69  LLADYQMYD-YSLDMWSLGCMLASMIFRKEPF 99
           +L   Q YD    D+WS G  L  M+    PF
Sbjct: 188 VLLR-QEYDGKIADVWSCGVTLYVMLVGAYPF 218

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 62/314 (19%), Positives = 112/314 (35%), Gaps = 58/314 (18%)

Query: 172 DYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-----------PVKKKKIKREIKILE 220
            Y  +  LG G +  V+ A++ + + + VVK +K             K  K+  EI IL 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 221 NLRGGTNIITLQAVVKDPVSRTPALIFEHVNNT----DFKQLYQTLTDYDIRYYLYELLK 276
            +    NII +  + ++       L+ E   +      F   +  L +    Y   +L+ 
Sbjct: 85  RVEH-ANIIKVLDIFENQ--GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141

Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 336
           A+ Y     I+HRD+K  N++I  E+  ++LID+G A +   G+ +     +  +  PE+
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200

Query: 337 LADYQYHIELDPRFADILGRHSRKRWER----FVHTENQHLVSPEALDF--LDKNILGRH 390
           L    Y         ++        W      +       LV  E   F  L++ +    
Sbjct: 201 LMGNPY----RGPELEM--------WSLGVTLYT------LVF-EENPFCELEETVEAAI 241

Query: 391 SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF---YPIVKDQSR 447
                           VS E +  +  LL+     R T  + +  P+      +      
Sbjct: 242 HPPYL-----------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWE 290

Query: 448 HTLPSSSPTPIVNS 461
                + P   V S
Sbjct: 291 EVFRVNKPESGVLS 304

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 77.8 bits (192), Expect = 5e-16
 Identities = 31/103 (30%), Positives = 53/103 (51%), Gaps = 7/103 (6%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+ Y     I+HRD+K  N++I  E+  ++LID+G A +   G+ +     +  +  PE+
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200

Query: 70  LADYQMYD-YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 111
           L     Y    L+MWSLG  L +++F + PF       ++ V 
Sbjct: 201 LMG-NPYRGPELEMWSLGVTLYTLVFEENPF----CELEETVE 238

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 97.8 bits (244), Expect = 7e-23
 Identities = 60/307 (19%), Positives = 120/307 (39%), Gaps = 41/307 (13%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK----KKIKREIKILENLRGGT 226
           +D+ LV+ LG G Y EV  A+N  + +   VKI+   +     + IK+EI I + L    
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           N++      ++       L  E+ +     D  +    + + D + + ++L+  + Y H 
Sbjct: 66  NVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV---RVASRYFKGPELLADY 340
           +GI HRD+KP N+++D E   L++ D+GLA  +       +      +  +  PELL   
Sbjct: 124 IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 341 QYHIELDPRFAD------ILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR 394
           ++         D      +L                  +++   L +   +   +     
Sbjct: 183 EF----HAEPVDVWSCGIVL----------TA------MLA-GELPWDQPSDSCQEYSDW 221

Query: 395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSS 454
            E+  +      +    L  L K+L  +   R+T  +     ++   +K  ++    +S 
Sbjct: 222 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSG 281

Query: 455 PTPIVNS 461
                 S
Sbjct: 282 GVSESPS 288

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 29/109 (26%), Positives = 54/109 (49%), Gaps = 6/109 (5%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV---RVASRYFKG 66
            + Y H +GI HRD+KP N+++D E   L++ D+GLA  +       +      +  +  
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 67  PELLADYQMYD-YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           PELL   + +    +D+WS G +L +M+  + P+    D+  +     +
Sbjct: 176 PELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 98.1 bits (244), Expect = 1e-22
 Identities = 34/205 (16%), Positives = 77/205 (37%), Gaps = 30/205 (14%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSD-----KCVVKILKPVKKKKIKREIKILENLRGG 225
               +   LG G +++V+EA     +D     K V+K+ KP    +     +++E L+  
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124

Query: 226 T--NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ--------TLTDYDIRYYLYELL 275
                +   +           L+ E  +                  +    +  +   +L
Sbjct: 125 MQHMFMKFYSAHLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 276 KALDYCHSMGIMHRDVKPHNVMIDH----------ENRKLRLIDWGLA---EFYHPGQEY 322
             ++  H   I+H D+KP N ++ +           +  L LID G +   + +  G  +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 323 NVRVASRYFKGPELLADYQYHIELD 347
             +  +  F+  E+L++  ++ ++D
Sbjct: 243 TAKCETSGFQCVEMLSNKPWNYQID 267

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 20/118 (16%), Positives = 49/118 (41%), Gaps = 14/118 (11%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDH----------ENRKLRLIDWGLA---EFYHPGQEYN 56
            ++  H   I+H D+KP N ++ +           +  L LID G +   + +  G  + 
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243

Query: 57  VRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
            +  +  F+  E+L++ + ++Y +D + +   +  M+F             +   + +
Sbjct: 244 AKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 41/152 (26%), Positives = 79/152 (51%), Gaps = 13/152 (8%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRG 224
           DD+ + R LG+GK+  V+ A   Q+     +K+L   +      + +++REI+I  +LR 
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQL--YQTLTDYDIRYYLYELLKALDYC 281
             NI+ +     D   +   L+ E     + +K+L  +    +     ++ EL  AL YC
Sbjct: 74  -PNILRMYNYFHDR--KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 130

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           H   ++HRD+KP N+++ ++   L++ D+G +
Sbjct: 131 HERKVIHRDIKPENLLMGYKGE-LKIADFGWS 161

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 27/116 (23%), Positives = 53/116 (45%), Gaps = 24/116 (20%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---------EYNVRVA 60
           AL YCH   ++HRD+KP N+++ ++   L++ D+G +  + P           +Y   + 
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMGYKGE-LKIADFGWS-VHAPSLRRRTMCGTLDY---LP 180

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV-RIAKV 115
                 PE++   + +D  +D+W  G +    +    PF     ++ +   RI  V
Sbjct: 181 ------PEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFD--SPSHTETHRRIVNV 227

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 56/334 (16%), Positives = 120/334 (35%), Gaps = 81/334 (24%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK--KKIKREIKILENLRGGTNIIT 230
           Y++   +G+G + +V +A +    +   +KI+K  K    + + E+++LE +        
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK------ 109

Query: 231 LQAVVKDPVSRT--------------PALIFE--HVNNTDF--KQLYQTLTDYDIRYYLY 272
                 D   +                 L+FE    N  D      ++ ++    R +  
Sbjct: 110 -----HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQ 164

Query: 273 ELLKALDYCHS--MGIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFYHPGQEYNVRVASR 329
           ++  AL +  +  + I+H D+KP N+++ +  R  ++++D+G +      Q     + SR
Sbjct: 165 QMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSR 222

Query: 330 YFKGPELLADYQYHIELD---------------------------PRFADILG------- 355
           +++ PE+L    Y + +D                            +  ++LG       
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282

Query: 356 RHSRKRWERFVHTENQHLVSPEALDFLDK----------NILGRHSRKRWERFVHTENQH 405
             + K  + F    +      +  D   +          NILG  +     R        
Sbjct: 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHT 342

Query: 406 LVSPEAL-DFLDKLLRYDHYERLTAREAMDHPYF 438
           +       D + ++L YD   R+    A+ H +F
Sbjct: 343 VADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 87.1 bits (216), Expect = 8e-19
 Identities = 38/111 (34%), Positives = 65/111 (58%), Gaps = 7/111 (6%)

Query: 10  ALDYCHS--MGIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKG 66
           AL +  +  + I+H D+KP N+++ +  R  ++++D+G +      Q     + SR+++ 
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRFYRS 226

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
           PE+L     YD ++DMWSLGC+L  M    EP F G +  DQ+ +I +VLG
Sbjct: 227 PEVLLGMP-YDLAIDMWSLGCILVEM-HTGEPLFSGANEVDQMNKIVEVLG 275

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 61/309 (19%), Positives = 123/309 (39%), Gaps = 70/309 (22%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL---KPVKKK------------------- 210
           Y L  ++G+G Y  V  A N   +    +K+L   K +++                    
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 211 -------KIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQT- 261
                  ++ +EI IL+ L    N++ L  V+ DP      ++FE VN     +      
Sbjct: 75  QPRGPIEQVYQEIAILKKLDH-PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133

Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
           L++   R+Y  +L+K ++Y H   I+HRD+KP N+++  E+  +++ D+G++  +     
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDA 192

Query: 322 Y-NVRVASRYFKGPELLADYQYHIELDPRFADI-----------LGRHSRKRWERFVHTE 369
             +  V +  F  PE L++         +  D+            G+             
Sbjct: 193 LLSNTVGTPAFMAPESLSE--TRKIFSGKALDVWAMGVTLYCFVFGQ------------- 237

Query: 370 NQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTA 429
                      F+D+ I+  HS+ + +      +Q  ++ +  D + ++L  +   R+  
Sbjct: 238 ---------CPFMDERIMCLHSKIKSQAL-EFPDQPDIAEDLKDLITRMLDKNPESRIVV 287

Query: 430 REAMDHPYF 438
            E   HP+ 
Sbjct: 288 PEIKLHPWV 296

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 25/93 (26%), Positives = 53/93 (56%), Gaps = 4/93 (4%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGPE 68
            ++Y H   I+HRD+KP N+++  E+  +++ D+G++  +       +  V +  F  PE
Sbjct: 149 GIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPE 207

Query: 69  LLADY-QMYD-YSLDMWSLGCMLASMIFRKEPF 99
            L++  +++   +LD+W++G  L   +F + PF
Sbjct: 208 SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 70/282 (24%), Positives = 119/282 (42%), Gaps = 45/282 (15%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGT 226
           Y L   LG G + +V    +  +  K  VKIL   K        KIKREI+ L+  R   
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-P 71

Query: 227 NIITLQAVVKDPVSRTPALIF---EHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDY 280
           +II L  V+      TP   F   E+V+     D+   +  + + + R    ++L A+DY
Sbjct: 72  HIIKLYQVIS-----TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           CH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE+++  
Sbjct: 127 CHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 185

Query: 341 QYHIELDPRFADILGRHSRKRWE----RFVHTENQHLVSPEALDFLDKNILGRHSRKRWE 396
            Y         DI        W      +       L+    L F D+++      K+  
Sbjct: 186 LY----AGPEVDI--------WSCGVILYA------LLC-GTLPFDDEHV--PTLFKKIR 224

Query: 397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
             V    ++L +      L  +L+ D  +R T ++  +H +F
Sbjct: 225 GGVFYIPEYL-NRSVATLLMHMLQVDPLKRATIKDIREHEWF 265

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 64.1 bits (157), Expect = 1e-11
 Identities = 28/91 (30%), Positives = 52/91 (57%), Gaps = 3/91 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A+DYCH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE+
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181

Query: 70  LADYQMYD-YSLDMWSLGCMLASMIFRKEPF 99
           ++  ++Y    +D+WS G +L +++    PF
Sbjct: 182 ISG-RLYAGPEVDIWSCGVILYALLCGTLPF 211

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 95.0 bits (237), Expect = 6e-22
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 13/160 (8%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-------PVKKKKIKREIKILENLRGG 225
           Y +   LG G Y +V E ++ ++  +  VKILK       P  +  +K+EI++L  LR  
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH- 65

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDF----KQLYQTLTDYDIRYYLYELLKALDYC 281
            N+I L  V+ +   +   ++ E+              +         Y  +L+  L+Y 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
           HS GI+H+D+KP N+++      L++   G+AE  HP   
Sbjct: 126 HSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAA 164

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 5/94 (5%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV---RVASRYFKG 66
            L+Y HS GI+H+D+KP N+++      L++   G+AE  HP    +       S  F+ 
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 67  PELLADYQMYD-YSLDMWSLGCMLASMIFRKEPF 99
           PE+      +  + +D+WS G  L ++     PF
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 95.2 bits (237), Expect = 9e-22
 Identities = 33/183 (18%), Positives = 84/183 (45%), Gaps = 15/183 (8%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI-----LKPVKKKKIKREIKILENLRGG 225
           + Y  ++K+G G + +     + +   + V+K      +   ++++ +RE+ +L N++  
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH- 82

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDF-----KQLYQTLTDYDIRYYLYELLKALDY 280
            NI+  +   ++  + +  ++ ++    D       Q      +  I  +  ++  AL +
Sbjct: 83  PNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGPELLAD 339
            H   I+HRD+K  N+ +  ++  ++L D+G+A   +   E     + + Y+  PE+  +
Sbjct: 141 VHDRKILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199

Query: 340 YQY 342
             Y
Sbjct: 200 KPY 202

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 80.5 bits (199), Expect = 9e-17
 Identities = 26/92 (28%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGP 67
           +AL + H   I+HRD+K  N+ +  ++  ++L D+G+A   +   E     + + Y+  P
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSP 194

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           E+  + + Y+   D+W+LGC+L  +   K  F
Sbjct: 195 EICEN-KPYNNKSDIWALGCVLYELCTLKHAF 225

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 39/173 (22%), Positives = 75/173 (43%), Gaps = 17/173 (9%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL---KPVKKKKIKREIKILENLRGGTNII 229
            ++ R L  G ++ V+EA +V S  +  +K L   +  K + I +E+  ++ L G  NI+
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 230 TL--QAVVKDPVSRTPALIF----EHVNNTDFKQLYQT-----LTDYDIRYYLYELLKAL 278
                A +    S T    F    E       + L +      L+   +    Y+  +A+
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 279 DYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 329
            + H     I+HRD+K  N+++ ++   ++L D+G A       +Y+     R
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGT-IKLCDFGSATTISHYPDYSWSAQRR 201

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 28/116 (24%), Positives = 53/116 (45%), Gaps = 18/116 (15%)

Query: 1   MRIATGASMALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR 58
           ++I      A+ + H     I+HRD+K  N+++ ++   ++L D+G A       +Y+  
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT-IKLCDFGSATTISHYPDYSWS 197

Query: 59  VASR-------------YFKGPELLADY--QMYDYSLDMWSLGCMLASMIFRKEPF 99
              R              ++ PE++  Y         D+W+LGC+L  + FR+ PF
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 67/300 (22%), Positives = 125/300 (41%), Gaps = 47/300 (15%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL------KPVKKKKIKREIKILENLRGGT 226
           Y +   LG G + +V  A + ++  K  +K +      K     +++REI  L+ LR   
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-P 69

Query: 227 NIITLQAVVKDPVSRTPALIF---EHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDYC 281
           +II L  V+      TP  I    E+     F  + +   +T+ + R +  +++ A++YC
Sbjct: 70  HIIKLYDVIT-----TPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           H   I+HRD+KP N+++D +N  +++ D+GL+     G        S  +  PE++    
Sbjct: 125 HRHKIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKL 183

Query: 342 YHIELDPRFADILGRHSRKRWE----RFVHTENQHLVSPEALDFLDKNILGRHSRKRWER 397
           Y         D+        W      +V      ++    L F D+ I   +  K+   
Sbjct: 184 Y----AGPEVDV--------WSCGIVLYV------MLV-GRLPFDDEFI--PNLFKKVNS 222

Query: 398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTP 457
            V+     L SP A   + +++  D  +R+T +E    P+F     +   +  P      
Sbjct: 223 CVYVMPDFL-SPGAQSLIRRMIVADPMQRITIQEIRRDPWF---NVNLPDYLRPMEEVQG 278

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 29/91 (31%), Positives = 52/91 (57%), Gaps = 3/91 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
           A++YCH   I+HRD+KP N+++D +N  +++ D+GL+     G        S  +  PE+
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 178

Query: 70  LADYQMYD-YSLDMWSLGCMLASMIFRKEPF 99
           +   ++Y    +D+WS G +L  M+  + PF
Sbjct: 179 ING-KLYAGPEVDVWSCGIVLYVMLVGRLPF 208

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 68/336 (20%), Positives = 132/336 (39%), Gaps = 89/336 (26%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCV-VKILKPVKK--KKIKREIKILENLR-----G 224
           Y++V  LG G + +V E I+ ++  + V VKI+K V +  +  + EI++LE+L       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNT------------DF--KQLYQTLTDYDIRYY 270
               + +               FEH  +             DF  +  +       IR  
Sbjct: 76  TFRCVQMLEW------------FEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKM 123

Query: 271 LYELLKALDYCHSMGIMHRDVKPHNVMIDHENR------------------KLRLIDWGL 312
            Y++ K++++ HS  + H D+KP N++    +                    ++++D+G 
Sbjct: 124 AYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183

Query: 313 AEFYHPGQEYNVRVASRYFKGPE--LLADYQYHI----------EL---DPRFA------ 351
           A +        + V++R+++ PE  L   +              E       F       
Sbjct: 184 ATYDDE-HHSTL-VSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241

Query: 352 ------DILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR---KRWERFVHTE 402
                  ILG   +   ++   T  +     + LD+ + +  GR+     K  + F+ ++
Sbjct: 242 HLAMMERILGPLPKHMIQK---TRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298

Query: 403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           +         D + K+L YD  +R+T REA+ HP+F
Sbjct: 299 DVEH--ERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 26/126 (20%), Positives = 59/126 (46%), Gaps = 22/126 (17%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENR------------------KLRLIDWGLAEFYHP 51
           ++++ HS  + H D+KP N++    +                    ++++D+G A +   
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189

Query: 52  GQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 111
                + V++R+++ PE++     +    D+WS+GC+L    +     F  HD+ + L  
Sbjct: 190 -HHSTL-VSTRHYRAPEVILALG-WSQPCDVWSIGCILIEY-YLGFTVFPTHDSKEHLAM 245

Query: 112 IAKVLG 117
           + ++LG
Sbjct: 246 MERILG 251

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 93.2 bits (232), Expect = 5e-21
 Identities = 70/354 (19%), Positives = 132/354 (37%), Gaps = 90/354 (25%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCV-VKILKPVKK--KKIKREIKILENLRGGTNII 229
           Y++V  LG G + +V E ++       V +KI++ V K  +  + EI +L+ ++      
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKE----- 75

Query: 230 TLQAVVKDPVSRTP--------------ALIFE--HVNNTDF--KQLYQTLTDYDIRYYL 271
                 KD  ++                 + FE    N  +F  +  +Q      +R+  
Sbjct: 76  ------KDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMA 129

Query: 272 YELLKALDYCHSMGIMHRDVKPHNVMIDHENRK------------------LRLIDWGLA 313
           Y+L  AL + H   + H D+KP N++  +   +                  +R+ D+G A
Sbjct: 130 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 314 EFYHPGQEYNVRVASRYFKGPE--LLADYQYHI----------EL---DPRFA------- 351
            F H  + +   VA+R+++ PE  L   +              E       F        
Sbjct: 190 TFDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247

Query: 352 -----DILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW----ERFVHTE 402
                 ILG        R   T  Q       L + + +  GR+ ++         +   
Sbjct: 248 LVMMEKILGPIPSHMIHR---TRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304

Query: 403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPT 456
            +H    +  D + ++L +D  +R+T  EA+ HP+F   +  + R    S +P+
Sbjct: 305 LEH---VQLFDLMRRMLEFDPAQRITLAEALLHPFFAG-LTPEERSFHTSRNPS 354

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 34/126 (26%), Positives = 62/126 (49%), Gaps = 22/126 (17%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRK------------------LRLIDWGLAEFYHP 51
           AL + H   + H D+KP N++  +   +                  +R+ D+G A F H 
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH- 193

Query: 52  GQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 111
            + +   VA+R+++ PE++ +   +    D+WS+GC+L    +R    F  H+N + LV 
Sbjct: 194 -EHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEY-YRGFTLFQTHENREHLVM 250

Query: 112 IAKVLG 117
           + K+LG
Sbjct: 251 MEKILG 256

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 93.2 bits (231), Expect = 8e-21
 Identities = 48/353 (13%), Positives = 101/353 (28%), Gaps = 97/353 (27%)

Query: 168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK------KKIKREIKILEN 221
            +         LG+       EA + ++ +   V +    ++      K++K E+  L  
Sbjct: 75  ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDI-------------- 267
           LRG  N    +  ++      P  + +        ++     D  +              
Sbjct: 135 LRGIKNQKQAKVHLRFIF---PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 191

Query: 268 ----------------------RYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKL 305
                                      ++++ L   H  G++H  ++P ++++D     +
Sbjct: 192 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-V 250

Query: 306 RLIDWGLAEFYHPGQEYNVRVASRY----FKGPELLADYQYHIELDPRFADI--LGRHSR 359
            L  +        G      +   +         +L   Q+H  L     D   LG    
Sbjct: 251 FLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG---- 304

Query: 360 KRWERFVHTENQHLV---------SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPE 410
                         +          P      D   LG         ++    ++ +   
Sbjct: 305 --------------LAIYWIWCADLP----NTDDAALGG------SEWIFRSCKN-IPQP 339

Query: 411 ALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIVNSVP 463
               L+  LRY   +RL   +AM+ P +     +Q R  L ++ P    +  P
Sbjct: 340 VRALLEGFLRYPKEDRLLPLQAMETPEY-----EQLRTELSAALPLYQTDGEP 387

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 18/110 (16%), Positives = 37/110 (33%), Gaps = 13/110 (11%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           +++       L   H  G++H  ++P ++++D     + L  +             V   
Sbjct: 214 LQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEHL---VRDGASAVSPI 269

Query: 61  SRYFKGPELLA---------DYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
            R F  PE  A            +  ++ D W+LG  +  +     P   
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 61/309 (19%), Positives = 116/309 (37%), Gaps = 58/309 (18%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVK------ILKPVKKKKIKREIKILENLRG 224
            ++++ +K+GRG++SEV+ A  +       +K      ++    +    +EI +L+ L  
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTD-------FKQLYQTLTDYDIRYYLYELLKA 277
             N+I   A   +       ++ E  +  D       FK+  + + +  +  Y  +L  A
Sbjct: 92  -PNVIKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGPEL 336
           L++ HS  +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE 
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207

Query: 337 LADYQYHIELDPRFADI--LG---------RHSRKRWERFVHTENQHLVSPEALDFLDKN 385
           + +  Y    + + +DI  LG         +        F + +  +L S      L K 
Sbjct: 208 IHENGY----NFK-SDIWSLGCLLYEMAALQSP------F-YGDKMNLYS------LCKK 249

Query: 386 IL-GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY-FYPIVK 443
           I    +     + +         S E    ++  +  D  +R       D     +    
Sbjct: 250 IEQCDYPPLPSDHY---------SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300

Query: 444 DQSRHTLPS 452
               H    
Sbjct: 301 SSLEHHHHH 309

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 77.3 bits (191), Expect = 6e-16
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 3/105 (2%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGP 67
            AL++ HS  +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  P
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 112
           E + +   Y++  D+WSLGC+L  M   + PF+    N   L + 
Sbjct: 206 ERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 29/148 (19%), Positives = 63/148 (42%), Gaps = 18/148 (12%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-----PVKKKKIKREIKILENLRG 224
             ++  + K+G G++  VF+ +         +K  K      V ++   RE+     L  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 225 GTNIIT-LQAVVKDPVSRTPALIF-EHVNN-------TDFKQLYQTLTDYDIRYYLYELL 275
            ++++    A  +D       LI  E+ N        ++  ++     + +++  L ++ 
Sbjct: 70  HSHVVRYFSAWAED----DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 276 KALDYCHSMGIMHRDVKPHNVMIDHENR 303
           + L Y HSM ++H D+KP N+ I   + 
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSI 153

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 20/111 (18%), Positives = 38/111 (34%), Gaps = 15/111 (13%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG-------------LAEFYHPGQ- 53
              L Y HSM ++H D+KP N+ I   +      + G             + +  H  + 
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 54  -EYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
               V      F   E+L +   +    D+++L   +      +    +G 
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 64/350 (18%), Positives = 125/350 (35%), Gaps = 111/350 (31%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK--KKIKREIKILENLR----GGT 226
           + ++RK+G G +  V    ++ +     VK+++ +KK  +  K E  IL+ ++       
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNT------------DF--KQLYQTLTDYDIRYYLY 272
           NI+                 F + ++             +   +  Y      DI+ Y  
Sbjct: 97  NIVKYHGK------------FMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCI 144

Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHENRK------------------------LRLI 308
           E+LKAL+Y   M + H D+KP N+++D    +                        ++LI
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 309 DWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRW------ 362
           D+G A F      +   + +R ++ PE++ +  + +  D              W      
Sbjct: 205 DFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVSSD-------------MWSFGCVL 249

Query: 363 -ERFV-------HTENQHLVSPEA-LDFLDKNILGRHSRKRWERFVHTENQHLVSPEA-- 411
            E +        H   +HL   E+ +  + KN+L   ++    ++V+ +   L  PE   
Sbjct: 250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENAS 309

Query: 412 -----------------------LDFLDKLLRYDHYERLTAREAMDHPYF 438
                                   DFL  +L+ D   R +  E + H + 
Sbjct: 310 SINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 77.4 bits (191), Expect = 9e-16
 Identities = 32/132 (24%), Positives = 60/132 (45%), Gaps = 28/132 (21%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRK------------------------LRLIDWGL 45
           AL+Y   M + H D+KP N+++D    +                        ++LID+G 
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208

Query: 46  AEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 105
           A F      +   + +R ++ PE++ +   +D S DMWS GC+LA + +     F  H++
Sbjct: 209 ATFKS--DYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAEL-YTGSLLFRTHEH 264

Query: 106 YDQLVRIAKVLG 117
            + L  +  ++ 
Sbjct: 265 MEHLAMMESIIQ 276

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 92.9 bits (231), Expect = 2e-20
 Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 45/302 (14%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGT 226
           Y L   LG G + +V    +  +  K  VKIL   K        KI+REI+ L+  R   
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-P 76

Query: 227 NIITLQAVVKDPVSRTPALIF---EHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDY 280
           +II L  V+      TP+ IF   E+V+     D+      L + + R    ++L  +DY
Sbjct: 77  HIIKLYQVIS-----TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           CH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE+++  
Sbjct: 132 CHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 190

Query: 341 QYHIELDPRFADILGRHSRKRWE----RFVHTENQHLVSPEALDFLDKNILGRHSRKRWE 396
            Y         DI        W      +       L+    L F D ++      K+  
Sbjct: 191 LY----AGPEVDI--------WSSGVILYA------LLC-GTLPFDDDHV--PTLFKKIC 229

Query: 397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPT 456
             +    Q+L +P  +  L  +L+ D  +R T ++  +H +F   +        PS S T
Sbjct: 230 DGIFYTPQYL-NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSST 288

Query: 457 PI 458
            I
Sbjct: 289 MI 290

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 62.5 bits (152), Expect = 9e-11
 Identities = 27/91 (29%), Positives = 51/91 (56%), Gaps = 3/91 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            +DYCH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE+
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186

Query: 70  LADYQMYD-YSLDMWSLGCMLASMIFRKEPF 99
           ++  ++Y    +D+WS G +L +++    PF
Sbjct: 187 ISG-RLYAGPEVDIWSSGVILYALLCGTLPF 216

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 39/167 (23%), Positives = 66/167 (39%), Gaps = 10/167 (5%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIIT 230
                  ++GRG + EV    + Q+  +C VK ++   +     E+     L     I+ 
Sbjct: 58  HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRVEELVACAGLSS-PRIVP 114

Query: 231 LQAVVKDPVSRTPALIF-EHVNN---TDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGI 286
           L   V++        IF E +         +    L +    YYL + L+ L+Y H+  I
Sbjct: 115 LYGAVRE---GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171

Query: 287 MHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 333
           +H DVK  NV++  +  +  L D+G A    P       +   Y  G
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 27/100 (27%), Positives = 44/100 (44%), Gaps = 7/100 (7%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 66
            L+Y H+  I+H DVK  NV++  +  +  L D+G A    P       +   Y  G   
Sbjct: 162 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221

Query: 67  ---PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
              PE++   +  D  +D+WS  CM+  M+    P+    
Sbjct: 222 HMAPEVV-MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 40.9 bits (96), Expect = 7e-04
 Identities = 10/62 (16%), Positives = 16/62 (25%)

Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIV 459
             E     +P     + + LR +   R +A E               +         P  
Sbjct: 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG 334

Query: 460 NS 461
           NS
Sbjct: 335 NS 336

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 56/316 (17%), Positives = 120/316 (37%), Gaps = 68/316 (21%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK--------------------PVKKK 210
           +DY+++R L +GK++++             +K  +                      K  
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEKDNK--FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 211 KIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNN-----------TDFKQLY 259
             K E++I+ +++     +T + ++ +       +I+E++ N              K   
Sbjct: 89  DFKNELQIITDIKN-EYCLTCEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYT 145

Query: 260 QTLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
             +    I+  +  +L +  Y H+   I HRDVKP N+++D +N +++L D+G +E Y  
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-KNGRVKLSDFGESE-YMV 203

Query: 319 GQEYNVRVASRYFKGPELLA-DYQYHIELDPRFADI--LG-------------RHSRKRW 362
            ++      +  F  PE  + +  Y+     +  DI  LG                    
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYN---GAK-VDIWSLGICLYVMFYNVVPFSLKISLV 259

Query: 363 ERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYD 422
           E F +   +++  P   +     +  + S      F+  E+   +           LR +
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNN-FLSNEDIDFLK--------LFLRKN 310

Query: 423 HYERLTAREAMDHPYF 438
             ER+T+ +A+ H + 
Sbjct: 311 PAERITSEDALKHEWL 326

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 31/108 (28%), Positives = 52/108 (48%), Gaps = 4/108 (3%)

Query: 10  ALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           +  Y H+   I HRDVKP N+++D +N +++L D+G +E Y   ++      +  F  PE
Sbjct: 163 SFSYIHNEKNICHRDVKPSNILMD-KNGRVKLSDFGESE-YMVDKKIKGSRGTYEFMPPE 220

Query: 69  LLADYQMYD-YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
             ++   Y+   +D+WSLG  L  M +   PF       +    I   
Sbjct: 221 FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 41/155 (26%), Positives = 78/155 (50%), Gaps = 12/155 (7%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI--LKPVKKKKIKREIKILENLRGGTN 227
              ++LV  +G G Y +V++  +V++     +K+  +   ++++IK+EI +L+      N
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82

Query: 228 IIT-LQAVVKDPVSRTPA---LIFEHVNN---TDF--KQLYQTLTDYDIRYYLYELLKAL 278
           I T   A +K           L+ E       TD        TL +  I Y   E+L+ L
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            + H   ++HRD+K  NV++  EN +++L+D+G++
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVS 176

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 6/100 (6%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGP 67
             L + H   ++HRD+K  NV++  EN +++L+D+G+ A+        N  + + Y+  P
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198

Query: 68  ELLADYQM----YDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E++A  +     YD+  D+WSLG     M     P    H
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 46/298 (15%), Positives = 112/298 (37%), Gaps = 71/298 (23%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK-----IKREIKILENLRGGTN 227
            +   ++GRG +  V++ ++ +++ +     L+  K  K      K E ++L+ L+   N
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PN 86

Query: 228 IITLQAVVKDPVSRTPALIF--EHVNN---TDFKQLYQTLTDYDIRYYLYELLKALDYCH 282
           I+      +  V     ++   E + +     + + ++ +    +R +  ++LK L + H
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146

Query: 283 SMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           +    I+HRD+K  N+ I      +++ D GLA          V + +  F  PE+  + 
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMYEE- 204

Query: 341 QYH------------IEL---DPRFADILGRHSRKRWERFVHTEN-----QHLVSPEALD 380
           +Y             +E+   +  +++     +  +  R V +         +  PE  +
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSEC---QNAAQIYRRVTSGVKPASFDKVAIPEVKE 261

Query: 381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                                             ++  +R +  ER + ++ ++H +F
Sbjct: 262 I---------------------------------IEGCIRQNKDERYSIKDLLNHAFF 286

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 29/136 (21%), Positives = 54/136 (39%), Gaps = 12/136 (8%)

Query: 9   MALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 66
             L + H+    I+HRD+K  N+ I      +++ D GLA          V + +  F  
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMA 198

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLD 126
           PE+    + YD S+D+++ G  +  M   + P+           +I + + +       D
Sbjct: 199 PEMYE--EKYDESVDVYAFGMCMLEMATSEYPYS----ECQNAAQIYRRVTSGVKPASFD 252

Query: 127 KYHIELDPRFADILGR 142
           K      P   +I+  
Sbjct: 253 K---VAIPEVKEIIEG 265

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 34/155 (21%), Positives = 68/155 (43%), Gaps = 14/155 (9%)

Query: 169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK---KKIKREIKILENLRGG 225
           + D+      LG+G Y  V+   ++ +  +  +K +        + +  EI + ++L+  
Sbjct: 20  EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH- 78

Query: 226 TNIITLQAVVKDPVSRTPALIF-EHVNNTDFKQLYQT------LTDYDIRYYLYELLKAL 278
            NI+       +        IF E V       L ++        +  I +Y  ++L+ L
Sbjct: 79  KNIVQYLGSFSE---NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            Y H   I+HRD+K  NV+I+  +  L++ D+G +
Sbjct: 136 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTS 170

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 61.9 bits (151), Expect = 8e-11
 Identities = 29/111 (26%), Positives = 51/111 (45%), Gaps = 12/111 (10%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---- 66
           L Y H   I+HRD+K  NV+I+  +  L++ D+G +      +   +   +  F G    
Sbjct: 135 LKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTS-----KRLAGINPCTETFTGTLQY 189

Query: 67  --PE-LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
             PE +    + Y  + D+WSLGC +  M   K PF+   +    + ++  
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM 240

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 37/208 (17%), Positives = 76/208 (36%), Gaps = 65/208 (31%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL----KPVKKKKIKREIKILENLRGG 225
             D++ ++ +GRG +  VFEA N        +K +    + + ++K+ RE+K L  L   
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 226 TNIITLQAVVKDPV---------------------------------------SRTPALI 246
             +    A ++ P                                          T   +
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 247 FEHVNNTDFKQLY--------QTLTDY-------------DIRYYLYELLKALDYCHSMG 285
            +   ++    LY        + L D+                +   ++ +A+++ HS G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 286 IMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           +MHRD+KP N+    ++  +++ D+GL 
Sbjct: 185 LMHRDLKPSNIFFTMDD-VVKVGDFGLV 211

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 24/117 (20%), Positives = 53/117 (45%), Gaps = 18/117 (15%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-------------EFYHPGQEY 55
            A+++ HS G+MHRD+KP N+    ++  +++ D+GL                      +
Sbjct: 175 EAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233

Query: 56  NVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 112
             +V ++ +  PE +     Y + +D++SLG +L  +++    F    +    +  +
Sbjct: 234 TGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDV 286

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 50/196 (25%), Positives = 95/196 (48%), Gaps = 20/196 (10%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK----PVKKKKIKREIKILENLRGG 225
           ++ +  + K+G+G + EVF+ I+ ++     +KI+       + + I++EI +L      
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS- 79

Query: 226 TNIIT-LQAVVKDPVSRTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCH 282
             +     + +KD       +I E++       L +   L +  I   L E+LK LDY H
Sbjct: 80  PYVTKYYGSYLKDT---KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLH 136

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           S   +HRD+K  NV++  E+ +++L D+G+  +      + N  V + ++  PE++    
Sbjct: 137 SEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 195

Query: 342 YHIELDPRFADI--LG 355
           Y    D + ADI  LG
Sbjct: 196 Y----DSK-ADIWSLG 206

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 3/96 (3%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGP 67
             LDY HS   +HRD+K  NV++  E+ +++L D+G+  +      + N  V + ++  P
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 188

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E++     YD   D+WSLG     +   + P    H
Sbjct: 189 EVIKQSA-YDSKADIWSLGITAIELARGEPPHSELH 223

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 76.1 bits (187), Expect = 3e-15
 Identities = 57/335 (17%), Positives = 104/335 (31%), Gaps = 62/335 (18%)

Query: 171 DDYQLVRKLGRG--KYSEVFEAINVQSSDKCVVKILKPVKKKK-----IKREIKILENLR 223
             Y+L+  +G+G      V  A    + +   V+ +            ++ E+ + +   
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84

Query: 224 GGTNIIT-LQAVVKDPVSRTPALIFEHVNN---TDFKQLY--QTLTDYDIRYYLYELLKA 277
              NI+      + D       ++   +      D    +    + +  I Y L  +LKA
Sbjct: 85  HP-NIVPYRATFIAD---NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG-LAEFYHPGQEYNVR-VASRYFKG-- 333
           LDY H MG +HR VK  +++I   + K+ L            GQ   V     +Y     
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 334 ----PELLA--DYQYH------------IEL---DPRFADILGRHSRK------------ 360
               PE+L      Y              EL      F D+    + +            
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM---PATQMLLEKLNGTVPC 256

Query: 361 ---RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDK 417
                               A   L  ++     R               SP    F+++
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316

Query: 418 LLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPS 452
            L+ +   R +A   ++H  F+  +K ++   LP 
Sbjct: 317 CLQRNPDARPSASTLLNHS-FFKQIKRRASEALPE 350

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 59.9 bits (145), Expect = 6e-10
 Identities = 29/104 (27%), Positives = 42/104 (40%), Gaps = 10/104 (9%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG-LAEFYHPGQEYNVR-VASRYFKG 66
            ALDY H MG +HR VK  +++I   + K+ L            GQ   V     +Y   
Sbjct: 139 KALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 67  ------PELLA-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
                 PE+L  + Q YD   D++S+G     +     PF    
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 74.7 bits (184), Expect = 5e-15
 Identities = 44/195 (22%), Positives = 94/195 (48%), Gaps = 19/195 (9%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK-KKIKREIKILENLRGGTNI 228
           ++ + ++ KLG G Y  V++AI+ ++     +K +      ++I +EI I++      ++
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS-PHV 86

Query: 229 IT-LQAVVKDPVSRTPALIFEHVNN---TD-FKQLYQTLTDYDIRYYLYELLKALDYCHS 283
           +    +  K+       ++ E+      +D  +   +TLT+ +I   L   LK L+Y H 
Sbjct: 87  VKYYGSYFKN---TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLADYQY 342
           M  +HRD+K  N++++      +L D+G+  +      + N  + + ++  PE++ +  Y
Sbjct: 144 MRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202

Query: 343 HIELDPRFADI--LG 355
               +   ADI  LG
Sbjct: 203 ----NCV-ADIWSLG 212

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 25/96 (26%), Positives = 47/96 (48%), Gaps = 3/96 (3%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGP 67
             L+Y H M  +HRD+K  N++++      +L D+G+  +      + N  + + ++  P
Sbjct: 136 KGLEYLHFMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 194

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E++ +   Y+   D+WSLG     M   K P+   H
Sbjct: 195 EVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIH 229

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 63/307 (20%), Positives = 112/307 (36%), Gaps = 50/307 (16%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI----LKPVKKKKIKREIKILENLRGGT 226
           DD++ + +LG G    VF+  +  S      K+    +KP  + +I RE+++L       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-P 91

Query: 227 NIIT-LQAVVKDP-VSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYC 281
            I+    A   D  +S    +  EH++        +    + +  +      ++K L Y 
Sbjct: 92  YIVGFYGAFYSDGEIS----ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 147

Query: 282 HSMG-IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPEL 336
                IMHRDVKP N++++    +++L D+G++     GQ      N  V +R +  PE 
Sbjct: 148 REKHKIMHRDVKPSNILVNS-RGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPER 201

Query: 337 LADYQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEALDF 381
           L    Y ++ D                       +     +   V  +            
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261

Query: 382 LDKNILGRHSRKRWERF------VH----TENQHLVSPEALDFLDKLLRYDHYERLTARE 431
              N  G  SR     F      V+         + S E  DF++K L  +  ER   ++
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

Query: 432 AMDHPYF 438
            M H + 
Sbjct: 322 LMVHAFI 328

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 44/192 (22%), Positives = 72/192 (37%), Gaps = 30/192 (15%)

Query: 2   RIATGASMALDYCHSMG-IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYN 56
           +++      L Y      IMHRDVKP N++++    +++L D+G++     GQ      N
Sbjct: 135 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVS-----GQLIDSMAN 188

Query: 57  VRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 116
             V +R +  PE L     Y    D+WS+G  L  M   + P                  
Sbjct: 189 SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--------- 238

Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLV 176
             E +F    +      P      GR      ++S  P   ++   Y+V+       +  
Sbjct: 239 --ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVN-------EPP 289

Query: 177 RKLGRGKYSEVF 188
            KL  G +S  F
Sbjct: 290 PKLPSGVFSLEF 301

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 37/152 (24%), Positives = 74/152 (48%), Gaps = 13/152 (8%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGT 226
            + +++V +LG G + +V++A N ++      K+++     + +    EI+IL       
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH-P 76

Query: 227 NIIT-LQAVVKDPVSRTPALIFEHVNN---TD-FKQLYQTLTDYDIRYYLYELLKALDYC 281
            I+  L A   D       ++ E            +L + LT+  I+    ++L+AL++ 
Sbjct: 77  YIVKLLGAYYHD---GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 133

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           HS  I+HRD+K  NV++      +RL D+G++
Sbjct: 134 HSKRIIHRDLKAGNVLMT-LEGDIRLADFGVS 164

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 6/100 (6%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGP 67
            AL++ HS  I+HRD+K  NV++      +RL D+G+ A+     Q+ +  + + Y+  P
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186

Query: 68  ELLADYQM----YDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E++    M    YDY  D+WSLG  L  M   + P    +
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 37/154 (24%), Positives = 75/154 (48%), Gaps = 15/154 (9%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK------IKREIKILENLR 223
           +  +  +R++G G +  V+ A +V++S+   +K +    K+       I +E++ L+ LR
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 224 GGTNIIT-LQAVVKDPVSRTPALIFEHVN---NTDFKQLYQTLTDYDIRYYLYELLKALD 279
              N I      +++    T  L+ E+     +   +   + L + +I    +  L+ L 
Sbjct: 113 H-PNTIQYRGCYLRE---HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           Y HS  ++HRDVK  N+++  E   ++L D+G A
Sbjct: 169 YLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSA 201

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 31/99 (31%), Positives = 48/99 (48%), Gaps = 10/99 (10%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKG 66
             L Y HS  ++HRDVK  N+++  E   ++L D+G A           N  V + Y+  
Sbjct: 165 QGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSA-----SIMAPANSFVGTPYWMA 218

Query: 67  PELLADYQM--YDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           PE++       YD  +D+WSLG     +  RK P F+ +
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 36/164 (21%), Positives = 68/164 (41%), Gaps = 26/164 (15%)

Query: 163 YVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-KKKIKREIKILEN 221
           +++D+    + ++   +GRG +  V +A     +    +K ++    +K    E++ L  
Sbjct: 3   HMIDY---KEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKAFIVELRQLSR 57

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLK---AL 278
           +    NI+ L     +PV     L+ E+        LY  L   +   Y          L
Sbjct: 58  VNH-PNIVKLYGACLNPVC----LVMEYAEGGS---LYNVLHGAEPLPYYTAAHAMSWCL 109

Query: 279 D------YCHSM---GIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
                  Y HSM    ++HRD+KP N+++      L++ D+G A
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 62.3 bits (152), Expect = 7e-11
 Identities = 27/111 (24%), Positives = 45/111 (40%), Gaps = 24/111 (21%)

Query: 1   MRIATGASMALDYCHSM---GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV 57
           M      S  + Y HSM    ++HRD+KP N+++      L++ D+G A           
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----------- 153

Query: 58  RVASRYFKG---------PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
                +            PE+      Y    D++S G +L  +I R++PF
Sbjct: 154 CDIQTHMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPF 203

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 27/169 (15%), Positives = 60/169 (35%), Gaps = 21/169 (12%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK--PVKKKKIKREIKILENLRGGTNIIT 230
           + L +K+G G +  ++ A      +K    ++K    +   +  E+K  + +     I  
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 231 LQAVVKDPVSRTPALIF---EHVNNTDFKQLYQTLTDYDIRYYL---------------Y 272
                +      P              ++ +       D++                   
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158

Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHEN-RKLRLIDWGLAEFYHPGQ 320
            +L  L+Y H    +H D+K  N+++ ++N  ++ L D+GL+  Y P  
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 14/45 (31%), Positives = 26/45 (57%), Gaps = 1/45 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHEN-RKLRLIDWGLAEFYHPGQ 53
            L+Y H    +H D+K  N+++ ++N  ++ L D+GL+  Y P  
Sbjct: 163 VLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 33/170 (19%), Positives = 68/170 (40%), Gaps = 41/170 (24%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK----PVKKKKIKREIKILENLRGG 225
           +DDY+L   +G G  + V  A      +K  +K +          ++ +EI+ +      
Sbjct: 14  RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH- 72

Query: 226 TNIIT----------------------LQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLT 263
            NI++                      +  ++K  V++              +     L 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKG-------------EHKSGVLD 119

Query: 264 DYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           +  I   L E+L+ L+Y H  G +HRDVK  N+++  +   +++ D+G++
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVS 168

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 25/101 (24%), Positives = 46/101 (45%), Gaps = 7/101 (6%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 66
             L+Y H  G +HRDVK  N+++  +   +++ D+G++ F   G +       + F G  
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 67  ----PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
               PE++   + YD+  D+WS G     +     P+    
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 73.7 bits (181), Expect = 4e-14
 Identities = 36/150 (24%), Positives = 66/150 (44%), Gaps = 12/150 (8%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCV-VKILKPVK----KKKIKREIKILENLRGGTN 227
           Y++   +  G    ++ A++   + + V +K L        +     E + L  +    +
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVH-PS 140

Query: 228 IITLQAVVKDP---VSRTPALIFEHVNNTDFKQ-LYQTLTDYDIRYYLYELLKALDYCHS 283
           I+ +   V+           ++ E+V     K+   Q L   +   YL E+L AL Y HS
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHS 200

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           +G+++ D+KP N+M+  E  K  LID G  
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK--LIDLGAV 228

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 24/99 (24%), Positives = 43/99 (43%), Gaps = 7/99 (7%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           +        AL Y HS+G+++ D+KP N+M+  E  K  LID G          +     
Sbjct: 185 IAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLK--LIDLGAV---SRINSFGYLYG 239

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +  F+ PE +        + D++++G  LA++       
Sbjct: 240 TPGFQAPE-IVRTGPTVAT-DIYTVGRTLAALTLDLPTR 276

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 38/152 (25%), Positives = 75/152 (49%), Gaps = 13/152 (8%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP---VKKKKI---KREIKILENLRG 224
           +D++  + LG G +S V  A  + +S +  +KIL+    +K+ K+    RE  ++  L  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTD-FKQL--YQTLTDYDIRYYLYELLKALDYC 281
               + L    +D           +  N +  K +    +  +   R+Y  E++ AL+Y 
Sbjct: 90  -PFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           H  GI+HRD+KP N++++ +   +++ D+G A
Sbjct: 147 HGKGIIHRDLKPENILLNEDMH-IQITDFGTA 177

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 11/100 (11%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 66
            AL+Y H  GI+HRD+KP N++++ +   +++ D+G A+     +    R  S  F G  
Sbjct: 141 SALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAK-VLSPESKQARANS--FVGTA 196

Query: 67  ----PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 102
               PELL + +    S D+W+LGC++  ++    PF  G
Sbjct: 197 QYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAG 235

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 35/155 (22%), Positives = 68/155 (43%), Gaps = 17/155 (10%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTN 227
            D      LG+G + +  +  + ++ +  V+K L       ++   +E+K++  L    N
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH-PN 68

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLK-ALD------Y 280
           ++    V+     +    I E++       L   +   D +Y   + +  A D      Y
Sbjct: 69  VLKFIGVLYKD--KRLNFITEYIKGGT---LRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF 315
            HSM I+HRD+  HN ++  EN+ + + D+GLA  
Sbjct: 124 LHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARL 157

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 29/114 (25%), Positives = 49/114 (42%), Gaps = 17/114 (14%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF---------YHP 51
           +  A   +  + Y HSM I+HRD+  HN ++  EN+ + + D+GLA              
Sbjct: 111 VSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLR 169

Query: 52  GQEYNVRVASRYFKG------PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
             +   R       G      PE++   + YD  +D++S G +L  +I R    
Sbjct: 170 SLKKPDRKKRYTVVGNPYWMAPEMIN-GRSYDEKVDVFSFGIVLCEIIGRVNAD 222

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 62/309 (20%), Positives = 114/309 (36%), Gaps = 79/309 (25%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR---------EIKILEN 221
           +D+ + R +GRG + EV+      +     +K L    KK+IK          E  +L  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSL 245

Query: 222 LRGGTN--IITLQAVVKDPVSRTPA---LIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYE 273
           +  G    I+ +          TP     I + +N  D    L Q    ++ D+R+Y  E
Sbjct: 246 VSTGDCPFIVCMSYAFH-----TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 300

Query: 274 LLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 333
           ++  L++ H+  +++RD+KP N+++D     +R+ D GLA      ++ +  V +  +  
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLAC-DFSKKKPHASVGTHGYMA 358

Query: 334 PELLADYQYH----------------IELDPRFADILGRHSRKRWERFVHTENQHLVSPE 377
           PE+L     +                +     F       ++ + E              
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ---HKTKDKHE-------------- 401

Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREA 432
               +D+  L                    SPE    L+ LL+ D   RL      A+E 
Sbjct: 402 ----IDRMTL--TMAVELPDS--------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 447

Query: 433 MDHPYFYPI 441
            + P+F  +
Sbjct: 448 KESPFFRSL 456

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 71.1 bits (174), Expect = 3e-13
 Identities = 32/115 (27%), Positives = 57/115 (49%), Gaps = 5/115 (4%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
           + L++ H+  +++RD+KP N+++D     +R+ D GLA      ++ +  V +  +  PE
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLAC-DFSKKKPHASVGTHGYMAPE 360

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFF-HGHDNYDQLVRIAKVLGTEELF 122
           +L     YD S D +SLGCML  ++    PF  H   +  ++ R    L      
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--MTLTMAVEL 413

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 25/141 (17%), Positives = 59/141 (41%), Gaps = 14/141 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL----KPVKKKKIKREIKILENLRGGT 226
           +D + + ++G G   +V++    ++     VK +       + K+I  ++ ++       
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 227 NIIT-LQAVVKDP-VSRTPALIFEHVN---NTDFKQLYQTLTDYDIRYYLYELLKALDYC 281
            I+      + +  V     +  E +        K++   + +  +      ++KAL Y 
Sbjct: 85  YIVQCFGTFITNTDVF----IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140

Query: 282 HS-MGIMHRDVKPHNVMIDHE 301
               G++HRDVKP N+++D  
Sbjct: 141 KEKHGVIHRDVKPSNILLDER 161

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 30/124 (24%), Positives = 57/124 (45%), Gaps = 18/124 (14%)

Query: 2   RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           ++      AL Y     G++HRDVKP N+++D    +++L D+G++     G+  +   A
Sbjct: 128 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGIS-----GRLVD-DKA 180

Query: 61  SRYFKG------PELLADYQM----YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
                G      PE +         YD   D+WSLG  L  +   + P+ +   +++ L 
Sbjct: 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT 240

Query: 111 RIAK 114
           ++ +
Sbjct: 241 KVLQ 244

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 36/177 (20%), Positives = 71/177 (40%), Gaps = 34/177 (19%)

Query: 160 YESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----------KK 209
                +     ++ +  +++G+G +  V +   V+      +K L             K 
Sbjct: 11  SRLPTLAD---NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67

Query: 210 KKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRY 269
           ++ +RE+ I+ NL    NI+ L  ++ +P    P ++ E V   D   LY  L D     
Sbjct: 68  QEFQREVFIMSNLNH-PNIVKLYGLMHNP----PRMVMEFVPCGD---LYHRLLDKAHPI 119

Query: 270 YLYELLK-ALD------YCHSMG--IMHRDVKPHNVMID----HENRKLRLIDWGLA 313
                L+  LD      Y  +    I+HRD++  N+ +     +     ++ D+GL+
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 19/115 (16%), Positives = 47/115 (40%), Gaps = 27/115 (23%)

Query: 1   MRIATGASMALDYCHSMG--IMHRDVKPHNVMID----HENRKLRLIDWGLAEFYHPGQE 54
           +R+    ++ ++Y  +    I+HRD++  N+ +     +     ++ D+GL+        
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-------- 176

Query: 55  YNVRVASRYFKG---------PELLA-DYQMYDYSLDMWSLGCMLASMIFRKEPF 99
              + +     G         PE +  + + Y    D +S   +L +++  + PF
Sbjct: 177 ---QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 62/280 (22%), Positives = 122/280 (43%), Gaps = 36/280 (12%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL---KPVKKKKIKREIKILENLRGGT 226
           +  Y    K+G+G    V+ A++V +  +  ++ +   +  KK+ I  EI ++   +   
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-P 77

Query: 227 NIIT-LQAVVKDPVSRTPALIFEHVNN---TDFKQLYQTLTDYDIRYYLYELLKALDYCH 282
           NI+  L + +         ++ E++     TD       + +  I     E L+AL++ H
Sbjct: 78  NIVNYLDSYLVG---DELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLH 133

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           S  ++HRD+K  N+++   +  ++L D+G  A+      + +  V + Y+  PE++    
Sbjct: 134 SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 342 YHIELDPRFADI--LGRHSRKRWERFVHTENQHLVSP-EALDFLDKNILGRHSRKRWERF 398
           Y     P+  DI  LG  + +  E      N++   P  AL  +  N  G    +  E+ 
Sbjct: 193 Y----GPK-VDIWSLGIMAIEMIEGEPPYLNEN---PLRALYLIATN--GTPELQNPEKL 242

Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                    S    DFL++ L  D  +R +A+E + H + 
Sbjct: 243 ---------SAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 27/96 (28%), Positives = 52/96 (54%), Gaps = 3/96 (3%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGP 67
            AL++ HS  ++HRD+K  N+++   +  ++L D+G  A+      + +  V + Y+  P
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E++     Y   +D+WSLG M   MI  + P+ + +
Sbjct: 186 EVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 36/156 (23%), Positives = 76/156 (48%), Gaps = 20/156 (12%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP-VKKKKIKREIKILENLRGGTNIITL 231
           Y+L RK+G G + +++   ++ + ++  +K+     K  ++  E KI + ++GG  I T+
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 232 ---------QAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCH 282
                      +V + +   P+L  E +    F    +  +   +     +++  ++Y H
Sbjct: 71  RWCGAEGDYNVMVMELLG--PSL--EDL----FNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 283 SMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFY 316
           S   +HRDVKP N ++    +   + +ID+GLA+ Y
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 16/41 (39%), Positives = 26/41 (63%), Gaps = 2/41 (4%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFY 49
           ++Y HS   +HRDVKP N ++    +   + +ID+GLA+ Y
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 34/132 (25%), Positives = 60/132 (45%), Gaps = 8/132 (6%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 68
             L+  H   I++RD+KP N+++D     +R+ D GLA     GQ    RV +  +  PE
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPE 355

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY 128
           ++   + Y +S D W+LGC+L  MI  + P F       +   + +++          +Y
Sbjct: 356 VV-KNERYTFSPDWWALGCLLYEMIAGQSP-FQQRKKKIKREEVERLVKEVPE-----EY 408

Query: 129 HIELDPRFADIL 140
                P+   + 
Sbjct: 409 SERFSPQARSLC 420

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 63/306 (20%), Positives = 107/306 (34%), Gaps = 73/306 (23%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIIT 230
           + ++  R LG+G + EV       +      K L+   KK+IK+  K          I+ 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKR-KGEAMALNEKQIL- 238

Query: 231 LQAVVKDP--VS-----RTPA---LIFEHVNNTD-FKQLYQ----TLTDYDIRYYLYELL 275
               V     VS      T     L+   +N  D    +Y        +    +Y  E+ 
Sbjct: 239 --EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296

Query: 276 KALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 335
             L+  H   I++RD+KP N+++D     +R+ D GLA     GQ    RV +  +  PE
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPE 355

Query: 336 LLADYQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPEALD 380
           ++ + +Y    D                 F                    + +   E   
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQSPF----------------QQRKKKIKREE--- 396

Query: 381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDH 435
            +++ +      + +            SP+A     +LL  D  ERL     +ARE  +H
Sbjct: 397 -VERLVK--EVPEEYSER--------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445

Query: 436 PYFYPI 441
           P F  +
Sbjct: 446 PLFKKL 451

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 47/254 (18%), Positives = 95/254 (37%), Gaps = 22/254 (8%)

Query: 148 DVNSHKPREYWDYESYVVDWGQ--QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK 205
           D     P +Y     ++V  G      Y ++RKLG G +S V+ + ++Q      +K++K
Sbjct: 12  DDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK 71

Query: 206 PVKK--KKIKREIKILENLR-------GGTNIITLQA--VVKDPVSRTPALIFE--HVNN 252
             +   +    EI++L+++R           ++ L     +         ++FE    + 
Sbjct: 72  SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHL 131

Query: 253 TDFKQL--YQTLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLID 309
             +     YQ L    ++  + ++L+ LDY H+   I+H D+KP N+++    + +R + 
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191

Query: 310 WGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADI-LGRHSRKRWERFVHT 368
               E+   G       A                   +     + +       W     T
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT 251

Query: 369 EN---QHLVSPEAL 379
           E+   +   S E L
Sbjct: 252 EDIQTRQYRSLEVL 265

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 30/164 (18%), Positives = 54/164 (32%), Gaps = 59/164 (35%)

Query: 9   MALDYCHS-MGIMHRDVKPHNVMI------------------------------------ 31
             LDY H+   I+H D+KP N+++                                    
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 32  ------------DHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS 79
                       + E  K+++ D G A      + +   + +R ++  E+L     Y+  
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQYRSLEVLIGSG-YNTP 273

Query: 80  LDMWSLGCMLASMIFRKEPFFHGHDNY------DQLVRIAKVLG 117
            D+WS  CM    +   +  F  H         D +  I ++LG
Sbjct: 274 ADIWSTACMAFE-LATGDYLFEPHSGEEYTRDEDHIALIIELLG 316

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 26/157 (16%), Positives = 55/157 (35%), Gaps = 42/157 (26%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL----KPVKKKKIKREIKILENLRGGT 226
           +D + + ++GRG Y  V + ++  S     VK +       ++K++  ++ ++       
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 227 NIIT---------------------LQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDY 265
            I+                           K   S    +I E +               
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI--------------- 126

Query: 266 DIRYYLYELLKALDYCHSMG-IMHRDVKPHNVMIDHE 301
            +       +KAL++      I+HRD+KP N+++D  
Sbjct: 127 -LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS 162

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 33/123 (26%), Positives = 58/123 (47%), Gaps = 17/123 (13%)

Query: 2   RIATGASMALDYCHSMG-IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           +I      AL++      I+HRD+KP N+++D  +  ++L D+G++     GQ  +  +A
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDR-SGNIKLCDFGIS-----GQLVD-SIA 181

Query: 61  SRYFKG------PELLADYQM---YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 111
                G      PE +        YD   D+WSLG  L  +   + P+   +  +DQL +
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ 241

Query: 112 IAK 114
           + K
Sbjct: 242 VVK 244

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.8 bits (169), Expect = 6e-13
 Identities = 68/315 (21%), Positives = 120/315 (38%), Gaps = 85/315 (26%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIIT 230
            D+ L+R +GRG Y++V      ++     +K++K   K+ +  + + ++ ++   ++  
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVK---KELVNDD-EDIDWVQTEKHV-- 62

Query: 231 LQAVVKDP--VS-----RTPA---LIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKA 277
            +     P  V      +T +    + E+VN  D    + +   L +   R+Y  E+  A
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQ---------EYNVRVA 327
           L+Y H  GI++RD+K  NV++D E   ++L D+G+  E   PG           Y   +A
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY---IA 178

Query: 328 SRYFKGPELLADYQYHIELDPRFADILGRHSRKRW--------ER------FVHTENQHL 373
                 PE+L    Y   +D              W        E       F    +   
Sbjct: 179 ------PEILRGEDYGFSVD--------------WWALGVLMFEMMAGRSPFDIVGSSDN 218

Query: 374 VSPEALDFLDKNILGRHSR-KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL----- 427
                 D+L + IL +  R  R            +S +A   L   L  D  ERL     
Sbjct: 219 PDQNTEDYLFQVILEKQIRIPRS-----------LSVKAASVLKSFLNKDPKERLGCHPQ 267

Query: 428 -TAREAMDHPYFYPI 441
               +   HP+F  +
Sbjct: 268 TGFADIQGHPFFRNV 282

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 21/104 (20%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQ---------EYNV 57
           S+AL+Y H  GI++RD+K  NV++D E   ++L D+G+  E   PG           Y  
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY-- 176

Query: 58  RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
            +A      PE+L   + Y +S+D W+LG ++  M+  + PF  
Sbjct: 177 -IA------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI 212

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 69.3 bits (170), Expect = 6e-13
 Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 18/154 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP---VKKKKIKR---EIKILENLRG 224
           +DY++V+ +GRG + EV    +  +     +K+L     +K+        E  I+     
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF--- 125

Query: 225 GTN---IITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALD 279
             N   ++ L    +D   R   ++ E++   D   L     + +   R+Y  E++ ALD
Sbjct: 126 -ANSPWVVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD 182

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
             HSMG +HRDVKP N+++D     L+L D+G  
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTC 215

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 36/141 (25%), Positives = 59/141 (41%), Gaps = 20/141 (14%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 66
           +ALD  HSMG +HRDVKP N+++D     L+L D+G     +        V      G  
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNK----EGMVRCDTAVGTP 233

Query: 67  ----PELLAD---YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
               PE+L        Y    D WS+G  L  M+    PF+   D+       +K++  +
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY--ADSLVGT--YSKIMNHK 289

Query: 120 ELFEYLDKYHIELDPRFADIL 140
               + D    ++     +++
Sbjct: 290 NSLTFPD--DNDISKEAKNLI 308

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 43/217 (19%), Positives = 80/217 (36%), Gaps = 63/217 (29%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL---KPVKKKKIKREIKIL------- 219
           +       K+G G    V  A    S  +  VK++   K  +++ +  E+ I+       
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 220 ------------------ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT 261
                             E L+GG         + D VS+                    
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGA--------LTDIVSQVR------------------ 137

Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQ 320
           L +  I      +L+AL Y H+ G++HRD+K  ++++   + +++L D+G  A+      
Sbjct: 138 LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVP 196

Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADI--LG 355
           +    V + Y+  PE+++   Y         DI  LG
Sbjct: 197 KRKSLVGTPYWMAPEVISRSLY----ATE-VDIWSLG 228

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 27/96 (28%), Positives = 53/96 (55%), Gaps = 3/96 (3%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGP 67
            AL Y H+ G++HRD+K  ++++   + +++L D+G  A+      +    V + Y+  P
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 103
           E+++    Y   +D+WSLG M+  M+  + P+F   
Sbjct: 211 EVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDS 245

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 26/112 (23%), Positives = 50/112 (44%), Gaps = 16/112 (14%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 66
           MALDY  +  I+HRD+KP N+++D     + + D+ +A       +           G  
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITT------MAGTK 178

Query: 67  ----PELLADYQM--YDYSLDMWSLGCMLASMIFRKEPFF-HGHDNYDQLVR 111
               PE+ +  +   Y +++D WSLG     ++  + P+      +  ++V 
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 30/170 (17%), Positives = 70/170 (41%), Gaps = 35/170 (20%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK--PVKKKK----IKREIKILE---- 220
           D ++++R +G+G + +V       +     +K +      ++     + +E++I++    
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 221 ----NLRGGTNIITLQAVVKDPVSRTPA---LIFEHVNNTD-FKQLYQ--TLTDYDIRYY 270
               NL       + Q               ++ + +   D    L Q     +  ++ +
Sbjct: 75  PFLVNLWY-----SFQ---------DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF 120

Query: 271 LYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
           + EL+ ALDY  +  I+HRD+KP N+++D     + + D+ +A       
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRET 169

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 3/93 (3%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGP 67
             L++ H   I++RD+KP NV++D +   +R+ D GLA E      +      +  F  P
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358

Query: 68  ELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF 100
           ELL   + YD+S+D ++LG  L  MI  + PF 
Sbjct: 359 ELLLG-EEYDFSVDYFALGVTLYEMIAARGPFR 390

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 67/309 (21%), Positives = 107/309 (34%), Gaps = 76/309 (24%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIIT 230
           D +   R LGRG + EVF      +      K L    KK++K+  K  +       I+ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN---KKRLKKR-KGYQGAMVEKKIL- 239

Query: 231 LQAVVKDP--VS-----RTPA---LIFEHVNNTD-FKQLYQTLTDYDI------RYYLYE 273
             A V     VS      T     L+   +N  D    +Y    D          +Y  +
Sbjct: 240 --AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297

Query: 274 LLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFK 332
           ++  L++ H   I++RD+KP NV++D +   +R+ D GLA E      +      +  F 
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFM 356

Query: 333 GPELLADYQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVSPE 377
            PELL   +Y   +D                 F                    + + + E
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPF----------------RARGEKVENKE 400

Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREA 432
               L + +L       +            SP + DF + LL+ D  +RL     +    
Sbjct: 401 ----LKQRVL--EQAVTYPDK--------FSPASKDFCEALLQKDPEKRLGFRDGSCDGL 446

Query: 433 MDHPYFYPI 441
             HP F  I
Sbjct: 447 RTHPLFRDI 455

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 38/154 (24%), Positives = 77/154 (50%), Gaps = 16/154 (10%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP-VKKKKIKREIKILENLRGGTNIITL 231
           ++L RK+G G + E++   N+Q++++  +K+     K  ++  E KI   L+GGT I  +
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 232 QAVVKDPVSRT-------PALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSM 284
           +    +            P+L  E +    F    + L+   +     +++  +++ HS 
Sbjct: 69  RWFGVEGDYNVLVMDLLGPSL--EDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122

Query: 285 GIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFY 316
             +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 15/41 (36%), Positives = 27/41 (65%), Gaps = 2/41 (4%)

Query: 11  LDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFY 49
           +++ HS   +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 42/189 (22%), Positives = 68/189 (35%), Gaps = 30/189 (15%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGG 225
                + KL      E+++    Q +D  VVK+LK       K +    E   L      
Sbjct: 10  KQLNFLTKLNENHSGELWKGR-WQGND-IVVKVLKVRDWSTRKSRDFNEECPRLRIFSH- 66

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTD-YDIRYYLYELLK-ALD---- 279
            N++ +    + P +  P LI   +       LY  L +  +      + +K ALD    
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPY---GSLYNVLHEGTNFVVDQSQAVKFALDMARG 123

Query: 280 --YCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVR-VASRYFKG 333
             + H++   I    +   +VMID E+   R+    +   F  PG+ Y    VA      
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPAWVA------ 176

Query: 334 PELLADYQY 342
           PE L     
Sbjct: 177 PEALQKKPE 185

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 27/105 (25%), Positives = 44/105 (41%), Gaps = 13/105 (12%)

Query: 1   MRIATGASMALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNV 57
           ++ A   +  + + H++   I    +   +VMID E+   R+    +   F  PG+ Y  
Sbjct: 114 VKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAP 172

Query: 58  R-VASRYFKGPELLAD--YQMYDYSLDMWSLGCMLASMIFRKEPF 99
             VA      PE L          S DMWS   +L  ++ R+ PF
Sbjct: 173 AWVA------PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 22/157 (14%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR--------EIKILENL 222
           +D+++++ +GRG + EV       +     +KIL   K + +KR        E  +L N 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVN- 130

Query: 223 RGGTN--IITLQAVVKDPVSRTPALIFEHVNNTD-FKQLY---QTLTDYDIRYYLYELLK 276
             G +  I TL    +D       L+ ++    D    L      L +   R+YL E++ 
Sbjct: 131 --GDSKWITTLHYAFQDD--NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186

Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           A+D  H +  +HRD+KP N+++D     +RL D+G  
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSC 222

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 35/145 (24%), Positives = 65/145 (44%), Gaps = 22/145 (15%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKG- 66
           +A+D  H +  +HRD+KP N+++D     +RL D+G   +    G      V S    G 
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDGT-----VQSSVAVGT 239

Query: 67  -----PELLADYQM----YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
                PE+L   +     Y    D WSLG  +  M++ + PF+   ++  +     K++ 
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY--AESLVET--YGKIMN 295

Query: 118 TEELFEYLDKYHIELDPRFADILGR 142
            +E F++      ++     D++ R
Sbjct: 296 HKERFQF-PTQVTDVSENAKDLIRR 319

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 44/229 (19%)

Query: 107 DQLVRIAKVLGTEELFEYLDKYHIEL-------DPRFADILGRAR-VYADVNSHKPREYW 158
            QLV     LG E L + L   H EL       D   AD L  A  +   +   + +   
Sbjct: 3   QQLVLDPGFLGLEPLLDLLLGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQR-- 60

Query: 159 DYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR---- 214
                       DD+++++ +GRG +SEV      Q+     +KI+   K   +KR    
Sbjct: 61  ------------DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN--KWDMLKRGEVS 106

Query: 215 ----EIKILENLRGGTN--IITLQAVVKDPVSRTPALIFEHVNNTD-FKQLYQ---TLTD 264
               E  +L N   G    I  L    +D       L+ E+    D    L +    +  
Sbjct: 107 CFREERDVLVN---GDRRWITQLHFAFQDE--NYLYLVMEYYVGGDLLTLLSKFGERIPA 161

Query: 265 YDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
              R+YL E++ A+D  H +G +HRD+KP N+++D     +RL D+G  
Sbjct: 162 EMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSC 209

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 34/144 (23%), Positives = 55/144 (38%), Gaps = 22/144 (15%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 66
           MA+D  H +G +HRD+KP N+++D     +RL D+G              V S    G  
Sbjct: 173 MAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSCLKLRADGT----VRSLVAVGTP 227

Query: 67  ----PELL------ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 116
               PE+L           Y    D W+LG     M + + PF+   D+  +     K++
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY--ADSTAET--YGKIV 283

Query: 117 GTEELFEYLDKYHIELDPRFADIL 140
             +E           +     D +
Sbjct: 284 HYKEHLSL-PLVDEGVPEEARDFI 306

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 31/156 (19%), Positives = 69/156 (44%), Gaps = 18/156 (11%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-PVKKKKIKREIKILENLRGGTNIITL 231
           +++ +K+G G + E+    N+ +++   +K+     +  ++  E +  + L  G  I  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 232 QAVVKDPVSRT-------PALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSM 284
                             P+L  E +    F    +T +   +     +L+  ++Y HS 
Sbjct: 71  YYFGPCGKYNAMVLELLGPSL--EDL----FDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 285 GIMHRDVKPHNVMI----DHENRKLRLIDWGLAEFY 316
            +++RDVKP N +I    +   + + +ID+ LA+ Y
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 15/43 (34%), Positives = 27/43 (62%), Gaps = 4/43 (9%)

Query: 11  LDYCHSMGIMHRDVKPHNVMI----DHENRKLRLIDWGLAEFY 49
           ++Y HS  +++RDVKP N +I    +   + + +ID+ LA+ Y
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 28/156 (17%), Positives = 67/156 (42%), Gaps = 18/156 (11%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP-VKKKKIKREIKILENLRGGTNIITL 231
           Y++ R++G G +  +FE  N+ ++ +  +K         +++ E +  + L G T I  +
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 232 QAVVKDPVSRT-------PALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSM 284
               ++ +          P+L  E +         +  +   +     ++L  +   H  
Sbjct: 72  YYFGQEGLHNVLVIDLLGPSL--EDL----LDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125

Query: 285 GIMHRDVKPHNVMI----DHENRKLRLIDWGLAEFY 316
            +++RD+KP N +I          + ++D+G+ +FY
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 11/43 (25%), Positives = 23/43 (53%), Gaps = 4/43 (9%)

Query: 11  LDYCHSMGIMHRDVKPHNVMI----DHENRKLRLIDWGLAEFY 49
           +   H   +++RD+KP N +I          + ++D+G+ +FY
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 36/178 (20%), Positives = 73/178 (41%), Gaps = 37/178 (20%)

Query: 151 SHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAI---NVQSSDKCVVKILK-- 205
           S    + W+     +         + +++G G +  V++     +V       VK+L   
Sbjct: 12  SRDAADDWE-----IPD---GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVT 57

Query: 206 ---PVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTL 262
              P + +  K E+ +L   R   NI+        P     A++ +         LY  L
Sbjct: 58  APTPQQLQAFKNEVGVLRKTRH-VNILLFMGYSTAP---QLAIVTQWCEG---SSLYHHL 110

Query: 263 TDYDIRYYLYELLK-ALD------YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
              + ++ + +L+  A        Y H+  I+HRD+K +N+ +  E+  +++ D+GLA
Sbjct: 111 HASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLA 167

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 34/148 (22%), Positives = 66/148 (44%), Gaps = 16/148 (10%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           + IA   +  +DY H+  I+HRD+K +N+ +  E+  +++ D+GLA         +    
Sbjct: 123 IDIARQTARGMDYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQ 181

Query: 61  SRYFKG------PELL--ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 112
                G      PE++   D   Y +  D+++ G +L  ++  + P +   +N DQ   I
Sbjct: 182 L---SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQ---I 234

Query: 113 AKVLGTEELFEYLDKYHIELDPRFADIL 140
            +++G   L   L K       R   ++
Sbjct: 235 IEMVGRGSLSPDLSKVRSNCPKRMKRLM 262

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 37/150 (24%), Positives = 72/150 (48%), Gaps = 13/150 (8%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK------PVKKKKIKREIKILENLRGGT 226
           Y++V KLG G  S V+ A +   + K  +K +           K+ +RE+     L    
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH-Q 71

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYCHS 283
           NI+++  V ++       L+ E++      +  ++   L+      +  ++L  + + H 
Sbjct: 72  NIVSMIDVDEE--DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           M I+HRD+KP N++ID     L++ D+G+A
Sbjct: 130 MRIVHRDIKPQNILIDSNKT-LKIFDFGIA 158

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 15/46 (32%), Positives = 26/46 (56%), Gaps = 1/46 (2%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 46
           +         + + H M I+HRD+KP N++ID     L++ D+G+A
Sbjct: 114 INFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT-LKIFDFGIA 158

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 67/315 (21%), Positives = 120/315 (38%), Gaps = 85/315 (26%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIIT 230
            D+ L+R +GRG Y++V      ++     ++++K   K+ +  + + ++ ++   ++  
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVK---KELVNDD-EDIDWVQTEKHV-- 105

Query: 231 LQAVVKDP--VS-----RTPA---LIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKA 277
            +     P  V      +T +    + E+VN  D    + +   L +   R+Y  E+  A
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 165

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQ---------EYNVRVA 327
           L+Y H  GI++RD+K  NV++D E   ++L D+G+  E   PG           Y   +A
Sbjct: 166 LNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY---IA 221

Query: 328 SRYFKGPELLADYQYHIELDPRFADILGRHSRKRW--------ER------FVHTENQHL 373
                 PE+L    Y   +D              W        E       F    +   
Sbjct: 222 ------PEILRGEDYGFSVD--------------WWALGVLMFEMMAGRSPFDIVGSSDN 261

Query: 374 VSPEALDFLDKNILGRHSR-KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL----- 427
                 D+L + IL +  R  R            +S +A   L   L  D  ERL     
Sbjct: 262 PDQNTEDYLFQVILEKQIRIPRS-----------LSVKAASVLKSFLNKDPKERLGCHPQ 310

Query: 428 -TAREAMDHPYFYPI 441
               +   HP+F  +
Sbjct: 311 TGFADIQGHPFFRNV 325

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 21/104 (20%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQ---------EYNV 57
           S+AL+Y H  GI++RD+K  NV++D E   ++L D+G+  E   PG           Y  
Sbjct: 163 SLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY-- 219

Query: 58  RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
            +A      PE+L   + Y +S+D W+LG ++  M+  + PF  
Sbjct: 220 -IA------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI 255

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 13/152 (8%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK------PVKKKKIKREIKILENLRGGT 226
           Y+L   LG G  SEV  A +++      VK+L+      P    + +RE +    L    
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH-P 72

Query: 227 NIITL--QAVVKDPVSRTPALIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYC 281
            I+ +      + P    P ++ E+V+    + +  T   +T       + +  +AL++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           H  GI+HRDVKP N+MI   N  ++++D+G+A
Sbjct: 133 HQNGIIHRDVKPANIMISATNA-VKVMDFGIA 163

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 8/104 (7%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           + +   A  AL++ H  GI+HRDVKP N+MI   N  ++++D+G+A           + A
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTA 177

Query: 61  S-----RYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           +     +Y   PE  A     D   D++SLGC+L  ++  + PF
Sbjct: 178 AVIGTAQYL-SPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 33/173 (19%), Positives = 66/173 (38%), Gaps = 26/173 (15%)

Query: 173 YQLVRKLGRGKYSEVFEAI-----NVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTN 227
           +++   +G+G +  ++ A      +V S   CVVK+ +P     +  E+K  +       
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQ 95

Query: 228 IITLQAVVKDPVSRTPALIF---EHVNNTDFKQLYQTLTDYDIRYYL------------- 271
           I       K      P          N   ++ +       D++                
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155

Query: 272 ---YELLKALDYCHSMGIMHRDVKPHNVMIDHEN-RKLRLIDWGLAEFYHPGQ 320
                +L  L+Y H    +H D+K  N++++++N  ++ L+D+GLA  Y P  
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 15/45 (33%), Positives = 28/45 (62%), Gaps = 1/45 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHEN-RKLRLIDWGLAEFYHPGQ 53
            L+Y H    +H D+K  N++++++N  ++ L+D+GLA  Y P  
Sbjct: 164 ILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 43/159 (27%), Positives = 86/159 (54%), Gaps = 22/159 (13%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDK---CVVKILKPVKKKKIKREIKILENLRGGTN 227
           ++++L++ LG G Y +VF    +   D      +K+LK   K  I ++ K  E+ R    
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK---KATIVQKAKTTEHTRTERQ 110

Query: 228 IITLQAVVKDP--VS-----RTPA---LIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYEL 274
           +  L+ + + P  V+     +T     LI +++N  + F  L Q    T+++++ Y+ E+
Sbjct: 111 V--LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168

Query: 275 LKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           + AL++ H +GI++RD+K  N+++D     + L D+GL+
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLS 206

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 31/122 (25%), Positives = 60/122 (49%), Gaps = 14/122 (11%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKG- 66
           +AL++ H +GI++RD+K  N+++D     + L D+GL+ EF     +   R     F G 
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVA---DETERAYD--FCGT 223

Query: 67  -----PELLADYQM-YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
                P+++      +D ++D WSLG ++  ++    PF    +   Q     ++L +E 
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283

Query: 121 LF 122
            +
Sbjct: 284 PY 285

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 34/150 (22%), Positives = 69/150 (46%), Gaps = 13/150 (8%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK------PVKKKKIKREIKILENLRGGT 226
           Y+L R +GRG   +V+EA +        +K++       PV + +++RE +    L+   
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-P 94

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT---LTDYDIRYYLYELLKALDYCHS 283
           +++ +    +        +    +N  D   + +    L        + ++  ALD  H+
Sbjct: 95  HVVPIHDFGEI--DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA 152

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            G  HRDVKP N+++  ++    L+D+G+A
Sbjct: 153 AGATHRDVKPENILVSADDF-AYLVDFGIA 181

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 27/101 (26%), Positives = 49/101 (48%), Gaps = 4/101 (3%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--EYNVR 58
           + I      ALD  H+ G  HRDVKP N+++  ++    L+D+G+A      +  +    
Sbjct: 137 VAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF-AYLVDFGIASATTDEKLTQLGNT 195

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           V + Y+  PE  ++     Y  D+++L C+L   +    P+
Sbjct: 196 VGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPY 235

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 64.5 bits (156), Expect = 4e-11
 Identities = 65/430 (15%), Positives = 129/430 (30%), Gaps = 113/430 (26%)

Query: 97  EPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPRE 156
           + F    D  D       +L  EE+    D  HI +     D +            K  E
Sbjct: 27  DAFVDNFDCKDVQDMPKSILSKEEI----D--HIIMSK---DAVSGTLRLFWTLLSKQEE 77

Query: 157 YWDYESYVVDWGQQDDYQLV----------RKLGRGKYSEVFEAI--NVQSSDKCVVKIL 204
               + +V +   + +Y+ +            +    Y E  + +  + Q   K  V  L
Sbjct: 78  M--VQKFVEE-VLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRL 134

Query: 205 KPVKKKKIKREIKILENLRGGTNII------------TLQAVVKDPV------------- 239
           +P  K +     + L  LR   N++             L   +   V             
Sbjct: 135 QPYLKLR-----QALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNL 189

Query: 240 --SRTPALIFEHVNN--TDFKQLYQTLTDY---------DIRYYLYELLKALDYCHSMGI 286
               +P  + E +          + + +D+          I+  L  LLK+  Y + + +
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249

Query: 287 MHRDVKPHNVMIDHENRKLRLI----DWGLAEFYHPGQEYNVRV--ASRYFKGPE---LL 337
           +  +V+      +  N   +++       + +F       ++ +   S      E   LL
Sbjct: 250 L-LNVQNAKA-WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307

Query: 338 ADYQYHIELD---------PRFADILG---RHSRKRWERFVHTENQHL--VSPEALDFLD 383
             Y      D         PR   I+    R     W+ + H     L  +   +L+ L+
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367

Query: 384 KNILGRHSRKRWERF------VHTENQHL-------VSPEALDFLDKLLRYDHYERLTAR 430
                   RK ++R        H     L       +  + +  ++KL +Y     L  +
Sbjct: 368 PAEY----RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY----SLVEK 419

Query: 431 EAMDHPYFYP 440
           +  +     P
Sbjct: 420 QPKESTISIP 429

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 63.3 bits (153), Expect = 1e-10
 Identities = 65/530 (12%), Positives = 147/530 (27%), Gaps = 129/530 (24%)

Query: 6   GASMALDYCHSMG-IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYF 64
              + ++Y   M  I     +P  +   +  ++ RL  +   + +     YNV   SR  
Sbjct: 84  EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRL--YNDNQVFAK---YNV---SR-- 133

Query: 65  KGPELLADYQMYDYSLD---------MWSLGC---MLASMIFRKEPFFHGHDNYDQLVRI 112
              +     +     L          +  LG     +A  +          D     + +
Sbjct: 134 --LQPYLKLRQALLELRPAKNVLIDGV--LGSGKTWVALDVCLSYKVQCKMDFKIFWLNL 189

Query: 113 AKVLGTEELFEYLDKYHIELDPRF---ADILGRARVYADVNSHKPREYWDYESY-----V 164
                 E + E L K   ++DP +   +D     ++       + R     + Y     V
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249

Query: 165 VD--WGQQDDYQLVRKLGRG-------KYSEVFEAINVQS-SDKCVVKILKP-------- 206
           +        + +               ++ +V + ++  + +   +              
Sbjct: 250 LLNVQ----NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS 305

Query: 207 -------VKKKKIKREIK---------ILENLRGGTNII-TLQAVVKDPVSRTPALIFEH 249
                   + + + RE+          I E++R G       + V  D ++         
Sbjct: 306 LLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNV 365

Query: 250 VNNTDFKQLYQTLT----DYDIRYYLYELL----------KALDYCHSMGIMHRDVKP-- 293
           +   ++++++  L+       I   L  L+            ++  H   ++ +  K   
Sbjct: 366 LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST 425

Query: 294 --------------------HNVMIDHENRKLRLIDWGLAE------FY-HPGQEYNVRV 326
                               H  ++DH N         L        FY H G  ++++ 
Sbjct: 426 ISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG--HHLKN 483

Query: 327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI 386
                +       +     LD RF +   RH    W       N          ++  N 
Sbjct: 484 IEHPERMTLFRMVF-----LDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDND 538

Query: 387 LGRHSR-KRWERFVHTENQHLVSPEALDFLDKLLRYDH---YERLTAREA 432
                       F+    ++L+  +  D L   L  +    +E    ++ 
Sbjct: 539 PKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEE-AHKQV 587

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 42/179 (23%), Positives = 73/179 (40%), Gaps = 36/179 (20%)

Query: 159 DYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAI----NVQSSDKCVVKILKPVK-----K 209
           D +   + W    D  +  K+G G +  V  A     +V       VKIL          
Sbjct: 28  DGDDMDIPW---CDLNIKEKIGAGSFGTVHRAEWHGSDV------AVKILMEQDFHAERV 78

Query: 210 KKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRY 269
            +  RE+ I++ LR   NI+     V  P     +++ E+++      LY+ L     R 
Sbjct: 79  NEFLREVAIMKRLRH-PNIVLFMGAVTQP--PNLSIVTEYLSRGS---LYRLLHKSGARE 132

Query: 270 YL--YELLK-ALD------YCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH 317
            L     L  A D      Y H+    I+HR++K  N+++D +   +++ D+GL+    
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKA 190

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 23/107 (21%), Positives = 56/107 (52%), Gaps = 15/107 (14%)

Query: 1   MRIATGASMALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR 58
           + +A   +  ++Y H+    I+HR++K  N+++D +   +++ D+GL+       + +  
Sbjct: 140 LSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRL-----KASTF 193

Query: 59  VASRYFKG------PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
           ++S+   G      PE+L D +  +   D++S G +L  +   ++P+
Sbjct: 194 LSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPW 239

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 38/199 (19%), Positives = 75/199 (37%), Gaps = 36/199 (18%)

Query: 159 DYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-----PVKKKKIK 213
             + + + +   +  ++   +G+G++ +V+         +  ++++        + K  K
Sbjct: 24  FLQEWDIPF---EQLEIGELIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFK 77

Query: 214 REIKILENLRGGTNIITLQAVVKDPVSRTP--ALIFEHVNNTDFKQLYQTLTDYDIRYYL 271
           RE+      R   N++        P    P  A+I           LY  + D  I   +
Sbjct: 78  REVMAYRQTRH-ENVVLFMGACMSP----PHLAIITSLCKGRT---LYSVVRDAKIVLDV 129

Query: 272 YELLK-ALD------YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV 324
            +  + A +      Y H+ GI+H+D+K  NV  D  N K+ + D+GL       Q    
Sbjct: 130 NKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRR 187

Query: 325 RVASRYFKG------PELL 337
               R   G      PE++
Sbjct: 188 EDKLRIQNGWLCHLAPEII 206

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 29/113 (25%), Positives = 47/113 (41%), Gaps = 16/113 (14%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
            +IA      + Y H+ GI+H+D+K  NV  D  N K+ + D+GL       Q       
Sbjct: 133 RQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDK 190

Query: 61  SRYFKG------PELL--------ADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
            R   G      PE++         D   +    D+++LG +   +  R+ PF
Sbjct: 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 61.9 bits (151), Expect = 6e-11
 Identities = 34/157 (21%), Positives = 58/157 (36%), Gaps = 43/157 (27%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKI----LKPVKKKKIKREIKILENLRGGT 226
           DD + + +LGRG Y  V +  +V S     VK     +   ++K++  ++ I        
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 227 NIIT---------------------LQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDY 265
             +T                     L    K  V      I E +               
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQ-VIDKGQTIPEDI--------------- 110

Query: 266 DIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHE 301
            +      ++KAL++ HS + ++HRDVKP NV+I+  
Sbjct: 111 -LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL 146

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 32/123 (26%), Positives = 58/123 (47%), Gaps = 17/123 (13%)

Query: 2   RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           +IA     AL++ HS + ++HRDVKP NV+I+    ++++ D+G++     G   +  VA
Sbjct: 113 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGIS-----GYLVD-DVA 165

Query: 61  SRYFKG------PELLADYQM---YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 111
                G      PE +        Y    D+WSLG  +  +   + P+      + QL +
Sbjct: 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ 225

Query: 112 IAK 114
           + +
Sbjct: 226 VVE 228

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 37/154 (24%), Positives = 74/154 (48%), Gaps = 17/154 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK--PVKKKK----IKREIKILENLRG 224
           D +  ++ LG G +  V    + +S +   +KIL    V K K       E +IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99

Query: 225 GTN--IITLQAVVKDPVSRTPALIFEHVNNTD-FKQLY--QTLTDYDIRYYLYELLKALD 279
                ++ L+   KD       ++ E+V   + F  L      ++   R+Y  +++   +
Sbjct: 100 --FPFLVKLEFSFKDN--SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           Y HS+ +++RD+KP N++ID +   +++ D+G A
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFA 188

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 26/100 (26%), Positives = 51/100 (51%), Gaps = 18/100 (18%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-------QEYNVRVAS 61
           +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+             E    +A 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPEA---LA- 206

Query: 62  RYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH 101
                PE++   + Y+ ++D W+LG ++  M     PFF 
Sbjct: 207 -----PEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 23/111 (20%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQ---------EYNVR 58
            AL Y HS+ I++RD+KP N+++D +   + L D+GL  E               EY   
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEY--- 205

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
           +A      PE+L   Q YD ++D W LG +L  M++   PF+    N  ++
Sbjct: 206 LA------PEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY--SRNTAEM 247

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 59.6 bits (145), Expect = 7e-10
 Identities = 41/156 (26%), Positives = 77/156 (49%), Gaps = 20/156 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIIT 230
            D+  ++ +G+G + +V  A +        VK+L+  KK  +K+  K  +++    N+  
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ--KKAILKK--KEEKHIMSERNV-- 91

Query: 231 LQAVVKDP--VS-----RTPA---LIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKA 277
           L   VK P  V      +T      + +++N  + F  L +     +   R+Y  E+  A
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA 151

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           L Y HS+ I++RD+KP N+++D +   + L D+GL 
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLC 186

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 23/111 (20%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQ---------EYNVR 58
            AL + H  GI++RD+K  NV++DHE    +L D+G+  E    G          +Y   
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDY--- 190

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
           +A      PE+L +  +Y  ++D W++G +L  M+    PF    +N D L
Sbjct: 191 IA------PEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFE--AENEDDL 232

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 20/156 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIIT 230
           D+++ +R LG+G + +V  A   ++ D   VK+LK   K  I ++   +E       I  
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQD-DDVECTMTEKRI-- 76

Query: 231 LQAVVKDP--VS-----RTPA---LIFEHVNNTD-FKQLYQT--LTDYDIRYYLYELLKA 277
           L      P         +TP     + E VN  D    + ++    +   R+Y  E++ A
Sbjct: 77  LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA 136

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           L + H  GI++RD+K  NV++DHE    +L D+G+ 
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMC 171

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 61.0 bits (149), Expect = 2e-10
 Identities = 38/154 (24%), Positives = 73/154 (47%), Gaps = 17/154 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK--PVKKKK----IKREIKILENLRG 224
            D+Q++R LG G +  V    +  +     +K+LK   V + K       E  +L  +  
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT- 64

Query: 225 GTN--IITLQAVVKDPVSRTPALIFEHVNNTD-FKQLY--QTLTDYDIRYYLYELLKALD 279
             +  II +    +D   +   +I +++   + F  L   Q   +   ++Y  E+  AL+
Sbjct: 65  --HPFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           Y HS  I++RD+KP N+++D     +++ D+G A
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGH-IKITDFGFA 153

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 54.8 bits (133), Expect = 2e-08
 Identities = 28/106 (26%), Positives = 52/106 (49%), Gaps = 16/106 (15%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-P 67
           +AL+Y HS  I++RD+KP N+++D     +++ D+G A      +       +    G P
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFA------KYVPDVTYT--LCGTP 167

Query: 68  ELLA----DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
           + +A      + Y+ S+D WS G ++  M+    PF+    N  + 
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY--DSNTMKT 211

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 30/107 (28%), Positives = 58/107 (54%), Gaps = 15/107 (14%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 66
            AL+Y HS  +++RD+K  N+M+D +   +++ D+GL +    G      + +  F G  
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCK---EGISDGATMKT--FCGTP 169

Query: 67  ----PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
               PE+L D   Y  ++D W LG ++  M+  + PF+  + ++++L
Sbjct: 170 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERL 213

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 59.2 bits (144), Expect = 8e-10
 Identities = 39/163 (23%), Positives = 76/163 (46%), Gaps = 35/163 (21%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR--------EIKILENL 222
           +D+  ++ LG+G + +V       +     +KIL+  K+  I +        E ++L+N 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQNT 62

Query: 223 RGGTN--IITL----QAVVKDPVSRTPA---LIFEHVNNTD-FKQLYQ--TLTDYDIRYY 270
           R   +  +  L    Q         T      + E+ N  + F  L +    T+   R+Y
Sbjct: 63  R---HPFLTALKYAFQ---------THDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110

Query: 271 LYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
             E++ AL+Y HS  +++RD+K  N+M+D +   +++ D+GL 
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLC 152

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 37/156 (23%), Positives = 67/156 (42%), Gaps = 20/156 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIIT 230
            D+  +  LG+G + +V  +    + +   VKILK   K  + ++   +E       +  
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQD-DDVECTMVEKRV-- 73

Query: 231 LQAVVKDP--VS-----RTPA---LIFEHVNNTD-FKQLYQT--LTDYDIRYYLYELLKA 277
           L    K P         +T      + E+VN  D    + Q     +    +Y  E+   
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG 133

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           L +  S GI++RD+K  NVM+D E   +++ D+G+ 
Sbjct: 134 LFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMC 168

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 23/112 (20%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQ---------EYNV 57
           ++ L +  S GI++RD+K  NVM+D E   +++ D+G+  E    G          +Y  
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDY-- 187

Query: 58  RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
            +A      PE++A  Q Y  S+D W+ G +L  M+  + PF    ++ D+L
Sbjct: 188 -IA------PEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE--GEDEDEL 229

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 59.1 bits (144), Expect = 7e-10
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 23/159 (14%)

Query: 171 DDYQLVRKLGRGKYSEVF--EAINVQSSDK-CVVKILKPVKKKKIKREIKILENLRGGTN 227
           + ++L+R LG+G Y +VF    +   ++ K   +K+LK   K  I R  K   + +   N
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLK---KAMIVRNAKDTAHTKAERN 73

Query: 228 IITLQAVVKDP--VS-----RTPA---LIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYEL 274
           I+     VK P  V      +T     LI E+++  + F QL +     +    +YL E+
Sbjct: 74  IL---EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130

Query: 275 LKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
             AL + H  GI++RD+KP N+M++H+   ++L D+GL 
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLC 168

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 58.7 bits (143), Expect = 1e-09
 Identities = 35/111 (31%), Positives = 57/111 (51%), Gaps = 23/111 (20%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQ---------EYNVR 58
           MAL + H  GI++RD+KP N+M++H+   ++L D+GL  E  H G          EY   
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEY--- 187

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
           +A      PE+L     ++ ++D WSLG ++  M+    PF    +N  + 
Sbjct: 188 MA------PEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFT--GENRKKT 229

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 59.1 bits (144), Expect = 9e-10
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 23/111 (20%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQ---------EYNVR 58
           +ALD+ HS+GI++RD+KP N+++D E   ++L D+GL+ E     +         EY   
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEY--- 192

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
           +A      PE++ + + +  S D WS G ++  M+    PF     +  + 
Sbjct: 193 MA------PEVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQ--GKDRKET 234

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 57.2 bits (139), Expect = 3e-09
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 35/164 (21%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR--------EIKILENL 222
             ++L++ LG+G + +VF    +  SD   +  +K +KK  +K         E  IL   
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE- 82

Query: 223 RGGTN---IITL----QAVVKDPVSRTPA---LIFEHVNNTD-FKQLYQ--TLTDYDIRY 269
               N   I+ L    Q         T     LI + +   D F +L +    T+ D+++
Sbjct: 83  ---VNHPFIVKLHYAFQ---------TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF 130

Query: 270 YLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           YL EL  ALD+ HS+GI++RD+KP N+++D E   ++L D+GL+
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLS 173

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 30/112 (26%), Positives = 56/112 (50%), Gaps = 23/112 (20%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQ---------EYNV 57
            + L + HS GI++RD+K  N+++D +   +++ D+G+  E               +Y  
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDY-- 184

Query: 58  RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
            +A      PE+L   Q Y++S+D WS G +L  M+  + PF     + ++L
Sbjct: 185 -IA------PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH--GQDEEEL 226

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 33/156 (21%), Positives = 69/156 (44%), Gaps = 20/156 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIIT 230
           +D+ L + LG+G + +VF A   +++    +K LK   K  +  +   +E       +  
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK---KDVVLMD-DDVECTMVEKRV-- 70

Query: 231 LQAVVKDP--VS-----RTPA---LIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYELLKA 277
           L    + P         +T      + E++N  D    +            +Y  E++  
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 130

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           L + HS GI++RD+K  N+++D +   +++ D+G+ 
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMC 165

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 15/107 (14%)

Query: 9   MALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 66
           + L +  S GI++RD+K  NVM+D E   +++ D+G+ +         V   +  F G  
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCK---ENIWDGVTTKT--FCGTP 506

Query: 67  ----PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
               PE++A  Q Y  S+D W+ G +L  M+  + PF    ++ D+L
Sbjct: 507 DYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE--GEDEDEL 550

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 37/156 (23%), Positives = 67/156 (42%), Gaps = 20/156 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIIT 230
            D+  +  LG+G + +V  +    + +   VKILK   K  + ++   +E       +  
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQD-DDVECTMVEKRV-- 394

Query: 231 LQAVVKDP--VS-----RTPA---LIFEHVNNTD-FKQLYQT--LTDYDIRYYLYELLKA 277
           L    K P         +T      + E+VN  D    + Q     +    +Y  E+   
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG 454

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           L +  S GI++RD+K  NVM+D E   +++ D+G+ 
Sbjct: 455 LFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMC 489

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 39/165 (23%), Positives = 72/165 (43%), Gaps = 16/165 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI----NVQSSDKCVVKILKP----VKKKKIKREIKILENL 222
              + +R LG G + +V           + ++  VK LKP         +K+EI+IL NL
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY-----QTLTDYDIRYYLYELLKA 277
               NI+  + +  +       LI E + +   K+ Y       +       Y  ++ K 
Sbjct: 81  Y-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-YLPKNKNKINLKQQLKYAVQICKG 138

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 322
           +DY  S   +HRD+   NV+++    ++++ D+GL +     +EY
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEY 182

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 39/164 (23%), Positives = 65/164 (39%), Gaps = 20/164 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCV-VKILKPVKKKKIKRE--IKILENLRGGTN 227
              Q+V+++G+G+Y EV+         + V VK+    ++    RE  I     +R   N
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGK---WRGEKVAVKVFFTTEEASWFRETEIYQTVLMRH-EN 92

Query: 228 IITLQAVVKDPVSRTP--ALIFE-HVNNTDFKQLYQTLTDYDIRYYL-YELLKALDYCHS 283
           I+   A             LI + H N + +  L  T  D      L Y  +  L + H+
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 284 --------MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
                     I HRD+K  N+++  +N    + D GLA  +   
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISD 195

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 25/123 (20%), Positives = 47/123 (38%), Gaps = 21/123 (17%)

Query: 1   MRIATGASMALDYCHS--------MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 52
           +++A  +   L + H+          I HRD+K  N+++  +N    + D GLA  +   
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISD 195

Query: 53  QEYNVRVASRYFKG------PELL---ADYQMYDYSL--DMWSLGCMLASMIFRKEPFFH 101
               V +      G      PE+L    +   +   +  DM+S G +L  +  R      
Sbjct: 196 TN-EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254

Query: 102 GHD 104
             +
Sbjct: 255 VEE 257

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 39/162 (24%), Positives = 73/162 (45%), Gaps = 12/162 (7%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI----NVQSSDKCVVKILK----PVKKKKIKREIKILENL 222
              + +R LG G + +V        N  + +   VK LK    P  +   K+EI IL  L
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT--LTDYDIRYYLYELLKALDY 280
               +II  +   +D  + +  L+ E+V     +       +    +  +  ++ + + Y
Sbjct: 91  Y-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAY 149

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 322
            H+   +HRD+   NV++D  +R +++ D+GLA+    G EY
Sbjct: 150 LHAQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEY 190

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 55.9 bits (135), Expect = 6e-09
 Identities = 14/113 (12%), Positives = 28/113 (24%), Gaps = 30/113 (26%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           +R     + A D  H  G+      P  V +  +                      V +A
Sbjct: 132 IRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--------------------VVLA 171

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 113
                           +   D+  +G  L +++  + P           +  A
Sbjct: 172 YPATMPDA--------NPQDDIRGIGASLYALLVNRWPL--PEAGVRSGLAPA 214

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 17/138 (12%), Positives = 43/138 (31%), Gaps = 10/138 (7%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP------VKKKKIKREIKILENLRGGT 226
           Y+L+   G     + ++A++     +  +  + P         ++       L  +    
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK-P 91

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT-LTDYDIRYYLYELLKALDYCHSMG 285
            +  +  VV         ++ E +     +++  T  +       +  L  A D  H  G
Sbjct: 92  GVARVLDVVHT--RAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG 149

Query: 286 IMHRDVKPHNVMIDHENR 303
           +      P  V +  +  
Sbjct: 150 VALSIDHPSRVRVSIDGD 167

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 56.7 bits (137), Expect = 7e-09
 Identities = 44/222 (19%), Positives = 96/222 (43%), Gaps = 22/222 (9%)

Query: 137 ADILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSS 196
           AD L          S    +    +++ +    ++  +L  KLG+G + EV+       +
Sbjct: 153 ADGLCHRLTTVCPTSKPQTQGLAKDAWEIP---RESLRLEVKLGQGCFGEVWMGT-WNGT 208

Query: 197 DKCVVKILKP--VKKKKIKREIKILENLRGGTNIITLQAVV-KDPVSRTPALIFEHVNNT 253
            +  +K LKP  +  +   +E ++++ LR    ++ L AVV ++P+     ++ E+++  
Sbjct: 209 TRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSEEPI----YIVTEYMSKG 263

Query: 254 DFKQL-----YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLI 308
                      + L    +     ++   + Y   M  +HRD++  N+++  EN   ++ 
Sbjct: 264 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVA 322

Query: 309 DWGLAEFYHPGQEYNVRVASRY---FKGPELLADYQYHIELD 347
           D+GLA       EY  R  +++   +  PE     ++ I+ D
Sbjct: 323 DFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 56.4 bits (136), Expect = 9e-09
 Identities = 44/222 (19%), Positives = 96/222 (43%), Gaps = 22/222 (9%)

Query: 137 ADILGRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSS 196
           AD L          S    +    +++ +    ++  +L  KLG+G + EV+       +
Sbjct: 236 ADGLCHRLTTVCPTSKPQTQGLAKDAWEIP---RESLRLEVKLGQGCFGEVWMGT-WNGT 291

Query: 197 DKCVVKILKP--VKKKKIKREIKILENLRGGTNIITLQAVV-KDPVSRTPALIFEHVNNT 253
            +  +K LKP  +  +   +E ++++ LR    ++ L AVV ++P+     ++ E+++  
Sbjct: 292 TRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSEEPI----YIVTEYMSKG 346

Query: 254 DFKQL-----YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLI 308
                      + L    +     ++   + Y   M  +HRD++  N+++  EN   ++ 
Sbjct: 347 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVA 405

Query: 309 DWGLAEFYHPGQEYNVRVASRY---FKGPELLADYQYHIELD 347
           D+GLA       EY  R  +++   +  PE     ++ I+ D
Sbjct: 406 DFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 26/173 (15%), Positives = 57/173 (32%), Gaps = 24/173 (13%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGT 226
           ++L     R     ++EA    +         +        K  ++  E    +      
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYE------------- 273
            +   + +   P+   P  +   V+   ++ L        ++  L               
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQ 163

Query: 274 ----LLKALDYCHSMGIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFYHPGQE 321
               LL AL++ H    +H +V   N+ +D E++ ++ L  +G A  Y P  +
Sbjct: 164 VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 46.7 bits (111), Expect = 8e-06
 Identities = 13/46 (28%), Positives = 25/46 (54%), Gaps = 1/46 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFYHPGQE 54
           AL++ H    +H +V   N+ +D E++ ++ L  +G A  Y P  +
Sbjct: 171 ALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 36/153 (23%), Positives = 62/153 (40%), Gaps = 16/153 (10%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP----VKKKKIKREIKILENLRGGT 226
           +D  L  ++GRG + EVF       +    VK  +       K K  +E +IL+      
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HP 172

Query: 227 NIITLQAVVKDPVSRTPALI-FEHVNNTDFKQLY-----QTLTDYDIRYYLYELLKALDY 280
           NI+ L  V      + P  I  E V   DF   +       L    +   + +    ++Y
Sbjct: 173 NIVRLIGVC---TQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEY 228

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
             S   +HRD+   N ++  E   L++ D+G++
Sbjct: 229 LESKCCIHRDLAARNCLVT-EKNVLKISDFGMS 260

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 38/171 (22%), Positives = 66/171 (38%), Gaps = 42/171 (24%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI----NVQSSDKCVVKILKPVK-------KKKIKREIKIL 219
            +  L   +G G + +V+ A      V       VK  +           + +++E K+ 
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWIGDEV------AVKAARHDPDEDISQTIENVRQEAKLF 60

Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLK-AL 278
             L+   NII L+ V          L+ E         L + L+   I   +  L+  A+
Sbjct: 61  AMLKH-PNIIALRGVCLKE--PNLCLVMEFARGGP---LNRVLSGKRIPPDI--LVNWAV 112

Query: 279 D------YCHSMG---IMHRDVKPHNVMIDHE-------NRKLRLIDWGLA 313
                  Y H      I+HRD+K  N++I  +       N+ L++ D+GLA
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 28/115 (24%), Positives = 52/115 (45%), Gaps = 24/115 (20%)

Query: 1   MRIATGASMALDYCHSMG---IMHRDVKPHNVMIDHE-------NRKLRLIDWGLAEFYH 50
           +  A   +  ++Y H      I+HRD+K  N++I  +       N+ L++ D+GLA  +H
Sbjct: 108 VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH 167

Query: 51  PGQEYNVRVASRYFKG------PELLADYQMYDYSLDMWSLGCMLASMIFRKEPF 99
              + +         G      PE++    M+    D+WS G +L  ++  + PF
Sbjct: 168 RTTKMS-------AAGAYAWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPF 214

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 30/103 (29%), Positives = 56/103 (54%), Gaps = 6/103 (5%)

Query: 9   MALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKG 66
            ALDY HS   +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  
Sbjct: 259 SALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLA 317

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
           PE+L D   Y  ++D W LG ++  M+  + PF+  + ++++L
Sbjct: 318 PEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKL 357

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 53.2 bits (128), Expect = 9e-08
 Identities = 36/161 (22%), Positives = 77/161 (47%), Gaps = 30/161 (18%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKR--------EIKILENL 222
           ++++ ++ LG+G + +V       +     +KILK  K+  + +        E ++L+N 
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--KEVIVAKDEVAHTLTENRVLQN- 204

Query: 223 RGGTN---IITLQAVVKDPVSRTPA---LIFEHVNNTD-FKQLYQ--TLTDYDIRYYLYE 273
              +    +  L+   +     T      + E+ N  + F  L +    ++   R+Y  E
Sbjct: 205 ---SRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 256

Query: 274 LLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           ++ ALDY HS   +++RD+K  N+M+D +   +++ D+GL 
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLC 296

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 37/169 (21%), Positives = 76/169 (44%), Gaps = 18/169 (10%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTNI 228
            D  +  KLG G+Y EV+E +  + S    VK LK   ++ ++  +E  +++ ++   N+
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNL 71

Query: 229 ITLQAVV--KDPVSRTPALIFEHVNNTDFKQLY------QTLTDYDIRYYLYELLKALDY 280
           + L  V   + P      +I E +   +    Y      Q ++   + Y   ++  A++Y
Sbjct: 72  VQLLGVCTREPPF----YIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEY 126

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 329
                 +HRD+   N ++  EN  +++ D+GL+     G  Y     ++
Sbjct: 127 LEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAK 173

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 42/190 (22%), Positives = 87/190 (45%), Gaps = 21/190 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTNI 228
            D  +  KLG G+Y EV+E +  + S    VK LK   ++ ++  +E  +++ ++   N+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNL 278

Query: 229 ITLQAVV--KDPVSRTPALIFEHVNNTDFKQLY------QTLTDYDIRYYLYELLKALDY 280
           + L  V   + P      +I E +   +    Y      Q ++   + Y   ++  A++Y
Sbjct: 279 VQLLGVCTREPPF----YIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEY 333

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY---FKGPELL 337
                 +HR++   N ++  EN  +++ D+GL+     G  Y     +++   +  PE L
Sbjct: 334 LEKKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 391

Query: 338 ADYQYHIELD 347
           A  ++ I+ D
Sbjct: 392 AYNKFSIKSD 401

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 35/166 (21%), Positives = 60/166 (36%), Gaps = 20/166 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCV-VKILKPVKKKKIKRE--IKILENLRGGTN 227
               L   +G+G++ EV+         + V VKI    +++   RE  I     LR   N
Sbjct: 42  RTIVLQESIGKGRFGEVWRGK---WRGEEVAVKIFSSREERSWFREAEIYQTVMLRH-EN 97

Query: 228 IITLQAVVKDPVSRTP--ALIFE-HVNNTDFKQLYQTLTDYDIRYYL-YELLKALDYCHS 283
           I+   A             L+ + H + + F  L +     +    L       L + H 
Sbjct: 98  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHM 157

Query: 284 --------MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
                     I HRD+K  N+++  +N    + D GLA  +    +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATD 202

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 21/108 (19%), Positives = 47/108 (43%), Gaps = 21/108 (19%)

Query: 1   MRIATGASMALDYCHS--------MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 52
           +++A   +  L + H           I HRD+K  N+++  +N    + D GLA  +   
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSA 200

Query: 53  QEYNVRVASRYFKG------PELL---ADYQMYDYSL--DMWSLGCML 89
            +  + +A  +  G      PE+L    + + ++     D++++G + 
Sbjct: 201 TDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 35/163 (21%), Positives = 76/163 (46%), Gaps = 13/163 (7%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI----NVQSSDKCVVKILK---PVKKKKIKREIKILENLR 223
              + + +LG+G +  V           +     VK L+   P +++  +REI+IL+ L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNN---TDF-KQLYQTLTDYDIRYYLYELLKALD 279
               I+  + V   P  ++  L+ E++ +    DF ++    L    +  Y  ++ K ++
Sbjct: 83  -SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 322
           Y  S   +HRD+   N++++     +++ D+GLA+     ++Y
Sbjct: 142 YLGSRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDY 183

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 34/170 (20%), Positives = 58/170 (34%), Gaps = 38/170 (22%)

Query: 174 QLVRKLGRGKYSEVFEAINVQSSDKCV-VKILKPVKKKKIKREIKI--LENLRGGTNIIT 230
            L+  +G+G+Y EV+         + V VKI     +K   RE ++     LR   NI+ 
Sbjct: 11  TLLECVGKGRYGEVWRGS---WQGENVAVKIFSSRDEKSWFRETELYNTVMLRH-ENILG 66

Query: 231 LQAVVKDPVSRTPA--LIFE-----------HVNNTDFKQLYQTLTDYDIRYYLYELLKA 277
             A        +    LI              +   D     + +           +   
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS---------IASG 117

Query: 278 LDYCHS--------MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 319
           L + H           I HRD+K  N+++  +N +  + D GLA  +   
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQS 166

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 26/118 (22%), Positives = 45/118 (38%), Gaps = 21/118 (17%)

Query: 1   MRIATGASMALDYCHS--------MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG 52
           +RI    +  L + H           I HRD+K  N+++  +N +  + D GLA  +   
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQS 166

Query: 53  QEYNVRVASRYFKG------PELL---ADYQMYDYSL--DMWSLGCMLASMIFRKEPF 99
               + V +    G      PE+L        +D     D+W+ G +L  +  R    
Sbjct: 167 TNQ-LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 35/163 (21%), Positives = 77/163 (47%), Gaps = 13/163 (7%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCV----VKILKPVKKKKIK---REIKILENLR 223
              + +++LG+G +  V         D       VK L+   ++ ++   REI+IL++L+
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNN---TDFKQLYQ-TLTDYDIRYYLYELLKALD 279
              NI+  + V      R   LI E++      D+ Q ++  +    +  Y  ++ K ++
Sbjct: 101 -HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 322
           Y  +   +HRD+   N++++    ++++ D+GL +     +EY
Sbjct: 160 YLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEY 201

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 37/205 (18%), Positives = 72/205 (35%), Gaps = 34/205 (16%)

Query: 159 DYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV-VKILKPVKKKKIKREIK 217
                 +D    D+ +L+  +GRG+Y  V++       ++ V VK+     ++    E  
Sbjct: 4   AASEPSLDL---DNLKLLELIGRGRYGAVYKG---SLDERPVAVKVFSFANRQNFINEKN 57

Query: 218 I--LENLRGGTNIIT-LQAVVKDPVSRTP--ALIFE-HVNNTDFKQLYQTLTDYDIRYYL 271
           I  +  +    NI   +    +          L+ E + N +  K L    +D+     L
Sbjct: 58  IYRVPLMEH-DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL 116

Query: 272 -YELLKALDYCHSM---------GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
            + + + L Y H+           I HRD+   NV++   +    + D+GL+      + 
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRL 175

Query: 322 YNVRVASRYFKG---------PELL 337
                                PE+L
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVL 200

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 28/151 (18%), Positives = 50/151 (33%), Gaps = 25/151 (16%)

Query: 1   MRIATGASMALDYCHSM---------GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 51
            R+A   +  L Y H+           I HRD+   NV++   +    + D+GL+     
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTG 172

Query: 52  GQEYNVRVASRYFKG---------PELL------ADYQMYDYSLDMWSLGCMLASMIFRK 96
            +                      PE+L       D +     +DM++LG +   +  R 
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 97  EPFFHGHDNYDQLVRIAKVLGTEELFEYLDK 127
              F G    +  +     +G    FE +  
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQV 263

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 53.2 bits (128), Expect = 7e-08
 Identities = 41/180 (22%), Positives = 69/180 (38%), Gaps = 25/180 (13%)

Query: 158 WDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV-VKILKPVKKK--KIKR 214
              E+           QL+    RG++  V++A   Q  ++ V VKI     K+  + + 
Sbjct: 14  LGTENLYFQS---MPLQLLEVKARGRFGCVWKA---QLLNEYVAVKIFPIQDKQSWQNEY 67

Query: 215 EIKILENLRGGTNIITLQAVVKDPVSRTPA--LIFE-HVNNTDFKQLYQTLTDYDIRY-- 269
           E+  L  ++   NI+      K   S      LI   H   +    L   +  ++     
Sbjct: 68  EVYSLPGMKH-ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHI 126

Query: 270 ---------YLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
                    YL+E +  L   H   I HRD+K  NV++   N    + D+GLA  +  G+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGK 185

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 30/124 (24%), Positives = 45/124 (36%), Gaps = 20/124 (16%)

Query: 1   MRIATGASMALDYCHSM----------GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH 50
             IA   +  L Y H             I HRD+K  NV++   N    + D+GLA  + 
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFE 182

Query: 51  PGQEYNVRVAS----RYFKGPELLADYQMYDYSL----DMWSLGCMLASMIFRKEPFFHG 102
            G+            RY   PE+L     +        DM+++G +L  +  R       
Sbjct: 183 AGKSAGDTHGQVGTRRYM-APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

Query: 103 HDNY 106
            D Y
Sbjct: 242 VDEY 245

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 52.7 bits (127), Expect = 7e-08
 Identities = 33/163 (20%), Positives = 77/163 (47%), Gaps = 13/163 (7%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCV----VKILKPVKKKKIK---REIKILENLR 223
              + +++LG+G +  V         D       VK L+   ++ ++   REI+IL++L+
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNN---TDF-KQLYQTLTDYDIRYYLYELLKALD 279
              NI+  + V      R   LI E++      D+ ++  + +    +  Y  ++ K ++
Sbjct: 70  -HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 322
           Y  +   +HRD+   N++++    ++++ D+GL +     +E+
Sbjct: 129 YLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEF 170

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 32/190 (16%), Positives = 72/190 (37%), Gaps = 20/190 (10%)

Query: 137 ADILGRARVYAD-VNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAI---- 191
            DI     +Y        P +     +  +           + +G G++ EV++ +    
Sbjct: 12  YDIPTTENLYFQGAMGSDPNQAVLKFTTEIH---PSCVTRQKVIGAGEFGEVYKGMLKTS 68

Query: 192 NVQSSDKCVVKILKP----VKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF 247
           + +      +K LK      ++     E  I+       NII L+ V+     +   +I 
Sbjct: 69  SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISK--YKPMMIIT 125

Query: 248 EHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR 303
           E++ N    +  +      +   +   L  +   + Y  +M  +HRD+   N++++  N 
Sbjct: 126 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN-SNL 184

Query: 304 KLRLIDWGLA 313
             ++ D+GL+
Sbjct: 185 VCKVSDFGLS 194

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 35/200 (17%), Positives = 82/200 (41%), Gaps = 15/200 (7%)

Query: 141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV 200
           G   V+ D+++  P      +  V+             +GRG +  V+    + +  K +
Sbjct: 60  GANTVHIDLSALNPELVQAVQHVVIG-PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKI 118

Query: 201 ---VKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNT 253
              VK L  +    +  +   E  I+++     N+++L  +       +P ++  ++ + 
Sbjct: 119 HCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRS-EGSPLVVLPYMKHG 176

Query: 254 DFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLID 309
           D +   +      T  D+  +  ++ K + +  S   +HRD+   N M+D E   +++ D
Sbjct: 177 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVAD 235

Query: 310 WGLAEFYHPGQEYNVRVASR 329
           +GLA   +  +  +V   + 
Sbjct: 236 FGLARDMYDKEFDSVHNKTG 255

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 33/179 (18%), Positives = 75/179 (41%), Gaps = 15/179 (8%)

Query: 146 YADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV---VK 202
           + D+++  P      +  V+             +GRG +  V+    + +  K +   VK
Sbjct: 1   HIDLSALNPELVQAVQHVVIG-PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 59

Query: 203 ILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL 258
            L  +    +  +   E  I+++     N+++L  +       +P ++  ++ + D +  
Sbjct: 60  SLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNF 117

Query: 259 YQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            +      T  D+  +  ++ K + Y  S   +HRD+   N M+D E   +++ D+GLA
Sbjct: 118 IRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLA 175

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 34/155 (21%), Positives = 66/155 (42%), Gaps = 18/155 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCV---VKILKP----VKKKKIKREIKILENLR 223
           +  +L R +G G++ +V + I +   +  +   +K  K       ++K  +E   +    
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 224 GGTNIITLQAVVKDPVSRTPALI-FEHVNNTDF----KQLYQTLTDYDIRYYLYELLKAL 278
              +I+ L  V    ++  P  I  E     +     +    +L    +  Y Y+L  AL
Sbjct: 75  -HPHIVKLIGV----ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            Y  S   +HRD+   NV++   N  ++L D+GL+
Sbjct: 130 AYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLS 163

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 38/180 (21%), Positives = 69/180 (38%), Gaps = 23/180 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI---NVQSSDKCVVKILKP-----VKKKKIKREIKILENL 222
             + L R LG+G++  V EA       S  K  VK+LK         ++  RE   ++  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 223 RGGTNIITLQAVV--KDPVSRTPAL--IFEHVNNTDFK---------QLYQTLTDYDIRY 269
               ++  L  V        R P    I   + + D           +    L    +  
Sbjct: 83  DH-PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141

Query: 270 YLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 329
           ++ ++   ++Y  S   +HRD+   N M+  E+  + + D+GL+   + G  Y    AS+
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLA-EDMTVCVADFGLSRKIYSGDYYRQGCASK 200

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 51.8 bits (123), Expect = 2e-07
 Identities = 51/343 (14%), Positives = 101/343 (29%), Gaps = 91/343 (26%)

Query: 166 DWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL-----------KPVKKKKIKR 214
                +  Q   K+G G + EVF+ I         +KI+                ++I  
Sbjct: 15  HCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72

Query: 215 EIKILENLRG--------GTNIITLQAVVKDPVSRTPALIFEHVNNTDFK---------- 256
           EI I + L              I L +V     S  P L+    +    K          
Sbjct: 73  EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132

Query: 257 ---QLY-----------------QTLTDYDIRYYLYELLKALDYCH-SMGIMHRDVKPHN 295
              QL+                 +  +    +  L++L  +L     S+   HRD+   N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192

Query: 296 VMIDHENRK-------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 336
           V++   + K                   + +ID+ L+     G    V            
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLF 249

Query: 337 LADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE 396
             D  Y  ++      ++ + +  RW  +    N        L +L   +L    +  ++
Sbjct: 250 TGDGDYQFDI----YRLMKKENNNRWGEYHPYSNVLW-----LHYLTDKML---KQMTFK 297

Query: 397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY 439
              +T     +  +  +F   +L +      +A + +     +
Sbjct: 298 TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLF 335

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 24/151 (15%), Positives = 64/151 (42%), Gaps = 15/151 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTNI 228
            +   V+++G G++  V       + DK  +K ++   + ++    E +++  L     +
Sbjct: 8   SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKL 65

Query: 229 ITLQAVV--KDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKALDYCH 282
           + L  V   + P+     L+ E + +       +T         +     ++ + + Y  
Sbjct: 66  VQLYGVCLEQAPI----CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
              ++HRD+   N ++  EN+ +++ D+G+ 
Sbjct: 122 EACVIHRDLAARNCLVG-ENQVIKVSDFGMT 151

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 36/167 (21%), Positives = 74/167 (44%), Gaps = 16/167 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTNI 228
           +  +LV +LG G++ EV+         K  VK LK   +       E  +++ L+    +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRL 70

Query: 229 ITLQAVV-KDPVSRTPALIFEHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCH 282
           + L AVV ++P+     +I E++ N       +T     LT   +     ++ + + +  
Sbjct: 71  VRLYAVVTQEPI----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASR 329
               +HRD++  N+++  +    ++ D+GLA       EY  R  ++
Sbjct: 127 ERNYIHRDLRAANILVS-DTLSCKIADFGLARLIE-DNEYTAREGAK 171

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 37/155 (23%), Positives = 67/155 (43%), Gaps = 18/155 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI---NVQSSDKCVVKILKP----VKKKKIKREIKILENLR 223
           +D  L R LG G + EV+E +   +        VK  K       K+K   E  I++NL 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 224 GGTNIITLQAVVKDPVSRTPALI-FEHVNNTDF----KQLYQTLTDYDIRYYLYELLKAL 278
              +I+ L  +    +   P  I  E     +     ++   +L    +  Y  ++ KA+
Sbjct: 72  -HPHIVKLIGI----IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            Y  S+  +HRD+   N+++      ++L D+GL+
Sbjct: 127 AYLESINCVHRDIAVRNILVA-SPECVKLGDFGLS 160

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 34/154 (22%), Positives = 64/154 (41%), Gaps = 15/154 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCV---VKILKP----VKKKKIKREIKILENLR 223
            +  + + +G G++ EV        S K +   +K LK      +++    E  I+    
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKALD 279
              NII L+ VV    S+   ++ E++ N       +      T   +   L  +   + 
Sbjct: 105 H-PNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           Y   MG +HRD+   N++I+  N   ++ D+GL 
Sbjct: 162 YLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLG 194

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 50.7 bits (122), Expect = 4e-07
 Identities = 27/164 (16%), Positives = 73/164 (44%), Gaps = 17/164 (10%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCV----VKILK----PVKKKKIKREIKILENL 222
            +++ ++ LG G +  V++ + +   +K      +K L+    P   K+I  E  ++ ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNN---TDF-KQLYQTLTDYDIRYYLYELLKAL 278
               ++  L  +       T  LI + +      D+ ++    +    +  +  ++ K +
Sbjct: 75  D-NPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 322
           +Y     ++HRD+   NV++    + +++ D+GLA+     ++ 
Sbjct: 131 NYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKE 173

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 36/155 (23%), Positives = 70/155 (45%), Gaps = 18/155 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCV---VKILKP----VKKKKIKREIKILENLR 223
           +  +L R +G G++ +V + I +   +  +   +K  K       ++K  +E   +    
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 224 GGTNIITLQAVV-KDPVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKAL 278
              +I+ L  V+ ++PV     +I E     + +   Q    +L    +  Y Y+L  AL
Sbjct: 450 H-PHIVKLIGVITENPV----WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            Y  S   +HRD+   NV++   N  ++L D+GL+
Sbjct: 505 AYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLS 538

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 32/197 (16%), Positives = 75/197 (38%), Gaps = 23/197 (11%)

Query: 154 PREYWDYESYVVDWG-QQDDYQLVRKLGRGKYSEVFEAI---NVQSSDKCVVKILKP--- 206
           PR   + ++ + D    ++   L + LG G++  V E        +S K  VK +K    
Sbjct: 16  PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS 75

Query: 207 --VKKKKIKREIKILENLRGGTNIITLQAVV--KDPVSRTPAL-IFEHVNNTDFKQ---- 257
              + ++   E   +++     N+I L  V            + I   +   D       
Sbjct: 76  SQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLY 134

Query: 258 -----LYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL 312
                  + +    +  ++ ++   ++Y  +   +HRD+   N M+  ++  + + D+GL
Sbjct: 135 SRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADFGL 193

Query: 313 AEFYHPGQEYNVRVASR 329
           ++  + G  Y     ++
Sbjct: 194 SKKIYSGDYYRQGRIAK 210

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 49.5 bits (119), Expect = 7e-07
 Identities = 27/151 (17%), Positives = 66/151 (43%), Gaps = 15/151 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTNI 228
            D   +++LG G++  V      +      +K++K   + + +   E K++ NL     +
Sbjct: 24  KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKL 81

Query: 229 ITLQAVV--KDPVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCH 282
           + L  V   + P+     +I E++ N       +          +     ++ +A++Y  
Sbjct: 82  VQLYGVCTKQRPI----FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           S   +HRD+   N +++ +   +++ D+GL+
Sbjct: 138 SKQFLHRDLAARNCLVN-DQGVVKVSDFGLS 167

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 49.5 bits (119), Expect = 7e-07
 Identities = 25/152 (16%), Positives = 67/152 (44%), Gaps = 17/152 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTNI 228
           ++  L+++LG G++  V      +      VK++K   + + +  +E + +  L     +
Sbjct: 8   EEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKL 65

Query: 229 ITLQAVV--KDPVSRTPALIFEHVNNTDFKQLY-----QTLTDYDIRYYLYELLKALDYC 281
           +    V   + P+     ++ E+++N      Y     + L    +    Y++ + + + 
Sbjct: 66  VKFYGVCSKEYPI----YIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAFL 120

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            S   +HRD+   N ++D  +  +++ D+G+ 
Sbjct: 121 ESHQFIHRDLAARNCLVD-RDLCVKVSDFGMT 151

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 49.6 bits (119), Expect = 8e-07
 Identities = 34/154 (22%), Positives = 61/154 (39%), Gaps = 15/154 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCV---VKILKP----VKKKKIKREIKILENLR 223
               + + +G G   EV          + V   +K LK      +++    E  I+    
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108

Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKALD 279
              NII L+ VV     R   ++ E++ N       +T     T   +   L  +   + 
Sbjct: 109 H-PNIIRLEGVVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           Y   +G +HRD+   NV++D  N   ++ D+GL+
Sbjct: 166 YLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLS 198

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 50.1 bits (120), Expect = 9e-07
 Identities = 38/189 (20%), Positives = 84/189 (44%), Gaps = 19/189 (10%)

Query: 149 VNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP-- 206
             S KP++ W+ +++ +    ++  +L +KLG G++ EV+ A       K  VK +KP  
Sbjct: 169 CMSSKPQKPWEKDAWEIP---RESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGS 224

Query: 207 VKKKKIKREIKILENLRGGTNIITLQAVV-KDPVSRTPALIFEHVNNTDFKQ-----LYQ 260
           +  +    E  +++ L+    ++ L AVV K+P+     +I E +               
Sbjct: 225 MSVEAFLAEANVMKTLQH-DKLVKLHAVVTKEPI----YIITEFMAKGSLLDFLKSDEGS 279

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
                 +  +  ++ + + +      +HRD++  N+++   +   ++ D+GLA       
Sbjct: 280 KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLARVIE-DN 337

Query: 321 EYNVRVASR 329
           EY  R  ++
Sbjct: 338 EYTAREGAK 346

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 44/208 (21%), Positives = 80/208 (38%), Gaps = 32/208 (15%)

Query: 171 DDYQLVRKLGRGKYSEVFEA-----INVQSSDKCVVKILKP----VKKKKIKREIKILEN 221
           +     + LG G + +V EA     I   ++    VK+LKP     +++ +  E+K+L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 222 LRGGTNIITLQAVV--KDPV-----------------SRTPALIFEHVNNTDFKQLYQTL 262
           L    NI+ L        P                   +  + I    +    +     L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 263 TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 322
              D+  + Y++ K + +  S   +HRD+   N+++    R  ++ D+GLA        Y
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNY 201

Query: 323 NVRVASRY-FK--GPELLADYQYHIELD 347
            V+  +R   K   PE + +  Y  E D
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESD 229

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 32/165 (19%), Positives = 73/165 (44%), Gaps = 18/165 (10%)

Query: 174 QLVRKLGRGKYSEVFEAI---NVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGT 226
              R +G+G +  V+        Q+  +C +K L  +    + +   RE  ++  L    
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH-P 82

Query: 227 NIITLQAVV--KDPVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDY 280
           N++ L  ++   +     P ++  ++ + D  Q  +      T  D+  +  ++ + ++Y
Sbjct: 83  NVLALIGIMLPPEG---LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139

Query: 281 CHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR 325
                 +HRD+   N M+D E+  +++ D+GLA      + Y+V+
Sbjct: 140 LAEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQ 183

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 38/188 (20%), Positives = 74/188 (39%), Gaps = 32/188 (17%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI-----NVQSSDKCVVKILKP----VKKKKIKREIKILEN 221
           D  +L + LGRG + +V EA         +     VK+LK      + + +  E+KIL +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 222 LRGGTNIITLQAVVKDPVSRTPA-LIFEHVNNTDFK-------------------QLYQT 261
           +    N++ L           P  +I E     +                          
Sbjct: 87  IGHHLNVVNLLGACTK--PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144

Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
           LT   +  Y +++ K +++  S   +HRD+   N+++  E   +++ D+GLA   +   +
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 203

Query: 322 YNVRVASR 329
           Y  +  +R
Sbjct: 204 YVRKGDAR 211

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 27/164 (16%), Positives = 73/164 (44%), Gaps = 17/164 (10%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCV----VKILK----PVKKKKIKREIKILENL 222
            +++ ++ LG G +  V++ + +   +K      +K L+    P   K+I  E  ++ ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNN---TDF-KQLYQTLTDYDIRYYLYELLKAL 278
               ++  L  +       T  LI + +      D+ ++    +    +  +  ++ K +
Sbjct: 75  D-NPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 322
           +Y     ++HRD+   NV++    + +++ D+GLA+     ++ 
Sbjct: 131 NYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKE 173

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 26/184 (14%), Positives = 76/184 (41%), Gaps = 20/184 (10%)

Query: 174 QLVRKLGRGKYSEVFEAINVQSSDKCV----VKILK----PVKKKKIKREIKILENLRGG 225
           + ++ LG G +  V + + +   +       +K+++        + +   +  + +L   
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH- 74

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNN---TDF-KQLYQTLTDYDIRYYLYELLKALDYC 281
            +I+ L  +       +  L+ +++      D  +Q    L    +  +  ++ K + Y 
Sbjct: 75  AHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRY-FK--GPELLA 338
              G++HR++   NV++     ++++ D+G+A+   P  +  +   ++   K    E + 
Sbjct: 132 EEHGMVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 339 DYQY 342
             +Y
Sbjct: 191 FGKY 194

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 31/173 (17%), Positives = 73/173 (42%), Gaps = 20/173 (11%)

Query: 150 NSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP-VK 208
            S   ++ +    + ++     + +L++ +G+G++ +V         +K  VK +K    
Sbjct: 3   GSVAAQDEFYRSGWALN---MKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDAT 57

Query: 209 KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL--IFEHVNNTDFKQLY------Q 260
            +    E  ++  LR  +N++ L  V+   V     L  + E++        Y       
Sbjct: 58  AQAFLAEASVMTQLR-HSNLVQLLGVI---VEEKGGLYIVTEYMAKGSLVD-YLRSRGRS 112

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            L    +  +  ++ +A++Y      +HRD+   NV++  E+   ++ D+GL 
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLT 164

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 26/167 (15%), Positives = 64/167 (38%), Gaps = 30/167 (17%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI-----NVQSSDKCVVKILKP----VKKKKIKREIKILEN 221
           +   + R+LG+G +  V+E +       +   +  +K +       ++ +   E  +++ 
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 222 LRGGTNIITLQAVV--KDPVSRTPALIFEHVNNTDFKQ-------------LYQTLTDYD 266
                +++ L  VV    P      +I E +   D K              +    +   
Sbjct: 85  FN-CHHVVRLLGVVSQGQP----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139

Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           +     E+   + Y ++   +HRD+   N M+  E+  +++ D+G+ 
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMT 185

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 23/179 (12%), Positives = 58/179 (32%), Gaps = 28/179 (15%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI-------NVQSSDKCVVKILKPV---KKKKIKREIKILE 220
           +D      LG+G ++++F+ +             + ++K+L        +       ++ 
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 221 NLRGGTNIITLQAVV--KDPVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYEL 274
            L    +++    V    D       L+ E V         +     +          +L
Sbjct: 68  KLS-HKHLVLNYGVCVCGDEN----ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQL 122

Query: 275 LKALDYCHSMGIMHRDVKPHNVMIDH-------ENRKLRLIDWGLAEFYHPGQEYNVRV 326
             A+ +     ++H +V   N+++             ++L D G++    P      R+
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 47.6 bits (114), Expect = 4e-06
 Identities = 31/157 (19%), Positives = 66/157 (42%), Gaps = 17/157 (10%)

Query: 177 RKLGRGKYSEVFEAI-NVQSSDKCV-VKILK-----PVKKKKIKREIKILENLRGGTNII 229
           ++LG G +  V +    ++   K V VKILK     P  K ++  E  +++ L     I+
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIV 81

Query: 230 TLQAVV-KDPVSRTPALIFEHVNN---TDFKQLYQTLTDYDIRYYLYELLKALDYCHSMG 285
            +  +   +       L+ E         + Q  + + D +I   ++++   + Y     
Sbjct: 82  RMIGICEAESW----MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 137

Query: 286 IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 322
            +HRD+   NV++       ++ D+GL++     + Y
Sbjct: 138 FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENY 173

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 30/152 (19%), Positives = 66/152 (43%), Gaps = 17/152 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP-VKKKKIKREIKILENLRGGTNII 229
            + +L++ +G+G++ +V         +K  VK +K     +    E  ++  LR  +N++
Sbjct: 193 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SNLV 249

Query: 230 TLQAVVKDPVSRTPAL--IFEHVNNTDFKQLY------QTLTDYDIRYYLYELLKALDYC 281
            L  V+   V     L  + E++        Y        L    +  +  ++ +A++Y 
Sbjct: 250 QLLGVI---VEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
                +HRD+   NV++  E+   ++ D+GL 
Sbjct: 306 EGNNFVHRDLAARNVLVS-EDNVAKVSDFGLT 336

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 46.9 bits (112), Expect = 8e-06
 Identities = 40/183 (21%), Positives = 72/183 (39%), Gaps = 33/183 (18%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI-----NVQSSDKCVVKILKP----VKKKKIKREIKILEN 221
           ++ Q  + LG G + +V EA         +  K  VK+LK      +K+ +  E+KI+ +
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 222 LRGGTNIITLQAVV--KDPVSRTPALIFEHVNNTDFK-----------------QLYQTL 262
           L    NI+ L        PV     +I E+    D                       T 
Sbjct: 106 LGQHENIVNLLGACTHGGPV----LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161

Query: 263 TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 322
           +  D+ ++  ++ + + +  S   +HRDV   NV++       ++ D+GLA        Y
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNY 220

Query: 323 NVR 325
            V+
Sbjct: 221 IVK 223

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 46.5 bits (111), Expect = 9e-06
 Identities = 35/188 (18%), Positives = 70/188 (37%), Gaps = 40/188 (21%)

Query: 153 KPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEA-INVQSSDKCV-VKILKP---- 206
            P  Y      V+DW   +D +    +G G + +V +A I          +K +K     
Sbjct: 15  DPTIYP-----VLDW---NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK 66

Query: 207 VKKKKIKREIKILENLRGGTNIITLQAVV--KDPVSRTPALIFEHVNNTDFKQ------- 257
              +    E+++L  L    NII L      +  +     L  E+  + +          
Sbjct: 67  DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY----LAIEYAPHGNLLDFLRKSRV 122

Query: 258 ------------LYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKL 305
                          TL+   + ++  ++ + +DY      +HRD+   N+++  EN   
Sbjct: 123 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVA 181

Query: 306 RLIDWGLA 313
           ++ D+GL+
Sbjct: 182 KIADFGLS 189

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 30/168 (17%), Positives = 63/168 (37%), Gaps = 34/168 (20%)

Query: 174 QLVRKLGRGKYSEVFEAI-----NVQSSDKCVVKILKPVKKKKIK---REIKILENLRGG 225
            L  +LG G + +VF A        Q      VK LK   +   +   RE ++L  L+  
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-H 102

Query: 226 TNIITLQAVV--KDPVSRTPALIFEHVNNTDFKQ------------------LYQTLTDY 265
            +I+    V     P+     ++FE++ + D  +                      L   
Sbjct: 103 QHIVRFFGVCTEGRPLL----MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158

Query: 266 DIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            +     ++   + Y   +  +HRD+   N ++  +   +++ D+G++
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMS 205

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 34/166 (20%), Positives = 58/166 (34%), Gaps = 28/166 (16%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI-----NVQSSDKCVVKILKPV----KKKKIKREIKILEN 221
            +  L+R LG G + EV+E       N  S  +  VK L  V     +     E  I+  
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 222 LRGGTNIITLQAVV--KDPVSRTPALIFEHVNNTDFKQ----------LYQTLTDYDIRY 269
                NI+    V     P      ++ E +   D K              +L   D+ +
Sbjct: 90  FN-HQNIVRCIGVSLQSLPRF----ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144

Query: 270 YLYELLKALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLA 313
              ++     Y      +HRD+   N ++      R  ++ D+G+A
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 39/199 (19%), Positives = 69/199 (34%), Gaps = 32/199 (16%)

Query: 140 LGRARVYADVNSHKPREYWDYESYVVD-WG-QQDDYQLVRKLGRGKYSEVFEAI-----N 192
           L  + +  D N +    +    S + D     + +  L+R LG G + EV+E       N
Sbjct: 40  LRTSTIMTDYNPNY--CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPN 97

Query: 193 VQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVV--KDPVSRTPALI 246
             S  +  VK L  V     +     E  I+       NI+    V     P      ++
Sbjct: 98  DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRF----IL 152

Query: 247 FEHVNNTDFKQL----------YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNV 296
            E +   D K              +L   D+ +   ++     Y      +HRD+   N 
Sbjct: 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC 212

Query: 297 MIDH--ENRKLRLIDWGLA 313
           ++      R  ++ D+G+A
Sbjct: 213 LLTCPGPGRVAKIGDFGMA 231

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 36/172 (20%), Positives = 67/172 (38%), Gaps = 35/172 (20%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI-----NVQSSDKCVVKILKPVKKKKIK---REIKILENL 222
            D  L R+LG G + +VF A        +      VK LK       K   RE ++L NL
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 223 RGGTNIITLQAVV--KDPVSRTPALIFEHVNNTDFKQ-------------------LYQT 261
           +   +I+    V    DP+     ++FE++ + D  +                       
Sbjct: 75  Q-HEHIVKFYGVCGDGDPLI----MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129

Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
           L    + +   ++   + Y  S   +HRD+   N ++   N  +++ D+G++
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMS 180

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 38/191 (19%), Positives = 72/191 (37%), Gaps = 37/191 (19%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI-------NVQSSDKCVVKILKP----VKKKKIKREIKIL 219
           D   L + LG G + +V  A          + +    VK+LK          +  E++++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 220 ENLRGGTNIITLQAVV--KDPVSRTPALIFEHVNNTDFK-------------------QL 258
           + +    NII L        P      +I E+ +  + +                     
Sbjct: 95  KMIGKHKNIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
            + +T  D+    Y+L + ++Y  S   +HRD+   NV++  EN  +++ D+GLA   + 
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINN 209

Query: 319 GQEYNVRVASR 329
              Y      R
Sbjct: 210 IDYYKKTTNGR 220

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 32/176 (18%), Positives = 70/176 (39%), Gaps = 34/176 (19%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI-----NVQSSDKCVVKILKP----VKKKKIKREIKILEN 221
           ++ +  + LG G + +V  A          S +  VK+LK      +++ +  E+K++  
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 222 LRGGTNIITLQAVV------------------------KDPVSRTPALIFEHVNNTDFKQ 257
           L    NI+ L                            K        + +E+    + ++
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 258 LYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
               LT  D+  + Y++ K +++      +HRD+   NV++    + +++ D+GLA
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLA 219

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 44.5 bits (106), Expect = 4e-05
 Identities = 18/46 (39%), Positives = 30/46 (65%), Gaps = 1/46 (2%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 46
           + I  GA+  L Y H+  I+HRDVK  N+++D EN   ++ D+G++
Sbjct: 142 LEICIGAARGLHYLHTRAIIHRDVKSINILLD-ENFVPKITDFGIS 186

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 28/155 (18%), Positives = 63/155 (40%), Gaps = 18/155 (11%)

Query: 171 DDYQLVR-KLGRGKYSEVFEAI-NVQSSDKCV-VKILKP----VKKKKIKREIKILENLR 223
           D+  +   +LG G +  V + +  ++     V +K+LK        +++ RE +I+  L 
Sbjct: 9   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 68

Query: 224 GGTNIITLQAVV-KDPVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKAL 278
               I+ L  V   + +     L+ E        +        +   ++   L+++   +
Sbjct: 69  N-PYIVRLIGVCQAEALM----LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
            Y      +HRD+   NV++       ++ D+GL+
Sbjct: 124 KYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLS 157

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 43.8 bits (104), Expect = 6e-05
 Identities = 36/166 (21%), Positives = 64/166 (38%), Gaps = 20/166 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCV---VKILKP------VKKKKIKREIKILEN 221
            D +L+ KLG G +  V        S K V   VK LKP             RE+  + +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 222 LRGGTNIITLQAVV-KDPVSRTPALIFEHVNN---TDF-KQLYQTLTDYDIRYYLYELLK 276
           L    N+I L  VV   P+     ++ E        D  ++         +  Y  ++ +
Sbjct: 78  LD-HRNLIRLYGVVLTPPM----KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 132

Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 322
            + Y  S   +HRD+   N+++      +++ D+GL        ++
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDH 177

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 43.7 bits (104), Expect = 6e-05
 Identities = 28/170 (16%), Positives = 70/170 (41%), Gaps = 36/170 (21%)

Query: 174 QLVRKLGRGKYSEVFEAI-----NVQSSDKCVVKILKP----VKKKKIKREIKILENLRG 224
           + + +LG  ++ +V++         + +    +K LK       +++ + E  +   L+ 
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ- 70

Query: 225 GTNIITLQAVV--KDPVSRTPALIFEHVNNTDFKQ-------------------LYQTLT 263
             N++ L  VV    P+S    +IF + ++ D  +                   +   L 
Sbjct: 71  HPNVVCLLGVVTKDQPLS----MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 264 DYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
             D  + + ++   ++Y  S  ++H+D+   NV++  +   +++ D GL 
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY-DKLNVKISDLGLF 175

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 38/191 (19%), Positives = 73/191 (38%), Gaps = 37/191 (19%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI-------NVQSSDKCVVKILKP----VKKKKIKREIKIL 219
           D   L + LG G + +V  A          + +    VK+LK          +  E++++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 220 ENLRGGTNIITLQAVV--KDPVSRTPALIFEHVNNTDFKQ-------------------L 258
           + +    NII L        P      +I E+ +  + ++                    
Sbjct: 141 KMIGKHKNIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
            + +T  D+    Y+L + ++Y  S   +HRD+   NV++  EN  +++ D+GLA   + 
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINN 255

Query: 319 GQEYNVRVASR 329
              Y      R
Sbjct: 256 IDYYKKTTNGR 266

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 20/109 (18%), Positives = 45/109 (41%), Gaps = 11/109 (10%)

Query: 207 VKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYD 266
           ++K +  RE + L  ++    I      + D       ++  ++N    K + +   D  
Sbjct: 381 IRKSRTAREARYLALVKDF-GIPA--PYIFDVDLDNKRIMMSYINGKLAKDVIEDNLDI- 436

Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF 315
                Y++ + +   H   ++H D+   N + D   + L +ID+GL + 
Sbjct: 437 ----AYKIGEIVGKLHKNDVIHNDLTTSNFIFD---KDLYIIDFGLGKI 478

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 42.5 bits (101), Expect = 2e-04
 Identities = 17/63 (26%), Positives = 32/63 (50%), Gaps = 5/63 (7%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHPGQEYNV-- 57
            +IA GA+  +++ H    +HRD+K  N+++D     K+   D+GLA       +  +  
Sbjct: 136 CKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKIS--DFGLARASEKFAQTVMTS 193

Query: 58  RVA 60
           R+ 
Sbjct: 194 RIV 196

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 38/191 (19%), Positives = 71/191 (37%), Gaps = 37/191 (19%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI-------NVQSSDKCVVKILKP----VKKKKIKREIKIL 219
           D   L + LG G + +V  A              K  VK+LK          +  E++++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 220 ENLRGGTNIITLQAVV--KDPVSRTPALIFEHVNNTDFK-------------------QL 258
           + +    NII L        P      +I E+ +  + +                     
Sbjct: 129 KMIGKHKNIINLLGACTQDGP----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 259 YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
            + L+  D+    Y++ + ++Y  S   +HRD+   NV++  E+  +++ D+GLA   H 
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHH 243

Query: 319 GQEYNVRVASR 329
              Y      R
Sbjct: 244 IDYYKKTTNGR 254

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 41.0 bits (97), Expect = 5e-04
 Identities = 20/57 (35%), Positives = 29/57 (50%), Gaps = 6/57 (10%)

Query: 1   MRIATGASMALDYCH---SMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHPGQ 53
            RIA G++  L Y H      I+HRDVK  N+++D E    +   D+GLA+      
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG--DFGLAKLMDYKD 188

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 40/209 (19%), Positives = 79/209 (37%), Gaps = 45/209 (21%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP---------------------VKKKK 211
             + + +G GK S VF   + +   +CVVK  K                      +  + 
Sbjct: 92  DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150

Query: 212 IKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYL 271
            + E + L+ L+G        AV K       A++ E ++  +  ++       +    L
Sbjct: 151 ARNEFRALQKLQGL-------AVPKVYAWEGNAVLMELIDAKELYRV----RVENPDEVL 199

Query: 272 YELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHP-GQEY---NVRV 326
             +L+ +   +  GI+H D+  +NV++  E   + +ID+  + E      +E    +VR 
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREILERDVRN 257

Query: 327 ASRYFKGPELLADYQYHIELDPRFADILG 355
              YF        Y+   +++     IL 
Sbjct: 258 IITYFSRT-----YRTEKDINSAIDRILQ 281

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 33/181 (18%), Positives = 65/181 (35%), Gaps = 44/181 (24%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI-----NVQSSDKCVVKILKP----VKKKKIKREIKILEN 221
           ++ + VR +G G +  VF+A        +      VK+LK       +   +RE  ++  
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 222 LRGGTNIITLQAVV--KDPVSRTPALIFEHVNNTDFKQ---------------------- 257
                NI+ L  V     P+     L+FE++   D  +                      
Sbjct: 107 FDN-PNIVKLLGVCAVGKPMC----LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161

Query: 258 -----LYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL 312
                    L+  +      ++   + Y      +HRD+   N ++  EN  +++ D+GL
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGL 220

Query: 313 A 313
           +
Sbjct: 221 S 221

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 32/177 (18%), Positives = 69/177 (38%), Gaps = 36/177 (20%)

Query: 171 DDYQLVRKLGRGKYSEVFEAI-----NVQSSDKCVVKILKP----VKKKKIKREIKILEN 221
            +  L + LG G++ +V +A               VK+LK      + + +  E  +L+ 
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 222 LRGGTNIITLQAVV--KDPV------------------SRTPALIFEHVNNTDFKQLY-- 259
           +    ++I L        P+                  SR     +     +        
Sbjct: 83  V-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141

Query: 260 ---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
              + LT  D+  + +++ + + Y   M ++HRD+   N+++  E RK+++ D+GL+
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA-EGRKMKISDFGLS 197

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	467
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.95
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.95
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.95
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.95
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.94
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.94
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.94
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.94
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.94
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.94
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.93
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.93
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.93
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.93
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.92
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.9
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.9
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.9
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.89
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.89
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.89
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.88
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.88
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.88
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.87
3niz_A	311	Rhodanese family protein; structural genomics, str	99.87
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.87
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.87
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.87
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.87
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.86
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.86
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.86
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.86
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.86
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.86
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.86
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.86
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.86
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.86
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.86
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.86
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.86
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.86
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.85
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.85
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.85
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.85
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.85
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.85
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.85
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.85
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.85
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.85
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.85
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.85
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.85
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.85
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.85
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.85
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.85
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.84
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.84
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.84
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.84
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.84
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.84
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.84
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.84
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.84
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.84
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.84
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.84
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.84
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.84
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.84
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.84
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.84
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.84
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.83
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.83
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.83
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.83
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.83
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.83
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.83
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.83
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.83
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.83
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.83
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.83
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.83
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.83
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.83
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.83
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.83
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.83
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.83
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.83
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.83
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.83
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.83
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.83
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.83
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.83
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.83
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.83
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.83
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.82
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.82
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.82
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.82
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.82
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.82
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.82
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.82
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.82
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.82
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.82
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.82
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.81
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.81
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.81
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.81
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.81
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.81
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.81
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.81
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.81
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.81
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.81
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.81
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.81
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.81
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.81
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.81
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.81
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.81
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.81
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.81
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.81
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.81
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.81
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.81
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.81
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.81
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.81
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.8
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.8
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.8
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.8
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.8
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.8
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.8
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.8
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.8
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.8
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.8
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.8
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.8
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.8
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.8
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.8
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.8
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.8
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.8
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.8
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.8
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.8
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.8
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.8
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.8
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.79
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.79
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.79
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.79
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.79
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.79
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.79
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.79
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.79
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.79
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.79
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.79
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.79
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.79
3bhy_A	283	Death-associated protein kinase 3; death associate	99.79
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.78
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.78
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.78
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.78
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.78
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.78
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.78
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.78
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.78
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.78
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.78
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.78
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.78
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.78
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.78
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.78
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.78
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.78
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.78
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.78
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.78
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.78
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.78
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.78
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.77
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.77
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.77
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.77
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.77
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.77
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.77
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.77
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.77
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.77
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.77
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.77
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.77
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.77
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.77
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.77
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.76
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.76
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.76
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.76
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.76
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.76
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.76
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.76
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.76
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.76
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.75
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.75
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.75
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.75
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.75
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.75
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.75

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.4e-57  Score=433.49  Aligned_cols=258  Identities=23%  Similarity=0.359  Sum_probs=216.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++++.||+|+||+||+|.++.+++.||||++++.      ..+.+.+|+++|+.|+ |||||++++++.+.  ...
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~--~~~  107 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDD--EKL  107 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECS--SEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC--CEE
Confidence            47899999999999999999999999999999998642      2356889999999996 89999999999874  568


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      |+|||||++|+|.+++.   .+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+....
T Consensus       108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-CEEEEEcCCceecCCCC
Confidence            99999999999988763   599999999999999999999999999999999999998655 79999999999875332


Q ss_pred             ---CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         321 ---EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       321 ---~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                         ...+.+||+.|||||++.+..|+.++|+|+.+++.+..+.+..||.....        ...........        
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~--------  250 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKIIKLE--------  250 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTC--------
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC--------
Confidence               24457899999999999999999999999999988888787777643211        11111111111        


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHH------HhCCCCCCCcccccccCCC
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTARE------AMDHPYFYPIVKDQSRHTL  450 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e------~l~Hp~f~~~~~~~~~~~~  450 (467)
                         ...+..+|++++|||++||++||++|+|++|      +++||||.+++|+......
T Consensus       251 ---~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~  306 (311)
T 4aw0_A          251 ---YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT  306 (311)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSC
T ss_pred             ---CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCC
Confidence               1123458999999999999999999999988      5899999999999876554

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.8e-55  Score=427.12  Aligned_cols=253  Identities=21%  Similarity=0.335  Sum_probs=210.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      .+.|++++.||+|+||+||+|.++.+|+.||||+++..   ..+.+.+|+.+|+.++ |||||++++++.+.  ..+|+|
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~--~~~~iv  149 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVG--DELWVV  149 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCC-CTTBCCEEEEEEET--TEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC--CEEEEE
Confidence            35799999999999999999999999999999998643   3456889999999996 89999999999864  568999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CCcc
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYN  323 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~~~  323 (467)
                      ||||++|+|.+++.  .+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..... ...+
T Consensus       150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBC
T ss_pred             EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-CEEEecCcCceecCCCCCccc
Confidence            99999999988764  599999999999999999999999999999999999999655 7999999999977543 3455


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      ..+||+.|||||++.+..|+.++|+|+.+++.+....+..||.....     .+....+....   .        .....
T Consensus       229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i~~~~---~--------~~~~~  292 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIRDNL---P--------PRLKN  292 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSS---C--------CCCSC
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHcCC---C--------CCCCc
Confidence            67999999999999999999999999999988877777777643211     01111111110   0        01122


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      +..+|++++|||.+||++||++||||+|+|+||||+...
T Consensus       293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            345899999999999999999999999999999998543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.1e-54  Score=429.05  Aligned_cols=252  Identities=21%  Similarity=0.338  Sum_probs=210.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      .+.|++++.||+|+||.||+|.++.+|+.||||+++..   ..+.+.+|+.+|+.++ |||||++++++.+.  ..+|+|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~--~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVG--DELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCC-CTTBCCEEEEEEET--TEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCC-CCCCCceEEEEEEC--CEEEEE
Confidence            46799999999999999999999999999999998643   3467899999999996 89999999999864  568999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CCcc
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYN  323 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~~~  323 (467)
                      ||||++|+|.+++.  .+++.+++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+... ....
T Consensus       227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-CEEECCCTTCEECCSSCCCBC
T ss_pred             EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEecCccceECCCCCcccc
Confidence            99999999988764  599999999999999999999999999999999999999655 7999999999977543 3456


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      ..+||++|||||++.+..|+.++|+|+.+++.+.++.+..||......     .....+....           ......
T Consensus       306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-----~~~~~i~~~~-----------~~~~~~  369 (423)
T 4fie_A          306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----KAMKMIRDNL-----------PPRLKN  369 (423)
T ss_dssp             CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSC-----------CCCCSC
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----HHHHHHHcCC-----------CCCCcc
Confidence            679999999999999999999999999999888777777776432210     1111111110           001123


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      +..+|++++|||.+||++||++|+||+|+|+||||...
T Consensus       370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence            34689999999999999999999999999999999754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.4e-54  Score=422.99  Aligned_cols=252  Identities=16%  Similarity=0.302  Sum_probs=202.2

Q ss_pred             cCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       167 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      +...++|++++.||+|+||+||+|.++.+++.||||+++..     ..+.+.+|+.+|+.|+ |||||++++++.+.  .
T Consensus        20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~--~   96 (350)
T 4b9d_A           20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESFEEN--G   96 (350)
T ss_dssp             CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET--T
T ss_pred             CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEEC--C
Confidence            34458999999999999999999999999999999998643     2456889999999996 89999999999864  5


Q ss_pred             ccEEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         242 TPALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      .+|+|||||++|+|.+++.     .+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..
T Consensus        97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~  175 (350)
T 4b9d_A           97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVL  175 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC-CEEECSTTEESCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-CEEEcccccceee
Confidence            6899999999999988763     368899999999999999999999999999999999999655 7999999999976


Q ss_pred             CCCCC-cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         317 HPGQE-YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       317 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      ..... .+..+||+.|||||++.+..|+.++|+|+.+++.+....+..||....        ..........+..     
T Consensus       176 ~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~~-----  242 (350)
T 4b9d_A          176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKIISGSF-----  242 (350)
T ss_dssp             CHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTCC-----
T ss_pred             cCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcCCC-----
Confidence            43322 345689999999999999999999999999998877777777764321        1111111111111     


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                           .+.+..+|++++|||.+||++||++|||++|+|+||||+.
T Consensus       243 -----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          243 -----PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                 1123458999999999999999999999999999999964

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.4e-54  Score=425.55  Aligned_cols=270  Identities=26%  Similarity=0.402  Sum_probs=208.6

Q ss_pred             cceeeeEeecccCCcceEEEEEc---cCCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINV---QSSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +.|++.+.||+|+||+||+|.++   .+++.||+|.+... ...++.+|+++|+.+.+||||+++++++.+.  ...|+|
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~--~~~~lv   98 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN--DHVVIA   98 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET--TEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC--CEEEEE
Confidence            67999999999999999999875   35778999987653 4567889999999998899999999999864  578999


Q ss_pred             EeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC------
Q psy3714         247 FEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ------  320 (467)
Q Consensus       247 ~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~------  320 (467)
                      |||+++++|.++++.+++.+++.++.||+.||+|||++|||||||||+|||++.+.+.+||+|||+|+......      
T Consensus        99 mE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~  178 (361)
T 4f9c_A           99 MPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKF  178 (361)
T ss_dssp             EECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGG
T ss_pred             EeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccc
Confidence            99999999999999999999999999999999999999999999999999999765689999999998653221      


Q ss_pred             -----------------------CcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcc----
Q psy3714         321 -----------------------EYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQH----  372 (467)
Q Consensus       321 -----------------------~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~----  372 (467)
                                             ..+..+||++|||||++.+.. |+.++|+|+.+++.+..+.|..||+.+.+..    
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~  258 (361)
T 4f9c_A          179 VQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALA  258 (361)
T ss_dssp             C--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence                                   123458999999999998865 8999999999998888888888887665421    


Q ss_pred             -----cCChhhhhhhhh---hccC--CCCcc-----------------c-----ccccccccCCCCCChHHHHHHHhhcC
Q psy3714         373 -----LVSPEALDFLDK---NILG--RHSRK-----------------R-----WERFVHTENQHLVSPEALDFLDKLLR  420 (467)
Q Consensus       373 -----~~~~~~~~~~~~---~~~~--~~~~~-----------------~-----~~~~~~~~~~~~~s~~~~dli~~lL~  420 (467)
                           .+++........   ....  ..+..                 .     .......+.+..+|++|+|||++||+
T Consensus       259 ~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~  338 (361)
T 4f9c_A          259 QIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLD  338 (361)
T ss_dssp             HHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTC
T ss_pred             HHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCc
Confidence                 001000000000   0000  00000                 0     00011123345689999999999999


Q ss_pred             cCCCCCCCHHHHhCCCCCCCcc
Q psy3714         421 YDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       421 ~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      +||++|+||+|+|+||||+++.
T Consensus       339 ~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          339 LNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             SCTTTSCCHHHHHTSGGGTTC-
T ss_pred             CChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999998763

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.1e-54  Score=407.28  Aligned_cols=246  Identities=24%  Similarity=0.448  Sum_probs=189.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++++.||+|+||+||+|.++.+++.||||++++.      ...++.+|+++|+.++ |||||++++++.+.  ...
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~--~~~   88 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSK--DEI   88 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECS--SEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEEC--CEE
Confidence            36899999999999999999999999999999998643      2356889999999996 89999999999874  568


Q ss_pred             EEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      |+||||+ +|++.+.+   ..+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+......
T Consensus        89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-CEEECCSSCC-------
T ss_pred             EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC-CEEEeecCCCeecCCCC
Confidence            9999999 56776654   3599999999999999999999999999999999999998654 79999999999876655


Q ss_pred             CcceeeeccCccCCcccccCCC-CccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQY-HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~-~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      .....+||+.|||||++.+..| +.++|+|+.+++.+....+..||.....     ......+..   +.          
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----~~~~~~i~~---~~----------  228 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----PVLFKNISN---GV----------  228 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH---TC----------
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHc---CC----------
Confidence            5666899999999999999887 5789999999988777777777643211     111111111   10          


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                       ...+..+|++++|||++||++||++|||++|+|+||||.
T Consensus       229 -~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k  267 (275)
T 3hyh_A          229 -YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK  267 (275)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence             111345899999999999999999999999999999995

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.3e-54  Score=416.26  Aligned_cols=255  Identities=24%  Similarity=0.361  Sum_probs=203.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEc---cCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINV---QSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      .++|++++.||+|+||+||+|++.   .+++.||||++++.     ...++.+|+++|+.++ |||||++++++.++  .
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~--~   99 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLHYAFQTE--G   99 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCC-CTTEECEEEEEEET--T
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEEC--C
Confidence            478999999999999999999874   46788999998643     2346789999999996 89999999999864  5


Q ss_pred             ccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      ..|+|||||++|+|.+++.   .+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+....
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-CEEEESSEEEEC---
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-CEEecccccceeccC
Confidence            6899999999999987764   589999999999999999999999999999999999999655 799999999986533


Q ss_pred             -CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         319 -GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       319 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                       .....+.+||+.|||||++.+..|+.++|+|+.+++.+....+..||....        ....... +...        
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~-i~~~--------  241 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--------RKETMTM-ILKA--------  241 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH-HHHC--------
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--------HHHHHHH-HHcC--------
Confidence             333456789999999999999999999999999998887777777764321        1111111 1100        


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCH-----HHHhCCCCCCCccccccc
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTA-----REAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta-----~e~l~Hp~f~~~~~~~~~  447 (467)
                        ....+..+|++++|||++||++||++|+||     +|+++||||++++|+...
T Consensus       242 --~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~  294 (304)
T 3ubd_A          242 --KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLY  294 (304)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred             --CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHH
Confidence              011234589999999999999999999984     799999999999987654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.4e-53  Score=402.50  Aligned_cols=249  Identities=17%  Similarity=0.325  Sum_probs=200.2

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC--CCCccEE
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDP--VSRTPAL  245 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~--~~~~~~l  245 (467)
                      |++.++||+|+||+||+|.++.++..||+|.+...     ..+++.+|+++|+.|+ |||||++++++.+.  ....+|+
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcEEEE
Confidence            47778899999999999999999999999998643     2456889999999996 89999999988653  2345799


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~--IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      |||||++|+|.+++.   .+++..++.++.||+.||+|||++|  ||||||||+|||++..++.+||+|||+|+... ..
T Consensus       107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-~~  185 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-AS  185 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-TT
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-CC
Confidence            999999999988764   5899999999999999999999999  99999999999998655589999999998643 33


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      .....+||+.|||||++.+ .|+.++|+|+.+++.+....+..||......    .....    .+......        
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~----~~~~~----~i~~~~~~--------  248 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYR----RVTSGVKP--------  248 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHH----HHTTTCCC--------
T ss_pred             ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH----HHHHH----HHHcCCCC--------
Confidence            4556789999999998865 6999999999998877777777776432211    01111    11111100        


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      ...+..+|++++|||.+||+.||++|||++|+|+||||.+
T Consensus       249 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            1112347899999999999999999999999999999974

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.8e-53  Score=409.15  Aligned_cols=252  Identities=20%  Similarity=0.253  Sum_probs=204.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      .+.|++.++||+|+||.||+|.++.+++.||||+++...  ...+|+.+|+.|+ |||||++++++.+.  ..+|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--~~~~E~~il~~l~-HpnIV~l~~~~~~~--~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLS-SPRIVPLYGAVREG--PWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCTHHHHTTTTCC-CTTBCCEEEEEEET--TEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--hHHHHHHHHHhCC-CCCCCcEEEEEEEC--CEEEEEEec
Confidence            467999999999999999999999999999999997532  2357999999996 89999999999864  568999999


Q ss_pred             cCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-----
Q psy3714         250 VNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----  321 (467)
Q Consensus       250 ~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-----  321 (467)
                      |++|+|.++++   .+++.+++.++.||+.||+|||++|||||||||+|||++.++..+||+|||+|+.......     
T Consensus       132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~  211 (336)
T 4g3f_A          132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL  211 (336)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence            99999988764   5899999999999999999999999999999999999997665799999999997654321     


Q ss_pred             -cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         322 -YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       322 -~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                       ....+||+.|||||++.+..|+.++|+|+.+++.+..+.+..||.......+    ......    ..   ..+     
T Consensus       212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~i~~----~~---~~~-----  275 (336)
T 4g3f_A          212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----CLKIAS----EP---PPI-----  275 (336)
T ss_dssp             --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC----HHHHHH----SC---CGG-----
T ss_pred             cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----HHHHHc----CC---CCc-----
Confidence             1234799999999999999999999999999988877777777644322111    011110    00   001     


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHH-------------hCCCCCCCcc
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREA-------------MDHPYFYPIV  442 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~-------------l~Hp~f~~~~  442 (467)
                      ...++.+|++++|||.+||++||++||||+|+             |+|||+.+..
T Consensus       276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred             hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence            12245689999999999999999999999996             6899998754

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-51  Score=410.43  Aligned_cols=268  Identities=25%  Similarity=0.471  Sum_probs=204.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC----C
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDP----V  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~----~  239 (467)
                      ..++|++++.||+|+||+||+|.++.+|+.||||+++..     ..+++.+|+++|+.|+ |||||++++++...    .
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~  130 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPYGE  130 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCTTT
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC-CCCcceEeeeeeccccccc
Confidence            457899999999999999999999999999999999643     2356789999999996 89999999987643    2


Q ss_pred             CCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      ...+|+|||||+ |+|.+++.   .+++.+++.+++||+.||+|||++|||||||||+|||++..+ .+||+|||+|+.+
T Consensus       131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~  208 (398)
T 4b99_A          131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARGL  208 (398)
T ss_dssp             CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC
T ss_pred             CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC-CEEEeecceeeec
Confidence            356899999997 56776653   589999999999999999999999999999999999999654 7999999999865


Q ss_pred             CC-----CCCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcc--------cCChhhh--h
Q psy3714         317 HP-----GQEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQH--------LVSPEAL--D  380 (467)
Q Consensus       317 ~~-----~~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~--~  380 (467)
                      ..     .......+||++|||||++.+.. |+.++|+|+.+++.+..+.+..||.+.....        .+.+...  .
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            32     22344579999999999998865 6899999999988777777666654321100        0000000  0


Q ss_pred             hhh-----h--hccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         381 FLD-----K--NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       381 ~~~-----~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                      ...     .  ..........|..     ..+.+|++++|||++||++||++|+||+|+|+||||+....+
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p  354 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWET-----VYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP  354 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHH-----HSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHH-----hCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence            000     0  0000001111211     123579999999999999999999999999999999976543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.1e-52  Score=398.42  Aligned_cols=252  Identities=19%  Similarity=0.283  Sum_probs=186.7

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC------
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS------  240 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~------  240 (467)
                      ++|++++.||+|+||+||+|.++.+++.||||+++..    ..+.+.+|+.+|+.|+ |||||++++++.+...      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccccc
Confidence            5799999999999999999999999999999998642    2356889999999996 8999999998864332      


Q ss_pred             ----CccEEEEeccCCccHHHHhhc------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEec
Q psy3714         241 ----RTPALIFEHVNNTDFKQLYQT------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW  310 (467)
Q Consensus       241 ----~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DF  310 (467)
                          .+.|+|||||++++|.+++..      .+...++.++.||+.||+|||++|||||||||+|||++.++ .+||+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl~DF  162 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDF  162 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEEccC
Confidence                236899999999999887652      33455788999999999999999999999999999999655 7999999


Q ss_pred             ccceecCCCCC-------------cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChh
Q psy3714         311 GLAEFYHPGQE-------------YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE  377 (467)
Q Consensus       311 Gla~~~~~~~~-------------~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (467)
                      |+|+.......             .+..+||+.|||||++.+..|+.++|+|+.+++.+....   ||...       .+
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-------~~  232 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-------ME  232 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-------HH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-------cH
Confidence            99987643221             234589999999999999999999999999887554432   22110       01


Q ss_pred             hhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                      ...... .+...    .+.     +.+...++++++||++||+.||++|||++|+|+||||.+++++
T Consensus       233 ~~~~~~-~~~~~----~~p-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          233 RVRTLT-DVRNL----KFP-----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHHHH-HHHTT----CCC-----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             HHHHHH-HHhcC----CCC-----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            111111 01100    010     0111247889999999999999999999999999999998764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.2e-51  Score=423.44  Aligned_cols=262  Identities=21%  Similarity=0.327  Sum_probs=210.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhc--CCCCeeEEEEEEeCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLR--GGTNIITLQAVVKDPVS  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~--~~~~iv~l~~~~~~~~~  240 (467)
                      ..++|++++.||+|+||.||+|.++.+++.||||++++..      ...+.+|..++..+.  +|||||++++.+.++  
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~--  264 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--  264 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC--
Confidence            4589999999999999999999999999999999986431      233455544444332  589999999999875  


Q ss_pred             CccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..+|+||||++||+|..++.   .+++..+++|+.||+.||+|||++|||||||||+||||+.++ ++||+|||+|+.+.
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G-~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS  343 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS-CEEECCCTTCEECS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC-CEEecccceeeecC
Confidence            56899999999999987764   599999999999999999999999999999999999999655 89999999999875


Q ss_pred             CCCCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         318 PGQEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       318 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      ... ..+.|||+.|||||++.. ..|+.++|+|+.+++.+.++.|..||......     ....... .+..        
T Consensus       344 ~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-----~~~~i~~-~i~~--------  408 (689)
T 3v5w_A          344 KKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDR-MTLT--------  408 (689)
T ss_dssp             SCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-----CHHHHHH-HHHH--------
T ss_pred             CCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHH-hhcC--------
Confidence            443 345789999999999975 57999999999999988888888777543211     0111111 1110        


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCcccccccCCC
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKDQSRHTL  450 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~~~~~~~  450 (467)
                        .....+..+|++++|||++||++||++|+|     |+|+++||||.+++|+......
T Consensus       409 --~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~  465 (689)
T 3v5w_A          409 --MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQK  465 (689)
T ss_dssp             --CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTC
T ss_pred             --CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCC
Confidence              011223468999999999999999999998     8999999999999998764443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.1e-50  Score=418.68  Aligned_cols=258  Identities=22%  Similarity=0.377  Sum_probs=214.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      .++|++++.||+|+||.||+|.++.+|+.||+|+++..   ..+.+.+|+.+|+.|+ |||||++++++.+.  ..+|+|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDD--NEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECS--SEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEEC--CEEEEE
Confidence            47899999999999999999999999999999998653   3456889999999996 89999999999874  578999


Q ss_pred             EeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC-CCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~-~~~ikl~DFGla~~~~~~~~  321 (467)
                      ||||++|+|.+++.    .+++.+++.++.||+.||+|||++|||||||||+|||++.+ .+.+||+|||+|+.+.+...
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            99999999988763    48899999999999999999999999999999999999854 35899999999999877777


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+||+.|||||++.+..|+.++|+|+.+++.+.++.+..||.....        ..... .+...    .+  ....
T Consensus       313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~~~~-~i~~~----~~--~~~~  377 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLR-NVKSC----DW--NMDD  377 (573)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHH-HHHTT----CC--CCCS
T ss_pred             eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHH-HHHhC----CC--CCCc
Confidence            7778999999999999999999999999999887777777666643221        11111 11110    00  0111


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccccc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ  445 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~  445 (467)
                      ..+..+|++++|||++||++||++|||++|+|+||||.+..+..
T Consensus       378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence            23346899999999999999999999999999999999876543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-48  Score=382.96  Aligned_cols=303  Identities=79%  Similarity=1.269  Sum_probs=251.7

Q ss_pred             cccccccccCCCCCcccccCccccccCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHH
Q psy3714         142 RARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILEN  221 (467)
Q Consensus       142 ~~~v~~~~~~~~p~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~  221 (467)
                      +++...+.....|.+.+.+....+.++..++|++++.||+|+||.||+|.+..+++.||+|+++....+.+.+|+.+++.
T Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~   86 (330)
T 3nsz_A            7 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILEN   86 (330)
T ss_dssp             CCSSSTTTTTTSCHHHHCGGGCCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHH
T ss_pred             ceeEeccccccCchhHHHhhhhhhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHH
Confidence            45566777788888899999999999999999999999999999999999999999999999988778889999999999


Q ss_pred             hcCCCCeeEEEEEEeCCCCCccEEEEeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC
Q psy3714         222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE  301 (467)
Q Consensus       222 l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~  301 (467)
                      +.+|+||+.+.+++.++.....++||||++++++.++.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        87 l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~  166 (330)
T 3nsz_A           87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE  166 (330)
T ss_dssp             HTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred             cCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCC
Confidence            98899999999999887677889999999999999999999999999999999999999999999999999999999977


Q ss_pred             CCcEEEEecccceecCCCCCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcc--------
Q psy3714         302 NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQH--------  372 (467)
Q Consensus       302 ~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------  372 (467)
                      +..+||+|||+|+...........+||+.|+|||++.+ ..|+.++|+|..+++.+....+..||+.+....        
T Consensus       167 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~  246 (330)
T 3nsz_A          167 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  246 (330)
T ss_dssp             TTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred             CCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHH
Confidence            66899999999998776666667789999999999987 558999999988887666666666664433210        


Q ss_pred             -cCChhhhhhhhh----------hccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         373 -LVSPEALDFLDK----------NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       373 -~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                       +..+........          ..........|..+.....+..+|+++++||++||++||++||||+|+|+||||.++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             HHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence             001111111111          112233445566665555556689999999999999999999999999999999988


Q ss_pred             ccc
Q psy3714         442 VKD  444 (467)
Q Consensus       442 ~~~  444 (467)
                      .++
T Consensus       327 ~~~  329 (330)
T 3nsz_A          327 VKD  329 (330)
T ss_dssp             C--
T ss_pred             ccC
Confidence            754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.5e-46  Score=367.10  Aligned_cols=248  Identities=21%  Similarity=0.302  Sum_probs=196.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCC-----CeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSS-----DKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++.+.||+|+||+||+|.+..++     +.||||.++..    ..+.+.+|+.+|.++.||||||++++++..+ 
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~-  140 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-  140 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence            3588999999999999999999976543     57999998653    2356889999999999889999999988653 


Q ss_pred             CCccEEEEeccCCccHHHHhhc-------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQT-------------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH  300 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~~-------------------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~  300 (467)
                      ....++|||||++|+|.+++..                   +++.++..++.||+.||+|||+++||||||||+|||++.
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~  220 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  220 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence            2457999999999999887642                   688899999999999999999999999999999999985


Q ss_pred             CCCcEEEEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCCh
Q psy3714         301 ENRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSP  376 (467)
Q Consensus       301 ~~~~ikl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  376 (467)
                      ++ .+||+|||+|+.......+   ...+||+.|||||++.+..|+.++|+|+.+++.+.... +..||.....    ..
T Consensus       221 ~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~----~~  295 (353)
T 4ase_A          221 KN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DE  295 (353)
T ss_dssp             GG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----SH
T ss_pred             CC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH----HH
Confidence            54 8999999999976544332   23579999999999999999999999999987655443 4444432111    11


Q ss_pred             hhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      .....+...             ...+.+..+|+++.+||.+|++.||++|||++|+++|
T Consensus       296 ~~~~~i~~g-------------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          296 EFCRRLKEG-------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcC-------------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            111111111             0112234579999999999999999999999999987

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.6e-46  Score=360.73  Aligned_cols=249  Identities=18%  Similarity=0.274  Sum_probs=194.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEc-----cCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINV-----QSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      ..++|.+.+.||+|+||+||+|...     .++..||||.++...   .+.+.+|+++|++|+ |||||++++++.+.  
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~--   87 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG--   87 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS--
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeC--
Confidence            4578999999999999999999864     357789999997542   456889999999996 89999999999764  


Q ss_pred             CccEEEEeccCCccHHHHhh----------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCc
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ----------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRK  304 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~----------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~  304 (467)
                      ...++|||||++|+|.+++.                .+++.++..++.||+.||+|||+++||||||||+|||++.+ ..
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~-~~  166 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-LL  166 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC-Cc
Confidence            46899999999999988763                37889999999999999999999999999999999999855 47


Q ss_pred             EEEEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhh
Q psy3714         305 LRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALD  380 (467)
Q Consensus       305 ikl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  380 (467)
                      +||+|||+|+........   ...+||+.|||||++.+..|+.++|+|+.+++.+.... +..||....     ..+...
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~-----~~~~~~  241 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-----NNEVIE  241 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Confidence            999999999865433222   23579999999999999999999999999987655543 444543221     111111


Q ss_pred             hhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      .+...   .          ..+.+..+|+++.+||.+||+.||++|||++|+  |+|+..+
T Consensus       242 ~i~~~---~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~  287 (299)
T 4asz_A          242 CITQG---R----------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL  287 (299)
T ss_dssp             HHHHT---C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred             HHHcC---C----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence            11111   0          012234589999999999999999999999999  5566544

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.8e-46  Score=371.44  Aligned_cols=267  Identities=23%  Similarity=0.350  Sum_probs=211.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++++..      ...+.+|..+++.+..||||+++++++.+.  ..
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~  127 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR  127 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--SE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--CE
Confidence            3578999999999999999999999999999999987532      235788999999887799999999999864  56


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec-CC
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~-~~  318 (467)
                      .++||||+++++|..++.   .+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.. ..
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-CEEEeecceeeecccC
Confidence            899999999999977653   589999999999999999999999999999999999999665 7999999999863 34


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      +......+||+.|+|||++.+..|+.++|+|..+++.+....+..||....................+...         
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---------  277 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---------  277 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC---------
T ss_pred             CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc---------
Confidence            44456678999999999999999999999999988877666666665322110000000001111111100         


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCH------HHHhCCCCCCCcccccccC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTA------REAMDHPYFYPIVKDQSRH  448 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta------~e~l~Hp~f~~~~~~~~~~  448 (467)
                       ....+..+|++++|||++||+.||++|+|+      +|+++||||.+++|+....
T Consensus       278 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~  332 (396)
T 4dc2_A          278 -QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ  332 (396)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHT
T ss_pred             -ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHc
Confidence             111234589999999999999999999985      7999999999999875543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-46  Score=358.05  Aligned_cols=248  Identities=16%  Similarity=0.240  Sum_probs=188.5

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..+++++.+.||+|+||+||+|...   ..||||+++..     ..+.+.+|+.+|++++ |||||++++++.+   ...
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~---~~~  106 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK---DNL  106 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS---SSC
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC---CeE
Confidence            3478899999999999999999753   46999998642     2356889999999996 8999999998754   357


Q ss_pred             EEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ++|||||++|+|.+++.    .+++.++..++.||+.||+|||+++||||||||+|||++.+ +.+||+|||+|+.....
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT-EEEEECCCSSCBC----
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC-CcEEEeeccCceecccC
Confidence            99999999999988763    48899999999999999999999999999999999999955 48999999999865432


Q ss_pred             C---CcceeeeccCccCCcccccC---CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         320 Q---EYNVRVASRYFKGPELLADY---QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       320 ~---~~~~~~gt~~y~aPE~l~~~---~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      .   .....+||+.|||||++.+.   .|+.++|+|+.+++.+....+..||.....     .....   ..+.......
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-----~~~~~---~~~~~~~~~p  257 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-----RDQII---FMVGRGYASP  257 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHH---HHHHTTCCCC
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-----HHHHH---HHHhcCCCCC
Confidence            2   23456899999999999643   589999999999887766666666543221     11111   0111111111


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHH------hCCCC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREA------MDHPY  437 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~------l~Hp~  437 (467)
                      ..     ...+..+++++++||.+||+.||++|||++|+      |+||+
T Consensus       258 ~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          258 DL-----SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             CS-----TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             Cc-----ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            11     11234578999999999999999999999875      56776

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.2e-46  Score=361.96  Aligned_cols=245  Identities=18%  Similarity=0.270  Sum_probs=187.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEc-----cCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINV-----QSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      ..++|.+.++||+|+||+||+|...     .++..||||+++...   .+.+.+|+++|++++ |||||++++++.+.  
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~--  115 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-HQHIVRFFGVCTEG--  115 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS--
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC--
Confidence            3578999999999999999999864     467889999997542   456889999999996 89999999999764  


Q ss_pred             CccEEEEeccCCccHHHHhh------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN  302 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~  302 (467)
                      ...++|||||++|+|.+++.                  .+++.++..++.||+.||+|||+++||||||||+|||++.+ 
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~-  194 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG-  194 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC-
Confidence            46899999999999988763                  37888999999999999999999999999999999999955 


Q ss_pred             CcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhh
Q psy3714         303 RKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEA  378 (467)
Q Consensus       303 ~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  378 (467)
                      ..+||+|||+|+.......   .+..+||+.|||||++.+..|+.++|+|+.+++.+.... +..||....     ..+.
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~-----~~~~  269 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS-----NTEA  269 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC-----HHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC-----HHHH
Confidence            5899999999987643322   234579999999999999999999999999887655443 444543221     1111


Q ss_pred             hhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ...+..   +.          ..+.+..+++++.+||.+||+.||++|||++|++++
T Consensus       270 ~~~i~~---g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          270 IDCITQ---GR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHH---TC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHHc---CC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            111111   10          112234689999999999999999999999999764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=364.80  Aligned_cols=257  Identities=23%  Similarity=0.334  Sum_probs=204.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++++.      ....+.+|+.+++.+.+||||+++++++.+.  ..
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~   98 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--DR   98 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--CE
Confidence            357899999999999999999999999999999998753      2345778999999887799999999999864  46


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-C
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-P  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~  318 (467)
                      .++||||+++++|..++.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+... .
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-CEEEccccceeecccC
Confidence            899999999999987663   589999999999999999999999999999999999998665 79999999998643 2


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      .......+||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ..........+.         
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~---------  240 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDE---------  240 (353)
T ss_dssp             --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC---------
T ss_pred             CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC---------
Confidence            233455689999999999999899999999999888766666655653221        111111111010         


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCH------HHHhCCCCCCCccccccc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTA------REAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta------~e~l~Hp~f~~~~~~~~~  447 (467)
                        ...+..+++++++||++||++||++|+|+      +|+++||||.+++|+...
T Consensus       241 --~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~  293 (353)
T 3txo_A          241 --VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLN  293 (353)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHH
T ss_pred             --CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHh
Confidence              01123479999999999999999999998      899999999999986543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.2e-45  Score=354.31  Aligned_cols=245  Identities=13%  Similarity=0.217  Sum_probs=192.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEc-----cCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINV-----QSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..+++++++.||+|+||+||+|...     .+++.||||.++..    ..+.+.+|+.+|++++ |||||++++++.++ 
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~-  101 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKD-  101 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSS-
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEEC-
Confidence            4567899999999999999999853     46678999998643    2467899999999996 89999999998764 


Q ss_pred             CCccEEEEeccCCccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH  300 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~  300 (467)
                       ...++|||||++|+|.+++.                   .+++.++..++.||+.||+|||+++||||||||+|||++.
T Consensus       102 -~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          102 -QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             -SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             -CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence             46899999999999988762                   3788899999999999999999999999999999999995


Q ss_pred             CCCcEEEEecccceecCCCC---CcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCCh
Q psy3714         301 ENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSP  376 (467)
Q Consensus       301 ~~~~ikl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  376 (467)
                      ++ .+||+|||+|+.....+   ..+..+||+.|||||++.+..|+.++|+|+.+++.+.... +..||....     ..
T Consensus       181 ~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-----~~  254 (308)
T 4gt4_A          181 KL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQ  254 (308)
T ss_dssp             GG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-----HH
T ss_pred             CC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-----HH
Confidence            54 79999999998654322   2334679999999999999999999999999887654443 334443211     11


Q ss_pred             hhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      +....+...    .         ..+.+..+++++.+|+.+|++.||++|||++|++++
T Consensus       255 ~~~~~i~~~----~---------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          255 DVVEMIRNR----Q---------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHHHTT----C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcC----C---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            111111110    0         012234579999999999999999999999999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.8e-44  Score=353.92  Aligned_cols=254  Identities=22%  Similarity=0.359  Sum_probs=208.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++++.||+|+||.||+|.+..+++.||+|++++.      ....+.+|+.+|+.++ ||||+++++.+.+.  ...
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~--~~~   80 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTH--DRL   80 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECS--SEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeC--CEE
Confidence            47899999999999999999999999999999998643      2356788999999985 89999999999864  468


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-CC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PG  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~~  319 (467)
                      ++||||+++++|...+.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+... .+
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC-CEEEeeccchhhcccCC
Confidence            99999999999977653   589999999999999999999999999999999999998655 79999999998643 33


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      ......+||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ............          
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~----------  221 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEE----------  221 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC----------
T ss_pred             CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC----------
Confidence            34456789999999999999999999999998888766666655653221        111111110000          


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccc
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~  446 (467)
                       ...+..+|+++++||++||+.||++|+     |++|+++||||.+++|+..
T Consensus       222 -~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~  272 (337)
T 1o6l_A          222 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV  272 (337)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHH
Confidence             011235799999999999999999999     9999999999999988654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.7e-44  Score=355.51  Aligned_cols=266  Identities=24%  Similarity=0.347  Sum_probs=209.5

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++++..      ...+.+|+.+++.+.+||||+++++++.+.  ..
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~   84 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR   84 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CE
Confidence            3578999999999999999999999999999999987531      345788999999887799999999998764  56


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-C
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-P  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~  318 (467)
                      .++||||+++++|..++.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+... .
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCGGGCBCSCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEEeccccccccCC
Confidence            899999999999987653   589999999999999999999999999999999999998655 79999999998642 3


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      +......+||+.|+|||++.+..|+.++|+|..+++.+....+..||....................+...         
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~---------  234 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---------  234 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC---------
T ss_pred             CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC---------
Confidence            33455678999999999999999999999999888876666666665321110000000000111111100         


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCH------HHHhCCCCCCCccccccc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTA------REAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta------~e~l~Hp~f~~~~~~~~~  447 (467)
                       ....+..+|+++++||++||+.||++|+|+      +|+++||||.+++|+...
T Consensus       235 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~  288 (345)
T 3a8x_A          235 -QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME  288 (345)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHH
Confidence             011234589999999999999999999996      899999999999986543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.3e-44  Score=350.09  Aligned_cols=251  Identities=20%  Similarity=0.380  Sum_probs=205.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .++|++++.||+|+||.||+|.+..+++.||||++...     ..+++.+|+.+|+.++ ||||+++++++.+.  ...+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~~   90 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEVIETE--KTLY   90 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS--SEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEC--CEEE
Confidence            47899999999999999999999999999999998643     2356789999999996 89999999998764  5689


Q ss_pred             EEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         245 LIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       245 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      +||||++++++.+.+   +.+++.+++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+....+..
T Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~  169 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGK  169 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTCCGGGSSSCG
T ss_pred             EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC-CEEEeeccCceecCCCCc
Confidence            999999999988765   3589999999999999999999999999999999999998654 799999999987766666


Q ss_pred             cceeeeccCccCCcccccCCCC-ccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYH-IELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~-~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      ....+||+.|+|||++.+..|. .++|+|..+++.+....+..||....        ..........+.           
T Consensus       170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~-----------  230 (328)
T 3fe3_A          170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERVLRGK-----------  230 (328)
T ss_dssp             GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-----------
T ss_pred             cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-----------
Confidence            6677899999999999988875 78999988887666555555543221        111111111111           


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      ...+..+|+++.+||++||+.||++|||++|+++||||.....
T Consensus       231 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          231 YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            1122357999999999999999999999999999999986543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.3e-44  Score=355.88  Aligned_cols=257  Identities=21%  Similarity=0.287  Sum_probs=209.2

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++.+.||+|+||.||+|.++.+++.||+|++++.      ....+.+|..++..+.+||||+++++.+.+.  ..
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~~   92 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--EN   92 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--CE
Confidence            357899999999999999999999999999999998753      2345778999998886799999999999864  46


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-  318 (467)
                      .++||||+++++|.+++.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... 
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-CEEEeEChhhhhcccC
Confidence            899999999999987764   589999999999999999999999999999999999999655 799999999986432 


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      .......+||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ...... .+...         
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~-~i~~~---------  233 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFH-SIRMD---------  233 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH-HHHHC---------
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--------HHHHHH-HHHhC---------
Confidence            233455789999999999999999999999999887766666655553221        111111 11100         


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHH-HHhCCCCCCCccccccc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAR-EAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~-e~l~Hp~f~~~~~~~~~  447 (467)
                       ....+..+|+++++||++||+.||++|||++ |+++||||.+++|+...
T Consensus       234 -~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~  282 (345)
T 1xjd_A          234 -NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELE  282 (345)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHH
T ss_pred             -CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHh
Confidence             0111235899999999999999999999998 99999999999986553

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.5e-45  Score=359.84  Aligned_cols=256  Identities=26%  Similarity=0.394  Sum_probs=210.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---------KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|+++...         .+.+.+|+.+|+.+. ||||+++++++.+.  
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--   87 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYENR--   87 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEECS--
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEEeC--
Confidence            478999999999999999999999999999999987532         356889999999996 89999999999864  


Q ss_pred             CccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC---cEEEEecccce
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR---KLRLIDWGLAE  314 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~---~ikl~DFGla~  314 (467)
                      ...++||||+++++|.+++.   .+++.++..++.||+.||.|||++||+||||||+|||++..+.   .+||+|||+|+
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            56899999999999988764   4899999999999999999999999999999999999985543   69999999999


Q ss_pred             ecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         315 FYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       315 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ....+......+||+.|+|||++.+..|+.++|+|..+++.+....+..||.....        .............   
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--------~~~~~~i~~~~~~---  236 (361)
T 2yab_A          168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANITAVSYD---  236 (361)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTCCC---
T ss_pred             EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcCCC---
Confidence            87666556667899999999999998999999999999887666666666543211        1111111001100   


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      +    ....+..+|++++|||++||+.||++|||++|+|+||||.+.++
T Consensus       237 ~----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          237 F----DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             C----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred             C----CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence            0    11123458999999999999999999999999999999997764

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.2e-44  Score=368.36  Aligned_cols=273  Identities=23%  Similarity=0.365  Sum_probs=198.1

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC--
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS--  240 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~--  240 (467)
                      ...++|++++.||+|+||.||+|.+..+++.||||++...     ..+++.+|+.+|+.++ ||||+++++++.....  
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~  137 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLE  137 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTT
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCccc
Confidence            3458899999999999999999999999999999998642     2456789999999995 8999999999865421  


Q ss_pred             --CccEEEEeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         241 --RTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       241 --~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                        ...++||||++++.+..+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus       138 ~~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          138 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGT  216 (464)
T ss_dssp             TCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCCC-----
T ss_pred             cCCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-CEEEEEEEeeeecCC
Confidence              35699999999875555556799999999999999999999999999999999999999654 799999999998766


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCc--------ccCC--hhhhhhhhh---h
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQ--------HLVS--PEALDFLDK---N  385 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~--~~~~~~~~~---~  385 (467)
                      ....+..+||+.|+|||++.+..|+.++|+|..+++.+....+..+|......        .++.  +........   .
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~  296 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  296 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred             CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence            55566789999999999999999999999998888766655555554321100        0000  000000000   0


Q ss_pred             c---cCCCCcccccccccccCC-------CCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         386 I---LGRHSRKRWERFVHTENQ-------HLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       386 ~---~~~~~~~~~~~~~~~~~~-------~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .   ........+.........       ...+++++|||++||++||++||||+|+|+||||....
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence            0   000111111111110000       01267899999999999999999999999999998543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.2e-44  Score=352.72  Aligned_cols=257  Identities=21%  Similarity=0.278  Sum_probs=209.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++++.      ....+.+|..++..+.+||||+.++..+.+.  ..
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~   95 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DR   95 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--SE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--CE
Confidence            357899999999999999999999999999999998753      2345778999998887899999999998864  56


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-C
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-P  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~  318 (467)
                      .|+||||+++++|.+++.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+... .
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-cEEEEeCCcccccccC
Confidence            899999999999987764   589999999999999999999999999999999999999655 79999999998643 2


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      +......+||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ...... .+...         
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~-~i~~~---------  236 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQ-SIMEH---------  236 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH-HHHHC---------
T ss_pred             CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHHHH-HHHhC---------
Confidence            333455789999999999999999999999998888766666655553221        111111 11110         


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCccccccc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~~~~  447 (467)
                       ....+..+|+++++||++||+.||++|++     ++|+++||||.+++|+...
T Consensus       237 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~  289 (353)
T 2i0e_A          237 -NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE  289 (353)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHH
Confidence             01112358999999999999999999994     7999999999999987653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-43  Score=354.79  Aligned_cols=272  Identities=26%  Similarity=0.496  Sum_probs=194.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .++|++++.||+|+||.||+|.+..+++.||||++...     ..++..+|+.+++.+.+|+||+++++++........|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            47899999999999999999999999999999988532     2456789999999998899999999999876556789


Q ss_pred             EEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC----
Q psy3714         245 LIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP----  318 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~----  318 (467)
                      +||||+.+ ++.....  .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+..    
T Consensus        88 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~  165 (388)
T 3oz6_A           88 LVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRV  165 (388)
T ss_dssp             EEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEESSSCCCC
T ss_pred             EEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC-CEEecCCcccccccccccc
Confidence            99999984 7766654  588999999999999999999999999999999999998654 799999999986532    


Q ss_pred             ------------------CCCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcc-------
Q psy3714         319 ------------------GQEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQH-------  372 (467)
Q Consensus       319 ------------------~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~-------  372 (467)
                                        ....+..+||++|+|||++.+ ..|+.++|+|+.+++.+....+..+|.......       
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  245 (388)
T 3oz6_A          166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG  245 (388)
T ss_dssp             CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence                              112344689999999999987 568999999988887666555555543221100       


Q ss_pred             -cCChh--hh---------hhhhh---hc--cCCCC---cccccccc-cccCCCCCChHHHHHHHhhcCcCCCCCCCHHH
Q psy3714         373 -LVSPE--AL---------DFLDK---NI--LGRHS---RKRWERFV-HTENQHLVSPEALDFLDKLLRYDHYERLTARE  431 (467)
Q Consensus       373 -~~~~~--~~---------~~~~~---~~--~~~~~---~~~~~~~~-~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e  431 (467)
                       +..+.  ..         .+...   ..  .....   ...|.... ....+...|++++|||++||++||++||||+|
T Consensus       246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e  325 (388)
T 3oz6_A          246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND  325 (388)
T ss_dssp             HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence             00000  00         00000   00  00000   00011100 01122357999999999999999999999999


Q ss_pred             HhCCCCCCCccc
Q psy3714         432 AMDHPYFYPIVK  443 (467)
Q Consensus       432 ~l~Hp~f~~~~~  443 (467)
                      +|+||||+....
T Consensus       326 ~l~Hp~~~~~~~  337 (388)
T 3oz6_A          326 ALKHPFVSIFHN  337 (388)
T ss_dssp             HTTSTTTTTTCC
T ss_pred             HhCCHHHHHhcC
Confidence            999999987653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.3e-44  Score=361.76  Aligned_cols=267  Identities=23%  Similarity=0.322  Sum_probs=211.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++++.||+|+||.||+|.+..+++.||+|++++..      ...+.+|+.++..++ ||||+.+++.+.+.  ...
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~--~~~  149 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDD--NNL  149 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECS--SEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeC--CEE
Confidence            478999999999999999999999999999999987532      223788999999884 89999999999864  568


Q ss_pred             EEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ++||||+++++|.+++.    .+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMED  228 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTT
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-CEEEcchhhhhhcccC
Confidence            99999999999988764    489999999999999999999999999999999999999655 8999999999876443


Q ss_pred             CC--cceeeeccCccCCcccc-----cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         320 QE--YNVRVASRYFKGPELLA-----DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       320 ~~--~~~~~gt~~y~aPE~l~-----~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      ..  ....+||+.|+|||++.     ...|+.++|+|..+++.+....+..||.....        ..... .+....  
T Consensus       229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--------~~~~~-~i~~~~--  297 (437)
T 4aw2_A          229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYG-KIMNHK--  297 (437)
T ss_dssp             SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH-HHHTHH--
T ss_pred             CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh--------hHHHH-hhhhcc--
Confidence            32  23368999999999997     45689999999999887766666666543211        11111 111000  


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCCcccccccCCCCCCC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYE--RLTAREAMDHPYFYPIVKDQSRHTLPSSS  454 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~--R~ta~e~l~Hp~f~~~~~~~~~~~~~~~~  454 (467)
                         ..+..+.....+|++++|||++||+.+|++  |++++|+++||||.+++|+..+...++..
T Consensus       298 ---~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~~~p~~  358 (437)
T 4aw2_A          298 ---ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYI  358 (437)
T ss_dssp             ---HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGSCCSCC
T ss_pred             ---ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhCCCCCC
Confidence               001111122458999999999999999998  99999999999999999988765555443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.6e-44  Score=360.30  Aligned_cols=257  Identities=22%  Similarity=0.301  Sum_probs=207.2

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++++..      ...+.+|+.+++.++ ||||+++++.+.+.  ..
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~--~~  143 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDD--RY  143 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECS--SE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEEC--CE
Confidence            3578999999999999999999999999999999986522      234788999999885 89999999999864  56


Q ss_pred             cEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      .++||||+++++|.+++.  .+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+......
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTS
T ss_pred             EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC-CEEEeccceeEeeccCC
Confidence            899999999999988765  488999999999999999999999999999999999998655 79999999998765433


Q ss_pred             C--cceeeeccCccCCcccccCC----CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         321 E--YNVRVASRYFKGPELLADYQ----YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       321 ~--~~~~~gt~~y~aPE~l~~~~----~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      .  ....+||+.|+|||++.+..    |+.++|+|..+++.+....+..||.....        ..... .+..      
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~-~i~~------  287 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYS-KIMN------  287 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH-HHHT------
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--------hhHHH-HHHh------
Confidence            2  23568999999999998766    78899999999887776666666543211        11111 1110      


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCCcccc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYE--RLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~--R~ta~e~l~Hp~f~~~~~~  444 (467)
                      +......+.+..+|++++|||++||+.+|++  |+|++|+++||||.+++|+
T Consensus       288 ~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          288 HKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             HHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             ccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence            0000111223458999999999999999999  9999999999999998875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-43  Score=344.56  Aligned_cols=253  Identities=21%  Similarity=0.377  Sum_probs=207.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++++.||+|+||.||+|.+..+++.||+|++++.      ..+.+.+|+.+++.+. ||||+++++.+.+.  ...
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~--~~~   81 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDA--QQI   81 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECS--SEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeC--CEE
Confidence            57899999999999999999999999999999998653      2356778999999885 89999999998764  568


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++||||+++++|.+++.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....  
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD--  158 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS--
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC-CEEEeecCcceecCC--
Confidence            99999999999988764   489999999999999999999999999999999999998655 799999999987543  


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      .....+||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ...... .+...          .
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~-~i~~~----------~  219 (318)
T 1fot_A          159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYE-KILNA----------E  219 (318)
T ss_dssp             CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHH-HHHHC----------C
T ss_pred             ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHH-HHHhC----------C
Confidence            2345689999999999999999999999999888766666655553221        111111 11100          0


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCccccccc
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~  447 (467)
                      ...+..+|+++++||++||+.||++|+     |++|+++||||.+++|+...
T Consensus       220 ~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~  271 (318)
T 1fot_A          220 LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLL  271 (318)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHH
Confidence            011235799999999999999999999     89999999999999987553

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=351.41  Aligned_cols=259  Identities=17%  Similarity=0.342  Sum_probs=210.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|+++..      ....+.+|+.+|+.++ ||||+++++.+.+.  ..
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~--~~   89 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDE--ED   89 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS--SE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC--CE
Confidence            358899999999999999999999999999999998643      2356789999999995 89999999999864  46


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      .++||||+.+++|..++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC-CEEEeccceeeeccCC
Confidence            899999999999987764   589999999999999999999999999999999999998655 7999999999987666


Q ss_pred             CCcceeeeccCccCCccccc---CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         320 QEYNVRVASRYFKGPELLAD---YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~---~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      ......+||+.|+|||++..   ..|+.++|+|..+++.+....+..||......     ........ +..        
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----~~~~~~~~-~~~--------  234 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-----SSKEIVHT-FET--------  234 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-----CHHHHHHH-HHH--------
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-----cHHHHHHH-Hhh--------
Confidence            66677889999999999974   45899999999988877666666665322111     00111100 000        


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCC-HHHHhCCCCCCCccccccc
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLT-AREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~t-a~e~l~Hp~f~~~~~~~~~  447 (467)
                        .....+..+|+++++||++||+.||++|++ ++++++||||.+++|+...
T Consensus       235 --~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~  284 (384)
T 4fr4_A          235 --TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVF  284 (384)
T ss_dssp             --CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHH
T ss_pred             --cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHH
Confidence              011123457999999999999999999998 8999999999999986543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.6e-43  Score=356.62  Aligned_cols=279  Identities=25%  Similarity=0.451  Sum_probs=202.2

Q ss_pred             cccCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         165 VDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       165 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..+.-.++|++++.||+|+||.||+|.+..+++.||||+++..     ..+++.+|+.+|+.++ |+||+.+++++....
T Consensus        20 ~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           20 KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDD   98 (432)
T ss_dssp             GGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred             CcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCC
Confidence            3455568999999999999999999999999999999998652     2357889999999996 899999999886543


Q ss_pred             C---CccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccc
Q psy3714         240 S---RTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA  313 (467)
Q Consensus       240 ~---~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla  313 (467)
                      .   ...|+||||+.+ +|.+.+.   .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|
T Consensus        99 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~~kL~DFGla  176 (432)
T 3n9x_A           99 LLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD-CSVKVCDFGLA  176 (432)
T ss_dssp             TTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTC
T ss_pred             CCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCC-CCEEEccCCCc
Confidence            2   468999999874 8877765   38999999999999999999999999999999999999855 47999999999


Q ss_pred             eecCCCC-----------------------CcceeeeccCccCCccc-ccCCCCccchhHHHhhhccccccc--------
Q psy3714         314 EFYHPGQ-----------------------EYNVRVASRYFKGPELL-ADYQYHIELDPRFADILGRHSRKR--------  361 (467)
Q Consensus       314 ~~~~~~~-----------------------~~~~~~gt~~y~aPE~l-~~~~~~~~~D~~~~~~~~~~~~~~--------  361 (467)
                      +......                       ..+..+||++|+|||++ ....|+.++|+|..+++.+....+        
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~  256 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP  256 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence            8764322                       13567899999999986 455699999999888776554432        


Q ss_pred             --cccccccCCcccCChh----------hhhhhhh--hccCCCCcccc--------cc----------cccccCCCCCCh
Q psy3714         362 --WERFVHTENQHLVSPE----------ALDFLDK--NILGRHSRKRW--------ER----------FVHTENQHLVSP  409 (467)
Q Consensus       362 --~~~~~~~~~~~~~~~~----------~~~~~~~--~~~~~~~~~~~--------~~----------~~~~~~~~~~s~  409 (467)
                        ..|++.+.......+.          .......  +.++......+        ..          .......+.+|+
T Consensus       257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  336 (432)
T 3n9x_A          257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD  336 (432)
T ss_dssp             GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred             ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence              2333332211000000          0000000  00010000000        00          000011245899


Q ss_pred             HHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccccc
Q psy3714         410 EALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       410 ~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~~  446 (467)
                      +++|||++||++||++||||+|+|+||||.++.++..
T Consensus       337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~  373 (432)
T 3n9x_A          337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKL  373 (432)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTT
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCccc
Confidence            9999999999999999999999999999999876544

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.9e-43  Score=359.26  Aligned_cols=277  Identities=26%  Similarity=0.430  Sum_probs=188.6

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC---
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPV---  239 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~---  239 (467)
                      ...++|++++.||+|+||.||+|.+..+++.||||++...     ..+++.+|+.+|+.++ |+||+++++++....   
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  128 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVEK  128 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTT
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCccc
Confidence            3457899999999999999999999999999999988642     2356889999999995 899999999885432   


Q ss_pred             CCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      ....|+||||+. +++.+++.   .+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..
T Consensus       129 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~  206 (458)
T 3rp9_A          129 FDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTV  206 (458)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCT
T ss_pred             CceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC-CEeecccccchhc
Confidence            256899999875 57776654   489999999999999999999999999999999999999654 8999999999875


Q ss_pred             CCCC----------------------------CcceeeeccCccCCcccc-cCCCCccchhHHHhhhccccccc------
Q psy3714         317 HPGQ----------------------------EYNVRVASRYFKGPELLA-DYQYHIELDPRFADILGRHSRKR------  361 (467)
Q Consensus       317 ~~~~----------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~~D~~~~~~~~~~~~~~------  361 (467)
                      ....                            ..+..+||++|+|||++. ...|+.++|+|..+++.+....+      
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            4211                            234568899999999874 55699999999888765544432      


Q ss_pred             ----cccccccCCcccC-------------Chhhhhhhhh--hccCCCCcccc------------------cccccccCC
Q psy3714         362 ----WERFVHTENQHLV-------------SPEALDFLDK--NILGRHSRKRW------------------ERFVHTENQ  404 (467)
Q Consensus       362 ----~~~~~~~~~~~~~-------------~~~~~~~~~~--~~~~~~~~~~~------------------~~~~~~~~~  404 (467)
                          ..++|.+......             ..........  .+++......+                  ........+
T Consensus       287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (458)
T 3rp9_A          287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF  366 (458)
T ss_dssp             SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred             ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence                1222222110000             0000000000  00010000000                  000011223


Q ss_pred             CCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccccccc
Q psy3714         405 HLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       405 ~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~~~  447 (467)
                      +.+|++++|||++||++||++|||++|+|+||||.++.+....
T Consensus       367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e  409 (458)
T 3rp9_A          367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVE  409 (458)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGC
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccC
Confidence            4579999999999999999999999999999999998765443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.1e-43  Score=338.33  Aligned_cols=263  Identities=25%  Similarity=0.489  Sum_probs=201.0

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++|++++.||+|+||.||+|.+..+++.||+|+++..     ....+.+|+.+++.++ ||||+++++++.+.  ...++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~l   78 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSD--KKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEET--TEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeC--CEEEE
Confidence            6899999999999999999999999999999998643     2356789999999996 89999999998764  56899


Q ss_pred             EEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CC
Q psy3714         246 IFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~  321 (467)
                      ||||++++.+..+.   ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+..... ..
T Consensus        79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCSCCSC
T ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecCCcccc
Confidence            99999875444333   3589999999999999999999999999999999999999655 7999999999876432 33


Q ss_pred             cceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc-
Q psy3714         322 YNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV-  399 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  399 (467)
                      ....+||+.|+|||++.+.. |+.++|+|..+++.+....+..|++.+.+..    .....+.. ..+......|.... 
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~----~~~~~i~~-~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD----DQLKRIFR-LLGTPTEEQWPSMTK  232 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH----HHHHHHHH-HHCCCCTTTCTTGGG
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH----HHHHHHHH-HhCCCChhhhhhhcc
Confidence            44567899999999998766 8999999998887666655556654433210    00000000 00111111111100 


Q ss_pred             ---------------cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         400 ---------------HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       400 ---------------~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                                     .....+.+|++++|||++||+.||++|||++|+|+||||.+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                           0111235789999999999999999999999999999998753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-43  Score=340.28  Aligned_cols=265  Identities=23%  Similarity=0.408  Sum_probs=199.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--------HHHHHHHHHHHHHhc--CCCCeeEEEEEEeCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--------KKKIKREIKILENLR--GGTNIITLQAVVKDPV  239 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--------~~~~~~Ei~il~~l~--~~~~iv~l~~~~~~~~  239 (467)
                      .++|++++.||+|+||.||+|.+..+++.||+|+++...        .....+|+.+++.+.  .||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            478999999999999999999999999999999986422        346788999888876  4899999999886543


Q ss_pred             C---CccEEEEeccCCccHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecc
Q psy3714         240 S---RTPALIFEHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG  311 (467)
Q Consensus       240 ~---~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFG  311 (467)
                      .   ...+++|||+.+ ++.+++..     +++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus        88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg  165 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFG  165 (308)
T ss_dssp             SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS-CEEECSCS
T ss_pred             CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEEeeCc
Confidence            2   247899999985 77776542     88999999999999999999999999999999999998655 79999999


Q ss_pred             cceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         312 LAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       312 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      +|+...........+||+.|+|||++.+..|+.++|+|..+++.+....+..+|......     .....+. ...+...
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~i~-~~~~~~~  239 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-----DQLGKIF-DLIGLPP  239 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-----HHHHHHH-HHHCCCC
T ss_pred             cccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH-HHhCCCC
Confidence            998776555556678999999999999999999999999888766665555554322110     0000000 0001111


Q ss_pred             ccccccccc--------------ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         392 RKRWERFVH--------------TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       392 ~~~~~~~~~--------------~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ...|.....              ....+.+++++++||.+||++||++|||++|+|+||||....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            111111000              011235789999999999999999999999999999998643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=356.09  Aligned_cols=268  Identities=26%  Similarity=0.366  Sum_probs=210.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||+|+||.||+|.++.+++.||+|++++..      ...+.+|+.++..+. |+||++++..+.+.  ..
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~--~~  135 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDE--NY  135 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECS--SE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeC--CE
Confidence            3579999999999999999999999999999999986421      234788999999885 89999999999864  56


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .|+||||+++++|.+++.    .+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+....
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-~vkL~DFGla~~~~~  214 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSCLKLRA  214 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC-CEEEeechhheeccC
Confidence            899999999999988763    589999999999999999999999999999999999999655 799999999987654


Q ss_pred             CCC--cceeeeccCccCCccccc-------CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCC
Q psy3714         319 GQE--YNVRVASRYFKGPELLAD-------YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGR  389 (467)
Q Consensus       319 ~~~--~~~~~gt~~y~aPE~l~~-------~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (467)
                      ...  ....+||+.|+|||++..       ..|+.++|+|..+++.+....+..||.....        ..... .+...
T Consensus       215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~-~i~~~  285 (412)
T 2vd5_A          215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--------AETYG-KIVHY  285 (412)
T ss_dssp             TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH-HHHTH
T ss_pred             CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--------HHHHH-HHHhc
Confidence            332  223589999999999973       4689999999999887766666666543211        11110 11100


Q ss_pred             CCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCC---CHHHHhCCCCCCCcccccccCCCCCCCC
Q psy3714         390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL---TAREAMDHPYFYPIVKDQSRHTLPSSSP  455 (467)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~---ta~e~l~Hp~f~~~~~~~~~~~~~~~~~  455 (467)
                      .     ..+..+.....+|++++|||++||+ ||++|+   |++|+++||||.+++|+..+...++..|
T Consensus       286 ~-----~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p  348 (412)
T 2vd5_A          286 K-----EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTP  348 (412)
T ss_dssp             H-----HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCC
T ss_pred             c-----cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCC
Confidence            0     0000011123589999999999999 999985   8999999999999999887765555443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.4e-43  Score=344.76  Aligned_cols=254  Identities=20%  Similarity=0.331  Sum_probs=208.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|+++..      ....+.+|+.+|+.+. ||||++++..+.+.  ..
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~  115 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDN--SN  115 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECS--SE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcC--CE
Confidence            358999999999999999999999999999999998643      2356788999999985 89999999998864  56


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      .++||||+++++|.+++.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSC
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC-CEEEcccccceeccCC
Confidence            899999999999987764   589999999999999999999999999999999999998655 7999999999976432


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                        ....+||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ..........+.          
T Consensus       195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~----------  254 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSGK----------  254 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC----------
T ss_pred             --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHcCC----------
Confidence              345689999999999999999999999998888766666655553221        111111110010          


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCccccccc
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~~~~  447 (467)
                       ...+..+|+++++||++||+.||++|++     ++|+++||||.+++|....
T Consensus       255 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~  306 (350)
T 1rdq_E          255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY  306 (350)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHh
Confidence             0112357999999999999999999998     9999999999999986543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.8e-43  Score=365.27  Aligned_cols=261  Identities=23%  Similarity=0.324  Sum_probs=212.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|+++..      ....+.+|+.+|+.++ ||||+.+++.+.+.  ..
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~--~~  258 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETK--DA  258 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS--SE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeC--CE
Confidence            457899999999999999999999999999999998643      2345788999999995 89999999998764  56


Q ss_pred             cEEEEeccCCccHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         243 PALIFEHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      .++||||+++++|..++..     +++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+...
T Consensus       259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-~vKL~DFGla~~~~  337 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-HIRISDLGLAVHVP  337 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC-CeEEEecccceecc
Confidence            8999999999999877642     88999999999999999999999999999999999999655 89999999999876


Q ss_pred             CCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       318 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      .+......+||+.|+|||++.+..|+.++|+|..+++.+....+..||...... .........+..             
T Consensus       338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~-~~~~~i~~~i~~-------------  403 (576)
T 2acx_A          338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-IKREEVERLVKE-------------  403 (576)
T ss_dssp             TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC-CCHHHHHHHHHH-------------
T ss_pred             cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc-hhHHHHHHHhhc-------------
Confidence            655556678999999999999988999999999998877666666665432211 000011111100             


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccccC
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSRH  448 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~~  448 (467)
                       .....+..+|+++++||++||+.||++|+     |++|+++||||..++|+....
T Consensus       404 -~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~  458 (576)
T 2acx_A          404 -VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGA  458 (576)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHT
T ss_pred             -ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhc
Confidence             00112245899999999999999999999     899999999999999875543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.1e-43  Score=372.70  Aligned_cols=258  Identities=21%  Similarity=0.279  Sum_probs=211.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||||++++.      ......+|..++..+.+|++|+.++..+.+.  ..
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~--~~  416 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DR  416 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS--SE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC--CE
Confidence            357899999999999999999999999999999998743      2345788999999888899999999998763  56


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-C
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-P  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-~  318 (467)
                      .|+||||+++++|..++.   .+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+... .
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-CEEECCCTTCEECCCT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-cEEEeecceeeccccC
Confidence            899999999999987764   589999999999999999999999999999999999999665 89999999998643 3


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      +......+||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ...... .+...         
T Consensus       496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--------~~~~~~-~i~~~---------  557 (674)
T 3pfq_A          496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQ-SIMEH---------  557 (674)
T ss_dssp             TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH-HHHSS---------
T ss_pred             CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--------HHHHHH-HHHhC---------
Confidence            334556789999999999999999999999999988776666666653321        111111 11110         


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCH-----HHHhCCCCCCCcccccccC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTA-----REAMDHPYFYPIVKDQSRH  448 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta-----~e~l~Hp~f~~~~~~~~~~  448 (467)
                       ....+..+|++++|||++||++||++|+++     +|+++||||.+++|+....
T Consensus       558 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~  611 (674)
T 3pfq_A          558 -NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER  611 (674)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTT
T ss_pred             -CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHh
Confidence             011234589999999999999999999997     9999999999999876543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=8.5e-43  Score=338.57  Aligned_cols=264  Identities=28%  Similarity=0.528  Sum_probs=197.3

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      +-.++|++++.||+|+||.||+|.+. +++.||+|+++...     ...+.+|+.+++.++ ||||+++++++.+.  ..
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~   93 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELH-HPNIVSLIDVIHSE--RC   93 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECCS--SC
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcC-CCCEeeeeeEEccC--CE
Confidence            34589999999999999999999985 58899999986432     356789999999995 89999999998754  56


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .++||||+++ ++.+.+.    .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGI  171 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEETTS
T ss_pred             EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-CEEEccCcCceecCC
Confidence            8999999986 5555442    388999999999999999999999999999999999998665 799999999987643


Q ss_pred             C-CCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         319 G-QEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       319 ~-~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      . ......+||+.|+|||++.+ ..|+.++|+|..+++.+....+..||.......     ....+. ...+......|.
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~-~~~~~~~~~~~~  245 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-----QLPKIF-SILGTPNPREWP  245 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-----HHHHHH-HHHCCCCTTTSG
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHH-HHHCCCChHHhh
Confidence            2 33445679999999999977 458999999988887666555555553322110     000000 000000001111


Q ss_pred             cc-----------------ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         397 RF-----------------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       397 ~~-----------------~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      ..                 ......+.++++++|||++||++||++|||++|+|+||||.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            00                 000112347899999999999999999999999999999998753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.2e-43  Score=352.47  Aligned_cols=258  Identities=22%  Similarity=0.357  Sum_probs=198.0

Q ss_pred             ccceeee-EeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeC--CCCCccEEE
Q psy3714         170 QDDYQLV-RKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKD--PVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~--~~~~~~~lv  246 (467)
                      .++|.+. +.||+|+||.||+|.+..+++.||||+++.  .....+|+.++.++.+|+||+++++++..  ......++|
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv  137 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV  137 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence            4788887 689999999999999999999999999874  34678899998777789999999998754  223467999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC--CCcEEEEecccceecCCC
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~--~~~ikl~DFGla~~~~~~  319 (467)
                      |||+++++|.+++.     .+++.+++.++.||+.||.|||++||+||||||+|||++..  ++.+||+|||+|+.....
T Consensus       138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~  217 (400)
T 1nxk_A          138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  217 (400)
T ss_dssp             EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred             EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence            99999999988764     38899999999999999999999999999999999999863  457999999999977655


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      ......+||+.|+|||++.+..|+.++|+|..+++.+....+..||........ .......+..   +...       .
T Consensus       218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~i~~---~~~~-------~  286 (400)
T 1nxk_A          218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKTRIRM---GQYE-------F  286 (400)
T ss_dssp             ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS-CCSHHHHHHH---TCCC-------C
T ss_pred             CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc-cHHHHHHHHc---Cccc-------C
Confidence            555667899999999999998999999999998887766666666543322111 0111111110   1000       0


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      ....+..+|+++++||++||+.||++|||++|+|+||||..
T Consensus       287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence            11223458999999999999999999999999999999964

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-43  Score=345.29  Aligned_cols=254  Identities=24%  Similarity=0.411  Sum_probs=207.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.++..  ....+.+|+.+++.++ ||||+++++++.+.  ...++||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNILHLHESFESM--EELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSC-CTTBCCEEEEEEET--TEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCC-CCCCCeEeEEEecC--CEEEEEE
Confidence            47899999999999999999999999999999998754  3456789999999995 89999999998764  5689999


Q ss_pred             eccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC-CCcEEEEecccceecCCCCCc
Q psy3714         248 EHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       248 e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~-~~~ikl~DFGla~~~~~~~~~  322 (467)
                      ||+++++|.+.+.    .+++.++..++.|++.||.|||++||+||||||+|||++.. ++.+||+|||+|+...++...
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~  160 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence            9999999988764    48899999999999999999999999999999999999852 458999999999988766666


Q ss_pred             ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccccc
Q psy3714         323 NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE  402 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
                      ...+||+.|+|||++.+..++.++|+|..+++.+....+..||.....        .............   +    ...
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~---~----~~~  225 (321)
T 1tki_A          161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYT---F----DEE  225 (321)
T ss_dssp             EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCC---C----CHH
T ss_pred             ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHcCCCC---C----Chh
Confidence            677899999999999988889999999988876666566555533211        1111110001000   0    111


Q ss_pred             CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       403 ~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      .+..+|+++++||++||..||++|||++|+|+||||...
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            234589999999999999999999999999999999764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.3e-43  Score=348.63  Aligned_cols=256  Identities=23%  Similarity=0.345  Sum_probs=200.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHH-HHhcCCCCeeEEEEEEeCCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKIL-ENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il-~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++++..      ...+.+|..++ +.+ +||||+++++.+.+.  .
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~--~  112 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTA--D  112 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECS--S
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeC--C
Confidence            4589999999999999999999999999999999986532      23456676664 444 589999999998864  5


Q ss_pred             ccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC-
Q psy3714         242 TPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-  317 (467)
                      ..|+||||+++++|..++.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+... 
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCBCGGGBC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEeeCcccccccc
Confidence            7899999999999987664   489999999999999999999999999999999999999655 89999999998642 


Q ss_pred             CCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       318 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      ........+||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ...... .+...        
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~-~i~~~--------  254 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYD-NILNK--------  254 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--------HHHHHH-HHHHS--------
T ss_pred             CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHH-HHHhc--------
Confidence            3334456789999999999999999999999999888766666665653221        111111 11110        


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCH----HHHhCCCCCCCccccccc
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTA----REAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta----~e~l~Hp~f~~~~~~~~~  447 (467)
                        ....+..+|+++++||++||+.||++|+++    +|+++||||.+++|+...
T Consensus       255 --~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~  306 (373)
T 2r5t_A          255 --PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLI  306 (373)
T ss_dssp             --CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHH
T ss_pred             --ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHH
Confidence              001123589999999999999999999986    699999999999987653

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.6e-43  Score=346.61  Aligned_cols=257  Identities=25%  Similarity=0.377  Sum_probs=204.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+|++++.++.+||||+++++++.+.  ...++||||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~   97 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDDG--KYVYVVTEL   97 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEECS--SEEEEEECC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEcC--CEEEEEEeC
Confidence            478999999999999999999999999999999987543 34567999999997799999999999764  568999999


Q ss_pred             cCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC---cEEEEecccceecCCC-CCc
Q psy3714         250 VNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPG-QEY  322 (467)
Q Consensus       250 ~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~---~ikl~DFGla~~~~~~-~~~  322 (467)
                      +++++|.+.+.   .+++.++..++.||+.||+|||++||+||||||+|||+...++   .+||+|||+|+..... ...
T Consensus        98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  177 (342)
T 2qr7_A           98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL  177 (342)
T ss_dssp             CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence            99999887653   4899999999999999999999999999999999999864432   4999999999876433 234


Q ss_pred             ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccccc
Q psy3714         323 NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE  402 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
                      ...+||+.|+|||++.+..|+.++|+|..+++.+....+..||.......  ..+....+..   +...       ....
T Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~~---~~~~-------~~~~  245 (342)
T 2qr7_A          178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT--PEEILARIGS---GKFS-------LSGG  245 (342)
T ss_dssp             CCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--HHHHHHHHHH---CCCC-------CCST
T ss_pred             eccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--HHHHHHHHcc---CCcc-------cCcc
Confidence            45689999999999998889999999999888766666666654321110  0011111111   1100       1112


Q ss_pred             CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       403 ~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      .+..+|+++++||++||+.||++|||++|+++||||...
T Consensus       246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            234689999999999999999999999999999999653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.7e-43  Score=339.03  Aligned_cols=258  Identities=19%  Similarity=0.189  Sum_probs=179.6

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHH--HHHhcCCCCeeEEEEEEeCCCC--CccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKI--LENLRGGTNIITLQAVVKDPVS--RTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~i--l~~l~~~~~iv~l~~~~~~~~~--~~~~lv  246 (467)
                      .+|.+.+.||+|+||+||+|..  +|+.||||+++....+...+|.++  +..++ |||||++++++.++..  ...++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCceEEEEE
Confidence            4689999999999999999986  588999999987655555555544  45564 8999999999865432  247999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSM--------GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~--------~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      |||+++|+|.++++  .++..++..++.|++.||+|||++        +||||||||+|||++.++ .+||+|||+|+..
T Consensus        80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~  158 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEEE
T ss_pred             ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCCCCccc
Confidence            99999999988875  578889999999999999999987        999999999999999654 8999999999876


Q ss_pred             CCCCCc-----ceeeeccCccCCcccccC------CCCccchhHHHhhhccccccccccccccCCcccCC------hhhh
Q psy3714         317 HPGQEY-----NVRVASRYFKGPELLADY------QYHIELDPRFADILGRHSRKRWERFVHTENQHLVS------PEAL  379 (467)
Q Consensus       317 ~~~~~~-----~~~~gt~~y~aPE~l~~~------~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~  379 (467)
                      ......     ...+||+.|||||++.+.      .|+.++|+|+.+++.+....+..++..........      ....
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            543321     235799999999999764      36678999988887554433332222111110000      0000


Q ss_pred             hhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         380 DFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ......+.....+.....   .......++++.+|+.+|++.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~rp~~p~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcccCCCCCCc---cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            001111111100000000   00001123577899999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.8e-43  Score=354.34  Aligned_cols=254  Identities=24%  Similarity=0.413  Sum_probs=202.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|+++...     .+.+.+|+.+++.++ ||||+++++++.+.  ...+
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~~~~   86 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK-HPNIVRLHDSISEE--GHHY   86 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECS--SEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEEC--CEEE
Confidence            478999999999999999999999999999999986532     356789999999995 89999999998764  5689


Q ss_pred             EEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC--CCcEEEEecccceecCCC
Q psy3714         245 LIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       245 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~--~~~ikl~DFGla~~~~~~  319 (467)
                      +||||+.+++|.+.+   ..+++.++..++.||+.||.|||++||+||||||+|||++..  ++.+||+|||+|+.....
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            999999999997765   358999999999999999999999999999999999999842  357999999999876543


Q ss_pred             C-CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         320 Q-EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       320 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      . .....+||+.|+|||++.+..|+.++|+|..+++.+....+..||.....     ......+..   +...       
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~---~~~~-------  231 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----HRLYQQIKA---GAYD-------  231 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHH---TCCC-------
T ss_pred             CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHh---CCCC-------
Confidence            3 23456899999999999998999999999998887666666555533211     011111111   1100       


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      ...+.+..+|+++++||.+||+.||++|||++|+|+||||...
T Consensus       232 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          232 FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            0112234689999999999999999999999999999999643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-42  Score=340.67  Aligned_cols=248  Identities=23%  Similarity=0.388  Sum_probs=201.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....      ...+.+|+.+++.++ ||||+++++++.++  ...
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~   84 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTP--TDI   84 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECS--SEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC--CEE
Confidence            478999999999999999999999999999999986431      346889999999996 89999999999864  468


Q ss_pred             EEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++||||+ ++++.+.+   ..+++.+++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|.....+.
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-CEEECCSSCTBTTTTSB
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-CEEEEEeccceeccCCc
Confidence            9999999 56666554   3589999999999999999999999999999999999999554 79999999999876665


Q ss_pred             CcceeeeccCccCCcccccCCC-CccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQY-HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~-~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      .....+||+.|+|||++.+..| +.++|+|..+++.+....+..||......             .........      
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------------~~~~~i~~~------  223 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-------------NLFKKVNSC------  223 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-------------TCBCCCCSS------
T ss_pred             ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-------------HHHHHHHcC------
Confidence            5666789999999999998876 67899999888766655555554322110             000000000      


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      ....+..+|+++++||++||+.||++|||++|+++||||...
T Consensus       224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            011234589999999999999999999999999999999753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.9e-43  Score=337.00  Aligned_cols=252  Identities=21%  Similarity=0.349  Sum_probs=203.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      .++|++++.||+|+||.||+|.+..+++.||+|.+...   ..+.+.+|+.+++.++ ||||+++++.+.+.  ...++|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLVG--DELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEET--TEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCC-CCCCCeEeEEEEEC--CEEEEE
Confidence            47899999999999999999999999999999998643   3566889999999995 89999999988764  468999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-Ccc
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYN  323 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~~~  323 (467)
                      |||+++++|.++..  .+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+...... ...
T Consensus        96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBC
T ss_pred             EECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-CEEEeeCCCceecCCcccccC
Confidence            99999999988765  488999999999999999999999999999999999998655 79999999998765433 234


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      ..+||+.|+|||++.+..|+.++|+|..+++.+....+..||.....     ..........   .        ......
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~---~--------~~~~~~  238 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIATN---G--------TPELQN  238 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHH---C--------SCCCSC
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC---C--------CCCCCC
Confidence            56899999999999999999999999988876665555555432110     0000000000   0        001112


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      +..+|+++++||.+||+.||++|||++|+|+||||...
T Consensus       239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            33579999999999999999999999999999999754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.9e-42  Score=358.11  Aligned_cols=261  Identities=23%  Similarity=0.316  Sum_probs=210.3

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++++..      ...+.+|+.+|+.++ ||||+.++..+.+.  ..
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~--~~  259 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETK--TD  259 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS--SE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeC--CE
Confidence            4589999999999999999999999999999999986432      245788999999995 89999999998764  56


Q ss_pred             cEEEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         243 PALIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                      .++||||+++++|..++.       .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-~vkL~DFGla~~  338 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVE  338 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC-CEEEeecceeee
Confidence            899999999999987653       388999999999999999999999999999999999999655 799999999997


Q ss_pred             cCCCCC-cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         316 YHPGQE-YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       316 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ...... ....+||+.|+|||++.+..|+.++|+|..+++.+....+..||...... . .  ..... ..+...     
T Consensus       339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~-~--~~~~~-~~i~~~-----  408 (543)
T 3c4z_A          339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-V-E--NKELK-QRVLEQ-----  408 (543)
T ss_dssp             CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-C-C--HHHHH-HHHHHC-----
T ss_pred             ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-h-h--HHHHH-HHHhhc-----
Confidence            754443 33458999999999999999999999999998877666666665432211 0 0  00111 111100     


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCcccccccC
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKDQSRH  448 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~~~~~  448 (467)
                           ....+..+|+++++||++||+.||++||+     ++|+++||||.+++|+....
T Consensus       409 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~  462 (543)
T 3c4z_A          409 -----AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEA  462 (543)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHT
T ss_pred             -----ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHc
Confidence                 01123458999999999999999999995     58999999999999875543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.8e-43  Score=341.11  Aligned_cols=256  Identities=25%  Similarity=0.398  Sum_probs=207.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---------KKKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|+++..         ....+.+|+.+|+.++ ||||+++++++.+.  
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--   86 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYENK--   86 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS--
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC--
Confidence            46799999999999999999999999999999998643         2456889999999996 89999999998764  


Q ss_pred             CccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC---cEEEEecccce
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR---KLRLIDWGLAE  314 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~---~ikl~DFGla~  314 (467)
                      ...++||||+++++|.+++.   .+++.++..++.||+.||.|||++||+||||||+|||++..+.   .+||+|||+|+
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            56899999999999988764   4889999999999999999999999999999999999985442   69999999999


Q ss_pred             ecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         315 FYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       315 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ...........+||+.|+|||++.+..|+.++|+|..+++.+....+..||.....     .........   ...   .
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~~~~---~~~---~  235 (326)
T 2y0a_A          167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLANVSA---VNY---E  235 (326)
T ss_dssp             ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHH---TCC---C
T ss_pred             ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----HHHHHHHHh---cCC---C
Confidence            87655555667899999999999988899999999988876665555555532211     011111100   000   0


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      +    ....+..+|+++++||++||+.||++|||++|+|+||||.+..+
T Consensus       236 ~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          236 F----EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             C----CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred             c----CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence            0    01112357999999999999999999999999999999987654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.4e-42  Score=344.04  Aligned_cols=256  Identities=21%  Similarity=0.371  Sum_probs=193.2

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++...  ....+.+|+.+++.++ ||||+++++++.+.  ...++|
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~lv   94 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAII   94 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCC-CTTBCCEEEEEECS--SEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCC-CCCCCcEEEEEeeC--CEEEEE
Confidence            458899999999999999999999999999999998753  2467889999999996 89999999999864  468999


Q ss_pred             EeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC-CcEEEEecccceecCCCCCc
Q psy3714         247 FEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN-RKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       247 ~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~-~~ikl~DFGla~~~~~~~~~  322 (467)
                      |||+++++|.+.+   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+|+........
T Consensus        95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~  174 (361)
T 3uc3_A           95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  174 (361)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence            9999999998765   3589999999999999999999999999999999999998543 24999999999865444444


Q ss_pred             ceeeeccCccCCcccccCCCCcc-chhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         323 NVRVASRYFKGPELLADYQYHIE-LDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~~~~~~-~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ...+||+.|+|||++.+..|... +|+|..+++.+....+..||.......    ........ +...    .    ...
T Consensus       175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~~-~~~~----~----~~~  241 (361)
T 3uc3_A          175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR----DYRKTIQR-ILSV----K----YSI  241 (361)
T ss_dssp             ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC----CHHHHHHH-HHTT----C----CCC
T ss_pred             CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH----HHHHHHHH-HhcC----C----CCC
Confidence            55789999999999998887655 899988887666555555553322110    01111111 1100    0    011


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      +....+|+++++||++||+.||++|||++|+++||||..
T Consensus       242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          242 PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence            122357999999999999999999999999999999954

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.7e-43  Score=340.63  Aligned_cols=261  Identities=24%  Similarity=0.374  Sum_probs=186.9

Q ss_pred             cceeee---EeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         171 DDYQLV---RKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       171 ~~y~~~---~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ++|++.   +.||+|+||.||+|.+..+++.||||++.........+|+.+++.+.+||||+++++++.+.  ...++||
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~   85 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVM   85 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEE
Confidence            566665   78999999999999999999999999998777778899999999998899999999999864  5689999


Q ss_pred             eccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC--cEEEEecccceecCCC-CC
Q psy3714         248 EHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPG-QE  321 (467)
Q Consensus       248 e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~--~ikl~DFGla~~~~~~-~~  321 (467)
                      ||+++++|.+.+.   .+++.+++.++.||+.||+|||++||+||||||+|||++.++.  .+||+|||+|+..... ..
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            9999999987764   4899999999999999999999999999999999999985442  7999999999876433 23


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+||+.|+|||++.+..|+.++|+|..+++.+....+..||........ .............+...       ...
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~i~~~~~~-------~~~  237 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKKIKKGDFS-------FEG  237 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTCCC-------CCS
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHHHHcCCCC-------CCc
Confidence            3456789999999999999999999999888876665555555533221100 00111111111001100       011


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      +.+..+|+++++||++||+.||++|||++|+++||||.+.
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            1123579999999999999999999999999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.5e-43  Score=356.85  Aligned_cols=268  Identities=22%  Similarity=0.343  Sum_probs=204.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|+++..      ....+.+|+.+++.++ ||||+.+.+.+.+.  ..
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~--~~  222 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTH--DR  222 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEET--TE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeC--CE
Confidence            357899999999999999999999999999999998743      1245678999998886 89999999998764  46


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCCcEEEEecccceecC-
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-  317 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~-  317 (467)
                      .++||||+++++|...+.   .+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+... 
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCCCTTCC
T ss_pred             EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCceeccC
Confidence            899999999999877653   58999999999999999999998 9999999999999999655 79999999998643 


Q ss_pred             CCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       318 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      ........+||+.|+|||++.+..|+.++|+|..+++.+....+..||.....     ......+.   ...        
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~---~~~--------  365 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELIL---MEE--------  365 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHH---HCC--------
T ss_pred             CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHH---hCC--------
Confidence            23334557899999999999999999999999988886666565555533211     01111110   000        


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccccCCCCCCCCCCCC
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSRHTLPSSSPTPIV  459 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~~~~~~~~~~~~~  459 (467)
                         ...+..+++++++||.+||++||++||     |++|+++||||.+++|........++...|.+
T Consensus       366 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~  429 (446)
T 4ejn_A          366 ---IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQV  429 (446)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSC
T ss_pred             ---CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCC
Confidence               111235799999999999999999999     99999999999999987665444333333333

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-42  Score=343.27  Aligned_cols=254  Identities=25%  Similarity=0.379  Sum_probs=203.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      .+.|++.+.||+|+||.||+|.+..+++.||||+++..        ..+.+.+|+.+++.++ ||||+++++++.+.  .
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~   99 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSD--G   99 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEET--T
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC--C
Confidence            47899999999999999999999999999999998642        2456889999999995 89999999998764  5


Q ss_pred             ccEEEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC--CcEEEEeccc
Q psy3714         242 TPALIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGL  312 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~--~~ikl~DFGl  312 (467)
                      ..++||||+++++|...+.       .+++..+..++.||+.||.|||++||+||||||+|||++.++  ..+||+|||+
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            6899999999999865542       278999999999999999999999999999999999998543  2499999999


Q ss_pred             ceecCCCCC-cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         313 AEFYHPGQE-YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       313 a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      |+....... ....+||+.|+|||++.+..|+.++|+|..+++.+....+..||....      .....   ....+...
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~---~i~~~~~~  250 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------ERLFE---GIIKGKYK  250 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------HHHHH---HHHHTCCC
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------HHHHH---HHHcCCCC
Confidence            987654332 345689999999999999899999999998887666555555553211      11111   11111100


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                             .....+..+|+++++||++||+.||++|||++|+|+||||....
T Consensus       251 -------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          251 -------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             -------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             -------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence                   01112245799999999999999999999999999999998654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-42  Score=343.84  Aligned_cols=255  Identities=25%  Similarity=0.428  Sum_probs=207.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      .++|++++.||+|+||.||+|.+..+++.+|+|++...   ....+.+|+.+|+.++ ||||+++++++.+.  ...++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~--~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDK--YEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC-STTBCCEEEEEECS--SEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeC--CEEEEE
Confidence            47899999999999999999999999999999998754   3456889999999995 89999999998764  568999


Q ss_pred             EeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC-CCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~-~~~ikl~DFGla~~~~~~~~  321 (467)
                      |||+.+++|.+.+.    .+++.++..++.||+.||+|||++||+||||||+|||++.. ++.+||+|||+|+.......
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            99999999988764    48899999999999999999999999999999999999743 34799999999998766555


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ...........     .|.  ...
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~i~~~-----~~~--~~~  271 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRC-----DWE--FDE  271 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHC-----CCC--CCS
T ss_pred             eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-----CCC--CCc
Confidence            566789999999999999889999999998887666666555553221        11111110000     010  111


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ..+..+|+++++||++||+.||++|||++|+|+||||.+..
T Consensus       272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            22345899999999999999999999999999999998654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.1e-42  Score=341.62  Aligned_cols=253  Identities=22%  Similarity=0.398  Sum_probs=204.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++..     ..+.+.+|+.+++.++ ||||+++++++.+.  ...+
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~--~~~~  104 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE--SFHY  104 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS--SEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC--CEEE
Confidence            47899999999999999999999999999999998643     2356789999999995 89999999998764  5689


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC--CcEEEEecccceecCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~--~~ikl~DFGla~~~~~~  319 (467)
                      +||||+.+++|.+.+.   .+++.++..++.||+.||.|||++||+||||||+|||++..+  ..+||+|||+|+.....
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            9999999999977664   478999999999999999999999999999999999998543  36999999999887655


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      ......+||+.|+|||++.+..|+.++|+|..+++.+....+..||.....     ......+..   +...       .
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----~~~~~~i~~---~~~~-------~  249 (362)
T 2bdw_A          185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQIKA---GAYD-------Y  249 (362)
T ss_dssp             CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH---TCCC-------C
T ss_pred             cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHh---CCCC-------C
Confidence            555667899999999999998999999999998887666666555533211     011111111   1100       0


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      ....+..+|+++++||.+||+.||++|||++|+|+||||..
T Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            11122347999999999999999999999999999999964

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.2e-42  Score=336.56  Aligned_cols=264  Identities=25%  Similarity=0.498  Sum_probs=188.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .++|++++.||+|+||.||+|.+..+++.||+|+++..    ....+.+|+.+++.++ ||||+++++++.+.  ...++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK-HENIVRLYDVIHTE--NKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCT--TEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcC-CCCcceEEEEEEEC--CeEEE
Confidence            46899999999999999999999999999999998643    2356889999999995 89999999998764  56899


Q ss_pred             EEeccCCccHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         246 IFEHVNNTDFKQLYQ---------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      ||||+++ ++.+++.         .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus        81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARAF  158 (317)
T ss_dssp             EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCSSCEET
T ss_pred             EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-CEEECcCccceec
Confidence            9999985 7766542         378899999999999999999999999999999999998655 7999999999876


Q ss_pred             CCC-CCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCC----
Q psy3714         317 HPG-QEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRH----  390 (467)
Q Consensus       317 ~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  390 (467)
                      ... ......+||+.|+|||++.+. .|+.++|+|..+++.+....+..||......     +....+.. ..+..    
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~-~~~~~~~~~  232 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-----EQLKLIFD-IMGTPNESL  232 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHH-HHCSCCTTT
T ss_pred             CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHH-HhCCCChhH
Confidence            432 234456799999999999874 5899999998888766655555554322110     00000000 00000    


Q ss_pred             -----------------CcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         391 -----------------SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       391 -----------------~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                                       ....+...........++++++|||++||+.||++|||++|+|+||||....++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                             001111111222334589999999999999999999999999999999987654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-42  Score=348.18  Aligned_cols=272  Identities=19%  Similarity=0.241  Sum_probs=198.7

Q ss_pred             CccceeeeEeeccc--CCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         169 QQDDYQLVRKLGRG--KYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       169 ~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ..++|++++.||+|  +||.||+|.+..+++.||||+++...     .+.+.+|+.+++.++ ||||+++++++.+.  .
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~   99 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRATFIAD--N   99 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET--T
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEEC--C
Confidence            45889999999999  99999999999999999999986432     356778999999996 89999999998764  5


Q ss_pred             ccEEEEeccCCccHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         242 TPALIFEHVNNTDFKQLY-----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      ..++||||++++++.+++     ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~kl~dfg~~~~~  178 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCGGGCEEC
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccccceee
Confidence            689999999999998876     3488999999999999999999999999999999999998655 8999999998654


Q ss_pred             CCC--------CCcceeeeccCccCCccccc--CCCCccchhHHHhhhccccccccccccccCCcccCCh----hhhhhh
Q psy3714         317 HPG--------QEYNVRVASRYFKGPELLAD--YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP----EALDFL  382 (467)
Q Consensus       317 ~~~--------~~~~~~~gt~~y~aPE~l~~--~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  382 (467)
                      ...        ......+||+.|+|||++.+  ..|+.++|+|..+++.+....+..||...........    ......
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            211        11122478999999999988  5689999999888876665555555533221100000    000000


Q ss_pred             hh-----------------------hccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         383 DK-----------------------NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       383 ~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                      +.                       .................+.+..+|++++|||++||++||++|||++|+|+||||.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence            00                       0000000000001111123345799999999999999999999999999999999


Q ss_pred             Ccccc
Q psy3714         440 PIVKD  444 (467)
Q Consensus       440 ~~~~~  444 (467)
                      .+.+.
T Consensus       339 ~~~~~  343 (389)
T 3gni_B          339 QIKRR  343 (389)
T ss_dssp             GC---
T ss_pred             HHhhc
Confidence            87653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.7e-42  Score=336.48  Aligned_cols=256  Identities=26%  Similarity=0.365  Sum_probs=197.5

Q ss_pred             CccceeeeEeecccCCcceEEEEEc---cCCCeEEEEEeccch-------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINV---QSSDKCVVKILKPVK-------KKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~-------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      ..++|++++.||+|+||.||+|.+.   .+++.||+|+++...       ...+.+|+.+|+.++ ||||+++++.+.+.
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~   93 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTG   93 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcC
Confidence            3578999999999999999999985   688999999987531       245678999999996 89999999998764


Q ss_pred             CCCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                        ...++||||+++++|.+.+.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus        94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~  170 (327)
T 3a62_A           94 --GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKE  170 (327)
T ss_dssp             --SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS-CEEECCCSCC--
T ss_pred             --CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC-cEEEEeCCcccc
Confidence              56899999999999987654   488999999999999999999999999999999999998655 799999999986


Q ss_pred             cCC-CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         316 YHP-GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       316 ~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ... .......+||+.|+|||++.+..|+.++|+|..+++.+....+..||....        ....... +...     
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~-i~~~-----  236 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--------RKKTIDK-ILKC-----  236 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHH-HHHT-----
T ss_pred             cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--------HHHHHHH-HHhC-----
Confidence            432 222344679999999999999889999999988887666555555543221        1111111 1100     


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCccccccc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~  447 (467)
                           ....+..+++++++||.+||+.||++||     |++|+++||||..++|+...
T Consensus       237 -----~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~  289 (327)
T 3a62_A          237 -----KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELL  289 (327)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHh
Confidence                 0112235799999999999999999999     89999999999999886543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.4e-42  Score=337.13  Aligned_cols=253  Identities=22%  Similarity=0.363  Sum_probs=200.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .++|++++.||+|+||.||+|.+..+++.||+|+++...    .+.+.+|+.+++.++ |+||+++++++.+.  ...++
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~~~l   82 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREG--NIQYL   82 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCC-CTTBCCEEEEEECS--SEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCC-CCCCCeEEEEEecC--CeEEE
Confidence            478999999999999999999999999999999986432    356789999999996 89999999998764  56799


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC--
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~--  320 (467)
                      ||||+++++|.+.+.   .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+....  
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEE
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC-CEEEEEeeccceeccCCcc
Confidence            999999999887764   589999999999999999999999999999999999998655 79999999998653221  


Q ss_pred             -CcceeeeccCccCCcccccCCC-CccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         321 -EYNVRVASRYFKGPELLADYQY-HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       321 -~~~~~~gt~~y~aPE~l~~~~~-~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                       .....+||+.|+|||++.+..+ +.++|+|..+++.+....+..||.......   ........    ....       
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~~----~~~~-------  227 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWKE----KKTY-------  227 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---HHHHHHHT----TCTT-------
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHHhc----cccc-------
Confidence             2334679999999999988775 678999988887666555555553222110   00000000    0000       


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                        ...+..+++++++||.+||+.||++|||++|+++||||....
T Consensus       228 --~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          228 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             --CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence              011234799999999999999999999999999999998643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=338.14  Aligned_cols=268  Identities=28%  Similarity=0.479  Sum_probs=197.3

Q ss_pred             cCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC-
Q psy3714         167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS-  240 (467)
Q Consensus       167 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~-  240 (467)
                      +...++|++++.||+|+||.||+|.+..+++.||||.+...     ..+++.+|+.+|+.++ ||||+++.+++..... 
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETL   99 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSST
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCcc
Confidence            34568899999999999999999999999999999998532     2356789999999996 8999999999865422 


Q ss_pred             ---CccEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         241 ---RTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       241 ---~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                         ...++||||+ +++|.++..  .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  177 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  177 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             ccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-CEEEEeeecccc
Confidence               3469999999 778887764  589999999999999999999999999999999999998654 799999999987


Q ss_pred             cCCCCCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcc--------cCCh--hhhhhhhh
Q psy3714         316 YHPGQEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQH--------LVSP--EALDFLDK  384 (467)
Q Consensus       316 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~--~~~~~~~~  384 (467)
                      ...  ..+..+||++|+|||++.+ ..|+.++|+|..+++......+..+|.......        .+.+  +.......
T Consensus       178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            543  3445689999999999987 569999999988887665555555543221100        0000  00000000


Q ss_pred             ----h---ccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         385 ----N---ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       385 ----~---~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                          .   .+.......|..     .....+++++|||.+||++||++|||++|+|+||||......
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFAS-----ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGG-----TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHHHHHHhCCCCCCCCHHH-----HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                0   000111112211     224579999999999999999999999999999999987654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.2e-42  Score=345.52  Aligned_cols=270  Identities=28%  Similarity=0.467  Sum_probs=200.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC----CCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPV----SRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~----~~~~~l  245 (467)
                      ..+|++.+.||+|+||.||+|.+..+++ +|+|.+... .....+|+++++.++ |+||+++++++....    ....++
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~-~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD-KRFKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECC-TTSCCHHHHHHHTCC-CTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecC-cchHHHHHHHHHhCC-CCCcceEEEEEEecCCCCCceEEEE
Confidence            4679999999999999999999887665 788876542 223457999999996 899999999885432    233789


Q ss_pred             EEeccCCccHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         246 IFEHVNNTDFKQLY------QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       246 v~e~~~~~~l~~~~------~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ||||++++.+....      +.+++..++.++.||+.||+|||++||+||||||+|||++..++.+||+|||+|+....+
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG  195 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence            99999987544332      358899999999999999999999999999999999999955568999999999987666


Q ss_pred             CCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCc--------ccCCh--hhhhhhhhhccC
Q psy3714         320 QEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQ--------HLVSP--EALDFLDKNILG  388 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~~  388 (467)
                      ......+||+.|+|||++.+.. |+.++|+|..+++.+....+..||......        .++.+  +.......+...
T Consensus       196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~  275 (394)
T 4e7w_A          196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME  275 (394)
T ss_dssp             CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS
T ss_pred             CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence            6666678999999999997754 899999998888766665555555332110        00000  000000000000


Q ss_pred             ----CCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccccc
Q psy3714         389 ----RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       389 ----~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~~  446 (467)
                          ......|..    ..+..++++++|||++||++||++|||++|+|+||||.++.+...
T Consensus       276 ~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  333 (394)
T 4e7w_A          276 HKFPQIRPHPFSK----VFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA  333 (394)
T ss_dssp             SCCCCCCCCCHHH----HSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred             hccccccCCcHHH----hccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccc
Confidence                000111111    112347899999999999999999999999999999998876543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=333.11  Aligned_cols=252  Identities=23%  Similarity=0.394  Sum_probs=197.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----------------------------HHHHHHHHHHH
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----------------------------KKKIKREIKIL  219 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----------------------------~~~~~~Ei~il  219 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.||||+++...                             .+.+.+|++++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            3578999999999999999999999999999999986432                             13578899999


Q ss_pred             HHhcCCCCeeEEEEEEeCCCCCccEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceE
Q psy3714         220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVM  297 (467)
Q Consensus       220 ~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nil  297 (467)
                      +.++ ||||+++++++.++.....++||||++++++.++..  .+++.++..++.||+.||+|||++||+||||||+|||
T Consensus        91 ~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           91 KKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             HTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            9995 899999999998766677899999999998866543  5889999999999999999999999999999999999


Q ss_pred             EeCCCCcEEEEecccceecCCCCC-cceeeeccCccCCcccccCC---CCccchhHHHhhhccccccccccccccCCccc
Q psy3714         298 IDHENRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLADYQ---YHIELDPRFADILGRHSRKRWERFVHTENQHL  373 (467)
Q Consensus       298 l~~~~~~ikl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~---~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (467)
                      ++.++ .+||+|||+|+....... ....+||+.|+|||++.+..   ++.++|+|..+++.+....+..||....    
T Consensus       170 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----  244 (298)
T 2zv2_A          170 VGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER----  244 (298)
T ss_dssp             ECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred             ECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc----
Confidence            98655 799999999987654322 34467999999999998765   3677899988887665555555543211    


Q ss_pred             CChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         374 VSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                          ...... .+...        ....+....+++++++||.+||+.||++|||++|+|+||||.
T Consensus       245 ----~~~~~~-~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          245 ----IMCLHS-KIKSQ--------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             ----HHHHHH-HHHHC--------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             ----HHHHHH-HHhcc--------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence                111111 11000        001112345899999999999999999999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.8e-42  Score=337.58  Aligned_cols=266  Identities=26%  Similarity=0.502  Sum_probs=194.2

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||||+++...     ...+.+|+.+++.++ ||||+++++++.+.  ...
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~  108 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHN--HRL  108 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCC-CTTBCCEEEEEEET--TEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcC-CCCcceEEEEEecC--CEE
Confidence            4588999999999999999999999999999999986432     234678999999995 89999999998764  568


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC----CCcEEEEecccceec
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE----NRKLRLIDWGLAEFY  316 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~----~~~ikl~DFGla~~~  316 (467)
                      ++||||+.+ ++.++..   .+++..++.++.||+.||+|||++||+||||||+|||++.+    ...+||+|||+|+..
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            999999985 7776654   48899999999999999999999999999999999999633    235999999999866


Q ss_pred             CCC-CCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         317 HPG-QEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       317 ~~~-~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ... ......+||+.|+|||++.+.. |+.++|+|..+++.+....+..+|......    ........  ..+......
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~~~--~~~~~~~~~  261 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI----DQLFKIFE--VLGLPDDTT  261 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH--HHCCCCTTT
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH----HHHHHHHH--HhCCCchhh
Confidence            422 2344567899999999998754 899999998888766555554444322110    00000000  000000011


Q ss_pred             cccccc-----------------ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         395 WERFVH-----------------TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       395 ~~~~~~-----------------~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                      |.....                 ......++++++|||.+||++||++|||++|+|+||||...+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence            110000                 00012278999999999999999999999999999999988765

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.1e-42  Score=349.62  Aligned_cols=270  Identities=26%  Similarity=0.426  Sum_probs=200.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC----CCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDP----VSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~----~~~~~~l  245 (467)
                      ..+|++.+.||+|+||.||+|.+..+++.||||.+... .....+|+++|+.++ |+||+++++++...    ...+.++
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHHTCC-CTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-chhHHHHHHHHHHcC-CCCccceeeEEeccCCCCcceeEEe
Confidence            45799999999999999999999999999999988653 233457999999996 89999998887432    2234678


Q ss_pred             EEeccCCccHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         246 IFEHVNNTDFKQLY------QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       246 v~e~~~~~~l~~~~------~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ||||++++.+....      ..+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+|+....+
T Consensus       131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~  210 (420)
T 1j1b_A          131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  210 (420)
T ss_dssp             EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence            99999874332211      348889999999999999999999999999999999999976667999999999987655


Q ss_pred             CCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcc--------cCChh--hhhhhhhhc--
Q psy3714         320 QEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQH--------LVSPE--ALDFLDKNI--  386 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~--  386 (467)
                      ......+||+.|+|||++.+. .|+.++|+|..+++.+....+..+|.......        ++.+.  .........  
T Consensus       211 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~  290 (420)
T 1j1b_A          211 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE  290 (420)
T ss_dssp             CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC
T ss_pred             CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence            555667899999999999775 68999999988887666666555543321100        00000  000000000  


Q ss_pred             --cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccccc
Q psy3714         387 --LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ  445 (467)
Q Consensus       387 --~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~  445 (467)
                        ........|...    ....++++++|||++||++||++|||++|+|+||||..+.+..
T Consensus       291 ~~~p~~~~~~~~~~----~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          291 FKFPQIKAHPWTKV----FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  347 (420)
T ss_dssp             CCCCCCCCCCHHHH----SCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             hccCccCCCCHHHh----cCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence              000011112111    1234789999999999999999999999999999998776543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-42  Score=346.09  Aligned_cols=267  Identities=24%  Similarity=0.444  Sum_probs=200.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC-----------
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDP-----------  238 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~-----------  238 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+|+.++ |+||+++.+++...           
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-PRYKNRELDIMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHTTCC-CTTBCCEEEEEEEC-----------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHHcC-CCCccchhheeeecCcccccccccc
Confidence            47899999999999999999999999999999988653 233458999999995 89999999987432           


Q ss_pred             -------------------------CCCccEEEEeccCCccHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy3714         239 -------------------------VSRTPALIFEHVNNTDFKQLY-------QTLTDYDIRYYLYELLKALDYCHSMGI  286 (467)
Q Consensus       239 -------------------------~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qll~al~~lH~~~I  286 (467)
                                               ...+.++||||+++ ++.+.+       ..+++..++.++.||+.||.|||++||
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  162 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI  162 (383)
T ss_dssp             --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence                                     22347899999995 554433       248899999999999999999999999


Q ss_pred             cccCCCCCceEEeCCCCcEEEEecccceecCCCCCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccc
Q psy3714         287 MHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERF  365 (467)
Q Consensus       287 iHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~  365 (467)
                      +||||||+|||++..++.+||+|||+|+...........+||+.|+|||++.+.. |+.++|+|..+++.+....+..+|
T Consensus       163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  242 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF  242 (383)
T ss_dssp             ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence            9999999999998655689999999999876666666678999999999988765 899999998888766655555554


Q ss_pred             cccCCcc--------cCChhhhhhh--hhhc----cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHH
Q psy3714         366 VHTENQH--------LVSPEALDFL--DKNI----LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTARE  431 (467)
Q Consensus       366 ~~~~~~~--------~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e  431 (467)
                      .......        ++.+......  ....    ........|...    .+..+|++++|||++||++||++|||++|
T Consensus       243 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~R~t~~e  318 (383)
T 3eb0_A          243 SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI----LPEGTPSLAIDLLEQILRYEPDLRINPYE  318 (383)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHH----SCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhh----CCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            3221100        0000000000  0000    000111122211    22347899999999999999999999999


Q ss_pred             HhCCCCCCCccc
Q psy3714         432 AMDHPYFYPIVK  443 (467)
Q Consensus       432 ~l~Hp~f~~~~~  443 (467)
                      +|+||||..+..
T Consensus       319 ~l~hp~f~~~~~  330 (383)
T 3eb0_A          319 AMAHPFFDHLRN  330 (383)
T ss_dssp             HHTSGGGHHHHH
T ss_pred             HhcCHHHHHHHh
Confidence            999999987654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.3e-42  Score=334.66  Aligned_cols=250  Identities=18%  Similarity=0.289  Sum_probs=191.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC-----
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS-----  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~-----  240 (467)
                      .++|++++.||+|+||.||+|.+..+++.||||+++..    ..+.+.+|+.+|+.++ ||||+++++.+.+...     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccchhhh
Confidence            36899999999999999999999999999999998632    3467889999999995 8999999988754321     


Q ss_pred             --------------------------------------------------CccEEEEeccCCccHHHHhhc------CCH
Q psy3714         241 --------------------------------------------------RTPALIFEHVNNTDFKQLYQT------LTD  264 (467)
Q Consensus       241 --------------------------------------------------~~~~lv~e~~~~~~l~~~~~~------~~~  264 (467)
                                                                        ...++||||+++++|.++...      .++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                              237899999999999887643      445


Q ss_pred             HHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-------------CcceeeeccCc
Q psy3714         265 YDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-------------EYNVRVASRYF  331 (467)
Q Consensus       265 ~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-------------~~~~~~gt~~y  331 (467)
                      ..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......             .....+||+.|
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            56889999999999999999999999999999998655 79999999998765432             12335799999


Q ss_pred             cCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHH
Q psy3714         332 KGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEA  411 (467)
Q Consensus       332 ~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  411 (467)
                      +|||++.+..|+.++|+|..+++.+....+..++.          ........ ....    .+.     ..+...++++
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~----------~~~~~~~~-~~~~----~~~-----~~~~~~~~~~  302 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM----------ERVRIITD-VRNL----KFP-----LLFTQKYPQE  302 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH----------HHHHHHHH-HHTT----CCC-----HHHHHHCHHH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh----------HHHHHHHH-hhcc----CCC-----cccccCChhH
Confidence            99999999999999999988887554433222110          00111100 0000    000     0011247889


Q ss_pred             HHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         412 LDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       412 ~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      ++||.+||+.||++|||++|+|+||||..+
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             HHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            999999999999999999999999999863

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=8.3e-42  Score=327.81  Aligned_cols=259  Identities=27%  Similarity=0.531  Sum_probs=191.8

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++|++++.||+|+||.||+|.+ .+++.+|+|.++...     ...+.+|+.+++.++ ||||+++++++.+.  ...++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~l   77 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHTK--KRLVL   77 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECS--SCEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcC-CCCEeeeeeEEccC--CeEEE
Confidence            6899999999999999999998 678899999986432     356789999999996 89999999998764  56899


Q ss_pred             EEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-CC
Q psy3714         246 IFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQ  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~~  320 (467)
                      ||||+.+ ++.+...    .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.... ..
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC---
T ss_pred             EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEeECccccccCcccc
Confidence            9999986 6666543    478999999999999999999999999999999999998655 799999999986542 22


Q ss_pred             CcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc--
Q psy3714         321 EYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER--  397 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  397 (467)
                      .....+||+.|+|||++.+. .|+.++|+|..+++.+....+..+|......     +...... ...+......|..  
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~-~~~~~~~~~~~~~~~  229 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-----DQLMRIF-RILGTPNSKNWPNVT  229 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHH-HHHCCCCTTTSTTGG
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH-HHHCCCChhhchhhh
Confidence            33456789999999999765 4899999998888766555555554322110     0000000 0000000001100  


Q ss_pred             --------------cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         398 --------------FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       398 --------------~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                                    .........+++++++||++||+.||++|||++|+|+||||.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                          00011123579999999999999999999999999999999764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.3e-42  Score=337.81  Aligned_cols=257  Identities=26%  Similarity=0.396  Sum_probs=190.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      .+.|++.+.||+|+||.||+|.+..+++.||||+++.. ..+.+.+|+.+++.++ ||||+++.+++.+.  ...++|||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  128 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLS-HPNIIKLKEIFETP--TEISLVLE  128 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCC-CTTBCCEEEEEECS--SEEEEEEC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCC-CCCCcceeeeEecC--CeEEEEEE
Confidence            46799999999999999999999999999999998764 3456788999999996 89999999999764  46899999


Q ss_pred             ccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC--CCCcEEEEecccceecCCCCCcc
Q psy3714         249 HVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYN  323 (467)
Q Consensus       249 ~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~--~~~~ikl~DFGla~~~~~~~~~~  323 (467)
                      |+++++|.+.+.   .+++.++..++.|++.||.|||++||+||||||+|||++.  .++.+||+|||+|+.........
T Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  208 (349)
T 2w4o_A          129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK  208 (349)
T ss_dssp             CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence            999999987764   3789999999999999999999999999999999999974  24579999999998765544445


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      ..+||+.|+|||++.+..|+.++|+|..+++.+....+..||......     .   .....+....    .  ....+.
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~---~~~~~i~~~~----~--~~~~~~  274 (349)
T 2w4o_A          209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----Q---FMFRRILNCE----Y--YFISPW  274 (349)
T ss_dssp             ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----H---HHHHHHHTTC----C--CCCTTT
T ss_pred             cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----H---HHHHHHHhCC----C--ccCCch
Confidence            578999999999999988999999998888766655555555432211     0   0001111100    0  001122


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      +..+++++++||++||+.||++|||++|+|+||||.+...
T Consensus       275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             hhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence            3458999999999999999999999999999999987553

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1e-41  Score=333.26  Aligned_cols=260  Identities=22%  Similarity=0.314  Sum_probs=203.4

Q ss_pred             ccceeee-EeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLV-RKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .+.|.+. +.||+|+||.||+|.+..+++.||+|+++..     ....+.+|+.+++.+.+||||+++++++.+.  ...
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~--~~~  104 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT--SEI  104 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC--CeE
Confidence            3668887 8899999999999999999999999998753     2467889999999998899999999998764  468


Q ss_pred             EEEEeccCCccHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC--CCCcEEEEecccceec
Q psy3714         244 ALIFEHVNNTDFKQLY-----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFY  316 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~--~~~~ikl~DFGla~~~  316 (467)
                      ++||||+.+++|.++.     ..+++.++..++.||+.||+|||++||+||||||+|||++.  .++.+||+|||+|+..
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~  184 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI  184 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence            9999999999988775     34889999999999999999999999999999999999985  1357999999999987


Q ss_pred             CCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         317 HPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       317 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      .........+||+.|+|||++.+..|+.++|+|..+++.+....+..||.....     .......... ...       
T Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~-~~~-------  251 (327)
T 3lm5_A          185 GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-----QETYLNISQV-NVD-------  251 (327)
T ss_dssp             ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHT-CCC-------
T ss_pred             CCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHHHhc-ccc-------
Confidence            655555567899999999999998999999999888876655555555432211     0111101000 000       


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccccc
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~~  446 (467)
                        .....+..+++++++||.+||+.||++|||++|+|+||||...+++..
T Consensus       252 --~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          252 --YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL  299 (327)
T ss_dssp             --CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred             --cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence              011223457999999999999999999999999999999998877644

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=338.16  Aligned_cols=262  Identities=26%  Similarity=0.550  Sum_probs=192.1

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHH----HHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKK----KIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ++|++++.||+|+||.||+|.+..+++.||+|+++.....    .+.+|+.+++.++ ||||+++++++.+.  ...++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTE--KSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCC-CTTBCCEEEEEECS--SCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcC-CCCCCeeeeEEeeC--CEEEEE
Confidence            6899999999999999999999999999999998654322    3457999999996 89999999998764  568999


Q ss_pred             EeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-CCC
Q psy3714         247 FEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~~~  321 (467)
                      |||+++ ++.+.+.    .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.... ...
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC-CEEECSSSEEECC------
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC-CEEEccCcccccccCCccc
Confidence            999985 6666543    378899999999999999999999999999999999998655 799999999986542 223


Q ss_pred             cceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc-
Q psy3714         322 YNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV-  399 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  399 (467)
                      ....+||+.|+|||++.+ ..|+.++|+|..+++.+....+..||......     +....+. ...+......|.... 
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~i~-~~~~~~~~~~~~~~~~  230 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-----EQLHFIF-RILGTPTEETWPGILS  230 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHH-HHHCCCCTTTSTTGGG
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH-HHhCCCChHhchhhhc
Confidence            345678999999999987 45899999998888766555555554322110     0000000 000111111111100 


Q ss_pred             ----------------cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         400 ----------------HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       400 ----------------~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                                      .....+.++++++|||++||++||++|||++|+|+||||..+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence                            01123457999999999999999999999999999999987654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=8.8e-42  Score=339.67  Aligned_cols=273  Identities=25%  Similarity=0.369  Sum_probs=190.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC---
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS---  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~---  240 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||||+++..     ..+.+.+|+.+++.++ ||||+++.+++.....   
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCSTTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcC-CCCccceEEeecccccccc
Confidence            357899999999999999999999999999999998642     2356789999999995 8999999999865431   


Q ss_pred             -CccEEEEeccCCccHHHH-hhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         241 -RTPALIFEHVNNTDFKQL-YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       241 -~~~~lv~e~~~~~~l~~~-~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                       ...++||||+.++ +.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus       102 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          102 FQDVYIVMELMDAN-LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGT  179 (371)
T ss_dssp             CCEEEEEEECCSEE-HHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCC------
T ss_pred             ccceEEEEEcCCCC-HHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEEEeeccccccc
Confidence             3579999999864 5444 45689999999999999999999999999999999999998655 799999999987654


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCc--------ccC--Chhhhhhhhhh---
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQ--------HLV--SPEALDFLDKN---  385 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~~---  385 (467)
                      .......+||+.|+|||++.+..|+.++|+|..+++.+....+..||......        .+.  .++........   
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  259 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  259 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred             ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence            44445578999999999999999999999998888766655555554322110        000  00000000000   


Q ss_pred             ---ccCCCCcccccccccccCC-------CCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         386 ---ILGRHSRKRWERFVHTENQ-------HLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       386 ---~~~~~~~~~~~~~~~~~~~-------~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                         .........+.........       ...+++++|||++||++||++|||++|+|+||||.....+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~  328 (371)
T 2xrw_A          260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP  328 (371)
T ss_dssp             HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCH
T ss_pred             HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCc
Confidence               0000000111111000000       0126789999999999999999999999999999865543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-41  Score=345.56  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=204.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++...      ...+.+|+.+++.++ ||||+++++++.+.  ...
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~--~~~   91 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTP--SDI   91 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECS--SEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC--CEE
Confidence            478999999999999999999999999999999986432      346889999999986 89999999998864  468


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++||||+++++|.+++.   .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....+.
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~-~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-CEEECCCSSCEECCTTC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-CeEEEeccchhhccccc
Confidence            99999999999988764   489999999999999999999999999999999999998654 79999999999876665


Q ss_pred             CcceeeeccCccCCcccccCCC-CccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQY-HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~-~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      .....+||+.|+|||++.+..| +.++|+|..+++.+....+..||.....     ......+...   .          
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~~~~~i~~~---~----------  232 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----PTLFKKICDG---I----------  232 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----HHHHHHHHTT---C----------
T ss_pred             cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcC---C----------
Confidence            5666789999999999998876 6789999988876665555555432211     1111111110   0          


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                       ...+..+|+++++||++||+.||++|||++|+++||||..
T Consensus       233 -~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          233 -FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             -cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence             1123457999999999999999999999999999999975

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=330.87  Aligned_cols=246  Identities=23%  Similarity=0.237  Sum_probs=189.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .++|++++.||+|+||+||+|.+..+++.||||++...     ......+|+..+..+..|+||+++.+++.+.  ...+
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~~~  133 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GILY  133 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CEEE
Confidence            37899999999999999999999999999999987542     2234556777777776799999999998753  5689


Q ss_pred             EEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      +||||+. +++.+...    .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       134 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          134 LQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EEEECCC-CBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG-CEEECCCTTCEECC---
T ss_pred             EEEeccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEccceeeeecccCC
Confidence            9999994 56655543    489999999999999999999999999999999999998655 79999999998876555


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      ......||+.|+|||++.+ .|+.++|+|..+++......+..++..        ..........    ..        .
T Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~--------~~~~~~~~~~----~~--------~  270 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG--------GEGWQQLRQG----YL--------P  270 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS--------HHHHHHHTTT----CC--------C
T ss_pred             CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC--------ccHHHHHhcc----CC--------C
Confidence            5555679999999999876 789999999888875544333333221        1111111100    00        1


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      ...+..+++++++||.+||+.||++|||++|+|+||||..
T Consensus       271 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          271 PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            1112357999999999999999999999999999999964

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.6e-42  Score=332.25  Aligned_cols=266  Identities=23%  Similarity=0.357  Sum_probs=196.1

Q ss_pred             ccceeee-EeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLV-RKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .+.|++. +.||+|+||.||+|.+..+++.||||+++..   ....+.+|++++.++.+||||+++++++.+.  ...++
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~~~l   88 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DRFYL   88 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEEEE
Confidence            4789986 7899999999999999999999999998653   3567889999999977799999999998764  56899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC--cEEEEecccceecCCCC
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~--~ikl~DFGla~~~~~~~  320 (467)
                      ||||+++++|.+++.   .+++.+++.++.||+.||+|||++||+||||||+|||++.++.  .+||+|||+++......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            999999999987763   4899999999999999999999999999999999999986542  39999999997653211


Q ss_pred             --------CcceeeeccCccCCccccc-----CCCCccchhHHHhhhccccccccccccccCCcccCC------hhhhhh
Q psy3714         321 --------EYNVRVASRYFKGPELLAD-----YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVS------PEALDF  381 (467)
Q Consensus       321 --------~~~~~~gt~~y~aPE~l~~-----~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  381 (467)
                              .....+||+.|+|||++.+     ..|+.++|+|..+++.+....+..||..........      +.....
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  248 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM  248 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence                    1223569999999999975     457889999988887666656655554322111000      000000


Q ss_pred             hhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         382 LDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      ....+....  ..+    ....+..+|+++++||++||+.||++|||++|+|+||||.+..+
T Consensus       249 ~~~~i~~~~--~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          249 LFESIQEGK--YEF----PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             HHHHHHHCC--CCC----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             HHHHHhccC--ccc----CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence            000110000  000    01112357999999999999999999999999999999987654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.1e-42  Score=345.28  Aligned_cols=256  Identities=24%  Similarity=0.385  Sum_probs=194.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----------KKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....           ...+.+|+.+|+.++ ||||+++++++.. 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~-  211 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFDA-  211 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEEES-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEEec-
Confidence            478999999999999999999999999999999986432           124789999999995 8999999998864 


Q ss_pred             CCCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC--CcEEEEecccc
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLA  313 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~--~~ikl~DFGla  313 (467)
                        ...++||||+++++|.+.+.   .+++.+++.++.|++.||+|||++||+||||||+|||++..+  ..+||+|||+|
T Consensus       212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence              34689999999999877653   588999999999999999999999999999999999997543  35999999999


Q ss_pred             eecCCCCCcceeeeccCccCCccccc---CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCC
Q psy3714         314 EFYHPGQEYNVRVASRYFKGPELLAD---YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRH  390 (467)
Q Consensus       314 ~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (467)
                      +...........+||+.|+|||++.+   ..|+.++|+|..+++.+....+..||.......    .........   ..
T Consensus       290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~~~i~~~---~~  362 (419)
T 3i6u_A          290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKDQITSG---KY  362 (419)
T ss_dssp             TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC----CHHHHHHTT---CC
T ss_pred             eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH----HHHHHHhcC---CC
Confidence            98765555556789999999999864   457889999998887766666655553322110    011111110   00


Q ss_pred             CcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         391 SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       391 ~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      .       .....+..+|+++++||++||+.||++|||++|+|+||||.+..+
T Consensus       363 ~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  408 (419)
T 3i6u_A          363 N-------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  408 (419)
T ss_dssp             C-------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHH
T ss_pred             C-------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhH
Confidence            0       001122357999999999999999999999999999999987554

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.2e-41  Score=331.46  Aligned_cols=266  Identities=27%  Similarity=0.425  Sum_probs=195.2

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC----
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPV----  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~----  239 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++....     ...+.+|+.+++.++ |+||+++.+++....    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC-----
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCcccHhheeeccccccc
Confidence            4589999999999999999999999999999999885432     346789999999996 899999999886542    


Q ss_pred             --CCccEEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccce
Q psy3714         240 --SRTPALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE  314 (467)
Q Consensus       240 --~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~  314 (467)
                        ....++||||+.++.+..+.   ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus        94 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~  172 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLAR  172 (351)
T ss_dssp             ---CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             cCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-CEEEccchhcc
Confidence              34579999999874333332   3589999999999999999999999999999999999998655 79999999998


Q ss_pred             ecCC-----CCCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccC
Q psy3714         315 FYHP-----GQEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILG  388 (467)
Q Consensus       315 ~~~~-----~~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (467)
                      .+..     .......+||+.|+|||++.+. .|+.++|+|..+++.+....+..+|......     .....+. ...+
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~-~~~~  246 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQLALIS-QLCG  246 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHH-HHHC
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHH-HHhC
Confidence            7642     1223446789999999999764 4899999998888766555544444321110     0000000 0001


Q ss_pred             CCCcccccccccccC-------------------CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         389 RHSRKRWERFVHTEN-------------------QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       389 ~~~~~~~~~~~~~~~-------------------~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ......|........                   ....+++++|||.+||++||++|||++|+|+||||....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            111111111000000                   001378899999999999999999999999999997643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2e-41  Score=349.02  Aligned_cols=254  Identities=22%  Similarity=0.435  Sum_probs=202.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .++|++++.||+|+||.||+|.+..+++.||||+++..     ....+.+|+.+|+.++ ||||+++++++.+.  ...+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~   97 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDS--SSFY   97 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS--SEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcC--CEEE
Confidence            47899999999999999999999999999999998542     3457889999999995 89999999998864  5689


Q ss_pred             EEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC--CCcEEEEecccceecCCC
Q psy3714         245 LIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       245 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~--~~~ikl~DFGla~~~~~~  319 (467)
                      +||||+.+++|.+.+   ..+++.+++.++.||+.||.|||++||+||||||+|||++..  +..+||+|||+|+.....
T Consensus        98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            999999999987654   358999999999999999999999999999999999999643  347999999999877665


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      ......+||+.|+|||++.+ .|+.++|+|..+++.+....+..||.....        .........+...       .
T Consensus       178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~-------~  241 (486)
T 3mwu_A          178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVETGKYA-------F  241 (486)
T ss_dssp             ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCC-------S
T ss_pred             CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCC-------C
Confidence            55566789999999999876 589999999998886666666555533211        1111111111100       0


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ..+.+..+|+++++||++||+.||++|||++|+|+||||....
T Consensus       242 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            1122345799999999999999999999999999999997543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.9e-41  Score=328.30  Aligned_cols=256  Identities=26%  Similarity=0.402  Sum_probs=206.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---------KKKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++..         ..+.+.+|+.+++.+. ||||+++++++.+.  
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--   87 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYENR--   87 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS--
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEecC--
Confidence            47899999999999999999999999999999998643         2456889999999996 89999999998764  


Q ss_pred             CccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC---cEEEEecccce
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR---KLRLIDWGLAE  314 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~---~ikl~DFGla~  314 (467)
                      ...++||||+++++|.+++.   .+++..+..++.|++.||.|||++||+||||||+|||++.++.   .+||+|||+++
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            56899999999999988764   4788999999999999999999999999999999999986552   69999999999


Q ss_pred             ecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         315 FYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       315 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ............||+.|+|||++.+..++.++|+|..+++.+....+..||.....        ...... +....  ..
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~-i~~~~--~~  236 (321)
T 2a2a_A          168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLAN-ITSVS--YD  236 (321)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHH-HHTTC--CC
T ss_pred             ecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--------HHHHHH-HHhcc--cc
Confidence            87665555667899999999999988899999999888876655555555532211        111111 10000  00


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      +    ....+..+|+++++||++||..||++|||++|+++||||.+..+
T Consensus       237 ~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          237 F----DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             C----CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             c----ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            0    01112357899999999999999999999999999999998764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=332.73  Aligned_cols=242  Identities=24%  Similarity=0.354  Sum_probs=199.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----------KKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      .++|++++.||+|+||.||+|.+..+++.||||+++...           ...+.+|+.+++.++ ||||+++++++.+.
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEeeC
Confidence            478999999999999999999999999999999987532           235678999999995 89999999998764


Q ss_pred             CCCccEEEEeccCCc-cHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccce
Q psy3714         239 VSRTPALIFEHVNNT-DFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE  314 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~-~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~  314 (467)
                        ...++||||+.++ ++.++..   .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus       102 --~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~  178 (335)
T 3dls_A          102 --GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-TIKLIDFGSAA  178 (335)
T ss_dssp             --SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             --CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-cEEEeecccce
Confidence              5689999998766 8877764   488999999999999999999999999999999999998654 79999999999


Q ss_pred             ecCCCCCcceeeeccCccCCcccccCCC-CccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         315 FYHPGQEYNVRVASRYFKGPELLADYQY-HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       315 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ...........+||+.|+|||++.+..+ +.++|+|..+++.+....+..||....          .     ....    
T Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----------~-----~~~~----  239 (335)
T 3dls_A          179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE----------E-----TVEA----  239 (335)
T ss_dssp             ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG----------G-----GTTT----
T ss_pred             ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH----------H-----HHhh----
Confidence            8776666666789999999999998886 778999988887655544444442110          0     0000    


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                            ....+..+|+++++||.+||+.||++|||++|+++||||..
T Consensus       240 ------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          240 ------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             ------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             ------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence                  00112347999999999999999999999999999999975

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=338.84  Aligned_cols=252  Identities=25%  Similarity=0.424  Sum_probs=197.0

Q ss_pred             eeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEecc
Q psy3714         174 QLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHV  250 (467)
Q Consensus       174 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~  250 (467)
                      ...+.||+|+||.||+|.+..+++.||+|+++..   ..+.+.+|+.+|+.++ ||||+++++++.+.  ...++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD-HANLIQLYDAFESK--NDIVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECS--SEEEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCC-CCCCCeEEEEEEEC--CEEEEEEeCC
Confidence            3367899999999999999999999999998763   3457889999999995 89999999998764  4689999999


Q ss_pred             CCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC-CCCcEEEEecccceecCCCCCccee
Q psy3714         251 NNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH-ENRKLRLIDWGLAEFYHPGQEYNVR  325 (467)
Q Consensus       251 ~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~-~~~~ikl~DFGla~~~~~~~~~~~~  325 (467)
                      ++++|.+.+.    .+++.++..++.||+.||+|||++||+||||||+|||++. .++.+||+|||+|+...........
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~  248 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN  248 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence            9999876542    4889999999999999999999999999999999999852 3458999999999987766666667


Q ss_pred             eeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCC
Q psy3714         326 VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQH  405 (467)
Q Consensus       326 ~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (467)
                      +||+.|+|||++.+..++.++|+|..+++.+....+..||.....        ...... +..    ..|.  .....+.
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~-i~~----~~~~--~~~~~~~  313 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--------AETLNN-ILA----CRWD--LEDEEFQ  313 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHH-HHH----TCCC--SCSGGGT
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH-HHh----ccCC--CChhhhc
Confidence            899999999999888899999999888876665555555533211        111111 110    0110  0111234


Q ss_pred             CCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         406 LVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       406 ~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      .+++++++||.+||+.||++|||++|+|+||||.+...
T Consensus       314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~  351 (373)
T 2x4f_A          314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL  351 (373)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence            58999999999999999999999999999999987653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.7e-42  Score=352.07  Aligned_cols=255  Identities=24%  Similarity=0.440  Sum_probs=205.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...      ....+.+|+.+++.++ ||||+++++++.+.  ...
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~  101 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDK--GYF  101 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECS--SEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC--CEE
Confidence            47899999999999999999999999999999998532      3467889999999995 89999999999863  568


Q ss_pred             EEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC--CCCcEEEEecccceecCC
Q psy3714         244 ALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~--~~~~ikl~DFGla~~~~~  318 (467)
                      ++||||+.++++.+.+   ..+++.++..++.||+.||.|||++||+||||||+|||++.  .++.+||+|||+|+.+..
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            9999999999997765   35889999999999999999999999999999999999953  345799999999998766


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      .......+||+.|+|||++.+ .|+.++|+|..+++.+....+..||.....     ......+..   +...       
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~---~~~~-------  245 (484)
T 3nyv_A          182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-----YDILKKVEK---GKYT-------  245 (484)
T ss_dssp             CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH---CCCC-------
T ss_pred             ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHc---CCCC-------
Confidence            666666789999999999876 689999999998886666555555532211     011111111   1100       


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      ...+.+..+|+++++||++||++||++|||++|+|+||||....+
T Consensus       246 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          246 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            011223458999999999999999999999999999999986544

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4e-41  Score=348.36  Aligned_cols=254  Identities=24%  Similarity=0.444  Sum_probs=202.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----------------HHHHHHHHHHHHHhcCCCCeeEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----------------KKKIKREIKILENLRGGTNIITLQA  233 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----------------~~~~~~Ei~il~~l~~~~~iv~l~~  233 (467)
                      .++|++++.||+|+||.||+|.+..+++.+|+|+++...                .+.+.+|+.+|+.++ ||||+++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~  113 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKLFD  113 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTBCCEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCCCeEEE
Confidence            478999999999999999999999999999999986421                346789999999995 899999999


Q ss_pred             EEeCCCCCccEEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC--cEEEE
Q psy3714         234 VVKDPVSRTPALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLI  308 (467)
Q Consensus       234 ~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~--~ikl~  308 (467)
                      ++.+.  ...++||||+++++|.+.+   ..+++..+..++.||+.||.|||++||+||||||+|||++..+.  .+||+
T Consensus       114 ~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          114 VFEDK--KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EEECS--SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             EEEcC--CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence            99864  5689999999999987665   35899999999999999999999999999999999999986542  69999


Q ss_pred             ecccceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccC
Q psy3714         309 DWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILG  388 (467)
Q Consensus       309 DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (467)
                      |||+|+...........+||+.|+|||++.+ .|+.++|+|..+++.+....+..||.....     ......+..   +
T Consensus       192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~---~  262 (504)
T 3q5i_A          192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND-----QDIIKKVEK---G  262 (504)
T ss_dssp             CCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH---C
T ss_pred             ECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHc---C
Confidence            9999998766655666789999999999874 689999999998887666566555533211     111111111   1


Q ss_pred             CCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         389 RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       389 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ...       ...+.+..+|+++++||++||++||++|||++|+|+||||....
T Consensus       263 ~~~-------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          263 KYY-------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             CCC-------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             CCC-------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            100       01122345899999999999999999999999999999997543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=341.61  Aligned_cols=270  Identities=25%  Similarity=0.432  Sum_probs=185.2

Q ss_pred             cceeee-EeecccCCcceEEEEEc--cCCCeEEEEEeccch-HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         171 DDYQLV-RKLGRGKYSEVFEAINV--QSSDKCVVKILKPVK-KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       171 ~~y~~~-~~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~~-~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      +.|++. ++||+|+||.||+|.+.  .+++.||+|+++... ...+.+|+.+|+.++ ||||+++++++........++|
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCC-CTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcC-CCCeeeEeeEEecCCCCeEEEE
Confidence            567764 47999999999999965  568899999987543 457889999999996 8999999999866556778999


Q ss_pred             EeccCCccHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEe---CCCCcEEEEecc
Q psy3714         247 FEHVNNTDFKQLYQ------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID---HENRKLRLIDWG  311 (467)
Q Consensus       247 ~e~~~~~~l~~~~~------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~---~~~~~ikl~DFG  311 (467)
                      |||+.+ ++.+.+.            .+++..++.++.||+.||.|||++||+||||||+|||+.   ..++.+||+|||
T Consensus        99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  177 (405)
T 3rgf_A           99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  177 (405)
T ss_dssp             EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred             EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence            999986 5544432            388999999999999999999999999999999999993   234589999999


Q ss_pred             cceecCCC----CCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCccc----CChhhhhhh
Q psy3714         312 LAEFYHPG----QEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHL----VSPEALDFL  382 (467)
Q Consensus       312 la~~~~~~----~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  382 (467)
                      +|+.....    ......+||+.|+|||++.+.. |+.++|+|..+++.+....+..+|........    ...+....+
T Consensus       178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i  257 (405)
T 3rgf_A          178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  257 (405)
T ss_dssp             CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred             CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence            99876432    2234468999999999998754 89999999888876665555555532221100    000000000


Q ss_pred             hhhccCCCCccccccccc-------------------------ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q psy3714         383 DKNILGRHSRKRWERFVH-------------------------TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY  437 (467)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~  437 (467)
                      - ..++......|..+..                         .......+++++|||++||++||++||||+|+|+|||
T Consensus       258 ~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~  336 (405)
T 3rgf_A          258 F-NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  336 (405)
T ss_dssp             H-HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             H-HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence            0 0011111111111100                         0111234889999999999999999999999999999


Q ss_pred             CCCccc
Q psy3714         438 FYPIVK  443 (467)
Q Consensus       438 f~~~~~  443 (467)
                      |.+...
T Consensus       337 f~~~~~  342 (405)
T 3rgf_A          337 FLEDPL  342 (405)
T ss_dssp             GTSSSC
T ss_pred             hccCCC
Confidence            986543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.3e-41  Score=341.73  Aligned_cols=264  Identities=22%  Similarity=0.425  Sum_probs=195.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhc-----CCCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLR-----GGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~-----~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..+|++++.||+|+||.||+|.+..+++.||||+++...  ...+.+|+.+++.+.     +|+||+.+.+.+...  ..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR--NH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET--TE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC--Ce
Confidence            467999999999999999999999999999999997653  356788999999886     367999999988753  56


Q ss_pred             cEEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC-cEEEEecccceec
Q psy3714         243 PALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFY  316 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~-~ikl~DFGla~~~  316 (467)
                      .++||||+.+ ++.+++.     .+++..++.++.||+.||+|||++|||||||||+|||++.++. .+||+|||+|+..
T Consensus       174 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~  252 (429)
T 3kvw_A          174 ICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE  252 (429)
T ss_dssp             EEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence            8999999975 6665543     3889999999999999999999999999999999999986652 3999999999875


Q ss_pred             CCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcc----------cCChhhhh------
Q psy3714         317 HPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQH----------LVSPEALD------  380 (467)
Q Consensus       317 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~------  380 (467)
                      ..  .....+||+.|+|||++.+..|+.++|+|..+++.+....+..+|.......          ........      
T Consensus       253 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~  330 (429)
T 3kvw_A          253 HQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAK  330 (429)
T ss_dssp             TC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHH
T ss_pred             CC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhh
Confidence            42  3345689999999999999999999999988887666555544442221100          00000000      


Q ss_pred             -hhhhhccCCC---------------------------CcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHH
Q psy3714         381 -FLDKNILGRH---------------------------SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREA  432 (467)
Q Consensus       381 -~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~  432 (467)
                       +.+..-...+                           ....|..    ......+++++|||++||++||++||||+|+
T Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~  406 (429)
T 3kvw_A          331 NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGN----ALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA  406 (429)
T ss_dssp             HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHH----HTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hccCCCCCcccccccccccccccccccccchhhccCCccchhhHh----hccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence             0000000000                           0000000    0012347899999999999999999999999


Q ss_pred             hCCCCCCCcc
Q psy3714         433 MDHPYFYPIV  442 (467)
Q Consensus       433 l~Hp~f~~~~  442 (467)
                      |+||||....
T Consensus       407 L~Hpw~~~~~  416 (429)
T 3kvw_A          407 LRHPWLRRRL  416 (429)
T ss_dssp             HTSTTTC---
T ss_pred             hCChhhccCC
Confidence            9999998653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.3e-41  Score=324.19  Aligned_cols=269  Identities=26%  Similarity=0.422  Sum_probs=194.7

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....     .+.+.+|+.+++.++ ||||+++.+++.+.  ...++
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~l   79 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRK--RRLHL   79 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET--TEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCCccchhheeecC--CeEEE
Confidence            68999999999999999999999999999999875432     345778999999996 89999999998763  56899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CC
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~  321 (467)
                      ||||++++++..+..   .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+..... ..
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC-----
T ss_pred             EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC-CEEEeeCCCchhccCcccc
Confidence            999999998877654   488999999999999999999999999999999999998655 7999999999876532 23


Q ss_pred             cceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCccc----------CChhhhh-hhhhhccCC
Q psy3714         322 YNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQHL----------VSPEALD-FLDKNILGR  389 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~-~~~~~~~~~  389 (467)
                      ....+||+.|+|||++.+ ..|+.++|+|..+++......+..||........          ..+.... +........
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            345689999999999976 5589999999888876655555444432211000          0000000 000000000


Q ss_pred             CCccccccc-ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         390 HSRKRWERF-VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       390 ~~~~~~~~~-~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      ......... ......+.+|+++.+||++||+.||++|||++|+|+||||..+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence            000000000 000112357999999999999999999999999999999998754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.6e-41  Score=320.98  Aligned_cols=256  Identities=22%  Similarity=0.387  Sum_probs=204.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....     .+.+.+|+.+++.++ |+||+++.+++.+.  ...+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~   81 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE--SFHY   81 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS--SEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcC--CEEE
Confidence            478999999999999999999999999999999986432     356789999999996 89999999998764  4679


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC--CcEEEEecccceecCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~--~~ikl~DFGla~~~~~~  319 (467)
                      +||||+.++++.+...   .+++.++..++.|++.||.|||++||+||||||+||+++.++  ..+||+|||++......
T Consensus        82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            9999999999876543   489999999999999999999999999999999999997543  34999999999877655


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      .......||+.|+|||++.+..++.+.|+|..+++......+..||.....     ..........   ...       .
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~---~~~-------~  226 (284)
T 3kk8_A          162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQIKAG---AYD-------Y  226 (284)
T ss_dssp             CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHT---CCC-------C
T ss_pred             ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----hHHHHHHHhc---ccc-------C
Confidence            555567899999999999999999999999888876655555555432211     0111111110   000       0


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      ....+..+++++++||.+||+.||++|||++|+|+||||.....
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          227 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            11123457999999999999999999999999999999976543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.2e-41  Score=332.54  Aligned_cols=265  Identities=22%  Similarity=0.363  Sum_probs=197.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhc----CCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLR----GGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~----~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++++.||+|+||.||+|.+..+++.||||+++...  .....+|+.+++.+.    .|+||+++++.+...  ...
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~--~~~  111 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY--DHM  111 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--TEE
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--Cee
Confidence            478999999999999999999999999999999997532  456778999999997    489999999988764  468


Q ss_pred             EEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC------------------
Q psy3714         244 ALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH------------------  300 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~------------------  300 (467)
                      ++||||+ +++|.+++.     .+++.+++.++.||+.||+|||++||+||||||+|||++.                  
T Consensus       112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~  190 (360)
T 3llt_A          112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK  190 (360)
T ss_dssp             EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence            9999999 888877764     3888999999999999999999999999999999999974                  


Q ss_pred             ------CCCcEEEEecccceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCccc-
Q psy3714         301 ------ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHL-  373 (467)
Q Consensus       301 ------~~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~-  373 (467)
                            .+..+||+|||+|+....  .....+||+.|+|||++.+..|+.++|+|..+++.+....+..||........ 
T Consensus       191 ~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  268 (360)
T 3llt_A          191 IQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL  268 (360)
T ss_dssp             EEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence                  245799999999987543  23446799999999999999999999999888876665555555432211000 


Q ss_pred             ---------CChhhhhhhhhh----cc-CCCCcccccccc------------cccCCCCCChHHHHHHHhhcCcCCCCCC
Q psy3714         374 ---------VSPEALDFLDKN----IL-GRHSRKRWERFV------------HTENQHLVSPEALDFLDKLLRYDHYERL  427 (467)
Q Consensus       374 ---------~~~~~~~~~~~~----~~-~~~~~~~~~~~~------------~~~~~~~~s~~~~dli~~lL~~dp~~R~  427 (467)
                               ............    .. .......|....            ........++++.+||++||++||++||
T Consensus       269 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  348 (360)
T 3llt_A          269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP  348 (360)
T ss_dssp             HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC
Confidence                     000000000000    00 000000010000            0000112357889999999999999999


Q ss_pred             CHHHHhCCCCCC
Q psy3714         428 TAREAMDHPYFY  439 (467)
Q Consensus       428 ta~e~l~Hp~f~  439 (467)
                      ||+|+|+||||+
T Consensus       349 ta~elL~hp~f~  360 (360)
T 3llt_A          349 SPAELLKHKFLE  360 (360)
T ss_dssp             CHHHHTTSGGGC
T ss_pred             CHHHHhcCcccC
Confidence            999999999984

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5e-41  Score=321.90  Aligned_cols=251  Identities=22%  Similarity=0.375  Sum_probs=193.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .++|++.+.||+|+||.||+|.+..++..+|+|++...    ..+.+.+|+++++.++ ||||+++++++.+.  ...++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~~~l   97 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDY--HNMYI   97 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS--SEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCC-CchHHhHHHheecC--CeEEE
Confidence            47899999999999999999999999999999998653    2467889999999996 89999999998764  46899


Q ss_pred             EEeccCCccHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC--CCcEEEEecccceec
Q psy3714         246 IFEHVNNTDFKQLY-------QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFY  316 (467)
Q Consensus       246 v~e~~~~~~l~~~~-------~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~--~~~ikl~DFGla~~~  316 (467)
                      ||||++++++.+.+       ..+++..+..++.|++.||+|||++||+||||||+|||++..  ++.+||+|||+|+..
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999987665       358899999999999999999999999999999999999532  347999999999876


Q ss_pred             CCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         317 HPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       317 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      .........+||+.|+|||++. ..++.++|+|..+++......+..||....        .............   .  
T Consensus       178 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~~~---~--  243 (285)
T 3is5_A          178 KSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS--------LEEVQQKATYKEP---N--  243 (285)
T ss_dssp             ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCC---C--
T ss_pred             CCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC--------HHHHHhhhccCCc---c--
Confidence            6555555678999999999886 468889999988887655555555543211        0111111000000   0  


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                         .......+++++++||++||+.||++|||++|+|+||||..
T Consensus       244 ---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          244 ---YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             ---CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             ---cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence               00111237899999999999999999999999999999974

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.2e-41  Score=332.81  Aligned_cols=268  Identities=26%  Similarity=0.473  Sum_probs=185.9

Q ss_pred             cCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC--
Q psy3714         167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPV--  239 (467)
Q Consensus       167 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~--  239 (467)
                      |...++|++++.||+|+||.||+|.+..+++.||||++...     ..+++.+|+.+|+.++ |+||+.+.+++....  
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~  103 (367)
T 2fst_X           25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL  103 (367)
T ss_dssp             EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSG
T ss_pred             cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCcc
Confidence            34458999999999999999999999999999999998642     2456789999999996 899999999886531  


Q ss_pred             --CCccEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         240 --SRTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       240 --~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                        ....+++++++ +++|.++..  .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus       104 ~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~  181 (367)
T 2fst_X          104 EEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARH  181 (367)
T ss_dssp             GGCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC------
T ss_pred             ccCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-CEEEeecccccc
Confidence              24579999998 567766553  589999999999999999999999999999999999998554 799999999987


Q ss_pred             cCCCCCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcc--------cCCh--hhhhhhhh
Q psy3714         316 YHPGQEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQH--------LVSP--EALDFLDK  384 (467)
Q Consensus       316 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~--~~~~~~~~  384 (467)
                      ...  ..+..+||++|+|||++.+ ..|+.++|+|..+++.+....+..+|.......        ++.+  +.......
T Consensus       182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            542  2445689999999999987 568999999988887665555555543221100        0000  00000000


Q ss_pred             -------hccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         385 -------NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       385 -------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                             ..+.......+..     .....+++++|||++||++||++|||++|+|+||||.....+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFAN-----VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHH-----HTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHHHHhccCCCCCCCHHH-----HCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence                   0000011111111     123478999999999999999999999999999999976544

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.8e-41  Score=346.93  Aligned_cols=254  Identities=24%  Similarity=0.448  Sum_probs=201.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .+.|++++.||+|+||.||+|.+..++..+|+|+++..     ....+.+|+.+++.++ ||||+++++++.+.  ...+
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~  112 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDK--RNYY  112 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCC-CTTBCCEEEEEECS--SEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC--CEEE
Confidence            36799999999999999999999999999999998643     2456889999999995 89999999999864  5689


Q ss_pred             EEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC--CcEEEEecccceecCCC
Q psy3714         245 LIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       245 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~--~~ikl~DFGla~~~~~~  319 (467)
                      +||||+.+++|.+.+   ..+++.++..++.||+.||.|||++||+||||||+|||++..+  ..+||+|||+|+.....
T Consensus       113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            999999999987654   3589999999999999999999999999999999999997532  35999999999987666


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      ......+||+.|+|||++. ..|+.++|+|..+++.+....+..||.....     .+....+..   +...       .
T Consensus       193 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~---~~~~-------~  256 (494)
T 3lij_A          193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----QEILRKVEK---GKYT-------F  256 (494)
T ss_dssp             BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH---TCCC-------C
T ss_pred             ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh---CCCC-------C
Confidence            5566678999999999986 4699999999988876665555555532211     111111111   1100       0


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ..+.+..+|+++++||++||+.||++|||++|+|+||||....
T Consensus       257 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          257 DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence            1122345899999999999999999999999999999997653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-41  Score=332.16  Aligned_cols=264  Identities=21%  Similarity=0.340  Sum_probs=204.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEc---cCCCeEEEEEeccc-------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINV---QSSDKCVVKILKPV-------KKKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~-------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      ..++|++++.||+|+||.||+|.+.   .+++.||||+++..       ....+.+|+++++.+.+|+||+.++..+...
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            3478999999999999999999985   47899999998642       2355778999999998899999999988763


Q ss_pred             CCCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                        ...++||||+++++|.+++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus       132 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~  208 (355)
T 1vzo_A          132 --TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKE  208 (355)
T ss_dssp             --TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEE
T ss_pred             --ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-cEEEeeCCCCee
Confidence              46899999999999987764   589999999999999999999999999999999999998655 799999999986


Q ss_pred             cCCCC--CcceeeeccCccCCccccc--CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         316 YHPGQ--EYNVRVASRYFKGPELLAD--YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       316 ~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      +....  .....+||+.|+|||++.+  ..++.++|+|..+++.+....+..||.......    ....... .+..   
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~~~~-~~~~---  280 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISR-RILK---  280 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHH-HHHH---
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc----hHHHHHH-HHhc---
Confidence            53222  2234579999999999986  347889999988887666555555553221110    0001110 1100   


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccccCCC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSRHTL  450 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~~~~  450 (467)
                             .....+..+++++++||.+||+.||++||     |++|+++||||..++|.......
T Consensus       281 -------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~  337 (355)
T 1vzo_A          281 -------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKK  337 (355)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTC
T ss_pred             -------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhcc
Confidence                   01112345799999999999999999999     99999999999999876555444

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=324.25  Aligned_cols=267  Identities=17%  Similarity=0.255  Sum_probs=202.5

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.||||+++..    ..+.+.+|+++++.++ ||||+++++++........+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCceEE
Confidence            357899999999999999999999999999999998753    2356789999999996 89999999998876666789


Q ss_pred             EEEeccCCccHHHHhhc------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE----eCCCCcEEEEecccce
Q psy3714         245 LIFEHVNNTDFKQLYQT------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI----DHENRKLRLIDWGLAE  314 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill----~~~~~~ikl~DFGla~  314 (467)
                      +||||+++++|.+++..      +++.++..++.||+.||+|||++||+||||||+|||+    + ....+||+|||+|+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED-GQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTT-SCEEEEECCCTTCE
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCC-CCceEEEccCCCce
Confidence            99999999999888753      8999999999999999999999999999999999998    4 33469999999999


Q ss_pred             ecCCCCCcceeeeccCccCCcccc--------cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhc
Q psy3714         315 FYHPGQEYNVRVASRYFKGPELLA--------DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI  386 (467)
Q Consensus       315 ~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (467)
                      ...........+||+.|+|||++.        +..|+.++|+|..+++.+....+..||.....................
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            876666666678999999999986        466889999998888766655555555432211100000111111000


Q ss_pred             cC--------CCCcccccccccc--cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q psy3714         387 LG--------RHSRKRWERFVHT--ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY  437 (467)
Q Consensus       387 ~~--------~~~~~~~~~~~~~--~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~  437 (467)
                      ..        ......|......  .....+++.+.+||++||++||++|||++|+|+||=
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            00        0001112111110  011124568899999999999999999999999984

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-40  Score=326.91  Aligned_cols=265  Identities=25%  Similarity=0.448  Sum_probs=194.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--------KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      .++|++++.||+|+||.||+|.+..+++.||+|+++...        .+.+.+|+.+++.++ ||||+++++++.+.  .
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~   85 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHK--S   85 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCT--T
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeC--C
Confidence            478999999999999999999999999999999986421        235779999999996 89999999998753  5


Q ss_pred             ccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..++||||+.+ ++...+.    .+++.++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG  163 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-CEEEEecccceecc
Confidence            68999999987 6666553    378899999999999999999999999999999999998655 79999999998764


Q ss_pred             C-CCCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         318 P-GQEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       318 ~-~~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      . .......+||+.|+|||++.+. .|+.++|+|..+++.+....+..++. +...    ......+.. ..+......|
T Consensus       164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~-~~~~----~~~~~~i~~-~~~~~~~~~~  237 (346)
T 1ua2_A          164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP-GDSD----LDQLTRIFE-TLGTPTEEQW  237 (346)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSH----HHHHHHHHH-HHCCCCTTTS
T ss_pred             CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCC-CCCH----HHHHHHHHH-HcCCCChhhh
Confidence            3 2334556899999999999765 48889999988877655444433332 2110    000000000 0011111111


Q ss_pred             ccccc---------------ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccccc
Q psy3714         396 ERFVH---------------TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ  445 (467)
Q Consensus       396 ~~~~~---------------~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~  445 (467)
                      .....               ...+..++++++|||++||+.||++|||++|+|+||||....+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence            11000               011245789999999999999999999999999999998765443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.6e-40  Score=329.77  Aligned_cols=252  Identities=25%  Similarity=0.410  Sum_probs=202.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----------KKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      .++|++.+.||+|+||.||+|.+..+|+.||||+++...           .+.+.+|+.+++.+.+||||+.+.+++.. 
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  171 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-  171 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-
Confidence            367999999999999999999999999999999986432           34577899999999779999999998875 


Q ss_pred             CCCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                       ....++||||++++++.++..   .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus       172 -~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-~ikl~DfG~~~~  249 (365)
T 2y7j_A          172 -SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCH  249 (365)
T ss_dssp             -SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             -CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEEecCcccc
Confidence             356899999999999987764   589999999999999999999999999999999999998654 799999999998


Q ss_pred             cCCCCCcceeeeccCccCCccccc------CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCC
Q psy3714         316 YHPGQEYNVRVASRYFKGPELLAD------YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGR  389 (467)
Q Consensus       316 ~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (467)
                      ..........+||+.|+|||++.+      ..|+.++|+|..+++.+....+..||.....     ......+..   +.
T Consensus       250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----~~~~~~i~~---~~  321 (365)
T 2y7j_A          250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-----ILMLRMIME---GQ  321 (365)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH---TC
T ss_pred             cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHh---CC
Confidence            776666666789999999999863      3578899999888876665555555532210     011111111   00


Q ss_pred             CCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                      ..   +    ..+.+..+++++++||++||+.||++|||++|+|+||||.
T Consensus       322 ~~---~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          322 YQ---F----SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             CC---C----CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             CC---C----CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            00   0    0111235789999999999999999999999999999996

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.7e-40  Score=316.24  Aligned_cols=261  Identities=24%  Similarity=0.388  Sum_probs=204.3

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------------HHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------------KKKIKREIKILENLRGGTNIITLQAVVK  236 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------------~~~~~~Ei~il~~l~~~~~iv~l~~~~~  236 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|+++...            .+.+.+|+.+++++.+||||+++.+++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3589999999999999999999999999999999986421            3456789999999987999999999987


Q ss_pred             CCCCCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccc
Q psy3714         237 DPVSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA  313 (467)
Q Consensus       237 ~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla  313 (467)
                      +.  ...++||||+++++|.+++.   .+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus        95 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~  171 (298)
T 1phk_A           95 TN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFS  171 (298)
T ss_dssp             CS--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTC
T ss_pred             cC--CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-cEEEecccch
Confidence            63  56899999999999987764   589999999999999999999999999999999999998655 7999999999


Q ss_pred             eecCCCCCcceeeeccCccCCcccc------cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhcc
Q psy3714         314 EFYHPGQEYNVRVASRYFKGPELLA------DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL  387 (467)
Q Consensus       314 ~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (467)
                      .............||+.|+|||++.      ...++.++|+|..+++......+..|+.....     .........   
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~---  243 (298)
T 1phk_A          172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----MLMLRMIMS---  243 (298)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH---
T ss_pred             hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----HHHHHHHhc---
Confidence            9876665556678999999999985      34578899999888776555555444432110     011111110   


Q ss_pred             CCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccccccc
Q psy3714         388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR  447 (467)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~~~  447 (467)
                      +...   +    ..+.+..+++++++||.+||+.||++|||++|+++||||.....+..+
T Consensus       244 ~~~~---~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  296 (298)
T 1phk_A          244 GNYQ---F----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR  296 (298)
T ss_dssp             TCCC---C----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-----
T ss_pred             CCcc---c----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhhc
Confidence            0000   0    011123478999999999999999999999999999999987765543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.5e-41  Score=334.53  Aligned_cols=261  Identities=15%  Similarity=0.133  Sum_probs=183.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhc-CCCCeeEEE-------EEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLR-GGTNIITLQ-------AVV  235 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~-~~~~iv~l~-------~~~  235 (467)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|+++...      .+.+.+|+.+++.|. .||||+++.       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            356999999999999999999999999999999987632      345678877777665 489988754       333


Q ss_pred             eCCCC---------------CccEEEEeccCCccHHHHhhc----CCHHHH------HHHHHHHHHHHHHHHHCCccccC
Q psy3714         236 KDPVS---------------RTPALIFEHVNNTDFKQLYQT----LTDYDI------RYYLYELLKALDYCHSMGIMHRD  290 (467)
Q Consensus       236 ~~~~~---------------~~~~lv~e~~~~~~l~~~~~~----~~~~~~------~~~~~qll~al~~lH~~~IiHrD  290 (467)
                      ..+..               ...++||||++ ++|.+++..    ++....      ..++.||+.||+|||++||||||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            32211               33799999999 788877642    333333      35669999999999999999999


Q ss_pred             CCCCceEEeCCCCcEEEEecccceecCCCCCcceeeeccCccCCccccc--CCCCccchhHHHhhhcccccccccccccc
Q psy3714         291 VKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD--YQYHIELDPRFADILGRHSRKRWERFVHT  368 (467)
Q Consensus       291 lKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~D~~~~~~~~~~~~~~~~~~~~~  368 (467)
                      |||+|||++.++ .+||+|||+|+....  ......+|+.|+|||++.+  ..|+.++|+|..+++.+....+..||...
T Consensus       220 ikp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          220 FTPDNLFIMPDG-RLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             CSGGGEEECTTS-CEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             CCHHHEEECCCC-CEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            999999999655 799999999997642  2224567799999999987  67999999999888766665655555432


Q ss_pred             CCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         369 ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                      .....      ............    ..-...+.+..+|+++++||.+||+.||++|||++|+|+||||..+.+.
T Consensus       297 ~~~~~------~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  362 (371)
T 3q60_A          297 TPGIK------GSWKRPSLRVPG----TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE  362 (371)
T ss_dssp             CTTCT------TCCCBCCTTSCC----CCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred             Ccccc------cchhhhhhhhcc----ccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence            21100      000000000000    0001112234689999999999999999999999999999999887654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.2e-40  Score=327.56  Aligned_cols=266  Identities=26%  Similarity=0.504  Sum_probs=199.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC---CCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPV---SRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~---~~~  242 (467)
                      .++|++++.||+|+||.||+|.+..+++.||+|++....    .+.+.+|+.+++.++ ||||+.+.+++..+.   ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCccccce
Confidence            468999999999999999999999999999999987432    356789999999996 899999999886543   246


Q ss_pred             cEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      .++||||+.+ ++.++..  .+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       105 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGG
T ss_pred             EEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-CEEEEeCcceEecCCCC
Confidence            7999999985 7766653  589999999999999999999999999999999999998654 79999999998764322


Q ss_pred             C----cceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCccc--------CChh--hhhhh---
Q psy3714         321 E----YNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHL--------VSPE--ALDFL---  382 (467)
Q Consensus       321 ~----~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~--~~~~~---  382 (467)
                      .    ....+||+.|+|||++.+. .|+.++|+|..+++.+....+..||........        ..+.  .....   
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            1    2345899999999987654 489999999888876655555555432211100        0000  00000   


Q ss_pred             -hhh---ccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         383 -DKN---ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       383 -~~~---~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                       ...   .........|..     ....+++++++||++||++||++|||++|+|+||||.....
T Consensus       263 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNR-----LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHH-----HCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hHHHHHHhcCCccCCCHHH-----hCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence             000   000001111111     12357899999999999999999999999999999998643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.2e-41  Score=337.19  Aligned_cols=267  Identities=22%  Similarity=0.381  Sum_probs=197.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcC-------CCCeeEEEEEEeCC--
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRG-------GTNIITLQAVVKDP--  238 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~-------~~~iv~l~~~~~~~--  238 (467)
                      .++|++++.||+|+||.||+|.+..+++.||||+++...  .+.+.+|+.+++.+.+       |+||+++++.+...  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            478999999999999999999999999999999997543  4567899999999963       78899999987621  


Q ss_pred             CCCccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEeCCC-----------
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSM-GIMHRDVKPHNVMIDHEN-----------  302 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~-~IiHrDlKp~Nill~~~~-----------  302 (467)
                      .....++||||+.++.+..+..    .+++..++.++.||+.||+|||++ ||+||||||+|||++.++           
T Consensus       116 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~  195 (397)
T 1wak_A          116 NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT  195 (397)
T ss_dssp             TEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred             CCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence            2356899999996655544432    489999999999999999999998 999999999999998543           


Q ss_pred             -------------------------------------CcEEEEecccceecCCCCCcceeeeccCccCCcccccCCCCcc
Q psy3714         303 -------------------------------------RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIE  345 (467)
Q Consensus       303 -------------------------------------~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~  345 (467)
                                                           ..+||+|||+|+....  .....+||+.|+|||++.+..|+.+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~  273 (397)
T 1wak_A          196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNTP  273 (397)
T ss_dssp             ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCTH
T ss_pred             HHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCCcH
Confidence                                                 2699999999987643  2345679999999999999999999


Q ss_pred             chhHHHhhhccccccccccccccCCcccCCh-hhhhhhhhhccCCC----------Cc---------------ccccc--
Q psy3714         346 LDPRFADILGRHSRKRWERFVHTENQHLVSP-EALDFLDKNILGRH----------SR---------------KRWER--  397 (467)
Q Consensus       346 ~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~----------~~---------------~~~~~--  397 (467)
                      +|+|..+++.+....+..||........... .....+. ...+..          ..               ..|..  
T Consensus       274 ~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (397)
T 1wak_A          274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII-ELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE  352 (397)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHH-HHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred             HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHH-HhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence            9999888876666566555533221111100 0000000 000000          00               00000  


Q ss_pred             -cc-cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         398 -FV-HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       398 -~~-~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                       +. ........++++++||.+||+.||++|||++|+|+||||.
T Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence             00 0000112356889999999999999999999999999996

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.3e-40  Score=315.68  Aligned_cols=254  Identities=25%  Similarity=0.439  Sum_probs=202.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      .++|++.+.||+|+||.||+|.+..++..+|+|.+...   ..+.+.+|+++++.++ ||||+++.+++.+.  ...++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv   84 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD-HPNIIRLYETFEDN--TDIYLV   84 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS--SEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCC-CCCEeeEEEEEecC--CeEEEE
Confidence            46799999999999999999999999999999998653   3467889999999995 89999999998764  568999


Q ss_pred             EeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE---eCCCCcEEEEecccceecCCCC
Q psy3714         247 FEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI---DHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       247 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill---~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      |||++++++.+...   .+++.++..++.|++.||+|||++||+||||||+|||+   + .++.+||+|||+|.......
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS-PDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-TTCCEEECCCTTCEECCTTS
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCC-CCCcEEEEecccceeccCcc
Confidence            99999999876653   48999999999999999999999999999999999999   4 34579999999999876666


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      ......||+.|+|||++.+. ++.++|+|..+++......+..||.....     .........   +...       ..
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~---~~~~-------~~  227 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD-----SEVMLKIRE---GTFT-------FP  227 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH---CCCC-------CC
T ss_pred             chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHh---CCCC-------CC
Confidence            66667899999999998764 88999999888876555555445432111     011111110   0000       00


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      ...+..+|+++++||.+||+.||++|||+.|+|+||||.....
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence            1112347999999999999999999999999999999976443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4e-40  Score=314.20  Aligned_cols=251  Identities=20%  Similarity=0.367  Sum_probs=178.5

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....      .+.+.+|+.+++.++ ||||+++++++.+.  ..
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~   85 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDS--NY   85 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECS--SE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccC--Ce
Confidence            3478999999999999999999999999999999986432      256789999999995 89999999998764  56


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .++||||++++++.+++.    .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKM  164 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC-CEEECCCTTCEECC-
T ss_pred             EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEEeecceeeccC
Confidence            899999999999988764    378999999999999999999999999999999999998654 799999999987642


Q ss_pred             C-CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         319 G-QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       319 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      . ......+||+.|+|||++.+..++.+.|+|..+++......+..||......        .......     ..    
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~-----~~----  227 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK--------NTLNKVV-----LA----  227 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CC-----SS----
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH--------HHHHHHh-----hc----
Confidence            2 2233467999999999999888999999998887765554444444221110        0000000     00    


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                        ....+..+++++++||.+||+.||++|||++|+++||||....
T Consensus       228 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          228 --DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             --ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence              0112345799999999999999999999999999999997643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.5e-40  Score=327.53  Aligned_cols=275  Identities=24%  Similarity=0.341  Sum_probs=190.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC-----CCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGGTNIITLQAVVKDPV-----SRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~-----~~~  242 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....  ..+..+|+..+..++ ||||+++.+++....     ...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSCTTCEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcC-CCCcccHHHhhhcccccccccee
Confidence            478999999999999999999999999999999885432  345667777778785 899999999885422     123


Q ss_pred             cEEEEeccCCccHHHHh------hcCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCceEEeCCCCcEEEEecccce
Q psy3714         243 PALIFEHVNNTDFKQLY------QTLTDYDIRYYLYELLKALDYCH--SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE  314 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~~qll~al~~lH--~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~  314 (467)
                      .++||||+.++.+..+.      ..+++..++.++.|++.||.|||  ++||+||||||+|||++..++.+||+|||+|+
T Consensus       101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~  180 (360)
T 3e3p_A          101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK  180 (360)
T ss_dssp             EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred             EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence            78999999986433222      24788889999999999999999  99999999999999999645689999999999


Q ss_pred             ecCCCCCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCccc--------C--Chhhhhhhh
Q psy3714         315 FYHPGQEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHL--------V--SPEALDFLD  383 (467)
Q Consensus       315 ~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~--------~--~~~~~~~~~  383 (467)
                      ...........+||+.|+|||++.+.. |+.++|+|..+++.+....+..||........        .  .........
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3e3p_A          181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN  260 (360)
T ss_dssp             CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence            876555555678999999999997665 89999999888876655555555433211000        0  000000000


Q ss_pred             hhc----cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccccc
Q psy3714         384 KNI----LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       384 ~~~----~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~~  446 (467)
                      ...    ........|..... ......++++++||.+||++||++|||++|+|+||||.++..+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          261 PSHTDVDLYNSKGIPWSNVFS-DHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             TTCCCGGGGCCCCCCHHHHTT-TCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             cchhhccccccccCCcccccc-hhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence            000    00001111211111 112236789999999999999999999999999999998765444

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.2e-40  Score=322.11  Aligned_cols=267  Identities=24%  Similarity=0.451  Sum_probs=200.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEc-cCCCeEEEEEeccch-----HHHHHHHHHHHHHhc--CCCCeeEEEEEEeC---C
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINV-QSSDKCVVKILKPVK-----KKKIKREIKILENLR--GGTNIITLQAVVKD---P  238 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~--~~~~iv~l~~~~~~---~  238 (467)
                      .++|++++.||+|+||.||+|.+. .+++.||+|+++...     .....+|+.+++.+.  .||||+++++++..   .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            478999999999999999999995 677889999986432     235778999988885  69999999998752   2


Q ss_pred             CCCccEEEEeccCCccHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccc
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA  313 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla  313 (467)
                      .....++||||+.+ ++.+++..     +++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus        90 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~-~~kl~Dfg~~  167 (326)
T 1blx_A           90 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLA  167 (326)
T ss_dssp             SEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSC
T ss_pred             CCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-CEEEecCccc
Confidence            34567999999984 77776542     78999999999999999999999999999999999998655 7999999999


Q ss_pred             eecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         314 EFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       314 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      +............||+.|+|||++.+..++.++|+|..+++......+..+|......     .....+.. ..+.....
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~-~~~~~~~~  241 (326)
T 1blx_A          168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILD-VIGLPGEE  241 (326)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHH-HHCCCCGG
T ss_pred             ccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHH-HcCCCCcc
Confidence            8765444445567999999999999988999999998887765554444444322110     00000000 00000000


Q ss_pred             cccc--------c------ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         394 RWER--------F------VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       394 ~~~~--------~------~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                      .|..        +      ........+++++++||.+||+.||++|||++|+++||||.++.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence            1100        0      0011224579999999999999999999999999999999987654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.6e-40  Score=320.18  Aligned_cols=251  Identities=22%  Similarity=0.348  Sum_probs=200.3

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ..|+..+.||+|+||.||+|.+..+++.||||+++..   ..+.+.+|+.+++.++ |+||+.+++.+...  ...++||
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~  121 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVG--EELWVLM  121 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEET--TEEEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEEC--CEEEEEE
Confidence            3578888999999999999999999999999998643   3456889999999995 89999999988764  4689999


Q ss_pred             eccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-Ccce
Q psy3714         248 EHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNV  324 (467)
Q Consensus       248 e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~~~~  324 (467)
                      ||+++++|.++..  .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...... ....
T Consensus       122 e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~  200 (321)
T 2c30_A          122 EFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKS  200 (321)
T ss_dssp             CCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCC
T ss_pred             ecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccCcccccc
Confidence            9999999988775  488999999999999999999999999999999999998655 79999999998764332 2345


Q ss_pred             eeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCC
Q psy3714         325 RVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQ  404 (467)
Q Consensus       325 ~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (467)
                      .+||+.|+|||++.+..|+.++|+|..+++.+....+..||.....     ..........   .  ...      ....
T Consensus       201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~---~--~~~------~~~~  264 (321)
T 2c30_A          201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-----VQAMKRLRDS---P--PPK------LKNS  264 (321)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHS---S--CCC------CTTG
T ss_pred             ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcC---C--CCC------cCcc
Confidence            6799999999999998899999999888876655555555432210     0111111000   0  000      0112


Q ss_pred             CCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         405 HLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       405 ~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      ..+++++++||.+||+.||++|||++|+++||||...
T Consensus       265 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          265 HKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence            3478999999999999999999999999999999754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-40  Score=328.22  Aligned_cols=256  Identities=26%  Similarity=0.412  Sum_probs=196.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++..        ..+.+.+|+.+++.++ ||||+++++++.+.  .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~  101 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDE--Q  101 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS--S
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhccC--C
Confidence            47899999999999999999999999999999998643        2356889999999996 89999999999764  5


Q ss_pred             ccEEEEeccCCccHHHHhhc-------------------------------------------CCHHHHHHHHHHHHHHH
Q psy3714         242 TPALIFEHVNNTDFKQLYQT-------------------------------------------LTDYDIRYYLYELLKAL  278 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~~-------------------------------------------~~~~~~~~~~~qll~al  278 (467)
                      ..++||||+++++|.+.+..                                           +++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            68999999999999887631                                           24667888999999999


Q ss_pred             HHHHHCCccccCCCCCceEEeCCC-CcEEEEecccceecCCCC-----CcceeeeccCccCCccccc--CCCCccchhHH
Q psy3714         279 DYCHSMGIMHRDVKPHNVMIDHEN-RKLRLIDWGLAEFYHPGQ-----EYNVRVASRYFKGPELLAD--YQYHIELDPRF  350 (467)
Q Consensus       279 ~~lH~~~IiHrDlKp~Nill~~~~-~~ikl~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~~D~~~  350 (467)
                      +|||++||+||||||+|||++.++ ..+||+|||+|+.+....     ......||+.|+|||++.+  ..|+.++|+|.
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            999999999999999999998543 279999999998653211     1234679999999999975  56889999998


Q ss_pred             HhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHH
Q psy3714         351 ADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAR  430 (467)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~  430 (467)
                      .+++.+....+..||.....        ...... +.....  .    ...+....+++++++||.+||+.||++|||++
T Consensus       262 lG~il~el~~g~~pf~~~~~--------~~~~~~-~~~~~~--~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  326 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVND--------ADTISQ-VLNKKL--C----FENPNYNVLSPLARDLLSNLLNRNVDERFDAM  326 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSH--------HHHHHH-HHHCCC--C----TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred             HHHHHHHHHHCCCCCCCCCh--------HHHHHH-HHhccc--c----cCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence            88876555555555432111        011111 100000  0    01111224799999999999999999999999


Q ss_pred             HHhCCCCCCCccc
Q psy3714         431 EAMDHPYFYPIVK  443 (467)
Q Consensus       431 e~l~Hp~f~~~~~  443 (467)
                      |+|+||||....+
T Consensus       327 ~~l~hp~~~~~~~  339 (345)
T 3hko_A          327 RALQHPWISQFSD  339 (345)
T ss_dssp             HHHHSHHHHTTSS
T ss_pred             HHhcChhhccChH
Confidence            9999999987643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.1e-40  Score=326.36  Aligned_cols=268  Identities=28%  Similarity=0.484  Sum_probs=197.9

Q ss_pred             cCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       167 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      |.-.++|++.+.||+|+||.||+|.+..+++.||||+++..     ..+.+.+|+.+++.++ ||||+++.+++......
T Consensus        38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  116 (371)
T 4exu_A           38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSL  116 (371)
T ss_dssp             EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSS
T ss_pred             ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCCc
Confidence            34457999999999999999999999999999999998652     2356789999999996 89999999998754321


Q ss_pred             ----ccEEEEeccCCccHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         242 ----TPALIFEHVNNTDFKQLYQ-TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       242 ----~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                          ..++||||+.+ ++.+... .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus       117 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~  194 (371)
T 4exu_A          117 RNFYDFYLVMPFMQT-DLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHA  194 (371)
T ss_dssp             TTCCCCEEEEECCCE-EHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSTTCC---
T ss_pred             ccceeEEEEEccccc-cHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC-CEEEEecCccccc
Confidence                24999999984 6666554 589999999999999999999999999999999999998654 7999999999865


Q ss_pred             CCCCCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCccc----------CChhhhhhhhh-
Q psy3714         317 HPGQEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQHL----------VSPEALDFLDK-  384 (467)
Q Consensus       317 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~-  384 (467)
                      ..  .....+||+.|+|||++.+ ..|+.++|+|..+++.+....+..||........          ........... 
T Consensus       195 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          195 DA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             cc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            42  2344678999999999987 5689999999888876665555555432211000          00000000000 


Q ss_pred             ------hccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         385 ------NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       385 ------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                            ..........+.     ..++.+++++++||++||++||++|||++|+|+||||.+...+
T Consensus       273 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  333 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFT-----QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  333 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHH-----HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhhhhhccCCCcchhHH-----HhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence                  000000111111     1123579999999999999999999999999999999987544

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.5e-40  Score=315.85  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=196.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++.+.||+|+||.||+|.+..++..+|+|++....      ...+.+|+.+++.++ ||||+++.+++.+.  ...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~   84 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDA--TRV   84 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECS--SEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecC--CEE
Confidence            478999999999999999999999999999999986432      346788999999996 89999999998764  468


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++||||++++++.+...   .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++...... 
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS-CEEECSCCEESCC----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC-CEEEEeccccccCCcc-
Confidence            99999999999877654   588999999999999999999999999999999999998655 7999999998755332 


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      ......||+.|+|||++.+..++.+.|+|..+++......+..||.....     .........              ..
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~--------------~~  223 (279)
T 3fdn_A          163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRISR--------------VE  223 (279)
T ss_dssp             -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHH--------------TC
T ss_pred             cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----HHHHHHHHh--------------CC
Confidence            23446799999999999998899999999888876555444444421110     001110000              01


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ...+..+++++++||.+||+.||++|||++|+++||||....
T Consensus       224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          224 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence            112335789999999999999999999999999999997643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.1e-40  Score=323.26  Aligned_cols=255  Identities=24%  Similarity=0.396  Sum_probs=198.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----------KKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++...           ...+.+|+.+++.+. ||||+++++++...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEEESS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEEcCC
Confidence            368999999999999999999999999999999986431           134778999999995 89999999998753


Q ss_pred             CCCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC--cEEEEecccc
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLA  313 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~--~ikl~DFGla  313 (467)
                         ..++||||+++++|.+.+.   .+++..++.++.||+.||.|||++||+||||||+|||++..+.  .+||+|||++
T Consensus        88 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           88 ---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             ---SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             ---ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence               3799999999999887653   5889999999999999999999999999999999999985432  4999999999


Q ss_pred             eecCCCCCcceeeeccCccCCcccc---cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCC
Q psy3714         314 EFYHPGQEYNVRVASRYFKGPELLA---DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRH  390 (467)
Q Consensus       314 ~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (467)
                      +...........+||+.|+|||++.   ...|+.++|+|..+++.+....+..||.......    .........   ..
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~---~~  237 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKDQITSG---KY  237 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS----CHHHHHHHT---CC
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH----HHHHHHHhC---cc
Confidence            8765443334567999999999974   4568889999988887665555555543221110    011111110   00


Q ss_pred             CcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         391 SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       391 ~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .   +    ....+..+++++++||.+||..||++|||++|+|+||||.+..
T Consensus       238 ~---~----~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          238 N---F----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             C---C----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             c---c----CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence            0   0    0111234799999999999999999999999999999998755

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.5e-40  Score=313.65  Aligned_cols=246  Identities=16%  Similarity=0.224  Sum_probs=192.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .++|++++.||+|+||.||+|.+..+++.||+|+++..     ....+.+|+.++..+..||||+++++++.+.  ...+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~~   87 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHML   87 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEE
Confidence            47899999999999999999999999999999998742     3456788999999996799999999998764  4689


Q ss_pred             EEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC----------------
Q psy3714         245 LIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE----------------  301 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~----------------  301 (467)
                      +||||+++++|.+++.       .+++.++..++.||+.||.|||++||+||||||+|||++..                
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            9999999999987763       37899999999999999999999999999999999999732                


Q ss_pred             --CCcEEEEecccceecCCCCCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhh
Q psy3714         302 --NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEA  378 (467)
Q Consensus       302 --~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (467)
                        ...+||+|||++......   ....||+.|+|||++.+. .++.++|+|..+++......+. +++.       ....
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~-~~~~-------~~~~  236 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE-PLPR-------NGDQ  236 (289)
T ss_dssp             --CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCC-CCCS-------SSHH
T ss_pred             CCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCC-CCCc-------chhH
Confidence              236999999999876533   234699999999999876 4667899998887654332222 1111       1111


Q ss_pred             hhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      .......        .     ....+..+++++++||.+||+.||++|||++|+++||||...
T Consensus       237 ~~~~~~~--------~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 WHEIRQG--------R-----LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHHTT--------C-----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHHHcC--------C-----CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            1111100        0     011234579999999999999999999999999999999753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.6e-40  Score=317.62  Aligned_cols=258  Identities=25%  Similarity=0.399  Sum_probs=201.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|+++..         ..+.+.+|+.+++.++ ||||+++.+++.+.  .
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~   81 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENK--T   81 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS--S
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCC--C
Confidence            6799999999999999999999999999999998643         2467889999999996 89999999998764  4


Q ss_pred             ccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC---cEEEEeccccee
Q psy3714         242 TPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEF  315 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~---~ikl~DFGla~~  315 (467)
                      ..++||||+++++|.+++.   .+++.++..++.|++.||.|||++||+||||||+||+++.++.   .+||+|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            6899999999999988764   4899999999999999999999999999999999999985542   699999999988


Q ss_pred             cCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         316 YHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       316 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      ...........||+.|+|||++.+..++.+.|+|..+++......+..||.....        ............   .+
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~---~~  230 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QETLTNISAVNY---DF  230 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCC---CC
T ss_pred             ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHHHHHhHhccc---CC
Confidence            7655555566799999999999988899999999888776555555444432110        111110000000   00


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccccc
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~~  446 (467)
                          ....+..+++++++||++||..||++|||++|+++||||..+.+...
T Consensus       231 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  277 (283)
T 3bhy_A          231 ----DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV  277 (283)
T ss_dssp             ----CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC
T ss_pred             ----cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhh
Confidence                01112357899999999999999999999999999999988765543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.5e-40  Score=326.05  Aligned_cols=265  Identities=24%  Similarity=0.447  Sum_probs=189.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--------------HHHHHHHHHHHHHhcCCCCeeEEEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--------------KKKIKREIKILENLRGGTNIITLQAVV  235 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--------------~~~~~~Ei~il~~l~~~~~iv~l~~~~  235 (467)
                      .++|++.+.||+|+||.||+|.+.. +..||||.+....              .+.+.+|+.+++.++ ||||+++++++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   98 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLRDIF   98 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccceeeeE
Confidence            4789999999999999999998865 8899999885421              256889999999996 89999999887


Q ss_pred             eC---CCCCccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEE
Q psy3714         236 KD---PVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLI  308 (467)
Q Consensus       236 ~~---~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~  308 (467)
                      ..   +.....++||||+.+ ++.+.+.    .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~  176 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITIC  176 (362)
T ss_dssp             EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEEC
T ss_pred             EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-CEEEE
Confidence            53   233467999999985 5555442    478999999999999999999999999999999999998555 79999


Q ss_pred             ecccceecCCCCCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCccc--------CCh---
Q psy3714         309 DWGLAEFYHPGQEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQHL--------VSP---  376 (467)
Q Consensus       309 DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~---  376 (467)
                      |||+|+...........+||+.|+|||++.+ ..++.++|+|..+++.+....+..||........        ..+   
T Consensus       177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (362)
T 3pg1_A          177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE  256 (362)
T ss_dssp             CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence            9999986655445556789999999999987 5689999999888876655555555432211000        000   


Q ss_pred             --------hhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         377 --------EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       377 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                              ....+.. ..........|..     ..+..++++++||.+||+.||++|||++|+|+||||..+..+
T Consensus       257 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          257 DVVMFSSPSARDYLR-NSLSNVPARAWTA-----VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             HHHHTSCHHHHHHTT-TCCCCCCCCCHHH-----HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HhhhccchhhhHHHH-hhcccCChhhHHh-----hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence                    0000000 0000111111111     123468999999999999999999999999999999987543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-40  Score=323.05  Aligned_cols=249  Identities=23%  Similarity=0.360  Sum_probs=188.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCC-CCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGG-TNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~-~~iv~l~~~~~~~~~~~~  243 (467)
                      .+.|++++.||+|+||.||+|.+ .+++.||||+++..     ....+.+|+.+|+.+.+| +||+.+++++.+.  ...
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~~~   84 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYI   84 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC--CEE
Confidence            46799999999999999999987 46889999998643     125678999999999854 8999999998764  568


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++||| +.+++|.+++.   .+++.+++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||+|+......
T Consensus        85 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~-~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           85 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSSSCCC----
T ss_pred             EEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CC-cEEEeecccccccCccc
Confidence            99999 56778877664   488999999999999999999999999999999999997 44 79999999998764332


Q ss_pred             C---cceeeeccCccCCccccc-----------CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhc
Q psy3714         321 E---YNVRVASRYFKGPELLAD-----------YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI  386 (467)
Q Consensus       321 ~---~~~~~gt~~y~aPE~l~~-----------~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (467)
                      .   ....+||+.|+|||++.+           ..|+.++|+|..+++.+....+..||......       ...... +
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~-~  233 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLHA-I  233 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHH-H
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-------HHHHHH-H
Confidence            2   234679999999999965           56888999998888766555555554321110       000000 0


Q ss_pred             cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      .....        ....+...++++.+||.+||+.||++|||++|+|+||||..
T Consensus       234 ~~~~~--------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          234 IDPNH--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             HCTTS--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             hcCCc--------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            00000        11122346789999999999999999999999999999963

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.6e-40  Score=328.67  Aligned_cols=250  Identities=23%  Similarity=0.353  Sum_probs=190.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcC-CCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRG-GTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~-~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..+|++++.||+|+||.||+|.+.. ++.||||+++..     ....+.+|+.+|+.+.+ |+||+++++++...  ...
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~~~  131 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYI  131 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--CEE
Confidence            3569999999999999999998865 889999998643     23567899999999985 79999999988764  458


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++||| +.+++|.+++.   .+++.+++.++.||+.||.|||++||+||||||+|||++ + +.+||+|||+|+.+....
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~-~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D-GMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-S-SCEEECCCSSSCCC----
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-C-CeEEEEecCccccccCCC
Confidence            99999 66778877764   478889999999999999999999999999999999996 4 479999999998764332


Q ss_pred             C---cceeeeccCccCCccccc-----------CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhc
Q psy3714         321 E---YNVRVASRYFKGPELLAD-----------YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI  386 (467)
Q Consensus       321 ~---~~~~~gt~~y~aPE~l~~-----------~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (467)
                      .   ....+||+.|+|||++.+           ..|+.++|+|..+++.+....+..||......       ..... .+
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~-~~  280 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLH-AI  280 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHH-HH
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------HHHHH-HH
Confidence            2   234679999999999975           35888999999888766655555555322110       00011 01


Q ss_pred             cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      .....        ....+...++++++||.+||+.||++|||++|+|+||||...
T Consensus       281 ~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          281 IDPNH--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             HCTTS--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             hCccc--------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            10000        011123358899999999999999999999999999999643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1e-39  Score=319.69  Aligned_cols=273  Identities=25%  Similarity=0.414  Sum_probs=198.4

Q ss_pred             cccCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         165 VDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       165 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      +.+...++|++++.||+|+||.||+|.+..+++.||+|++....     .+.+.+|+.+++.++ ||||+++.+++.+. 
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~-   96 (331)
T 4aaa_A           19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKK-   96 (331)
T ss_dssp             CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET-
T ss_pred             hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecC-
Confidence            34556789999999999999999999999999999999885432     345678999999996 89999999998753 


Q ss_pred             CCccEEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         240 SRTPALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                       ...++||||++++++..+.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus        97 -~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  174 (331)
T 4aaa_A           97 -KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTL  174 (331)
T ss_dssp             -TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCTTC---
T ss_pred             -CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC-cEEEEeCCCceee
Confidence             5689999999999887764   3588999999999999999999999999999999999998655 7999999999865


Q ss_pred             CC-CCCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCccc----------CChhhhhhhhh
Q psy3714         317 HP-GQEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHL----------VSPEALDFLDK  384 (467)
Q Consensus       317 ~~-~~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~  384 (467)
                      .. .......+||+.|+|||++.+. .++.++|+|..+++.+....+..||........          ..+........
T Consensus       175 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             cCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence            43 2334456799999999999876 588999999888876655555544432211000          00000000000


Q ss_pred             h-ccCCCCccccc-ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         385 N-ILGRHSRKRWE-RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       385 ~-~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      . ........... ........+.+|+++++||.+||+.||++|||++|+|+||||...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            0 00000000000 000011123579999999999999999999999999999999754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5e-40  Score=328.30  Aligned_cols=268  Identities=18%  Similarity=0.315  Sum_probs=194.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcCCCC-----eeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGGTN-----IITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~~~~-----iv~l~~~~~~~~~~~  242 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++...  .....+|+.+++.+.+|++     |+.+.+.+...  ..
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~~  130 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR--NH  130 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET--TE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC--Cc
Confidence            478999999999999999999999999999999997543  3567789999998876664     88888887753  56


Q ss_pred             cEEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCceEEeC-CCCcEEEEecccce
Q psy3714         243 PALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCH--SMGIMHRDVKPHNVMIDH-ENRKLRLIDWGLAE  314 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH--~~~IiHrDlKp~Nill~~-~~~~ikl~DFGla~  314 (467)
                      .++||||+.+ ++.+++.     .+++..++.++.|++.||.|||  ++|||||||||+|||++. .++.+||+|||+|+
T Consensus       131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            8999999975 7766653     3788999999999999999999  579999999999999963 34579999999998


Q ss_pred             ecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCccc--------C--Chhhhhhhh-
Q psy3714         315 FYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHL--------V--SPEALDFLD-  383 (467)
Q Consensus       315 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~--------~--~~~~~~~~~-  383 (467)
                      ....  .....+||+.|+|||++.+..|+.++|+|..+++.+....+..||........        .  ......... 
T Consensus       210 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  287 (382)
T 2vx3_A          210 QLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK  287 (382)
T ss_dssp             ETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT
T ss_pred             eccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH
Confidence            7643  33456899999999999999999999999888876665555555533211000        0  000000000 


Q ss_pred             -hhccCCCCcccccccc--------cccCC------------------CC-------CChHHHHHHHhhcCcCCCCCCCH
Q psy3714         384 -KNILGRHSRKRWERFV--------HTENQ------------------HL-------VSPEALDFLDKLLRYDHYERLTA  429 (467)
Q Consensus       384 -~~~~~~~~~~~~~~~~--------~~~~~------------------~~-------~s~~~~dli~~lL~~dp~~R~ta  429 (467)
                       ...........|....        ..+..                  ..       .+++++|||++||++||++||||
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta  367 (382)
T 2vx3_A          288 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQP  367 (382)
T ss_dssp             HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCH
T ss_pred             HHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCH
Confidence             0000000001110000        00000                  00       01478999999999999999999


Q ss_pred             HHHhCCCCCCCcc
Q psy3714         430 REAMDHPYFYPIV  442 (467)
Q Consensus       430 ~e~l~Hp~f~~~~  442 (467)
                      +|+|+||||....
T Consensus       368 ~e~L~hp~f~~~~  380 (382)
T 2vx3_A          368 YYALQHSFFKKTA  380 (382)
T ss_dssp             HHHTTSGGGCC--
T ss_pred             HHHhcCcccccCC
Confidence            9999999998654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3e-39  Score=318.84  Aligned_cols=267  Identities=27%  Similarity=0.470  Sum_probs=197.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC---CC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPV---SR  241 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~---~~  241 (467)
                      -.++|++.+.||+|+||.||+|.+..+++.||||.++...    ...+.+|+.+++.++ |+||+++++++....   ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK-HENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCSTTCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccccCccc
Confidence            4578999999999999999999999999999999986432    345679999999996 899999998875431   25


Q ss_pred             ccEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ..++||||+.+ ++.+...  .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus        88 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           88 EVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDES  165 (353)
T ss_dssp             CEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECC--
T ss_pred             eEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC-cEEEEecccccccccc
Confidence            67999999984 7776654  489999999999999999999999999999999999998654 7999999999876422


Q ss_pred             CC-----------cceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCccc--------C-----
Q psy3714         320 QE-----------YNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQHL--------V-----  374 (467)
Q Consensus       320 ~~-----------~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~--------~-----  374 (467)
                      ..           ....+||+.|+|||++.. ..++.++|+|..+++......+..+|........        .     
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD  245 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence            11           123478999999998865 5688999999888776554444444422110000        0     


Q ss_pred             -------ChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccccc
Q psy3714         375 -------SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ  445 (467)
Q Consensus       375 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~  445 (467)
                             ......+...  ........+     ...++.+++++++||.+||+.||++|||++|+|+||||....+..
T Consensus       246 ~~~~~~~~~~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          246 NDLRCIESPRAREYIKS--LPMYPAAPL-----EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             TTTTTCCCHHHHHHHHT--SCCCCCCCH-----HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             ccccccccchhhHHhhc--ccCCCCcch-----hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence                   0000000000  000000011     011245899999999999999999999999999999998876543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-39  Score=309.62  Aligned_cols=253  Identities=22%  Similarity=0.358  Sum_probs=199.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++..    ..+.+.+|+.+++.++ |+||+++++++.+.  ...++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~l   82 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREG--NIQYL   82 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEET--TEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcC--CEEEE
Confidence            36899999999999999999999999999999998643    2356889999999995 89999999988753  56799


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC--
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~--  320 (467)
                      ||||+++++|.+...   .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......  
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEE
T ss_pred             EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-CEEEeeCCCccccCCCcch
Confidence            999999999877654   488999999999999999999999999999999999998655 79999999998653221  


Q ss_pred             -CcceeeeccCccCCcccccCCC-CccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         321 -EYNVRVASRYFKGPELLADYQY-HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       321 -~~~~~~gt~~y~aPE~l~~~~~-~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                       .....+||+.|+|||++.+..+ +.++|+|..+++......+..||......   ......+..    ...        
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~----~~~--------  226 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDWKE----KKT--------  226 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT---SHHHHHHHT----TCT--------
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHhhh----ccc--------
Confidence             2344678999999999988775 67899998888766555555554322110   000000000    000        


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                       ....+..+++++++||.+||+.||++|||++|+++||||....
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             -ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence             0011234799999999999999999999999999999998653

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4e-39  Score=309.27  Aligned_cols=252  Identities=17%  Similarity=0.320  Sum_probs=196.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC--CCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDP--VSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~--~~~~  242 (467)
                      ...|++.+.||+|+||.||+|.+..++..||+|.++..     ..+.+.+|+.+++.++ ||||+++++++...  ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCCce
Confidence            45689999999999999999999999999999998643     2356789999999995 89999999987543  2345


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~--IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      .++||||+++++|.++..   .+++..+..++.||+.||.|||++|  |+||||||+|||++..++.+||+|||+|....
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            799999999999988764   4889999999999999999999999  99999999999998555589999999997654


Q ss_pred             CCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       318 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      .. ......||+.|+|||++.+ .++.+.|+|..+++.+....+..||.....       ..... ..+.....      
T Consensus       184 ~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~-~~~~~~~~------  247 (290)
T 1t4h_A          184 AS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIY-RRVTSGVK------  247 (290)
T ss_dssp             TT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHH-HHHTTTCC------
T ss_pred             cc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-------HHHHH-HHHhccCC------
Confidence            32 3345679999999998864 588999999888876655555445432111       00000 01110000      


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                        ....+...++++.+||.+||+.||++|||++|+++||||.+
T Consensus       248 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 --PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             --CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             --ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence              01112346789999999999999999999999999999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.3e-41  Score=333.79  Aligned_cols=245  Identities=17%  Similarity=0.202  Sum_probs=189.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhc--CCCCeeEEE-------EE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLR--GGTNIITLQ-------AV  234 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~--~~~~iv~l~-------~~  234 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++..      ..+.+.+|+.+++.+.  .||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            47899999999999999999999999999999998632      2366889996666554  589999887       55


Q ss_pred             EeCCCC----------C-----ccEEEEeccCCccHHHHhh---cCCH-------HHHHHHHHHHHHHHHHHHHCCcccc
Q psy3714         235 VKDPVS----------R-----TPALIFEHVNNTDFKQLYQ---TLTD-------YDIRYYLYELLKALDYCHSMGIMHR  289 (467)
Q Consensus       235 ~~~~~~----------~-----~~~lv~e~~~~~~l~~~~~---~~~~-------~~~~~~~~qll~al~~lH~~~IiHr  289 (467)
                      +.++..          .     ..+++|||+ +|+|.+++.   .+++       ..+..++.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            554321          0     368999999 578887764   3555       6667799999999999999999999


Q ss_pred             CCCCCceEEeCCCCcEEEEecccceecCCCCCcceeeeccCccCCcccccC-----------CCCccchhHHHhhhcccc
Q psy3714         290 DVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY-----------QYHIELDPRFADILGRHS  358 (467)
Q Consensus       290 DlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~~~D~~~~~~~~~~~  358 (467)
                      ||||+|||++.++ .+||+|||+|+...  ......+| +.|+|||++.+.           .|+.++|+|..+++.+..
T Consensus       231 Dikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRG-GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCC-CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999655 89999999998643  23445677 999999999988           799999999998876655


Q ss_pred             ccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         359 RKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                      ..+..||.......        .             ....  ...+..+++++++||.+||+.||++|||++|+++||||
T Consensus       307 ltg~~Pf~~~~~~~--------~-------------~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f  363 (377)
T 3byv_A          307 WCADLPITKDAALG--------G-------------SEWI--FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY  363 (377)
T ss_dssp             HHSSCCC------C--------C-------------SGGG--GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred             HHCCCCCccccccc--------c-------------hhhh--hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence            55555542211100        0             0000  01123579999999999999999999999999999999


Q ss_pred             CCcc
Q psy3714         439 YPIV  442 (467)
Q Consensus       439 ~~~~  442 (467)
                      ..+.
T Consensus       364 ~~~~  367 (377)
T 3byv_A          364 EQLR  367 (377)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8765

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.8e-39  Score=310.64  Aligned_cols=249  Identities=24%  Similarity=0.384  Sum_probs=200.3

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...      ....+.+|+++++.++ |+||+++++++.+.  ..
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~   88 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDR--KR   88 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS--SE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcC--CE
Confidence            357899999999999999999999999999999998643      2356789999999996 89999999998763  56


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      .++||||++++++.+.+.   .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC-CEEECCCTTCEECSSS
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC-CEEEecccccccCccc
Confidence            899999999999877654   488999999999999999999999999999999999998655 7999999999865432


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                       .....+||+.|+|||++.+..++.+.|+|..+++......+..||....        ...... .+...          
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~-~~~~~----------  227 (284)
T 2vgo_A          168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--------HTETHR-RIVNV----------  227 (284)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHH-HHHTT----------
T ss_pred             -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC--------HhHHHH-HHhcc----------
Confidence             2344679999999999999889999999988887655544444442211        011110 11100          


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      ....+..+|+++++||.+||+.||.+|||++|+++||||...
T Consensus       228 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          228 DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence            011224579999999999999999999999999999999743

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.3e-39  Score=323.82  Aligned_cols=271  Identities=24%  Similarity=0.376  Sum_probs=197.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcC----------CCCeeEEEEEEe
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRG----------GTNIITLQAVVK  236 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~----------~~~iv~l~~~~~  236 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.||||+++...  ...+.+|+.+++.+.+          |+||+++.+.+.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            3578999999999999999999999999999999987542  4567889999998863          689999998876


Q ss_pred             CC--CCCccEEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEeCC-----CC
Q psy3714         237 DP--VSRTPALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSM-GIMHRDVKPHNVMIDHE-----NR  303 (467)
Q Consensus       237 ~~--~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~-~IiHrDlKp~Nill~~~-----~~  303 (467)
                      ..  .....+++||++ ++++.+++.     .+++..+..++.||+.||+|||++ ||+||||||+|||++..     ..
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence            43  223678999999 788877664     388899999999999999999998 99999999999999632     23


Q ss_pred             cEEEEecccceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChh-hhhhh
Q psy3714         304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE-ALDFL  382 (467)
Q Consensus       304 ~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  382 (467)
                      .+||+|||+|+....  .....+||+.|+|||++.+..|+.++|+|..+++.+....+..||............ ....+
T Consensus       176 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  253 (373)
T 1q8y_A          176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  253 (373)
T ss_dssp             EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             eEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence            699999999987643  234457999999999999999999999998888766655555555332211100000 00000


Q ss_pred             hhhccCCCC------------------------c-cccc--ccc--cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHh
Q psy3714         383 DKNILGRHS------------------------R-KRWE--RFV--HTENQHLVSPEALDFLDKLLRYDHYERLTAREAM  433 (467)
Q Consensus       383 ~~~~~~~~~------------------------~-~~~~--~~~--~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l  433 (467)
                      . ...+..+                        . ..|.  ...  ....+..+++++++||++||+.||++|||++|+|
T Consensus       254 ~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  332 (373)
T 1q8y_A          254 I-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  332 (373)
T ss_dssp             H-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             H-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence            0 0000000                        0 0000  000  0001122467899999999999999999999999


Q ss_pred             CCCCCCCccc
Q psy3714         434 DHPYFYPIVK  443 (467)
Q Consensus       434 ~Hp~f~~~~~  443 (467)
                      +||||.+...
T Consensus       333 ~hp~f~~~~~  342 (373)
T 1q8y_A          333 NHPWLKDTLG  342 (373)
T ss_dssp             TCGGGTTCTT
T ss_pred             hChhhhcccC
Confidence            9999987543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.5e-39  Score=308.94  Aligned_cols=257  Identities=21%  Similarity=0.315  Sum_probs=204.2

Q ss_pred             cccccCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q psy3714         163 YVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVK  236 (467)
Q Consensus       163 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~  236 (467)
                      ..++....++|++.+.||+|+||.||+|.+..+++.+|+|++...      ....+.+|+.+++.+. |+||+++++++.
T Consensus         7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~   85 (294)
T 2rku_A            7 VLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFE   85 (294)
T ss_dssp             EEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE
T ss_pred             eeeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeec
Confidence            344445678999999999999999999999999999999998643      2356788999999995 899999999987


Q ss_pred             CCCCCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccc
Q psy3714         237 DPVSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA  313 (467)
Q Consensus       237 ~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla  313 (467)
                      +.  ...++||||++++++.++..   .+++.++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus        86 ~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~  162 (294)
T 2rku_A           86 DN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLA  162 (294)
T ss_dssp             CS--SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred             cC--CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC-CEEEEeccCc
Confidence            63  56899999999999887654   489999999999999999999999999999999999998654 7999999999


Q ss_pred             eecCC-CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         314 EFYHP-GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       314 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      +.... ........||+.|+|||++.+..++.+.|+|..+++......+..+|....        ...... .+...   
T Consensus       163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~-~~~~~---  230 (294)
T 2rku_A          163 TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYL-RIKKN---  230 (294)
T ss_dssp             EECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHH-HHHTT---
T ss_pred             eecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH-HHhhc---
Confidence            87642 233344679999999999998889999999988877655444444442211        000000 00000   


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                             ....+..+++++.+||++||+.||++|||++|+++||||....
T Consensus       231 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          231 -------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             -------cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence                   0111235789999999999999999999999999999997644

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.3e-39  Score=315.81  Aligned_cols=256  Identities=22%  Similarity=0.330  Sum_probs=204.3

Q ss_pred             ccccCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeC
Q psy3714         164 VVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKD  237 (467)
Q Consensus       164 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~  237 (467)
                      .++....++|++.+.||+|+||.||+|.+..+++.+|+|++...      ....+.+|+.+++.+. |+||+++++++.+
T Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  112 (335)
T 2owb_A           34 LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFED  112 (335)
T ss_dssp             EEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred             ecCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEec
Confidence            34445568999999999999999999999999999999998643      2456788999999995 8999999999876


Q ss_pred             CCCCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccce
Q psy3714         238 PVSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE  314 (467)
Q Consensus       238 ~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~  314 (467)
                      .  ...++||||+.++++.++..   .+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus       113 ~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~  189 (335)
T 2owb_A          113 N--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLAT  189 (335)
T ss_dssp             S--SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             C--CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC-CEEEeeccCce
Confidence            4  56899999999999887754   489999999999999999999999999999999999998654 79999999998


Q ss_pred             ecCC-CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         315 FYHP-GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       315 ~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      .... .......+||+.|+|||++.+..++.+.|+|..+++.+....+..+|.....     .+........        
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~--------  256 (335)
T 2owb_A          190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYLRIKKN--------  256 (335)
T ss_dssp             ECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHT--------
T ss_pred             ecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----HHHHHHHhcC--------
Confidence            7642 2334456799999999999998899999999888876555444444422110     0011000000        


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                            ....+..+++++++||++||+.||++|||++|+++||||....
T Consensus       257 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          257 ------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             ------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence                  0011235789999999999999999999999999999997644

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3e-39  Score=312.39  Aligned_cols=253  Identities=23%  Similarity=0.386  Sum_probs=199.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++..   ....+.+|+.+++.++ ||||+++.+++.+.  ...++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv   84 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK-HENIVTLEDIYEST--THYYLV   84 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCC-CTTBCCEEEEEECS--SEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCC-CCCeeehhhhcccC--CEEEEE
Confidence            46899999999999999999999999999999998754   2356789999999995 89999999998764  468999


Q ss_pred             EeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEe--CCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~--~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      |||+++++|.+.+.   .+++..+..++.|++.||.|||++||+||||||+||++.  ..++.+||+|||+++..... .
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~  163 (304)
T 2jam_A           85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-I  163 (304)
T ss_dssp             ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-T
T ss_pred             EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-c
Confidence            99999999877653   588999999999999999999999999999999999993  13457999999999865432 2


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+||+.|+|||++.+..|+.++|+|..+++.+....+..||.....     ......+...   ..   .+    ..
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~---~~---~~----~~  228 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----SKLFEKIKEG---YY---EF----ES  228 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHC---CC---CC----CT
T ss_pred             cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcC---CC---CC----Cc
Confidence            3445799999999999998899999999888876555555445432110     0111111110   00   00    11


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      +.+..+++++++||.+||+.||++|||++|+|+||||.+.
T Consensus       229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          229 PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            1234579999999999999999999999999999999754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.3e-40  Score=324.86  Aligned_cols=271  Identities=19%  Similarity=0.263  Sum_probs=200.3

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|+++..    ..+.+.+|+.+++.++ |+||+++++++.+.  ...+
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~  107 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSD--GEIS  107 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEET--TEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEEC--CEEE
Confidence            457899999999999999999999999999999998643    2356789999999995 89999999988764  5689


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~-~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      +||||+++++|.+++.   .+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+|+..... 
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH-
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCcccccc-
Confidence            9999999999987764   588999999999999999999996 999999999999999655 7999999999755322 


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCccc---------CChhhhh---hhhhhccC
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHL---------VSPEALD---FLDKNILG  388 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~---~~~~~~~~  388 (467)
                      .....+||+.|+|||++.+..|+.++|+|..+++.+....+..||........         .......   ........
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence            22345799999999999998999999999888876655555555432211000         0000000   00000000


Q ss_pred             -----CCCccc----cc----ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         389 -----RHSRKR----WE----RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       389 -----~~~~~~----~~----~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                           ......    ..    ..........+|+++++||++||++||++|||++|+|+||||....++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  334 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  334 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence                 000000    00    000011122478999999999999999999999999999999876654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.1e-39  Score=320.04  Aligned_cols=260  Identities=25%  Similarity=0.372  Sum_probs=178.1

Q ss_pred             CCccceeeeE-eecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC--CCccE
Q psy3714         168 GQQDDYQLVR-KLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPV--SRTPA  244 (467)
Q Consensus       168 ~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~--~~~~~  244 (467)
                      ...++|++++ .||+|+||.||+|.+..+++.||||++...  ....+|+..+..+.+|+||+++.+++....  ....+
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            3458899976 599999999999999999999999998753  334455555545557999999999886421  34578


Q ss_pred             EEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC--CCcEEEEecccceecC
Q psy3714         245 LIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYH  317 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~--~~~ikl~DFGla~~~~  317 (467)
                      +||||+++++|.+++.     .+++.+++.++.||+.||.|||++||+||||||+|||++..  +..+||+|||+|+...
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~  182 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT  182 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence            9999999999988764     38899999999999999999999999999999999999753  2359999999998764


Q ss_pred             CCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         318 PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       318 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      .. .....+||+.|+|||++.+..|+.++|+|..+++.+....+..||......... .....    .+.    ...+  
T Consensus       183 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~----~~~----~~~~--  250 (336)
T 3fhr_A          183 QN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-PGMKR----RIR----LGQY--  250 (336)
T ss_dssp             ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------------
T ss_pred             cc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-hhHHH----hhh----cccc--
Confidence            32 234567899999999998888999999998888766555555555332211100 00000    000    0000  


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      ......+..+++++++||.+||+.||++|||++|+|+||||...
T Consensus       251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            01112234589999999999999999999999999999999764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.5e-39  Score=310.32  Aligned_cols=253  Identities=21%  Similarity=0.300  Sum_probs=179.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|+++...    ......|...+.+..+||||+++++++.+.  ...+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~~~~   82 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--GDVW   82 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SSEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--CCEE
Confidence            3578999999999999999999999999999999986532    223334444433334699999999998764  4689


Q ss_pred             EEEeccCCccHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         245 LIFEHVNNTDFKQLY-------QTLTDYDIRYYLYELLKALDYCHSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       245 lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qll~al~~lH~~-~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      +||||+++ ++.+++       ..+++..+..++.|++.||+|||++ ||+||||||+|||++..+ .+||+|||+|+..
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  160 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISGYL  160 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC------
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCcccc
Confidence            99999986 554443       2488999999999999999999998 999999999999998655 7999999999876


Q ss_pred             CCCCCcceeeeccCccCCccc----ccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         317 HPGQEYNVRVASRYFKGPELL----ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       317 ~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      ..........||+.|+|||++    .+..++.++|+|..+++......+..|+.....      . ............  
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~-~~~~~~~~~~~~--  231 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------P-FQQLKQVVEEPS--  231 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC------H-HHHHHHHHHSCC--
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc------h-HHHHHHHhccCC--
Confidence            554444556799999999996    455688899999888876555455444422110      0 011111110000  


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                             .......+|+++++||.+||+.||++|||++|+++||||...
T Consensus       232 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          232 -------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             -------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             -------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                   001123478999999999999999999999999999999754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-39  Score=314.18  Aligned_cols=256  Identities=22%  Similarity=0.355  Sum_probs=194.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC----CCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPV----SRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~----~~~  242 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++...  ....+.+|+.+++.+.+|+||+++++++....    ...
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            357899999999999999999999999999999998643  35678899999999977999999999886532    356


Q ss_pred             cEEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         243 PALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      .++||||+++++|.+++.     .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD  180 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCTTTC---
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC-CEEEeeCcCceecC
Confidence            899999999999988764     478899999999999999999999999999999999998554 79999999998654


Q ss_pred             CC-CCcceeeeccCccCCcccc-----cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         318 PG-QEYNVRVASRYFKGPELLA-----DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       318 ~~-~~~~~~~gt~~y~aPE~l~-----~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      .. ......+||+.|+|||++.     +..++.++|+|..+++.+....+..||.....     ..........   .  
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~---~--  250 (326)
T 2x7f_A          181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----MRALFLIPRN---P--  250 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHS---C--
T ss_pred             cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHHHHhhcC---c--
Confidence            32 2233457999999999997     45688999999888876655555444422110     0000000000   0  


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                         .    .......+++++++||.+||..||++|||++|+++||||.+..
T Consensus       251 ---~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          251 ---A----PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             ---C----CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             ---c----ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence               0    0011234789999999999999999999999999999998654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=315.55  Aligned_cols=269  Identities=26%  Similarity=0.430  Sum_probs=193.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCC-------
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDP-------  238 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~-------  238 (467)
                      -.++|++++.||+|+||.||+|.+..+++.||+|.+....   .+.+.+|+.+++.++ ||||+++++++...       
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSCBCCC-
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccccccccc
Confidence            3578999999999999999999999999999999886543   356789999999995 89999999887432       


Q ss_pred             -----CCCccEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecc
Q psy3714         239 -----VSRTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG  311 (467)
Q Consensus       239 -----~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFG  311 (467)
                           .....++||||+. +++.+.+.  .+++..++.++.|++.||+|||++||+||||||+|||++.++..+||+|||
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence                 2356799999998 58887765  488999999999999999999999999999999999998666689999999


Q ss_pred             cceecCCC----CCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhh-
Q psy3714         312 LAEFYHPG----QEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN-  385 (467)
Q Consensus       312 la~~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  385 (467)
                      +++.....    .......+|+.|+|||++.+ ..++.++|+|..+++......+..||......     ......... 
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~  241 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-----EQMQLILESI  241 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHS
T ss_pred             cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhc
Confidence            99865422    12233567999999998876 56889999998888766555555554322110     000000000 


Q ss_pred             ----------ccCCCC---cccc--cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         386 ----------ILGRHS---RKRW--ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       386 ----------~~~~~~---~~~~--~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                                ......   ...+  ...........+|+++++||++||+.||++|||++|+|+||||....++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence                      000000   0000  0000001123579999999999999999999999999999999876544

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.2e-39  Score=310.54  Aligned_cols=253  Identities=23%  Similarity=0.369  Sum_probs=194.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|+++..       ....+.+|+.+++.++ |+||+++.+++.+.....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---C
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCCe
Confidence            36899999999999999999999999999999998643       2356789999999996 899999999986555567


Q ss_pred             cEEEEeccCCccHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         243 PALIFEHVNNTDFKQLY-----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      .++||||+.++ +.+.+     ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISALGVAEALH  160 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-cEEeeccccccccC
Confidence            89999999987 43333     2488899999999999999999999999999999999998654 79999999998764


Q ss_pred             CCC---CcceeeeccCccCCcccccCC--CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         318 PGQ---EYNVRVASRYFKGPELLADYQ--YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       318 ~~~---~~~~~~gt~~y~aPE~l~~~~--~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      +..   ......||+.|+|||++.+..  ++.++|+|..+++.+....+..||....        ..........+.   
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~~~~---  229 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFENIGKGS---  229 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCC---
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHHHhcCC---
Confidence            322   123456899999999998654  3678999988887655545444442211        111111100000   


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                              ...+..+++++.+||.+||..||++|||++|+++||||......
T Consensus       230 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          230 --------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             --------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             --------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence                    01123478999999999999999999999999999999876543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=315.19  Aligned_cols=266  Identities=28%  Similarity=0.476  Sum_probs=196.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC---
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS---  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~---  240 (467)
                      -.++|.+.+.||+|+||.||+|.+..+++.||||++...     ..+.+.+|+.+++.++ ||||+++.+++.....   
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGGG
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCcccHhheEeccccccc
Confidence            347899999999999999999999999999999998642     1356789999999996 8999999999875432   


Q ss_pred             -CccEEEEeccCCccHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         241 -RTPALIFEHVNNTDFKQLYQ-TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       241 -~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                       ...++||||+.+ ++.+... .+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          101 FYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADA  178 (353)
T ss_dssp             CCCCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC-CEEECSTTCTTC---
T ss_pred             ceeEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC-cEEEeecccccCCCC
Confidence             235999999984 6665543 589999999999999999999999999999999999998654 799999999986532


Q ss_pred             CCCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCccc----------CChhhhhhhhh---
Q psy3714         319 GQEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQHL----------VSPEALDFLDK---  384 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~---  384 (467)
                        .....+||+.|+|||++.+ ..++.++|+|..+++.+....+..||........          ...........   
T Consensus       179 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  256 (353)
T 3coi_A          179 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  256 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred             --CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence              2344678999999999987 5689999999888876655555555432211000          00000000000   


Q ss_pred             -hc---cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         385 -NI---LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       385 -~~---~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                       ..   ........+     ......+++++++||.+||+.||++|||++|+|+||||.....+
T Consensus       257 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  315 (353)
T 3coi_A          257 KSYIQSLPQTPRKDF-----TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  315 (353)
T ss_dssp             HHHHHTSCBCSSCCT-----TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHHhCcCCCCccH-----HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence             00   000000111     11123579999999999999999999999999999999976644

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.9e-39  Score=313.14  Aligned_cols=263  Identities=19%  Similarity=0.275  Sum_probs=178.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+...    ....+.+|+.+++.++ ||||+++++.+...  ...+
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~   89 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVK--DELW   89 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCC-CTTBCCEEEEEESS--SCEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcC-CCCEeeEEEEEeec--CCcE
Confidence            357899999999999999999999989999999988643    2345778999998885 89999999998764  4689


Q ss_pred             EEEeccCCccHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccc
Q psy3714         245 LIFEHVNNTDFKQLYQT-----------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA  313 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~~-----------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla  313 (467)
                      +||||+++++|.++...           +++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~  168 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVS  168 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCHHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-CEEEEeccch
Confidence            99999999998877642           78999999999999999999999999999999999998655 7999999999


Q ss_pred             eecCCCC------CcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhc
Q psy3714         314 EFYHPGQ------EYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI  386 (467)
Q Consensus       314 ~~~~~~~------~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (467)
                      .......      ......||+.|+|||++.+ ..++.++|+|..+++......+..||......     ...   ....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~---~~~~  240 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-----KVL---MLTL  240 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----GHH---HHHH
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-----hHH---HHHh
Confidence            7654322      1233579999999999976 45889999998887765555555554322110     000   0000


Q ss_pred             cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                      ... ................+++++++||.+||+.||++|||++|+++||||......
T Consensus       241 ~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          241 QND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             TSS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             ccC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            000 000000011112234578999999999999999999999999999999876543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-38  Score=307.30  Aligned_cols=257  Identities=22%  Similarity=0.293  Sum_probs=195.3

Q ss_pred             cCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       167 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ....+.|++++.||+|+||.||+|.+..+++.+|+|++...   ....+.+|+.+++.+. ||||+++.+++.+.  ...
T Consensus        15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~   91 (302)
T 2j7t_A           15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD-HPYIVKLLGAYYHD--GKL   91 (302)
T ss_dssp             SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC---CE
T ss_pred             cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeC--CeE
Confidence            34568899999999999999999999999999999998643   3467789999999995 89999999998764  468


Q ss_pred             EEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-
Q psy3714         244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-  318 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-  318 (467)
                      ++||||++++++..+..    .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..... 
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKT  170 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-CEEEEECCCCcccccc
Confidence            99999999999877643    489999999999999999999999999999999999998655 799999999764311 


Q ss_pred             CCCcceeeeccCccCCcccc-----cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         319 GQEYNVRVASRYFKGPELLA-----DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ........||+.|+|||++.     +..++.++|+|..+++......+..|+....        ..............  
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~--  240 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSDPP--  240 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCCC--
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC--------HHHHHHHHhccCCc--
Confidence            11223457999999999984     5668889999988887555444444432111        00111000000000  


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                            ....+..+|+++.+||.+||..||++|||++|+++||||....+
T Consensus       241 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          241 ------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             ------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             ------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence                  00112346899999999999999999999999999999987654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.9e-39  Score=305.17  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=190.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++...      ...+.+|+.+++.++ ||||+++.+.+.+.  ...
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~   86 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTP--TDF   86 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS--SEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecC--CeE
Confidence            478999999999999999999999999999999986432      346789999999996 89999999998764  468


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++||||+.+++|.++..   .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-CEEECCCCGGGCCCC--
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-CEEEeecccccccCCCc
Confidence            99999999999987763   588999999999999999999999999999999999998655 79999999998775544


Q ss_pred             CcceeeeccCccCCcccccCCC-CccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQY-HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~-~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      ......||+.|+|||++.+..+ +.+.|+|..+++......+..||....     ...........   .          
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~---~----------  227 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-----VPTLFKKIRGG---V----------  227 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHC---C----------
T ss_pred             ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHhhcC---c----------
Confidence            4455679999999999988775 578999988877555444444432211     00111111000   0          


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                       ...+..+++++.+||.+||+.||++|||++|+++||||...
T Consensus       228 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          228 -FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence             01123478999999999999999999999999999999753

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.1e-39  Score=317.88  Aligned_cols=247  Identities=23%  Similarity=0.374  Sum_probs=198.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---------HHHHHHHHHHHHHhcC-CCCeeEEEEEEeCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---------KKKIKREIKILENLRG-GTNIITLQAVVKDPV  239 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------~~~~~~Ei~il~~l~~-~~~iv~l~~~~~~~~  239 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++...         ...+.+|+.+++.+.+ |+||+++.+++.++ 
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~-  120 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-  120 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC-
Confidence            578999999999999999999999999999999986532         2456789999999974 79999999998864 


Q ss_pred             CCccEEEEeccCC-ccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         240 SRTPALIFEHVNN-TDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       240 ~~~~~lv~e~~~~-~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                       ...+++||++.+ +++.+++.   .+++..+..++.||+.||+|||++||+||||||+|||++.+++.+||+|||+++.
T Consensus       121 -~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          121 -DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  199 (320)
T ss_dssp             -SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             -CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence             468999999976 78877653   5889999999999999999999999999999999999985555899999999987


Q ss_pred             cCCCCCcceeeeccCccCCcccccCCC-CccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         316 YHPGQEYNVRVASRYFKGPELLADYQY-HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       316 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      .... ......||+.|+|||++.+..+ +.++|+|..+++.+....+..||...        .  ....    ..     
T Consensus       200 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~--------~--~~~~----~~-----  259 (320)
T 3a99_A          200 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--------E--EIIR----GQ-----  259 (320)
T ss_dssp             CCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--------H--HHHH----CC-----
T ss_pred             cccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh--------h--hhhc----cc-----
Confidence            6533 3344679999999999987776 67889998888755444444343110        0  0000    00     


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                            ......+++++++||.+||+.||++|||++|+++||||.+...+
T Consensus       260 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          260 ------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             ------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             ------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence                  01123479999999999999999999999999999999987643

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.8e-39  Score=315.89  Aligned_cols=247  Identities=23%  Similarity=0.317  Sum_probs=193.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .+.|++++.||+|+||.||+|.+..+++.||||++...      ..+.+.+|+.+++.++ ||||+++.+++.+.  ...
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~  129 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLRE--HTA  129 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET--TEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEC--CeE
Confidence            35699999999999999999999999999999998642      1246789999999996 89999999998764  568


Q ss_pred             EEEEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         244 ALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ++||||+.+ ++.+.+    ..+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+...+.
T Consensus       130 ~lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          130 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA  207 (348)
T ss_dssp             EEEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSSB
T ss_pred             EEEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEeeccCceecCCC
Confidence            999999985 554443    3588999999999999999999999999999999999999554 8999999999876432


Q ss_pred             CCcceeeeccCccCCcccc---cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         320 QEYNVRVASRYFKGPELLA---DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~---~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                         ...+||+.|+|||++.   ...|+.++|+|..+++......+..||.....        ............      
T Consensus       208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------~~~~~~~~~~~~------  270 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNES------  270 (348)
T ss_dssp             ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCC------
T ss_pred             ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHhcCC------
Confidence               3457999999999985   45688999999888876655555555432210        011100000000      


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                         .......+++++++||.+||+.||++|||++|+++||||...
T Consensus       271 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          271 ---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence               001123468999999999999999999999999999999643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.2e-40  Score=318.34  Aligned_cols=256  Identities=19%  Similarity=0.235  Sum_probs=193.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC--C
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVS--R  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~--~  241 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++...      ...+.+|+.+++.++ ||||+++++.+.....  .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEETTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccCCCCc
Confidence            478999999999999999999999999999999986531      245788999999885 8999999998765322  2


Q ss_pred             ccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      ..++||||+++++|.+++.   .+++.++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-CEEECCCSCC-----
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-CEEEeeccCcccccc
Confidence            3489999999999988764   489999999999999999999999999999999999999655 799999999986543


Q ss_pred             CC----CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         319 GQ----EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       319 ~~----~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ..    .....+||+.|+|||++.+..++.++|+|..+++.+....+..||.....        .............   
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~---  237 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVREDPI---  237 (311)
T ss_dssp             -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCCCC---
T ss_pred             cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhcCCCC---
Confidence            22    12335689999999999998999999999888876665555555432110        1111111000000   


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                          ........+|+++.+||.+||+.||++||++.++++|+|+....
T Consensus       238 ----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          238 ----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             ----CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ----CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence                00111235799999999999999999999999999999987543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.4e-39  Score=319.00  Aligned_cols=264  Identities=20%  Similarity=0.342  Sum_probs=199.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchH--------------------HHHHHHHHHHHHhcCCCCee
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK--------------------KKIKREIKILENLRGGTNII  229 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------------------~~~~~Ei~il~~l~~~~~iv  229 (467)
                      .++|++.+.||+|+||.||+|.+  +++.||+|.+.....                    ..+.+|+.+++.++ ||||+
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~  106 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCL  106 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTTBC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCCcc
Confidence            47899999999999999999998  889999999864321                    67899999999996 89999


Q ss_pred             EEEEEEeCCCCCccEEEEeccCCccHHHH------h-----hcCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceE
Q psy3714         230 TLQAVVKDPVSRTPALIFEHVNNTDFKQL------Y-----QTLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVM  297 (467)
Q Consensus       230 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~------~-----~~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nil  297 (467)
                      ++.+++.+.  ...++||||+++++|.++      .     ..+++..+..++.|++.||.|||+ +||+||||||+|||
T Consensus       107 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          107 TCEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             CCSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             eEEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            999998864  568999999999988765      3     347889999999999999999999 99999999999999


Q ss_pred             EeCCCCcEEEEecccceecCCCCCcceeeeccCccCCcccccC-CCCc-cchhHHHhhhccccccccccccccCCcccCC
Q psy3714         298 IDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY-QYHI-ELDPRFADILGRHSRKRWERFVHTENQHLVS  375 (467)
Q Consensus       298 l~~~~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (467)
                      ++.++ .+||+|||++...... ......||+.|+|||++.+. .|+. ++|+|..+++......+..||......    
T Consensus       185 ~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  258 (348)
T 2pml_X          185 MDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----  258 (348)
T ss_dssp             ECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred             EcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence            98655 7999999999876433 33446799999999999887 5666 899998888766555555554322110    


Q ss_pred             hhhhhhhhhhccCCC-Ccccc----cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         376 PEALDFLDKNILGRH-SRKRW----ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       376 ~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                      ............... ....+    ...........+++++++||.+||+.||.+|||++|+++||||.+..++
T Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~  332 (348)
T 2pml_X          259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE  332 (348)
T ss_dssp             HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHH
Confidence            111111111000000 00000    0000001124579999999999999999999999999999999987654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.3e-38  Score=306.95  Aligned_cols=255  Identities=20%  Similarity=0.302  Sum_probs=189.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcCCCCeeEEEEEEeCC---------
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGGTNIITLQAVVKDP---------  238 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~---------  238 (467)
                      .++|++++.||+|+||.||+|.+..+++.||+|+++...  ...+.+|+.+++.++ ||||+++++.+.+.         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchhhhhcc
Confidence            368999999999999999999999999999999986542  356789999999995 89999999877542         


Q ss_pred             --CCCccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccc
Q psy3714         239 --VSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGL  312 (467)
Q Consensus       239 --~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGl  312 (467)
                        .....++||||+++++|.+++.    .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~  162 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKIGDFGL  162 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-CEEEeeCcc
Confidence              1345789999999999988774    367788999999999999999999999999999999998655 799999999


Q ss_pred             ceecCCC---------------CCcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCCh
Q psy3714         313 AEFYHPG---------------QEYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP  376 (467)
Q Consensus       313 a~~~~~~---------------~~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (467)
                      ++.....               ......+||+.|+|||++.+. .++.++|+|..+++.+....   ++...       .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-------~  232 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-------M  232 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-------H
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-------h
Confidence            9865321               122345799999999999875 58899999988876543322   21110       0


Q ss_pred             hhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      ....... .+...  ...+    ........++++++||++||+.||++|||++|+++||||....+
T Consensus       233 ~~~~~~~-~~~~~--~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (303)
T 1zy4_A          233 ERVNILK-KLRSV--SIEF----PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ  292 (303)
T ss_dssp             HHHHHHH-HHHST--TCCC----CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred             hHHHHHH-hcccc--cccc----CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence            0011111 00000  0001    11112346788999999999999999999999999999986543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.9e-39  Score=307.70  Aligned_cols=255  Identities=21%  Similarity=0.427  Sum_probs=200.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .++|++++.||+|+||.||+|.+..+++.||+|++...     ....+.+|+.+++.++ ||||+++.+++.+.  ...+
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~   97 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDS--SSFY   97 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS--SEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCC--CeEE
Confidence            37899999999999999999999999999999998642     3467889999999995 89999999998764  5689


Q ss_pred             EEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC--CcEEEEecccceecCCC
Q psy3714         245 LIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       245 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~--~~ikl~DFGla~~~~~~  319 (467)
                      +||||+.++++.+.+   ..+++.++..++.|++.||.|||++||+||||||+||+++..+  ..+||+|||++......
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            999999999987654   3589999999999999999999999999999999999997543  36999999999876555


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      .......||+.|+|||++.+. ++.+.|+|..+++......+..||.....     .........   +...       .
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~---~~~~-------~  241 (287)
T 2wei_A          178 TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDILKRVET---GKYA-------F  241 (287)
T ss_dssp             SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH---CCCC-------C
T ss_pred             CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHc---CCCC-------C
Confidence            555556799999999998764 88899999888776554444444432110     011111111   1000       0


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      ..+.+..+|+++++||++||..||++|||++|+|+||||....+
T Consensus       242 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence            11122457999999999999999999999999999999976543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-39  Score=319.72  Aligned_cols=248  Identities=18%  Similarity=0.240  Sum_probs=179.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----------HHHHHHHHHHHHHhc--------CCCCee
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----------KKKIKREIKILENLR--------GGTNII  229 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----------~~~~~~Ei~il~~l~--------~~~~iv  229 (467)
                      ..++|++++.||+|+||.||+|.+  +++.||||+++...           .+.+.+|+.+++.++        .|+||+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            357899999999999999999987  67999999987532           267889999999997        588888


Q ss_pred             EEEEEEeCC----------------------------CCCccEEEEeccCCccHHHHh--hcCCHHHHHHHHHHHHHHHH
Q psy3714         230 TLQAVVKDP----------------------------VSRTPALIFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALD  279 (467)
Q Consensus       230 ~l~~~~~~~----------------------------~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qll~al~  279 (467)
                      .+.+.+...                            .....++||||++++++.+.+  ..+++..++.++.||+.||+
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence            887764210                            145789999999988644333  35789999999999999999


Q ss_pred             HHH-HCCccccCCCCCceEEeCCC-------------------CcEEEEecccceecCCCCCcceeeeccCccCCccccc
Q psy3714         280 YCH-SMGIMHRDVKPHNVMIDHEN-------------------RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD  339 (467)
Q Consensus       280 ~lH-~~~IiHrDlKp~Nill~~~~-------------------~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~  339 (467)
                      ||| ++|||||||||+|||++.++                   ..+||+|||+|+.....    ..+||+.|+|||++.+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            999 99999999999999998654                   27999999999976532    4589999999999987


Q ss_pred             CCCCccchhHHHhhh-ccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhh
Q psy3714         340 YQYHIELDPRFADIL-GRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKL  418 (467)
Q Consensus       340 ~~~~~~~D~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~l  418 (467)
                      .. +.++|+|..... ......+..|+..        ..........+....   .+........+..+|++++|||++|
T Consensus       252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~--------~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~dli~~~  319 (336)
T 2vuw_A          252 DG-DYQFDIYRLMKKENNNRWGEYHPYSN--------VLWLHYLTDKMLKQM---TFKTKCNTPAMKQIKRKIQEFHRTM  319 (336)
T ss_dssp             CS-SHHHHHHHHHHHHHTTCTTSCCTHHH--------HHHHHHHHHHHHHTC---CCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred             CC-ccceehhhhhCCCCcccccccCCCcc--------hhhhhHHHHhhhhhh---ccCcccchhhhhhcCHHHHHHHHHH
Confidence            76 888999975332 1111112222110        000000111111000   0000000011223689999999999


Q ss_pred             cCcCCCCCCCHHHHh-CCCCCC
Q psy3714         419 LRYDHYERLTAREAM-DHPYFY  439 (467)
Q Consensus       419 L~~dp~~R~ta~e~l-~Hp~f~  439 (467)
                      |++|     ||+|+| +||||+
T Consensus       320 L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          320 LNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             GGSS-----SHHHHHHHCGGGC
T ss_pred             hccC-----CHHHHHhcCCCcC
Confidence            9987     999999 999984

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.8e-39  Score=312.76  Aligned_cols=262  Identities=24%  Similarity=0.443  Sum_probs=194.0

Q ss_pred             ccceeeeEeecccCCcceEEEEE-ccCCCeEEEEEeccch--HHHHHHHHHHHHHhcC-----CCCeeEEEEEEeCCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAIN-VQSSDKCVVKILKPVK--KKKIKREIKILENLRG-----GTNIITLQAVVKDPVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~-----~~~iv~l~~~~~~~~~~  241 (467)
                      .++|++++.||+|+||.||+|.+ ..+++.||+|+++...  ...+.+|+.+++.+.+     +++++.+.+++.+.  .
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~--~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH--G   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET--T
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC--C
Confidence            47899999999999999999998 5578899999997643  3567889999998863     23588998888753  4


Q ss_pred             ccEEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC---------------
Q psy3714         242 TPALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE---------------  301 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~---------------  301 (467)
                      ..++||||+ ++++.+.+.     .+++..+..++.||+.||+|||++||+||||||+|||++..               
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~  169 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER  169 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence            689999999 677766653     37789999999999999999999999999999999999853               


Q ss_pred             ---CCcEEEEecccceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhh
Q psy3714         302 ---NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEA  378 (467)
Q Consensus       302 ---~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (467)
                         +..+||+|||+|+....  .....+||+.|+|||++.+..|+.++|+|..+++.+....+..+|......     +.
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~  242 (339)
T 1z57_A          170 TLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK-----EH  242 (339)
T ss_dssp             EESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH-----HH
T ss_pred             cccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-----HH
Confidence               34699999999987543  234467999999999999989999999998887765555554444321110     00


Q ss_pred             hhhhhhhccCCC----------------Cccccccc--------------cc-ccCCCCCChHHHHHHHhhcCcCCCCCC
Q psy3714         379 LDFLDKNILGRH----------------SRKRWERF--------------VH-TENQHLVSPEALDFLDKLLRYDHYERL  427 (467)
Q Consensus       379 ~~~~~~~~~~~~----------------~~~~~~~~--------------~~-~~~~~~~s~~~~dli~~lL~~dp~~R~  427 (467)
                      ...... ..+..                ....|...              .. .......++++++||.+||+.||++||
T Consensus       243 ~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          243 LAMMER-ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHH-HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHH-HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            000000 00000                00011000              00 001112357889999999999999999


Q ss_pred             CHHHHhCCCCCCCcc
Q psy3714         428 TAREAMDHPYFYPIV  442 (467)
Q Consensus       428 ta~e~l~Hp~f~~~~  442 (467)
                      |++|+++||||..+.
T Consensus       322 t~~ell~hp~f~~~~  336 (339)
T 1z57_A          322 TLREALKHPFFDLLK  336 (339)
T ss_dssp             CHHHHTTSGGGGGGG
T ss_pred             CHHHHhcCHHHHHHh
Confidence            999999999998754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.7e-38  Score=314.13  Aligned_cols=248  Identities=21%  Similarity=0.290  Sum_probs=194.4

Q ss_pred             CccceeeeEeecccCCcceEEEE-----EccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAI-----NVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++.+.||+|+||.||+|.     +..+++.||||+++..    ..+.+.+|+.++..+.+||||+++++++.+..
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~   99 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   99 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence            35889999999999999999998     4556689999998753    23468899999999988999999999987643


Q ss_pred             CCccEEEEeccCCccHHHHhhc----------------------------------------------------------
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQT----------------------------------------------------------  261 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~~----------------------------------------------------------  261 (467)
                       ...++||||+++++|.+++..                                                          
T Consensus       100 -~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A          100 -GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             -SCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             -CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence             457999999999999877642                                                          


Q ss_pred             -----------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC---cceeee
Q psy3714         262 -----------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVA  327 (467)
Q Consensus       262 -----------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~---~~~~~g  327 (467)
                                 +++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.......   .....|
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~  257 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARL  257 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccccCC
Confidence                       78888999999999999999999999999999999998555 799999999986643322   234578


Q ss_pred             ccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCC
Q psy3714         328 SRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHL  406 (467)
Q Consensus       328 t~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
                      |+.|+|||++.+..|+.++|+|..+++.+.... +..||.....    ...........             .....+..
T Consensus       258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~~~~~~-------------~~~~~~~~  320 (359)
T 3vhe_A          258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DEEFCRRLKEG-------------TRMRAPDY  320 (359)
T ss_dssp             CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----SHHHHHHHHHT-------------CCCCCCTT
T ss_pred             CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch----hHHHHHHHHcC-------------CCCCCCCC
Confidence            999999999999899999999988887665543 4444422111    01111111110             01112345


Q ss_pred             CChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         407 VSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       407 ~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      +++++.+||.+||+.||++|||++|+++|
T Consensus       321 ~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          321 TTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            78999999999999999999999999976

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.8e-38  Score=306.78  Aligned_cols=254  Identities=21%  Similarity=0.352  Sum_probs=196.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||+|.+... ....+.+|+.+++.+. ||||+++++.+.+.  ...++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCD-SPHVVKYYGSYFKN--TDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCC-CTTBCCEEEEEEET--TEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeC--CEEEEEe
Confidence            357899999999999999999999999999999998754 3467889999999995 89999999988753  4679999


Q ss_pred             eccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-Cc
Q psy3714         248 EHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EY  322 (467)
Q Consensus       248 e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~~  322 (467)
                      ||+.+++|.++..    .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....... ..
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~  182 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDTMAKR  182 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTTBSCB
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhhcccc
Confidence            9999999987764    588999999999999999999999999999999999998655 79999999998764332 23


Q ss_pred             ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccccc
Q psy3714         323 NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE  402 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
                      ....||+.|+|||++.+..++.+.|+|..+++.+....+..||.....     ..........     ....+      .
T Consensus       183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~-----~~~~~------~  246 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-----MRAIFMIPTN-----PPPTF------R  246 (314)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHS-----CCCCC------S
T ss_pred             CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhcC-----CCccc------C
Confidence            445799999999999998899999999888876555444444422110     0000000000     00000      1


Q ss_pred             CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       403 ~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .+..+++++.+||.+||..||++|||++|+++||||....
T Consensus       247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            1234689999999999999999999999999999998654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.3e-38  Score=303.82  Aligned_cols=252  Identities=21%  Similarity=0.341  Sum_probs=197.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .++|++++.||+|+||.||+|.+..+++.||+|.++..     ..+.+.+|+.+++.++ ||||+++++.+.+......+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceEE
Confidence            47899999999999999999999999999999998642     2456789999999995 89999999987654456789


Q ss_pred             EEEeccCCccHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCceEEeCCCCcEEEEeccc
Q psy3714         245 LIFEHVNNTDFKQLYQT-------LTDYDIRYYLYELLKALDYCHSMG-----IMHRDVKPHNVMIDHENRKLRLIDWGL  312 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qll~al~~lH~~~-----IiHrDlKp~Nill~~~~~~ikl~DFGl  312 (467)
                      +||||+++++|.+++..       +++..+..++.|++.||+|||++|     |+||||||+|||++.++ .+||+|||+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~dfg~  162 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGL  162 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-CEEECCCCH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-CEEEecCch
Confidence            99999999999877642       889999999999999999999999     99999999999998554 799999999


Q ss_pred             ceecCCCCC-cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         313 AEFYHPGQE-YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       313 a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      ++....... .....||+.|+|||++.+..++.+.|+|..+++.+....+..||.....     ......+..   +.  
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~i~~---~~--  232 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIRE---GK--  232 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH---TC--
T ss_pred             heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----HHHHHHHhh---cc--
Confidence            987643322 2335789999999999998899999999888876555444444322110     011111111   00  


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                         +     ...+..+++++.+||.+||+.||++|||++|+++|||+.+-
T Consensus       233 ---~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          233 ---F-----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             ---C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             ---c-----ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence               0     01123478999999999999999999999999999999764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.3e-38  Score=305.89  Aligned_cols=246  Identities=16%  Similarity=0.240  Sum_probs=192.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|.+...   ..+.+.+|+.+++.++ ||||+++++++.+.  ...++
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~~~l   84 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKD--KRLNF   84 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEET--TEEEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecC--CeeEE
Confidence            357899999999999999999999999999999988543   3456789999999996 89999999998764  56899


Q ss_pred             EEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         246 IFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      ||||+++++|.++..    .+++.++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS-CEEECCCTTCEECC----
T ss_pred             EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC-CEEEeecccceecccccc
Confidence            999999999988764    478899999999999999999999999999999999998554 799999999987643221


Q ss_pred             c---------------ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhc
Q psy3714         322 Y---------------NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI  386 (467)
Q Consensus       322 ~---------------~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (467)
                      .               ...+||+.|+|||++.+..|+.++|+|..+++.+....+..++.........            
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------------  231 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------------  231 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT------------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH------------
Confidence            1               1457999999999999999999999998887755443333222111100000            


Q ss_pred             cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                          .............+..+++++.+||.+||+.||++|||++|+++
T Consensus       232 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          232 ----FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             ----SSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----HhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                00000011111223457899999999999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.8e-39  Score=323.89  Aligned_cols=254  Identities=20%  Similarity=0.256  Sum_probs=185.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      ..+|++.+.||+|+||.|+. ....+++.||||.+.........+|+.+|+.+..||||+++++.+.+.  ...++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDR--QFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecC--CEEEEEEEC
Confidence            45799999999999999764 345678999999987655556789999999997799999999988753  567999999


Q ss_pred             cCCccHHHHhhc----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC----CcEEEEecccceecCCCC-
Q psy3714         250 VNNTDFKQLYQT----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN----RKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       250 ~~~~~l~~~~~~----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~----~~ikl~DFGla~~~~~~~-  320 (467)
                      +.+ ++.+++..    +++.++..++.||+.||+|||++||+||||||+|||++.++    ..+||+|||+|+....+. 
T Consensus       100 ~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~  178 (432)
T 3p23_A          100 CAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH  178 (432)
T ss_dssp             CSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred             CCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence            975 77776642    45567789999999999999999999999999999995322    258899999998764332 


Q ss_pred             ---CcceeeeccCccCCccccc---CCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         321 ---EYNVRVASRYFKGPELLAD---YQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       321 ---~~~~~~gt~~y~aPE~l~~---~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                         .....+||+.|+|||++.+   ..++.++|+|..+++.+.... +..|+. ...     .....    .........
T Consensus       179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~-~~~-----~~~~~----~~~~~~~~~  248 (432)
T 3p23_A          179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG-KSL-----QRQAN----ILLGACSLD  248 (432)
T ss_dssp             -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB-STT-----THHHH----HHTTCCCCT
T ss_pred             ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc-hhh-----HHHHH----HHhccCCcc
Confidence               2334679999999999984   457778999988887555444 333331 110     00000    001110000


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      ..      ......++.+++||.+||+.||++|||++|+++||||..+.+
T Consensus       249 ~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          249 CL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             TS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             cc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence            00      011124667999999999999999999999999999987654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.2e-38  Score=314.19  Aligned_cols=266  Identities=24%  Similarity=0.428  Sum_probs=193.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCC-CeEEEEEeccc--hHHHHHHHHHHHHHhcCCC-----CeeEEEEEEeCCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSS-DKCVVKILKPV--KKKKIKREIKILENLRGGT-----NIITLQAVVKDPVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~-----~iv~l~~~~~~~~~~  241 (467)
                      .++|++++.||+|+||.||+|.+..++ ..||+|+++..  ....+.+|+.+++.+.++.     +++.+...+...  .
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~--~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH--G   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET--T
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC--C
Confidence            478999999999999999999998777 68999999764  2456788999999987322     377777777653  4


Q ss_pred             ccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC-----------------
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH-----------------  300 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~-----------------  300 (467)
                      ..++||||+.++.+..+..    .+++.+++.++.||+.||+|||++||+||||||+|||++.                 
T Consensus        96 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~  175 (355)
T 2eu9_A           96 HMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS  175 (355)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred             eEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence            6899999996554443332    4889999999999999999999999999999999999932                 


Q ss_pred             -CCCcEEEEecccceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhh
Q psy3714         301 -ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEAL  379 (467)
Q Consensus       301 -~~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (467)
                       .+..+||+|||+|+....  .....+||+.|+|||++.+..|+.++|+|..+++.+....+..||......     ...
T Consensus       176 ~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~  248 (355)
T 2eu9_A          176 VKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR-----EHL  248 (355)
T ss_dssp             ESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHH
T ss_pred             cCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HHH
Confidence             345799999999987543  234467999999999999999999999998888766555555554322110     000


Q ss_pred             hhhhhhccCCCC----------------cccccccc---------------cccCCCCCChHHHHHHHhhcCcCCCCCCC
Q psy3714         380 DFLDKNILGRHS----------------RKRWERFV---------------HTENQHLVSPEALDFLDKLLRYDHYERLT  428 (467)
Q Consensus       380 ~~~~~~~~~~~~----------------~~~~~~~~---------------~~~~~~~~s~~~~dli~~lL~~dp~~R~t  428 (467)
                      ..+.. ..+..+                ...|....               ........++++++||++||+.||++|||
T Consensus       249 ~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          249 VMMEK-ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHH-HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHH-HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence            00000 000000                00000000               00001123568999999999999999999


Q ss_pred             HHHHhCCCCCCCccccc
Q psy3714         429 AREAMDHPYFYPIVKDQ  445 (467)
Q Consensus       429 a~e~l~Hp~f~~~~~~~  445 (467)
                      ++|+|+||||.++.++.
T Consensus       328 ~~e~l~hp~f~~~~~~~  344 (355)
T 2eu9_A          328 LAEALLHPFFAGLTPEE  344 (355)
T ss_dssp             HHHHTTSGGGGGCCHHH
T ss_pred             HHHHhcChhhcCCChhh
Confidence            99999999999887543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5e-38  Score=303.56  Aligned_cols=250  Identities=22%  Similarity=0.337  Sum_probs=200.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ..+.|++++.||+|+||.||+|.+..+++.||+|+++..    ..+.+.+|+.+++.+. |+||+++++.+.+.  ...+
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~   96 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKD--TKLW   96 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCC-CTTBCCEEEEEEET--TEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecC--CeEE
Confidence            457799999999999999999999999999999998643    2467889999999995 89999999988753  4689


Q ss_pred             EEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-C
Q psy3714         245 LIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-E  321 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~  321 (467)
                      +||||++++++.++..  .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....... .
T Consensus        97 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  175 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIK  175 (303)
T ss_dssp             EEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECBTTBCC
T ss_pred             EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-CEEEeecccceecCccccc
Confidence            9999999999988775  488999999999999999999999999999999999998655 79999999998764332 2


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      .....||+.|+|||++.+..++.++|+|..+++......+..|+.....     ..........   .          ..
T Consensus       176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~---~----------~~  237 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-----MKVLFLIPKN---N----------PP  237 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHS---C----------CC
T ss_pred             cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-----HHHHHHhhcC---C----------CC
Confidence            3446799999999999998899999999888776554444444321110     0011111000   0          01


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      .....+++++++||.+||..||++|||++|+++||||..
T Consensus       238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence            112357899999999999999999999999999999964

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.8e-38  Score=311.90  Aligned_cols=245  Identities=19%  Similarity=0.246  Sum_probs=190.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEcc-------CCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQ-------SSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      .++|++.+.||+|+||.||+|.+..       ++..||+|+++..    ....+.+|+.+|+.+..||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            4789999999999999999998753       3457999998753    2346789999999996699999999998764


Q ss_pred             CCCccEEEEeccCCccHHHHhhc-------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEe
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQT-------------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID  299 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~~-------------------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~  299 (467)
                        ...++||||+++++|.+++..                   ++..++..++.||+.||+|||++||+||||||+|||++
T Consensus       160 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          160 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             --CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence              468999999999999887642                   67788999999999999999999999999999999998


Q ss_pred             CCCCcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCC
Q psy3714         300 HENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVS  375 (467)
Q Consensus       300 ~~~~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  375 (467)
                      .++ .+||+|||+|+.......   .....+|+.|+|||++.+..|+.++|+|..+++.+.... +..||.....     
T Consensus       238 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-----  311 (370)
T 2psq_A          238 ENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----  311 (370)
T ss_dssp             TTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----
T ss_pred             CCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence            655 799999999987643322   223457889999999999999999999988887655443 3344322110     


Q ss_pred             hhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         376 PEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ..........             .....+..+++++.+||.+||..||++|||++|++++
T Consensus       312 ~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          312 EELFKLLKEG-------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGHHHHHHTT-------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcC-------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1111111110             0111234578999999999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.9e-38  Score=309.30  Aligned_cols=260  Identities=20%  Similarity=0.290  Sum_probs=176.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCC---eEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSD---KCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      ..++|++.+.||+|+||.||+|.+..+++   .||+|+++..     ..+.+.+|+.+++.++ ||||+++++++.....
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC--
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC-CCceehhhceeecccc
Confidence            35789999999999999999999887765   7999998643     2456889999999995 8999999998865432


Q ss_pred             C----ccEEEEeccCCccHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEE
Q psy3714         241 R----TPALIFEHVNNTDFKQLYQ---------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRL  307 (467)
Q Consensus       241 ~----~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl  307 (467)
                      .    ..+++|||+.+++|.++..         .+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~-~~kl  178 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-TVCV  178 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC-CEEE
Confidence            1    2389999999999987753         388899999999999999999999999999999999998654 7999


Q ss_pred             EecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhh
Q psy3714         308 IDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLD  383 (467)
Q Consensus       308 ~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  383 (467)
                      +|||+|+........   ....+|+.|+|||++.+..|+.++|+|..+++.+.... +..||.....     ....... 
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~~~-  252 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----AEIYNYL-  252 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHH-
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----HHHHHHH-
Confidence            999999876433222   23456788999999999999999999988887554444 3333322111     1111111 


Q ss_pred             hhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCC-------HHHHhCCCCCCCcccccccC
Q psy3714         384 KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLT-------AREAMDHPYFYPIVKDQSRH  448 (467)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~t-------a~e~l~Hp~f~~~~~~~~~~  448 (467)
                         ....         ....+..+++++++||.+||+.||++|||       ++++++|||+....+++...
T Consensus       253 ---~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~  312 (323)
T 3qup_A          253 ---IGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYI  312 (323)
T ss_dssp             ---HTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------------
T ss_pred             ---hcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCC
Confidence               0000         01123457899999999999999999999       78899999998765554443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.1e-38  Score=303.47  Aligned_cols=253  Identities=20%  Similarity=0.282  Sum_probs=193.3

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ++|.....||+|+||.||+|.+..++..||+|.++...   .+.+.+|+.+++.++ ||||+++.+++.+.  ...++||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~   98 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK-HKNIVQYLGSFSEN--GFIKIFM   98 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCC-CTTBCCEEEEEEET--TEEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeC--CcEEEEE
Confidence            44555668999999999999999999999999986532   456789999999995 89999999998753  4689999


Q ss_pred             eccCCccHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-
Q psy3714         248 EHVNNTDFKQLYQ------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       248 e~~~~~~l~~~~~------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-  320 (467)
                      ||+++++|.++..      .+++..+..++.|++.||.|||++||+||||||+||+++..++.+||+|||+++...... 
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            9999999988764      245778889999999999999999999999999999999745689999999998764322 


Q ss_pred             CcceeeeccCccCCcccccCC--CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQ--YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~--~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      ......||+.|+|||++.+..  ++.+.|+|..+++.+....+..||.....     ... .........          
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~-~~~~~~~~~----------  242 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE-----PQA-AMFKVGMFK----------  242 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS-----HHH-HHHHHHHHC----------
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc-----hhH-HHHhhcccc----------
Confidence            223457899999999997654  78899999888876555454444432111     000 000000000          


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .....+..+++++++||.+||+.||++|||++|+|+||||....
T Consensus       243 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            01112345799999999999999999999999999999997543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=319.10  Aligned_cols=262  Identities=18%  Similarity=0.266  Sum_probs=197.5

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.||||+++..    ....+.+|+++++.++ ||||+++++++.+......+
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCCeeE
Confidence            357899999999999999999999999999999998753    2356789999999996 89999999998876666789


Q ss_pred             EEEeccCCccHHHHhhc------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE----eCCCCcEEEEecccce
Q psy3714         245 LIFEHVNNTDFKQLYQT------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI----DHENRKLRLIDWGLAE  314 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill----~~~~~~ikl~DFGla~  314 (467)
                      +||||+++++|.+++..      +++..+..++.||+.||+|||++||+||||||+|||+    + .+..+||+|||+|+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG~a~  164 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED-GQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTT-SCEEEEECCGGGCE
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCC-CceeEEEecCCCce
Confidence            99999999999988753      8999999999999999999999999999999999998    4 33469999999999


Q ss_pred             ecCCCCCcceeeeccCccCCccccc--------CCCCccchhHHHhhhccccccccccccccCCcccCChhh-hhhhhhh
Q psy3714         315 FYHPGQEYNVRVASRYFKGPELLAD--------YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEA-LDFLDKN  385 (467)
Q Consensus       315 ~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  385 (467)
                      ...........+||+.|+|||++.+        ..|+.++|+|..+++.+....+..||........ .... .......
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~-~~~~~~~~~~~~  243 (396)
T 4eut_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR-NKEVMYKIITGK  243 (396)
T ss_dssp             ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT-CHHHHHHHHHSC
T ss_pred             EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc-hHHHHHHHhcCC
Confidence            8765555556789999999999875        4577889999888877666666666543221100 0111 0110000


Q ss_pred             cc--------CCCCcccccccccccC--CCCCChHHHHHHHhhcCcCCCCCCCHHHHh
Q psy3714         386 IL--------GRHSRKRWERFVHTEN--QHLVSPEALDFLDKLLRYDHYERLTAREAM  433 (467)
Q Consensus       386 ~~--------~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~lL~~dp~~R~ta~e~l  433 (467)
                      ..        .......|........  ...+++.+.+||++||++||++|+|++|++
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l  301 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF  301 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHH
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHH
Confidence            00        0001112221111110  112456889999999999999999999874

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.8e-38  Score=302.63  Aligned_cols=255  Identities=20%  Similarity=0.259  Sum_probs=194.3

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      -.++|++++.||+|+||.||+|.+..++..||+|++...      ..+.+.+|+.+++.++ ||||+++++++.+.  ..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~--~~   85 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEED--DC   85 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECS--SE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeC--Ce
Confidence            357899999999999999999999999999999987432      2356789999999996 89999999998763  56


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      .++||||+++++|.++..   .+++.++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSET  164 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCSSSTTC---
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEEeCCCccccccc
Confidence            899999999999988764   489999999999999999999999999999999999998655 7999999999866433


Q ss_pred             C--CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         320 Q--EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       320 ~--~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      .  .....+||+.|+|||++.+..++.++|+|..+++.+....+..||....        ........+......     
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~~-----  231 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--------AVSIAIKHIQDSVPN-----  231 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC--------HHHHHHHHHSSCCCC-----
T ss_pred             cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhhccCCC-----
Confidence            2  2234579999999999999999999999988887666555555543211        011011111111000     


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                       ........+++++.++|.+||+.||++||+..+.+.++|..-.
T Consensus       232 -~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          232 -VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             -HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             -cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence             0111234578999999999999999999977777777775543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.9e-38  Score=318.43  Aligned_cols=254  Identities=21%  Similarity=0.272  Sum_probs=184.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      .+.|.+.+.||+|+||+||.+ ...+++.||||.+.........+|+.+|+.+.+||||+++++.+.+.  ...++||||
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~lv~E~   90 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD--RFLYIALEL   90 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECS--SEEEEEECC
T ss_pred             hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecC--CeEEEEEec
Confidence            355677889999999999875 45678999999987766677889999999887799999999988753  568999999


Q ss_pred             cCCccHHHHhhcC----------CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC------------CCcEEE
Q psy3714         250 VNNTDFKQLYQTL----------TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE------------NRKLRL  307 (467)
Q Consensus       250 ~~~~~l~~~~~~~----------~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~------------~~~ikl  307 (467)
                      ++ ++|.+++...          ++.++..++.||+.||+|||++||+||||||+|||++.+            +..+||
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            96 5888776432          222456799999999999999999999999999999743            247999


Q ss_pred             EecccceecCCCCC-----cceeeeccCccCCccccc-------CCCCccchhHHHhhhcccccc-ccccccccCCcccC
Q psy3714         308 IDWGLAEFYHPGQE-----YNVRVASRYFKGPELLAD-------YQYHIELDPRFADILGRHSRK-RWERFVHTENQHLV  374 (467)
Q Consensus       308 ~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~l~~-------~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~  374 (467)
                      +|||+|+.......     ....+||+.|+|||++.+       ..++.++|+|..+++.+.... +..||.....    
T Consensus       170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----  245 (434)
T 2rio_A          170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS----  245 (434)
T ss_dssp             CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT----
T ss_pred             cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh----
Confidence            99999997754322     224579999999999976       568899999988887655544 3444321110    


Q ss_pred             ChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         375 SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                        .......    +.........    .....+++++++||.+||+.||++|||++|+++||||.+.
T Consensus       246 --~~~~i~~----~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          246 --RESNIIR----GIFSLDEMKC----LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             --HHHHHHH----TCCCCCCCTT----CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             --hHHHHhc----CCCCcccccc----cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence              0111111    1111000000    0011256899999999999999999999999999999754

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.4e-38  Score=302.47  Aligned_cols=245  Identities=18%  Similarity=0.285  Sum_probs=196.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC-----------
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDP-----------  238 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~-----------  238 (467)
                      ..+|++++.||+|+||.||+|.+..+++.||+|.++... ..+.+|+++++.++ ||||+++.+++...           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC--------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhCC-CCCEEEEeeeEeccccCcccccccc
Confidence            368999999999999999999999999999999987543 46789999999996 89999998877531           


Q ss_pred             ---CCCccEEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEec
Q psy3714         239 ---VSRTPALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDW  310 (467)
Q Consensus       239 ---~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DF  310 (467)
                         .....++||||+++++|.+++.     .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+||
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Df  166 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDF  166 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCC
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-CEEECcc
Confidence               1234789999999999988763     478889999999999999999999999999999999999554 8999999


Q ss_pred             ccceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCC
Q psy3714         311 GLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRH  390 (467)
Q Consensus       311 Gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (467)
                      |+++............||+.|+|||++.+..++.+.|+|..+++......+..++..          ...... ...   
T Consensus       167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~----------~~~~~~-~~~---  232 (284)
T 2a19_B          167 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE----------TSKFFT-DLR---  232 (284)
T ss_dssp             TTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH----------HHHHHH-HHH---
T ss_pred             hhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh----------HHHHHH-Hhh---
Confidence            999887655555556799999999999998899999999888775443333222211          000100 000   


Q ss_pred             CcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         391 SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       391 ~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                               ....+..+++++++||.+||..||++|||++|+++|++...
T Consensus       233 ---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          233 ---------DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ---------TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ---------cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                     00112347899999999999999999999999999988643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-38  Score=313.54  Aligned_cols=251  Identities=17%  Similarity=0.235  Sum_probs=193.3

Q ss_pred             CccceeeeEeecccCCcceEEEE-----EccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAI-----NVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++++.||+|+||.||+|.     +..++..||||.++..    ....+.+|+.+++.++ ||||+++++++.+. 
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~-  146 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQS-  146 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS-
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEecC-
Confidence            35789999999999999999999     4557788999998643    2346788999999995 89999999998753 


Q ss_pred             CCccEEEEeccCCccHHHHhh----------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC--CcEEE
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ----------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRL  307 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~--~~ikl  307 (467)
                       ...++||||+++++|.+++.          .++..++..++.||+.||+|||++||+||||||+|||++.++  ..+||
T Consensus       147 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          147 -LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             -CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence             45799999999999988764          278889999999999999999999999999999999998433  35999


Q ss_pred             EecccceecCC---CCCcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhh
Q psy3714         308 IDWGLAEFYHP---GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLD  383 (467)
Q Consensus       308 ~DFGla~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  383 (467)
                      +|||+|+....   ........||+.|+|||++.+..|+.++|+|..+++...... +..||.....     ........
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-----~~~~~~i~  300 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVLEFVT  300 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHHHH
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH
Confidence            99999975421   122234568999999999999999999999988887555443 3344322110     11111111


Q ss_pred             hhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         384 KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      ..   .          ....+..+++++.+||.+||+.||++|||++|+++|.++..
T Consensus       301 ~~---~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          301 SG---G----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             TT---C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cC---C----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            10   0          01123357899999999999999999999999999998753

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8e-39  Score=335.32  Aligned_cols=273  Identities=19%  Similarity=0.302  Sum_probs=199.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeC----CCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKD----PVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~----~~~~  241 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++..    ....+.+|+.+++.++ ||||+.+.+++..    ....
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccCCC
Confidence            37899999999999999999999999999999988643    2456788999999995 8999999988654    1245


Q ss_pred             ccEEEEeccCCccHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC--cEEEEecccc
Q psy3714         242 TPALIFEHVNNTDFKQLYQ------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLA  313 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~--~ikl~DFGla  313 (467)
                      ..++||||+++++|.++..      .+++..++.++.|++.||.|||++||+||||||+|||++.++.  .+||+|||+|
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            6799999999999988765      3788899999999999999999999999999999999986542  4899999999


Q ss_pred             eecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhcc-C--CC
Q psy3714         314 EFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL-G--RH  390 (467)
Q Consensus       314 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~  390 (467)
                      +...........+||+.|+|||++.+..|+.++|+|..+++.+....+..||.......-.............. .  ..
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~  251 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT  251 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred             cccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence            98766555566789999999999999999999999988887666556655654321000000000000000000 0  00


Q ss_pred             Ccccccccccc--cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         391 SRKRWERFVHT--ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       391 ~~~~~~~~~~~--~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      ....+......  .....+++++.+||.+||.+||++|||++|+++||||..+..
T Consensus       252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~  306 (676)
T 3qa8_A          252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS  306 (676)
T ss_dssp             SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred             cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence            00111111110  111235789999999999999999999999999999987654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6e-38  Score=301.83  Aligned_cols=258  Identities=17%  Similarity=0.280  Sum_probs=189.2

Q ss_pred             CccceeeeEeecccCCcceEEEE----EccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAI----NVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ..++|++++.||+|+||.||+|.    +..+++.||+|+++...   .+.+.+|+.+++.++ ||||+++.+++......
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHHHHT
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCC
Confidence            45789999999999999999998    56788999999987543   356789999999996 89999999988654445


Q ss_pred             ccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..++||||+++++|.+++.    .+++.++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLP  165 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCSCC---
T ss_pred             ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-eEEEccCccccccc
Confidence            6899999999999988764    388999999999999999999999999999999999999655 89999999998764


Q ss_pred             CCCC----cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCC---
Q psy3714         318 PGQE----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRH---  390 (467)
Q Consensus       318 ~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  390 (467)
                      ....    .....+|..|+|||++.+..|+.++|+|..+++......+..++.....      ..............   
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH------HHHHHHCTTCCTHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH------HHHhhhcCccccchhHH
Confidence            3322    1223578889999999999999999999888775544443333211100      00000000000000   


Q ss_pred             -CcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         391 -SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       391 -~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                       ...........+.+..+++++.+||.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             00000000111223457999999999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.9e-38  Score=305.96  Aligned_cols=257  Identities=18%  Similarity=0.302  Sum_probs=173.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||||+++...    .....+|+..+.+..+||||+++++++.+.  ...+
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~~~   97 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GDCW   97 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--CceE
Confidence            3578999999999999999999999999999999986532    234556666444444699999999998764  4689


Q ss_pred             EEEeccCCccHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         245 LIFEHVNNTDFKQLY--------QTLTDYDIRYYLYELLKALDYCHSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       245 lv~e~~~~~~l~~~~--------~~~~~~~~~~~~~qll~al~~lH~~-~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                      +||||+.+ ++.+++        ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~  175 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGISGQ  175 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSSCC
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCcee
Confidence            99999986 554443        2478889999999999999999999 999999999999999554 899999999987


Q ss_pred             cCCCCCcceeeeccCccCCccc----ccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         316 YHPGQEYNVRVASRYFKGPELL----ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       316 ~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      ...........||+.|+|||++    .+..|+.+.|+|..+++......+..||.....       ..........+   
T Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~---  245 (327)
T 3aln_A          176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS-------VFDQLTQVVKG---  245 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCS---
T ss_pred             cccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch-------HHHHHHHHhcC---
Confidence            6544444445799999999999    455688999999888876655555445432110       00000000000   


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                        .... ........+++++++||++||+.||++|||++|+++||||....
T Consensus       246 --~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          246 --DPPQ-LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             --CCCC-CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             --CCCC-CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence              0000 01112235799999999999999999999999999999997654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.1e-37  Score=302.19  Aligned_cols=249  Identities=18%  Similarity=0.308  Sum_probs=186.2

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..++|++.+.||+|+||.||+|.+  +++.||+|++....     .+.+.+|+.+++.++ ||||+++.+++.+.  ...
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~~  109 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQP--PNL  109 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECST--TCC
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEC--Cce
Confidence            357899999999999999999976  57889999986432     346789999999996 89999999998764  458


Q ss_pred             EEEEeccCCccHHHHhhc------CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         244 ALIFEHVNNTDFKQLYQT------LTDYDIRYYLYELLKALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qll~al~~lH~~~--IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                      ++||||+++++|.+++..      +++..+..++.|++.||+|||++|  |+||||||+|||++.++ .+||+|||+|+.
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~  188 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-TVKVCDFGLSRL  188 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-CEEECCCC----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC-cEEECCCCCCcc
Confidence            999999999999887642      888999999999999999999999  99999999999998554 799999999986


Q ss_pred             cCCCC-CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         316 YHPGQ-EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       316 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ..... .....+||+.|+|||++.+..++.++|+|..+++.+....+..||.....     ........   . ..    
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-----~~~~~~~~---~-~~----  255 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-----AQVVAAVG---F-KC----  255 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-----HHHHHHHH---H-SC----
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH---h-cC----
Confidence            53322 23346799999999999999999999999888876655555555432110     00111000   0 00    


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC--CCCCCC
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD--HPYFYP  440 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~--Hp~f~~  440 (467)
                          .....+..+++++.+||.+||+.||++|||++|+++  ++++..
T Consensus       256 ----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          256 ----KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ----CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                011223457999999999999999999999999987  566544

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-38  Score=304.97  Aligned_cols=245  Identities=22%  Similarity=0.344  Sum_probs=190.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---------HHHHHHHHHHHHHhc---CCCCeeEEEEEEeC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---------KKKIKREIKILENLR---GGTNIITLQAVVKD  237 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------~~~~~~Ei~il~~l~---~~~~iv~l~~~~~~  237 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++...         ...+.+|+.+++.+.   .|+||+++++++.+
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            478999999999999999999999999999999986432         223467999999985   58999999998865


Q ss_pred             CCCCccEEEEec-cCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccc
Q psy3714         238 PVSRTPALIFEH-VNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA  313 (467)
Q Consensus       238 ~~~~~~~lv~e~-~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla  313 (467)
                      .  ...++|||+ +.+++|.+++.   .+++..+..++.||+.||+|||++||+||||||+||+++..++.+||+|||++
T Consensus       110 ~--~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~  187 (312)
T 2iwi_A          110 Q--EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG  187 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred             C--CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence            3  467999999 78889887764   48999999999999999999999999999999999999855558999999999


Q ss_pred             eecCCCCCcceeeeccCccCCcccccCCCC-ccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         314 EFYHPGQEYNVRVASRYFKGPELLADYQYH-IELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       314 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      +..... ......||+.|+|||++.+..+. .++|+|..+++.+....+..+|...          .......       
T Consensus       188 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----------~~~~~~~-------  249 (312)
T 2iwi_A          188 ALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----------QEILEAE-------  249 (312)
T ss_dssp             EECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----------HHHHHTC-------
T ss_pred             hhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----------HHHhhhc-------
Confidence            876543 34456799999999999877764 5899998888755544444443210          0111000       


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                              ...+..+++++++||.+||+.||++|||++|+++||||....
T Consensus       250 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          250 --------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             --------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence                    011235799999999999999999999999999999998654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.3e-37  Score=302.74  Aligned_cols=249  Identities=16%  Similarity=0.212  Sum_probs=191.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+.+|+||+.+++++.+.  ...++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEET--TEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecC--CccEEEEE
Confidence            47899999999999999999999999999999998643 3456889999999997799999999988763  56899999


Q ss_pred             ccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCc-----EEEEecccceecCCC
Q psy3714         249 HVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRK-----LRLIDWGLAEFYHPG  319 (467)
Q Consensus       249 ~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~-----ikl~DFGla~~~~~~  319 (467)
                      |+ +++|.+++.    .+++..+..++.|++.||+|||++||+||||||+|||++.++ .     +||+|||+|+.+...
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCEESBCT
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCC-CCCCceEEEEEcccceeeecC
Confidence            99 888887764    589999999999999999999999999999999999998554 4     999999999876433


Q ss_pred             CC--------cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         320 QE--------YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       320 ~~--------~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      ..        ....+||+.|+|||++.+..|+.++|+|..+++.+....+..||......     ........ +..   
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~-----~~~~~~~~-i~~---  234 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD-----TLKERYQK-IGD---  234 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS-----SHHHHHHH-HHH---
T ss_pred             CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc-----cHHHHHHH-HHh---
Confidence            21        23567999999999999999999999998888766665555555432211     11110000 000   


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                       ....  ...+......+++.+||.+||..||.+|||++++++
T Consensus       235 -~~~~--~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          235 -TKRA--TPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             -HHHH--SCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -hhcc--CCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence             0000  000000112349999999999999999999887765

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-37  Score=307.37  Aligned_cols=246  Identities=20%  Similarity=0.267  Sum_probs=192.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCC-------CeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSS-------DKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKD  237 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~  237 (467)
                      ..++|++.+.||+|+||.||+|.+..++       ..||+|+++...    ...+.+|+++++.+..||||+++.+++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            3578999999999999999999976433       479999987532    35678999999999779999999999876


Q ss_pred             CCCCccEEEEeccCCccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE
Q psy3714         238 PVSRTPALIFEHVNNTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI  298 (467)
Q Consensus       238 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill  298 (467)
                      .  ...++||||+.+++|.+++.                   .+++.++..++.||+.||+|||++||+||||||+|||+
T Consensus       147 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          147 D--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             S--SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             C--CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence            4  46899999999999988764                   27899999999999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceecCCCC---CcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccC
Q psy3714         299 DHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLV  374 (467)
Q Consensus       299 ~~~~~~ikl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~  374 (467)
                      +.++ .+||+|||+|+......   ......+|+.|+|||++.+..++.++|+|..+++...... +..|+....     
T Consensus       225 ~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-----  298 (382)
T 3tt0_A          225 TEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----  298 (382)
T ss_dssp             CTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred             cCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-----
Confidence            8655 79999999998764332   2233467899999999999889999999988877554443 333332111     


Q ss_pred             ChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         375 SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ...........             .....+..+++++.+||++||+.||++|||++|+++|
T Consensus       299 ~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          299 VEELFKLLKEG-------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHHTT-------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcC-------------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            01111111110             0111234579999999999999999999999999886

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.4e-38  Score=301.36  Aligned_cols=256  Identities=19%  Similarity=0.221  Sum_probs=186.3

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHh-cCCCCeeEEEEEEeCC--CCCccEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENL-RGGTNIITLQAVVKDP--VSRTPAL  245 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l-~~~~~iv~l~~~~~~~--~~~~~~l  245 (467)
                      ..++|++++.||+|+||.||+|.+  +++.||||++.........+|.+++... -.||||+++.+.+.+.  .....++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            357899999999999999999987  6889999999877777778888888773 2589999998876432  2245789


Q ss_pred             EEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         246 IFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCH--------SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       246 v~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH--------~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                      ||||+++++|.++++  .+++..+..++.|++.||+|||        ++||+||||||+|||++.++ .+||+|||+|+.
T Consensus        84 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~  162 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIADLGLAVM  162 (301)
T ss_dssp             EECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred             ehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-CEEEeeCCCeee
Confidence            999999999998875  4889999999999999999999        99999999999999999554 799999999986


Q ss_pred             cCCCCCc-----ceeeeccCccCCcccccC------CCCccchhHHHhhhccccccc----------cccccccCCcccC
Q psy3714         316 YHPGQEY-----NVRVASRYFKGPELLADY------QYHIELDPRFADILGRHSRKR----------WERFVHTENQHLV  374 (467)
Q Consensus       316 ~~~~~~~-----~~~~gt~~y~aPE~l~~~------~~~~~~D~~~~~~~~~~~~~~----------~~~~~~~~~~~~~  374 (467)
                      .......     ...+||+.|+|||++.+.      .++.++|+|..+++.+....+          ..||.......  
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~--  240 (301)
T 3q4u_A          163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND--  240 (301)
T ss_dssp             EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS--
T ss_pred             cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC--
Confidence            6433221     234799999999999876      445689999888775544444          22221111000  


Q ss_pred             ChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         375 SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                        ...................   .........++++.+||.+||+.||++|||++|+++
T Consensus       241 --~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          241 --PSFEDMRKVVCVDQQRPNI---PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             --CCHHHHHHHHTTSCCCCCC---CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             --cchhhhhHHHhccCCCCCC---ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence              0000000000000000000   000001124578999999999999999999999985

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.5e-37  Score=293.45  Aligned_cols=244  Identities=14%  Similarity=0.245  Sum_probs=191.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..++|++++.||+|+||.||+|.+. +++.||+|+++..  ..+.+.+|+.+++.++ ||||+++++++.+.  ...++|
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv   83 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQ--APICLV   83 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC-CTTBCCEEEEECSS--SSEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCC-CCCEeeEEEEEecC--CceEEE
Confidence            3578999999999999999999986 4678999998753  3567899999999996 89999999998764  468999


Q ss_pred             EeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC--
Q psy3714         247 FEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--  320 (467)
Q Consensus       247 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~--  320 (467)
                      |||++++++.++..    .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+|+......  
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEEECCTTGGGGBCCHHHH
T ss_pred             EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-CEEeccccccccccccccc
Confidence            99999999988764    378899999999999999999999999999999999998554 79999999998653321  


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      ......+|+.|+|||++.+..++.++|+|..+++.+.... +..||....        ....... +...         .
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--------~~~~~~~-~~~~---------~  224 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVED-ISTG---------F  224 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHH-HHTT---------C
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHH-HhcC---------c
Confidence            1223456788999999998899999999988877554443 333332111        1111111 1000         0


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ....+...++++.+||.+||+.||++|||++|+++|
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            111234578999999999999999999999999876

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.3e-37  Score=300.33  Aligned_cols=251  Identities=23%  Similarity=0.345  Sum_probs=187.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcC-CCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRG-GTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~-~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++++.||+|+||.||+|.+. +++.||+|++...     ....+.+|+.+++.+.+ |+||+++++++.+.  ...
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~~~  103 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYI  103 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS--SEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC--CEE
Confidence            478999999999999999999885 5889999998642     23567899999999985 79999999988764  468


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      +++|| +.+++|.+++.   .+++.++..++.|++.||.|||++||+||||||+|||++ + +.+||+|||+++......
T Consensus       104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~-~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D-GMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-T-TEEEECCCSSSCC-----
T ss_pred             EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-C-CeEEEeeccccccccCcc
Confidence            99999 66778877664   478899999999999999999999999999999999997 3 479999999998764332


Q ss_pred             C---cceeeeccCccCCccccc-----------CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhc
Q psy3714         321 E---YNVRVASRYFKGPELLAD-----------YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI  386 (467)
Q Consensus       321 ~---~~~~~gt~~y~aPE~l~~-----------~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (467)
                      .   ....+||+.|+|||++.+           ..++.++|+|..+++.+....+..||......      . ..... .
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~-~~~~~-~  252 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------I-SKLHA-I  252 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------H-HHHHH-H
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------H-HHHHH-H
Confidence            2   234579999999999876           35788999998888765555554444321110      0 00000 0


Q ss_pred             cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .....        ....+...++++++||.+||+.||++|||++|+++||||....
T Consensus       253 ~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          253 IDPNH--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             HCTTS--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             Hhccc--------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            00000        0111234588999999999999999999999999999997543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.9e-37  Score=301.46  Aligned_cols=244  Identities=16%  Similarity=0.216  Sum_probs=188.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCe---EEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDK---CVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~---~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.   ||||+++..    ..+.+.+|+.+++.++ ||||+++++++.+.  .
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~  123 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRG--R  123 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGG--G
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC--C
Confidence            457899999999999999999999866654   999998753    2356789999999996 89999999998753  4


Q ss_pred             ccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..++||||+++++|.+++.    .+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVLE  202 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCSSCEECC
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC-CEEECCCCcccccc
Confidence            6899999999999988763    588999999999999999999999999999999999998554 79999999998764


Q ss_pred             CCCC----cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         318 PGQE----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       318 ~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      ....    .....+|+.|+|||++.+..|+.++|+|..+++.+.... +..||.....     ..........       
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~~~~~~-------  270 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-----RDVISSVEEG-------  270 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----HHHHHHHHTT-------
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHHcC-------
Confidence            3322    122345778999999998889999999988887554443 4444322110     1111111100       


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                            ...+.+..+++++.+||.+||..||++|||++|+++
T Consensus       271 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          271 ------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                  011223457999999999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.7e-38  Score=306.13  Aligned_cols=261  Identities=17%  Similarity=0.253  Sum_probs=196.7

Q ss_pred             CCccceeeeEeecccCCcceEEEE----EccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAI----NVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      ...++|++++.||+|+||.||+|.    +..+++.||+|+++...   .+.+.+|+++++.++ |+||+.+.+++..+..
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCC
Confidence            456899999999999999999998    56788899999987543   345789999999995 8999999998876666


Q ss_pred             CccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      ...++||||+++++|.+++.    .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~  177 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADFGLAKLL  177 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCGGGCEEC
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC-CEEEcccccceec
Confidence            77899999999999987764    389999999999999999999999999999999999998655 8999999999876


Q ss_pred             CCCCC----cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcc---cC----Chhhhhhhhhh
Q psy3714         317 HPGQE----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQH---LV----SPEALDFLDKN  385 (467)
Q Consensus       317 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~---~~----~~~~~~~~~~~  385 (467)
                      .....    .....||+.|+|||++.+..++.++|+|..+++.+....+..++.......   ..    .+...... ..
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~  256 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL-EL  256 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH-HH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH-HH
Confidence            43332    123457888999999998889999999988887655544444432211000   00    00000000 00


Q ss_pred             ccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHh---CCCCCCC
Q psy3714         386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM---DHPYFYP  440 (467)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l---~Hp~f~~  440 (467)
                      +         ..-.....+..+++++.+||.+||+.||++|||++|++   +..|...
T Consensus       257 ~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          257 L---------EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             H---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             h---------hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            0         00011122345799999999999999999999999995   5555443

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-37  Score=301.12  Aligned_cols=249  Identities=19%  Similarity=0.279  Sum_probs=193.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEc-----cCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINV-----QSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|+++..    ....+.+|+.+++.+..||||+++++++... 
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-  121 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-  121 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-
Confidence            4589999999999999999999973     34567999998643    2356889999999996699999999998764 


Q ss_pred             CCccEEEEeccCCccHHHHhhc--------------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQT--------------------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKP  293 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~~--------------------------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp  293 (467)
                       ...++||||+++++|.+++..                          +++.++..++.||+.||+|||++||+||||||
T Consensus       122 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp  200 (344)
T 1rjb_A          122 -GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  200 (344)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             -CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence             468999999999999887642                          67888999999999999999999999999999


Q ss_pred             CceEEeCCCCcEEEEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccC
Q psy3714         294 HNVMIDHENRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTE  369 (467)
Q Consensus       294 ~Nill~~~~~~ikl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~  369 (467)
                      +|||++.++ .+||+|||+|+........   ....||+.|+|||++.+..|+.++|+|..+++...... +..||....
T Consensus       201 ~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          201 RNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            999999554 8999999999866433322   23467889999999998889999999988887665543 444442221


Q ss_pred             CcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q psy3714         370 NQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY  437 (467)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~  437 (467)
                      .    ...........             .....+..+++++.+||.+||..||.+|||++|+++|-.
T Consensus       280 ~----~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          280 V----DANFYKLIQNG-------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             C----SHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             c----HHHHHHHHhcC-------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            1    01111111110             011123457899999999999999999999999998743

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.6e-37  Score=295.74  Aligned_cols=251  Identities=12%  Similarity=0.168  Sum_probs=194.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+.+|+|++.+..++.+  ....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEEEE
Confidence            47899999999999999999999999999999988643 345688999999999889999999988865  356799999


Q ss_pred             ccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC----CcEEEEecccceecCCCC
Q psy3714         249 HVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN----RKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       249 ~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~----~~ikl~DFGla~~~~~~~  320 (467)
                      |+ +++|.+++.    .+++.++..++.|++.||.|||++||+||||||+|||++.++    ..+||+|||+|+......
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            99 889988765    489999999999999999999999999999999999998543    139999999998764332


Q ss_pred             C--------cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         321 E--------YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       321 ~--------~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      .        ....+||+.|+|||++.+..++.++|+|..+++.+....+..||.......  .............    .
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~----~  239 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT--NKQKYERIGEKKQ----S  239 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC--HHHHHHHHHHHHH----H
T ss_pred             ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc--cHHHHHHHHhhcc----C
Confidence            1        234579999999999999899999999988887666555555553321100  0000000000000    0


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ...     ......+++++.+||.+||+.||++|||++++++
T Consensus       240 ~~~-----~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          240 TPL-----RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             SCH-----HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccH-----HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            000     0112347899999999999999999999988754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.3e-37  Score=296.07  Aligned_cols=247  Identities=19%  Similarity=0.281  Sum_probs=193.0

Q ss_pred             CccceeeeEeecccCCcceEEEEE-----ccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAIN-----VQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||+|+++..    ..+.+.+|+.+++.+..||||+++.+++.+. 
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-   99 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-   99 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-
Confidence            347899999999999999999985     456778999998753    2456789999999996699999999998764 


Q ss_pred             CCccEEEEeccCCccHHHHhh---------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ---------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI  298 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~---------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill  298 (467)
                       ...++||||+++++|.+++.                     .+++.++..++.|++.||.|||++||+||||||+|||+
T Consensus       100 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          100 -GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (313)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             -CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence             46799999999999987764                     27888999999999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccC
Q psy3714         299 DHENRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLV  374 (467)
Q Consensus       299 ~~~~~~ikl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~  374 (467)
                      +.++ .+||+|||+|+........   ....||+.|+|||++.+..++.++|+|..+++...... +..|+.....    
T Consensus       179 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----  253 (313)
T 1t46_A          179 THGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV----  253 (313)
T ss_dssp             ETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS----
T ss_pred             cCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc----
Confidence            9554 8999999999876544322   23457889999999999889999999988877554443 3334322111    


Q ss_pred             ChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         375 SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ...........             .....+..+++++.+||.+||..||++|||++|++++
T Consensus       254 ~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          254 DSKFYKMIKEG-------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SHHHHHHHHHT-------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHhccC-------------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            01111111111             0111234578999999999999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.6e-37  Score=298.58  Aligned_cols=253  Identities=17%  Similarity=0.260  Sum_probs=174.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHH-HHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIK-ILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~-il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..++|++++.||+|+||.||+|.+..+++.||||+++...    .....+|.. +++.+ .||||+++++++.+.  ...
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~--~~~   99 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITN--TDV   99 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECS--SEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC--CcE
Confidence            3578999999999999999999999999999999986532    123334444 45555 689999999998764  468


Q ss_pred             EEEEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         244 ALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~-~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      ++||||+ ++.+..+.    ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+++....
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISGRLVD  177 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC-----
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCchhccC
Confidence            9999999 44554443    3588999999999999999999995 999999999999998655 799999999987655


Q ss_pred             CCCcceeeeccCccCCcccc-----cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         319 GQEYNVRVASRYFKGPELLA-----DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ........||+.|+|||++.     ...++.++|+|..+++......+..||.....       .............   
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~---  247 (318)
T 2dyl_A          178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-------DFEVLTKVLQEEP---  247 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHHHHHHSCC---
T ss_pred             CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-------cHHHHHHHhccCC---
Confidence            44445567999999999995     45588899999888876555554444432111       0011111100000   


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                           ...+....+++++++||.+||+.||.+|||++|+++||||...
T Consensus       248 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          248 -----PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             -----CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             -----CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence                 0011123478999999999999999999999999999999754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.3e-36  Score=292.28  Aligned_cols=251  Identities=15%  Similarity=0.213  Sum_probs=187.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+.+++++..+..+...  ....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~~~lv~e   85 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE--GDYNVMVME   85 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEE--TTEEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCC--CCceEEEEE
Confidence            47899999999999999999999999999999986543 345688999999999877666666655543  356799999


Q ss_pred             ccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEe--CCCCcEEEEecccceecCCCCC-
Q psy3714         249 HVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQE-  321 (467)
Q Consensus       249 ~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~--~~~~~ikl~DFGla~~~~~~~~-  321 (467)
                      |+ +++|.+++.    .+++.++..++.||+.||.|||++||+||||||+|||++  ..++.+||+|||+|+....... 
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~  164 (296)
T 4hgt_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence            99 888887764    589999999999999999999999999999999999993  2344799999999987643322 


Q ss_pred             -------cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         322 -------YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       322 -------~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                             .....||+.|+|||++.+..++.++|+|..+++.+....+..||......... ............       
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~-------  236 (296)
T 4hgt_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMS-------  236 (296)
T ss_dssp             CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHHHHH-------
T ss_pred             ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-hhhhhhhccccc-------
Confidence                   23457999999999999999999999998888766555555555332211100 000000000000       


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                         .........+++++.+||.+||+.||++|||++|+++
T Consensus       237 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          237 ---TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             ---SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ---chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence               0000111346899999999999999999999988876

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.1e-37  Score=297.44  Aligned_cols=248  Identities=21%  Similarity=0.307  Sum_probs=193.4

Q ss_pred             CccceeeeEeecccCCcceEEEEE-----ccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAIN-----VQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||+|+++..    ..+.+.+|+.+++.+.+||||+++.+++..+ 
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-  103 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-  103 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence            357899999999999999999985     346688999998753    2346789999999998899999999998654 


Q ss_pred             CCccEEEEeccCCccHHHHhhc-------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQT-------------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH  300 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~~-------------------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~  300 (467)
                      ....+++|||+++++|.+++..                   +++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~  183 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  183 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence            3458999999999999887642                   678889999999999999999999999999999999985


Q ss_pred             CCCcEEEEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCCh
Q psy3714         301 ENRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSP  376 (467)
Q Consensus       301 ~~~~ikl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  376 (467)
                      ++ .+||+|||+|+........   ....||+.|+|||++.+..++.++|+|..+++.+.... +..||.....    ..
T Consensus       184 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~  258 (316)
T 2xir_A          184 KN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DE  258 (316)
T ss_dssp             GG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC----SH
T ss_pred             CC-CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch----hH
Confidence            54 7999999999876433322   23568899999999999899999999988887555443 4444322110    01


Q ss_pred             hhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      .........             .....+..+++++.+||.+||..||++|||++|+++|
T Consensus       259 ~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 EFCRRLKEG-------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccC-------------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            111111110             0011223478999999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.5e-37  Score=303.01  Aligned_cols=258  Identities=19%  Similarity=0.243  Sum_probs=188.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchH--HHHHHHHHHHHHhcCCCCeeEEEEEEeCCC--CCccE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK--KKIKREIKILENLRGGTNIITLQAVVKDPV--SRTPA  244 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~--~~~~~  244 (467)
                      ..++|++.+.||+|+||.||+|.+.  ++.||||+++....  ....+|+.+++.++ ||||+++++++.+..  ....+
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCceEE
Confidence            4578999999999999999999865  78999999875433  34566888888885 899999999987543  23469


Q ss_pred             EEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC----------CccccCCCCCceEEeCCCCcEEEEeccc
Q psy3714         245 LIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSM----------GIMHRDVKPHNVMIDHENRKLRLIDWGL  312 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~----------~IiHrDlKp~Nill~~~~~~ikl~DFGl  312 (467)
                      +||||+++++|.+++.  .+++..+..++.|++.||+|||++          ||+||||||+|||++.++ .+||+|||+
T Consensus        99 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL~DFg~  177 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIADFGL  177 (322)
T ss_dssp             EEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-CEEECCCTT
T ss_pred             EEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-eEEEccCCc
Confidence            9999999999988875  488999999999999999999999          999999999999998654 799999999


Q ss_pred             ceecCCCCC---cceeeeccCccCCcccccC-----CCCccchhHHHhhhccccccccccccccCCcccC-C-------h
Q psy3714         313 AEFYHPGQE---YNVRVASRYFKGPELLADY-----QYHIELDPRFADILGRHSRKRWERFVHTENQHLV-S-------P  376 (467)
Q Consensus       313 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~-----~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-------~  376 (467)
                      |+.......   ....+||+.|+|||++.+.     .++.++|+|..+++.+....+..||......... .       +
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  257 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP  257 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence            987643322   2335799999999999873     4566789998888766665655555332211100 0       0


Q ss_pred             hhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ...... ...............   ......++++.+||.+||+.||++|||++|+++
T Consensus       258 ~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          258 SLEDMQ-EVVVHKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             CHHHHH-HHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhhhh-hhhhcccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            000000 000000000000000   001112456999999999999999999999885

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-36  Score=291.79  Aligned_cols=244  Identities=15%  Similarity=0.229  Sum_probs=189.2

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----------KKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....          .+.+.+|+.+++.++ |+||+++++++.++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNP   95 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecCC
Confidence            4588999999999999999999999999999999985321          156789999999995 89999999988643


Q ss_pred             CCCccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEeCCCC----cEEEE
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMG--IMHRDVKPHNVMIDHENR----KLRLI  308 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~--IiHrDlKp~Nill~~~~~----~ikl~  308 (467)
                          .++||||++++++.+.+.    .+++..+..++.|++.||+|||++|  |+||||||+|||++..+.    .+||+
T Consensus        96 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           96 ----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             ----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             ----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence                379999999999976652    4788999999999999999999999  999999999999985442    29999


Q ss_pred             ecccceecCCCCCcceeeeccCccCCcccc--cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhc
Q psy3714         309 DWGLAEFYHPGQEYNVRVASRYFKGPELLA--DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI  386 (467)
Q Consensus       309 DFGla~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (467)
                      |||+|+....  ......||+.|+|||++.  ...|+.++|+|..+++.+....+..||......      .........
T Consensus       172 Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~  243 (287)
T 4f0f_A          172 DFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------KIKFINMIR  243 (287)
T ss_dssp             CCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC------HHHHHHHHH
T ss_pred             CCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc------HHHHHHHHh
Confidence            9999985432  334467999999999994  445788999998888766555555554322111      011011000


Q ss_pred             cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ...         .....+..+++++.+||.+||+.||++|||++|+++
T Consensus       244 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          244 EEG---------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HSC---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccC---------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            000         011123457899999999999999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.2e-37  Score=301.13  Aligned_cols=245  Identities=14%  Similarity=0.231  Sum_probs=187.9

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCe----EEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDK----CVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ...++|++++.||+|+||.||+|.+..+++.    +++|.+....    ...+.+|+.+++.++ |+||+++++++.+  
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--   86 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCPG--   86 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCC-CTTBCCEEEEECB--
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--
Confidence            3468899999999999999999999888876    6666654321    245678999999995 8999999998853  


Q ss_pred             CCccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                       ...++||||+.++++.+.+.    .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus        87 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~  164 (325)
T 3kex_A           87 -SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADL  164 (325)
T ss_dssp             -SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-CEEECSCSGGGG
T ss_pred             -CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC-eEEECCCCcccc
Confidence             45799999999999887753    588899999999999999999999999999999999998655 799999999987


Q ss_pred             cCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         316 YHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       316 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      ......   .....||..|+|||++.+..|+.++|+|..+++.+.... +..||.....     ..........      
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~------  233 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----AEVPDLLEKG------  233 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----THHHHHHHTT------
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----HHHHHHHHcC------
Confidence            643322   234567889999999998889999999988887655444 4444432111     1111111110      


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                             .....+...++++.+||.+||..||++|||++|+++|
T Consensus       234 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          234 -------ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             -------CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             -------CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                   0111223468899999999999999999999999886

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.3e-37  Score=290.96  Aligned_cols=244  Identities=15%  Similarity=0.200  Sum_probs=190.2

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..++|++++.||+|+||.||+|.+. ++..||+|+++..  ....+.+|+.+++.++ ||||+++.+++.+.  ...++|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv   81 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKLVKFYGVCSKE--YPIYIV   81 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCC-CTTBCCEEEEECSS--SSEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCC-CCCEeeEEEEEccC--CceEEE
Confidence            4578999999999999999999765 5668999998754  3567889999999996 89999999998653  568999


Q ss_pred             EeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc
Q psy3714         247 FEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       247 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~  322 (467)
                      |||++++++.++..    .+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+........
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC-CEEECCTTCEEECCTTCEE
T ss_pred             EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC-CEEEccCccceecchhhhh
Confidence            99999999887753    389999999999999999999999999999999999998655 7999999999876443221


Q ss_pred             --ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         323 --NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       323 --~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                        ....+|+.|+|||++.+..++.++|+|..+++...... +..||....        ..........+          .
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~----------~  222 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--------NSEVVLKVSQG----------H  222 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTT----------C
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC--------hHHHHHHHHcC----------C
Confidence              22345678999999998889999999988877554443 333332111        00111000000          0


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ....+...++++.+||.+||+.||++|||++|+++|
T Consensus       223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            111223468999999999999999999999999976

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.6e-37  Score=293.32  Aligned_cols=244  Identities=17%  Similarity=0.292  Sum_probs=194.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..++|++.+.||+|+||.||+|.+..++..||+|+++..  ..+.+.+|+.+++.++ |+||+++++++.+.  ...++|
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~~v   87 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE--PPFYII   87 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS--SSEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC--CCEEEE
Confidence            458899999999999999999999999999999998754  3467889999999996 89999999998754  468999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      |||+.+++|.++..     .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+|........
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-CEEECCCCGGGTSCSSSS
T ss_pred             EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-CEEEccCccceeccCCcc
Confidence            99999999988764     278899999999999999999999999999999999998655 799999999987643322


Q ss_pred             --cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         322 --YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       322 --~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                        .....+|+.|+|||++.+..++.++|+|..+++...... +..|+.....     ..........             
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~~~~~~~~~~-------------  228 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKD-------------  228 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHHHTT-------------
T ss_pred             ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhcc-------------
Confidence              223467889999999998899999999988877555444 3333321110     0111111110             


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .....+..+++++.+||++||..||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            011223457999999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.5e-37  Score=299.92  Aligned_cols=255  Identities=19%  Similarity=0.271  Sum_probs=191.1

Q ss_pred             CccceeeeEeecccCCcceEEEE----EccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAI----NVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      ....|++++.||+|+||.||+|.    +..+++.||+|+++..    ....+.+|+.+++.++ |+||+++++++.+...
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGG   97 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC---
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCC
Confidence            35679999999999999999998    5678899999998743    2367889999999996 8999999999987655


Q ss_pred             CccEEEEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         241 RTPALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      ...++||||+++++|.++.    ..+++.++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~  176 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAI  176 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEEC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-CEEECcccccccc
Confidence            6789999999999998876    2488999999999999999999999999999999999998655 8999999999876


Q ss_pred             CCCCC----cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCc------ccCChhhhhhhhhhc
Q psy3714         317 HPGQE----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQ------HLVSPEALDFLDKNI  386 (467)
Q Consensus       317 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~  386 (467)
                      .....    .....||..|+|||++.+..++.++|+|..+++.+....+..++......      ...............
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence            54432    22346788899999999988999999998887755444333321100000      000000000000000


Q ss_pred             cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                               ......+.+..+++++.+||.+||+.||++|||++|+++
T Consensus       257 ---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          257 ---------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             ---------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ---------hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                     000111223458999999999999999999999999875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.2e-37  Score=295.62  Aligned_cols=242  Identities=13%  Similarity=0.218  Sum_probs=189.5

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCC-------eEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSD-------KCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-------~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      ..++|++.+.||+|+||.||+|.+..+++       .||+|+++..   ..+.+.+|+.+++.++ ||||+++++++.+.
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS-HKHLVLNYGVCVCG   84 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSC-CTTBCCEEEEECCT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEeC
Confidence            45789999999999999999999988774       6999998653   2466889999999996 89999999998764


Q ss_pred             CCCccEEEEeccCCccHHHHhhc----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCc-------EEE
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRK-------LRL  307 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~-------ikl  307 (467)
                        ...++||||+.+++|.+++..    +++..+..++.||+.||.|||++||+||||||+|||++.++..       +||
T Consensus        85 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           85 --DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             --TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             --CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence              457999999999999887642    8899999999999999999999999999999999999865521       999


Q ss_pred             EecccceecCCCCCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhc
Q psy3714         308 IDWGLAEFYHPGQEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI  386 (467)
Q Consensus       308 ~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (467)
                      +|||++.....   .....||+.|+|||++.+ ..++.++|+|..+++.+....+..+++.....    .........  
T Consensus       163 ~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~----~~~~~~~~~--  233 (289)
T 4fvq_A          163 SDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS----QRKLQFYED--  233 (289)
T ss_dssp             CCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHHHHT--
T ss_pred             ccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch----HHHHHHhhc--
Confidence            99999976532   233568999999999987 56899999998888755544433333222110    000000000  


Q ss_pred             cCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         387 LGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                                   ....+...++++.+||.+||+.||++|||++|+++|
T Consensus       234 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          234 -------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             -------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                         011123458899999999999999999999999976

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.4e-36  Score=292.01  Aligned_cols=251  Identities=14%  Similarity=0.222  Sum_probs=190.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+.+++++..+..+...  ....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE--GDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEE--TTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCC--CCceEEEEE
Confidence            47899999999999999999999999999999998643 345688999999999876666665554443  356799999


Q ss_pred             ccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEe--CCCCcEEEEecccceecCCCCC-
Q psy3714         249 HVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQE-  321 (467)
Q Consensus       249 ~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~--~~~~~ikl~DFGla~~~~~~~~-  321 (467)
                      |+ +++|.+++.    .+++.++..++.|++.||.|||++||+||||||+|||++  ..++.+||+|||+|+....... 
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~  164 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence            99 888887764    589999999999999999999999999999999999995  2345799999999987654322 


Q ss_pred             -------cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         322 -------YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       322 -------~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                             .....||+.|+|||++.+..++.++|+|..+++.+....+..||........  .............      
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~------  236 (296)
T 3uzp_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQKYERISEKKMS------  236 (296)
T ss_dssp             CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--SSHHHHHHHHHHH------
T ss_pred             cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh--hhhhhhhcccccC------
Confidence                   2345799999999999998999999999888876665555555533211100  0000000000000      


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                         .........+|+++.+||.+||+.||++|||++|+++
T Consensus       237 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          237 ---TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             ---SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ---CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence               0000112347899999999999999999999988775

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-36  Score=290.91  Aligned_cols=244  Identities=18%  Similarity=0.286  Sum_probs=178.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCC---CeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSS---DKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ..++|++.+.||+|+||.||+|.+..++   ..+|+|.++..    ..+.+.+|+.+++.++ ||||+++++++.+   .
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~---~   88 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITE---N   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS---S
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCccceEEEEEcc---C
Confidence            3578999999999999999999987543   46999987653    2356789999999995 8999999998753   4


Q ss_pred             ccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..++||||+++++|.+++.    .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYME  167 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC--------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC-CEEECccccccccC
Confidence            5799999999999988764    488899999999999999999999999999999999999654 89999999998764


Q ss_pred             CCCC--cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         318 PGQE--YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       318 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ....  .....+|+.|+|||++.+..|+.++|+|..+++.+.... +..||.....     .+....+...   .     
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-----~~~~~~i~~~---~-----  234 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGRIENG---E-----  234 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHTT---C-----
T ss_pred             cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-----HHHHHHHHcC---C-----
Confidence            3322  223456788999999998889999999988876554432 3334322111     1111111100   0     


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                           ....+..+++++.+||.+||..||++|||++|++++
T Consensus       235 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          235 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                 011234579999999999999999999999998864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.5e-37  Score=298.09  Aligned_cols=245  Identities=17%  Similarity=0.244  Sum_probs=190.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEc-----cCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINV-----QSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|+++...    .+.+.+|+.+++.++ ||||+++++++.+. 
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~-   98 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQD-   98 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS-
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEecC-
Confidence            3578999999999999999999884     345789999987532    356788999999995 89999999998764 


Q ss_pred             CCccEEEEeccCCccHHHHhhc---------------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQT---------------------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVK  292 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~~---------------------------~~~~~~~~~~~qll~al~~lH~~~IiHrDlK  292 (467)
                       ...++||||+.+++|.+++..                           +++.++..++.||+.||.|||++||+|||||
T Consensus        99 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           99 -GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             -CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence             468999999999999887642                           7888999999999999999999999999999


Q ss_pred             CCceEEeCCCCcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-cccccccc
Q psy3714         293 PHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHT  368 (467)
Q Consensus       293 p~Nill~~~~~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~  368 (467)
                      |+|||++.++ .+||+|||+|+.......   .....+|+.|+|||++.+..++.++|+|..+++.+.... +..||...
T Consensus       178 p~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          178 ARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             GGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             hheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999554 899999999987643322   123457888999999998889999999988877655444 43443221


Q ss_pred             CCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         369 ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ..     ..........             .....+..+++++.+||.+||+.||++|||++|+++|
T Consensus       257 ~~-----~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          257 PP-----ERLFNLLKTG-------------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CG-----GGHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CH-----HHHHHHhhcC-------------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            11     1111111110             0111234579999999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-37  Score=300.06  Aligned_cols=260  Identities=19%  Similarity=0.226  Sum_probs=185.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhc-CCCCeeEEEEEEeCCCC--CccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLR-GGTNIITLQAVVKDPVS--RTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~-~~~~iv~l~~~~~~~~~--~~~~lv  246 (467)
                      .++|++++.||+|+||.||+|.+.  ++.||||++.........+|.+++..+. .|+||+++.+.+.....  ...++|
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  113 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI  113 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence            478999999999999999999874  7899999998766666677777776542 69999999998865432  568999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSM--------GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~--------~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      |||+++++|.+++.  .+++..+..++.|++.||.|||++        ||+||||||+|||++.++ .+||+|||+|+..
T Consensus       114 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~  192 (337)
T 3mdy_A          114 TDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVKF  192 (337)
T ss_dssp             ECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEEeCCCceee
Confidence            99999999988875  488999999999999999999999        999999999999998655 7999999999876


Q ss_pred             CCCCCc-----ceeeeccCccCCcccccCCCCcc------chhHHHhhhccccccccccccccCCcccC------Chhhh
Q psy3714         317 HPGQEY-----NVRVASRYFKGPELLADYQYHIE------LDPRFADILGRHSRKRWERFVHTENQHLV------SPEAL  379 (467)
Q Consensus       317 ~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~------~D~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~  379 (467)
                      ......     ...+||+.|+|||++.+..+...      +|+|..+++.+....+..++.........      .....
T Consensus       193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~  272 (337)
T 3mdy_A          193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY  272 (337)
T ss_dssp             C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCch
Confidence            433221     23579999999999988776655      89998887755544442221110000000      00000


Q ss_pred             hhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         380 DFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ...............+.   .......+++++.+||.+||+.||++|||++|+++|
T Consensus       273 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          273 EDMREIVCIKKLRPSFP---NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HHHHHHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhhHHHHhhhccCcccc---ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            00000000000000000   000011346789999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.4e-37  Score=298.12  Aligned_cols=246  Identities=15%  Similarity=0.224  Sum_probs=186.2

Q ss_pred             cCCccceeeeEeecccCCcceEEEEEccCCCeE----EEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKC----VVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       167 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~----avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      ....++|++++.||+|+||.||+|.+..+++.+    |+|.++..    ..+.+.+|+.+++.++ ||||+++++++.+.
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   89 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS   89 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESS
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecC
Confidence            345688999999999999999999988877654    77766432    2456889999999996 89999999998763


Q ss_pred             CCCccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccce
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE  314 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~  314 (467)
                         ..+++++|+.++++.+++.    .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus        90 ---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~  165 (327)
T 3poz_A           90 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAK  165 (327)
T ss_dssp             ---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTHHH
T ss_pred             ---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC-CEEEccCccee
Confidence               3789999999999987764    478899999999999999999999999999999999999655 89999999998


Q ss_pred             ecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCC
Q psy3714         315 FYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRH  390 (467)
Q Consensus       315 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (467)
                      .......   .....+|+.|+|||++.+..|+.++|+|..+++.+.... +..||.....     ..........     
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~~~~~-----  235 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEKG-----  235 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHTT-----
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----HHHHHHHHcC-----
Confidence            7643322   123456889999999999999999999988887655444 4444322111     1111111110     


Q ss_pred             CcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         391 SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       391 ~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                              .....+...++++.+||.+||+.||++|||++|+++|
T Consensus       236 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          236 --------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             --------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             --------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                    0111234578999999999999999999999999876

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.7e-37  Score=302.83  Aligned_cols=255  Identities=14%  Similarity=0.168  Sum_probs=185.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccC-----CCeEEEEEeccchHHHHHHHHHHHHHhcC--------------CCCee
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQS-----SDKCVVKILKPVKKKKIKREIKILENLRG--------------GTNII  229 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~Ei~il~~l~~--------------~~~iv  229 (467)
                      ..++|++.+.||+|+||.||+|.+..+     ++.||||++.... ....+|+.+++.+.+              |+||+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            456899999999999999999998765     5789999986543 234455555554433              89999


Q ss_pred             EEEEEEeCCC--CCccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC-CC
Q psy3714         230 TLQAVVKDPV--SRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH-EN  302 (467)
Q Consensus       230 ~l~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~-~~  302 (467)
                      ++++++....  ....++||||+ +++|.+++.    .+++.++..++.||+.||+|||++||+||||||+|||++. .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            9999876532  24579999999 899988763    4899999999999999999999999999999999999982 23


Q ss_pred             CcEEEEecccceecCCCCC--------cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccC
Q psy3714         303 RKLRLIDWGLAEFYHPGQE--------YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLV  374 (467)
Q Consensus       303 ~~ikl~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (467)
                      +.+||+|||+|+.+.....        ....+||+.|+|||++.+..|+.++|+|..+++.+....+..||......   
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~---  267 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD---  267 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC---
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC---
Confidence            4799999999987643211        13345999999999999999999999999888766666666665432211   


Q ss_pred             ChhhhhhhhhhccCCCCccccccccccc-CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         375 SPEALDFLDKNILGRHSRKRWERFVHTE-NQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                       ............     .....+.... .....++++.+||.+|+..||++|||++++++
T Consensus       268 -~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          268 -PKYVRDSKIRYR-----ENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             -HHHHHHHHHHHH-----HCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             -HHHHHHHHHHhh-----hhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence             111100000000     0000000000 11347899999999999999999999887664

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.8e-37  Score=312.54  Aligned_cols=264  Identities=15%  Similarity=0.226  Sum_probs=201.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEe
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFE  248 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e  248 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++.. ....+.+|+++++.+.+++++..+..+...  ....++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEEEEE
Confidence            47899999999999999999999999999999987643 345688999999999987888777666553  356799999


Q ss_pred             ccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEe--CCCCcEEEEecccceecCCCCC-
Q psy3714         249 HVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQE-  321 (467)
Q Consensus       249 ~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~--~~~~~ikl~DFGla~~~~~~~~-  321 (467)
                      |+ +++|.+++.    .+++.++..++.||+.||+|||++|||||||||+|||++  ..++.+||+|||+|+.+..... 
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH  162 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence            99 888887764    589999999999999999999999999999999999994  2345799999999987654322 


Q ss_pred             -------cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         322 -------YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       322 -------~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                             ....+||+.|+|||++.+..|+.++|+|..+++.+....+..||........  ......+......    ..
T Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~i~~~~~~----~~  236 (483)
T 3sv0_A          163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQKYEKISEKKVA----TS  236 (483)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HHHHHHHHHHHHH----SC
T ss_pred             cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HHHHHHHhhcccc----cc
Confidence                   1246799999999999999999999999888876666666566543221100  0000000000000    00


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHh----------CCCCCCCccccccc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM----------DHPYFYPIVKDQSR  447 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l----------~Hp~f~~~~~~~~~  447 (467)
                      ..     .....+++++.+||.+||..||++|||+++++          .|+|+..++|+...
T Consensus       237 ~~-----~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~  294 (483)
T 3sv0_A          237 IE-----ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILK  294 (483)
T ss_dssp             HH-----HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHT
T ss_pred             HH-----HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhc
Confidence            00     01124689999999999999999999987654          48999988886443

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.9e-37  Score=306.35  Aligned_cols=243  Identities=16%  Similarity=0.194  Sum_probs=189.8

Q ss_pred             CccceeeeEeecccCCcceEEE-----EEccCCCeEEEEEeccchHHHHHHHHHHHHHhcC--CCCeeEEEEEEeCCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEA-----INVQSSDKCVVKILKPVKKKKIKREIKILENLRG--GTNIITLQAVVKDPVSR  241 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~-----~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~--~~~iv~l~~~~~~~~~~  241 (467)
                      ..++|++.+.||+|+||.||+|     .+..+++.||+|+++......+.+|+++++.+.+  |+||+.+++.+...  .
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~--~  140 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ--N  140 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS--S
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC--C
Confidence            3578999999999999999999     4677899999999988777888899999988863  78999999988764  4


Q ss_pred             ccEEEEeccCCccHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC----------CC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ--------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE----------NR  303 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~----------~~  303 (467)
                      ..++||||+++++|.+++.        .+++..+..++.||+.||+|||++|||||||||+|||++..          ++
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence            6799999999999988763        38899999999999999999999999999999999999851          35


Q ss_pred             cEEEEecccceecC---CCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhh
Q psy3714         304 KLRLIDWGLAEFYH---PGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD  380 (467)
Q Consensus       304 ~ikl~DFGla~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (467)
                      .+||+|||+|+...   ........+||+.|+|||++.+..|+.++|+|..+++.+....+..|+........       
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------  293 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-------  293 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-------
T ss_pred             CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-------
Confidence            79999999997653   22334456799999999999999999999999988876666566555533211000       


Q ss_pred             hhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCC
Q psy3714         381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP  436 (467)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp  436 (467)
                          . ..    ..+..       ...++...+++.+||+.+|.+|++..+.+.+.
T Consensus       294 ----~-~~----~~~~~-------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          294 ----K-PE----GLFRR-------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             ----E-EC----SCCTT-------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             ----e-ec----hhccc-------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence                0 00    00000       12467889999999999999997655555443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.5e-36  Score=295.58  Aligned_cols=247  Identities=18%  Similarity=0.249  Sum_probs=192.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCC-----eEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSD-----KCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++.+.||+|+||.||+|.+..+++     .||+|.++..    ..+.+.+|+.+++.+..||||+++++++.+. 
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-  122 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG-  122 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC-
Confidence            45789999999999999999999877664     7999998753    2456789999999996699999999998764 


Q ss_pred             CCccEEEEeccCCccHHHHhh-----------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ-----------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN  302 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~-----------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~  302 (467)
                       ...++||||+++++|.+++.                 .+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus       123 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          123 -GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred             -CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence             46899999999999987653                 258889999999999999999999999999999999998554


Q ss_pred             CcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhh
Q psy3714         303 RKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEA  378 (467)
Q Consensus       303 ~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  378 (467)
                       .+||+|||+|+.......   .....||+.|+|||++.+..++.++|+|..+++.+.... +..|+.....    ....
T Consensus       202 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~  276 (333)
T 2i1m_A          202 -VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV----NSKF  276 (333)
T ss_dssp             -EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS----SHHH
T ss_pred             -eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch----hHHH
Confidence             899999999986543322   123457889999999998889999999988887655443 3334322110    1111


Q ss_pred             hhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         379 LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      .......             .....+...++++.+||.+||+.||.+|||++|++++
T Consensus       277 ~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          277 YKLVKDG-------------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHHT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcC-------------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            1111110             0111233468999999999999999999999999863

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.7e-37  Score=303.03  Aligned_cols=262  Identities=18%  Similarity=0.174  Sum_probs=192.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|+++...    ...+.+|+.+++.++ |+||+++++++.++  ...+
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~  103 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP--TERL  103 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCC-CTTBCCCCEEECCS--SCCE
T ss_pred             HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhcc-CCCccceEEEEecC--CceE
Confidence            357899999999999999999974 468899999987543    236789999999986 89999999998764  4578


Q ss_pred             EEEeccCCccHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCceEEeCCCCcEEEEecccce
Q psy3714         245 LIFEHVNNTDFKQLYQT-------LTDYDIRYYLYELLKALDYCHSM---GIMHRDVKPHNVMIDHENRKLRLIDWGLAE  314 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qll~al~~lH~~---~IiHrDlKp~Nill~~~~~~ikl~DFGla~  314 (467)
                      +||||+.+++|.+++..       +++..+..++.|++.||+|||++   ||+||||||+|||++.++ .+||+|||+|+
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~~  182 (326)
T 3uim_A          104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK  182 (326)
T ss_dssp             EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCCSSCE
T ss_pred             EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccCcccc
Confidence            99999999999887642       78889999999999999999999   999999999999998654 79999999998


Q ss_pred             ecCCCCC--cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         315 FYHPGQE--YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       315 ~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      .......  .....||+.|+|||++.+..++.++|+|..+++.+....+..||.......-.......+....    ...
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~  258 (326)
T 3uim_A          183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL----LKE  258 (326)
T ss_dssp             ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT----TSS
T ss_pred             ccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH----hhc
Confidence            7643222  2334699999999999888899999999888876655555555421100000000000111000    000


Q ss_pred             cccccccc----ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         393 KRWERFVH----TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       393 ~~~~~~~~----~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                      ........    .......++++.+||.+||+.||++|||++|+++|-.-.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            00111100    011112357899999999999999999999999986543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.2e-36  Score=290.78  Aligned_cols=244  Identities=16%  Similarity=0.233  Sum_probs=187.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..++|++++.||+|+||.||+|.+. ++..||+|+++..  ..+.+.+|+.+++.++ |+||+++++++.+.  ...++|
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv   97 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQ--RPIFII   97 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC-CTTBCCEEEEECSS--SSEEEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCC-CCCEeeEEEEEecC--CCeEEE
Confidence            4578999999999999999999775 5678999998754  3567889999999996 89999999998753  568999


Q ss_pred             EeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC--
Q psy3714         247 FEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--  320 (467)
Q Consensus       247 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~--  320 (467)
                      |||++++++.++..    .+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+......  
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A           98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS-CEEECSTTGGGGBCCHHHH
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC-CEEEccccccccccccccc
Confidence            99999999988764    488999999999999999999999999999999999998554 79999999998653221  


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      ......+|+.|+|||++.+..++.+.|+|..+++.+.... +..||....     ...........             .
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~~~~-------------~  238 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-----NSETAEHIAQG-------------L  238 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHHHHHTT-------------C
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC-----hhHHHHHHhcc-------------c
Confidence            1122346788999999998889999999988877554443 333332111     00111111000             0


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ....+...++++.+||.+||+.||++|||++|+++|
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            111234578999999999999999999999999876

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.1e-37  Score=304.90  Aligned_cols=244  Identities=20%  Similarity=0.292  Sum_probs=190.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.||||+++...    ...+.+|+.+|+.++ ||||+++++++.+.  ...+
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~  188 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQK--QPIY  188 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSS--SSCE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecC--CCcE
Confidence            3578999999999999999999999899999999987532    245778999999995 89999999998753  4689


Q ss_pred             EEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         245 LIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      +||||+++++|.+++.    .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN-VLKISDFGMSREEADGV  267 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECTTSE
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC-cEEECcCCCceecCCCc
Confidence            9999999999987753    488999999999999999999999999999999999998554 79999999998653321


Q ss_pred             C---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         321 E---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       321 ~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                      .   .....++..|+|||++....|+.++|+|..+++...... +..|+....     ...........           
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~-----~~~~~~~~~~~-----------  331 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS-----NQQTREFVEKG-----------  331 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC-----HHHHHHHHHTT-----------
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcC-----------
Confidence            1   112346778999999998889999999988877544332 333332111     11111111111           


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                        ...+.+..+++++.+||.+||+.||++|||++++++
T Consensus       332 --~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          332 --GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence              011123457899999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-36  Score=299.32  Aligned_cols=245  Identities=16%  Similarity=0.223  Sum_probs=189.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEcc-----CCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQ-----SSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++++.||+|+||.||+|.+..     +++.||+|+++...    ...+.+|+.+++.++ ||||+++++++.+. 
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~-  122 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVCAVG-  122 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS-
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEccC-
Confidence            35789999999999999999999873     45789999987532    356789999999995 89999999998763 


Q ss_pred             CCccEEEEeccCCccHHHHhh---------------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ---------------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVK  292 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlK  292 (467)
                       ...++||||+++++|.+++.                           .+++.++..++.||+.||.|||++||+|||||
T Consensus       123 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          123 -KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             -CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence             56899999999999987763                           37788899999999999999999999999999


Q ss_pred             CCceEEeCCCCcEEEEecccceecCCCC---CcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-cccccccc
Q psy3714         293 PHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHT  368 (467)
Q Consensus       293 p~Nill~~~~~~ikl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~  368 (467)
                      |+|||++.++ .+||+|||+++......   ......+|+.|+|||++.+..|+.++|+|..+++.+.... +..||...
T Consensus       202 p~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          202 TRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             GGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            9999998554 79999999998653221   1233568899999999998889999999988887555443 33443221


Q ss_pred             CCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         369 ENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ..     .+........   .          ....+..+++++.+||++||+.||++|||++|++++
T Consensus       281 ~~-----~~~~~~~~~~---~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          281 AH-----EEVIYYVRDG---N----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             CH-----HHHHHHHHTT---C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Ch-----HHHHHHHhCC---C----------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            10     1111111100   0          011233578999999999999999999999998763

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.6e-37  Score=300.93  Aligned_cols=246  Identities=16%  Similarity=0.224  Sum_probs=190.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeE--EEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKC--VVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~--avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++.+.||+|+||.||+|.+..++..+  ++|.++..    ..+.+.+|+.+++.+.+||||+++++++.+.  ..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~  100 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY  100 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--Cc
Confidence            3578999999999999999999999888765  88887642    2356789999999996799999999998764  56


Q ss_pred             cEEEEeccCCccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR  303 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~  303 (467)
                      .++||||+++++|.+++.                   .+++.++..++.||+.||.|||++||+||||||+|||++.++ 
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-  179 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-  179 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC-
Confidence            899999999999988763                   378899999999999999999999999999999999998654 


Q ss_pred             cEEEEecccceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhh
Q psy3714         304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFL  382 (467)
Q Consensus       304 ~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  382 (467)
                      .+||+|||+++............+|+.|+|||++.+..++.++|+|..+++.+.... +..||....        .....
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~  251 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELY  251 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHH
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc--------HHHHH
Confidence            799999999985433233334567889999999988889999999988887655443 444432211        11111


Q ss_pred             hhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         383 DKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      . .+...         .....+..+++++++||.+||+.||++|||++|+++|
T Consensus       252 ~-~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          252 E-KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             H-HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H-HhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1 11000         0111233578999999999999999999999999886

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=297.98  Aligned_cols=245  Identities=18%  Similarity=0.262  Sum_probs=175.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeC------CCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKD------PVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~------~~~  240 (467)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+....   .+.+.+|+.+++.+.+||||+++++.+..      ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            468999999999999999999999999999999885432   35678999999999879999999988742      123


Q ss_pred             CccEEEEeccCCccHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEeCCCCcEEEEeccc
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ------TLTDYDIRYYLYELLKALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGL  312 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qll~al~~lH~~~--IiHrDlKp~Nill~~~~~~ikl~DFGl  312 (467)
                      ...+++|||+. +++.+++.      .+++.++..++.||+.||.|||++|  |+||||||+|||++.++ .+||+|||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG-TIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence            34789999997 56665543      3899999999999999999999999  99999999999999655 799999999


Q ss_pred             ceecCCCCCc-------------ceeeeccCccCCccc---ccCCCCccchhHHHhhhccccccccccccccCCcccCCh
Q psy3714         313 AEFYHPGQEY-------------NVRVASRYFKGPELL---ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSP  376 (467)
Q Consensus       313 a~~~~~~~~~-------------~~~~gt~~y~aPE~l---~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (467)
                      ++........             ...+||+.|+|||++   .+..++.++|+|..+++.+....+..||.....      
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------  258 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK------  258 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH------
Confidence            9876432221             135699999999998   566688899999888876554444444422110      


Q ss_pred             hhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q psy3714         377 EALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY  437 (467)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~  437 (467)
                        ......             ..........++++.+||++||+.||++|||++|+++|-.
T Consensus       259 --~~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          259 --LRIVNG-------------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             --HHhhcC-------------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence              000000             0011122346788999999999999999999999999854

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7e-37  Score=298.10  Aligned_cols=257  Identities=16%  Similarity=0.188  Sum_probs=192.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|.+...   ..+.+.+|+.+++.++ ||||+++++++.+.  ...++
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~l  112 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCR-HPHLVSLIGFCDER--NEMIL  112 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCT--TCCEE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCC--CeEEE
Confidence            347899999999999999999986 46889999987643   2456889999999986 89999999988653  56899


Q ss_pred             EEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         246 IFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       246 v~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      ||||+.+++|.+++.       .+++.++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF-VPKITDFGISKKGTE  191 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC-CEEECCCTTCEECSS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC-CEEEeeccccccccc
Confidence            999999999987653       378889999999999999999999999999999999998554 799999999986532


Q ss_pred             C---CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         319 G---QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       319 ~---~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      .   .......||+.|+|||++.+..++.++|+|..+++.+....+..|+...........  ..+.......    ...
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~--~~~~~~~~~~----~~~  265 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL--AEWAVESHNN----GQL  265 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCH--HHHTHHHHTT----TCC
T ss_pred             ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHH--HHHhhhcccc----ccH
Confidence            2   122345699999999999988899999999888876665556555543322211110  0000000000    000


Q ss_pred             cccccc----cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCC
Q psy3714         396 ERFVHT----ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP  436 (467)
Q Consensus       396 ~~~~~~----~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp  436 (467)
                      ......    ......++++.+||.+||+.||++|||++|+++|-
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            000000    01112456889999999999999999999999764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-36  Score=293.17  Aligned_cols=240  Identities=22%  Similarity=0.333  Sum_probs=182.0

Q ss_pred             Cccceeee-EeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeC--CCCCccEE
Q psy3714         169 QQDDYQLV-RKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKD--PVSRTPAL  245 (467)
Q Consensus       169 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~--~~~~~~~l  245 (467)
                      ..++|.++ +.||+|+||.||+|.+..+++.||+|+++.  .....+|+.++.++.+||||+++.+++..  ......++
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l   92 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   92 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence            34788888 779999999999999999999999999874  35678899999777789999999998764  22346799


Q ss_pred             EEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC--CCcEEEEecccceecCC
Q psy3714         246 IFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       246 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~--~~~ikl~DFGla~~~~~  318 (467)
                      ||||+++++|.++..     .+++..+..++.|++.||.|||++||+||||||+|||++..  ++.+||+|||+|.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  172 (299)
T 3m2w_A           93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG  172 (299)
T ss_dssp             EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc
Confidence            999999999988764     38899999999999999999999999999999999999863  45799999999975431


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                                           ..|+.++|+|..+++.+....+..||........        . ...........+.  
T Consensus       173 ---------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~--------~-~~~~~~~~~~~~~--  220 (299)
T 3m2w_A          173 ---------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--------S-PGMKTRIRMGQYE--  220 (299)
T ss_dssp             ---------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------CCSCCSSCTTCCS--
T ss_pred             ---------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh--------h-HHHHHHHhhcccc--
Confidence                                 3467788999888876655555555432211100        0 0000000000000  


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .....+..+|+++++||.+||+.||++|||++|+++||||....
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            01111245799999999999999999999999999999997643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8.6e-37  Score=289.87  Aligned_cols=244  Identities=18%  Similarity=0.280  Sum_probs=182.3

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-------KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ..++|++.+.||+|+||.||+|.+.  ++.+|+|+++...       .+.+.+|+.+++.++ ||||+++.+++.+.  .
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~   79 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKE--P   79 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC---
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecC--C
Confidence            3578999999999999999999874  7889999986431       256788999999996 89999999998764  4


Q ss_pred             ccEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCceEEeCC-------CCcEEEEe
Q psy3714         242 TPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMG---IMHRDVKPHNVMIDHE-------NRKLRLID  309 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~---IiHrDlKp~Nill~~~-------~~~ikl~D  309 (467)
                      ..++||||++++++.++..  .+++..+..++.|++.||.|||++|   |+||||||+|||++..       ++.+||+|
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             ceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            5899999999999988764  5889999999999999999999999   9999999999999852       45799999


Q ss_pred             cccceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCC
Q psy3714         310 WGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGR  389 (467)
Q Consensus       310 FGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (467)
                      ||+|+....... ....||+.|+|||++.+..++.+.|+|..+++......+..||.....        ...........
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~  230 (271)
T 3dtc_A          160 FGLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--------LAVAYGVAMNK  230 (271)
T ss_dssp             CCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHHHHHTSC
T ss_pred             CCcccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHhhhcCC
Confidence            999987644332 345799999999999998899999999888876555555445432110        00000000000


Q ss_pred             CCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                               .....+..+++++.+||.+||+.||++|||++|+++|
T Consensus       231 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          231 ---------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                     0111234578999999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.3e-36  Score=293.58  Aligned_cols=246  Identities=19%  Similarity=0.252  Sum_probs=189.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEc-------cCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINV-------QSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKD  237 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~  237 (467)
                      ..++|++.+.||+|+||.||+|.+.       .++..||+|+++...    ...+.+|+.+++.+..||||+++.+++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3589999999999999999999976       456789999987532    34678999999999779999999999876


Q ss_pred             CCCCccEEEEeccCCccHHHHhhc-------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE
Q psy3714         238 PVSRTPALIFEHVNNTDFKQLYQT-------------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI  298 (467)
Q Consensus       238 ~~~~~~~lv~e~~~~~~l~~~~~~-------------------~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill  298 (467)
                      .  ...++||||+.+++|.+++..                   ++..++..++.||+.||.|||++||+||||||+|||+
T Consensus       113 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          113 D--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  190 (334)
T ss_dssp             S--SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             C--CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence            3  468999999999999887642                   6788899999999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccC
Q psy3714         299 DHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLV  374 (467)
Q Consensus       299 ~~~~~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~  374 (467)
                      +.++ .+||+|||+|+.......   .....+|+.|+|||++.+..++.++|+|..+++.+.... +..|+....     
T Consensus       191 ~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----  264 (334)
T 2pvf_A          191 TENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----  264 (334)
T ss_dssp             CTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred             cCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-----
Confidence            8554 799999999987654322   223456888999999988889999999988877554443 333332111     


Q ss_pred             ChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         375 SPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ...........             .....+..+++++.+||.+||..||++|||++|++++
T Consensus       265 ~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          265 VEELFKLLKEG-------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHHT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcC-------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            01111111110             0011223578999999999999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.5e-36  Score=289.52  Aligned_cols=248  Identities=18%  Similarity=0.244  Sum_probs=186.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ..++|++.+.||+|+||.||+|.+.  ++.||+|.++.. ..+.+.+|+.+++.++ ||||+++++.+.+    ..++||
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~----~~~lv~   78 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVN-HPNIVKLYGACLN----PVCLVM   78 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCC-CTTBCCEEEBCTT----TTEEEE
T ss_pred             CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC----CcEEEE
Confidence            4578999999999999999999874  678999998654 3567889999999995 8999999987753    479999


Q ss_pred             eccCCccHHHHhhc------CCHHHHHHHHHHHHHHHHHHHH---CCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         248 EHVNNTDFKQLYQT------LTDYDIRYYLYELLKALDYCHS---MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       248 e~~~~~~l~~~~~~------~~~~~~~~~~~qll~al~~lH~---~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      ||+++++|.+++..      ++...+..++.|++.||.|||+   +||+||||||+|||++.++..+||+|||+|+....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            99999999888752      5778889999999999999999   89999999999999986665589999999986542


Q ss_pred             CCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      .  .....||+.|+|||++.+..++.++|+|..+++......+..||.....     . ..........+          
T Consensus       159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~-~~~~~~~~~~~----------  220 (307)
T 2eva_A          159 H--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG-----P-AFRIMWAVHNG----------  220 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS-----S-HHHHHHHHHTT----------
T ss_pred             c--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc-----c-HHHHHHHHhcC----------
Confidence            2  2345699999999999998899999999888876655555545432111     0 00100000000          


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC-----CCCCCCc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD-----HPYFYPI  441 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~-----Hp~f~~~  441 (467)
                      ........+++++.+||.+||+.||++|||++|+++     .+++.+.
T Consensus       221 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  268 (307)
T 2eva_A          221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA  268 (307)
T ss_dssp             CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred             CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence            011122357899999999999999999999999987     4666543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.6e-36  Score=287.29  Aligned_cols=244  Identities=21%  Similarity=0.326  Sum_probs=187.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccC---CCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQS---SDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ..++|++.+.||+|+||.||+|.+...   +..||+|+++..    ..+.+.+|+.+++.++ ||||+++.+++.+   .
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~---~   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEE---E   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECS---S
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCC-CCCcceEEEEEcC---C
Confidence            357899999999999999999987643   335999998753    3456889999999995 8999999998864   3


Q ss_pred             ccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..++||||+.+++|.+++.    .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIE  164 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-EEEECCCCGGGCC-
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-cEEeCccCCCcccc
Confidence            4689999999999987764    388999999999999999999999999999999999999655 89999999998764


Q ss_pred             CCCC--cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         318 PGQE--YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       318 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ....  .....+|+.|+|||++.+..++.++|+|..+++...... +..||......     .........         
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~~~~~~~~~---------  230 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DVIGVLEKG---------  230 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----GHHHHHHHT---------
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----HHHHHHhcC---------
Confidence            3322  233457889999999998889999999988877555443 44444322111     111111110         


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                          .....+..+++++.+||.+||..||++|||++|++++
T Consensus       231 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          231 ----DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                0111233578999999999999999999999999865

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2e-36  Score=297.98  Aligned_cols=256  Identities=16%  Similarity=0.151  Sum_probs=184.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEcc---CCCeEEEEEeccch--------------HHHHHHHHHHHHHhcCCCCeeEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQ---SSDKCVVKILKPVK--------------KKKIKREIKILENLRGGTNIITL  231 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~--------------~~~~~~Ei~il~~l~~~~~iv~l  231 (467)
                      ..++|++.+.||+|+||.||+|.+..   ++..+|+|+.....              ...+.+|+.+++.+. |+||+++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~  113 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLF  113 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCccee
Confidence            45789999999999999999999987   78899999886432              123456777777775 8999999


Q ss_pred             EEEEeCC--CCCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCC-CcE
Q psy3714         232 QAVVKDP--VSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHEN-RKL  305 (467)
Q Consensus       232 ~~~~~~~--~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~-~~i  305 (467)
                      ++.+...  .....++||||+ +++|.+++.   .+++.++..++.||+.||+|||++||+||||||+|||++.++ ..+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            9987652  245689999999 899988865   589999999999999999999999999999999999998543 279


Q ss_pred             EEEecccceecCCCC--------CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChh
Q psy3714         306 RLIDWGLAEFYHPGQ--------EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE  377 (467)
Q Consensus       306 kl~DFGla~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (467)
                      ||+|||+|+.+....        .....+||+.|+|||++.+..|+.++|+|+.+++.+....+..||......    ..
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~~  268 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD----PV  268 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC----HH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc----cH
Confidence            999999998763221        113457999999999999988999999999888766655555555322111    11


Q ss_pred             hhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ............... .+.   .......+++++++||.+||+.||++|||++++++
T Consensus       269 ~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          269 AVQTAKTNLLDELPQ-SVL---KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHHTTTH-HHH---HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhcccccH-HHH---hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            111110010000000 000   00011257899999999999999999999998775

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.9e-36  Score=294.93  Aligned_cols=253  Identities=14%  Similarity=0.234  Sum_probs=194.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEc-----cCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINV-----QSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|.++...    ...+.+|+.+++.+. |+||+++.+++.+.  
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--  100 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG--  100 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSS--
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCEeeeEEEEccC--
Confidence            478999999999999999999876     457789999986432    345789999999995 89999999998754  


Q ss_pred             CccEEEEeccCCccHHHHhh-------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEE
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ-------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRL  307 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl  307 (467)
                      ...++||||+.+++|.+++.             .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~-~~kl  179 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKI  179 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-CEEE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC-eEEE
Confidence            46899999999999987753             247788999999999999999999999999999999998654 7999


Q ss_pred             EecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhh
Q psy3714         308 IDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLD  383 (467)
Q Consensus       308 ~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  383 (467)
                      +|||+|+.......   .....+|+.|+|||++.+..++.++|+|..+++.+.... +..|+....     .........
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~~~~~  254 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----NEQVLRFVM  254 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----HHHHHHHHH
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-----HHHHHHHHH
Confidence            99999986533221   223467899999999998889999999988877554433 233332111     011111111


Q ss_pred             hhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC------CCCCCcccc
Q psy3714         384 KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH------PYFYPIVKD  444 (467)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H------p~f~~~~~~  444 (467)
                      ..   .          ....+..+++++++||.+||..||++|||++|+++|      |+|.++.+.
T Consensus       255 ~~---~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~  308 (322)
T 1p4o_A          255 EG---G----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY  308 (322)
T ss_dssp             TT---C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCST
T ss_pred             cC---C----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccc
Confidence            00   0          011223578999999999999999999999999987      777665443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.2e-36  Score=309.66  Aligned_cols=244  Identities=17%  Similarity=0.290  Sum_probs=192.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..++|++.+.||+|+||.||+|.+..++..||||+++..  ..+.+.+|+.+|+.++ ||||+++++++.+.  ...++|
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~~~lv  294 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE--PPFYII  294 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECSS--SSCEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcC-CCCEeeEEEEEecC--CcEEEE
Confidence            357899999999999999999999999999999998754  3567889999999996 89999999998754  468999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      |||+.+++|.+++.     .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus       295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEECCTTCCE
T ss_pred             EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC-cEEEeecccceeccCCce
Confidence            99999999988764     378888999999999999999999999999999999998554 799999999987643221


Q ss_pred             --cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         322 --YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       322 --~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                        .....+|..|+|||++....|+.++|+|..+++...... +..|+....     ...........             
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~~-------------  435 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEKD-------------  435 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHHHHTT-------------
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcC-------------
Confidence              122346778999999998889999999988887554443 333332211     11111111111             


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .....+..+++++.+||.+||+.||++|||++|+++
T Consensus       436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            011223457899999999999999999999999875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-36  Score=293.40  Aligned_cols=244  Identities=15%  Similarity=0.229  Sum_probs=184.0

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeE----EEEEecc----chHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKC----VVKILKP----VKKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~----avK~~~~----~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ...++|++++.||+|+||.||+|.+..+++.+    ++|.++.    ...+.+.+|+.+++.++ ||||+++++++... 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~-   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESS-
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecC-
Confidence            45688999999999999999999998888766    5555532    23467889999999996 89999999998763 


Q ss_pred             CCccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                        ..+++++++.++++.+++.    .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus        90 --~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kL~DfG~a~~  166 (327)
T 3lzb_A           90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKL  166 (327)
T ss_dssp             --SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTC---
T ss_pred             --CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC-CEEEccCcceeE
Confidence              3789999999999987763    488999999999999999999999999999999999998655 899999999987


Q ss_pred             cCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         316 YHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       316 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      ......   .....+|+.|+|||++.+..|+.++|+|..+++.+.... +..||.....     ..........      
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~~~~~~------  235 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEKG------  235 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHTT------
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcC------
Confidence            643222   223456788999999999999999999988887655444 4444322111     1111111110      


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                             .....+..+++++.+||++||..||.+|||++|+++
T Consensus       236 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          236 -------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             -------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                   011123457899999999999999999999999886

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2e-36  Score=296.51  Aligned_cols=267  Identities=17%  Similarity=0.191  Sum_probs=186.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHH-hcCCCCeeEEEEEEeC---CCCCccE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILEN-LRGGTNIITLQAVVKD---PVSRTPA  244 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~-l~~~~~iv~l~~~~~~---~~~~~~~  244 (467)
                      ..++|++.+.||+|+||.||+|..  +++.||||+++.........|.+++.. ...|+||+++...+..   ......+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            458999999999999999999965  678999999987666666666665442 2258999999875432   2233568


Q ss_pred             EEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCceEEeCCCCcEEEEecccc
Q psy3714         245 LIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSM---------GIMHRDVKPHNVMIDHENRKLRLIDWGLA  313 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~---------~IiHrDlKp~Nill~~~~~~ikl~DFGla  313 (467)
                      +||||+++++|.+++.  ..++..+..++.||+.||+|||++         ||+||||||+|||++.++ .+||+|||+|
T Consensus        89 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL~DFG~a  167 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISDFGLS  167 (336)
T ss_dssp             EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-cEEEeeccce
Confidence            9999999999988874  467888899999999999999999         999999999999998655 7999999999


Q ss_pred             eecCCCC---------CcceeeeccCccCCccccc-------CCCCccchhHHHhhhccccccccccccccCCcccCChh
Q psy3714         314 EFYHPGQ---------EYNVRVASRYFKGPELLAD-------YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE  377 (467)
Q Consensus       314 ~~~~~~~---------~~~~~~gt~~y~aPE~l~~-------~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (467)
                      +......         .....+||+.|+|||++.+       ..++.++|+|..+++.+....+..+++...........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  247 (336)
T 3g2f_A          168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA  247 (336)
T ss_dssp             EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred             eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence            8764221         1223469999999999987       34667899998888766555555555443321100000


Q ss_pred             h---------hhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHH------hCCCCCCC
Q psy3714         378 A---------LDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREA------MDHPYFYP  440 (467)
Q Consensus       378 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~------l~Hp~f~~  440 (467)
                      .         .............+..+..  ........++++.+||.+||+.||++|||++|+      +.++|-..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          248 FQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             hhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence            0         0000000000000000000  000111245689999999999999999999999      55788643

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.9e-37  Score=297.42  Aligned_cols=254  Identities=19%  Similarity=0.284  Sum_probs=190.4

Q ss_pred             cceeeeEeecccCCcceEEEE----EccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAI----NVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~----~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..|++++.||+|+||.||++.    +..+++.||||+++...    ...+.+|+.+++.++ ||||+++.+++.+.....
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTTTE
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC-CcchhhEEEEEecCCCce
Confidence            345999999999999998775    44578899999987532    356789999999997 899999999998765667


Q ss_pred             cEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      .++||||+++++|.++..  .+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~  188 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGH  188 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECCTTC
T ss_pred             EEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC-CEEECCccccccccccc
Confidence            899999999999998875  388999999999999999999999999999999999998654 79999999999775443


Q ss_pred             C----cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcc---c-CChhhhhhhh-hhccCCCC
Q psy3714         321 E----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQH---L-VSPEALDFLD-KNILGRHS  391 (467)
Q Consensus       321 ~----~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~-~~~~~~~~  391 (467)
                      .    .....||+.|+|||++.+..++.++|+|..+++......+..++.......   . .......... ....    
T Consensus       189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  264 (318)
T 3lxp_A          189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL----  264 (318)
T ss_dssp             SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH----
T ss_pred             cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH----
Confidence            2    223467888999999998889999999988887655544444432111000   0 0000000000 0000    


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                          ........+..+++++.+||++||+.||++|||++|+++
T Consensus       265 ----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          265 ----ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             ----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                000111223457999999999999999999999999984

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.8e-36  Score=288.41  Aligned_cols=248  Identities=21%  Similarity=0.332  Sum_probs=181.8

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|+++..      ....+.+|+.+++.++ |+||+++++.+...  .
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~  105 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIED--N  105 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEET--T
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcC--C
Confidence            3457899999999999999999999999999999998642      2356789999999995 89999999988753  4


Q ss_pred             ccEEEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccce
Q psy3714         242 TPALIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE  314 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~  314 (467)
                      ..++||||+.+++|.+++.       .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~  184 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGR  184 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCC----
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-CEEEEecccee
Confidence            6899999999999987764       278899999999999999999999999999999999998655 79999999998


Q ss_pred             ecCCCC-CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         315 FYHPGQ-EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       315 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ...... ......||+.|+|||++.+..++.+.|+|..+++......+..+|......      ....... +..    .
T Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~----~  253 (310)
T 2wqm_A          185 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKK-IEQ----C  253 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHHHHHH-HHT----T
T ss_pred             eecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHHHHHH-hhc----c
Confidence            654322 223457899999999999988999999998888765555554454322110      0011100 000    0


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .+.    ......+++++++||.+||..||++|||++++++
T Consensus       254 ~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          254 DYP----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             CSC----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCC----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            000    0112347899999999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.1e-36  Score=291.51  Aligned_cols=247  Identities=19%  Similarity=0.247  Sum_probs=180.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEcc---CCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQ---SSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      ..++|++.+.||+|+||.||+|.+..   ++..||+|.++..     ..+.+.+|+.+++.++ ||||+++++++.+...
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC---
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeeccc
Confidence            45789999999999999999998765   4458999998643     2346788999999996 8999999998876433


Q ss_pred             C---ccEEEEeccCCccHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEE
Q psy3714         241 R---TPALIFEHVNNTDFKQLY---------QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLI  308 (467)
Q Consensus       241 ~---~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~  308 (467)
                      .   ..+++|||+.+++|.+++         ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kl~  189 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVA  189 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS-CEEEC
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEEe
Confidence            2   459999999999998876         2488899999999999999999999999999999999998654 79999


Q ss_pred             ecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhh
Q psy3714         309 DWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDK  384 (467)
Q Consensus       309 DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  384 (467)
                      |||+|+.......   .....+|+.|+|||++.+..|+.++|+|..+++.+.... +..|+.....     .........
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~~~~~  264 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----HEMYDYLLH  264 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHHHT
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-----HHHHHHHHc
Confidence            9999987643321   223457889999999999889999999988877554444 3333321110     111111100


Q ss_pred             hccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                         +.          ....+..+++++.+||.+||..||++|||++++++|
T Consensus       265 ---~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          265 ---GH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             ---TC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---CC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               00          011234578999999999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.6e-36  Score=293.32  Aligned_cols=249  Identities=16%  Similarity=0.198  Sum_probs=187.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC--CCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDP--VSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~--~~~~~  243 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...   ..+.+.+|+.+++.++ ||||+++++++...  .....
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCCcee
Confidence            457899999999999999999999999999999988543   3456789999999995 89999999887532  23467


Q ss_pred             EEEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         244 ALIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      ++||||+.+++|.+++.       .+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~  184 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQA  184 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCSSCEES
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-CEEEEecCcchhc
Confidence            89999999999987654       378999999999999999999999999999999999998655 7999999998764


Q ss_pred             CCCCC----------cceeeeccCccCCcccccCC---CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhh
Q psy3714         317 HPGQE----------YNVRVASRYFKGPELLADYQ---YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLD  383 (467)
Q Consensus       317 ~~~~~----------~~~~~gt~~y~aPE~l~~~~---~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (467)
                      .....          .....||+.|+|||++.+..   ++.++|+|..+++.+....+..||......   ......   
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~---  258 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---GDSVAL---  258 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---TSCHHH---
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---cchhhH---
Confidence            31110          12245799999999997654   688999998888765544444443210000   000000   


Q ss_pred             hhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         384 KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                       ....         ....+....+++++.+||.+||+.||++|||++|+++|
T Consensus       259 -~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          259 -AVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             -HHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -Hhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence             0000         00111224578999999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.7e-36  Score=290.15  Aligned_cols=246  Identities=17%  Similarity=0.245  Sum_probs=182.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|+++...      .+.+.+|+.+++.++ ||||+++++++.+.  ..
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~--~~  108 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEID--GQ  108 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEET--TE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeC--Ce
Confidence            3578999999999999999999999999999999986532      256789999999995 89999999998763  56


Q ss_pred             cEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      .+++|||+++++|.+++.   .+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-FAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSCCC-------
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC-CEEEecCccCcccccc
Confidence            899999999999988764   489999999999999999999999999999999999998655 7999999999865432


Q ss_pred             C--CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         320 Q--EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       320 ~--~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      .  ......||+.|+|||++.+..++.+.|+|..+++.+....+..||....        . ......+.....      
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~-~~~~~~~~~~~~------  252 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ--------L-SVMGAHINQAIP------  252 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH--------H-HHHHHHHHSCCC------
T ss_pred             ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch--------H-HHHHHHhccCCC------
Confidence            2  2234579999999999998889999999988877655544444442211        0 011111111000      


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCC-CHHHHhC
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERL-TAREAMD  434 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~-ta~e~l~  434 (467)
                       .....+..+++++.+||.+||+.||++|| |++++++
T Consensus       253 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          253 -RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             -CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             -CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence             01112345899999999999999999999 7877764

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.2e-36  Score=294.17  Aligned_cols=251  Identities=16%  Similarity=0.231  Sum_probs=189.3

Q ss_pred             CCccceeeeEeecccCCcceEEEE-----EccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAI-----NVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDP  238 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~  238 (467)
                      ...++|++++.||+|+||.||+|.     +..++..||+|.+...    ....+.+|+.+++.++ ||||+++++++.+.
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQS  105 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCC-CCCCCeEEEEEcCC
Confidence            345899999999999999999998     5567889999998643    2346788999999995 89999999998764


Q ss_pred             CCCccEEEEeccCCccHHHHhh----------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC--CCcEE
Q psy3714         239 VSRTPALIFEHVNNTDFKQLYQ----------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLR  306 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~--~~~ik  306 (467)
                        ...++||||+++++|.+++.          .+++.++..++.|++.||.|||++||+||||||+|||++..  +..+|
T Consensus       106 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          106 --LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             --SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             --CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence              45799999999999988764          27788899999999999999999999999999999999843  33699


Q ss_pred             EEecccceecCCCC---CcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhh
Q psy3714         307 LIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFL  382 (467)
Q Consensus       307 l~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  382 (467)
                      |+|||+++......   ......||+.|+|||++.+..++.++|+|..+++.+.... +..||....     ........
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~~~~~  258 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----NQEVLEFV  258 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHH
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC-----HHHHHHHH
Confidence            99999997543222   1223467899999999998889999999988877554443 333332111     01111111


Q ss_pred             hhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         383 DKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                      ...   .          ....+..+++++.+||.+||+.||++|||++|+++|.|+.
T Consensus       259 ~~~---~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          259 TSG---G----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HTT---C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcC---C----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            110   0          0112235789999999999999999999999999999874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.5e-35  Score=302.18  Aligned_cols=241  Identities=17%  Similarity=0.271  Sum_probs=188.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ..++|++.+.||+|+||.||+|.+.  ++.||||+++.. ..+.+.+|+.+|+.++ ||||+++++++... ....++||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~-~~~~~iv~  266 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVEE-KGGLYIVT  266 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCC-CTTBCCEEEEEECT-TSCEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhcc-CCCEEEEEEEEEcC-CCceEEEE
Confidence            4578999999999999999999874  679999999764 3467889999999996 89999999987653 23689999


Q ss_pred             eccCCccHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc
Q psy3714         248 EHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       248 e~~~~~~l~~~~~~-----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~  322 (467)
                      ||+++++|.+++..     +++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......  
T Consensus       267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~--  343 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ--  343 (450)
T ss_dssp             ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS-CEEECCCTTCEECC-----
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-CEEEeeCCCcccccccc--
Confidence            99999999887642     68888999999999999999999999999999999998554 79999999998653222  


Q ss_pred             ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         323 NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+|..|+|||++.+..|+.++|+|..+++...... +..||.....     .+........             ...
T Consensus       344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~~~~i~~~-------------~~~  405 (450)
T 1k9a_A          344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEKG-------------YKM  405 (450)
T ss_dssp             ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-----TTHHHHHHTT-------------CCC
T ss_pred             cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcC-------------CCC
Confidence            22367889999999999999999999988887554443 3344322111     1111111110             011


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ..+..+++++.+||.+||..||++|||++|+++
T Consensus       406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            223457999999999999999999999998874

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-35  Score=283.74  Aligned_cols=246  Identities=16%  Similarity=0.281  Sum_probs=191.5

Q ss_pred             CccceeeeE-eecccCCcceEEEEEc--cCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         169 QQDDYQLVR-KLGRGKYSEVFEAINV--QSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       169 ~~~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ..++|.+++ .||+|+||.||+|.+.  .++..||+|+++..    ..+.+.+|+++++.++ ||||+++.+++..   .
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~---~   82 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA---E   82 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES---S
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCC-CCCEeEEEEEecC---C
Confidence            357788887 9999999999999854  46778999998753    2456789999999995 8999999999854   3


Q ss_pred             ccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..++||||+.+++|.+++.    .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++...
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALG  161 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-CEEECcccceeeec
Confidence            5899999999999988763    488999999999999999999999999999999999999554 89999999998764


Q ss_pred             CCCCc----ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         318 PGQEY----NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       318 ~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      .....    ....+|+.|+|||++.+..++.++|+|..+++...... +..||....     ...........   .   
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~~~~i~~~---~---  230 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GPEVMAFIEQG---K---  230 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----THHHHHHHHTT---C---
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHHhcC---C---
Confidence            33221    22346889999999988889999999988877555443 444442211     11111111110   0   


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY  437 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~  437 (467)
                             ....+..+++++.+||.+||..||++|||++|+++|.+
T Consensus       231 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          231 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                   01123457999999999999999999999999998754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=8.8e-36  Score=286.99  Aligned_cols=245  Identities=17%  Similarity=0.213  Sum_probs=184.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCC---CeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSS---DKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ...|++.+.||+|+||.||+|.+..++   ..+|+|.++...    .+.+.+|+.+++.++ ||||+++.+++... ...
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~-~~~  101 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRS-EGS  101 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCS-SSC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcC-CCc
Confidence            357999999999999999999876443   358899876532    356789999999996 89999999986543 346


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .+++|||+++++|.++..    .+++.++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYD  180 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSCGGGCCCSC
T ss_pred             eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-CEEECcccccccccc
Confidence            799999999999988874    378889999999999999999999999999999999998554 799999999986543


Q ss_pred             CC-----CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         319 GQ-----EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       319 ~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ..     ......||+.|+|||++.+..++.+.|+|..+++......+..+++.....    .........   +.    
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~~~~~~~~~---~~----  249 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FDITVYLLQ---GR----  249 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT----TTHHHHHHT---TC----
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH----HHHHHHHhc---CC----
Confidence            22     123346788999999999989999999998887765544433333322111    011110000   00    


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                            ....+..+++++.+||.+||..||++|||++|+++
T Consensus       250 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          250 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                  11123347899999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-36  Score=297.46  Aligned_cols=252  Identities=12%  Similarity=0.120  Sum_probs=186.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccC--------CCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeE-----------
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQS--------SDKCVVKILKPVKKKKIKREIKILENLRGGTNIIT-----------  230 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~--------~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~-----------  230 (467)
                      .++|++.+.||+|+||.||+|.+..+        ++.||+|+++..  ..+.+|+.+++.++ |+||++           
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAA-KPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHC-CHHHHHHHHHHTTCTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhc-ccchhhhhhhhccCCcc
Confidence            47899999999999999999999874        789999998754  56889999999996 788876           


Q ss_pred             ----EEEEEeCCCCCccEEEEeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC
Q psy3714         231 ----LQAVVKDPVSRTPALIFEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE  301 (467)
Q Consensus       231 ----l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~  301 (467)
                          +.+++.. .....++||||+ +++|.+++.     .+++.++..++.||+.||.|||++||+||||||+|||++.+
T Consensus       118 ~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~  195 (352)
T 2jii_A          118 AIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE  195 (352)
T ss_dssp             SCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred             Cccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence                4444443 235689999999 899988764     48899999999999999999999999999999999999954


Q ss_pred             C-CcEEEEecccceecCCCC--------CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcc
Q psy3714         302 N-RKLRLIDWGLAEFYHPGQ--------EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQH  372 (467)
Q Consensus       302 ~-~~ikl~DFGla~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~  372 (467)
                      + ..+||+|||+|+.+....        ......||+.|+|||++.+..++.++|+|..+++.+....+..||...... 
T Consensus       196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-  274 (352)
T 2jii_A          196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN-  274 (352)
T ss_dssp             EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred             CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC-
Confidence            3 179999999998654221        113347999999999999988999999998888766555555555332110 


Q ss_pred             cCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         373 LVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                         ...............  ..+.  .....+..+++++++||.+||+.||++|||++|+++
T Consensus       275 ---~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          275 ---TEDIMKQKQKFVDKP--GPFV--GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             ---HHHHHHHHHHHHHSC--CCEE--CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ---HHHHHHHHHhccCCh--hhhh--hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence               000000000000000  0000  000112347899999999999999999999998865

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.7e-36  Score=293.97  Aligned_cols=256  Identities=18%  Similarity=0.194  Sum_probs=187.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHh-cCCCCeeEEEEEEeCCCC--CccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENL-RGGTNIITLQAVVKDPVS--RTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l-~~~~~iv~l~~~~~~~~~--~~~~lv  246 (467)
                      .++|++.+.||+|+||.||+|.+  +++.||||+++........+|+++++.+ ..||||+++.+.+.....  ...++|
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv  118 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV  118 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence            47899999999999999999987  5889999999877777788999999874 258999999999876532  268999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCH--------SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH--------~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      |||+++++|.+++.  .+++.++..++.|++.||.|||        ++||+||||||+|||++.++ .+||+|||+|+..
T Consensus       119 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~  197 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH  197 (342)
T ss_dssp             ECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CEEECCCTTCEEE
T ss_pred             EeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CEEEEECCCceec
Confidence            99999999988875  4889999999999999999999        89999999999999998655 7999999999876


Q ss_pred             CCCCC-----cceeeeccCccCCcccccCC------CCccchhHHHhhhccccccc----------cccccccCCcccCC
Q psy3714         317 HPGQE-----YNVRVASRYFKGPELLADYQ------YHIELDPRFADILGRHSRKR----------WERFVHTENQHLVS  375 (467)
Q Consensus       317 ~~~~~-----~~~~~gt~~y~aPE~l~~~~------~~~~~D~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~  375 (467)
                      .....     ....+||+.|+|||++.+..      ++.++|+|..+++.+....+          ..||.......   
T Consensus       198 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~---  274 (342)
T 1b6c_B          198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD---  274 (342)
T ss_dssp             ETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS---
T ss_pred             cccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc---
Confidence            54332     23457999999999997752      33678999888775544433          12221111000   


Q ss_pred             hhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         376 PEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ... ......+...........   .-.....++.+.+||.+||+.||++|||++|+++|
T Consensus       275 ~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          275 PSV-EEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CCH-HHHHHHHTTSCCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccH-HHHHHHHHHHHhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            000 000011110000000000   00001234578999999999999999999999876

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-35  Score=283.60  Aligned_cols=244  Identities=17%  Similarity=0.245  Sum_probs=188.6

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCC---eEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSD---KCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..|++.+.||+|+||.||+|.+..+++   .+|+|+++...    .+.+.+|+.+++.++ ||||+++++++.+.. ...
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~~~   98 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPE-GLP   98 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSS-SCC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCC-CCc
Confidence            467788999999999999999766655   79999987532    356789999999995 899999999987643 345


Q ss_pred             EEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      +++|+|+.++++.++..    .+++.++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDR  177 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECCTTSSCTTTTG
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEeCcCCCcccccCC
Confidence            89999999999988764    377889999999999999999999999999999999998554 7999999999865322


Q ss_pred             -----CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         320 -----QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       320 -----~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                           .......+|+.|+|||.+.+..++.++|+|..+++.+....+..+++...+.    ..........         
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~~---------  244 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----FDLTHFLAQG---------  244 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG----GGHHHHHHTT---------
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH----HHHHHHhhcC---------
Confidence                 1223356789999999999999999999998888765554444443332211    0111111100         


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                          .....+..+++++.+||.+||+.||.+|||++|+++
T Consensus       245 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          245 ----RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                011123457899999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8.2e-36  Score=296.68  Aligned_cols=244  Identities=17%  Similarity=0.255  Sum_probs=178.5

Q ss_pred             CccceeeeEeecccCCcceEEEEEc---cCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINV---QSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ..++|++.+.||+|+||.||+|.+.   .++..||||.++..    ..+.+.+|+.+++.++ ||||+++++++.+.  .
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~  119 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKS--K  119 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS--S
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeC--C
Confidence            4578999999999999999999876   45678999998743    2356889999999995 89999999998753  5


Q ss_pred             ccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..++||||+++++|.+++.    .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLGRVLE  198 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC-------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-CEEECcCccccccc
Confidence            6899999999999988764    478899999999999999999999999999999999998554 79999999998764


Q ss_pred             CCCC--c--ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         318 PGQE--Y--NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       318 ~~~~--~--~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      ....  .  ....+|+.|+|||++.+..|+.++|+|..+++.+.... +..||.....     ..........       
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~~~~~i~~~-------  266 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEG-------  266 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HHHHHHHHTT-------
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcC-------
Confidence            3221  1  12235778999999998899999999988876554332 3344322110     1111111110       


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                            ...+.+..+++++.+||.+||+.||++|||++|+++
T Consensus       267 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          267 ------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                  011122347889999999999999999999988775

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.1e-36  Score=284.12  Aligned_cols=241  Identities=16%  Similarity=0.201  Sum_probs=188.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..++|++.+.||+|+||.||+|.+.  ++.+|+|+++..     ..+.+.+|+.+++.++ ||||+++++++.++.....
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSSC
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCCe
Confidence            3578999999999999999999974  788999998743     2356789999999995 8999999999987655678


Q ss_pred             EEEEeccCCccHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         244 ALIFEHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qll~al~~lH~~~--IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      ++||||+++++|.+++..     +++.++..++.|++.||.|||++|  |+||||||+|||++.++ .++|+|||++...
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~~~~~  163 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TARISMADVKFSF  163 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS-CEEEEGGGSCCTT
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc-ceeEEeccceeee
Confidence            999999999999888752     789999999999999999999999  99999999999998554 7999999887653


Q ss_pred             CCCCCcceeeeccCccCCcccccCCCCc---cchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         317 HPGQEYNVRVASRYFKGPELLADYQYHI---ELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       317 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~---~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ..    ....||+.|+|||++.+..+..   ++|+|..+++.+....+..||.....        ...........    
T Consensus       164 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~----  227 (271)
T 3kmu_A          164 QS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------MEIGMKVALEG----  227 (271)
T ss_dssp             SC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--------HHHHHHHHHSC----
T ss_pred             cc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--------HHHHHHHHhcC----
Confidence            22    2357899999999998766554   69999888876555555444422110        01000000000    


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                           .....+..+++++.+||.+||+.||++|||++|+++
T Consensus       228 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          228 -----LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                 011223457999999999999999999999999885

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.4e-35  Score=302.70  Aligned_cols=242  Identities=17%  Similarity=0.252  Sum_probs=189.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..++|++.+.||+|+||.||+|.+. ++..||||+++..  ..+.+.+|+.+|+.++ ||||+++++++..   ...++|
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~---~~~~lv  260 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK---EPIYII  260 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCC-CTTBCCEEEEECS---SSCEEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCC-CCCEeeEEEEEeC---CccEEE
Confidence            3578999999999999999999875 4678999998753  3567899999999996 8999999998863   457999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-  320 (467)
                      |||+.+++|.+++.     .++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...... 
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-CEEECSTTGGGGBCCHHH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC-cEEEeeCCCceEcCCCce
Confidence            99999999988764     478888999999999999999999999999999999998654 79999999998754221 


Q ss_pred             -CcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         321 -EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       321 -~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                       ......+|..|+|||++....|+.++|+|..+++...... +..||....     ..+........             
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~-----~~~~~~~i~~~-------------  401 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRALERG-------------  401 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHHHT-------------
T ss_pred             eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcC-------------
Confidence             1122346778999999998889999999988887554443 333432111     11111111111             


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ...+.+..+++++.+||.+||..||++|||++++++
T Consensus       402 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            011223457899999999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.8e-35  Score=283.81  Aligned_cols=245  Identities=16%  Similarity=0.276  Sum_probs=177.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..++|++.+.||+|+||.||+|.+.   ..+|+|+++..     ..+.+.+|+.+++.++ |+||+.+.++...   ...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~---~~~   94 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYSTA---PQL   94 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS---SSC
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCcEEEEEeeccC---Ccc
Confidence            3578999999999999999999753   45999998643     2356789999999996 8999999986543   357


Q ss_pred             EEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-
Q psy3714         244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-  318 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-  318 (467)
                      ++||||+.++++.+.+.    .+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.... 
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRW  173 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC--------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEEccceeccccccc
Confidence            99999999999987763    478899999999999999999999999999999999999655 899999999986532 


Q ss_pred             --CCCcceeeeccCccCCcccc---cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         319 --GQEYNVRVASRYFKGPELLA---DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       319 --~~~~~~~~gt~~y~aPE~l~---~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                        ........||+.|+|||++.   +..++.++|+|..+++......+..||......    ............    ..
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~----~~  245 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR----DQIIEMVGRGSL----SP  245 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH----HHHHHHHHHTSC----CC
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH----HHHHHHhccccc----Cc
Confidence              12233457999999999987   556888999998888766555555554322110    011111111100    00


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .+.     .....+++++++||.+||+.||++|||++|+++
T Consensus       246 ~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 DLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            010     112347899999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-35  Score=281.12  Aligned_cols=244  Identities=13%  Similarity=0.235  Sum_probs=189.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|+++..  ..+.+.+|+.+++.++ ||||+++++++.+.  ...+++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv   81 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQ--APICLV   81 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCC-CTTBCCEEEEECSS--SSCEEE
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCC-CCCEeeEEEEEccC--CCeEEE
Confidence            3578999999999999999999986 5678999998754  3467889999999995 89999999998764  468999


Q ss_pred             EeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC--
Q psy3714         247 FEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--  320 (467)
Q Consensus       247 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~--  320 (467)
                      |||+++++|.++..    .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++......  
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBCCHHHH
T ss_pred             EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-CEEEccccccccccccccc
Confidence            99999999988764    378899999999999999999999999999999999998554 79999999998653221  


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      ......+|+.|+|||++.+..++.++|+|..+++.+.... +..|+....        ...... .+...         .
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~-~i~~~---------~  222 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVE-DISTG---------F  222 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHH-HHHTT---------C
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--------HHHHHH-HHhcC---------C
Confidence            1223457788999999998889999999988877554444 333332111        011111 11100         0


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ....+...++++.+||.+||+.||++|||++|++++
T Consensus       223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            011223478999999999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.3e-35  Score=283.27  Aligned_cols=243  Identities=17%  Similarity=0.253  Sum_probs=187.0

Q ss_pred             CccceeeeE-eecccCCcceEEEEE--ccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         169 QQDDYQLVR-KLGRGKYSEVFEAIN--VQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       169 ~~~~y~~~~-~lG~G~~g~V~~~~~--~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      ..++|++.+ .||+|+||.||+|.+  ..+++.||||+++...     .+.+.+|+.+++.++ ||||+++.+++..   
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---   89 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICEA---   89 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEES---
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEECC---
Confidence            357899998 999999999999954  5567889999987532     456889999999995 8999999999843   


Q ss_pred             CccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ...++||||+.+++|.+++.   .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALR  168 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECC
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC-cEEEccCCcceeec
Confidence            45799999999999988764   488999999999999999999999999999999999999655 89999999998765


Q ss_pred             CCCCc----ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         318 PGQEY----NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       318 ~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      .....    ....+|+.|+|||++.+..++.++|+|..+++...... +..||.....     ..........   .   
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~---~---  237 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKG---E---  237 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTT---C---
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcC---C---
Confidence            43322    12345788999999988889999999988877555444 4444322110     1111111100   0   


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                             ....+..+++++.+||.+||+.||++|||++|+++
T Consensus       238 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          238 -------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                   01123457999999999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-35  Score=288.18  Aligned_cols=259  Identities=17%  Similarity=0.280  Sum_probs=189.7

Q ss_pred             CccceeeeEeecccCCcceEEEE----EccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAI----NVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ..++|++++.||+|+||.||+|.    +..+++.||+|+++...   .+.+.+|+.+++.++ |+||+++.+++......
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC----
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEecCCC
Confidence            35789999999999999999998    46688999999987532   356789999999995 89999999988765555


Q ss_pred             ccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..++||||+++++|.+++.    .+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLP  196 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECC
T ss_pred             ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-cEEEecCcchhhcc
Confidence            7899999999999988764    378899999999999999999999999999999999998654 89999999998765


Q ss_pred             CCCCc----ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCc---ccCChhhhhhhhhhccCCC
Q psy3714         318 PGQEY----NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQ---HLVSPEALDFLDKNILGRH  390 (467)
Q Consensus       318 ~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  390 (467)
                      .....    ....+|..|+|||++.+..++.++|+|..+++......+..++......   ..............+..  
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  274 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE--  274 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH--
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH--
Confidence            43321    2245778899999999888999999998887755444433332110000   00000000000000000  


Q ss_pred             CcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         391 SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       391 ~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                         ........+.+..+++++.+||++||..||++|||++|+++
T Consensus       275 ---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          275 ---LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             ---HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               00000011223457899999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.5e-35  Score=280.02  Aligned_cols=242  Identities=18%  Similarity=0.245  Sum_probs=188.6

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..++|++++.||+|+||.||+|.+. ++..||+|.++..  ..+.+.+|+++++.++ |+||+++++++.+   ...++|
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~---~~~~~v   85 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ---EPIYII   85 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS---SSCEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCC-CcCcceEEEEEcC---CCcEEE
Confidence            3578999999999999999999865 5678999998753  3567889999999995 8999999998764   357999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      |||+.+++|.++..     .+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCE
T ss_pred             EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-CEEECCCcccccccCccc
Confidence            99999999988764     488999999999999999999999999999999999998554 799999999987643321


Q ss_pred             --cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         322 --YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       322 --~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                        .....+|+.|+|||++.+..++.+.|+|..+++...... +..|+....     ...........             
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~~~~~~~-------------  226 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NPEVIQNLERG-------------  226 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTT-------------
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC-----HHHHHHHHhcc-------------
Confidence              122456788999999988889999999988877554443 333332111     01111111100             


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      .....+..+++++.+||.+||..||++|||++++++
T Consensus       227 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            011123457899999999999999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.6e-35  Score=282.38  Aligned_cols=241  Identities=15%  Similarity=0.260  Sum_probs=181.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ..++|++.+.||+|+||.||+|.+  +++.||+|+++.. ..+.+.+|+.+++.++ |+||+++.+++... ....++||
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~-~~~~~lv~   94 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVEE-KGGLYIVT   94 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCC-CTTBCCEEEEECCC---CCEEEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcC-CCceEEEE
Confidence            357899999999999999999986  4789999998754 3467889999999996 89999999987543 34679999


Q ss_pred             eccCCccHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc
Q psy3714         248 EHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       248 e~~~~~~l~~~~~~-----~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~  322 (467)
                      ||+++++|.++...     +++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.....  .
T Consensus        95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~--~  171 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST--Q  171 (278)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC----------
T ss_pred             ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-cEEEeecccccccccc--c
Confidence            99999999877642     78889999999999999999999999999999999998554 7999999999865432  2


Q ss_pred             ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         323 NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+|+.|+|||++.+..++.++|+|..+++...... +..|+.....     ..........             ...
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~~~~~~-------------~~~  233 (278)
T 1byg_A          172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEKG-------------YKM  233 (278)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHHHHTTT-------------CCC
T ss_pred             cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhcC-------------CCC
Confidence            23467899999999998889999999988877554443 3333321110     1111111000             011


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ..+..+++++.+||.+||..||++|||++|+++
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            123457899999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-35  Score=286.16  Aligned_cols=245  Identities=15%  Similarity=0.231  Sum_probs=181.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCC----eEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSD----KCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      ...+|++.+.||+|+||.||+|.+..++.    .||+|+++..    ....+.+|+.+++.++ ||||+++.+++.+.  
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--  118 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKY--  118 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS--
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC--
Confidence            35789999999999999999999876543    4999998753    2345789999999995 89999999998753  


Q ss_pred             CccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      ...++||||+.+++|.+++.    .+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL  197 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC-cEEECCCCcchhh
Confidence            56899999999999988764    488999999999999999999999999999999999998554 7999999999876


Q ss_pred             CCCCC----cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         317 HPGQE----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       317 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      .....    .....+|+.|+|||++.+..++.++|+|..+++...... +..||.....     .+........      
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~~~~~~~------  266 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMKAINDG------  266 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTT------
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHHCC------
Confidence            43221    112345788999999998889999999988876554333 3344322110     1111111100      


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                             ...+.+..+++++.+||.+||+.||++|||++|++++
T Consensus       267 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          267 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                   0011223578999999999999999999999998874

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-36  Score=304.46  Aligned_cols=245  Identities=16%  Similarity=0.137  Sum_probs=177.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCee--------------
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNII--------------  229 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv--------------  229 (467)
                      ...|...+.||+|+||.||+|.+..+++.||||+++..      ..+.+.+|+.+++.+.+..|+.              
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            35688999999999999999999999999999998732      1356789999998886433211              


Q ss_pred             -EE------EEEEeCC---CCCccEEEEeccCCccHHHHhh----------cCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q psy3714         230 -TL------QAVVKDP---VSRTPALIFEHVNNTDFKQLYQ----------TLTDYDIRYYLYELLKALDYCHSMGIMHR  289 (467)
Q Consensus       230 -~l------~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~qll~al~~lH~~~IiHr  289 (467)
                       .+      ...+...   .....+++|+. .+++|.++.+          .+++..+..++.||+.||+|||++|||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence             11      0111110   12234555554 4567776652          25566777888999999999999999999


Q ss_pred             CCCCCceEEeCCCCcEEEEecccceecCCCCCcceeeeccCccCCccc----------ccCCCCccchhHHHhhhccccc
Q psy3714         290 DVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL----------ADYQYHIELDPRFADILGRHSR  359 (467)
Q Consensus       290 DlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~~~D~~~~~~~~~~~~  359 (467)
                      ||||+|||++.++ .+||+|||+|+....  .....+| +.|+|||++          ....|+.++|+|..+++.+...
T Consensus       236 DiKp~NILl~~~~-~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          236 YLRPVDIVLDQRG-GVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCC-eEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            9999999999665 699999999987542  2444678 999999999          5555888999999888766555


Q ss_pred             cccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         360 KRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                      .+..||......        ..             +...  ......+++++++||.+||+.||++|||+.|+++||||.
T Consensus       312 tg~~Pf~~~~~~--------~~-------------~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~  368 (413)
T 3dzo_A          312 CADLPNTDDAAL--------GG-------------SEWI--FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE  368 (413)
T ss_dssp             HSSCCCCTTGGG--------SC-------------SGGG--GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             HCCCCCCCcchh--------hh-------------HHHH--HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence            555554321100        00             0000  011234789999999999999999999999999999997


Q ss_pred             Ccc
Q psy3714         440 PIV  442 (467)
Q Consensus       440 ~~~  442 (467)
                      .+.
T Consensus       369 ~~~  371 (413)
T 3dzo_A          369 QLR  371 (413)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4e-35  Score=299.15  Aligned_cols=248  Identities=19%  Similarity=0.254  Sum_probs=188.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..++|++.+.||+|+||.||+|.+.. +..||||+++..  ..+.+.+|+.+|+.++ ||||+++++++.+   ...++|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~---~~~~iv  256 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE---EPIYIV  256 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS---SSCEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCC-CCCEeeEEEEEcC---CceEEE
Confidence            35789999999999999999999865 457999998753  3467899999999996 8999999998864   457999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      |||+.+++|.+++.     .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC-------
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC-CEEECCCccceecCCCce
Confidence            99999999988764     388899999999999999999999999999999999998554 799999999987643221


Q ss_pred             --cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         322 --YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       322 --~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                        .....+|..|+|||++....|+.++|+|..+++...... +..|+....     ..+........             
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-----~~~~~~~i~~~-------------  397 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLDQVERG-------------  397 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTT-------------
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcC-------------
Confidence              123456788999999998889999999988887554443 333332111     11111111110             


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC--CCCCCC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD--HPYFYP  440 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~--Hp~f~~  440 (467)
                      ...+.+..+++++.+||.+||+.||++|||++++++  ..+|..
T Consensus       398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            011223457899999999999999999999999986  466654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-35  Score=294.15  Aligned_cols=245  Identities=16%  Similarity=0.205  Sum_probs=178.6

Q ss_pred             cceeeeEeecccCCcceEEEEEccCC---CeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSS---DKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..|++.+.||+|+||.||+|.+..++   ..+|+|.++..    ..+.+.+|+.+++.++ ||||+++++++... ....
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~-~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRS-EGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCC-SSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcC-CCCe
Confidence            46889999999999999999876543   35889988642    2456789999999995 89999999986543 3467


Q ss_pred             EEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ++||||+++++|.+++.    .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDK  245 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC---------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC-CEEEeecccccccccc
Confidence            89999999999998874    367888999999999999999999999999999999998554 7999999999865332


Q ss_pred             CC-----cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         320 QE-----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       320 ~~-----~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ..     .....+|+.|+|||++.+..|+.++|+|..+++.+....+..+++.....    .+.......   +.     
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~----~~~~~~~~~---~~-----  313 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FDITVYLLQ---GR-----  313 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS----SCHHHHHHT---TC-----
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH----HHHHHHHHc---CC-----
Confidence            21     12345778899999999989999999998888765544433332222110    011111100   00     


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                           ....+..+++++.+||.+||+.||++|||++|++++
T Consensus       314 -----~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          314 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                 011234578999999999999999999999998864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=8.2e-35  Score=279.03  Aligned_cols=244  Identities=18%  Similarity=0.223  Sum_probs=180.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccC-CC--eEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQS-SD--KCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~--~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++.+.||+|+||.||+|.+..+ ++  .||+|+++..      ..+.+.+|+.+++.++ |+||+++++++.+. 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-   93 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTP-   93 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccC-
Confidence            457899999999999999999986543 33  5899988642      2356789999999995 89999999998754 


Q ss_pred             CCccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                        ..++||||+.++++.+.+.    .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.
T Consensus        94 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~  170 (291)
T 1u46_A           94 --PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRA  170 (291)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEE
T ss_pred             --CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-CEEEcccccccc
Confidence              3789999999999887653    488999999999999999999999999999999999998554 899999999987


Q ss_pred             cCCCCC----cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCC
Q psy3714         316 YHPGQE----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRH  390 (467)
Q Consensus       316 ~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (467)
                      ......    .....+|..|+|||++.+..++.+.|+|..+++...... +..||....        ....... +....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~-~~~~~  241 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHK-IDKEG  241 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHH-HHTSC
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC--------HHHHHHH-HHccC
Confidence            654332    123457888999999998889999999988877555444 444432211        0111111 10000


Q ss_pred             CcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         391 SRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       391 ~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                              .....+..+++++++||.+||..||++|||++++++
T Consensus       242 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          242 --------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                    011123457999999999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.1e-34  Score=307.06  Aligned_cols=240  Identities=17%  Similarity=0.240  Sum_probs=182.5

Q ss_pred             ceeee-EeecccCCcceEEEEE--ccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         172 DYQLV-RKLGRGKYSEVFEAIN--VQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       172 ~y~~~-~~lG~G~~g~V~~~~~--~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .+.+. +.||+|+||.||+|.+  ..+++.||||+++...     .+.+.+|+++|+.++ |+||+++++++.+   ...
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~---~~~  444 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICEA---ESW  444 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES---SSE
T ss_pred             hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec---CCE
Confidence            34443 4799999999999955  4566789999987532     367889999999996 8999999999864   347


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++||||+.+++|.+++.   .+++.++..++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+......
T Consensus       445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADE  523 (635)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCTTHHHHTTC--
T ss_pred             EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-CEEEEEcCCccccccCc
Confidence            89999999999988764   488999999999999999999999999999999999999655 89999999998764332


Q ss_pred             C----cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         321 E----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       321 ~----~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      .    .....+|+.|+|||++.+..|+.++|+|..+++.+.... +..||.....     .+....+...          
T Consensus       524 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~~~~i~~~----------  588 (635)
T 4fl3_A          524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKG----------  588 (635)
T ss_dssp             -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTT----------
T ss_pred             cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcC----------
Confidence            2    122346788999999999899999999988887655443 4444422110     1111111111          


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                         .....+..+++++.+||.+||..||++|||++++++
T Consensus       589 ---~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          589 ---ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence               011123457999999999999999999999999874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1e-34  Score=280.68  Aligned_cols=252  Identities=15%  Similarity=0.197  Sum_probs=185.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ...|...+.||+|+||.||+|.+  +++.+|+|.+...       ..+.+.+|+.+++.++ ||||+++++++.+.  ..
T Consensus        30 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~  104 (307)
T 2nru_A           30 RPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDG--DD  104 (307)
T ss_dssp             SBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS--SS
T ss_pred             ccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecC--Cc
Confidence            34455668999999999999986  5789999988642       2456889999999996 89999999998764  46


Q ss_pred             cEEEEeccCCccHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         243 PALIFEHVNNTDFKQLYQ------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      .+++|||++++++.+.+.      .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~  183 (307)
T 2nru_A          105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF-TAKISDFGLARAS  183 (307)
T ss_dssp             CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC-cEEEeeccccccc
Confidence            899999999999987764      378889999999999999999999999999999999998554 7999999999876


Q ss_pred             CCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         317 HPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       317 ~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      .....   .....||+.|+|||++.+ .++.+.|+|..+++.+....+..|+.......... .........      ..
T Consensus       184 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~------~~  255 (307)
T 2nru_A          184 EKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL-DIKEEIEDE------EK  255 (307)
T ss_dssp             CSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT-HHHHHHHTT------SC
T ss_pred             ccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH-HHHHHhhhh------hh
Confidence            43222   223478999999998875 47889999988887666555555553322211110 000000000      00


Q ss_pred             cccccccc---cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         394 RWERFVHT---ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       394 ~~~~~~~~---~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      .+..+...   ......++++.+||.+||..||++|||++|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          256 TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            01111000   0111245788999999999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-34  Score=301.74  Aligned_cols=249  Identities=18%  Similarity=0.255  Sum_probs=192.2

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..++|++.+.||+|+||.||+|.+.. +..||||+++..  ..+.+.+|+.+|+.++ |+||+++++++.+   ...++|
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~---~~~~lv  339 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE---EPIYIV  339 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS---SSCEEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCC-CCCEeeEEEEEee---ccceEe
Confidence            35789999999999999999998865 467999998753  3467899999999996 8999999998864   457999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-  320 (467)
                      |||+.+++|.+++.     .+++.++..++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+...... 
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCTTSTTTCCCHHH
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-cEEEcccccceecCCCce
Confidence            99999999988764     388899999999999999999999999999999999998554 79999999998654221 


Q ss_pred             -CcceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         321 -EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       321 -~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                       ......+|..|+|||++....|+.++|+|..+++...... +..||....     ..+....+...             
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~-----~~~~~~~i~~~-------------  480 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLDQVERG-------------  480 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC-----HHHHHHHHHTT-------------
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcC-------------
Confidence             1122346788999999998889999999988887554444 333332111     11111111111             


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC--CCCCCc
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH--PYFYPI  441 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H--p~f~~~  441 (467)
                      .....+..+++++.+||.+||+.||++|||++++++.  .+|...
T Consensus       481 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          481 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            0111234578999999999999999999999998863  666543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-34  Score=301.75  Aligned_cols=246  Identities=16%  Similarity=0.281  Sum_probs=186.6

Q ss_pred             ccceeeeE-eecccCCcceEEEEEcc--CCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVR-KLGRGKYSEVFEAINVQ--SSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~-~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      .+++.+.+ .||+|+||.||+|.+..  ++..||||+++..    ..+.+.+|+++|+.++ ||||+++++++.+   ..
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~---~~  409 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA---EA  409 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES---SS
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc---CC
Confidence            45666666 89999999999998763  4557999998753    3467899999999995 8999999999875   35


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .++||||+.+++|.+++.    .+++.++..++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+....
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLSKALGA  488 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCSTTTTCC-
T ss_pred             eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-cEEEeeccCcccccC
Confidence            899999999999988763    488999999999999999999999999999999999999654 899999999987643


Q ss_pred             CCCc----ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         319 GQEY----NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       319 ~~~~----~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ....    ....+|+.|+|||++....|+.++|+|..+++...... +..||....     ..+....+....       
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-----~~~~~~~i~~~~-------  556 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GPEVMAFIEQGK-------  556 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----SHHHHHHHHTTC-------
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHcCC-------
Confidence            3221    12345688999999998899999999988887655443 444443211     112222221110       


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHh---CCCCC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM---DHPYF  438 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l---~Hp~f  438 (467)
                            ....+..+++++.+||.+||..||++|||+++++   ++.|+
T Consensus       557 ------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          557 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                  1112345789999999999999999999999874   55554

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.8e-34  Score=301.62  Aligned_cols=243  Identities=19%  Similarity=0.299  Sum_probs=185.5

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCC---CeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSS---DKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ..++|++.+.||+|+||.||+|.+..++   ..+|+|.++...    .+.+.+|+.+++.++ ||||+++++++.+   .
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~---~  463 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITE---N  463 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS---S
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEec---C
Confidence            3578999999999999999999986543   468999876432    356789999999995 8999999998853   3


Q ss_pred             ccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..++||||+++++|.+++.    .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~-~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYME  542 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCCCCSCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC-CEEEEecCCCeecC
Confidence            5799999999999988764    478889999999999999999999999999999999999654 89999999998764


Q ss_pred             CCCCc--ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         318 PGQEY--NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       318 ~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      .....  ....+|+.|+|||++.+..|+.++|+|..+++...... +..||....     ..+....+...   .     
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-----~~~~~~~i~~~---~-----  609 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVIGRIENG---E-----  609 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHHT---C-----
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHcC---C-----
Confidence            33322  23456789999999998889999999988876554433 333332211     01111111110   0     


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                           ....+..+++++.+||.+||..||++|||++|+++
T Consensus       610 -----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          610 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                 01123457899999999999999999999999875

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-34  Score=310.37  Aligned_cols=239  Identities=18%  Similarity=0.203  Sum_probs=185.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEcc-CCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC---
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQ-SSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR---  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~---  241 (467)
                      .++|++.+.||+|+||.||+|.+.. +++.||||++...    ....+.+|+.+++.++ ||||+++++++......   
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEECTTSCE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeecCCCCCc
Confidence            3789999999999999999999976 6889999988643    2345788999999996 89999999988754321   


Q ss_pred             ccEEEEeccCCccHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ-TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ..|+||||+++++|.+... .+++.++..++.||+.||.|||++|||||||||+|||++. + .+||+|||+++..... 
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~-~-~~kl~DFG~a~~~~~~-  234 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-E-QLKLIDLGAVSRINSF-  234 (681)
T ss_dssp             EEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS-S-CEEECCCTTCEETTCC-
T ss_pred             eeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC-C-cEEEEecccchhcccC-
Confidence            1599999999999877654 6899999999999999999999999999999999999985 4 7999999999876533 


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                        ...+||+.|+|||++.+. ++.++|+|..+++......+..++......             .+    .  ..     
T Consensus       235 --~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------~~----~--~~-----  287 (681)
T 2pzi_A          235 --GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-------------GL----P--ED-----  287 (681)
T ss_dssp             --SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-------------SC----C--TT-----
T ss_pred             --CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-------------cc----c--cc-----
Confidence              446799999999998764 478899998887754433332222110000             00    0  00     


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                       ......++++.+||.+||+.||++|||+.+++.|+|+.-
T Consensus       288 -~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          288 -DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence             000114688999999999999999999999999999853

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.5e-33  Score=274.00  Aligned_cols=241  Identities=19%  Similarity=0.268  Sum_probs=181.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..++|++.+.||+|+||.||+|.+..   .+|+|+++...     .+.+.+|+.+++.++ |+||+++.+++.+.  ...
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~  104 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTR-HENVVLFMGACMSP--PHL  104 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEECS--SCE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEecC--Cce
Confidence            35789999999999999999998743   59999886431     245678999999995 89999999998764  458


Q ss_pred             EEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-
Q psy3714         244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-  318 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-  318 (467)
                      +++|||+.+++|.+++.    .+++.++..++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+|+.... 
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-KVVITDFGLFSISGVL  182 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC-----
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-CEEEeecCCccccccc
Confidence            99999999999998875    378899999999999999999999999999999999998 44 799999999875421 


Q ss_pred             -----CCCcceeeeccCccCCccccc---------CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhh
Q psy3714         319 -----GQEYNVRVASRYFKGPELLAD---------YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK  384 (467)
Q Consensus       319 -----~~~~~~~~gt~~y~aPE~l~~---------~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (467)
                           ........||+.|+|||++..         ..|+.++|+|..+++.+....+..||.....     .........
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~  257 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-----EAIIWQMGT  257 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-----HHHHHHHHT
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHhcc
Confidence                 122234568999999999975         3478889999888876555454444422110     001100000


Q ss_pred             hccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                         +.         ........+++++.+||.+||..||++|||++|+++
T Consensus       258 ---~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          258 ---GM---------KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             ---TC---------CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             ---CC---------CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence               00         000112247889999999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.5e-32  Score=263.06  Aligned_cols=222  Identities=11%  Similarity=0.041  Sum_probs=169.7

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++...      .+.+.+|+.++..+. |+||+++++++.+.  ...+
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~--~~~~  107 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTR--AGGL  107 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEET--TEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEEC--CcEE
Confidence            67999999999999999999999999999999987532      256789999999985 89999999998764  5689


Q ss_pred             EEEeccCCccHHHHhhc-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCcc
Q psy3714         245 LIFEHVNNTDFKQLYQT-LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYN  323 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~~-~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~~  323 (467)
                      +||||+++++|.++++. ....++..++.||+.||+|||++||+||||||+|||++.++ .+||+++|            
T Consensus       108 lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-~~kl~~~~------------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-DVVLAYPA------------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-CEEECSCC------------
T ss_pred             EEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-CEEEEecc------------
Confidence            99999999999888753 56677888999999999999999999999999999999655 78887543            


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                             |++|       ++.++|+|..+++.+....+..||.........     .........     ...  .....
T Consensus       175 -------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-----~~~~~~~~~-----~~~--~~~~~  228 (286)
T 3uqc_A          175 -------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-----APAERDTAG-----QPI--EPADI  228 (286)
T ss_dssp             -------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-----EECCBCTTS-----CBC--CHHHH
T ss_pred             -------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-----HHHHHHhcc-----CCC--Chhhc
Confidence                   3333       678899998888766665665555432211000     000000000     000  00011


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ...+++++.+||.+||+.||++| |++|+++.
T Consensus       229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             ccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            24589999999999999999999 99998873

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=4.9e-32  Score=282.83  Aligned_cols=178  Identities=21%  Similarity=0.164  Sum_probs=126.0

Q ss_pred             eEeecccCCcceEEEEEccCCCeEEEEEeccc-------------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         176 VRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-------------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       176 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-------------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ....+.|+.|.+..++....|+.+++|.+...             ..+.+.+|+++|+++.+|+||+++.+++++.  ..
T Consensus       239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~  316 (569)
T 4azs_A          239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QS  316 (569)
T ss_dssp             ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SE
T ss_pred             hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CE
Confidence            34567788888888888888999999998542             1245789999999998899999999999874  56


Q ss_pred             cEEEEeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CC
Q psy3714         243 PALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QE  321 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~  321 (467)
                      .||||||++|++|.+.+......+...++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..... ..
T Consensus       317 ~yLVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-HARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-CEEECCCTTEESCC---CC
T ss_pred             EEEEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-CEEEeecccCeeCCCCCcc
Confidence            899999999999999886543334456899999999999999999999999999999665 7999999999876432 33


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRH  357 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~  357 (467)
                      .++.+||+.|||||++.+. +....|.|..++....
T Consensus       396 ~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~  430 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFN  430 (569)
T ss_dssp             SHHHHHHHHHHHHHHC------------------CC
T ss_pred             ccCceechhhccHHHhCCC-CCCcccccccccchhh
Confidence            4567899999999999764 5567788877665433

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.95  E-value=2.7e-29  Score=247.60  Aligned_cols=125  Identities=30%  Similarity=0.530  Sum_probs=106.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC----------------------------
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----------------------------   53 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~----------------------------   53 (467)
                      .++.||+.||+|||++|||||||||+|||++.+.+.+||+|||+|+...+..                            
T Consensus       121 ~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (361)
T 4f9c_A          121 EYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRR  200 (361)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC---------------------
T ss_pred             HHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccccccccccccccccc
Confidence            5789999999999999999999999999998665689999999998653321                            


Q ss_pred             -cccccccccccccccccccccCCCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchhHhhhh
Q psy3714          54 -EYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLD  126 (467)
Q Consensus        54 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  126 (467)
                       ..+..+||+.|+|||++.+...|+.++|+||+||++|||++|+.||+.+.++.+++..+.+.+|+++......
T Consensus       201 ~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~  274 (361)
T 4f9c_A          201 QQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAK  274 (361)
T ss_dssp             -----CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             ccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhh
Confidence             1234579999999999987677899999999999999999999999999999999999999999876654443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.95  E-value=1.3e-28  Score=232.50  Aligned_cols=98  Identities=30%  Similarity=0.602  Sum_probs=76.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.........+.+||+.|||||++.+...++.++|
T Consensus       116 ~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~D  194 (275)
T 3hyh_A          116 RFFQQIISAVEYCHRHKIVHRDLKPENLLLDE-HLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVD  194 (275)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT-TCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHH
T ss_pred             HHHHHHHHHHHHHHHCCcccccCChHHeEECC-CCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhh
Confidence            58899999999999999999999999999984 45899999999988766555666799999999999987555578999


Q ss_pred             EEchhHHHHHHHhcCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~  100 (467)
                      |||+||++|+|++|+.||.
T Consensus       195 iwSlGvily~lltg~~PF~  213 (275)
T 3hyh_A          195 VWSCGVILYVMLCRRLPFD  213 (275)
T ss_dssp             HHHHHHHHHHHHHSSCSSC
T ss_pred             hHHHHHHHHHHHHCCCCCC
Confidence            9999999999999999984

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.95  E-value=3.1e-28  Score=236.79  Aligned_cols=109  Identities=26%  Similarity=0.546  Sum_probs=91.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-CcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+..... ......+||+.|||||++.+ ..|+.++
T Consensus       174 ~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~  251 (346)
T 4fih_A          174 AVCLAVLQALSVLHAQGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEV  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHH
T ss_pred             HHHHHHHHHHHHHHHCCcccccCCHHHEEECC-CCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC-CCCCcHH
Confidence            58899999999999999999999999999985 458999999999976543 34566799999999999875 5689999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA  113 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~  113 (467)
                      |||||||++|||++|+.||. +.+..+.+..+.
T Consensus       252 DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~  283 (346)
T 4fih_A          252 DIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIR  283 (346)
T ss_dssp             HHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHH
Confidence            99999999999999999985 444444444443

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.95  E-value=2.1e-28  Score=234.52  Aligned_cols=110  Identities=29%  Similarity=0.561  Sum_probs=91.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      .++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+......   ...+.+||+.|||||++.+ ..|+.
T Consensus       136 ~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~  213 (311)
T 4aw0_A          136 FYTAEIVSALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACK  213 (311)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH-SCBCH
T ss_pred             HHHHHHHHHHHHHHHCCCccCCCCHHHeEEcC-CCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC-CCCCc
Confidence            57899999999999999999999999999984 4589999999999775332   2456789999999999976 56899


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      ++|+||+||++|+|++|+.||. +.+..+.+.++.+
T Consensus       214 ~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~  248 (311)
T 4aw0_A          214 SSDLWALGCIIYQLVAGLPPFR-AGNEGLIFAKIIK  248 (311)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHc
Confidence            9999999999999999999984 4444444444433

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.94  E-value=4.1e-28  Score=231.11  Aligned_cols=104  Identities=24%  Similarity=0.410  Sum_probs=87.9

Q ss_pred             hHHHHHHHHHHHHHhCC--CcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~--iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.||+.||+|||++|  ||||||||+|||++..++.+||+|||+|+.... ....+.+||+.|||||++.+  .|+.+
T Consensus       133 ~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~--~y~~~  209 (290)
T 3fpq_A          133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDES  209 (290)
T ss_dssp             HHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTH
T ss_pred             HHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcCC--CCCcH
Confidence            58999999999999999  999999999999985556899999999986543 33456789999999998863  48999


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCCCCHHHH
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGHDNYDQL  109 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~  109 (467)
                      +|||||||++|||++|+.||.. .++...+
T Consensus       210 ~DiwSlGvilyelltg~~Pf~~-~~~~~~~  238 (290)
T 3fpq_A          210 VDVYAFGMCMLEMATSEYPYSE-CQNAAQI  238 (290)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTT-CSSHHHH
T ss_pred             HHHHHHHHHHHHHHHCCCCCCC-CCcHHHH
Confidence            9999999999999999999853 3444443

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.94  E-value=2.5e-28  Score=234.34  Aligned_cols=110  Identities=25%  Similarity=0.472  Sum_probs=86.5

Q ss_pred             ChHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC---Ccccccccccccccccccccc--cC
Q psy3714           1 MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLADY--QM   75 (467)
Q Consensus         1 ~~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~---~~~~~~~~~~~~~~pe~~~~~--~~   75 (467)
                      ++|+.|||.||+|||++|||||||||+|||++ +++.+||+|||+|+.....   ......+||+.|||||++.+.  ..
T Consensus       135 ~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~  213 (307)
T 3omv_A          135 IDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH-EGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNP  213 (307)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE-TTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCC
T ss_pred             HHHHHHHHHHHHHHHHCCccCCccCHHHEEEC-CCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCC
Confidence            36899999999999999999999999999999 4569999999999865432   223456899999999998642  34


Q ss_pred             CCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          76 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        76 ~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      |+.++|||||||++|||++|+.||. +.+....+..+
T Consensus       214 y~~ksDVwS~Gvvl~Elltg~~Pf~-~~~~~~~~~~~  249 (307)
T 3omv_A          214 FSFQSDVYSYGIVLYELMTGELPYS-HINNRDQIIFM  249 (307)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTT-TCCCHHHHHHH
T ss_pred             CCcHHHhHhHHHHHHHHHHCCCCCC-CCChHHHHHHH
Confidence            7889999999999999999999984 44444444443

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.94  E-value=4.3e-28  Score=232.19  Aligned_cols=110  Identities=28%  Similarity=0.480  Sum_probs=90.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-CcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+..... ....+.+||+.|||||++.+ ..|+.++
T Consensus       130 ~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~  207 (304)
T 3ubd_A          130 FYLAELALALDHLHSLGIIYRDLKPENILLDE-EGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSA  207 (304)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT-TSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHT-SCCCTHH
T ss_pred             HHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcC-CCCEEecccccceeccCCCccccccccCcccCCHHHhcc-CCCCCCC
Confidence            57899999999999999999999999999985 458999999999865432 33456789999999999976 5689999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      |+||+||++|||++|+.||. +.+..+.+..+.+
T Consensus       208 DiwSlGvilyemltG~~PF~-~~~~~~~~~~i~~  240 (304)
T 3ubd_A          208 DWWSFGVLMFEMLTGTLPFQ-GKDRKETMTMILK  240 (304)
T ss_dssp             HHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH
T ss_pred             cccchHHHHHHHHhCCCCCC-CcCHHHHHHHHHc
Confidence            99999999999999999884 5444444444443

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.94  E-value=1.4e-27  Score=237.97  Aligned_cols=109  Identities=26%  Similarity=0.546  Sum_probs=91.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-CcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+..... ......+||+.|||||++.+ ..|+.++
T Consensus       251 ~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~  328 (423)
T 4fie_A          251 AVCLAVLQALSVLHAQGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEV  328 (423)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSTTTEEECT-TCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT-CCBCTHH
T ss_pred             HHHHHHHHHHHHHHHCCeecccCCHHHEEEcC-CCCEEEecCccceECCCCCccccccccCcCcCCHHHHCC-CCCCcHH
Confidence            58999999999999999999999999999985 458999999999876543 34566799999999999975 5689999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA  113 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~  113 (467)
                      |||||||++|||++|..||. +.+..+.+..+.
T Consensus       329 DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~  360 (423)
T 4fie_A          329 DIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIR  360 (423)
T ss_dssp             HHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHH
Confidence            99999999999999999985 444444444443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.94  E-value=5.6e-28  Score=234.24  Aligned_cols=98  Identities=27%  Similarity=0.434  Sum_probs=83.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc------ccccccccccccccccccccC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE------YNVRVASRYFKGPELLADYQM   75 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~------~~~~~~~~~~~~pe~~~~~~~   75 (467)
                      .|+.||+.||+|||++|||||||||+|||++.++..+||+|||+|+....+..      ....+||+.|||||++.+ ..
T Consensus       154 ~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~  232 (336)
T 4g3f_A          154 YYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KP  232 (336)
T ss_dssp             HHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT-CC
T ss_pred             HHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC-CC
Confidence            58999999999999999999999999999986554799999999997654321      123579999999999986 56


Q ss_pred             CCCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          76 YDYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        76 ~~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+.++|||||||++|||++|+.||.
T Consensus       233 y~~~~DiwSlGvilyemltG~~Pf~  257 (336)
T 4g3f_A          233 CDAKVDIWSSCCMMLHMLNGCHPWT  257 (336)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred             CCcHHHHHHHHHHHHHHHHCcCCCC
Confidence            8999999999999999999999985

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.94  E-value=3.7e-28  Score=236.59  Aligned_cols=110  Identities=24%  Similarity=0.479  Sum_probs=91.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-cccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+...... .....+||+.|||||++.+ ..|+.++
T Consensus       129 ~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~  206 (350)
T 4b9d_A          129 DWFVQICLALKHVHDRKILHRDIKSQNIFLTK-DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYNNKS  206 (350)
T ss_dssp             HHHHHHHHHHHHHHHTTCEETTCCGGGEEECT-TCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT-CCCCHHH
T ss_pred             HHHHHHHHHHHHHHHCCeeeccCCHHHEEECC-CCCEEEcccccceeecCCcccccccCCCccccCHHHHCC-CCCCcHH
Confidence            58899999999999999999999999999985 4589999999998765332 2345689999999999976 5689999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      |||||||++|||++|+.||. +.+..+.+.++..
T Consensus       207 DiwSlGvilyemltG~~PF~-~~~~~~~~~~i~~  239 (350)
T 4b9d_A          207 DIWALGCVLYELCTLKHAFE-AGSMKNLVLKIIS  239 (350)
T ss_dssp             HHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHc
Confidence            99999999999999999884 4444444444443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.94  E-value=2.1e-27  Score=236.68  Aligned_cols=117  Identities=32%  Similarity=0.613  Sum_probs=100.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-----CcccccccccccccccccccccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-----QEYNVRVASRYFKGPELLADYQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~   76 (467)
                      .|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.+...     ......+||++|||||++.+...+
T Consensus       162 ~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~-~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~  240 (398)
T 4b99_A          162 YFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE-NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEY  240 (398)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCC
T ss_pred             HHHHHHHHHHHHHHHCcCcCCCcCccccccCC-CCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCC
Confidence            58999999999999999999999999999984 458999999999865322     224557899999999999876778


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCch
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE  120 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~  120 (467)
                      +.++||||+||++|||++|+.|| .+.+..+++..|.+..|++.
T Consensus       241 ~~~~DiWSlG~il~ell~G~~pF-~g~~~~~~l~~I~~~~g~p~  283 (398)
T 4b99_A          241 TQAIDLWSVGCIFGEMLARRQLF-PGKNYVHQLQLIMMVLGTPS  283 (398)
T ss_dssp             CTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCC
T ss_pred             CChhheehhHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhcCCCC
Confidence            99999999999999999998776 67788888999988887654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=3.4e-27  Score=244.94  Aligned_cols=166  Identities=16%  Similarity=0.180  Sum_probs=124.9

Q ss_pred             eeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         174 QLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       174 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      ...+.||+|+||.||+|.  ..+..+++|.....           ..+++.+|+++|+.++ ||||+.+..+..+  ...
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~--~~~  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVD--LDN  413 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEE--TTT
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEe--CCc
Confidence            345689999999999993  45678888875321           1245789999999996 8999944333332  245


Q ss_pred             cEEEEeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc
Q psy3714         243 PALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~  322 (467)
                      .++||||+++++|.+++..     +..++.|++.||+|||++||+||||||+|||++.   .+||+|||+|+........
T Consensus       414 ~~lVmE~~~ggsL~~~l~~-----~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          414 KRIMMSYINGKLAKDVIED-----NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             TEEEEECCCSEEHHHHSTT-----CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHH
T ss_pred             cEEEEECCCCCCHHHHHHH-----HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCcccc
Confidence            6999999999999988765     6789999999999999999999999999999985   7999999999987543221


Q ss_pred             --------ceeeeccCccCCccccc--CCCCccchhHHHh
Q psy3714         323 --------NVRVASRYFKGPELLAD--YQYHIELDPRFAD  352 (467)
Q Consensus       323 --------~~~~gt~~y~aPE~l~~--~~~~~~~D~~~~~  352 (467)
                              ...+||++|||||++..  ..|+..+|.|...
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~v  525 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEII  525 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHH
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHH
Confidence                    24689999999999987  5577777887443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.93  E-value=2.9e-27  Score=226.71  Aligned_cols=108  Identities=21%  Similarity=0.356  Sum_probs=87.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.|||.||+|||+++||||||||+|||++. +..+||+|||+|+.......   .....||+.|||||++.+ ..|+.
T Consensus       132 ~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~-~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~  209 (299)
T 4asz_A          132 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGE-NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTT  209 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHhCCcccCccCHhhEEECC-CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCc
Confidence            68999999999999999999999999999985 46899999999986543322   223468999999999986 55899


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCCCCCCCHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~~~~  112 (467)
                      ++|||||||++|||+| |+.||. +.+..+.+..+
T Consensus       210 k~DVwS~Gvvl~Ellt~G~~Pf~-~~~~~~~~~~i  243 (299)
T 4asz_A          210 ESDVWSLGVVLWEIFTYGKQPWY-QLSNNEVIECI  243 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHH
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHH
Confidence            9999999999999998 788874 44443333333

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.93  E-value=3.2e-27  Score=227.42  Aligned_cols=107  Identities=19%  Similarity=0.353  Sum_probs=87.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.|||.||+|||+++||||||||+|||++. ++.+||+|||+|+......   ..+..+||+.|||||++.+ ..++.
T Consensus       149 ~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~-~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~  226 (308)
T 4gt4_A          149 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD-KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSI  226 (308)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCccccceEECC-CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCc
Confidence            68999999999999999999999999999994 4589999999998654322   2334578999999999976 55899


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCCCCCCCHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVR  111 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~~~  111 (467)
                      ++|||||||++|||+| |..|| .+.+..+.+..
T Consensus       227 ksDVwSfGvvl~El~t~g~~Pf-~~~~~~~~~~~  259 (308)
T 4gt4_A          227 DSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVVEM  259 (308)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCTT-TTCCHHHHHHH
T ss_pred             cchhhhHHHHHHHHHhCCCCCC-CCCCHHHHHHH
Confidence            9999999999999998 67776 44444433333

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.93  E-value=5.9e-27  Score=229.54  Aligned_cols=107  Identities=20%  Similarity=0.390  Sum_probs=87.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.|||.||+|||+++||||||||+|||++. ++.+||+|||+|+....+..   .+..+||+.|||||++.+ ..|+.
T Consensus       189 ~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~-~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~  266 (353)
T 4ase_A          189 CYSFQVAKGMEFLASRKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTI  266 (353)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHhHhhCCeecCccCccceeeCC-CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCC
Confidence            58999999999999999999999999999985 45899999999997654332   234578999999999986 56899


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCCCCCCCHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVR  111 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~~~  111 (467)
                      ++|||||||++|||+| |+.||. +.+..+.+..
T Consensus       267 ksDVwS~Gv~l~El~t~G~~Pf~-~~~~~~~~~~  299 (353)
T 4ase_A          267 QSDVWSFGVLLWEIFSLGASPYP-GVKIDEEFCR  299 (353)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCSST-TCCCSHHHHH
T ss_pred             cccEeehHHHHHHHHhCCCCCCC-CCCHHHHHHH
Confidence            9999999999999998 787774 4433333333

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.93  E-value=9.5e-27  Score=226.18  Aligned_cols=108  Identities=18%  Similarity=0.351  Sum_probs=81.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.|||.||+|||+++||||||||+|||++ .+..+||+|||+|+.......   .+...||+.|||||++.+ ..++.
T Consensus       162 ~i~~qia~gl~yLH~~~iiHRDLKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~  239 (329)
T 4aoj_A          162 AVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTT  239 (329)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE-TTTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCH
T ss_pred             HHHHHHHHHHHHHhcCCeecccccHhhEEEC-CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCc
Confidence            6899999999999999999999999999999 456999999999987643322   234578999999999986 55899


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCCCCCCCHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~~~~  112 (467)
                      ++|||||||++|||++ |+.||. +.+..+.+..+
T Consensus       240 ~sDvwS~Gvvl~Ellt~G~~Pf~-~~~~~~~~~~i  273 (329)
T 4aoj_A          240 ESDVWSFGVVLWEIFTYGKQPWY-QLSNTEAIDCI  273 (329)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTC-SSCHHHHHHHH
T ss_pred             cccccchHHHHHHHHcCCCCCCC-CCCHHHHHHHH
Confidence            9999999999999998 788874 33443334443

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.92  E-value=1.2e-26  Score=222.81  Aligned_cols=94  Identities=29%  Similarity=0.589  Sum_probs=74.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc-------------cccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-------------YNVRVASRYFKGPE   68 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~-------------~~~~~~~~~~~~pe   68 (467)
                      +|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.......             .+..+||+.|||||
T Consensus       122 ~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~-~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE  200 (299)
T 4g31_A          122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE  200 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECCCCCC--------------------------CCCTTSCHH
T ss_pred             HHHHHHHHHHHHHHHCcCccccCcHHHeEECC-CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHH
Confidence            58899999999999999999999999999985 45899999999987643221             23357999999999


Q ss_pred             ccccccCCCCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          69 LLADYQMYDYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        69 ~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      ++.+ ..|+.++|||||||++|||++   ||.
T Consensus       201 ~~~~-~~y~~~~DiwSlGvilyell~---Pf~  228 (299)
T 4g31_A          201 QIHG-NSYSHKVDIFSLGLILFELLY---PFS  228 (299)
T ss_dssp             HHTT-CCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             HHcC-CCCCCHHHHHHHHHHHHHHcc---CCC
Confidence            9986 568999999999999999995   663

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.92  E-value=6.4e-26  Score=236.21  Aligned_cols=98  Identities=31%  Similarity=0.497  Sum_probs=87.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+...... ..+.+||+.|||||++.+...|+.++|
T Consensus       296 ~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~-~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vD  373 (689)
T 3v5w_A          296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDE-HGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSAD  373 (689)
T ss_dssp             HHHHHHHHHHHHHHTTTEECCCCSGGGEEECT-TSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHH
T ss_pred             HHHHHHHHHHHHHHHCCccccCCchHHeEEeC-CCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHH
Confidence            47899999999999999999999999999995 4599999999999876543 345689999999999976567899999


Q ss_pred             EEchhHHHHHHHhcCCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|||||++|||++|..||..
T Consensus       374 iWSLGvilYEmLtG~~PF~~  393 (689)
T 3v5w_A          374 WFSLGCMLFKLLRGHSPFRQ  393 (689)
T ss_dssp             HHHHHHHHHHHHHSSCTTCG
T ss_pred             HHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999853

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=3.2e-25  Score=211.37  Aligned_cols=144  Identities=22%  Similarity=0.273  Sum_probs=116.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---------------------hHHHHHHHHHHHHHhcCCCCe
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---------------------KKKKIKREIKILENLRGGTNI  228 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---------------------~~~~~~~Ei~il~~l~~~~~i  228 (467)
                      ...|++.+.||+|+||.||+|.+ .+++.||+|+++..                     ....+.+|+.+|+.++ |.++
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~v  166 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAV  166 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSS
T ss_pred             CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCCc
Confidence            34566779999999999999999 88999999998632                     1345789999999997 3444


Q ss_pred             eEEEEEEeCCCCCccEEEEeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEE
Q psy3714         229 ITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLI  308 (467)
Q Consensus       229 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~  308 (467)
                      ..   .+..   ...++||||+++++|.+ +   ...+...++.|++.||.|||++||+||||||+|||++ + +.+||+
T Consensus       167 ~~---~~~~---~~~~lvmE~~~g~~L~~-l---~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~-~~vkl~  234 (282)
T 1zar_A          167 PK---VYAW---EGNAVLMELIDAKELYR-V---RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIWII  234 (282)
T ss_dssp             CC---EEEE---ETTEEEEECCCCEEGGG-C---CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEEEC
T ss_pred             Ce---EEec---cceEEEEEecCCCcHHH-c---chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C-CcEEEE
Confidence            44   3432   34699999999999876 2   3345668999999999999999999999999999999 4 489999


Q ss_pred             ecccceecCCCCCcceeeeccCccCCccccc
Q psy3714         309 DWGLAEFYHPGQEYNVRVASRYFKGPELLAD  339 (467)
Q Consensus       309 DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~  339 (467)
                      |||+|+.            +..++|||++.+
T Consensus       235 DFG~a~~------------~~~~~a~e~l~r  253 (282)
T 1zar_A          235 DFPQSVE------------VGEEGWREILER  253 (282)
T ss_dssp             CCTTCEE------------TTSTTHHHHHHH
T ss_pred             ECCCCeE------------CCCCCHHHHHHH
Confidence            9999873            346789998753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.90  E-value=2.1e-25  Score=214.85  Aligned_cols=97  Identities=25%  Similarity=0.336  Sum_probs=78.8

Q ss_pred             hHHHHHHHHHHHHHhC--------CCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc-----cccccccccccccc
Q psy3714           2 RIATGASMALDYCHSM--------GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYFKGPE   68 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~--------~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~-----~~~~~~~~~~~~pe   68 (467)
                      +|+.|||.||+|||++        +||||||||+|||++. ++.+||+|||+|+.......     ....+||+.|||||
T Consensus       104 ~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~-~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE  182 (303)
T 3hmm_A          104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE  182 (303)
T ss_dssp             HHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT-TSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC-CCCEEEEeCCCCccccCCCCceeeecccccccccccCHH
Confidence            6899999999999987        9999999999999984 56999999999987643321     22357999999999


Q ss_pred             cccccc-----CCCCeeeEEchhHHHHHHHhcCCCC
Q psy3714          69 LLADYQ-----MYDYSLDMWSLGCMLASMIFRKEPF   99 (467)
Q Consensus        69 ~~~~~~-----~~~~~~D~ws~G~~l~~~l~g~~~~   99 (467)
                      ++.+..     .++.++|||||||++|||++|+.|+
T Consensus       183 ~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~  218 (303)
T 3hmm_A          183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             HHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             HhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence            986531     2567899999999999999997665

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.90  E-value=2e-24  Score=210.52  Aligned_cols=140  Identities=89%  Similarity=1.488  Sum_probs=123.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++..+..+||+|||+|+............++..|+|||.+.+...++.++|
T Consensus       134 ~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  213 (330)
T 3nsz_A          134 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD  213 (330)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHH
T ss_pred             HHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhh
Confidence            57899999999999999999999999999996655899999999998766655666788999999999977566889999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchhHhhhhhhccCCCchhhhhcc
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADILG  141 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~  141 (467)
                      +|||||++++|++|+.||+.+.+..+++..+.+.++.+.+.+.+.+.....++.+.....
T Consensus       214 iwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (330)
T 3nsz_A          214 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG  273 (330)
T ss_dssp             HHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHC
T ss_pred             HHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhh
Confidence            999999999999999999998888899999999999999888888888887777766543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.90  E-value=1.5e-24  Score=226.42  Aligned_cols=111  Identities=27%  Similarity=0.483  Sum_probs=94.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC-CCcEEEEecccceecCCCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~-~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++.. .+.+||+|||+|+...+.......+||+.|||||++.+ ..|+.++
T Consensus       259 ~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~-~~y~~~~  337 (573)
T 3uto_A          259 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYT  337 (573)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTT-CCBCHHH
T ss_pred             HHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCC-CCCCcHH
Confidence            578999999999999999999999999999853 35899999999998877766777899999999999986 5589999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      ||||+||++|+|++|..||. +.+..+.+..+.+
T Consensus       338 DiWSlGvilyeml~G~~Pf~-~~~~~~~~~~i~~  370 (573)
T 3uto_A          338 DMWSVGVLSYILLSGLSPFG-GENDDETLRNVKS  370 (573)
T ss_dssp             HHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHh
Confidence            99999999999999998884 5555555555443

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.89  E-value=5.9e-24  Score=214.50  Aligned_cols=119  Identities=39%  Similarity=0.661  Sum_probs=102.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++.++..+||+|||+++............+|+.|+|||++.+...++.++|
T Consensus       160 ~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  239 (420)
T 1j1b_A          160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSID  239 (420)
T ss_dssp             HHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHH
T ss_pred             HHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhh
Confidence            57899999999999999999999999999996656789999999997755544555688999999999976556889999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchh
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL  121 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~  121 (467)
                      ||||||++|||++|+.|| .+.+..+++..+.+.+|++..
T Consensus       240 iwSlG~il~ell~G~~pf-~~~~~~~~l~~i~~~lg~p~~  278 (420)
T 1j1b_A          240 VWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTR  278 (420)
T ss_dssp             HHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCH
T ss_pred             hHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCH
Confidence            999999999999998776 566777888888888887654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.89  E-value=8.7e-24  Score=211.48  Aligned_cols=119  Identities=38%  Similarity=0.670  Sum_probs=103.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++..++.+||+|||+|+............+|+.|+|||.+.+...++.++|
T Consensus       145 ~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  224 (394)
T 4e7w_A          145 LYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNID  224 (394)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHH
T ss_pred             HHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHH
Confidence            47899999999999999999999999999985566899999999998765555556688999999999977666899999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchh
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL  121 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~  121 (467)
                      +|||||++|+|++|+.|| .+.+..+++..+.+.+|++..
T Consensus       225 iwSlG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~  263 (394)
T 4e7w_A          225 IWSTGCVMAELMQGQPLF-PGESGIDQLVEIIKVLGTPSR  263 (394)
T ss_dssp             HHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCH
Confidence            999999999999998776 567777888888888887644

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.89  E-value=1.4e-23  Score=214.28  Aligned_cols=115  Identities=31%  Similarity=0.606  Sum_probs=94.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...........+||+.|+|||++.+ ..++.++|
T Consensus       168 ~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D  245 (464)
T 3ttj_A          168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVD  245 (464)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEECCCCCC-----CCCC----CCCTTCCHHHHTT-CCCCTTHH
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCChHhEEEeC-CCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcC-CCCCHHHH
Confidence            58899999999999999999999999999985 45899999999987765545566789999999999986 45889999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      ||||||++++|++|+.|| .+.+..+++..+.+.+|++
T Consensus       246 iwSlG~il~ell~g~~pF-~g~~~~~~~~~i~~~lg~p  282 (464)
T 3ttj_A          246 IWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTP  282 (464)
T ss_dssp             HHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSC
T ss_pred             HHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCC
Confidence            999999999999998776 6778888899998888865

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.88  E-value=1.2e-23  Score=209.93  Aligned_cols=118  Identities=31%  Similarity=0.598  Sum_probs=97.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC----------------------CCcccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP----------------------GQEYNVRV   59 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~----------------------~~~~~~~~   59 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+....                      .......+
T Consensus       113 ~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (388)
T 3oz6_A          113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA-ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYV  191 (388)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CC
T ss_pred             HHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcC-CCCEEecCCcccccccccccccccccccccccccccccccccccCCc
Confidence            47899999999999999999999999999985 45899999999986532                      11123457


Q ss_pred             cccccccccccccccCCCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchh
Q psy3714          60 ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL  121 (467)
Q Consensus        60 ~~~~~~~pe~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~  121 (467)
                      ||++|+|||++.+...++.++|+|||||++++|++|+.|| .+.+..+++..+...++.+..
T Consensus       192 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~p~~  252 (388)
T 3oz6_A          192 ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF-PGSSTMNQLERIIGVIDFPSN  252 (388)
T ss_dssp             CGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCH
T ss_pred             ccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCH
Confidence            9999999999987567899999999999999999998776 677778888888887776543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.88  E-value=2.4e-23  Score=199.47  Aligned_cols=117  Identities=36%  Similarity=0.713  Sum_probs=100.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.... ........+|+.|+|||.+.+...++.++
T Consensus       105 ~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~  183 (292)
T 3o0g_A          105 SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI  183 (292)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHH
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchH
Confidence            58899999999999999999999999999985 45899999999987643 23345567899999999998766688999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      |+|||||++++|++|+.|++.+.+..+.+..+.+..+.+
T Consensus       184 DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~  222 (292)
T 3o0g_A          184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  222 (292)
T ss_dssp             HHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            999999999999999999998888778888887776654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.88  E-value=2.7e-23  Score=207.17  Aligned_cols=120  Identities=34%  Similarity=0.662  Sum_probs=104.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||.|||++||+||||||+|||++..++.+||+|||+|+............+|+.|+|||.+.+...++.++|
T Consensus       145 ~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  224 (383)
T 3eb0_A          145 IYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSID  224 (383)
T ss_dssp             HHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHH
T ss_pred             HHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchh
Confidence            57899999999999999999999999999985566899999999998766555566688999999999887666889999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchhH
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELF  122 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  122 (467)
                      +||+||++++|++|+.|| .+.+..+++..+.+.+|++...
T Consensus       225 iwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~g~p~~~  264 (383)
T 3eb0_A          225 LWSIGCVFGELILGKPLF-SGETSIDQLVRIIQIMGTPTKE  264 (383)
T ss_dssp             HHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHH
T ss_pred             hhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHH
Confidence            999999999999998776 5677788888898888876543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.87  E-value=5.5e-23  Score=209.80  Aligned_cols=118  Identities=31%  Similarity=0.650  Sum_probs=90.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC----------------------------
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----------------------------   53 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~----------------------------   53 (467)
                      .|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+......                            
T Consensus       160 ~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (458)
T 3rp9_A          160 TLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ-DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR  238 (458)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TCCEEECCCTTCBCTTSCTTCCCCCC---------------------
T ss_pred             HHHHHHHHHHHHHHhCCcCCCCCChhhEEECC-CCCEeecccccchhccCccccccccccCccccccccccccccccccc
Confidence            57899999999999999999999999999985 4589999999998653211                            


Q ss_pred             cccccccccccccccccccccCCCCeeeEEchhHHHHHHHhc----------CCCCCCCCCC------------------
Q psy3714          54 EYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFR----------KEPFFHGHDN------------------  105 (467)
Q Consensus        54 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~ws~G~~l~~~l~g----------~~~~~~~~~~------------------  105 (467)
                      .....+||++|+|||++.....++.++|||||||++|||++|          +.|+|+|.+.                  
T Consensus       239 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~  318 (458)
T 3rp9_A          239 QLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTR  318 (458)
T ss_dssp             ------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CH
T ss_pred             cccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccccccccccccccc
Confidence            123457899999999876556689999999999999999984          4566666542                  


Q ss_pred             --HHHHHHHHHHhCCch
Q psy3714         106 --YDQLVRIAKVLGTEE  120 (467)
Q Consensus       106 --~~~~~~~~~~~~~~~  120 (467)
                        .+++..+...+|++.
T Consensus       319 ~~~~~l~~i~~~~g~p~  335 (458)
T 3rp9_A          319 GNRDQLNVIFNILGTPS  335 (458)
T ss_dssp             HHHHHHHHHHHHHCCCC
T ss_pred             CCHHHHHHHHHHcCCCC
Confidence              466777777777654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.87  E-value=9.5e-23  Score=197.30  Aligned_cols=116  Identities=34%  Similarity=0.654  Sum_probs=95.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-CcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..... .......+|+.|+|||.+.+...++.++
T Consensus       123 ~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~  201 (311)
T 3niz_A          123 IYLYQLLRGVAHCHQHRILHRDLKPQNLLINS-DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV  201 (311)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHH
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCchHhEEECC-CCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchH
Confidence            57899999999999999999999999999985 458999999999876432 2344557899999999987666688999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      |+|||||++++|++|+.|| .+.+..+.+..+...++.+
T Consensus       202 DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~  239 (311)
T 3niz_A          202 DIWSIGCIFAEMITGKPLF-PGVTDDDQLPKIFSILGTP  239 (311)
T ss_dssp             HHHHHHHHHHHHHHSSCSC-CCSSTTTHHHHHHHHHCCC
T ss_pred             HhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHHCCC
Confidence            9999999999999998877 4556667777777766654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.87  E-value=7.6e-23  Score=197.53  Aligned_cols=115  Identities=33%  Similarity=0.638  Sum_probs=97.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++............||+.|+|||.+.+ ..++.++|
T Consensus       124 ~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D  201 (308)
T 3g33_A          124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS-GGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVD  201 (308)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCTTTEEECT-TSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHH
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCEEEeeCccccccCCCcccCCccccccccCchHHcC-CCCCchHH
Confidence            58999999999999999999999999999984 45899999999987665555566788999999999976 45788999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      +|||||++++|++|+.|| .+.+..+.+..+.+..+.+
T Consensus       202 iwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          202 MWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             HHHHHHHHHHTTTSSCSC-CCSSHHHHHHHHHHHHCCC
T ss_pred             HHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCC
Confidence            999999999999998877 4556666777777766543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.87  E-value=6.8e-23  Score=195.97  Aligned_cols=116  Identities=31%  Similarity=0.702  Sum_probs=92.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-CcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..... .......+|+.|+|||.+.+...++.++
T Consensus       104 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~  182 (288)
T 1ob3_A          104 SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI  182 (288)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHH
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-CCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHH
Confidence            58899999999999999999999999999984 458999999999865422 2234457899999999997656688999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      |+|||||++++|++|+.|| .+.+..+.+..+.+.++.+
T Consensus       183 DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~  220 (288)
T 1ob3_A          183 DIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTP  220 (288)
T ss_dssp             HHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHHCCC
Confidence            9999999999999998887 4555666777777766643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.87  E-value=4.3e-23  Score=201.18  Aligned_cols=98  Identities=26%  Similarity=0.537  Sum_probs=87.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....+......+||+.|+|||.+.+....+.++|
T Consensus       118 ~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  196 (328)
T 3fe3_A          118 SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVD  196 (328)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHH
T ss_pred             HHHHHHHHHHHHHHHCCEeccCCCHHHEEEcC-CCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhh
Confidence            57899999999999999999999999999984 45899999999987766656667789999999999987554557899


Q ss_pred             EEchhHHHHHHHhcCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~  100 (467)
                      +||+||++++|++|+.||.
T Consensus       197 iwslG~il~ell~g~~pf~  215 (328)
T 3fe3_A          197 VWSLGVILYTLVSGSLPFD  215 (328)
T ss_dssp             HHHHHHHHHHHHHSSCSSC
T ss_pred             hhhhHHHHHHHHhCCCCCC
Confidence            9999999999999998884

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=6.1e-22  Score=186.33  Aligned_cols=135  Identities=19%  Similarity=0.228  Sum_probs=107.1

Q ss_pred             ceeeeEeecccCCcceEEEEEccCCCe--EEEEEeccch---------------------------HHHHHHHHHHHHHh
Q psy3714         172 DYQLVRKLGRGKYSEVFEAINVQSSDK--CVVKILKPVK---------------------------KKKIKREIKILENL  222 (467)
Q Consensus       172 ~y~~~~~lG~G~~g~V~~~~~~~~~~~--~avK~~~~~~---------------------------~~~~~~Ei~il~~l  222 (467)
                      -|++.+.||+|+||.||+|.+..+|+.  ||||+++...                           ...+.+|+.+|..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478899999999999999998788888  9999865321                           12578899999999


Q ss_pred             cCCCCe--eEEEEEEeCCCCCccEEEEeccCC-c----cHHHHhhcCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCC
Q psy3714         223 RGGTNI--ITLQAVVKDPVSRTPALIFEHVNN-T----DFKQLYQTLTDYDIRYYLYELLKALDYCH-SMGIMHRDVKPH  294 (467)
Q Consensus       223 ~~~~~i--v~l~~~~~~~~~~~~~lv~e~~~~-~----~l~~~~~~~~~~~~~~~~~qll~al~~lH-~~~IiHrDlKp~  294 (467)
                      .+ +++  +.....      ...++||||+.+ |    .+.+.....++.++..++.|++.||.||| ++|||||||||+
T Consensus       128 ~~-~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~  200 (258)
T 1zth_A          128 KE-AGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEY  200 (258)
T ss_dssp             HH-TTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred             Hh-CCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence            73 432  333322      246899999942 3    56665544556688899999999999999 999999999999


Q ss_pred             ceEEeCCCCcEEEEecccceec
Q psy3714         295 NVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       295 Nill~~~~~~ikl~DFGla~~~  316 (467)
                      |||++.   .++|+|||+|...
T Consensus       201 NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          201 NIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEESS---SEEECCCTTCEET
T ss_pred             HEEEcC---cEEEEECcccccC
Confidence            999985   6999999999764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.87  E-value=1.9e-22  Score=195.67  Aligned_cols=115  Identities=34%  Similarity=0.665  Sum_probs=95.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-CcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..... .......+|+.|+|||++.+...++.++
T Consensus       112 ~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~  190 (317)
T 2pmi_A          112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINK-RGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSI  190 (317)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHH
T ss_pred             HHHHHHHHHHHHHHHCCeeeCCCChHHeEEcC-CCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHH
Confidence            47789999999999999999999999999985 458999999999876432 2334557899999999997656688999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      |+|||||++++|++|+.|| .+.+..+++..+.+..+.
T Consensus       191 DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~  227 (317)
T 2pmi_A          191 DIWSCGCILAEMITGKPLF-PGTNDEEQLKLIFDIMGT  227 (317)
T ss_dssp             HHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCS
T ss_pred             HHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCC
Confidence            9999999999999998887 455566667777766654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.86  E-value=1.4e-22  Score=205.20  Aligned_cols=119  Identities=31%  Similarity=0.640  Sum_probs=94.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-----------------------ccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-----------------------EYNVR   58 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-----------------------~~~~~   58 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+......                       .....
T Consensus       133 ~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (432)
T 3n9x_A          133 TILYNLLLGENFIHESGIIHRDLKPANCLLNQ-DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSH  211 (432)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEEC-------------------------------C
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCHHHeEECC-CCCEEEccCCCcccccccccccccccccccccccccccchhccccCC
Confidence            58999999999999999999999999999984 4589999999998764321                       12556


Q ss_pred             ccccccccccccccccCCCCeeeEEchhHHHHHHHh----------cCCCCCCCCC-----------------CHHHHHH
Q psy3714          59 VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIF----------RKEPFFHGHD-----------------NYDQLVR  111 (467)
Q Consensus        59 ~~~~~~~~pe~~~~~~~~~~~~D~ws~G~~l~~~l~----------g~~~~~~~~~-----------------~~~~~~~  111 (467)
                      +||++|+|||++.....++.++|+|||||+++||++          |+.|+|.|.+                 ..+++..
T Consensus       212 ~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~  291 (432)
T 3n9x_A          212 VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNI  291 (432)
T ss_dssp             CCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHH
T ss_pred             CCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHH
Confidence            889999999997655678999999999999999996          4667776655                 2467777


Q ss_pred             HHHHhCCchh
Q psy3714         112 IAKVLGTEEL  121 (467)
Q Consensus       112 ~~~~~~~~~~  121 (467)
                      +...+|++..
T Consensus       292 i~~~~g~p~~  301 (432)
T 3n9x_A          292 IFNIIGTPTE  301 (432)
T ss_dssp             HHHHHCSCCH
T ss_pred             HHHhcCCCCH
Confidence            8888887643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.86  E-value=8.2e-23  Score=201.21  Aligned_cols=108  Identities=28%  Similarity=0.474  Sum_probs=84.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.... .......+||+.|+|||++.+ ..++.++
T Consensus       128 ~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  205 (353)
T 3txo_A          128 FYAAEIISALMFLHDKGIIYRDLKLDNVLLDH-EGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE-MLYGPAV  205 (353)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCCTTCBCSCC---------CCGGGCCHHHHHH-HHCTTHH
T ss_pred             HHHHHHHHHHHHHHHCCCcccCCCHHHEEECC-CCCEEEccccceeecccCCccccccCCCcCeEChhhcCC-CCcCCcc
Confidence            47899999999999999999999999999985 45899999999986432 233455689999999999975 5588999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      |+|||||++|+|++|..||. +.+..+....+
T Consensus       206 DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i  236 (353)
T 3txo_A          206 DWWAMGVLLYEMLCGHAPFE-AENEDDLFEAI  236 (353)
T ss_dssp             HHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHH
T ss_pred             CCCcchHHHHHHHhCCCCCC-CCCHHHHHHHH
Confidence            99999999999999998884 44443334433

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.86  E-value=2.9e-22  Score=197.71  Aligned_cols=117  Identities=33%  Similarity=0.659  Sum_probs=98.8

Q ss_pred             hHHHHHHHHHHHHH--hCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCH--SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH--~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      .++.||+.||.|||  ++||+||||||+|||++..++.+||+|||+++............||+.|+|||.+.+...++.+
T Consensus       133 ~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  212 (360)
T 3e3p_A          133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTA  212 (360)
T ss_dssp             HHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTH
T ss_pred             HHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcH
Confidence            57899999999999  9999999999999999964669999999999877655555566789999999998766668899


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      +|+|||||++++|++|+.|| .+.+..+.+..+.+.++.+
T Consensus       213 ~Di~slG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~  251 (360)
T 3e3p_A          213 VDIWSVGCIFAEMMLGEPIF-RGDNSAGQLHEIVRVLGCP  251 (360)
T ss_dssp             HHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHhCCCCc-CCCChHHHHHHHHHHcCCC
Confidence            99999999999999998887 4555666677777666544

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.86  E-value=4.7e-22  Score=195.62  Aligned_cols=114  Identities=33%  Similarity=0.603  Sum_probs=94.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-----CcccccccccccccccccccccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-----QEYNVRVASRYFKGPELLADYQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~   76 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.....     .......||+.|+|||.+.+...+
T Consensus       128 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  206 (351)
T 3mi9_A          128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY  206 (351)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSC
T ss_pred             HHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC-CCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCC
Confidence            58999999999999999999999999999984 458999999999875421     223445789999999999766668


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhC
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG  117 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~  117 (467)
                      +.++|+|||||++++|++|+.|| .+.+..+++..+....+
T Consensus       207 ~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          207 GPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCG  246 (351)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHC
T ss_pred             CcHhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhC
Confidence            89999999999999999998776 55566666666666554

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.86  E-value=1.3e-22  Score=202.39  Aligned_cols=97  Identities=31%  Similarity=0.619  Sum_probs=85.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceec-CCCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~-~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.. .........+||+.|+|||++.+ ..++.++
T Consensus       157 ~~~~qi~~aL~~LH~~givHrDLKp~NILl~~-~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~  234 (396)
T 4dc2_A          157 FYSAEISLALNYLHERGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSV  234 (396)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT-CCBCTHH
T ss_pred             HHHHHHHHHHHHHHHCCEEeccCCHHHEEECC-CCCEEEeecceeeecccCCCccccccCCcccCCchhhcC-CCCChHH
Confidence            47899999999999999999999999999985 458999999999863 33444566789999999999986 5588999


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+|||||++|+|++|+.||.
T Consensus       235 DiwslGvllyell~G~~Pf~  254 (396)
T 4dc2_A          235 DWWALGVLMFEMMAGRSPFD  254 (396)
T ss_dssp             HHHHHHHHHHHHHHSSCSST
T ss_pred             HHHHHHHHHHHHHhCCCCCc
Confidence            99999999999999999985

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.86  E-value=2.5e-22  Score=195.50  Aligned_cols=116  Identities=31%  Similarity=0.608  Sum_probs=91.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.... ........+|+.|+|||.+.+...++.++
T Consensus       104 ~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~  182 (324)
T 3mtl_A          104 LFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQI  182 (324)
T ss_dssp             HHHHHHHHHHHHHHHTTEEESSCCGGGEEECT-TCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHH
T ss_pred             HHHHHHHHHHHHHHHCCccCCCcCHHHEEECC-CCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHH
Confidence            57899999999999999999999999999985 45899999999986542 22334457899999999987656688999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      |+|||||++++|++|+.|| .+.+..+++..+.+.++.+
T Consensus       183 DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~  220 (324)
T 3mtl_A          183 DMWGVGCIFYEMATGRPLF-PGSTVEEQLHFIFRILGTP  220 (324)
T ss_dssp             HHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCC
Confidence            9999999999999998777 5666667777777766643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.86  E-value=3.2e-22  Score=195.69  Aligned_cols=98  Identities=28%  Similarity=0.545  Sum_probs=85.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC-CCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+... ........+||+.|+|||++.+ ..++.++
T Consensus       109 ~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  186 (337)
T 1o6l_A          109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAV  186 (337)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTH
T ss_pred             HHHHHHHHHHHHHHHCCeecCcCCHHHEEECC-CCCEEEeeccchhhcccCCCcccccccChhhCChhhhcC-CCCCchh
Confidence            47899999999999999999999999999985 4589999999998643 3334456689999999999975 5578999


Q ss_pred             eEEchhHHHHHHHhcCCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      |+|||||++|+|++|+.||..
T Consensus       187 DiwslG~il~ell~g~~Pf~~  207 (337)
T 1o6l_A          187 DWWGLGVVMYEMMCGRLPFYN  207 (337)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCC
T ss_pred             hcccchhHHHHHhcCCCCCCC
Confidence            999999999999999999853

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.86  E-value=2.6e-22  Score=198.83  Aligned_cols=114  Identities=37%  Similarity=0.715  Sum_probs=98.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....  ......+|++|+|||.+.+...++.++|
T Consensus       132 ~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~D  208 (367)
T 1cm8_A          132 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE-DCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVD  208 (367)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHH
T ss_pred             HHHHHHHHHHHHHHHCCccccCcCHHHEEEcC-CCCEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhh
Confidence            57899999999999999999999999999985 45899999999987543  2345578999999999987566889999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      +||+||++++|++|+.|| .+.+..+++..+.+..|++
T Consensus       209 iwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~~  245 (367)
T 1cm8_A          209 IWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTP  245 (367)
T ss_dssp             HHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCC
T ss_pred             HHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCC
Confidence            999999999999998776 5667778888888887764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.86  E-value=2.8e-22  Score=202.69  Aligned_cols=114  Identities=32%  Similarity=0.641  Sum_probs=96.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCC-cEEEEecccceecCCCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~-~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +|+.||+.||+|||++||+||||||+|||++..+. .+||+|||+|+....  .....+||+.|+|||++.+ ..++.++
T Consensus       204 ~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~  280 (429)
T 3kvw_A          204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILG-ARYGMPI  280 (429)
T ss_dssp             HHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHT-BCCCTHH
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC--cccccCCCCCccChHHHhC-CCCCchH
Confidence            58999999999999999999999999999985542 399999999986543  2345678999999999986 4588999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      |||||||++|+|++|..|| .+.+..+++..+...++.+
T Consensus       281 DiwSlG~il~elltG~~pf-~~~~~~~~l~~i~~~~~~p  318 (429)
T 3kvw_A          281 DMWSLGCILAELLTGYPLL-PGEDEGDQLACMIELLGMP  318 (429)
T ss_dssp             HHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCC
T ss_pred             HHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCC
Confidence            9999999999999997665 6777778888888777654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.86  E-value=2.5e-22  Score=197.69  Aligned_cols=97  Identities=29%  Similarity=0.501  Sum_probs=84.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC-CCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+... ........+||+.|+|||++.+ ..++.++
T Consensus       125 ~~~~qi~~aL~~LH~~givHrDlkp~NIll~~-~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  202 (353)
T 2i0e_A          125 FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS-EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSV  202 (353)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBSTHH
T ss_pred             HHHHHHHHHHHHHHHCCEEeccCCHHHEEEcC-CCcEEEEeCCcccccccCCcccccccCCccccChhhhcC-CCcCCcc
Confidence            57899999999999999999999999999985 4589999999998643 2333455689999999999975 5588999


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+|||||++|||++|+.||.
T Consensus       203 DiwslG~il~ell~G~~Pf~  222 (353)
T 2i0e_A          203 DWWAFGVLLYEMLAGQAPFE  222 (353)
T ss_dssp             HHHHHHHHHHHHHHSSCSSC
T ss_pred             cccchHHHHHHHHcCCCCCC
Confidence            99999999999999998884

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.86  E-value=7.3e-23  Score=202.60  Aligned_cols=99  Identities=21%  Similarity=0.405  Sum_probs=85.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC----------CCcEEEEecccceecC---CCCccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE----------NRKLRLIDWGLAEFYH---PGQEYNVRVASRYFKGPE   68 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~----------~~~~kl~dfG~a~~~~---~~~~~~~~~~~~~~~~pe   68 (467)
                      +|+.||+.||+|||++|||||||||+|||++..          ++.+||+|||+|+...   ........+||..|+|||
T Consensus       176 ~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE  255 (365)
T 3e7e_A          176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE  255 (365)
T ss_dssp             HHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHH
T ss_pred             HHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChH
Confidence            589999999999999999999999999999851          4589999999997643   233345567999999999


Q ss_pred             ccccccCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          69 LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        69 ~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      ++.+ ..++.++|+|||||++|+|++|+.||..
T Consensus       256 ~~~~-~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          256 MLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             HHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             HhcC-CCCCccccHHHHHHHHHHHHhCCCcccc
Confidence            9986 4489999999999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.86  E-value=2.1e-22  Score=199.36  Aligned_cols=114  Identities=33%  Similarity=0.697  Sum_probs=88.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....  ......||+.|+|||.+.+...++.++|
T Consensus       136 ~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~-~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~D  212 (367)
T 2fst_X          136 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNE-DCELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVD  212 (367)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHH
T ss_pred             HHHHHHHHHHHHHHHCCeeeCCCCHhhEEECC-CCCEEEeeccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhh
Confidence            58899999999999999999999999999984 45899999999986543  2344578999999999976566889999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      +|||||++++|++|+.|| .+.+..+++..+.+.+|++
T Consensus       213 iwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p  249 (367)
T 2fst_X          213 IWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTP  249 (367)
T ss_dssp             HHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSC
T ss_pred             HHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCC
Confidence            999999999999998777 5677778888888887765

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.86  E-value=3.5e-22  Score=200.55  Aligned_cols=118  Identities=26%  Similarity=0.581  Sum_probs=90.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEe---cCCCcEEEEecccceecCCC----Cccccccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMID---HENRKLRLIDWGLAEFYHPG----QEYNVRVASRYFKGPELLADYQ   74 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~---~~~~~~kl~dfG~a~~~~~~----~~~~~~~~~~~~~~pe~~~~~~   74 (467)
                      +|+.||+.||.|||++||+||||||+|||+.   ..++.+||+|||+|+.....    ......+||+.|+|||++.+..
T Consensus       132 ~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  211 (405)
T 3rgf_A          132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR  211 (405)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCC
Confidence            5889999999999999999999999999994   23458999999999865432    2234467899999999998766


Q ss_pred             CCCCeeeEEchhHHHHHHHhcCCCCCCCCC--------CHHHHHHHHHHhCCc
Q psy3714          75 MYDYSLDMWSLGCMLASMIFRKEPFFHGHD--------NYDQLVRIAKVLGTE  119 (467)
Q Consensus        75 ~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~--------~~~~~~~~~~~~~~~  119 (467)
                      .++.++|||||||++|+|++|..||.....        ..+++..+...+|.+
T Consensus       212 ~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p  264 (405)
T 3rgf_A          212 HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP  264 (405)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCC
T ss_pred             cccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCC
Confidence            688999999999999999999988853322        246777787777654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.86  E-value=2.3e-22  Score=203.22  Aligned_cols=109  Identities=28%  Similarity=0.505  Sum_probs=88.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--cccccccccccccccccc----ccC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLAD----YQM   75 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~----~~~   75 (467)
                      .++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.......  ....+||+.|+|||++..    ...
T Consensus       179 ~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~  257 (437)
T 4aw2_A          179 FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM-NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR  257 (437)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCE
T ss_pred             HHHHHHHHHHHHHHhCCeEecccCHHHeeEcC-CCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCC
Confidence            47899999999999999999999999999985 45899999999987654332  234589999999999862    345


Q ss_pred             CCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          76 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        76 ~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      ++.++|+|||||++|||++|+.||. +.+..+....+
T Consensus       258 ~~~~~DvwSlGvil~elltG~~Pf~-~~~~~~~~~~i  293 (437)
T 4aw2_A          258 YGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKI  293 (437)
T ss_dssp             ECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHH
T ss_pred             CCCcCeeHHHHHHHHHHHhCCCCCC-CCChhHHHHhh
Confidence            7889999999999999999999985 44444444444

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.85  E-value=3.7e-22  Score=198.38  Aligned_cols=99  Identities=24%  Similarity=0.541  Sum_probs=87.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCccccccccccccccccccc--ccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD--YQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~   79 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...........+||+.|+|||++..  ...++.+
T Consensus       119 ~~~~qi~~aL~~LH~~givHrDlkp~NIll~~-~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~  197 (384)
T 4fr4_A          119 LFICELVMALDYLQNQRIIHRDMKPDNILLDE-HGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFA  197 (384)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTT
T ss_pred             HHHHHHHHHHHHHHHCCceeccCcHHHeEECC-CCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCcc
Confidence            57899999999999999999999999999985 45899999999998766655667789999999999864  2347889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|+|||||++|+|++|..||..
T Consensus       198 ~DiwSlG~il~elltG~~Pf~~  219 (384)
T 4fr4_A          198 VDWWSLGVTAYELLRGRRPYHI  219 (384)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ceeechHHHHHHHHhCCCCCCC
Confidence            9999999999999999999863

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.85  E-value=2.6e-22  Score=201.27  Aligned_cols=109  Identities=30%  Similarity=0.534  Sum_probs=88.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccC---C
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQM---Y   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~---~   76 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.......  ....+||+.|+|||++.+...   +
T Consensus       172 ~~~~qi~~aL~~LH~~givHrDLKp~NILl~~-~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~  250 (410)
T 3v8s_A          172 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY  250 (410)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEE
T ss_pred             HHHHHHHHHHHHHHHCCeEeccCCHHHeeECC-CCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCC
Confidence            47899999999999999999999999999985 45899999999987654332  335689999999999975332   6


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      +.++|+|||||++|+|++|+.||. +.+..+....+
T Consensus       251 ~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i  285 (410)
T 3v8s_A          251 GRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKI  285 (410)
T ss_dssp             ETHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHH
T ss_pred             CCcceEecchHHHHHHHhCCCCCC-CCChhhHHHHH
Confidence            789999999999999999999985 44444444444

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.85  E-value=4.5e-22  Score=195.24  Aligned_cols=97  Identities=29%  Similarity=0.560  Sum_probs=84.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.... .......+||+.|+|||++.+ ..++.++
T Consensus       122 ~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  199 (345)
T 1xjd_A          122 FYAAEIILGLQFLHSKGIVYRDLKLDNILLDK-DGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSV  199 (345)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHH
T ss_pred             HHHHHHHHHHHHHHHCCeEeCCCChhhEEECC-CCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC-CCCCChh
Confidence            57899999999999999999999999999985 45899999999986432 233455689999999999976 5588999


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+|||||++|+|++|..||.
T Consensus       200 DiwslG~il~ell~g~~Pf~  219 (345)
T 1xjd_A          200 DWWSFGVLLYEMLIGQSPFH  219 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSC
T ss_pred             hhHHHHHHHHHHhcCCCCCC
Confidence            99999999999999998884

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.85  E-value=3.1e-22  Score=198.61  Aligned_cols=114  Identities=32%  Similarity=0.605  Sum_probs=84.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++............||+.|+|||++.+ ..++.++|
T Consensus       131 ~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D  208 (371)
T 2xrw_A          131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVD  208 (371)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEECCCCC----------------CTTCCHHHHTT-CCCCTTHH
T ss_pred             HHHHHHHHHHHHHHHCCeecccCCHHHEEEcC-CCCEEEEEeecccccccccccCCceecCCccCHHHhcC-CCCCchHh
Confidence            58899999999999999999999999999984 45899999999987654434455688999999999986 45788999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      +|||||++++|++|+.|| .+.+..+++..+.+.++.
T Consensus       209 iwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~  244 (371)
T 2xrw_A          209 IWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGT  244 (371)
T ss_dssp             HHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHC-CCC
T ss_pred             HHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCC
Confidence            999999999999999887 555666666666665554

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.85  E-value=7.8e-22  Score=189.57  Aligned_cols=108  Identities=28%  Similarity=0.574  Sum_probs=89.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-cccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....... ......||+.|+|||.+.+ ..++.++
T Consensus       120 ~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  197 (297)
T 3fxz_A          120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKV  197 (297)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHC-SCBCTHH
T ss_pred             HHHHHHHHHHHHHHhCCceeCCCCHHHEEECC-CCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcC-CCCCcHH
Confidence            58899999999999999999999999999985 4589999999998765432 2445679999999999976 5578999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      |+|||||++|+|++|..||. +.+....+..+
T Consensus       198 DiwslG~il~ell~g~~pf~-~~~~~~~~~~~  228 (297)
T 3fxz_A          198 DIWSLGIMAIEMIEGEPPYL-NENPLRALYLI  228 (297)
T ss_dssp             HHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHH
Confidence            99999999999999999985 33333333333

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.85  E-value=4e-22  Score=197.62  Aligned_cols=97  Identities=32%  Similarity=0.588  Sum_probs=84.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC-CCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++... ........+||+.|+|||++.+ ..++.++
T Consensus       143 ~~~~qi~~aL~~LH~~givHrDlkp~NIll~~-~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  220 (373)
T 2r5t_A          143 FYAAEIASALGYLHSLNIVYRDLKPENILLDS-QGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTV  220 (373)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT-CCCCTHH
T ss_pred             HHHHHHHHHHHHHHHCCceecCCCHHHEEECC-CCCEEEeeCccccccccCCCccccccCCccccCHHHhCC-CCCCchh
Confidence            47899999999999999999999999999985 4589999999998643 3334456689999999999976 5588999


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+|||||++|||++|..||.
T Consensus       221 DiwslG~il~ell~G~~Pf~  240 (373)
T 2r5t_A          221 DWWCLGAVLYEMLYGLPPFY  240 (373)
T ss_dssp             HHHHHHHHHHHHHHSSCTTC
T ss_pred             hhHHHHHHHHHHHcCCCCCC
Confidence            99999999999999999885

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.85  E-value=4.5e-22  Score=194.06  Aligned_cols=117  Identities=30%  Similarity=0.636  Sum_probs=90.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEec----CCCcEEEEecccceecCCC-CcccccccccccccccccccccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDH----ENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~----~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~   76 (467)
                      +|+.||+.||+|||++||+||||||+|||++.    ....+||+|||+++..... .......+|..|+|||.+.+...+
T Consensus       136 ~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  215 (329)
T 3gbz_A          136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHY  215 (329)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCC
Confidence            58999999999999999999999999999963    2335999999999865422 233455789999999999876668


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      +.++|+|||||++++|++|..|| .+.+..+.+..+...++.+
T Consensus       216 ~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~  257 (329)
T 3gbz_A          216 STSVDIWSIACIWAEMLMKTPLF-PGDSEIDQLFKIFEVLGLP  257 (329)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCC
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCc-CCCCHHHHHHHHHHHhCCC
Confidence            89999999999999999998777 5566667777777665543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.85  E-value=3.1e-22  Score=198.05  Aligned_cols=99  Identities=19%  Similarity=0.269  Sum_probs=83.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEec-CCCcEEEEecccceecCCCCc--------cccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDH-ENRKLRLIDWGLAEFYHPGQE--------YNVRVASRYFKGPELLAD   72 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~-~~~~~kl~dfG~a~~~~~~~~--------~~~~~~~~~~~~pe~~~~   72 (467)
                      +|+.||+.||+|||++||+||||||+|||++. .++.+||+|||+|+.......        .....||+.|+|||.+.+
T Consensus       156 ~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  235 (364)
T 3op5_A          156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG  235 (364)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC
Confidence            68999999999999999999999999999982 235899999999987643211        123458999999999976


Q ss_pred             ccCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          73 YQMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        73 ~~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                       ..++.++|||||||++|+|++|+.||..
T Consensus       236 -~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          236 -VAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             -CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence             4478999999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.85  E-value=3.2e-22  Score=195.52  Aligned_cols=99  Identities=29%  Similarity=0.584  Sum_probs=87.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||++............+||+.|+|||.+.+....+.++|
T Consensus       112 ~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~-~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  190 (336)
T 3h4j_B          112 RFFQQIICAIEYCHRHKIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVD  190 (336)
T ss_dssp             HHHHHHHHHHHHHHHHTCCCCCCSTTTEEECT-TCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHH
T ss_pred             HHHHHHHHHHHHHHHCCeEecCCchhhEEEcC-CCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccc
Confidence            58899999999999999999999999999984 45899999999987766655666789999999999986554477899


Q ss_pred             EEchhHHHHHHHhcCCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|||||++|+|++|+.||..
T Consensus       191 iwslG~il~~ll~g~~Pf~~  210 (336)
T 3h4j_B          191 VWSCGIVLYVMLVGRLPFDD  210 (336)
T ss_dssp             HHHHHHHHHHHHHSSCSSBC
T ss_pred             hhHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999853

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.85  E-value=7.6e-22  Score=193.85  Aligned_cols=116  Identities=38%  Similarity=0.734  Sum_probs=96.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.... ........+|+.|+|||.+.+...++.++
T Consensus       116 ~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~  194 (346)
T 1ua2_A          116 AYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV  194 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHH
T ss_pred             HHHHHHHHHHHHHHHCCEECCCCCHHHEEEcC-CCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchh
Confidence            58999999999999999999999999999984 45899999999986542 23345567899999999997656678899


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      |+|||||++++|++|..| +.+.+..+.+..+....+.+
T Consensus       195 DiwslG~il~ell~g~~~-~~~~~~~~~~~~i~~~~~~~  232 (346)
T 1ua2_A          195 DMWAVGCILAELLLRVPF-LPGDSDLDQLTRIFETLGTP  232 (346)
T ss_dssp             HHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHHHCCC
T ss_pred             hhHhHHHHHHHHHHCCCC-CCCCCHHHHHHHHHHHcCCC
Confidence            999999999999998655 56777777777777766543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.85  E-value=7.3e-22  Score=195.38  Aligned_cols=116  Identities=34%  Similarity=0.680  Sum_probs=97.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----ccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......    .....||+.|+|||.+.+...++
T Consensus       132 ~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  210 (364)
T 3qyz_A          132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT  210 (364)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCS
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCChHhEEECC-CCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCC
Confidence            58999999999999999999999999999984 45899999999987643221    23457899999999987666688


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      .++|+|||||++++|++|+.|| .+.+..+.+..+...++.+
T Consensus       211 ~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~  251 (364)
T 3qyz_A          211 KSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSP  251 (364)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSS-CCSSGGGHHHHHHHHHCSC
T ss_pred             cchhHHHHHHHHHHHHHCCCCC-CCCChHHHHHHHHHHhCCC
Confidence            9999999999999999998776 5666777787777776654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.85  E-value=3.5e-22  Score=200.42  Aligned_cols=109  Identities=28%  Similarity=0.516  Sum_probs=88.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--cccccccccccccccccc------c
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLAD------Y   73 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~------~   73 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.......  ....+||+.|+|||++..      .
T Consensus       166 ~~~~qi~~aL~~LH~~giiHrDLKp~NILld~-~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~  244 (412)
T 2vd5_A          166 FYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR-CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT  244 (412)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTC
T ss_pred             HHHHHHHHHHHHHHHCCeeecccCHHHeeecC-CCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCC
Confidence            47899999999999999999999999999985 45899999999987654432  234589999999999873      2


Q ss_pred             cCCCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          74 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        74 ~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      ..++.++|+|||||++|||++|+.||. +.+..+....+
T Consensus       245 ~~~~~~~DiwSlGvilyelltG~~Pf~-~~~~~~~~~~i  282 (412)
T 2vd5_A          245 GSYGPECDWWALGVFAYEMFYGQTPFY-ADSTAETYGKI  282 (412)
T ss_dssp             SEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHH
T ss_pred             CCCChHHhhhHHhHHHHHHHhCCCCCC-CCCHHHHHHHH
Confidence            457889999999999999999999985 33333444444

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.85  E-value=8.7e-22  Score=194.35  Aligned_cols=112  Identities=29%  Similarity=0.564  Sum_probs=92.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEec------------------------CCCcEEEEecccceecCCCCcccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDH------------------------ENRKLRLIDWGLAEFYHPGQEYNV   57 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~------------------------~~~~~kl~dfG~a~~~~~~~~~~~   57 (467)
                      +++.||+.||+|||++||+||||||+|||++.                        .+..+||+|||+|+.....  ...
T Consensus       141 ~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~  218 (360)
T 3llt_A          141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGS  218 (360)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCS
T ss_pred             HHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcC
Confidence            58899999999999999999999999999973                        2458999999999875432  344


Q ss_pred             cccccccccccccccccCCCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhC
Q psy3714          58 RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG  117 (467)
Q Consensus        58 ~~~~~~~~~pe~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~  117 (467)
                      ..||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||. +.+..+.+..+....+
T Consensus       219 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~~~~~~~  276 (360)
T 3llt_A          219 IINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFR-THEHMEHLAMMESIIQ  276 (360)
T ss_dssp             CCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHHTC
T ss_pred             ccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCC-CCcHHHHHHHHHHhcC
Confidence            578999999999986 458899999999999999999998874 4455555665555544

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.85  E-value=4.8e-22  Score=199.14  Aligned_cols=100  Identities=34%  Similarity=0.631  Sum_probs=80.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC--CCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~--~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.||+.||+|||++||+||||||+|||++..  ++.+||+|||+++...........+||+.|+|||++.+ ..++.+
T Consensus       165 ~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~  243 (400)
T 1nxk_A          165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKS  243 (400)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCC-CCSSSH
T ss_pred             HHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCC-CCCCCc
Confidence            589999999999999999999999999999853  45899999999997765444566788999999999875 558899


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHG  102 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~  102 (467)
                      +|||||||++|+|++|..||...
T Consensus       244 ~DiwslG~il~ell~g~~pf~~~  266 (400)
T 1nxk_A          244 CDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999998643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.85  E-value=6.6e-22  Score=195.26  Aligned_cols=109  Identities=28%  Similarity=0.519  Sum_probs=91.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCC---cEEEEecccceecCCCCcccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~---~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      .++.||+.||+|||++||+||||||+|||++..+.   .+||+|||+++...........+||+.|+|||++.+ ..++.
T Consensus       119 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~  197 (361)
T 2yab_A          119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGL  197 (361)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCT
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC-CCCCc
Confidence            58999999999999999999999999999985442   799999999998766555566789999999999875 55889


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      ++|+|||||++|+|++|..||. +.+..+.+..+
T Consensus       198 ~~DiwslGvil~~ll~g~~Pf~-~~~~~~~~~~i  230 (361)
T 2yab_A          198 EADMWSIGVITYILLSGASPFL-GDTKQETLANI  230 (361)
T ss_dssp             HHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHH
T ss_pred             cccHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHH
Confidence            9999999999999999998885 33433334433

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.85  E-value=4.8e-22  Score=195.18  Aligned_cols=97  Identities=31%  Similarity=0.611  Sum_probs=84.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC-CCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+... ........+||+.|+|||++.+ ..++.++
T Consensus       114 ~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  191 (345)
T 3a8x_A          114 FYSAEISLALNYLHERGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSV  191 (345)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHH
T ss_pred             HHHHHHHHHHHHHHHCCceecCCCHHHEEECC-CCCEEEEeccccccccCCCCcccccCCCccccCccccCC-CCCChHH
Confidence            57899999999999999999999999999985 4589999999998642 3334456689999999999976 5578999


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+|||||++|+|++|+.||.
T Consensus       192 DiwslG~il~ell~g~~pf~  211 (345)
T 3a8x_A          192 DWWALGVLMFEMMAGRSPFD  211 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCTTT
T ss_pred             hHHHHHHHHHHHHhCCCCcC
Confidence            99999999999999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.84  E-value=1.3e-21  Score=193.36  Aligned_cols=118  Identities=31%  Similarity=0.611  Sum_probs=89.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++............+++.|+|||.+.+...++.++|
T Consensus       138 ~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  216 (362)
T 3pg1_A          138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLAD-NNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVD  216 (362)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHH
T ss_pred             HHHHHHHHHHHHHHHCcCEecCCChHHEEEcC-CCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhH
Confidence            58999999999999999999999999999984 45899999999986654444555678999999999876566889999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchh
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL  121 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~  121 (467)
                      +|||||+++++++|+.|| .+.+..+.+..+....+.+..
T Consensus       217 iwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          217 MWSAGCVMAEMFNRKALF-RGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             HHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCH
T ss_pred             HHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCh
Confidence            999999999999999887 455666677777776665543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.84  E-value=1e-21  Score=190.68  Aligned_cols=96  Identities=29%  Similarity=0.610  Sum_probs=84.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....  ....+||+.|+|||++.+ ..++.++|
T Consensus       110 ~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~D  185 (318)
T 1fot_A          110 FYAAEVCLALEYLHSKDIIYRDLKPENILLDK-NGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST-KPYNKSID  185 (318)
T ss_dssp             HHHHHHHHHHHHHHTTTEECCCCCGGGEEECT-TSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT-CCBCTTHH
T ss_pred             HHHHHHHHHHHHHHHCCccccCCChheEEEcC-CCCEEEeecCcceecCCc--cccccCCccccCHhHhcC-CCCCcccc
Confidence            47899999999999999999999999999984 458999999999876432  334578999999999875 55788999


Q ss_pred             EEchhHHHHHHHhcCCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|||||++|+|++|..||..
T Consensus       186 iwslG~il~ell~g~~pf~~  205 (318)
T 1fot_A          186 WWSFGILIYEMLAGYTPFYD  205 (318)
T ss_dssp             HHHHHHHHHHHHHSSCTTCC
T ss_pred             hhhhHHHHHHHHhCCCCCCC
Confidence            99999999999999999853

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.84  E-value=7.1e-22  Score=192.03  Aligned_cols=109  Identities=24%  Similarity=0.509  Sum_probs=91.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC-CCcEEEEecccceecCCCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~-~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++.. +..+||+|||+++....+.......||+.|+|||++.+ ..++.++
T Consensus       106 ~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  184 (321)
T 1tki_A          106 SYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTAT  184 (321)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT-CEECHHH
T ss_pred             HHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcC-CCCCchh
Confidence            588999999999999999999999999999852 46899999999998876666666789999999999976 4478899


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      |+|||||++|+|++|..||. +.+..+.+..+
T Consensus       185 DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i  215 (321)
T 1tki_A          185 DMWSLGTLVYVLLSGINPFL-AETNQQIIENI  215 (321)
T ss_dssp             HHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCc-CCCHHHHHHHH
Confidence            99999999999999999885 33333333333

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.84  E-value=9.9e-22  Score=209.28  Aligned_cols=108  Identities=29%  Similarity=0.497  Sum_probs=89.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecC-CCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+... ........+||+.|+|||++.+ ..++.++
T Consensus       446 ~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~-~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~  523 (674)
T 3pfq_A          446 FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS-EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSV  523 (674)
T ss_dssp             HHHHHHHHHHHHHHHTSEECCCCCSTTEEECS-SSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHH
T ss_pred             HHHHHHHHHHHHHHhCCeEeccCChhhEEEcC-CCcEEEeecceeeccccCCcccccccCCCcccCHhhhcC-CCCCccc
Confidence            57899999999999999999999999999985 4589999999998643 3334456689999999999975 5689999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      |+|||||++|||++|..||. +.+..+....+
T Consensus       524 DvwSlGvilyelltG~~Pf~-~~~~~~~~~~i  554 (674)
T 3pfq_A          524 DWWAFGVLLYEMLAGQAPFE-GEDEDELFQSI  554 (674)
T ss_dssp             HHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHH
T ss_pred             eEechHHHHHHHHcCCCCCC-CCCHHHHHHHH
Confidence            99999999999999998884 44433333333

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.84  E-value=1.5e-21  Score=193.04  Aligned_cols=99  Identities=26%  Similarity=0.568  Sum_probs=86.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCC--CcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~--~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +++.||+.||.|||++||+||||||+|||++..+  ..+||+|||++.............||+.|+|||++.+ ..++.+
T Consensus       132 ~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~  210 (362)
T 2bdw_A          132 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKP  210 (362)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTT-CCCCTH
T ss_pred             HHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHcc-CCCCch
Confidence            5889999999999999999999999999998532  3699999999987765555556689999999999975 458889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|+|||||++|+|++|..||..
T Consensus       211 ~DiwslG~il~~ll~g~~Pf~~  232 (362)
T 2bdw_A          211 VDIWACGVILYILLVGYPPFWD  232 (362)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCC
T ss_pred             hhHHHHHHHHHHHHHCCCCCCC
Confidence            9999999999999999988853

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.84  E-value=1.9e-21  Score=187.76  Aligned_cols=114  Identities=33%  Similarity=0.680  Sum_probs=88.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-CcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..... .......++..|+|||.+.+...++.++
T Consensus       106 ~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  184 (311)
T 4agu_A          106 SITWQTLQAVNFCHKHNCIHRDVKPENILITK-HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPV  184 (311)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHH
T ss_pred             HHHHHHHHHHHHHHHCCCcCCCCChhhEEEcC-CCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcch
Confidence            58899999999999999999999999999984 458999999999876532 2334567899999999997656678999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG  117 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~  117 (467)
                      |+|||||+++++++|..|| .+.+..+.+..+.+.++
T Consensus       185 Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~  220 (311)
T 4agu_A          185 DVWAIGCVFAELLSGVPLW-PGKSDVDQLYLIRKTLG  220 (311)
T ss_dssp             HHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHC
T ss_pred             hhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhc
Confidence            9999999999999998877 45556666666655544

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.84  E-value=3.4e-21  Score=189.45  Aligned_cols=115  Identities=32%  Similarity=0.618  Sum_probs=91.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc-----------cccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----------YNVRVASRYFKGPELL   70 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~-----------~~~~~~~~~~~~pe~~   70 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......           .....||+.|+|||.+
T Consensus       116 ~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  194 (353)
T 2b9h_A          116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVM  194 (353)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEECT-TCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHeEEcC-CCcEEEEecccccccccccccccCccccccchhhccccccccCCeee
Confidence            58999999999999999999999999999984 45899999999987542211           1224678999999988


Q ss_pred             ccccCCCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          71 ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        71 ~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      .....++.++|+|||||++++|++|+.|| .+.+..+++..+....+.
T Consensus       195 ~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          195 LTSAKYSRAMDVWSCGCILAELFLRRPIF-PGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             HSCCCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCC
T ss_pred             ccCCCccchhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCC
Confidence            76566888999999999999999998777 455555566666655554

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.84  E-value=1.9e-21  Score=189.35  Aligned_cols=109  Identities=28%  Similarity=0.520  Sum_probs=90.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCC---cEEEEecccceecCCCCcccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~---~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      .++.||+.||.|||++||+||||||+|||++..+.   .+||+|||+++............||+.|+|||++.. ..++.
T Consensus       118 ~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~  196 (326)
T 2y0a_A          118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGL  196 (326)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCT
T ss_pred             HHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecC-CCCCc
Confidence            58999999999999999999999999999985432   799999999988765555556689999999999875 55788


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      ++|+|||||++++|++|..||. +.+..+.+..+
T Consensus       197 ~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~~  229 (326)
T 2y0a_A          197 EADMWSIGVITYILLSGASPFL-GDTKQETLANV  229 (326)
T ss_dssp             HHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHH
Confidence            9999999999999999998884 33333334333

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.84  E-value=1.5e-21  Score=191.98  Aligned_cols=95  Identities=26%  Similarity=0.517  Sum_probs=83.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....  ....+||+.|+|||++.+ ..++.++|
T Consensus       145 ~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~D  220 (350)
T 1rdq_E          145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS-KGYNKAVD  220 (350)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT-CCBCTHHH
T ss_pred             HHHHHHHHHHHHHHHCCcccccCccceEEECC-CCCEEEcccccceeccCC--cccccCCccccCHHHhcC-CCCCCcCC
Confidence            57899999999999999999999999999984 458999999999876432  334578999999999976 55889999


Q ss_pred             EEchhHHHHHHHhcCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~  100 (467)
                      +|||||++|+|++|..||.
T Consensus       221 iwslG~il~ell~g~~Pf~  239 (350)
T 1rdq_E          221 WWALGVLIYEMAAGYPPFF  239 (350)
T ss_dssp             HHHHHHHHHHHHHSSCSSC
T ss_pred             EecccHhHhHHhhCCCCCC
Confidence            9999999999999998885

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.84  E-value=2.4e-21  Score=188.26  Aligned_cols=115  Identities=33%  Similarity=0.661  Sum_probs=95.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++............++..|+|||.+.+ ..++.++|
T Consensus       124 ~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  201 (326)
T 1blx_A          124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVD  201 (326)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHH
T ss_pred             HHHHHHHHHHHHHHHCCceeccCCHHHeEEcC-CCCEEEecCcccccccCCCCccccccccceeCHHHHhc-CCCCcchh
Confidence            58999999999999999999999999999985 45899999999987654434455678999999999976 45788999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      +|||||++++|++|+.|| .+.+..+.+..+....+.+
T Consensus       202 i~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~  238 (326)
T 1blx_A          202 LWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLP  238 (326)
T ss_dssp             HHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCC
T ss_pred             HHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCC
Confidence            999999999999998887 4555566677776665543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.84  E-value=2.2e-21  Score=193.72  Aligned_cols=114  Identities=26%  Similarity=0.498  Sum_probs=91.9

Q ss_pred             hHHHHHHHHHHHHHhC-CCcccCCCCCcEEEecCC---------------------------------------------
Q psy3714           2 RIATGASMALDYCHSM-GIMHRDVKPHNVMIDHEN---------------------------------------------   35 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~-~iiHrDlkp~Nil~~~~~---------------------------------------------   35 (467)
                      +|+.||+.||+|||++ ||+||||||+|||++..+                                             
T Consensus       150 ~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (397)
T 1wak_A          150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKN  229 (397)
T ss_dssp             HHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGG
T ss_pred             HHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccc
Confidence            5899999999999998 999999999999998442                                             


Q ss_pred             ---CcEEEEecccceecCCCCcccccccccccccccccccccCCCCeeeEEchhHHHHHHHhcCCCCCCCCC-----CHH
Q psy3714          36 ---RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-----NYD  107 (467)
Q Consensus        36 ---~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~-----~~~  107 (467)
                         ..+||+|||+|+.....  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....     ..+
T Consensus       230 ~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  306 (397)
T 1wak_A          230 AEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDED  306 (397)
T ss_dssp             GGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHH
T ss_pred             ccccceEecccccccccccc--CccCCCCCcccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHH
Confidence               26999999999876432  344578999999999986 4488899999999999999999988853322     234


Q ss_pred             HHHHHHHHhCC
Q psy3714         108 QLVRIAKVLGT  118 (467)
Q Consensus       108 ~~~~~~~~~~~  118 (467)
                      ++..+.+.+|.
T Consensus       307 ~~~~~~~~~~~  317 (397)
T 1wak_A          307 HIALIIELLGK  317 (397)
T ss_dssp             HHHHHHHHHCS
T ss_pred             HHHHHHHhcCC
Confidence            45566665554

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.84  E-value=2.7e-21  Score=191.81  Aligned_cols=113  Identities=35%  Similarity=0.727  Sum_probs=91.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....  ......+|+.|+|||.+.+...++.++|
T Consensus       148 ~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~D  224 (371)
T 4exu_A          148 YLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE-DCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVD  224 (371)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHH
T ss_pred             HHHHHHHHHHHHHHHCCCcCCCcCHHHeEECC-CCCEEEEecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHh
Confidence            58899999999999999999999999999984 45899999999986542  2344578999999999976566888999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      +|||||++++|++|+.|| .+.+..+.+..+.+..+.
T Consensus       225 iwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~  260 (371)
T 4exu_A          225 IWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGV  260 (371)
T ss_dssp             HHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCC
Confidence            999999999999999887 455666667777666554

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.84  E-value=2.1e-21  Score=198.17  Aligned_cols=98  Identities=28%  Similarity=0.569  Sum_probs=87.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....+......+||+.|+|||.+.+....+.++|
T Consensus       120 ~i~~qi~~aL~~LH~~givHrDLkp~NIll~~-~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  198 (476)
T 2y94_A          120 RLFQQILSGVDYCHRHMVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVD  198 (476)
T ss_dssp             HHHHHHHHHHHHHHTTTEECSCCSGGGEEECT-TCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHH
T ss_pred             HHHHHHHHHHHHHHHCCCCcccccHHHEEEec-CCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcce
Confidence            58999999999999999999999999999984 45899999999998766555566789999999999987554577899


Q ss_pred             EEchhHHHHHHHhcCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~  100 (467)
                      +|||||++|+|++|+.||.
T Consensus       199 iwSlGvil~elltG~~Pf~  217 (476)
T 2y94_A          199 IWSSGVILYALLCGTLPFD  217 (476)
T ss_dssp             HHHHHHHHHHHHHSSCSSC
T ss_pred             ehhhHHHHHHHhhCCCCCC
Confidence            9999999999999998884

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.84  E-value=1.3e-21  Score=195.32  Aligned_cols=99  Identities=32%  Similarity=0.551  Sum_probs=80.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccc-----
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADY-----   73 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~-----   73 (467)
                      +|+.||+.||+|||++||+||||||+|||++ + +.+||+|||+++.......   ....+||+.|+|||++.+.     
T Consensus       159 ~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  236 (390)
T 2zmd_A          159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE  236 (390)
T ss_dssp             HHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-S-SCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC-----
T ss_pred             HHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-C-CeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhcccccc
Confidence            5889999999999999999999999999996 3 5899999999987643321   2345799999999998641     


Q ss_pred             -----cCCCCeeeEEchhHHHHHHHhcCCCCCCC
Q psy3714          74 -----QMYDYSLDMWSLGCMLASMIFRKEPFFHG  102 (467)
Q Consensus        74 -----~~~~~~~D~ws~G~~l~~~l~g~~~~~~~  102 (467)
                           ..++.++|||||||++|+|++|+.||...
T Consensus       237 ~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~  270 (390)
T 2zmd_A          237 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  270 (390)
T ss_dssp             -------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence                 34788999999999999999999998543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.84  E-value=3.6e-21  Score=189.06  Aligned_cols=112  Identities=31%  Similarity=0.565  Sum_probs=91.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEec------------------CCCcEEEEecccceecCCCCcccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDH------------------ENRKLRLIDWGLAEFYHPGQEYNVRVASRY   63 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~------------------~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~   63 (467)
                      +|+.||+.||+|||++||+||||||+|||++.                  .+..+||+|||+++.....  .....||+.
T Consensus       127 ~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~  204 (355)
T 2eu9_A          127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRH  204 (355)
T ss_dssp             HHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGG
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCc
Confidence            58999999999999999999999999999931                  3458999999999875432  344578999


Q ss_pred             cccccccccccCCCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhC
Q psy3714          64 FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG  117 (467)
Q Consensus        64 ~~~pe~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~  117 (467)
                      |+|||.+.+ ..++.++|+|||||++|+|++|..||. +.+..+.+..+.+..+
T Consensus       205 y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~  256 (355)
T 2eu9_A          205 YRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQ-THENREHLVMMEKILG  256 (355)
T ss_dssp             GCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHHHC
T ss_pred             ccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHcC
Confidence            999999975 457889999999999999999998874 4444555555555544

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.84  E-value=1.2e-21  Score=189.63  Aligned_cols=97  Identities=27%  Similarity=0.370  Sum_probs=81.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +|+.||+.||+|||++||+||||||+|||++.. +.+||+|||+++............||+.|+|||++.+  .++.++|
T Consensus       161 ~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~D  237 (311)
T 3p1a_A          161 GYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAAD  237 (311)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG-GCEEECCCTTCEECC------CCCCCGGGCCGGGGGT--CCSTHHH
T ss_pred             HHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEccceeeeecccCCCCcccCCCccccCHhHhcC--CCCchhh
Confidence            589999999999999999999999999999854 5899999999987755444555678999999999874  4788999


Q ss_pred             EEchhHHHHHHHhcCCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~  101 (467)
                      ||||||++++|++|..+++.
T Consensus       238 iwslG~il~el~~g~~~~~~  257 (311)
T 3p1a_A          238 VFSLGLTILEVACNMELPHG  257 (311)
T ss_dssp             HHHHHHHHHHHHHTCCCCSS
T ss_pred             HHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999877653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.84  E-value=3.1e-21  Score=188.26  Aligned_cols=115  Identities=32%  Similarity=0.711  Sum_probs=89.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.... ........++..|+|||.+.+...++.++
T Consensus       128 ~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~  206 (331)
T 4aaa_A          128 KYLFQIINGIGFCHSHNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAV  206 (331)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHH
T ss_pred             HHHHHHHHHHHHHHHCCEEccCcChheEEEcC-CCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHH
Confidence            58999999999999999999999999999985 45899999999976543 22344567899999999997655678899


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      |+|||||++++|++|+.|| .+.+..+.+..+....+.
T Consensus       207 Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~  243 (331)
T 4aaa_A          207 DVWAIGCLVTEMFMGEPLF-PGDSDIDQLYHIMMCLGN  243 (331)
T ss_dssp             HHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCS
T ss_pred             HHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCC
Confidence            9999999999999998777 455566666666665553

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.83  E-value=1.3e-21  Score=193.38  Aligned_cols=100  Identities=27%  Similarity=0.427  Sum_probs=74.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCC-CcEEEEecccceecCCCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHEN-RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~-~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +++.||+.||+|||++||+||||||+|||++..+ ..+||+|||+|+............||+.|+|||++.+....+.++
T Consensus       120 ~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  199 (361)
T 3uc3_A          120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA  199 (361)
T ss_dssp             HHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHH
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCee
Confidence            5899999999999999999999999999998443 249999999998554444445567999999999997655434458


Q ss_pred             eEEchhHHHHHHHhcCCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      |+|||||++|+|++|+.||..
T Consensus       200 DiwslG~il~ell~g~~Pf~~  220 (361)
T 3uc3_A          200 DVWSCGVTLYVMLVGAYPFED  220 (361)
T ss_dssp             HHHHHHHHHHHHHHSSCSCC-
T ss_pred             eeehhHHHHHHHHhCCCCCCC
Confidence            999999999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.83  E-value=3.1e-21  Score=192.14  Aligned_cols=114  Identities=31%  Similarity=0.621  Sum_probs=94.5

Q ss_pred             hHHHHHHHHHHHHH--hCCCcccCCCCCcEEEec-CCCcEEEEecccceecCCCCcccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCH--SMGIMHRDVKPHNVMIDH-ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH--~~~iiHrDlkp~Nil~~~-~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||.|||  +.||+||||||+|||++. .+..+||+|||+|+....  ......+|+.|+|||++.+ ..++.
T Consensus       161 ~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~  237 (382)
T 2vx3_A          161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLG-MPYDL  237 (382)
T ss_dssp             HHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTT-CCCCT
T ss_pred             HHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc--ccccccCCccccChHHHcC-CCCCc
Confidence            58999999999999  479999999999999963 345799999999987643  2345678999999999986 45889


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      ++|+|||||++++|++|+.|| .+.+..+++..+.+.++.+
T Consensus       238 ~~DiwSlG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~  277 (382)
T 2vx3_A          238 AIDMWSLGCILVEMHTGEPLF-SGANEVDQMNKIVEVLGIP  277 (382)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSC
T ss_pred             HHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCC
Confidence            999999999999999998877 4566667777777766643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.83  E-value=1.9e-21  Score=193.65  Aligned_cols=109  Identities=28%  Similarity=0.532  Sum_probs=90.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC-CCcEEEEecccceecCCCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~-~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++.. +..+||+|||+++............||+.|+|||++.+ ..++.++
T Consensus       153 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  231 (387)
T 1kob_A          153 NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYT  231 (387)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHH
T ss_pred             HHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccC-CCCCCcc
Confidence            589999999999999999999999999999742 35799999999998766555556689999999999975 5578899


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      |+|||||++|+|++|..||. +.+..+.+..+
T Consensus       232 DiwSlG~il~elltg~~Pf~-~~~~~~~~~~i  262 (387)
T 1kob_A          232 DMWAIGVLGYVLLSGLSPFA-GEDDLETLQNV  262 (387)
T ss_dssp             HHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHH
T ss_pred             cEeeHhHHHHHHHhCCCCCC-CCCHHHHHHHH
Confidence            99999999999999998884 44444444443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.83  E-value=7.1e-22  Score=195.97  Aligned_cols=97  Identities=18%  Similarity=0.167  Sum_probs=82.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCccccccccccccccccccc-ccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD-YQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~~   80 (467)
                      .|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.....  .....+++.|+|||.+.+ ...++.++
T Consensus       198 ~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~-~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~  274 (371)
T 3q60_A          198 ILTAQLIRLAANLQSKGLVHGHFTPDNLFIMP-DGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHAL  274 (371)
T ss_dssp             HHHHHHHHHHHHHHHTTEEETTCSGGGEEECT-TSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHH
T ss_pred             HHHHHHHHHHHHHHHCCCccCcCCHHHEEECC-CCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccc
Confidence            45689999999999999999999999999985 458999999999876432  223456689999999964 24578899


Q ss_pred             eEEchhHHHHHHHhcCCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      |+|||||++|+|++|+.||..
T Consensus       275 DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          275 NAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             HHHHHHHHHHHHHHSSCSTTB
T ss_pred             cHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999853

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.83  E-value=2.3e-21  Score=185.88  Aligned_cols=99  Identities=17%  Similarity=0.265  Sum_probs=83.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCC----CcEEEEecccceecCCCCc--------ccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHEN----RKLRLIDWGLAEFYHPGQE--------YNVRVASRYFKGPEL   69 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~----~~~kl~dfG~a~~~~~~~~--------~~~~~~~~~~~~pe~   69 (467)
                      +|+.||+.||+|||++||+||||||+|||++..+    ..+||+|||+++.......        .....||+.|+|||.
T Consensus       110 ~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  189 (298)
T 1csn_A          110 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT  189 (298)
T ss_dssp             HHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             HHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchh
Confidence            6899999999999999999999999999997433    2399999999987643321        234578999999999


Q ss_pred             cccccCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          70 LADYQMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        70 ~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +.+ ..++.++|+|||||++++|++|+.||..
T Consensus       190 ~~~-~~~~~~~Di~slG~il~el~~g~~pf~~  220 (298)
T 1csn_A          190 HLG-REQSRRDDLEALGHVFMYFLRGSLPWQG  220 (298)
T ss_dssp             HTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             hcC-CCCChHHHHHHHHHHHHHHHcCCCCcch
Confidence            876 4578899999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.83  E-value=2.4e-21  Score=188.40  Aligned_cols=101  Identities=29%  Similarity=0.530  Sum_probs=85.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......   ......||+.|+|||.+.+...++.
T Consensus       109 ~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  187 (323)
T 3tki_A          109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE  187 (323)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHH
T ss_pred             HHHHHHHHHHHHHHHCCccccccchHHEEEeC-CCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCC
Confidence            58999999999999999999999999999984 4589999999998653222   2345678999999999986554577


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGH  103 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~  103 (467)
                      ++|+|||||++++|++|+.||....
T Consensus       188 ~~DiwslG~il~~ll~g~~pf~~~~  212 (323)
T 3tki_A          188 PVDVWSCGIVLTAMLAGELPWDQPS  212 (323)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCc
Confidence            8999999999999999999986433

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.83  E-value=1.2e-21  Score=203.22  Aligned_cols=98  Identities=34%  Similarity=0.602  Sum_probs=87.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+....+......+||+.|+|||++.+ ..++.++|
T Consensus       290 ~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~-~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~D  367 (576)
T 2acx_A          290 FYAAEICCGLEDLHRERIVYRDLKPENILLDD-HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPD  367 (576)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTT-CEESSHHH
T ss_pred             HHHHHHHHHHHHHHHCCEeccCCchheEEEeC-CCCeEEEecccceecccCccccccCCCccccCHHHHcC-CCCCccch
Confidence            57899999999999999999999999999984 45899999999998766555566689999999999976 45789999


Q ss_pred             EEchhHHHHHHHhcCCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|||||++|+|++|..||..
T Consensus       368 iwSLGvilyeLltG~~PF~~  387 (576)
T 2acx_A          368 WWALGCLLYEMIAGQSPFQQ  387 (576)
T ss_dssp             HHHHHHHHHHHHHSSCSSSC
T ss_pred             HHHHHHHHHHHHhCCCCCcc
Confidence            99999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.83  E-value=1.9e-21  Score=190.90  Aligned_cols=103  Identities=19%  Similarity=0.284  Sum_probs=85.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCC-CcEEEEecccceecCCCC--------ccccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHEN-RKLRLIDWGLAEFYHPGQ--------EYNVRVASRYFKGPELLAD   72 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~-~~~kl~dfG~a~~~~~~~--------~~~~~~~~~~~~~pe~~~~   72 (467)
                      +|+.||+.||+|||++||+||||||+|||++..+ ..+||+|||+|+......        ......||..|+|||.+.+
T Consensus       155 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  234 (345)
T 2v62_A          155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG  234 (345)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC
Confidence            6899999999999999999999999999998532 289999999998764221        1234578999999999876


Q ss_pred             ccCCCCeeeEEchhHHHHHHHhcCCCCCCCCCC
Q psy3714          73 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN  105 (467)
Q Consensus        73 ~~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~  105 (467)
                       ..++.++|+|||||++|+|++|+.||......
T Consensus       235 -~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          235 -VALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             -CCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence             45788999999999999999999998543333

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.83  E-value=1.5e-21  Score=190.94  Aligned_cols=99  Identities=29%  Similarity=0.545  Sum_probs=87.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++............||+.|+|||.+.+...++.++|
T Consensus       134 ~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  212 (335)
T 3dls_A          134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE-DFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELE  212 (335)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHH
T ss_pred             HHHHHHHHHHHHHHhCCeEEeccCHHHEEEcC-CCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCccc
Confidence            58999999999999999999999999999985 45899999999998766555566789999999999987554578899


Q ss_pred             EEchhHHHHHHHhcCCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|||||++|+|++|..||..
T Consensus       213 iwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          213 MWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             HHHHHHHHHHHHHSSCSCSS
T ss_pred             chhHHHHHHHHHhCCCchhh
Confidence            99999999999999999853

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.83  E-value=5.3e-21  Score=186.56  Aligned_cols=112  Identities=25%  Similarity=0.555  Sum_probs=91.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC------------------CCcEEEEecccceecCCCCcccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE------------------NRKLRLIDWGLAEFYHPGQEYNVRVASRY   63 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~------------------~~~~kl~dfG~a~~~~~~~~~~~~~~~~~   63 (467)
                      +++.||+.||+|||++||+||||||+|||++..                  +..+||+|||+++.....  .....||+.
T Consensus       122 ~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~  199 (339)
T 1z57_A          122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRH  199 (339)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGG
T ss_pred             HHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCcc
Confidence            589999999999999999999999999999753                  346999999999875432  344578999


Q ss_pred             cccccccccccCCCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhC
Q psy3714          64 FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG  117 (467)
Q Consensus        64 ~~~pe~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~  117 (467)
                      |+|||.+.+ ..++.++|+|||||++++|++|..||. +.+..+.+..+.+..+
T Consensus       200 y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~  251 (339)
T 1z57_A          200 YRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFP-THDSKEHLAMMERILG  251 (339)
T ss_dssp             GCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCC-CSCHHHHHHHHHHHHC
T ss_pred             ccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhC
Confidence            999999975 457899999999999999999988874 4455555555555444

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.83  E-value=2.6e-21  Score=191.94  Aligned_cols=111  Identities=26%  Similarity=0.547  Sum_probs=92.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEec-CCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDH-ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~-~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||+.. .++.+||+|||+++............||+.|+|||.+.. ..++.++
T Consensus       191 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  269 (373)
T 2x4f_A          191 LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY-DFVSFPT  269 (373)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTT-CBCCHHH
T ss_pred             HHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccC-CCCCcHH
Confidence            57899999999999999999999999999953 445899999999998766555566679999999999875 5578899


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      |+|||||++++|++|..||. +.+..+.+..+..
T Consensus       270 DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~  302 (373)
T 2x4f_A          270 DMWSVGVIAYMLLSGLSPFL-GDNDAETLNNILA  302 (373)
T ss_dssp             HHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh
Confidence            99999999999999998885 4444444554443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.83  E-value=3.9e-21  Score=194.81  Aligned_cols=98  Identities=27%  Similarity=0.519  Sum_probs=84.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEec--CCCcEEEEecccceecCCCC-cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~--~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||+|||++||+||||||+|||++.  .+..+||+|||+|+...... ......||+.|+|||++.+ ..++.
T Consensus       114 ~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~  192 (444)
T 3soa_A          114 HCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGK  192 (444)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT-CCBCT
T ss_pred             HHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcC-CCCCC
Confidence            58899999999999999999999999999984  23579999999998665432 2345689999999999975 45889


Q ss_pred             eeeEEchhHHHHHHHhcCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      ++|+|||||++|+|++|..||.
T Consensus       193 ~~DIwSlGvilyell~G~~Pf~  214 (444)
T 3soa_A          193 PVDLWACGVILYILLVGYPPFW  214 (444)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999998885

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.83  E-value=3.1e-21  Score=187.99  Aligned_cols=109  Identities=29%  Similarity=0.501  Sum_probs=84.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.... .......+||+.|+|||.+.+ ..++.++
T Consensus       125 ~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  202 (327)
T 3a62_A          125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNH-QGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAV  202 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT-TSCEEECCCSCC----------CTTSSCCTTSCHHHHTT-SCCCTHH
T ss_pred             HHHHHHHHHHHHHHhCCEEcccCCHHHeEECC-CCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcC-CCCCCcc
Confidence            47899999999999999999999999999984 45899999999975432 222345578999999999975 4578899


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA  113 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~  113 (467)
                      |+|||||++|+|++|+.||. +.+..+.+..+.
T Consensus       203 DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~  234 (327)
T 3a62_A          203 DWWSLGALMYDMLTGAPPFT-GENRKKTIDKIL  234 (327)
T ss_dssp             HHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHH
T ss_pred             cchhHHHHHHHHHHCCCCCC-CCCHHHHHHHHH
Confidence            99999999999999998884 333333344433

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.83  E-value=3.8e-21  Score=184.20  Aligned_cols=99  Identities=23%  Similarity=0.342  Sum_probs=84.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEe--cCCCcEEEEecccceecCCCCc--------ccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQE--------YNVRVASRYFKGPELLA   71 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~--~~~~~~kl~dfG~a~~~~~~~~--------~~~~~~~~~~~~pe~~~   71 (467)
                      +++.||+.||+|||++||+||||||+|||++  ..++.+||+|||+++.......        .....|+..|+|||.+.
T Consensus       109 ~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  188 (296)
T 3uzp_A          109 LLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL  188 (296)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhc
Confidence            6899999999999999999999999999995  2445899999999987643321        23457899999999997


Q ss_pred             cccCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          72 DYQMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        72 ~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      + ..++.++|+|||||++++|++|+.||..
T Consensus       189 ~-~~~~~~~Di~slG~il~~l~~g~~pf~~  217 (296)
T 3uzp_A          189 G-IEQSRRDDLESLGYVLMYFNLGSLPWQG  217 (296)
T ss_dssp             T-CCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             C-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            6 4478899999999999999999999864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.83  E-value=7.4e-22  Score=198.65  Aligned_cols=95  Identities=18%  Similarity=0.289  Sum_probs=81.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccc---------c
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA---------D   72 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~---------~   72 (467)
                      .|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+++....  .....+| +.|+|||.+.         .
T Consensus       215 ~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~-~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~  290 (413)
T 3dzo_A          215 QLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHH  290 (413)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGC
T ss_pred             HHHHHHHHHHHHHHhCCcccCCcccceEEEecC-CeEEEEeccceeecCC--ccccCCC-CceeCchhhhcccccccccc
Confidence            578999999999999999999999999999954 5799999999986542  2444567 8899999983         2


Q ss_pred             ccCCCCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          73 YQMYDYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        73 ~~~~~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      ...++.++|||||||++|+|++|+.||.
T Consensus       291 ~~~~~~~~DvwSlGvil~elltg~~Pf~  318 (413)
T 3dzo_A          291 PTLMTFAFDTWTLGLAIYWIWCADLPNT  318 (413)
T ss_dssp             CEEECHHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             CcCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            3447789999999999999999999985

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.83  E-value=2.2e-21  Score=190.36  Aligned_cols=98  Identities=33%  Similarity=0.567  Sum_probs=78.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---cccccccccccccccccc------
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLAD------   72 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~------   72 (467)
                      .|+.||+.||+|||++||+||||||+|||++ + +.+||+|||+++.......   .....||+.|+|||.+.+      
T Consensus       112 ~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  189 (343)
T 3dbq_A          112 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE  189 (343)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-T-TEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC----
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCcceEEEE-C-CcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhcccccc
Confidence            5899999999999999999999999999997 3 4799999999987643322   234578999999999853      


Q ss_pred             ----ccCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          73 ----YQMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        73 ----~~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                          ...++.++|||||||++++|++|+.||..
T Consensus       190 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          190 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             -------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence                24577899999999999999999999854

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.83  E-value=2.9e-21  Score=187.93  Aligned_cols=97  Identities=20%  Similarity=0.412  Sum_probs=80.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......   ......++..|+|||.+.+ ..++.
T Consensus       119 ~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~  196 (325)
T 3kex_A          119 NWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS-PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF-GKYTH  196 (325)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSSTTEEESS-SSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCccchheEEECC-CCeEEECCCCcccccCcccccccccCCCCcccccChHHhcc-CCCCh
Confidence            58899999999999999999999999999984 4589999999998764332   2234567778999999975 45788


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCC
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      ++|+|||||++|++++ |..||.
T Consensus       197 ~~Di~slG~~l~el~~~g~~p~~  219 (325)
T 3kex_A          197 QSDVWSYGVTVWELMTFGAEPYA  219 (325)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             hhHhHHhHHHHHHHHhCCCCCcc
Confidence            9999999999999999 888874

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.83  E-value=2.5e-21  Score=196.80  Aligned_cols=98  Identities=29%  Similarity=0.549  Sum_probs=83.2

Q ss_pred             hHHHHHHHHHHHHHh-CCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~-~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      .++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+.... .......+||+.|+|||++.+ ..++.+
T Consensus       252 ~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~  329 (446)
T 4ejn_A          252 FYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRA  329 (446)
T ss_dssp             HHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS-SSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHT-SCCCTH
T ss_pred             HHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC-CCCEEEccCCCceeccCCCcccccccCCccccCHhhcCC-CCCCCc
Confidence            578999999999998 99999999999999985 45899999999986432 233455689999999999975 558899


Q ss_pred             eeEEchhHHHHHHHhcCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|+|||||++++|++|+.||..
T Consensus       330 ~DiwslG~il~ell~g~~Pf~~  351 (446)
T 4ejn_A          330 VDWWGLGVVMYEMMCGRLPFYN  351 (446)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cchhhhHHHHHHHhhCCCCCCC
Confidence            9999999999999999999853

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.83  E-value=1.9e-21  Score=200.94  Aligned_cols=99  Identities=33%  Similarity=0.511  Sum_probs=86.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc-ccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....... ....+||+.|+|||++.+ ..++.++
T Consensus       293 ~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~  370 (543)
T 3c4z_A          293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDD-DGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSV  370 (543)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHH
T ss_pred             HHHHHHHHHHHHHHHcCCcccCCChHHEEEeC-CCCEEEeecceeeeccCCCcccccccCCccccChhhhcC-CCCChHH
Confidence            47899999999999999999999999999985 45899999999987654433 334589999999999976 5688999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHG  102 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~  102 (467)
                      |+|||||++|||++|..||...
T Consensus       371 DiwSlGvilyelltG~~PF~~~  392 (543)
T 3c4z_A          371 DYFALGVTLYEMIAARGPFRAR  392 (543)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCT
T ss_pred             hcCcchHHHHHHHhCCCCCCCC
Confidence            9999999999999999998643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.83  E-value=2e-21  Score=185.61  Aligned_cols=110  Identities=25%  Similarity=0.504  Sum_probs=78.7

Q ss_pred             hHHHHHHHHHHHHHhC-CCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccc---cccCCC
Q psy3714           2 RIATGASMALDYCHSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA---DYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~-~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~   77 (467)
                      +|+.||+.||+|||++ ||+||||||+|||++. ++.+||+|||+++............|++.|+|||.+.   ....++
T Consensus       113 ~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~  191 (290)
T 3fme_A          113 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYS  191 (290)
T ss_dssp             HHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECT-TCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CC
T ss_pred             HHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC-CCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCC
Confidence            5899999999999998 9999999999999985 4589999999998765544445557899999999972   335578


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      .++|+|||||++++|++|+.||.........+...
T Consensus       192 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  226 (290)
T 3fme_A          192 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV  226 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH
Confidence            89999999999999999999985434444444333

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.83  E-value=1.7e-21  Score=191.71  Aligned_cols=107  Identities=20%  Similarity=0.286  Sum_probs=87.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCC--cEEEEecccceecCCCC--------cccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQ--------EYNVRVASRYFKGPELLA   71 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~--~~kl~dfG~a~~~~~~~--------~~~~~~~~~~~~~pe~~~   71 (467)
                      +|+.||+.||.|||++||+||||||+|||++. ++  .+||+|||+++......        ......||+.|+|||.+.
T Consensus       163 ~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  241 (352)
T 2jii_A          163 QVACRLLDALEFLHENEYVHGNVTAENIFVDP-EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK  241 (352)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET-TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC-CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc
Confidence            68999999999999999999999999999994 44  79999999998654221        113347899999999987


Q ss_pred             cccCCCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHH
Q psy3714          72 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  110 (467)
Q Consensus        72 ~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~  110 (467)
                      + ..++.++|+|||||++|+|++|+.||.......+.+.
T Consensus       242 ~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  279 (352)
T 2jii_A          242 G-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIM  279 (352)
T ss_dssp             T-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred             c-CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHH
Confidence            6 4578899999999999999999999865443444433

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.83  E-value=1.7e-21  Score=189.95  Aligned_cols=98  Identities=22%  Similarity=0.317  Sum_probs=84.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCc-----EEEEecccceecCCCCc--------cccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRK-----LRLIDWGLAEFYHPGQE--------YNVRVASRYFKGPE   68 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~-----~kl~dfG~a~~~~~~~~--------~~~~~~~~~~~~pe   68 (467)
                      +|+.||+.||+|||++||+||||||+|||++..+ .     +||+|||+|+.......        .....||+.|+|||
T Consensus       109 ~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  187 (330)
T 2izr_A          109 MIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSIN  187 (330)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred             HHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCC-CCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChH
Confidence            6899999999999999999999999999998543 4     99999999987543221        23457899999999


Q ss_pred             ccccccCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          69 LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        69 ~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      .+.+ ..++.++|+|||||++++|++|+.||..
T Consensus       188 ~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~  219 (330)
T 2izr_A          188 THLG-KEQSRRDDLEALGHMFMYFLRGSLPWQG  219 (330)
T ss_dssp             HHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             HHcC-CCCCchhHHHHHHHHHHHHhcCCCCccc
Confidence            9986 5578899999999999999999999864

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.83  E-value=1.2e-21  Score=194.78  Aligned_cols=95  Identities=21%  Similarity=0.342  Sum_probs=82.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccc--------
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY--------   73 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~--------   73 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...  ......+| +.|+|||.+.+.        
T Consensus       210 ~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~-~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~  285 (377)
T 3byv_A          210 QLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ-RGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRD  285 (377)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEECT-TCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHC
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEEechhheecC--CcccCCCC-cCccChhhhccccccccccc
Confidence            58999999999999999999999999999995 4589999999998643  23445567 889999999864        


Q ss_pred             --cCCCCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          74 --QMYDYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        74 --~~~~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                        ..++.++|+|||||++|+|++|+.||.
T Consensus       286 ~~~~~~~~~DvwSlG~il~elltg~~Pf~  314 (377)
T 3byv_A          286 RRTLMTFSFDAWALGLVIYWIWCADLPIT  314 (377)
T ss_dssp             CEEECCHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             ccccCChhhhHHHHHHHHHHHHHCCCCCc
Confidence              258899999999999999999999984

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.83  E-value=2e-21  Score=188.53  Aligned_cols=100  Identities=20%  Similarity=0.383  Sum_probs=85.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEe---cCCCcEEEEecccceecCCCCccccccccccccccccccc------
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMID---HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD------   72 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~---~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~------   72 (467)
                      .|+.||+.||+|||++||+||||||+|||+.   ..+..+||+|||+++............||..|+|||.+..      
T Consensus       116 ~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  195 (319)
T 4euu_A          116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKD  195 (319)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCC
T ss_pred             HHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhcccccc
Confidence            5899999999999999999999999999982   1334799999999998766555556679999999999852      


Q ss_pred             -ccCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          73 -YQMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        73 -~~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                       ...++.++|+|||||++|+|++|+.||..
T Consensus       196 ~~~~~~~~~DiwslG~il~el~~g~~pf~~  225 (319)
T 4euu_A          196 HQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (319)
T ss_dssp             CCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             ccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence             24578899999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.83  E-value=3.4e-21  Score=189.46  Aligned_cols=101  Identities=27%  Similarity=0.506  Sum_probs=76.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEec--CCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~--~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +++.||+.||+|||++||+||||||+|||++.  .+..+||+|||+++............||+.|+|||.+.+ ..++.+
T Consensus       152 ~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~  230 (349)
T 2w4o_A          152 DAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG-CAYGPE  230 (349)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTT-CCCCTH
T ss_pred             HHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcC-CCCCcc
Confidence            58999999999999999999999999999973  245899999999987654444455678999999999976 457889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGH  103 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~  103 (467)
                      +|+|||||++|+|++|..||....
T Consensus       231 ~DiwslG~il~ell~g~~pf~~~~  254 (349)
T 2w4o_A          231 VDMWSVGIITYILLCGFEPFYDER  254 (349)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred             cchHHHHHHHHHHHhCCCCCCCCc
Confidence            999999999999999999986543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.83  E-value=6.6e-21  Score=185.17  Aligned_cols=98  Identities=27%  Similarity=0.627  Sum_probs=84.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-cccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++
T Consensus       145 ~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  222 (321)
T 2c30_A          145 TVCEAVLQALAYLHAQGVIHRDIKSDSILLTL-DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEV  222 (321)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHH
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHEEECC-CCcEEEeeeeeeeecccCccccccccCCccccCHhhhcC-CCCCchh
Confidence            58999999999999999999999999999984 4589999999998764332 2345578999999999975 5578899


Q ss_pred             eEEchhHHHHHHHhcCCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      |+|||||++++|++|+.||..
T Consensus       223 Dv~slG~il~el~~g~~pf~~  243 (321)
T 2c30_A          223 DIWSLGIMVIEMVDGEPPYFS  243 (321)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTT
T ss_pred             hHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999853

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.83  E-value=5.5e-21  Score=188.19  Aligned_cols=113  Identities=35%  Similarity=0.727  Sum_probs=90.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....  ......+++.|+|||.+.+...++.++|
T Consensus       130 ~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~D  206 (353)
T 3coi_A          130 YLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE-DCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVD  206 (353)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT-TCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHH
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCHHHEeECC-CCcEEEeecccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhh
Confidence            58999999999999999999999999999984 45899999999976532  2334578899999999876566788999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      +|||||++++|++|+.|| .+.+..+.+..+.+..|.
T Consensus       207 i~slG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~  242 (353)
T 3coi_A          207 IWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGV  242 (353)
T ss_dssp             HHHHHHHHHHHHHSSCSS-BSSCHHHHHHHHHHHHCB
T ss_pred             HHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCC
Confidence            999999999999999887 455556667777666554

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.82  E-value=4.3e-21  Score=190.26  Aligned_cols=97  Identities=23%  Similarity=0.398  Sum_probs=81.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......   .....+++.|+|||++.+ ..++.
T Consensus       207 ~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~  284 (370)
T 2psq_A          207 SCTYQLARGMEYLASQKCIHRDLAARNVLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTH  284 (370)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEECT-TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCH
T ss_pred             HHHHHHHHHHHHHHhCCeeccccchhhEEECC-CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCc
Confidence            57899999999999999999999999999984 45899999999987643322   223356778999999976 55888


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCC
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      ++|+|||||++|||++ |..||.
T Consensus       285 ~~DvwslG~il~ellt~g~~p~~  307 (370)
T 2psq_A          285 QSDVWSFGVLMWEIFTLGGSPYP  307 (370)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSST
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999 777763

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.82  E-value=7.5e-21  Score=186.89  Aligned_cols=96  Identities=34%  Similarity=0.605  Sum_probs=83.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCccccccccccccccccccc--ccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD--YQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~   79 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....   .....||+.|+|||.+..  ...++.+
T Consensus       158 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~  233 (348)
T 1u5q_A          158 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSE-PGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGK  233 (348)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET-TTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTH
T ss_pred             HHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC-CCCEEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCCCcH
Confidence            58899999999999999999999999999994 45999999999987643   234578999999999852  3457889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|+|||||++++|++|+.||..
T Consensus       234 ~DiwslG~il~ell~g~~p~~~  255 (348)
T 1u5q_A          234 VDVWSLGITCIELAERKPPLFN  255 (348)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999854

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.82  E-value=2.6e-21  Score=188.47  Aligned_cols=97  Identities=18%  Similarity=0.397  Sum_probs=80.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.||+.||+|||++||+||||||+|||++.. +.+||+|||+|+.......   .....+|..|+|||.+.+ ..++.
T Consensus       121 ~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~  198 (327)
T 3poz_A          121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTH  198 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHhhCCeeCCCCChheEEECCC-CCEEEccCcceeEccCCcccccccCCCccccccChHHhcc-CCCCc
Confidence            589999999999999999999999999999854 5899999999987643322   122345778999999975 55789


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCC
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      ++|+|||||++|++++ |+.||.
T Consensus       199 ~~Di~slG~il~ellt~g~~p~~  221 (327)
T 3poz_A          199 QSDVWSYGVTVWELMTFGSKPYD  221 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             hhhhhhhHHHHHHHHhcCCCCcc
Confidence            9999999999999999 887774

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.82  E-value=5e-21  Score=184.99  Aligned_cols=97  Identities=22%  Similarity=0.434  Sum_probs=74.8

Q ss_pred             hHHHHHHHHHHHHHhCC--CcccCCCCCcEEEecCCCcEEEEecccceecCCCC-cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~--iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||+|||++|  |+||||||+|||++. ++.+||+|||+++...... ......||+.|+|||.+.+ ..++.
T Consensus       141 ~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~  218 (309)
T 3p86_A          141 SMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNE  218 (309)
T ss_dssp             HHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECT-TCCEEECCCC-----------------CCTTSCHHHHTT-CCCCT
T ss_pred             HHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeC-CCcEEECCCCCCccccccccccccCCCCccccChhhhcC-CCCCc
Confidence            58899999999999999  999999999999984 4589999999998654322 2344578999999999976 45788


Q ss_pred             eeeEEchhHHHHHHHhcCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      ++|+|||||++|+|++|+.||.
T Consensus       219 ~~DiwslG~il~elltg~~Pf~  240 (309)
T 3p86_A          219 KSDVYSFGVILWELATLQQPWG  240 (309)
T ss_dssp             THHHHHHHHHHHHHHHCCCTTT
T ss_pred             hhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999884

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.82  E-value=4.5e-21  Score=184.14  Aligned_cols=98  Identities=24%  Similarity=0.541  Sum_probs=83.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-cccccccccccccccccccccC--CCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQM--YDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~--~~~   78 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...... ......||+.|+|||.+.+...  ++.
T Consensus       141 ~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  219 (298)
T 2zv2_A          141 FYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE-DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGK  219 (298)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESH
T ss_pred             HHHHHHHHHHHHHHHCCeeccCCCHHHEEECC-CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCc
Confidence            58899999999999999999999999999984 4589999999998765432 2345578999999999875432  366


Q ss_pred             eeeEEchhHHHHHHHhcCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      ++|+|||||++|+|++|+.||.
T Consensus       220 ~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          220 ALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSC
T ss_pred             hhhhHhHHHHHHHHHHCCCCCC
Confidence            7899999999999999999985

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.82  E-value=7.2e-21  Score=185.39  Aligned_cols=109  Identities=23%  Similarity=0.476  Sum_probs=85.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEec--CCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~--~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.||+.||+|||++||+||||||+|||++.  .++.+||+|||+++............|++.|+|||.+.. ..++.+
T Consensus       135 ~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~  213 (327)
T 3lm5_A          135 RLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY-DPITTA  213 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTT-CCCCTH
T ss_pred             HHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecC-CCCCch
Confidence            58999999999999999999999999999985  145899999999987765444455678999999999975 457889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      +|+|||||++++|++|+.||. +.+..+....+
T Consensus       214 ~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i  245 (327)
T 3lm5_A          214 TDMWNIGIIAYMLLTHTSPFV-GEDNQETYLNI  245 (327)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhCCCCCC-CCCchHHHHHH
Confidence            999999999999999998884 33433344333

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.82  E-value=4.5e-21  Score=188.76  Aligned_cols=99  Identities=29%  Similarity=0.516  Sum_probs=84.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCC--CcEEEEecccceecCCCCc-ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~--~~~kl~dfG~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||+|||++||+||||||+|||++..+  ..+||+|||+++....... ....+||+.|+|||++.+ ..++.
T Consensus       134 ~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~  212 (351)
T 3c0i_A          134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGK  212 (351)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCT
T ss_pred             HHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC-CCCCc
Confidence            5789999999999999999999999999997533  2499999999987654332 345679999999999976 45789


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      ++|+|||||++|+|++|..||..
T Consensus       213 ~~DiwslG~il~~ll~g~~pf~~  235 (351)
T 3c0i_A          213 PVDVWGCGVILFILLSGCLPFYG  235 (351)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             hHhhHHHHHHHHHHHHCCCCCCC
Confidence            99999999999999999999853

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.82  E-value=2.8e-21  Score=197.63  Aligned_cols=99  Identities=21%  Similarity=0.333  Sum_probs=84.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEe--cCCCcEEEEecccceecCCCCc--------ccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQE--------YNVRVASRYFKGPELLA   71 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~--~~~~~~kl~dfG~a~~~~~~~~--------~~~~~~~~~~~~pe~~~   71 (467)
                      +|+.||+.||+|||++|||||||||+|||++  ..++.+||+|||+++.......        .....||..|+|||.+.
T Consensus       107 ~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~  186 (483)
T 3sv0_A          107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHL  186 (483)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhc
Confidence            6899999999999999999999999999994  2445899999999987654322        12457899999999997


Q ss_pred             cccCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          72 DYQMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        72 ~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      + ..++.++|||||||++|+|++|+.||..
T Consensus       187 ~-~~~s~~sDvwSlGvil~elltG~~Pf~~  215 (483)
T 3sv0_A          187 G-IEQSRRDDLESLGYVLMYFLRGSLPWQG  215 (483)
T ss_dssp             T-CCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             C-CCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            6 4578899999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.82  E-value=4.8e-21  Score=183.74  Aligned_cols=97  Identities=28%  Similarity=0.516  Sum_probs=78.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC--cccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......  ......||+.|+|||.+.+ ..++.+
T Consensus       115 ~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~  192 (294)
T 4eqm_A          115 NFTNQILDGIKHAHDMRIVHRDIKPQNILIDS-NKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-EATDEC  192 (294)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEECCCSSSTTC-------------CCSSCCHHHHHT-CCCCTT
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEEEEeCCCccccccccccccCccccCccccCHhHhcC-CCCCch
Confidence            58899999999999999999999999999984 4589999999998654322  1234568999999999976 557889


Q ss_pred             eeEEchhHHHHHHHhcCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +|+|||||++|+|++|+.||.
T Consensus       193 ~Di~slG~~l~~ll~g~~pf~  213 (294)
T 4eqm_A          193 TDIYSIGIVLYEMLVGEPPFN  213 (294)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSC
T ss_pred             HhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999998884

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.82  E-value=1e-20  Score=187.17  Aligned_cols=99  Identities=29%  Similarity=0.613  Sum_probs=86.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccc-----cCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY-----QMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~   76 (467)
                      .++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.............||+.|+|||++.+.     ..+
T Consensus       204 ~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~-~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  282 (365)
T 2y7j_A          204 SIMRSLLEAVSFLHANNIVHRDLKPENILLDD-NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY  282 (365)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCB
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCHHHEEECC-CCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCC
Confidence            58899999999999999999999999999984 458999999999887665555667899999999998632     346


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +.++|+|||||++|+|++|..||..
T Consensus       283 ~~~~Di~slG~il~ell~g~~pf~~  307 (365)
T 2y7j_A          283 GKEVDLWACGVILFTLLAGSPPFWH  307 (365)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CchhhHHhHHHHHHHHHHCCCCCCC
Confidence            7899999999999999999998853

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.82  E-value=9.5e-21  Score=194.70  Aligned_cols=109  Identities=31%  Similarity=0.714  Sum_probs=88.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC--CCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~--~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.||+.||.|||++||+||||||+|||++..  +..+||+|||+|+...........+||+.|+|||++.+  .++.+
T Consensus       125 ~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~  202 (486)
T 3mwu_A          125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEK  202 (486)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHH
T ss_pred             HHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCch
Confidence            589999999999999999999999999999632  34799999999987765555566789999999999874  47889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA  113 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~  113 (467)
                      +|+||+||++|+|++|..||. +.+..+.+..+.
T Consensus       203 ~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~  235 (486)
T 3mwu_A          203 CDVWSAGVILYILLSGTPPFY-GKNEYDILKRVE  235 (486)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHH
Confidence            999999999999999998884 444444444443

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.81  E-value=7.1e-21  Score=182.19  Aligned_cols=99  Identities=23%  Similarity=0.342  Sum_probs=83.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEe--cCCCcEEEEecccceecCCCCc--------ccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQE--------YNVRVASRYFKGPELLA   71 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~--~~~~~~kl~dfG~a~~~~~~~~--------~~~~~~~~~~~~pe~~~   71 (467)
                      +++.||+.||.|||++||+||||||+|||++  ..++.+||+|||+++.......        .....|++.|+|||.+.
T Consensus       109 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  188 (296)
T 4hgt_A          109 LLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL  188 (296)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhc
Confidence            6899999999999999999999999999993  2445899999999987643321        23457899999999997


Q ss_pred             cccCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          72 DYQMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        72 ~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      + ..++.++|+|||||++++|++|+.||..
T Consensus       189 ~-~~~~~~~Di~slG~il~~l~~g~~pf~~  217 (296)
T 4hgt_A          189 G-IEQSRRDDLESLGYVLMYFNLGSLPWQG  217 (296)
T ss_dssp             T-CCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             C-CCCCchhHHHHHHHHHHHHhcCCCCCcc
Confidence            6 4578899999999999999999999864

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.81  E-value=3.3e-21  Score=188.97  Aligned_cols=100  Identities=31%  Similarity=0.585  Sum_probs=84.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCC---cEEEEecccceecCCC-CcccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~---~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      .++.||+.||+|||++||+||||||+|||+...++   .+||+|||+++..... ......+||+.|+|||++.+ ..++
T Consensus       120 ~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~  198 (342)
T 2qr7_A          120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER-QGYD  198 (342)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHH-HHHH
T ss_pred             HHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcC-CCCC
Confidence            58899999999999999999999999999964332   4999999999876433 23445678999999999875 4478


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFFHG  102 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~~~  102 (467)
                      .++|+|||||++|+|++|..||...
T Consensus       199 ~~~DiwslG~il~ell~g~~Pf~~~  223 (342)
T 2qr7_A          199 AACDIWSLGVLLYTMLTGYTPFANG  223 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             CccCeeeHhHHHHHHhcCCCCCCCC
Confidence            8999999999999999999998643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.81  E-value=7.7e-21  Score=183.76  Aligned_cols=97  Identities=30%  Similarity=0.574  Sum_probs=76.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC----cccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......    ......||+.|+|||.+.+ ..++
T Consensus       120 ~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~  197 (311)
T 3ork_A          120 EVIADACQALNFSHQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVD  197 (311)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TSCEEECCCSCC------------------CCTTCCHHHHHT-CCCC
T ss_pred             HHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcC-CCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcC-CCCC
Confidence            58999999999999999999999999999985 4589999999998654321    1233568999999999976 4578


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      .++|+|||||++|+|++|+.||.
T Consensus       198 ~~~Di~slG~~l~~ll~g~~pf~  220 (311)
T 3ork_A          198 ARSDVYSLGCVLYEVLTGEPPFT  220 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             chHhHHHHHHHHHHHHhCCCCCC
Confidence            89999999999999999998884

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.81  E-value=5.9e-21  Score=196.17  Aligned_cols=110  Identities=31%  Similarity=0.674  Sum_probs=91.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEec--CCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~--~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.||+.||.|||++||+||||||+|||++.  .+..+||+|||+|+...........+||+.|+|||++.+  .++.+
T Consensus       130 ~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~  207 (484)
T 3nyv_A          130 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEK  207 (484)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTH
T ss_pred             HHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC--CCCCc
Confidence            58999999999999999999999999999952  345899999999987766555666789999999999864  47889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      +|+||+||++|+|++|..||. +.+..+.+..+.+
T Consensus       208 ~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~  241 (484)
T 3nyv_A          208 CDVWSTGVILYILLSGCPPFN-GANEYDILKKVEK  241 (484)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH
T ss_pred             ceeHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHc
Confidence            999999999999999998874 4444444444433

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.81  E-value=2e-20  Score=185.36  Aligned_cols=113  Identities=28%  Similarity=0.580  Sum_probs=88.0

Q ss_pred             hHHHHHHHHHHHHHhC-CCcccCCCCCcEEEecC-----CCcEEEEecccceecCCCCcccccccccccccccccccccC
Q psy3714           2 RIATGASMALDYCHSM-GIMHRDVKPHNVMIDHE-----NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQM   75 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~-~iiHrDlkp~Nil~~~~-----~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~   75 (467)
                      +|+.||+.||+|||++ ||+||||||+|||++..     ...+||+|||+++.....  .....+|+.|+|||.+.+ ..
T Consensus       135 ~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~  211 (373)
T 1q8y_A          135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-AP  211 (373)
T ss_dssp             HHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-CC
T ss_pred             HHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhC-CC
Confidence            5899999999999998 99999999999999632     236999999999876432  344578999999999976 45


Q ss_pred             CCCeeeEEchhHHHHHHHhcCCCCCCCCC-----CHHHHHHHHHHhC
Q psy3714          76 YDYSLDMWSLGCMLASMIFRKEPFFHGHD-----NYDQLVRIAKVLG  117 (467)
Q Consensus        76 ~~~~~D~ws~G~~l~~~l~g~~~~~~~~~-----~~~~~~~~~~~~~  117 (467)
                      ++.++|+|||||++|+|++|..||.....     ..+.+..+...+|
T Consensus       212 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (373)
T 1q8y_A          212 WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG  258 (373)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred             CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcC
Confidence            78999999999999999999988853221     2334555555444

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.81  E-value=6.3e-21  Score=183.12  Aligned_cols=99  Identities=29%  Similarity=0.500  Sum_probs=82.2

Q ss_pred             hHHHHHHHHHHHHH--------hCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc-----cccccccccccccc
Q psy3714           2 RIATGASMALDYCH--------SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYFKGPE   68 (467)
Q Consensus         2 ~i~~~i~~al~~lH--------~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~-----~~~~~~~~~~~~pe   68 (467)
                      +|+.||+.||+|||        ++||+||||||+|||++. ++.+||+|||+|+.......     .....||+.|+|||
T Consensus       109 ~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  187 (301)
T 3q4u_A          109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE  187 (301)
T ss_dssp             HHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECT-TSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcC-CCCEEEeeCCCeeecccccccccccccccccccceeChh
Confidence            68999999999999        999999999999999984 45899999999986543322     12347899999999


Q ss_pred             cccccc-----CCCCeeeEEchhHHHHHHHhc----------CCCCCC
Q psy3714          69 LLADYQ-----MYDYSLDMWSLGCMLASMIFR----------KEPFFH  101 (467)
Q Consensus        69 ~~~~~~-----~~~~~~D~ws~G~~l~~~l~g----------~~~~~~  101 (467)
                      .+.+..     .++.++|+|||||++|+|++|          +.||..
T Consensus       188 ~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             HHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             hhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            997642     234689999999999999999          788764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.81  E-value=1.2e-20  Score=182.64  Aligned_cols=114  Identities=30%  Similarity=0.595  Sum_probs=90.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC----CcccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG----QEYNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +++.||+.||+|||++||+||||||+|||++..+..+||+|||+++.....    .......++..|+|||.+.+...++
T Consensus       124 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  203 (320)
T 2i6l_A          124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT  203 (320)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCC
T ss_pred             HHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCC
Confidence            588999999999999999999999999999866668999999999865422    1223446788899999987656688


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHh
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL  116 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~  116 (467)
                      .++|+|||||++++|++|+.||. +.+..+.+..+....
T Consensus       204 ~~~Di~slG~il~el~~g~~pf~-~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          204 KAIDMWAAGCIFAEMLTGKTLFA-GAHELEQMQLILESI  241 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHHS
T ss_pred             chhhhHhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhc
Confidence            89999999999999999998874 444445555554443

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.81  E-value=6.6e-21  Score=194.15  Aligned_cols=108  Identities=17%  Similarity=0.373  Sum_probs=85.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +++.|||.||+|||++||+||||||+|||++. ++.+||+|||+++.......  .....++..|+|||.+.. ..++.+
T Consensus       288 ~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  365 (454)
T 1qcf_A          288 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSA-SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIK  365 (454)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT-TCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHHHHhCCccCCCCCHHHEEECC-CCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc-CCCCcH
Confidence            58999999999999999999999999999984 45899999999987643211  122345667999999975 558899


Q ss_pred             eeEEchhHHHHHHHh-cCCCCCCCCCCHHHHHHH
Q psy3714          80 LDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~~~~  112 (467)
                      +|||||||++|||++ |+.|| .+.+..+....+
T Consensus       366 ~DvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i  398 (454)
T 1qcf_A          366 SDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRAL  398 (454)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHH
T ss_pred             HHHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHH
Confidence            999999999999999 87776 444444444433

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.81  E-value=5.7e-21  Score=189.16  Aligned_cols=104  Identities=18%  Similarity=0.352  Sum_probs=82.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCC--CcEEEEecccceecCC---CCcccccccccccccccccccccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYHP---GQEYNVRVASRYFKGPELLADYQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~--~~~kl~dfG~a~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~   76 (467)
                      +|+.||+.||+|||++||+||||||+|||++..+  ..+||+|||+|+....   ........+|+.|+|||.+.+ ..+
T Consensus       185 ~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~  263 (367)
T 3l9p_A          185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIF  263 (367)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCC
T ss_pred             HHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC-CCC
Confidence            5899999999999999999999999999998432  3599999999975421   122334567889999999875 458


Q ss_pred             CCeeeEEchhHHHHHHHh-cCCCCCCCCCCHH
Q psy3714          77 DYSLDMWSLGCMLASMIF-RKEPFFHGHDNYD  107 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~-g~~~~~~~~~~~~  107 (467)
                      +.++|||||||++++|++ |..|| .+.+..+
T Consensus       264 ~~~~DvwslG~il~ellt~g~~pf-~~~~~~~  294 (367)
T 3l9p_A          264 TSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQE  294 (367)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHH
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCC-CCCCHHH
Confidence            889999999999999998 76666 4444333

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.81  E-value=1.3e-20  Score=180.10  Aligned_cols=109  Identities=24%  Similarity=0.508  Sum_probs=79.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC---CCccccccccccccccccccc--ccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP---GQEYNVRVASRYFKGPELLAD--YQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~---~~~~~~~~~~~~~~~pe~~~~--~~~~   76 (467)
                      +|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....   ........||+.|+|||.+..  ...+
T Consensus       124 ~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  202 (289)
T 3og7_A          124 DIARQTARGMDYLHAKSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY  202 (289)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET-TTEEEECCCC------------------CCCTTCCHHHHC----CCS
T ss_pred             HHHHHHHHHHHHHHhCCcccccCccceEEECC-CCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCC
Confidence            68999999999999999999999999999995 45899999999976532   122344578999999999862  2446


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      +.++|+|||||++++|++|+.||.. ....+.+...
T Consensus       203 ~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~  237 (289)
T 3og7_A          203 SFQSDVYAFGIVLYELMTGQLPYSN-INNRDQIIEM  237 (289)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTSS-CCCHHHHHHH
T ss_pred             CcccchHHHHHHHHHHHHCCCCccc-cchHHHHHHH
Confidence            7789999999999999999998854 3344444433

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.81  E-value=2.3e-21  Score=189.29  Aligned_cols=102  Identities=25%  Similarity=0.423  Sum_probs=84.3

Q ss_pred             hHHHHHHHHHHHHHhC---------CCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---------cccccccccc
Q psy3714           2 RIATGASMALDYCHSM---------GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---------EYNVRVASRY   63 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~---------~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---------~~~~~~~~~~   63 (467)
                      +|+.||+.||.|||++         ||+||||||+|||++. ++.+||+|||+++......         ......||+.
T Consensus       115 ~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~  193 (336)
T 3g2f_A          115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN-DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR  193 (336)
T ss_dssp             HHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT-TSCEEECCCTTCEECSSSSCC---------CCTTSCGG
T ss_pred             HHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC-CCcEEEeeccceeecccccccCccccccccccCCCccc
Confidence            5899999999999999         9999999999999985 4589999999998764321         1224468999


Q ss_pred             cccccccccc------cCCCCeeeEEchhHHHHHHHhcCCCCCCCCC
Q psy3714          64 FKGPELLADY------QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD  104 (467)
Q Consensus        64 ~~~pe~~~~~------~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~  104 (467)
                      |+|||.+.+.      ..++.++|||||||++|+|++|+.|++.+..
T Consensus       194 y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          194 YMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             GCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             eeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            9999998752      3355689999999999999999989886654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.81  E-value=9.9e-21  Score=188.92  Aligned_cols=99  Identities=28%  Similarity=0.353  Sum_probs=82.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC--------Ccccccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG--------QEYNVRVASRYFKGPELLADY   73 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~--------~~~~~~~~~~~~~~pe~~~~~   73 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||++......        .......||..|+|||++.+.
T Consensus       132 ~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  210 (389)
T 3gni_B          132 YILQGVLKALDYIHHMGYVHRSVKASHILISV-DGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN  210 (389)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEcccccceeeccccccccccccccccccccccccCHHHHhcc
Confidence            58899999999999999999999999999984 458999999998643211        112234788889999999763


Q ss_pred             -cCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          74 -QMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        74 -~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                       ..++.++|+|||||++++|++|+.||..
T Consensus       211 ~~~~~~~~DiwslG~il~el~~g~~pf~~  239 (389)
T 3gni_B          211 LQGYDAKSDIYSVGITACELANGHVPFKD  239 (389)
T ss_dssp             SSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence             4578899999999999999999988853

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.81  E-value=7.1e-21  Score=185.47  Aligned_cols=97  Identities=18%  Similarity=0.397  Sum_probs=75.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.||+.||.|||++||+||||||+|||++.. +.+||+|||+++.......   .....++..|+|||.+.+ ..++.
T Consensus       121 ~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~  198 (327)
T 3lzb_A          121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTH  198 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTC----------------CCCGGGSCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC-CCEEEccCcceeEccCccccccccCCCccccccCHHHHcC-CCCCh
Confidence            589999999999999999999999999999854 5899999999987643221   222345678999999975 55788


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCC
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      ++|+|||||++|+|++ |..||.
T Consensus       199 ~~Di~slG~il~ell~~g~~p~~  221 (327)
T 3lzb_A          199 QSDVWSYGVTVWELMTFGSKPYD  221 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCC
Confidence            9999999999999999 877773

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.81  E-value=1.5e-20  Score=182.58  Aligned_cols=98  Identities=29%  Similarity=0.519  Sum_probs=85.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCC---cEEEEecccceecCCCCcccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~---~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||+|||++||+||||||+|||++..+.   .+||+|||+++............||+.|+|||.+.+ ..++.
T Consensus       119 ~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~  197 (321)
T 2a2a_A          119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGL  197 (321)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCT
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccC-CCCCC
Confidence            58999999999999999999999999999985442   699999999987765544555678999999999875 45788


Q ss_pred             eeeEEchhHHHHHHHhcCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      ++|+|||||++++|++|..||.
T Consensus       198 ~~Di~slG~il~~l~~g~~pf~  219 (321)
T 2a2a_A          198 EADMWSIGVITYILLSGASPFL  219 (321)
T ss_dssp             HHHHHHHHHHHHHHHHSCCSSC
T ss_pred             ccccHHHHHHHHHHHHCCCCCC
Confidence            9999999999999999999884

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.81  E-value=1e-20  Score=182.69  Aligned_cols=98  Identities=29%  Similarity=0.531  Sum_probs=82.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcc---------------ccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY---------------NVRVASRYFKG   66 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~---------------~~~~~~~~~~~   66 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++........               ....||+.|+|
T Consensus       112 ~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  190 (310)
T 3s95_A          112 SFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA  190 (310)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSTTSEEECT-TSCEEECCCTTCEECC--------------------CCCCSCGGGCC
T ss_pred             HHHHHHHHHHHHHHhCCccCCCCCcCeEEECC-CCCEEEeecccceecccccccccccccccccccccccccCCCcceeC
Confidence            58999999999999999999999999999984 558999999999876432211               14578999999


Q ss_pred             ccccccccCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          67 PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        67 pe~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      ||.+.+ ..++.++|||||||+++++++|..|+..
T Consensus       191 PE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~  224 (310)
T 3s95_A          191 PEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD  224 (310)
T ss_dssp             HHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred             HHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence            999976 5578899999999999999999887753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.81  E-value=7.6e-21  Score=191.65  Aligned_cols=100  Identities=26%  Similarity=0.478  Sum_probs=77.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCC--CcEEEEecccceecCCCCccccccccccccccccccc--ccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD--YQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~--~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~   77 (467)
                      .|+.||+.||+|||++||+||||||+|||++..+  ..+||+|||+|+...........+||+.|+|||++.+  ...++
T Consensus       243 ~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  322 (419)
T 3i6u_A          243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN  322 (419)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTH
T ss_pred             HHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCC
Confidence            5789999999999999999999999999997433  3599999999987765544556789999999999853  34567


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      .++|+|||||++++|++|..||..
T Consensus       323 ~~~DiwslG~il~~lltg~~pf~~  346 (419)
T 3i6u_A          323 RAVDCWSLGVILFICLSGYPPFSE  346 (419)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             chhhhHhHHHHHHHHHHCCCCCCC
Confidence            899999999999999999999854

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.81  E-value=1.4e-20  Score=190.33  Aligned_cols=98  Identities=29%  Similarity=0.524  Sum_probs=77.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC----CCcEEEEecccceecCCCC----ccccccccccccccccccc-
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE----NRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLAD-   72 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~----~~~~kl~dfG~a~~~~~~~----~~~~~~~~~~~~~pe~~~~-   72 (467)
                      +++.||+.||+|||++||+||||||+|||++..    ...+||+|||+|+......    ......||+.|+|||++.+ 
T Consensus       122 ~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~  201 (432)
T 3p23_A          122 TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED  201 (432)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC
T ss_pred             HHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcc
Confidence            589999999999999999999999999999532    2258899999998764331    2344578999999999974 


Q ss_pred             -ccCCCCeeeEEchhHHHHHHHh-cCCCC
Q psy3714          73 -YQMYDYSLDMWSLGCMLASMIF-RKEPF   99 (467)
Q Consensus        73 -~~~~~~~~D~ws~G~~l~~~l~-g~~~~   99 (467)
                       ...++.++|||||||++++|++ |..||
T Consensus       202 ~~~~~t~~~DiwSlG~il~ellt~g~~pf  230 (432)
T 3p23_A          202 CKENPTYTVDIFSAGCVFYYVISEGSHPF  230 (432)
T ss_dssp             ---CCCTHHHHHHHHHHHHHHHTTSCBTT
T ss_pred             cccCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence             2445678999999999999999 76666

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.81  E-value=9.5e-21  Score=186.70  Aligned_cols=99  Identities=24%  Similarity=0.440  Sum_probs=82.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC--cccccccccccccccccccc-cCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLADY-QMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~-~~~~~   78 (467)
                      .++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++......  .....+||+.|+|||.+.+. ..++.
T Consensus       163 ~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  241 (355)
T 1vzo_A          163 IYVGEIVLALEHLHKLGIIYRDIKLENILLDS-NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK  241 (355)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CT
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCc
Confidence            57889999999999999999999999999984 4589999999998654322  22345789999999998752 34678


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      ++|+|||||++|+|++|+.||..
T Consensus       242 ~~DvwslG~il~ell~g~~pf~~  264 (355)
T 1vzo_A          242 AVDWWSLGVLMYELLTGASPFTV  264 (355)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTSC
T ss_pred             hhhHHHHHHHHHHHHHCCCCCcc
Confidence            99999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.81  E-value=8.7e-21  Score=181.09  Aligned_cols=101  Identities=18%  Similarity=0.312  Sum_probs=84.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCc-------EEEEecccceecCCCCccccccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRK-------LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ   74 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~-------~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~   74 (467)
                      +|+.||+.||.|||++||+||||||+|||++..+..       +||+|||++.....   .....++..|+|||.+.+..
T Consensus       117 ~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~  193 (289)
T 4fvq_A          117 EVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPK  193 (289)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGG
T ss_pred             HHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCC
Confidence            589999999999999999999999999999865421       99999999875532   23345788899999998656


Q ss_pred             CCCCeeeEEchhHHHHHHHhcCCCCCCCCCC
Q psy3714          75 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDN  105 (467)
Q Consensus        75 ~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~  105 (467)
                      .++.++|+|||||++++|++|+.|++...+.
T Consensus       194 ~~~~~~DiwslG~il~el~~g~~~~~~~~~~  224 (289)
T 4fvq_A          194 NLNLATDKWSFGTTLWEICSGGDKPLSALDS  224 (289)
T ss_dssp             GCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             CCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence            6888999999999999999987777765443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.81  E-value=1.8e-20  Score=177.86  Aligned_cols=97  Identities=34%  Similarity=0.710  Sum_probs=84.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEe--cCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~--~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.||+.||+|||++||+||||||+|||+.  ..+..+||+|||++.............+|+.|+|||.+.+  .++.+
T Consensus       110 ~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~  187 (277)
T 3f3z_A          110 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPE  187 (277)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTT
T ss_pred             HHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc--cCCch
Confidence            5899999999999999999999999999992  2445899999999988766555566689999999999864  37889


Q ss_pred             eeEEchhHHHHHHHhcCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +|+|||||++++|++|..||.
T Consensus       188 ~Di~slG~~l~~l~~g~~p~~  208 (277)
T 3f3z_A          188 CDEWSAGVMMYVLLCGYPPFS  208 (277)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSC
T ss_pred             hhehhHHHHHHHHHHCCCCCC
Confidence            999999999999999998884

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.81  E-value=8e-21  Score=184.94  Aligned_cols=99  Identities=34%  Similarity=0.631  Sum_probs=67.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCC--cEEEEecccceecCCC-CcccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~--~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      .|+.||+.||+|||++||+||||||+|||++..+.  .+||+|||+++..... ......++|+.|+|||.+.+ ..++.
T Consensus       110 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~  188 (325)
T 3kn6_A          110 YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDE  188 (325)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------------------CCCCH
T ss_pred             HHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcC-CCCCC
Confidence            58999999999999999999999999999985432  7999999999876433 23445678999999999975 55888


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      ++|+|||||++++|++|..||..
T Consensus       189 ~~DiwslG~il~~ll~g~~pf~~  211 (325)
T 3kn6_A          189 SCDLWSLGVILYTMLSGQVPFQS  211 (325)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTC-
T ss_pred             ccchHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999853

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.81  E-value=9.4e-21  Score=187.93  Aligned_cols=105  Identities=21%  Similarity=0.346  Sum_probs=76.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc-----ccccccccccccccccccccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYFKGPELLADYQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~   76 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......     .....++..|+|||.+.+ ..+
T Consensus       196 ~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~  273 (373)
T 3c1x_A          196 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKF  273 (373)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECCC---------------------CCGGGSCHHHHHH-CCC
T ss_pred             HHHHHHHHHHHHHHHCCEecCccchheEEECC-CCCEEEeeccccccccccccccccccCCCCCcccccChHHhcC-CCC
Confidence            57899999999999999999999999999984 45899999999986533221     122356678999999875 557


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHH
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ  108 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~  108 (467)
                      +.++|+|||||++|+|++|+.|++.+.+..+.
T Consensus       274 ~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~  305 (373)
T 3c1x_A          274 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI  305 (373)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH
T ss_pred             CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH
Confidence            88999999999999999966666655544433

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.81  E-value=1.3e-20  Score=185.62  Aligned_cols=97  Identities=20%  Similarity=0.386  Sum_probs=81.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+++......   ......+|..|+|||.+.+ ..++.
T Consensus       197 ~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~  274 (359)
T 3vhe_A          197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTI  274 (359)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCChhhEEEcC-CCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC-CCCCc
Confidence            58899999999999999999999999999984 4589999999998654322   2234567888999999875 55788


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCC
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      ++|||||||++++|++ |..||.
T Consensus       275 ~~Di~slG~il~ellt~g~~p~~  297 (359)
T 3vhe_A          275 QSDVWSFGVLLWEIFSLGASPYP  297 (359)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCSST
T ss_pred             hhhhhhHHHHHHHHHhcCCCCCC
Confidence            9999999999999998 887774

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.81  E-value=3e-20  Score=177.34  Aligned_cols=97  Identities=25%  Similarity=0.556  Sum_probs=78.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEec--CCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~--~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.||+.||+|||++||+||||||+|||++.  .+..+||+|||+++............+++.|+|||.+.  ..++.+
T Consensus       128 ~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~  205 (285)
T 3is5_A          128 ELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK--RDVTFK  205 (285)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT--TCCCHH
T ss_pred             HHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc--cCCCcc
Confidence            58999999999999999999999999999953  23579999999998765544455567899999999985  347889


Q ss_pred             eeEEchhHHHHHHHhcCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +|+|||||++++|++|+.||.
T Consensus       206 ~Di~slG~il~~ll~g~~pf~  226 (285)
T 3is5_A          206 CDIWSAGVVMYFLLTGCLPFT  226 (285)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCeehHHHHHHHHHhCCCCCC
Confidence            999999999999999999884

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.81  E-value=9.9e-21  Score=184.25  Aligned_cols=97  Identities=22%  Similarity=0.494  Sum_probs=79.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----ccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......    .....+|..|+|||.+.+ ..++
T Consensus       155 ~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~  232 (325)
T 3kul_A          155 GMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS-NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFS  232 (325)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH-CEEC
T ss_pred             HHHHHHHHHHHHHHHCCeeCCCCCcceEEECC-CCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC-CCCC
Confidence            58999999999999999999999999999984 56899999999987643321    122345667999999975 4578


Q ss_pred             CeeeEEchhHHHHHHHh-cCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      .++|||||||++++|++ |..||.
T Consensus       233 ~~~Di~slG~il~ell~~g~~p~~  256 (325)
T 3kul_A          233 SASDVWSFGVVMWEVLAYGERPYW  256 (325)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             cHHHHHHHHHHHHHHHcCCCCCcc
Confidence            89999999999999998 888874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.81  E-value=1.8e-20  Score=192.92  Aligned_cols=108  Identities=27%  Similarity=0.618  Sum_probs=89.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC--CCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~--~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      .|+.||+.||.|||++||+||||||+|||++..  +..+||+|||+|+...........+||+.|+|||++.  ..++.+
T Consensus       140 ~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~  217 (494)
T 3lij_A          140 VIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR--KKYDEK  217 (494)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT--TCBCTH
T ss_pred             HHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc--ccCCCc
Confidence            589999999999999999999999999999743  2359999999998876655556678999999999986  347899


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      +|+||+||++|+|++|..||. +.+..+.+..+
T Consensus       218 ~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i  249 (494)
T 3lij_A          218 CDVWSIGVILFILLAGYPPFG-GQTDQEILRKV  249 (494)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHH
Confidence            999999999999999998874 44443444443

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.81  E-value=3e-20  Score=176.03  Aligned_cols=102  Identities=29%  Similarity=0.540  Sum_probs=85.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||+|||++||+||||||+||+++. ++.+||+|||++.......   ......|+..|+|||.+.+...++.
T Consensus       109 ~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  187 (276)
T 2yex_A          109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE  187 (276)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHH
T ss_pred             HHHHHHHHHHHHHHhCCeeccCCChHHEEEcc-CCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCC
Confidence            58999999999999999999999999999984 4589999999998653221   2334578899999999976554467


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHD  104 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~  104 (467)
                      ++|+|||||++++|++|..||.....
T Consensus       188 ~~Di~slG~il~~l~~g~~p~~~~~~  213 (276)
T 2yex_A          188 PVDVWSCGIVLTAMLAGELPWDQPSD  213 (276)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred             cchHHHHHHHHHHHHhCCCCCCCCch
Confidence            89999999999999999999865443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.80  E-value=1.5e-20  Score=182.53  Aligned_cols=98  Identities=24%  Similarity=0.401  Sum_probs=83.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......   ......|++.|+|||.+.+ ..++.
T Consensus       143 ~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~  220 (321)
T 2qkw_B          143 EICIGAARGLHYLHTRAIIHRDVKSINILLDE-NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK-GRLTE  220 (321)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCSTTEEECT-TCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH-CBCCT
T ss_pred             HHHHHHHHHHHHhcCCCeecCCCCHHHEEECC-CCCEEEeecccccccccccccccccccCCCccccCHHHhcC-CCCCc
Confidence            58999999999999999999999999999984 5689999999998653221   2234468899999999875 45788


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      ++|+|||||++++|++|+.||..
T Consensus       221 ~~Di~slG~il~ell~g~~p~~~  243 (321)
T 2qkw_B          221 KSDVYSFGVVLFEVLCARSAIVQ  243 (321)
T ss_dssp             HHHHHHHHHHHHHHHHCCTTCSC
T ss_pred             ccchHhHHHHHHHHHhCCCcccc
Confidence            99999999999999999999864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.80  E-value=2.4e-20  Score=178.75  Aligned_cols=108  Identities=20%  Similarity=0.343  Sum_probs=87.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-----cccccccccccccccccccccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-----EYNVRVASRYFKGPELLADYQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~   76 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......     ......++..|+|||.+.+ ..+
T Consensus       128 ~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~  205 (298)
T 3pls_A          128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDE-SFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRF  205 (298)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCC
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCCcceEEEcC-CCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc-CCC
Confidence            57899999999999999999999999999984 4589999999997553321     1233466788999999975 457


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHH
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR  111 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~  111 (467)
                      +.++|+|||||++++|++|+.|++.+.+..+....
T Consensus       206 ~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~  240 (298)
T 3pls_A          206 TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF  240 (298)
T ss_dssp             CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH
T ss_pred             ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH
Confidence            88999999999999999988888776655444433

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.80  E-value=4.6e-21  Score=191.84  Aligned_cols=100  Identities=20%  Similarity=0.381  Sum_probs=84.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEe---cCCCcEEEEecccceecCCCCcccccccccccccccccccc-----
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMID---HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY-----   73 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~---~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~-----   73 (467)
                      +|+.||+.||+|||++||+||||||+|||+.   ..+..+||+|||+++............||..|+|||.+.+.     
T Consensus       116 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  195 (396)
T 4eut_A          116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKD  195 (396)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--C
T ss_pred             HHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccc
Confidence            5899999999999999999999999999982   13346999999999987655555566789999999998641     


Q ss_pred             --cCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          74 --QMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        74 --~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                        ..++.++|+|||||++|+|++|+.||..
T Consensus       196 ~~~~~~~~~DiwSlG~il~el~tg~~Pf~~  225 (396)
T 4eut_A          196 HQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             cccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence              3467789999999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.80  E-value=1e-20  Score=183.99  Aligned_cols=96  Identities=25%  Similarity=0.503  Sum_probs=80.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-------------ccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-------------EYNVRVASRYFKGPE   68 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-------------~~~~~~~~~~~~~pe   68 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......             ......||+.|+|||
T Consensus       168 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  246 (332)
T 3qd2_B          168 HIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE  246 (332)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred             HHHHHHHHHHHHHHhCCeeecCCCcccEEEeC-CCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence            58999999999999999999999999999984 4589999999998765431             123357899999999


Q ss_pred             ccccccCCCCeeeEEchhHHHHHHHhcCCCC
Q psy3714          69 LLADYQMYDYSLDMWSLGCMLASMIFRKEPF   99 (467)
Q Consensus        69 ~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~   99 (467)
                      .+.+ ..++.++|+|||||++++|++|..|+
T Consensus       247 ~~~~-~~~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          247 QIHG-NNYSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             HHHC-CCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             HhcC-CCCcchhhHHHHHHHHHHHHHcCCCh
Confidence            9976 45789999999999999999986554

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.80  E-value=2e-20  Score=181.72  Aligned_cols=101  Identities=26%  Similarity=0.468  Sum_probs=85.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCC--CcEEEEecccceecCCCCcccccccccccccccccc--cccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA--DYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~--~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~   77 (467)
                      .++.||+.||+|||++||+||||||+|||++..+  ..+||+|||+++............|++.|+|||.+.  ....++
T Consensus       118 ~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  197 (322)
T 2ycf_A          118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN  197 (322)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCT
T ss_pred             HHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCC
Confidence            5789999999999999999999999999998543  249999999998775544344567899999999974  235578


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFFHG  102 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~~~  102 (467)
                      .++|+|||||++++|++|..||...
T Consensus       198 ~~~Di~slG~il~~l~~g~~pf~~~  222 (322)
T 2ycf_A          198 RAVDCWSLGVILFICLSGYPPFSEH  222 (322)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCST
T ss_pred             chhhHHHHHHHHHHHHhCCCCCccc
Confidence            8999999999999999999998643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.80  E-value=5.2e-20  Score=175.60  Aligned_cols=102  Identities=18%  Similarity=0.353  Sum_probs=83.6

Q ss_pred             hHHHHHHHHHHHHHhCC--CcccCCCCCcEEEecCCC----cEEEEecccceecCCCCccccccccccccccccccc-cc
Q psy3714           2 RIATGASMALDYCHSMG--IMHRDVKPHNVMIDHENR----KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD-YQ   74 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~--iiHrDlkp~Nil~~~~~~----~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~-~~   74 (467)
                      +++.||+.||+|||++|  |+||||||+|||++..+.    .+||+|||+++....  ......|++.|+|||.+.. ..
T Consensus       126 ~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~  203 (287)
T 4f0f_A          126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEE  203 (287)
T ss_dssp             HHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSC
T ss_pred             HHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCC
Confidence            58999999999999999  999999999999984431    399999999985433  3445678999999999842 24


Q ss_pred             CCCCeeeEEchhHHHHHHHhcCCCCCCCCCC
Q psy3714          75 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDN  105 (467)
Q Consensus        75 ~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~  105 (467)
                      .++.++|+|||||++|+|++|+.||......
T Consensus       204 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  234 (287)
T 4f0f_A          204 SYTEKADTYSFAMILYTILTGEGPFDEYSYG  234 (287)
T ss_dssp             EECHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred             CcCchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence            4677899999999999999999998644333

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.80  E-value=1.7e-20  Score=178.54  Aligned_cols=106  Identities=24%  Similarity=0.390  Sum_probs=74.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      .++.||+.||+|||++||+||||||+|||++.. +.+||+|||+++.......  .....+++.|+|||.+.. ..++.+
T Consensus       120 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  197 (281)
T 1mp8_A          120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSA  197 (281)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC-------------------CCGGGCCHHHHHH-CCCSHH
T ss_pred             HHHHHHHHHHHHHHhCCeecccccHHHEEECCC-CCEEECccccccccCcccccccccCCCcccccChhhccc-CCCCCc
Confidence            578999999999999999999999999999954 5899999999987643322  223355678999999875 557889


Q ss_pred             eeEEchhHHHHHHHh-cCCCCCCCCCCHHHHH
Q psy3714          80 LDMWSLGCMLASMIF-RKEPFFHGHDNYDQLV  110 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~~  110 (467)
                      +|+|||||+++++++ |..||. +.+..+...
T Consensus       198 ~Di~slG~~l~ell~~g~~pf~-~~~~~~~~~  228 (281)
T 1mp8_A          198 SDVWMFGVCMWEILMHGVKPFQ-GVKNNDVIG  228 (281)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHH
T ss_pred             cCchHHHHHHHHHHhcCCCCCC-cCCHHHHHH
Confidence            999999999999997 777764 444433333

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.80  E-value=6.3e-21  Score=185.39  Aligned_cols=99  Identities=28%  Similarity=0.421  Sum_probs=83.0

Q ss_pred             hHHHHHHHHHHHHHhC----------CCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---cccccccccccccc
Q psy3714           2 RIATGASMALDYCHSM----------GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE   68 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~----------~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe   68 (467)
                      +|+.||+.||.|||++          ||+||||||+|||++. ++.+||+|||+|+.......   .....||+.|+|||
T Consensus       125 ~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~-~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE  203 (322)
T 3soc_A          125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE  203 (322)
T ss_dssp             HHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT-TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC-CCeEEEccCCcccccccccCccccccCccCccccCHh
Confidence            6899999999999999          9999999999999984 45899999999987643322   23357899999999


Q ss_pred             ccccc----cCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          69 LLADY----QMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        69 ~~~~~----~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      .+.+.    ..++.++|||||||++|+|++|+.||..
T Consensus       204 ~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  240 (322)
T 3soc_A          204 VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG  240 (322)
T ss_dssp             HHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred             hcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence            98753    2345678999999999999999998853

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.80  E-value=2.4e-20  Score=182.79  Aligned_cols=110  Identities=29%  Similarity=0.575  Sum_probs=85.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCC-CcEEEEecccceecCCCC-----cccccccccccccccccccc-c
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHEN-RKLRLIDWGLAEFYHPGQ-----EYNVRVASRYFKGPELLADY-Q   74 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~-~~~kl~dfG~a~~~~~~~-----~~~~~~~~~~~~~pe~~~~~-~   74 (467)
                      +|+.||+.||+|||++||+||||||+|||++.++ ..+||+|||+++......     ......||+.|+|||.+.+. .
T Consensus       172 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  251 (345)
T 3hko_A          172 NIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE  251 (345)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred             HHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence            4899999999999999999999999999997433 279999999998653211     12445789999999998642 4


Q ss_pred             CCCCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          75 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        75 ~~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      .++.++|+|||||++++|++|+.||. +.+..+....+
T Consensus       252 ~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~~  288 (345)
T 3hko_A          252 SYGPKCDAWSAGVLLHLLLMGAVPFP-GVNDADTISQV  288 (345)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCC-CCChHHHHHHH
Confidence            57889999999999999999998884 44444444433

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.80  E-value=1.8e-20  Score=186.60  Aligned_cols=97  Identities=25%  Similarity=0.438  Sum_probs=81.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+......   ......++..|+|||.+.+ ..++.
T Consensus       195 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~  272 (382)
T 3tt0_A          195 SCAYQVARGMEYLASKKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTH  272 (382)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCH
T ss_pred             HHHHHHHHHHHHHHhCCEecCCCCcceEEEcC-CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCc
Confidence            68999999999999999999999999999984 4589999999998664322   1233456778999999976 55788


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCC
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      ++|||||||++++|++ |..||.
T Consensus       273 ~~DiwslG~il~ellt~g~~p~~  295 (382)
T 3tt0_A          273 QSDVWSFGVLLWEIFTLGGSPYP  295 (382)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSST
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999 777763

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.80  E-value=1.7e-20  Score=183.81  Aligned_cols=98  Identities=21%  Similarity=0.395  Sum_probs=82.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||++........   .....+++.|+|||.+.+ ..++.
T Consensus       176 ~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~  253 (344)
T 1rjb_A          176 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTI  253 (344)
T ss_dssp             HHHHHHHHHHHHHHHTTEEETTCSGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCChhhEEEcC-CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCCh
Confidence            48999999999999999999999999999994 55899999999986543322   233456778999999875 45788


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCCC
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFFH  101 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~~  101 (467)
                      ++|+|||||++++|++ |..||..
T Consensus       254 ~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          254 KSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             hHhHHHHHHHHHHHHcCCCCCccc
Confidence            9999999999999998 8777743

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.80  E-value=3.9e-20  Score=176.77  Aligned_cols=97  Identities=24%  Similarity=0.419  Sum_probs=83.4

Q ss_pred             hHHHHHHHHHHHHHhCC--CcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~--iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +++.||+.||.|||++|  |+||||||+|||++..++.+||+|||++...... ......|++.|+|||.+.+  .++.+
T Consensus       133 ~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~  209 (290)
T 1t4h_A          133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDES  209 (290)
T ss_dssp             HHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTH
T ss_pred             HHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHhc--cCCCc
Confidence            58899999999999999  9999999999999755568999999999765433 3344578999999998863  47889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|+|||||++++|++|+.||..
T Consensus       210 ~Di~slG~~l~~l~~g~~pf~~  231 (290)
T 1t4h_A          210 VDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTT
T ss_pred             chHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999854

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.80  E-value=1.3e-20  Score=182.98  Aligned_cols=98  Identities=30%  Similarity=0.507  Sum_probs=84.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||+|||++||+||||||+|||++..++.+||+|||+++..... ......|++.|+|||.+.+...++.++|
T Consensus       153 ~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~D  231 (320)
T 3a99_A          153 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAA  231 (320)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccch
Confidence            588999999999999999999999999999855568999999999876543 3344578999999999876554567899


Q ss_pred             EEchhHHHHHHHhcCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~  100 (467)
                      +|||||++++|++|+.||.
T Consensus       232 i~slG~il~el~~g~~pf~  250 (320)
T 3a99_A          232 VWSLGILLYDMVCGDIPFE  250 (320)
T ss_dssp             HHHHHHHHHHHHHSSCSCC
T ss_pred             HHhHHHHHHHHHHCCCCCC
Confidence            9999999999999999884

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.80  E-value=3.8e-20  Score=178.58  Aligned_cols=98  Identities=27%  Similarity=0.415  Sum_probs=77.5

Q ss_pred             hHHHHHHHHHHHHHh---CCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHS---MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~---~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||+|||+   +||+||||||+|||++..+..+||+|||++......  .....||..|+|||.+.+ ..++.
T Consensus       106 ~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~  182 (307)
T 2eva_A          106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEG-SNYSE  182 (307)
T ss_dssp             HHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTC-CCCCT
T ss_pred             HHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCC-CCCCc
Confidence            578999999999999   899999999999999865545899999999765422  233468999999999975 45788


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHG  102 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~  102 (467)
                      ++|+|||||++++|++|+.||...
T Consensus       183 ~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          183 KCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             HHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             HHHHHHHHHHHHHHHHCCCCchhh
Confidence            999999999999999999998643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.80  E-value=2.8e-20  Score=192.03  Aligned_cols=108  Identities=27%  Similarity=0.642  Sum_probs=90.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCC--cEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~--~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.||+.||.|||++||+||||||+|||++..+.  .+||+|||+|+............||+.|+|||++.+  .++.+
T Consensus       150 ~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~  227 (504)
T 3q5i_A          150 NIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEK  227 (504)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTH
T ss_pred             HHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCch
Confidence            58999999999999999999999999999985442  699999999998766555666789999999999863  47889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      +|+||+||++|+|++|..||. +.+..+.+..+
T Consensus       228 ~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i  259 (504)
T 3q5i_A          228 CDVWSCGVIMYILLCGYPPFG-GQNDQDIIKKV  259 (504)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHH
Confidence            999999999999999998874 44444444443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.80  E-value=2.5e-20  Score=178.81  Aligned_cols=108  Identities=22%  Similarity=0.349  Sum_probs=86.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc-----ccccccccccccccccccccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYFKGPELLADYQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~   76 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......     .....+++.|+|||.+.+ ..+
T Consensus       132 ~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~  209 (298)
T 3f66_A          132 GFGLQVAKGMKYLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT-QKF  209 (298)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH-CCC
T ss_pred             HHHHHHHHHHHHHHhCCccCCCCchheEEECC-CCCEEECcccccccccccchhccccccCCCCCccccChHHhcC-CCC
Confidence            57899999999999999999999999999984 55899999999986543221     223456778999999975 457


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHH
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR  111 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~  111 (467)
                      +.++|+|||||+++++++|+.|++.+.+..+....
T Consensus       210 ~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~  244 (298)
T 3f66_A          210 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY  244 (298)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH
T ss_pred             ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence            88999999999999999977777766655444433

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.80  E-value=3.2e-20  Score=176.68  Aligned_cols=99  Identities=26%  Similarity=0.568  Sum_probs=85.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCC--CcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~--~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +++.||+.||+|||++||+||||||+||+++..+  ..+||+|||++.............|++.|+|||.+.+ ..++.+
T Consensus       109 ~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  187 (284)
T 3kk8_A          109 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKP  187 (284)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTT-CCBCTH
T ss_pred             HHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcC-CCCCcc
Confidence            5889999999999999999999999999997433  2499999999987765555555678999999999976 457889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|+|||||++++|++|..||..
T Consensus       188 ~Di~slG~~l~~l~~g~~pf~~  209 (284)
T 3kk8_A          188 VDIWACGVILYILLVGYPPFWD  209 (284)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cchHHHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999853

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.80  E-value=2.4e-20  Score=176.13  Aligned_cols=97  Identities=18%  Similarity=0.365  Sum_probs=80.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcc--cccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.||+.||.|||++||+||||||+||+++. ++.+||+|||+++........  ....++..|+|||.+.+ ..++.+
T Consensus       108 ~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  185 (268)
T 3sxs_A          108 EMCYDVCEGMAFLESHQFIHRDLAARNCLVDR-DLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY-FKYSSK  185 (268)
T ss_dssp             HHHHHHHHHHHHHHHTTEEESSCSGGGEEECT-TCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH-SEEETT
T ss_pred             HHHHHHHHHHHHHHHCCeecCCcCcceEEECC-CCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc-cCCchh
Confidence            58999999999999999999999999999984 458999999999876544322  22345567999999875 447889


Q ss_pred             eeEEchhHHHHHHHh-cCCCCC
Q psy3714          80 LDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      +|+|||||+++++++ |+.||.
T Consensus       186 ~Di~slG~il~~l~~~g~~p~~  207 (268)
T 3sxs_A          186 SDVWAFGILMWEVFSLGKMPYD  207 (268)
T ss_dssp             HHHHHHHHHHHHHHTTTCCTTT
T ss_pred             hhhHHHHHHHHHHHcCCCCCcc
Confidence            999999999999998 877763

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.80  E-value=1.9e-20  Score=190.45  Aligned_cols=95  Identities=20%  Similarity=0.428  Sum_probs=79.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....  .....++..|+|||.+.. ..++.++|
T Consensus       293 ~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~sD  368 (450)
T 1k9a_A          293 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE-KKFSTKSD  368 (450)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEECT-TSCEEECCCTTCEECC--------CCCTTTSCHHHHHS-SCCCHHHH
T ss_pred             HHHHHHHHHHHHHHhCCeeCCCCCHhhEEECC-CCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcC-CCCCcHHH
Confidence            58999999999999999999999999999984 458999999999865432  222356778999999975 55889999


Q ss_pred             EEchhHHHHHHHh-cCCCCC
Q psy3714          82 MWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        82 ~ws~G~~l~~~l~-g~~~~~  100 (467)
                      +|||||++|||++ |..||.
T Consensus       369 vwslG~~l~el~t~g~~P~~  388 (450)
T 1k9a_A          369 VWSFGILLWEIYSFGRVPYP  388 (450)
T ss_dssp             HHHHHHHHHHHHTTTCCSST
T ss_pred             HHHHHHHHHHHHhCCCCCCC
Confidence            9999999999998 877774

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.80  E-value=2.4e-20  Score=188.80  Aligned_cols=99  Identities=28%  Similarity=0.555  Sum_probs=78.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC------------CCcEEEEecccceecCCCCc-----cccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE------------NRKLRLIDWGLAEFYHPGQE-----YNVRVASRYF   64 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~------------~~~~kl~dfG~a~~~~~~~~-----~~~~~~~~~~   64 (467)
                      +|+.||+.||+|||++||+||||||+|||++..            +..+||+|||+|+.......     .....||+.|
T Consensus       119 ~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y  198 (434)
T 2rio_A          119 SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW  198 (434)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTT
T ss_pred             HHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCc
Confidence            489999999999999999999999999999742            24799999999987654321     2345789999


Q ss_pred             cccccccc------ccCCCCeeeEEchhHHHHHHHh-cCCCCC
Q psy3714          65 KGPELLAD------YQMYDYSLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        65 ~~pe~~~~------~~~~~~~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      +|||++.+      ...++.++|||||||++++|++ |..||.
T Consensus       199 ~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             SCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             cCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence            99999864      2457889999999999999998 777774

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.80  E-value=3.3e-20  Score=179.49  Aligned_cols=110  Identities=25%  Similarity=0.514  Sum_probs=79.3

Q ss_pred             hHHHHHHHHHHHHHhC-CCcccCCCCCcEEEecCCCcEEEEecccceecCCCCccccccccccccccccccc----ccCC
Q psy3714           2 RIATGASMALDYCHSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD----YQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~-~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~   76 (467)
                      +++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||++.............+++.|+|||.+..    ...+
T Consensus       128 ~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  206 (318)
T 2dyl_A          128 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY  206 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECT-TSCEEECCCTTC--------------CCTTCCHHHHC--------C
T ss_pred             HHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECC-CCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCC
Confidence            5899999999999995 9999999999999984 45899999999986654444445578999999999852    3457


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      +.++|+|||||++++|++|+.||.......+.+..+
T Consensus       207 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  242 (318)
T 2dyl_A          207 DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV  242 (318)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             ccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence            789999999999999999999986544444444433

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.80  E-value=5.7e-20  Score=179.63  Aligned_cols=97  Identities=25%  Similarity=0.544  Sum_probs=83.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.... ........|+..|+|||.+.+ ..++.++
T Consensus       145 ~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  222 (335)
T 2owb_A          145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEV  222 (335)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEECT-TCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHT-SCBCTHH
T ss_pred             HHHHHHHHHHHHHHHCCCEecCCCchhEEEcC-CCCEEEeeccCceecccCcccccccCCCccccCHHHhcc-CCCCchh
Confidence            58999999999999999999999999999984 45899999999987642 223445578999999999875 4578899


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+|||||++++|++|+.||.
T Consensus       223 Di~slG~il~~l~~g~~pf~  242 (335)
T 2owb_A          223 DVWSIGCIMYTLLVGKPPFE  242 (335)
T ss_dssp             HHHHHHHHHHHHHHSSCTTC
T ss_pred             hHHHHHHHHHHHHHCcCCCC
Confidence            99999999999999998884

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.80  E-value=5.1e-20  Score=177.73  Aligned_cols=97  Identities=21%  Similarity=0.413  Sum_probs=81.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.......   .....++..|+|||.+.+ ..++.
T Consensus       149 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~  226 (313)
T 1t46_A          149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTF  226 (313)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCccceEEEcC-CCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCCh
Confidence            58899999999999999999999999999984 46899999999987654332   223456778999999875 45788


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCC
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      ++|+|||||++++|++ |..||.
T Consensus       227 ~~Di~slG~il~ellt~g~~p~~  249 (313)
T 1t46_A          227 ESDVWSYGIFLWELFSLGSSPYP  249 (313)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCSST
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999998 777764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.80  E-value=1.7e-20  Score=186.41  Aligned_cols=97  Identities=23%  Similarity=0.422  Sum_probs=79.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcc---cccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++........   ....++..|+|||.+.. ..++.
T Consensus       217 ~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~-~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~  294 (377)
T 3cbl_A          217 QMVGDAAAGMEYLESKCCIHRDLAARNCLVTE-KNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY-GRYSS  294 (377)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH-CEEEH
T ss_pred             HHHHHHHHHHHHHHHCCcCCcccCHHHEEEcC-CCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc-CCCCc
Confidence            58999999999999999999999999999984 458999999999865432211   12234667999999875 45788


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCC
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      ++|+|||||++||+++ |..||.
T Consensus       295 ~~DvwslG~il~el~t~g~~p~~  317 (377)
T 3cbl_A          295 ESDVWSFGILLWETFSLGASPYP  317 (377)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSST
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999998 776663

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.80  E-value=4.2e-20  Score=175.54  Aligned_cols=96  Identities=29%  Similarity=0.567  Sum_probs=79.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.++|+|||++...... ......|+..|+|||.+.+ ..++.++|
T Consensus       113 ~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~-~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~D  189 (279)
T 3fdn_A          113 TYITELANALSYCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEG-RMHDEKVD  189 (279)
T ss_dssp             HHHHHHHHHHHHHHTTTCEECCCCGGGEEECT-TSCEEECSCCEESCC---------CCCCTTCCHHHHTT-CCCCTTHH
T ss_pred             HHHHHHHHHHHHHHhCCEecccCChHhEEEcC-CCCEEEEeccccccCCcc-cccccCCCCCccCHhHhcc-CCCCccch
Confidence            58899999999999999999999999999984 458999999998654332 2344578899999999875 55788999


Q ss_pred             EEchhHHHHHHHhcCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~  100 (467)
                      +||||+++++|++|..||.
T Consensus       190 i~slG~il~~l~~g~~p~~  208 (279)
T 3fdn_A          190 LWSLGVLCYEFLVGKPPFE  208 (279)
T ss_dssp             HHHHHHHHHHHHHSSCTTC
T ss_pred             hHhHHHHHHHHHHCCCCCC
Confidence            9999999999999998874

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.79  E-value=2.9e-20  Score=180.58  Aligned_cols=105  Identities=22%  Similarity=0.419  Sum_probs=77.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......   .....+++.|+|||.+.+ ..++.
T Consensus       141 ~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~  218 (323)
T 3qup_A          141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAE-DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTV  218 (323)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TSCEEECCCCC-----------------CCGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHcCCcccCCCCcceEEEcC-CCCEEEeeccccccccccccccccccccCcccccCchhhcC-CCCCC
Confidence            68999999999999999999999999999984 45899999999986543322   123345677999999875 45788


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCCCCCCCHHHH
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFFHGHDNYDQL  109 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~  109 (467)
                      ++|+|||||++++|++ |..|| .+.+..+..
T Consensus       219 ~~Di~slG~il~ell~~g~~p~-~~~~~~~~~  249 (323)
T 3qup_A          219 HSDVWAFGVTMWEIMTRGQTPY-AGIENAEIY  249 (323)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHH
T ss_pred             ccchhhHHHHHHHHHhCCCCCc-cccChHHHH
Confidence            9999999999999999 66665 444443333

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.79  E-value=4e-20  Score=178.70  Aligned_cols=105  Identities=20%  Similarity=0.413  Sum_probs=78.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.......   .....+++.|+|||.+.+ ..++.
T Consensus       151 ~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~  228 (313)
T 3brb_A          151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRD-DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTS  228 (313)
T ss_dssp             HHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT-TSCEEECSCSCC----------------CCGGGSCHHHHHS-SCCCH
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCCcceEEEcC-CCcEEEeecCcceecccccccCcccccCCCccccCchhhcC-CCccc
Confidence            68999999999999999999999999999984 45899999999986543221   223456778999999975 55788


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCCCCCCCHHHH
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFFHGHDNYDQL  109 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~  109 (467)
                      ++|+|||||++++|++ |..|| .+.+.....
T Consensus       229 ~~Di~slG~il~el~~~g~~p~-~~~~~~~~~  259 (313)
T 3brb_A          229 KSDVWAFGVTMWEIATRGMTPY-PGVQNHEMY  259 (313)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHH
T ss_pred             hhhhHHHHHHHHHHHhcCCCCC-ccCCHHHHH
Confidence            9999999999999999 65555 444443333

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.79  E-value=4.4e-20  Score=178.26  Aligned_cols=97  Identities=24%  Similarity=0.434  Sum_probs=81.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......   .....++..|+|||.+.+ ..++.
T Consensus       154 ~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~  231 (314)
T 2ivs_A          154 SFAWQISQGMQYLAEMKLVHRDLAARNILVAE-GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTT  231 (314)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECH
T ss_pred             HHHHHHHHHHHHHHHCCCcccccchheEEEcC-CCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCc
Confidence            58999999999999999999999999999994 55899999999987643322   123356778999999875 45788


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCC
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      ++|+|||||++++|++ |..||.
T Consensus       232 ~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          232 QSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSST
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999 877764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.79  E-value=7.4e-20  Score=175.09  Aligned_cols=100  Identities=27%  Similarity=0.466  Sum_probs=83.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-cccccccccccccccccccc-cCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADY-QMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~   79 (467)
                      .++.||+.||+|||++||+||||||+||+++..++.+||+|||+++...... ......|+..|+|||.+.+. ..++.+
T Consensus       126 ~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  205 (295)
T 2clq_A          126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA  205 (295)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHH
T ss_pred             HHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcH
Confidence            4789999999999999999999999999999646689999999998764322 23445788999999998653 236789


Q ss_pred             eeEEchhHHHHHHHhcCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|+|||||++++|++|+.||..
T Consensus       206 ~Di~slG~il~~l~~g~~pf~~  227 (295)
T 2clq_A          206 ADIWSLGCTIIEMATGKPPFYE  227 (295)
T ss_dssp             HHHHHHHHHHHHHHHTSCTTGG
T ss_pred             HHHHHHHHHHHHHHHCCCCccC
Confidence            9999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.79  E-value=1.7e-20  Score=179.69  Aligned_cols=97  Identities=20%  Similarity=0.442  Sum_probs=78.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----ccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +++.||+.||+|||++||+||||||+|||++.. +.+||+|||+++.......    .....++..|+|||.+.+ ..++
T Consensus       118 ~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  195 (295)
T 3ugc_A          118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFS  195 (295)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCSCC-------------CTTCGGGGCCHHHHHH-CCCC
T ss_pred             HHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC-CeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC-CCCC
Confidence            589999999999999999999999999999954 5899999999987643321    223356677999999875 4578


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      .++|+|||||+++++++|..|+.
T Consensus       196 ~~~Di~slG~~l~~l~~g~~~~~  218 (295)
T 3ugc_A          196 VASDVWSFGVVLYELFTYIEKSK  218 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCTTC
T ss_pred             hHHHHHHHHHHHHHHHhcccccC
Confidence            89999999999999999988874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.79  E-value=2.8e-20  Score=176.96  Aligned_cols=97  Identities=23%  Similarity=0.471  Sum_probs=85.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.............+++.|+|||.+.+ ..++.++|
T Consensus       126 ~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  203 (284)
T 2a19_B          126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVD-TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVD  203 (284)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE-TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHH
T ss_pred             HHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC-CCCEEECcchhheeccccccccccCCcccccChhhhcc-CCCcchhh
Confidence            58899999999999999999999999999995 45899999999987765544555678999999999875 45788999


Q ss_pred             EEchhHHHHHHHhcCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~  100 (467)
                      +|||||++++|++|..|++
T Consensus       204 i~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          204 LYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             HHHHHHHHHHHHSCCSSHH
T ss_pred             hHHHHHHHHHHHhcCCcch
Confidence            9999999999999988764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.79  E-value=5.4e-20  Score=174.96  Aligned_cols=98  Identities=20%  Similarity=0.398  Sum_probs=80.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +++.||+.||+|||++||+||||||+|||++.. +.+||+|||+++.......  .....++..|+|||.+.+ ..++.+
T Consensus       117 ~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  194 (281)
T 3cc6_A          117 LYSLQICKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTA  194 (281)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET-TEEEECCCCGGGCC---------CCCCCGGGCCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCccceEEECCC-CcEEeCccCCCcccccccccccccCCCCcceeCchhhcc-CCCCch
Confidence            578999999999999999999999999999854 5899999999986543321  233456778999999865 557889


Q ss_pred             eeEEchhHHHHHHHh-cCCCCCC
Q psy3714          80 LDMWSLGCMLASMIF-RKEPFFH  101 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~-g~~~~~~  101 (467)
                      +|+|||||++++|++ |+.||..
T Consensus       195 ~Di~slG~il~~llt~g~~p~~~  217 (281)
T 3cc6_A          195 SDVWMFAVCMWEILSFGKQPFFW  217 (281)
T ss_dssp             HHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             hccHHHHHHHHHHHhCCCCCccc
Confidence            999999999999998 9888853

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.79  E-value=2.6e-20  Score=176.06  Aligned_cols=102  Identities=19%  Similarity=0.402  Sum_probs=82.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +++.||+.||+|||++||+||||||+||+++.. +.+||+|||+++.......  .....++..|+|||.+.+ ..++.+
T Consensus       110 ~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  187 (269)
T 4hcu_A          110 GMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSK  187 (269)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-GCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHHHHhCCeecCCcchheEEEcCC-CCEEeccccccccccccccccccCcccccccCCHHHhcC-CCCCch
Confidence            588999999999999999999999999999854 5899999999986543221  222345667999999875 457889


Q ss_pred             eeEEchhHHHHHHHh-cCCCCCCCCCCH
Q psy3714          80 LDMWSLGCMLASMIF-RKEPFFHGHDNY  106 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~-g~~~~~~~~~~~  106 (467)
                      +|+||+||++++|++ |..|| .+.+..
T Consensus       188 ~Di~slG~~l~~ll~~g~~p~-~~~~~~  214 (269)
T 4hcu_A          188 SDVWSFGVLMWEVFSEGKIPY-ENRSNS  214 (269)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTT-TTCCHH
T ss_pred             hhhHHHHHHHHHHhcCCCCCC-CCCCHH
Confidence            999999999999999 77666 444333

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.79  E-value=1.1e-19  Score=174.12  Aligned_cols=97  Identities=24%  Similarity=0.521  Sum_probs=83.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-CcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... .......|+..|+|||.+.+ ..++.++
T Consensus       119 ~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~  196 (294)
T 2rku_A          119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEV  196 (294)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHH
T ss_pred             HHHHHHHHHHHHHHHCCccccCCChHhEEEcC-CCCEEEEeccCceecccCccccccccCCCCcCCcchhcc-CCCCchh
Confidence            58999999999999999999999999999984 458999999999876432 23344578899999999875 4578899


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+||||+++++|++|..||.
T Consensus       197 Di~slG~~l~~l~~g~~p~~  216 (294)
T 2rku_A          197 DVWSIGCIMYTLLVGKPPFE  216 (294)
T ss_dssp             HHHHHHHHHHHHHHSSCTTC
T ss_pred             hHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999998884

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.79  E-value=6.9e-20  Score=177.06  Aligned_cols=98  Identities=19%  Similarity=0.385  Sum_probs=82.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.......   .....++..|+|||.+.+ ..++.
T Consensus       152 ~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~  229 (316)
T 2xir_A          152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTI  229 (316)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHhCCcccccCccceEEECC-CCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccc
Confidence            57899999999999999999999999999984 45899999999986643322   233467788999999875 55788


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCCC
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFFH  101 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~~  101 (467)
                      ++|+|||||++++|++ |..||..
T Consensus       230 ~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          230 QSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999998 8777743

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.79  E-value=2.5e-20  Score=182.39  Aligned_cols=97  Identities=20%  Similarity=0.386  Sum_probs=80.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+++......   ......++..|+|||.+.+ ..++.
T Consensus       178 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~  255 (343)
T 1luf_A          178 CIARQVAAGMAYLSERKFVHRDLATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTT  255 (343)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCcceEEECC-CCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCc
Confidence            48999999999999999999999999999984 4589999999997653221   1233467888999999875 45788


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCC
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      ++|+|||||++|+|++ |..||.
T Consensus       256 ~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          256 ESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             ccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999998 887874

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.79  E-value=7e-20  Score=177.09  Aligned_cols=100  Identities=32%  Similarity=0.540  Sum_probs=78.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccc-----
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADY-----   73 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~-----   73 (467)
                      +++.||+.||.|||++||+||||||+|||++ + +.+||+|||+++.......   .....|++.|+|||.+.+.     
T Consensus       131 ~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  208 (313)
T 3cek_A          131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE  208 (313)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-T-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----
T ss_pred             HHHHHHHHHHHHHHHCCceecCCCcccEEEE-C-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccc
Confidence            5889999999999999999999999999997 3 5899999999986643321   2345689999999998641     


Q ss_pred             -----cCCCCeeeEEchhHHHHHHHhcCCCCCCCC
Q psy3714          74 -----QMYDYSLDMWSLGCMLASMIFRKEPFFHGH  103 (467)
Q Consensus        74 -----~~~~~~~D~ws~G~~l~~~l~g~~~~~~~~  103 (467)
                           ..++.++|+|||||++++|++|+.||....
T Consensus       209 ~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (313)
T 3cek_A          209 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  243 (313)
T ss_dssp             ------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence                 346778999999999999999999985443

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.79  E-value=3e-20  Score=180.65  Aligned_cols=97  Identities=29%  Similarity=0.411  Sum_probs=83.4

Q ss_pred             hHHHHHHHHHHHHHhC---CCcccCCCCCcEEEecCCCcEEEEecccceecCCCC--cccccccccccccccccccccCC
Q psy3714           2 RIATGASMALDYCHSM---GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLADYQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~---~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~   76 (467)
                      +|+.||+.||+|||++   ||+||||||+|||++. ++.+||+|||+++......  ......||+.|+|||.+.+ ..+
T Consensus       135 ~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~  212 (326)
T 3uim_A          135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKS  212 (326)
T ss_dssp             HHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT-TCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH-SEE
T ss_pred             HHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC-CCCEEeccCccccccCcccccccccccCCcCccCHHHhcc-CCC
Confidence            5899999999999999   9999999999999984 4589999999998764322  2334468999999999875 447


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +.++|+|||||++++|++|..||.
T Consensus       213 ~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          213 SEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             CHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             CccccchhHHHHHHHHHhCCCccc
Confidence            889999999999999999999983

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.79  E-value=3.1e-20  Score=184.26  Aligned_cols=98  Identities=24%  Similarity=0.514  Sum_probs=71.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--cc--ccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YN--VRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~--~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......  ..  ...++..|+|||.+.. ..++
T Consensus       151 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  228 (373)
T 2qol_A          151 GMLRGIASGMKYLSDMGYVHRDLAARNILINS-NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFT  228 (373)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECCC----------------------CTTSCHHHHHH-CCCC
T ss_pred             HHHHHHHHHHHHHHHCCeeCCCCCcceEEEcC-CCCEEECcCccccccccCCccceeccCCCcCCCccChhhhcc-CCcC
Confidence            58999999999999999999999999999984 56899999999987643221  11  1234567999999875 5578


Q ss_pred             CeeeEEchhHHHHHHHh-cCCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIF-RKEPFFH  101 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~-g~~~~~~  101 (467)
                      .++|+|||||++||+++ |+.||..
T Consensus       229 ~~~Dv~SlG~il~ellt~g~~P~~~  253 (373)
T 2qol_A          229 SASDVWSYGIVLWEVMSYGERPYWE  253 (373)
T ss_dssp             HHHHHHHHHHHHHHHHTTC-CTTTT
T ss_pred             chhcHHHHHHHHHHHHhCCCCCCCC
Confidence            89999999999999997 8888753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.79  E-value=7.5e-20  Score=174.03  Aligned_cols=98  Identities=29%  Similarity=0.541  Sum_probs=80.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCC---CcEEEEecccceecCCCCcccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHEN---RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~---~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||.|||++||+||||||+||+++..+   ..+||+|||++.............+++.|+|||.+.. ..++.
T Consensus       112 ~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~  190 (283)
T 3bhy_A          112 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY-EPLGL  190 (283)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTT-CCCCT
T ss_pred             HHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecC-CCCCc
Confidence            5899999999999999999999999999998543   2799999999987755444455678999999999875 45788


Q ss_pred             eeeEEchhHHHHHHHhcCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      ++|+||||+++++|++|..||.
T Consensus       191 ~~Di~slG~il~~l~~g~~p~~  212 (283)
T 3bhy_A          191 EADMWSIGVITYILLSGASPFL  212 (283)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTC
T ss_pred             chhhhhHHHHHHHHHHCCCCCC
Confidence            9999999999999999998874

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.78  E-value=4.4e-20  Score=187.89  Aligned_cols=108  Identities=21%  Similarity=0.411  Sum_probs=80.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......  .....++..|+|||.+.. ..++.+
T Consensus       284 ~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  361 (452)
T 1fmk_A          284 DMAAQIASGMAYVERMNYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIK  361 (452)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCCTTC--------------CCGGGSCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHHHHhCCeeCCCCChhhEEECC-CCCEEECCCccceecCCCceecccCCcccccccCHhHHhc-CCCCcc
Confidence            68999999999999999999999999999984 45899999999987643221  122345677999999875 457889


Q ss_pred             eeEEchhHHHHHHHh-cCCCCCCCCCCHHHHHHH
Q psy3714          80 LDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~~~~  112 (467)
                      +|||||||++|||++ |+.|| .+.+..+.+..+
T Consensus       362 sDvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i  394 (452)
T 1fmk_A          362 SDVWSFGILLTELTTKGRVPY-PGMVNREVLDQV  394 (452)
T ss_dssp             HHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHH
T ss_pred             ccHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHH
Confidence            999999999999999 77666 444444434333

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.78  E-value=4.7e-20  Score=179.44  Aligned_cols=99  Identities=27%  Similarity=0.481  Sum_probs=66.6

Q ss_pred             hHHHHHHHHHHHHHhC-CCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccc---cccCCC
Q psy3714           2 RIATGASMALDYCHSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA---DYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~-~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~   77 (467)
                      +++.|++.||.|||++ ||+||||||+|||++. ++.+||+|||+++............|++.|+|||.+.   ....++
T Consensus       129 ~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  207 (327)
T 3aln_A          129 KITLATVKALNHLKENLKIIHRDIKPSNILLDR-SGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYD  207 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEET-TTEEEECCCSSSCC------------------------------CC
T ss_pred             HHHHHHHHHHHHHhccCCEeECCCCHHHEEEcC-CCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCC
Confidence            5889999999999998 9999999999999984 5689999999998765444444457899999999983   234578


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      .++|+|||||++++|++|+.||..
T Consensus       208 ~~~Di~slG~il~~l~~g~~pf~~  231 (327)
T 3aln_A          208 VRSDVWSLGITLYELATGRFPYPK  231 (327)
T ss_dssp             SHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred             chhhHHHHHHHHHHHHHCCCCCCC
Confidence            899999999999999999999853

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.78  E-value=4e-20  Score=180.31  Aligned_cols=97  Identities=22%  Similarity=0.373  Sum_probs=80.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......   .....++..|+|||.+.+ ..++.
T Consensus       168 ~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~  245 (333)
T 2i1m_A          168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTN-GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTV  245 (333)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG-GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHhcCCcccCCcccceEEECC-CCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCCh
Confidence            57899999999999999999999999999985 45899999999986543221   223456778999999875 45788


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCC
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      ++|+|||||++++|++ |..||.
T Consensus       246 ~~Di~slG~il~el~t~g~~p~~  268 (333)
T 2i1m_A          246 QSDVWSYGILLWEIFSLGLNPYP  268 (333)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCSST
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCc
Confidence            9999999999999998 766664

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.78  E-value=4.6e-20  Score=179.00  Aligned_cols=100  Identities=20%  Similarity=0.390  Sum_probs=81.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.......   .....+++.|+|||.+.+ ..++.
T Consensus       142 ~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~  219 (322)
T 1p4o_A          142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTT  219 (322)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT-TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHHCCCccCCCccceEEEcC-CCeEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCc
Confidence            58899999999999999999999999999984 45899999999986533221   223456788999999875 45788


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCCCCCC
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFFHGHD  104 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~~~~~  104 (467)
                      ++|+|||||++++|++ |..|| .+.+
T Consensus       220 ~~Di~slG~il~el~~~g~~p~-~~~~  245 (322)
T 1p4o_A          220 YSDVWSFGVVLWEIATLAEQPY-QGLS  245 (322)
T ss_dssp             HHHHHHHHHHHHHHHHTSCCTT-TTSC
T ss_pred             hhhHHHHHHHHHHHHhcCCCcc-ccCC
Confidence            9999999999999999 66665 4443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.78  E-value=8e-20  Score=178.28  Aligned_cols=92  Identities=28%  Similarity=0.427  Sum_probs=75.7

Q ss_pred             hHHHHHHHHHHHHHhC--------CCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc-----cccccccccccccc
Q psy3714           2 RIATGASMALDYCHSM--------GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYFKGPE   68 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~--------~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~-----~~~~~~~~~~~~pe   68 (467)
                      +++.||+.||.|||++        ||+||||||+|||++. ++.+||+|||+++.......     .....||+.|+|||
T Consensus       138 ~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  216 (337)
T 3mdy_A          138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE  216 (337)
T ss_dssp             HHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT-TSCEEECCCTTCEECC---------CCSSCSCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC-CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChh
Confidence            6899999999999998        9999999999999984 45899999999976543322     12457899999999


Q ss_pred             ccccccCCCCe------eeEEchhHHHHHHHhc
Q psy3714          69 LLADYQMYDYS------LDMWSLGCMLASMIFR   95 (467)
Q Consensus        69 ~~~~~~~~~~~------~D~ws~G~~l~~~l~g   95 (467)
                      .+.+.. ++..      +|+|||||++|+|++|
T Consensus       217 ~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          217 VLDESL-NRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             HHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hccccc-CCccccCccccchHHHHHHHHHHHhc
Confidence            997643 3333      8999999999999999

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.78  E-value=3.6e-20  Score=195.93  Aligned_cols=101  Identities=19%  Similarity=0.393  Sum_probs=80.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----ccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      .|+.||+.||+|||++|||||||||+|||++.. +.+||+|||+|+.......    .....++..|+|||++.. ..++
T Consensus       473 ~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~  550 (635)
T 4fl3_A          473 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFS  550 (635)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC-------------CGGGSCHHHHHH-CCCC
T ss_pred             HHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC-CCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC-CCCC
Confidence            589999999999999999999999999999954 5899999999987643321    222345677999999975 5588


Q ss_pred             CeeeEEchhHHHHHHHh-cCCCCCCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIF-RKEPFFHGHDN  105 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~-g~~~~~~~~~~  105 (467)
                      .++|||||||++|||++ |+.||. +.+.
T Consensus       551 ~~sDvwSlGv~l~ellt~G~~Pf~-~~~~  578 (635)
T 4fl3_A          551 SKSDVWSFGVLMWEAFSYGQKPYR-GMKG  578 (635)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCSST-TCCH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCC-CCCH
Confidence            99999999999999998 887773 4433

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.78  E-value=4e-20  Score=180.22  Aligned_cols=98  Identities=28%  Similarity=0.531  Sum_probs=69.1

Q ss_pred             hHHHHHHHHHHHHHhCC--CcccCCCCCcEEEecCCCcEEEEecccceecCCCCcc-------------ccccccccccc
Q psy3714           2 RIATGASMALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-------------NVRVASRYFKG   66 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~--iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~-------------~~~~~~~~~~~   66 (467)
                      +|+.||+.||.|||++|  |+||||||+|||++. ++.+||+|||+++........             ....+++.|+|
T Consensus       140 ~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~a  218 (337)
T 3ll6_A          140 KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN-QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRT  218 (337)
T ss_dssp             HHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECT-TSCEEBCCCTTCBCCSSCC--------------------------
T ss_pred             HHHHHHHHHHHHHHhCCCCEEEccCCcccEEECC-CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCC
Confidence            68999999999999999  999999999999985 458999999999876432211             13468889999


Q ss_pred             ccccc--cccCCCCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          67 PELLA--DYQMYDYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        67 pe~~~--~~~~~~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      ||.+.  ....++.++|+|||||++++|++|+.||.
T Consensus       219 PE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  254 (337)
T 3ll6_A          219 PEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE  254 (337)
T ss_dssp             -----CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             hhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            99983  23456789999999999999999999984

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.78  E-value=4.3e-20  Score=175.02  Aligned_cols=98  Identities=29%  Similarity=0.578  Sum_probs=75.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.............+++.|+|||.+.+....+.++|
T Consensus       115 ~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  193 (276)
T 2h6d_A          115 RLFQQILSAVDYCHRHMVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVD  193 (276)
T ss_dssp             HHHHHHHHHHHHHHHHCSSCCCCCGGGEEECT-TSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCCccCCCChhhEEECC-CCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccch
Confidence            58999999999999999999999999999984 45899999999987655444455678899999999976544467899


Q ss_pred             EEchhHHHHHHHhcCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~  100 (467)
                      +||||+++++|++|..||.
T Consensus       194 i~slG~~l~~l~~g~~p~~  212 (276)
T 2h6d_A          194 IWSCGVILYALLCGTLPFD  212 (276)
T ss_dssp             HHHHHHHHHHHHHSSCSSC
T ss_pred             HHHHHHHHHHHHhCCCCCC
Confidence            9999999999999998884

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.78  E-value=4e-20  Score=190.35  Aligned_cols=101  Identities=23%  Similarity=0.418  Sum_probs=82.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcc--cccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      .|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++........  ....++..|+|||.+.. ..++.+
T Consensus       322 ~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  399 (495)
T 1opk_A          322 YMATQISSAMEYLEKKNFIHRNLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIK  399 (495)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECG-GGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHH-CEECHH
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCChhhEEECC-CCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhc-CCCCcH
Confidence            57899999999999999999999999999984 458999999999876543221  22234567999999875 457889


Q ss_pred             eeEEchhHHHHHHHh-cCCCCCCCCCC
Q psy3714          80 LDMWSLGCMLASMIF-RKEPFFHGHDN  105 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~-g~~~~~~~~~~  105 (467)
                      +|||||||++|||++ |..|| .+.+.
T Consensus       400 sDvwSlG~~l~el~t~g~~p~-~~~~~  425 (495)
T 1opk_A          400 SDVWAFGVLLWEIATYGMSPY-PGIDL  425 (495)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSS-TTCCG
T ss_pred             HhHHhHHHHHHHHHhCCCCCC-CCCCH
Confidence            999999999999998 76665 44443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.78  E-value=3.7e-20  Score=179.18  Aligned_cols=100  Identities=30%  Similarity=0.563  Sum_probs=78.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCC--cEEEEecccceecCCCC--------cccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR--KLRLIDWGLAEFYHPGQ--------EYNVRVASRYFKGPELLA   71 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~--~~kl~dfG~a~~~~~~~--------~~~~~~~~~~~~~pe~~~   71 (467)
                      .++.||+.||+|||++||+||||||+|||++..+.  .+||+|||+++......        .....+||+.|+|||.+.
T Consensus       115 ~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  194 (316)
T 2ac3_A          115 VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE  194 (316)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhh
Confidence            58899999999999999999999999999985442  39999999987653211        122346899999999986


Q ss_pred             c----ccCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          72 D----YQMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        72 ~----~~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      .    ...++.++|+|||||++++|++|+.||..
T Consensus       195 ~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  228 (316)
T 2ac3_A          195 AFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG  228 (316)
T ss_dssp             HTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence            4    13367899999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.78  E-value=3.6e-20  Score=176.34  Aligned_cols=97  Identities=19%  Similarity=0.399  Sum_probs=80.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.......  .....++..|+|||.+.+ ..++.+
T Consensus       124 ~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  201 (283)
T 3gen_A          124 EMCKDVCEAMEYLESKQFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSK  201 (283)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT-TSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH-CCCSHH
T ss_pred             HHHHHHHHHHHHHHHCCccCCCCccceEEEcC-CCCEEEccccccccccccccccccCCccCcccCCHHHhcc-CCCCch
Confidence            58999999999999999999999999999984 45899999999986543211  122345677999999975 457889


Q ss_pred             eeEEchhHHHHHHHh-cCCCCC
Q psy3714          80 LDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      +|+|||||++++|++ |+.||.
T Consensus       202 ~Dv~slG~~l~~l~t~g~~p~~  223 (283)
T 3gen_A          202 SDIWAFGVLMWEIYSLGKMPYE  223 (283)
T ss_dssp             HHHHHHHHHHHHHHTTTCCTTT
T ss_pred             hhHHHHHHHHHHHHhCCCCCcc
Confidence            999999999999998 877774

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.78  E-value=3.9e-20  Score=177.62  Aligned_cols=99  Identities=25%  Similarity=0.551  Sum_probs=80.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC------cccccccccccccccccccccC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ------EYNVRVASRYFKGPELLADYQM   75 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~   75 (467)
                      +++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.......      ......|++.|+|||.+.....
T Consensus       125 ~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  203 (303)
T 2vwi_A          125 TILREVLEGLEYLHKNGQIHRDVKAGNILLGE-DGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG  203 (303)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT-TCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCChhhEEEcC-CCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccC
Confidence            58899999999999999999999999999984 4589999999987653221      1234568899999999875455


Q ss_pred             CCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          76 YDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        76 ~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      ++.++|+|||||++++|++|+.||..
T Consensus       204 ~~~~~Di~slG~il~~l~~g~~pf~~  229 (303)
T 2vwi_A          204 YDFKADIWSFGITAIELATGAAPYHK  229 (303)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            78899999999999999999998853

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.78  E-value=1.3e-19  Score=173.77  Aligned_cols=98  Identities=26%  Similarity=0.572  Sum_probs=85.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCccccccccccccccccccc-----ccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD-----YQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~   76 (467)
                      +++.||+.||+|||++||+||||||+||+++. ++.+||+|||++.............++..|+|||.+.+     ...+
T Consensus       128 ~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~  206 (298)
T 1phk_A          128 KIMRALLEVICALHKLNIVHRDLKPENILLDD-DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY  206 (298)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCB
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCcceEEEcC-CCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccC
Confidence            58999999999999999999999999999984 45899999999988765555556678999999999852     3446


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +.++|+|||||++++|++|..||.
T Consensus       207 ~~~~Di~slG~~l~~l~~g~~p~~  230 (298)
T 1phk_A          207 GKEVDMWSTGVIMYTLLAGSPPFW  230 (298)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CcccccHhHHHHHHHHHHCCCCCc
Confidence            789999999999999999998885

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.78  E-value=1e-19  Score=176.20  Aligned_cols=97  Identities=25%  Similarity=0.426  Sum_probs=78.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC------CCccccccccccccccccccc---
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP------GQEYNVRVASRYFKGPELLAD---   72 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~------~~~~~~~~~~~~~~~pe~~~~---   72 (467)
                      +|+.||+.||+|||++||+||||||+|||++ + +.+||+|||+++....      ........|+..|+|||.+..   
T Consensus       134 ~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  211 (319)
T 2y4i_B          134 QIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-N-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP  211 (319)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSC
T ss_pred             HHHHHHHHHHHHHHhCCccccCCChhhEEEe-C-CCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccc
Confidence            5899999999999999999999999999997 3 4899999999875421      112234468889999999864   


Q ss_pred             -----ccCCCCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          73 -----YQMYDYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        73 -----~~~~~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                           ...++.++|+|||||++++|++|+.||.
T Consensus       212 ~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  244 (319)
T 2y4i_B          212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFK  244 (319)
T ss_dssp             C--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSS
T ss_pred             cccccccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                 2346788999999999999999999884

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.78  E-value=1.1e-19  Score=174.71  Aligned_cols=98  Identities=29%  Similarity=0.498  Sum_probs=82.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC---Cccccccccccccccccccccc-CCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLADYQ-MYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~---~~~~~~~~~~~~~~pe~~~~~~-~~~   77 (467)
                      +++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......   .......|+..|+|||.+.+.. .++
T Consensus       113 ~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  191 (305)
T 2wtk_C          113 GYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTT-GGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSG  191 (305)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEES
T ss_pred             HHHHHHHHHHHHHHHCCeeecCCCcccEEEcC-CCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCc
Confidence            58899999999999999999999999999984 458999999999876432   2234456889999999987532 236


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      .++|+|||||++++|++|..||.
T Consensus       192 ~~~Di~slG~il~~l~~g~~p~~  214 (305)
T 2wtk_C          192 FKVDIWSAGVTLYNITTGLYPFE  214 (305)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             chhhHHHHHHHHHHHHhCCCCCC
Confidence            68999999999999999998874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.78  E-value=5.3e-20  Score=173.90  Aligned_cols=97  Identities=28%  Similarity=0.534  Sum_probs=76.2

Q ss_pred             hHHHHHHHHHHHHHhCC---CcccCCCCCcEEEecC-------CCcEEEEecccceecCCCCcccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMG---IMHRDVKPHNVMIDHE-------NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA   71 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~---iiHrDlkp~Nil~~~~-------~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~   71 (467)
                      +++.||+.||.|||++|   |+||||||+|||++..       ++.+||+|||+++...... .....|++.|+|||.+.
T Consensus       109 ~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~  187 (271)
T 3dtc_A          109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIR  187 (271)
T ss_dssp             HHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhc
Confidence            58899999999999999   9999999999999852       4579999999998654332 23457889999999987


Q ss_pred             cccCCCCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          72 DYQMYDYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        72 ~~~~~~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      + ..++.++|+|||||+++++++|+.||.
T Consensus       188 ~-~~~~~~~Di~slG~~l~~l~~g~~p~~  215 (271)
T 3dtc_A          188 A-SMFSKGSDVWSYGVLLWELLTGEVPFR  215 (271)
T ss_dssp             H-CCCSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred             c-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            5 457889999999999999999999885

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.78  E-value=8.1e-20  Score=192.66  Aligned_cols=108  Identities=17%  Similarity=0.326  Sum_probs=82.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----ccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.......    .....++..|+|||++.. ..++
T Consensus       440 ~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~  517 (613)
T 2ozo_A          440 ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFS  517 (613)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE-TTEEEECCCSTTTTCC--------------CCTTSCHHHHHH-CCCC
T ss_pred             HHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcC-CCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC-CCCC
Confidence            58999999999999999999999999999995 45899999999986543221    112234577999999975 5588


Q ss_pred             CeeeEEchhHHHHHHHh-cCCCCCCCCCCHHHHHHH
Q psy3714          78 YSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~~~~  112 (467)
                      .++|||||||++|||++ |+.||. +.+..+....+
T Consensus       518 ~~sDvwSlGv~l~ellt~G~~Pf~-~~~~~~~~~~i  552 (613)
T 2ozo_A          518 SRSDVWSYGVTMWEALSYGQKPYK-KMKGPEVMAFI  552 (613)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTT-TCCSHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCC-CCCHHHHHHHH
Confidence            99999999999999998 888774 44444444333

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.78  E-value=7e-20  Score=173.84  Aligned_cols=98  Identities=26%  Similarity=0.515  Sum_probs=65.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-CcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +++.||+.||+|||++||+||||||+||+++. ++.+||+|||++...... .......+++.|+|||.+.+ ..++.++
T Consensus       116 ~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~  193 (278)
T 3cok_A          116 HFMHQIITGMLYLHSHGILHRDLTLSNLLLTR-NMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR-SAHGLES  193 (278)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSSCCGGGEEECT-TCCEEECCCTTCEECC-----------------------------CT
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-CCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC-CCCCchh
Confidence            58999999999999999999999999999984 458999999999876432 22334578899999999875 4578899


Q ss_pred             eEEchhHHHHHHHhcCCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      |+|||||++++|++|+.||..
T Consensus       194 Di~slG~il~~l~~g~~p~~~  214 (278)
T 3cok_A          194 DVWSLGCMFYTLLIGRPPFDT  214 (278)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCC
T ss_pred             hHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999988853

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.78  E-value=1e-19  Score=177.70  Aligned_cols=97  Identities=20%  Similarity=0.466  Sum_probs=75.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----ccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.......    .....++..|+|||.+.+ ..++
T Consensus       151 ~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  228 (333)
T 1mqb_A          151 GMLRGIAAGMKYLANMNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFT  228 (333)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECCCCC-----------------CCCGGGSCHHHHHS-CCCC
T ss_pred             HHHHHHHHHHHHHHhCCeeCCCCChheEEECC-CCcEEECCCCcchhhccccccccccCCCCccccccCchhccc-CCCC
Confidence            58999999999999999999999999999984 56899999999986543221    112245677999999875 4578


Q ss_pred             CeeeEEchhHHHHHHHh-cCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      .++|+|||||+++++++ |..||.
T Consensus       229 ~~~Di~slG~il~ellt~g~~pf~  252 (333)
T 1mqb_A          229 SASDVWSFGIVMWEVMTYGERPYW  252 (333)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             chhhhHHHHHHHHHHHcCCCCCcc
Confidence            89999999999999998 888874

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.78  E-value=1.9e-19  Score=173.12  Aligned_cols=97  Identities=30%  Similarity=0.517  Sum_probs=83.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-cccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +++.||+.||.|||++||+||||||+||+++. ++.+||+|||++....... ......|+..|+|||.+.+ ..++.++
T Consensus       123 ~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~  200 (303)
T 3a7i_A          123 TILREILKGLDYLHSEKKIHRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKA  200 (303)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT-CCBCTHH
T ss_pred             HHHHHHHHHHHHHHHCCCccCCCChheEEECC-CCCEEEeecccceecCccccccCccCCCcCccCHHHHhc-CCCCchh
Confidence            58999999999999999999999999999984 4589999999998765432 2344578899999999975 4578899


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+|||||++++|++|..||.
T Consensus       201 Di~slG~il~~l~~g~~p~~  220 (303)
T 3a7i_A          201 DIWSLGITAIELARGEPPHS  220 (303)
T ss_dssp             HHHHHHHHHHHHHHSSCTTT
T ss_pred             hhHHHHHHHHHHccCCCCCC
Confidence            99999999999999998874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.78  E-value=1.5e-19  Score=174.51  Aligned_cols=105  Identities=32%  Similarity=0.599  Sum_probs=75.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-cccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++...... ......++..|+|||.+.+ ..++.++
T Consensus       140 ~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~  217 (310)
T 2wqm_A          140 KYFVQLCSALEHMHSRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKS  217 (310)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEECCC------------------CCSSCCHHHHTT-CCCCHHH
T ss_pred             HHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcC-CCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCC-CCCCchh
Confidence            58899999999999999999999999999984 4589999999998654322 2234568889999999875 4578899


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQ  108 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~  108 (467)
                      |+|||||++++|++|+.||.........
T Consensus       218 Dv~slG~il~~l~~g~~p~~~~~~~~~~  245 (310)
T 2wqm_A          218 DIWSLGCLLYEMAALQSPFYGDKMNLYS  245 (310)
T ss_dssp             HHHHHHHHHHHHHHSSCTTC---CCHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCcccchhHHH
Confidence            9999999999999999998654434333

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.78  E-value=1.5e-19  Score=175.64  Aligned_cols=98  Identities=28%  Similarity=0.509  Sum_probs=76.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-Cccccccccccccccccccc----ccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLAD----YQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~----~~~~   76 (467)
                      .|+.||+.||.|||++||+||||||+|||++. ++.+||+|||++...... .......|+..|+|||.+..    ...+
T Consensus       133 ~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  211 (326)
T 2x7f_A          133 YICREILRGLSHLHQHKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY  211 (326)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT-TCCEEECCCTTTC-------------CCGGGCCHHHHC--------C
T ss_pred             HHHHHHHHHHHHHHHCCccccCCcHHHEEEcC-CCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCC
Confidence            57899999999999999999999999999984 558999999998765432 12334578999999999862    2447


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +.++|+|||||++++|++|..||.
T Consensus       212 ~~~~Di~slG~il~~l~~g~~p~~  235 (326)
T 2x7f_A          212 DFKSDLWSLGITAIEMAEGAPPLC  235 (326)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CccchHHHHHHHHHHHHhCCCCCC
Confidence            788999999999999999998884

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.78  E-value=1.7e-19  Score=171.72  Aligned_cols=96  Identities=23%  Similarity=0.482  Sum_probs=83.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||+|||++||+||||||+||+++. ++.+||+|||++...... ......|+..|+|||.+.+ ..++.++|
T Consensus       118 ~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~D  194 (284)
T 2vgo_A          118 TFMEELADALHYCHERKVIHRDIKPENLLMGY-KGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEG-KTHDEKVD  194 (284)
T ss_dssp             HHHHHHHHHHHHHHTTTEECCCCSGGGEEECT-TCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTT-CCBCTTHH
T ss_pred             HHHHHHHHHHHHHHHCCceecCCCHHHEEEcC-CCCEEEecccccccCccc-ccccccCCCCcCCHHHhcc-CCCCcccc
Confidence            58899999999999999999999999999984 458999999999765432 2344578899999999876 45788999


Q ss_pred             EEchhHHHHHHHhcCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~  100 (467)
                      +||||+++++|++|..||.
T Consensus       195 i~slG~il~~l~~g~~pf~  213 (284)
T 2vgo_A          195 LWCAGVLCYEFLVGMPPFD  213 (284)
T ss_dssp             HHHHHHHHHHHHHSSCTTC
T ss_pred             hhhHHHHHHHHHHCCCCCC
Confidence            9999999999999998884

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.78  E-value=1.3e-19  Score=172.90  Aligned_cols=103  Identities=18%  Similarity=0.374  Sum_probs=83.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcc----cccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +++.||+.||.|||++||+||||||+||+++.. +.+||+|||+++........    ....++..|+|||.+.+ ..++
T Consensus       114 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  191 (287)
T 1u59_A          114 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFS  191 (287)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEEC
T ss_pred             HHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC-CCEEECcccceeeeccCcceeeccccccccccccCHHHhcc-CCCC
Confidence            689999999999999999999999999999854 58999999999876433221    22345778999999875 4578


Q ss_pred             CeeeEEchhHHHHHHHh-cCCCCCCCCCCHH
Q psy3714          78 YSLDMWSLGCMLASMIF-RKEPFFHGHDNYD  107 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~-g~~~~~~~~~~~~  107 (467)
                      .++|+|||||++++|++ |..||. +.+..+
T Consensus       192 ~~~Di~slG~il~ellt~g~~p~~-~~~~~~  221 (287)
T 1u59_A          192 SRSDVWSYGVTMWEALSYGQKPYK-KMKGPE  221 (287)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTT-TCCTHH
T ss_pred             chhhHHHHHHHHHHHHcCCCCCcc-cCCHHH
Confidence            89999999999999998 888874 333333

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.77  E-value=6.8e-20  Score=177.04  Aligned_cols=98  Identities=31%  Similarity=0.531  Sum_probs=84.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||+|||++||+||||||+||+++..++.+||+|||+++..... ......|+..|+|||.+.+....+.++|
T Consensus       143 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~D  221 (312)
T 2iwi_A          143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPAT  221 (312)
T ss_dssp             HHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccch
Confidence            589999999999999999999999999999855568999999999876543 3445578999999999876554455899


Q ss_pred             EEchhHHHHHHHhcCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~  100 (467)
                      +|||||+++++++|+.||.
T Consensus       222 i~slG~il~~l~~g~~pf~  240 (312)
T 2iwi_A          222 VWSLGILLYDMVCGDIPFE  240 (312)
T ss_dssp             HHHHHHHHHHHHHSSCSCC
T ss_pred             HHHHHHHHHHHHHCCCCCC
Confidence            9999999999999998884

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.77  E-value=8.2e-20  Score=173.82  Aligned_cols=96  Identities=21%  Similarity=0.253  Sum_probs=80.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC------------------CCcEEEEecccceecCCCCcccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE------------------NRKLRLIDWGLAEFYHPGQEYNVRVASRY   63 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~------------------~~~~kl~dfG~a~~~~~~~~~~~~~~~~~   63 (467)
                      +|+.||+.||+|||++||+||||||+|||++..                  ...+||+|||++.......   ...|++.
T Consensus       119 ~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~  195 (289)
T 1x8b_A          119 DLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSR  195 (289)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGG
T ss_pred             HHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCcc
Confidence            589999999999999999999999999999732                  2368999999998765332   3458899


Q ss_pred             cccccccccccCCCCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          64 FKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        64 ~~~pe~~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+|||.+.+...++.++|+|||||+++++++|..++.
T Consensus       196 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          196 FLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             GCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             ccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence            9999999865556679999999999999998876553

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.77  E-value=1.4e-19  Score=171.78  Aligned_cols=101  Identities=19%  Similarity=0.430  Sum_probs=82.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +++.||+.||+|||++||+||||||+||+++. ++.+||+|||++........  .....++..|+|||.+.+ ..++.+
T Consensus       113 ~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  190 (279)
T 1qpc_A          113 DMAAQIAEGMAFIEERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIK  190 (279)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHH
T ss_pred             HHHHHHHHHHHHHHHCCeeccCCCHhhEEEcC-CCCEEECCCcccccccCcccccccCCCCccCccChhhhcc-CCCCch
Confidence            68999999999999999999999999999984 55899999999987654322  122345677999999875 447889


Q ss_pred             eeEEchhHHHHHHHh-cCCCCCCCCCC
Q psy3714          80 LDMWSLGCMLASMIF-RKEPFFHGHDN  105 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~-g~~~~~~~~~~  105 (467)
                      +|+|||||++++|++ |..|| .+.+.
T Consensus       191 ~Di~slG~il~el~~~g~~p~-~~~~~  216 (279)
T 1qpc_A          191 SDVWSFGILLTEIVTHGRIPY-PGMTN  216 (279)
T ss_dssp             HHHHHHHHHHHHHHTTTCCSS-TTCCH
T ss_pred             hhhHHHHHHHHHHHhCCCCCC-cccCH
Confidence            999999999999999 77666 44333

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.77  E-value=1.3e-19  Score=176.82  Aligned_cols=97  Identities=23%  Similarity=0.398  Sum_probs=81.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.......   .....++..|+|||.+.+ ..++.
T Consensus       161 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~  238 (334)
T 2pvf_A          161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTH  238 (334)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECH
T ss_pred             HHHHHHHHHHHHHHhCCeeCCCCccceEEEcC-CCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcCh
Confidence            57899999999999999999999999999984 45899999999987654322   122355678999999875 44788


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCC
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      ++|+|||||++++|++ |..||.
T Consensus       239 ~~Di~slG~il~ellt~g~~p~~  261 (334)
T 2pvf_A          239 QSDVWSFGVLMWEIFTLGGSPYP  261 (334)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSST
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcC
Confidence            9999999999999999 777763

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.77  E-value=9.1e-20  Score=174.86  Aligned_cols=92  Identities=35%  Similarity=0.635  Sum_probs=73.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC---------------Cccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG---------------QEYNVRVASRYFKG   66 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~---------------~~~~~~~~~~~~~~   66 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....               .......|+..|+|
T Consensus       120 ~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~a  198 (303)
T 1zy4_A          120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA  198 (303)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEECCCCCCSCTTC-------------------------CTTSC
T ss_pred             HHHHHHHHHHHHHHhCCeecccCCHHhEEEcC-CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccC
Confidence            58899999999999999999999999999984 458999999999765321               12234568889999


Q ss_pred             ccccccccCCCCeeeEEchhHHHHHHHh
Q psy3714          67 PELLADYQMYDYSLDMWSLGCMLASMIF   94 (467)
Q Consensus        67 pe~~~~~~~~~~~~D~ws~G~~l~~~l~   94 (467)
                      ||.+.+...++.++|+|||||++|+|++
T Consensus       199 PE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          199 TEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             HHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             cccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            9999765568889999999999999997

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.77  E-value=3.8e-20  Score=180.12  Aligned_cols=97  Identities=21%  Similarity=0.375  Sum_probs=79.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++............++..|+|||.+.+ ..++.++|
T Consensus       146 ~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  223 (327)
T 1fvr_A          146 HFAADVARGMDYLSQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSD  223 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECG-GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHH
T ss_pred             HHHHHHHHHHHHHHhCCccCCCCccceEEEcC-CCeEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhc
Confidence            58999999999999999999999999999985 45899999999975432222333456778999999875 45788999


Q ss_pred             EEchhHHHHHHHh-cCCCCC
Q psy3714          82 MWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        82 ~ws~G~~l~~~l~-g~~~~~  100 (467)
                      +|||||++++|++ |+.||.
T Consensus       224 i~slG~il~ellt~g~~pf~  243 (327)
T 1fvr_A          224 VWSYGVLLWEIVSLGGTPYC  243 (327)
T ss_dssp             HHHHHHHHHHHHTTSCCTTT
T ss_pred             chHHHHHHHHHHcCCCCCCC
Confidence            9999999999998 888874

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.77  E-value=1.5e-19  Score=172.42  Aligned_cols=97  Identities=30%  Similarity=0.691  Sum_probs=83.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCC--CcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHEN--RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~--~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +++.||+.||.|||++||+||||||+||+++..+  ..+||+|||++.............+++.|+|||.+.+  .++.+
T Consensus       125 ~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~  202 (287)
T 2wei_A          125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEK  202 (287)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTH
T ss_pred             HHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC--CCCCc
Confidence            6899999999999999999999999999997533  3699999999987655444455578889999999864  37889


Q ss_pred             eeEEchhHHHHHHHhcCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +|+||||+++++|++|..||.
T Consensus       203 ~Di~slG~~l~~l~~g~~p~~  223 (287)
T 2wei_A          203 CDVWSAGVILYILLSGTPPFY  223 (287)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSC
T ss_pred             hhhHhHHHHHHHHHhCCCCCC
Confidence            999999999999999998885

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.77  E-value=1.4e-19  Score=173.14  Aligned_cols=97  Identities=20%  Similarity=0.420  Sum_probs=80.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcc----cccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +++.||+.||+|||++||+||||||+|||++.. +.+||+|||+++........    ....++..|+|||.+.+ ..++
T Consensus       121 ~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  198 (291)
T 1xbb_A          121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFS  198 (291)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEE
T ss_pred             HHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC-CcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc-CCCC
Confidence            689999999999999999999999999999954 58999999999876543221    22345677999999875 4477


Q ss_pred             CeeeEEchhHHHHHHHh-cCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      .++|+|||||++++|++ |..||.
T Consensus       199 ~~~Di~slG~il~~l~~~g~~p~~  222 (291)
T 1xbb_A          199 SKSDVWSFGVLMWEAFSYGQKPYR  222 (291)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             hhhhHHHHHHHHHHHHhcCCCCCC
Confidence            89999999999999999 888774

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.77  E-value=3.9e-19  Score=171.76  Aligned_cols=97  Identities=27%  Similarity=0.513  Sum_probs=83.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-cccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +++.||+.||.|||++||+||||||+||+++. ++.+||+|||++....... ......|+..|+|||.+.+ ..++.++
T Consensus       129 ~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~  206 (314)
T 3com_A          129 TILQSTLKGLEYLHFMRKIHRDIKAGNILLNT-EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVA  206 (314)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS-SCBCTTH
T ss_pred             HHHHHHHHHHHHHHhCCCcCCCcCHHHEEECC-CCCEEEeecccchhhhhhccccCccCCCCCccChhhcCC-CCCCccc
Confidence            58999999999999999999999999999985 4589999999998664332 2344578899999999876 4578899


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+|||||++++|++|..||.
T Consensus       207 Di~slG~il~~l~~g~~p~~  226 (314)
T 3com_A          207 DIWSLGITAIEMAEGKPPYA  226 (314)
T ss_dssp             HHHHHHHHHHHHHHSSCTTT
T ss_pred             cHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999998885

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.77  E-value=2.7e-19  Score=175.54  Aligned_cols=99  Identities=30%  Similarity=0.547  Sum_probs=84.5

Q ss_pred             hHHHHHHHHHHHHHh-CCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCC-e
Q psy3714           2 RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDY-S   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~-~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~   79 (467)
                      +++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++...... ......++..|+|||.+.+...++. +
T Consensus       155 ~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~  232 (348)
T 2pml_X          155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK-NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAK  232 (348)
T ss_dssp             HHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT-TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHH
T ss_pred             HHHHHHHHHHHHHhccCCEeecCCChHhEEEcC-CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcch
Confidence            589999999999999 99999999999999984 458999999999876543 3445678899999999986534555 8


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHG  102 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~  102 (467)
                      +|+|||||++++|++|..||...
T Consensus       233 ~Di~slG~il~~l~~g~~pf~~~  255 (348)
T 2pml_X          233 VDIWSLGICLYVMFYNVVPFSLK  255 (348)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999888543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.77  E-value=1.6e-19  Score=173.85  Aligned_cols=97  Identities=25%  Similarity=0.385  Sum_probs=82.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.......   .....|++.|+|||.+.+  .++.
T Consensus       137 ~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~  213 (307)
T 2nru_A          137 KIAQGAANGINFLHENHHIHRDIKSANILLDE-AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITP  213 (307)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEECT-TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECT
T ss_pred             HHHHHHHHHHHHHhcCCeecCCCCHHHEEEcC-CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCc
Confidence            58999999999999999999999999999984 55899999999987643221   233468899999999864  3678


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      ++|+|||||++++|++|..||..
T Consensus       214 ~~Dv~slG~il~~l~~g~~p~~~  236 (307)
T 2nru_A          214 KSDIYSFGVVLLEIITGLPAVDE  236 (307)
T ss_dssp             HHHHHHHHHHHHHHHHCCCSBCT
T ss_pred             cchhHHHHHHHHHHHHCCCCccc
Confidence            99999999999999999888753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.77  E-value=1.8e-19  Score=173.37  Aligned_cols=98  Identities=30%  Similarity=0.582  Sum_probs=83.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEe--cCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMID--HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~--~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      .++.||+.||+|||++||+||||||+||++.  ..+..+||+|||+++..... ......|++.|+|||.+.+ ..++.+
T Consensus       110 ~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~  187 (304)
T 2jam_A          110 LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQ-KPYSKA  187 (304)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSS-CSCCHH
T ss_pred             HHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhcc-CCCCch
Confidence            5889999999999999999999999999993  14458999999999765432 2344578999999999975 557889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|+|||||++++|++|..||..
T Consensus       188 ~Di~slG~il~~l~~g~~pf~~  209 (304)
T 2jam_A          188 VDCWSIGVITYILLCGYPPFYE  209 (304)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTT
T ss_pred             hhHHHHHHHHHHHHHCCCCCCC
Confidence            9999999999999999988853

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.77  E-value=1.6e-19  Score=171.29  Aligned_cols=97  Identities=34%  Similarity=0.670  Sum_probs=80.3

Q ss_pred             hHHHHHHHHHHHHHhCC-----CcccCCCCCcEEEecCCCcEEEEecccceecCCCCc-ccccccccccccccccccccC
Q psy3714           2 RIATGASMALDYCHSMG-----IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLADYQM   75 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~-----iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~   75 (467)
                      +|+.||+.||+|||++|     |+||||||+|||++. ++.+||+|||+++....... .....++..|+|||.+.+ ..
T Consensus       115 ~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~  192 (279)
T 2w5a_A          115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR-MS  192 (279)
T ss_dssp             HHHHHHHHHHHHHHHHC------CCCCCSGGGEEECS-SSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC-C-
T ss_pred             HHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcC-CCCEEEecCchheeeccccccccccCCCccccChHHhcc-CC
Confidence            68999999999999999     999999999999984 45899999999986643322 234578889999999876 45


Q ss_pred             CCCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          76 YDYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        76 ~~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      ++.++|+|||||++++|++|..||.
T Consensus       193 ~~~~~Di~slG~il~~l~~g~~p~~  217 (279)
T 2w5a_A          193 YNEKSDIWSLGCLLYELCALMPPFT  217 (279)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCc
Confidence            7889999999999999999998874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.77  E-value=2e-19  Score=173.61  Aligned_cols=97  Identities=28%  Similarity=0.530  Sum_probs=73.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC--cccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......  ......++..|+|||.+.+ ..++.+
T Consensus       138 ~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  215 (309)
T 2h34_A          138 AIVRQIGSALDAAHAAGATHRDVKPENILVSA-DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYR  215 (309)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEECSCCC----------------CCGGGCCGGGTCC-----CC
T ss_pred             HHHHHHHHHHHHHHHCcCCcCCCChHHEEEcC-CCCEEEecCccCccccccccccccccCCCcCccCHHHHcC-CCCCch
Confidence            58999999999999999999999999999985 4589999999997654322  2234578899999999875 457889


Q ss_pred             eeEEchhHHHHHHHhcCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +|+|||||++++|++|+.||.
T Consensus       216 ~Di~slG~il~~l~~g~~pf~  236 (309)
T 2h34_A          216 ADIYALTCVLYECLTGSPPYQ  236 (309)
T ss_dssp             CHHHHHHHHHHHHHHSSCSSC
T ss_pred             HhHHHHHHHHHHHHHCCCCCC
Confidence            999999999999999998884

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.77  E-value=1.8e-19  Score=171.84  Aligned_cols=100  Identities=23%  Similarity=0.429  Sum_probs=81.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.||+.||+|||++||+||||||+||+++.. +.+||+|||++........  .....++..|+|||.+.+ ..++.+
T Consensus       115 ~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  192 (288)
T 3kfa_A          115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIK  192 (288)
T ss_dssp             HHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG-GCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC-CCEEEccCccceeccCCccccccCCccccCcCChhhhcc-CCCCch
Confidence            578999999999999999999999999999854 5899999999986643322  233456778999999875 457889


Q ss_pred             eeEEchhHHHHHHHh-cCCCCCCCCC
Q psy3714          80 LDMWSLGCMLASMIF-RKEPFFHGHD  104 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~-g~~~~~~~~~  104 (467)
                      +|+|||||++++|++ |..|| .+.+
T Consensus       193 ~Di~slG~il~~ll~~g~~p~-~~~~  217 (288)
T 3kfa_A          193 SDVWAFGVLLWEIATYGMSPY-PGID  217 (288)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSS-TTCC
T ss_pred             hhHHHHHHHHHHHHhCCCCCC-CCCC
Confidence            999999999999999 76666 4433

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.77  E-value=9.3e-20  Score=189.32  Aligned_cols=108  Identities=21%  Similarity=0.411  Sum_probs=84.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.||+.||+|||++||+||||||+|||++. +..+||+|||+++.......  .....++..|+|||.+.. ..++.+
T Consensus       367 ~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  444 (535)
T 2h8h_A          367 DMAAQIASGMAYVERMNYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIK  444 (535)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcC-CCcEEEcccccceecCCCceecccCCcCcccccCHHHhcc-CCCCch
Confidence            68999999999999999999999999999984 45899999999986543211  122345667999999875 457889


Q ss_pred             eeEEchhHHHHHHHh-cCCCCCCCCCCHHHHHHH
Q psy3714          80 LDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~~~~  112 (467)
                      +|||||||++|||++ |..|| .+....+.+..+
T Consensus       445 sDvwSlGv~l~el~t~g~~P~-~~~~~~~~~~~i  477 (535)
T 2h8h_A          445 SDVWSFGILLTELTTKGRVPY-PGMVNREVLDQV  477 (535)
T ss_dssp             HHHHHHHHHHHHHTTTTCCSS-TTCCHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHH
Confidence            999999999999999 77666 444444433333

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.76  E-value=8.6e-20  Score=177.60  Aligned_cols=97  Identities=21%  Similarity=0.453  Sum_probs=82.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----ccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +|+.||+.||+|||++||+||||||+|||++.. +.+||+|||+++.......    .....++..|+|||.+.+ ..++
T Consensus       131 ~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  208 (327)
T 3lxl_A          131 LYSSQICKGMEYLGSRRCVHRDLAARNILVESE-AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD-NIFS  208 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH-CEEE
T ss_pred             HHHHHHHHHHHHHHhCCccCCCCChhhEEECCC-CCEEEcccccceecccCCccceeeccCCccccccCHHHhcc-CCCC
Confidence            588999999999999999999999999999854 5899999999987653322    223457778999999875 4578


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      .++|+|||||++++|++|+.||.
T Consensus       209 ~~~Di~slG~il~~ll~g~~p~~  231 (327)
T 3lxl_A          209 RQSDVWSFGVVLYELFTYCDKSC  231 (327)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             hHHhHHHHHHHHHHHHhCCCCCc
Confidence            89999999999999999998875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.76  E-value=1.4e-19  Score=170.61  Aligned_cols=97  Identities=20%  Similarity=0.407  Sum_probs=79.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.......  .....++..|+|||.+.+ ..++.+
T Consensus       108 ~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  185 (267)
T 3t9t_A          108 GMCLDVCEGMAYLEEACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSK  185 (267)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSSCCGGGEEECG-GGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCchheEEECC-CCCEEEcccccccccccccccccccccccccccChhhhcC-CCccch
Confidence            58899999999999999999999999999984 45899999999986543211  122355677999999875 457889


Q ss_pred             eeEEchhHHHHHHHh-cCCCCC
Q psy3714          80 LDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      +|+||||+++++|++ |..||.
T Consensus       186 ~Di~slG~il~~l~~~g~~p~~  207 (267)
T 3t9t_A          186 SDVWSFGVLMWEVFSEGKIPYE  207 (267)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTT
T ss_pred             hchhhhHHHHHHHhccCCCCCC
Confidence            999999999999999 776663

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.76  E-value=2.3e-19  Score=175.49  Aligned_cols=93  Identities=26%  Similarity=0.390  Sum_probs=77.6

Q ss_pred             hHHHHHHHHHHHHH--------hCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc-----cccccccccccccc
Q psy3714           2 RIATGASMALDYCH--------SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYFKGPE   68 (467)
Q Consensus         2 ~i~~~i~~al~~lH--------~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~-----~~~~~~~~~~~~pe   68 (467)
                      +++.||+.||.|||        ++||+||||||+|||++. ++.+||+|||+++.......     .....|++.|+|||
T Consensus       143 ~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  221 (342)
T 1b6c_B          143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE  221 (342)
T ss_dssp             HHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT-TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC-CCCEEEEECCCceeccccccccccccccCCcCcccCCHh
Confidence            68999999999999        899999999999999985 45899999999987644321     23457899999999


Q ss_pred             ccccccC-----CCCeeeEEchhHHHHHHHhc
Q psy3714          69 LLADYQM-----YDYSLDMWSLGCMLASMIFR   95 (467)
Q Consensus        69 ~~~~~~~-----~~~~~D~ws~G~~l~~~l~g   95 (467)
                      .+.+...     ++.++|+|||||++|+|++|
T Consensus       222 ~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          222 VLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             HHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            9875422     22579999999999999999

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.76  E-value=7.6e-20  Score=175.70  Aligned_cols=96  Identities=24%  Similarity=0.453  Sum_probs=81.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----ccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +++.||+.||+|||++||+||||||+|||++.. +.+||+|||+++.......    .....++..|+|||.+.+ ..++
T Consensus       130 ~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  207 (302)
T 4e5w_A          130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFY  207 (302)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEE
T ss_pred             HHHHHHHHHHHHhhcCCcccCCCchheEEEcCC-CCEEECcccccccccCCCcceeccCCCCCCccccCCeeecC-CCCC
Confidence            588999999999999999999999999999854 5899999999987654332    233467778999999875 4467


Q ss_pred             CeeeEEchhHHHHHHHhcCCCC
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPF   99 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~   99 (467)
                      .++|+|||||++++|++|+.|+
T Consensus       208 ~~~Di~slG~il~~l~~g~~p~  229 (302)
T 4e5w_A          208 IASDVWSFGVTLHELLTYCDSD  229 (302)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCGG
T ss_pred             cchhHHHHHHHHHHHHHccCCC
Confidence            8899999999999999998875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.76  E-value=1.5e-19  Score=173.71  Aligned_cols=98  Identities=31%  Similarity=0.522  Sum_probs=78.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccc----cccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLA----DYQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~----~~~~~   76 (467)
                      .++.||+.||.|||++||+||||||+||+++. ++.+||+|||++..... ........|+..|+|||.+.    ....+
T Consensus       121 ~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  199 (302)
T 2j7t_A          121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL-EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY  199 (302)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT-TSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTT
T ss_pred             HHHHHHHHHHHHHhcCCcccCCCCHHHEEECC-CCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCC
Confidence            58899999999999999999999999999984 45899999998754311 11123346888999999984    23457


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +.++|+|||||++++|++|..||.
T Consensus       200 ~~~~Di~slG~il~~l~~g~~p~~  223 (302)
T 2j7t_A          200 DYKADIWSLGITLIEMAQIEPPHH  223 (302)
T ss_dssp             TTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             chhhhHHHHHHHHHHHhcCCCCCc
Confidence            789999999999999999998874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.76  E-value=2.4e-19  Score=190.26  Aligned_cols=108  Identities=26%  Similarity=0.430  Sum_probs=83.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......  .....++..|+|||.+.+ ..++.+
T Consensus       495 ~i~~qi~~aL~~LH~~givHrDikp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~  572 (656)
T 2j0j_A          495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSA  572 (656)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE-TTEEEECCCCCCCSCCC----------CCGGGCCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHHHHhCCccccccchHhEEEeC-CCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC-CCCCch
Confidence            57899999999999999999999999999995 45899999999987644322  123356678999999875 458889


Q ss_pred             eeEEchhHHHHHHHh-cCCCCCCCCCCHHHHHHH
Q psy3714          80 LDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~~~~  112 (467)
                      +|+|||||++|||++ |..|| .+.+..+.+..+
T Consensus       573 ~DiwSlG~il~ellt~g~~Pf-~~~~~~~~~~~i  605 (656)
T 2j0j_A          573 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRI  605 (656)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHH
Confidence            999999999999997 76666 444444444333

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.76  E-value=1.9e-19  Score=171.83  Aligned_cols=97  Identities=23%  Similarity=0.426  Sum_probs=79.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----ccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +++.||+.||.|||++||+||||||+||+++.. +.+||+|||+++.......    .....++..|+|||.+.+ ..++
T Consensus       125 ~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  202 (291)
T 1u46_A          125 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFS  202 (291)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEE
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCchheEEEcCC-CCEEEccccccccccccccchhhhccCCCCceeeCchhhcC-CCCC
Confidence            588999999999999999999999999999854 5899999999987654322    123456778999999875 4478


Q ss_pred             CeeeEEchhHHHHHHHh-cCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      .++|+|||||++++|++ |..||.
T Consensus       203 ~~~Di~slG~il~~l~~~g~~p~~  226 (291)
T 1u46_A          203 HASDTWMFGVTLWEMFTYGQEPWI  226 (291)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             chhhHHHHHHHHHHHHhCCCCCcc
Confidence            89999999999999999 887774

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.76  E-value=1.1e-19  Score=177.58  Aligned_cols=98  Identities=33%  Similarity=0.616  Sum_probs=66.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC--CCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~--~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.||+.||.|||++||+||||||+|||++..  +..+||+|||+++..... ......+++.|+|||.+.. ..++.+
T Consensus       132 ~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~  209 (336)
T 3fhr_A          132 EIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGP-EKYDKS  209 (336)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCC-CCCCch
Confidence            589999999999999999999999999999743  335999999999876533 2344578999999999865 457889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|+|||||++++|++|..||..
T Consensus       210 ~Di~slG~il~~l~~g~~pf~~  231 (336)
T 3fhr_A          210 CDMWSLGVIMYILLCGFPPFYS  231 (336)
T ss_dssp             HHHHHHHHHHHHHHHSSCCC--
T ss_pred             hhHHHHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999853

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.76  E-value=2.5e-19  Score=170.05  Aligned_cols=95  Identities=20%  Similarity=0.428  Sum_probs=74.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.||+.||+|||++||+||||||+||+++. ++.+||+|||+++.....  .....++..|+|||.+.+ ..++.++|
T Consensus       121 ~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~D  196 (278)
T 1byg_A          121 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE-KKFSTKSD  196 (278)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TSCEEECCCCC--------------CCTTTSCHHHHHH-CCCCHHHH
T ss_pred             HHHHHHHHHHHHHHhCCccccCCCcceEEEeC-CCcEEEeecccccccccc--ccCCCccccccCHHHhCC-CCCCchhc
Confidence            58899999999999999999999999999984 458999999998765432  223356778999999875 45788999


Q ss_pred             EEchhHHHHHHHh-cCCCCC
Q psy3714          82 MWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        82 ~ws~G~~l~~~l~-g~~~~~  100 (467)
                      +|||||++++|++ |..||.
T Consensus       197 i~slG~il~~l~t~g~~p~~  216 (278)
T 1byg_A          197 VWSFGILLWEIYSFGRVPYP  216 (278)
T ss_dssp             HHHHHHHHHHHHTTSCCSCT
T ss_pred             HHHHHHHHHHHHhCCCCCCC
Confidence            9999999999998 877764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.76  E-value=1.4e-19  Score=175.52  Aligned_cols=97  Identities=26%  Similarity=0.478  Sum_probs=81.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----ccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.......    .....++..|+|||.+.+ ..++
T Consensus       138 ~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  215 (318)
T 3lxp_A          138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFY  215 (318)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEE
T ss_pred             HHHHHHHHHHHHHHhCCccCCCCchheEEEcC-CCCEEECCccccccccccccccccccCCCCCceeeChHHhcC-CCCC
Confidence            58999999999999999999999999999984 45899999999987654322    223457778999999975 4467


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      .++|+|||||++++|++|+.||.
T Consensus       216 ~~~Di~slG~il~~ll~g~~p~~  238 (318)
T 3lxp_A          216 YASDVWSFGVTLYELLTHCDSSQ  238 (318)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             cHHHHHHHHHHHHHHHhCCCccc
Confidence            89999999999999999998874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.75  E-value=2.4e-19  Score=173.56  Aligned_cols=98  Identities=29%  Similarity=0.538  Sum_probs=80.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----------ccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----------YNVRVASRYFKGPELLA   71 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----------~~~~~~~~~~~~pe~~~   71 (467)
                      +++.||+.||.|||++||+||||||+|||++. ++.+||+|||++........          .....|++.|+|||.+.
T Consensus       138 ~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  216 (317)
T 2buj_A          138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS  216 (317)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSS
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC-CCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhc
Confidence            58999999999999999999999999999984 45899999999876532110          12345688999999986


Q ss_pred             ccc--CCCCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          72 DYQ--MYDYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        72 ~~~--~~~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      ...  .++.++|+|||||++++|++|..||.
T Consensus       217 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~  247 (317)
T 2buj_A          217 VQSHCVIDERTDVWSLGCVLYAMMFGEGPYD  247 (317)
T ss_dssp             CCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred             cCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence            432  25789999999999999999999884

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.75  E-value=7.5e-19  Score=165.72  Aligned_cols=94  Identities=22%  Similarity=0.365  Sum_probs=78.0

Q ss_pred             hHHHHHHHHHHHHHhCC--CcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccC--CC
Q psy3714           2 RIATGASMALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQM--YD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~--iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~--~~   77 (467)
                      +|+.||+.||.|||++|  |+||||||+|||++. ++.++++|||++.....    ....+|+.|+|||.+.+...  ++
T Consensus       115 ~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~-~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~  189 (271)
T 3kmu_A          115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE-DMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNR  189 (271)
T ss_dssp             HHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECT-TSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCH
T ss_pred             HHHHHHHHHHHHHhcCCCceecCCCccceEEEcC-CcceeEEeccceeeecc----cCccCCccccChhhhccCCCCCCC
Confidence            68999999999999999  999999999999984 45899999988754332    23467889999999876332  22


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      .++|+|||||++++|++|+.||.
T Consensus       190 ~~~Di~slG~il~el~~g~~p~~  212 (271)
T 3kmu_A          190 RSADMWSFAVLLWELVTREVPFA  212 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHCSCTTT
T ss_pred             chhhHHHHHHHHHHHHhCCCCcc
Confidence            37999999999999999998884

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.75  E-value=2.6e-19  Score=174.20  Aligned_cols=98  Identities=18%  Similarity=0.354  Sum_probs=79.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC--CCcEEEEecccceecCCCC---cccccccccccccccccccccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~--~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~   76 (467)
                      +++.||+.||.|||++||+||||||+|||++..  +..+||+|||+++......   ......++..|+|||.+.+ ..+
T Consensus       144 ~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~  222 (327)
T 2yfx_A          144 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIF  222 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCC
T ss_pred             HHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCC
Confidence            588999999999999999999999999999832  3369999999987543221   1233467888999999875 457


Q ss_pred             CCeeeEEchhHHHHHHHh-cCCCCC
Q psy3714          77 DYSLDMWSLGCMLASMIF-RKEPFF  100 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~-g~~~~~  100 (467)
                      +.++|+|||||++++|++ |..||.
T Consensus       223 ~~~~Di~slG~il~ellt~g~~p~~  247 (327)
T 2yfx_A          223 TSKTDTWSFGVLLWEIFSLGYMPYP  247 (327)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CchhhHHHHHHHHHHHHcCCCCCCC
Confidence            889999999999999998 766663

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.75  E-value=1.7e-19  Score=177.95  Aligned_cols=97  Identities=29%  Similarity=0.521  Sum_probs=81.0

Q ss_pred             hHHHHHHHHHHHHHhC-CCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~-~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +|+.||+.||.|||+. ||+||||||+|||++. ++.+||+|||++...... ......|++.|+|||.+.+ ..++.++
T Consensus       135 ~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~  211 (360)
T 3eqc_A          135 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYSVQS  211 (360)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT-TCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTT-CCCSHHH
T ss_pred             HHHHHHHHHHHHHHHhCCEEcCCccHHHEEECC-CCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcC-CCCCchh
Confidence            5889999999999995 9999999999999985 458999999998754321 2234578999999999976 4578899


Q ss_pred             eEEchhHHHHHHHhcCCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      |+|||||++++|++|+.||..
T Consensus       212 Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          212 DIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             HHHHHHHHHHHHHHTSCCSSC
T ss_pred             hHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999854

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.75  E-value=2e-19  Score=174.93  Aligned_cols=97  Identities=19%  Similarity=0.433  Sum_probs=81.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----ccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......    .....++..|+|||.+.+ ..++
T Consensus       149 ~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  226 (326)
T 2w1i_A          149 QYTSQICKGMEYLGTKRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFS  226 (326)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE-TTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEE
T ss_pred             HHHHHHHHHHHHHHhCCEeccCCCcceEEEcC-CCcEEEecCcchhhccccccccccccCCCCceeEECchhhcC-CCCC
Confidence            58899999999999999999999999999985 45899999999987654322    122356677999999875 4478


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      .++|+|||||++++|++|..|+.
T Consensus       227 ~~~Di~slG~il~el~tg~~~~~  249 (326)
T 2w1i_A          227 VASDVWSFGVVLYELFTYIEKSK  249 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCGGG
T ss_pred             chhhHHHHHHHHHHHHhcCCCCC
Confidence            89999999999999999988764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.75  E-value=1.9e-19  Score=175.87  Aligned_cols=92  Identities=21%  Similarity=0.312  Sum_probs=77.5

Q ss_pred             hHHHHHHHHHHHHH-hCCCcccCCCCCcEEEecCC-------------------CcEEEEecccceecCCCCcccccccc
Q psy3714           2 RIATGASMALDYCH-SMGIMHRDVKPHNVMIDHEN-------------------RKLRLIDWGLAEFYHPGQEYNVRVAS   61 (467)
Q Consensus         2 ~i~~~i~~al~~lH-~~~iiHrDlkp~Nil~~~~~-------------------~~~kl~dfG~a~~~~~~~~~~~~~~~   61 (467)
                      +|+.||+.||+||| ++||+||||||+|||++..+                   ..+||+|||+|+.....    ..+||
T Consensus       165 ~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt  240 (336)
T 2vuw_A          165 SILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFC  240 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECC
T ss_pred             HHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEe
Confidence            58999999999999 99999999999999999643                   27999999999876532    34789


Q ss_pred             cccccccccccccCCCCeeeEEchhHH-HHHHHhcCCCC
Q psy3714          62 RYFKGPELLADYQMYDYSLDMWSLGCM-LASMIFRKEPF   99 (467)
Q Consensus        62 ~~~~~pe~~~~~~~~~~~~D~ws~G~~-l~~~l~g~~~~   99 (467)
                      +.|+|||++.+..  +.++||||++++ .+++++|..||
T Consensus       241 ~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~  277 (336)
T 2vuw_A          241 DVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPY  277 (336)
T ss_dssp             CCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred             ecccChhhhcCCC--ccceehhhhhCCCCcccccccCCC
Confidence            9999999997643  779999998776 66677787776

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.75  E-value=1.2e-19  Score=189.40  Aligned_cols=91  Identities=24%  Similarity=0.195  Sum_probs=62.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-CcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+..... ....+.+||+.|++||.+.+.  +..++
T Consensus       343 ~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~-dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~  419 (569)
T 4azs_A          343 KILGSLLRSLAALEKQGFWHDDVRPWNVMVDA-RQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNG  419 (569)
T ss_dssp             HHHHHHHHHHHHHHHTTCEESCCCGGGEEECT-TSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC----------
T ss_pred             HHHHHHHHHHHHHHHCCceeccCchHhEEECC-CCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC--CCCcc
Confidence            58899999999999999999999999999985 458999999999876433 334567899999999999753  46689


Q ss_pred             eEEchhHHHHHHHhc
Q psy3714          81 DMWSLGCMLASMIFR   95 (467)
Q Consensus        81 D~ws~G~~l~~~l~g   95 (467)
                      |+||+|++++++.++
T Consensus       420 d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          420 FWRSAPVHPFNLPQP  434 (569)
T ss_dssp             ---------CCCCTT
T ss_pred             cccccccchhhhccc
Confidence            999999987776544

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	467
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-87
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-34
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-43
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-19
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-19
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-23
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-40
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-19
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-17
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-39
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-21
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-39
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-22
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-39
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-20
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-38
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-21
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-37
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-20
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-19
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-19
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-36
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-15
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-36
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-18
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-15
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-35
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-18
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-34
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-17
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-19
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-34
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-19
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-34
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-18
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-34
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-19
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-33
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-16
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-33
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-15
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-14
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-32
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-21
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-32
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-20
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-31
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-18
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-31
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-17
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-31
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-16
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-30
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-15
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-28
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-13
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-27
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-13
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-27
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-12
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-26
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-13
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-25
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-16
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-25
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-19
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-25
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-11
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-24
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-15
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-24
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-10
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-24
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-14
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-24
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-15
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-24
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-13
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-13
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-24
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-14
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-24
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-15
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-23
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-12
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-23
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-13
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-23
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-16
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-23
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-16
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-22
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-14
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-22
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-12
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-22
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-13
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-22
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-13
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-21
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-14
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-21
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-17
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-20
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-13
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-20
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-14
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-19
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-10
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-18
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-14
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-17
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-11
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-17
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-11
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-14
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-08

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  269 bits (687), Expect = 1e-87
 Identities = 238/323 (73%), Positives = 263/323 (81%), Gaps = 20/323 (6%)

Query: 142 RARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVV 201
           RARVY DVN+H+PREYWDYES+VV+WG QDDYQLVRKLGRGKYSEVFEAIN+ +++K VV
Sbjct: 6   RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65

Query: 202 KILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT 261
           KILKPVKKKKIKREIKILENLRGG NIITL  +VKDPVSRTPAL+FEHVNNTDFKQLYQT
Sbjct: 66  KILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT 125

Query: 262 LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE 321
           LTDYDIR+Y+YE+LKALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHPGQE
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185

Query: 322 YNVRVASRYFKGPELLADYQYH-------------IEL----DPRFADILGRHSRKRWER 364
           YNVRVASRYFKGPELL DYQ +               +    +P F          R  +
Sbjct: 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245

Query: 365 FVHTENQH---LVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRY 421
            + TE+ +         LD    +ILGRHSRKRWERFVH+ENQHLVSPEALDFLDKLLRY
Sbjct: 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305

Query: 422 DHYERLTAREAMDHPYFYPIVKD 444
           DH  RLTAREAM+HPYFY +VKD
Sbjct: 306 DHQSRLTAREAMEHPYFYTVVKD 328

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  129 bits (324), Expect = 2e-34
 Identities = 125/141 (88%), Positives = 131/141 (92%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS 61
                   ALDYCHSMGIMHRDVKPHNVMIDHE+RKLRLIDWGLAEFYHPGQEYNVRVAS
Sbjct: 133 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 192

Query: 62  RYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
           RYFKGPELL DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE+L
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252

Query: 122 FEYLDKYHIELDPRFADILGR 142
           ++Y+DKY+IELDPRF DILGR
Sbjct: 253 YDYIDKYNIELDPRFNDILGR 273

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  152 bits (386), Expect = 6e-43
 Identities = 62/301 (20%), Positives = 117/301 (38%), Gaps = 26/301 (8%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTN 227
           D Y +  +LG G +  V       + +    K +       K+ +++EI+ +  LR    
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PT 84

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQL----YQTLTDYDIRYYLYELLKALDYCHS 283
           ++ L    +D       +I+E ++  +  +     +  +++ +   Y+ ++ K L + H 
Sbjct: 85  LVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 284 MGIMHRDVKPHNVMID-HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
              +H D+KP N+M     + +L+LID+GL     P Q   V   +  F  PE+      
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 202

Query: 343 HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE 402
               D     +L          F    +   +         +N+           F    
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETL---------RNVKSCDWNMDDSAFSG-- 251

Query: 403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIVNSV 462
               +S +  DF+ KLL  D   R+T  +A++HP+  P         +PSS  T I +S+
Sbjct: 252 ----ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSI 307

Query: 463 P 463
            
Sbjct: 308 K 308

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 32/143 (22%), Positives = 57/143 (39%), Gaps = 8/143 (5%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMID-HENRKLRLIDWGLAEFYHPGQEYNVRV 59
           +         L + H    +H D+KP N+M     + +L+LID+GL     P Q   V  
Sbjct: 127 VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 186

Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
            +  F  PE+  + +   Y  DMWS+G +   ++    P F G ++ + L  +       
Sbjct: 187 GTAEFAAPEVA-EGKPVGYYTDMWSVGVLSYILLSGLSP-FGGENDDETLRNVKS----- 239

Query: 120 ELFEYLDKYHIELDPRFADILGR 142
             +   D     +     D + +
Sbjct: 240 CDWNMDDSAFSGISEDGKDFIRK 262

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  149 bits (376), Expect = 2e-41
 Identities = 65/301 (21%), Positives = 116/301 (38%), Gaps = 31/301 (10%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK---PVKKKKIKREIKILENLRGGTN 227
           D Y ++ +LG G +  V   +   +    V K +    P+ K  +K EI I+  L     
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PK 87

Query: 228 IITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKALDYCHS 283
           +I L    +D       LI E ++  +           +++ ++  Y+ +  + L + H 
Sbjct: 88  LINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 284 MGIMHRDVKPHNVMIDH-ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
             I+H D+KP N+M +  +   +++ID+GLA   +P +   V  A+  F  PE++     
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 205

Query: 343 HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE 402
               D     +LG      +                     K          +       
Sbjct: 206 GFYTDMWAIGVLG------YVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS----- 254

Query: 403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIVNSV 462
               VSPEA DF+  LL+ +  +RLT  +A++HP+            L S  P+   N +
Sbjct: 255 ----VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL-----KGDHSNLTSRIPSSRYNKI 305

Query: 463 P 463
            
Sbjct: 306 R 306

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 87.4 bits (216), Expect = 1e-19
 Identities = 34/142 (23%), Positives = 65/142 (45%), Gaps = 8/142 (5%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDH-ENRKLRLIDWGLAEFYHPGQEYNVRVA 60
                A   L + H   I+H D+KP N+M +  +   +++ID+GLA   +P +   V  A
Sbjct: 131 NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA 190

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +  F  PE++ D +   +  DMW++G +   ++    P F G D+ + L  + +      
Sbjct: 191 TAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSP-FAGEDDLETLQNVKRC----- 243

Query: 121 LFEYLDKYHIELDPRFADILGR 142
            +E+ +     + P   D +  
Sbjct: 244 DWEFDEDAFSSVSPEAKDFIKN 265

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 5e-41
 Identities = 71/310 (22%), Positives = 125/310 (40%), Gaps = 25/310 (8%)

Query: 169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNI 228
           Q+  Y   + +G G +  V++A    S +   +K +    K+   RE++I+  L    NI
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQIMRKLDH-CNI 75

Query: 229 ITLQAVVKDPVSRTP----ALIFEHVNNTDFKQL------YQTLTDYDIRYYLYELLKAL 278
           + L+        +       L+ ++V  T ++         QTL    ++ Y+Y+L ++L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP-ELL 337
            Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ P  + 
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195

Query: 338 ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLV----------SPEALDFLDKNIL 387
               Y   +D   A  +          F        +          + E +  ++ N  
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSR 447
                +          +    PEA+    +LL Y    RLT  EA  H +F  +      
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN-- 313

Query: 448 HTLPSSSPTP 457
             LP+   TP
Sbjct: 314 VKLPNGRDTP 323

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 1e-23
 Identities = 49/142 (34%), Positives = 73/142 (51%), Gaps = 1/142 (0%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
                    +L Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + 
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           SRY++ PEL+     Y  S+D+WS GC+LA ++  + P F G    DQLV I KVLGT  
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPT 243

Query: 121 LFEYLDKYHIELDPRFADILGR 142
             +  +      + +F  I   
Sbjct: 244 REQIREMNPNYTEFKFPQIKAH 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-40
 Identities = 56/287 (19%), Positives = 114/287 (39%), Gaps = 23/287 (8%)

Query: 160 YESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK---REI 216
           YE    D   +D ++++ +LG G + +V++A N ++S     K++    +++++    EI
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 217 KILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY----QTLTDYDIRYYLY 272
            IL +     NI+ L             ++ E         +     + LT+  I+    
Sbjct: 61  DILASCDH-PNIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 117

Query: 273 ELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYF 331
           + L AL+Y H   I+HRD+K  N++   +   ++L D+G++ +     Q  +  + + Y+
Sbjct: 118 QTLDALNYLHDNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYW 176

Query: 332 KGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS 391
             PE++             AD+        W   +       + P   +     +L + +
Sbjct: 177 MAPEVVMCETSKDRPYDYKADV--------WSLGITLIEMAEIEPPHHELNPMRVLLKIA 228

Query: 392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           +               S    DFL K L  +   R T  + + HP+ 
Sbjct: 229 KSEPPTLAQPSR---WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.8 bits (212), Expect = 2e-19
 Identities = 33/119 (27%), Positives = 57/119 (47%), Gaps = 7/119 (5%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRV 59
             +      AL+Y H   I+HRD+K  N++   +   ++L D+G++ +     Q  +  +
Sbjct: 113 QVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFI 171

Query: 60  ASRYFKGPELLADYQM----YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
            + Y+  PE++         YDY  D+WSLG  L  M   + P  H  +    L++IAK
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAK 229

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 6e-40
 Identities = 58/278 (20%), Positives = 114/278 (41%), Gaps = 23/278 (8%)

Query: 171 DDYQLVRK-LGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNII 229
           DDY++  + LG G   +V +  N ++ +K  +K+L+     K +RE+++        +I+
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 68

Query: 230 TLQAVVKDPVS--RTPALIFEHVNNTDFKQL-----YQTLTDYDIRYYLYELLKALDYCH 282
            +  V ++  +  +   ++ E ++  +          Q  T+ +    +  + +A+ Y H
Sbjct: 69  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 283 SMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           S+ I HRDVKP N++      N  L+L D+G A+             + Y+  PE+L   
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188

Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH 400
           +Y    D     ++       +  F       +             +    R     F +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------PGMKTRIRMGQYEFPN 238

Query: 401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            E    VS E    +  LL+ +  +R+T  E M+HP+ 
Sbjct: 239 PEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.5 bits (198), Expect = 3e-17
 Identities = 36/144 (25%), Positives = 62/144 (43%), Gaps = 5/144 (3%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVR 58
             I      A+ Y HS+ I HRDVKP N++      N  L+L D+G A+           
Sbjct: 114 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 173

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
             + Y+  PE+L   + YD S DMWSLG ++  ++    P F+ +        +   +  
Sbjct: 174 CYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPP-FYSNHGLAISPGMKTRIRM 231

Query: 119 EELFEYLDKYHIELDPRFADILGR 142
            + +E+ +    E+      ++  
Sbjct: 232 GQ-YEFPNPEWSEVSEEVKMLIRN 254

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 2e-39
 Identities = 53/301 (17%), Positives = 100/301 (33%), Gaps = 38/301 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK----PVKKKKIKREIKILENLRGGT 226
           DD++ + +LG G    VF+  +  S      K++     P  + +I RE+++L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SP 64

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYCHS 283
            I+              ++  EH++     Q+      + +  +      ++K L Y   
Sbjct: 65  YIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 284 M-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQY 342
              IMHRDVKP N++++     ++L D+G++         N  V +R +  PE L    Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHY 180

Query: 343 HIELD-------------------------PRFADILGRHSRKRWERFVHTENQHLVSPE 377
            ++ D                                                   +S  
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240

Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
            +D      +                  + S E  DF++K L  +  ER   ++ M H +
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300

Query: 438 F 438
            
Sbjct: 301 I 301

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.9 bits (225), Expect = 7e-21
 Identities = 32/159 (20%), Positives = 57/159 (35%), Gaps = 4/159 (2%)

Query: 1   MRIATGASMALDYCHSM-GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRV 59
            +++      L Y      IMHRDVKP N++++     ++L D+G++         N  V
Sbjct: 107 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM-ANSFV 164

Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
            +R +  PE L     Y    D+WS+G  L  M   + P         +L+   +V G  
Sbjct: 165 GTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223

Query: 120 ELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYW 158
                  +        +           ++  +   E  
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 6e-39
 Identities = 62/277 (22%), Positives = 116/277 (41%), Gaps = 33/277 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRG 224
           +D+++ R LG+GK+  V+ A   QS     +K+L   +      + +++RE++I  +LR 
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYC 281
             NI+ L     D       LI E+       +         +     Y+ EL  AL YC
Sbjct: 66  -PNILRLYGYFHDA--TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ 341
           HS  ++HRD+KP N+++      L++ D+G +  + P         +  +  PE++    
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGE-LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 180

Query: 342 YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT 401
           +  ++D     +L       +E  V              F        + R     F   
Sbjct: 181 HDEKVDLWSLGVL------CYEFLVGK----------PPFEANTYQETYKRISRVEFTFP 224

Query: 402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           +    V+  A D + +LL+++  +R   RE ++HP+ 
Sbjct: 225 DF---VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.3 bits (229), Expect = 9e-22
 Identities = 32/115 (27%), Positives = 58/115 (50%), Gaps = 4/115 (3%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
               T  + AL YCHS  ++HRD+KP N+++      L++ D+G +  + P         
Sbjct: 109 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWS-VHAPSSRRTTLCG 166

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
           +  +  PE++   +M+D  +D+WSLG +    +  K P F  +   +   RI++V
Sbjct: 167 TLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRV 219

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 8e-39
 Identities = 66/281 (23%), Positives = 121/281 (43%), Gaps = 37/281 (13%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTNI 228
           + Y +   LGRG++  V   +   S    + K +K     +  +K+EI IL   R   NI
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNI 63

Query: 229 ITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKALDYCHSM 284
           + L    +        +IFE ++  D  +   T    L + +I  Y++++ +AL + HS 
Sbjct: 64  LHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 285 GIMHRDVKPHNVMID-HENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYH 343
            I H D++P N++     +  +++I++G A    PG  + +   +  +  PE+       
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181

Query: 344 IELD------PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER 397
              D        +  + G +       F+   NQ ++         +NI+        E 
Sbjct: 182 TATDMWSLGTLVYVLLSGINP------FLAETNQQII---------ENIMNAEYTFDEEA 226

Query: 398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           F        +S EA+DF+D+LL  +   R+TA EA+ HP+ 
Sbjct: 227 FKE------ISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 29/143 (20%), Positives = 60/143 (41%), Gaps = 8/143 (5%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMID-HENRKLRLIDWGLAEFYHPGQEYNVRV 59
           +        AL + HS  I H D++P N++     +  +++I++G A    PG  + +  
Sbjct: 105 VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164

Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
            +  +  PE+   + +   + DMWSLG ++  ++    P F    N   +  I       
Sbjct: 165 TAPEYYAPEVH-QHDVVSTATDMWSLGTLVYVLLSGINP-FLAETNQQIIENIMN----- 217

Query: 120 ELFEYLDKYHIELDPRFADILGR 142
             + + ++   E+     D + R
Sbjct: 218 AEYTFDEEAFKEISIEAMDFVDR 240

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  138 bits (348), Expect = 3e-38
 Identities = 54/284 (19%), Positives = 108/284 (38%), Gaps = 27/284 (9%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------------KKKIKREIK 217
            ++Y+    LGRG  S V   I+  +  +  VKI+                ++   +E+ 
Sbjct: 2   YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61

Query: 218 ILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYEL 274
           IL  + G  NII L+   +        L+F+ +   +         TL++ + R  +  L
Sbjct: 62  ILRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119

Query: 275 LKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 334
           L+ +   H + I+HRD+KP N+++D +   ++L D+G +    PG++      +  +  P
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178

Query: 335 ELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR 394
           E++                +       +     +          +  +  +   +     
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238

Query: 395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
           W+           S    D + + L     +R TA EA+ HP+F
Sbjct: 239 WDD---------YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 91.3 bits (226), Expect = 3e-21
 Identities = 29/147 (19%), Positives = 62/147 (42%), Gaps = 12/147 (8%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
            +I       +   H + I+HRD+KP N+++D +   ++L D+G +    PG++      
Sbjct: 113 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCG 171

Query: 61  SRYFKGPELLA-----DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
           +  +  PE++      ++  Y   +DMWS G ++ +++    P F        L  I   
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHRKQMLMLRMI--- 227

Query: 116 LGTEELFEYLDKYHIELDPRFADILGR 142
                 +++      +      D++ R
Sbjct: 228 --MSGNYQFGSPEWDDYSDTVKDLVSR 252

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-37
 Identities = 58/280 (20%), Positives = 111/280 (39%), Gaps = 33/280 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGT 226
           +D+ LV+ LG G Y EV  A+N  + +   VKI+   +     + IK+EI I + L    
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 63

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHS 283
           N++      ++       L  E+ +  +     +    + + D + + ++L+  + Y H 
Sbjct: 64  NVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADY 340
           +GI HRD+KP N+++D  +  L++ D+GLA  +         N    +  +  PELL   
Sbjct: 122 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 341 QYHIELDPRFADI--LGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           ++H        D+   G                   S    ++ D            E+ 
Sbjct: 181 EFH----AEPVDVWSCG---IVLTAMLAGELPWDQPSDSCQEYSDWK----------EKK 223

Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
            +      +    L  L K+L  +   R+T  +     ++
Sbjct: 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.6 bits (214), Expect = 8e-20
 Identities = 32/135 (23%), Positives = 61/135 (45%), Gaps = 4/135 (2%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNV 57
            R        + Y H +GI HRD+KP N+++D  +  L++ D+GLA  +         N 
Sbjct: 106 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNK 164

Query: 58  RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
              +  +  PELL   + +   +D+WS G +L +M+  + P+    D+  +     +   
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224

Query: 118 TEELFEYLDKYHIEL 132
               ++ +D   + L
Sbjct: 225 YLNPWKKIDSAPLAL 239

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 8e-37
 Identities = 69/294 (23%), Positives = 126/294 (42%), Gaps = 24/294 (8%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCV-VKILKPVK-----KKKIKREIKILENLRG 224
             Y+ V ++G G Y +VF+A ++++  + V +K ++             RE+ +L +L  
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 225 GT--NIITLQAVVKDPVSRTPA---LIFEHVNNTDFKQLY----QTLTDYDIRYYLYELL 275
               N++ L  V     +       L+FEHV+      L       +    I+  +++LL
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 276 KALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 335
           + LD+ HS  ++HRD+KP N+++    +  +L D+GLA  Y         V + +++ PE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVVTLWYRAPE 185

Query: 336 LLADYQYHIELDPR-----FADILGRHSRKRWERFVHTENQHL---VSPEALDFLDKNIL 387
           +L    Y   +D       FA++  R    R    V    + L     P   D+     L
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 388 GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI 441
            R +          +    +     D L K L ++  +R++A  A+ HPYF  +
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.5 bits (213), Expect = 2e-19
 Identities = 39/130 (30%), Positives = 65/130 (50%), Gaps = 3/130 (2%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS 61
            +       LD+ HS  ++HRD+KP N+++    +  +L D+GLA  Y         V +
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVVT 178

Query: 62  RYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
            +++ PE+L     Y   +D+WS+GC+ A M  RK P F G  + DQL +I  V+G    
Sbjct: 179 LWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGLPGE 236

Query: 122 FEYLDKYHIE 131
            ++     + 
Sbjct: 237 EDWPRDVALP 246

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 9e-37
 Identities = 68/293 (23%), Positives = 125/293 (42%), Gaps = 27/293 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK----KKIKREIKILENLRGGT 226
             Y  +  +G G Y  V  A +  +  +  +K + P +     ++  REIKIL   R   
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-E 66

Query: 227 NIITLQAVVKDPVSRTPALIF--EHVNNTDFKQL--YQTLTDYDIRYYLYELLKALDYCH 282
           NII +  +++ P       ++   H+   D  +L   Q L++  I Y+LY++L+ L Y H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFKGPELLA 338
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++ 
Sbjct: 127 SANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 339 -DYQYHIELDPRFADIL------------GRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
               Y   +D      +            G+H   +    +                 K 
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245

Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                S     +            +ALD LDK+L ++ ++R+   +A+ HPY 
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.7 bits (211), Expect = 5e-19
 Identities = 40/134 (29%), Positives = 72/134 (53%), Gaps = 6/134 (4%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV---- 57
                    L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++      
Sbjct: 113 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTE 171

Query: 58  RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
            VA+R+++ PE++ + + Y  S+D+WS+GC+LA M+  + P F G    DQL  I  +LG
Sbjct: 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILG 230

Query: 118 TEELFEYLDKYHIE 131
           +    +     +++
Sbjct: 231 SPSQEDLNCIINLK 244

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (337), Expect = 2e-36
 Identities = 60/278 (21%), Positives = 114/278 (41%), Gaps = 27/278 (9%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP----VKKKKIKREIKILENLRGG 225
           +D Y     LG G +SEV  A + ++     +K +       K+  ++ EI +L  ++  
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH- 66

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYCH 282
            NI+ L  + +        LI + V+  +           T+ D    ++++L A+ Y H
Sbjct: 67  PNIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 283 SMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
            +GI+HRD+KP N++     E+ K+ + D+GL++   PG   +    +  +  PE+LA  
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 184

Query: 341 QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH 400
            Y   +D     ++       +         +  +   L               W+    
Sbjct: 185 PYSKAVDCWSIGVI------AYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD--- 235

Query: 401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                 +S  A DF+  L+  D  +R T  +A+ HP+ 
Sbjct: 236 ------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 75.5 bits (185), Expect = 1e-15
 Identities = 35/144 (24%), Positives = 68/144 (47%), Gaps = 9/144 (6%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVR 58
            R+      A+ Y H +GI+HRD+KP N++     E+ K+ + D+GL++   PG   +  
Sbjct: 110 SRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA 169

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
             +  +  PE+LA  + Y  ++D WS+G +   ++    P F+  ++     +I K    
Sbjct: 170 CGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPP-FYDENDAKLFEQILK---- 223

Query: 119 EELFEYLDKYHIELDPRFADILGR 142
              +E+   Y  ++     D +  
Sbjct: 224 -AEYEFDSPYWDDISDSAKDFIRH 246

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 4e-36
 Identities = 61/300 (20%), Positives = 122/300 (40%), Gaps = 38/300 (12%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP---VKKKKIKREIKILENLRGGT 226
           +  Y    K+G+G    V+ A++V +  +  ++ +      KK+ I  EI ++   +   
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-P 77

Query: 227 NIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY--QTLTDYDIRYYLYELLKALDYCHSM 284
           NI+               ++ E++       +     + +  I     E L+AL++ HS 
Sbjct: 78  NIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYH 343
            ++HRD+K  N+++  +   ++L D+G   +      + +  V + Y+  PE++    Y 
Sbjct: 136 QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193

Query: 344 IELDPRFADI--LGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT 401
               P+  DI  LG          +  E      P    +L++N L              
Sbjct: 194 ---GPK-VDIWSLG---------IMAIEMIEGEPP----YLNENPLRALYLIATNGTPEL 236

Query: 402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIVNS 461
           +N   +S    DFL++ L  D  +R +A+E + H +         +   P SS TP++ +
Sbjct: 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL--------KIAKPLSSLTPLIAA 288

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 29/114 (25%), Positives = 55/114 (48%), Gaps = 4/114 (3%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVA 60
            +      AL++ HS  ++HRD+K  N+++  +   ++L D+G   +      + +  V 
Sbjct: 120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVG 178

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           + Y+  PE++   + Y   +D+WSLG M   MI  + P +   +    L  IA 
Sbjct: 179 TPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPP-YLNENPLRALYLIAT 230

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 3e-35
 Identities = 68/323 (21%), Positives = 145/323 (44%), Gaps = 27/323 (8%)

Query: 157 YWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-----PVKKKK 211
           ++  E     W  +  Y+ ++ +G G Y  V  A++ ++  K  +K L       +  K+
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 212 IKREIKILENLRGGTNIITLQAVVKDPVSRTPA----LIFEHVNNTDFKQL-YQTLTDYD 266
             RE+++L+++R   N+I L  V     +        L+   +     K + ++ L +  
Sbjct: 64  AYRELRLLKHMRH-ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 122

Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRV 326
           I++ +Y++LK L Y H+ GI+HRD+KP N+ ++ +    +++D+GLA       E    V
Sbjct: 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLA--RQADSEMTGYV 179

Query: 327 ASRYFKGPELLADYQYHIELDPRFAD-------ILGRHSRKRWERFVHTENQHLVSPEAL 379
            +R+++ PE++ ++  + +    ++        I G+   K  +     +    V+    
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239

Query: 380 DFLDKNILGRHSRKRWERFVHTENQHL------VSPEALDFLDKLLRYDHYERLTAREAM 433
               + +    ++   +     E +         SP A++ L+K+L  D  +R+TA EA+
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299

Query: 434 DHPYFYPIVKDQSRHTLPSSSPT 456
            HPYF  +   +    +     +
Sbjct: 300 AHPYFESLHDTEDEPQVQKYDDS 322

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.5 bits (182), Expect = 3e-15
 Identities = 41/117 (35%), Positives = 68/117 (58%), Gaps = 4/117 (3%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS 61
            +       L Y H+ GI+HRD+KP N+ ++ +    +++D+GLA       E    V +
Sbjct: 125 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLA--RQADSEMTGYVVT 181

Query: 62  RYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           R+++ PE++ ++  Y  ++D+WS+GC++A MI  K   F G D+ DQL  I KV GT
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL-FKGSDHLDQLKEIMKVTGT 237

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 3e-35
 Identities = 57/285 (20%), Positives = 106/285 (37%), Gaps = 38/285 (13%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-----PVKKKKIKREIKILENLRGG 225
           +DY+++  +G G Y    +          V K L        +K+ +  E+ +L  L+  
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 62

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY-------QTLTDYDIRYYLYELLKAL 278
            NI+     + D  + T  ++ E+    D   +        Q L +  +   + +L  AL
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 279 DYCHSMG-----IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRVASRYFK 332
             CH        ++HRD+KP NV +D +   ++L D+GLA   +    +    V + Y+ 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 333 GPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR 392
            PE +    Y+ + D      L          F     + L            I     R
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA---------GKIREGKFR 232

Query: 393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
           +   R+         S E  + + ++L    Y R +  E +++P 
Sbjct: 233 RIPYRY---------SDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.3 bits (203), Expect = 2e-18
 Identities = 34/120 (28%), Positives = 59/120 (49%), Gaps = 9/120 (7%)

Query: 1   MRIATGASMALDYCHSMG-----IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 55
           +R+ T  ++AL  CH        ++HRD+KP NV +D +   ++L D+GLA   +    +
Sbjct: 112 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSF 170

Query: 56  -NVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
               V + Y+  PE + +   Y+   D+WSLGC+L  +     P F      +   +I +
Sbjct: 171 AKAFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPP-FTAFSQKELAGKIRE 228

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 1e-34
 Identities = 61/292 (20%), Positives = 114/292 (39%), Gaps = 45/292 (15%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---------KKKIKREIKILE 220
           +  YQ+   LG G +  V+  I V  +    +K ++  +           ++  E+ +L+
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62

Query: 221 NLRGG-TNIITLQAVVKDPVSRTPALIFEHVNNT----DFKQLYQTLTDYDIRYYLYELL 275
            +  G + +I L    + P   +  LI E         DF      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120

Query: 276 KALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 335
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPE 179

Query: 336 LLADYQYHIELDPRFADI--LGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK 393
            +  ++YH     R A +  LG          +  E+   +    + F  +         
Sbjct: 180 WIRYHRYH----GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--------- 226

Query: 394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ 445
                        VS E    +   L     +R T  E  +HP+   ++  Q
Sbjct: 227 -------------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 265

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.6 bits (193), Expect = 5e-17
 Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 1/104 (0%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
                    A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     
Sbjct: 113 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDG 171

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 104
           +R +  PE +  ++ +  S  +WSLG +L  M+    PF H  +
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-34
 Identities = 67/304 (22%), Positives = 128/304 (42%), Gaps = 39/304 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK-----IKREIKILENLRGG 225
             Y+ + K+G+G + EVF+A + ++  K  +K +    +K+       REIKIL+ L+  
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH- 68

Query: 226 TNIITLQAVVKDPVSR------TPALIFEHVNNTDF---KQLYQTLTDYDIRYYLYELLK 276
            N++ L  + +   S       +  L+F+   +        +    T  +I+  +  LL 
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYF 331
            L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   +      Y  RV + ++
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 332 KGPELLADYQYH----------------IELDPRFADILGRHSRKRWERFVHTENQHLVS 375
           + PELL   + +                    P       +H      +   +    +  
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV-- 245

Query: 376 PEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH 435
              +D  +        + +  +       ++  P ALD +DKLL  D  +R+ + +A++H
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305

Query: 436 PYFY 439
            +F+
Sbjct: 306 DFFW 309

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.7 bits (211), Expect = 4e-19
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 7/160 (4%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YN 56
           R+       L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   +      Y 
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYT 179

Query: 57  VRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 116
            RV + +++ PELL   + Y   +D+W  GC++A M  R  P   G+    QL  I+++ 
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLC 238

Query: 117 GTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPRE 156
           G+     + +  + EL  +   + G+ R   D      R+
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRD 278

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 2e-34
 Identities = 71/294 (24%), Positives = 131/294 (44%), Gaps = 25/294 (8%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK-----IKREIKILENLRGG 225
           +++Q V K+G G Y  V++A N  + +   +K ++   + +       REI +L+ L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH- 60

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDF--KQLYQTLTDYDIRYYLYELLKALDYCHS 283
            NI+ L  V+           F H +   F        +    I+ YL++LL+ L +CHS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQY 342
             ++HRD+KP N++I+ E   ++L D+GLA  +  P + Y   V + +++ PE+L   +Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 343 H-------------IELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGR 389
           +              E+  R A   G     +  R   T             +      +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP--DEVVWPGVTSMPDYK 237

Query: 390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK 443
            S  +W R   ++    +  +    L ++L YD  +R++A+ A+ HP+F  + K
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.5 bits (208), Expect = 7e-19
 Identities = 43/131 (32%), Positives = 71/131 (54%), Gaps = 3/131 (2%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRV 59
                     L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  +  P + Y   V
Sbjct: 105 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEV 163

Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
            + +++ PE+L   + Y  ++D+WSLGC+ A M+ R+   F G    DQL RI + LGT 
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL-FPGDSEIDQLFRIFRTLGTP 222

Query: 120 ELFEYLDKYHI 130
           +   +     +
Sbjct: 223 DEVVWPGVTSM 233

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  127 bits (320), Expect = 4e-34
 Identities = 71/293 (24%), Positives = 128/293 (43%), Gaps = 35/293 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGG 225
           + Y  + K+G G Y  V++A N    +   +K ++  K          REI IL+ L+  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCH 282
           +NI+ L  V+         L+FEH++    K L      L     + +L +LL  + YCH
Sbjct: 60  SNIVKLYDVIHTKKRLV--LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 283 SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLADYQ 341
              ++HRD+KP N++I+ E   L++ D+GLA  +  P ++Y   + + +++ P++L   +
Sbjct: 118 DRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 342 YH----------------IELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKN 385
            +                +   P F  +       R  R + T N               
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236

Query: 386 ILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
               +    WE F+       +    +D L K+L+ D  +R+TA++A++H YF
Sbjct: 237 NFTVYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 82.2 bits (202), Expect = 4e-18
 Identities = 39/122 (31%), Positives = 72/122 (59%), Gaps = 3/122 (2%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPE 68
            + YCH   ++HRD+KP N++I+ E   L++ D+GLA  +  P ++Y   + + +++ P+
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170

Query: 69  LLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKY 128
           +L   + Y  ++D+WS+GC+ A M+    P F G    DQL+RI ++LGT     + +  
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229

Query: 129 HI 130
            +
Sbjct: 230 EL 231

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  127 bits (321), Expect = 5e-34
 Identities = 54/280 (19%), Positives = 108/280 (38%), Gaps = 36/280 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK------KKIKREIKILENLRG 224
             +  +R++G G +  V+ A +V++S+   +K +    K      + I +E++ L+ LR 
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNT---DFKQLYQTLTDYDIRYYLYELLKALDYC 281
             N I  +         T  L+ E+   +     +   + L + +I    +  L+ L Y 
Sbjct: 75  -PNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLA--- 338
           HS  ++HRDVK  N+++      ++L D+G A    P   +   V + Y+  PE++    
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMD 187

Query: 339 DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           + QY  ++D     I      +R     +              L           +   +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNESPALQSGHW 239

Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                    S    +F+D  L+    +R T+   + H + 
Sbjct: 240 ---------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 85.8 bits (212), Expect = 3e-19
 Identities = 36/116 (31%), Positives = 55/116 (47%), Gaps = 7/116 (6%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
             +  GA   L Y HS  ++HRDVK  N+++      ++L D+G A    P   +   V 
Sbjct: 118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSF---VG 173

Query: 61  SRYFKGPELLA--DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           + Y+  PE++   D   YD  +D+WSLG     +  RK P F   +    L  IA+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQ 228

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 1e-33
 Identities = 65/302 (21%), Positives = 126/302 (41%), Gaps = 36/302 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---------KKKIKREIKILEN 221
           D Y    +LG G+++ V +     +  +   K +K  +         ++ I+RE+ IL+ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKAL 278
           ++   N+ITL  V ++       LI E V   +        ++LT+ +   +L ++L  +
Sbjct: 70  IQH-PNVITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 335
            Y HS+ I H D+KP N+M+   N    ++++ID+GLA     G E+     +  F  PE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186

Query: 336 LLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW 395
           ++      +E D     ++       +            + +        +      + +
Sbjct: 187 IVNYEPLGLEADMWSIGVI------TYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240

Query: 396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSP 455
                       S  A DF+ +LL  D  +R+T ++++ HP+  P    Q+   L S+  
Sbjct: 241 SN---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA---LSSAWS 288

Query: 456 TP 457
            P
Sbjct: 289 HP 290

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.3 bits (187), Expect = 4e-16
 Identities = 37/145 (25%), Positives = 64/145 (44%), Gaps = 10/145 (6%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPGQEYNV 57
                     + Y HS+ I H D+KP N+M+   N    ++++ID+GLA     G E+  
Sbjct: 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175

Query: 58  RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
              +  F  PE++ +Y+      DMWS+G +   ++    P F G    + L  ++ V  
Sbjct: 176 IFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASP-FLGDTKQETLANVSAV-- 231

Query: 118 TEELFEYLDKYHIELDPRFADILGR 142
               +E+ D+Y         D + R
Sbjct: 232 ---NYEFEDEYFSNTSALAKDFIRR 253

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 3e-33
 Identities = 74/312 (23%), Positives = 138/312 (44%), Gaps = 34/312 (10%)

Query: 153 KPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-----PV 207
           +P  ++  E     W   + YQ +  +G G Y  V  A + ++  +  VK L       +
Sbjct: 1   RP-TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59

Query: 208 KKKKIKREIKILENLRGGTNIITLQAVVKDPVS---RTPALIFEHVNNTDFKQLY--QTL 262
             K+  RE+++L++++   N+I L  V     S        +  H+   D   +   Q L
Sbjct: 60  HAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118

Query: 263 TDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY 322
           TD  +++ +Y++L+ L Y HS  I+HRD+KP N+ ++ +    +++D+GLA   H   E 
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLA--RHTDDEM 175

Query: 323 NVRVASRYFKGPELLADYQYH----------------IELDPRFADILGRHSRKRWERFV 366
              VA+R+++ PE++ ++ ++                +     F         K   R V
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

Query: 367 HTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYER 426
            T    L+   + +     I    S  +  +          +P A+D L+K+L  D  +R
Sbjct: 236 GTPGAELLKKISSESARNYI---QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292

Query: 427 LTAREAMDHPYF 438
           +TA +A+ H YF
Sbjct: 293 ITAAQALAHAYF 304

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.8 bits (180), Expect = 5e-15
 Identities = 38/109 (34%), Positives = 70/109 (64%), Gaps = 4/109 (3%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 69
            L Y HS  I+HRD+KP N+ ++ +    +++D+GLA   H   E    VA+R+++ PE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLA--RHTDDEMTGYVATRWYRAPEI 189

Query: 70  LADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + ++  Y+ ++D+WS+GC++A ++  +   F G D+ DQL  I +++GT
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTL-FPGTDHIDQLKLILRLVGT 237

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 7e-33
 Identities = 62/315 (19%), Positives = 124/315 (39%), Gaps = 34/315 (10%)

Query: 156 EYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-----PVKKK 210
           +++  E     +     YQ ++ +G G    V  A +        +K L          K
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 211 KIKREIKILENLRGGTNIITLQAVVKDPVS----RTPALIFEHVNNTDFKQLYQTLTDYD 266
           +  RE+ +++ +    NII+L  V     +    +   L+ E ++    + +   L    
Sbjct: 62  RAYRELVLMKCVNH-KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 120

Query: 267 IRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRV 326
           + Y LY++L  + + HS GI+HRD+KP N+++  +    +++D+GLA            V
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYV 179

Query: 327 ASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVS----------- 375
            +RY++ PE++    Y   +D      +     +    F   +     +           
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239

Query: 376 --PEALDFLDKNILGRHSRKRWERF----------VHTENQHLVSPEALDFLDKLLRYDH 423
              + L    +N +    +     F            +E+  L + +A D L K+L  D 
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299

Query: 424 YERLTAREAMDHPYF 438
            +R++  +A+ HPY 
Sbjct: 300 AKRISVDDALQHPYI 314

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.1 bits (173), Expect = 4e-14
 Identities = 43/180 (23%), Positives = 81/180 (45%), Gaps = 10/180 (5%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS 61
            +       + + HS GI+HRD+KP N+++  +    +++D+GLA            V +
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVT 181

Query: 62  RYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL 121
           RY++ PE++        ++D+WS+GC++  M+  K   F G D  DQ  ++ + LGT   
Sbjct: 182 RYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIEQLGTP-- 237

Query: 122 FEYLDKYHIELDPRFADILGRARVYADVNSHK--PREYWDYESYVVDWGQQDDYQLVRKL 179
                ++  +L P   + +     YA +   K  P   +  +S            L+ K+
Sbjct: 238 ---CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 3e-32
 Identities = 60/286 (20%), Positives = 118/286 (41%), Gaps = 19/286 (6%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKK-----IKREIKILENLRGG 225
             Y+ + K+G G Y  VF+A N ++ +   +K ++     +       REI +L+ L+  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMG 285
             +     +  D          +      F      L    ++ +L++LLK L +CHS  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 286 IMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYHI 344
           ++HRD+KP N++I+      +L ++GLA  F  P + Y+  V + +++ P++L   + + 
Sbjct: 122 VLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 345 E------LDPRFADILGRHSRKRWERFVHTENQHLV------SPEALDFLDKNILGRHSR 392
                      FA++            V  + + +       + E    + K    +   
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                         ++    D L  LL+ +  +R++A EA+ HPYF
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.8 bits (224), Expect = 6e-21
 Identities = 42/131 (32%), Positives = 71/131 (54%), Gaps = 2/131 (1%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRV 59
                     L +CHS  ++HRD+KP N++I+      +L ++GLA  F  P + Y+  V
Sbjct: 104 KSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEV 162

Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
            + +++ P++L   ++Y  S+DMWS GC+ A +     P F G+D  DQL RI ++LGT 
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222

Query: 120 ELFEYLDKYHI 130
              ++     +
Sbjct: 223 TEEQWPSMTKL 233

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 4e-32
 Identities = 67/303 (22%), Positives = 124/303 (40%), Gaps = 30/303 (9%)

Query: 177 RKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK--------KKIKREIKILENLRGGTNI 228
             LG G+++ V++A +  ++    +K +K   +        +   REIK+L+ L    NI
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNI 62

Query: 229 ITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMG 285
           I L            +L+F+ +       +      LT   I+ Y+   L+ L+Y H   
Sbjct: 63  IGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 286 IMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQYH- 343
           I+HRD+KP+N+++D EN  L+L D+GLA  F  P + Y  +V +R+++ PELL   + + 
Sbjct: 121 ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 344 IELDPRFADIL------GR---HSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR 394
           + +D      +                 ++            E       ++    + K 
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQSRHTLPSSS 454
           +              + LD +  L  ++   R+TA +A+   YF     ++   T     
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF----SNRPGPTPGCQL 295

Query: 455 PTP 457
           P P
Sbjct: 296 PRP 298

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.5 bits (221), Expect = 2e-20
 Identities = 51/137 (37%), Positives = 78/137 (56%), Gaps = 3/137 (2%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRV 59
                     L+Y H   I+HRD+KP+N+++D EN  L+L D+GLA  F  P + Y  +V
Sbjct: 103 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQV 161

Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 119
            +R+++ PELL   +MY   +DMW++GC+LA ++ R  PF  G  + DQL RI + LGT 
Sbjct: 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTP 220

Query: 120 ELFEYLDKYHIELDPRF 136
              ++ D   +     F
Sbjct: 221 TEEQWPDMCSLPDYVTF 237

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-31
 Identities = 48/279 (17%), Positives = 112/279 (40%), Gaps = 33/279 (11%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTN 227
            +   ++GRG +  V++ ++ +++ +     L+  K     +++ K E ++L+ L+   N
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PN 69

Query: 228 IITLQAVVKDPVS--RTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYCH 282
           I+      +  V   +   L+ E + +   K     ++ +    +R +  ++LK L + H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 283 SMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY 340
           +    I+HRD+K  N+ I      +++ D GLA          V + +  F  PE+  + 
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMYEE- 187

Query: 341 QYHIELD-PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
           +Y   +D   F   +        E                 + +     +  R+      
Sbjct: 188 KYDESVDVYAFGMCM-------LEMATSE----------YPYSECQNAAQIYRRVTSGVK 230

Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF 438
                 +  PE  + ++  +R +  ER + ++ ++H +F
Sbjct: 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.3 bits (203), Expect = 3e-18
 Identities = 27/144 (18%), Positives = 51/144 (35%), Gaps = 12/144 (8%)

Query: 1   MRIATGASMALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR 58
                     L + H+    I+HRD+K  N+ I      +++ D GLA          V 
Sbjct: 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV- 173

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 118
           + +  F  PE+    + YD S+D+++ G  +  M   + P+    +      R+      
Sbjct: 174 IGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS---- 227

Query: 119 EELFEYLDKYHIELDPRFADILGR 142
                    +     P   +I+  
Sbjct: 228 ---GVKPASFDKVAIPEVKEIIEG 248

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  121 bits (305), Expect = 2e-31
 Identities = 55/291 (18%), Positives = 104/291 (35%), Gaps = 35/291 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRG 224
           +D+ + R +GRG + EV+      +     +K L   +      +     E  +L  +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 225 GT--NIITLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALD 279
           G    I+ +      P     + I + +N  D       +   ++ D+R+Y  E++  L+
Sbjct: 64  GDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           + H+  +++RD+KP N+++D     +R+ D GLA  +   + +       Y     L   
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 180

Query: 340 YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
             Y    D      +                   +      F       +H   R    +
Sbjct: 181 VAYDSSADWFSLGCM----------------LFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224

Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKDQ 445
             E     SPE    L+ LL+ D   RL      A+E  + P+F  +    
Sbjct: 225 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 275

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 79.4 bits (195), Expect = 7e-17
 Identities = 32/122 (26%), Positives = 55/122 (45%), Gaps = 3/122 (2%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
              A    + L++ H+  +++RD+KP N+++D     +R+ D GLA  +   + +     
Sbjct: 110 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-G 167

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE 120
           +  +  PE+L     YD S D +SLGCML  ++    P F  H   D+       L    
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKHEIDRMTLTMAV 226

Query: 121 LF 122
             
Sbjct: 227 EL 228

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 3e-31
 Identities = 63/299 (21%), Positives = 115/299 (38%), Gaps = 41/299 (13%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRG 224
           +D++  + LG G +S V  A  + +S +  +KIL+        K   + RE  ++  L  
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYC 281
               + L    +D           +  N +  +      +  +   R+Y  E++ AL+Y 
Sbjct: 68  -PFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLA 338
           H  GI+HRD+KP N++++ +   +++ D+G A+   P  +    N  V +  +  PELL 
Sbjct: 125 HGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 339 DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF 398
           +       D      +          F    N++L+         K I   +        
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLI-------FQKIIKLEYDFPEK--- 232

Query: 399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREA------MDHPYFYPIVKDQSRHTLP 451
                     P+A D ++KLL  D  +RL   E         HP+F  +  +      P
Sbjct: 233 --------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 283

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.4 bits (185), Expect = 7e-16
 Identities = 33/117 (28%), Positives = 58/117 (49%), Gaps = 6/117 (5%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY---NV 57
                    AL+Y H  GI+HRD+KP N++++ +   +++ D+G A+   P  +    N 
Sbjct: 111 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANS 169

Query: 58  RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
            V +  +  PELL   +    S D+W+LGC++  ++    P F   + Y    +I K
Sbjct: 170 FVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKIIK 224

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 2e-30
 Identities = 57/303 (18%), Positives = 113/303 (37%), Gaps = 35/303 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRG 224
           +D+ L + LG+G + +VF A   +++    +K LK          +    E ++L     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYC 281
              +  +    +         + E++N  D                 +Y  E++  L + 
Sbjct: 62  HPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADY 340
           HS GI++RD+K  N+++D +    ++ D+G+  E      + N    +  +  PE+L   
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178

Query: 341 QYHIELDP-RFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
           +Y+  +D   F  +L                  ++  ++  F  ++        R +   
Sbjct: 179 KYNHSVDWWSFGVLLY----------------EMLIGQSP-FHGQDEEELFHSIRMDNPF 221

Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAR-EAMDHPYFYPIVKDQSRHTLPSSSPTPI 458
           +      +  EA D L KL   +  +RL  R +   HP F  I  ++           P 
Sbjct: 222 YPRW---LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPK 278

Query: 459 VNS 461
           V S
Sbjct: 279 VKS 281

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.2 bits (179), Expect = 5e-15
 Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 4/113 (3%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRV 59
              A    + L + HS GI++RD+K  N+++D +    ++ D+G+  E      + N   
Sbjct: 106 TFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFC 164

Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 112
            +  +  PE+L   Q Y++S+D WS G +L  M+  + P FHG D  +    I
Sbjct: 165 GTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEELFHSI 215

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 1e-28
 Identities = 59/284 (20%), Positives = 108/284 (38%), Gaps = 34/284 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRG 224
           +D+  ++ LG+G + +V       +     +KIL+               E ++L+N R 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 225 GTNIITLQAVVKDPVSR-TPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
              +  L+   +                        +  T+   R+Y  E++ AL+Y HS
Sbjct: 65  -PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLADYQY 342
             +++RD+K  N+M+D ++  +++ D+GL  E    G        +  +  PE+L D  Y
Sbjct: 124 RDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 343 HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE 402
              +D              +E        +    E L   +  ++      R        
Sbjct: 183 GRAVD------WWGLGVVMYEMMCGRLPFYNQDHERL--FELILMEEIRFPRT------- 227

Query: 403 NQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPI 441
               +SPEA   L  LL+ D  +RL      A+E M+H +F  I
Sbjct: 228 ----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.7 bits (167), Expect = 2e-13
 Identities = 24/114 (21%), Positives = 48/114 (42%), Gaps = 2/114 (1%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
                    AL+Y HS  +++RD+K  N+M+D ++  +++ D+GL +             
Sbjct: 108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFC 166

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
                    + +   Y  ++D W LG ++  M+  + P F+  D+      I  
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLFELILM 219

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  109 bits (274), Expect = 1e-27
 Identities = 55/287 (19%), Positives = 112/287 (39%), Gaps = 35/287 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK------PVKKKKIKREIKILENLRG 224
            D+Q++R LG G +  V    +  +     +K+LK        + +    E  +L  +  
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 225 GTNIITLQAVVKDPVSRTPALIF-EHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
              II +    +D       + + E        +  Q   +   ++Y  E+  AL+Y HS
Sbjct: 64  -PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYH 343
             I++RD+KP N+++D +N  +++ D+G A++            +  +  PE+++   Y+
Sbjct: 123 KDIIYRDLKPENILLD-KNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 344 IELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN 403
             +D     IL       +E                 F D N +  + +           
Sbjct: 180 KSIDWWSFGILI------YEMLAGY----------TPFYDSNTMKTYEKILNAELRFPPF 223

Query: 404 QHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQ 445
               + +  D L +L+  D  +RL        +  +HP+F  +V ++
Sbjct: 224 ---FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK 267

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 68.2 bits (166), Expect = 2e-13
 Identities = 29/113 (25%), Positives = 58/113 (51%), Gaps = 5/113 (4%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS 61
             A    +AL+Y HS  I++RD+KP N+++D +N  +++ D+G A++            +
Sbjct: 108 FYAAEVCLALEYLHSKDIIYRDLKPENILLD-KNGHIKITDFGFAKYVP--DVTYTLCGT 164

Query: 62  RYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
             +  PE+++  + Y+ S+D WS G ++  M+    P F+  +      +I  
Sbjct: 165 PDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTP-FYDSNTMKTYEKILN 215

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  110 bits (276), Expect = 2e-27
 Identities = 48/283 (16%), Positives = 102/283 (36%), Gaps = 35/283 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIK------REIKILENLRG 224
           D +  ++ LG G +  V    + +S +   +KIL   K  K+K       E +IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 225 GTNIITLQAVVKDPVSRTPALIFEHVNNT-DFKQLYQTLTDYDIRYYLYELLKALDYCHS 283
              ++ L+   KD  +    + +          +     ++   R+Y  +++   +Y HS
Sbjct: 101 -PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYH 343
           + +++RD+KP N++ID +   +++ D+G A+             +     PE++    Y+
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKGYN 216

Query: 344 IELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN 403
             +D     +L       +  F   +   +                              
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIY-------------------EKIVSGKVRF 257

Query: 404 QHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPI 441
               S +  D L  LL+ D  +R         +  +H +F   
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 66.0 bits (160), Expect = 2e-12
 Identities = 25/114 (21%), Positives = 51/114 (44%), Gaps = 5/114 (4%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
              A    +  +Y HS+ +++RD+KP N++ID +   +++ D+G A+             
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK--GRTWTLCG 200

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +     PE++   + Y+ ++D W+LG ++  M     P F          +I  
Sbjct: 201 TPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPP-FFADQPIQIYEKIVS 252

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  105 bits (262), Expect = 3e-26
 Identities = 53/281 (18%), Positives = 95/281 (33%), Gaps = 30/281 (10%)

Query: 170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK------PVKKKKIKREIKILENLR 223
            D Y+L   LG G  SEV  A +++      VK+L+      P    + +RE +    L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 224 GGTNIITLQAVV--KDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKAL 278
               I+ +      + P    P ++ E+V+    + +      +T       + +  +AL
Sbjct: 66  H-PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 335
           ++ H  GI+HRDVKP N+MI   N        I   +A+  +   +    + +  +  PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184

Query: 336 LLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW 395
                      D      +       +E           SP ++ +            R 
Sbjct: 185 QARGDSVDARSDVYSLGCVL------YEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238

Query: 396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP 436
           E          +S +    + K L  +   R      M   
Sbjct: 239 EG---------LSADLDAVVLKALAKNPENRYQTAAEMRAD 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 67.8 bits (165), Expect = 3e-13
 Identities = 34/146 (23%), Positives = 58/146 (39%), Gaps = 10/146 (6%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPGQEYNV 57
           + +   A  AL++ H  GI+HRDVKP N+MI   N        I   +A+  +   +   
Sbjct: 114 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173

Query: 58  RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 117
            + +  +  PE        D   D++SLGC+L  ++  + P F G        +  +   
Sbjct: 174 VIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPP-FTGDSPVSVAYQHVR--- 228

Query: 118 TEELFEYLDKYHIELDPRFADILGRA 143
             E        H  L      ++ +A
Sbjct: 229 --EDPIPPSARHEGLSADLDAVVLKA 252

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 2e-25
 Identities = 54/303 (17%), Positives = 102/303 (33%), Gaps = 57/303 (18%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCV-----VKILK----PVKKKKIKREIKILEN 221
           ++ +  + LG G + +V  A     S   V     VK+LK      +++ +  E+K++  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL----------------------- 258
           L    NI+ L             LIFE+    D                           
Sbjct: 97  LGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 259 ---YQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF 315
                 LT  D+  + Y++ K +++      +HRD+   NV++ H  + +++ D+GLA  
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH-GKVVKICDFGLARD 213

Query: 316 YHPGQEYNVR---VASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQH 372
                 Y VR        +  PE L +  Y I+ D     IL       WE  + +   +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL------LWE--IFSLGVN 265

Query: 373 LVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREA 432
                 +D     ++    +     +         + E    +     +D  +R +    
Sbjct: 266 PYPGIPVDANFYKLIQNGFKMDQPFY--------ATEEIYIIMQSCWAFDSRKRPSFPNL 317

Query: 433 MDH 435
              
Sbjct: 318 TSF 320

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.9 bits (191), Expect = 2e-16
 Identities = 24/117 (20%), Positives = 48/117 (41%), Gaps = 5/117 (4%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR-- 58
           +  A   +  +++      +HRD+   NV++ H  + +++ D+GLA        Y VR  
Sbjct: 167 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGN 225

Query: 59  -VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
                 +  PE L +  +Y    D+WS G +L  +       + G        ++ +
Sbjct: 226 ARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 281

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (254), Expect = 4e-25
 Identities = 38/282 (13%), Positives = 93/282 (32%), Gaps = 40/282 (14%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-----PVKKKKIKREIKILENLRGG 225
               + +++G G +  V++    +      VK+L      P + +  K E+ +L   R  
Sbjct: 8   GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 63

Query: 226 TNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYC 281
            NI+        P     A++ +    +                 +     +  + +DY 
Sbjct: 64  VNILLFMGYSTAP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120

Query: 282 HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKGPELLA 338
           H+  I+HRD+K +N+ +  E+  +++ D+GLA         +       S  +  PE++ 
Sbjct: 121 HAKSIIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 339 DYQYHIELDPR-----FADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK 393
               +     +     F  +L       +E          ++         + +     +
Sbjct: 180 MQDKN-PYSFQSDVYAFGIVL-------YELMTGQLPYSNINNR-------DQIIFMVGR 224

Query: 394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH 435
            +     ++ +          + + L+    ER    + +  
Sbjct: 225 GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.6 bits (214), Expect = 1e-19
 Identities = 31/147 (21%), Positives = 64/147 (43%), Gaps = 10/147 (6%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR-- 58
           + IA   +  +DY H+  I+HRD+K +N+ +  E+  +++ D+GLA         +    
Sbjct: 107 IDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQ 165

Query: 59  -VASRYFKGPELL--ADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 115
              S  +  PE++   D   Y +  D+++ G +L  ++  + P+     N +   +I  +
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY----SNINNRDQIIFM 221

Query: 116 LGTEELFEYLDKYHIELDPRFADILGR 142
           +G   L   L K           ++  
Sbjct: 222 VGRGYLSPDLSKVRSNCPKAMKRLMAE 248

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  102 bits (254), Expect = 5e-25
 Identities = 40/287 (13%), Positives = 99/287 (34%), Gaps = 34/287 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP-VKKKKIKREIKILENLRGGTNII 229
           + Y+L RK+G G + +++   ++ + ++  +K+     K  ++  E KI + ++GG  I 
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 230 TLQAVVKDPVSRTPALIFEHVNNTD---FKQLYQTLTDYDIRYYLYELLKALDYCHSMGI 286
           T++    +       ++ E +  +    F    +  +   +     +++  ++Y HS   
Sbjct: 67  TIRWCGAEG--DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124

Query: 287 MHRDVKPHNVMIDHENRKLRL--IDWGLAEFYHPGQEYNVR--------VASRYFKGPEL 336
           +HRDVKP N ++    +   +  ID+GLA+ Y   + +             +  +     
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 337 LADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR--KR 394
               +          D+                  +L S             ++ R  ++
Sbjct: 185 HLGIEQSRR-----DDL--------ESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231

Query: 395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTA---REAMDHPYF 438
                          E   +L+        ++      R+   + + 
Sbjct: 232 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 62.6 bits (151), Expect = 2e-11
 Identities = 30/172 (17%), Positives = 57/172 (33%), Gaps = 19/172 (11%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRL--IDWGLAEFYHPGQEYNVR 58
           + +A      ++Y HS   +HRDVKP N ++    +   +  ID+GLA+ Y   + +   
Sbjct: 106 LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165

Query: 59  --------VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 110
                     +  +                D+ SLG +L          + G     +  
Sbjct: 166 PYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGS-LPWQGLKAATKRQ 223

Query: 111 RIAKVLGTEELFEYLDKYHIELDPRFADILGRARVYADVNSHKPREYWDYES 162
           +  ++   +     ++         FA  L   R      S +  +  DY  
Sbjct: 224 KYERISEKKMSTP-IEVLCKGYPSEFATYLNFCR------SLRFDDKPDYSY 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 1e-24
 Identities = 45/330 (13%), Positives = 103/330 (31%), Gaps = 52/330 (15%)

Query: 164 VVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK------PVKKKKIKREIK 217
           V+DW   +D +    +G G + +V +A   +   +    I +          +    E++
Sbjct: 6   VLDW---NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 62

Query: 218 ILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ----------------- 260
           +L  L    NII L    +        L  E+  + +     +                 
Sbjct: 63  VLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120

Query: 261 --TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP 318
             TL+   + ++  ++ + +DY      +HRD+   N+++  EN   ++ D+GL+     
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEV 179

Query: 319 GQEYNVRVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKRWERFVHTENQHLVSPE 377
             +  +      +   E L    Y    D   +  +L          +       L    
Sbjct: 180 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY--- 236

Query: 378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY 437
                          ++  +    E       E  D + +  R   YER +  + +    
Sbjct: 237 ---------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS-- 279

Query: 438 FYPIVKDQSRHTLPSSSPTPIVNSVPVVGE 467
              +++++  +   +         +    E
Sbjct: 280 LNRMLEERKTYVNTTLYEKFTYAGIDCSAE 309

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.2 bits (184), Expect = 1e-15
 Identities = 22/114 (19%), Positives = 49/114 (42%), Gaps = 2/114 (1%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           +  A   +  +DY      +HRD+   N+++  EN   ++ D+GL+       +  +   
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRL 188

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
              +   E L +Y +Y  + D+WS G +L  ++      + G    +   ++ +
Sbjct: 189 PVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (254), Expect = 1e-24
 Identities = 64/342 (18%), Positives = 119/342 (34%), Gaps = 52/342 (15%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK--PVKKKKIKREIKILENLR------- 223
           Y LVRKLG G +S V+ A ++ ++    +KI++   V  +  + EIK+L+ +        
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 224 ---GGTNIITLQAVVKDPVSRTPALIFEHVNNTDF------KQLYQTLTDYDIRYYLYEL 274
              G  +I+ L             ++       +       K  ++ +    ++    +L
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 275 LKALDYC-HSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVAS---RY 330
           L  LDY     GI+H D+KP NV+++  +    LI   +A+  +          S   R 
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 331 FKGPELLADYQYHIELD---------------PRFADILGRHSRKRWERFVHTENQHLVS 375
           ++ PE+L    +    D                 F    G    K  +            
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 376 PEAL---------DFLDKNILGRHSRKRWERFVHTENQHL-----VSPEALDFLDKLLRY 421
           P  L          F  + +L   S+ ++        +        + E  DFL  +L+ 
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314

Query: 422 DHYERLTAREAMDHPYFYPIVKDQSRHTLPSSSPTPIVNSVP 463
           D  +R  A   ++HP+            +P        + +P
Sbjct: 315 DPRKRADAGGLVNHPWLKD-TLGMEEIRVPDRELYGSGSDIP 355

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 58.1 bits (139), Expect = 8e-10
 Identities = 31/127 (24%), Positives = 56/127 (44%), Gaps = 10/127 (7%)

Query: 1   MRIATGASMALDYCH-SMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRV 59
            +I+    + LDY H   GI+H D+KP NV+++  +    LI   +A+  +         
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 60  AS---RYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPF-----FHGHDNYDQLVR 111
            S   R ++ PE+L     +    D+WS  C++  +I     F          + D + +
Sbjct: 188 NSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246

Query: 112 IAKVLGT 118
           I ++LG 
Sbjct: 247 IIELLGE 253

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 2e-24
 Identities = 35/273 (12%), Positives = 89/273 (32%), Gaps = 30/273 (10%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTNI 228
            +   V+++G G++  V       + DK  +K ++   + ++    E +++  L     +
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKL 62

Query: 229 ITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT----LTDYDIRYYLYELLKALDYCHSM 284
           + L  V  +       L+FE + +       +T         +     ++ + + Y    
Sbjct: 63  VQLYGVCLEQ--APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR--VASRYFKGPELLADYQY 342
            ++HRD+   N ++  EN+ +++ D+G+  F    Q  +         +  PE+ +  +Y
Sbjct: 121 CVIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 343 HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE 402
             + D     +L        +      +   V                  +         
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----------------VEDISTGFRLY 222

Query: 403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMDH 435
              L S      ++   +    +R      +  
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.1 bits (171), Expect = 4e-14
 Identities = 20/116 (17%), Positives = 47/116 (40%), Gaps = 4/116 (3%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR-- 58
           + +       + Y     ++HRD+   N ++  EN+ +++ D+G+  F    Q  +    
Sbjct: 104 LGMCLDVCEGMAYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGT 162

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
                +  PE+ +    Y    D+WS G ++  +    +  +    N + +  I+ 
Sbjct: 163 KFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 217

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.7 bits (248), Expect = 2e-24
 Identities = 42/272 (15%), Positives = 100/272 (36%), Gaps = 32/272 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK-PVKKKKIKREIKILENLRGGTNII 229
            + +L++ +G+G++ +V         +K  VK +K     +    E  ++  LR  +N++
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SNLV 63

Query: 230 TLQAVVKDPVSRTPALIFEHVNNTDFKQL-----YQTLTDYDIRYYLYELLKALDYCHSM 284
            L  V+ +       ++ E++                L    +  +  ++ +A++Y    
Sbjct: 64  QLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHI 344
             +HRD+   NV++  +N   ++ D+GL +     Q  +       +  PE L + ++  
Sbjct: 123 NFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFST 179

Query: 345 ELD-PRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN 403
           + D   F  +L       WE         + S   + +    +  +    R E+    + 
Sbjct: 180 KSDVWSFGILL-------WE---------IYSFGRVPYPRIPL--KDVVPRVEKGYKMDA 221

Query: 404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDH 435
                P   + +      D   R +  +  + 
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.3 bits (182), Expect = 1e-15
 Identities = 23/114 (20%), Positives = 48/114 (42%), Gaps = 4/114 (3%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           ++ +     A++Y      +HRD+   NV++  +N   ++ D+GL +     Q  +    
Sbjct: 106 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ--DTGKL 162

Query: 61  SRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
              +  PE L + + +    D+WS G +L  +       +      D + R+ K
Sbjct: 163 PVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 3e-24
 Identities = 49/293 (16%), Positives = 95/293 (32%), Gaps = 46/293 (15%)

Query: 171 DDYQLVRKLGRGKYSEVFEA-----INVQSSDKCVVKILKPVK----KKKIKREIKILEN 221
           +     + LG G + +V EA     I   ++    VK+LKP      ++ +  E+K+L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ--------------------- 260
           L    NI+ L             +I E+    D     +                     
Sbjct: 83  LGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
            L   D+  + Y++ K + +  S   +HRD+   N+++    R  ++ D+GLA       
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-THGRITKICDFGLARDIKNDS 199

Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD 380
            Y   V     + P      +               ++ +            L S  +  
Sbjct: 200 NY---VVKGNARLPVKWMAPESIFN---------CVYTFESDVWSYGIFLWELFSLGSSP 247

Query: 381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM 433
           +    +  +  +   E F     +H    E  D +      D  +R T ++ +
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEH-APAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.7 bits (167), Expect = 2e-13
 Identities = 21/116 (18%), Positives = 44/116 (37%), Gaps = 3/116 (2%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           +  +   +  + +  S   +HRD+   N+++    R  ++ D+GLA        Y V+  
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILL-THGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 61  SRYFKG--PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +R              +Y +  D+WS G  L  +       + G     +  ++ K
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 3e-24
 Identities = 57/311 (18%), Positives = 120/311 (38%), Gaps = 36/311 (11%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSD---KCVVKILKPVK-------KKKIKREIKILE 220
           ++++L++ LG G Y +VF    +   D      +K+LK           +  + E ++LE
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 221 NLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFK-QLYQTLTDYDIRYYLYELLKALD 279
           ++R    ++TL    +        L + +           +  T+++++ Y+ E++ AL+
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPEL 336
           + H +GI++RD+K  N+++D     + L D+GL++ +   +    Y+      Y     +
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 337 L-ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW 395
              D  +   +D     +L          +         + +        I  R  +   
Sbjct: 203 RGGDSGHDKAVDWWSLGVLM---------YELLTGASPFTVDGEKNSQAEISRRILKSEP 253

Query: 396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSRHTL 450
                      +S  A D + +LL  D  +RL      A E  +H +F  I  D      
Sbjct: 254 PYPQE------MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKK 307

Query: 451 PSSSPTPIVNS 461
             +   P++  
Sbjct: 308 VPAPFKPVIRD 318

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.8 bits (162), Expect = 8e-13
 Identities = 30/136 (22%), Positives = 61/136 (44%), Gaps = 10/136 (7%)

Query: 10  ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 66
           AL++ H +GI++RD+K  N+++D     + L D+GL++ +   +    Y+      Y   
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 67  PELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLD 126
             +      +D ++D WSLG ++  ++    P F      +    I++ +   E      
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASP-FTVDGEKNSQAEISRRILKSEP----- 253

Query: 127 KYHIELDPRFADILGR 142
            Y  E+     D++ R
Sbjct: 254 PYPQEMSALAKDLIQR 269

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.6 bits (245), Expect = 6e-24
 Identities = 49/279 (17%), Positives = 95/279 (34%), Gaps = 34/279 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTNI 228
           +  +LV +LG G++ EV+         K  VK LK   +       E  +++ L+    +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRL 70

Query: 229 ITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT-----LTDYDIRYYLYELLKALDYCHS 283
           + L AVV         +I E++ N       +T     LT   +     ++ + + +   
Sbjct: 71  VRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLADYQ 341
              +HRD++  N+++       ++ D+GLA      +            +  PE +    
Sbjct: 128 RNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 342 YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT 401
           + I+ D     IL                     PE +  L          +R  R V  
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTN----PEVIQNL----------ERGYRMVRP 232

Query: 402 ENQHLVSPEALDFLDKLLRYDHYERLTARE--AMDHPYF 438
           +N      E    +    +    +R T     ++   +F
Sbjct: 233 DN---CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.2 bits (174), Expect = 2e-14
 Identities = 19/116 (16%), Positives = 47/116 (40%), Gaps = 4/116 (3%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY--NVR 58
           + +A   +  + +      +HRD++  N+++       ++ D+GLA      +       
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGA 170

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
                +  PE + +Y  +    D+WS G +L  ++      + G  N + +  + +
Sbjct: 171 KFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 99.1 bits (246), Expect = 7e-24
 Identities = 37/276 (13%), Positives = 81/276 (29%), Gaps = 26/276 (9%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK-------KKIKREIKILENLR 223
              ++ + +G G++ EV          + +   +K +K        +    E  I+    
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85

Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALD 279
              N+I L+ VV         +I E + N       +      T   +   L  +   + 
Sbjct: 86  H-PNVIHLEGVVTKS--TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD 339
           Y   M  +HRD+   N++++  N   ++ D+GL+ F           ++   K P     
Sbjct: 143 YLADMNYVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201

Query: 340 YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV 399
            +         A  +  +    WE    +  +          +   I   +         
Sbjct: 202 PEAIQYRKFTSASDVWSYGIVMWEVM--SYGERPYWDMTNQDVINAIEQDYRLPPPMD-- 257

Query: 400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH 435
                          +    + D   R    + ++ 
Sbjct: 258 -------CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 74.0 bits (181), Expect = 3e-15
 Identities = 23/119 (19%), Positives = 50/119 (42%), Gaps = 6/119 (5%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           + +  G +  + Y   M  +HRD+   N++++  N   ++ D+GL+ F           +
Sbjct: 131 VGMLRGIAAGMKYLADMNYVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTS 189

Query: 61  SRYFKGPELLAD-----YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +   K P          Y+ +  + D+WS G ++  ++   E  +    N D +  I +
Sbjct: 190 ALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 1e-23
 Identities = 46/278 (16%), Positives = 90/278 (32%), Gaps = 35/278 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKK-------KKIKREIKILENLR 223
           +  +L R +G G++ +V + I +   +  +   +K  K        +K  +E   +    
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 224 GGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALD 279
              +I+ L  V+ +       +I E     + +   Q    +L    +  Y Y+L  AL 
Sbjct: 67  H-PHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122

Query: 280 YCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELL 337
           Y  S   +HRD+   NV++   +  ++L D+GL+ +      Y  +       +  PE +
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 338 ADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER 397
              ++    D     +        WE  +             + +   I           
Sbjct: 182 NFRRFTSASDVWMFGVC------MWE--ILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 233

Query: 398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH 435
                      P     + K   YD   R    E    
Sbjct: 234 ---------CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.6 bits (159), Expect = 1e-12
 Identities = 25/115 (21%), Positives = 47/115 (40%), Gaps = 2/115 (1%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV-RV 59
           +  A   S AL Y  S   +HRD+   NV++   +  ++L D+GL+ +      Y   + 
Sbjct: 111 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKG 169

Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
                       +++ +  + D+W  G  +  ++      F G  N D + RI  
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.1 bits (241), Expect = 2e-23
 Identities = 39/273 (14%), Positives = 95/273 (34%), Gaps = 30/273 (10%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTNI 228
            D   +++LG G++  V      +      +K++K   + + +   E K++ NL     +
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKL 61

Query: 229 ITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSM 284
           + L  V      R   +I E++ N       +          +     ++ +A++Y  S 
Sbjct: 62  VQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 285 GIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV--RVASRYFKGPELLADYQY 342
             +HRD+   N +++ +   +++ D+GL+ +    +  +         +  PE+L   ++
Sbjct: 120 QFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 343 HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE 402
             + D     +L        +             E  + + + +                
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETAEHIAQGL-------------RLY 221

Query: 403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMDH 435
             HL S +    +         ER T +  + +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.2 bits (166), Expect = 1e-13
 Identities = 20/118 (16%), Positives = 50/118 (42%), Gaps = 4/118 (3%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV--R 58
           + +      A++Y  S   +HRD+   N +++ +   +++ D+GL+ +    +  +    
Sbjct: 103 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGS 161

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 116
                +  PE+L     +    D+W+ G ++  +    +  +    N +    IA+ L
Sbjct: 162 KFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 218

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.5 bits (242), Expect = 2e-23
 Identities = 49/279 (17%), Positives = 96/279 (34%), Gaps = 34/279 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP--VKKKKIKREIKILENLRGGTNI 228
           +  +L  KLG+G + EV+       + +  +K LKP  +  +   +E ++++ LR    +
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKL 74

Query: 229 ITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDY-----DIRYYLYELLKALDYCHS 283
           + L AVV +       ++ E+++        +  T        +     ++   + Y   
Sbjct: 75  VQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 284 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLADYQ 341
           M  +HRD++  N+++  EN   ++ D+GLA      +            +  PE     +
Sbjct: 132 MNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 342 YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT 401
           + I+ D     IL      +            V                   + ER    
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----------------LDQVERGYRM 233

Query: 402 ENQHLVSPEALDFLDKLLRYDHYERLTARE--AMDHPYF 438
                      D + +  R +  ER T     A    YF
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.1 bits (189), Expect = 2e-16
 Identities = 24/116 (20%), Positives = 49/116 (42%), Gaps = 4/116 (3%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY--NVR 58
           + +A   +  + Y   M  +HRD++  N+++  EN   ++ D+GLA      +       
Sbjct: 116 VDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGA 174

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
                +  PE    Y  +    D+WS G +L  +  +    + G  N + L ++ +
Sbjct: 175 KFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.7 bits (240), Expect = 3e-23
 Identities = 51/283 (18%), Positives = 91/283 (32%), Gaps = 40/283 (14%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCV---VKILKPVK------KKKIKREIKILEN 221
            D +L+ KLG G +  V        S K V   VK LKP             RE+  + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKA 277
           L    N+I L  VV  P      ++ E           +          +  Y  ++ + 
Sbjct: 68  LDH-RNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV----RVASRYFKG 333
           + Y  S   +HRD+   N+++   +  +++ D+GL        ++ V    R     +  
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 334 PELLADYQYHIELDP-RFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR 392
           PE L    +    D   F   L        E ++      ++                  
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL--------------HKID 228

Query: 393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH 435
           K  ER    E+      +  + + +   +   +R T     D 
Sbjct: 229 KEGERLPRPED---CPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.3 bits (187), Expect = 4e-16
 Identities = 21/117 (17%), Positives = 44/117 (37%), Gaps = 4/117 (3%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR-- 58
            R A   +  + Y  S   +HRD+   N+++   +  +++ D+GL        ++ V   
Sbjct: 114 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQE 172

Query: 59  -VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
                +          + + ++ D W  G  L  M    +  + G +    L +I K
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.6 bits (237), Expect = 2e-22
 Identities = 44/316 (13%), Positives = 105/316 (33%), Gaps = 44/316 (13%)

Query: 169 QQDDYQLVRKLGRGKYSEVFEAINVQSSD----KCVVKILKPVKKKK----IKREIKILE 220
           ++ +++ ++ LG G +  V++ + +   +       +K L+     K    I  E  ++ 
Sbjct: 7   KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66

Query: 221 NLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDY----DIRYYLYELLK 276
           ++    ++  L  +       T  LI + +         +   D      +  +  ++ K
Sbjct: 67  SVDN-PHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122

Query: 277 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKG 333
            ++Y     ++HRD+   NV++    + +++ D+GLA+     ++            +  
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 334 PELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK 393
            E +    Y  + D     +          +            E    L+K         
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEKG-------- 229

Query: 394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH-------PYFYPIVKDQS 446
             ER          + +    + K    D   R   RE +         P  Y +++   
Sbjct: 230 --ERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDE 284

Query: 447 RHTLPSSSPTPIVNSV 462
           R  LPS + +    ++
Sbjct: 285 RMHLPSPTDSNFYRAL 300

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.8 bits (170), Expect = 7e-14
 Identities = 18/117 (15%), Positives = 47/117 (40%), Gaps = 5/117 (4%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY---NV 57
           +      +  ++Y     ++HRD+   NV++    + +++ D+GLA+     ++      
Sbjct: 114 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEG 172

Query: 58  RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
                 +   E +   ++Y +  D+WS G  +  ++      + G    +    + K
Sbjct: 173 GKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 2e-22
 Identities = 50/306 (16%), Positives = 104/306 (33%), Gaps = 46/306 (15%)

Query: 158 WDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCV-----VKILKP----VK 208
           +D   +       D  +L + LGRG + +V EA               VK+LK      +
Sbjct: 3   YDASKWEFPR---DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 59

Query: 209 KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQT------- 261
            + +  E+KIL ++    N++ L      P      +I E     +     ++       
Sbjct: 60  HRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVP 118

Query: 262 ------------LTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLID 309
                       LT   +  Y +++ K +++  S   +HRD+   N+++  +N  +++ D
Sbjct: 119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICD 177

Query: 310 WGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTE 369
           +GLA   +   +Y   V     + P      +   +           ++ +         
Sbjct: 178 FGLARDIYKDPDY---VRKGDARLPLKWMAPETIFD---------RVYTIQSDVWSFGVL 225

Query: 370 NQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTA 429
              + S  A  +    I      +R +           +PE    +      +  +R T 
Sbjct: 226 LWEIFSLGASPYPGVKID-EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 284

Query: 430 REAMDH 435
            E ++H
Sbjct: 285 SELVEH 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.1 bits (160), Expect = 1e-12
 Identities = 21/118 (17%), Positives = 52/118 (44%), Gaps = 7/118 (5%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----N 56
           +  +   +  +++  S   +HRD+   N+++  +N  +++ D+GLA   +   +Y    +
Sbjct: 137 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGD 195

Query: 57  VRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
            R+  ++     +    ++Y    D+WS G +L  +       + G    ++  R  K
Sbjct: 196 ARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 94.8 bits (235), Expect = 2e-22
 Identities = 46/286 (16%), Positives = 107/286 (37%), Gaps = 35/286 (12%)

Query: 159 DYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILK--PVKKKKIKREI 216
           +Y+ + ++     D  +  KLG G+Y EV+E +  + S    VK LK   ++ ++  +E 
Sbjct: 8   NYDKWEMER---TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 64

Query: 217 KILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL-----YQTLTDYDIRYYL 271
            +++ ++   N++ L  V          +I E +   +          Q ++   + Y  
Sbjct: 65  AVMKEIKH-PNLVQLLGVCTREPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121

Query: 272 YELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASR 329
            ++  A++Y      +HRD+   N ++  EN  +++ D+GL+          +       
Sbjct: 122 TQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 330 YFKGPELLADYQYHIELDPR-FADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILG 388
            +  PE LA  ++ I+ D   F  +L   +      +   +   +               
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------------- 225

Query: 389 RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD 434
               +  E+    E       +  + +    +++  +R +  E   
Sbjct: 226 ---YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 67.8 bits (165), Expect = 3e-13
 Identities = 22/115 (19%), Positives = 45/115 (39%), Gaps = 3/115 (2%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-NVRV 59
           + +AT  S A++Y      +HRD+   N ++  EN  +++ D+GL+          +   
Sbjct: 118 LYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGA 176

Query: 60  ASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
                        Y  +    D+W+ G +L  +       + G D   Q+  + +
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLE 230

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.2 bits (231), Expect = 5e-22
 Identities = 45/298 (15%), Positives = 97/298 (32%), Gaps = 40/298 (13%)

Query: 169 QQDDYQLV-RKLGRGKYSEVFEAINVQSSDKCVV--KILKPVKKKK----IKREIKILEN 221
           ++D+  +   +LG G +  V + +      +  V  K+LK   +K     + RE +I+  
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQL----YQTLTDYDIRYYLYELLKA 277
           L     I+ L  V +        L+ E        +      + +   ++   L+++   
Sbjct: 66  LDN-PYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121

Query: 278 LDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----VASRYFKG 333
           + Y      +HRD+   NV++       ++ D+GL++       Y            +  
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 334 PELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK 393
           PE +   ++    D     +    +    ++           PE + F+++         
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVMAFIEQG-------- 228

Query: 394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTARE---AMDHPYFYPIVKDQSRH 448
             +R           PE    +     Y   +R         M   Y+    K +  H
Sbjct: 229 --KRMECPPE---CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.2 bits (166), Expect = 2e-13
 Identities = 17/117 (14%), Positives = 42/117 (35%), Gaps = 4/117 (3%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
             +    SM + Y      +HRD+   NV++       ++ D+GL++       Y    +
Sbjct: 112 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARS 170

Query: 61  SR---YFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +             +++ +    D+WS G  +   +   +  +      + +  I +
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 91.4 bits (226), Expect = 3e-21
 Identities = 28/191 (14%), Positives = 73/191 (38%), Gaps = 18/191 (9%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKIL-KPVKKKKIKREIKILENLRGGTNIITL 231
           Y++ R++G G +  +FE  N+ ++ +  +K   +     +++ E +  + L G T I  +
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 232 QAVVKDPVSRTPALIFEHVNNTDF---KQLYQTLTDYDIRYYLYELLKALDYCHSMGIMH 288
               ++       L+ + +  +         +  +   +     ++L  +   H   +++
Sbjct: 67  YYFGQEG--LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124

Query: 289 RDVKPHNVMID----HENRKLRLIDWGLAEFYHPG--------QEYNVRVASRYFKGPEL 336
           RD+KP N +I          + ++D+G+ +FY           +E      +  +     
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 337 LADYQYHIELD 347
               +     D
Sbjct: 185 HLGREQSRRDD 195

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 71.0 bits (173), Expect = 2e-14
 Identities = 21/155 (13%), Positives = 49/155 (31%), Gaps = 15/155 (9%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMID----HENRKLRLIDWGLAEFYHPG----- 52
             A      +   H   +++RD+KP N +I          + ++D+G+ +FY        
Sbjct: 105 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164

Query: 53  ---QEYNVRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 109
              +E      +  +         +      D+ +LG +    +      + G       
Sbjct: 165 IPYREKKNLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGS-LPWQGLKAATNK 222

Query: 110 VRIAKVLGTEELFEYLDKYHIELDPRFADILGRAR 144
            +  ++   ++    L +        F   +  AR
Sbjct: 223 QKYERIGEKKQST-PLRELCAGFPEEFYKYMHYAR 256

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 91.1 bits (225), Expect = 5e-21
 Identities = 39/302 (12%), Positives = 91/302 (30%), Gaps = 62/302 (20%)

Query: 170 QDDYQLVRKLGRGKYSEVFEA-----INVQSSDKCVVKILKPVK----KKKIKREIKILE 220
           +++ + VR +G G +  VF+A     +  +      VK+LK       +   +RE  ++ 
Sbjct: 12  RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 71

Query: 221 NLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ-------------------- 260
                  +  L             L+FE++   D  +  +                    
Sbjct: 72  EFDNPNIVKLLGVCAVGK---PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128

Query: 261 -------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
                   L+  +      ++   + Y      +HRD+   N ++  EN  +++ D+GL+
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLS 187

Query: 314 EFYHPGQEYNV---RVASRYFKGPELLADYQYHIELDP-RFADILGRHSRKRWERFVHTE 369
              +    Y           +  PE +   +Y  E D   +  +L        + +    
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247

Query: 370 NQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTA 429
           ++ ++           +   +     E             E  + +         +R + 
Sbjct: 248 HEEVI---------YYVRDGNILACPEN---------CPLELYNLMRLCWSKLPADRPSF 289

Query: 430 RE 431
             
Sbjct: 290 CS 291

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 80.3 bits (197), Expect = 2e-17
 Identities = 22/116 (18%), Positives = 45/116 (38%), Gaps = 3/116 (2%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNV--R 58
           + IA   +  + Y      +HRD+   N ++  EN  +++ D+GL+   +    Y     
Sbjct: 143 LCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGN 201

Query: 59  VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
            A      P     Y  Y    D+W+ G +L  +       ++G  + + +  +  
Sbjct: 202 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.6 bits (219), Expect = 2e-20
 Identities = 45/288 (15%), Positives = 96/288 (33%), Gaps = 39/288 (13%)

Query: 177 RKLGRGKYSEVFEAINVQSSD--KCVVKILK-----PVKKKKIKREIKILENLRGGTNII 229
           ++LG G +  V +             VKILK     P  K ++  E  +++ L     I+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIV 71

Query: 230 TLQAVVKDPVSRTPALIFEHVNNTDFKQL---YQTLTDYDIRYYLYELLKALDYCHSMGI 286
            +  + +     +  L+ E        +     + + D +I   ++++   + Y      
Sbjct: 72  RMIGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128

Query: 287 MHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR----VASRYFKGPELLADYQY 342
           +HRD+   NV++  ++   ++ D+GL++     + Y            +  PE +  Y++
Sbjct: 129 VHRDLAARNVLLVTQHY-AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 343 HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE 402
             + D      +       WE F  +  Q          +   +                
Sbjct: 188 SSKSD------VWSFGVLMWEAF--SYGQKPYRGMKGSEVTAMLEKGERMGCPAG----- 234

Query: 403 NQHLVSPEALDFLDKLLRYDHYERLTARE--AMDHPYFYPIVKDQSRH 448
                  E  D ++    YD   R            Y+Y +V ++  H
Sbjct: 235 ----CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV-NEGHH 277

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.4 bits (164), Expect = 3e-13
 Identities = 21/118 (17%), Positives = 47/118 (39%), Gaps = 6/118 (5%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVR-- 58
           + +    SM + Y      +HRD+   NV++  ++   ++ D+GL++     + Y     
Sbjct: 110 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY-AKISDFGLSKALRADENYYKAQT 168

Query: 59  --VASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
                  +  PE + +Y  +    D+WS G ++       +  + G    +    + K
Sbjct: 169 HGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.7 bits (219), Expect = 2e-20
 Identities = 41/280 (14%), Positives = 91/280 (32%), Gaps = 37/280 (13%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDK----CVVKILKPV----KKKKIKREIKILENL 222
                 + +G G++ EV++ +   SS K      +K LK      ++     E  I+   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 223 RGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKAL 278
               NII L+ V+         +I E++ N    +  +      +   +   L  +   +
Sbjct: 67  SH-HNIIRLEGVISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGP 334
            Y  +M  +HRD+   N++++  N   ++ D+GL+       E     +       +  P
Sbjct: 124 KYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 335 ELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR 394
           E ++  ++    D     I+        ER     + H    E +  ++           
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----EVMKAINDGFRLPTPMD- 237

Query: 395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD 434
                               + +  + +   R    + + 
Sbjct: 238 ------------CPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.4 bits (174), Expect = 2e-14
 Identities = 22/118 (18%), Positives = 51/118 (43%), Gaps = 6/118 (5%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----N 56
           + +  G +  + Y  +M  +HRD+   N++++  N   ++ D+GL+       E     +
Sbjct: 113 VGMLRGIAAGMKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTS 171

Query: 57  VRVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
                  +  PE ++  +    S D+WS G ++  ++   E  +    N++ +  I  
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.0 bits (212), Expect = 3e-19
 Identities = 47/294 (15%), Positives = 93/294 (31%), Gaps = 36/294 (12%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGG-TNII 229
               L   +G+G++ EV+        ++  VKI    +++   RE +I + +     NI+
Sbjct: 3   RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60

Query: 230 TLQAVV--KDPVSRTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHS-- 283
              A     +       L+ ++  +          T+T   +          L + H   
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 284 ------MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-----NVRVASRYFK 332
                   I HRD+K  N+++        + D GLA  +    +      N RV ++ + 
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 333 GPELLAD--YQYHIELDPR-----FADIL-----GRHSRKRWERFVHTENQHLVSPEALD 380
            PE+L D     H E   R        +              E +       + S  +++
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD 434
            + K +  +  R        +             + +    +   RLTA     
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCE---ALRVMAKIMRECWYANGAARLTALRIKK 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.3 bits (140), Expect = 5e-10
 Identities = 20/102 (19%), Positives = 39/102 (38%), Gaps = 11/102 (10%)

Query: 8   SMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY-----NVRVASR 62
              +       I HRD+K  N+++        + D GLA  +    +      N RV ++
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 63  YFKGPELLAD-----YQMYDYSLDMWSLGCMLASMIFRKEPF 99
            +  PE+L D     +       D++++G +   +  R    
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.3 bits (205), Expect = 2e-18
 Identities = 47/304 (15%), Positives = 106/304 (34%), Gaps = 31/304 (10%)

Query: 145 VYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDK---CVV 201
           V+ D+++  P      +  V+             +GRG +  V+    + +  K   C V
Sbjct: 2   VHIDLSALNPELVQAVQHVVIGPSSLI-VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 60

Query: 202 KILKPVKK----KKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQ 257
           K L  +       +   E  I+++     N+++L  +       +P ++  ++ + D + 
Sbjct: 61  KSLNRITDIGEVSQFLTEGIIMKDFSH-PNVLSLLGICLRS-EGSPLVVLPYMKHGDLRN 118

Query: 258 LYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA 313
             +      T  D+  +  ++ K + +  S   +HRD+   N M+D E   +++ D+GLA
Sbjct: 119 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADFGLA 177

Query: 314 EFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADI--LGRHSRKRWERFVHTENQ 371
              +  +  +V   +      + +A      +     +D+   G          +  E  
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG---------VLLWELM 228

Query: 372 HLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTARE 431
              +P   D    +I       +  R +  E          + + K        R +  E
Sbjct: 229 TRGAPPYPDVNTFDITVYL--LQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSE 283

Query: 432 AMDH 435
            +  
Sbjct: 284 LVSR 287

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.3 bits (174), Expect = 3e-14
 Identities = 24/118 (20%), Positives = 51/118 (43%), Gaps = 5/118 (4%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVA 60
           +      +  + +  S   +HRD+   N M+D E   +++ D+GLA   +  +  +V   
Sbjct: 133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNK 191

Query: 61  SRYFKGPELLA----DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
           +      + +A      Q +    D+WS G +L  ++ R  P +   + +D  V + +
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.7 bits (198), Expect = 2e-17
 Identities = 48/295 (16%), Positives = 101/295 (34%), Gaps = 47/295 (15%)

Query: 171 DDYQLVRKLGRGKYSEVFEAINVQSSD-------KCVVKILKPVKKKK----IKREIKIL 219
           D   L + LG G + +V  A  +           K  VK+LK    +K    +  E++++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 220 ENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ------------------- 260
           + +    NII L             +I E+ +  + ++  Q                   
Sbjct: 73  KMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 261 TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ 320
            L+  D+    Y++ + ++Y  S   +HRD+   NV++  +N   ++ D+GLA   H   
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHHID 189

Query: 321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALD 380
            Y  +  +      + +A       +    +D+    S       + T          ++
Sbjct: 190 YY--KKTTNGRLPVKWMAPEALFDRIYTHQSDV---WSFGVLLWEIFTLGGSPYPGVPVE 244

Query: 381 FLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH 435
            L K +   H   +             + E    +         +R T ++ ++ 
Sbjct: 245 ELFKLLKEGHRMDKPSN---------CTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.8 bits (149), Expect = 3e-11
 Identities = 26/117 (22%), Positives = 49/117 (41%), Gaps = 5/117 (4%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY---NV 57
           +  A   +  ++Y  S   +HRD+   NV++  +N   ++ D+GLA   H    Y     
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHHIDYYKKTTN 196

Query: 58  RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
                 +  PE L D ++Y +  D+WS G +L  +       + G    +    + +
Sbjct: 197 GRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.1 bits (194), Expect = 6e-17
 Identities = 35/291 (12%), Positives = 93/291 (31%), Gaps = 48/291 (16%)

Query: 171 DDYQLVRKLGRGKYSEVFEAIN-----VQSSDKCVVKILKPVK----KKKIKREIKILEN 221
           +   + R+LG+G +  V+E +       +   +  +K +        + +   E  +++ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 222 LRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ-------------TLTDYDIR 268
                 +  L  V +        +I E +   D K   +               +   + 
Sbjct: 80  FNCHHVVRLLGVVSQGQ---PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 269 YYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY---NVR 325
               E+   + Y ++   +HRD+   N M+  +   +++ D+G+    +    Y      
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKG 195

Query: 326 VASRYFKGPELLADYQYHIELDP-RFADILGRHSRKRWERFVHTENQHLVSPEALDFLDK 384
           +    +  PE L D  +    D   F  +L   +    + +    N+ ++         +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---------R 246

Query: 385 NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH 435
            ++      + +                + +    +Y+   R +  E +  
Sbjct: 247 FVMEGGLLDKPDN---------CPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.6 bits (151), Expect = 2e-11
 Identities = 23/117 (19%), Positives = 50/117 (42%), Gaps = 5/117 (4%)

Query: 1   MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY---NV 57
           +++A   +  + Y ++   +HRD+   N M+  +   +++ D+G+    +    Y     
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGK 194

Query: 58  RVASRYFKGPELLADYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 114
            +    +  PE L D  ++    D+WS G +L  +    E  + G  N   L  + +
Sbjct: 195 GLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 69.8 bits (170), Expect = 1e-14
 Identities = 41/201 (20%), Positives = 74/201 (36%), Gaps = 31/201 (15%)

Query: 173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKP----VKKKKIKREIKILENLRGGTNI 228
             + + +G GK S VF   + +   +CVVK  K      KK K KR+   L         
Sbjct: 2   DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 229 ITLQA----------VVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKAL 278
              +           V K       A++ E ++  +  ++       +    L  +L+ +
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRV----ENPDEVLDMILEEV 116

Query: 279 DYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEY----NVRVASRYFKG 333
              +  GI+H D+  +NV++  E     +ID+  + E    G       +VR    YF  
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEGIW--IIDFPQSVEVGEEGWREILERDVRNIITYFSR 174

Query: 334 PELLADYQYHIELDPRFADIL 354
                 Y+   +++     IL
Sbjct: 175 -----TYRTEKDINSAIDRIL 190

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 52.5 bits (125), Expect = 1e-08
 Identities = 18/93 (19%), Positives = 33/93 (35%), Gaps = 15/93 (16%)

Query: 2   RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA-EFYHPGQEY----N 56
            +       +   +  GI+H D+  +NV++  E     +ID+  + E    G       +
Sbjct: 107 EVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIW--IIDFPQSVEVGEEGWREILERD 164

Query: 57  VRVASRYFKGPELLADYQMYDYSLDMWSLGCML 89
           VR    YF         + Y    D+ S    +
Sbjct: 165 VRNIITYFS--------RTYRTEKDINSAIDRI 189

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	467
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.93
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.93
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.93
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.93
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.93
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.93
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.92
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.92
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.92
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.92
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.92
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.92
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.92
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.92
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.92
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.92
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.92
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.92
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.92
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.91
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.91
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.91
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.91
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.91
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.91
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.91
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.91
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.91
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.91
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.9
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.9
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.9
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.9
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.9
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.9
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.9
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.9
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.9
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.9
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.89
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.89
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.89
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.89
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.89
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.89
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.89
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.89
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.88
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.88
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.88
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.88
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.88
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.88
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.88
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.88
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.87
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.87
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.86
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.86
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.85
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.85
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.8
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.32
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.23
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.82
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.64
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.62
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.0
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.53
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	90.0
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	84.22
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	83.41

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.2e-57  Score=439.61  Aligned_cols=304  Identities=80%  Similarity=1.280  Sum_probs=254.0

Q ss_pred             ccccccccccCCCCCcccccCccccccCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHH
Q psy3714         141 GRARVYADVNSHKPREYWDYESYVVDWGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILE  220 (467)
Q Consensus       141 ~~~~v~~~~~~~~p~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~  220 (467)
                      ++.+++...+.+.|.++|++....+.++..++|++++.||+|+||+||+|+++.+++.||||+++....+++.+|+++|+
T Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~   84 (328)
T d3bqca1           5 SRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE   84 (328)
T ss_dssp             CCCSSSTTTTTTSCHHHHCGGGCCCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHH
T ss_pred             CcceeeccccccCCCccchhhhcccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHH
Confidence            46778889999999999999999999999999999999999999999999999999999999999888888999999999


Q ss_pred             HhcCCCCeeEEEEEEeCCCCCccEEEEeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC
Q psy3714         221 NLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH  300 (467)
Q Consensus       221 ~l~~~~~iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~  300 (467)
                      .+++||||+++++++..+.....++||||+.+++|.+..+.+++.+++.++.||+.||+|||++|||||||||+|||++.
T Consensus        85 ~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~  164 (328)
T d3bqca1          85 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH  164 (328)
T ss_dssp             HHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred             hccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC
Confidence            99889999999999987767789999999999999988889999999999999999999999999999999999999997


Q ss_pred             CCCcEEEEecccceecCCCCCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcc-------
Q psy3714         301 ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQH-------  372 (467)
Q Consensus       301 ~~~~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~-------  372 (467)
                      ++..+||+|||+|+...+.......+||+.|+|||++.+.. |+.++|+|+.+++......+..||....+..       
T Consensus       165 ~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~  244 (328)
T d3bqca1         165 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA  244 (328)
T ss_dssp             TTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH
T ss_pred             CCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHH
Confidence            77679999999999887776677788999999999988764 7999999988887666556656654433210       


Q ss_pred             --cCChhhhhhhhh----------hccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         373 --LVSPEALDFLDK----------NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       373 --~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                        ++.+........          ..........|...........+|++++|||++||++||++||||+|+|+||||++
T Consensus       245 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             HHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence              001111111110          11222333445444444555668999999999999999999999999999999998


Q ss_pred             cccc
Q psy3714         441 IVKD  444 (467)
Q Consensus       441 ~~~~  444 (467)
                      +.|+
T Consensus       325 v~~~  328 (328)
T d3bqca1         325 VVKD  328 (328)
T ss_dssp             SCCC
T ss_pred             CCCC
Confidence            8764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-53  Score=398.76  Aligned_cols=251  Identities=22%  Similarity=0.349  Sum_probs=202.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .++|++++.||+|+||+||+|.++.+++.||||+++...    .+.+.+|+++|+.++ ||||+++++++.+.  ...|+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~--~~~~i   80 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREG--NIQYL   80 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCC-CTTBCCEEEEEEET--TEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCC-CCCEeeEeeeeccC--ceeEE
Confidence            478999999999999999999999999999999986432    346789999999996 89999999999864  56899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC--
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~--  320 (467)
                      ||||+++++|.+++.   .+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+......  
T Consensus        81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECEETTEE
T ss_pred             EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-CEEEccchhheeeccCCcc
Confidence            999999999987753   589999999999999999999999999999999999998655 79999999999764322  


Q ss_pred             -CcceeeeccCccCCcccccCCC-CccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         321 -EYNVRVASRYFKGPELLADYQY-HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       321 -~~~~~~gt~~y~aPE~l~~~~~-~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                       ..+..+||+.|||||++.+..| +.++|+|+.+++.+....+..||.......    .......   ....        
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~~~~~---~~~~--------  224 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----QEYSDWK---EKKT--------  224 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS----HHHHHHH---TTCT--------
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH----HHHHHHh---cCCC--------
Confidence             2345689999999999998886 567999999988777666666664322110    0000000   0000        


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                       ....+..+|++++|||++||+.||++|||++|+|+||||..
T Consensus       225 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         225 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             -CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence             01112357999999999999999999999999999999964

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=398.94  Aligned_cols=260  Identities=23%  Similarity=0.381  Sum_probs=210.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++++.||+|+||+||+|.++.+++.||||+++..      ..+.+.+|+++|++++ ||||+++++++.+.  ...
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~--~~~   83 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDD--EKL   83 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECS--SEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEEC--CEE
Confidence            37899999999999999999999999999999998642      2356889999999996 89999999999864  568


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      |+||||+++++|.++..   .+++..++.++.|++.||+|||++|||||||||+|||++.++ .+||+|||+|+......
T Consensus        84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPES  162 (288)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECC---
T ss_pred             EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc-eEEecccccceecccCC
Confidence            99999999999977653   589999999999999999999999999999999999999655 79999999999764322


Q ss_pred             ---CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         321 ---EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       321 ---~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                         .....+||+.|+|||++.+..|+.++|+|+.+++.+....+..||....        ...... .+...    .   
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~-~i~~~----~---  226 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQ-KIIKL----E---  226 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH-HHHTT----C---
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHH-HHHcC----C---
Confidence               2344689999999999999999999999999998777777666654321        111111 11110    0   


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCCHHH------HhCCCCCCCcccccccCCCCC
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLTARE------AMDHPYFYPIVKDQSRHTLPS  452 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e------~l~Hp~f~~~~~~~~~~~~~~  452 (467)
                         ...+..+|++++|||++||+.||++|||++|      +++||||.+++|+..+...|+
T Consensus       227 ---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP  284 (288)
T d1uu3a_         227 ---YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP  284 (288)
T ss_dssp             ---CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCC
T ss_pred             ---CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCC
Confidence               0123458999999999999999999999988      589999999999877665443

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=405.02  Aligned_cols=254  Identities=22%  Similarity=0.363  Sum_probs=211.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++++.||+|+||.||+|+++.+++.||||++++.      ..+.+.+|+.+|+.++ ||||+++++++.+.  ...
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~--~~~   80 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTH--DRL   80 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECS--SEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccc--ccc
Confidence            47899999999999999999999999999999998643      2356789999999996 89999999999874  568


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC-C
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-G  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~-~  319 (467)
                      |+||||+++|+|..+..   .+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.... .
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC-CEEEeecccccccccCC
Confidence            99999999999977654   589999999999999999999999999999999999999655 799999999997543 3


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      ......+||+.|+|||++.+.+|+.++|+|+.+++.+....|..||.....        ...........          
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~~~~----------  221 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEE----------  221 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC----------
T ss_pred             cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHhcCC----------
Confidence            445567999999999999999999999999999987777776666543221        11111111110          


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccc
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~  446 (467)
                       ...+..+|++++|||++||++||++|+     |++|+++||||.+++|+..
T Consensus       222 -~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l  272 (337)
T d1o6la_         222 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV  272 (337)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             -CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHH
Confidence             112345899999999999999999999     4999999999999887544

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-52  Score=397.82  Aligned_cols=251  Identities=21%  Similarity=0.335  Sum_probs=206.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      .++|++++.||+|+||+||+|.++.+++.||||+++..   ..+.+.+|+.+|+.++ |||||++++++.+.  ...|+|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~--~~~~iv   95 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLVG--DELWVV   95 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEET--TEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCC-CCCEeeEeEEEEEC--CEEEEE
Confidence            35799999999999999999999999999999998643   3467899999999996 89999999999864  568999


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-Ccc
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYN  323 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~~~  323 (467)
                      |||+++++|.++..  .+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+.... ...
T Consensus        96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBC
T ss_pred             EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-cEeeccchhheeecccccccc
Confidence            99999999987764  589999999999999999999999999999999999998655 79999999999875433 345


Q ss_pred             eeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccccC
Q psy3714         324 VRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTEN  403 (467)
Q Consensus       324 ~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
                      ..+||+.|+|||++.+..|+.++|+|+.+++.+....+..||.....        ............        .....
T Consensus       175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~~~~~~~--------~~~~~  238 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGT--------PELQN  238 (293)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHHCS--------CCCSS
T ss_pred             ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH--------HHHHHHHHhCCC--------CCCCC
Confidence            56899999999999999999999999999987777776666533211        111111100000        01122


Q ss_pred             CCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         404 QHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       404 ~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      +..+|++++|||++||+.||++|||++|+|+||||..
T Consensus       239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            3458999999999999999999999999999999963

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-52  Score=390.89  Aligned_cols=246  Identities=24%  Similarity=0.374  Sum_probs=204.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++++.||+|+||+||+|.++.+++.||+|++.+.      ....+.+|+++|+.++ ||||+++++++.+.  ...
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~--~~~   81 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDA--TRV   81 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS--SEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEEC--CEE
Confidence            47899999999999999999999999999999998642      2356789999999995 89999999999864  568


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++||||+++|+|.+++.   .+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..... 
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~~~~~~-  159 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSS-  159 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCSCSCCCCC-
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC-CEeecccceeeecCCC-
Confidence            99999999999987653   589999999999999999999999999999999999999665 7999999999876433 


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      .....+||+.|||||++.+..|+.++|+|+.+++.+....+..||....        ....... +...          .
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~-i~~~----------~  220 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKR-ISRV----------E  220 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHH-HHTT----------C
T ss_pred             cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHH-HHcC----------C
Confidence            3455689999999999999999999999999988777666666653221        1111111 1100          0


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                      ...+..+|++++|||.+||+.||++|||++|+|+||||.
T Consensus       221 ~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         221 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence            112345899999999999999999999999999999996

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.8e-51  Score=401.96  Aligned_cols=257  Identities=22%  Similarity=0.387  Sum_probs=211.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      .++|++++.||+|+||.||+|.++.+|+.||||++...   ..+.+.+|+.+|+.++ |||||++++++.+.  ...++|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~--~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDD--NEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEET--TEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC--CEEEEE
Confidence            36899999999999999999999999999999998653   2456789999999996 89999999999864  578999


Q ss_pred             EeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC-CCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~-~~~ikl~DFGla~~~~~~~~  321 (467)
                      |||+++++|.+++.    .+++.+++.++.||+.||+|||++|||||||||+|||++.+ ++.+||+|||+|+.......
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            99999999987762    48999999999999999999999999999999999999743 45799999999998876666


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+||+.|||||++.+..|+.++|+|+.+++.+....|..||.....     .+....+..   ..     +.  ...
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~---~~-----~~--~~~  246 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETLRNVKS---CD-----WN--MDD  246 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH---TC-----CC--SCC
T ss_pred             cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHHHh---CC-----CC--CCc
Confidence            6778999999999999999999999999999987777666666532211     111111100   00     00  011


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                      ..+..+|++++|||++||++||++|||++|+|+||||.+..+.
T Consensus       247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            1223589999999999999999999999999999999876643

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=404.94  Aligned_cols=270  Identities=19%  Similarity=0.276  Sum_probs=205.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .|+|++++.||+|+||+||+|.++.+++.||+|+++..    ....+.+|+.+|+.++ |||||++++++.++  ...++
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~i   81 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSD--GEISI   81 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECS--SEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC--CEEEE
Confidence            58999999999999999999999999999999998642    2457889999999996 89999999999875  46899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      ||||+++++|.+++.   .+++..++.++.|++.||.|||+ +|||||||||+|||++.++ .+||+|||+|+...+. .
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~-~  159 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M  159 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH-T
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccccCCC-c
Confidence            999999999988764   58999999999999999999997 5999999999999998655 7999999999876432 2


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCccc---CChhhhh----------hhhhh---
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHL---VSPEALD----------FLDKN---  385 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~----------~~~~~---  385 (467)
                      .+..+||++|||||++.+..|+.++|+|+.+++.+....+..||........   .......          .....   
T Consensus       160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            3456899999999999999999999999999887777677667654322100   0000000          00000   


Q ss_pred             -ccCCCCccc----cccccc----ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         386 -ILGRHSRKR----WERFVH----TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       386 -~~~~~~~~~----~~~~~~----~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                       .........    ......    ......+|++++|||.+||++||++||||+|+|+||||...+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~  307 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  307 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence             000000000    000000    00112368999999999999999999999999999999866554

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-51  Score=395.48  Aligned_cols=253  Identities=24%  Similarity=0.416  Sum_probs=191.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      .+.|++.+.||+|+||+||+|.++.+++.||||++...    ....+.+|+.+|+.++ ||||+++++++.+.  ...|+
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~l   84 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPNIVALDDIYESG--GHLYL   84 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCC-CTTBCCEEEEEECS--SEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC--CEEEE
Confidence            36799999999999999999999999999999998643    2345778999999996 89999999999864  56899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC--CCCcEEEEecccceecCCCC
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~--~~~~ikl~DFGla~~~~~~~  320 (467)
                      ||||+++++|.+++.   .+++.+++.++.||+.||+|||++|||||||||+|||+..  +++.+||+|||+|+....+.
T Consensus        85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            999999999988764   5899999999999999999999999999999999999963  34579999999999876666


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      .....+||+.|||||++.+..|+.++|+|+.+++.+....+..||.....        ..... .+.....      ...
T Consensus       165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~-~i~~~~~------~~~  229 (307)
T d1a06a_         165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--------AKLFE-QILKAEY------EFD  229 (307)
T ss_dssp             --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHH-HHHTTCC------CCC
T ss_pred             eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--------HHHHH-HHhccCC------CCC
Confidence            56667899999999999999999999999999887776666666543211        11111 1111000      011


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      .+.+..+|++++|||++||++||++|||++|+|+||||.+
T Consensus       230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            1223468999999999999999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=387.52  Aligned_cols=249  Identities=22%  Similarity=0.347  Sum_probs=191.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      .++|++++.||+|+||+||+|.++.+++.||+|.++..     ..+.+.+|+++|+.++ ||||+++++++.+.....+|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence            47999999999999999999999999999999998643     2355789999999996 89999999998766566789


Q ss_pred             EEEeccCCccHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCceEEeCCCCcEEEEeccc
Q psy3714         245 LIFEHVNNTDFKQLYQ-------TLTDYDIRYYLYELLKALDYCHSMG-----IMHRDVKPHNVMIDHENRKLRLIDWGL  312 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qll~al~~lH~~~-----IiHrDlKp~Nill~~~~~~ikl~DFGl  312 (467)
                      +||||+++|+|.+++.       .+++..++.++.||+.||+|||++|     ||||||||+|||++.++ .+||+|||+
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DFG~  160 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGL  160 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-CEEECCHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-cEEEeeccc
Confidence            9999999999987753       4899999999999999999999976     99999999999999655 799999999


Q ss_pred             ceecCCCCC-cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         313 AEFYHPGQE-YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       313 a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      |+....... ....+||+.|||||++.+..|+.++|+|+.+++.+....+..||.....     .+....+..   +   
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~~~~~i~~---~---  229 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIRE---G---  229 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHH---T---
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HHHHHHHHc---C---
Confidence            987654332 3457899999999999999999999999999887766666655532110     111111111   0   


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                        .+.     ..+..+|+++++||++||+.||++|||++|+|+|||+
T Consensus       230 --~~~-----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         230 --KFR-----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             --CCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             --CCC-----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence              010     1233579999999999999999999999999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=392.06  Aligned_cols=252  Identities=21%  Similarity=0.297  Sum_probs=202.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ..|.|++++.||+|+||.||+|.++.+++.||||+++..   ..+.+.+|+++|+.++ |||||++++++.++  ...++
T Consensus        10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~--~~~~l   86 (288)
T d2jfla1          10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYYE--NNLWI   86 (288)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEET--TEEEE
T ss_pred             cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeC--CeEEE
Confidence            457899999999999999999999999999999998653   3357889999999996 89999999998864  56899


Q ss_pred             EEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-C
Q psy3714         246 IFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-Q  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~  320 (467)
                      ||||+++++|.++..    .+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..... .
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHHHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-CEEEEechhhhccCCCcc
Confidence            999999999987642    489999999999999999999999999999999999999655 7999999999865322 1


Q ss_pred             CcceeeeccCccCCcccc-----cCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         321 EYNVRVASRYFKGPELLA-----DYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~-----~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      .....+||+.|||||++.     +..|+.++|+|+.+++.+....+..||......     +..   .....+...    
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-----~~~---~~i~~~~~~----  233 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-----RVL---LKIAKSEPP----  233 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----GHH---HHHHHSCCC----
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-----HHH---HHHHcCCCC----
Confidence            233568999999999984     455889999999998877666666665332111     111   111001100    


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                          ....+..+|++++|||++||+.||++|||++|+|+||||..
T Consensus       234 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         234 ----TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             ----CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ----CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                11122357999999999999999999999999999999974

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.9e-51  Score=391.67  Aligned_cols=252  Identities=21%  Similarity=0.385  Sum_probs=209.4

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++++.||+|+||+||+|.++.+|+.||||++++.      ..+.+.+|+.+|+.++ ||||+++++++.++  ...
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~--~~~   79 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDA--QQI   79 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECS--SEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeC--Cee
Confidence            47899999999999999999999999999999998642      2356889999999995 89999999999864  578


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      |+||||+.++++.....   .+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+....  
T Consensus        80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~~~~--  156 (316)
T d1fota_          80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD--  156 (316)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS--
T ss_pred             eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC-CEEEecCccceEecc--
Confidence            99999999999877654   478899999999999999999999999999999999999655 799999999998643  


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      .....+||+.|||||++.+..|+.++|+|+.+++.+....+..||....        ....... +...          .
T Consensus       157 ~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~-i~~~----------~  217 (316)
T d1fota_         157 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEK-ILNA----------E  217 (316)
T ss_dssp             CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHH-HHHC----------C
T ss_pred             ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--------HHHHHHH-HHcC----------C
Confidence            2345689999999999999999999999999998877777766664321        1111111 1100          0


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccc
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~  446 (467)
                      ...++.+|++++|||++||++||.+|+     |++|+|+||||.+++|+..
T Consensus       218 ~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l  268 (316)
T d1fota_         218 LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL  268 (316)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHH
Confidence            112345899999999999999999997     9999999999999988754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=388.31  Aligned_cols=259  Identities=25%  Similarity=0.405  Sum_probs=208.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---------KKKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .+.|++.+.||+|+||+||+|.++.+|+.||||++++.         ..+.+.+|+.+|+.++ |||||++++++.+.  
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~--   85 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYENK--   85 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS--
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC--
Confidence            36799999999999999999999999999999998642         2457899999999996 89999999999874  


Q ss_pred             CccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC---cEEEEecccce
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR---KLRLIDWGLAE  314 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~---~ikl~DFGla~  314 (467)
                      ...++|||||++++|.+++.   .+++..++.++.|++.||+|||++|||||||||+|||++.++.   .+||+|||+|+
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            56899999999999987753   5999999999999999999999999999999999999986542   59999999999


Q ss_pred             ecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         315 FYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       315 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ....+......+||+.|+|||++.+..|+.++|+|+.+++.+....+..||.....        ..... .+.....  .
T Consensus       166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~-~i~~~~~--~  234 (293)
T d1jksa_         166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLA-NVSAVNY--E  234 (293)
T ss_dssp             ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-HHHTTCC--C
T ss_pred             hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--------HHHHH-HHHhcCC--C
Confidence            88766666677899999999999998999999999999887766666666543211        11111 1111000  0


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccccc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~~  446 (467)
                      +    ....+..+|++++|||++||+.||++|||++|+|+||||.+.++.+.
T Consensus       235 ~----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~  282 (293)
T d1jksa_         235 F----EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA  282 (293)
T ss_dssp             C----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC------
T ss_pred             C----CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHh
Confidence            0    11122458999999999999999999999999999999998765443

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.4e-51  Score=397.24  Aligned_cols=254  Identities=24%  Similarity=0.411  Sum_probs=210.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc---hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV---KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      .++|++++.||+|+||.||+|.++.+++.||||+++..   ....+.+|+.+|+.++ |||||++++++.+.  ...|+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~--~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDK--YEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC-STTBCCEEEEEECS--SEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC--CEEEEE
Confidence            47899999999999999999999999999999998753   2456789999999995 89999999999864  568999


Q ss_pred             EeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC-CCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH-ENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~-~~~~ikl~DFGla~~~~~~~~  321 (467)
                      ||||++++|.+...    .+++.+++.++.||+.||+|||++|||||||||+|||++. .++.+||+|||+|+...+...
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            99999999987653    4899999999999999999999999999999999999974 345899999999999877766


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....+||+.|+|||++.+..|+.++|+|+.+++.+....+..||.....        .............       ...
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~~-------~~~  249 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKRCDWE-------FDE  249 (352)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHCCCC-------CCS
T ss_pred             eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCC-------CCc
Confidence            6778899999999999999999999999999987777777666643211        1111111001000       011


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                      ..+..+|++++|||++||++||++|||++|+|+||||.+.
T Consensus       250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            2234689999999999999999999999999999999764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=380.99  Aligned_cols=248  Identities=17%  Similarity=0.329  Sum_probs=198.1

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC--CCCccEE
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDP--VSRTPAL  245 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~--~~~~~~l  245 (467)
                      |++.++||+|+||+||+|.+..+++.||+|.++..     ..+.+.+|+++|+.++ |||||++++++.+.  ....+++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEEE
Confidence            47778899999999999999999999999988643     2356789999999996 89999999988643  2345799


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~--IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ||||+++++|.+++.   .+++.+++.++.||+.||+|||++|  ||||||||+|||++.+++.+||+|||+|+.... .
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-~  168 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-S  168 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-T
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-C
Confidence            999999999987764   5899999999999999999999999  999999999999975556899999999986533 3


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      .....+||+.|||||++.+ .|+.++|+|+.+++.+....+..||....+.     .  . ....+.......       
T Consensus       169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~--~-~~~~i~~~~~~~-------  232 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----A--Q-IYRRVTSGVKPA-------  232 (270)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----H--H-HHHHHTTTCCCG-------
T ss_pred             ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----H--H-HHHHHHcCCCCc-------
Confidence            3456789999999999865 5999999999998877766666665432211     1  1 111111111111       


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFY  439 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~  439 (467)
                       ..+...+++++|||.+||+.||++|||++|+|+||||.
T Consensus       233 -~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         233 -SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence             11234789999999999999999999999999999984

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-50  Score=393.82  Aligned_cols=252  Identities=19%  Similarity=0.330  Sum_probs=209.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      .++|++++.||+|+||.||+|.++.+|+.||||++++.      ..+.+.+|+.+|+.++ |||||++++++.+.  ...
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~--~~~  116 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDN--SNL  116 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECS--SEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccccc--ccc
Confidence            47999999999999999999999999999999998642      2356789999999995 89999999999864  568


Q ss_pred             EEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      ++||||+.++++...+.   .+++.+++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+..... 
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSC-
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC-CEEeeeceeeeecccc-
Confidence            99999999999877653   589999999999999999999999999999999999998655 7999999999987532 


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                       ....+||+.|||||++.+..|+.++|+|+.+++.+....+..||....        ..........+           .
T Consensus       195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~-----------~  254 (350)
T d1rdqe_         195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSG-----------K  254 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-----------C
T ss_pred             -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--------HHHHHHHHhcC-----------C
Confidence             345689999999999999999999999999998777777766664321        11111111000           0


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccc
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~  446 (467)
                      ...+..+|++++|||++||++||++|+     |++|+|+||||++++|+..
T Consensus       255 ~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~  305 (350)
T d1rdqe_         255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI  305 (350)
T ss_dssp             CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred             CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHH
Confidence            112345899999999999999999995     9999999999999988644

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-51  Score=395.81  Aligned_cols=258  Identities=22%  Similarity=0.335  Sum_probs=206.9

Q ss_pred             ccceeeeE-eecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC--CCCccEEE
Q psy3714         170 QDDYQLVR-KLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDP--VSRTPALI  246 (467)
Q Consensus       170 ~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~--~~~~~~lv  246 (467)
                      .++|++++ .||+|+||.||+|.+..+++.||||+++.  ...+.+|+.++.++.+|||||++++++.+.  ....+|+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv   87 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   87 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence            47899986 59999999999999999999999999874  356789999988777799999999998652  23568999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC--CCcEEEEecccceecCCC
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~--~~~ikl~DFGla~~~~~~  319 (467)
                      ||||++|+|.+++.     .+++.+++.++.||+.||+|||++||+||||||+|||++..  .+.+||+|||+|+.....
T Consensus        88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~  167 (335)
T d2ozaa1          88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  167 (335)
T ss_dssp             EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred             EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC
Confidence            99999999988763     38999999999999999999999999999999999999853  346999999999987766


Q ss_pred             CCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         320 QEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       320 ~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                      ......+||+.|||||++.+..|+.++|+|+.+++.+....+..||........     .......+..  ....+    
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-----~~~~~~~i~~--~~~~~----  236 (335)
T d2ozaa1         168 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPGMKTRIRM--GQYEF----  236 (335)
T ss_dssp             CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCS--CSSSC----
T ss_pred             CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-----HHHHHHHHhc--CCCCC----
Confidence            666678899999999999999999999999999988877777777644321110     0000000000  00000    


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      ....+..+|++++|||++||++||++|||++|+|+||||..
T Consensus       237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence            00112247999999999999999999999999999999954

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.6e-49  Score=388.98  Aligned_cols=257  Identities=21%  Similarity=0.342  Sum_probs=204.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhc--CCCCeeEEEEEEeCCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLR--GGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~--~~~~iv~l~~~~~~~~~~  241 (467)
                      .++|++++.||+|+||.||+|.++.+|+.||||++.+..      .....+|..+++.++  +|||||++++++.+.  .
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--~   80 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--D   80 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--S
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--C
Confidence            578999999999999999999999999999999986421      233455544444443  489999999999874  5


Q ss_pred             ccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      ..|+||||+++++|.+++.   .+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+....
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-~iKl~DFGla~~~~~  159 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-CEEECCCTTCEECSS
T ss_pred             EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-cEEEeeeceeeecCC
Confidence            6899999999999987764   488999999999999999999999999999999999998655 799999999997754


Q ss_pred             CCCcceeeeccCccCCccccc-CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccc
Q psy3714         319 GQEYNVRVASRYFKGPELLAD-YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWER  397 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (467)
                      .. ....+||+.|+|||++.. ..|+.++|+|+.+++.+....+..||......     ....... .+..         
T Consensus       160 ~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~~~-~~~~---------  223 (364)
T d1omwa3         160 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDR-MTLT---------  223 (364)
T ss_dssp             SC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-----CHHHHHH-HSSS---------
T ss_pred             Cc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH-hccc---------
Confidence            43 345689999999999975 56899999999999888777777776432211     1111111 1110         


Q ss_pred             cccccCCCCCChHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCcccccc
Q psy3714         398 FVHTENQHLVSPEALDFLDKLLRYDHYERLT-----AREAMDHPYFYPIVKDQS  446 (467)
Q Consensus       398 ~~~~~~~~~~s~~~~dli~~lL~~dp~~R~t-----a~e~l~Hp~f~~~~~~~~  446 (467)
                       .....+..+|++++|||.+||++||++|||     |+|+++||||.+++|...
T Consensus       224 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~  276 (364)
T d1omwa3         224 -MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV  276 (364)
T ss_dssp             -CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHH
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHH
Confidence             011223458999999999999999999999     899999999999987543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=383.76  Aligned_cols=254  Identities=21%  Similarity=0.299  Sum_probs=207.3

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      |+|++++.||+|+||+||+|.++.+++.||||++++.      ......+|+.++....+||||+++++++.+.  ...|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLF   79 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Ccee
Confidence            7899999999999999999999999999999998642      2345677888776544699999999999874  5689


Q ss_pred             EEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-C
Q psy3714         245 LIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-Q  320 (467)
Q Consensus       245 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~  320 (467)
                      +||||+++|+|.+++.   .+++.+++.++.||+.||+|||++|||||||||+|||++..+ .+||+|||+|+..... .
T Consensus        80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTTC
T ss_pred             EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC-ceeccccchhhhcccccc
Confidence            9999999999988763   589999999999999999999999999999999999999554 7999999999866433 3


Q ss_pred             CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         321 EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      ..+..+||+.|+|||++.+..|+.++|+|+.+++.+....|..||.....        .........+           .
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~-----------~  219 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMD-----------N  219 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-----------C
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC-----------C
Confidence            34456899999999999999999999999999987777776666543211        1111111000           1


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHH-HHhCCCCCCCcccccc
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAR-EAMDHPYFYPIVKDQS  446 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~-e~l~Hp~f~~~~~~~~  446 (467)
                      ...+..+|++++|||++||++||++|||++ |+++||||.+++|+..
T Consensus       220 ~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l  266 (320)
T d1xjda_         220 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL  266 (320)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred             CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHHH
Confidence            112345899999999999999999999996 8999999999887644

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-50  Score=384.26  Aligned_cols=267  Identities=24%  Similarity=0.420  Sum_probs=203.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccC-CCeEEEEEeccc-----hHHHHHHHHHHHHHhc--CCCCeeEEEEEEeCC---
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQS-SDKCVVKILKPV-----KKKKIKREIKILENLR--GGTNIITLQAVVKDP---  238 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~avK~~~~~-----~~~~~~~Ei~il~~l~--~~~~iv~l~~~~~~~---  238 (467)
                      .++|++++.||+|+||+||+|.+..+ ++.||||+++..     ......+|+.+|+.|.  +||||+++++++...   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999999776 556899998642     1335778999998885  699999999887532   


Q ss_pred             CCCccEEEEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccce
Q psy3714         239 VSRTPALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE  314 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~  314 (467)
                      .....+++|||+.++.+....    ..+++..++.++.|++.||+|||++|||||||||+|||++..+ .+||+|||+++
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-~~kl~dfg~~~  164 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLAR  164 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-Ceeecchhhhh
Confidence            234679999999998765332    2488999999999999999999999999999999999998655 79999999998


Q ss_pred             ecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         315 FYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       315 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ...........+||+.|||||++.+..|+.++|+|+.+++.+....+..||......     +....+. ...+......
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-----~~~~~i~-~~~~~~~~~~  238 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKIL-DVIGLPGEED  238 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHH-HHHCCCCGGG
T ss_pred             hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-----HHHHHHH-HhhCCCchhc
Confidence            765555566778999999999999999999999999998877766666665432211     0000000 0000000000


Q ss_pred             cc--------------ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         395 WE--------------RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       395 ~~--------------~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      |.              ..........+|++++|||++||++||++||||+|+|+||||.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            00              00011123457999999999999999999999999999999998753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=381.16  Aligned_cols=258  Identities=25%  Similarity=0.415  Sum_probs=195.1

Q ss_pred             eeeEeecccCCcceEEEEEccCCCeEEEEEeccch--------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         174 QLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       174 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      +.++.||+|+||+||+|.++.+++.||||+++...        .+.+.+|+.+|+.++ |||||++++++.+.  ...++
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~--~~~~i   77 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHK--SNISL   77 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCT--TCCEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccC--Cceee
Confidence            35789999999999999999999999999986432        235789999999996 89999999999764  56899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-CC
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QE  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~~  321 (467)
                      ||||+.++++..+..   .+++.+++.+++||+.||+|||++|||||||||+|||++..+ .+||+|||+|+..... ..
T Consensus        78 vmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          78 VFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             EEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCCCC
T ss_pred             hhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC-ccccccCccccccCCCccc
Confidence            999999988776653   488999999999999999999999999999999999999655 7999999999876433 23


Q ss_pred             cceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc------
Q psy3714         322 YNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR------  394 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  394 (467)
                      ....+||+.|+|||++... .|+.++|+|+.+++.+....+..+|....+.     +....+.. ..+......      
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-----~~l~~i~~-~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-----DQLTRIFE-TLGTPTEEQWPDMCS  230 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH-HHCCCCTTTSSSTTS
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-----HHHHHHHH-hcCCCChhhccchhc
Confidence            3456899999999998765 4799999999998877666655444222110     00000000 000000000      


Q ss_pred             ------cccc---ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCc
Q psy3714         395 ------WERF---VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPI  441 (467)
Q Consensus       395 ------~~~~---~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~  441 (467)
                            +..+   ........+|++++|||++||++||++||||+|+|+||||.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence                  0000   0011123579999999999999999999999999999999754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.6e-49  Score=373.57  Aligned_cols=253  Identities=24%  Similarity=0.390  Sum_probs=206.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------------HHHHHHHHHHHHHhcCCCCeeEEEEEEeC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------------KKKIKREIKILENLRGGTNIITLQAVVKD  237 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~  237 (467)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...            .+.+.+|+.+|++++.||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            479999999999999999999999999999999986421            23578999999999889999999999986


Q ss_pred             CCCCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccce
Q psy3714         238 PVSRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAE  314 (467)
Q Consensus       238 ~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~  314 (467)
                      +  ...|+||||+++++|.+++.   .+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+
T Consensus        82 ~--~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~  158 (277)
T d1phka_          82 N--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSC  158 (277)
T ss_dssp             S--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred             C--cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC-CeEEccchhee
Confidence            4  57899999999999987763   589999999999999999999999999999999999998554 79999999999


Q ss_pred             ecCCCCCcceeeeccCccCCccccc------CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccC
Q psy3714         315 FYHPGQEYNVRVASRYFKGPELLAD------YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILG  388 (467)
Q Consensus       315 ~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (467)
                      ...++...+..+||+.|+|||++.+      ..|+.++|+|..+++.+....+..||.....        .........+
T Consensus       159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~~~i~~~  230 (277)
T d1phka_         159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLRMIMSG  230 (277)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT
T ss_pred             EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHHHHHHhC
Confidence            8876666667789999999999863      2467889999999887777776666543211        1111111111


Q ss_pred             CCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         389 RHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       389 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      ..   .+    ..+....+|++++|||++||+.||++|||++|+|+||||.+
T Consensus       231 ~~---~~----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         231 NY---QF----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             CC---CC----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CC---CC----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            10   00    11122358999999999999999999999999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-49  Score=382.66  Aligned_cols=246  Identities=23%  Similarity=0.303  Sum_probs=198.1

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch------HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK------KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPA  244 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~  244 (467)
                      +.|+.++.||+|+||+||+|.+..+++.||||+++...      .+.+.+|+.+|+.++ |||||++++++.++  ...|
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~--~~~~   91 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLRE--HTAW   91 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEET--TEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEEC--CEEE
Confidence            45999999999999999999999999999999986431      245789999999996 89999999998764  5689


Q ss_pred             EEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         245 LIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       245 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      +|||||.++++..+.   +.+++.+++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+....   
T Consensus        92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP---  167 (309)
T ss_dssp             EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS---
T ss_pred             EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC-CEEEeecccccccCC---
Confidence            999999999886543   3589999999999999999999999999999999999999554 899999999987543   


Q ss_pred             cceeeeccCccCCccccc---CCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         322 YNVRVASRYFKGPELLAD---YQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~---~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                      ....+||+.|||||++.+   ..|+.++|+|+.+++.+....+..||....        ..........+..        
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--------~~~~~~~i~~~~~--------  231 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES--------  231 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCC--------
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCC--------
Confidence            334679999999999964   348899999999988766666655653221        1111111111110        


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                       ....+..+|++++|||++||++||++|||++|+|+||||..
T Consensus       232 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         232 -PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             -CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             -CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence             00112347999999999999999999999999999999964

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-50  Score=386.10  Aligned_cols=253  Identities=24%  Similarity=0.408  Sum_probs=208.9

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .++|++++.||+|+||+||+|.++.+++.||||+++...  ...+.+|+++|+.++ ||||+++++++.+.  ...|+||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~--~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNILHLHESFESM--EELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSC-CTTBCCEEEEEEET--TEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCC-CCCCCeEEEEEEEC--CEEEEEE
Confidence            478999999999999999999999999999999997643  345789999999996 89999999999864  5689999


Q ss_pred             eccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC-CCcEEEEecccceecCCCCCc
Q psy3714         248 EHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       248 e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~-~~~ikl~DFGla~~~~~~~~~  322 (467)
                      |||++++|.+.+.    .+++.+++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+|+........
T Consensus        81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~  160 (321)
T d1tkia_          81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence            9999999988764    48999999999999999999999999999999999999753 347999999999987766666


Q ss_pred             ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccccc
Q psy3714         323 NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE  402 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
                      ...+||+.|+|||.+.+..|+.++|+|+.|++.+....+..||.....        .............       ....
T Consensus       161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i~~~~~~-------~~~~  225 (321)
T d1tkia_         161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYT-------FDEE  225 (321)
T ss_dssp             EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCC-------CCHH
T ss_pred             cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCC-------CChh
Confidence            677899999999999999999999999999887777777666543221        1111111001100       0111


Q ss_pred             CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       403 ~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      .+..+|++++|||++||++||++|||++|+|+||||..
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            22358999999999999999999999999999999964

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-49  Score=377.54  Aligned_cols=268  Identities=25%  Similarity=0.463  Sum_probs=201.1

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      |+|++++.||+|+||+||+|.++.+++.||||+++..     ....+.+|+++|+.++ ||||+++++.+.+.  ...|+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~--~~~~i   78 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTE--NKLYL   78 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEET--TEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEEeccccccc--cceeE
Confidence            7999999999999999999999999999999998643     2456889999999996 89999999999864  56899


Q ss_pred             EEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC-C
Q psy3714         246 IFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-Q  320 (467)
Q Consensus       246 v~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~-~  320 (467)
                      ||||+.++.+....    ..+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..... .
T Consensus        79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHCCCSB
T ss_pred             EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-cceeccCCcceeccCCcc
Confidence            99999876554332    2489999999999999999999999999999999999998655 7999999999876432 3


Q ss_pred             CcceeeeccCccCCcccccCCC-CccchhHHHhhhccccccccccccccCCccc--------CChhhhhhhhhhccCC--
Q psy3714         321 EYNVRVASRYFKGPELLADYQY-HIELDPRFADILGRHSRKRWERFVHTENQHL--------VSPEALDFLDKNILGR--  389 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~~~-~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~--  389 (467)
                      .....+||+.|+|||++....+ +.++|+|+.+++.+....+..||........        ..+....+........  
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            3445689999999999888775 7889999999887776666666532211000        0000000000000000  


Q ss_pred             CCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         390 HSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      .....+...........+|++++|||++||++||++||||+|+|+||||.++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence            00000000000111235789999999999999999999999999999998774

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=375.92  Aligned_cols=245  Identities=23%  Similarity=0.381  Sum_probs=200.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---------HHHHHHHHHHHHHhcC-CCCeeEEEEEEeCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---------KKKIKREIKILENLRG-GTNIITLQAVVKDPV  239 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------~~~~~~Ei~il~~l~~-~~~iv~l~~~~~~~~  239 (467)
                      .++|++.+.||+|+||+||+|.+..+++.||||+++...         ..++.+|+.+|+.+++ ||||+++++++.++ 
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-   81 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-   81 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence            367999999999999999999999999999999986421         2346789999999974 89999999999874 


Q ss_pred             CCccEEEEeccCC-ccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         240 SRTPALIFEHVNN-TDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       240 ~~~~~lv~e~~~~-~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                       ...++||||+.+ +++..+.   ..+++.+++.++.||+.||+|||++|||||||||+|||++.+++.+||+|||+|+.
T Consensus        82 -~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          82 -DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             -SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             -CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence             568999999976 5665543   35899999999999999999999999999999999999996666899999999987


Q ss_pred             cCCCCCcceeeeccCccCCcccccCCC-CccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         316 YHPGQEYNVRVASRYFKGPELLADYQY-HIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       316 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ... ...+..+||+.|+|||++.+..| +.++|+|+.+++.+....+..||...        .  ....    +.     
T Consensus       161 ~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~--~i~~----~~-----  220 (273)
T d1xwsa_         161 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--------E--EIIR----GQ-----  220 (273)
T ss_dssp             CCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--------H--HHHH----CC-----
T ss_pred             ccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc--------h--HHhh----cc-----
Confidence            643 33455789999999999988775 56789999998876666655554211        0  0110    00     


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                            ...+..+|++++|||++||++||++|||++|+|+||||+++.
T Consensus       221 ------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         221 ------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             ------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                  012245899999999999999999999999999999998764

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=383.87  Aligned_cols=268  Identities=26%  Similarity=0.414  Sum_probs=204.3

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC----CCCccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDP----VSRTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~----~~~~~~lv  246 (467)
                      -+|+.+++||+|+||+||+|++..+++.||||+++... ....+|+++|++++ |+||+++++++...    ...+.++|
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCceEEEEE
Confidence            47999999999999999999999999999999987542 34468999999995 89999999987532    23457899


Q ss_pred             EeccCCccHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC
Q psy3714         247 FEHVNNTDFKQLY------QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ  320 (467)
Q Consensus       247 ~e~~~~~~l~~~~------~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~  320 (467)
                      |||++++.+..+.      ..+++.+++.++.||+.||+|||++|||||||||+|||++.++..+||+|||+|+......
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            9999887544332      2489999999999999999999999999999999999999776689999999999887666


Q ss_pred             CcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcc--------cCChhhhhhhhhh---cc-
Q psy3714         321 EYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQH--------LVSPEALDFLDKN---IL-  387 (467)
Q Consensus       321 ~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~---~~-  387 (467)
                      .....+||+.|+|||++.+. .|+.++|+|..+++.+....+..||.......        ++.+.. ......   .. 
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~-~~~~~~~~~~~~  256 (350)
T d1q5ka_         178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR-EQIREMNPNYTE  256 (350)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH-HHHHHHCC---C
T ss_pred             ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH-Hhhhhhccchhh
Confidence            66778899999999988764 58999999999988776666655553221100        000000 000000   00 


Q ss_pred             ---CCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccccc
Q psy3714         388 ---GRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKDQ  445 (467)
Q Consensus       388 ---~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~~  445 (467)
                         .......|..    .....+|++++|||++||++||++||||+|+|+||||.++....
T Consensus       257 ~~~~~~~~~~~~~----~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  313 (350)
T d1q5ka_         257 FKFPQIKAHPWTK----VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  313 (350)
T ss_dssp             CCCCCCCCCCGGG----TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             ccccccccCchhh----hcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence               0000111111    12235799999999999999999999999999999999876543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-47  Score=372.54  Aligned_cols=268  Identities=27%  Similarity=0.461  Sum_probs=198.3

Q ss_pred             cCCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC--
Q psy3714         167 WGQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPV--  239 (467)
Q Consensus       167 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~--  239 (467)
                      |...++|++++.||+|+||+||+|.++.+++.||||+++..     ..+.+.+|+.+|+.++ |||||++++++....  
T Consensus        14 ~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          14 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETL   92 (346)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSST
T ss_pred             eecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCccc
Confidence            34568999999999999999999999999999999998742     2356789999999995 899999999987543  


Q ss_pred             --CCccEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         240 --SRTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       240 --~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                        ....++||||+ +.++..+.+  .+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~  170 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  170 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             cccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc-ccccccccceec
Confidence              23579999999 556666543  699999999999999999999999999999999999999655 799999999997


Q ss_pred             cCCCCCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCccc--------CC--hhhhhhhh-
Q psy3714         316 YHPGQEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHL--------VS--PEALDFLD-  383 (467)
Q Consensus       316 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~--~~~~~~~~-  383 (467)
                      ...  ..+..+||+.|+|||++.+.. ++.++|+|+.+++.+....+..||........        ..  ........ 
T Consensus       171 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         171 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence            643  345678999999999998754 68899999999887766666655543221100        00  00000000 


Q ss_pred             ------hhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         384 ------KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       384 ------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                            ...........+.     .....+|++++|||++||++||++||||+|+|+||||..+.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~-----~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFA-----SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGG-----GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             hhhhhhhccCCcccccchH-----HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence                  0000111111121     1224579999999999999999999999999999999987643

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=368.17  Aligned_cols=268  Identities=26%  Similarity=0.475  Sum_probs=198.8

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC--Ccc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPVS--RTP  243 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~--~~~  243 (467)
                      .++|++++.||+|+||+||+|.+..+++.||||+++...    .+.+.+|+++|+.++ ||||++++.++..+..  ...
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTTCCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeeccccccce
Confidence            367999999999999999999999999999999987532    356789999999995 8999999999865432  233


Q ss_pred             EEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-
Q psy3714         244 ALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-  320 (467)
                      +++|+|+.+++|.++..  .+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+...... 
T Consensus        86 ~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGGC
T ss_pred             EEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-CEEEcccCceeeccCCCc
Confidence            56667788999988764  699999999999999999999999999999999999999655 79999999998764322 


Q ss_pred             ---CcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCccc--------CChhhhhh-------
Q psy3714         321 ---EYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHL--------VSPEALDF-------  381 (467)
Q Consensus       321 ---~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~-------  381 (467)
                         .....+||+.|+|||++... .|+.++|+|+.+++.+....+..||........        ..+.....       
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence               23446799999999998554 578999999999887776666656533211000        00000000       


Q ss_pred             hhh--hccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcccc
Q psy3714         382 LDK--NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVKD  444 (467)
Q Consensus       382 ~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~~  444 (467)
                      ...  ..........|..     ..+.+|++++|||++||++||++||||+|+|+||||......
T Consensus       245 ~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNR-----LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHH-----HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhcccccCCccCCCCHHH-----hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence            000  0000001111111     134579999999999999999999999999999999876543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=358.03  Aligned_cols=263  Identities=25%  Similarity=0.479  Sum_probs=204.3

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++|++++.||+|+||+||+|.+..+++.||||+++..     ...++.+|+.+|+.++ |+||+++...+.++  ...++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~--~~~~i   78 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSD--KKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECS--SEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcC-cCCEEeeccccccc--cceeE
Confidence            6899999999999999999999999999999998643     2467889999999986 89999999999875  46789


Q ss_pred             EEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-C
Q psy3714         246 IFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-E  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~  321 (467)
                      +++++.++++..+.   +.+++..++.++.|++.||+|||++|||||||||+|||++..+ .+||+|||.|+...... .
T Consensus        79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSCCSC
T ss_pred             EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC-ceeeeecchhhcccCCCcc
Confidence            99999998876654   3588999999999999999999999999999999999998655 79999999999775433 3


Q ss_pred             cceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc----
Q psy3714         322 YNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE----  396 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  396 (467)
                      .....++++|+|||++.... ++.++|+|+.+++......+..|++.+.+..    +....+.. ..+......|.    
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~~  232 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD----DQLKRIFR-LLGTPTEEQWPSMTK  232 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH----HHHHHHHH-HHCCCCTTTCTTGGG
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH----HHHHHHHh-hcCCCChhhhhhhhh
Confidence            34457889999999998776 6889999999988777767777765543311    00000000 00000000000    


Q ss_pred             ------------ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         397 ------------RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       397 ------------~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                                  ..........+|++++|||++||++||++||||+|+|+||||++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                        0001112345789999999999999999999999999999998753

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7e-47  Score=360.63  Aligned_cols=265  Identities=26%  Similarity=0.472  Sum_probs=195.2

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-----KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPAL  245 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~l  245 (467)
                      ++|++++.||+|+||+||+|.++ +++.||||+++...     .+++.+|+.+|+.++ ||||++++..+.+.  ...++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~--~~~~i   77 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHTK--KRLVL   77 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECS--SCEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccC--CceeE
Confidence            68999999999999999999985 77999999986432     357889999999996 89999999999864  46899


Q ss_pred             EEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCC-C
Q psy3714         246 IFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-E  321 (467)
Q Consensus       246 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~-~  321 (467)
                      +|+++.++.+..+..   .+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|....... .
T Consensus        78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC----
T ss_pred             EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-CEEecccccceecccCccc
Confidence            999999887766543   589999999999999999999999999999999999998654 79999999998764332 2


Q ss_pred             cceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCcc--------cCChhhhhhhhhhccCCCC-
Q psy3714         322 YNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQH--------LVSPEALDFLDKNILGRHS-  391 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~-  391 (467)
                      ....+||+.|+|||++.+.. ++.++|+|+.+++......|..||.......        .+.+....+.......... 
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence            34457999999999997765 6899999999888766666666653221100        0000000000000000000 


Q ss_pred             -cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         392 -RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       392 -~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                       ...............+|++++|||++||++||++||||+|+|+||||.+
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence             0000000111223457999999999999999999999999999999963

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-47  Score=372.15  Aligned_cols=268  Identities=23%  Similarity=0.392  Sum_probs=193.9

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCC----CCC
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDP----VSR  241 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~----~~~  241 (467)
                      ++|++++.||+|+||+||+|.++.+++.||||+++..     ...++.+|+.+|+.++ ||||+++++++...    ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecccccccCc
Confidence            6899999999999999999999999999999998643     2346789999999995 89999999998643    235


Q ss_pred             ccEEEEeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         242 TPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      ..|+||||+.++.+......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|++|||+++.......
T Consensus        96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~~~~~~~  174 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFM  174 (355)
T ss_dssp             EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC---------
T ss_pred             eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc-ceeeechhhhhccccccc
Confidence            7899999999888887778899999999999999999999999999999999999999665 799999999987766666


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcc--------cC--Chh--------hhhhhh
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQH--------LV--SPE--------ALDFLD  383 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~--------~~--~~~--------~~~~~~  383 (467)
                      .+..+||+.|+|||++.+..|+.++|+|+.+++......+..||.......        ..  .++        ...+..
T Consensus       175 ~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  254 (355)
T d2b1pa1         175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE  254 (355)
T ss_dssp             ------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHH
T ss_pred             cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhh
Confidence            667789999999999999999999999999887666666655543221100        00  000        000000


Q ss_pred             hhccCCCCcccccccccc-------cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCcc
Q psy3714         384 KNILGRHSRKRWERFVHT-------ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIV  442 (467)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~-------~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~  442 (467)
                      ..  .......+......       ......|++++|||++||++||++||||+|+|+||||+...
T Consensus       255 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         255 NR--PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             TS--CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             cC--ccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            00  00001111110000       00112578999999999999999999999999999998644

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=362.64  Aligned_cols=265  Identities=27%  Similarity=0.445  Sum_probs=195.5

Q ss_pred             CCccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC---
Q psy3714         168 GQQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPV---  239 (467)
Q Consensus       168 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~---  239 (467)
                      ...++|++++.||+|+||+||+|.+..+++.||||++...     ....+.+|+.+|+.++ |+||+.+...+....   
T Consensus         7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPY   85 (318)
T ss_dssp             CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC-----
T ss_pred             CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc-CCCccceEeeeecccccc
Confidence            4568999999999999999999999999999999987532     2356889999999996 899999998875432   


Q ss_pred             ---CCccEEEEeccCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccc
Q psy3714         240 ---SRTPALIFEHVNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLA  313 (467)
Q Consensus       240 ---~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla  313 (467)
                         ....+++|||+.++.+....   ..+++..++.++.|++.||+|||++|||||||||+|||++.++ .+||+|||+|
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-~~kl~dfg~~  164 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLA  164 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC-cEEeeeccee
Confidence               24579999999888766543   3588999999999999999999999999999999999999655 7999999999


Q ss_pred             eecCCCC-----CcceeeeccCccCCcccccC-CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhcc
Q psy3714         314 EFYHPGQ-----EYNVRVASRYFKGPELLADY-QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNIL  387 (467)
Q Consensus       314 ~~~~~~~-----~~~~~~gt~~y~aPE~l~~~-~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (467)
                      +.+....     .....+||+.|+|||++.+. .|+.++|+|+.+++.+....+..+|......     .....+. ...
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-----~~~~~i~-~~~  238 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQLALIS-QLC  238 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHH-HHH
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-----HHHHHHH-Hhc
Confidence            8664322     23345799999999999866 5899999999998877666665554321110     0000000 000


Q ss_pred             CCCCcccc---------ccccccc----------CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q psy3714         388 GRHSRKRW---------ERFVHTE----------NQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYP  440 (467)
Q Consensus       388 ~~~~~~~~---------~~~~~~~----------~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~  440 (467)
                      +......+         ..+....          .....+++++|||.+||++||++|+||+|+|+||||..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            00000000         0000000          00114789999999999999999999999999999974

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=363.42  Aligned_cols=265  Identities=21%  Similarity=0.340  Sum_probs=208.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEc---cCCCeEEEEEeccc-------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINV---QSSDKCVVKILKPV-------KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~-------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      .++|++++.||+|+||+||+|.+.   .+++.||||+++..       ..+.+.+|+++|++++|||||+++++.+.++ 
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence            488999999999999999999874   46889999998642       2356789999999999889999999998875 


Q ss_pred             CCccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                       ...+++|||+.+++|.+...   .+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+
T Consensus       102 -~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~vkL~DFG~a~~~  179 (322)
T d1vzoa_         102 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEF  179 (322)
T ss_dssp             -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEEC
T ss_pred             -CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC-CEEEeeccchhhh
Confidence             46899999999999987653   578999999999999999999999999999999999999665 7999999999876


Q ss_pred             CCCC--CcceeeeccCccCCcccccCC--CCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         317 HPGQ--EYNVRVASRYFKGPELLADYQ--YHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       317 ~~~~--~~~~~~gt~~y~aPE~l~~~~--~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      ....  ......||+.|+|||.+.+..  |+.++|+|+.+++.+..+.+..||.......     ....+......    
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-----~~~~i~~~~~~----  250 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-----SQAEISRRILK----  250 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-----CHHHHHHHHHH----
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhccc----
Confidence            4322  234467999999999997654  6778999999988777777776664332111     01111110000    


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCcccccccCCCCC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERL-----TAREAMDHPYFYPIVKDQSRHTLPS  452 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~-----ta~e~l~Hp~f~~~~~~~~~~~~~~  452 (467)
                            ...+.+..+|+++++||++||++||++|+     ||+|+|+||||.++.+.........
T Consensus       251 ------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~  309 (322)
T d1vzoa_         251 ------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP  309 (322)
T ss_dssp             ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             ------CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCC
Confidence                  01112345899999999999999999999     5899999999999887655544433

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.3e-46  Score=354.52  Aligned_cols=245  Identities=17%  Similarity=0.270  Sum_probs=197.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALI  246 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv  246 (467)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++..  ..+.+.+|+++|+.++ |||||++++++.+.  ...++|
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~--~~~~iv   91 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE--PPFYII   91 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCC-CTTBCCEEEEECSS--SSCEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCC-CCCEecCCccEeeC--CeeEEE
Confidence            357899999999999999999999999999999998753  3567899999999996 89999999998764  468999


Q ss_pred             EeccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC
Q psy3714         247 FEHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE  321 (467)
Q Consensus       247 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~  321 (467)
                      |||+++|++..++.     .+++..+..++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.......
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCCSSSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-cEEEccccceeecCCCCc
Confidence            99999999887753     478889999999999999999999999999999999998654 799999999987644332


Q ss_pred             --cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccc
Q psy3714         322 --YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFV  399 (467)
Q Consensus       322 --~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (467)
                        .....||+.|+|||++.+..|+.++|+|+.+++.+....+..+++...+.    ......+...             .
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~----~~~~~~i~~~-------------~  233 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYELLEKD-------------Y  233 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHHTT-------------C
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----HHHHHHHhcC-------------C
Confidence              23346899999999999999999999999988765544444444332211    1111111111             0


Q ss_pred             cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         400 HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       400 ~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ..+.+..+|+++++||.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            11233468999999999999999999999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-46  Score=363.96  Aligned_cols=266  Identities=26%  Similarity=0.465  Sum_probs=198.8

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC---C
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPV---S  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~---~  240 (467)
                      -.++|++++.||+|+||+||+|.++.+++.||||+++..     ..+++.+|+++|+.++ |+||++++.++....   .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSTTT
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeecccccc
Confidence            357899999999999999999999999999999998643     2346789999999996 899999999886432   2


Q ss_pred             CccEEEEeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      ...+++|+|+.+++|.++..  .+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+|++|||+|.... 
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~~~-  172 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTD-  172 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC----CCT-
T ss_pred             CceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-cccccccchhcccC-
Confidence            34467788889999988764  699999999999999999999999999999999999999665 79999999998653 


Q ss_pred             CCCcceeeeccCccCCcccccCC-CCccchhHHHhhhccccccccccccccCCccc----------CChhhhhhh----h
Q psy3714         319 GQEYNVRVASRYFKGPELLADYQ-YHIELDPRFADILGRHSRKRWERFVHTENQHL----------VSPEALDFL----D  383 (467)
Q Consensus       319 ~~~~~~~~gt~~y~aPE~l~~~~-~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~----~  383 (467)
                       ......+||+.|+|||++.+.. ++.++|+|+.+++.+....+..||........          ...+.....    .
T Consensus       173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (348)
T d2gfsa1         173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  251 (348)
T ss_dssp             -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred             -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence             2344567999999999987765 58899999998887766666655532211000          000000000    0


Q ss_pred             h---hccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCccc
Q psy3714         384 K---NILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYFYPIVK  443 (467)
Q Consensus       384 ~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f~~~~~  443 (467)
                      .   ..........+.     .....+|++++|||++||++||++||||+|+|+||||+....
T Consensus       252 ~~~~~~~~~~~~~~~~-----~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         252 RNYIQSLTQMPKMNFA-----NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHHTTSCCCCCCCHH-----HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhcccCCCcchh-----hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence            0   000011111111     112458999999999999999999999999999999997653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=355.38  Aligned_cols=247  Identities=19%  Similarity=0.296  Sum_probs=195.1

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCC-----eEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSD-----KCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++.+.||+|+||+||+|.+..+++     .||+|.+...    ....+.+|+.+|.++.+|||||++++++.++ 
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-  113 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-  113 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC-
Confidence            45899999999999999999999876554     5899987542    2356789999999997799999999999764 


Q ss_pred             CCccEEEEeccCCccHHHHhh--------------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ--------------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKP  293 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~--------------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp  293 (467)
                       ...++||||+++|+|.+++.                          .+++.++..++.||+.||+|||++|||||||||
T Consensus       114 -~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp  192 (325)
T d1rjba_         114 -GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  192 (325)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             -CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence             46899999999999988763                          267888999999999999999999999999999


Q ss_pred             CceEEeCCCCcEEEEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccC
Q psy3714         294 HNVMIDHENRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTE  369 (467)
Q Consensus       294 ~Nill~~~~~~ikl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~  369 (467)
                      +|||++.+ +.+||+|||+|+........   ...+||+.|||||++.+..|+.++|+|+.+++.+.... +..||....
T Consensus       193 ~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         193 RNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            99999955 48999999999876543332   24568999999999999999999999999988665553 444443221


Q ss_pred             CcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         370 NQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ..    ..........             ...+.+..+|+++++||.+||+.||++|||++|+++|
T Consensus       272 ~~----~~~~~~~~~~-------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         272 VD----ANFYKLIQNG-------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CS----HHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH----HHHHHHHhcC-------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            11    1111111111             0112234689999999999999999999999999876

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=347.38  Aligned_cols=247  Identities=18%  Similarity=0.243  Sum_probs=196.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .++|++.+.||+|+||.||+|.+. +++.||||+++..  ..+.+.+|+.+|++++ |||||++++++.+   ...++||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~---~~~~iv~   86 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ---EPIYIIT   86 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS---SSCEEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCC-CCCEeEEEeeecc---CCeEEEE
Confidence            478999999999999999999875 5678999998753  3567899999999995 8999999998754   3579999


Q ss_pred             eccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-
Q psy3714         248 EHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-  321 (467)
Q Consensus       248 e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-  321 (467)
                      ||+++|+|.+...     .+++.++..++.||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+....... 
T Consensus        87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCEE
T ss_pred             EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc-cceeeccccceEEccCCccc
Confidence            9999999987653     48999999999999999999999999999999999999955 4899999999997754332 


Q ss_pred             -cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         322 -YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       322 -~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                       .....||+.|+|||++....|+.++|+|+.+++.+....+..+++....    .......+...             ..
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~~~~~~~i~~~-------------~~  228 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVIQNLERG-------------YR  228 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHHTT-------------CC
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----HHHHHHHHHhc-------------CC
Confidence             2345789999999999988899999999998876555444344332211    01111111110             11


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC--CCCCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMD--HPYFY  439 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~--Hp~f~  439 (467)
                      ...+..+++++++||.+||+.||++|||++|+++  |+||.
T Consensus       229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            1223458999999999999999999999999998  88874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-45  Score=341.55  Aligned_cols=244  Identities=13%  Similarity=0.237  Sum_probs=184.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .++|++++.||+|+||.||+|.+. +++.||||+++..  ..+.+.+|+++++.++ ||||+++++++.++  ...++||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~--~~~~lv~   79 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQ--APICLVF   79 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECSS--SSCEEEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcC-CCCcccccceeccC--CceEEEE
Confidence            468999999999999999999875 5678999998753  3567899999999996 89999999998764  4689999


Q ss_pred             eccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC--
Q psy3714         248 EHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--  321 (467)
Q Consensus       248 e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~--  321 (467)
                      ||+++|+|.++..    .+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+.......  
T Consensus        80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-CEEECSCC------------
T ss_pred             EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-CeEecccchheeccCCCcee
Confidence            9999999988753    377888899999999999999999999999999999999554 799999999987643322  


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      .....||+.|+|||++.+..|+.++|+|+.+++.+....+..+++....    .......+...             ...
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~----~~~~~~~i~~~-------------~~~  221 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDISTG-------------FRL  221 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC----HHHHHHHHHHT-------------CCC
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC----HHHHHHHHHhc-------------CCC
Confidence            2335789999999999999999999999998875544433333322211    01111111111             011


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ..+...++++.+||.+||+.||++|||++|+++|
T Consensus       222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            2234578999999999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=347.08  Aligned_cols=249  Identities=20%  Similarity=0.267  Sum_probs=186.5

Q ss_pred             CccceeeeEeecccCCcceEEEEEccC-----CCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQS-----SDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++.+.||+|+||.||+|.+..+     ++.||||.++..    ..+.+.+|..++.++.+|+||+.+...+..+ 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-   89 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-   89 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence            347899999999999999999997643     467999998643    2345778889999998899999998887654 


Q ss_pred             CCccEEEEeccCCccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDH  300 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~  300 (467)
                      ....++||||+++|+|.+++.                   .+++.++..++.||+.||.|||++|||||||||+|||++.
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence            346799999999999988753                   2778899999999999999999999999999999999985


Q ss_pred             CCCcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChh
Q psy3714         301 ENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPE  377 (467)
Q Consensus       301 ~~~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (467)
                      ++ .+||+|||+|+.......   ....+||+.|+|||++.+..|+.++|+|+.+++.+....+..+++.+...   ...
T Consensus       170 ~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~---~~~  245 (299)
T d1ywna1         170 KN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DEE  245 (299)
T ss_dssp             GG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC---SHH
T ss_pred             CC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH---HHH
Confidence            54 799999999986543322   23457999999999999999999999999888765544433332222110   111


Q ss_pred             hhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         378 ALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ........             .....+..+|+++++||.+||+.||++|||++|+++|
T Consensus       246 ~~~~~~~~-------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         246 FCRRLKEG-------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcC-------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            11111111             0112234579999999999999999999999999987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3e-45  Score=347.49  Aligned_cols=252  Identities=19%  Similarity=0.248  Sum_probs=190.7

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC--C
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVS--R  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~--~  241 (467)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++..      ...++.+|+++|+.++ ||||+++++++.....  .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCCCc
Confidence            36799999999999999999999999999999998643      1346789999999985 8999999998865432  3


Q ss_pred             ccEEEEeccCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      ..|+||||+++++|.+...   .+++.+++.++.||+.||+|||++|||||||||+|||++.++ .++|+|||+++....
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-CEEECCCTTCEECC-
T ss_pred             eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc-cceeehhhhhhhhcc
Confidence            4789999999999886653   589999999999999999999999999999999999999665 799999999876532


Q ss_pred             CC----CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccc
Q psy3714         319 GQ----EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKR  394 (467)
Q Consensus       319 ~~----~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (467)
                      ..    .....+||+.|+|||++.+..|+.++|+|+.+++.+....+..||.....        .......+....    
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~~~~~~~----  231 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVREDP----  231 (277)
T ss_dssp             ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCCC----
T ss_pred             ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--------HHHHHHHHhcCC----
Confidence            22    23446899999999999999999999999999987777777666532211        111111111100    


Q ss_pred             ccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q psy3714         395 WERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPYF  438 (467)
Q Consensus       395 ~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~f  438 (467)
                         ......+..+|+++++||++||++||++||+..+.+.|+|.
T Consensus       232 ---~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         232 ---IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             ---CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ---CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence               01112234689999999999999999999954444556654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=341.88  Aligned_cols=246  Identities=15%  Similarity=0.242  Sum_probs=186.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCcc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~  243 (467)
                      ..++|++.+.||+|+||+||+|..   +..||||+++..     ..+.+.+|+.+|++++ |||||++++++.+   ...
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~---~~~   78 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYSTA---PQL   78 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCC-CTTBCCEEEEECS---SSC
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEec---cEE
Confidence            457899999999999999999974   346999998632     2457889999999995 8999999998754   357


Q ss_pred             EEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCC
Q psy3714         244 ALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG  319 (467)
Q Consensus       244 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~  319 (467)
                      ++||||+++|+|.+++.    .+++.++..++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-SEEECCCCCSCC----
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC-CEEEccccceeecccc
Confidence            99999999999988763    488999999999999999999999999999999999999654 8999999999876432


Q ss_pred             C---CcceeeeccCccCCcccccC---CCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         320 Q---EYNVRVASRYFKGPELLADY---QYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       320 ~---~~~~~~gt~~y~aPE~l~~~---~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      .   .....+||+.|||||++.+.   .|+.++|+|+.+++.+....+..||......    ..........    ....
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~----~~~~~~~~~~----~~~p  229 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR----DQIIFMVGRG----YLSP  229 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----HHHHHHHHHT----SCCC
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH----HHHHHHHhcC----CCCC
Confidence            2   23445799999999999653   4888999999998876665655555332111    0011111111    1111


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ..     ...+..+++++++||.+||+.||++|||++|+++|
T Consensus       230 ~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         230 DL-----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CG-----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cc-----hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            11     11234578999999999999999999999999976

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-44  Score=340.83  Aligned_cols=248  Identities=16%  Similarity=0.273  Sum_probs=193.6

Q ss_pred             CccceeeeEe-ecccCCcceEEEEEccC--CCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         169 QQDDYQLVRK-LGRGKYSEVFEAINVQS--SDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       169 ~~~~y~~~~~-lG~G~~g~V~~~~~~~~--~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      ..++|.+.+. ||+|+||.||+|.++.+  +..||||.++..    ..+.+.+|+++|+.++ |||||++++++.+   .
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~---~   81 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA---E   81 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES---S
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc---C
Confidence            4578888885 99999999999987644  447999998643    2356889999999996 8999999999875   3


Q ss_pred             ccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         242 TPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..++||||+++|+|.++..    .+++.++..++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+...
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~  160 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALG  160 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECT
T ss_pred             eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-ceeeccchhhhccc
Confidence            5799999999999988752    489999999999999999999999999999999999999654 89999999999765


Q ss_pred             CCCC----cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCc
Q psy3714         318 PGQE----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSR  392 (467)
Q Consensus       318 ~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
                      ....    ....+||+.|+|||++....|+.++|+|+.+++.+.... +..||....     ..+....+...       
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-----~~~~~~~i~~~-------  228 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GPEVMAFIEQG-------  228 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----THHHHHHHHTT-------
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcC-------
Confidence            4332    123468999999999998899999999999887654433 344442211     11222222111       


Q ss_pred             ccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHH---hCCCCCC
Q psy3714         393 KRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREA---MDHPYFY  439 (467)
Q Consensus       393 ~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~---l~Hp~f~  439 (467)
                            ...+.++.+|+++.+||.+||..||++|||+.++   |+|+|+.
T Consensus       229 ------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         229 ------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                  0112234689999999999999999999998877   7889874

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8e-44  Score=340.76  Aligned_cols=244  Identities=14%  Similarity=0.218  Sum_probs=179.6

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCC---eEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSD---KCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      .++|++.+.||+|+||+||+|.++.+++   .||||.+...    ..+.+.+|+++|+.++ |||||++++++.+.  ..
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~--~~  101 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKS--TP  101 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS--SS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeC--CE
Confidence            4789999999999999999999887765   4788877542    2356889999999995 89999999998764  46


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .++||||+++|+|.++..    .+++.++..++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+....
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLED  180 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC--------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC-cEEECCcccceEccC
Confidence            899999999999987653    478999999999999999999999999999999999999554 899999999987643


Q ss_pred             CCCc------ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         319 GQEY------NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       319 ~~~~------~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      ....      ....||+.|||||++.+..|+.++|+|+.+++.+.... +..||....     ..+....+...      
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-----~~~~~~~i~~~------  249 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-----NQDVINAIEQD------  249 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTT------
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcC------
Confidence            3221      12357899999999999999999999998887654443 333432211     11111111111      


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                             ...+.+..+++++.+||.+||+.||++|||++|++++
T Consensus       250 -------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         250 -------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                   0112234579999999999999999999999988764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-44  Score=333.57  Aligned_cols=243  Identities=16%  Similarity=0.229  Sum_probs=193.5

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .++|++++.||+|+||+||+|.++ +++.||||.++..  ..+.+.+|+.+++.++ ||||+++++++.++  ...++||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~--~~~~iv~   78 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQ--RPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCC-CTTBCCEEEEECCS--SSEEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcC-CCceeeEEEEEeeC--CceEEEE
Confidence            478999999999999999999974 6778999998753  4567899999999995 89999999998764  5689999


Q ss_pred             eccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC--
Q psy3714         248 EHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--  321 (467)
Q Consensus       248 e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~--  321 (467)
                      ||+++|++.++.    ..+++..+..++.|+++||+|||++||+||||||+|||++.++ .+||+|||+|+.......  
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSSSCCC
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-cEEECcchhheeccCCCcee
Confidence            999999987774    2478889999999999999999999999999999999999554 799999999987654332  


Q ss_pred             cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         322 YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       322 ~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                      .....||+.|+|||++.+..|+.++|+|+.+++.+.... +..||....     ..+....+...             ..
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-----~~~~~~~i~~~-------------~~  219 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-----NSETAEHIAQG-------------LR  219 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----HHHHHHHHHTT-------------CC
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-----HHHHHHHHHhC-------------CC
Confidence            223568999999999999999999999988887554433 333332111     11111111111             01


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ...+...++++++||++||+.||++|||++|+++|
T Consensus       220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            12234578999999999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-44  Score=338.16  Aligned_cols=240  Identities=18%  Similarity=0.276  Sum_probs=185.3

Q ss_pred             EeecccCCcceEEEEEc--cCCCeEEEEEeccc-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         177 RKLGRGKYSEVFEAINV--QSSDKCVVKILKPV-----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       177 ~~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~-----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      ++||+|+||.||+|...  .+++.||||+++..     ..+.+.+|+.+|++++ |||||++++++.++   ..++||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~~---~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICEAE---SWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEESS---SEEEEEEC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC-CCCCceEEEEeccC---CEEEEEEc
Confidence            46999999999999864  34568999998642     2356889999999996 89999999998653   46899999


Q ss_pred             cCCccHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc----
Q psy3714         250 VNNTDFKQLYQ---TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY----  322 (467)
Q Consensus       250 ~~~~~l~~~~~---~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~----  322 (467)
                      +++|+|.++..   .+++.++..++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+........    
T Consensus        89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCSEEEC-
T ss_pred             CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC-cccccchhhhhhccccccccccc
Confidence            99999988764   489999999999999999999999999999999999999655 8999999999976543322    


Q ss_pred             ceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccccccccc
Q psy3714         323 NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHT  401 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (467)
                      ....||+.|+|||++.+..|+.++|+|+.+++.+.... +..||....     ..+....+...             ...
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-----~~~~~~~i~~~-------------~~~  229 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GSEVTAMLEKG-------------ERM  229 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTT-------------CCC
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-----HHHHHHHHHcC-------------CCC
Confidence            22468999999999999999999999999887654433 334432211     11111111111             011


Q ss_pred             cCCCCCChHHHHHHHhhcCcCCCCCCCHHHH---hCCCCCC
Q psy3714         402 ENQHLVSPEALDFLDKLLRYDHYERLTAREA---MDHPYFY  439 (467)
Q Consensus       402 ~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~---l~Hp~f~  439 (467)
                      +.+..+|+++++||.+||+.||++|||++|+   |+|+|+.
T Consensus       230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            2234589999999999999999999999988   5677764

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=336.14  Aligned_cols=249  Identities=18%  Similarity=0.243  Sum_probs=192.0

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      .++|++.+.||+|+||.||+|.+..+ +.||||+++..  ..+.+.+|+.+|+.++ |+|||++++++.+   ...++||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~---~~~~lv~   90 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE---EPIYIVT   90 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS---SSCEEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcc-cCCEeEEEEEEec---CCeEEEE
Confidence            47899999999999999999998655 57999998754  3467899999999996 8999999998854   3479999


Q ss_pred             eccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC-
Q psy3714         248 EHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-  321 (467)
Q Consensus       248 e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~-  321 (467)
                      ||+++|++..++.     .+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....... 
T Consensus        91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC--------
T ss_pred             EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC-CcEEEcccchhhhccCCCce
Confidence            9999999876653     48999999999999999999999999999999999999855 4799999999987643332 


Q ss_pred             -cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccc
Q psy3714         322 -YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVH  400 (467)
Q Consensus       322 -~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
                       .....||+.|+|||++....|+.++|+|+.+++.+....+..+++....    ..+....+...             ..
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~----~~~~~~~i~~~-------------~~  232 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERG-------------YR  232 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHHTT-------------CC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC----HHHHHHHHHhc-------------CC
Confidence             2335789999999999999999999999888875544443344333221    11111111111             01


Q ss_pred             ccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC--CCCCCCc
Q psy3714         401 TENQHLVSPEALDFLDKLLRYDHYERLTAREAMD--HPYFYPI  441 (467)
Q Consensus       401 ~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~--Hp~f~~~  441 (467)
                      .+.+..+|+++++||.+||+.||++|||++++++  |+||...
T Consensus       233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            1233458999999999999999999999999988  9999653

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-43  Score=334.00  Aligned_cols=243  Identities=18%  Similarity=0.284  Sum_probs=180.2

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCC---CeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSS---DKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      .++|++.+.||+|+||.||+|.+..++   ..||||.++..    ..+.+.+|+.+|+.++ ||||+++++++.+   ..
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~---~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITE---NP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS---SS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec---Ce
Confidence            478999999999999999999987654   35888887643    2356789999999995 8999999999854   45


Q ss_pred             cEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP  318 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~  318 (467)
                      .++||||++++++.++..    .+++.++..++.||+.||+|||++|||||||||+|||++..+ .+||+|||+|+....
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMED  160 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC---------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC-cEEEccchhheeccC
Confidence            799999999999877643    478999999999999999999999999999999999999655 899999999987643


Q ss_pred             CCC--cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCCcccc
Q psy3714         319 GQE--YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHSRKRW  395 (467)
Q Consensus       319 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (467)
                      ...  .+..+||+.|+|||++.+..|+.++|+|+.+++.+.... +..|+.....     .+....+...    .     
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~~~~~i~~~----~-----  226 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGRIENG----E-----  226 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHTT----C-----
T ss_pred             CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcC----C-----
Confidence            322  234568999999999999999999999999887654443 3333322111     1111111110    0     


Q ss_pred             cccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         396 ERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       396 ~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                          ..+.+..+|+++++||.+||+.||++|||++|+++|
T Consensus       227 ----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         227 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                112244689999999999999999999999999876

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-44  Score=342.48  Aligned_cols=247  Identities=16%  Similarity=0.207  Sum_probs=193.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCe--EEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCc
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDK--CVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRT  242 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~  242 (467)
                      +.++|++.+.||+|+||+||+|.++.++..  ||||.++..    ..+.+.+|+++|.++.+||||+++++++.+.  ..
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~   85 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY   85 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TE
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--Ce
Confidence            458999999999999999999999888875  667766532    2346889999999997799999999998763  56


Q ss_pred             cEEEEeccCCccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCC
Q psy3714         243 PALIFEHVNNTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENR  303 (467)
Q Consensus       243 ~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~  303 (467)
                      .++||||+++|+|.+++.                   .+++..+..++.||+.||.|||++|||||||||+|||++..+ 
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~-  164 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-  164 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC-
Confidence            899999999999988762                   478889999999999999999999999999999999999655 


Q ss_pred             cEEEEecccceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhh
Q psy3714         304 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLD  383 (467)
Q Consensus       304 ~ikl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (467)
                      .+||+|||+|+............||..|+|||.+.+..|+.++|+|+.+++......+..+++...+       ......
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-------~~~~~~  237 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYE  237 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHH
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-------HHHHHH
Confidence            7999999999876544444456799999999999999999999999988876554443333322211       111111


Q ss_pred             hhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         384 KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                       .+...         ...+.+..+++++++||.+||+.||++|||++|+++|
T Consensus       238 -~i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         238 -KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             -HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHHhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             11110         0112334589999999999999999999999999988

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-43  Score=338.84  Aligned_cols=246  Identities=14%  Similarity=0.211  Sum_probs=188.2

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCC----eEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSD----KCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      ..++|++++.||+|+||+||+|.+..+++    +||+|.++..    ..+.+.+|+.+|++++ |||||++++++.+.  
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~--   83 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS--   83 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS--
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC--
Confidence            45789999999999999999999988776    5788877542    2457899999999996 89999999998753  


Q ss_pred             CccEEEEeccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         241 RTPALIFEHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                       ..+++|+++.++++.+...    .+++..+..++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-~~kl~DFGla~~~  161 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL  161 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCCSHHHHT
T ss_pred             -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-CeEeeccccceec
Confidence             4688999999998876543    488899999999999999999999999999999999999554 8999999999976


Q ss_pred             CCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         317 HPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       317 ~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ......   ....||+.|+|||++.+..|+.++|+|+.+++.+....+..+++.+..    ..+....+...        
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~----~~~~~~~i~~~--------  229 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSILEKG--------  229 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----GGGHHHHHHHT--------
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC----HHHHHHHHHcC--------
Confidence            543322   234689999999999999999999999988876554432222222211    11111211111        


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHP  436 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp  436 (467)
                           ...+.+..+++++.+||.+||..||++|||++|+++|.
T Consensus       230 -----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         230 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence                 01122345799999999999999999999999999883

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-42  Score=329.06  Aligned_cols=244  Identities=16%  Similarity=0.220  Sum_probs=182.3

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCC----CeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSS----DKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSR  241 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~  241 (467)
                      .+.|++.+.||+|+||.||+|....++    ..||||.++..    ....+.+|+++|+.++ |||||++++++.+.  .
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~--~   82 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKY--K   82 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS--S
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecC--C
Confidence            357999999999999999999877654    36999998643    2345789999999996 89999999998754  4


Q ss_pred             ccEEEEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecC
Q psy3714         242 TPALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYH  317 (467)
Q Consensus       242 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~  317 (467)
                      ..++||||+.++++.+..    ..+++.++..++.||+.||+|||+++||||||||+|||++.++ .+||+|||+|+...
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~  161 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLE  161 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC-----
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-eEEEcccchhhccc
Confidence            689999999999887654    3588899999999999999999999999999999999999654 89999999998764


Q ss_pred             CCCC----cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         318 PGQE----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       318 ~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                      ....    .....||+.|+|||++.+..|+.++|+|+.+++.+....+..+++....    .......+...        
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~----~~~~~~~i~~~--------  229 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----NHEVMKAINDG--------  229 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTT--------
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC----HHHHHHHHhcc--------
Confidence            3322    1234689999999999999999999999988875544333333322211    01111111111        


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                           ...+.+..+++++.+||.+||+.||++|||+.|+++
T Consensus       230 -----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         230 -----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             -----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                 011223457899999999999999999999999876

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.4e-43  Score=344.88  Aligned_cols=270  Identities=23%  Similarity=0.309  Sum_probs=190.9

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch--HHHHHHHHHHHHHhcC----------CCCeeEEEEEEeCC
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK--KKKIKREIKILENLRG----------GTNIITLQAVVKDP  238 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~Ei~il~~l~~----------~~~iv~l~~~~~~~  238 (467)
                      .+|++++.||+|+||+||+|+++.+++.||||+++...  .+...+|+.+++.+.+          |+||+++.+.+...
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            35999999999999999999999999999999997653  3567889999988863          57899998887654


Q ss_pred             CCCccEEEEeccCCccH-HHH-----hhcCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEeCCCC-----cEE
Q psy3714         239 VSRTPALIFEHVNNTDF-KQL-----YQTLTDYDIRYYLYELLKALDYCHS-MGIMHRDVKPHNVMIDHENR-----KLR  306 (467)
Q Consensus       239 ~~~~~~lv~e~~~~~~l-~~~-----~~~~~~~~~~~~~~qll~al~~lH~-~~IiHrDlKp~Nill~~~~~-----~ik  306 (467)
                      .....+++|+++..... ...     ...+++..++.++.||+.||+|||+ +||+||||||+|||++..+.     .+|
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence            44556677766644432 211     1257889999999999999999998 89999999999999985542     499


Q ss_pred             EEecccceecCCCCCcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhc
Q psy3714         307 LIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNI  386 (467)
Q Consensus       307 l~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (467)
                      ++|||.|.....  .....+||+.|+|||++....|+.++|+|..+++......+..+|.....................
T Consensus       173 l~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~  250 (362)
T d1q8ya_         173 IADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL  250 (362)
T ss_dssp             ECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred             Eeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHH
Confidence            999999987543  234567999999999999999999999998888765555555554322111000000000000000


Q ss_pred             cCC------------------------C---Ccccccccc--cccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q psy3714         387 LGR------------------------H---SRKRWERFV--HTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDHPY  437 (467)
Q Consensus       387 ~~~------------------------~---~~~~~~~~~--~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~Hp~  437 (467)
                      ++.                        .   ....+....  ........+++++|||.+||++||.+||||+|+|+|||
T Consensus       251 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~  330 (362)
T d1q8ya_         251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW  330 (362)
T ss_dssp             HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred             hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            000                        0   000000000  00111224789999999999999999999999999999


Q ss_pred             CCCcc
Q psy3714         438 FYPIV  442 (467)
Q Consensus       438 f~~~~  442 (467)
                      |++..
T Consensus       331 f~~~~  335 (362)
T d1q8ya_         331 LKDTL  335 (362)
T ss_dssp             GTTCT
T ss_pred             cCCCC
Confidence            98654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-42  Score=326.99  Aligned_cols=246  Identities=20%  Similarity=0.244  Sum_probs=188.0

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCC-------CeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSS-------DKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKD  237 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~  237 (467)
                      ..++|++.+.||+|+||.||+|.+..++       ..||||+++...    ...+.+|...+.++.+|||||++++++.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            4589999999999999999999876654       369999986532    35677899999999779999999999976


Q ss_pred             CCCCccEEEEeccCCccHHHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE
Q psy3714         238 PVSRTPALIFEHVNNTDFKQLYQ-------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI  298 (467)
Q Consensus       238 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill  298 (467)
                      +  ...++||||+++|++.+++.                   .+++.++..++.||+.||+|||++|||||||||+|||+
T Consensus        91 ~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          91 D--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             S--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             C--CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence            4  56899999999999988762                   37889999999999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCC
Q psy3714         299 DHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVS  375 (467)
Q Consensus       299 ~~~~~~ikl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (467)
                      +.++ .+||+|||+++.......   ....+||+.|+|||.+.+..|+.++|+|..+++.+.......+++....    .
T Consensus       169 ~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~----~  243 (299)
T d1fgka_         169 TEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----V  243 (299)
T ss_dssp             CTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----H
T ss_pred             cCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC----H
Confidence            9665 799999999987643322   2346789999999999999999999999888875544432222222211    1


Q ss_pred             hhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         376 PEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ......+...             ...+.+..+|+++++||.+||+.||++|||++|+++
T Consensus       244 ~~~~~~i~~~-------------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         244 EELFKLLKEG-------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHTT-------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcC-------------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            1111211111             111223468999999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.9e-42  Score=329.74  Aligned_cols=245  Identities=16%  Similarity=0.194  Sum_probs=189.9

Q ss_pred             CccceeeeEeecccCCcceEEEEEcc-----CCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQ-----SSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++++.||+|+||+||+|+...     +++.||||+++..    ..+.+.+|+++|+.++ ||||+.+++.+... 
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~-   88 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVCAVG-   88 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS-
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcC-CCCcccceeeeccC-
Confidence            35789999999999999999998753     4578999998643    2456889999999995 89999999998764 


Q ss_pred             CCccEEEEeccCCccHHHHhh---------------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ---------------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVK  292 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlK  292 (467)
                       ...+++|||+.+++|.+++.                           .++..++..++.|++.||+|||+++|||||||
T Consensus        89 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          89 -KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             -CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence             56899999999999987653                           26778899999999999999999999999999


Q ss_pred             CCceEEeCCCCcEEEEecccceecCCCC---CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccC
Q psy3714         293 PHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTE  369 (467)
Q Consensus       293 p~Nill~~~~~~ikl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~  369 (467)
                      |+|||++.++ .+||+|||+|+......   ..+..+||+.|+|||++.+..|+.++|+|+.+++.+....+..+++.+.
T Consensus       168 p~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         168 TRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             GGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             ccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            9999999654 79999999998653322   2234578999999999999999999999999887655444433322221


Q ss_pred             CcccCChhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         370 NQHLVSPEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      +    ..+....+    ....         ..+.+..+++++.+||.+||+.||++|||+.|+++
T Consensus       247 ~----~~e~~~~v----~~~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         247 A----HEEVIYYV----RDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             C----HHHHHHHH----HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C----HHHHHHHH----HcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            1    01111111    1100         11223468999999999999999999999999864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-41  Score=325.28  Aligned_cols=247  Identities=19%  Similarity=0.270  Sum_probs=194.4

Q ss_pred             CccceeeeEeecccCCcceEEEEEc-----cCCCeEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINV-----QSSDKCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++.+.||+|+||.||+|...     .+++.||||+++..    ....+.+|+.+++.+.+|||||++++.+.+. 
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-   99 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-   99 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-
Confidence            4589999999999999999999864     45568999998753    2346789999999998899999999999764 


Q ss_pred             CCccEEEEeccCCccHHHHhh---------------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ---------------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMI  298 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~---------------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill  298 (467)
                       ...+++|||++++++..++.                     .+++.++..++.||+.||+|||++|||||||||+|||+
T Consensus       100 -~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         100 -GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (311)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             -CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence             45899999999999887653                     37788999999999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceecCCCCCc---ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCC
Q psy3714         299 DHENRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVS  375 (467)
Q Consensus       299 ~~~~~~ikl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (467)
                      +..+ .+||+|||+|+........   ...+||+.|+|||++.+..|+.++|+|+.+++.........+++.....   .
T Consensus       179 ~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~---~  254 (311)
T d1t46a_         179 THGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---D  254 (311)
T ss_dssp             ETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---S
T ss_pred             cccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH---H
Confidence            9654 8999999999876543322   2357899999999999989999999998888755444433333322211   1


Q ss_pred             hhhhhhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC
Q psy3714         376 PEALDFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD  434 (467)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~  434 (467)
                      ...........             ....+..+|+++++||.+||+.||++|||++|+++
T Consensus       255 ~~~~~~i~~~~-------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         255 SKFYKMIKEGF-------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHHTC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCC-------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            11122221110             11223457899999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-41  Score=319.43  Aligned_cols=243  Identities=15%  Similarity=0.237  Sum_probs=183.2

Q ss_pred             CccceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch-HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK-KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ..++|++.+.||+|+||.||+|..  .+..||||.++... .+.+.+|++++++++ ||||+++++++.+. ....++||
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~-~~~~~lv~   80 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVEE-KGGLYIVT   80 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCC-CTTBCCEEEEECCC---CCEEEE
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEec-CCcEEEEE
Confidence            357899999999999999999987  46789999997643 467899999999995 89999999987543 24579999


Q ss_pred             eccCCccHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCCc
Q psy3714         248 EHVNNTDFKQLYQ-----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY  322 (467)
Q Consensus       248 e~~~~~~l~~~~~-----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~~  322 (467)
                      ||+++|++.+++.     .+++..+..++.||+.||.|||+++||||||||+|||++.++ .+||+|||+++.....  .
T Consensus        81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~~--~  157 (262)
T d1byga_          81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST--Q  157 (262)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC----------
T ss_pred             eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC-CEeecccccceecCCC--C
Confidence            9999999987753     389999999999999999999999999999999999999655 7999999999875433  2


Q ss_pred             ceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccccccc
Q psy3714         323 NVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERFVHTE  402 (467)
Q Consensus       323 ~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
                      ....+|..|+|||++.+..|+.++|+|+.+++.+.......+++....    ..+....+...             ...+
T Consensus       158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~----~~~~~~~i~~~-------------~~~~  220 (262)
T d1byga_         158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPRVEKG-------------YKMD  220 (262)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC----GGGHHHHHTTT-------------CCCC
T ss_pred             ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC----HHHHHHHHHcC-------------CCCC
Confidence            335689999999999999999999999888865544332222221111    11111111110             0112


Q ss_pred             CCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         403 NQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       403 ~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      .+..+++++++||++||..||++|||++|++++
T Consensus       221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            234578999999999999999999999999874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-41  Score=326.06  Aligned_cols=255  Identities=14%  Similarity=0.195  Sum_probs=190.4

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      ++|++++.||+|+||.||+|.+..+++.||||+++.. ....+.+|+++++.+++|++|+.+.....+  ....++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~--~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE--GDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE--TTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec--CCEEEEEEEE
Confidence            5799999999999999999999999999999987653 345688999999999877778777776654  3467899999


Q ss_pred             cCCccHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC--CCcEEEEecccceecCCCCC---
Q psy3714         250 VNNTDFKQLY---QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQE---  321 (467)
Q Consensus       250 ~~~~~l~~~~---~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~--~~~ikl~DFGla~~~~~~~~---  321 (467)
                      +.++......   ..+++..+..++.|++.||+|||++|||||||||+|||++..  +..+||+|||+|+.+.....   
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  164 (299)
T d1ckia_          85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  164 (299)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred             cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence            9665443332   358999999999999999999999999999999999998643  34699999999997753321   


Q ss_pred             -----cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccc
Q psy3714         322 -----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWE  396 (467)
Q Consensus       322 -----~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (467)
                           ....+||+.|||||++.+..|+.++|+|+.+++......+..||.......... ......... .         
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~~~~~~~~~-~---------  233 (299)
T d1ckia_         165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKK-M---------  233 (299)
T ss_dssp             CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHH-H---------
T ss_pred             eeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH-HHHHhhccc-C---------
Confidence                 234579999999999999999999999988887665555555553322110000 000000000 0         


Q ss_pred             ccccccCCCCCChHHHHHHHhhcCcCCCCCCCHH---HHhCCCCC
Q psy3714         397 RFVHTENQHLVSPEALDFLDKLLRYDHYERLTAR---EAMDHPYF  438 (467)
Q Consensus       397 ~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~---e~l~Hp~f  438 (467)
                      ..........+|+++.+||.+||+.||++|||++   ++|+|+|.
T Consensus       234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            0000111235789999999999999999999986   56788764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-41  Score=318.11  Aligned_cols=242  Identities=18%  Similarity=0.211  Sum_probs=179.1

Q ss_pred             ccceeeeEeecccCCcceEEEEEccCC---CeEEEEEeccc------hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCC
Q psy3714         170 QDDYQLVRKLGRGKYSEVFEAINVQSS---DKCVVKILKPV------KKKKIKREIKILENLRGGTNIITLQAVVKDPVS  240 (467)
Q Consensus       170 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~------~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~  240 (467)
                      .++|++++.||+|+||.||+|......   ..||||++++.      ..+.+.+|+.+|+.++ ||||+++++++.++  
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~~--   83 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTP--   83 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS--
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeec--
Confidence            478999999999999999999865432   36899988642      2356789999999995 89999999999753  


Q ss_pred             CccEEEEeccCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         241 RTPALIFEHVNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       241 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                       ..++||||++++++.+..    ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus        84 -~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-~vkl~DfGl~~~~  161 (273)
T d1u46a_          84 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRAL  161 (273)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEEC
T ss_pred             -chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc-ceeeccchhhhhc
Confidence             468999999999987654    3589999999999999999999999999999999999999655 8999999999987


Q ss_pred             CCCCC----cceeeeccCccCCcccccCCCCccchhHHHhhhcccccc-ccccccccCCcccCChhhhhhhhhhccCCCC
Q psy3714         317 HPGQE----YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRK-RWERFVHTENQHLVSPEALDFLDKNILGRHS  391 (467)
Q Consensus       317 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (467)
                      .....    .....||..|+|||++.+..|+.++|+|+.+++.+.... |..||...        ....... .+.... 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--------~~~~~~~-~i~~~~-  231 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------NGSQILH-KIDKEG-  231 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHH-HHHTSC-
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--------CHHHHHH-HHHhCC-
Confidence            54332    123467889999999999999999999998887554443 33343211        1111111 111000 


Q ss_pred             cccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHh
Q psy3714         392 RKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM  433 (467)
Q Consensus       392 ~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l  433 (467)
                             ...+.+..+|+++++||.+||..||++|||++|++
T Consensus       232 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         232 -------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             -------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence                   01122346899999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-40  Score=318.75  Aligned_cols=251  Identities=15%  Similarity=0.232  Sum_probs=192.7

Q ss_pred             CccceeeeEeecccCCcceEEEEEcc-----CCCeEEEEEeccch----HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCC
Q psy3714         169 QQDDYQLVRKLGRGKYSEVFEAINVQ-----SSDKCVVKILKPVK----KKKIKREIKILENLRGGTNIITLQAVVKDPV  239 (467)
Q Consensus       169 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~----~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~  239 (467)
                      ..++|++.+.||+|+||.||+|.+..     ++..||||+++...    ...+.+|++++++++ ||||+++++.+... 
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~-   95 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG-   95 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSS-
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEecC-
Confidence            35899999999999999999998753     35689999987532    245789999999996 89999999998653 


Q ss_pred             CCccEEEEeccCCccHHHHhh-------------cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEE
Q psy3714         240 SRTPALIFEHVNNTDFKQLYQ-------------TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLR  306 (467)
Q Consensus       240 ~~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ik  306 (467)
                       ...++||||+++|++..+..             .++...+..++.|++.||.|||+++|+||||||+|||++.+ ..+|
T Consensus        96 -~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~-~~~K  173 (308)
T d1p4oa_          96 -QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVK  173 (308)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCEE
T ss_pred             -CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC-ceEE
Confidence             46899999999999987653             24677888999999999999999999999999999999854 5899


Q ss_pred             EEecccceecCCCCC---cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhh
Q psy3714         307 LIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLD  383 (467)
Q Consensus       307 l~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (467)
                      |+|||+|+.......   .....||+.|+|||.+.+..|+.++|+|+.+++......+..+++.+.+    ..+....+.
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~----~~~~~~~i~  249 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----NEQVLRFVM  249 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----HHHHHHHHH
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC----HHHHHHHHH
Confidence            999999986643222   2334789999999999999999999999888764443333222222111    111111111


Q ss_pred             hhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhC------CCCCCC
Q psy3714         384 KNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMD------HPYFYP  440 (467)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~------Hp~f~~  440 (467)
                      ..        .     ..+.+..+++++.+||.+|++.||.+|||++|+++      +|+|..
T Consensus       250 ~~--------~-----~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         250 EG--------G-----LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             TT--------C-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             hC--------C-----CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            10        0     11123457899999999999999999999999987      788754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-40  Score=314.82  Aligned_cols=241  Identities=17%  Similarity=0.224  Sum_probs=183.5

Q ss_pred             eeEeecccCCcceEEEEEccCCC---eEEEEEeccc----hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         175 LVRKLGRGKYSEVFEAINVQSSD---KCVVKILKPV----KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       175 ~~~~lG~G~~g~V~~~~~~~~~~---~~avK~~~~~----~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ..++||+|+||+||+|.+..++.   .||||.++..    ..+++.+|+++|++++ ||||+++++++... ....++||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~-~~~~~lv~  108 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRS-EGSPLVVL  108 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEET-TTEEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEec-CCceEEEE
Confidence            35789999999999999866543   5899988642    2356889999999996 89999999987543 24679999


Q ss_pred             eccCCccHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecccceecCCCCC--
Q psy3714         248 EHVNNTDFKQLYQ----TLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--  321 (467)
Q Consensus       248 e~~~~~~l~~~~~----~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~~~~~~--  321 (467)
                      ||++++++.++..    ..+...+..++.|++.||.|||+++|+||||||+|||++. +..+||+|||+|+.......  
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~-~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TCCEEECSSGGGCCTTTTTCCC
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECC-CCCEEEecccchhhcccccccc
Confidence            9999999988765    3567788899999999999999999999999999999985 45899999999987643321  


Q ss_pred             ---cceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCccccccc
Q psy3714         322 ---YNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRKRWERF  398 (467)
Q Consensus       322 ---~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
                         .....||+.|+|||.+....|+.++|+|+.+++......+..|+......    .+....+..   +.         
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~----~~~~~~i~~---g~---------  251 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FDITVYLLQ---GR---------  251 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHT---TC---------
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH----HHHHHHHHc---CC---------
Confidence               22356899999999999999999999998888765544444444322111    011111111   10         


Q ss_pred             ccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         399 VHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       399 ~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                       ....+..+++++.+||.+||..||++|||+.|+++|
T Consensus       252 -~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         252 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence             112234578999999999999999999999999998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=311.89  Aligned_cols=258  Identities=19%  Similarity=0.183  Sum_probs=179.7

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHH--HhcCCCCeeEEEEEEeCCCC--CccEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILE--NLRGGTNIITLQAVVKDPVS--RTPALI  246 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~--~l~~~~~iv~l~~~~~~~~~--~~~~lv  246 (467)
                      .+|.+.+.||+|+||.||+|..  +|+.||||+++....+...+|.+++.  .+ +||||+++++++.+...  ...++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEE
Confidence            4789999999999999999985  68899999998766666666666553  44 58999999998865432  357899


Q ss_pred             EeccCCccHHHHhh--cCCHHHHHHHHHHHHHHHHHHHH--------CCccccCCCCCceEEeCCCCcEEEEecccceec
Q psy3714         247 FEHVNNTDFKQLYQ--TLTDYDIRYYLYELLKALDYCHS--------MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFY  316 (467)
Q Consensus       247 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qll~al~~lH~--------~~IiHrDlKp~Nill~~~~~~ikl~DFGla~~~  316 (467)
                      |||+++++|..+++  .++..+...++.|++.||.|||+        +|||||||||+|||++.++ .+||+|||+|+..
T Consensus        80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl~~~~  158 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEEE
T ss_pred             EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCccccc
Confidence            99999999988876  57888889999999999999996        5999999999999998654 8999999999876


Q ss_pred             CCCCC-----cceeeeccCccCCcccccCC------CCccchhHHHhhhccccccccccccccCCcccC------Chhhh
Q psy3714         317 HPGQE-----YNVRVASRYFKGPELLADYQ------YHIELDPRFADILGRHSRKRWERFVHTENQHLV------SPEAL  379 (467)
Q Consensus       317 ~~~~~-----~~~~~gt~~y~aPE~l~~~~------~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~  379 (467)
                      .....     ....+||+.|+|||++.+..      ++.++|+|+.+++.+....+..++.........      .....
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            44332     23467999999999987653      566789998887654433332222211111000      00000


Q ss_pred             hhhhhhccCCCCcccccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHhCC
Q psy3714         380 DFLDKNILGRHSRKRWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAMDH  435 (467)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l~H  435 (467)
                      ............+......   ........++.+|+.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~p~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGG---GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhccccCCCCCcc---cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            0000000000000000000   0001123468999999999999999999999763

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.2e-39  Score=308.03  Aligned_cols=249  Identities=12%  Similarity=0.166  Sum_probs=189.7

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEEec
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEH  249 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~e~  249 (467)
                      .+|++.+.||+|+||+||+|.+..+++.||||+++.. ....+.+|+++++.+.+++|++.+..++..  ....++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEEEEEe
Confidence            5799999999999999999999999999999988543 345678899999999988999999988865  3567999999


Q ss_pred             cCCccHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCC----CCcEEEEecccceecCCCC-
Q psy3714         250 VNNTDFKQLY----QTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHE----NRKLRLIDWGLAEFYHPGQ-  320 (467)
Q Consensus       250 ~~~~~l~~~~----~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~----~~~ikl~DFGla~~~~~~~-  320 (467)
                      + ++++..+.    ..++..++..++.|++.||+|||++|||||||||+|||++..    .+.+||+|||+|+.+.... 
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  161 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence            8 46666554    258899999999999999999999999999999999999742    3479999999998764321 


Q ss_pred             -------CcceeeeccCccCCcccccCCCCccchhHHHhhhccccccccccccccCCcccCChhhhhhhhhhccCCCCcc
Q psy3714         321 -------EYNVRVASRYFKGPELLADYQYHIELDPRFADILGRHSRKRWERFVHTENQHLVSPEALDFLDKNILGRHSRK  393 (467)
Q Consensus       321 -------~~~~~~gt~~y~aPE~l~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (467)
                             .....+||+.|||||++.+..|+.++|+|+.+++.+....+..||........  ......+......    .
T Consensus       162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~--~~~~~~i~~~~~~----~  235 (293)
T d1csna_         162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQKYERIGEKKQS----T  235 (293)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHHHHHHHHHHHH----S
T ss_pred             ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH--HHHHHHHHhccCC----C
Confidence                   22345799999999999999999999999988887666666666543221100  0000000000000    0


Q ss_pred             cccccccccCCCCCChHHHHHHHhhcCcCCCCCCCHHHHh
Q psy3714         394 RWERFVHTENQHLVSPEALDFLDKLLRYDHYERLTAREAM  433 (467)
Q Consensus       394 ~~~~~~~~~~~~~~s~~~~dli~~lL~~dp~~R~ta~e~l  433 (467)
                      ..     ......+++++.+|+..|+..+|++||+.+.+.
T Consensus       236 ~~-----~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         236 PL-----RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             CH-----HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             Ch-----HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence            00     011234789999999999999999999876543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.1e-27  Score=222.63  Aligned_cols=102  Identities=29%  Similarity=0.540  Sum_probs=86.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+....+.   .....+||+.|+|||++.+...++.
T Consensus       107 ~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~-~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~  185 (271)
T d1nvra_         107 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE  185 (271)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEECT-TCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHH
T ss_pred             HHHHHHHHHHHHHHHcCCccCcccHHHEEECC-CCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCC
Confidence            58999999999999999999999999999985 4589999999998764332   2345689999999999987555567


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHD  104 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~  104 (467)
                      ++||||+||++|+|++|+.||....+
T Consensus       186 ~~DiwSlGvilyeml~G~~pf~~~~~  211 (271)
T d1nvra_         186 PVDVWSCGIVLTAMLAGELPWDQPSD  211 (271)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred             ceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence            89999999999999999999864433

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=8.9e-27  Score=220.65  Aligned_cols=110  Identities=28%  Similarity=0.571  Sum_probs=92.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-cccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+...... .....+||+.|+|||++.+ ..++.++
T Consensus       120 ~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~-~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~  197 (293)
T d1yhwa1         120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKV  197 (293)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS-SCBCTHH
T ss_pred             HHHHHHHHHHHHHHHCCCcccCCcHHHeEECC-CCcEeeccchhheeeccccccccccccCCCccChhhhcC-CCCCchh
Confidence            58999999999999999999999999999985 4589999999999765433 3456689999999999986 5588999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      |||||||++|+|++|..||. +.+..+.+..+..
T Consensus       198 DiwSlGvilyemltG~~Pf~-~~~~~~~~~~~~~  230 (293)
T d1yhwa1         198 DIWSLGIMAIEMIEGEPPYL-NENPLRALYLIAT  230 (293)
T ss_dssp             HHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHH
T ss_pred             ceehHhHHHHHHhhCCCCCC-CCCHHHHHHHHHh
Confidence            99999999999999998884 4444555554443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.93  E-value=1.2e-26  Score=224.07  Aligned_cols=139  Identities=88%  Similarity=1.483  Sum_probs=120.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .|+.||+.||+|||++||+||||||+|||++.++..+||+|||+|+...........++|+.|+|||.+.+...++.++|
T Consensus       133 ~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  212 (328)
T d3bqca1         133 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD  212 (328)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHH
T ss_pred             HHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccc
Confidence            58999999999999999999999999999997666799999999998876666677789999999999987777899999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchhHhhhhhhccCCCchhhhhc
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFADIL  140 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~  140 (467)
                      +||+||+++++++|+.||..+.+..++...+.+.+|.+...+..........+.+....
T Consensus       213 iwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~  271 (328)
T d3bqca1         213 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL  271 (328)
T ss_dssp             HHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTC
T ss_pred             hhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhc
Confidence            99999999999999999998888888888888888887777777666665555554443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.8e-27  Score=220.36  Aligned_cols=109  Identities=24%  Similarity=0.485  Sum_probs=85.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---cccccccccccccccccccc--cCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADY--QMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~--~~~   76 (467)
                      +|+.|||.||+|||++|||||||||+|||++. ++.+||+|||+|+......   ......||+.|+|||++...  ..+
T Consensus       108 ~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~  186 (276)
T d1uwha_         108 DIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY  186 (276)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET-TSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCC
T ss_pred             HHHHHHHHHHHHHhcCCEeccccCHHHEEEcC-CCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCC
Confidence            68999999999999999999999999999994 5689999999998764322   23456789999999998642  347


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      +.++|||||||++|||++|+.||. +.+...++...
T Consensus       187 ~~~sDiwS~Gv~l~el~tg~~Pf~-~~~~~~~~~~~  221 (276)
T d1uwha_         187 SFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFM  221 (276)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTT-TCCCHHHHHHH
T ss_pred             CchhhhhhhHHHHHHHHHCCCCCC-CCChHHHHHHH
Confidence            889999999999999999999984 44444444433

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=8.5e-27  Score=217.54  Aligned_cols=107  Identities=28%  Similarity=0.557  Sum_probs=89.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+..... ......||+.|+|||++.+ ..++.++|
T Consensus       110 ~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~-~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~-~~~~~~~D  186 (263)
T d2j4za1         110 TYITELANALSYCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEG-RMHDEKVD  186 (263)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTT-CCCCTTHH
T ss_pred             HHHHHHHHHHHHHHHCCeeeeeeccccceecC-CCCEeecccceeeecCCC-cccccCCCCcccCHHHHcC-CCCCchhh
Confidence            58999999999999999999999999999985 458999999999876543 3445689999999999986 55889999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      ||||||++|+|++|+.|| .+.+..+.+..+
T Consensus       187 iwSlGvilyell~G~~Pf-~~~~~~~~~~~i  216 (263)
T d2j4za1         187 LWSLGVLCYEFLVGKPPF-EANTYQETYKRI  216 (263)
T ss_dssp             HHHHHHHHHHHHHSSCTT-CCSSHHHHHHHH
T ss_pred             hhhHhHHHHHHhcCCCCC-CCCCHHHHHHHH
Confidence            999999999999999987 444433333333

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.8e-26  Score=218.62  Aligned_cols=117  Identities=38%  Similarity=0.722  Sum_probs=99.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-CcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+..... ......+||+.|+|||++.....++.++
T Consensus       104 ~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~-~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  182 (299)
T d1ua2a_         104 AYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV  182 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHH
T ss_pred             HHHHHHHHHHHHhhccceecccCCcceEEecC-CCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhh
Confidence            57899999999999999999999999999984 458999999999866433 2344568999999999997767789999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCch
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE  120 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~  120 (467)
                      |||||||++|||++|..| |.+.+..+++..+.+.+|++.
T Consensus       183 DiwSlGvil~el~~g~~p-f~~~~~~~~l~~i~~~~~~~~  221 (299)
T d1ua2a_         183 DMWAVGCILAELLLRVPF-LPGDSDLDQLTRIFETLGTPT  221 (299)
T ss_dssp             HHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHHHCCCC
T ss_pred             hhhhcchHHHHHHhCcCC-CCCCCHHHHHHHHHHhcCCCC
Confidence            999999999999999755 467788888888888877543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.6e-26  Score=216.53  Aligned_cols=97  Identities=24%  Similarity=0.419  Sum_probs=84.7

Q ss_pred             hHHHHHHHHHHHHHhCC--CcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMG--IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~--iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      .++.||+.||+|||++|  ||||||||+|||++..++.+||+|||+|+..... .....+||+.|+|||++.+  .++.+
T Consensus       116 ~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~--~~~~~  192 (270)
T d1t4ha_         116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDES  192 (270)
T ss_dssp             HHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTH
T ss_pred             HHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhCC--CCCCc
Confidence            58899999999999998  9999999999999755668999999999865433 3445689999999999864  48999


Q ss_pred             eeEEchhHHHHHHHhcCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      +|||||||++|+|++|+.||..
T Consensus       193 ~DIwSlGvilyel~~g~~Pf~~  214 (270)
T d1t4ha_         193 VDVYAFGMCMLEMATSEYPYSE  214 (270)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CchhhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999853

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.3e-26  Score=218.80  Aligned_cols=116  Identities=33%  Similarity=0.653  Sum_probs=100.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++|||||||||+|||++. .+.+||+|||+++............||+.|+|||++.+ ..++.++|
T Consensus       120 ~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~-~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~D  197 (305)
T d1blxa_         120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVD  197 (305)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHH
T ss_pred             HHHHHHHHHHHHHHhCCEEecCCCccEEEEcC-CCCeeecchhhhhhhcccccCCCcccChhhcCcchhcC-CCCChheh
Confidence            58999999999999999999999999999984 45899999999987665555667789999999999976 55899999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCch
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE  120 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~  120 (467)
                      |||+||++|||++|+.|| .+.+..+++..+.+..+.+.
T Consensus       198 iwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~  235 (305)
T d1blxa_         198 LWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPG  235 (305)
T ss_dssp             HHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCC
T ss_pred             hhchHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCc
Confidence            999999999999998887 56667777888877776543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.7e-26  Score=220.18  Aligned_cols=111  Identities=19%  Similarity=0.337  Sum_probs=85.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.|||.||+|||++|||||||||+|||++. ++.+||+|||+|+......   ..+...||+.|+|||++.+ ..++.
T Consensus       138 ~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~  215 (299)
T d1ywna1         138 CYSFQVAKGMEFLASRKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTI  215 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG-GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHhCCCcCCcCCccceeECC-CCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCc
Confidence            58999999999999999999999999999985 4589999999998654332   2334578999999999976 55889


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      ++|||||||++|||++|..|++.+.+..+.+....+
T Consensus       216 ~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~  251 (299)
T d1ywna1         216 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK  251 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred             ccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            999999999999999987766666655555444433

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.92  E-value=5.5e-26  Score=216.95  Aligned_cols=107  Identities=34%  Similarity=0.583  Sum_probs=88.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccc--cCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADY--QMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~   79 (467)
                      +|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+....   .....||+.|+|||++.+.  ..|+.+
T Consensus       119 ~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~-~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~  194 (309)
T d1u5ra_         119 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSE-PGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGK  194 (309)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET-TTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTH
T ss_pred             HHHHHHHHHHHHHHhCCEeccCCCcceEEECC-CCCEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCch
Confidence            58999999999999999999999999999994 56899999999987643   2345799999999998642  347889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA  113 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~  113 (467)
                      +|||||||++|||++|..||.. .+..+.+..+.
T Consensus       195 ~DiwSlGvilyel~~g~~Pf~~-~~~~~~~~~i~  227 (309)
T d1u5ra_         195 VDVWSLGITCIELAERKPPLFN-MNAMSALYHIA  227 (309)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHH
T ss_pred             hhhhhHHHHHHHHHHCCCCCCC-CCHHHHHHHHH
Confidence            9999999999999999999853 33444444443

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=6.5e-26  Score=218.87  Aligned_cols=97  Identities=28%  Similarity=0.550  Sum_probs=85.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.... .......+||+.|+|||++.+ ..|+.++
T Consensus       109 ~~~~qil~al~ylH~~~iiHRDlKP~NILl~~-~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~-~~y~~~~  186 (337)
T d1o6la_         109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAV  186 (337)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTH
T ss_pred             HHHHHHhhhhhhhhhcCccccccCHHHeEecC-CCCEEEeecccccccccCCcccccceeCHHHhhhhhccC-CCCChhh
Confidence            47899999999999999999999999999985 45899999999986543 344556789999999999986 5589999


Q ss_pred             eEEchhHHHHHHHhcCCCCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~  100 (467)
                      |+||+||++|||++|+.||.
T Consensus       187 DiwSlGvilyeml~G~~pf~  206 (337)
T d1o6la_         187 DWWGLGVVMYEMMCGRLPFY  206 (337)
T ss_dssp             HHHHHHHHHHHHHHSSCSSC
T ss_pred             cccchhhHHHHHHHCCCCCC
Confidence            99999999999999988875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.3e-26  Score=223.15  Aligned_cols=105  Identities=28%  Similarity=0.476  Sum_probs=87.1

Q ss_pred             hHHHHHHHHHHHHHh-CCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~-~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...+. .....+||+.|+|||++.+ ..|+.++
T Consensus       108 ~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~-~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~-~~y~~~~  184 (322)
T d1s9ja_         108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYSVQS  184 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT-TCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHC-SCCCTTH
T ss_pred             HHHHHHHHHHHHHHHhCCEEccccCHHHeeECC-CCCEEEeeCCCccccCCC-ccccccCCccccCchHHcC-CCCCcHH
Confidence            578999999999997 59999999999999985 458999999999865432 2345689999999999986 5589999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQL  109 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~  109 (467)
                      ||||+||++|||++|+.||........+.
T Consensus       185 DiWSlGvil~ell~G~~Pf~~~~~~~~~~  213 (322)
T d1s9ja_         185 DIWSMGLSLVEMAVGRYPIPPPDAKELEL  213 (322)
T ss_dssp             HHHHHHHHHHHHHHSSCCSSCCCTTHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            99999999999999999997655444433

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.7e-26  Score=217.03  Aligned_cols=111  Identities=29%  Similarity=0.498  Sum_probs=89.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-Cccccccccccccccccccc----ccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLAD----YQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~----~~~~   76 (467)
                      .|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+..... ......+||+.|+|||++..    ...|
T Consensus       114 ~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~-~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y  192 (288)
T d2jfla1         114 VVCKQTLDALNYLHDNKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY  192 (288)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSST
T ss_pred             HHHHHHHHHHHHHHHCCEEEeecChhheeECC-CCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCC
Confidence            58899999999999999999999999999985 458999999999865322 22345689999999999842    3457


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      +.++|||||||++|+|++|+.||. +.+..+.+..+.+
T Consensus       193 ~~k~DiwSlGvilyemltg~~Pf~-~~~~~~~~~~i~~  229 (288)
T d2jfla1         193 DYKADVWSLGITLIEMAEIEPPHH-ELNPMRVLLKIAK  229 (288)
T ss_dssp             TTHHHHHHHHHHHHHHHHSSCTTT-TSCGGGHHHHHHH
T ss_pred             ChhhhHHHHHHHHHHHhhCCCCCC-CCCHHHHHHHHHc
Confidence            889999999999999999998874 4455555555544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=5.8e-26  Score=221.16  Aligned_cols=119  Identities=39%  Similarity=0.661  Sum_probs=103.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .|+.||+.||+|||++||+||||||+|||++.++..+||+|||+|+...........+|++.|+|||.+.+...++.++|
T Consensus       126 ~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  205 (350)
T d1q5ka_         126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSID  205 (350)
T ss_dssp             HHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHH
T ss_pred             HHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCccee
Confidence            57999999999999999999999999999986666899999999998776666666789999999999877667899999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCchh
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEEL  121 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~  121 (467)
                      |||+||++|||++|+.|| .+.+..+++..+.+.+|.+..
T Consensus       206 IwSlG~il~el~~g~~pf-~~~~~~~~l~~i~~~~g~~~~  244 (350)
T d1q5ka_         206 VWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTR  244 (350)
T ss_dssp             HHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCH
T ss_pred             ecccceEEEehhhCCCCC-CCCCHHHHHHHHHHHhCCChH
Confidence            999999999999998776 566677888888888876543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.92  E-value=4.9e-26  Score=221.11  Aligned_cols=107  Identities=24%  Similarity=0.472  Sum_probs=90.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .|+.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+.....  .....||+.|+|||++.+ ..++.++|
T Consensus       145 ~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~-~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~-~~~~~~~D  220 (350)
T d1rdqe_         145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS-KGYNKAVD  220 (350)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT-CCBCTHHH
T ss_pred             HHHHHHHHHHHHHHhCCEecCcCCHHHcccCC-CCCEEeeeceeeeecccc--cccccCccccCCHHHHcC-CCCCcccc
Confidence            58999999999999999999999999999985 458999999999987532  345689999999999986 55889999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA  113 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~  113 (467)
                      ||||||++|+|++|..||. +.+....+..+.
T Consensus       221 iwSlGvilyemltG~~Pf~-~~~~~~~~~~i~  251 (350)
T d1rdqe_         221 WWALGVLIYEMAAGYPPFF-ADQPIQIYEKIV  251 (350)
T ss_dssp             HHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHH
T ss_pred             ccchhHHHHHHHhCCCCCC-CcCHHHHHHHHh
Confidence            9999999999999999884 444444444443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.2e-26  Score=216.37  Aligned_cols=108  Identities=30%  Similarity=0.596  Sum_probs=87.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      .++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+......   .....+||+.|+|||++.+ ..++.
T Consensus       112 ~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~-~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~  189 (288)
T d1uu3a_         112 FYTAEIVSALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACK  189 (288)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TSCEEECCCTTCEECC----------CCCCGGGCCHHHHHT-CCCCH
T ss_pred             HHHHHHHHHHHhhccccEEcCcCCccccccCC-CceEEecccccceecccCCcccccccccCCccccCceeecc-CCCCc
Confidence            57899999999999999999999999999985 4589999999999765322   2345679999999999976 55889


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      ++||||+||++|+|++|..||. +.+..+....+
T Consensus       190 ~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i  222 (288)
T d1uu3a_         190 SSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKI  222 (288)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHH
T ss_pred             ccceehhhHHHHHHhhCCCCCC-CcCHHHHHHHH
Confidence            9999999999999999998884 44444444444

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3e-26  Score=215.13  Aligned_cols=110  Identities=16%  Similarity=0.372  Sum_probs=91.3

Q ss_pred             ChHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCC
Q psy3714           1 MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         1 ~~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      ++|+.|||.||.|||++||+||||||+|||++. ++.+||+|||+|+....+..  .....|+..|+|||++.. ..++.
T Consensus       112 ~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~  189 (272)
T d1qpca_         112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTI  189 (272)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECH
T ss_pred             HHHHHHHHHHHHHHHhCCcccCccchhheeeec-ccceeeccccceEEccCCccccccccCCcccccChHHHhC-CCCCc
Confidence            368999999999999999999999999999984 56899999999998754432  233567888999999875 45789


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      ++|||||||++|||++|+.|++.+.+..+.+..+
T Consensus       190 ~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i  223 (272)
T d1qpca_         190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL  223 (272)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred             hhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999999999888887766554444444

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.92  E-value=6.4e-26  Score=217.28  Aligned_cols=106  Identities=27%  Similarity=0.576  Sum_probs=88.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.....  ....+||+.|+|||++.+ ..++.++|
T Consensus       108 ~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~-~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~-~~y~~~~D  183 (316)
T d1fota_         108 FYAAEVCLALEYLHSKDIIYRDLKPENILLDK-NGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST-KPYNKSID  183 (316)
T ss_dssp             HHHHHHHHHHHHHHTTTEECCCCCGGGEEECT-TSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT-CCBCTTHH
T ss_pred             HHHHHHHHhhhhhccCcEEccccCchheeEcC-CCCEEEecCccceEeccc--cccccCcccccCHHHHcC-CCCCchhh
Confidence            47899999999999999999999999999985 558999999999986532  345689999999999975 55889999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      ||||||++|+|++|+.||. +.+..+....+
T Consensus       184 iwSlGvilyemltG~~Pf~-~~~~~~~~~~i  213 (316)
T d1fota_         184 WWSFGILIYEMLAGYTPFY-DSNTMKTYEKI  213 (316)
T ss_dssp             HHHHHHHHHHHHHSSCTTC-CSSHHHHHHHH
T ss_pred             ccccchhHHHHHhCCCCCC-CcCHHHHHHHH
Confidence            9999999999999999984 44433434443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.92  E-value=6.2e-26  Score=220.27  Aligned_cols=111  Identities=27%  Similarity=0.492  Sum_probs=94.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEec-CCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDH-ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~-~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .|+.||+.||+|||++|||||||||+|||++. .++.+||+|||+|+............||+.|+|||++.+ ..++.++
T Consensus       128 ~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~-~~~~~~~  206 (350)
T d1koaa2         128 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYT  206 (350)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHT-CCBCHHH
T ss_pred             HHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcC-CCCChhH
Confidence            58999999999999999999999999999974 245899999999998876666667789999999999976 5578899


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      |||||||++|+|++|+.|| .+.+..+.+..+..
T Consensus       207 DiwSlGvilyell~G~~Pf-~~~~~~~~~~~i~~  239 (350)
T d1koaa2         207 DMWSVGVLSYILLSGLSPF-GGENDDETLRNVKS  239 (350)
T ss_dssp             HHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHH
T ss_pred             hhhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHh
Confidence            9999999999999999887 45555555555544

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=3.6e-26  Score=214.05  Aligned_cols=101  Identities=33%  Similarity=0.635  Sum_probs=76.2

Q ss_pred             hHHHHHHHHHHHHHhCC-----CcccCCCCCcEEEecCCCcEEEEecccceecCCCC-cccccccccccccccccccccC
Q psy3714           2 RIATGASMALDYCHSMG-----IMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQM   75 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~-----iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~   75 (467)
                      +|+.||+.||+|||++|     ||||||||+|||++. ++.+||+|||+|+...... .....+||+.|+|||++.+ ..
T Consensus       113 ~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~-~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~  190 (269)
T d2java1         113 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR-MS  190 (269)
T ss_dssp             HHHHHHHHHHHHHHHHCC---------CCGGGEEECT-TSCEEECCHHHHHHC-----------CCCSCCCHHHHTT-CC
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC-CCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcC-CC
Confidence            58999999999999976     999999999999985 4589999999998765433 2345689999999999975 55


Q ss_pred             CCCeeeEEchhHHHHHHHhcCCCCCCCCCC
Q psy3714          76 YDYSLDMWSLGCMLASMIFRKEPFFHGHDN  105 (467)
Q Consensus        76 ~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~  105 (467)
                      ++.++|||||||++|||++|..||. +.+.
T Consensus       191 ~~~~~DIwSlGvilyel~tg~~Pf~-~~~~  219 (269)
T d2java1         191 YNEKSDIWSLGCLLYELCALMPPFT-AFSQ  219 (269)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCSCC-CSSH
T ss_pred             CChHHHHHhhCHHHHHHhhCCCCCC-CCCH
Confidence            8899999999999999999998874 4433

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=5.4e-26  Score=214.73  Aligned_cols=107  Identities=19%  Similarity=0.377  Sum_probs=82.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----ccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +|+.|||.||+|||++|||||||||+|||++. ++.+||+|||+|+.......    .....||..|+|||++.+ ..++
T Consensus       114 ~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~  191 (283)
T d1mqba_         114 GMLRGIAAGMKYLANMNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFT  191 (283)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECCCCC-----------------CCCGGGSCHHHHHS-CCCC
T ss_pred             HHHHHHHHhhhhccccccccCccccceEEECC-CCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc-CCCC
Confidence            68999999999999999999999999999994 56999999999987643321    223467888999999876 5588


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHH
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  110 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~  110 (467)
                      .++|||||||++|||++++.|++.+.+..+.+.
T Consensus       192 ~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~  224 (283)
T d1mqba_         192 SASDVWSFGIVMWEVMTYGERPYWELSNHEVMK  224 (283)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             CcccccccHHHHHHHHhCCCCccccCCHHHHHH
Confidence            899999999999999998888876555443333

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=4.1e-26  Score=213.19  Aligned_cols=110  Identities=17%  Similarity=0.361  Sum_probs=81.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.|||.||+|||+++|+||||||+|||++. ++.+||+|||+|+.......  .....||..|+|||++.+ ..++.+
T Consensus       105 ~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k  182 (263)
T d1sm2a_         105 GMCLDVCEGMAYLEEACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSK  182 (263)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCTTCSGGGEEECG-GGCEEECSCC------------------CTTSCCHHHHTT-CCCCHH
T ss_pred             HHHHHHHHHHHhhhccceeecccchhheeecC-CCCeEecccchheeccCCCceeecceecCcccCChHHhcC-CCCCch
Confidence            68999999999999999999999999999995 45899999999987654322  233568889999999976 558899


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA  113 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~  113 (467)
                      +|||||||++|||++++.|++.+.+..+.+..+.
T Consensus       183 ~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~  216 (263)
T d1sm2a_         183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS  216 (263)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH
T ss_pred             hhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence            9999999999999998778776655544444443

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.91  E-value=4.2e-26  Score=215.76  Aligned_cols=102  Identities=23%  Similarity=0.376  Sum_probs=86.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.|||.||+|||++|||||||||+|||++. ++.+||+|||+|+.......  .....|+..|+|||++.+ ..++.+
T Consensus       119 ~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~-~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k  196 (287)
T d1opja_         119 YMATQISSAMEYLEKKNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIK  196 (287)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH-CCCSHH
T ss_pred             HHHHHHHHHHHHHHHCCcccCccccCeEEECC-CCcEEEccccceeecCCCCceeeccccccccccChHHHcC-CCCCch
Confidence            58999999999999999999999999999985 45899999999987654332  233457888999999876 558899


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGHDN  105 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~~~  105 (467)
                      +|||||||++|||++|+.|++.+.+.
T Consensus       197 ~DiwS~Gv~l~ell~~~~p~~~~~~~  222 (287)
T d1opja_         197 SDVWAFGVLLWEIATYGMSPYPGIDL  222 (287)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             hhhhhHHHHHHHHHhCCCCCCCcchH
Confidence            99999999999999998888766543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=5.8e-26  Score=218.76  Aligned_cols=110  Identities=20%  Similarity=0.383  Sum_probs=89.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.|||.||+|||++|||||||||+|||++. ++.+||+|||+|+.......   .....||+.|+|||++.+ ..++.
T Consensus       168 ~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~  245 (325)
T d1rjba_         168 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTI  245 (325)
T ss_dssp             HHHHHHHHHHHHHHHTTEEETTCSGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHhCCeeeccCchhcccccc-CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCc
Confidence            58999999999999999999999999999984 56999999999987643322   234567899999999875 55899


Q ss_pred             eeeEEchhHHHHHHHh-cCCCCCCCCCCHHHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~~~~~~  114 (467)
                      ++|||||||++|||++ |..|| .+.+..+.+..+.+
T Consensus       246 ~~DiwS~Gvil~emlt~g~~Pf-~~~~~~~~~~~~~~  281 (325)
T d1rjba_         246 KSDVWSYGILLWEIFSLGVNPY-PGIPVDANFYKLIQ  281 (325)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCSS-TTCCCSHHHHHHHH
T ss_pred             ceeccchhHHHHHHHhCCCCCC-CCCCHHHHHHHHHh
Confidence            9999999999999998 67666 45544445544443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.91  E-value=6.5e-26  Score=216.31  Aligned_cols=98  Identities=31%  Similarity=0.632  Sum_probs=73.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEec--CCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDH--ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~--~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      .++.||+.||+|||++|||||||||+|||+..  .++.+||+|||+|+....+......+||+.|+|||++.+ ..++.+
T Consensus       111 ~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~~  189 (307)
T d1a06a_         111 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKA  189 (307)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTT-CCCCTH
T ss_pred             HHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcC-CCCCcH
Confidence            58999999999999999999999999999963  345899999999997766555666789999999999976 558999


Q ss_pred             eeEEchhHHHHHHHhcCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +|||||||++|+|++|..||.
T Consensus       190 ~DiwSlGvilyell~g~~Pf~  210 (307)
T d1a06a_         190 VDCWSIGVIAYILLCGYPPFY  210 (307)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCC
T ss_pred             HHhhhhhHHHHHHHhCCCCCC
Confidence            999999999999999999884

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.91  E-value=1.1e-25  Score=218.75  Aligned_cols=111  Identities=27%  Similarity=0.534  Sum_probs=94.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEec-CCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDH-ENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~-~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .|+.||+.||+|||++|||||||||+|||++. .++.+||+|||+|+....+.......||+.|+|||++.+ ..++.++
T Consensus       131 ~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  209 (352)
T d1koba_         131 NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYT  209 (352)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHH
T ss_pred             HHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcC-CCCCCcc
Confidence            58999999999999999999999999999973 345899999999998877666677789999999999976 5589999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      |||||||++|+|++|..|| .+.+..+.+..+.+
T Consensus       210 DiwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~  242 (352)
T d1koba_         210 DMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKR  242 (352)
T ss_dssp             HHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHh
Confidence            9999999999999999887 45555555555544

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.91  E-value=1e-25  Score=220.00  Aligned_cols=98  Identities=31%  Similarity=0.497  Sum_probs=86.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+...... ....+||+.|+|||++.....++.++|
T Consensus       111 ~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~-~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~D  188 (364)
T d1omwa3         111 FYAAEIILGLEHMHNRFVVYRDLKPANILLDE-HGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSAD  188 (364)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECS-SSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHH
T ss_pred             HHHHHHHHHHHHHHHCCccceeeccceeEEcC-CCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccc
Confidence            57899999999999999999999999999984 4589999999999775443 345689999999999976667899999


Q ss_pred             EEchhHHHHHHHhcCCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~  101 (467)
                      ||||||++|+|++|+.||..
T Consensus       189 iwSlGvilyemltG~~Pf~~  208 (364)
T d1omwa3         189 WFSLGCMLFKLLRGHSPFRQ  208 (364)
T ss_dssp             HHHHHHHHHHHHHSSCSSCS
T ss_pred             hhHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999854

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=7.7e-26  Score=212.51  Aligned_cols=98  Identities=30%  Similarity=0.507  Sum_probs=86.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++.+++.+||+|||+|+..... ..+...||+.|+|||++.+...++.++|
T Consensus       114 ~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~D  192 (273)
T d1xwsa_         114 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAA  192 (273)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccc
Confidence            578999999999999999999999999999866568999999999876433 3456689999999999987665677899


Q ss_pred             EEchhHHHHHHHhcCCCCC
Q psy3714          82 MWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~  100 (467)
                      |||+||++|+|++|+.||.
T Consensus       193 iwSlGvilyell~g~~Pf~  211 (273)
T d1xwsa_         193 VWSLGILLYDMVCGDIPFE  211 (273)
T ss_dssp             HHHHHHHHHHHHHSSCSCC
T ss_pred             cccceeeehhHhhCCCCCC
Confidence            9999999999999999984

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.91  E-value=2e-25  Score=212.30  Aligned_cols=107  Identities=20%  Similarity=0.419  Sum_probs=76.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcc------cccccccccccccccccccC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEY------NVRVASRYFKGPELLADYQM   75 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~------~~~~~~~~~~~pe~~~~~~~   75 (467)
                      +|+.|||.||+|||++|||||||||+|||++. ++.+||+|||+|+........      ....||+.|+|||.+.+ ..
T Consensus       132 ~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~  209 (299)
T d1jpaa_         132 GMLRGIAAGMKYLADMNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RK  209 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECCC-----------------------CGGGSCHHHHHS-CC
T ss_pred             HHHHHHHHHHHHHhhCCCccCccccceEEECC-CCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc-CC
Confidence            68999999999999999999999999999984 568999999999876533221      12356888999999876 55


Q ss_pred             CCCeeeEEchhHHHHHHHh-cCCCCCCCCCCHHHHHH
Q psy3714          76 YDYSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVR  111 (467)
Q Consensus        76 ~~~~~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~~~  111 (467)
                      ++.++|||||||++|||++ |..||. +.+..+.+..
T Consensus       210 ~~~~sDvwS~Gvvl~el~t~g~~Pf~-~~~~~~~~~~  245 (299)
T d1jpaa_         210 FTSASDVWSYGIVMWEVMSYGERPYW-DMTNQDVINA  245 (299)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHH
T ss_pred             CCcccccccchHHHHHHHhCCCCCCC-CCCHHHHHHH
Confidence            8889999999999999998 677764 4443333333

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=2e-25  Score=214.29  Aligned_cols=104  Identities=16%  Similarity=0.346  Sum_probs=83.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.|||.||+|||++|||||||||+|||++. ++.+||+|||+|+.......   .....||..|+|||.+.+ ..++.
T Consensus       115 ~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~  192 (317)
T d1xkka_         115 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTH  192 (317)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE-TTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHHcCcccCcchhhcceeCC-CCCeEeeccccceecccccccccccccccCccccChHHHhc-CCCCh
Confidence            68999999999999999999999999999995 45899999999987654322   223467899999999976 55899


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCCHH
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDNYD  107 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~~~  107 (467)
                      ++|||||||++|||++++.+++.+.+..+
T Consensus       193 ~sDvwS~Gvil~el~t~g~~p~~~~~~~~  221 (317)
T d1xkka_         193 QSDVWSYGVTVWELMTFGSKPYDGIPASE  221 (317)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTSCGGG
T ss_pred             hhhhhhHHHHHHHHHHCCCCCCCCCCHHH
Confidence            99999999999999995555556555443

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=4.3e-25  Score=210.12  Aligned_cols=116  Identities=35%  Similarity=0.727  Sum_probs=98.3

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCC-CCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.... ........||+.|+|||.+.....++.++
T Consensus       106 ~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~-~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~  184 (298)
T d1gz8a_         106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV  184 (298)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHH
T ss_pred             HHHHHHHHHHHHhhcCCEEccccCchheeecc-cCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccc
Confidence            68999999999999999999999999999985 45899999999987643 33445568999999999988777678899


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCc
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  119 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  119 (467)
                      |+||+||++|+|++|+.|| .+.+..+++..+.+..+.+
T Consensus       185 DiwSlGvily~m~~G~~Pf-~~~~~~~~~~~i~~~~~~~  222 (298)
T d1gz8a_         185 DIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTP  222 (298)
T ss_dssp             HHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCC
T ss_pred             cccccchhhhHHhhCCCCC-CCCCHHHHHHHHHHhcCCC
Confidence            9999999999999999887 5666677777777766543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=2.6e-25  Score=214.70  Aligned_cols=98  Identities=35%  Similarity=0.643  Sum_probs=87.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC--CCcEEEEecccceecCCCCcccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~--~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      .|+.||+.||+|||++||+||||||+|||++..  .+.+||+|||+|+...........+||+.|+|||++.+ ..|+.+
T Consensus       115 ~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~  193 (335)
T d2ozaa1         115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKS  193 (335)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCG-GGGSHH
T ss_pred             HHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcC-CCCCHH
Confidence            589999999999999999999999999999852  34699999999998766666667789999999999976 558899


Q ss_pred             eeEEchhHHHHHHHhcCCCCC
Q psy3714          80 LDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +|+|||||++|+|++|+.||.
T Consensus       194 ~DiwSlGvily~lltg~~Pf~  214 (335)
T d2ozaa1         194 CDMWSLGVIMYILLCGYPPFY  214 (335)
T ss_dssp             HHHHHHHHHHHHHTTSSCSCE
T ss_pred             HHHHhhchhHHHHhhCCCCCC
Confidence            999999999999999999985

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.90  E-value=9.7e-25  Score=206.47  Aligned_cols=117  Identities=31%  Similarity=0.690  Sum_probs=95.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-cccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      +|+.||+.||+|||++|||||||||+|||++. ++.+|++|||+|....... ......+++.|++||.+.+...++.++
T Consensus       104 ~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~  182 (286)
T d1ob3a_         104 SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI  182 (286)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHH
T ss_pred             HHHHHHHHHHHHhccCcEEecCCCCceeeEcC-CCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcce
Confidence            68999999999999999999999999999985 4689999999998764322 234457888999999998777789999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCCch
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEE  120 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~  120 (467)
                      |+||+||+++||++|+.|| .+.+..+++.++.+..+.+.
T Consensus       183 DiwslGv~l~el~~G~~pf-~~~~~~~~~~~i~~~~~~~~  221 (286)
T d1ob3a_         183 DIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPN  221 (286)
T ss_dssp             HHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCC
T ss_pred             eehhcCcHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCC
Confidence            9999999999999999887 45666777787777766543

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=5e-25  Score=207.78  Aligned_cols=111  Identities=20%  Similarity=0.372  Sum_probs=86.7

Q ss_pred             ChHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCC
Q psy3714           1 MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         1 ~~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      ++|+.|||.||+|||++||+||||||+|||++. ++.+||+|||+|+....+..  .....||+.|+|||++.. ..++.
T Consensus       116 ~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~  193 (285)
T d1fmka3         116 VDMAAQIASGMAYVERMNYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTI  193 (285)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCCTTC--------------CCGGGSCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHhhhheecccccceEEEECC-CCcEEEcccchhhhccCCCceeeccccccccccChHHHhC-CCCCc
Confidence            368999999999999999999999999999984 46899999999987643322  233568899999999976 55789


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA  113 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~  113 (467)
                      ++|||||||++|||++|+.|++.+....+.+..+.
T Consensus       194 ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~  228 (285)
T d1fmka3         194 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE  228 (285)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             HHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999999999999999888887766555555444

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=9.7e-24  Score=187.26  Aligned_cols=131  Identities=21%  Similarity=0.305  Sum_probs=104.9

Q ss_pred             eeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---------------------HHHHHHHHHHHHHhcCCCCeeEE
Q psy3714         173 YQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---------------------KKKIKREIKILENLRGGTNIITL  231 (467)
Q Consensus       173 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------------------~~~~~~Ei~il~~l~~~~~iv~l  231 (467)
                      +.+.+.||+|+||+||+|.+. +++.||||+++...                     .....+|...+..+. +.+++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence            457889999999999999874 68899999865210                     123456888888885 6778776


Q ss_pred             EEEEeCCCCCccEEEEeccCCccHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEeCCCCcEEEEecc
Q psy3714         232 QAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWG  311 (467)
Q Consensus       232 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qll~al~~lH~~~IiHrDlKp~Nill~~~~~~ikl~DFG  311 (467)
                      ++..      ..+++||++++..+.    .++...+..++.|++.+|.|||++||+||||||+|||++. + .++|+|||
T Consensus        80 ~~~~------~~~lvme~~~~~~~~----~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~-~~~liDFG  147 (191)
T d1zara2          80 YAWE------GNAVLMELIDAKELY----RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-E-GIWIIDFP  147 (191)
T ss_dssp             EEEE------TTEEEEECCCCEEGG----GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-T-EEEECCCT
T ss_pred             EEec------CCEEEEEeecccccc----chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC-C-CEEEEECC
Confidence            6542      237999999987653    4667778889999999999999999999999999999984 3 58999999


Q ss_pred             cceecC
Q psy3714         312 LAEFYH  317 (467)
Q Consensus       312 la~~~~  317 (467)
                      +|+...
T Consensus       148 ~a~~~~  153 (191)
T d1zara2         148 QSVEVG  153 (191)
T ss_dssp             TCEETT
T ss_pred             CcccCC
Confidence            998653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=4.8e-25  Score=207.31  Aligned_cols=101  Identities=19%  Similarity=0.402  Sum_probs=82.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----ccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +|+.|||.||+|||++|||||||||+|||++. ++.+||+|||+|+.......    .....||+.|+|||.+.. ..++
T Consensus       111 ~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~  188 (277)
T d1xbba_         111 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFS  188 (277)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE-TTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEE
T ss_pred             HHHHHHHHHHhhHHhCCcccCCCcchhhcccc-cCcccccchhhhhhccccccccccccccCCCceecCchhhcC-CCCC
Confidence            68999999999999999999999999999995 45899999999987654322    123468889999999975 5578


Q ss_pred             CeeeEEchhHHHHHHHh-cCCCCCCCCCC
Q psy3714          78 YSLDMWSLGCMLASMIF-RKEPFFHGHDN  105 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~-g~~~~~~~~~~  105 (467)
                      .++|||||||++|||++ |..|| .+.+.
T Consensus       189 ~~sDiwS~Gv~l~ellt~g~~Pf-~~~~~  216 (277)
T d1xbba_         189 SKSDVWSFGVLMWEAFSYGQKPY-RGMKG  216 (277)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCSS-TTCCH
T ss_pred             chhhhccchhhhhHHhhCCCCCC-CCCCH
Confidence            89999999999999997 77776 44443

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=5e-25  Score=207.90  Aligned_cols=108  Identities=18%  Similarity=0.334  Sum_probs=87.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----ccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +|+.|||.||+|||++|||||||||+|||++. ++.+||+|||+|+.......    .....||+.|+|||++.. ..++
T Consensus       113 ~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~  190 (285)
T d1u59a_         113 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFS  190 (285)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE-TTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEEC
T ss_pred             HHHHHHHHHHHHHHhCCeecCcCchhheeecc-CCceeeccchhhhcccccccccccccccccCccccChHHHhC-CCCC
Confidence            68999999999999999999999999999995 45899999999997654322    223467888999999875 4588


Q ss_pred             CeeeEEchhHHHHHHHh-cCCCCCCCCCCHHHHHHH
Q psy3714          78 YSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~~~~  112 (467)
                      .++|||||||++|||++ |..||. +.+..+....+
T Consensus       191 ~ksDVwS~Gv~l~E~lt~G~~Pf~-~~~~~~~~~~i  225 (285)
T d1u59a_         191 SRSDVWSYGVTMWEALSYGQKPYK-KMKGPEVMAFI  225 (285)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTT-TCCTHHHHHHH
T ss_pred             ccchhhcchHHHHHHHhCCCCCCC-CCCHHHHHHHH
Confidence            99999999999999998 777774 44444433333

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=9.2e-25  Score=207.27  Aligned_cols=109  Identities=28%  Similarity=0.520  Sum_probs=91.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCC---cEEEEecccceecCCCCcccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENR---KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~---~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      .++.||+.||+|||++||+||||||+|||++..+.   .+|++|||+|+............||+.|+|||++.+ ..++.
T Consensus       117 ~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~  195 (293)
T d1jksa_         117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGL  195 (293)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCT
T ss_pred             HHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCC
Confidence            58999999999999999999999999999985442   599999999998766655666789999999999976 55889


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      ++|||||||++|+|++|+.||. +.+..+.+..+
T Consensus       196 ~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i  228 (293)
T d1jksa_         196 EADMWSIGVITYILLSGASPFL-GDTKQETLANV  228 (293)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHH
T ss_pred             cccchhhhHHHHHHHcCCCCCC-CCCHHHHHHHH
Confidence            9999999999999999998884 44444444444

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=1.2e-24  Score=208.58  Aligned_cols=108  Identities=30%  Similarity=0.571  Sum_probs=89.5

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCC-CcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+..... .......||+.|+|||++.+ ..++.++
T Consensus       107 ~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~-~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  184 (320)
T d1xjda_         107 FYAAEIILGLQFLHSKGIVYRDLKLDNILLDK-DGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSV  184 (320)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHH
T ss_pred             HHHHHHHHHHHHHHhCCeeeccCcccceeecC-CCceeccccchhhhcccccccccccCCCCCcCCHHHHcC-CCCCchh
Confidence            58999999999999999999999999999984 558999999999865432 33455689999999999986 5588999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      |+|||||++|+|++|+.||. +.+..+....+
T Consensus       185 DiwSlGvilyemltG~~PF~-~~~~~~~~~~i  215 (320)
T d1xjda_         185 DWWSFGVLLYEMLIGQSPFH-GQDEEELFHSI  215 (320)
T ss_dssp             HHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHH
T ss_pred             hhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHH
Confidence            99999999999999998884 44443333333

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.90  E-value=3.5e-25  Score=211.06  Aligned_cols=109  Identities=17%  Similarity=0.296  Sum_probs=88.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.|||.||+|||++|||||||||+|||++. ++.+||+|||+|+......   ..+...+++.|+|||.+.+ ..++.
T Consensus       144 ~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~-~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~  221 (301)
T d1lufa_         144 CIARQVAAGMAYLSERKFVHRDLATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTT  221 (301)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHhhhcccCCeEeeEEcccceEECC-CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCCh
Confidence            68999999999999999999999999999995 4689999999998654322   2334578889999999986 55889


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      ++|||||||++|||++|..|++.+.+..+.+..+
T Consensus       222 ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v  255 (301)
T d1lufa_         222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV  255 (301)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             hhhhccchhhHHHHHccCCCCCCCCCHHHHHHHH
Confidence            9999999999999999987666666555544443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=2.5e-24  Score=206.81  Aligned_cols=115  Identities=33%  Similarity=0.605  Sum_probs=94.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-----cccccccccccccccccccccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-----EYNVRVASRYFKGPELLADYQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~   76 (467)
                      .|+.||+.||+|||++||+||||||+|||++. ++.+|++|||+|+......     .....+||+.|+|||++.+...+
T Consensus       121 ~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~  199 (318)
T d3blha1         121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY  199 (318)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSC
T ss_pred             HHHHHHHHHHHHhccCCEEecCcCchheeecC-CCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCC
Confidence            57899999999999999999999999999984 4589999999998654321     22345799999999999876678


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      +.++|+||+||+++||++|+.|| .+.+..+.+..+.+..+.
T Consensus       200 ~~k~DiwSlGvil~el~~g~~pf-~~~~~~~~~~~i~~~~~~  240 (318)
T d3blha1         200 GPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGS  240 (318)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCC
T ss_pred             CcHHHcccCCceeeeHhhCCCCC-CCCCHHHHHHHHHHhcCC
Confidence            99999999999999999998776 556666666666666553

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=3.6e-24  Score=208.12  Aligned_cols=113  Identities=37%  Similarity=0.722  Sum_probs=95.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++|||||||||+|||++. ++.+|++|||+|+....  ..+...||+.|+|||++.+...++.++|
T Consensus       125 ~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~-~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~D  201 (346)
T d1cm8a_         125 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE-DCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVD  201 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHH
T ss_pred             HHHHHHHHHHHHHHhCCCcccccCcchhhccc-ccccccccccceeccCC--ccccccccccccCHHHHcCCCCCCccch
Confidence            58999999999999999999999999999984 56899999999987643  3455689999999999987667789999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      +||+||++++|++|+.|| .+.+..+.+..+....+.
T Consensus       202 iwSlGvil~ell~g~~pf-~~~~~~~~~~~~~~~~~~  237 (346)
T d1cm8a_         202 IWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGT  237 (346)
T ss_dssp             HHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCC
T ss_pred             hhcchHHHHHHHHCcCCC-CCCChHHHHHHHHhccCC
Confidence            999999999999998877 455666666666665554

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=1.2e-24  Score=204.40  Aligned_cols=109  Identities=24%  Similarity=0.378  Sum_probs=76.6

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +++.|||.||+|||++|||||||||+|||++.. +.+||+|||+|+.......  .....||+.|+|||.+.+ ..++.+
T Consensus       112 ~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~  189 (273)
T d1mp8a_         112 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSA  189 (273)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC-------------------CCGGGCCHHHHHH-CCCSHH
T ss_pred             HHHHHHHHHhhhhcccCeeccccchhheeecCC-CcEEEccchhheeccCCcceeccceecCcccchhhHhcc-CCCCCc
Confidence            689999999999999999999999999999954 5899999999987653322  234567889999999975 558889


Q ss_pred             eeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          80 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      +|||||||++|||++++.|++.+.+..+....+
T Consensus       190 ~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i  222 (273)
T d1mp8a_         190 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI  222 (273)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred             cccccchHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            999999999999998434444555544444433

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=3.5e-24  Score=207.99  Aligned_cols=114  Identities=34%  Similarity=0.670  Sum_probs=93.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC----cccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      .++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+......    .....+||+.|+|||++.....++
T Consensus       113 ~i~~qil~al~yLH~~~iiHRDIKp~NILl~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~  191 (345)
T d1pmea_         113 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT  191 (345)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCS
T ss_pred             HHHHHHHHHHHHHHHCCCcCCCCCcceEEECC-CCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCC
Confidence            58999999999999999999999999999985 4589999999998764322    234567899999999987767788


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhC
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG  117 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~  117 (467)
                      .++|+||+||++++|++|+.|| .+.+..++.......++
T Consensus       192 ~~~DiwSlG~il~eml~g~~pf-~~~~~~~~~~~~~~~~~  230 (345)
T d1pmea_         192 KSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILG  230 (345)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHC
T ss_pred             chhhhhccCceehHHhhCCCCC-CCCCHHHHHHHHhhhcc
Confidence            9999999999999999998887 45555566555555444

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.89  E-value=2.9e-24  Score=201.70  Aligned_cols=110  Identities=25%  Similarity=0.513  Sum_probs=90.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCccccccccccccccccccc-----ccCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLAD-----YQMY   76 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~   76 (467)
                      +++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+....+.......||+.|++||.+.+     ...+
T Consensus       114 ~~~~qi~~al~~lH~~~ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~  192 (277)
T d1phka_         114 KIMRALLEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY  192 (277)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCB
T ss_pred             HHHHHHHHHHHHHHHcCCcccccccceEEEc-CCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCC
Confidence            5899999999999999999999999999998 456899999999998766555666789999999999864     2346


Q ss_pred             CCeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q psy3714          77 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA  113 (467)
Q Consensus        77 ~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~  113 (467)
                      +.++||||+||++++|++|+.||. +.+..+....+.
T Consensus       193 ~~~~DiwslGvilyeml~g~~Pf~-~~~~~~~~~~i~  228 (277)
T d1phka_         193 GKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIM  228 (277)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHH
T ss_pred             CchheEcccchhhhhhccCCCCCC-CCCHHHHHHHHH
Confidence            778999999999999999999885 444333343333

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=2.3e-24  Score=200.39  Aligned_cols=108  Identities=19%  Similarity=0.387  Sum_probs=87.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc--ccccccccccccccccccccCCCCe
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLADYQMYDYS   79 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~   79 (467)
                      +|+.|||+||+|||++||+||||||+|||++. +..+||+|||+|+.......  .....+|..|+|||.+.+ ..++.+
T Consensus       104 ~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~k  181 (258)
T d1k2pa_         104 EMCKDVCEAMEYLESKQFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSK  181 (258)
T ss_dssp             HHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT-TCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHHHhhcCcccccccceeEEEcC-CCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC-CCCCcc
Confidence            68999999999999999999999999999994 55899999999986644332  223568889999999986 458889


Q ss_pred             eeEEchhHHHHHHHh-cCCCCCCCCCCHHHHHHH
Q psy3714          80 LDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        80 ~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~~~~  112 (467)
                      +|||||||++|||++ |+.|| .+.+..+....+
T Consensus       182 sDiwS~G~~l~el~t~g~~Pf-~~~~~~~~~~~i  214 (258)
T d1k2pa_         182 SDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHI  214 (258)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTT-TTSCHHHHHHHH
T ss_pred             eeecccchhhHhHHhcCCCCC-CCCCHHHHHHHH
Confidence            999999999999998 66665 554444433333

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=5.4e-24  Score=201.86  Aligned_cols=116  Identities=36%  Similarity=0.716  Sum_probs=98.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-cccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .++.|++.||+|||++||+||||||+|||++. +..+||+|||.|+...... ......+++.|+|||.+.....++.++
T Consensus       105 ~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~  183 (292)
T d1unla_         105 SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI  183 (292)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHH
T ss_pred             HHHHHHHHHHHHhhcCCEeeecccCccccccc-CCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchh
Confidence            57899999999999999999999999999985 4589999999998765433 334456778899999988766678999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      |+||+||+++||++|+.||+.+.+..+++..+....+.
T Consensus       184 DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  221 (292)
T d1unla_         184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT  221 (292)
T ss_dssp             HHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred             hccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCC
Confidence            99999999999999999999888877777777666554

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.89  E-value=3.8e-24  Score=201.38  Aligned_cols=108  Identities=28%  Similarity=0.527  Sum_probs=81.8

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC----cccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      .|+.||+.||+|||++|||||||||+|||++. +..++++|||.+.......    .....+||+.|+|||++.+ ..++
T Consensus       115 ~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~  192 (277)
T d1o6ya_         115 EVIADACQALNFSHQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVD  192 (277)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TSCEEECCCTTCEECC----------------TTCCHHHHTT-CCCC
T ss_pred             HHHHHHHHHHHHHHhCCccCccccCcccccCc-cccceeehhhhhhhhccccccccccccccCcccccCHHHHcC-CCCC
Confidence            68999999999999999999999999999995 4589999999987653221    2344579999999999875 5588


Q ss_pred             CeeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHH
Q psy3714          78 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  112 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~  112 (467)
                      .++|||||||++|+|++|..|| .+.+..+.+.++
T Consensus       193 ~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~~  226 (277)
T d1o6ya_         193 ARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQH  226 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHH
T ss_pred             cceecccchHHHHHHHhCCCCC-CCcCHHHHHHHH
Confidence            9999999999999999999887 444444444433

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=3.8e-24  Score=205.38  Aligned_cols=111  Identities=23%  Similarity=0.500  Sum_probs=92.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC-CCcEEEEecccceecCCCCcccccccccccccccccccccCCCCee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE-NRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~-~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      .|+.||+.||+|||++||+||||||+|||++.. ...+||+|||+++............+++.|+|||...+ ..++.++
T Consensus       106 ~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~-~~~~~~~  184 (321)
T d1tkia_         106 SYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTAT  184 (321)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT-CEECHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccC-CCCCchh
Confidence            578999999999999999999999999999743 34799999999998776666666789999999999876 5578899


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      |+||+||++|+|++|..||. +.+..+.+..+.+
T Consensus       185 DiWSlGvily~ll~G~~Pf~-~~~~~~~~~~i~~  217 (321)
T d1tkia_         185 DMWSLGTLVYVLLSGINPFL-AETNQQIIENIMN  217 (321)
T ss_dssp             HHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHH
T ss_pred             hcccHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh
Confidence            99999999999999998884 4444444555543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.88  E-value=2.8e-24  Score=204.58  Aligned_cols=99  Identities=24%  Similarity=0.339  Sum_probs=84.4

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC--CCcEEEEecccceecCCCC--------cccccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE--NRKLRLIDWGLAEFYHPGQ--------EYNVRVASRYFKGPELLA   71 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~--~~~~kl~dfG~a~~~~~~~--------~~~~~~~~~~~~~pe~~~   71 (467)
                      +++.||+.||+|||++|||||||||+|||++..  +..+|++|||+|+......        ......||+.|+|||.+.
T Consensus       107 ~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  186 (299)
T d1ckia_         107 LLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL  186 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHh
Confidence            689999999999999999999999999998642  3469999999999764322        123457999999999997


Q ss_pred             cccCCCCeeeEEchhHHHHHHHhcCCCCCC
Q psy3714          72 DYQMYDYSLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        72 ~~~~~~~~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      + ..++.++|||||||+++||++|+.||..
T Consensus       187 ~-~~~~~~~DiwSlG~~l~el~tg~~P~~~  215 (299)
T d1ckia_         187 G-IEQSRRDDLESLGYVLMYFNLGSLPWQG  215 (299)
T ss_dssp             T-BCCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             C-CCCCChhhEEecCHHHHHHHhCCCcccc
Confidence            6 4588999999999999999999999854

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=3e-24  Score=201.36  Aligned_cols=109  Identities=23%  Similarity=0.408  Sum_probs=86.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc----ccccccccccccccccccccCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLADYQMYD   77 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~   77 (467)
                      +++.|||.||.|||++||+||||||+|||++.. ..+||+|||+++.......    .....|+..|+|||.+.+ ..++
T Consensus       115 ~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~-~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~  192 (273)
T d1u46a_         115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFS  192 (273)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEE
T ss_pred             HHHHHHHHHHHHhhhCCEeeeeecHHHhccccc-cceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC-CCCC
Confidence            689999999999999999999999999999954 5899999999997654322    123456778999999986 5588


Q ss_pred             CeeeEEchhHHHHHHHh-cCCCCCCCCCCHHHHHHHH
Q psy3714          78 YSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRIA  113 (467)
Q Consensus        78 ~~~D~ws~G~~l~~~l~-g~~~~~~~~~~~~~~~~~~  113 (467)
                      .++|||||||++|||++ |+.|| .+.+..+.+..+.
T Consensus       193 ~~~Di~S~Gvil~emlt~G~~Pf-~~~~~~~~~~~i~  228 (273)
T d1u46a_         193 HASDTWMFGVTLWEMFTYGQEPW-IGLNGSQILHKID  228 (273)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHH
T ss_pred             cchhhhhhHHHHHHHHhCCCCCC-CCcCHHHHHHHHH
Confidence            89999999999999998 77765 5555544444443

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=6.3e-24  Score=201.99  Aligned_cols=102  Identities=24%  Similarity=0.388  Sum_probs=84.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC---cccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +++.|||.||+|||++|||||||||+|||++. ++.+||+|||+++......   ......+++.|+|||.+.+ ..++.
T Consensus       139 ~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~  216 (299)
T d1fgka_         139 SCAYQVARGMEYLASKKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTH  216 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHhhhCCEEeeeecccceeecC-CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCc
Confidence            68999999999999999999999999999985 4589999999998664332   2334578888999999976 56899


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDN  105 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~  105 (467)
                      ++|||||||++|||++++.|++.+.+.
T Consensus       217 k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         217 QSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             hhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            999999999999999865555555443

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=1.2e-23  Score=201.09  Aligned_cols=111  Identities=19%  Similarity=0.359  Sum_probs=92.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.|||.||+|||++|||||||||+|||++. ++.+|++|||+++.......   .....||+.|+|||.+.. ..++.
T Consensus       149 ~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~-~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~  226 (311)
T d1t46a_         149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTF  226 (311)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHhCCeeecccccccccccc-cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCC
Confidence            58999999999999999999999999999995 45899999999987654322   234578999999999975 55889


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  114 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~  114 (467)
                      ++|||||||++|||++++.|++.+.+..+.+.++.+
T Consensus       227 ~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~  262 (311)
T d1t46a_         227 ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK  262 (311)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH
T ss_pred             cccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            999999999999999987888877766666655544

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=6.1e-24  Score=202.99  Aligned_cols=105  Identities=22%  Similarity=0.370  Sum_probs=85.0

Q ss_pred             ChHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc-----ccccccccccccccccccccC
Q psy3714           1 MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE-----YNVRVASRYFKGPELLADYQM   75 (467)
Q Consensus         1 ~~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~   75 (467)
                      ++++.|||.||.|||++||+||||||+|||++ ++..+||+|||+++.......     .....||..|+|||.+.. ..
T Consensus       133 ~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~-~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  210 (311)
T d1r0pa_         133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QK  210 (311)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-TTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH-CC
T ss_pred             HHHHHHHHHhhhhhcccCcccCCccHHhEeEC-CCCCEEEecccchhhccccccccceecccccccccccChHHHhc-CC
Confidence            36899999999999999999999999999998 456899999999987643322     223467889999999876 55


Q ss_pred             CCCeeeEEchhHHHHHHHhcCCCCCCCCCCHH
Q psy3714          76 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD  107 (467)
Q Consensus        76 ~~~~~D~ws~G~~l~~~l~g~~~~~~~~~~~~  107 (467)
                      ++.++|||||||++|||++|+.||+.+.+..+
T Consensus       211 ~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~  242 (311)
T d1r0pa_         211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD  242 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCSCC------
T ss_pred             CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH
Confidence            78999999999999999999899876554433

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=2.9e-24  Score=205.36  Aligned_cols=107  Identities=18%  Similarity=0.290  Sum_probs=86.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.|||.||.|||++|||||||||+|||++.. ..+||+|||+|+............||..|+|||.+.. ..++.++|
T Consensus       131 ~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sD  208 (309)
T d1fvra_         131 HFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSD  208 (309)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHH
T ss_pred             HHHHHHHHHHHhhhcCCccccccccceEEEcCC-CceEEccccccccccccccccceecCCcccchHHhcc-CCCCccce
Confidence            689999999999999999999999999999854 5899999999986654333344568889999999976 55888999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHH
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLV  110 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~  110 (467)
                      ||||||++|||++|..|++.+.+..+...
T Consensus       209 vwSfGvil~ell~~~~~p~~~~~~~~~~~  237 (309)
T d1fvra_         209 VWSYGVLLWEIVSLGGTPYCGMTCAELYE  237 (309)
T ss_dssp             HHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             eehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            99999999999998877776655444333

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.88  E-value=8.9e-24  Score=200.36  Aligned_cols=98  Identities=17%  Similarity=0.271  Sum_probs=84.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecC----CCcEEEEecccceecCCCC--------cccccccccccccccc
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHE----NRKLRLIDWGLAEFYHPGQ--------EYNVRVASRYFKGPEL   69 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~----~~~~kl~dfG~a~~~~~~~--------~~~~~~~~~~~~~pe~   69 (467)
                      +|+.|++.||+|||++|||||||||+|||++..    .+.+||+|||+|+......        .....+||+.|+|||.
T Consensus       105 ~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~  184 (293)
T d1csna_         105 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT  184 (293)
T ss_dssp             HHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             HHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHH
Confidence            689999999999999999999999999999742    3479999999998764321        1234579999999999


Q ss_pred             cccccCCCCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          70 LADYQMYDYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        70 ~~~~~~~~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      +.+ ..++.++|+|||||++|||++|+.||.
T Consensus       185 ~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~  214 (293)
T d1csna_         185 HLG-REQSRRDDLEALGHVFMYFLRGSLPWQ  214 (293)
T ss_dssp             HTT-CCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             hcC-CCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence            976 558899999999999999999999985

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=1.7e-23  Score=199.74  Aligned_cols=110  Identities=21%  Similarity=0.330  Sum_probs=89.9

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCc---ccccccccccccccccccccCCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLADYQMYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~   78 (467)
                      +|+.|||.||.|||+++|+||||||+|||++ .+..+||+|||+|+.......   .....+++.|+|||.+.+ ..++.
T Consensus       137 ~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~  214 (308)
T d1p4oa_         137 QMAGEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTT  214 (308)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHhhCCeeeceEcCCceeec-CCceEEEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCc
Confidence            5899999999999999999999999999998 456999999999986543222   233468899999999976 55788


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA  113 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~  113 (467)
                      ++|+|||||++|||++|+.|++.+.+..+.+..+.
T Consensus       215 ~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~  249 (308)
T d1p4oa_         215 YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  249 (308)
T ss_dssp             HHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             ccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999999999999999877777665555454443

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=2.5e-23  Score=193.62  Aligned_cols=106  Identities=18%  Similarity=0.330  Sum_probs=79.7

Q ss_pred             ChHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCee
Q psy3714           1 MRIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSL   80 (467)
Q Consensus         1 ~~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~   80 (467)
                      ++|+.|||.||.|||+++|+||||||+|||++. ++.+|++|||+++.....  .....++..|+|||++.+ ..++.++
T Consensus       106 ~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~-~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~-~~~t~~s  181 (262)
T d1byga_         106 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE-KKFSTKS  181 (262)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TSCEEECCCCC--------------CCTTTSCHHHHHH-CCCCHHH
T ss_pred             HHHHHHHHhhccccccCceeccccchHhheecC-CCCEeecccccceecCCC--CccccccccCCChHHHhC-CCCChHH
Confidence            368999999999999999999999999999995 568999999999876433  233467888999999976 4588999


Q ss_pred             eEEchhHHHHHHHhcCCCCCCCCCCHHHHH
Q psy3714          81 DMWSLGCMLASMIFRKEPFFHGHDNYDQLV  110 (467)
Q Consensus        81 D~ws~G~~l~~~l~g~~~~~~~~~~~~~~~  110 (467)
                      |||||||++|||++++.|++.+.+..+...
T Consensus       182 DIwSfG~il~el~t~~~~p~~~~~~~~~~~  211 (262)
T d1byga_         182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVP  211 (262)
T ss_dssp             HHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred             HHHhHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence            999999999999985555555554433333

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=6.3e-23  Score=196.84  Aligned_cols=99  Identities=23%  Similarity=0.432  Sum_probs=83.0

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC--ccccccccccccccccccccc-CCCC
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLADYQ-MYDY   78 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~-~~~~   78 (467)
                      .++.||+.||+|||++||+||||||+|||++.. +.+||+|||+|+.+....  ......|++.|++||.+.+.. .++.
T Consensus       133 ~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~  211 (322)
T d1vzoa_         133 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK  211 (322)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CT
T ss_pred             HHHHHHHHHHHHhhcCCEEeccCCccceeecCC-CCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCc
Confidence            478999999999999999999999999999954 589999999998764322  234567899999999997543 4677


Q ss_pred             eeeEEchhHHHHHHHhcCCCCCC
Q psy3714          79 SLDMWSLGCMLASMIFRKEPFFH  101 (467)
Q Consensus        79 ~~D~ws~G~~l~~~l~g~~~~~~  101 (467)
                      ++|||||||++|+|++|+.||..
T Consensus       212 ksDIWSlG~iLyelltG~~PF~~  234 (322)
T d1vzoa_         212 AVDWWSLGVLMYELLTGASPFTV  234 (322)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTSC
T ss_pred             hhhhHHHHHHHHHHHhCCCCCCC
Confidence            89999999999999999999853

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=9.7e-23  Score=198.09  Aligned_cols=113  Identities=34%  Similarity=0.713  Sum_probs=91.1

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .|+.||+.||+|||++||+||||||+|||++. ++.+|++|||+|....  .......|++.|+|||...+...++.++|
T Consensus       125 ~i~~qil~aL~~LH~~giiHrDiKp~NILi~~-~~~~kl~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~D  201 (348)
T d2gfsa1         125 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNE-DCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVD  201 (348)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECCC----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHH
T ss_pred             HHHHHHHHHHHHHHhCCCcccccCCccccccc-cccccccccchhcccC--cccccccccccccCchhhcCCccCCcccc
Confidence            58999999999999999999999999999985 4589999999997653  23455678899999999887677788999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      +||+||++|+|++|+.|| .+.+.......+.+..+.
T Consensus       202 iwSlGv~l~~ll~g~~pF-~~~~~~~~~~~i~~~~~~  237 (348)
T d2gfsa1         202 IWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGT  237 (348)
T ss_dssp             HHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCC
T ss_pred             hhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCC
Confidence            999999999999998777 566666666666665553

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=1.6e-22  Score=197.01  Aligned_cols=114  Identities=32%  Similarity=0.612  Sum_probs=87.2

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      .++.||+.||+|||++||+||||||+|||++. +..+|++|||+++...........++|+.|+|||++.+ ..++.++|
T Consensus       123 ~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~-~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~D  200 (355)
T d2b1pa1         123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVD  200 (355)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECCCCC---------------CCTTCCHHHHTT-CCCCTTHH
T ss_pred             HHHHHHHHHHHHhhhcccccccCCcccccccc-ccceeeechhhhhccccccccccccccccccChhhhcC-CCCCCCcc
Confidence            58999999999999999999999999999985 45899999999987766555666789999999999986 56889999


Q ss_pred             EEchhHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhCC
Q psy3714          82 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  118 (467)
Q Consensus        82 ~ws~G~~l~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  118 (467)
                      +||+||++++|++|+.|| .+.+...++..+...++.
T Consensus       201 iwSlG~~l~ell~g~~pF-~~~~~~~~~~~i~~~~~~  236 (355)
T d2b1pa1         201 IWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGT  236 (355)
T ss_dssp             HHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCC
T ss_pred             cccccchHHHHhhCCCCC-CCCCHHHHHHHHHHhccC
Confidence            999999999999998766 566777777777766654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=5.8e-23  Score=195.54  Aligned_cols=98  Identities=24%  Similarity=0.304  Sum_probs=79.6

Q ss_pred             hHHHHHHHHHHHHHh--------CCCcccCCCCCcEEEecCCCcEEEEecccceecCCCC-----ccccccccccccccc
Q psy3714           2 RIATGASMALDYCHS--------MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQ-----EYNVRVASRYFKGPE   68 (467)
Q Consensus         2 ~i~~~i~~al~~lH~--------~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~-----~~~~~~~~~~~~~pe   68 (467)
                      +++.|||.||.|||+        +|||||||||+|||++. ++.+||+|||+++......     ......||+.|+|||
T Consensus       104 ~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~-~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE  182 (303)
T d1vjya_         104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE  182 (303)
T ss_dssp             HHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT-TSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC-CCCeEEEecCccccccCCCcceeccccceecccCcCChh
Confidence            689999999999996        69999999999999984 5699999999998764332     123467999999999


Q ss_pred             cccccc-----CCCCeeeEEchhHHHHHHHhcCCCCC
Q psy3714          69 LLADYQ-----MYDYSLDMWSLGCMLASMIFRKEPFF  100 (467)
Q Consensus        69 ~~~~~~-----~~~~~~D~ws~G~~l~~~l~g~~~~~  100 (467)
                      ++....     .++.++|||||||++|||++|..|+.
T Consensus       183 ~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             HHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             hccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            986532     24568999999999999999976653

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.80  E-value=1.3e-20  Score=183.84  Aligned_cols=114  Identities=28%  Similarity=0.604  Sum_probs=88.9

Q ss_pred             hHHHHHHHHHHHHHh-CCCcccCCCCCcEEEecCCC-----cEEEEecccceecCCCCcccccccccccccccccccccC
Q psy3714           2 RIATGASMALDYCHS-MGIMHRDVKPHNVMIDHENR-----KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQM   75 (467)
Q Consensus         2 ~i~~~i~~al~~lH~-~~iiHrDlkp~Nil~~~~~~-----~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~   75 (467)
                      .++.||+.||+|||+ +||+||||||+|||++..+.     .++++|||.|.....  .....+||+.|+|||.+.. ..
T Consensus       129 ~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~-~~  205 (362)
T d1q8ya_         129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG-AP  205 (362)
T ss_dssp             HHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-CC
T ss_pred             HHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc--ccccccccccccChhhccc-cC
Confidence            478999999999998 99999999999999985432     489999999986543  2345679999999999886 55


Q ss_pred             CCCeeeEEchhHHHHHHHhcCCCCCCCCC-----CHHHHHHHHHHhCC
Q psy3714          76 YDYSLDMWSLGCMLASMIFRKEPFFHGHD-----NYDQLVRIAKVLGT  118 (467)
Q Consensus        76 ~~~~~D~ws~G~~l~~~l~g~~~~~~~~~-----~~~~~~~~~~~~~~  118 (467)
                      ++.++|+||+||++++|++|+.||.....     ..+.+......+|+
T Consensus       206 ~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~  253 (362)
T d1q8ya_         206 WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE  253 (362)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCS
T ss_pred             CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCC
Confidence            78999999999999999999998753221     12344555556664

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.32  E-value=1e-13  Score=121.71  Aligned_cols=81  Identities=14%  Similarity=0.053  Sum_probs=55.7

Q ss_pred             hHHHHHHHHHHHHHhCCCcccCCCCCcEEEecCCCcEEEEecccceecCCCCcccccccccccccccccccccCCCCeee
Q psy3714           2 RIATGASMALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLADYQMYDYSLD   81 (467)
Q Consensus         2 ~i~~~i~~al~~lH~~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D   81 (467)
                      +++.|++.||.|||++||+||||||+|||++. + .++|+|||.|................. .-.+..  .+.|+.++|
T Consensus       107 ~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~-~~~liDFG~a~~~~~~~~~~~l~rd~~-~~~~~f--~r~y~~~~d  181 (191)
T d1zara2         107 EVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-E-GIWIIDFPQSVEVGEEGWREILERDVR-NIITYF--SRTYRTEKD  181 (191)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-T-EEEECCCTTCEETTSTTHHHHHHHHHH-HHHHHH--HHHHCCCCC
T ss_pred             HHHHHHHHHHHHHhhCCEEEccCChhheeeeC-C-CEEEEECCCcccCCCCCcHHHHHHHHH-HHHHHH--cCCCCCccc
Confidence            58899999999999999999999999999984 3 699999999987643221110000000 001122  134677889


Q ss_pred             EEchhH
Q psy3714          82 MWSLGC   87 (467)
Q Consensus        82 ~ws~G~   87 (467)
                      +||..-
T Consensus       182 ~~s~~~  187 (191)
T d1zara2         182 INSAID  187 (191)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999764

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.23  E-value=7e-06  Score=73.95  Aligned_cols=83  Identities=11%  Similarity=0.190  Sum_probs=55.6

Q ss_pred             cceeeeEeecccCCcceEEEEEccCCCeEEEEEeccch---HHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         171 DDYQLVRKLGRGKYSEVFEAINVQSSDKCVVKILKPVK---KKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       171 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      +.|+.++..+-++.+.||+..  .+++.+++|+.....   ...+.+|..+++.|..+--+.++.....++  ...++||
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv~   89 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLM   89 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEEEE
Confidence            345566654445557899874  356678888875432   335788999999887553455666655443  4578999


Q ss_pred             eccCCccHHH
Q psy3714         248 EHVNNTDFKQ  257 (467)
Q Consensus       248 e~~~~~~l~~  257 (467)
                      ++++|..+..
T Consensus        90 ~~l~G~~~~~   99 (263)
T d1j7la_          90 SEADGVLCSE   99 (263)
T ss_dssp             ECCSSEEHHH
T ss_pred             Eecccccccc
Confidence            9999987643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.82  E-value=5.4e-05  Score=67.49  Aligned_cols=134  Identities=19%  Similarity=0.152  Sum_probs=81.5

Q ss_pred             eecccCC-cceEEEEEccCCCeEEEEEeccchHHHHHHHHHHHHHhcCCC-CeeEEEEEEeCCCCCccEEEEeccCCccH
Q psy3714         178 KLGRGKY-SEVFEAINVQSSDKCVVKILKPVKKKKIKREIKILENLRGGT-NIITLQAVVKDPVSRTPALIFEHVNNTDF  255 (467)
Q Consensus       178 ~lG~G~~-g~V~~~~~~~~~~~~avK~~~~~~~~~~~~Ei~il~~l~~~~-~iv~l~~~~~~~~~~~~~lv~e~~~~~~l  255 (467)
                      .+..|.. +.||+... .++..+++|.........+.+|...|+.|..+. .+.+++....++  ...++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEEeeecccc
Confidence            3444543 57888764 456678899877666667889999999887542 244555555543  467899999988654


Q ss_pred             HH-----------H---h---hcCCHH---------H----HHHHHH----------------HHHHHHHHHHHC-----
Q psy3714         256 KQ-----------L---Y---QTLTDY---------D----IRYYLY----------------ELLKALDYCHSM-----  284 (467)
Q Consensus       256 ~~-----------~---~---~~~~~~---------~----~~~~~~----------------qll~al~~lH~~-----  284 (467)
                      ..           +   +   +..+..         .    ......                .....+..+.++     
T Consensus        94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  173 (255)
T d1nd4a_          94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  173 (255)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence            21           0   0   001000         0    000000                022234444432     


Q ss_pred             --CccccCCCCCceEEeCCCCcEEEEeccccee
Q psy3714         285 --GIMHRDVKPHNVMIDHENRKLRLIDWGLAEF  315 (467)
Q Consensus       285 --~IiHrDlKp~Nill~~~~~~ikl~DFGla~~  315 (467)
                        .++|+|+.|.|||++. +..+-|+||+.+..
T Consensus       174 ~~~liHgD~~~~Nvl~~~-~~~~~iID~~~~~~  205 (255)
T d1nd4a_         174 DLVVTHGDACLPNIMVEN-GRFSGFIDCGRLGV  205 (255)
T ss_dssp             CEEEECSSCCGGGEEEET-TEEEEECCCTTCEE
T ss_pred             CceEEeCCCCCcceEEeC-CceEEEEEchhccc
Confidence              3799999999999984 43567999998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.64  E-value=0.00015  Score=69.16  Aligned_cols=75  Identities=12%  Similarity=0.170  Sum_probs=48.4

Q ss_pred             eEeecccCCcceEEEEEccCCCeEEEEEeccc----------hHHHHHHHHHHHHHhcCC--CCeeEEEEEEeCCCCCcc
Q psy3714         176 VRKLGRGKYSEVFEAINVQSSDKCVVKILKPV----------KKKKIKREIKILENLRGG--TNIITLQAVVKDPVSRTP  243 (467)
Q Consensus       176 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~----------~~~~~~~Ei~il~~l~~~--~~iv~l~~~~~~~~~~~~  243 (467)
                      .+.||.|....||+..+..+++.+++|.-.+.          ...+..+|.+.|+.+..+  ..++.++.+..    ...
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~----~~~  106 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT----EMA  106 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET----TTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC----CCC
Confidence            45689999999999988777888999964321          124567899999877643  23444444322    245


Q ss_pred             EEEEeccCCcc
Q psy3714         244 ALIFEHVNNTD  254 (467)
Q Consensus       244 ~lv~e~~~~~~  254 (467)
                      +++||++.+..
T Consensus       107 ~lvmE~L~~~~  117 (392)
T d2pula1         107 VTVMEDLSHLK  117 (392)
T ss_dssp             EEEECCCTTSE
T ss_pred             EEEEeccCCcc
Confidence            89999997643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.62  E-value=0.0046  Score=58.51  Aligned_cols=73  Identities=11%  Similarity=0.111  Sum_probs=48.0

Q ss_pred             eEeecccCCcceEEEEEcc-------CCCeEEEEEeccc-hHHHHHHHHHHHHHhcCCCCeeEEEEEEeCCCCCccEEEE
Q psy3714         176 VRKLGRGKYSEVFEAINVQ-------SSDKCVVKILKPV-KKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIF  247 (467)
Q Consensus       176 ~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~~~~iv~l~~~~~~~~~~~~~lv~  247 (467)
                      ++.|+.|-.-.+|++....       ..+.+++++.-.. ......+|..+++.+..+.-..+++.++.+      .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~------g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG------GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC------ceEE
Confidence            3567778778889887543       2356777775432 223456899999988765444566666532      6889


Q ss_pred             eccCCcc
Q psy3714         248 EHVNNTD  254 (467)
Q Consensus       248 e~~~~~~  254 (467)
                      +|++|..
T Consensus       121 efi~g~~  127 (395)
T d1nw1a_         121 EYIPSRP  127 (395)
T ss_dssp             CCCCEEE
T ss_pred             EEecccc
Confidence            9987753

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.00  E-value=0.0036  Score=57.57  Aligned_cols=39  Identities=21%  Similarity=0.339  Sum_probs=29.8

Q ss_pred             cceEEEEEccCCCeEEEEEeccc--hHHHHHHHHHHHHHhcC
Q psy3714         185 SEVFEAINVQSSDKCVVKILKPV--KKKKIKREIKILENLRG  224 (467)
Q Consensus       185 g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~Ei~il~~l~~  224 (467)
                      -.||++.. .+|..+++|+.++.  ....+..|...+..|..
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~   76 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVN   76 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHH
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHh
Confidence            46888864 56788999998764  34668889999988874

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.53  E-value=0.016  Score=52.60  Aligned_cols=47  Identities=11%  Similarity=0.219  Sum_probs=29.8

Q ss_pred             eEeecccCCcceEEEEEccCCCeEEEEEeccc-hHHHHHHHHHHHHHhcC
Q psy3714         176 VRKLGRGKYSEVFEAINVQSSDKCVVKILKPV-KKKKIKREIKILENLRG  224 (467)
Q Consensus       176 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~Ei~il~~l~~  224 (467)
                      ++.|..|.--+.|+....  +..+++|+.... ....+..|+.++..|..
T Consensus        23 ~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~~~~l~~~~~~l~~L~~   70 (316)
T d2ppqa1          23 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAA   70 (316)
T ss_dssp             EEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHH
T ss_pred             eecCCCCcccCeEEEEEC--CCcEEEEEcCCCCCHHHHHHHHHHHHhhhh
Confidence            345566666777887643  346899998653 44567888888888864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=90.00  E-value=0.045  Score=49.41  Aligned_cols=31  Identities=29%  Similarity=0.353  Sum_probs=25.7

Q ss_pred             CCCcccCCCCCcEEEecCCCcEEEEeccccee
Q psy3714          17 MGIMHRDVKPHNVMIDHENRKLRLIDWGLAEF   48 (467)
Q Consensus        17 ~~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~   48 (467)
                      .|+||.|+.++|++++. +..+-++||+.|..
T Consensus       183 ~giIHgDl~~dNvl~~~-~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLG-DELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEET-TEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhccc-ccceeEeccccccc
Confidence            58999999999999984 43557999998754

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=84.22  E-value=0.22  Score=43.05  Aligned_cols=30  Identities=20%  Similarity=0.339  Sum_probs=24.1

Q ss_pred             CCcccCCCCCcEEEecCCCcEEEEeccccee
Q psy3714          18 GIMHRDVKPHNVMIDHENRKLRLIDWGLAEF   48 (467)
Q Consensus        18 ~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~   48 (467)
                      .++|+|+.|.|||++ ++..+-|+||+.+..
T Consensus       184 ~l~HgD~~~~Nil~~-~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         184 VFSHGDLGDSNIFVK-DGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EEECSCCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred             EEEEeeccCcceeec-CCceEEEeechhccc
Confidence            489999999999998 443456999987754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=83.41  E-value=0.2  Score=43.11  Aligned_cols=30  Identities=27%  Similarity=0.356  Sum_probs=24.3

Q ss_pred             CCcccCCCCCcEEEecCCCcEEEEeccccee
Q psy3714          18 GIMHRDVKPHNVMIDHENRKLRLIDWGLAEF   48 (467)
Q Consensus        18 ~iiHrDlkp~Nil~~~~~~~~kl~dfG~a~~   48 (467)
                      .++|+|+.|.|||++. +..+-|+||+.+..
T Consensus       176 ~liHgD~~~~Nvl~~~-~~~~~iID~~~~~~  205 (255)
T d1nd4a_         176 VVTHGDACLPNIMVEN-GRFSGFIDCGRLGV  205 (255)
T ss_dssp             EEECSSCCGGGEEEET-TEEEEECCCTTCEE
T ss_pred             eEEeCCCCCcceEEeC-CceEEEEEchhccc
Confidence            4899999999999984 43567999987654